PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kipfer, S; Pirovino, C; El-Koussy, M; Nyffeler, T; Lukes, A; Muri, RM				Kipfer, Stefan; Pirovino, Christian; El-Koussy, Marwan; Nyffeler, Thomas; Lukes, Anton; Mueri, Rene M.			Dancing eyes and uvula after brain tumour extirpation-a sign of tumour progression?	LANCET			English	Editorial Material									[Kipfer, Stefan; Nyffeler, Thomas; Mueri, Rene M.] Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Pirovino, Christian] Univ Hosp Bern, Inselspital, Dept Otorhinolaryngol, CH-3010 Bern, Switzerland; [El-Koussy, Marwan] Univ Hosp Bern, Inselspital, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; Univ Bern, Bern, Switzerland; [Lukes, Anton] Lindenhofspital, Dept Neurosurg, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Kipfer, S (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, Freiburgstr 10, CH-3010 Bern, Switzerland.	s.kipfer@gmx.ch	Müri, René M/E-9320-2012	Müri, René M/0000-0001-6990-4188; Nyffeler, Thomas/0000-0003-2504-8935					0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 26	2012	379	9830					1983	1983		10.1016/S0140-6736(11)61612-7	http://dx.doi.org/10.1016/S0140-6736(11)61612-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22364663				2022-12-28	WOS:000304757700033
J	Hsu, J; Santesso, N; Mustafa, R; Brozek, J; Chen, YL; Hopkins, JP; Cheung, A; Hovhannisyan, G; Ivanova, L; Flottorp, SA; Saeterdal, I; Wong, AD; Tian, J; Uyeki, TM; Akl, EA; Alonso-Coello, P; Smaill, F; Schunemann, HJ				Hsu, Jonathan; Santesso, Nancy; Mustafa, Reem; Brozek, Jan; Chen, Yao Long; Hopkins, Jessica P.; Cheung, Adrienne; Hovhannisyan, Gayane; Ivanova, Liudmila; Flottorp, Signe A.; Saeterdal, Ingvil; Wong, Arthur D.; Tian, Jinhui; Uyeki, Timothy M.; Akl, Elie A.; Alonso-Coello, Pablo; Smaill, Fiona; Schuenemann, Holger J.			Antivirals for Treatment of Influenza A Systematic Review and Meta-analysis of Observational Studies	ANNALS OF INTERNAL MEDICINE			English	Review							H1N1 VIRUS-INFECTION; OSELTAMIVIR TREATMENT; SEASONAL INFLUENZA; ADULT PATIENTS; RISK-FACTORS; CLINICAL EFFECTIVENESS; HOSPITALIZED ADULTS; CHILDREN; OUTCOMES; COMPLICATIONS	Background: Systematic reviews of randomized, controlled trials in patients with influenza suggest a lack of evidence about the effects of antiviral therapy on several patient-important outcomes of influenza. Purpose: To systematically review observational studies for benefits and harms of oseltamivir, zanamivir, amantadine, or rimantadine in the treatment of influenza. Data Sources: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, SIGLE, the Chinese Biomedical Literature Database, Panteleimon, and LILACS up to November 2010; contact with pharmaceutical companies; and reference lists. Study Selection: Observational studies in any language that compared single antiviral therapy with no therapy or other antiviral therapy, or that had no comparator, for influenza or influenza-like illness. Data Extraction: Two independent investigators extracted data. Confidence in the estimates of the obtained effects (quality of evidence) was assessed by using the Grading of Recommendations Assessment, Development, and Evaluation approach. Data Synthesis: 74 studies fulfilled the inclusion criteria. Meta-analyses of the few studies providing effects with adjustment for confounders suggest that, in high-risk populations, oral oseltamivir may reduce mortality (odds ratio, 0.23 [95% CI, 0.13 to 0.43]; low-quality evidence), hospitalization (odds ratio, 0.75 [CI, 0.66 to 0.89]; low-quality evidence), and duration of symptoms (33 hours [CI, 21 to 45 hours]; very low-quality evidence) compared with no treatment. Earlier treatment with oseltamivir was generally associated with better outcomes. Inhaled zanamivir may lead to shorter symptom duration (23 hours [CI, 17 to 28 hours]; moderate-quality evidence) and fewer hospitalizations (odds ratio, 0.66 [CI, 0.37 to 1.18]) but more complications than no treatment. Direct comparison of oral oseltamivir and inhaled zanamivir suggests no important differences in key outcomes. Data from 1 study suggest that oral amantadine may reduce mortality and pneumonia associated with influenza A. No included study evaluated rimantadine. Limitations: Mortality was assessed in high-risk patients, and generalizability is limited. The overall body of evidence is limited by risk for confounding and selection, reporting, and publication bias. Conclusion: Therapy with oral oseltamivir and inhaled zanamivir may provide a net benefit over no treatment of influenza. However, as with the randomized trials, the confidence in the estimates of the effects for decision making is low to very low.	[Schuenemann, Holger J.] McMaster Univ, WHO Collaborating Ctr Evidence Informed Policy Ma, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 4K1, Canada; Lanzhou Univ, Evidence Based Med Ctr, Lanzhou, Gansu, Peoples R China; Niagara Reg Publ Hlth, Thorold, ON, Canada; Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; Univ Bergen, Bergen, Norway; Ctr Dis Control & Prevent, Atlanta, GA USA; SUNY Buffalo, Buffalo, NY 14260 USA; CIBERESP IIB Sant Pau, Iberoamer Cochrane Ctr, Barcelona, Spain	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Lanzhou University; Norwegian Knowledge Centre for Health Services; University of Bergen; Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Schunemann, HJ (corresponding author), McMaster Univ, WHO Collaborating Ctr Evidence Informed Policy Ma, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Room 2C16,1280 Main St W, Hamilton, ON L8N 4K1, Canada.	schuneh@mcmaster.ca	Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Akl, Elie A/0000-0002-3444-8618; Schunemann, Holger/0000-0003-3211-8479; Mustafa, Reem/0000-0002-2091-0875; Flottorp, Signe/0000-0003-2961-7461; Alonso-Coello, Pablo/0000-0002-8001-8504	World Health Organization; McMaster University; Faculty of Health Sciences of McMaster University	World Health Organization(World Health Organization); McMaster University; Faculty of Health Sciences of McMaster University	World Health Organization and McMaster University.; By agreement I2-APW-223 from the World Health Organization and by the Faculty of Health Sciences of McMaster University (internal grant to McMaster Healthcare Grading and Recommendations Center).	[Anonymous], 2010, WHO GUID PHARM MAN P; Barr CE, 2007, CURR MED RES OPIN, V23, P523, DOI 10.1185/030079906X167499; Blumentals William A, 2007, MedGenMed, V9, P23; Blumentals WA, 2007, CURR MED RES OPIN, V23, P2961, DOI 10.1185/030079907X242520; Casscells SW, 2009, CIRC-CARDIOVASC QUAL, V2, P108, DOI 10.1161/CIRCOUTCOMES.108.820357; Chemaly RF, 2007, CLIN INFECT DIS, V44, P964, DOI 10.1086/512374; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; Chien YS, 2010, J INFECTION, V60, P168, DOI 10.1016/j.jinf.2009.12.012; Chitnis Amit S, 2010, WMJ, V109, P201; Coffin SE, 2011, PEDIATR INFECT DIS J, V30, P962, DOI 10.1097/INF.0b013e318232ede9; Cole JA, 2002, CLIN THER, V24, P1824; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Cui W, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-145; Dharan NJ, 2010, CLIN INFECT DIS, V50, P621, DOI 10.1086/650178; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Enger C, 2004, PHARMACOEPIDEM DR S, V13, P227, DOI 10.1002/pds.845; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; GAGARINOVA VM, 1983, ZH MIKROB EPID IMMUN, P60; Galvao M.G. Alves, 2012, COCHRANE DB SYST REV, V1; Gums JG, 2008, EXPERT OPIN PHARMACO, V9, P151, DOI 10.1517/14656566.9.2.151 ; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Harvala H, 2010, EURO SURVEILL, V15; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hien ND, 2009, EMERG INFECT DIS, V15, P19, DOI 10.3201/eid1501.080073; Hien Tran Tinh, 2010, PLoS Med, V7, pe1000277, DOI 10.1371/journal.pmed.1000277; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Huang YC, 2009, PEDIATR INFECT DIS J, V28, P647, DOI 10.1097/INF.0b013e3181986bf9; Hurt AC, 2011, LANCET INFECT DIS; Hurt AC, 2011, NEW ENGL J MED, V365, P2541, DOI 10.1056/NEJMc1111078; Imamura Takashi, 2003, Kansenshogaku Zasshi, V77, P971; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub3; Johnson R, 2000, CLIN DRUG INVEST, V20, P327, DOI 10.2165/00044011-200020050-00004; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kawai N, 2005, CLIN INFECT DIS, V40, P1309, DOI 10.1086/429241; Kawai Naoki, 2007, Journal of Infection and Chemotherapy, V13, P314, DOI 10.1007/s10156-007-0538-3; Kawai N, 2008, J INFECTION, V56, P51, DOI 10.1016/j.jinf.2007.09.002; Kawai N, 2006, CLIN INFECT DIS, V43, P439, DOI 10.1086/505868; Kawai N, 2009, J INFECTION, V59, P207, DOI 10.1016/j.jinf.2009.07.002; KOMIYA N, 2009, EURO SURVEILL, V14; Kumar D, 2010, LANCET INFECT DIS, V10, P521, DOI 10.1016/S1473-3099(10)70133-X; Lee CS, 2010, CLIN MICROBIOL INFEC, V16, P389, DOI 10.1111/j.1469-0691.2010.03117.x; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Lee N, 2007, ANTIVIR THER, V12, P501; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Libow LS, 1996, J AM GERIATR SOC, V44, P1153, DOI 10.1111/j.1532-5415.1996.tb01363.x; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Machado CM, 2003, BONE MARROW TRANSPL, V31, P695, DOI 10.1038/sj.bmt.1703900; Madjid M, 2009, CARDIOLOGY, V113, P98, DOI 10.1159/000172796; McGeer A, 2009, CLIN MICROBIOL INFEC, V15, pS26; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; McLean E, 2010, EPIDEMIOL INFECT, V138, P1531, DOI 10.1017/S0950268810001366; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Nordstrom BL, 2005, CURR MED RES OPIN, V21, P761, DOI 10.1185/030079905X46214; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Orzeck EA, 2007, CLIN THER, V29, P2246, DOI 10.1016/j.clinthera.2007.10.001; Peters Patrick H, 2008, Medscape J Med, V10, P131; Piedra PA, 2009, PEDIATRICS, V124, P170, DOI 10.1542/peds.2008-0977; Rabagliati R, 2004, REV MED CHILE, V132, P317; Rodriguez A, 2010, INTENS CARE MED, V36, pS136; Saito R, 2003, J CLIN MICROBIOL, V41, P2164, DOI 10.1128/JCM.41.5.2164-2165.2003; Saito R, 2010, PEDIATR INFECT DIS J, V29, P898, DOI 10.1097/INF.0b013e3181de9d24; Sato M, 2008, TOHOKU J EXP MED, V214, P113, DOI 10.1620/tjem.214.113; Schunemann H, 2011, STRUNGMANN FORUM REP, P83; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; SHADRIN AS, 1980, SOV MEDITISINA, P103; Shen YZ, 2010, EMERG INFECT DIS, V16, P1011, DOI 10.3201/eid1606.090991; Silagy C, 2000, CLIN DRUG INVEST, V19, P111, DOI 10.2165/00044011-200019020-00004; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; Smith JR, 2009, INT J CLIN PRACT, V63, P596, DOI 10.1111/j.1742-1241.2009.02010.x; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Subramony H, 2010, ANN ACAD MED SINGAP, V39, P283; Sugaya N, 2008, CLIN INFECT DIS, V47, P339, DOI 10.1086/589748; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; The GRADE Working Group, 2019, GRADE HDB GRADING QU; Tramontana AR, 2010, EMERG INFECT DIS, V16, P1068, DOI 10.3201/eid1607.091691; Tsalik EL, 2010, J CLIN VIROL, V47, P286, DOI 10.1016/j.jcv.2009.12.012; Viasus D, 2011, CLIN MICROBIOL INFEC, V17, P738, DOI 10.1111/j.1469-0691.2010.03362.x; Viasus D, 2011, CHEST, V140, P1025, DOI 10.1378/chest.10-2792; Wang K, 2012, COCHRANE DB SYST REV, V1; World Health Organization, 2005, STAT ART VACC RES DE; Xi XM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-256; Yamagishi T, 2010, JPN J INFECT DIS, V63, P327; Yang P, 2010, J INFECTION, V61, P277, DOI 10.1016/j.jinf.2010.07.010; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Yu HJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4779	93	188	204	1	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					512	U95		10.7326/0003-4819-156-7-201204030-00411	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00411			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921GP	22371849	Green Accepted			2022-12-28	WOS:000302466400005
J	Hotta, K; Chen, X; Paton, RS; Minami, A; Li, H; Swaminathan, K; Mathews, II; Watanabe, K; Oikawa, H; Houk, KN; Kim, CY				Hotta, Kinya; Chen, Xi; Paton, Robert S.; Minami, Atsushi; Li, Hao; Swaminathan, Kunchithapadam; Mathews, Irimpan I.; Watanabe, Kenji; Oikawa, Hideaki; Houk, Kendall N.; Kim, Chu-Young			Enzymatic catalysis of anti-Baldwin ring closure in polyether biosynthesis	NATURE			English	Article							GENE-CLUSTER; EPOXIDE HYDROLASE; ANTIBIOTIC-STRUCTURE; ACTIVE-SITE; INSIGHTS; MODEL; CRYSTALLOGRAPHY; ISOMERASE; ENERGY; RULES	Polycyclic polyether natural products have fascinated chemists and biologists alike owing to their useful biological activity, highly complex structure and intriguing biosynthetic mechanisms. Following the original proposal for the polyepoxide origin of lasalocid and isolasalocid(1) and the experimental determination of the origins of the oxygen and carbon atoms of both lasalocid and monensin, a unified stereochemical model for the biosynthesis of polyether ionophore antibiotics was proposed(2). The model was based on a cascade of nucleophilic ring closures of postulated polyepoxide substrates generated by stereospecific oxidation of all-trans polyene polyketide intermediates(2). Shortly thereafter, a related model was proposed for the biogenesis of marine ladder toxins, involving a series of nominally disfavoured anti-Baldwin, endo-tet epoxide-ring-opening reactions(3-5). Recently, we identified Lsd19 from the Streptomyces lasaliensis gene cluster as the epoxide hydrolase responsible for the epoxide-opening cyclization of bisepoxyprelasalocid A(6) to form lasalocid A(7,8). Here we report the X-ray crystal structure of Lsd19 in complex with its substrate and product analogue(9) to provide the first atomic structure-to our knowledge-of a natural enzyme capable of catalysing the disfavoured epoxide-opening cyclic ether formation. On the basis of our structural and computational studies, we propose a general mechanism for the enzymatic catalysis of polyether natural product biosynthesis.	[Hotta, Kinya; Chen, Xi; Li, Hao; Swaminathan, Kunchithapadam; Kim, Chu-Young] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Paton, Robert S.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Minami, Atsushi; Oikawa, Hideaki] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan; [Mathews, Irimpan I.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 95124 USA; [Watanabe, Kenji] Univ Shizuoka, Grad Sch Pharmaceut Sci, Div Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan; [Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	National University of Singapore; University of Oxford; Hokkaido University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Shizuoka; University of California System; University of California Los Angeles	Kim, CY (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	chuyoung@nus.edu.sg	Hotta, Kinya/A-2574-2009; Watanabe, Kenji/N-2012-2015; Paton, Robert/A-4564-2010; Minami, Atsushi/A-4314-2012; Oikawa, Hideaki/F-9128-2012; Kim, Chu-Young/D-8849-2012; kikuchi, sachiko/G-5650-2012	Hotta, Kinya/0000-0002-9427-0081; Watanabe, Kenji/0000-0002-0463-4831; Paton, Robert/0000-0002-0104-4166; Minami, Atsushi/0000-0002-4183-0268; Oikawa, Hideaki/0000-0002-6947-3397; Kim, Chu-Young/0000-0003-3744-7802; 	Royal Commission; Fulbright-AstraZeneca; Japan Society for the Promotion of Science [LS103]; National Institutes of Health [GM075962]; MEXT [22108002]; National University of Singapore Life Sciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075962] Funding Source: NIH RePORTER	Royal Commission; Fulbright-AstraZeneca(AstraZeneca); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National University of Singapore Life Sciences Institute(National University of Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Royal Commission for the Exhibition of 1851 and Fulbright-AstraZeneca Research Fellowship (R.S.P.), the Japan Society for the Promotion of Science (No. LS103) (K.W.), the National Institutes of Health grant GM075962 (K.N.H.), the MEXT research grant on innovative area 22108002 (H.O.), and the National University of Singapore Life Sciences Institute Young Investigator Award (C.-Y.K.). Data collection was performed at the Stanford Synchrotron Radiation Lightsource. We thank D. W. Christianson, D. Hilvert and C. Khosla for critical reading and discussion of the manuscript.	BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P734, DOI 10.1039/c39760000734; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CANE DE, 1983, J AM CHEM SOC, V105, P3594, DOI 10.1021/ja00349a040; Demydchuk Y, 2008, CHEMBIOCHEM, V9, P1136, DOI 10.1002/cbic.200700715; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gilmore K, 2011, CHEM REV, V111, P6513, DOI 10.1021/cr200164y; Grimme S, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2148954; Gruber K, 1999, BIOCHEMISTRY-US, V38, P7062, DOI 10.1021/bi990210s; Ha NC, 2000, J BIOL CHEM, V275, P41100, DOI 10.1074/jbc.M007561200; Ha NC, 2001, CURR OPIN STRUC BIOL, V11, P674, DOI 10.1016/S0959-440X(01)00268-8; Harvey BM, 2007, CHEM BIOL, V14, P703, DOI 10.1016/j.chembiol.2007.05.011; Hopmann KH, 2005, J AM CHEM SOC, V127, P14339, DOI 10.1021/ja050940p; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim DH, 2000, BIOCHEMISTRY-US, V39, P4581, DOI 10.1021/bi992119u; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leadlay PF, 2001, J IND MICROBIOL BIOT, V27, P360, DOI 10.1038/sj.jim.7000204; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Migita A, 2009, BIOSCI BIOTECH BIOCH, V73, P169, DOI 10.1271/bbb.80631; Minami A, 2011, ORG LETT, V13, P1638, DOI 10.1021/ol200100e; NA J, 1993, J AM CHEM SOC, V115, P8453, DOI 10.1021/ja00071a067; NAKANISHI K, 1985, TOXICON, V23, P473, DOI 10.1016/0041-0101(85)90031-5; Nakata T, 2005, CHEM REV, V105, P4314, DOI 10.1021/cr040627q; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Shichijo Y, 2008, J AM CHEM SOC, V130, P12230, DOI 10.1021/ja8040543; Smith L, 2008, CHEMBIOCHEM, V9, P2967, DOI 10.1002/cbic.200800585; Sun YH, 2003, CHEM BIOL, V10, P431, DOI 10.1016/S1074-5521(03)00092-9; TOUHARA K, 1993, J BIOL CHEM, V268, P19604; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van der Werf MJ, 1998, J BACTERIOL, V180, P5052, DOI 10.1128/JB.180.19.5052-5057.1998; WESTLEY JW, 1974, J ANTIBIOT, V27, P597, DOI 10.7164/antibiotics.27.597; WESTLEY JW, 1986, J NAT PROD, V49, P35, DOI 10.1021/np50043a003; Zhang X, 2008, J ORG CHEM, V73, P889, DOI 10.1021/jo701974n	37	79	80	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					355	U154		10.1038/nature10865	http://dx.doi.org/10.1038/nature10865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22388816	Green Accepted			2022-12-28	WOS:000301481800054
J	Kim, SE; Coste, B; Chadha, A; Cook, B; Patapoutian, A				Kim, Sung Eun; Coste, Bertrand; Chadha, Abhishek; Cook, Boaz; Patapoutian, Ardem			The role of Drosophila Piezo in mechanical nociception	NATURE			English	Article							MECHANOSENSORY TRANSDUCTION; SENSORY NEURONS; CHANNEL; MECHANOTRANSDUCTION; LOCOMOTION; SUBUNITS; HEARING	Transduction of mechanical stimuli by receptor cells is essential for senses such as hearing, touch and pain(1-4). Ion channels have a role in neuronal mechanotransduction in invertebrates(1); however, functional conservation of these ion channels in mammalian mechanotransduction is not observed. For example, no mechanoreceptor potential C (NOMPC), a member of transient receptor potential (TRP) ion channel family, acts as a mechanotransducer in Drosophila melanogaster(5) and Caenorhabditis elegans(6,7); however, it has no orthologues in mammals. Degenerin/epithelial sodium channel (DEG/ENaC) family members are mechanotransducers in C. elegans(8) and potentially in D. melanogaster(9); however, a direct role of its mammalian homologues in sensing mechanical force has not been shown. Recently, Piezo1 (also known as Fam38a) and Piezo2 (also known as Fam38b) were identified as components of mechanically activated channels in mammals(10). The Piezo family are evolutionarily conserved transmembrane proteins. It is unknown whether they function in mechanical sensing in vivo and, if they do, which mechanosensory modalities they mediate. Here we study the physiological role of the single Piezo member in D. melanogaster (Dmpiezo; also known as CG8486). Dmpiezo expression in human cells induces mechanically activated currents, similar to its mammalian counterparts(11). Behavioural responses to noxious mechanical stimuli were severely reduced in Dmpiezo knockout larvae, whereas responses to another noxious stimulus or touch were not affected. Knocking down Dmpiezo in sensory neurons that mediate nociception and express the DEG/ENaC ion channel pickpocket (ppk) was sufficient to impair responses to noxious mechanical stimuli. Furthermore, expression of Dmpiezo in these same neurons rescued the phenotype of the constitutive Dmpiezo knockout larvae. Accordingly, electrophysiological recordings from ppk-positive neurons revealed a Dmpiezo-dependent, mechanically activated current. Finally, we found that Dmpiezo and ppk function in parallel pathways in ppk-positive cells, and that mechanical nociception is abolished in the absence of both channels. These data demonstrate the physiological relevance of the Piezo family in mechanotransduction in vivo, supporting a role of Piezo proteins in mechanosensory nociception.	[Kim, Sung Eun; Coste, Bertrand; Chadha, Abhishek; Cook, Boaz; Patapoutian, Ardem] Scripps Res Inst TSRI, Dorris Neurosci Ctr, Dept Cell Biol, La Jolla, CA 92037 USA; [Patapoutian, Ardem] Novartis Res Fdn GNF, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Cook, B (corresponding author), Scripps Res Inst TSRI, Dorris Neurosci Ctr, Dept Cell Biol, La Jolla, CA 92037 USA.	bcook@scripps.edu; apatapou@gnf.org	KIM, SUNG EUN/E-4918-2011	Coste, Bertrand/0000-0002-0163-2494	National Institutes of Health; Novartis Research Foundation; Skaggs Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; Skaggs Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Y. N. Jan of the University of California San Francisco for providing ppk-EGFP5. Research was support by the National Institutes of Health and Novartis Research Foundation. S.E.K. and A.C. are supported by the Skaggs Institute.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Caldwell JC, 2003, P NATL ACAD SCI USA, V100, P16053, DOI 10.1073/pnas.2535546100; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	21	288	303	9	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					209	212		10.1038/nature10801	http://dx.doi.org/10.1038/nature10801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22343891	Green Accepted			2022-12-28	WOS:000301174900038
J	Touboul, M; Puchtel, IS; Walker, RJ				Touboul, Mathieu; Puchtel, Igor S.; Walker, Richard J.			W-182 Evidence for Long-Term Preservation of Early Mantle Differentiation Products	SCIENCE			English	Article							TUNGSTEN ISOTOPIC COMPOSITION; HF-W CHRONOMETRY; CORE FORMATION; EARTHS MANTLE; METAMORPHOSED SEDIMENTS; BARBERTON KOMATIITES; TERRESTRIAL PLANETS; TRACE-ELEMENTS; BALTIC SHIELD; RE-OS	Late accretion, early mantle differentiation, and core-mantle interaction are processes that could have created subtle W-182 isotopic heterogeneities within Earth's mantle. Tungsten isotopic data for Kostomuksha komatiites dated at 2.8 billion years ago show a well-resolved W-182 excess relative to modern terrestrial samples, whereas data for Komati komatiites dated at 3.5 billion years ago show no such excess. Combined W-182, Os-186,Os-187, and Nd-142,Nd-143 isotopic data indicate that the mantle source of the Kostomuksha komatiites included material from a primordial reservoir that represents either a deep mantle region that underwent metal-silicate equilibration or a product of large-scale magmatic differentiation of the mantle. The preservation, until at least 2.8 billion years ago, of this reservoir-which likely formed within the first 30 million years of solar system history-indicates that the mantle may have never been well mixed.	[Touboul, Mathieu; Puchtel, Igor S.; Walker, Richard J.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Touboul, M (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	mtouboul@umd.edu	Walker, Richard/K-6869-2016	Walker, Richard/0000-0003-0348-2407	NSF [0757808]; Division Of Earth Sciences [0946629, 0757808] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by NSF Cooperative Studies of Earth's Deep Interior grant 0757808. We thank J. Day for providing the La Palma basalt, and T. Kleine and one anonymous reviewer for their thorough and constructive reviews. Methods and detailed data are presented in the supporting online material.	Arevalo R, 2008, EARTH PLANET SC LETT, V272, P656, DOI 10.1016/j.epsl.2008.05.031; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; Bennett VC, 2007, SCIENCE, V318, P1907, DOI 10.1126/science.1145928; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; Chavagnac V, 2004, LITHOS, V75, P253, DOI 10.1016/j.lithos.2004.03.001; Corgne A, 2005, GEOCHIM COSMOCHIM AC, V69, P485, DOI 10.1016/j.gca.2004.06.041; Dalrymple G. B., 1996, LUNAR PLANET SCI, V27, P285; DePaolo D. J., 1981, Evolution of the Earth, P59, DOI 10.1029/GD005p0059; Frei R, 2004, GEOCHIM COSMOCHIM AC, V68, P1645, DOI 10.1016/j.gca.2003.10.009; GOLDSTEIN SL, 1984, EARTH PLANET SC LETT, V70, P221, DOI 10.1016/0012-821X(84)90007-4; Harper CL, 1996, GEOCHIM COSMOCHIM AC, V60, P1131, DOI 10.1016/0016-7037(96)00027-0; Horan MF, 1998, GEOCHIM COSMOCHIM AC, V62, P545, DOI 10.1016/S0016-7037(97)00368-2; Iizuka T, 2010, EARTH PLANET SC LETT, V291, P189, DOI 10.1016/j.epsl.2010.01.012; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Lee DC, 2000, SCIENCE, V288, P1629, DOI 10.1126/science.288.5471.1629; Maier WD, 2009, NATURE, V460, P620, DOI 10.1038/nature08205; MITCHELL RH, 1981, GEOCHIM COSMOCHIM AC, V45, P2425, DOI 10.1016/0016-7037(81)90096-X; MORGAN JW, 1981, TECTONOPHYSICS, V75, P47, DOI 10.1016/0040-1951(81)90209-2; MORGAN JW, 1967, EARTH PLANET SC LETT, V3, P219, DOI 10.1016/0012-821X(67)90041-6; Moynier F, 2010, P NATL ACAD SCI USA, V107, P10810, DOI 10.1073/pnas.0913605107; Palme H., 1981, P LUNAR PLANET SCI, V12B, P949; Puchtel IS, 2010, GEOCHIM COSMOCHIM AC, V74, pA834; Puchtel I. S., 2005, EARTH PLANET SC LETT, V206, P411; Puchtel IS, 2005, GEOCHIM COSMOCHIM AC, V69, P1607, DOI 10.1016/j.gca.2004.09.007; Puchtel IS, 1998, EARTH PLANET SC LETT, V155, P57, DOI 10.1016/S0012-821X(97)00202-1; Righter K, 2003, GEOCHIM COSMOCHIM AC, V67, P2497, DOI 10.1016/S0016-7037(02)01349-2; RINGWOOD AE, 1966, GEOCHIM COSMOCHIM AC, V30, P41, DOI 10.1016/0016-7037(66)90090-1; Schersten A, 2004, NATURE, V427, P234, DOI 10.1038/nature02221; Schoenberg R, 2002, NATURE, V418, P403, DOI 10.1038/nature00923; Shirey SB, 1998, ANNU REV EARTH PL SC, V26, P423, DOI 10.1146/annurev.earth.26.1.423; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Touboul M, 2012, INT J MASS SPECTROM, V309, P109, DOI 10.1016/j.ijms.2011.08.033; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Walter M., 2000, ORIGIN EARTH MOON, P265; WALTER MJ, 1995, SCIENCE, V270, P1186, DOI 10.1126/science.270.5239.1186; Willbold M, 2011, NATURE, V477, P195, DOI 10.1038/nature10399; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	41	172	176	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1065	1069		10.1126/science.1216351	http://dx.doi.org/10.1126/science.1216351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22345398				2022-12-28	WOS:000300931100037
J	Shevde, N				Shevde, Nirupama			STEM CELLS Flexible friends	NATURE			English	Editorial Material							PATIENT		Morgridge Inst Res Madison, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.	Shevde, N (corresponding author), Morgridge Inst Res Madison, Madison, WI USA.	rshevde@morgridgeinstitue.org						Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	4	12	20	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					S22	S26		10.1038/483S22a	http://dx.doi.org/10.1038/483S22a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900HP	22378125	Bronze			2022-12-28	WOS:000300877900009
J	Primack, BA				Primack, Brian A.			Review: Minimal interventions (e.g., a letter) reduce long-term benzodiazepine use in primary care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Primack, BA (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.		McGuire, Treasure Madeleine/O-1427-2017; Glasziou, Paul/A-7832-2008	McGuire, Treasure Madeleine/0000-0003-1417-7037; Glasziou, Paul/0000-0001-7564-073X	NCI NIH HHS [K07 CA114315] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA114315] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		National Drug Intelligence Center, 2002, INF BRIEF PRESCR DRU; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2011, TEDS REP SUBST AB TR	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-8	10.7326/0003-4819-156-4-201202210-02008	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351734	Green Accepted			2022-12-28	WOS:000208885400007
J	Tollefson, TT; Larrabee, WF				Tollefson, Travis T.; Larrabee, Wayne F., Jr.			Global Surgical Initiatives to Reduce the Surgical Burden of Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURGERY		[Larrabee, Wayne F., Jr.] Univ Washington, Larrabee Ctr, Seattle, WA 98122 USA; [Tollefson, Travis T.] Univ Calif Davis, Dept Otolaryngol Head & Neck Surg, Davis, CA 95616 USA	University of Washington; University of Washington Seattle; University of California System; University of California Davis	Larrabee, WF (corresponding author), Univ Washington, Larrabee Ctr, 600 Broadway,Ste 280, Seattle, WA 98122 USA.	larrabee@uw.edu		Tollefson, Travis T/0000-0002-8658-8647				Bae JY, 2011, B WORLD HEALTH ORGAN, V89, P395, DOI 10.2471/BLT.11.088229; Bickler S, 2010, WORLD J SURG, V34, P374, DOI 10.1007/s00268-009-0261-6; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Duba RB, 2007, B AM COLL SURG, V92, P35; Duba Rosemay B, 2007, Bull Am Coll Surg, V92, P12; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Gosselin RA, 2008, WORLD J SURG, V32, P2450, DOI 10.1007/s00268-008-9708-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Ozgediz Doruk, 2009, Bull Am Coll Surg, V94, P14; Ozgediz D, 2009, WORLD J SURG, V33, P1, DOI 10.1007/s00268-008-9799-y; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	11	40	40	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					667	668		10.1001/jama.2012.158	http://dx.doi.org/10.1001/jama.2012.158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22337675				2022-12-28	WOS:000300278500020
J	Brenner, B; Avivi, I; Lishner, M				Brenner, Benjamin; Avivi, Irit; Lishner, Michael			Haematological cancers in pregnancy	LANCET			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; NON-HODGKINS-LYMPHOMA; ACUTE PROMYELOCYTIC LEUKEMIA; PRIMARY BREAST LYMPHOMA; ESSENTIAL THROMBOCYTHEMIA; INTERFERON-ALPHA; CHEMOTHERAPEUTIC-AGENTS; MULTIPLE-MYELOMA; IMATINIB THERAPY	Haematological cancer in pregnancy, although rare, poses a substantial risk to both mother and fetus. Hodgkin's lymphoma is the most common, followed by non-Hodgkin lymphoma and acute leukaemia. Diagnosis of haematological cancers is challenged by an overlap of the disease and gestation-related symptoms and limitations of imaging studies in pregnancy. Data for safety and effectiveness of therapy are scarce and mostly retrospective. This report provides updated guidance for management, focusing on chemotherapy and biological agents. The primary goal of treatment is to preserve the mother's health; hence, pregnancy termination is often advisable at early stages, allowing delivery of adequate therapy. However, at later gestational stages treatment is often feasible. Pregnancy-related hypercoagulability, augmented by cancer, often necessitates thromboprophylaxis. The consequences and complex management of haematological cancer during pregnancy emphasise the need for collaborative research, focusing on basic mechanisms of disease and prospective epidemiological studies.	[Brenner, Benjamin; Avivi, Irit] Technion Israel Inst Technol, Dept Hematol & Bone Marrow Transplantat, IL-31096 Haifa, Israel; [Brenner, Benjamin; Avivi, Irit] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Lishner, Michael] Meir Med Ctr, Dept Med, Kefar Sava, Israel; [Lishner, Michael] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Brenner, B (corresponding author), Technion Israel Inst Technol, Dept Hematol & Bone Marrow Transplantat, Rambam Hlth Care Campus, IL-31096 Haifa, Israel.	b_brenner@rambam.health.gov.il						Abadi U, 2011, HEMATOL ONCOL CLIN N, V25, P277, DOI 10.1016/j.hoc.2011.01.001; Achtari C, 2000, AM J OBSTET GYNECOL, V183, P511, DOI 10.1067/mob.2000.105964; Aharon A, 2009, BEST PRACT RES CL HA, V22, P61, DOI 10.1016/j.beha.2008.11.002; Ali R, 2005, LEUKEMIA RES, V29, P971, DOI 10.1016/j.leukres.2005.01.009; Ali R, 2004, JPN J CLIN ONCOL, V34, P215, DOI 10.1093/jjco/hyh038; Apperley J, 2009, BEST PRACT RES CL HA, V22, P455, DOI 10.1016/j.beha.2009.09.008; Ault P, 2006, J CLIN ONCOL, V24, P1204, DOI 10.1200/JCO.2005.04.6557; Aviles A, 2006, ANN ONCOL, V17, P286, DOI 10.1093/annonc/mdj053; Aviles A, 2001, CLIN LYMPHOMA, V2, P173, DOI 10.3816/CLM.2001.n.023; Azim HA, 2010, EXPERT REV CLIN IMMU, V6, P821, DOI [10.1586/eci.10.77, 10.1586/ECI.10.77]; Azim HA, 2010, CANCER TREAT REV, V36, P110, DOI 10.1016/j.ctrv.2009.11.004; Barbui T, 2004, HAEMATOLOGICA, V89, P215; Barbui T, 2011, CURR HEMATOL MALIG R, V6, P28, DOI 10.1007/s11899-010-0073-7; Bartlett RM, 2010, J NUCL MED, V51, P288, DOI 10.2967/jnumed.109.068734; BAZARBASHI MS, 1991, AM J HEMATOL, V38, P235, DOI 10.1002/ajh.2830380316; BROCCIA G, 1984, TUMORI, V70, P371, DOI 10.1177/030089168407000412; Burchert A, 2010, J CLIN ONCOL, V28, P1429, DOI 10.1200/JCO.2009.25.5075; Bwire R, 2011, EXPERT OPIN DRUG SAF, V10, P3, DOI 10.1517/14740338.2011.527331; Cardonick E, 2010, CANCER J, V16, P76, DOI 10.1097/PPO.0b013e3181ce46f9; Cardonick E, 2010, AM J CLIN ONCOL-CANC, V33, P221, DOI 10.1097/COC.0b013e3181a44ca9; Chakravarty EF, 2011, BLOOD, V117, P1499, DOI 10.1182/blood-2010-07-295444; Chelghoum Y, 2005, CANCER-AM CANCER SOC, V104, P110, DOI 10.1002/cncr.21137; Cohen-Kerem R, 2005, AM J SURG, V190, P467, DOI 10.1016/j.amjsurg.2005.03.033; Cole S, 2009, CLIN LYMPHOMA MYELOM, V9, P324, DOI 10.3816/CLM.2009.n.064; Conchon M, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-42; Connors Joseph M, 2008, Hematology Am Soc Hematol Educ Program, P334, DOI 10.1182/asheducation-2008.1.334; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Cortes JE, 2008, BLOOD, V112, P284; Dale DC, 2003, AM J HEMATOL, V72, P82, DOI 10.1002/ajh.10255; Davis SM, 2010, OBSTET GYN CLIN N AM, V37, P333, DOI 10.1016/j.ogc.2010.02.004; Djokanovic N, 2008, J OBSTET GYNAECOL CA, V30, P1146, DOI 10.1016/S1701-2163(16)34026-9; Einarson A, 2004, BJOG-INT J OBSTET GY, V111, P940, DOI 10.1111/j.1471-0528.2004.00236.x; Einarson A, 2001, Paediatr Drugs, V3, P803, DOI 10.2165/00128072-200103110-00003; Einarson A, 2007, CAN FAM PHYSICIAN, V53, P1412; Elliott MA, 2003, BEST PRACT RES CL HA, V16, P227, DOI 10.1016/S1521-6926(03)00019-7; FITZGERALD D, 1986, AM J HEMATOL, V22, P213, DOI 10.1002/ajh.2830220213; Forthman CL, 2004, J BONE JOINT SURG AM, V86A, P1284, DOI 10.2106/00004623-200406000-00023; Froesch P., 2008, V178, P111; Gangat N, 2009, EUR J HAEMATOL, V82, P350, DOI 10.1111/j.1600-0609.2009.01214.x; Giagounidis AAN, 2000, EUR J HAEMATOL, V64, P267, DOI 10.1034/j.1600-0609.2000.9c118.x; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Griesshammer M, 2006, SEMIN THROMB HEMOST, V32, P422, DOI 10.1055/s-2006-942763; HAAS JF, 1984, INT J CANCER, V34, P229, DOI 10.1002/ijc.2910340214; Harrison C, 2005, BRIT J HAEMATOL, V129, P293, DOI 10.1111/j.1365-2141.2005.05400.x; Heartin E, 2004, LEUKEMIA LYMPHOMA, V45, P1307, DOI 10.1080/10428190310001645195; Hurley TJ, 2005, OBSTET GYN CLIN N AM, V32, P595, DOI 10.1016/j.ogc.2005.08.008; Kal HB, 2005, LANCET ONCOL, V6, P328, DOI 10.1016/S1470-2045(05)70169-8; Kasenda B, 2011, CL LYMPH MYELOM LEUK, V11, P190, DOI 10.1016/j.clml.2011.03.009; Kirkpatrick AW, 1996, CAN J SURG, V39, P333; Kitawaki T, 1998, INTERNAL MED, V37, P311, DOI 10.2169/internalmedicine.37.311; Koren G, 1998, NEW ENGL J MED, V338, P1128, DOI 10.1056/NEJM199804163381607; Koren G, 2005, MOTHERISK GUIDE CANC; LISHNER M, 1992, BRIT J CANCER, V65, P114, DOI 10.1038/bjc.1992.21; Martinelli P, 2004, AM J OBSTET GYNECOL, V191, P2016, DOI 10.1016/j.ajog.2004.05.001; Maruko K, 2004, AM J OBSTET GYNECOL, V191, P380, DOI 10.1016/j.ajog.2003.12.036; Matalon ST, 2005, HUM REPROD, V20, P1390, DOI 10.1093/humrep/deh721; Matok I, 2009, NEW ENGL J MED, V360, P2528, DOI 10.1056/NEJMoa0807154; Mauro MJ, 2004, LEUKEMIA RES, V28, pS71, DOI 10.1016/j.leukres.2003.10.017; MeguerianBedoyan Z, 1997, AM J SURG PATHOL, V21, P1236, DOI 10.1097/00000478-199710000-00016; Muhler MR, 2011, RADIOLOGY, V258, P455, DOI 10.1148/radiol.10100652; Muller AMS, 2005, ANN HEMATOL, V84, P1, DOI 10.1007/s00277-004-0939-7; Nadir Y, 2010, THROMB RES, V126, pE444, DOI 10.1016/j.thromres.2010.09.007; Nadir Y, 2009, BEST PRACT RES CL HA, V22, P85, DOI 10.1016/j.beha.2008.12.004; Nulman I, 2001, BRIT J CANCER, V85, P1611, DOI 10.1054/bjoc.2001.2090; Oto A, 2007, AM J PERINAT, V24, P243, DOI 10.1055/s-2007-973444; PACIFICI GM, 1995, CLIN PHARMACOKINET, V28, P235, DOI 10.2165/00003088-199528030-00005; Passamonti F, 2007, BLOOD, V110, P485, DOI 10.1182/blood-2007-01-071068; Pavlidis NA, 2002, ONCOLOGIST, V7, P279; Pereg D., 2008, V178, P21; Pereg D, 2008, MATERNAL FETAL EFF E; Pereg D, 2008, CANCER TREAT REV, V34, P302, DOI 10.1016/j.ctrv.2008.01.002; Pereg D, 2007, HAEMATOLOGICA, V92, P1230, DOI 10.3324/haematol.11097; POLLACK RN, 1993, OBSTET GYNECOL, V81, P856; Pye SM, 2008, BLOOD, V111, P5505, DOI 10.1182/blood-2007-10-114900; Rizack T, 2009, AM J HEMATOL, V84, P830, DOI 10.1002/ajh.21547; ROUMEN FJME, 1990, OBSTET GYNECOL, V75, P527; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Seror J, 2009, FETAL DIAGN THER, V25, P136, DOI 10.1159/000207555; Shapira T, 2008, BLOOD REV, V22, P247, DOI 10.1016/j.blre.2008.03.006; SHELLOCK FG, 1991, JMRI-J MAGN RESON IM, V1, P97, DOI 10.1002/jmri.1880010114; Sherer DM, 2004, AM J PERINAT, V21, P223, DOI 10.1055/s-2004-828613; Shulman LN, 2008, NEW ENGL J MED, V358, P513, DOI 10.1056/NEJMcpc0707921; Siu BL, 2002, INT J GYNECOL CANCER, V12, P399, DOI 10.1046/j.1525-1438.2002.01128.x; So M, 2010, CAN FAM PHYSICIAN, V56, P427; Sorosky JI, 1997, OBSTET GYN CLIN N AM, V24, P591, DOI 10.1016/S0889-8545(05)70324-7; STEWART HL, 1952, AM J OBSTET GYNECOL, V63, P570; Tallman Martin S, 2005, Leuk Res, V29, P347, DOI 10.1016/j.leukres.2004.04.021; TSUJIMURA T, 1993, ARCH PATHOL LAB MED, V117, P325; Van Calsteren K, 2010, GYNECOL ONCOL, V119, P594, DOI 10.1016/j.ygyno.2010.08.019; Van Calsteren K, 2010, ACTA OBSTET GYN SCAN, V89, P1338, DOI 10.3109/00016349.2010.512070; Vasilakaki T, 2006, EUR J GYNAECOL ONCOL, V27, P623; Wang PH, 1999, J REPROD MED, V44, P630; WARKANY J, 1959, AMA J DIS CHILD, V97, P274, DOI 10.1001/archpedi.1959.02070010276003; Weisz Boaz, 2004, Expert Rev Anticancer Ther, V4, P889, DOI 10.1586/14737140.4.5.889; WOO SY, 1992, INT J RADIAT ONCOL, V23, P407, DOI 10.1016/0360-3016(92)90761-6; Yamasaki M, 2010, BIOSCI BIOTECH BIOCH, V74, P2113, DOI 10.1271/bbb.100359; Yang D, 2009, PHARMACOTHERAPY, V29, P709, DOI [10.1592/phco.29.6.709, 10.3760/cma.j.issn.0253-2727.2019.05.019]; Zanotti-Fregonara P, 2010, J NUCL MED, V51, P803, DOI 10.2967/jnumed.109.071878; ZEMLICKIS D, 1992, ARCH INTERN MED, V152, P573, DOI 10.1001/archinte.152.3.573	100	101	110	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					580	587		10.1016/S0140-6736(11)61348-2	http://dx.doi.org/10.1016/S0140-6736(11)61348-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22325663				2022-12-28	WOS:000300188800035
J	Kolkowitz, S; Jayich, ACB; Unterreithmeier, QP; Bennett, SD; Rabl, P; Harris, JGE; Lukin, MD				Kolkowitz, Shimon; Jayich, Ania C. Bleszynski; Unterreithmeier, Quirin P.; Bennett, Steven D.; Rabl, Peter; Harris, J. G. E.; Lukin, Mikhail D.			Coherent Sensing of a Mechanical Resonator with a Single-Spin Qubit	SCIENCE			English	Article							QUANTUM GROUND-STATE; NANOMECHANICAL OSCILLATOR; DIAMOND; MAGNETOMETRY; ELECTRON; MOTION	Mechanical systems can be influenced by a wide variety of small forces, ranging from gravitational to optical, electrical, and magnetic. When mechanical resonators are scaled down to nanometer-scale dimensions, these forces can be harnessed to enable coupling to individual quantum systems. We demonstrate that the coherent evolution of a single electronic spin associated with a nitrogen vacancy center in diamond can be coupled to the motion of a magnetized mechanical resonator. Coherent manipulation of the spin is used to sense driven and Brownian motion of the resonator under ambient conditions with a precision below 6 picometers. With future improvements, this technique could be used to detect mechanical zero-point fluctuations, realize strong spin-phonon coupling at a single quantum level, and implement quantum spin transducers.	[Kolkowitz, Shimon; Unterreithmeier, Quirin P.; Bennett, Steven D.; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Jayich, Ania C. Bleszynski] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Rabl, Peter] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-6020 Innsbruck, Austria; [Harris, J. G. E.] Yale Univ, Dept Phys, New Haven, CT USA; [Harris, J. G. E.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Harvard University; University of California System; University of California Santa Barbara; Austrian Academy of Sciences; Yale University; Yale University	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu	Kolkowitz, Shimon/AAD-5921-2019; Rabl, Peter/F-2810-2012; Bremner, James D/B-1632-2013; Harris, Jack/AAA-3829-2020	Kolkowitz, Shimon/0000-0001-7095-1547; Rabl, Peter/0000-0002-2560-8835; Jayich, Ania/0000-0003-3480-7032	NSF [DGE-1144152]; Center for Ultracold Atoms; Air Force Office of Scientific Research Multidisciplinary University Research Initiative; Defense Advanced Research Projects Agency Quantum-Assisted Sensing and Readout; European Union (EU) Diamond-Based Atomic Nanotechnologies; Packard Foundation; U.S. Department of Defense; Deutschen Forschungsgemeinschaft; EU; Austrian Science Fund (FWF) through Sonderforschungsbereich FOQUS; START [Y 591-N16]	NSF(National Science Foundation (NSF)); Center for Ultracold Atoms; Air Force Office of Scientific Research Multidisciplinary University Research Initiative(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Defense Advanced Research Projects Agency Quantum-Assisted Sensing and Readout; European Union (EU) Diamond-Based Atomic Nanotechnologies; Packard Foundation(The David & Lucile Packard Foundation); U.S. Department of Defense(United States Department of Defense); Deutschen Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); Austrian Science Fund (FWF) through Sonderforschungsbereich FOQUS(Austrian Science Fund (FWF)); START(Austrian Science Fund (FWF))	We thank T. Baart, M. Grinolds, P. Maletinsky, S. Hong, and A. Yacoby for stimulating discussions and R. Ilic, F. Koppens, and A. Zibrov for early contributions to the experiment. This work was supported in part by the NSF, the Center for Ultracold Atoms, the Air Force Office of Scientific Research Multidisciplinary University Research Initiative, the Defense Advanced Research Projects Agency Quantum-Assisted Sensing and Readout, the European Union (EU) Diamond-Based Atomic Nanotechnologies, and the Packard Foundation. S.K. acknowledges support by the U.S. Department of Defense through the National Defense Science and Engineering Graduate Program and the NSF through the Graduate Research Fellowship Program under grant no. DGE-1144152. Q.U. acknowledges support from Deutschen Forschungsgemeinschaft, and P.R. acknowledges support by the EU network Atomic Quantum Technologies Integrating Project and the Austrian Science Fund (FWF) through Sonderforschungsbereich FOQUS and the START grant Y 591-N16.	Arcizet O, 2011, NAT PHYS, V7, P879, DOI [10.1038/nphys2070, 10.1038/NPHYS2070]; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Bargatin I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138302; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; Degen CL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2943282; Grinolds MS, 2011, NAT PHYS, V7, P687, DOI [10.1038/nphys1999, 10.1038/NPHYS1999]; Haroche S., 2006, EXPLORING QUANTUM; Hunger D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.143002; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Kotler S, 2011, NATURE, V473, P61, DOI 10.1038/nature10010; LaHaye MD, 2009, NATURE, V459, P960, DOI 10.1038/nature08093; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Rabl P, 2010, NAT PHYS, V6, P602, DOI 10.1038/NPHYS1679; Rabl P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.041302; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; Scully M.O., 1997, QUANTUM OPT; Steele GA, 2009, SCIENCE, V325, P1103, DOI 10.1126/science.1176076; Stipe BC, 2001, PHYS REV LETT, V86, P2874, DOI 10.1103/PhysRevLett.86.2874; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Treutlein P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.140403; Verbridge SS, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2822406; Xue F, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.033407	29	289	293	7	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1603	1606		10.1126/science.1216821	http://dx.doi.org/10.1126/science.1216821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22362881				2022-12-28	WOS:000302062600039
J	Chen, L; Xu, D				Chen, Lincoln; Xu, Dong			Trends in China's reforms: the Rashomon effect	LANCET			English	Editorial Material									[Chen, Lincoln] China Med Board, Cambridge, MA 02138 USA; [Xu, Dong] CMB Beijing Off, Beijing, Peoples R China		Chen, L (corresponding author), China Med Board, Arrow St, Cambridge, MA 02138 USA.	lchen@cmbfound.org	Xu, Dong/Z-1502-2019	Xu, Dong/0000-0001-7438-632X				Huang Y, 2011, FOREIGN AFF, V90, P119; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	3	14	16	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2012	379	9818					782	783		10.1016/S0140-6736(12)60285-2	http://dx.doi.org/10.1016/S0140-6736(12)60285-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386015				2022-12-28	WOS:000300983400006
J	Heyward, AJ; Negri, AP				Heyward, A. J.; Negri, A. P.			Turbulence, Cleavage, and the Naked Embryo: A Case for Coral Clones	SCIENCE			English	Article									[Heyward, A. J.] Univ Western Australia, Australian Inst Marine Sci, Nedlands, WA 6009, Australia; [Negri, A. P.] AIMS, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; University of Western Australia; Australian Institute of Marine Science	Heyward, AJ (corresponding author), Univ Western Australia, Australian Inst Marine Sci, 35 Stirling Highway, Nedlands, WA 6009, Australia.	a.heyward@aims.gov.au	Negri, Andrew P/G-9909-2017	Negri, Andrew P/0000-0003-1388-7395	AIMS, Monbusho (Japan); Sesoko Station; Palau International Coral Reef Center; Global Environmental Facility/World Bank	AIMS, Monbusho (Japan); Sesoko Station; Palau International Coral Reef Center; Global Environmental Facility/World Bank	We thank V. Beltran-Ramirez, A. Baird, R. Brinkman, J. Kerry, G. Jones, N. Webster, J. Gilmour, and M. van Oppen for assistance and AIMS, Monbusho (Japan), Sesoko Station, Palau International Coral Reef Center, and Global Environmental Facility/World Bank for funding and field support.	[Anonymous], 2011, BEAUF SCAL WIND SPEE; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Deane GB, 2002, NATURE, V418, P839, DOI 10.1038/nature00967; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Horstadius S, 1973, EXPT EMBRYOLOGY ECHI	6	39	39	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1064	1064		10.1126/science.1216055	http://dx.doi.org/10.1126/science.1216055			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383841				2022-12-28	WOS:000300931100036
J	Hou, Y; Song, LT; Zhu, P; Zhang, B; Tao, Y; Xu, X; Li, FQ; Wu, K; Liang, J; Shao, D; Wu, HJ; Ye, XF; Ye, C; Wu, RH; Jian, M; Chen, Y; Xie, W; Zhang, RR; Chen, L; Liu, X; Yao, XT; Zheng, HC; Yu, C; Li, QB; Gong, ZL; Mao, M; Yang, X; Yang, L; Li, JX; Wang, W; Lu, ZH; Gu, N; Laurie, G; Bolund, L; Kristiansen, K; Wang, J; Yang, HM; Li, YR; Zhang, XQ; Wang, J				Hou, Yong; Song, Luting; Zhu, Ping; Zhang, Bo; Tao, Ye; Xu, Xun; Li, Fuqiang; Wu, Kui; Liang, Jie; Shao, Di; Wu, Hanjie; Ye, Xiaofei; Ye, Chen; Wu, Renhua; Jian, Min; Chen, Yan; Xie, Wei; Zhang, Ruren; Chen, Lei; Liu, Xin; Yao, Xiaotian; Zheng, Hancheng; Yu, Chang; Li, Qibin; Gong, Zhuolin; Mao, Mao; Yang, Xu; Yang, Lin; Li, Jingxiang; Wang, Wen; Lu, Zuhong; Gu, Ning; Laurie, Goodman; Bolund, Lars; Kristiansen, Karsten; Wang, Jian; Yang, Huanming; Li, Yingrui; Zhang, Xiuqing; Wang, Jun			Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm	CELL			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; ESSENTIAL THROMBOCYTHEMIA; CANCER; MUTATIONS; VARIANTS; ORIGIN; GENES	Tumor heterogeneity presents a challenge for inferring clonal evolution and driver gene identification. Here, we describe a method for analyzing the cancer genome at a single-cell nucleotide level. To perform our analyses, we first devised and validated a high-throughput whole-genome single-cell sequencing method using two lymphoblastoid cell line single cells. We then carried out whole-exome single-cell sequencing of 90 cells from a JAK2-negative myeloproliferative neoplasm patient. The sequencing data from 58 cells passed our quality control criteria, and these data indicated that this neoplasm represented a monoclonal evolution. We further identified essential thrombocythemia (ET)-related candidate mutations such as SESN2 and NTRK1, which may be involved in neoplasm progression. This pilot study allowed the initial characterization of the disease-related genetic architecture at the single-cell nucleotide level. Further, we established a single-cell sequencing method that opens the way for detailed analyses of a variety of tumor types, including those with high genetic complex between patients.	[Hou, Yong; Song, Luting; Zhang, Bo; Tao, Ye; Xu, Xun; Li, Fuqiang; Wu, Kui; Liang, Jie; Shao, Di; Wu, Hanjie; Ye, Xiaofei; Ye, Chen; Wu, Renhua; Jian, Min; Xie, Wei; Zhang, Ruren; Chen, Lei; Liu, Xin; Yao, Xiaotian; Zheng, Hancheng; Yu, Chang; Li, Qibin; Gong, Zhuolin; Yang, Xu; Yang, Lin; Li, Jingxiang; Laurie, Goodman; Bolund, Lars; Kristiansen, Karsten; Wang, Jian; Yang, Huanming; Li, Yingrui; Zhang, Xiuqing; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Hou, Yong; Lu, Zuhong; Gu, Ning] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Hou, Yong; Xie, Wei; Zhang, Ruren; Lu, Zuhong; Gu, Ning] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Song, Luting; Chen, Lei] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Song, Luting; Chen, Lei; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, CAS Max Planck Jr Res Grp, Kunming 650223, Yunnan, Peoples R China; [Song, Luting; Chen, Lei] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Zhu, Ping] Peking Univ, Hosp 1, Dept Hematol, Beijing 100034, Peoples R China; [Mao, Mao] Pfizer Inc, San Diego, CA 92121 USA; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1165 Copenhagen, Denmark	Beijing Genomics Institute (BGI); Southeast University - China; Southeast University - China; Wuhan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Pfizer; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Li, YR (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn; liyr@genomics.org.cn; zhangxq@genomics.org.cn; wangj@genomics.org.cn	Wang, Jun/A-7261-2013; Kristiansen, Karsten/J-5148-2014; Wang, Wen/AAP-9873-2020; Wu, Hanjie/AAY-2936-2020; Lu, Zuhong/A-5448-2013; Yu, Chang/AAE-8538-2019; Li, Yingrui/K-1064-2015; Xu, Xun/AAI-6763-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Kristiansen, Karsten/0000-0002-6024-0917; Wu, Hanjie/0000-0002-5451-4969; Xu, Xun/0000-0002-5338-5173; Lu, Zuhong/0000-0003-3332-2615; Liu, Xin/0000-0003-3256-2940; Zhang, Bo/0000-0001-8890-8416; Wang, Jun/0000-0002-8540-8931; Shao, Di/0000-0002-1485-2074; hou, yong/0000-0002-0420-0726; Yao, Xiaotian/0000-0002-3466-461X; chen, lei/0000-0003-3989-9239; Wang, Jun/0000-0002-2113-5874	National Basic Research Program of China (973 program) [2011CB809202, 2011CB809203]; Chinese 863 program [2009AA022707, 2012AA02A201]; Shenzhen Municipal Government of China [ZYC201005250020A]; Key Laboratory Project, Shenzhen City [CX B200903110066A, CXB201108250096A]; Shenzhen Key Laboratory of Gene Bank for National Life Science; Innovative Research Team of Guangdong; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Danish Natural Science Research Council; Danish National Research Foundation; National Natural Science Foundation of China; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen	National Basic Research Program of China (973 program)(National Basic Research Program of China); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Key Laboratory Project, Shenzhen City; Shenzhen Key Laboratory of Gene Bank for National Life Science; Innovative Research Team of Guangdong; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen	This work was supported by a National Basic Research Program of China (973 program number 2011CB809202;2011CB809203), the Chinese 863 program (numbers 2009AA022707 and 2012AA02A201), the Shenzhen Municipal Government of China (grant ZYC201005250020A), the Key Laboratory Project Supported by Shenzhen City (grants CX B200903110066A and CXB201108250096A), and Shenzhen Key Laboratory of Gene Bank for National Life Science. This project was also supported by grants from the Innovative Research Team Project of Guangdong and the Guangdong Enterprise Key Laboratory of Human Disease Genomics. We also acknowledge the Ole Romer grant from the Danish Natural Science Research Council, the Danish National Research Foundation, the National Natural Science Foundation of China, and funds from the Shenzhen Municipal Government and the Local Government of Yantian District of Shenzhen.	Abramson N, 2000, AM FAM PHYSICIAN, V62, P2053; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Frank NY, 2009, LEUKEMIA RES, V33, P1303, DOI 10.1016/j.leukres.2009.04.035; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haeno H, 2009, P NATL ACAD SCI USA, V106, P16616, DOI 10.1073/pnas.0908107106; Kawamata N, 2008, EXP HEMATOL, V36, P1471, DOI 10.1016/j.exphem.2008.06.006; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Mesa RA, 1999, AM J HEMATOL, V61, P10, DOI 10.1002/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.3.CO;2-9; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stegelmann F, 2010, HAEMATOL-HEMATOL J, V95, P666, DOI 10.3324/haematol.2009.013623; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Tefferi A, 2001, LEUKEMIA RES, V25, P369, DOI 10.1016/S0145-2126(00)00131-4; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630	32	396	430	6	175	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					873	885		10.1016/j.cell.2012.02.028	http://dx.doi.org/10.1016/j.cell.2012.02.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385957	Bronze			2022-12-28	WOS:000300985000009
J	Jaeger, TF; Pontillo, D; Graff, P				Jaeger, T. Florian; Pontillo, Daniel; Graff, Peter			Comment on "Phonemic Diversity Supports a Serial Founder Effect Model of Language Expansion from Africa"	SCIENCE			English	Editorial Material									[Jaeger, T. Florian; Pontillo, Daniel] Univ Rochester, Rochester, NY 14627 USA; [Graff, Peter] MIT, Dept Linguist & Philosophy, Cambridge, MA 02139 USA	University of Rochester; Massachusetts Institute of Technology (MIT)	Jaeger, TF (corresponding author), Univ Rochester, Meliora Hall,Box 270268, Rochester, NY 14627 USA.	fjaeger@bcs.rochester.edu	Jaeger, T. Florian/O-8224-2019; Jaeger, T. Florian/D-3339-2011	Jaeger, T. Florian/0000-0002-1158-7308; Jaeger, T. Florian/0000-0002-1158-7308				Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Dryer Matthew S., 2008, WORLD ATLAS LANGUAGE; Hay J, 2007, LANGUAGE, V83, P388, DOI 10.1353/lan.2007.0071; Maddieson I., 2008, WORLD ATLAS LANGUAGE, P14	4	3	3	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072								10.1126/science.1215107	http://dx.doi.org/10.1126/science.1215107			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	900ZL	22383830				2022-12-28	WOS:000300931100023
J	Revill, P; Sculpher, M				Revill, Paul; Sculpher, Mark			Cost effectiveness of interventions to tackle non-communicable diseases	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Revill, Paul; Sculpher, Mark] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of York - UK	Revill, P (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	paul.revill@york.ac.uk		Sculpher, Mark/0000-0003-3746-9913; Revill, Paul/0000-0001-8632-0600				[Anonymous], 2008, GUID METH TECHN APPR; Baltussen R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e615; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e612; Claxton K, 2010, 54 CHE U YORK; Edejer T, 2003, MAKING CHOICES HLTH; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Kumaranayake L, 2002, HLTH POLICY GLOBALIS; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Stanciole AE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e608	10	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2012	344								d7883	10.1136/bmj.d7883	http://dx.doi.org/10.1136/bmj.d7883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XQ	22389332				2022-12-28	WOS:000301232600013
J	Salomon, JA; Carvalho, N; Gutierrez-Delgado, C; Orozco, R; Mancuso, A; Hogan, DR; Lee, D; Murakami, Y; Sridharan, L; Medina-Mora, ME; Gonzalez-Pier, E				Salomon, Joshua A.; Carvalho, Natalie; Gutierrez-Delgado, Cristina; Orozco, Ricardo; Mancuso, Anna; Hogan, Daniel R.; Lee, Diana; Murakami, Yuki; Sridharan, Lakshmi; Elena Medina-Mora, Maria; Gonzalez-Pier, Eduardo			Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUB-SAHARAN AFRICA; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; HEALTH; COMPARABILITY; STATISTICS; PRIORITIES; INJURIES; AMERICA; CANCER	Objective To inform decision making regarding intervention strategies against non-communicable diseases in Mexico, in the context of health reform. Design Cost effectiveness analysis based on epidemiological modelling. Interventions 101 intervention strategies relating to nine major clusters of non-communicable disease: depression, heavy alcohol use, tobacco use, cataracts, breast cancer, cervical cancer, chronic obstructive pulmonary disease, cardiovascular disease, and diabetes. Data sources Mexican data sources were used for most key input parameters, including administrative registries; disease burden and population estimates; household surveys; and drug price databases. These sources were supplemented as needed with estimates for Mexico from the WHO-CHOICE unit cost database or with estimates extrapolated from the published literature. Main outcome measures Population health outcomes, measured in disability adjusted life years (DALYs); costs in 2005 international dollars ($Int); and costs per DALY. Results Across 101 intervention strategies examined in this study, average yearly costs at the population level would range from around <=$Int1m (such as for cataract surgeries) to >$Int1bn for certain strategies for primary prevention in cardiovascular disease. Wide variation also appeared in total population health benefits, from <1000 DALYs averted a year (for some components of cancer treatments or aspirin for acute ischaemic stroke) to >300 000 averted DALYs (for aggressive combinations of interventions to deal with alcohol use or cardiovascular risks). Interventions in this study spanned a wide range of average cost effectiveness ratios, differing by more than three orders of magnitude between the lowest and highest ratios. Overall, community and public health interventions such as non-personal interventions for alcohol use, tobacco use, and cardiovascular risks tended to have lower cost effectiveness ratios than many clinical interventions (of varying complexity). Even within the community and public health interventions, however, there was a 200-fold difference between the most and least cost effective strategies examined. Likewise, several clinical interventions appeared among the strategies with the lowest average cost effectiveness ratios-for example, cataract surgeries. Conclusions Wide variations in costs and effects exist within and across intervention categories. For every major disease area examined, at least some strategies provided excellent value for money, including both population based and personal interventions.	[Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Gutierrez-Delgado, Cristina] Secretaria Salud Mexico, Unidad Anal Econ, Mexico City, DF, Mexico; [Carvalho, Natalie] Harvard Univ, Cambridge, MA 02138 USA; [Orozco, Ricardo; Elena Medina-Mora, Maria] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Mexico City, DF, Mexico; [Mancuso, Anna] Boston Med Ctr, Boston Ctr Refugee Hlth & Human Rights, Boston, MA USA; [Lee, Diana] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Murakami, Yuki] Org Econ Cooperat & Dev, Paris, France; [Sridharan, Lakshmi] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Gonzalez-Pier, Eduardo] Inst Mexicano Seguro Social, Mexico City, DF, Mexico	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Boston Medical Center; University of California System; University of California Berkeley; Organisation for Economic Co-operation & Development (OECD); University of California System; University of California San Francisco; Instituto Mexicano del Seguro Social	Salomon, JA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	jsalomon@hsph.harvard.edu	Salomon, Joshua/S-1929-2019; Orozco, Ricardo/I-3518-2015; Gonzalez Pier, Eduardo/AIB-2488-2022; Medina-Mora, María Elena I/T-5937-2018; Salomon, Joshua A/D-3898-2009; Carvalho, Natalie/AAD-4321-2022	Salomon, Joshua/0000-0003-3929-5515; Orozco, Ricardo/0000-0002-6580-585X; Medina-Mora, María Elena I/0000-0001-9300-0752; Salomon, Joshua A/0000-0003-3929-5515; Carvalho, Natalie/0000-0002-5599-2209	Ministry of Health, Mexico	Ministry of Health, Mexico	This project was supported by funding from the Ministry of Health, Mexico.	Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Augustovski F, 2009, PHARMACOECONOMICS, V27, P919, DOI 10.2165/11313670-000000000-00000; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Baltussen R, 2012, BMJ-BRIT MED J, V344, P615; Brass W., 1975, LAB POPULATION STAT; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chisholm D, 2004, BRIT J PSYCHIAT, V184, P393, DOI 10.1192/bjp.184.5.393; Chisholm D, 2012, BMJ-BRIT MED J, V344, P612; Comision Nacional de Proteccion Social en Salud, 2011, SIST PROT SOC SAL IN; Daniels N, 2005, B WORLD HEALTH ORGAN, V83, P534; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Frenk J, 2009, B WORLD HEALTH ORGAN, V87, P542, DOI 10.2471/BLT.08.053199; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Hill K, 1987, Asian Pac Popul Forum, V1, P8; Knaul F, 2005, SALUD PUBLICA MEXICO, V47, pS54; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Lauer Jeremy A, 2003, Cost Eff Resour Alloc, V1, P6, DOI 10.1186/1478-7547-1-6; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Murray CJL, 2008, DIABETES CARE, V31, P451, DOI 10.2337/dc07-1370; Murray CJL, 2006, CIRCULATION, V113, P2071, DOI 10.1161/CIRCULATIONAHA.105.595777; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Qaseem A, 2011, ANN INTERN MED, V154, P260, DOI 10.7326/0003-4819-154-4-201102150-00007; Saxena S, 2012, BMJ-BRIT MED J, V344, P609; Secretaria de Hacienda y Credito Publico, PRES EGR FED; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Stanciole A, 2012, BMJ-BRIT MED J, V344, P608; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; U.S. Preventive Services Task Force, 2009, SCREEN BREAST CANC R; World Health Organization, 2008, GLOB BURD DIS 2004 U	35	49	52	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e355	10.1136/bmj.e355	http://dx.doi.org/10.1136/bmj.e355			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389335	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000301232600001
J	Brody, H; Miko, I				Brody, Herb; Miko, Ilona			LENSES ON BIOLOGY	NATURE			English	Editorial Material														miko, ilona/0000-0001-5640-7641					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					S1	S1		10.1038/483S1a	http://dx.doi.org/10.1038/483S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22378118	Bronze			2022-12-28	WOS:000300877900057
J	Cohen, D				Cohen, Deborah			MEDICAL DEVICES How safe are metal-on-metal hip implants?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ION LEVELS; WEAR PARTICLES; JOHN CHARNLEY; ARTHROPLASTY; REPLACEMENT; COBALT; DEBRIS; TRIAL; JOINT; BLOOD					dcohen@bmj.com						Antoniou J, 2008, J BONE JOINT SURG AM, V90A, P142, DOI 10.2106/JBJS.H.00442; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P201, DOI 10.1081/CLT-100102420; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Cobb AG, 2006, P I MECH ENG H, V220, P385, DOI 10.1243/09544119JEIM78; Cohen D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5977; Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; Committee of Mutagencity of Chemicals in Food Consumer Products and the Environment, 2006, COM06S1 COMM MUT CHE; Daniel J, 2004, J BONE JOINT SURG BR, V86B, P177, DOI 10.1302/0301-620X.86B2.14600; Engh CA, 2009, CLIN ORTHOP RELAT R, V467, P101, DOI 10.1007/s11999-008-0540-9; FDA, 510K SUMM SAF EFF; FDA, MET ON MET IMPL FDAS; FREEMAN MAR, 1969, ANN RHEUM DIS, V28, P29; Fricka K, 2012, AM AC ORTH SURG ANN; Garbuz DS, 2010, CLIN ORTHOP RELAT R, V468, P318, DOI 10.1007/s11999-009-1029-x; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Hart AJ, 2010, ACTA BIOMATER, V6, P4439, DOI 10.1016/j.actbio.2010.06.006; Heneghan C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1349; International Agency for Research on Cancer, 1990, IARC MON S; JONES DA, 1975, J BONE JOINT SURG BR, V57, P289, DOI 10.1302/0301-620X.57B3.289; Ladon D, 2004, J ARTHROPLASTY, V19, P78, DOI 10.1016/j.arth.2004.09.010; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Langton DJ, 2011, ORTHOP CLIN N AM, V42, P169, DOI 10.1016/j.ocl.2011.01.006; Lavigne M, 2011, J BONE JOINT SURG AM, V93A, P128, DOI 10.2106/JBJS.J.01885; Learmonth ID, 2007, LANCET, V369, P542, DOI 10.1016/S0140-6736(07)60251-7; Malviya A, 2011, J BONE JOINT SURG BR, V93B, P1602, DOI 10.1302/0301-620X.93B12.27533; Medicines and Healthcare products Regulatory Agency (MHRA), 2010, MED DEV AL ALL MET O; MHRA, 2006, COMM SAF DEV EXP ADV; MHRA, 2007, COMM SAF DEV EXP ADV; MHRA, 2006, COMM SAF DEV M MARCH; MHRA, 2007, COMM SAF DEV M 5 JUL; National joint registry for England and Wales, 2011, 8 NAT JOINT REG ENGL; Schmalzried TP, 2000, CLIN ORTHOP RELAT R, P36; Takamua KM, 2012, AM AC ORTH SURG ANN; Treacy R, 2009, MODERN HIP RESURFACI; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002	35	101	103	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 28	2012	344								e1410	10.1136/bmj.e1410	http://dx.doi.org/10.1136/bmj.e1410			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XA	22374741	Green Submitted, Bronze			2022-12-28	WOS:000301231000011
J	Medina-Elizalde, M; Rohling, EJ				Medina-Elizalde, Martin; Rohling, Eelco J.			Collapse of Classic Maya Civilization Related to Modest Reduction in Precipitation	SCIENCE			English	Article							ENVIRONMENTAL-CHANGE; CLIMATE-CHANGE; LOWLANDS; RECORD; DROUGHT; MEXICO; PETEN	The disintegration of the Classic Maya civilization in the Yucatan Peninsula and Central America was a complex process that occurred over an approximately 200-year interval and involved a catastrophic depopulation of the region. Although it is well established that the civilization collapse coincided with widespread episodes of drought, their nature and severity remain enigmatic. We present a quantitative analysis that offers a coherent interpretation of four of the most detailed paleoclimate records of the event. We conclude that the droughts occurring during the disintegration of the Maya civilization represented up to a 40% reduction in annual precipitation, probably due to a reduction in summer season tropical storm frequency and intensity.	[Medina-Elizalde, Martin; Rohling, Eelco J.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Medina-Elizalde, M (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.		Rohling, Eelco J/B-9736-2008	Rohling, Eelco J/0000-0001-5349-2158	UK Natural Environment Research Council [NE/C003152/1, NE/I009906/1, NE/H004424/1]; Natural Environment Research Council [NE/I009906/1, NE/H004424/1, NE/C003152/1] Funding Source: researchfish; NERC [NE/I009906/1, NE/H004424/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper contributes to UK Natural Environment Research Council projects NE/C003152/1, NE/I009906/1, and NE/H004424/1. We thank two anonymous reviewers for their valuable comments and suggestions.	Aimers J, 2011, NATURE, V479, P44, DOI 10.1038/479044a; Andrews P. A., 2003, ANCIENT MESOAM, V14, P151; Braswell Geoff E., 2004, TERMINAL CLASSIC MAY, P162; Carmean K., 2004, TERMINAL CLASSIC MAY, P424; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; COVICH A, 1974, LIMNOL OCEANOGR, V19, P682, DOI 10.4319/lo.1974.19.4.0682; Culbert T. P., 1990, PRECOLUMBIAN POPULAT, P395; Culbert T.P., 1990, PRECOLUMBIAN POPULAT, P301; Culbert T. Patrick, 1990, PRECOLUMBIAN POPULAT, P103, DOI DOI 10.1525/JLAT.1992.4.1.33; Curtis JH, 1996, QUATERNARY RES, V46, P37, DOI 10.1006/qres.1996.0042; Curtis JH, 1998, J PALEOLIMNOL, V19, P139, DOI 10.1023/A:1007968508262; Demarest A. A., 2004, TERMINAL CLASSIC MAY, P1; Folan W. J., 1988, INFORMACION, V13, P122; Frappier AB, 2007, GEOLOGY, V35, P111, DOI 10.1130/G23145A.1; Gill Richardson, 2000, GREAT MAYA DROUGHTS; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Hodell DA, 2005, QUATERNARY SCI REV, V24, P1413, DOI 10.1016/j.quascirev.2004.10.013; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; Jiang HY, 2010, J CLIMATE, V23, P1526, DOI 10.1175/2009JCLI3303.1; Karmalkar AV, 2011, CLIM DYNAM, V37, P605, DOI 10.1007/s00382-011-1099-9; Lawrence JR, 1996, GEOPHYS RES LETT, V23, P527, DOI 10.1029/96GL00425; Medina-Elizalde M, 2010, EARTH PLANET SC LETT, V298, P255, DOI 10.1016/j.epsl.2010.08.016; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Perry E., 2003, HYDROGEOLOGY YUCATAN, P115; Rosenmeier MF, 2002, QUATERNARY RES, V57, P183, DOI 10.1006/qres.2001.2305; SCATENA FN, 1991, BIOTROPICA, V23, P317, DOI 10.2307/2388247; Schele L., 1986, BLOOD KINGS DYNASTY, P335	27	153	164	3	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					956	959		10.1126/science.1216629	http://dx.doi.org/10.1126/science.1216629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363005				2022-12-28	WOS:000300931800043
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Seeing through the alcohol statistics haze	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						2011, BRIT MED J, V343, pD5869, DOI DOI 10.1136/BMJ.D5869; 2011, BRIT MED J, V342, DOI DOI 10.1136/BMJ.D4166; 2010, BRIT MED J, V341, DOI DOI 10.1136/BMJ.C4790; 2010, BRIT MED J, V340, DOI DOI 10.1136/BMJ.C2153	4	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2012	344								e1273	10.1136/bmj.e1273	http://dx.doi.org/10.1136/bmj.e1273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JQ	22362248				2022-12-28	WOS:000300883600010
J	Sun, YL; Christensen, J; Hviid, A; Li, J; Vedsted, P; Olsen, J; Vestergaard, M				Sun, Yuelian; Christensen, Jakob; Hviid, Anders; Li, Jiong; Vedsted, Peter; Olsen, Jorn; Vestergaard, Mogens			Risk of Febrile Seizures and Epilepsy After Vaccination With Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, and Haemophilus Influenzae Type b	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-HOSPITAL-REGISTER; WHOLE-CELL PERTUSSIS; CASE-SERIES METHOD; CONTROLLED TRIAL; ADVERSE REACTIONS; DRAVET SYNDROME; TOXOID VACCINE; MEASLES; MUMPS; SAFETY	Context Vaccination with whole-cell pertussis vaccine carries an increased risk of febrile seizures, but whether this risk applies to the acellular pertussis vaccine is not known. In Denmark, acellular pertussis vaccine has been included in the combined diphtheriatetanus toxoids-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine since September 2002. Objective To estimate the risk of febrile seizures and epilepsy after DTaP-IPV-Hib vaccination given at 3, 5, and 12 months. Design, Setting, and Participants A population-based cohort study of 378 834 children who were born in Denmark between January 1, 2003, and December 31, 2008, and followed up through December 31, 2009; and a self-controlled case series (SCCS) study based on children with febrile seizures during follow-up of the cohort. Main Outcome Measures Hazard ratio (HR) of febrile seizures within 0 to 7 days (0, 1-3, and 4-7 days) after each vaccination and HR of epilepsy after first vaccination in the cohort study. Relative incidence of febrile seizures within 0 to 7 days (0, 1-3, and 4-7 days) after each vaccination in the SCCS study. Results A total of 7811 children were diagnosed with febrile seizures before 18 months, of whom 17 were diagnosed within 0 to 7 days after the first (incidence rate, 0.8 per 100 000 person-days), 32 children after the second (1.3 per 100 000 person-days), and 201 children after the third (8.5 per 100 000 person-days) vaccinations. Overall, children did not have higher risks of febrile seizures during the 0 to 7 days after the 3 vaccinations vs a reference cohort of children who were not within 0 to 7 days of vaccination. However, a higher risk of febrile seizures was found on the day of the first (HR, 6.02; 95% CI, 2.86-12.65) and on the day of the second (HR, 3.94; 95% CI, 2.18-7.10), but not on the day of the third vaccination (HR, 1.07; 95% CI, 0.73-1.57) vs the reference cohort. On the day of vaccination, 9 children were diagnosed with febrile seizures after the first (5.5 per 100 000 person-days), 12 children after the second (5.7 per 100 000 person-days), and 27 children after the third (13.1 per 100 000 person-days) vaccinations. The relative incidences from the SCCS study design were similar to the cohort study design. Within 7 years of follow-up, 131 unvaccinated children and 2117 vaccinated children were diagnosed with epilepsy, 813 diagnosed between 3 and 15 months (2.4 per 1000 person-years) and 1304 diagnosed later in life (1.3 per 1000 person-years). After vaccination, children had a lower risk of epilepsy between 3 and 15 months (HR, 0.63; 95% CI, 0.50-0.79) and a similar risk for epilepsy later in life (HR, 1.01; 95% CI, 0.66-1.56) vs unvaccinated children. Conclusions DTaP-IPV-Hib vaccination was associated with an increased risk of febrile seizures on the day of the first 2 vaccinations given at 3 and 5 months, although the absolute risk was small. Vaccination with DTaP-IPV-Hib was not associated with an increased risk of epilepsy. JAMA. 2012;307(8):823-831 www.jama.com	[Sun, Yuelian; Li, Jiong; Olsen, Jorn; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, DK-8000 Aarhus C, Denmark; [Vedsted, Peter; Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark; [Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Statens Serum Institut; University of California System; University of California Los Angeles	Sun, YL (corresponding author), Aarhus Univ, Dept Publ Hlth, Bartholins Alle 2, DK-8000 Aarhus C, Denmark.	ys@soci.au.dk	Sun, Yuelian/AFF-2622-2022; Hviid, Anders/AAH-4319-2020; Vedsted, Peter/C-2583-2008; Vestergaard, Mogens/M-9333-2014; Olsen, Jørn/F-8801-2015; li, jiong/L-6534-2014	Sun, Yuelian/0000-0002-6905-0503; Hviid, Anders/0000-0002-7509-9127; Vedsted, Peter/0000-0003-2113-5599; Vestergaard, Mogens/0000-0001-8830-2174; Olsen, Jørn/0000-0001-7462-5140; li, jiong/0000-0002-1716-8067; li, jiong/0000-0003-1125-026X; Christensen, Jakob/0000-0002-9385-6435	Lundbeck Foundation [195/04]; Lennart Grams Memorial Foundation; Danish Medical Research Council; NordForsk [070331]; European Research Council [206242]	Lundbeck Foundation(Lundbeckfonden); Lennart Grams Memorial Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk; European Research Council(European Research Council (ERC)European Commission)	This study was supported by a grant 195/04 from the Lundbeck Foundation. Dr Sun also received support from the Lennart Grams Memorial Foundation. The data recruitment was supported by grants 271-07-0437 and 09-072986 from the Danish Medical Research Council, grant 070331 from NordForsk, and Seventh Framework Programme (FP7) grant 206242 from the European Research Council.	Andersen TF, 1999, DAN MED BULL, V46, P263; Andrews N, 2010, VACCINE, V28, P7215, DOI 10.1016/j.vaccine.2010.08.062; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Berkovic SF, 2006, LANCET NEUROL, V5, P488, DOI 10.1016/S1474-4422(06)70446-X; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Commenges D, 1998, STAT MED, V17, P1973, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5; DECKER MD, 1995, PEDIATRICS, V96, P557; Edwards KM, 1996, NEW ENGL J MED, V334, P391, DOI 10.1056/NEJM199602083340609; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Huang WT, 2010, PEDIATRICS, V126, pE263, DOI 10.1542/peds.2009-1496; Hviid A, 2004, VACCINE, V22, P3530, DOI 10.1016/j.vaccine.2004.03.046; Klein NP, 2010, PEDIATRICS, V126, pE1, DOI 10.1542/peds.2010-0665; Knudsen LB, 1998, DAN MED BULL, V45, P320; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Madsen T, 1933, J AMER MED ASSOC, V101, P187, DOI 10.1001/jama.1933.02740280007003; McIntosh AM, 2010, LANCET NEUROL, V9, P592, DOI 10.1016/S1474-4422(10)70107-1; MILLER DL, 1981, BRIT MED J, V282, P1595, DOI 10.1136/bmj.282.6276.1595; Pedersen CB, 2006, DAN MED BULL, V53, P441; Schmitt HJ, 2003, VACCINE, V21, P3653, DOI 10.1016/S0264-410X(03)00389-X; Tro-Baumann B, 2011, EPILEPSIA, V52, P175, DOI 10.1111/j.1528-1167.2010.02885.x; TROLLFORS B, 1995, NEW ENGL J MED, V333, P1045, DOI 10.1056/NEJM199510193331604; Vestergaard M, 2006, J CLIN EPIDEMIOL, V59, P61, DOI 10.1016/j.jclinepi.2005.05.008; Vestergaard M, 2004, JAMA-J AM MED ASSOC, V292, P351, DOI 10.1001/jama.292.3.351; Weldeselassie YG, 2011, EPIDEMIOL INFECT, V139, P1805, DOI 10.1017/S0950268811001531; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	28	58	64	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					823	831		10.1001/jama.2012.165	http://dx.doi.org/10.1001/jama.2012.165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FQ	22357833				2022-12-28	WOS:000300551300025
J	Eggleston, AK; Eccleston, A; Marte, B; Lupp, C				Eggleston, Angela K.; Eccleston, Alex; Marte, Barbara; Lupp, Claudia			REGULATORY RNA	NATURE			English	Editorial Material														Eggleston, Angela/0000-0001-8682-397X					0	6	6	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					321	321		10.1038/482321a	http://dx.doi.org/10.1038/482321a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337050	Bronze			2022-12-28	WOS:000300287100054
J	Graff, J; Rei, D; Guan, JS; Wang, WY; Seo, J; Hennig, KM; Nieland, TJF; Fass, DM; Kao, PF; Kahn, M; Su, SC; Samiei, A; Joseph, N; Haggarty, SJ; Delalle, I; Tsai, LH				Graeff, Johannes; Rei, Damien; Guan, Ji-Song; Wang, Wen-Yuan; Seo, Jinsoo; Hennig, Krista M.; Nieland, Thomas J. F.; Fass, Daniel M.; Kao, Patricia F.; Kahn, Martin; Su, Susan C.; Samiei, Alireza; Joseph, Nadine; Haggarty, Stephen J.; Delalle, Ivana; Tsai, Li-Huei			An epigenetic blockade of cognitive functions in the neurodegenerating brain	NATURE			English	Article							LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; CLINICAL-IMPLICATIONS; TRANSGENIC MICE; REMOTE MEMORIES; CDK5; PHOSPHORYLATION; EXPRESSION; CHROMATIN	Cognitive decline is a debilitating feature of most neurodegenerative diseases of the central nervous system, including Alzheimer's disease(1). The causes leading to such impairment are only poorly understood and effective treatments are slow to emerge(2). Here we show that cognitive capacities in the neurodegenerating brain are constrained by an epigenetic blockade of gene transcription that is potentially reversible. This blockade is mediated by histone deacetylase 2, which is increased by Alzheimer's-disease-related neurotoxic insults in vitro, in two mouse models of neurodegeneration and in patients with Alzheimer's disease. Histone deacetylase 2 associates with and reduces the histone acetylation of genes important for learning and memory, which show a concomitant decrease in expression. Importantly, reversing the build-up of histone deacetylase 2 by short-hairpin-RNA-mediated knockdown unlocks the repression of these genes, reinstates structural and synaptic plasticity, and abolishes neurodegeneration-associated memory impairments. These findings advocate for the development of selective inhibitors of histone deacetylase 2 and suggest that cognitive capacities following neurodegeneration are not entirely lost, but merely impaired by this epigenetic blockade.	[Graeff, Johannes; Rei, Damien; Guan, Ji-Song; Wang, Wen-Yuan; Seo, Jinsoo; Kahn, Martin; Su, Susan C.; Samiei, Alireza; Joseph, Nadine; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Graeff, Johannes; Rei, Damien; Guan, Ji-Song; Wang, Wen-Yuan; Seo, Jinsoo; Su, Susan C.; Joseph, Nadine; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Graeff, Johannes; Guan, Ji-Song; Wang, Wen-Yuan; Hennig, Krista M.; Nieland, Thomas J. F.; Fass, Daniel M.; Joseph, Nadine; Haggarty, Stephen J.; Tsai, Li-Huei] Broad Inst Harvard Univ & Massachusetts Inst Tech, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Hennig, Krista M.; Fass, Daniel M.; Haggarty, Stephen J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kao, Patricia F.; Delalle, Ivana] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Seo, Jinsoo/AAD-4950-2019; Haggarty, Stephen J/M-9495-2016; Core, Vector/CAF-4832-2022	Seo, Jinsoo/0000-0001-6432-6964; Haggarty, Stephen J/0000-0002-7872-168X; Graff, Johannes/0000-0002-3219-3578; Delalle, Ivana/0000-0002-1873-3064; Guan, Ji-Song/0000-0001-5219-0289; Kahn, Martin/0000-0002-4211-5020	Stanley Medical Research Institution; National Institutes of Health/National Institute on Drug Abuse [RO1DA028301]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1NS078839]; Bard Richmond fellowship; Swiss National Science Foundation; Simons Foundation; Theodor und Ida Herzog-Egli foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028301] Funding Source: NIH RePORTER	Stanley Medical Research Institution; National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bard Richmond fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Simons Foundation; Theodor und Ida Herzog-Egli foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Mungenast, S. Jemielity, R. Madabushi, F. Calderon de Anda and M. Horn for reading the manuscript, A. M. for manuscript editing, M. Eichler for mouse colony maintenance, K. Fitch for sectioning the human brain samples and M. H. for quantification of Fig. 2a. This work was partly supported by the Stanley Medical Research Institution (to S.J.H. and L.-H.T.), National Institutes of Health/National Institute on Drug Abuse (RO1DA028301, to S.J.H.) and National Institutes of Health/National Institute of Neurological Disorders and Stroke (RO1NS078839, to L.-H.T.). J.G. was supported by a Bard Richmond fellowship and by the Swiss National Science Foundation, W.Y.W. by the Simons Foundation and M.K. by the Theodor und Ida Herzog-Egli foundation. L.-H.T. is an investigator of the Howard Hughes Medical Institute.	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Koshibu K, 2009, J NEUROSCI, V29, P13079, DOI 10.1523/JNEUROSCI.3610-09.2009; Lauterborn JC, 1996, J NEUROSCI, V16, P7428; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Qi YP, 1997, J NEUROSCI, V17, P1217; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sun JM, 2007, J BIOL CHEM, V282, P33227, DOI 10.1074/jbc.M703549200; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	38	560	594	6	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					222	U123		10.1038/nature10849	http://dx.doi.org/10.1038/nature10849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22388814	Green Submitted, Green Accepted			2022-12-28	WOS:000301174900041
J	Li, TJ; Vedula, SS; Scherer, R; Dickersin, K				Li, Tianjing; Vedula, S. Swaroop; Scherer, Roberta; Dickersin, Kay			What Comparative Effectiveness Research Is Needed? A Framework for Using Guidelines and Systematic Reviews to Identify Evidence Gaps and Research Priorities	ANNALS OF INTERNAL MEDICINE			English	Article							OPEN-ANGLE GLAUCOMA; RANDOMIZED CONTROLLED-TRIALS; INTRAOCULAR-PRESSURE; PROSTAGLANDIN ANALOGS; OCULAR HYPERTENSION; DATA EXTRACTION; METHODOLOGICAL QUALITY; COMPARING LATANOPROST; MEASUREMENT TOOL; METAANALYSIS	The authors developed and tested a framework for identifying evidence gaps and prioritizing comparative effectiveness research by using a combination of clinical practice guidelines and systematic reviews. In phase 1 of the project, reported elsewhere, 45 clinical questions on the management of primary open-angle glaucoma were derived from practice guidelines and prioritized by using a 2-round Delphi survey of clinicians. On the basis of the clinicians' responses, 9 questions were classified as high-priority. In phase 2, reported here, systematic reviews that addressed the 45 clinical questions were identified. The reviews were classified as at low, high, or unclear risk of bias, and evidence gaps (in which no systematic review was at low risk of bias) were identified. The following comparative effectiveness research agenda is proposed: Two of the 9 high-priority questions require new primary research (such as a randomized, controlled trial) and 4 require a new systematic review. The utility and limitations of the framework and future adaptations are discussed.	[Li, Tianjing] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Dept Epidemiol, Baltimore, MD 21205 USA; Jikei Univ Hosp, Tokyo, Japan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jikei University	Li, TJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Dept Epidemiol, 615 N Wolfe St,Mail Room W5010, Baltimore, MD 21205 USA.	tli@jhsph.edu		Li, Tianjing/0000-0001-5371-4558	National Eye Institute, National Institutes of Health [N01-EY2-1003, U01-EY020522-01]; Cochrane Prioritization Fund, The Cochrane Collaboration; NATIONAL EYE INSTITUTE [N01EY021003, U01EY020522] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cochrane Prioritization Fund, The Cochrane Collaboration; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Grant Support: By contract N01-EY2-1003 and grant U01-EY020522-01 from the National Eye Institute, National Institutes of Health. Phase 1 of the study was supported by the Cochrane Prioritization Fund, The Cochrane Collaboration.	American Academy of Ophthalmology, 2010, PRIM OP ANGL GLAUC P; [Anonymous], 2017, NATION; Aptel F, 2008, J GLAUCOMA, V17, P667, DOI 10.1097/IJG.0b013e3181666557; Bhandari M, 2001, J BONE JOINT SURG AM, V83A, P15, DOI 10.2106/00004623-200101000-00003; Burr J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004399.pub2; Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010; Chalkidou K, 2009, INT J TECHNOL ASSESS, V25, P241, DOI 10.1017/S0266462309990225; Cheng JW, 2008, CLIN THER, V30, P622, DOI 10.1016/j.clinthera.2008.04.006; Cheng JW, 2009, OPHTHALMIC RES, V42, P99, DOI 10.1159/000225963; Cheng JW, 2009, J OCUL PHARMACOL TH, V25, P55, DOI 10.1089/jop.2008.0080; Cheng JW, 2004, CHINESE MED J-PEKING, V117, P1006; Cox JA, 2008, BRIT J OPHTHALMOL, V92, P729, DOI 10.1136/bjo.2008.139329; Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; Denise P, 2007, CURR MED RES OPIN, V23, P601, DOI 10.1185/030079907X178720; Douw K, 2006, HEALTH POLICY, V76, P334, DOI 10.1016/j.healthpol.2005.06.016; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Edwards P, 2002, STAT MED, V21, P1635, DOI 10.1002/sim.1190; Einarson TR, 2000, CLIN THER, V22, P1502, DOI 10.1016/S0149-2918(00)83048-9; Feyi-Waboso A, 2004, COCHRANE DB SYST REV; Ford AC, 2010, AM J GASTROENTEROL, V105, P280, DOI 10.1038/ajg.2009.658; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Friedman DS, 2002, OPHTHALMOLOGY, V109, P1902, DOI 10.1016/S0161-6420(02)01267-8; Fung AT, 2007, BRIT J OPHTHALMOL, V91, P62, DOI 10.1136/bjo.2006.096693; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Glenny AM, 2003, EUR J ORAL SCI, V111, P85, DOI 10.1034/j.1600-0722.2003.00013.x; Goodman S, 2011, ANN INTERN MED, V155, P61, DOI 10.7326/0003-4819-155-1-201107050-00010; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Gray TA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006132.pub2; Guyatt G., 2015, USERS GUIDES MED LIT; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haynes RB, 2005, CLIN EPIDEMIOLOGY DO; Hodge WG, 2008, BRIT J OPHTHALMOL, V92, P7, DOI 10.1136/bjo.2007.123737; Holmstrom S, 2005, CURR MED RES OPIN, V21, P1875, DOI 10.1185/030079905X65600; Hondur A, 2008, J GLAUCOMA, V17, P139, DOI 10.1097/IJG.0b013e31814b98f7; Hong CH, 2005, SURV OPHTHALMOL, V50, P48, DOI 10.1016/j.survophthal.2004.10.006; Honrubia F, 2009, BRIT J OPHTHALMOL, V93, P316, DOI 10.1136/bjo.2007.135111; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Hrobjartsson A, 2006, J CLIN EPIDEMIOL, V59, P336, DOI 10.1016/j.jclinepi.2005.05.011; Husereau D, 2010, INT J TECHNOL ASSESS, V26, P341, DOI 10.1017/S0266462310000383; Hylton C, 2003, AM J OPHTHALMOL, V135, P231, DOI 10.1016/S0002-9394(02)01919-0; Iglehart JK, 2009, NEW ENGL J MED, V361, P325, DOI 10.1056/NEJMp0904133; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Jampel HD, 2002, OPHTHALMOLOGY, V109, P2215, DOI 10.1016/S0161-6420(02)01439-2; Jampel HD, 2003, AHRQ PUBLICATION; Johnston SC, 2009, ANN NEUROL, V66, pA4, DOI 10.1002/ana.21913; Jones AP, 2005, J CLIN EPIDEMIOL, V58, P741, DOI 10.1016/j.jclinepi.2004.11.024; Katz LJ, 2007, CURR MED RES OPIN, V23, P2971, DOI 10.1185/030079907X242476; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Li N, 2006, CLIN EXP OPHTHALMOL, V34, P755, DOI 10.1111/j.1442-9071.2006.01237.x; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Li TJ, 2010, OPHTHALMOLOGY, V117, P1937, DOI 10.1016/j.ophtha.2010.07.004; Li TJ, 2010, CAN MED ASSOC J, V182, P805, DOI 10.1503/cmaj.110-2064; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loon SC, 2008, CLIN EXP OPHTHALMOL, V36, P281, DOI 10.1111/j.1442-9071.2008.01720.x; Lundh A, 2009, CANCER TREAT REV, V35, P645, DOI 10.1016/j.ctrv.2009.08.010; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Maciosek MV, 2001, AM J PREV MED, V21, P10, DOI 10.1016/S0749-3797(01)00309-9; Maier PC, 2005, BMJ-BRIT MED J, V331, P134, DOI 10.1136/bmj.38506.594977.E0; [梅丽克木·艾山 MEI LI KE MU Ai shan], 2009, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V9, P350; [米娜瓦尔·阿不都 Minawaer Abudu], 2008, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V8, P1094; Minckler DS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004918.pub2; Moher D, 2003, Health Technol Assess, V7, P1; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Netland PA, 2001, OPHTHALMOLOGY, V108, P416; Noorani HZ, 2007, INT J TECHNOL ASSESS, V23, P310, DOI 10.1017/S026646230707050X; O'Leary TJ, 2010, J AM GERIATR SOC, V58, P1187, DOI 10.1111/j.1532-5415.2010.02939.x; Pastor SA, 2001, OPHTHALMOLOGY, V108, P2130, DOI 10.1016/S0161-6420(01)00889-2; Patient-Centered Outcomes Research Institute, 2011, PCORI FUND ANN PIL P; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rolim de Moura C, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003919; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Simmons ST, 2004, ADV THER, V21, P247, DOI 10.1007/BF02850157; Smith N, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-165; Stewart WC, 2008, EUR J OPHTHALMOL, V18, P765, DOI 10.1177/112067210801800517; Straus S, 2010, CAN MED ASSOC J, V182, P13, DOI 10.1503/cmaj.081849; Sun W, 2008, INT J OPHTHALMOL, V8, P749; van der Valk R, 2005, OPHTHALMOLOGY, V112, P1177, DOI 10.1016/j.ophtha.2005.01.042; Vass C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003167.pub3; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Vinuesa-Silva J.M., 2009, Arch Soc Esp Oftalmol, V84, P199; Webers CAB, 2008, DRUG AGING, V25, P729, DOI 10.2165/00002512-200825090-00002; Webers CAB, 2007, OPHTHALMOLOGY, V114, P40, DOI 10.1016/j.ophtha.2006.07.018; Whitlock EP, 2010, J CLIN EPIDEMIOL, V63, P491, DOI 10.1016/j.jclinepi.2009.03.008; Wilkins M, 2005, Cochrane Database Syst Rev, pCD002897; Wormald R, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001132; Zhang WY, 2001, BRIT J OPHTHALMOL, V85, P983, DOI 10.1136/bjo.85.8.983	93	52	52	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2012	156	5					367	U199		10.7326/0003-4819-156-5-201203060-00009	http://dx.doi.org/10.7326/0003-4819-156-5-201203060-00009			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902OC	22393132	Green Accepted			2022-12-28	WOS:000301046800005
J	Dana, GV; Kuiken, T; Rejeski, D; Snow, AA				Dana, Genya V.; Kuiken, Todd; Rejeski, David; Snow, Allison A.			Four steps to avoid a synthetic-biology disaster	NATURE			English	Editorial Material									[Dana, Genya V.; Kuiken, Todd; Rejeski, David] Woodrow Wilson Int Ctr Scholars, Washington, DC 20004 USA; [Snow, Allison A.] Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Dana, GV (corresponding author), Woodrow Wilson Int Ctr Scholars, Washington, DC 20004 USA.	gvdana@gmail.com	Kuiken, Todd/A-3784-2016; Kuiken, Todd/U-3476-2019	Kuiken, Todd/0000-0001-7851-6232; Kuiken, Todd/0000-0001-7851-6232				Bergin J, 2011, SYNTHETIC BIOL EMERG; Michael Davis J, 2010, COMPREHENSIVE ENV AS	2	61	63	7	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					29	29		10.1038/483029a	http://dx.doi.org/10.1038/483029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900HP	22382962	Bronze			2022-12-28	WOS:000300877900025
J	Bouffard, C; Bouffard, M				Bouffard, Chantal; Bouffard, Mickael			The art of medicine Spectacular anatomy: plastination and salutary dread	LANCET			English	Editorial Material									[Bouffard, Chantal] Univ Sherbrooke, Div Genet, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; [Bouffard, Mickael] Univ Montreal, Dept Art Hist, Fac Arts & Sci, Montreal, PQ, Canada	University of Sherbrooke; Universite de Montreal	Bouffard, C (corresponding author), Univ Sherbrooke, Div Genet, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada.	chantal.bouffard@usherbrooke.ca						Barnett R, 2008, LANCET, V372, P366, DOI 10.1016/S0140-6736(08)61145-9; Cuir R, 2006, ANTHROPOL TODAY, V22, P20, DOI 10.1111/j.1467-8322.2006.00473.x; Delpeux S, 2001, ART PRESS        MAY, P76; Hoffmann KA, 2010, EARLY POPULAR VISUAL, V4, P139; Le Floch-Prigent P., 2010, Morphologie, V94, P81, DOI 10.1016/j.morpho.2010.03.007; Lemire Michel, 1990, ARTISTES MORTELS; Morone JA, 1997, J HEALTH POLIT POLIC, V22, P993, DOI 10.1215/03616878-22-4-993; van Dijck J, 2001, CONFIGURATIONS, V9, P99, DOI 10.1353/con.2001.0008; von Hagens G, 2004, BODY WORLDS ANATOMIC	9	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2012	379	9817					704	705		10.1016/S0140-6736(12)60298-0	http://dx.doi.org/10.1016/S0140-6736(12)60298-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	899CU	22371965	Bronze			2022-12-28	WOS:000300792600014
J	Brooks, R; Hassabis, D; Bray, D; Shashua, A				Brooks, Rodney; Hassabis, Demis; Bray, Dennis; Shashua, Amnon			Is the brain a good model for machine intelligence?	NATURE			English	Editorial Material									[Brooks, Rodney] MIT, Cambridge, MA 02139 USA; [Hassabis, Demis] UCL, London WC1E 6BT, England; [Bray, Dennis] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1TN, England; [Shashua, Amnon] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel; [Shashua, Amnon] Mobileye, Amstelveen, Netherlands	Massachusetts Institute of Technology (MIT); University of London; University College London; University of Cambridge; Hebrew University of Jerusalem	Brooks, R (corresponding author), MIT, Cambridge, MA 02139 USA.							McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230	2	16	16	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					462	463						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	898VM	22358812	Bronze			2022-12-28	WOS:000300770500017
J	Le Cleach, L; Chosidow, O				Le Cleach, Laurence; Chosidow, Olivier			Lichen Planus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-THE-LITERATURE; TERM-FOLLOW-UP; DOUBLE-BLIND; MALIGNANT-TRANSFORMATION; ESOPHAGEAL INVOLVEMENT; ALOE-VERA; PLANOPILARIS; PREVALENCE; EFFICACY; LONG	A 53-year-old woman presents with intensely itchy skin lesions and burning in her mouth, which makes eating difficult. These signs and symptoms have become progressively evident during the past several weeks. Examination of her skin and oral cavity reveals violaceous, polygonal papules, mainly on the flexural aspect of the wrists and ankles and in the lumbar region, as well as erosions associated with a lace-like, white-line network apparent in the posterior buccal mucosa. How should this case be managed?	[Le Cleach, Laurence; Chosidow, Olivier] Hop Henri Mondor, Dept Dermatol, F-94010 Creteil, France; [Chosidow, Olivier] Univ Paris Est, Creteil Val De Marne, France; [Le Cleach, Laurence; Chosidow, Olivier] Hop Hotel Dieu, Ctr Cochrane Francais, F-75181 Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Le Cleach, L (corresponding author), Hop Henri Mondor, Dept Dermatol, F-94010 Creteil, France.	laurence.le-cleach@hmn.aphp.fr		le cleach, Laurence/0000-0003-1385-6839	Abbott; Galderma; Bailleul-Biorga; Pierre Fabre Dermatologie; Astellas; Bayer	Abbott(Abbott Laboratories); Galderma; Bailleul-Biorga; Pierre Fabre Dermatologie; Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG)	Dr. Le Cleach reports receiving funds from Abbott and Galderma for meeting expenses. Dr. Chosidow reports receiving honoraria for attending board meetings from Basilea, consulting fees from Bailleul-Biorga, Pierre Fabre Dermatologie, Astellas, Bayer, and Galderma, and reimbursement for meeting expenses from Basilea and Galderma. No other potential conflict of interest relevant to this article was reported.	Al-Hashimi I, 2007, ORAL SURG ORAL MED S, V103, pS25e1; [Anonymous], 2011, UK GUID MAN VULV CON; Asarch A, 2009, J AM ACAD DERMATOL, V61, P104, DOI 10.1016/j.jaad.2008.09.032; Assouly P, 2009, SEMIN CUTAN MED SURG, V28, P3, DOI 10.1016/j.sder.2008.12.006; Belfiore P, 2006, BRIT J DERMATOL, V155, P994, DOI 10.1111/j.1365-2133.2006.07480.x; Bermejo-Fenoll A, 2010, J ORAL PATHOL MED, V39, P491, DOI 10.1111/j.1600-0714.2010.00894.x; Bigby M, 2009, ARCH DERMATOL, V145, P1048, DOI 10.1001/archderm.145.9.1048; BOISNIC S, 1994, ANN DERMATOL VENER, V121, P459; Brewer JD, 2011, J EUR ACAD DERMATOL, V25, P100, DOI 10.1111/j.1468-3083.2010.03693.x; Buajeeb W, 1997, ORAL SURG ORAL MED O, V83, P21, DOI 10.1016/S1079-2104(97)90085-8; CAINELLI T, 1991, ARCH DERMATOL, V127, P688; Carbone M, 2009, ORAL DIS, V15, P235, DOI 10.1111/j.1601-0825.2009.01516.x; Chieregato C, 2003, INT J DERMATOL, V42, P342, DOI 10.1046/j.1365-4362.2003.01695.x; Choonhakarn C, 2008, BRIT J DERMATOL, V158, P573, DOI 10.1111/j.1365-2133.2007.08370.x; Cooper SM, 2006, ARCH DERMATOL, V142, P289, DOI 10.1001/archderm.142.3.289; Eisen D, 1999, ORAL SURG ORAL MED O, V88, P431, DOI 10.1016/S1079-2104(99)70057-0; GIUSTINA TA, 1986, ARCH DERMATOL, V122, P534, DOI 10.1001/archderm.122.5.534; Goettmann S, 2011, J EUR ACAD DERMATOL; GONZALEZ E, 1984, J AM ACAD DERMATOL, V10, P958, DOI 10.1016/S0190-9622(84)80312-6; Guyot AD, 2007, BRIT J DERMATOL, V156, P553, DOI 10.1111/j.1365-2133.2006.07647.x; HALEVY S, 1993, J AM ACAD DERMATOL, V29, P249, DOI 10.1016/0190-9622(93)70176-T; HELLGREN L, 1970, ACTA DERM-VENEREOL, V50, P374; IRVINE C, 1991, ACTA DERM-VENEREOL, V71, P242; Issa Y, 2004, ORAL SURG ORAL MED O, V98, P553, DOI 10.1016/j.tripleo.2003.12.027; KELLETT JK, 1990, BRIT J DERMATOL, V123, P550; Kuraishi N, 2010, ACTA DERM-VENEREOL, V90, P73, DOI 10.2340/00015555-0758; LAURBERG G, 1991, J AM ACAD DERMATOL, V24, P434, DOI 10.1016/0190-9622(91)70067-C; Le Cleach L, 2008, EVIDENCE BASED DERMA, P189; Liu SY, 2009, ARCH DERMATOL, V145, P1040, DOI 10.1001/archdermatol.2009.200; Lodi G, 2005, ORAL SURG ORAL MED O, V100, P164, DOI 10.1016/j.tripleo.2004.06.076; Lodi G, 2010, ORAL DIS, V16, P601, DOI 10.1111/j.1601-0825.2010.01670.x; Malhotra AK, 2008, J AM ACAD DERMATOL, V58, P596, DOI 10.1016/j.jaad.2007.11.022; Mallon E, 2000, ARCH DERMATOL, V136, P350, DOI 10.1001/archderm.136.3.350; McCartan BE, 2008, J ORAL PATHOL MED, V37, P447, DOI 10.1111/j.1600-0714.2008.00662.x; Mirmirani P, 2009, ARCH DERMATOL, V145, P1363, DOI 10.1001/archdermatol.2009.283; Parmentier L, 2008, ARCH DERMATOL, V144, P1427, DOI 10.1001/archderm.144.11.1427; Pavlotsky F, 2008, PHOTODERMATOL PHOTO, V24, P83, DOI 10.1111/j.1600-0781.2008.00344.x; Piraccini BM, 2010, EUR J DERMATOL, V20, P489, DOI 10.1684/ejd.2010.0952; Pittelkow MR, 2008, FITZPATRICKS DERMATO, P244; Quispel R, 2009, ENDOSCOPY, V41, P187, DOI 10.1055/s-0028-1119590; Salazar-Sanchez N, 2010, J ORAL PATHOL MED, V39, P735, DOI 10.1111/j.1600-0714.2010.00947.x; Singh SK, 2006, J EUR ACAD DERMATOL, V20, P745, DOI 10.1111/j.1468-3083.2006.01500.x; Soria A, 2009, DERMATOLOGY, V218, P22, DOI 10.1159/000172830; Sperling LC, 2010, J AM ACAD DERMATOL, V62, P398, DOI 10.1016/j.jaad.2009.10.025; Sugerman PB, 2002, CRIT REV ORAL BIOL M, V13, P350, DOI 10.1177/154411130201300405; Tabolli S, 2009, DERMATOLOGY, V218, P314, DOI 10.1159/000196973; The British Society for Oral Medicine, 2010, GUID MAN OR LICH PLA; Thongprasom K, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001168, 10.1002/14651858.CD001168.pub2]; Turan H, 2009, J AM ACAD DERMATOL, V60, P164, DOI 10.1016/j.jaad.2008.09.054; TYLDESLEY WR, 1977, BRIT J DERMATOL, V96, P659, DOI 10.1111/j.1365-2133.1977.tb05211.x; Usman A, 2001, PEDIATR DERMATOL, V18, P123, DOI 10.1046/j.1525-1470.2001.018002123.x; VOUTE ABE, 1993, ORAL SURG ORAL MED O, V75, P181, DOI 10.1016/0030-4220(93)90091-H; Walton KE, 2010, PEDIATR DERMATOL, V27, P34, DOI 10.1111/j.1525-1470.2009.01072.x; Warnakulasuriya S, 2011, J ORAL PATHOL MED, V40, P677, DOI 10.1111/j.1600-0714.2011.01054.x	54	152	154	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					723	732		10.1056/NEJMcp1103641	http://dx.doi.org/10.1056/NEJMcp1103641			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356325				2022-12-28	WOS:000300551500010
J	White, MC				White, M. Christina			Adding Aliphatic C-H Bond Oxidations to Synthesis	SCIENCE			English	Editorial Material							HYDROXYLATION; INSERTION; CYCLOHEXANE; COMPLEXES; KETONE		Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	White, MC (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	white@scs.uiuc.edu						ADAM W, 1991, J AM CHEM SOC, V113, P7654, DOI 10.1021/ja00020a029; Bergman RG, 2007, NATURE, V446, P391, DOI 10.1038/446391a; BOVICELLI P, 1992, J ORG CHEM, V57, P5052, DOI 10.1021/jo00045a004; BRESLOW R, 1982, J CHEM SOC CHEM COMM, P1400, DOI 10.1039/c39820001400; Chen M. S., 2009, THESIS HARVARD U; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; CRABTREE RH, 1979, J AM CHEM SOC, V101, P7738, DOI 10.1021/ja00520a030; DEMONCEAU A, 1984, B SOC CHIM BELG, V93, P945; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; DOYLE MP, 1995, TETRAHEDRON LETT, V36, P7579, DOI 10.1016/0040-4039(95)01561-U; Espino CG, 2005, MODERN RHODIUM-CATALYZED ORGANIC REACTIONS, P379, DOI 10.1002/3527604693.ch17; Fraunhoffer KJ, 2005, ORG LETT, V7, P223, DOI 10.1021/ol047800p; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P2112, DOI 10.1002/anie.200462884; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; GROVES JT, 1979, J AM CHEM SOC, V101, P1032, DOI 10.1021/ja00498a040; Litvinas ND, 2009, ANGEW CHEM INT EDIT, V48, P4513, DOI 10.1002/anie.200901353; Liu W, 2010, J AM CHEM SOC, V132, P12847, DOI 10.1021/ja105548x; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; RUSSELL GA, 1955, J AM CHEM SOC, V77, P4578, DOI 10.1021/ja01622a041; TABER DF, 1986, J AM CHEM SOC, V108, P7686, DOI 10.1021/ja00284a037	21	550	553	6	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					807	809		10.1126/science.1207661	http://dx.doi.org/10.1126/science.1207661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344434				2022-12-28	WOS:000300356400030
J	Agnelli, G; George, DJ; Kakkar, AK; Fisher, W; Lassen, MR; Mismetti, P; Mouret, P; Chaudhari, U; Lawson, F; Turpie, AGG				Agnelli, Giancarlo; George, Daniel J.; Kakkar, Ajay K.; Fisher, William; Lassen, Michael R.; Mismetti, Patrick; Mouret, Patrick; Chaudhari, Umesh; Lawson, Francesca; Turpie, Alexander G. G.		SAVE-ONCO Investigators	Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	47th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	JUN 01-08, 2011	Chicago, IL	Amer Soc Clin Oncol			MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; PROGNOSTIC-FACTORS; RISK-FACTORS; BEVACIZUMAB; THROMBOSIS; EVENTS; PREVENTION; SURGERY; DEATH	BACKGROUND Patients receiving chemotherapy for cancer are at increased risk for venous thromboembolism. Limited data support the clinical benefit of antithrombotic prophylaxis. METHODS In this double-blind, multicenter trial, we evaluated the efficacy and safety of the ultralow-molecular-weight heparin semuloparin for prevention of venous thromboembolism in patients receiving chemotherapy for cancer. Patients with metastatic or locally advanced solid tumors who were beginning to receive a course of chemotherapy were randomly assigned to receive subcutaneous semuloparin, 20 mg once daily, or placebo until there was a change of chemotherapy regimen. The primary efficacy outcome was the composite of any symptomatic deep-vein thrombosis, any nonfatal pulmonary embolism, and death related to venous thromboembolism. Clinically relevant bleeding (major and nonmajor) was the main safety outcome. RESULTS The median treatment duration was 3.5 months. Venous thromboembolism occurred in 20 of 1608 patients (1.2%) receiving semuloparin, as compared with 55 of 1604 (3.4%) receiving placebo (hazard ratio, 0.36; 95% confidence interval [CI], 0.21 to 0.60; P<0.001), with consistent efficacy among subgroups defined according to the origin and stage of cancer and the baseline risk of venous thromboembolism. The incidence of clinically relevant bleeding was 2.8% and 2.0% in the semuloparin and placebo groups, respectively (hazard ratio, 1.40; 95% CI, 0.89 to 2.21). Major bleeding occurred in 19 of 1589 patients (1.2%) receiving semuloparin and 18 of 1583 (1.1%) receiving placebo (hazard ratio, 1.05; 95% CI, 0.55 to 1.99). Incidences of all other adverse events were similar in the two study groups. CONCLUSIONS Semuloparin reduces the incidence of thromboembolic events in patients receiving chemotherapy for cancer, with no apparent increase in major bleeding. (Funded by Sanofi; ClinicalTrials. gov number, NCT00694382.)	[Agnelli, Giancarlo] Univ Perugia, Div Internal & Cardiovasc Med, Dept Internal Med, I-06132 Perugia, Italy; [Agnelli, Giancarlo] Univ Perugia, Stroke Unit, Dept Internal Med, I-06132 Perugia, Italy; [George, Daniel J.] Duke Univ, Med Ctr, Durham, NC USA; [Kakkar, Ajay K.] Thrombosis Res Inst, London, England; [Kakkar, Ajay K.] UCL, London WC1E 6BT, England; [Fisher, William] McGill Univ, Dept Orthoped Surg, Ctr Hlth, Montreal, PQ, Canada; [Lassen, Michael R.] Copenhagen Univ Hosp Glostrup, Spine Ctr Copenhagen, Glostrup, Denmark; Univ St Etienne, Clin Pharmacol Unit, St Etienne, France; Klinikum Frankfurt, Hochst, Germany; [Chaudhari, Umesh; Lawson, Francesca] Sanofi, Bridgewater, NJ USA; [Turpie, Alexander G. G.] McMaster Univ, Hamilton, ON, Canada	University of Perugia; University of Perugia; Duke University; Thrombosis Research Institute; University of London; University College London; McGill University; University of Copenhagen; Universite Jean Monnet; Sanofi-Aventis; McMaster University	Agnelli, G (corresponding author), Univ Perugia, Dept Internal & Cardiovasc Med, I-06132 Perugia, Italy.	agnellig@unipg.it	Ales-Martinez, Jose E/D-6927-2016; Roslani, April Camilla/B-8245-2010; Vynnychenko, Ihor O/E-1684-2012; Gascon, Pere/F-7905-2015; Kaynar, Leylagul/F-6991-2013; Volovat, Constantin/N-6580-2013; Folprecht, Gunnar/F-8638-2011	Ales-Martinez, Jose E/0000-0002-4256-0060; Roslani, April Camilla/0000-0003-2458-965X; Vynnychenko, Ihor O/0000-0002-2339-6509; Kaynar, Leylagul/0000-0002-2035-9462; Volovat, Constantin/0000-0003-1582-0135; Folprecht, Gunnar/0000-0002-9321-9911; Ychou, Marc/0000-0001-7378-9469; Azerad, Marie-Agnes/0000-0001-5094-8738; Borris, Lars/0000-0002-0527-1518; Harenberg, Job/0000-0003-4590-4225; McDermott, Ray/0000-0002-8952-4315				Agnelli G, 2006, ANN SURG, V243, P89, DOI 10.1097/01.sla.0000193959.44677.48; Agnelli G, 2009, LANCET ONCOL, V10, P943, DOI 10.1016/S1470-2045(09)70232-3; Ay C, 2008, BLOOD, V112, P2703, DOI 10.1182/blood-2008-02-142422; Ay C, 2010, BLOOD, V116, P5377, DOI 10.1182/blood-2010-02-270116; Bick RL, 2003, NEW ENGL J MED, V349, P109, DOI 10.1056/NEJMp030086; Blom JW, 2006, J THROMB HAEMOST, V4, P529, DOI 10.1111/j.1538-7836.2006.01804.x; Chew HK, 2008, J THROMB HAEMOST, V6, P601, DOI 10.1111/j.1538-7836.2008.02908.x; Chew HK, 2006, ARCH INTERN MED, V166, P458; Crino L, 2010, LANCET ONCOL, V11, P733, DOI 10.1016/S1470-2045(10)70151-0; Elting, 2008, ARCH INTERN MED, V168, P1218; Elting LS, 2004, ARCH INTERN MED, V164, P1653, DOI 10.1001/archinte.164.15.1653; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FREEDMAN LS, 1976, BIOMETRICS, V32, P691, DOI 10.2307/2529759; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Haas S., 2005, J THROMB HAEMOST S1, V3; Haddad TC, 2006, THROMB RES, V118, P555, DOI 10.1016/j.thromres.2005.10.015; Hurwitz HI, 2011, J CLIN ONCOL, V29, P1757, DOI 10.1200/JCO.2010.32.3220; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Khorana AA, 2005, CANCER-AM CANCER SOC, V104, P2822, DOI 10.1002/cncr.21496; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Khorana AA, 2007, CANCER-AM CANCER SOC, V110, P2339, DOI 10.1002/cncr.23062; Lassen MR, 2009, J THROMB HAEMOST, V7, P566, DOI 10.1111/j.1538-7836.2009.03301.x; LEVINE M, 1994, LANCET, V343, P886, DOI 10.1016/S0140-6736(94)90008-6; Lewis JH, 2006, PHARMACOEPIDEM DR S, V15, P221, DOI 10.1002/pds.1209; Lyman GH, 2007, J CLIN ONCOL, V25, P5490, DOI 10.1200/JCO.2007.14.1283; Mandala M, 2010, ANN ONCOL, V21, pv274, DOI 10.1093/annonc/mdq199; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Otten HMMB, 2004, ARCH INTERN MED, V164, P190, DOI 10.1001/archinte.164.2.190; Perry JR, 2010, J THROMB HAEMOST, V8, P1959, DOI 10.1111/j.1538-7836.2010.03973.x; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Scappaticci FA, 2008, JNCI-J NATL CANCER I, V100, P156; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Shah MA, 2005, J CLIN ONCOL, V23, P2574, DOI 10.1200/JCO.2005.81.908; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Stein PD, 2006, AM J MED, V119, P163, DOI 10.1016/j.amjmed.2005.02.028; Streiff MB, 2011, J NATL COMPR CANC NE, V9, P714, DOI 10.6004/jnccn.2011.0062; Viskov C, 2009, J THROMB HAEMOST, V7, P1143, DOI 10.1111/j.1538-7836.2009.03447.x; Weitz IC, 2002, THROMB HAEMOSTASIS, V88, P213; Zangari M, 2009, J CLIN ONCOL, V27, P4865, DOI 10.1200/JCO.2009.22.3875; Zwicker JI, 2009, CLIN CANCER RES, V15, P6830, DOI 10.1158/1078-0432.CCR-09-0371	44	388	404	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					601	609		10.1056/NEJMoa1108898	http://dx.doi.org/10.1056/NEJMoa1108898			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	892IL	22335737				2022-12-28	WOS:000300279800005
J	Anheim, M; Tranchant, C; Koenig, M				Anheim, Mathieu; Tranchant, Christine; Koenig, Michel			The Autosomal Recessive Cerebellar Ataxias	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OCULOMOTOR APRAXIA TYPE-2; PLACEBO-CONTROLLED TRIAL; TRIPLET REPEAT EXPANSION; VITAMIN-E-DEFICIENCY; FRIEDREICHS-ATAXIA; PHENOTYPIC VARIABILITY; MOLECULAR-GENETICS; CLINICAL-FEATURES; REFSUMS-DISEASE; SPASTIC ATAXIA		[Anheim, Mathieu] Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Dept Genet & Cytogenet, Paris, France; [Anheim, Mathieu] Ctr Reference Malad Neurogenet Enfant & Adulte, Paris, France; [Anheim, Mathieu] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, INSERM,Unite Mixte Rech Sci S975, Paris, France; [Anheim, Mathieu] Ctr Natl Rech Sci, Unite Mixte Rech Sci 7225, Paris, France; [Tranchant, Christine] Univ Hosp Strasbourg, Dept Neurol, Strasbourg, France; [Koenig, Michel] Univ Hosp Strasbourg, Lab Diagnost Genet, Nouvel Hop Civil, Strasbourg, France; [Koenig, Michel] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, Ctr Natl Rech Sci, INSERM, Illkirch Graffenstaden, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CHU Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Anheim, M (corresponding author), Grp Hosp Pitie Salpetriere, Serv Genet, Batiment Pinel,47-83 Bd Hop, F-75651 Paris, France.	mathieu.anheim@psl.aphp.fr		tranchant, christine/0000-0002-2895-1292; Anheim, Mathieu/0000-0001-8121-0605				AMIEL J, 1995, J INHERIT METAB DIS, V18, P333, DOI 10.1007/BF00710425; Anheim M, 2008, REV NEUROL-FRANCE, V164, P363, DOI 10.1016/j.neurol.2008.02.001; Anheim M, 2010, NEUROGENETICS, V11, P1, DOI 10.1007/s10048-009-0196-y; Anheim M, 2009, BRAIN, V132, P2688, DOI 10.1093/brain/awp211; Anheim M, ARCH NEUROL IN PRESS; Anheim M, 2008, ARCH NEUROL-CHICAGO, V65, P958, DOI 10.1001/archneur.65.7.958; Assoum M, 2010, BRAIN, V133, P2439, DOI 10.1093/brain/awq181; Aure K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2; Berciano J, 2005, MOVEMENT DISORD, V20, P1643, DOI 10.1002/mds.20644; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X; Dupre N, 2007, ANN NEUROL, V62, P93, DOI 10.1002/ana.21143; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; HARDING AE, 1983, LANCET, V1, P1151; HUNGERBUHLER JP, 1985, EUR NEUROL, V24, P153, DOI 10.1159/000115788; Isnard R, 1997, CIRCULATION, V95, P2247, DOI 10.1161/01.CIR.95.9.2247; Jansen GA, 1997, NEW ENGL J MED, V337, P133, DOI 10.1056/NEJM199707103370215; Kearney M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007791.pub2; KOHLSCHUTTER A, 1988, J INHERIT METAB DIS, V11, P149, DOI 10.1007/BF01804221; Lagedrost SJ, AM HEART J, V161, p639e1; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Le Ber I, 2003, BRAIN, V126, P2761, DOI 10.1093/brain/awg283; Lynch DR, 2010, ARCH NEUROL-CHICAGO, V67, P941, DOI 10.1001/archneurol.2010.168; Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC; MASCALCHI M, 1994, AM J ROENTGENOL, V163, P187, DOI 10.2214/ajr.163.1.8010211; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; MULLER DPR, 1982, ANN NY ACAD SCI, V393, P133, DOI 10.1111/j.1749-6632.1982.tb31239.x; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Schols L, 1997, BRAIN, V120, P2131, DOI 10.1093/brain/120.12.2131; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SPIEKER S, 1995, J NEUROL, V242, P517; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stray-Pedersen A, 2007, EUR J PAEDIATR NEURO, V11, P375, DOI 10.1016/j.ejpn.2007.04.001; Su Y, 2000, ANN INTERN MED, V133, P770, DOI 10.7326/0003-4819-133-10-200011210-00009; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Tazir M, 2009, J NEUROL SCI, V278, P77, DOI 10.1016/j.jns.2008.12.004; Tranchant C, 2003, NEUROLOGY, V60, P868, DOI 10.1212/01.WNL.0000048562.88536.A4; Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097; Verhagen MMM, 2009, NEUROLOGY, V73, P430, DOI 10.1212/WNL.0b013e3181af33bd; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Vermeer S, 2009, NEUROGENETICS, V10, P87, DOI 10.1007/s10048-008-0160-2	56	218	221	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					636	646		10.1056/NEJMra1006610	http://dx.doi.org/10.1056/NEJMra1006610			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IL	22335741				2022-12-28	WOS:000300279800009
J	Freudenreich, O; Basgoz, N; Fernandez-Robles, C; Larvie, M; Misdraji, J				Freudenreich, Oliver; Basgoz, Nesli; Fernandez-Robles, Carlos; Larvie, Mykol; Misdraji, Joseph			Case 5-2012: A 39-Year-Old Man with a Recent Diagnosis of HIV Infection and Acute Psychosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIRETROVIRAL THERAPY; 1ST-EPISODE SCHIZOPHRENIA; EXTRAPYRAMIDAL SYMPTOMS; PHENOMENOLOGY; DEMENTIA		[Freudenreich, Oliver; Fernandez-Robles, Carlos] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Larvie, Mykol] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Misdraji, Joseph] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Basgoz, Nesli] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; [Freudenreich, Oliver; Fernandez-Robles, Carlos] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Basgoz, Nesli] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Larvie, Mykol] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Misdraji, Joseph] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Freudenreich, O (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.		Misdraji, Joseph/AGX-4779-2022; Misdraji, Joseph/AAD-4588-2019					BERRIOS GE, 1995, COMPR PSYCHIAT, V36, P218, DOI 10.1016/0010-440X(95)90085-A; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; BOAST N, 1994, BRIT J PSYCHIAT, V164, P842, DOI 10.1192/bjp.164.6.842; Brenner R P, 1991, Int Psychogeriatr, V3, P211, DOI 10.1017/S1041610291000686; Cardoso F, 2002, CNS DRUGS, V16, P663, DOI 10.2165/00023210-200216100-00002; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Costello D, 2007, CNS SPECTRUMS, V12, P842, DOI 10.1017/S1092852900015583; De Ronchi D, 2006, AIDS CARE, V18, P872, DOI 10.1080/09540120500307842; Debruyne H, 2009, CURR PSYCHIAT REP, V11, P197, DOI 10.1007/s11920-009-0031-z; Freudenreich O, 2009, EARLY INTERV PSYCHIA, V3, P10, DOI 10.1111/j.1751-7893.2008.00105.x; GREENBERG DB, 1984, AM J PSYCHIAT, V141, P1587; HARRIS MJ, 1991, J CLIN PSYCHIAT, V52, P369; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hernandez JL, 1997, POSTGRAD MED J, V73, P779, DOI 10.1136/pgmj.73.866.779; HRISO E, 1991, AM J PSYCHIAT, V148, P1558; JOHNSTON EC, 1988, BRIT J PSYCHIAT, V153, P770, DOI 10.1192/bjp.153.6.770; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Keefe RSE, 2007, SCHIZOPHRENIA BULL, V33, P912, DOI 10.1093/schbul/sbm046; Kelly DV, 2002, ANN PHARMACOTHER, V36, P827, DOI 10.1345/aph.1A335; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; Meagher DJ, 2007, BRIT J PSYCHIAT, V190, P135, DOI 10.1192/bjp.bp.106.023911; Meintjes G, 2010, CLIN INFECT DIS, V50, P1539, DOI 10.1086/652653; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; Meyer JM, 1998, BIOL PSYCHIAT, V44, P791, DOI 10.1016/S0006-3223(97)00552-0; Mirsattari SM, 1998, MOVEMENT DISORD, V13, P684, DOI 10.1002/mds.870130413; Nakimuli-Mpungu E, 2006, AM J PSYCHIAT, V163, P1349, DOI 10.1176/appi.ajp.163.8.1349; Norman Lisa R, 2009, Curr Drug Abuse Rev, V2, P143; Piggott DA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/103917; POWER C, 1995, J ACQ IMMUN DEF SYND, V8, P273, DOI 10.1097/00042560-199503010-00008; SEWELL DD, 1994, AM J PSYCHIAT, V151, P237; SHEDLACK KJ, 1994, BIOL PSYCHIAT, V35, P147, DOI 10.1016/0006-3223(94)91207-6; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004	32	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					648	657		10.1056/NEJMcpc1005311	http://dx.doi.org/10.1056/NEJMcpc1005311			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IL	22335743				2022-12-28	WOS:000300279800012
J	Katada, Y; Tanaka, T				Katada, Yoshinori; Tanaka, Toshio			Lingual Raynaud's Phenomenon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Katada, Yoshinori] Natl Hosp Org, Osaka Minami Med Ctr, Kawachinagano City, Japan; [Tanaka, Toshio] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan	Osaka University	Katada, Y (corresponding author), Natl Hosp Org, Osaka Minami Med Ctr, Kawachinagano City, Japan.	kataday@omh.hosp.go.jp							0	10	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					E12	E12		10.1056/NEJMicm1104140	http://dx.doi.org/10.1056/NEJMicm1104140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IL	22335764				2022-12-28	WOS:000300279800011
J	Nijhof, SL; Bleijenberg, G; Uiterwaal, CSPM; Kimpen, JLL; van de Putte, EM				Nijhof, Sanne L.; Bleijenberg, Gijs; Uiterwaal, Cuno S. P. M.; Kimpen, Jan L. L.; van de Putte, Elise M.			Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial	LANCET			English	Article							CLINICAL-TRIAL; THERAPY; CHILDREN; EPIDEMIOLOGY; POPULATION; PREVALENCE; CHILDHOOD; ANXIETY	Background Chronic fatigue syndrome is characterised by persistent fatigue and severe disability. Cognitive behavioural therapy seems to be a promising treatment, but its availability is restricted. We developed Fatigue In Teenagers on the interNET (FITNET), the first dedicated internet-based therapeutic program for adolescents with this disorder, and compared its effectiveness with that of usual care. Methods Adolescents aged 12-18 years with chronic fatigue syndrome were assigned to FITNET or usual care in a 1: 1 ratio at one tertiary treatment centre in the Netherlands by use of a computer-generated blocked randomisation allocation schedule. The study was open label. Primary outcomes were school attendance, fatigue severity, and physical functioning, and were assessed at 6 months with computerised questionnaires. Analysis was by intention to treat. Thereafter, all patients were offered FITNET if needed. This trial is registered, number ISRCTN59878666. Findings 68 of 135 adolescents were assigned to FITNET and 67 to usual care, and 67 and 64, respectively, were analysed. FITNET was significantly more effective than was usual care for all dichotomised primary outcomes at 6 months-full school attendance (50 [75%] vs 10 [16%], relative risk 4.8, 95% CI 2.7-8.9; p<0.0001), absence of severe fatigue (57 [85%] vs 17 [27%], 3.2, 2.1-4.9; p<0.0001), and normal physical functioning (52 [78%] vs 13 [20%], 3.8, 2.3-6.3; p<0.0001). No serious adverse events were reported. Interpretation FITNET offers a readily accessible and highly effective treatment for adolescents with chronic fatigue syndrome. The results of this study justify implementation on a broader scale.	[Nijhof, Sanne L.; Kimpen, Jan L. L.; van de Putte, Elise M.] Univ Med Ctr Utrecht, Dept Paediat, Wilhelmina Childrens Hosp, NL-3508 AB Utrecht, Netherlands; [Uiterwaal, Cuno S. P. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; [Bleijenberg, Gijs] Radboud Univ Nijmegen, Med Ctr, Expert Ctr Chron Fatigue, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Nijhof, SL (corresponding author), Univ Med Ctr Utrecht, Dept Paediat, Off KE 04-133-1,Postbox 85090, NL-3508 AB Utrecht, Netherlands.	s.l.nijhof@umcutrecht.nl	Nijhof, Sanne/ABG-4294-2020; Bleijenberg, Gijs/E-6984-2010	Nijhof, Sanne/0000-0003-1538-5014; 	Netherlands Organisation for Health Research and Development [ZonMW 60-60800-98-013]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This study was funded by the Netherlands Organisation for Health Research and Development (ID ZonMW 60-60800-98-013). We thank the patients and their parents who took part in this study, and Annemarie Gerritsen, Henriette Vermeer, Pauline Koetsier, Thea Berends, and Dennis Marcelissen who administered the therapy.	Bell DS, 2001, PEDIATRICS, V107, P994; Bleijenberg G., 2003, HDB CHRONIC FATIGUE, P493; Chalder T, 2003, BRIT MED J, V327, P654, DOI 10.1136/bmj.327.7416.654; Chalder T, 2010, PSYCHOL MED, V40, P1269, DOI 10.1017/S003329170999153X; Chalder T, 2002, ARCH DIS CHILD, V86, P95, DOI 10.1136/adc.86.2.95; Crawley E, 2009, ARCH DIS CHILD, V94, P752, DOI 10.1136/adc.2008.143537; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; Dowsett E. J., 1997, J CHRONIC FATIGUE SY, V3, P29, DOI DOI 10.1300/J092V03N02_; Emmelkamp PMG, 2005, PSYCHOTHER PSYCHOSOM, V74, P336, DOI 10.1159/000087780; Farmer A, 2004, BRIT J PSYCHIAT, V184, P477, DOI 10.1192/bjp.184.6.477; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Jones JF, 2004, J ADOLESCENT HEALTH, V35, P34, DOI [10.1016/j.jadohealth.2003.09.007, 10.1016/S1054-139X(03)00372-0]; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Marshall GS, 1999, J PEDIATR-US, V134, P395, DOI 10.1016/S0022-3476(99)70195-2; Nijhof SL, 2011, PEDIATRICS, V127, pE1169, DOI 10.1542/peds.2010-1147; Nijhof SL, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-23; O'Kearney Richard, 2006, Cognitive Behaviour Therapy, V35, P43, DOI 10.1080/16506070500303456; PAPAY JP, 1986, J ABNORM CHILD PSYCH, V14, P279, DOI 10.1007/BF00915446; Patten CA, 2006, PATIENT EDUC COUNS, V64, P249, DOI 10.1016/j.pec.2006.03.001; Prins JB, 2001, LANCET, V357, P841, DOI 10.1016/S0140-6736(00)04198-2; Raat H, 2002, QUAL LIFE RES, V11, P575, DOI 10.1023/A:1016393311799; Rangel L, 2000, J ROY SOC MED, V93, P129, DOI 10.1177/014107680009300306; Rimes KA, 2007, PEDIATRICS, V119, pE603, DOI 10.1542/peds.2006-2231; Ritterband LM, 2009, ANN BEHAV MED, V38, P18, DOI 10.1007/s12160-009-9133-4; Spence SH, 2006, J CONSULT CLIN PSYCH, V74, P614, DOI 10.1037/0022-006X.74.3.614; Stulemeijer M, 2005, BMJ-BRIT MED J, V330, P14, DOI 10.1136/bmj.38301.587106.63; Tate DF, 2009, ANN BEHAV MED, V38, P40, DOI 10.1007/s12160-009-9131-6; Trautmann E, 2010, BEHAV RES THER, V48, P28, DOI 10.1016/j.brat.2009.09.004; Tummers M, 2010, J CONSULT CLIN PSYCH, V78, P724, DOI 10.1037/a0020052; van Geelen SM, 2007, CLIN PSYCHOL REV, V27, P885, DOI 10.1016/j.cpr.2007.01.010; van Geelen SM, 2010, ARCH PEDIAT ADOL MED, V164, P810, DOI 10.1001/archpediatrics.2010.145; Vercoulen JHMM, 1998, J PSYCHOSOM RES, V45, P507, DOI 10.1016/S0022-3999(98)00023-3; Vercoulen JHMM, 1996, LANCET, V347, P858, DOI 10.1016/S0140-6736(96)91345-8; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X	34	137	137	0	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1412	1418		10.1016/S0140-6736(12)60025-7	http://dx.doi.org/10.1016/S0140-6736(12)60025-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	926BR	22385683				2022-12-28	WOS:000302806800029
J	Yao, P; Potdar, AA; Arif, A; Ray, PS; Mukhopadhyay, R; Willard, B; Xu, YC; Yan, J; Saidel, GM; Fox, PL				Yao, Peng; Potdar, Alka A.; Arif, Abul; Ray, Partho Sarothi; Mukhopadhyay, Rupak; Willard, Belinda; Xu, Yichi; Yan, Jun; Saidel, Gerald M.; Fox, Paul L.			Coding Region Polyadenylation Generates a Truncated tRNA Synthetase that Counters Translation Repression	CELL			English	Article							SECONDARY STRUCTURE; NONCANONICAL FUNCTION; INITIATION-FACTOR; GAMMA-INTERFERON; TRANSCRIPT; TERMINATION; MECHANISMS; PHOSPHORYLATION; RECOGNITION; EXPRESSION	Posttranscriptional regulatory mechanisms superimpose "fine-tuning" control upon "on-off" switches characteristic of gene transcription. We have exploited computational modeling with experimental validation to resolve an anomalous relationship between mRNA expression and protein synthesis. The GAIT (gamma-interferon-activated inhibitor of translation) complex repressed VEGF-A synthesis to a low, constant rate independent of VEGF-A mRNA expression levels. Dynamic model simulations predicted an inhibitory GAIT-element-interacting factor to account for this relationship and led to the identification of a truncated form of glutamylprolyl tRNA synthetase (EPRS), a GAIT constituent that mediates binding to target transcripts. The truncated protein, EPRSN1, shields GAIT-element-bearing transcripts from the inhibitory GAIT complex, thereby dictating a "translational trickle" of GAIT target proteins. EPRSN1 mRNA is generated by poly-adenylation-directed conversion of a Tyr codon in the EPRS-coding sequence to a stop codon (PAY*). Genome-wide analysis revealed multiple candidate PAY* targets, including the authenticated target RRM1, suggesting a general mechanism for production of C terminus-truncated regulatory proteins.	[Yao, Peng; Potdar, Alka A.; Arif, Abul; Ray, Partho Sarothi; Mukhopadhyay, Rupak; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Lerner Res Inst, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA; [Ray, Partho Sarothi] Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata 700064, W Bengal, India; [Mukhopadhyay, Rupak] Tezpur Univ, Dept Mol Biol & Biotechnol, Sonitpur 784028, Assam, India; [Xu, Yichi; Yan, Jun] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Potdar, Alka A.; Saidel, Gerald M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Saidel, Gerald M.] Case Western Reserve Univ, Ctr Modeling Integrated Metab Syst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Indian Institute of Science Education & Research (IISER) - Kolkata; Tezpur University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Case Western Reserve University; Case Western Reserve University	Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA.	foxp@ccf.org	Yao, Peng/J-4492-2013; Ray, Partho Sarothi/H-3020-2019; Potdar, Alka/E-6882-2012; Yao, Peng/Y-8047-2019; Yao, Peng/G-5218-2015; Mukhopadhyay, Rupak/Q-9168-2017	Yao, Peng/0000-0002-7029-8629; Ray, Partho Sarothi/0000-0002-8795-3060; Yao, Peng/0000-0002-1145-3967; Yao, Peng/0000-0003-1022-3948; Mukhopadhyay, Rupak/0000-0001-5211-1413; Saidel, Gerald/0000-0003-2159-2343; Yan, Jun/0000-0002-0405-0502; Xu, Yichi/0000-0002-8163-3920	National Institutes of Health [P01 HL029582, P01 HL076491, R01 GM086430, R01 DK083359]; American Heart Association, Great Rivers Affiliate; American Heart Association [10SDG3930003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Great Rivers Affiliate(American Heart Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Richard Padgett for helpful discussions and David Dignam for the gift of anti-PRS antibody. This work was supported in part by National Institutes of Health grants P01 HL029582, P01 HL076491, R01 GM086430, and R01 DK083359 to P.L.F. P.Y. was supported by a Postdoctoral Fellowship from the American Heart Association, Great Rivers Affiliate, and A.A. by National Center Scientist Development Grant 10SDG3930003 from the American Heart Association.	AHMED YF, 1991, CELL, V64, P727, DOI 10.1016/0092-8674(91)90502-P; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; BARSHIRA A, 1991, J VIROL, V65, P5165, DOI 10.1128/JVI.65.10.5165-5173.1991; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hans H, 2000, MOL CELL BIOL, V20, P2926, DOI 10.1128/MCB.20.8.2926-2932.2000; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jordheim LP, 2011, LANCET ONCOL, V12, P693, DOI 10.1016/S1470-2045(10)70244-8; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; McMahon KW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-35; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wu CX, 2004, MOL CELL BIOL, V24, P2789, DOI 10.1128/MCB.24.7.2789-2796.2004	48	70	74	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					88	100		10.1016/j.cell.2012.02.018	http://dx.doi.org/10.1016/j.cell.2012.02.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22386318	Bronze, Green Accepted			2022-12-28	WOS:000302235400012
J	Guo, WJ; Keckesova, Z; Donaher, JL; Shibue, T; Tischler, V; Reinhardt, F; Itzkovitz, S; Noske, A; Zurrer-Hardi, U; Bell, G; Tam, WL; Mani, SA; van Oudenaarden, A; Weinberg, RA				Guo, Wenjun; Keckesova, Zuzana; Donaher, Joana Liu; Shibue, Tsukasa; Tischler, Verena; Reinhardt, Ferenc; Itzkovitz, Shalev; Noske, Aurelia; Zuerrer-Haerdi, Ursina; Bell, George; Tam, Wai Leong; Mani, Sendurai A.; van Oudenaarden, Alexander; Weinberg, Robert A.			Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTIONAL NETWORK; CANCER; BREAST; GLAND; DIFFERENTIATION; MORPHOGENESIS; POPULATIONS; PROGENITORS; METASTASIS	Regulatory networks orchestrated by key transcription factors (TFs) have been proposed to play a central role in the determination of stem cell states. However, the master transcriptional regulators of adult stem cells are poorly understood. We have identified two TFs, Slug and Sox9, that act cooperatively to determine the mammary stem cell (MaSC) state. Inhibition of either Slug or Sox9 blocks MaSC activity in primary mammary epithelial cells. Conversely, transient coexpression of exogenous Slug and Sox9 suffices to convert differentiated luminal cells into MaSCs with long-term mammary gland-reconstituting ability. Slug and Sox9 induce MaSCs by activating distinct autoregulatory gene expression programs. We also show that coexpression of Slug and Sox9 promotes the tumorigenic and metastasis-seeding abilities of human breast cancer cells and is associated with poor patient survival, providing direct evidence that human breast cancer stem cells are controlled by key regulators similar to those operating in normal murine MaSCs.	[Guo, Wenjun; Keckesova, Zuzana; Donaher, Joana Liu; Shibue, Tsukasa; Reinhardt, Ferenc; Bell, George; Tam, Wai Leong; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tischler, Verena; Noske, Aurelia; Zuerrer-Haerdi, Ursina] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Itzkovitz, Shalev; van Oudenaarden, Alexander; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Itzkovitz, Shalev; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Mani, Sendurai A.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77054 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Zurich; University Zurich Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Tam, Wai Leong/P-1497-2019; Mani, Sendurai A./A-7244-2009; Tischler, Verena/Q-7263-2017; van Oudenaarden, Alexander/AAA-1705-2019	Tam, Wai Leong/0000-0003-2365-5264; Mani, Sendurai A./0000-0002-5918-4276; Tischler, Verena/0000-0002-6673-8329; 	Breast Cancer Research Foundation; Alexander and Margaret Stewart Trust, National Cancer Institute [P01-CA080111]; National Institute of Health (NIH) [R01-CA078461]; National Cancer Institute [F32CA144404]; American Cancer Society and Ludwig Foundation; Department of Defense Breast Cancer; NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; NATIONAL CANCER INSTITUTE [P01CA080111, R01CA078461, U54CA143874, F32CA144404] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Alexander and Margaret Stewart Trust, National Cancer Institute; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society and Ludwig Foundation; Department of Defense Breast Cancer(United States Department of Defense); NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Scott Valastyan, Christina Scheel, Christine Chaffer, and Richard Goldsby for critical review of the manuscript. We thank Kong Jie Kah and Dr. Tal Kafri for providing tetracycline-inducible lentiviral vectors and Dr. Rudolf Jaenisch for providing Rosa26-M2rtTA mice. This research was supported by grants from the Breast Cancer Research Foundation, The Alexander and Margaret Stewart Trust, National Cancer Institute Program P01-CA080111, and National Institute of Health (NIH) R01-CA078461. R. A. W. is an American Cancer Society and Ludwig Foundation professor. W. G. was supported by a Susan G. Komen for the Cure postdoctoral fellowship and a fellowship from the National Cancer Institute (F32CA144404). Z.K. was supported by a Department of Defense Breast Cancer Postdoctoral Fellowship. S. I. and A.v.O. were supported by the NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874). W. G., Z.K., and R. A. W. are inventors on a patent application in part based on findings detailed in this publication.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; DEOME KB, 1959, CANCER RES, V19, P515; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2006, CELL CYCLE, V5, P1519, DOI 10.4161/cc.5.14.2983; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310	40	685	705	7	103	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					1015	1028		10.1016/j.cell.2012.02.008	http://dx.doi.org/10.1016/j.cell.2012.02.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385965	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000300985000020
J	Wang, JW; Sun, Q; Morita, Y; Jiang, H; Gross, A; Lechel, A; Hildner, K; Guachalla, LM; Gompf, A; Hartmann, D; Schambach, A; Wuestefeld, T; Dauch, D; Schrezenmeier, H; Hofmann, WK; Nakauchi, H; Ju, ZY; Kestler, HA; Zender, L; Rudolph, KL				Wang, Jianwei; Sun, Qian; Morita, Yohei; Jiang, Hong; Gross, Alexander; Lechel, Andre; Hildner, Kai; Guachalla, Luis Miguel; Gompf, Anne; Hartmann, Daniel; Schambach, Axel; Wuestefeld, Torsten; Dauch, Daniel; Schrezenmeier, Hubert; Hofmann, Wolf-Karsten; Nakauchi, Hiromitsu; Ju, Zhenyu; Kestler, Hans A.; Zender, Lars; Rudolph, K. Lenhard			A Differentiation Checkpoint Limits Hematopoietic Stem Cell Self-Renewal in Response to DNA Damage	CELL			English	Article							TRANSCRIPTION FACTOR; LIFE-SPAN; MULTIPOTENT PROGENITORS; TELOMERE DYSFUNCTION; MYELOID-LEUKEMIA; CANCER; MOUSE; SCREEN; MICE; AGE	Checkpoints that limit stem cell self-renewal in response to DNA damage can contribute to cancer protection but may also promote tissue aging. Molecular components that control stem cell responses to DNA damage remain to be delineated. Using in vivo RNAi screens, we identified basic leucine zipper transcription factor, ATF-like (BATF) as a major component limiting self-renewal of hematopoietic stem cells (HSCs) in response to telomere dysfunction and g-irradiation. DNA damage induces BATF in a G-CSF/ STAT3-dependent manner resulting in lymphoid differentiation of HSCs. BATF deletion improves HSC self-renewal and function in response to g-irradiation or telomere shortening but results in accumulation of DNA damage in HSCs. Analysis of bone marrow from patients with myelodysplastic syndrome supports the conclusion that DNA damage-dependent induction of BATF is conserved in human HSCs. Together, these results provide experimental evidence that a BATF-dependent differentiation checkpoint limits self-renewal of HSCs in response to DNA damage.	[Wang, Jianwei; Sun, Qian; Morita, Yohei; Jiang, Hong; Lechel, Andre; Guachalla, Luis Miguel; Gompf, Anne; Hartmann, Daniel; Rudolph, K. Lenhard] Univ Ulm, Inst Mol Med, D-89069 Ulm, Germany; [Wang, Jianwei; Sun, Qian; Morita, Yohei; Jiang, Hong; Lechel, Andre; Guachalla, Luis Miguel; Gompf, Anne; Hartmann, Daniel; Rudolph, K. Lenhard] Univ Ulm, Max Planck Res Dept Stem Cell Aging, D-89069 Ulm, Germany; [Gross, Alexander; Kestler, Hans A.] Univ Ulm, Res Grp Bioinformat & Syst Biol, Inst Neural Informat Proc, D-89069 Ulm, Germany; [Schrezenmeier, Hubert] Univ Ulm, Inst Clin Transfus Med & Immunogenet, D-89069 Ulm, Germany; [Ju, Zhenyu] Hangzhou Normal Univ Coll Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Hildner, Kai] Univ Erlangen Nurnberg, Max Eder Res Grp, Dept Med 1, D-91054 Erlangen, Germany; [Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, D-30625 Hannover, Germany; [Wuestefeld, Torsten; Dauch, Daniel; Zender, Lars] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Wuestefeld, Torsten; Dauch, Daniel; Zender, Lars] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Hofmann, Wolf-Karsten] Mannheim Univ Hosp, Dept Hematol & Oncol, D-68167 Mannheim, Germany; [Nakauchi, Hiromitsu] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Tokyo 1088639, Japan; [Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Tokyo 1088639, Japan; [Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv Baden Wurtte, D-76530 Baden Baden, Germany	Ulm University; Max Planck Society; Ulm University; Ulm University; Ulm University; University of Erlangen Nuremberg; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Ruprecht Karls University Heidelberg; University of Tokyo; Japan Science & Technology Agency (JST)	Rudolph, KL (corresponding author), Univ Ulm, Inst Mol Med, D-89069 Ulm, Germany.	klrudolph@fli-leibniz.de	Kestler, Hans A./D-5799-2012; Schambach, Axel/C-5491-2011; Lechel, André/AAQ-2041-2021; Morita, Yohei/N-1260-2014	Kestler, Hans A./0000-0002-4759-5254; Lechel, André/0000-0003-0221-6959; Morita, Yohei/0000-0003-4163-5080; Rudolph, Karl Lenhard/0000-0002-4839-2862; Guachalla, Luis Miguel/0000-0003-1152-9930; Hartmann, Daniel/0000-0003-4366-8986	DFG [Ru745-11, Ru745-10, SFB497/C11, ZE545-2]; European Union (Telomarker); BMBF (SyStaR); International Graduate School in Molecular Medicine at Ulm University [GSC270]	DFG(German Research Foundation (DFG)); European Union (Telomarker)(European Commission); BMBF (SyStaR)(Federal Ministry of Education & Research (BMBF)); International Graduate School in Molecular Medicine at Ulm University	This work was supported by the DFG (Ru745-11 and -10, by the SFB497/C11, ZE545-2), the European Union (Telomarker), the BMBF (SyStaR), and by the International Graduate School in Molecular Medicine at Ulm University (GSC270). We thank Susan Schlenner and Hans-Reimer Rodewald for providing IL7R Cre reporter mice and Hans-Joerg Fehling for providing ROSA RFP mice.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; KASTAN MB, 1991, CANCER RES, V51, P4279; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu Y, 2011, BLOOD, V117, P3257, DOI 10.1182/blood-2010-09-304402; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; OHYASHIKI JH, 1994, CANCER RES, V54, P3557; Pelicci PG, 2004, J CLIN INVEST, V113, P4, DOI 10.1172/JCI200420750; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Schambach A, 2006, EXP HEMATOL, V34, P588, DOI 10.1016/j.exphem.2006.02.005; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Senga T, 2002, ONCOGENE, V21, P8186, DOI 10.1038/sj.onc.1205918; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SULLIVAN DM, 1987, CANCER RES, V47, P3973; TIAN SS, 1994, BLOOD, V84, P1760; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Wang JW, 2011, CURR OPIN IMMUNOL, V23, P532, DOI 10.1016/j.coi.2011.05.004; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; WRIGHT WE, 1992, TRENDS GENET, V8, P193, DOI 10.1016/0168-9525(92)90232-S; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	54	238	248	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					1001	1014		10.1016/j.cell.2012.01.040	http://dx.doi.org/10.1016/j.cell.2012.01.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385964	hybrid			2022-12-28	WOS:000300985000019
J	Kramer, DB; Xu, S; Kesselheim, AS				Kramer, Daniel B.; Xu, Shuai; Kesselheim, Aaron S.			Regulation of Medical Devices in the United States and European Union	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LEFT-ATRIAL-APPENDAGE; CARDIOVASCULAR DEVICES; CLINICAL-EVALUATION; APPROVAL PROCESS; AORTIC-STENOSIS; PUBLIC-HEALTH; FDA; CLOSURE; TRIAL; INTERVENTION		[Kramer, Daniel B.; Xu, Shuai; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Kramer, Daniel B.] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Kramer, DB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	AHRQ HHS [K08HS18465-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Altenstetter C, 2003, INT J TECHNOL ASSESS, V19, P228, DOI 10.1017/S0266462303000217; [Anonymous], 2009, FDA SHOULD TAK STEPS; [Anonymous], 2009, MED DEV DEV CLASS; [Anonymous], CE MARK FAST ROUT CO; Baim DS, 2002, CIRCULATION, V105, P1285, DOI 10.1161/01.CIR.0000012783.63093.0C; Bates ER, 2011, CIRCULATION, V124, P355, DOI 10.1161/CIRCULATIONAHA.110.974204; Brown SL, 2004, EXPERT REV MED DEVIC, V1, P1, DOI 10.1586/17434440.1.1.1; Chai JY, 2000, FOOD DRUG LAW J, V55, P57; Chen CE, 2011, ARCH INTERN MED, V171, P534, DOI 10.1001/archinternmed.2010.445; Cingolani E, 2011, ARCH INTERN MED, V171, P1670, DOI 10.1001/archinternmed.2011.329; Committee Staff House of Representatives Committee on Energy and Commerce, 2011, INT MEM; DePonte SL, 2010, SYSTEM; Dhruva SS, 2010, JAMA-J AM MED ASSOC, V303, P422, DOI 10.1001/jama.2010.59; Dhruva SS, 2011, CIRC-CARDIOVASC QUAL, V4, P165, DOI 10.1161/CIRCOUTCOMES.110.958215; DiBardino DJ, 2011, J THORAC CARDIOV SUR, V142, P222, DOI 10.1016/j.jtcvs.2011.04.014; Directorate B. Unit B2, 2010, MED DEV GUID DOC CLA; European Commission, 2011, MED DEV GUID MEDDEVS; EUROPEAN COMMISSION, 2010, CLASS CRIT; European Commission, 2009, 271 MEDDEV ER COMM; European Commission, 2004, 2122 MEDDEV EUR COMM; Ferman J, 2010, MED DEVICES IND ASSE; Food and Drug Administration, AMPL PAT DUCT ART OC; Food and Drug Administration, 2011, 515 PROGR IN; Food and Drug Administration, CARDIOSEAL SEPTAL OC; Food and Drug Administration, 2010, MED DEV US FEE PROGR; Fraser AG, 2011, EUR HEART J, V32, P1673, DOI 10.1093/eurheartj/ehr171; Gallagher J, 2012, BBC NEWS        0114; GLOBAL HARMONIZATION TASK FORCE, 2005, REV CURR REQ POSTM S; Gollaher D, 2011, COMPETITIVENESS REGU; Gottlieb S., 2011, WALL STREET J, pA17; Grunkemeier GL, 2006, ANN THORAC SURG, V82, P776, DOI 10.1016/j.athoracsur.2006.06.037; Hamburg MA, 2009, NEW ENGL J MED, V360, P2493, DOI 10.1056/NEJMp0903764; Hauser RG, 2007, HEART RHYTHM, V4, P892, DOI 10.1016/j.hrthm.2007.03.041; Heneghan C, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000155; Hines JZ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000280; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Horton R, 2012, LANCET, V379, P1060; Hulstaert F, 2011, PREMARKET CLIN EVALU; Kaplan AV, 2004, CIRCULATION, V109, P3068, DOI 10.1161/01.CIR.0000134695.65733.64; Kramer DB, 2010, AM J THER, V17, P2, DOI 10.1097/MJT.0b013e3181ca8105; Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416; Laskey Warren K, 2005, Am J Ther, V12, P179, DOI 10.1097/01.mjt.0000155116.73845.6c; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1901, DOI 10.1001/jama.295.16.1901; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Maisel WH, 2009, NEW ENGL J MED, V360, P2601, DOI 10.1056/NEJMp0903763; Makower J., 2010, FDA IMPACT US MEDICA; O'Dowd A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e11; O'Riordan M, 2011, BENEFIT AF CATHETER; Okie S, 2010, NEW ENGL J MED, V363, P1492, DOI 10.1056/NEJMp1009686; PricewaterhouseCoopers, 2011, MED TECHN INN SCOR R; Reynolds MR, 2011, CIRCULATION, V124, P1964, DOI 10.1161/CIRCULATIONAHA.111.040022; SAPIRSTEIN W, 1994, CIRCULATION, V89, P1900, DOI 10.1161/01.CIR.89.4.1900; Schreyogg J, 2010, HEALTH POLICY, V94, P90, DOI 10.1016/j.healthpol.2009.09.008; Sharfstein JM, 2011, JAMA-J AM MED ASSOC, V306, P1250, DOI 10.1001/jama.2011.1345; Shuren J, STATEMENT SUBCOMMITT; Sweet BV, 2011, J MANAGE CARE PHARM, V17, P40, DOI 10.18553/jmcp.2011.17.1.40; Thompson M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2973; Webb JG, 1999, J AM COLL CARDIOL, V34, P468, DOI 10.1016/S0735-1097(99)00196-5; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Wizemann T., 2010, PUBLIC HLTH EFFECTIV; Wood AJJ, 2008, NEW ENGL J MED, V358, P1774, DOI 10.1056/NEJMp0802227; Zuckerman DM, 2011, ARCH INTERN MED, V171, P1006, DOI 10.1001/archinternmed.2011.30; 1998, FED REG, V63, P59217	64	167	170	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					848	855		10.1056/NEJMhle1113918	http://dx.doi.org/10.1056/NEJMhle1113918			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900GI	22332952				2022-12-28	WOS:000300874300015
J	Gibson, JM				Gibson, J. Murray			Solving Amorphous Structures-Two Pairs Beat One	SCIENCE			English	Editorial Material									Northeastern Univ, Dept Phys, Boston, MA 02115 USA	Northeastern University	Gibson, JM (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.	m.gibson@neu.edu	Gibson, Murray/E-5855-2013	Gibson, Murray/0000-0002-0807-6224				ANDERSON PW, 1975, PHYS REV LETT, V34, P953, DOI 10.1103/PhysRevLett.34.953; Billinge S.J.L., 2010, PHYSICS, V3, P25, DOI DOI 10.1103/PHYSICS.3.25; Bogle SN, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/45/455204; Gibson JM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.125504; GRACZYK JF, 1975, J NON-CRYST SOLIDS, V17, P299, DOI 10.1016/0022-3093(75)90122-2; Polk D. E., 1971, Journal of Non-Crystalline Solids, V5, P365, DOI 10.1016/0022-3093(71)90038-X; RUDEE ML, 1972, PHILOS MAG, V25, P1001, DOI 10.1080/14786437208229319; SPEAR WE, 1975, SOLID STATE COMMUN, V17, P1193, DOI 10.1016/0038-1098(75)90284-7; Street R. A., 1991, HYDROGENATED AMORPHO, V1991, P36; Treacy MMJ, 2012, SCIENCE, V335, P950, DOI 10.1126/science.1214780; Treacy MMJ, 1996, ACTA CRYSTALLOGR A, V52, P212, DOI 10.1107/S0108767395012876; Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006	12	16	17	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					929	930		10.1126/science.1218723	http://dx.doi.org/10.1126/science.1218723			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22362998				2022-12-28	WOS:000300931800034
J	Dyson, G				Dyson, George			The dawn of computing	NATURE			English	Editorial Material												Gdyson@ias.edu						[Anonymous], 1945, I ADV STUD EL COMP P; Burks A. W., 1966, THEORY SELF REPRODUC, P74; Turing AM, 1939, P LOND MATH SOC, V45, P161; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Turing AM, 1947, COMMUNICATION   0220; von Neumann J., 1966, THEORY SELF REPRODUC, P42	6	2	4	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					459	460		10.1038/482459a	http://dx.doi.org/10.1038/482459a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	898VM	22358810				2022-12-28	WOS:000300770500015
J	Shojania, KG; Silver, I; Levinson, W				Shojania, Kaveh G.; Silver, Ivan; Levinson, Wendy			Continuing Medical Education and Quality Improvement: A Match Made in Heaven?	ANNALS OF INTERNAL MEDICINE			English	Article							CARE; PERFORMANCE; STRATEGIES; RISK; GAP	New models of continuing medical education (CME) seek not only to impart knowledge but to change physicians' behavior and even play a role in facilitating organizational improvement. These CME models thus share some of the same basic goals as the field of quality improvement (QI), namely behavioral change and systems redesign to improve patient outcomes. This article provides some practical ideas about how CME providers and QI experts may beneficially integrate these 2 fields. It outlines several models for harnessing the existing engagement in traditional CME to achieve the goal of equipping practitioners with knowledge and skills related to QI, while also addressing the widely recognized problems with traditional CME. The authors touch on possible incentives to make such integrated models of CME and QI attractive to practitioners.	[Shojania, Kaveh G.] Univ Toronto, Ctr Patient Safety, Sunnybrook Hlth Sci Ctr, Room H468,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Silver, Ivan] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5G 2C4, Canada; [Levinson, Wendy] Univ Toronto, Dept Med, Suite 3-805,R Fraser Elliott Bldg,190 Elizabeth S, Toronto, ON M5G 2C4, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Levinson, W (corresponding author), Univ Toronto, Dept Med, Suite 3-805,R Fraser Elliott Bldg,190 Elizabeth S, Toronto, ON M5G 2C4, Canada.	wen-dy.levinson@utoronto.ca						Albanese M, 2009, ACAD MED, V84, P1056, DOI 10.1097/ACM.0b013e3181ade83c; [Anonymous], AC CME US CAN 2010 A; Audet AMJ, 2005, PHYS VIEWS QUALITY C; Boonyasai RT, 2007, JAMA-J AM MED ASSOC, V298, P1023, DOI 10.1001/jama.298.9.1023; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Brown JA, 2011, J CONTIN EDUC HEALTH, V31, P57, DOI 10.1002/chp.20101; Campbell C, 2010, MED TEACH, V32, P657, DOI 10.3109/0142159X.2010.500708; Campbell EG, 2009, JAMA-J AM MED ASSOC, V302, P1807, DOI 10.1001/jama.2009.1560; Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Grimshaw Jeremy M, 2002, J Contin Educ Health Prof, V22, P237, DOI 10.1002/chp.1340220408; Hampton T, 2008, JAMA-J AM MED ASSOC, V299, P1003, DOI 10.1001/jama.299.9.1003; Lannon C, 2007, JT COMM J QUAL PATIE, V33, P66, DOI 10.1016/S1553-7250(07)33124-3; Mansouri M, 2007, J CONTIN EDUC HEALTH, V27, P6, DOI 10.1002/chp.88; Marinopoulos Spyridon S, 2007, Evid Rep Technol Assess (Full Rep), P1; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Newton WP, 2010, J CONTIN EDUC HEALTH, V30, P106, DOI 10.1002/chp.20066; Ontario Ministry of Health and Long-Term Care, MOST RESP PHYS QUAL; Parboosingh IJ, 2011, J CONTIN EDUC HEALTH, V31, P122, DOI 10.1002/chp.20116; Price D, 2005, MED TEACH, V27, P259, DOI 10.1080/01421590500046270; Schouten LMT, 2008, BMJ-BRIT MED J, V336, P1491, DOI 10.1136/bmj.39570.749884.BE; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Snow V, 2010, AM J MED QUAL, V25, P261, DOI 10.1177/1062860610362259; Zolotor AJ, 2007, PEDIATRICS, V120, pE644, DOI 10.1542/peds.2006-1749	25	48	48	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					305	+		10.7326/0003-4819-156-4-201202210-00008	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896YO	22351715				2022-12-28	WOS:000300607600007
J	Whalen, F				Whalen, Francis			Noninvasive ventilation reduced need for intubation in elderly patients with acute hypercapnic respiratory failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mayo Clin, Rochester, MN 55902 USA	Mayo Clinic	Whalen, F (corresponding author), Mayo Clin, Rochester, MN 55902 USA.		Fanfulla, Francesco/ABI-2221-2020	Fanfulla, Francesco/0000-0002-8601-423X; Grassi, Mario/0000-0001-6612-8566				Carlucci A, 2003, INTENS CARE MED, V29, P419, DOI 10.1007/s00134-002-1574-1; Garpestad E, 2007, CHEST, V132, P711, DOI 10.1378/chest.06-2643; Weng Min-Hsueh, 2008, Intensive Crit Care Nurs, V24, P295, DOI 10.1016/j.iccn.2007.11.005	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-2	10.7326/0003-4819-156-4-201202210-02002	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351728				2022-12-28	WOS:000208885400001
J	Koivunen, P; Lee, S; Duncan, CG; Lopez, G; Lu, G; Ramkissoon, S; Losman, JA; Joensuu, P; Bergmann, U; Gross, S; Travins, J; Weiss, S; Looper, R; Ligon, KL; Verhaak, RGW; Yan, H; Kaelin, WG				Koivunen, Peppi; Lee, Sungwoo; Duncan, Christopher G.; Lopez, Giselle; Lu, Gang; Ramkissoon, Shakti; Losman, Julie A.; Joensuu, Paivi; Bergmann, Ulrich; Gross, Stefan; Travins, Jeremy; Weiss, Samuel; Looper, Ryan; Ligon, Keith L.; Verhaak, Roel G. W.; Yan, Hai; Kaelin, William G., Jr.			Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation	NATURE			English	Article							HYPOXIA-INDUCIBLE FACTOR; ONCOMETABOLITE 2-HYDROXYGLUTARATE; PROLYL 4-HYDROXYLASE; ACTIVE-SITE; MUTATIONS; TUMORS; IDH1; HYDROXYLASES; KNOCKOUTS; CELLS	The identification of succinate dehydrogenase (SDH), fumarate hydratase (FH) and isocitrate dehydrogenase (IDH) mutations in human cancers has rekindled the idea that altered cellular metabolism can transform cells. Inactivating SDH and FH mutations cause the accumulation of succinate and fumarate, respectively, which can inhibit 2-oxoglutarate (2-OG)-dependent enzymes, including the EGLN prolyl 4-hydroxylases that mark the hypoxia inducible factor (HIF) transcription factor for polyubiquitylation and proteasomal degradation(1). Inappropriate HIF activation is suspected of contributing to the pathogenesis of SDH-defective and FH-defective tumours but can suppress tumour growth in some other contexts. IDH1 and IDH2, which catalyse the interconversion of isocitrate and 2-OG, are frequently mutated in human brain tumours and leukaemias. The resulting mutants have the neomorphic ability to convert 2-OG to the (R)-enantiomer of 2-hydroxyglutarate ((R)-2HG)(2,3). Here we show that (R)-2HG, but not (S)-2HG, stimulates EGLN activity, leading to diminished HIF levels, which enhances the proliferation and soft agar growth of human astrocytes. These findings define an enantiomer-specific mechanism by which the (R)-2HG that accumulates in IDH mutant brain tumours promotes transformation and provide a justification for exploring EGLN inhibition as a potential treatment strategy.	[Lee, Sungwoo; Lu, Gang; Ramkissoon, Shakti; Losman, Julie A.; Ligon, Keith L.; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lee, Sungwoo; Lu, Gang; Ramkissoon, Shakti; Losman, Julie A.; Ligon, Keith L.; Kaelin, William G., Jr.] Brigham & Womens Hosp, Boston, MA 02215 USA; [Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Bioctr Oulu, FIN-90014 Oulu, Finland; [Duncan, Christopher G.; Lopez, Giselle; Yan, Hai] Pediat Brain Tumor Fdn Inst, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC 27710 USA; [Duncan, Christopher G.; Lopez, Giselle; Yan, Hai] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Joensuu, Paivi] Univ Oulu, Dept Chem, FIN-90014 Oulu, Finland; [Bergmann, Ulrich] Univ Oulu, Dept Biochem, Mass Spectrometry Core Facil, Bioctr Oulu, FIN-90014 Oulu, Finland; [Gross, Stefan; Travins, Jeremy] Agios Pharmaceut, Cambridge, MA 02139 USA; [Weiss, Samuel] Univ Calgary, Fac Med, Dept Cell Biol, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Weiss, Samuel] Univ Calgary, Fac Med, Dept Anat, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Looper, Ryan] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Ligon, Keith L.] Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Oulu; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Agios Pharmaceuticals; University of Calgary; University of Calgary; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu	Lopez, Giselle/M-2575-2019; Verhaak, Roel/ABE-7058-2020	/0000-0001-5435-6668; Duncan, Christopher/0000-0001-7205-2414; Looper, Ryan/0000-0003-1626-1363	National Institutes of Health; HHMI; Doris Duke Foundation; Academy of Finland [120156, 140765, 218129]; S. Juselius Foundation; NATIONAL CANCER INSTITUTE [R01CA068490, R01CA140316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Academy of Finland(Academy of Finland); S. Juselius Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. P. Hausinger and J. D. Rabinowitz for helpful suggestions and critical reading of the manuscript, C. Schofield and Y. Zhang for reagents, S. Chen and Y. Shi for JMJD2D assays, K. Koski for modelling and T. Aatsinki and E. Lehtimaki for technical assistance. W. G. K. is a Doris Duke Distinguished Clinical Scholar and a Howard Hughes Medical Institute (HHMI) Investigator. Supported by the National Institutes of Health (W. G. K.), HHMI (W. G. K.), Doris Duke Foundation (W. G. K.), Academy of Finland Grants 120156, 140765 and 218129 (P. K.) and S. Juselius Foundation (P.K.).	Acker T, 2005, CANCER CELL, V8, P131, DOI 10.1016/j.ccr.2005.07.003; Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Moroni I, 2004, NEUROLOGY, V62, P1882, DOI 10.1212/01.WNL.0000125335.21381.87; Nickols NG, 2007, ACS CHEM BIOL, V2, P561, DOI 10.1021/cb700110z; Ozisik PA, 2002, PEDIATR NEUROSURG, V37, P22, DOI 10.1159/000065097; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; PRITCHARD JB, 1995, J PHARMACOL EXP THER, V274, P1278; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Sonoda Y, 2001, CANCER RES, V61, P4956; Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang XV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017691; Williams SC, 2011, ACTA NEUROPATHOL, V121, P279, DOI 10.1007/s00401-010-0790-y; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	41	541	562	5	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2012	483	7390					485	U144		10.1038/nature10898	http://dx.doi.org/10.1038/nature10898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22343896	Green Submitted, Green Accepted			2022-12-28	WOS:000301771200047
J	Basler, M; Pilhofer, M; Henderson, GP; Jensen, GJ; Mekalanos, JJ				Basler, M.; Pilhofer, M.; Henderson, G. P.; Jensen, G. J.; Mekalanos, J. J.			Type VI secretion requires a dynamic contractile phage tail-like structure	NATURE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; TARGET-CELLS; SYSTEM; TOMOGRAPHY; APPARATUS; ALIGNMENT; BACTERIA; ACTIN	Type VI secretion systems are bacterial virulence-associated nanomachines composed of proteins that are evolutionarily related to components of bacteriophage tails. Here we show that protein secretion by the type VI secretion system of Vibrio cholerae requires the action of a dynamic intracellular tubular structure that is structurally and functionally homologous to contractile phage tail sheath. Time-lapse fluorescence light microscopy reveals that sheaths of the type VI secretion system cycle between assembly, quick contraction, disassembly and re-assembly. Whole-cell electron cryotomography further shows that the sheaths appear as long tubular structures in either extended or contracted conformations that are connected to the inner membrane by a distinct basal structure. These data support a model in which the contraction of the type VI secretion system sheath provides the energy needed to translocate proteins out of effector cells and into adjacent target cells.	[Pilhofer, M.; Henderson, G. P.; Jensen, G. J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Basler, M.; Mekalanos, J. J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Pilhofer, M.; Jensen, G. J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Harvard University; Harvard Medical School; California Institute of Technology; Howard Hughes Medical Institute	Jensen, GJ (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	Jensen@caltech.edu; john_mekalanos@hms.harvard.edu	Basler, Marek/A-3559-2012	Basler, Marek/0000-0001-5414-2088	National Institute of Allergy and Infectious Diseases [AI-018045, AI-26289]; National Institute of General Medical Sciences [GM094800B]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289, R22AI018045, R37AI018045, R01AI018045] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. G. Bernhardt and N. T. Peters for assistance with fluorescence microscopy, discussions and for a gift of plasmids carrying sfGFP and mCherry2 genes. We thank the Nikon Imaging Center at Harvard Medical School for help with fluorescence microscopy, and Research Precision Instruments and Hamamatsu for lending an ORCA-Flash2.8 camera. We thank the Harvard Medical School Electron Microscopy Facility for help with and supervision of transmission electron microscopy. We thank M. K. Waldor for a V. cholerae 2740-80 strain and discussions. We thank D. Ewen Cameron for a knockout construct pWM91-flgG. We thank B. Wen and Z. Li for initial cryotomographic studies. This work was supported by National Institute of Allergy and Infectious Diseases grants AI-018045 and AI-26289 to J.J.M. and National Institute of General Medical Sciences grant GM094800B to G.J.J.	Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; GOLDBERG S, 1983, INFECT IMMUN, V42, P224, DOI 10.1128/IAI.42.1.224-230.1983; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pilhofer M, 2010, METHOD CELL BIOL, V96, P21, DOI 10.1016/S0091-679X(10)96002-0; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	36	433	457	10	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2012	483	7388					182	U78		10.1038/nature10846	http://dx.doi.org/10.1038/nature10846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22367545	Green Accepted			2022-12-28	WOS:000301174900031
J	Baltussen, R; Smith, A				Baltussen, Rob; Smith, Andrew			Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study	BRITISH MEDICAL JOURNAL			English	Article							REFRACTIVE ERRORS; VISUAL IMPAIRMENT; SCHOOLCHILDREN; INTERVENTIONS; CHILDREN; HEALTH	Objective To determine the relative costs, effects, and cost effectiveness of selected interventions to control cataract, trachoma, refractive error, hearing loss, meningitis and chronic otitis media. Design Cost effectiveness analysis of or combined strategies for controlling vision and hearing loss by means of a lifetime population model. Setting Two World Health Organization sub-regions of the world where vision and hearing loss are major burdens: sub-Saharan Africa and South East Asia. Data sources Biological and behavioural parameters from clinical and observational studies and population based surveys. Intervention effects and resource inputs based on published reports, expert opinion, and the WHO-CHOICE database. Main outcome measures Cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results Treatment of chronic otitis media, extracapsular cataract surgery, trichiasis surgery, treatment for meningitis, and annual screening of schoolchildren for refractive error are among the most cost effective interventions to control hearing and vision impairment, with the cost per DALY averted <$Int285 in both regions. Screening of both schoolchildren (annually) and adults (every five years) for hearing loss costs around $Int1000 per DALY averted. These interventions can be considered highly cost effective. Mass treatment with azithromycin to control trachoma can be considered cost effective in the African but not the South East Asian sub-region. Conclusions Vision and hearing impairment control interventions are generally cost effective. To decide whether substantial investments in these interventions is warranted, this finding should be considered in relation to the economic attractiveness of other, existing or new, interventions in health.	[Baltussen, Rob] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Smith, Andrew] Univ London London Sch Hyg & Trop Med, Ctr Disabil & Dev, London WC1E 7HT, England	Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine	Baltussen, R (corresponding author), Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	R.Baltussen@elg.umcn.nl	Baltussen, R.M.P.M./L-4181-2015					Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; [Anonymous], 2011, INT DRUG PRICE INDIC; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Baltussen R, 2009, INT J AUDIOL, V48, P144, DOI 10.1080/14992020802538081; Baltussen RMRM, 2005, OPHTHAL EPIDEMIOL, V12, P91, DOI 10.1080/09286580590932761; Baltussen R, 2009, HEALTH POLICY, V89, P201, DOI 10.1016/j.healthpol.2008.06.003; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Congdon N, 2008, ARCH OPHTHALMOL-CHIC, V126, P1717, DOI 10.1001/archopht.126.12.1717; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; HOGEWEG M, 1992, ACTA OPHTHALMOL, V70, P407; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Hutubessy RCW, 2001, HEALTH ECON, V10, P473, DOI 10.1002/hec.614; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Lauer Jeremy A, 2003, Cost Eff Resour Alloc, V1, P6, DOI 10.1186/1478-7547-1-6; Limburg H, 1999, ACTA OPHTHALMOL SCAN, V77, P310, DOI 10.1034/j.1600-0420.1999.770313.x; Limburg H, 1995, World Health Forum, V16, P173; Mackenzie I, 2009, ANN TROP MED PARASIT, V103, P565, DOI 10.1179/000349809X12459740922372; MATHERS C, 2002, GLOBAL BURDEN HEARIN; Mathers C., 2005, GLOBAL BURDEN ADULT; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Smith A, 2006, INFECT HEARING IMPAI; Tan Torres T, 2003, WHO GUIDE COST EFFEC; Unicef, 2008, DAT SCH ENR; Vincent JE, 2010, OPTOMETRY VISION SCI, V87, P958, DOI 10.1097/OPX.0b013e3181fef3a9; Vision 2020, 2011, GLOB IN EL AV BLINDN; World Health Organisation World Wide Hearing, 2009, 7 WORKSH PROV HEAR A; World Health Organization, 2011, FACT SHEET MAGN CAUS; World Health Organization, 2011, FACT SHEET DEAFN HEA; World Health Organization, 2004, GLOB BURD DIS 2004 U	34	43	43	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2012	344								e615	10.1136/bmj.e615	http://dx.doi.org/10.1136/bmj.e615			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XQ	22389341	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000301232600006
J	Wake, DB				Wake, David B.			Facing Extinction in Real Time	SCIENCE			English	Editorial Material							BATRACHOCHYTRIUM-DENDROBATIDIS; FUNGAL PATHOGEN; POPULATIONS; AMPHIBIANS; DECLINES; CHYTRIDIOMYCOSIS; DIVERSITY; DYNAMICS; AMERICA; CLIMATE		Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wake, DB (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	wakelab@berkeley.edu	Wake, David/AAA-6766-2021	Wake, David/0000-0003-4835-2497				Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Early R, 2011, ECOL LETT, V14, P1125, DOI 10.1111/j.1461-0248.2011.01681.x; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Martinez-Solano I, 2007, MOL ECOL, V16, P4335, DOI 10.1111/j.1365-294X.2007.03527.x; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	16	62	65	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1052	1053		10.1126/science.1218364	http://dx.doi.org/10.1126/science.1218364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383836				2022-12-28	WOS:000300931100031
J	Caseiro, MM; da Costa, SOP				Caseiro, Marcos Montani; Pinto da Costa, Sergio Olavo			Spider Angioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Caseiro, Marcos Montani; Pinto da Costa, Sergio Olavo] UNISANTOS, Sao Paulo, Brazil	Universidade Catolica de Santos	Caseiro, MM (corresponding author), UNISANTOS, Sao Paulo, Brazil.								0	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					E13	E13		10.1056/NEJMicm1109272	http://dx.doi.org/10.1056/NEJMicm1109272			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356347				2022-12-28	WOS:000300551500001
J	Fonagy, P; Lemma, A				Fonagy, Peter; Lemma, Alessandra			Does psychoanalysis have a valuable place in modern mental health services? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							TERM PSYCHODYNAMIC PSYCHOTHERAPY; METAANALYSIS; DISORDER		[Fonagy, Peter] UCL, Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England; [Lemma, Alessandra] Tavistock & Portman NHS Fdn Trust, Psychol Therapies Dev Unit, London, England; [Fonagy, Peter] Anna Freud Ctr, London, England; [Lemma, Alessandra] UCL, Psychol Intervent Res Ctr, London WC1E 6BT, England	University of London; University College London; The Anna Freud Centre; University of London; University College London	Fonagy, P (corresponding author), UCL, Dept Clin Educ & Hlth Psychol, Mortimer St, London WC1E 6BT, England.	p.fonagy@ucl.ac.uk		Fonagy, Peter/0000-0003-0229-0091	National Institute for Health Research [NF-SI-0510-10228] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abbass A, 2009, PSYCHOTHER PSYCHOSOM, V78, P265, DOI 10.1159/000228247; de Greck M, 2011, WORLD J BIOL PSYCHIA, V12, P296, DOI 10.3109/15622975.2010.539269; Department of Health, 2011, NO HLTH MENT HLTH CR; Fonagy P, 2010, PSYCHOANAL PSYCHOTHE, V24, P22, DOI 10.1080/02668731003590139; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Jakobsen JC, 2011, J AFFECT DISORD; Karlsson H, 2010, PSYCHOL MED, V40, P523, DOI 10.1017/S0033291709991607; Karlsson H, 2011, PSYCHIAT TIMES, V28; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Kobak R., 2008, HDB ATTACHMENT THEOR, P23; Leichsenring F, 2011, BRIT J PSYCHIAT, V199, P15, DOI 10.1192/bjp.bp.110.082776; Lemma A., 2011, DYNAMIC INTERPERSONA; Shedler J, 2010, AM PSYCHOL, V65, P98, DOI 10.1037/a0018378	13	11	11	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 20	2012	344								e1211	10.1136/bmj.e1211	http://dx.doi.org/10.1136/bmj.e1211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900IY	22349582	Green Accepted, Green Submitted			2022-12-28	WOS:000300881600011
J	Murchison, EP; Schulz-Trieglaff, OB; Ning, ZM; Alexandrov, LB; Bauer, MJ; Fu, BY; Hims, M; Ding, ZH; Ivakhno, S; Stewart, C; Ng, BL; Wong, WD; Aken, B; White, S; Alsop, A; Becq, J; Bignell, GR; Cheetham, RK; Cheng, W; Connor, TR; Cox, AJ; Feng, ZP; Gu, Y; Grocock, RJ; Harris, SR; Khrebtukova, I; Kingsbury, Z; Kowarsky, M; Kreiss, A; Luo, SJ; Marshall, J; McBride, DJ; Murray, L; Pearse, AM; Raine, K; Rasolonjatovo, I; Shaw, R; Tedder, P; Tregidgo, C; Vilella, AJ; Wedge, DC; Woods, GM; Gormley, N; Humphray, S; Schroth, G; Smith, G; Hall, K; Searle, SMJ; Carter, NP; Papenfuss, AT; Futreal, PA; Campbell, PJ; Yang, FT; Bentley, DR; Evers, DJ; Stratton, MR				Murchison, Elizabeth P.; Schulz-Trieglaff, Ole B.; Ning, Zemin; Alexandrov, Ludmil B.; Bauer, Markus J.; Fu, Beiyuan; Hims, Matthew; Ding, Zhihao; Ivakhno, Sergii; Stewart, Caitlin; Ng, Bee Ling; Wong, Wendy; Aken, Bronwen; White, Simon; Alsop, Amber; Becq, Jennifer; Bignell, Graham R.; Cheetham, R. Keira; Cheng, William; Connor, Thomas R.; Cox, Anthony J.; Feng, Zhi-Ping; Gu, Yong; Grocock, Russell J.; Harris, Simon R.; Khrebtukova, Irina; Kingsbury, Zoya; Kowarsky, Mark; Kreiss, Alexandre; Luo, Shujun; Marshall, John; McBride, David J.; Murray, Lisa; Pearse, Anne-Maree; Raine, Keiran; Rasolonjatovo, Isabelle; Shaw, Richard; Tedder, Philip; Tregidgo, Carolyn; Vilella, Albert J.; Wedge, David C.; Woods, Gregory M.; Gormley, Niall; Humphray, Sean; Schroth, Gary; Smith, Geoffrey; Hall, Kevin; Searle, Stephen M. J.; Carter, Nigel P.; Papenfuss, Anthony T.; Futreal, P. Andrew; Campbell, Peter J.; Yang, Fengtang; Bentley, David R.; Evers, Dirk J.; Stratton, Michael R.			Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer	CELL			English	Article							FACIAL-TUMOR DISEASE; EVOLUTION; DIVERSITY; PATTERNS; ORIGINS; DFTD	The Tasmanian devil (Sarcophilus harrisii), the largest marsupial carnivore, is endangered due to a transmissible facial cancer spread by direct transfer of living cancer cells through biting. Here we describe the sequencing, assembly, and annotation of the Tasmanian devil genome and whole-genome sequences for two geographically distant subclones of the cancer. Genomic analysis suggests that the cancer first arose from a female Tasmanian devil and that the clone has subsequently genetically diverged during its spread across Tasmania. The devil cancer genome contains more than 17,000 somatic base substitution mutations and bears the imprint of a distinct mutational process. Genotyping of somatic mutations in 104 geographically and temporally distributed Tasmanian devil tumors reveals the pattern of evolution and spread of this parasitic clonal lineage, with evidence of a selective sweep in one geographical area and persistence of parallel lineages in other populations.	[Murchison, Elizabeth P.; Ning, Zemin; Alexandrov, Ludmil B.; Fu, Beiyuan; Ding, Zhihao; Stewart, Caitlin; Ng, Bee Ling; Aken, Bronwen; White, Simon; Bignell, Graham R.; Cheng, William; Connor, Thomas R.; Gu, Yong; Harris, Simon R.; Marshall, John; McBride, David J.; Raine, Keiran; Wedge, David C.; Searle, Stephen M. J.; Carter, Nigel P.; Futreal, P. Andrew; Campbell, Peter J.; Yang, Fengtang; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Schulz-Trieglaff, Ole B.; Bauer, Markus J.; Hims, Matthew; Ivakhno, Sergii; Wong, Wendy; Becq, Jennifer; Cheetham, R. Keira; Cox, Anthony J.; Grocock, Russell J.; Kingsbury, Zoya; Murray, Lisa; Rasolonjatovo, Isabelle; Shaw, Richard; Tedder, Philip; Tregidgo, Carolyn; Gormley, Niall; Humphray, Sean; Smith, Geoffrey; Hall, Kevin; Bentley, David R.; Evers, Dirk J.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Alsop, Amber] Australian Natl Univ, Res Sch Biol Sci, Comparat Genom Grp, Canberra, ACT 2601, Australia; [Feng, Zhi-Ping; Kowarsky, Mark; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Feng, Zhi-Ping] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Khrebtukova, Irina; Luo, Shujun; Schroth, Gary] Illumina Hayward, Hayward, CA 94545 USA; [Kreiss, Alexandre; Woods, Gregory M.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7001, Australia; [Pearse, Anne-Maree] Dept Primary Ind Parks Water & Environm, Hlth Anim Lab, Kings Meadows, Tas 7249, Australia; [Vilella, Albert J.] European Bioinformat Inst, Hinxton CB10 1SA, England; [Papenfuss, Anthony T.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia	Wellcome Trust Sanger Institute; Illumina; Australian National University; Walter & Eliza Hall Institute; University of Melbourne; Illumina; University of Tasmania; European Molecular Biology Laboratory (EMBL); University of Melbourne	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	elizabeth.murchison@sanger.ac.uk; mrs@sanger.ac.uk	Woods, Greg/J-7533-2014; Feng, Zhi-Ping/L-2083-2016; Stewart, Caitlin Marie/AAA-9515-2022; Connor, Thomas/ABE-5989-2020; Harris, Simon R/K-1318-2013; Yang, Fan/GYU-4249-2022; Ning, Zemin/D-2411-2013; Alexandrov, Ludmil/AAS-1454-2021; Wedge, David/AAC-4977-2021; Alexandrov, Ludmil/B-6582-2014; Connor, Thomas/ABD-6533-2021; Papenfuss, Anthony T/C-6297-2008	Woods, Greg/0000-0001-8421-7917; Stewart, Caitlin Marie/0000-0002-5070-4810; Connor, Thomas/0000-0003-2394-6504; Harris, Simon R/0000-0003-1512-6194; Alexandrov, Ludmil/0000-0003-3596-4515; Alexandrov, Ludmil/0000-0003-3596-4515; Papenfuss, Anthony T/0000-0002-1102-8506; Ding, Zhihao/0000-0003-0961-2284; Vilella, Albert/0000-0002-2005-2516; Ning, Zemin/0000-0003-4359-776X; Yang, Fengtang/0000-0002-3573-2354; Cox, Anthony/0000-0002-6534-749X; Aken, Bronwen/0000-0002-3032-4095; Murchison, Elizabeth Proby/0000-0001-7462-8907; Shaw, Richard/0000-0001-8145-1601; Wedge, David/0000-0002-7572-3196; Kowarsky, Mark/0000-0001-5180-5683; White, Simon/0000-0001-6375-2363; Raine, Keiran/0000-0002-5634-1539	NHMRC; King's College, Cambridge; Wellcome Trust [077012/Z/05/Z]; Dr Eric Guiler Tasmanian Devil Research Grant; L'Oreal UNESCO, UK and Ireland	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); King's College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission); Dr Eric Guiler Tasmanian Devil Research Grant; L'Oreal UNESCO, UK and Ireland(L'Oreal Group)	We are grateful to Sarah Peck, Colette Harmsen, Rodrigo Hamede, Kate Swift, Bobby Hua, Robyn Taylor, Stephen Pyecroft, and the Save the Tasmanian Devil Program for assistance with sample collection. We thank Erin Pleasance, Thierry Voet, Chris Greenman, David Obendorf, Janine Deakin, Stephen Rice, Sue Bumpstead, and Emma Werner for assistance and discussions. Thanks to Hannah Bender for permission to use DFTD image, to Willem Rens and Malcolm Ferguson-Smith (University of Cambridge) for providing the Tasmanian devil and opossum fibroblast cell lines, and to Matthew Breen (North Carolina State University) for providing images of opossum metaphases. E.P.M. was supported by an NHMRC Overseas Biomedical Fellowship, an EMBO Fellowship, and a Research Fellowship from King's College, Cambridge. This work was supported in part by a Wellcome Trust grant (077012/Z/05/Z), a Dr Eric Guiler Tasmanian Devil Research Grant, and a L'Oreal UNESCO For Women in Science Fellowship, UK and Ireland (E.P.M.). All authors at Illumina (see the affiliations) are employees of Illumina Inc., a public company that develops and markets systems for genetic analysis. All authors at Illumina receive stocks as part of their compensation.	Arnett HA, 2009, CYTOKINE, V46, P370, DOI 10.1016/j.cyto.2009.03.009; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Eldridge M.D.B., 2006, ATLAS MAMMALIAN CHRO, P30; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gandhi Manish J., 2007, Cell and Tissue Banking, V8, P267, DOI 10.1007/s10561-007-9036-1; Gartner HV, 1996, NEW ENGL J MED, V335, P1494, DOI 10.1056/NEJM199611143352004; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hamede RK, 2008, AUSTRAL ECOL, V33, P614, DOI 10.1111/j.1442-9993.2007.01827.x; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Kreiss A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022402; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lachish S, 2011, CONSERV GENET RESOUR, V3, P279, DOI 10.1007/s12686-010-9341-z; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; MARTIN PG, 1967, CHROMOSOMA, V20, P290, DOI 10.1007/BF00326187; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller W., 2011, P NATL ACAD SCI US; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Owen D, 2005, TASMANIAN DEVIL UNIQ; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Potter SC, 2004, GENOME RES, V14, P934, DOI 10.1101/gr.1859804; Rebbeck CA, 2011, SCIENCE, V331, P303, DOI 10.1126/science.1197696; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; SOUTHAM CM, 1957, SCIENCE, V125, P158, DOI 10.1126/science.125.3239.158; Stammers M, 2000, IMMUNOGENETICS, V51, P373, DOI 10.1007/s002510050633; Thomas R, 2009, CHROMOSOME RES, V17, P927, DOI 10.1007/s10577-009-9080-8; Tolar J, 2003, J PEDIAT HEMATOL ONC, V25, P430, DOI 10.1097/00043426-200306000-00002; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005	40	229	233	2	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					780	791		10.1016/j.cell.2011.11.065	http://dx.doi.org/10.1016/j.cell.2011.11.065			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341448	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000300622400018
J	Price, DC; Chan, CX; Yoon, HS; Yang, EC; Qiu, H; Weber, APM; Schwacke, R; Gross, J; Blouin, NA; Lane, C; Reyes-Prieto, A; Durnford, DG; Neilson, JAD; Lang, BF; Burger, G; Steiner, JM; Loffelhardt, W; Meuser, JE; Posewitz, MC; Ball, S; Arias, MC; Henrissat, B; Coutinho, PM; Rensing, SA; Symeonidi, A; Doddapaneni, H; Green, BR; Rajah, VD; Boore, J; Bhattacharya, D				Price, Dana C.; Chan, Cheong Xin; Yoon, Hwan Su; Yang, Eun Chan; Qiu, Huan; Weber, Andreas P. M.; Schwacke, Rainer; Gross, Jeferson; Blouin, Nicolas A.; Lane, Chris; Reyes-Prieto, Adrian; Durnford, Dion G.; Neilson, Jonathan A. D.; Lang, B. Franz; Burger, Gertraud; Steiner, Juergen M.; Loeffelhardt, Wolfgang; Meuser, Jonathan E.; Posewitz, Matthew C.; Ball, Steven; Arias, Maria Cecilia; Henrissat, Bernard; Coutinho, Pedro M.; Rensing, Stefan A.; Symeonidi, Aikaterini; Doddapaneni, Harshavardhan; Green, Beverley R.; Rajah, Veeran D.; Boore, Jeffrey; Bhattacharya, Debashish			Cyanophora paradoxa Genome Elucidates Origin of Photosynthesis in Algae and Plants	SCIENCE			English	Article							PLASTID ENDOSYMBIOSIS; PROTEIN TRANSLOCATION; ANCIENT ORIGIN; COMMON ORIGIN; GREEN PLANTS; EVOLUTION; CYANELLES; NUCLEUS; SINGLE; ESTABLISHMENT	The primary endosymbiotic origin of the plastid in eukaryotes more than 1 billion years ago led to the evolution of algae and plants. We analyzed draft genome and transcriptome data from the basally diverging alga Cyanophora paradoxa and provide evidence for a single origin of the primary plastid in the eukaryote supergroup Plantae. C. paradoxa retains ancestral features of starch biosynthesis, fermentation, and plastid protein translocation common to plants and algae but lacks typical eukaryotic light-harvesting complex proteins. Traces of an ancient link to parasites such as Chlamydiae were found in the genomes of C. paradoxa and other Plantae. Apparently, Chlamydia-like bacteria donated genes that allow export of photosynthate from the plastid and its polymerization into storage polysaccharide in the cytosol.	[Price, Dana C.; Chan, Cheong Xin; Gross, Jeferson; Rajah, Veeran D.; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Price, Dana C.; Chan, Cheong Xin; Gross, Jeferson; Rajah, Veeran D.; Bhattacharya, Debashish] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Yoon, Hwan Su; Yang, Eun Chan; Qiu, Huan] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA; [Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Weber, Andreas P. M.] Univ Dusseldorf, Inst Plant Biochem, D-40225 Dusseldorf, Germany; [Schwacke, Rainer] Univ Cologne, Inst Bot, Bioctr Cologne, D-50674 Cologne, Germany; [Blouin, Nicolas A.; Lane, Chris] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Reyes-Prieto, Adrian] Univ New Brunswick, Canadian Inst Adv Res, Dept Biol, Fredericton, NB E3B 5A3, Canada; [Lang, B. Franz; Burger, Gertraud] Univ Montreal, Dept Biochim, Ctr Robert Cedergren, Montreal, PQ H3C 3J7, Canada; [Steiner, Juergen M.] Univ Halle Wittenberg, Dept Biol Plant Physiol, D-4010 Halle, Germany; [Loeffelhardt, Wolfgang] Univ Vienna, Dept Biochem & Cell Biol, Max F Perutz Labs, Vienna, Austria; [Meuser, Jonathan E.] Colorado Sch Mines, Dept Civil & Environm Engn, Golden, CO 80401 USA; [Posewitz, Matthew C.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Ball, Steven; Arias, Maria Cecilia] Univ Sci & Technol Lille, CNRS USTL, UMR 8576, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 1, F-13288 Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 2, F-13288 Marseille, France; [Rensing, Stefan A.; Symeonidi, Aikaterini] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Rensing, Stefan A.; Symeonidi, Aikaterini] Univ Freiburg, FRISYS Freiburg Initiat Syst Biol, D-79106 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Doddapaneni, Harshavardhan] Univ Iowa, Dept Biol, Roy J Carver Ctr Genom, Iowa City, IA 52242 USA; [Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Boore, Jeffrey] Genome Project Solut, Hercules, CA 94547 USA; [Boore, Jeffrey] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Bigelow Laboratory for Ocean Sciences; Sungkyunkwan University (SKKU); Heinrich Heine University Dusseldorf; University of Cologne; University of Rhode Island; Canadian Institute for Advanced Research (CIFAR); University of New Brunswick; Universite de Montreal; Martin Luther University Halle Wittenberg; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Colorado School of Mines; Colorado School of Mines; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Freiburg; University of Freiburg; University of Freiburg; University of Iowa; University of British Columbia; University of California System; University of California Berkeley	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.	bhattacharya@aesop.rutgers.edu	Green, Beverley R./AAJ-5199-2021; Chan, Cheong Xin/A-7005-2008; Henrissat, Bernard/J-2475-2012; Weber, Andreas PM/A-6250-2011; Arias, Maria Cecilia/H-4886-2012; Yoon, Hwan Su/A-2974-2013; Weber, Andreas Paul Michael/O-3043-2019; Qiu, Huan/C-2671-2016	Green, Beverley R./0000-0002-4021-9387; Chan, Cheong Xin/0000-0002-3729-8176; Henrissat, Bernard/0000-0002-3434-8588; Weber, Andreas PM/0000-0003-0970-4672; Weber, Andreas Paul Michael/0000-0003-0970-4672; Yang, Eun Chan/0000-0001-8211-8130; Ball, Steven/0000-0003-1629-1650; doddapaneni, harshavardhan/0000-0002-2433-633X; Steiner, Jurgen/0000-0002-6572-7468; Yoon, Hwan Su/0000-0001-9507-0105	National Science Foundation [MGSP 0625440, MCB 0946528, EF 0827023, DEB 0936884]; BioGreen 21 Rural Development Administration of South Korea [PJ008177]; Air Force Office of Scientific Research [FA9550-11-1-0211]; Deutsche Forschungsgemeinschaft CRC TR1; Austrian Science Foundation [P19683]; Canadian Institute for Health Research [MSP-14226]; German Federal Ministry of Education and Research; Natural Sciences and Engineering Research Council of Canada (NSERC); Office of Integrative Activities [1004057] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); BioGreen 21 Rural Development Administration of South Korea(Rural Development Administration (RDA), Republic of Korea); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Deutsche Forschungsgemeinschaft CRC TR1; Austrian Science Foundation(Austrian Science Fund (FWF)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was made possible by grants from the National Science Foundation (MGSP 0625440 and MCB 0946528) awarded to D. B. and J.B. Partial support came from NSF grants EF 0827023 and DEB 0936884 awarded to D. B. and H.S.Y. and by BioGreen 21 (PJ008177) Rural Development Administration of South Korea awarded to H.S.Y. Air Force Office of Scientific Research grant FA9550-11-1-0211 supported work by J.E.M. and M. C. P. A. P. M. W. appreciates support from Deutsche Forschungsgemeinschaft CRC TR1. W. L. acknowledges support from the Austrian Science Foundation (P19683). G. B. acknowledges funding from Canadian Institute for Health Research operating grant MSP-14226. S. R. and A. S. acknowledge funding from the German Federal Ministry of Education and Research. G. B. acknowledges the Natural Sciences and Engineering Research Council of Canada (NSERC) for general laboratory funding. We are grateful to B. Andersen and the staff at the Provasoli-Guillard National Center for Culture of Marine Phytoplankton (CCMP) for preparing the axenic culture of C. paradoxa. We thank I. Plante and L. Forget for technical assistance in mtDNA cloning and sequencing and N. Beck for development of the MFannot computer program. The sequence data used to assemble the draft C. paradoxa genome and the Illumina mRNA-seq reads from this alga are archived at the NCBI Sequence Read Archive (SRA) under accession number SRP00920. The assembled genome and cDNA contigs, gene models, gene annotations, supporting material that is not in the SOM, and the phylogenomic results are available at (22). The complete C. paradoxa and G. nostochinearum mitochondrial genomes are available at NCBI under accession numbers HQ849544 and NC_015117, respectively. The partial mitochondrial genome data from G. nostochinearum are available at the genome Web site as part of the aligned protein data set used to infer the plastid multigene tree. We are grateful for the helpful comments of two anonymous reviewers of this manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CAVALIERSMITH T, 1981, BIOSYSTEMS, V14, P461, DOI 10.1016/0303-2647(81)90050-2; Chan CX, 2011, CURR BIOL, V21, P328, DOI 10.1016/j.cub.2011.01.037; Colleoni C, 2010, MOL BIOL EVOL, V27, P2691, DOI 10.1093/molbev/msq158; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Gross J, 2009, TRENDS PLANT SCI, V14, P13, DOI 10.1016/j.tplants.2008.10.003; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; Huang JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r99; Loffelhardt W., 1997, PLANT SYST EVOL S, V11, P149; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meuser JE, 2009, J BIOTECHNOL, V142, P21, DOI 10.1016/j.jbiotec.2009.01.015; Moustafa A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002205; Moustafa A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-6; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Pfanzagl B, 1996, J BACTERIOL, V178, P332, DOI 10.1128/jb.178.2.332-339.1996; Plancke C, 2008, EUKARYOT CELL, V7, P247, DOI 10.1128/EC.00373-07; Posewitz MC, 2009, CHLAMYDOMONAS SOURCE, P217, DOI [10.1016/B978-0-12-370873, DOI 10.1016/B978-0-12-370873]; Reumann S, 2005, MOL MEMBR BIOL, V22, P73, DOI 10.1080/09687860500041916; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Reyes-Prieto A, 2010, MOL BIOL EVOL, V27, P1530, DOI 10.1093/molbev/msq032; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Sato Naoki, 2005, Genome Inform, V16, P56; Steiner JM, 2005, MOL MEMBR BIOL, V22, P123, DOI 10.1080/09687860500041411; Stiller JW, 2007, TRENDS PLANT SCI, V12, P391, DOI 10.1016/j.tplants.2007.08.002; Weber APM, 2006, EUKARYOT CELL, V5, P609, DOI 10.1128/EC.5.3.609-612.2006; WOLFE GR, 1994, NATURE, V367, P566, DOI 10.1038/367566a0; Wunder T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-236; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Yusa F, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-304	37	259	270	5	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					843	847		10.1126/science.1213561	http://dx.doi.org/10.1126/science.1213561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344442				2022-12-28	WOS:000300356400041
J	Singh, A; Sweeney, MF; Yu, M; Burger, A; Greninger, P; Benes, C; Haber, DA; Settleman, J				Singh, Anurag; Sweeney, Michael F.; Yu, Min; Burger, Alexa; Greninger, Patricia; Benes, Cyril; Haber, Daniel A.; Settleman, Jeff			TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers	CELL			English	Article							ONCOGENIC KRAS; BETA-CATENIN; RAS; PROTEIN; EXPRESSION; PROGRESSION; PATHWAYS; REVEALS; KINASE; GENES	Colon cancers frequently harbor KRAS mutations, yet only a subset of KRAS mutant colon cancer cell lines are dependent upon KRAS signaling for survival. In a screen for kinases that promote survival of KRAS-dependent colon cancer cells, we found that the TAK1 kinase (MAP3K7) is required for tumor cell viability. The induction of apoptosis by RNAi-mediated depletion or pharmacologic inhibition of TAK1 is linked to its suppression of hyperactivated Wnt signaling, evident in both endogenous and genetically reconstituted cells. In APC mutant/KRAS-dependent cells, KRAS stimulates BMP-7 secretion and BMP signaling, leading to TAK1 activation and enhancement of Wnt-dependent transcription. An in vitro-derived "TAK1 dependency signature'' is enriched in primary human colon cancers with mutations in both APC and KRAS, suggesting potential clinical utility in stratifying patient populations. Together, these findings identify TAK1 inhibition as a potential therapeutic strategy for a treatment-refractory subset of colon cancers exhibiting aberrant KRAS and Wnt pathway activation.	[Singh, Anurag; Sweeney, Michael F.; Yu, Min; Burger, Alexa; Greninger, Patricia; Benes, Cyril; Haber, Daniel A.; Settleman, Jeff] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Singh, Anurag; Sweeney, Michael F.; Yu, Min; Burger, Alexa; Greninger, Patricia; Benes, Cyril; Haber, Daniel A.; Settleman, Jeff] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu; settleman.jeffrey@gene.com	Singh, Anurag/C-7347-2014	Singh, Anurag/0000-0003-4705-8683; Yu, Min/0000-0002-3969-8720	NIH [K99 CA149169, R01 CA109447, R01 CA129933]; Lustgarten Foundation; NATIONAL CANCER INSTITUTE [K99CA149169, R01CA109447, R01CA129933, R00CA149169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lustgarten Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH K99 CA149169 to A.S. as well as NIH R01 CA109447 and a Lustgarten Foundation grant to J.S. and NIH R01 CA129933 to D.A.H. We are grateful to Randall Peterson, David Ting, and Andre Bernards for critical evaluation and comments on the manuscript. We thank Laura Libby and Brian Brannigan for technical assistance with mouse xenograft experiments and KRAS/BRAF sequencing analyses, respectively. We thank Vijay Yajnik for providing TOP-FLASH reporter plasmids. Finally, we also thank Kevin Haigis, Moon Yee Hang, Miguel Rivera, Jianmin Zhang, Mingzhu Liu, and Matt Zubrowski for intellectual and technical advice.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gasch AP, 2002, GENOME BIOL, V3; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Lin ZH, 2008, J BIOL CHEM, V283, P33053, DOI 10.1074/jbc.M804039200; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Melisi D, 2011, JNCI-J NATL CANCER I, V103, P1190, DOI 10.1093/jnci/djr243; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Rawlins P, 1999, INT J IMMUNOPHARMACO, V21, P799, DOI 10.1016/S0192-0561(99)00047-8; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	36	199	211	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					639	650		10.1016/j.cell.2011.12.033	http://dx.doi.org/10.1016/j.cell.2011.12.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341439	Green Accepted, Bronze			2022-12-28	WOS:000300622400007
J	Pincock, S				Pincock, Stephen			Shen Xiaoming: linking evidence to advocacy for health in China	LANCET			English	Biographical-Item														Pincock, Stephen/0000-0003-1655-2902					0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2012	379	9818					795	795		10.1016/S0140-6736(12)60335-3	http://dx.doi.org/10.1016/S0140-6736(12)60335-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901RB	22386021				2022-12-28	WOS:000300983400014
J	Honisch, B; Ridgwell, A; Schmidt, DN; Thomas, E; Gibbs, SJ; Sluijs, A; Zeebe, R; Kump, L; Martindale, RC; Greene, SE; Kiessling, W; Ries, J; Zachos, JC; Royer, DL; Barker, S; Marchitto, TM; Moyer, R; Pelejero, C; Ziveri, P; Foster, GL; Williams, B				Hoenisch, Baerbel; Ridgwell, Andy; Schmidt, Daniela N.; Thomas, Ellen; Gibbs, Samantha J.; Sluijs, Appy; Zeebe, Richard; Kump, Lee; Martindale, Rowan C.; Greene, Sarah E.; Kiessling, Wolfgang; Ries, Justin; Zachos, James C.; Royer, Dana L.; Barker, Stephen; Marchitto, Thomas M., Jr.; Moyer, Ryan; Pelejero, Carles; Ziveri, Patrizia; Foster, Gavin L.; Williams, Branwen			The Geological Record of Ocean Acidification	SCIENCE			English	Review							EOCENE THERMAL MAXIMUM; SURFACE-WATER ACIDIFICATION; CALCAREOUS NANNOPLANKTON RESPONSE; PALEOCENE-EARLY EOCENE; MASS-EXTINCTION; SATURATION STATE; SEAWATER MG/CA; DEEP-SEA; CARBON; END	Ocean acidification may have severe consequences for marine ecosystems; however, assessing its future impact is difficult because laboratory experiments and field observations are limited by their reduced ecologic complexity and sample period, respectively. In contrast, the geological record contains long-term evidence for a variety of global environmental perturbations, including ocean acidification plus their associated biotic responses. We review events exhibiting evidence for elevated atmospheric CO2, global warming, and ocean acidification over the past similar to 300 million years of Earth's history, some with contemporaneous extinction or evolutionary turnover among marine calcifiers. Although similarities exist, no past event perfectly parallels future projections in terms of disrupting the balance of ocean carbonate chemistry-a consequence of the unprecedented rapidity of CO2 release currently taking place.	[Hoenisch, Baerbel] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Ridgwell, Andy; Greene, Sarah E.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Schmidt, Daniela N.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Thomas, Ellen] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Thomas, Ellen; Royer, Dana L.] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA; [Gibbs, Samantha J.; Foster, Gavin L.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Sluijs, Appy] Univ Utrecht, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; [Zeebe, Richard] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Kump, Lee] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Martindale, Rowan C.; Greene, Sarah E.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Kiessling, Wolfgang] Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany; [Ries, Justin] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; [Zachos, James C.] Univ Calif Santa Cruz, Earth & Planetary Sci Dept, Santa Cruz, CA 95064 USA; [Barker, Stephen] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales; [Marchitto, Thomas M., Jr.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Marchitto, Thomas M., Jr.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Moyer, Ryan] Univ S Florida, Dept Environm Sci Policy & Geog, St Petersburg, FL 33701 USA; [Pelejero, Carles] CSIC, Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Catalonia, Spain; [Pelejero, Carles] CSIC, Dept Marine Biol & Oceanog, Barcelona 08003, Catalonia, Spain; [Ziveri, Patrizia] Univ Autonoma Barcelona, Inst Environm Sci & Technol, E-08193 Barcelona, Spain; [Ziveri, Patrizia] Vrije Univ, Dept Earth Sci, NL-1081 HV Amsterdam, Netherlands; [Williams, Branwen] Pitzer Coll, WM Keck Sci Dept, Claremont McKenna Coll, Claremont, CA 91711 USA; [Williams, Branwen] Scripps Coll, Claremont, CA 91711 USA	Columbia University; University of Bristol; University of Bristol; Yale University; Wesleyan University; NERC National Oceanography Centre; University of Southampton; Utrecht University; University of Hawaii System; University of Hawaii Manoa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Southern California; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Santa Cruz; Cardiff University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; State University System of Florida; University of South Florida; Consejo Superior de Investigaciones Cientificas (CSIC); ICREA; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Barcelona; Vrije Universiteit Amsterdam; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Pitzer College; Claremont Colleges; Scripps College	Honisch, B (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	hoenisch@ldeo.columbia.edu	Zachos, James C/A-7674-2008; Ridgwell, Andy/AAD-9487-2021; Martindale, Rowan/HDO-1408-2022; Hoenisch, Baerbel/ABF-4968-2021; Foster, Gavin/CAF-4654-2022; Ziveri, Patrizia/I-3856-2015; Stephen, Barker/C-2770-2009; Martindale, Rowan C/N-9853-2015; Kiessling, Wolfgang/E-2259-2015; Ries, Justin B/B-8391-2017; Foster, Gavin/W-5968-2019; Kump, Lee/H-8287-2012; Martindale, Rowan/N-2602-2019; Hoenisch, Baerbel/C-7530-2013; Moyer, Ryan P/W-4616-2017; Pelejero, Carles/AAF-4550-2019; Sluijs, Appy/B-3726-2009; Thomas, Ellen/E-5573-2011	Zachos, James C/0000-0001-8439-1886; Ridgwell, Andy/0000-0003-2333-0128; Hoenisch, Baerbel/0000-0001-5844-3398; Foster, Gavin/0000-0003-3688-9668; Ziveri, Patrizia/0000-0002-5576-0301; Stephen, Barker/0000-0001-7870-6431; Martindale, Rowan C/0000-0003-2681-083X; Kiessling, Wolfgang/0000-0002-1088-2014; Ries, Justin B/0000-0001-8427-206X; Martindale, Rowan/0000-0003-2681-083X; Hoenisch, Baerbel/0000-0001-5844-3398; Pelejero, Carles/0000-0002-7763-7769; Sluijs, Appy/0000-0003-2382-0215; Royer, Dana/0000-0003-0976-953X; Moyer, Ryan/0000-0002-4904-5520; Schmidt, Daniela/0000-0001-8419-2721; Greene, Sarah/0000-0002-3025-9043; Thomas, Ellen/0000-0002-7141-9904	NSF OCE [10-32374]; Past Global Changes (PAGES); ICREA Funding Source: Custom; Natural Environment Research Council [NE/H017453/1, NE/H017356/1, NE/H017518/1, NE/F017383/1, NE/H023852/1] Funding Source: researchfish; NERC [NE/H017453/1, NE/H017356/1, NE/H017518/1, NE/F017383/1, NE/H023852/1] Funding Source: UKRI; Directorate For Geosciences [0807744] Funding Source: National Science Foundation; Division Of Ocean Sciences [1032374] Funding Source: National Science Foundation	NSF OCE(National Science Foundation (NSF)); Past Global Changes (PAGES); ICREA(ICREA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for the "Workshop on Paleocean Acidification and Carbon Cycle Perturbation Events" was provided by NSF OCE 10-32374 and Past Global Changes (PAGES). We thank the workshop participants for stimulating discussions and contributions to this manuscript, and the USC Wrigley Institute on Catalina Island for hosting the workshop. Particular thanks are owed to Thorsten Kiefer of PAGES, who initiated the workshop and supported it at all stages. This work is a contribution to the "European Project on Ocean Acidification" (EPOCA). Data presented in Fig. 4 are presented in tables S2 and S3 (2).	Archer D, 1997, GEOPHYS RES LETT, V24, P405, DOI 10.1029/97GL00168; Barker S, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001004; Barker S, 2002, SCIENCE, V297, P833, DOI 10.1126/science.1072815; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; BERGER WH, 1968, DEEP-SEA RES, V15, P31, DOI 10.1016/0011-7471(68)90027-2; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Coggon RM, 2010, SCIENCE, V327, P1114, DOI 10.1126/science.1182252; Cohen AS, 2007, J GEOL SOC LONDON, V164, P1093, DOI 10.1144/0016-76492006-123; Crne AE, 2011, GEOL SOC AM BULL, V123, P40, DOI 10.1130/B30157.1; Cui Y, 2011, NAT GEOSCI, V4, P481, DOI [10.1038/ngeo1179, 10.1038/NGEO1179]; Demicco RV, 2005, GEOLOGY, V33, P877, DOI 10.1130/G21945.1; DHONDT S, 1994, GEOLOGY, V22, P983, DOI 10.1130/0091-7613(1994)022<0983:SWAAEA>2.3.CO;2; Dickson JAD, 2002, SCIENCE, V298, P1222, DOI 10.1126/science.1075882; Dowsett HJ, 2007, MICROPALEONTOLOGY, V53, P105, DOI 10.2113/gsmicropal.53.1-2.105; Erba E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000884; Erba E, 2010, SCIENCE, V329, P428, DOI 10.1126/science.1188886; Farrell JW, 1989, PALEOCEANOGRAPHY, V4, P447, DOI 10.1029/PA004i004p00447; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; Gibbs SJ, 2011, SCIENCE, V332, DOI 10.1126/science.1199459; Gibbs SJ, 2010, EARTH PLANET SC LETT, V295, P583, DOI 10.1016/j.epsl.2010.04.044; Gibbs SJ, 2006, GEOLOGY, V34, P233, DOI 10.1130/G22381.1; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Haywood AM, 2009, GLOBAL PLANET CHANGE, V66, P208, DOI 10.1016/j.gloplacha.2008.12.014; Honisch B, 2008, EARTH PLANET SC LETT, V272, P309, DOI 10.1016/j.epsl.2008.04.047; Honisch B, 2005, EARTH PLANET SC LETT, V236, P305, DOI 10.1016/j.epsl.2005.04.027; Jenkyns HC, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002788; Kemp DB, 2005, NATURE, V437, P396, DOI 10.1038/nature04037; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Kiessling W, 2011, GLOBAL CHANGE BIOL, V17, P56, DOI 10.1111/j.1365-2486.2010.02204.x; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Leckie RM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000623; Lemarchand D, 2000, NATURE, V408, P951, DOI 10.1038/35050058; Marchitto TM, 2005, EARTH PLANET SC LETT, V231, P317, DOI 10.1016/j.epsl.2004.12.024; Mattioli E, 2009, GLOBAL PLANET CHANGE, V65, P134, DOI 10.1016/j.gloplacha.2008.10.018; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Panchuk K, 2008, GEOLOGY, V36, P315, DOI 10.1130/G24474A.1; Payne JL, 2010, P NATL ACAD SCI USA, V107, P8543, DOI 10.1073/pnas.0914065107; Raffi I, 2008, MAR MICROPALEONTOL, V69, P119, DOI 10.1016/j.marmicro.2008.07.002; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; Ridgwell A, 2005, MAR GEOL, V217, P339, DOI 10.1016/j.margeo.2004.10.036; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Ries JB, 2010, BIOGEOSCIENCES, V7, P2795, DOI 10.5194/bg-7-2795-2010; Rodriguez-Tovar FJ, 2011, MAR GEOL, V282, P178, DOI 10.1016/j.margeo.2011.02.009; Ruhl M, 2010, EARTH PLANET SC LETT, V295, P262, DOI 10.1016/j.epsl.2010.04.008; Ruhl M, 2011, SCIENCE, V333, P430, DOI 10.1126/science.1204255; Scheibner C, 2008, EARTH-SCI REV, V90, P71, DOI 10.1016/j.earscirev.2008.07.002; Schlesinger W. H., 2004, TREATISE GEOCHEMISTR; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; Sluijs A, 2009, BIOGEOSCIENCES, V6, P1755, DOI 10.5194/bg-6-1755-2009; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; Sobolev SV, 2011, NATURE, V477, P312, DOI 10.1038/nature10385; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Suan G, 2008, EARTH PLANET SC LETT, V267, P666, DOI 10.1016/j.epsl.2007.12.017; Thomas E, 2007, GEOL SOC AM SPEC PAP, V424, P1, DOI 10.1130/2007.2424(01); Turley C, 2010, MAR POLLUT BULL, V60, P787, DOI 10.1016/j.marpolbul.2010.05.006; Whiteside JH, 2007, PALAEOGEOGR PALAEOCL, V244, P345, DOI 10.1016/j.palaeo.2006.06.035; Wignall PB, 2009, GEOL SOC AM BULL, V121, P954, DOI 10.1130/B26424.1; Yu JM, 2010, SCIENCE, V330, P1084, DOI 10.1126/science.1193221; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2010, EARTH PLANET SC LETT, V299, P242, DOI 10.1016/j.epsl.2010.09.004; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zeebe RE, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000538; Zeebe RE, 2011, OCEAN ACIDIFICATION, P21; Zeebe RE, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001395; Zeebe RE, 2009, NAT GEOSCI, V2, P576, DOI 10.1038/NGEO578	71	623	650	63	908	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1058	1063		10.1126/science.1208277	http://dx.doi.org/10.1126/science.1208277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383840	Green Published, Green Submitted			2022-12-28	WOS:000300931100035
J	Kierzkowski, D; Nakayama, N; Routier-Kierzkowska, AL; Weber, A; Bayer, E; Schorderet, M; Reinhardt, D; Kuhlemeier, C; Smith, RS				Kierzkowski, Daniel; Nakayama, Naomi; Routier-Kierzkowska, Anne-Lise; Weber, Alain; Bayer, Emmanuelle; Schorderet, Martine; Reinhardt, Didier; Kuhlemeier, Cris; Smith, Richard S.			Elastic Domains Regulate Growth and Organogenesis in the Plant Shoot Apical Meristem	SCIENCE			English	Article							IN-VIVO ANALYSIS; CELL-WALL; MECHANICAL FORCES; AUXIN TRANSPORT; GENE-EXPRESSION; ARABIDOPSIS; APEX; MORPHOGENESIS; ELONGATION; INITIATION	Although genetic control of morphogenesis is well established, elaboration of complex shapes requires changes in the mechanical properties of cells. In plants, the first visible sign of leaf formation is a bulge on the flank of the shoot apical meristem. Bulging results from local relaxation of cell walls, which causes them to yield to internal hydrostatic pressure. By manipulation of tissue tension in combination with quantitative live imaging and finite-element modeling, we found that the slow-growing area at the shoot tip is substantially strain-stiffened compared with surrounding fast-growing tissue. We propose that strain stiffening limits growth, restricts organ bulging, and contributes to the meristem's functional zonation. Thus, mechanical signals are not just passive readouts of gene action but feed back on morphogenesis.	[Kierzkowski, Daniel; Nakayama, Naomi; Routier-Kierzkowska, Anne-Lise; Weber, Alain; Kuhlemeier, Cris; Smith, Richard S.] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [Bayer, Emmanuelle] CNRS, Lab Biogenese Membranaire, UMR5200, F-33076 Bordeaux, France; [Schorderet, Martine; Reinhardt, Didier] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland	University of Bern; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Fribourg	Smith, RS (corresponding author), Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland.	richard.smith@ips.unibe.ch	bayer, emmanuelle/V-1329-2017; Routier-Kierzkowska, Anne-Lise/AAO-9760-2020; Reinhardt, Didier/M-8508-2014	bayer, emmanuelle/0000-0001-8642-5293; Routier-Kierzkowska, Anne-Lise/0000-0003-0383-0811; Reinhardt, Didier/0000-0003-3495-6783	Swiss National Science Foundation; SystemsX.ch; European Union; European Molecular Biology Organization; Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch; European Union(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Roche Research Foundation	We thank J. Dumais, A. Fleming, S. Robinson, D. Kwiatkowska, and P. Wojtaszek for reading the manuscript. This work was supported by the Swiss National Science Foundation, SystemsX.ch, and the European Union New and Emerging Science and Technology grant MechPlant. N.N. received European Molecular Biology Organization Long-Term and Roche Research Foundation fellowships.	Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dumais J, 2000, J PLANT GROWTH REGUL, V19, P7, DOI 10.1007/s003440000003; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Kutschera U, 2007, J PLANT PHYSIOL, V164, P1395, DOI 10.1016/j.jplph.2007.08.002; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; LOCKHART JA, 1965, J THEOR BIOL, V8, P264, DOI 10.1016/0022-5193(65)90077-9; Milani P, 2011, PLANT J, V67, P1116, DOI 10.1111/j.1365-313X.2011.04649.x; Mirabet V, 2011, ANNU REV PLANT BIOL, V62, P365, DOI 10.1146/annurev-arplant-042110-103852; Peaucelle A, 2008, CURR BIOL, V18, P1943, DOI 10.1016/j.cub.2008.10.065; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sablowski R, 2007, CURR OPIN PLANT BIOL, V10, P639, DOI 10.1016/j.pbi.2007.07.001; SELKER JML, 1992, DEV BIOL, V153, P29, DOI 10.1016/0012-1606(92)90089-Y; STEEVES T, 1988, PATTERNS PLANT DEV; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Vandiver R, 2009, PHILOS T R SOC A, V367, P3607, DOI 10.1098/rsta.2009.0114; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vernoux T, 2000, DEVELOPMENT, V127, P5157; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Vincent RR, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031909; Whitney SEC, 1999, PLANT PHYSIOL, V121, P657, DOI 10.1104/pp.121.2.657; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106	30	212	216	12	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1096	1099		10.1126/science.1213100	http://dx.doi.org/10.1126/science.1213100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383847	Green Submitted			2022-12-28	WOS:000300931100046
J	Rinne, ML; McGinnis, SM; Samuels, MA; Katz, JT; Loscalzo, J				Rinne, Mikael L.; McGinnis, Scott M.; Samuels, Martin A.; Katz, Joel T.; Loscalzo, Joseph			A Startling Decline	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CREUTZFELDT-JAKOB-DISEASE; DEMENTIAS; PRIONS; UK	An 89-year-old man was brought to the emergency department by his wife and son for an evaluation of changes in cognition and personality. Six months earlier, he began to require help managing finances and operating his computer. He had poor memory for recent events, had difficulty expressing himself, and had become increasingly irritable. He also exhibited unusual behaviors, such as eating a banana peel, pouring milk onto the table, and undressing immediately after getting dressed. He began to have difficulty walking and occasional urinary and fecal incontinence. During the course of several months, he became unable to dress, bathe, use the toilet, or walk independently.	[Rinne, Mikael L.; McGinnis, Scott M.; Samuels, Martin A.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Katz, Joel T.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Katz, JT (corresponding author), 75 Francis St, Boston, MA 02115 USA.	jkatz@partners.org	Loscalzo, Joseph/ABD-8980-2021					Chohan G, 2010, J NEUROL NEUROSUR PS, V81, P1243, DOI 10.1136/jnnp.2009.197962; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; Geschwind MD, 2008, ANN NEUROL, V64, P97, DOI 10.1002/ana.21430; Josephs KA, 2009, ARCH NEUROL-CHICAGO, V66, P201, DOI 10.1001/archneurol.2008.534; Meissner B, 2009, NEUROLOGY, V72, P1994, DOI 10.1212/WNL.0b013e3181a96e5d; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Vitali P, 2011, NEUROLOGY, V76, P1711, DOI 10.1212/WNL.0b013e31821a4439; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094	12	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					836	842		10.1056/NEJMcps1104209	http://dx.doi.org/10.1056/NEJMcps1104209			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900GI	22375976				2022-12-28	WOS:000300874300012
J	Stein, WE; Berry, CM; Hernick, LV; Mannolini, F				Stein, William E.; Berry, Christopher M.; Hernick, Linda VanAller; Mannolini, Frank			Surprisingly complex community discovered in the mid-Devonian fossil forest at Gilboa	NATURE			English	Article							NEW-YORK-STATE; EVOLUTION; PENNSYLVANIA; VENEZUELA; WETLANDS; USA	The origin of trees by the mid-Devonian epoch (398-385 million years ago) signals a major change in terrestrial ecosystems with potential long-term consequences including increased weathering, drop in atmospheric CO2, modified climate, changes in sedimentation patterns and mass extinction(1-3). However, little is known about the ecology of early forests or how changes in early terrestrial ecosystems influenced global processes. One of the most famous palaeontological records for this time is the 'oldest fossil forest' at Riverside Quarry, Gilboa, New York, USA, discovered in the 1920s(4,5). Hundreds of large Eospermatopteris sandstone casts, now thought to represent the bases of standing cladoxylopsid trees(6), were recovered from a horizon that was originally interpreted as a muddy swamp. After quarry operations ceased, relatively minor outcrops of similar fossils at nearby localities have provided limited opportunities to evaluate this pervasive view using modern methods(7,8). In 2010, removal of the quarry backfill enabled reappraisal of the palaeoecology of this important site. Here we describe a 1,200 m(2) map showing numerous Eospermatopteris root systems in life position within a mixed-age stand of trees. Unexpectedly, large woody rhizomes with adventitious roots and aerial branch systems identified as aneurophytalean progymnosperms run between, and probably climb into, Eospermatopteris trees. We describe the overall habit for these surprisingly large aneurophytaleans, the earliest fossil group having wood produced by a bifacial vascular cambium. The site also provides evidence for arborescence within lycopsids, extending the North American range for trees in this ecologically critical group. The rooting horizon is a dark grey sandy mudstone showing limited root penetration. Although clearly belonging to a wetland coastal plain environment(9), the forest was probably limited in duration and subject to periodic disturbance. These observations provide fundamental clarification of the palaeoecology of this mixed-group early forest, with important implications for interpreting coeval assemblage data worldwide.	[Stein, William E.] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; [Berry, Christopher M.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales; [Hernick, Linda VanAller; Mannolini, Frank] New York State Museum & Sci Serv, Albany, NY 12230 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Cardiff University	Stein, WE (corresponding author), SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA.	stein@binghamton.edu		Berry, Christopher/0000-0001-9521-5618	New York State Museum; UK Natural Environment Research Council (NERC) [NE/F010699/1]; NERC [NE/F010699/1] Funding Source: UKRI; Natural Environment Research Council [NE/F010699/1] Funding Source: researchfish	New York State Museum; UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support was provided by the New York State Museum. C.M.B. acknowledges support from the UK Natural Environment Research Council (NERC) grant NE/F010699/1. Permission to work at the site by New York City Department of Environmental Protection (DEP) is acknowledged. On-site and other assistance was provided by E. Chase, P. Costa and G. Heath (DEP), as well as by P. Kollak and C. Tompkins of the Thalle Construction Company. We also thank P. Wright for advice and guidance on the major palaeosol horizon.	Algeo T.J., 2001, PLANTS INVADE LAND, P213, DOI DOI 10.7312/GENS11160-013; Baird GC, 2008, B GEOSCI, V83, P357, DOI 10.3140/bull.geosci.2008.04.357; BANKS HP, 1985, GEOLOGICAL SOC AM SP, V201, P125; Beck C.B., 1988, ORIGIN EVOLUTION GYM, P1; BECK CB, 1976, REV PALAEOBOT PALYNO, V21, P5, DOI 10.1016/0034-6667(76)90020-8; Berry C.M., 2001, PLANTS INVADE LAND E, P120; Berry CM, 1997, REV PALAEOBOT PALYNO, V96, P47, DOI 10.1016/S0034-6667(96)00015-2; Berry CM, 2002, INT J PLANT SCI, V163, P699, DOI 10.1086/342037; BRIDGE JS, 1994, GEOL SOC AM BULL, V106, P1440, DOI 10.1130/0016-7606(1994)106<1440:MTARRI>2.3.CO;2; Bridge JS, 2000, GEOL SOC SPEC PUBL, V180, P85, DOI 10.1144/GSL.SP.2000.180.01.06; Dannenhoffer JM, 2007, INT J PLANT SCI, V168, P491, DOI 10.1086/512042; Davies NS, 2010, GEOLOGY, V38, P51, DOI 10.1130/G30443.1; Driese SG, 1997, PALAIOS, V12, P524, DOI 10.2307/3515409; Driese SG, 2001, PLANTS INVADE LAND E, P237; Gensel PG, 2001, AM FERN J, V91, P74, DOI 10.1640/0002-8444(2001)091[0074:ELE]2.0.CO;2; Goldring W., 1927, SCI MONTHLY, V24, P514; Goldring W., 1924, NEW YORK STATE MUSEU, V251, P50; Greb SF, 2006, GEOL SOC AM SPEC PAP, V399, P1, DOI 10.1130/2006.2399(01); GRIERSON J. D., 1963, PALAEONTOGRAPHICA AM, V4, P217; Hammond SE, 2005, BOT J LINN SOC, V148, P275, DOI 10.1111/j.1095-8339.2005.00418.x; Meyer-Berthaud B, 1999, NATURE, V398, P700, DOI 10.1038/19516; MILLER MF, 1991, DYNAMIC STRATIGRAPHY, P153; Mintz JS, 2010, PALAIOS, V25, P85, DOI 10.2110/palo.2009.p09-086r; PIGG KB, 1992, ANN MO BOT GARD, V79, P589, DOI 10.2307/2399754; Retallack GJ, 2011, PALAEOGEOGR PALAEOCL, V299, P110, DOI 10.1016/j.palaeo.2010.10.040; Stein WE, 2007, NATURE, V446, P904, DOI 10.1038/nature05705; White D., 1907, NY STATE MUS B, V107, P328; Wright VP, 2000, J SEDIMENT RES, V70, P619, DOI 10.1306/2DC4092C-0E47-11D7-8643000102C1865D	28	127	137	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					78	81		10.1038/nature10819	http://dx.doi.org/10.1038/nature10819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22382983				2022-12-28	WOS:000300877900048
J	Watanabe, K				Watanabe, Kenta			Hemotympanum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan		Watanabe, K (corresponding author), Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan.	quentaw@aol.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					E14	E14		10.1056/NEJMicm1110484	http://dx.doi.org/10.1056/NEJMicm1110484			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900GI	22375998				2022-12-28	WOS:000300874300011
J	Pocock, MJO; Evans, DM; Memmott, J				Pocock, Michael J. O.; Evans, Darren M.; Memmott, Jane			The Robustness and Restoration of a Network of Ecological Networks	SCIENCE			English	Article							POLLINATION NETWORKS; BIODIVERSITY; DIVERSITY; SERVICES	Understanding species' interactions and the robustness of interaction networks to species loss is essential to understand the effects of species' declines and extinctions. In most studies, different types of networks (such as food webs, parasitoid webs, seed dispersal networks, and pollination networks) have been studied separately. We sampled such multiple networks simultaneously in an agroecosystem. We show that the networks varied in their robustness; networks including pollinators appeared to be particularly fragile. We show that, overall, networks did not strongly covary in their robustness, which suggests that ecological restoration (for example, through agri-environment schemes) benefitting one functional group will not inevitably benefit others. Some individual plant species were disproportionately well linked to many other species. This type of information can be used in restoration management, because it identifies the plant taxa that can potentially lead to disproportionate gains in biodiversity.	[Pocock, Michael J. O.; Evans, Darren M.; Memmott, Jane] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Pocock, MJO (corresponding author), NERC Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England.	michael.pocock@ceh.ac.uk	Pocock, Michael/A-5632-2012; Evans, Darren Mark/J-9782-2012	Pocock, Michael/0000-0003-4375-0445; Evans, Darren/0000-0003-4061-6726	Biotechnology and Biological Sciences Research Council [BBD0156341]; Department for Environment, Food and Rural Affairs [BD2303]; BBSRC [BB/D015634/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D015634/1] Funding Source: researchfish; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J. Brooks helped throughout the project, and 14 field assistants helped with field and laboratory work; 15 taxonomists (listed in SOM text) assisted with species' identification; and Cate Le Grice-Mack (the landowner) gave full support throughout the project. The authors declare no competing interests. The interaction data are available from the Dryad Digital Repository, doi:10.5061/dryad.3s36r118. The project was supported by the Biotechnology and Biological Sciences Research Council (grant no. BBD0156341) and the Department for Environment, Food and Rural Affairs (grant no. BD2303).	Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; European Environment Agency, 2010, ASS BIOD EUR 2010 RE; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; HALL SJ, 1991, J ANIM ECOL, V60, P823, DOI 10.2307/5416; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; Melian CJ, 2009, OIKOS, V118, P122, DOI 10.1111/j.1600-0706.2008.16751.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Pocock MJO, 2010, AGR ECOSYST ENVIRON, V135, P279, DOI 10.1016/j.agee.2009.10.006; Sandhu HS, 2008, ECOL ECON, V64, P835, DOI 10.1016/j.ecolecon.2007.05.007; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; Wade MR, 2008, PHILOS T R SOC B, V363, P831, DOI 10.1098/rstb.2007.2186	30	373	384	20	565	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					973	977		10.1126/science.1214915	http://dx.doi.org/10.1126/science.1214915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363009	Green Accepted			2022-12-28	WOS:000300931800048
J	Ince, DC; Hatton, L; Graham-Cumming, J				Ince, Darrel C.; Hatton, Leslie; Graham-Cumming, John			The case for open computer programs	NATURE			English	Article							REPRODUCIBLE RESEARCH; ERRORS; CODE	Scientific communication relies on evidence that cannot be entirely included in publications, but the rise of computational science has added a new layer of inaccessibility. Although it is now accepted that data should be made available on request, the current regulations regarding the availability of software are inconsistent. We argue that, with some exceptions, anything less than the release of source programs is intolerable for results that depend on computation. The vagaries of hardware, software and natural language will always ensure that exact reproducibility remains uncertain, but withholding code increases the chances that efforts to reproduce results will fail.	[Ince, Darrel C.] Open Univ, Dept Comp, Walton Hall, Milton Keynes MK7 6AA, Bucks, England; [Hatton, Leslie] Kingston Univ, Sch Comp & Informat Syst, Kingston KT1 2EE, England	Open University - UK; Kingston University	Ince, DC (corresponding author), Open Univ, Dept Comp, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	d.c.ince@open.ac.uk						ADAMS EN, 1984, IBM J RES DEV, V28, P2, DOI 10.1147/rd.281.0002; [Anonymous], 2011, NATURE, V470, P305, DOI 10.1038/470305b; Badin M, 2011, SCI PROGRAMMING-NETH, V19, P3, DOI [10.3233/SPR-2011-0315, 10.1155/2011/417569]; Barnes N, 2010, NATURE, V467, P753, DOI 10.1038/467753a; Boehm Barry, 2010, FDN EMPIRICAL SOFTWA, V1st; Boldo S, 2011, IEEE T COMPUT, V60, P157, DOI 10.1109/TC.2010.139; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; de Bruijn F, 2010, LECT NOTES COMPUT SC, V6182, P233, DOI 10.1007/978-3-642-14192-8_21; Donoho DL, 2010, BIOSTATISTICS, V11, P385, DOI 10.1093/biostatistics/kxq028; Donoho DL, 2009, COMPUT SCI ENG, V11, P8, DOI 10.1109/MCSE.2009.15; Easterbrook SM, 2009, COMPUT SCI ENG, V11, P64; Gervasi V, 2010, LECT NOTES COMPUT SC, V6182, P248, DOI 10.1007/978-3-642-14192-8_22; Hanson B, 2011, SCIENCE, V331, P649, DOI 10.1126/science.1203354; Hatton L, 1997, IEEE COMPUT SCI ENG, V4, P27, DOI 10.1109/99.609829; HATTON L, 1994, IEEE T SOFTWARE ENG, V20, P785, DOI 10.1109/32.328993; HATTON L, 1988, SOFTWARE PRACT EXPER, V18, P301, DOI 10.1002/spe.4380180403; He Y, 2001, J SUPERCOMPUT, V18, P259, DOI 10.1023/A:1008153532043; Hey T., 2009, 4 PARADIGM DATA INTE; Kahan W., IFIP SIAM N IN PRESS; McCafferty D, 2010, COMMUN ACM, V53, P16, DOI 10.1145/1831407.1831415; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; Monniaux D, 2008, ACM T PROGR LANG SYS, V30, DOI 10.1145/1353445.1353446; Pan VY, 2009, COMPUT MATH APPL, V57, P560, DOI 10.1016/j.camwa.2008.09.051; Pedersen T, 2008, COMPUT LINGUIST, V34, P465, DOI 10.1162/coli.2008.34.3.465; Peng RD, 2009, BIOSTATISTICS, V10, P405, DOI 10.1093/biostatistics/kxp014; Pfleeger SL, 1997, COMPUTER, V30, P33, DOI 10.1109/2.566148; Raymond E. S., 2001, CATHEDRAL BAZAAR; Revol N, 2010, LECT NOTES COMPUT SC, V6327, P337, DOI 10.1007/978-3-642-15582-6_54; Rump S. M., 2009, SIAM J SCI COMPUT, V31, P189; Rump SM, 2010, LECT NOTES COMPUT SC, V6327, P105, DOI 10.1007/978-3-642-15582-6_22; Schwab M, 2000, COMPUT SCI ENG, V2, P61, DOI 10.1109/5992.881708; Thomas SJ, 2002, WEATHER FORECAST, V17, P898, DOI 10.1175/1520-0434(2002)017<0898:AEAOFE>2.0.CO;2; van Deemter K., 2010, NOT EXACTLY PRAISE V; van der Meulen MJP, 2008, IEEE T SOFTWARE ENG, V34, P753, DOI 10.1109/TSE.2008.70; Yang H., 2010, P IEEE ACM INT C AUT, P53; Yool A, 2011, GEOSCI MODEL DEV, V4, P381, DOI 10.5194/gmd-4-381-2011	37	318	321	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					485	488		10.1038/nature10836	http://dx.doi.org/10.1038/nature10836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358837	Bronze			2022-12-28	WOS:000300770500042
J	Farkouh, ME				Farkouh, Michael E.			High-sensitivity troponin < 3 ng/L ruled out acute myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Farkouh, Michael E.] Univ Toronto, Peter Munk Cardiac Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; Peter Munk Cardiac Centre	Farkouh, ME (corresponding author), Univ Toronto, Peter Munk Cardiac Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.		Body, Richard/C-2736-2010	Body, Richard/0000-0001-9089-8130; McDowell, Garry/0000-0002-2880-5236				BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; McCaig L. F., 2005, ADV DATA VITAL HLTH, V358	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-9	10.7326/0003-4819-156-4-201202210-02009	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351735				2022-12-28	WOS:000208885400008
J	Jones, AG; Evans, PH; Vaidya, B				Jones, Angus G.; Evans, Philip H.; Vaidya, Bijay			EASILY MISSED? Phaeochromocytoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS		[Jones, Angus G.; Vaidya, Bijay] Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England; [Vaidya, Bijay] Peninsula Med Sch, Exeter, Devon, England	University of Exeter; University of Exeter	Vaidya, B (corresponding author), Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England.	bijay.vaidya@pms.ac.uk	Vaidya, Bijay/AAF-1947-2020	Vaidya, Bijay/0000-0002-2223-0494; Evans, Philip/0000-0002-5277-3545; Jones, Angus/0000-0002-0883-7599	Department of Health [DRF-2010-03-72] Funding Source: Medline; National Institute for Health Research [DRF-2010-03-72] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Amar L, 2005, J CLIN ENDOCR METAB, V90, P2110, DOI 10.1210/jc.2004-1398; Ayala-Ramirez M, 2011, J CLIN ENDOCR METAB, V96, P717, DOI 10.1210/jc.2010-1946; Goldstein RE, 1999, ANN SURG, V229, P755, DOI 10.1097/00000658-199906000-00001; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427; Lo CY, 2000, AM J SURG, V179, P212, DOI 10.1016/S0002-9610(00)00296-8; Mannelli M, 1999, EUR J ENDOCRINOL, V141, P619, DOI 10.1530/eje.0.1410619; National Institute for Health and Clinical Excellence, 2011, NICE CLIN GUID 127 H; Pacak K, 2007, NAT CLIN PRACT ENDOC, V3, P92, DOI 10.1038/ncpendmet0396; Zeiger MA, 2009, ENDOCR PRACT, V15, P450, DOI 10.4158/EP.15.5.450	10	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2012	344								e1042	10.1136/bmj.e1042	http://dx.doi.org/10.1136/bmj.e1042			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900IY	22349579				2022-12-28	WOS:000300881600007
J	Spiegel, FW				Spiegel, Frederick W.			Contemplating the First Plantae	SCIENCE			English	Editorial Material							EUKARYOTIC SUPERGROUPS; PLASTIDS; PHYLOGENY; ORIGIN		1 Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Spiegel, FW (corresponding author), 1 Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA.	fspiegel@uark.edu						Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Chan CX, 2011, PLANT PHYSIOL, V155, P1552, DOI 10.1104/pp.111.173500; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Howe CJ, 2008, PHILOS T R SOC B, V363, P2675, DOI 10.1098/rstb.2008.0050; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; MIGNOT JP, 1969, J PROTOZOOL, V16, P138, DOI 10.1111/j.1550-7408.1969.tb02245.x; Nozaki H, 2007, MOL BIOL EVOL, V24, P1592, DOI 10.1093/molbev/msm091; Okamoto N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007080; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Sato M, 2009, PLANTA, V229, P781, DOI 10.1007/s00425-008-0872-4; Schaechter M, 2012, SCIENCE, V335, P302, DOI 10.1126/science.1218027; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Spiegel FW, 2011, P ROY SOC B-BIOL SCI, V278, P2096, DOI 10.1098/rspb.2011.0608; SPIEGEL FW, 1986, PROTOPLASMA, V132, P115, DOI 10.1007/BF01276991	16	13	13	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					809	810		10.1126/science.1218515	http://dx.doi.org/10.1126/science.1218515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344435				2022-12-28	WOS:000300356400031
J	Watts, G				Watts, Geoff			OBESITY The future of obesity treatment: what can drugs and surgery offer?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OVERWEIGHT; WEIGHT					geoff@scileg.freeserve.co.uk						Department of Health, HLTH LIV HLTH PEOPL; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; International Diabetes Federation, 2011, BAR SURG PROC INT TR; National Institutes of Health, 1991, GASTR SURG SEV OB CO; NICE, 2006, OB GUID PREV ID ASS; Wynne K, 2005, DIABETES, V54, P2390, DOI 10.2337/diabetes.54.8.2390; 2012, BRIT MED J, V344	8	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2012	344								e1011	10.1136/bmj.e1011	http://dx.doi.org/10.1136/bmj.e1011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896HZ	22334541				2022-12-28	WOS:000300557600009
J	Riveiro-Barciela, M; Ventura-Cots, M; Aparicio, G				Riveiro-Barciela, Mar; Ventura-Cots, Meritxell; Aparicio, Gloria			Palmoplantar pustulosis and chest pain	LANCET			English	Editorial Material									[Riveiro-Barciela, Mar; Ventura-Cots, Meritxell] Vall dHebron Hosp, Dept Internal Med, Barcelona 08036, Spain; [Aparicio, Gloria] Vall dHebron Hosp, Dept Dermatol, Barcelona 08036, Spain	Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Riveiro-Barciela, M (corresponding author), Vall dHebron Hosp, Dept Internal Med, Passeig Vall dHebron 119-129, Barcelona 08036, Spain.	mar.riveiro@gmail.com		Ventura-Cots, Meritxell/0000-0001-9513-2855					0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 5	2012	379	9827					E49	E49		10.1016/S0140-6736(11)61589-4	http://dx.doi.org/10.1016/S0140-6736(11)61589-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22325323	Bronze			2022-12-28	WOS:000303658500001
J	Yuan, J; Nguyen, CK; Liu, XH; Kanellopoulou, C; Muljo, SA				Yuan, Joan; Nguyen, Cuong K.; Liu, Xiuhuai; Kanellopoulou, Chrysi; Muljo, Stefan A.			Lin28b Reprograms Adult Bone Marrow Hematopoietic Progenitors to Mediate Fetal-Like Lymphopoiesis	SCIENCE			English	Article							CD8(+) T-CELLS; STEM-CELLS; DEVELOPMENTAL SWITCH; MICRORNA BIOGENESIS; B-LYMPHOPOIESIS; NKT CELLS; EXPRESSION; LEVEL; MOUSE; MICE	The immune system develops in waves during ontogeny; it is initially populated by cells generated from fetal hematopoietic stem cells (HSCs) and later by cells derived from adult HSCs. Remarkably, the genetic programs that control these two distinct stem cell fates remain poorly understood. We report that Lin28b is specifically expressed in mouse and human fetal liver and thymus, but not in adult bone marrow or thymus. We demonstrate that ectopic expression of Lin28 reprograms hematopoietic stem/progenitor cells (HSPCs) from adult bone marrow, which endows them with the ability to mediate multilineage reconstitution that resembles fetal lymphopoiesis, including increased development of B-1a, marginal zone B, gamma/delta (gamma delta) T cells, and natural killer T (NKT) cells.	[Yuan, Joan; Nguyen, Cuong K.; Liu, Xiuhuai; Kanellopoulou, Chrysi; Muljo, Stefan A.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Muljo, SA (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.	stefan.muljo@nih.gov	Muljo, Stefan A/F-5671-2015; Nguyen, Cuong Kieu/Q-8306-2019; Nguyen, Cuong/D-7567-2013; Nguyen, Cuong/GYU-8270-2022; yuan, joan/A-8185-2013	Muljo, Stefan A/0000-0003-1013-446X; Nguyen, Cuong/0000-0002-1741-669X; yuan, joan/0000-0001-9129-8356	NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001131, ZIAAI001185] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. E. Paul for his generous support and advice throughout; T. Bender, J. Daniel, B. J. Fowlkes, R. Germain, M. Lenardo, W. E. Paul, and M. Schlissel for critical reading of this manuscript and constructive suggestions; K. Laky and B. J. Fowlkes for valuable advice and antibodies; NIH Tetramer Core Facility for reagents; M. Holt for NKT cell discussions; P. Burr for sequencing; J. Edwards and C. Eigsti for cell sorting; M. Foster for animal care; R. Zahr for technical support; and N. Bartonicek (EMBL-EBI, Hinxton, UK) for providing the RefSeq 3'UTR library for Sylamer analysis. We gratefully acknowledge the high-performance computational capabilities of the Biowulf Linux cluster at the NIH (http://biowulf.nih.gov) and NIAID Office of Cyber Infrastructure and Computational Biology High-Performance Computing cluster required for massively parallel sequencing analyses. The data reported in this paper are tabulated in the main text and in the Supporting Online Material. The RNA-Seq and NanoString data are available in the Gene Expression Omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo) under the accession nos. GSE34854, GSE35081, and GSE35107. The materials and reagents used in the paper are available under a Materials Transfer Agreement. We apologize that we could not cite all the relevant references because of space limitations. The Integrative Immunobiology Unit is supported by the Intramural Research Program of the NIAID, NIH. The authors declare no competing financial interests.	Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Barber CL, 2011, P NATL ACAD SCI USA, V108, P13700, DOI 10.1073/pnas.1107172108; Belles C, 1996, J IMMUNOL, V156, P4280; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Brown JA, 2008, CLIN IMMUNOL, V127, P286, DOI 10.1016/j.clim.2008.02.008; Carey JB, 2008, J EXP MED, V205, P2043, DOI 10.1084/jem.20080559; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Grigoriadou K, 2003, J IMMUNOL, V171, P2413, DOI 10.4049/jimmunol.171.5.2413; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; IKUTA K, 1991, J EXP MED, V174, P1279, DOI 10.1084/jem.174.5.1279; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Ito T, 2000, EXP HEMATOL, V28, P1269, DOI 10.1016/S0301-472X(00)00535-X; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kiel MJ, 2005, DEV BIOL, V283, P29, DOI 10.1016/j.ydbio.2005.03.037; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lacombe J, 2010, BLOOD, V115, P792, DOI 10.1182/blood-2009-01-201384; Lai DZ, 2011, J EXP MED, V208, P1093, DOI 10.1084/jem.20101527; Lee YJ, 2010, J EXP MED, V207, P237, DOI 10.1084/jem.20091519; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Ranganath S, 1998, J IMMUNOL, V161, P3822; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Rebel VI, 1996, EXP HEMATOL, V24, P638; Tajima F, 2001, BLOOD, V97, P2618, DOI 10.1182/blood.V97.9.2618; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108	52	223	229	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1195	1200		10.1126/science.1216557	http://dx.doi.org/10.1126/science.1216557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22345399	Green Accepted			2022-12-28	WOS:000301225100037
J	Kanfi, Y; Naiman, S; Amir, G; Peshti, V; Zinman, G; Nahum, L; Bar-Joseph, Z; Cohen, HY				Kanfi, Yariv; Naiman, Shoshana; Amir, Gail; Peshti, Victoria; Zinman, Guy; Nahum, Liat; Bar-Joseph, Ziv; Cohen, Haim Y.			The sirtuin SIRT6 regulates lifespan in male mice	NATURE			English	Article							GENE-EXPRESSION; CALORIC RESTRICTION; METABOLIC SYNDROME; PROTECTS; RECEPTOR; ELEGANS; ABSENCE; TISSUE; MOUSE; IGF1	The significant increase in human lifespan during the past century confronts us with great medical challenges. To meet these challenges, the mechanisms that determine healthy ageing must be understood and controlled. Sirtuins are highly conserved deacetylases that have been shown to regulate lifespan in yeast, nematodes and fruitflies(1). However, the role of sirtuins in regulating worm and fly lifespan has recently become controversial(2). Moreover, the role of the seven mammalian sirtuins, SIRT1 to SIRT7 (homologues of the yeast sirtuin Sir2), in regulating lifespan is unclear(3). Here we show that male, but not female, transgenic mice overexpressing Sirt6 (ref. 4) have a significantly longer lifespan than wild-type mice. Gene expression analysis revealed significant differences between male Sirt6-transgenic mice and male wild-type mice: transgenic males displayed lower serum levels of insulin-like growth factor 1 (IGF1), higher levels of IGF-binding protein 1 and altered phosphorylation levels of major components of IGF1 signalling, a key pathway in the regulation of lifespan(5). This study shows the regulation of mammalian lifespan by a sirtuin family member and has important therapeutic implications for age-related diseases.	[Kanfi, Yariv; Naiman, Shoshana; Peshti, Victoria; Nahum, Liat; Cohen, Haim Y.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Amir, Gail] Hadassah Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel; [Amir, Gail] Hebrew Univ Jerusalem, IL-91120 Jerusalem, Israel; [Zinman, Guy; Bar-Joseph, Ziv] Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15217 USA	Bar Ilan University; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Carnegie Mellon University	Cohen, HY (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	Haim.Cohen@biu.ac.il	Kornweitz, Haya/L-6469-2018; Bar-Joseph, Ziv/GWN-2754-2022	Kornweitz, Haya/0000-0002-3562-0141; Bar-Joseph, Ziv/0000-0003-3430-6051; Cohen, Haim Y./0000-0002-6613-8710	National Institutes of Health [1RO1 GM085022]; Israeli Academy of Sciences; United States - Israel Binational Science Foundation; Israel Cancer Association; Koret Foundation; Israel Cancer Research Fund; Israel Health Ministry [41/1]; Israel Science Foundation; European Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Academy of Sciences; United States - Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Association; Koret Foundation; Israel Cancer Research Fund; Israel Health Ministry; Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. S. Levy-Drummer, C. Wachtel, S. Schwarzbaum and members of the Cohen laboratory for their comments on the manuscript. This study was supported by National Institutes of Health grant 1RO1 GM085022 to Z.B.-J. and by grants from the Israeli Academy of Sciences, the United States - Israel Binational Science Foundation, the Israel Cancer Association, the Koret Foundation, the Israel Cancer Research Fund, the Israel Health Ministry, I-CORE program (41/1), the Israel Science Foundation and the European Research Council to H.Y.C.	Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Baur JA, 2010, SCIENCE, V329, P1012, DOI 10.1126/science.329.5995.1012; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Rizki G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002235; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yeap BB, 2010, EUR J ENDOCRINOL, V162, P249, DOI 10.1530/EJE-09-0852; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x	26	700	730	4	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					218	221		10.1038/nature10815	http://dx.doi.org/10.1038/nature10815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22367546				2022-12-28	WOS:000301174900040
J	Holmes, D				Holmes, David			Wang Yu: protecting China's health	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2012	379	9818					794	794		10.1016/S0140-6736(12)60334-1	http://dx.doi.org/10.1016/S0140-6736(12)60334-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901RB	22386020	Bronze, Green Published			2022-12-28	WOS:000300983400013
J	Parducci, L; Jorgensen, T; Tollefsrud, MM; Elverland, E; Alm, T; Fontana, SL; Bennett, KD; Haile, J; Matetovici, I; Suyama, Y; Edwards, ME; Andersen, K; Rasmussen, M; Boessenkool, S; Coissac, E; Brochmann, C; Taberlet, P; Houmark-Nielsen, M; Larsen, NK; Orlando, L; Gilbert, MTP; Kjaer, KH; Alsos, IG; Willerslev, E				Parducci, Laura; Jorgensen, Tina; Tollefsrud, Mari Mette; Elverland, Ellen; Alm, Torbjorn; Fontana, Sonia L.; Bennett, K. D.; Haile, James; Matetovici, Irina; Suyama, Yoshihisa; Edwards, Mary E.; Andersen, Kenneth; Rasmussen, Morten; Boessenkool, Sanne; Coissac, Eric; Brochmann, Christian; Taberlet, Pierre; Houmark-Nielsen, Michael; Larsen, Nicolaj Krog; Orlando, Ludovic; Gilbert, M. Thomas P.; Kjaer, Kurt H.; Alsos, Inger Greve; Willerslev, Eske			Glacial Survival of Boreal Trees in Northern Scandinavia	SCIENCE			English	Article							ANCIENT DNA; PICEA-ABIES; POTENTIAL RANGE; HOLOCENE; MITOCHONDRIAL; NORWAY; POLLEN; SPRUCE; ANDOYA; PLANT	It is commonly believed that trees were absent in Scandinavia during the last glaciation and first recolonized the Scandinavian Peninsula with the retreat of its ice sheet some 9000 years ago. Here, we show the presence of a rare mitochondrial DNA haplotype of spruce that appears unique to Scandinavia and with its highest frequency to the west-an area believed to sustain ice-free refugia during most of the last ice age. We further show the survival of DNA from this haplotype in lake sediments and pollen of Trondelag in central Norway dating back similar to 10,300 years and chloroplast DNA of pine and spruce in lake sediments adjacent to the ice-free Andoya refugium in northwestern Norway as early as similar to 22,000 and 17,700 years ago, respectively. Our findings imply that conifer trees survived in ice-free refugia of Scandinavia during the last glaciation, challenging current views on survival and spread of trees as a response to climate changes.	[Parducci, Laura; Jorgensen, Tina; Haile, James; Andersen, Kenneth; Rasmussen, Morten; Houmark-Nielsen, Michael; Orlando, Ludovic; Gilbert, M. Thomas P.; Kjaer, Kurt H.; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Parducci, Laura; Fontana, Sonia L.; Matetovici, Irina] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Tollefsrud, Mari Mette] Norwegian Forest & Landscape Inst, N-1430 As, Norway; [Elverland, Ellen; Alm, Torbjorn; Alsos, Inger Greve] Tromso Univ Museum, NO-9037 Tromso, Norway; [Fontana, Sonia L.] Univ Gottingen, Dept Palynol & Climate Dynam, D-37073 Gottingen, Germany; [Fontana, Sonia L.] Univ Helsinki, Dept Geol, FI-00014 Helsinki, Finland; [Bennett, K. D.] Uppsala Univ, Dept Earth Sci, S-75236 Uppsala, Sweden; [Bennett, K. D.] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland; [Haile, James] Murdoch Univ, Ancient DNA Res Lab, Perth, WA 6150, Australia; [Matetovici, Irina] Univ Babes Bolyai, Mol Biol Ctr, Interdisciplinary Res Inst Bionanosci, RO-400271 Cluj Napoca, Romania; [Suyama, Yoshihisa] Tohoku Univ, Grad Sch Agr Sci, Osaki, Miyagi 9896711, Japan; [Edwards, Mary E.] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Coissac, Eric] Danish Natl High Throughput DNA Sequencing Facil, DK-1353 Copenhagen, Denmark; [Boessenkool, Sanne; Brochmann, Christian] Univ Oslo, Natl Ctr Biosystemat, Nat Hist Museum, NO-0318 Oslo, Norway; [Coissac, Eric; Taberlet, Pierre] Univ Grenoble, Lab Ecol Alpine, CNRS, UMR 5553, F-38041 Grenoble 9, France; [Larsen, Nicolaj Krog] Aarhus Univ, Dept Geosci, DK-8000 Aarhus C, Denmark	University of Copenhagen; Uppsala University; The Norwegian Forest & Landscape Institute; UiT The Arctic University of Tromso; University of Gottingen; University of Helsinki; Uppsala University; Queens University Belfast; Murdoch University; Babes Bolyai University from Cluj; Tohoku University; University of Southampton; University of Oslo; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Aarhus University	Willerslev, E (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.	ewillerslev@snm.ku.dk	Parducci, Laura/H-9355-2019; Suyama, Yoshihisa/H-6115-2017; Orlando, Ludovic/A-8932-2013; Alsos, Inger Greve/O-8154-2019; Alsos, Inger G/A-9507-2016; Bennett, Keith D/C-8619-2009; Gilbert, Marcus TP/A-8936-2013; Larsen, Nicolaj K./A-3509-2012; Boessenkool, Sanne/K-4274-2017; Houmark-Nielsen, Michael/A-9121-2013; Parducci, Laura/B-8918-2012; Willerslev, Eske/AAA-5686-2019; Coissac, Éric/AAE-8735-2019; Willerslev, Eske/A-9619-2011; Kjaer, Kurt/A-4199-2013; Taberlet, Pierre/D-1178-2010; Brochmann, Christian/A-4105-2009	Parducci, Laura/0000-0003-1956-4757; Suyama, Yoshihisa/0000-0002-3136-5489; Orlando, Ludovic/0000-0003-3936-1850; Alsos, Inger Greve/0000-0002-8610-1085; Alsos, Inger G/0000-0002-8610-1085; Bennett, Keith D/0000-0002-3423-1531; Gilbert, Marcus TP/0000-0002-5805-7195; Larsen, Nicolaj K./0000-0002-0117-1106; Boessenkool, Sanne/0000-0001-8033-1165; Parducci, Laura/0000-0003-1956-4757; Coissac, Éric/0000-0001-7507-6729; Willerslev, Eske/0000-0002-7081-6748; Kjaer, Kurt/0000-0002-8871-5179; Taberlet, Pierre/0000-0002-3554-5954; Fontana, Sonia/0000-0001-8238-4172	Swedish Research Council [2007-4490]; Carl Trygger's Foundation [08:303]; KAKENHI [22658046]; Royal Society; Danish National Research Foundation; Norwegian Forest and Landscape Institute, University of Tromso; Tromso University Museum; Roald Amundsen Centre for Arctic Research; European Commission [FP6-036866]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger's Foundation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Royal Society(Royal Society of London); Danish National Research Foundation(Danmarks Grundforskningsfond); Norwegian Forest and Landscape Institute, University of Tromso; Tromso University Museum; Roald Amundsen Centre for Arctic Research; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank T. Giesecke and M. Lascoux for helpful comments; J. Chen, T. Geburek, and C. Sperisen for providing modern samples; and L. Yuan for initial spruce genotyping. We also thank T. Vorren and K.-D. Vorren for providing Andoya core samples with lithostratigraphy and radiocarbon dates. This study was supported by the Swedish Research Council (grant 2007-4490 to L.P.) and the Carl Trygger's Foundation (grant 08:303 to L.P.); KAKENHI (22658046); a Royal Society-Wolfson Merit Award to K.D.B.; the Danish National Research Foundation; the Norwegian Forest and Landscape Institute, University of Tromso; and the Tromso University Museum, the Roald Amundsen Centre for Arctic Research, and the European Commission under the Sixth Framework 378 Programme (EcoChange project, contract no. FP6-036866). L.P., T.J., M.M.T., and E.E. should be considered joint first authors. I.G.A. and E.W. should be considered joint senior authors. The authors declare no competing financial interests. P.T. is coinventor of patents related to the g/h primers and the use of the P6 loop of the chloroplast trnL (UAA) intron for plant identification using degraded template DNA. These patents only restrict commercial applications and have no impact on the use of this locus by academic researchers. The trnL DNA sequences can be found at the European Nucleotide Archive with the study accession no. ERP001153. The mtDNA sequences can be found at the European Molecular Biology Laboratory database with the accession no. HE652882-HE653002.	ALM T, 1993, BOREAS, V22, P171, DOI 10.1111/j.1502-3885.1993.tb00178.x; ALM T, 1991, NORD J BOT, V11, P465, DOI 10.1111/j.1756-1051.1991.tb01249.x; Andersen K., 2011, MOL ECOL, DOI [10.1111/j.1365-.2011.05261.x, DOI 10.1111/J.1365-.2011.05261.X]; Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Birks HH, 2005, J BIOGEOGR, V32, P1461, DOI 10.1111/j.1365-2699.2005.01287.x; Giesecke T, 2004, J BIOGEOGR, V31, P1523, DOI 10.1111/j.1365-2699.2004.01095.x; Grivet D, 1999, THEOR APPL GENET, V99, P346, DOI 10.1007/s001220051243; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Heikkila M, 2009, J QUATERNARY SCI, V24, P802, DOI 10.1002/jqs.1254; Hicks S, 2006, VEG HIST ARCHAEOBOT, V15, P253, DOI 10.1007/s00334-006-0063-9; Huntley B., 1983, ATLAS PRESENT POLLEN; Jorgensen T., 2011, MOL ECOL, DOI [10.1111/j.1365-.2011.05287.x, DOI 10.1111/J.1365-.2011.05287.X]; Kullman L, 2006, J BIOGEOGR, V33, P377, DOI 10.1111/j.1365-2699.2005.01451.x; KULLMAN L, 1995, ECOLOGY, V76, P2490, DOI 10.2307/2265823; Kullman L, 2002, J BIOGEOGR, V29, P1117, DOI 10.1046/j.1365-2699.2002.00743.x; Magyari EK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-66; Mangerud J, 2004, DEV QUA SCI, V2, P271; Parducci L, 2005, MOL ECOL, V14, P2873, DOI 10.1111/j.1365-294X.2005.02644.x; Paus A, 2011, QUATERNARY SCI REV, V30, P1780, DOI 10.1016/j.quascirev.2011.04.010; Preuten T, 2010, PLANT J, V64, P948, DOI 10.1111/j.1365-313X.2010.04389.x; Rauwolf U, 2010, MOL GENET GENOMICS, V283, P35, DOI 10.1007/s00438-009-0491-1; Segerstrom U, 2003, HOLOCENE, V13, P897, DOI 10.1191/0959683603hl672rp; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tarasov P., 2009, PAGES (Past Global Changes) News, V17, P122; Tollefsrud MM, 2009, HEREDITY, V102, P549, DOI 10.1038/hdy.2009.16; Tollefsrud MM, 2008, MOL ECOL, V17, P4134, DOI 10.1111/j.1365-294X.2008.03893.x; VORREN KD, 1978, BOREAS, V7, P19, DOI 10.1111/j.1502-3885.1978.tb00047.x; VORREN TO, 1988, BOREAS, V17, P41; Vorren TO, 2002, BOREAS, V31, P97, DOI 10.1080/030094802320129926; Welk E, 2006, J BIOGEOGR, V33, P2013, DOI 10.1111/j.1365-2699.2006.01558.x; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zazula GD, 2006, ARCTIC, V59, P391	38	234	251	4	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1083	1086		10.1126/science.1216043	http://dx.doi.org/10.1126/science.1216043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383845				2022-12-28	WOS:000300931100042
J	Noinaj, N; Easley, NC; Oke, M; Mizuno, N; Gumbart, J; Boura, E; Steere, AN; Zak, O; Aisen, P; Tajkhorshid, E; Evans, RW; Gorringe, AR; Mason, AB; Steven, AC; Buchanan, SK				Noinaj, Nicholas; Easley, Nicole C.; Oke, Muse; Mizuno, Naoko; Gumbart, James; Boura, Evzen; Steere, Ashley N.; Zak, Olga; Aisen, Philip; Tajkhorshid, Emad; Evans, Robert W.; Gorringe, Andrew R.; Mason, Anne B.; Steven, Alasdair C.; Buchanan, Susan K.			Structural basis for iron piracy by pathogenic Neisseria	NATURE			English	Article							BINDING PROTEIN-B; HUMAN SERUM TRANSFERRIN; X-RAY; MOLECULAR-DYNAMICS; C-LOBE; MENINGITIDIS; RECEPTOR; IDENTIFICATION; ANTIBODIES; SCATTERING	Neisseria are obligate human pathogens causing bacterial meningitis, septicaemia and gonorrhoea. Neisseria require iron for survival and can extract it directly from human transferrin for transport across the outer membrane. The transport system consists of TbpA, an integral outer membrane protein, and TbpB, a co-receptor attached to the cell surface; both proteins are potentially important vaccine and therapeutic targets. Two key questions driving Neisseria research are how human transferrin is specifically targeted, and how the bacteria liberate iron from transferrin at neutral pH. To address these questions, we solved crystal structures of the TbpA-transferrin complex and of the corresponding co-receptor TbpB. We characterized the TbpB-transferrin complex by small-angle X-ray scattering and the TbpA-TbpB-transferrin complex by electron microscopy. Our studies provide a rational basis for the specificity of TbpA for human transferrin, show how TbpA promotes iron release from transferrin, and elucidate how TbpB facilitates this process.	[Noinaj, Nicholas; Easley, Nicole C.; Oke, Muse; Boura, Evzen; Buchanan, Susan K.] NIDDK, Mol Biol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Mizuno, Naoko; Steven, Alasdair C.] NIAMSD, Struct Biol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Gumbart, James] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Steere, Ashley N.; Mason, Anne B.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Zak, Olga; Aisen, Philip] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Tajkhorshid, Emad] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Tajkhorshid, Emad] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Evans, Robert W.] Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Metalloprot Res Grp, Uxbridge UB8 3PH, Middx, England; [Gorringe, Andrew R.] Hlth Protect Agcy, Salisbury SP2 8NY, Wilts, England	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); United States Department of Energy (DOE); Argonne National Laboratory; University of Vermont; Yeshiva University; Albert Einstein College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Brunel University; Health Protection Agency	Buchanan, SK (corresponding author), NIDDK, Mol Biol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA.	skbuchan@helix.nih.gov	Tajkhorshid, Emad/AAN-8323-2021; Mizuno, Naoko/AAY-1926-2021; Gorringe, Andrew R/L-6022-2017; Mason, Anne B/A-6754-2008; Boura, Evzen/G-5275-2014; Boura, Evzen/I-2626-2012	Mizuno, Naoko/0000-0002-1594-2821; Gorringe, Andrew R/0000-0003-2193-7954; Oke, Muse/0000-0002-0169-752X; Boura, Evzen/0000-0002-9652-4065; Tajkhorshid, Emad/0000-0001-8434-1010; Steere, Allen/0000-0002-5268-9853	NIH, National Institute of Diabetes and Digestive and Kidney Diseases; EPSRC Research Committee; NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases; USPHS [R01-DK21739]; AHA [10PRE4200010]; NIH [R01-GM086749, U54-GM087519, P41-RR05969]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036143, R01DK021739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM086749] Funding Source: NIH RePORTER	NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EPSRC Research Committee(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.N., N.C.E., M.O., E.B. and S.K.B. are supported by the Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases. M.O. was initially funded by an EPSRC Research Committee Studentship awarded to S.K.B. and R.W.E. N.M. and A.C.S. are supported by the Intramural Research Program of the NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases. A.B.M. was supported in part by USPHS grant R01-DK21739. A.N.S. is funded by an AHA Predoctoral Fellowship (10PRE4200010). E.T. acknowledges NIH support by R01-GM086749, U54-GM087519 and P41-RR05969. All the simulations were performed using TeraGrid resources (MCA06N060). We thank the respective staffs at the Southeast Regional Collaborative Access Team (SER-CAT) and General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory for their assistance during data collection. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38 (SER-CAT), and by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357 (GM/CA-CAT). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSON JE, 1994, J BACTERIOL, V176, P3162, DOI 10.1128/jb.176.11.3162-3170.1994; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boulton IC, 1998, BIOCHEM J, V334, P269, DOI 10.1042/bj3340269; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P873; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Cornelissen CN, 1997, INFECT IMMUN, V65, P822, DOI 10.1128/IAI.65.2.822-828.1997; CORNELISSEN CN, 1993, J BACTERIOL, V175, P2448, DOI 10.1128/JB.175.8.2448-2450.1993; Deasy A, 2011, EXPERT REV VACCINES, V10, P335, DOI [10.1586/erv.11.3, 10.1586/ERV.11.3]; Eckenroth BE, 2011, P NATL ACAD SCI USA, V108, P13089, DOI 10.1073/pnas.1105786108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; Gumbart J, 2009, J MOL BIOL, V393, P1129, DOI 10.1016/j.jmb.2009.09.004; Halbrooks PJ, 2003, BIOCHEMISTRY-US, V42, P3701, DOI 10.1021/bi027071q; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hobbs MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IRWIN SW, 1993, MOL MICROBIOL, V8, P1125, DOI 10.1111/j.1365-2958.1993.tb01657.x; Krell T, 2003, J BIOL CHEM, V278, P14712, DOI 10.1074/jbc.M204461200; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mason AB, 2004, PROTEIN EXPRES PURIF, V36, P318, DOI 10.1016/j.pep.2004.04.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Noto JM, 2008, INFECT IMMUN, V76, P1960, DOI 10.1128/IAI.00020-08; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Price GA, 2007, VACCINE, V25, P7247, DOI 10.1016/j.vaccine.2007.07.038; Rokbi B, 1997, INFECT IMMUN, V65, P55, DOI 10.1128/IAI.65.1.55-63.1997; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; SCHRYVERS AB, 1989, INFECT IMMUN, V57, P2425, DOI 10.1128/IAI.57.8.2425-2429.1989; SCHRYVERS AB, 1988, MOL MICROBIOL, V2, P281, DOI 10.1111/j.1365-2958.1988.tb00029.x; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Silva LP, 2011, J BIOL CHEM, V286, P21353, DOI 10.1074/jbc.M111.226449; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Steere A. N., 2011, BIOCH BIOPHYS ACTA; Steere AN, 2010, PROTEIN EXPRES PURIF, V72, P32, DOI 10.1016/j.pep.2010.01.008; Stokes RH, 2005, INFECT IMMUN, V73, P944, DOI 10.1128/IAI.73.2.944-952.2005; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; SVERGUN OY, 1991, ZH VYSSH NERV DEYAT+, V41, P700; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weynants VE, 2007, INFECT IMMUN, V75, P5434, DOI 10.1128/IAI.00411-07; Yost-Daljev MK, 2004, INFECT IMMUN, V72, P1775, DOI 10.1128/IAI.72.3.1775-1785.2004; Zak O, 2002, BIOCHEMISTRY-US, V41, P1647, DOI 10.1021/bi015868w	52	192	195	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					53	U92		10.1038/nature10823	http://dx.doi.org/10.1038/nature10823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22327295	Green Accepted			2022-12-28	WOS:000300877900042
J	Hawkes, N				Hawkes, Nigel			BRIEFING Speeding up access to new drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 17	2012	344								e999	10.1136/bmj.e999	http://dx.doi.org/10.1136/bmj.e999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IT	22344456				2022-12-28	WOS:000300559600003
J	Orchard, RC; Kittisopikul, M; Altschuler, SJ; Wu, LF; Suel, GM; Alto, NM				Orchard, Robert C.; Kittisopikul, Mark; Altschuler, Steven J.; Wu, Lani F.; Sueel, Guerol M.; Alto, Neal M.			Identification of F-actin as the Dynamic Hub in a Microbial-Induced GTPase Polarity Circuit	CELL			English	Article							SPONTANEOUS CELL POLARIZATION; N-WASP; PROTEIN; BINDING; CDC42; ACTIVATION; FAMILY; EZRIN; MECHANISM; NETWORK	Polarity in mammalian cells emerges from the assembly of signaling molecules into extensive biochemical interaction networks. Despite their complexity, bacterial pathogens have evolved parsimonious mechanisms to hijack these systems. Here, we develop a tractable experimental and theoretical model to uncover fundamental operating principles, in both mammalian cell polarity and bacterial pathogenesis. Using synthetic derivatives of the enteropathogenic Escherichia coli guanine-nucleotide exchange factor (GEF) Map, we discover that Cdc42 GTPase signal transduction is controlled by the interaction between Map and F-actin. Mathematical modeling reveals how actin dynamics coupled to a Map-dependent positive feedback loop spontaneously polarizes Cdc42 on the plasma membrane. By rewiring the pathogenic signaling circuit to operate through beta-integrin stimulation, we further show how Cdc42 is polarized in response to an extracellular spatial cue. Thus, a molecular pathway of polarity is proposed, centered on the interaction between GEFs and F-actin, which is likely to function in diverse biological systems.	[Orchard, Robert C.; Alto, Neal M.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Kittisopikul, Mark; Altschuler, Steven J.; Wu, Lani F.; Sueel, Guerol M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Kittisopikul, Mark; Altschuler, Steven J.; Wu, Lani F.; Sueel, Guerol M.] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Alto, NM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	neal.alto@utsouthwestern.edu	Kittisopikul, Mark/V-7680-2019	Kittisopikul, Mark/0000-0002-9558-6248	National Institutes of Health [AI083359, AI007520, GM T32008297, T32 08014, GM081549, GM071794, GM088428]; Welch Foundation [I-1704, I-1644, I-1619, I-1674]; James S. McDonnell Foundation [220020141]; NCI Cancer Center [1P30 CA142543-01]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071794, R01GM081549, R01GM088428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); James S. McDonnell Foundation; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank our colleagues, specifically K. Orth, M. Rosen, and members of the Alto lab, for helpful discussions in preparation of this manuscript. This work was supported National Institutes of Health grants (AI083359 to N.M.A, AI007520 to R.C.O, GM T32008297 to M.K., T32 08014 to M.K, GM081549 to L.F.W., GM071794 to S.J.A., GM088428 to G.M.S); the Welch Foundation (I-1704 to N.M.A, I-1644 to L.F.W., I-1619 to S.J.A., I-1674 to G.M.S); and the James S. McDonnell Foundation (220020141 to G.M.S). We are also grateful for the assistance of the UT Southwestern Live Cell Imaging Facility, a shared resource of the Harold C. Simmons Cancer Center, supported in part by an NCI Cancer Center Support Grant (1P30 CA142543-01).	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Banerjee J, 2009, BIOCHEMISTRY-US, V48, P8032, DOI 10.1021/bi9010013; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Berger CN, 2009, CELL MICROBIOL, V11, P309, DOI 10.1111/j.1462-5822.2008.01254.x; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kenny B, 2002, MOL MICROBIOL, V44, P1095, DOI 10.1046/j.1365-2958.2002.02952.x; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Park KC, 2004, EMBO J, V23, P4177, DOI 10.1038/sj.emboj.7600368; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Saleh HS, 2009, J MOL BIOL, V385, P1015, DOI 10.1016/j.jmb.2008.11.051; Simpson N, 2006, MOL MICROBIOL, V60, P349, DOI 10.1111/j.1365-2958.2006.05109.x; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Upadhyay A, 2008, BIOCHEM J, V411, P485, DOI 10.1042/BJ20071546; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2003, NAT CELL BIOL, V5, P267, DOI 10.1038/ncb0403-267; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033	36	24	24	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					803	815		10.1016/j.cell.2011.11.063	http://dx.doi.org/10.1016/j.cell.2011.11.063			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341450	Bronze, Green Accepted			2022-12-28	WOS:000300622400020
J	Giovannoni, SJ; Vergin, KL				Giovannoni, Stephen J.; Vergin, Kevin L.			Seasonality in Ocean Microbial Communities	SCIENCE			English	Review							DISSOLVED ORGANIC-CARBON; ATLANTIC TIME-SERIES; MARINE BACTERIOPLANKTON; DEEP-SEA; PHYTOPLANKTON; BACTERIAL; DYNAMICS; LINEAGES; ARCHAEAL; REVEAL	Ocean warming occurs every year in seasonal cycles that can help us to understand long-term responses of plankton to climate change. Rhythmic seasonal patterns of microbial community turnover are revealed when high-resolution measurements of microbial plankton diversity are applied to samples collected in lengthy time series. Seasonal cycles in microbial plankton are complex, but the expansion of fixed ocean stations monitoring long-term change and the development of automated instrumentation are providing the time-series data needed to understand how these cycles vary across broad geographical scales. By accumulating data and using predictive modeling, we gain insights into changes that will occur as the ocean surface continues to warm and as the extent and duration of ocean stratification increase. These developments will enable marine scientists to predict changes in geochemical cycles mediated by microbial communities and to gauge their broader impacts.	[Giovannoni, Stephen J.; Vergin, Kevin L.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu		VERGIN, KEVIN/0000-0002-8972-2813	Marine Microbiology Initiative of the Gordon and Betty Moore Foundation; NSF [MCB-0237713, OCE-0802004]	Marine Microbiology Initiative of the Gordon and Betty Moore Foundation; NSF(National Science Foundation (NSF))	We thank M. Behrenfeld, C. Thrash, and K. Halsey for critical comments. Supported by a grant from the Marine Microbiology Initiative of the Gordon and Betty Moore Foundation and NSF Microbial Observatory grants MCB-0237713 and OCE-0802004.	Al-Najjar T, 2007, HYDROBIOLOGIA, V579, P69, DOI 10.1007/s10750-006-0365-z; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Bertrand EM, 2007, LIMNOL OCEANOGR, V52, P1079, DOI 10.4319/lo.2007.52.3.1079; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Campbell L, 1997, DEEP-SEA RES PT I, V44, P167, DOI 10.1016/S0967-0637(96)00102-1; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Carlson CA, 2010, DEEP-SEA RES PT II, V57, P1433, DOI 10.1016/j.dsr2.2010.02.013; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DuRand MD, 2001, DEEP-SEA RES PT II, V48, P1983, DOI 10.1016/S0967-0645(00)00166-1; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Eiler A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00140; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fuchs BM, 2000, ENVIRON MICROBIOL, V2, P191, DOI 10.1046/j.1462-2920.2000.00092.x; Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Goldberg SJ, 2009, DEEP-SEA RES PT I, V56, P672, DOI 10.1016/j.dsr.2008.12.013; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kim E, 2011, P NATL ACAD SCI USA, V108, P1496, DOI 10.1073/pnas.1013337108; Koch BP, 2008, MAR CHEM, V111, P233, DOI 10.1016/j.marchem.2008.05.008; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; Lyman JM, 2010, NATURE, V465, P334, DOI 10.1038/nature09043; MOPPER K, 1991, NATURE, V353, P60, DOI 10.1038/353060a0; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Nelson JD, 2008, FEMS MICROBIOL ECOL, V65, P484, DOI 10.1111/j.1574-6941.2008.00553.x; Neufeld JD, 2007, ISME J, V1, P103, DOI 10.1038/ismej.2007.30; Oh HM, 2010, J BACTERIOL, V192, P3240, DOI 10.1128/JB.00347-10; Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Preston CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022522; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schattenhofer M, 2009, ENVIRON MICROBIOL, V11, P2078, DOI 10.1111/j.1462-2920.2009.01929.x; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24; Steinberg DK, 2001, DEEP-SEA RES PT II, V48, P1405, DOI 10.1016/S0967-0645(00)00148-X; Sun J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023973; Sverdrup H.U., 1953, J CONSEILCONSEIL PER, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Treusch A. H., 2011, ISME J; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	62	198	200	9	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					671	676		10.1126/science.1198078	http://dx.doi.org/10.1126/science.1198078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323811				2022-12-28	WOS:000300047100041
J	Liao, J; Li, H; Zeng, WZ; Sauer, DB; Belmares, R; Jiang, YX				Liao, Jun; Li, Hua; Zeng, Weizhong; Sauer, David B.; Belmares, Ricardo; Jiang, Youxing			Structural Insight into the Ion-Exchange Mechanism of the Sodium/Calcium Exchanger	SCIENCE			English	Article							SODIUM-CALCIUM EXCHANGE; SARCOLEMMAL NA+-CA2+ EXCHANGER; CARDIAC NA+/CA2+ EXCHANGER; NA-CA EXCHANGE; CRYSTAL-STRUCTURE; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL EXPRESSION; BACTERIAL HOMOLOG; CELLS; PROTEINS	Sodium/calcium (Na+/Ca2+) exchangers (NCX) are membrane transporters that play an essential role in maintaining the homeostasis of cytosolic Ca2+ for cell signaling. We demonstrated the Na+/Ca2+-exchange function of an NCX from Methanococcus jannaschii (NCX_Mj) and report its 1.9 angstrom crystal structure in an outward-facing conformation. Containing 10 transmembrane helices, the two halves of NCX_Mj share a similar structure with opposite orientation. Four ion-binding sites cluster at the center of the protein: one specific for Ca2+ and three that likely bind Na+. Two passageways allow for Na+ and Ca2+ access to the central ion-binding sites from the extracellular side. Based on the symmetry of NCX_Mj and its ability to catalyze bidirectional ion-exchange reactions, we propose a structure model for the inward-facing NCX_Mj.	[Liao, Jun; Li, Hua; Zeng, Weizhong; Sauer, David B.; Belmares, Ricardo; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Li, Hua; Zeng, Weizhong; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jiang, YX (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu	Li, Hua/ABH-1613-2021	Li, Hua/0000-0003-1903-836X; Sauer, David/0000-0001-9291-4640; Liao, Jun/0000-0001-7487-5545	U.S. DOE [DE-AC02-06CH11357]; Howard Hughes Medical Institute; David and Lucile Packard Foundation; Welch Foundation [I-1578]	U.S. DOE(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Welch Foundation(The Welch Foundation)	We thank D. Rosenbaum for technical support with LCP crystallization, D. Hilgemann for discussion, and N. Nguyen for critical review of the manuscript. Structures shown in this report are derived from work performed at the Advanced Photon Source (19-ID and 23-ID beamlines), Argonne National Laboratory. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U. S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract no. DE-AC02-06CH11357. We thank the beamline staff for assistance in data collection. This work was supported in part by the Howard Hughes Medical Institute and by grants from the David and Lucile Packard Foundation and the Welch Foundation (grant I-1578 to Y.J.). The atomic coordinates and structural factors have been deposited in the Protein Data Bank with the accession numbers 3V5U for the LCP crystal and 3V5S for the low-resolution crystal in detergent. The authors declare no competing financial interests.	Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BLAUSTEIN MP, 1975, J MEMBRANE BIOL, V22, P285, DOI 10.1007/BF01868176; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hilgemann DW, 1996, BIOPHYS J, V71, P759, DOI 10.1016/S0006-3495(96)79275-5; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; KHANANSHVILI D, 1990, BIOCHEMISTRY-US, V29, P2437, DOI 10.1021/bi00462a001; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; MILANICK MA, 1991, ANN NY ACAD SCI, V639, P604, DOI 10.1111/j.1749-6632.1991.tb17358.x; Nicoll DA, 2002, ANN NY ACAD SCI, V976, P11; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; REEVES JP, 1984, J BIOL CHEM, V259, P7733; REILANDER H, 1992, EMBO J, V11, P1689, DOI 10.1002/j.1460-2075.1992.tb05219.x; Ren XY, 2010, BIOCHEMISTRY-US, V49, P8585, DOI 10.1021/bi101173c; Saaf A, 2001, J BIOL CHEM, V276, P18905, DOI 10.1074/jbc.M101716200; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; TROSPER TL, 1983, BIOCHIM BIOPHYS ACTA, V731, P63, DOI 10.1016/0005-2736(83)90398-X; Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	37	182	185	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					686	690		10.1126/science.1215759	http://dx.doi.org/10.1126/science.1215759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323814				2022-12-28	WOS:000300047100044
J	Zhang, J; Coulston, RJ; Jones, ST; Geng, J; Scherman, OA; Abell, C				Zhang, Jing; Coulston, Roger J.; Jones, Samuel T.; Geng, Jin; Scherman, Oren A.; Abell, Chris			One-Step Fabrication of Supramolecular Microcapsules from Microfluidic Droplets	SCIENCE			English	Article							CONTROLLED MORPHOLOGY; POLYMER CAPSULES; ENCAPSULATION; CHEMISTRY; RELEASE; DEVICE; CARGO	Although many techniques exist for preparing microcapsules, it is still challenging to fabricate them in an efficient and scalable process without compromising functionality and encapsulation efficiency. We demonstrated a simple one-step approach that exploits a versatile host-guest system and uses microfluidic droplets to generate porous microcapsules with easily customizable functionality. The capsules comprise a polymer-gold nanoparticle composite held together by cucurbit[8]uril ternary complexes. The dynamic yet highly stable micrometer-sized structures can be loaded in one step during capsule formation and are amenable to on-demand encapsulant release. The internal chemical environment can be probed with surface enhanced Raman spectroscopy.	[Coulston, Roger J.; Jones, Samuel T.; Geng, Jin; Scherman, Oren A.; Abell, Chris] Univ Cambridge, Dept Chem, Melville Lab Polymer Synth, Cambridge CB2 1EW, England	University of Cambridge	Scherman, OA (corresponding author), Univ Cambridge, Dept Chem, Melville Lab Polymer Synth, Lensfield Rd, Cambridge CB2 1EW, England.	oas23@cam.ac.uk; ca26@cam.ac.uk	Geng, Jin/J-7106-2018	Jones, Samuel/0000-0002-3907-0810; Geng, Jin/0000-0003-2181-0718	Engineering and Physical Sciences Research Council [EP/H046593/1]; European Research Council [(ASPiRe) ERC-2009-StG-240629]; European Union [EP/H007024/1]; Engineering and Physical Sciences Research Council [EP/F035535/1] Funding Source: researchfish; EPSRC [EP/F035535/1, EP/H046593/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council Basic Technology Translational grant EP/H046593/1, a European Research Council Starting Investigator Grant (ASPiRe) ERC-2009-StG-240629, and a European Union NanoSci-E+ (CUBiHOLE) grant EP/H007024/1. SERS experiments were performed with the assistance of S. Mahajan. The DH5 alpha Escherichia coli strain was a kind gift from M. Welch and S. Bowden from the Department of Biochemistry, University of Cambridge. The naphthol-containing polymer was a kind gift from E. Appel from the Department of Chemistry, University of Cambridge. The authors thank X. Liu, C. A. Smith, S. Mahajan, J. J. Baumberg, and W. T. S. Huck for the helpful discussions. J.Z., R.J.C., O.A.S., and C. A. have filed a provisional application for a GB patent on the fabrication process.	Abalde-Cela S, 2011, SOFT MATTER, V7, P1321, DOI 10.1039/c0sm00601g; Abraham S, 2008, ADV MATER, V20, P2177, DOI 10.1002/adma.200700456; Anema JR, 2011, ANNU REV ANAL CHEM, V4, P129, DOI 10.1146/annurev.anchem.111808.073632; Arumugam P, 2007, POLYM INT, V56, P461, DOI 10.1002/pi.2210; Augustin MA, 2009, CHEM SOC REV, V38, P902, DOI 10.1039/b801739p; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Comiskey B, 1998, NATURE, V394, P253, DOI 10.1038/28349; Coulston RJ, 2011, CHEM COMMUN, V47, P164, DOI 10.1039/c0cc03250f; Cui JW, 2010, ADV FUNCT MATER, V20, P1625, DOI 10.1002/adfm.201000209; De Cock LJ, 2010, ANGEW CHEM INT EDIT, V49, P6954, DOI 10.1002/anie.200906266; Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Dong WF, 2003, PHYS CHEM CHEM PHYS, V5, P3003, DOI 10.1039/b301591b; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Esser-Kahn AP, 2011, MACROMOLECULES, V44, P5539, DOI 10.1021/ma201014n; Hwang H, 2011, LAB CHIP, V11, P87, DOI [10.1039/c0lc00125b, 10.1039/c01c00125b]; Jeon WS, 2002, CHEM COMMUN, P1828, DOI 10.1039/b202082c; Johnston APR, 2010, ANGEW CHEM INT EDIT, V49, P2664, DOI 10.1002/anie.200906840; Ke H. T., 2011, ANGEW CHEM, V123, P3073; Kim J, 2000, J AM CHEM SOC, V122, P540, DOI 10.1021/ja993376p; Leonard A, 2011, CHEM SOC REV, V40, P860, DOI 10.1039/c0cs00024h; Mahajan S, 2010, PHYS CHEM CHEM PHYS, V12, P10429, DOI 10.1039/c0cp00071j; Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104; Patra D, 2010, CHEM-ASIAN J, V5, P2442, DOI 10.1002/asia.201000301; Patra D, 2009, LANGMUIR, V25, P13852, DOI 10.1021/la9015756; Peyratout CS, 2004, ANGEW CHEM INT EDIT, V43, P3762, DOI 10.1002/anie.200300568; Rauwald U, 2008, ANGEW CHEM INT EDIT, V47, P3950, DOI 10.1002/anie.200705591; Theberge AB, 2010, ANGEW CHEM INT EDIT, V49, P5846, DOI 10.1002/anie.200906653; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164; van Dongen SFM, 2009, CHEM REV, V109, P6212, DOI 10.1021/cr900072y; Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358; Yow HN, 2006, SOFT MATTER, V2, P940, DOI 10.1039/b606965g; Zhang H, 2006, J AM CHEM SOC, V128, P12205, DOI 10.1021/ja0635682	34	355	406	31	761	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					690	694		10.1126/science.1215416	http://dx.doi.org/10.1126/science.1215416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323815				2022-12-28	WOS:000300047100045
J	Hsieh, AC; Liu, Y; Edlind, MP; Ingolia, NT; Janes, MR; Sher, A; Shi, EY; Stumpf, CR; Christensen, C; Bonham, MJ; Wang, SY; Ren, PD; Martin, M; Jessen, K; Feldman, ME; Weissman, JS; Shokat, KM; Rommel, C; Ruggero, D				Hsieh, Andrew C.; Liu, Yi; Edlind, Merritt P.; Ingolia, Nicholas T.; Janes, Matthew R.; Sher, Annie; Shi, Evan Y.; Stumpf, Craig R.; Christensen, Carly; Bonham, Michael J.; Wang, Shunyou; Ren, Pingda; Martin, Michael; Jessen, Katti; Feldman, Morris E.; Weissman, Jonathan S.; Shokat, Kevan M.; Rommel, Christian; Ruggero, Davide			The translational landscape of mTOR signalling steers cancer initiation and metastasis	NATURE			English	Article							TOP MESSENGER-RNAS; PROSTATE-CANCER; STEM-CELLS; IN-VIVO; PROTEIN-SYNTHESIS; PHOSPHORYLATION; RAPAMYCIN; PROMOTES; PATHWAY; COMPLEX	The mammalian target of rapamycin (mTOR) kinase is a master regulator of protein synthesis that couples nutrient sensing to cell growth and cancer. However, the downstream translationally regulated nodes of gene expression that may direct cancer development are poorly characterized. Using ribosome profiling, we uncover specialized translation of the prostate cancer genome by oncogenic mTOR signalling, revealing a remarkably specific repertoire of genes involved in cell proliferation, metabolism and invasion. We extend these findings by functionally characterizing a class of translationally controlled pro-invasion messenger RNAs that we show direct prostate cancer invasion and metastasis downstream of oncogenic mTOR signalling. Furthermore, we develop a clinically relevant ATP site inhibitor of mTOR, INK128, which reprograms this gene expression signature with therapeutic benefit for prostate cancer metastasis, for which there is presently no cure. Together, these findings extend our understanding of how the 'cancerous' translation machinery steers specific cancer cell behaviours, including metastasis, and may be therapeutically targeted.	[Hsieh, Andrew C.; Edlind, Merritt P.; Sher, Annie; Shi, Evan Y.; Stumpf, Craig R.; Christensen, Carly; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA; [Hsieh, Andrew C.; Edlind, Merritt P.; Sher, Annie; Shi, Evan Y.; Stumpf, Craig R.; Christensen, Carly; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Hsieh, Andrew C.] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Hsieh, Andrew C.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Liu, Yi; Janes, Matthew R.; Wang, Shunyou; Ren, Pingda; Martin, Michael; Jessen, Katti; Rommel, Christian] Intellikine Inc, La Jolla, CA 92037 USA; [Ingolia, Nicholas T.] Carnegie Inst Sci, Baltimore, MD 21218 USA; [Bonham, Michael J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Feldman, Morris E.; Weissman, Jonathan S.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Carnegie Institution for Science; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Ruggero, D (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA.	christian@intellikine.com; davide.ruggero@ucsf.edu	Stumpf, Craig/B-8703-2014	Stumpf, Craig/0000-0002-9946-8986; Weissman, Jonathan/0000-0003-2445-670X	American Cancer Society [119084-PF-10-233-01-TBE]; DOD; NIH [R01 CA154916, R01 CA140456]; Phi Beta Psi Sorority; NATIONAL CANCER INSTITUTE [R01CA140456, R01CA154916] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Phi Beta Psi Sorority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Barna for critical discussion and reading of this manuscript; T. Wilson for support and advice; T. Sanders and E. Llagostera-Martin for technical support with confocal microscopy; L. Li, E. Ulm, L. Kessler, J. Kucharski and L. Darjania for technical support for the discovery and development of INK128. J. Kurhanewicz and R. Bok of the Surbeck Institute for Advanced Imaging for technical support and MRI images; N. Sonenberg for providing the 4EBP1/2 double knockout mouse embryonic fibroblasts; J. M. Shen for support; and K. Tong for editing the manuscript. A. C. H. is supported in part by the American Cancer Society (119084-PF-10-233-01-TBE), and is a Prostate Cancer Foundation Young Investigator, and a recipient of the DOD Prostate Cancer Training Award. This work is supported by NIH R01 CA154916 (D. R.), NIH R01 CA140456 (D. R.) and the Phi Beta Psi Sorority (D. R.). D. R. is a Leukemia & Lymphoma Society Scholar.	Amato RJ, 2008, CLIN GENITOURIN CANC, V6, P97, DOI 10.3816/CGC.2008.n.015; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; George D. J, 2008, AM SOC CLIN ONC GEN; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Hofer MD, 2004, CANCER RES, V64, P825, DOI 10.1158/0008-5472.CAN-03-2755; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Nardella C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000189; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; PONTES JE, 1985, J UROLOGY, V134, P1137, DOI 10.1016/S0022-5347(17)47659-2; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Willett M, 2011, BIOCHEM J, V438, P217, DOI 10.1042/BJ20110435; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Zhou P, 2005, J CLIN ONCOL, V23, P6992, DOI 10.1200/JCO.2005.01.2906	41	861	886	2	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					55	U196		10.1038/nature10912	http://dx.doi.org/10.1038/nature10912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22367541	Green Accepted			2022-12-28	WOS:000303451900033
J	Avery, AJ; Rodgers, S; Cantrill, JA; Armstrong, S; Cresswell, K; Eden, M; Elliott, RA; Howard, R; Kendrick, D; Morris, CJ; Prescott, RJ; Swanwick, G; Franklin, M; Putman, K; Boyd, M; Sheikh, A				Avery, Anthony J.; Rodgers, Sarah; Cantrill, Judith A.; Armstrong, Sarah; Cresswell, Kathrin; Eden, Martin; Elliott, Rachel A.; Howard, Rachel; Kendrick, Denise; Morris, Caroline J.; Prescott, Robin J.; Swanwick, Glen; Franklin, Matthew; Putman, Koen; Boyd, Matthew; Sheikh, Aziz			A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis	LANCET			English	Article							ADVERSE DRUG EVENTS; CLINICAL-TRIALS; PRIMARY-CARE; ADMISSIONS; QUALITY	Background Medication errors are common in primary care and are associated with considerable risk of patient harm. We tested whether a pharmacist-led, information technology-based intervention was more effective than simple feedback in reducing the number of patients at risk of measures related to hazardous prescribing and inadequate blood-test monitoring of medicines 6 months after the intervention. Methods In this pragmatic, cluster randomised trial general practices in the UK were stratified by research site and list size, and randomly assigned by a web-based randomisation service in block sizes of two or four to one of two groups. The practices were allocated to either computer-generated simple feedback for at-risk patients (control) or a pharmacist-led information technology intervention (PINCER), composed of feedback, educational outreach, and dedicated support. The allocation was masked to general practices, patients, pharmacists, researchers, and statisticians. Primary outcomes were the proportions of patients at 6 months after the intervention who had had any of three clinically important errors: non-selective non-steroidal anti-inflammatory drugs (NSAIDs) prescribed to those with a history of peptic ulcer without co-prescription of a proton-pump inhibitor; beta blockers prescribed to those with a history of asthma; long-term prescription of angiotensin converting enzyme (ACE) inhibitor or loop diuretics to those 75 years or older without assessment of urea and electrolytes in the preceding 15 months. The cost per error avoided was estimated by incremental cost-effectiveness analysis. This study is registered with Controlled-Trials.com, number ISRCTN21785299. Findings 72 general practices with a combined list size of 480 942 patients were randomised. At 6 months' follow-up, patients in the PINCER group were significantly less likely to have been prescribed a non-selective NSAID if they had a history of peptic ulcer without gastroprotection (OR 0.58, 95% CI 0.38-0.89); a beta blocker if they had asthma (0.73, 0.58-0.91); or an ACE inhibitor or loop diuretic without appropriate monitoring (0.51, 0.34-0.78). PINCER has a 95% probability of being cost effective if the decision-maker's ceiling willingness to pay reaches 75 pound per error avoided at 6 months. Interpretation The PINCER intervention is an effective method for reducing a range of medication errors in general practices with computerised clinical records.	[Avery, Anthony J.; Kendrick, Denise] Univ Nottingham, Sch Med, Queens Med Ctr, Div Primary Care, Nottingham NG7 2UH, England; [Rodgers, Sarah] Univ Nottingham, NIHR Collaborat Leadership Appl Hlth Res & Care N, Div Primary Care, Nottingham NG7 2UH, England; [Elliott, Rachel A.; Franklin, Matthew; Boyd, Matthew] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham NG7 2UH, England; [Cantrill, Judith A.; Eden, Martin] Univ Manchester, Sch Pharm & Pharmaceut Sci, Drug Usage & Pharm Practice Grp, Manchester, Lancs, England; [Armstrong, Sarah] NIHR Res Design Serv, Div Primary Care, Nottingham, England; [Cresswell, Kathrin; Prescott, Robin J.; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, eHlth Res Grp, Edinburgh, Midlothian, Scotland; [Howard, Rachel] Univ Reading, Sch Pharm, Reading, Berks, England; [Morris, Caroline J.] Univ Otago, Wellington Sch Med & Hlth Sci, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand; [Swanwick, Glen] NHS Nottinghamshire Cty, Qual & Governance Directorate, Res & Evaluat Team, Consumers Res Advisory Grp, Mansfield, Notts, England; [Putman, Koen] Vrije Univ Brussel, Fac Med & Pharm, Dept Med Sociol & Hlth Sci, Brussels, Belgium	University of Nottingham; University of Nottingham; University of Nottingham; University of Manchester; University of Edinburgh; University of Reading; University of Otago; Vrije Universiteit Brussel	Avery, AJ (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Div Primary Care, Nottingham NG7 2UH, England.	tony.avery@nottingham.ac.uk	Putman, Koen/ABG-6361-2021; Boyd, Matthew/ABE-4187-2021; Franklin, Matthew/J-8109-2019; Elliott, Rachel/P-5894-2018; Sheikh, Aziz/D-2818-2009; Howard, Rachel/C-8993-2013	Boyd, Matthew/0000-0003-2997-5090; Franklin, Matthew/0000-0002-2774-9439; Elliott, Rachel/0000-0002-3650-0168; Sheikh, Aziz/0000-0001-7022-3056; Kendrick, Denise/0000-0003-3603-6542; Avery, Anthony/0000-0001-7591-4438; Putman, Koen/0000-0002-7235-3759; Eden, Martin/0000-0002-1542-2527; Morris, Caroline/0000-0002-8751-0657; Rodgers, Sarah/0000-0003-1676-1982	Patient Safety Research Portfolio, Department of Health, England; Department of Health's Patient Safety Research Portfolio; National Institute for Health Research [SPCR-042] Funding Source: researchfish	Patient Safety Research Portfolio, Department of Health, England; Department of Health's Patient Safety Research Portfolio; National Institute for Health Research(National Institute for Health Research (NIHR))	Patient Safety Research Portfolio, Department of Health, England.; The study was funded by a research grant awarded by the Department of Health's Patient Safety Research Portfolio. We thank the PINCER trial pharmacists, primary care trusts, general practices, and patients who took part in the study; Rachel Illingworth for facilitating the employment and management of the trial pharmacists; Sharon Mills for administrative support and assistance with collation of the costs for the pharmacists' interventions; Clive Morris and colleagues from The Computer Room (www.tcrnottingham.com) and Ed Longridge for their input about data extraction from general practices; Casey Quinn for contributions to the analysis of incremental cost-effectiveness ratios; Tom Turner for provision of advice about written materials that were issued to patients; Richard Lilford and colleagues from the Patient Safety Research Portfolio for their support. Finally, we thank the members of the independent Trial Steering Committee, Philip Hannaford (chair), Martin Buxton, and Marjorie Weiss; and the Data Monitoring and Ethics Committee, Richard Baker (chair), Christine Bond, and Peter Donnan for overseeing the trial.	Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Avery AJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-28; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Catwell L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000126; Chen YF, 2005, DRUG SAFETY, V28, P67, DOI 10.2165/00002018-200528010-00005; Department for Communities and Local Government, 2004, IND DEPR 2004; Donaldson L., 2005, ORG MEMORY REPORT EX; Elashoff J, 2005, NQUERY ADVISOR VERSI; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Garfield S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-50; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Holland R, 2005, BMJ-BRIT MED J, V330, P293, DOI 10.1136/bmj.38338.674583.AE; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Howard RL, 2003, QUAL SAF HEALTH CARE, V12, P280, DOI 10.1136/qhc.12.4.280; Karnon J, 2009, J EVAL CLIN PRACT, V15, P299, DOI 10.1111/j.1365-2753.2008.01000.x; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; Medical Research Council (MRC), 2000, FRAM DEV EV RCTS COM; OBRIEN MAT, 2000, COCHRANE DB SYST REV, V2; Richmond S, 2010, BR J GEN PRACT, pe10; Royal S, 2006, QUAL SAF HEALTH CARE, V15, P23, DOI 10.1136/qshc.2004.012153; Schedlbauer A, 2009, J AM MED INFORM ASSN, V16, P531, DOI 10.1197/jamia.M2910; Schnipper JL, 2010, CIRC-CARDIOVASC QUAL, V3, P212, DOI 10.1161/CIRCOUTCOMES.109.921833; Shih WCJ, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-4; Smith J., 2004, BUILDING SAFER NHS P; StataCorp LP, 2008, STAT DAT AN STAT SOF; Winterstein Almut G., 2000, Pharmacoepidemiology and Drug Safety, V9, pS147	34	240	250	1	58	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 7	2012	379	9823					1310	1319		10.1016/S0140-6736(11)61817-5	http://dx.doi.org/10.1016/S0140-6736(11)61817-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922FB	22357106	Green Published, Bronze			2022-12-28	WOS:000302531100028
J	Onder, TT; Kara, N; Cherry, A; Sinha, AU; Zhu, N; Bernt, KM; Cahan, P; Mancarci, BO; Unternaehrer, J; Gupta, PB; Lander, ES; Armstrong, SA; Daley, GQ				Onder, Tamer T.; Kara, Nergis; Cherry, Anne; Sinha, Amit U.; Zhu, Nan; Bernt, Kathrin M.; Cahan, Patrick; Mancarci, B. Ogan; Unternaehrer, Juli; Gupta, Piyush B.; Lander, Eric S.; Armstrong, Scott A.; Daley, George Q.			Chromatin-modifying enzymes as modulators of reprogramming	NATURE			English	Article							HISTONE METHYLATION; PLURIPOTENT; CELLS; LEUKEMIA; PRC2	Generation of induced pluripotent stem cells (iPSCs) by somatic cell reprogramming involves global epigenetic remodelling(1). Whereas several proteins are known to regulate chromatin marks associated with the distinct epigenetic states of cells before and after reprogramming(2,3), the role of specific chromatin-modifying enzymes in reprogramming remains to be determined. To address how chromatin-modifying proteins influence reprogramming, we used short hairpin RNAs (shRNAs) to target genes in DNA and histone methylation pathways, and identified positive and negative modulators of iPSC generation. Whereas inhibition of the core components of the polycomb repressive complex 1 and 2, including the histone 3 lysine 27 methyltransferase EZH2, reduced reprogramming efficiency, suppression of SUV39H1, YY1 and DOT1L enhanced reprogramming. Specifically, inhibition of the H3K79 histone methyltransferase DOT1L by shRNA or a small molecule accelerated reprogramming, significantly increased the yield of iPSC colonies, and substituted for KLF4 and c-Myc (also known as MYC). Inhibition of DOT1L early in the reprogramming process is associated with a marked increase in two alternative factors, NANOG and LIN28, which play essential functional roles in the enhancement of reprogramming. Genome-wide analysis of H3K79me2 distribution revealed that fibroblast-specific genes associated with the epithelial to mesenchymal transition lose H3K79me2 in the initial phases of reprogramming. DOT1L inhibition facilitates the loss of this mark from genes that are fated to be repressed in the pluripotent state. These findings implicate specific chromatin-modifying enzymes as barriers to or facilitators of reprogramming, and demonstrate how modulation of chromatinmodifying enzymes can be exploited to more efficiently generate iPSCs with fewer exogenous transcription factors.	[Onder, Tamer T.; Cherry, Anne; Cahan, Patrick; Unternaehrer, Juli; Daley, George Q.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Onder, Tamer T.; Cherry, Anne; Cahan, Patrick; Unternaehrer, Juli; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Onder, Tamer T.; Cherry, Anne; Cahan, Patrick; Unternaehrer, Juli; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Onder, Tamer T.; Cherry, Anne; Zhu, Nan; Bernt, Kathrin M.; Cahan, Patrick; Unternaehrer, Juli; Armstrong, Scott A.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Onder, Tamer T.; Cherry, Anne; Cahan, Patrick; Unternaehrer, Juli; Daley, George Q.] Childrens Hosp Boston, Stem Cell Program, Boston, MA 02115 USA; [Kara, Nergis] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Sinha, Amit U.; Zhu, Nan; Bernt, Kathrin M.; Armstrong, Scott A.; Daley, George Q.] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Sinha, Amit U.; Zhu, Nan; Bernt, Kathrin M.; Armstrong, Scott A.] Harvard Univ, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; [Mancarci, B. Ogan] Bilkent Univ, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey; [Gupta, Piyush B.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Gupta, Piyush B.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lander, Eric S.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Ihsan Dogramaci Bilkent University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.	George.Daley@childrens.harvard.edu	Cherry, Anne/E-7333-2011; Onder, Tamer T/H-3330-2013; Bernt, Kathrin/L-1826-2016; Onder, Tamer/O-3669-2019	Onder, Tamer T/0000-0002-2372-9158; Bernt, Kathrin/0000-0002-5400-0482; Onder, Tamer/0000-0002-2372-9158; Bernt, Kathrin/0000-0002-0691-356X; Kara, Nergis/0000-0002-7891-0747; Mancarci, B. Ogan/0000-0002-1452-0889; Cahan, Patrick/0000-0003-3652-2540; Unternaehrer-Hamm, Julia/0000-0001-5864-4704	US National Institutes of Health (NIH) [CA140575]; CHB Stem Cell Program; NATIONAL CANCER INSTITUTE [R01CA140575] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092760] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHB Stem Cell Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Hu and S. J. Elledge for providing the MSCV-PM vector, K. Ng and M. W. Lensch for teratoma injections and assessment and S. Loewer for discussions. We also thank E. Olhava and Epizyme Inc. for synthesizing and providing the DOT1L inhibitor, EPZ004777. G. Q. D. is an investigator of the Howard Hughes Medical Institute. Research was funded by grants from the US National Institutes of Health (NIH) to S. A. A. (CA140575) and G. Q. D., and the CHB Stem Cell Program.	Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Stulemeijer IJE, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-2; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	30	471	496	1	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					598	U119		10.1038/nature10953	http://dx.doi.org/10.1038/nature10953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22388813	Green Accepted, Green Submitted			2022-12-28	WOS:000302006100039
J	Bakulin, AA; Rao, A; Pavelyev, VG; van Loosdrecht, PHM; Pshenichnikov, MS; Niedzialek, D; Cornil, J; Beljonne, D; Friend, RH				Bakulin, Artem A.; Rao, Akshay; Pavelyev, Vlad G.; van Loosdrecht, Paul H. M.; Pshenichnikov, Maxim S.; Niedzialek, Dorota; Cornil, Jerome; Beljonne, David; Friend, Richard H.			The Role of Driving Energy and Delocalized States for Charge Separation in Organic Semiconductors	SCIENCE			English	Article							FULLERENE SOLAR-CELLS; EXCITON DISSOCIATION; CONJUGATED POLYMER; PHOTOVOLTAIC CELLS; BINDING-ENERGY; ACCEPTOR; BLENDS; HETEROJUNCTIONS; EFFICIENT; PHOTOGENERATION	The electron-hole pair created via photon absorption in organic photoconversion systems must overcome the Coulomb attraction to achieve long-range charge separation. We show that this process is facilitated through the formation of excited, delocalized band states. In our experiments on organic photovoltaic cells, these states were accessed for a short time (<1 picosecond) via infrared (IR) optical excitation of electron-hole pairs bound at the heterojunction. Atomistic modeling showed that the IR photons promote bound charge pairs to delocalized band states, similar to those formed just after singlet exciton dissociation, which indicates that such states act as the gateway for charge separation. Our results suggest that charge separation in efficient organic photoconversion systems occurs through hot-state charge delocalization rather than energy-gradient-driven intermolecular hopping.	[Bakulin, Artem A.; Rao, Akshay; Friend, Richard H.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Pavelyev, Vlad G.; van Loosdrecht, Paul H. M.; Pshenichnikov, Maxim S.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Niedzialek, Dorota; Cornil, Jerome; Beljonne, David] Univ Mons, Lab Chem Novel Mat, B-7000 Mons, Belgium	University of Cambridge; University of Groningen; University of Mons	Friend, RH (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	rhf10@cam.ac.uk	van Loosdrecht, Paul H.M./AAF-8505-2020; van Loosdrecht, Paul/F-7670-2011; Bakulin, Artem/B-3940-2012; Niedzialek, Dorota/ABF-7850-2020; Institute, Zernike/W-7033-2019; Rao, Akshay/D-6289-2012	van Loosdrecht, Paul H.M./0000-0002-3704-9890; Niedzialek, Dorota/0000-0003-3129-4577; Rao, Akshay/0000-0003-4261-0766; Pshenichnikov, Maxim S./0000-0002-5446-4287; Bakulin, Artem/0000-0002-3998-2000; Rao, Akshay/0000-0003-0320-2962; Friend, Richard Henry/0000-0001-6565-6308	Netherlands Organization for Scientific Research (NWO); Marie Curie Cofund Action; Corpus Christi College; Engineering and Physical Sciences Research Council; RTN SUPERIOR; EPSRC [EP/G060738/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G060738/1] Funding Source: researchfish	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Marie Curie Cofund Action; Corpus Christi College; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); RTN SUPERIOR; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank D. Y. Paraschuk, J. R. Durrant, J. Clark, and T. Strobel for useful discussions. A. A. B. acknowledges a Rubicon Grant from the Netherlands Organization for Scientific Research (NWO), cofinanced by a Marie Curie Cofund Action. A. R. thanks Corpus Christi College for a Research Fellowship. J. C. and D. B. are research fellows of the Belgian National Fund for Scientific Research (FNRS). This project was supported by the Engineering and Physical Sciences Research Council and the RTN SUPERIOR project.	[Anonymous], 2002, PHOTOSYNTHETICA; Arkhipov VI, 2003, APPL PHYS LETT, V82, P4605, DOI 10.1063/1.1586456; Bakulin AA, 2009, CHEM PHYS LETT, V482, P99, DOI 10.1016/j.cplett.2009.09.052; Benson-Smith JJ, 2007, ADV FUNCT MATER, V17, P451, DOI 10.1002/adfm.200600484; BRAZOVSKII SA, 1981, JETP LETT+, V33, P4; Bredas JL, 2009, ACCOUNTS CHEM RES, V42, P1691, DOI 10.1021/ar900099h; CAMPBELL DK, 1982, PHYS REV B, V26, P6862, DOI 10.1103/PhysRevB.26.6862; Clarke TM, 2010, CHEM REV, V110, P6736, DOI 10.1021/cr900271s; Deibel C, 2010, ADV MATER, V22, P4097, DOI 10.1002/adma.201000376; Drori T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075207; Etzold F, 2011, J AM CHEM SOC, V133, P9469, DOI 10.1021/ja201837e; Frolov SV, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205209; Gelinas S, 2011, J PHYS CHEM C, V115, P7114, DOI 10.1021/jp200466y; Holt J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195210; Huang YS, 2008, NAT MATER, V7, P483, DOI 10.1038/nmat2182; Jones MR, 2009, BIOCHEM SOC T, V37, P400, DOI 10.1042/BST0370400; Kim Y, 2006, NAT MATER, V5, P197, DOI 10.1038/nmat1574; Lee J, 2010, J AM CHEM SOC, V132, P11878, DOI 10.1021/ja1045742; Loi MA, 2007, ADV FUNCT MATER, V17, P2111, DOI 10.1002/adfm.200601098; Marsh RA, 2010, ADV MATER, V22, P3672, DOI 10.1002/adma.201001010; Matsuo Y, 2009, J AM CHEM SOC, V131, P16048, DOI 10.1021/ja9048702; McNeill CR, 2008, ADV FUNCT MATER, V18, P2309, DOI 10.1002/adfm.200800182; Morteani AC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.247402; Muller JG, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195208; Muller JG, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.147401; Osterbacka R, 2000, SCIENCE, V287, P839, DOI 10.1126/science.287.5454.839; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; Peet J, 2007, NAT MATER, V6, P497, DOI 10.1038/nmat1928; Pensack RD, 2009, J AM CHEM SOC, V131, P15986, DOI 10.1021/ja906293q; Piris J, 2009, J PHYS CHEM C, V113, P14500, DOI 10.1021/jp904229q; Png RQ, 2010, NAT MATER, V9, P152, DOI [10.1038/nmat2594, 10.1038/NMAT2594]; Scholes GD, 2008, ACS NANO, V2, P523, DOI 10.1021/nn700179k; Service RF, 2011, SCIENCE, V332, P293, DOI 10.1126/science.332.6027.293; Shoaee S, 2010, J AM CHEM SOC, V132, P12919, DOI 10.1021/ja1042726; Strobel T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266602; Vandewal K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125204; Vandewal K, 2009, NAT MATER, V8, P904, DOI [10.1038/NMAT2548, 10.1038/nmat2548]; Veldman D, 2008, J AM CHEM SOC, V130, P7721, DOI 10.1021/ja8012598; Veldman D, 2009, ADV FUNCT MATER, V19, P1939, DOI 10.1002/adfm.200900090; Wei X, 1996, PHYS REV B, V53, P2187, DOI 10.1103/PhysRevB.53.2187; Wienk MM, 2003, ANGEW CHEM INT EDIT, V42, P3371, DOI 10.1002/anie.200351647; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789	42	927	932	18	805	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1340	1344		10.1126/science.1217745	http://dx.doi.org/10.1126/science.1217745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22362882	Green Submitted			2022-12-28	WOS:000301531600045
J	Steinbrook, R; Ross, JS				Steinbrook, Robert; Ross, Joseph S.			"Transparency Reports" on Industry Payments to Physicians and Teaching Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Steinbrook, Robert; Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, 333 Cedar St,1-456 SHM,POB 208008, New Haven, CT 06520 USA.	rsteinbrook@attglobal.net		Ross, Joseph/0000-0002-9218-3320	NIA NIH HHS [K08 AG032886] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Accreditation Council for Continuing Medical Education, 2010, 2010 ANN REP DAT; American Hospital Association, FAST FACTS US HOSP; Center for Medicare & Medicaid Services HHS, 2011, FED REGISTER; Centers for Medicare & Medicaid Services, CMS PROP IMPL CERT D; Ornstein C, DOLLARS DOCS DATA; Ross JS, 2007, JAMA-J AM MED ASSOC, V297, P1216, DOI 10.1001/jama.297.11.1216; Steinbrook R, 2011, ARCH INTERN MED, V171, P1765, DOI 10.1001/archinternmed.2011.439; Steinbrook R, 2011, ARCH INTERN MED, V171, P257, DOI 10.1001/archinternmed.2010.498	8	17	17	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2012	307	10					1029	1030		10.1001/jama.2012.211	http://dx.doi.org/10.1001/jama.2012.211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908GU	22336624				2022-12-28	WOS:000301479700020
J	Roh-Johnson, M; Shemer, G; Higgins, CD; McClellan, JH; Werts, AD; Tulu, US; Gao, L; Betzig, E; Kiehart, DP; Goldstein, B				Roh-Johnson, Minna; Shemer, Gidi; Higgins, Christopher D.; McClellan, Joseph H.; Werts, Adam D.; Tulu, U. Serdar; Gao, Liang; Betzig, Eric; Kiehart, Daniel P.; Goldstein, Bob			Triggering a Cell Shape Change by Exploiting Preexisting Actomyosin Contractions	SCIENCE			English	Article							C-ELEGANS GASTRULATION; TISSUE MORPHOGENESIS; APICAL CONSTRICTION; DORSAL CLOSURE; CORTICAL FLOWS; FORCES; DROSOPHILA; POLARITY; INVAGINATION; INTEGRATION	Apical constriction changes cell shapes, driving critical morphogenetic events, including gastrulation in diverse organisms and neural tube closure in vertebrates. Apical constriction is thought to be triggered by contraction of apical actomyosin networks. We found that apical actomyosin contractions began before cell shape changes in both Caenorhabitis elegans and Drosophila. In C. elegans, actomyosin networks were initially dynamic, contracting and generating cortical tension without substantial shrinking of apical surfaces. Apical cell-cell contact zones and actomyosin only later moved increasingly in concert, with no detectable change in actomyosin dynamics or cortical tension. Thus, apical constriction appears to be triggered not by a change in cortical tension, but by dynamic linking of apical cell-cell contact zones to an already contractile apical cortex.	[Roh-Johnson, Minna; Shemer, Gidi; Higgins, Christopher D.; McClellan, Joseph H.; Werts, Adam D.; Goldstein, Bob] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Tulu, U. Serdar; Kiehart, Daniel P.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Gao, Liang; Betzig, Eric] Howard Hughes Med Inst, Ashburn, VA 20147 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Howard Hughes Medical Institute	Goldstein, B (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	bobg@unc.edu		Goldstein, Bob/0000-0001-6961-675X; Werts, Adam/0000-0002-8977-5704	NIH [R01 GM083071, R01 GM33830]; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083071, R01GM033830] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Bloom, G. Edwards, J. Iwasa, J. Johnson, E. Munro, M. Peifer, D. Reiner, S. Rogers, and members of the Goldstein lab for comments on the manuscript; B. Eastwood and R. Taylor for help with particle image velocimetry; J. Fricks for help with statistical analysis; and A. Martin and E. Wieschaus for providing fly strains and sharing movies. This work was supported by NIH R01 GM083071 to B.G., NIH R01 GM33830 to D.P.K., and a Human Frontier Science Program postdoctoral fellowship to G.S. Data reported in this paper are presented in the main paper and in the supporting online material. U.S. patent application no. 13/160,492 concerning Bessel beam plane illumination microscopy has been filed by the Howard Hughes Medical Institute on behalf of E.B.	Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Grill SW, 2011, CURR OPIN GENET DEV, V21, P647, DOI 10.1016/j.gde.2011.09.005; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Kasza KE, 2011, CURR OPIN CELL BIOL, V23, P30, DOI 10.1016/j.ceb.2010.10.014; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Lee JY, 2006, CURR BIOL, V16, P1986, DOI 10.1016/j.cub.2006.08.090; Lee JY, 2010, CURR BIOL, V20, P253, DOI 10.1016/j.cub.2009.12.021; Lee JY, 2003, DEVELOPMENT, V130, P307, DOI 10.1242/dev.00211; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2002, DEVELOPMENT, V129, P387; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103	29	173	178	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1232	1235		10.1126/science.1217869	http://dx.doi.org/10.1126/science.1217869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22323741	Green Accepted, Green Submitted			2022-12-28	WOS:000301225100047
J	Kovesdy, CP; Kalantar-Zadeh, K				Kovesdy, Csaba P.; Kalantar-Zadeh, Kamyar			Enter the dragon: a Chinese epidemic of chronic kidney disease?	LANCET			English	Editorial Material							PREVALENCE; HEALTH		[Kalantar-Zadeh, Kamyar] Harbor UCLA Med Ctr, Harold Simmons Ctr Chron Dis Res & Epidemiol, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Kalantar-Zadeh, Kamyar] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kovesdy, Csaba P.] Univ Virginia, Div Nephrol, Charlottesville, VA USA; [Kovesdy, Csaba P.] Salem Vet Affairs Med Ctr, Div Nephrol, Salem, VA USA; [Kovesdy, Csaba P.] Semmelweis Univ, Inst Pathophysiol, Budapest, Hungary	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Virginia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Salem Veterans Affairs Medical Center; Semmelweis University	Kalantar-Zadeh, K (corresponding author), Harbor UCLA Med Ctr, Harold Simmons Ctr Chron Dis Res & Epidemiol, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA.	kamkal@ucla.edu	Kalantar-Zadeh, Kamyar/Q-4734-2018	Kalantar-Zadeh, Kamyar/0000-0002-8666-0725				[Anonymous], 2011, ECONOMIST, V401, P61; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Kalantar-Zadeh K, 2007, NAT CLIN PRACT NEPHR, V3, P493, DOI 10.1038/ncpneph0570; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Roderick P, 2004, NEPHROL DIAL TRANSPL, V19, P692, DOI 10.1093/ndt/gfg591; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang LX, 2009, SEMIN NEPHROL, V29, P483, DOI 10.1016/j.semnephrol.2009.06.012	12	30	32	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2012	379	9818					783	785		10.1016/S0140-6736(12)60115-9	http://dx.doi.org/10.1016/S0140-6736(12)60115-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386016	Green Submitted			2022-12-28	WOS:000300983400007
J	Chisholm, D; Saxena, S				Chisholm, Dan; Saxena, Shekhar			Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study	BRITISH MEDICAL JOURNAL			English	Article							MIDDLE-INCOME COUNTRIES; POPULATION-LEVEL ANALYSIS; MENTAL-HEALTH; GLOBAL BURDEN; DEVELOPING-WORLD; DISORDERS; INTERVENTIONS	Objective To assess the comparative costs and effects of interventions to combat five neuropsychiatric conditions (schizophrenia, bipolar disorder, depression, epilepsy, and heavy alcohol use). Design Cost effectiveness analysis based on an epidemiological model. Setting Two epidemiologically defined World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE); and countries in South East Asia with high adult and high child mortality (SearD). Data sources Published studies, costing databases. Main outcome measures Cost per capita and cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results Across 44 assessed intervention strategies for the five neuropsychiatric conditions, cost effectiveness values differed by as much as two orders of magnitude (from $Int100-250 to $Int10 000-25 000 for a year of healthy life gained). In both sub-regions, inpatient based treatment of schizophrenia with newer antipsychotic drugs was the most costly and least cost effective strategy. The most cost effective strategies in the African sub-region related to population based alcohol control, while in the South East Asian sub-region the most cost effective intervention was drug treatment of epilepsy in primary care. The cumulative cost per capita of the most cost effective set of interventions covering all five conditions was estimated at $Int4.90-5.70. This package comprises interventions for epilepsy (older first line antiepileptic drugs); depression (generically produced newer antidepressants and psychosocial treatment); bipolar disorder (mood stabiliser drug lithium); schizophrenia (neuroleptic antipsychotic drugs and psychosocial treatment); and heavy alcohol use (increased taxation and its enforcement, reduced access, and, in the African sub-region, advertising bans and brief advice to heavy drinkers in primary care). Conclusions Reallocation of resources to cost effective intervention strategies would increase health gain, save money and help implement much needed expansion of services for neuropsychiatric conditions in low resource settings.	[Chisholm, Dan] World Hlth Org, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Saxena, Shekhar] World Hlth Org, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization	Chisholm, D (corresponding author), World Hlth Org, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland.	chisholmd@who.int						Babor TF, 2003, ALCOHOL NO ORDINARY; Chisholm D, 2005, BRIT J PSYCHIAT, V187, P559, DOI 10.1192/bjp.187.6.559; Chisholm D, 2005, EPILEPSIA, V46, P751, DOI 10.1111/j.1528-1167.2005.52704.x; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chisholm D, 2004, BRIT J PSYCHIAT, V184, P393, DOI 10.1192/bjp.184.5.393; Chisholm D, 2008, B WORLD HEALTH ORGAN, V86, P542, DOI 10.2471/BLT.07.045377; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Engel J., 1997, EPILEPSY COMPREHENSI; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Ferri C, 2004, SOC PSYCH PSYCH EPID, V39, P218, DOI 10.1007/s00127-004-0729-5; Gureje O, 2007, WORLD PSYCHIATRY, V6, P42; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Nathan P.E., 2002, GUIDE TREATMENTS WOR; Rehm J., 2004, COMP QUANTIFICATION; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Tan-Torres ET, 2003, MAKING CHOICES HLTH, V1; WHO, 2008, MHGAP MENTAL HLTH GA; World Health Organisation, 2003, ADHERENCE LONG TERM; World Health Organization, 2010, GLOB STRAT RED HARMF; World Health Organization, 2008, GLOB BURD DIS 2004 U; World health organization, 2006, DOLLARS DALYS DECISI; World Health Organization, 2016, MHGAP INT GUID MENT	28	66	66	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2012	344								e609	10.1136/bmj.e609	http://dx.doi.org/10.1136/bmj.e609			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389339	hybrid, Green Published			2022-12-28	WOS:000301232600004
J	Barry, MJ; Edgman-Levitan, S				Barry, Michael J.; Edgman-Levitan, Susan			Shared Decision Making - The Pinnacle of Patient-Centered Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Barry, Michael J.] Massachusetts Gen Hosp, Fdn Informed Med Decis Making, Boston, MA 02114 USA; Massachusetts Gen Hosp, John D Stoeckle Ctr Primary Care Innovat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Barry, MJ (corresponding author), Massachusetts Gen Hosp, Fdn Informed Med Decis Making, Boston, MA 02114 USA.							Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P3077, DOI 10.1001/jama.263.22.3077; Gerteis M., 1993, PATIENTS EYES; National Research Council, 2001, CROSS QUAL CHASM NEW; Stacey D, 2011, COCHRANE DATABASE SY, V10	5	1827	1848	12	199	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					780	781		10.1056/NEJMp1109283	http://dx.doi.org/10.1056/NEJMp1109283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900GI	22375967				2022-12-28	WOS:000300874300002
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING How can we treat multiple chronic conditions?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MULTIMORBIDITY; PREVALENCE; CHALLENGES; CARE					dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Chen HY, 2011, PREV CHRONIC DIS, V8; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Institute of Medicine, 2012, BRIT MED J, DOI DOI 10.1136/BMJ.D4265; Institute of Medicine, 2012, LIV WELL CHRON ILLN; KAMEROW DB, 2011, BRIT MED J, V342, P1004; Soubhi H, 2010, ANN FAM MED, V8, P170, DOI 10.1370/afm.1056; Stange KC, 2012, JAMA-J AM MED ASSOC, V10, P2; Stange KC, 2012, ANN FAM MED, V10, P2, DOI 10.1370/afm.1354; Tinetti ME, 2011, NEW ENGL J MED, V364, P2478, DOI 10.1056/NEJMp1100535; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	12	15	15	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 29	2012	344								e1487	10.1136/bmj.e1487	http://dx.doi.org/10.1136/bmj.e1487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XE	22378931				2022-12-28	WOS:000301231400007
J	Chung, HS; McHale, K; Louis, JM; Eaton, WA				Chung, Hoi Sung; McHale, Kevin; Louis, John M.; Eaton, William A.			Single-Molecule Fluorescence Experiments Determine Protein Folding Transition Path Times	SCIENCE			English	Article							BETA-HAIRPIN FORMATION; ENERGY LANDSCAPE; DYNAMICS; SIMULATIONS; INTERMEDIATE; COEFFICIENTS; MECHANISM; FUNNELS; DOMAIN; STATES	The transition path is the tiny fraction of an equilibrium molecular trajectory when a transition occurs as the free-energy barrier between two states is crossed. It is a single-molecule property that contains all the mechanistic information on how a process occurs. As a step toward observing transition paths in protein folding, we determined the average transition-path time for a fast- and a slow-folding protein from a photon-by-photon analysis of fluorescence trajectories in single-molecule Forster resonance energy transfer experiments. Whereas the folding rate coefficients differ by a factor of 10,000, the transition-path times differ by a factor of less than 5, which shows that a fast- and a slow-folding protein take almost the same time to fold when folding actually happens. A very simple model based on energy landscape theory can explain this result.	[Chung, Hoi Sung; McHale, Kevin; Louis, John M.; Eaton, William A.] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chung, HS (corresponding author), NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	chunghoi@niddk.nih.gov; eaton@helix.nih.gov	Chung, Hoi Sung/C-2624-2009	Chung, Hoi Sung/0000-0001-6897-4969; Louis, John M/0000-0002-0052-1899	National Institute of Diabetes and Digestive and Kidney Diseases, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029053, ZIADK029055] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank I. Gopich, A. Szabo, and G. Hummer for numerous helpful discussions and A. Aniana for technical assistance in the expression and purification of proteins. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH.	Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Bowman GR, 2010, P NATL ACAD SCI USA, V107, P10890, DOI 10.1073/pnas.1003962107; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Hummer G, 2004, J CHEM PHYS, V120, P516, DOI 10.1063/1.1630572; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2008, P NATL ACAD SCI USA, V105, P18655, DOI 10.1073/pnas.0808600105; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Liu F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3262489; McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971; Morrone A, 2011, BIOPHYS J, V101, P2053, DOI 10.1016/j.bpj.2011.09.013; Nguyen H, 2003, P NATL ACAD SCI USA, V100, P3948, DOI 10.1073/pnas.0538054100; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Park SH, 1999, NAT STRUCT BIOL, V6, P943, DOI 10.1038/13311; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Socci ND, 1996, J CHEM PHYS, V104, P5860, DOI 10.1063/1.471317; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; Yeh IC, 2004, J PHYS CHEM B, V108, P15873, DOI 10.1021/jp0477147	23	299	301	5	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					981	984		10.1126/science.1215768	http://dx.doi.org/10.1126/science.1215768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363011	Green Accepted			2022-12-28	WOS:000300931800050
J	Cho, TA; Larvie, M; Tian, D; Mino-Kenudson, M				Cho, Tracey A.; Larvie, Mykol; Tian, Di; Mino-Kenudson, Mari			Case 6-2012: A 45-Year-Old Man with a History of Alcohol Abuse and Rapid Cognitive Decline Alcoholic liver disease with fibrosis. Brain abscess due to toxoplasma. Advanced HIV infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; AIDS; ENCEPHALITIS; DIAGNOSIS; HEPATITIS; CRITERIA		[Cho, Tracey A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Larvie, Mykol] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Tian, Di; Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cho, Tracey A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Larvie, Mykol] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Tian, Di; Mino-Kenudson, Mari] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cho, TA (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Cho, Tracey/O-8645-2018	Cho, Tracey/0000-0002-6208-1489				[Anonymous], 1990, MMWR MORB MORTAL WKL, V39, P380; Antinori A, 1997, NEUROLOGY, V48, P687, DOI 10.1212/WNL.48.3.687; Artico M, 1997, NEUROSURG REV, V20, P135, DOI 10.1007/BF01138199; Buhring U, 2001, NEUROLOGY, V57, P393, DOI 10.1212/WNL.57.3.393; BURKE DS, 1988, NEW ENGL J MED, V319, P961, DOI 10.1056/NEJM198810133191501; Del Brutto OH, 2001, NEUROLOGY, V57, P177, DOI 10.1212/WNL.57.2.177; Dunn W, 2005, HEPATOLOGY, V41, P353, DOI 10.1002/hep.20503; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Katlama C, 1996, CLIN INFECT DIS, V22, P268, DOI 10.1093/clinids/22.2.268; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Omuro AMP, 2006, LANCET NEUROL, V5, P937, DOI 10.1016/S1474-4422(06)70597-X; Raffi F, 1997, AIDS, V11, P177, DOI 10.1097/00002030-199702000-00007; Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984; Schackman BR, 2008, AIDS, V22, P2025, DOI 10.1097/QAD.0b013e3283103ce6; Scheld WM, 1997, INFECT CENTRAL NERVO, P479; Scheld WM, 1997, INFECT CENTRAL NERVO, P713; Slone HW, 2005, AM J ROENTGENOL, V184, P1679, DOI 10.2214/ajr.184.5.01841679; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	19	2	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					745	755		10.1056/NEJMcpc1103558	http://dx.doi.org/10.1056/NEJMcpc1103558			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356328				2022-12-28	WOS:000300551500013
J	Chretien, JP				Chretien, Jean-Paul			Protecting Service Members in War - Non-Battle Morbidity and Command Responsibility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Chretien, Jean-Paul/0000-0001-8143-6823				Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P2; BAYNEJONES S, 1968, EVOLUTION PREVENTIVE; Slim William, 1956, DEFEAT VICTORY; Wanja Elizabeth W, 2010, US Army Med Dep J, P56; Whitman TJ, 2010, AM J TROP MED HYG, V83, P258, DOI 10.4269/ajtmh.2010.09-0774	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					677	679		10.1056/NEJMp1112981	http://dx.doi.org/10.1056/NEJMp1112981			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896FS	22356320				2022-12-28	WOS:000300551500002
J	Zauber, AG; Winawer, SJ; O'Brien, MJ; Lansdorp-Vogelaar, I; van Ballegooijen, M; Hankey, BF; Shi, WJ; Bond, JH; Schapiro, M; Panish, JF; Stewart, ET; Waye, JD				Zauber, Ann G.; Winawer, Sidney J.; O'Brien, Michael J.; Lansdorp-Vogelaar, Iris; van Ballegooijen, Marjolein; Hankey, Benjamin F.; Shi, Weiji; Bond, John H.; Schapiro, Melvin; Panish, Joel F.; Stewart, Edward T.; Waye, Jerome D.			Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FECAL-OCCULT-BLOOD; SOCIETY-TASK-FORCE; SCREENING COLONOSCOPY; NEGATIVE COLONOSCOPY; ADENOMATOUS POLYPS; QUALITY INDICATORS; NATIONAL POLYP; SOJOURN TIME; RISK; MORTALITY	BACKGROUND In the National Polyp Study (NPS), colorectal cancer was prevented by colonoscopic removal of adenomatous polyps. We evaluated the long-term effect of colonoscopic polypectomy in a study on mortality from colorectal cancer. METHODS We included in this analysis all patients prospectively referred for initial colonoscopy (between 1980 and 1990) at NPS clinical centers who had polyps (adenomas and nonadenomas). The National Death Index was used to identify deaths and to determine the cause of death; follow-up time was as long as 23 years. Mortality from colorectal cancer among patients with adenomas removed was compared with the expected incidence-based mortality from colorectal cancer in the general population, as estimated from the Surveillance Epidemiology and End Results (SEER) Program, and with the observed mortality from colorectal cancer among patients with nonadenomatous polyps (internal control group). RESULTS Among 2602 patients who had adenomas removed during participation in the study, after a median of 15.8 years, 1246 patients had died from any cause and 12 had died from colorectal cancer. Given an estimated 25.4 expected deaths from colorectal cancer in the general population, the standardized incidence-based mortality ratio was 0.47 (95% confidence interval [CI], 0.26 to 0.80) with colonoscopic polypectomy, suggesting a 53% reduction in mortality. Mortality from colorectal cancer was similar among patients with adenomas and those with nonadenomatous polyps during the first 10 years after polypectomy (relative risk, 1.2; 95% CI, 0.1 to 10.6). CONCLUSIONS These findings support the hypothesis that colonoscopic removal of adenomatous polyps prevents death from colorectal cancer. (Funded by the National Cancer Institute and others.)	[Zauber, Ann G.; Shi, Weiji] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Winawer, Sidney J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Waye, Jerome D.] Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA; [O'Brien, Michael J.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Lansdorp-Vogelaar, Iris; van Ballegooijen, Marjolein] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Hankey, Benjamin F.] CANSTAT, Plano, TX USA; [Bond, John H.] Minneapolis Vet Affairs Med Ctr, Dept Med, Minneapolis, MN USA; [Schapiro, Melvin] Valley Presbyterian Hosp, Dept Med, Van Nuys, CA USA; [Panish, Joel F.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Stewart, Edward T.] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Boston University; Erasmus University Rotterdam; Erasmus MC; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Cedars Sinai Medical Center; Medical College of Wisconsin	Zauber, AG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St, New York, NY 10065 USA.	zaubera@mskcc.org	O'Brien, Michael J/R-7179-2019; Hug, Balthasar L./G-1568-2010	O'Brien, Michael J/0000-0003-1124-3537	National Cancer Institute [R01 CA026852, R01 CA046940, R01 CA079572, U01 CA097426, U01 CA115953, U01 CA152959]; Society of Memorial Sloan-Kettering Cancer Center; Tavel-Reznik Fund; Cantor Colon Cancer Fund; NATIONAL CANCER INSTITUTE [R01CA026852, R01CA046940, R01CA079572, U01CA152959, P30CA008748, U01CA115953, U01CA097426] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Society of Memorial Sloan-Kettering Cancer Center; Tavel-Reznik Fund; Cantor Colon Cancer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Cancer Institute (R01 CA026852 and R01 CA046940, to Drs. Zauber, Winawer, O'Brien, Bond, Schapiro, Panish, Stewart, and Waye; R01 CA079572, to Drs. Zauber, Winawer, O'Brien, and Bond; and U01 CA097426, U01 CA115953, and U01 CA152959, to Drs. Zauber, Winawer, O'Brien, Lansdorp-Vogelaar, and van Ballegooijen); and by funding from the Society of Memorial Sloan-Kettering Cancer Center (to Dr. Zauber), the Tavel-Reznik Fund (to Drs. Zauber and Winawer), and the Cantor Colon Cancer Fund (to Dr. Winawer).	Atkin W, 2004, GASTROENTEROLOGY, V126, P1247, DOI 10.1053/j.gastro.2004.01.023; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, GASTROENTEROLOGY, V138, P870, DOI 10.1053/j.gastro.2009.10.054; Breslow NE, 1987, STAT METHODS CANC RE; Bretthauer M, 2009, NEW ENGL J MED, V361, P300, DOI 10.1056/NEJMe0903924; Centers for Disease Control and Prevention, 2011, NAT DEATH IND; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; CHU KC, 1994, J CLIN EPIDEMIOL, V47, P1451, DOI 10.1016/0895-4356(94)90089-2; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Gyrd-Hansen D, 1997, INT J EPIDEMIOL, V26, P1172, DOI 10.1093/ije/26.6.1172; Imperiale TF, 2009, NEW ENGL J MED, V361, P2004; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Jorgensen OD, 2007, ACTA ONCOL, V46, P355, DOI 10.1080/02841860600897918; Jouve JL, 2001, BRIT J CANCER, V84, P1477, DOI 10.1054/bjoc.2001.1752; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Launoy G, 1997, INT J CANCER, V73, P220, DOI 10.1002/(SICI)1097-0215(19971009)73:2<220::AID-IJC10>3.0.CO;2-J; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman D, 2006, NEW ENGL J MED, V355, P2588, DOI 10.1056/NEJMe068254; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Neugut AI, 2010, JAMA-J AM MED ASSOC, V304, P461, DOI 10.1001/jama.2010.1001; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Olson SH, 2011, CANCER-AM CANCER SOC, V117, P2762, DOI 10.1002/cncr.25871; Prevost TC, 1998, AM J EPIDEMIOL, V148, P609; Rabeneck L, 2010, CLIN GASTROENTEROL H, V8, P275, DOI 10.1016/j.cgh.2009.10.022; Ransohoff DF, 2009, ANN INTERN MED, V150, P50, DOI 10.7326/0003-4819-150-1-200901060-00308; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sandler RS, 2010, AM J GASTROENTEROL, V105, P1633, DOI 10.1038/ajg.2010.97; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Torlakovic E, 2003, AM J SURG PATHOL, V27, P65, DOI 10.1097/00000478-200301000-00008; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Winawer S, 2009, COLONOSCOPY PRINCIPL, P401; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; WINAWER SJ, 1992, CANCER, V70, P1236, DOI 10.1002/1097-0142(19920901)70:3+<1236::AID-CNCR2820701508>3.0.CO;2-4; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2006, GASTROENTEROLOGY, V130, P620, DOI 10.1053/j.gastro.2006.01.014	53	1927	2014	6	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					687	696		10.1056/NEJMoa1100370	http://dx.doi.org/10.1056/NEJMoa1100370			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356322	Green Accepted			2022-12-28	WOS:000300551500006
J	Brook, RH				Brook, Robert H.			Do Physicians Need a "Shopping Cart" for Health Care Services?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brook, Robert H.] RAND Corp, Santa Monica, CA 90401 USA; [Brook, Robert H.] David Geffen UCLA Sch Med, Los Angeles, CA USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	brook@rand.org						Centers for Medicare & Medicaid Services, CMS HER MEAN US OV; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Mehrotra A, 2008, HEALTH AFFAIR, V27, P1272, DOI 10.1377/hlthaff.27.5.1272; Stuebing EA, 2011, ARCH SURG-CHICAGO, V146, P524, DOI 10.1001/archsurg.2011.103	4	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					791	792		10.1001/jama.2012.204	http://dx.doi.org/10.1001/jama.2012.204			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896FQ	22357829				2022-12-28	WOS:000300551300020
J	Kizer, KW				Kizer, Kenneth W.			Veterans and the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEM; AFFAIRS; MEDICARE; QUALITY		Univ Calif Davis Hlth Syst, Inst Populat Hlth Improvement, Univ Calif Davis,Sch Med, Betty Irene Moore Sch Nursing,Moore Sch Nursing, Sacramento, CA 95817 USA	University of California System; University of California Davis	Kizer, KW (corresponding author), Univ Calif Davis Hlth Syst, Inst Populat Hlth Improvement, Univ Calif Davis,Sch Med, Betty Irene Moore Sch Nursing,Moore Sch Nursing, 4800 2nd St,Ste 2600, Sacramento, CA 95817 USA.	kenneth.kizer@ucdmc.ucdavis.edu						Boscarino Joseph A, 2010, Int J Emerg Ment Health, V12, P161; Himmelstein DU, 2007, AM J PUBLIC HEALTH, V97, P2199, DOI 10.2105/AJPH.2006.106302; Jia HG, 2007, STROKE, V38, P355, DOI 10.1161/01.STR.0000254457.38901.fb; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; Trivedi AN, 2011, MED CARE, V49, P560, DOI 10.1097/MLR.0b013e31820fb0f6; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575; Wilson NJ, 1997, HEALTH AFFAIR, V16, P200, DOI 10.1377/hlthaff.16.4.200; Wright SM, 1997, HEALTH SERV RES, V31, P739	8	49	49	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					789	790		10.1001/jama.2012.196	http://dx.doi.org/10.1001/jama.2012.196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896FQ	22357828	Green Published			2022-12-28	WOS:000300551300019
J	Raimundo, N; Song, L; Shutt, TE; McKay, SE; Cotney, J; Guan, MX; Gilliland, TC; Hohuan, D; Santos-Sacchi, J; Shadel, GS				Raimundo, Nuno; Song, Lei; Shutt, Timothy E.; McKay, Sharen E.; Cotney, Justin; Guan, Min-Xin; Gilliland, Thomas C.; Hohuan, David; Santos-Sacchi, Joseph; Shadel, Gerald S.			Mitochondrial Stress Engages E2F1 Apoptotic Signaling to Cause Deafness	CELL			English	Article							TRANSCRIPTION FACTOR B1; RIBOSOMAL-RNA MUTATION; NON-SYNDROMIC DEAFNESS; HEARING-LOSS; AMINOGLYCOSIDE OTOTOXICITY; GENE-EXPRESSION; A1555G MUTATION; DNA-POLYMERASE; HUMAN-DISEASE; MICE	Mitochondrial dysfunction causes poorly understood tissue-specific pathology stemming from primary defects in respiration, coupled with altered reactive oxygen species (ROS), metabolic signaling, and apoptosis. The A1555G mtDNA mutation that causes maternally inherited deafness disrupts mitochondrial ribosome function, in part, via increased methylation of the mitochondrial 12S rRNA by the methyltransferase mtTFB1. In patient-derived A1555G cells, we show that 12S rRNA hypermethylation causes ROS-dependent activation of AMP kinase and the proapoptotic nuclear transcription factor E2F1. This retrograde mitochondrial-stress relay is operative in vivo, as transgenic-mtTFB1 mice exhibit enhanced 12S rRNA methylation in multiple tissues, increased E2F1 and apoptosis in the stria vascularis and spiral ganglion neurons of the inner ear, and progressive E2F1-dependent hearing loss. This mouse mitochondrial disease model provides a robust platform for deciphering the complex tissue specificity of human mitochondrial- based disorders, as well as the precise pathogenic mechanism of maternally inherited deafness and its exacerbation by environmental factors.	[Raimundo, Nuno; Shutt, Timothy E.; McKay, Sharen E.; Gilliland, Thomas C.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Song, Lei; Hohuan, David; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Surg Otolaryngol, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Song, Lei; Hohuan, David; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Cotney, Justin; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China	Yale University; Yale University; Yale University; Yale University; Zhejiang University	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shadel@yale.edu	Shutt, Tim/U-9047-2019; Cotney, Justin/C-9631-2012; Raimundo, Nuno/AAD-9498-2020; Cotney, Justin L/ABE-8500-2021	Shutt, Tim/0000-0001-5299-2943; Cotney, Justin/0000-0001-8230-2157; Raimundo, Nuno/0000-0002-5988-9129; Cotney, Justin L/0000-0001-8230-2157; Guan, Min-Xin/0000-0001-5067-6736	U.S. NIH [R01 HL-059655, R01 DC000273]; UMDF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000273] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMDF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants R01 HL-059655 to G.S.S. and R01 DC000273 to J.S.-S. from the U.S. NIH and a UMDF fellowship to T.E.S. The authors thank Zimei Zhang for animal husbandry, Yale Animal Genomic Services for help in generating the Tg-mtTFB1 mice, and Dr. Susan Kaech for comments on the manuscript, helpful discussions and access to the SeaHorse instrument.	Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Bykhovskaya Y, 2004, MOL GENET METAB, V82, P27, DOI 10.1016/j.ymgme.2004.01.020; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cotney J, 2009, HUM MOL GENET, V18, P2670, DOI 10.1093/hmg/ddp208; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; DeGregori J, 2006, CURR MOL MED, V6, P739; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Goto Y, 2006, J CELL PHYSIOL, V209, P923, DOI 10.1002/jcp.20802; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; Hou ST, 2000, J NEUROCHEM, V75, P91, DOI 10.1046/j.1471-4159.2000.0750091.x; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi Y, 2004, LARYNGOSCOPE, V114, P344, DOI 10.1097/00005537-200402000-00031; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Pulicherla N, 2009, J MOL BIOL, V391, P884, DOI 10.1016/j.jmb.2009.06.015; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Raimundo N, 2009, ONCOGENE, V28, P1261, DOI 10.1038/onc.2008.472; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Shadel GS, 2008, AM J PATHOL, V172, P1445, DOI 10.2353/ajpath.2008.071163; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Shadel GS, 2004, MOL GENET METAB, V82, P1, DOI 10.1016/j.ymgme.2004.02.003; Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Warchol ME, 2010, CURR OPIN OTOLARYNGO, V18, P454, DOI 10.1097/MOO.0b013e32833e05ec	45	143	153	1	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					716	726		10.1016/j.cell.2011.12.027	http://dx.doi.org/10.1016/j.cell.2011.12.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341444	Bronze, Green Accepted			2022-12-28	WOS:000300622400013
J	Lyon, GJ				Lyon, Gholson J.			Bring clinical standards to human-genetics research	NATURE			English	Editorial Material									Utah Fdn Biomed Res, Inst Genom Med, Salt Lake City, UT 84106 USA		Lyon, GJ (corresponding author), Utah Fdn Biomed Res, Inst Genom Med, Salt Lake City, UT 84106 USA.	gholsonjlyon@gmail.com	Lyon, Gholson/D-2765-2014	Lyon, Gholson/0000-0002-5869-0716				Epstein CJ, 2002, AM J HUM GENET, V70, P300, DOI 10.1086/338915; Lyon GJ, 2011, DISCOV MED, V11, P41; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017	3	19	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					300	301		10.1038/482300a	http://dx.doi.org/10.1038/482300a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	892LG	22337032	Bronze			2022-12-28	WOS:000300287100015
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Assaulting alternative medicine: worthwhile or witch hunt?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Clinical evidence, WHAT CONCL HAS CLIN; Elshaug A, 2011, TRANSF HLTH EC INT H; Furlan AD, 2010, AHRQ PUBLICATION; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Wulff KC, 2011, HEALTH AFFAIR, V30, P2269, DOI 10.1377/hlthaff.2011.0159	5	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2012	344								e1075	10.1136/bmj.e1075	http://dx.doi.org/10.1136/bmj.e1075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IB	22337786	Green Submitted			2022-12-28	WOS:000300557800007
J	Orrell, M; Woods, B; Spector, A				Orrell, Martin; Woods, Bob; Spector, Aimee			UNCERTAINTIES PAGE Should we use individual cognitive stimulation therapy to improve cognitive function in people with dementia?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ALZHEIMERS-DISEASE; EFFICACY		[Orrell, Martin] UCL, UCL Mental Hlth Sci Unit, London, England; [Orrell, Martin; Spector, Aimee] NE London Fdn Trust, Goodmayes Hosp, London, England; [Woods, Bob] Bangor Univ, Dementia Serv Dev Ctr, Bangor, Gwynedd, Wales; [Spector, Aimee] UCL, Dept Clin Educ & Hlth Psychol, London, England	University of London; University College London; Bangor University; University of London; University College London	Orrell, M (corresponding author), UCL, UCL Mental Hlth Sci Unit, London, England.	m.orrell@ucl.ac.uk	Woods, Bob/E-7140-2011	Woods, Bob/0000-0002-6781-651X; Orrell, Martin/0000-0002-1169-3530				Clare L, 2008, COCHRANE DB SYST REV, V4; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Knapp M, 2006, BRIT J PSYCHIAT, V188, P574, DOI 10.1192/bjp.bp.105.010561; Kurz AF, 2011, INT PSYCHOGERIATR, V23, P1364, DOI 10.1017/S1041610211001001; National Institute of Clinical Excellence, 2006, DEM SUPP PEOPL DEM T; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Onder G, 2005, BRIT J PSYCHIAT, V187, P450, DOI 10.1192/bjp.187.5.450; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Prince M, 2011, WORLD ALZHEIMER REPO; Spector A, 2003, BRIT J PSYCHIAT, V183, P248, DOI 10.1192/bjp.183.3.248; Woods B, 2012, COCHRANE DA IN PRESS	11	19	19	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2012	344								e633	10.1136/bmj.e633	http://dx.doi.org/10.1136/bmj.e633			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IB	22337752				2022-12-28	WOS:000300557800002
J	Dubnau, J				Dubnau, Josh			Ode to the Mushroom Bodies	SCIENCE			English	Editorial Material							TERM-MEMORY; NEURONS; CONSOLIDATION; TRACE; CREB		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Dubnau, J (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	dubnau@cshl.edu		Dubnau, Josh/0000-0002-9285-7444				Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; Chen CC, 2012, SCIENCE, V335, P678, DOI 10.1126/science.1212735; Dash PK, 2004, BRAIN RES REV, V45, P30, DOI 10.1016/j.brainresrev.2004.02.001; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Trannoy S, 2011, CURR BIOL, V21, P1647, DOI 10.1016/j.cub.2011.08.032; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	15	4	4	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					664	665		10.1126/science.1218171	http://dx.doi.org/10.1126/science.1218171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323806				2022-12-28	WOS:000300047100036
J	Garcia, PJ; Holmes, KK; Carcamo, CP; Garnett, GP; Hughes, JP; Campos, PE; Whittington, WLH				Garcia, Patricia J.; Holmes, King K.; Carcamo, Cesar P.; Garnett, Geoff P.; Hughes, James P.; Campos, Pablo E.; Whittington, William L. H.		Peru PREVEN Study Team	Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial	LANCET			English	Article							EVALUATING-COMPLEX-INTERVENTIONS; HEALTH IMPROVEMENT PROGRAMS; FEMALE SEX WORKERS; SYNDROMIC MANAGEMENT; HIV; DISEASES; STDS; IMPLEMENTATION; TANZANIA; GUIDANCE	Background Previous community-randomised trials of interventions to control sexually transmitted infections (STIs) have involved rural settings, were rarely multicomponent, and had varying results. We aimed to assess the effect of a multicomponent intervention on curable STIs in urban young adults and female sex workers (FSWs). Methods In this community-randomised trial, baseline STI screening was done between August, and November, 2002, in random household samples of young adults (aged 18-29 years) and in FSWs in Peruvian cities with more than 50 000 inhabitants. Geographically separate cities were selected, matched into pairs, and randomly allocated to intervention or control groups with an S-PLUS program. Follow-up surveys of random samples were done after 2 years and 3 years. The intervention comprised four modalities: strengthened STI syndromic management by pharmacy workers and clinicians; mobile-team outreach to FSWs for STI screening and pathogen-specific treatment; periodic presumptive treatment of FSWs for trichomoniasis; and condom promotion for FSWs and the general population. Individuals in control cities received standard care. The composite primary endpoint was infection of young adults with Chlamydia trachomatis, Trichomonas vaginalis, or Neisseria gonorrhoeae, or syphilis seroreactivity. Laboratory workers and the data analyst were masked, but fieldworkers, the Peruvian study team, and participants in the outcome surveys were not. All analyses were done by intention to treat. This trial is registered, ISRCTN43722548. Findings We did baseline surveys of 15 261 young adults in 24 Peruvian cities. Of those, 20 geographically separate cities were matched into pairs, in each of which one city was assigned to intervention and the other to standard of care. In the 2006 follow-up survey, data for the composite primary outcome were available for 12 930 young adults. We report a non-significant reduction in prevalence of STIs in young adults, adjusted for baseline prevalence, in intervention cities compared with control cities (relative risk 0.84, 95% CI 0-69-1.02; p=0.096). In subgroup analyses, significant reductions were noted in intervention cities in young adult women and FSWs. Interpretation Syndromic management of STIs, mobile-team outreach to FSWs, presumptive treatment for trichomoniasis in FSWs, and condom promotion might reduce the composite prevalence of any of the four curable STIs investigated in this trial.	[Holmes, King K.; Carcamo, Cesar P.; Whittington, William L. H.] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA; [Garcia, Patricia J.; Carcamo, Cesar P.; Campos, Pablo E.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, STD AIDS Unit, Lima, Peru; [Carcamo, Cesar P.] Univ Peruana Cayetano Heredia, Dept Microbiol, Sch Sci, Lima, Peru; [Holmes, King K.; Carcamo, Cesar P.; Whittington, William L. H.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98104 USA; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Holmes, King K.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Garnett, Geoff P.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Garnett, Geoff P.] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA USA	University of Washington; University of Washington Seattle; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Imperial College London; Bill & Melinda Gates Foundation	Holmes, KK (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA.	kkh@u.washington.edu	, Holmes/K-6215-2019; Garnett, Geoffrey P/A-9312-2008	Thomas, Katherine K/0000-0002-7024-468X; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative [059131/Z/99/Z, 078835/Z/05/Z, 078835/Z/05/B]; National Institutes of Health NIAID STD Cooperative Research Center [AI31448]; Center for AIDS Research [AI27757]; CIPRA [U19 AI053218]; USAID-Peru; UPCH Research and Development Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, U19AI031448, U01AI031448, U19AI053218] Funding Source: NIH RePORTER	Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative(Burroughs Wellcome FundWellcome Trust); National Institutes of Health NIAID STD Cooperative Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Research; CIPRA; USAID-Peru(United States Agency for International Development (USAID)); UPCH Research and Development Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative 059131/Z/99/Z, 078835/Z/05/Z, and 078835/Z/05/B; National Institutes of Health NIAID STD Cooperative Research Center AI31448, Center for AIDS Research AI27757, and CIPRA U19 AI053218; and USAID-Peru. We thank the Peruvian Ministry of Health for participation in local health directorates; the National HIV/STI Program; the General Directorates of People's Health and of Epidemiology; the National Institute of Health of Peru; the National Institute of Statistics and Informatics); and local clinicians, counsellors, and laboratory personnel. We also thank the hundreds of members of the PREVEN network: pharmacy workers, midwives, physicians, trainers, and salespersons in charge of training of clinicians and pharmacy workers; members of mobile teams providing outreach to FSWs; survey interviewers; the US Naval Medical Research Center Detachment in Lima; the UPCH Research and Development Laboratories for valuable support in laboratory activities; Robert Coombs (University of Washington) for confirmatory testing of HIV western blot assays; and participants in the surveys and the intervention trial.	Bernabe-Ortiz A, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-11; Bertozzi SM, 2010, SEX TRANSM INFECT, V86, pI4, DOI 10.1136/sti.2009.039263; Bird L, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-24; Bond L, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1332; Campos PE, 2006, SEX TRANSM INFECT, V82, pV22, DOI 10.1136/sti.2006.023325; Canchihuaman FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019318; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Fontanet AL, 1998, AIDS, V12, P1851, DOI 10.1097/00002030-199814000-00017; Garcia P, 2003, B WORLD HEALTH ORGAN, V81, P806; Garcia PJ, 1998, SEX TRANSM INFECT, V74, pS153; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI55, DOI 10.1136/sti.2006.023663; Hayes RJ, 2009, INTERD STAT, P3; Hughes JP, 2005, STAT MED, V24, P1983, DOI 10.1002/sim.2080; Huppert JS, 2007, CLIN INFECT DIS, V45, P194, DOI 10.1086/518851; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; LIANG KY, 1986, AM J EPIDEMIOL, V124, P678, DOI 10.1093/oxfordjournals.aje.a114441; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; Mackenzie M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c185; Ng M, 2011, LANCET, V378, P1643, DOI 10.1016/S0140-6736(11)61390-1; Pan W, 2002, STAT MED, V21, P1429, DOI 10.1002/sim.1142; Pequegnat W, 2008, INT AIDS C MEX CIT M, P1196; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Sanchez J, 1996, AM J PUBLIC HEALTH, V86, P1098, DOI 10.2105/AJPH.86.8_Pt_1.1098; Sanchez J, 2003, SEX TRANSM DIS, V30, P273, DOI 10.1097/00007435-200304000-00001; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Wetmore CM, 2010, EPIDEMIOL REV, V32, P121, DOI 10.1093/epirev/mxq010; WHO, 2008, PER PRES TREATM SEX	30	48	52	2	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 24	2012	379	9821					1120	1128		10.1016/S0140-6736(11)61846-1	http://dx.doi.org/10.1016/S0140-6736(11)61846-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916VR	22341824	Green Published			2022-12-28	WOS:000302131800034
J	Bertrand, OF; Jolly, S				Bertrand, Olivier F.; Jolly, Sanjit			AIDA STEMI: no benefit for intracoronary abciximab	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; INHIBITORS; TRIALS		[Bertrand, Olivier F.] Univ Laval, Quebec Heart Lung Inst, Quebec City, PQ G1V 4G5, Canada; [Jolly, Sanjit] McMaster Univ, Hamilton Gen Hosp, Hamilton, ON, Canada	Laval University; Quebec Heart & Lung Institute; McMaster University	Bertrand, OF (corresponding author), Univ Laval, Quebec Heart Lung Inst, Quebec City, PQ G1V 4G5, Canada.	olivier.bertrand@crhl.ulaval.ca	Jolly, Sanjit/O-2534-2015					Bertrand OF, 2010, AM J CARDIOL, V105, P1520, DOI 10.1016/j.amjcard.2010.01.006; De Luca G, 2009, EUR HEART J, V30, P2705, DOI 10.1093/eurheartj/ehp118; Desch S, 2012, CLIN RES CARDIOL, V101, P117, DOI 10.1007/s00392-011-0372-6; Friedland S, 2011, AM J CARDIOL, V108, P1244, DOI 10.1016/j.amjcard.2011.06.039; RENTROP K P, 1979, Clinical Cardiology, V2, P354; Shimada YJ, 2012, AM J CARDIOL, V109, P624, DOI 10.1016/j.amjcard.2011.10.016; Thiele H, 2008, CIRCULATION, V118, P49, DOI 10.1161/CIRCULATIONAHA.107.747642; Thiele H, 2012, LANCET, V379, P923, DOI 10.1016/S0140-6736(11)61872-2	8	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 10	2012	379	9819					875	877		10.1016/S0140-6736(12)60079-8	http://dx.doi.org/10.1016/S0140-6736(12)60079-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906NY	22357108				2022-12-28	WOS:000301353700010
J	Qaseem, A; Denberg, TD; Hopkins, RH; Humphrey, LL; Levine, J; Sweet, DE; Shekelle, P				Qaseem, Amir; Denberg, Thomas D.; Hopkins, Robert H., Jr.; Humphrey, Linda L.; Levine, Joel; Sweet, Donna E.; Shekelle, Paul		Clinical Guidelines Comm Amer Coll	Screening for Colorectal Cancer: A Guidance Statement From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							GUIDELINES; POLYPS	Description: Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. The American College of Physicians (ACP) developed this guidance statement for clinicians by assessing the current guidelines developed by other organizations on screening for colorectal cancer. When multiple guidelines are available on a topic or when existing guidelines conflict, ACP believes that it is more valuable to provide clinicians with a rigorous review of the available guidelines rather than develop a new guideline on the same topic. Methods: The authors searched the National Guideline Clearing-house to identify guidelines developed in the United States. Four guidelines met the inclusion criteria: a joint guideline developed by the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology and individual guidelines developed by the Institute for Clinical Systems Improvement, the U.S. Preventive Services Task Force, and the American College of Radiology. Guidance Statement 1: ACP recommends that clinicians perform individualized assessment of risk for colorectal cancer in all adults. Guidance Statement 2: ACP recommends that clinicians screen for colorectal cancer in average-risk adults starting at the age of 50 years and in high-risk adults starting at the age of 40 years or 10 years younger than the age at which the youngest affected relative was diagnosed with colorectal cancer. Guidance Statement 3: ACP recommends using a stool-based test, flexible sigmoidoscopy, or optical colonoscopy as a screening test in patients who are at average risk. ACP recommends using optical colonoscopy as a screening test in patients who are at high risk. Clinicians should select the test based on the benefits and harms of the screening test, availability of the screening test, and patient preferences. Guidance Statement 4: ACP recommends that clinicians stop screening for colorectal cancer in adults over the age of 75 years or in adults with a life expectancy of less than 10 years.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP	ACP	Financial support for the development of this guidance statement comes exclusively from the ACP operating budget.	Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; HIXSON LJ, 1990, JNCI-J NATL CANCER I, V82, P1769, DOI 10.1093/jnci/82.22.1769; HIXSON LJ, 1991, GASTROINTEST ENDOSC, V37, P125, DOI 10.1016/S0016-5107(91)70668-8; Howlader N, 2011, SEER CANC STAT REV 1; Institute for Clinical Systems Improvement, 2010, HLTH CAR GUID COL CA; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Joseph D. A., 2008, Morbidity and Mortality Weekly Report, V57, P253; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; National Cancer Institute, PDQ COL CANC SCREEN; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; U. S. Cancer Statistics Working Group, 2010, US CANC STAT 1999 20; Yee J, 2010, J AM COLL RADIOL, V7, P670, DOI 10.1016/j.jacr.2010.05.005	16	235	251	2	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2012	156	5					378	U209		10.7326/0003-4819-156-5-201203060-00010	http://dx.doi.org/10.7326/0003-4819-156-5-201203060-00010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902OC	22393133				2022-12-28	WOS:000301046800006
J	Reuben, DB; Tinetti, ME				Reuben, David B.; Tinetti, Mary E.			Goal-Oriented Patient Care - An Alternative Health Outcomes Paradigm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Reuben, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA; [Tinetti, Mary E.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Reuben, David B.; Tinetti, Mary E.] Yale Univ, Sch Epidemiol & Publ Hlth, New Haven, CT USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University; Yale University	Reuben, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA.							Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; Institute of Medicine, 2001, CROSSING QUALITY CHA; Rockwood K, 2003, J CLIN EPIDEMIOL, V56, P736, DOI 10.1016/S0895-4356(03)00132-X; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Turner-Stokes L, 2011, J REHABIL MED, V43, P70, DOI 10.2340/16501977-0656	5	352	362	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					777	779		10.1056/NEJMp1113631	http://dx.doi.org/10.1056/NEJMp1113631			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900GI	22375966				2022-12-28	WOS:000300874300001
J	Sun, LL; Chen, XJ; Guo, J; Gao, PW; Huang, QZ; Wang, HD; Fang, MH; Chen, XL; Chen, GF; Wu, Q; Zhang, C; Gu, DC; Dong, XL; Wang, L; Yang, K; Li, AG; Dai, X; Mao, HK; Zhao, ZX				Sun, Liling; Chen, Xiao-Jia; Guo, Jing; Gao, Peiwen; Huang, Qing-Zhen; Wang, Hangdong; Fang, Minghu; Chen, Xiaolong; Chen, Genfu; Wu, Qi; Zhang, Chao; Gu, Dachun; Dong, Xiaoli; Wang, Lin; Yang, Ke; Li, Aiguo; Dai, Xi; Mao, Ho-kwang; Zhao, Zhongxian			Re-emerging superconductivity at 48 kelvin in iron chalcogenides	NATURE			English	Article							43 K; PRESSURE	Pressure has an essential role in the production(1) and control(2,3) of superconductivity in iron-based superconductors. Substitution of a large cation by a smaller rare-earth ion to simulate the pressure effect has raised the superconducting transition temperature T-c to a record high of 55 K in these materials(4,5). In the same way as T-c exhibits a bell-shaped curve of dependence on chemical doping, pressure-tuned T-c typically drops monotonically after passing the optimal pressure(1-3). Here we report that in the superconducting iron chalcogenides, a second superconducting phase suddenly re-emerges above 11.5 GPa, after the T-c drops from the first maximum of 32 K at 1 GPa. The T-c of the re-emerging superconducting phase is considerably higher than the first maximum, reaching 48.0-48.7 K for Tl0.6Rb0.4Fe1.67Se2, K0.8Fe1.7Se2 and K0.8Fe1.78Se2.	[Sun, Liling; Guo, Jing; Gao, Peiwen; Chen, Xiaolong; Chen, Genfu; Wu, Qi; Zhang, Chao; Gu, Dachun; Dong, Xiaoli; Dai, Xi; Zhao, Zhongxian] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Sun, Liling; Guo, Jing; Gao, Peiwen; Chen, Xiaolong; Chen, Genfu; Wu, Qi; Zhang, Chao; Gu, Dachun; Dong, Xiaoli; Dai, Xi; Zhao, Zhongxian] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Chen, Xiao-Jia; Mao, Ho-kwang] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Chen, Xiao-Jia] S China Univ Technol, Dept Phys, Guangzhou 510640, Guangdong, Peoples R China; [Huang, Qing-Zhen] Natl Inst Stand & Technol, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Wang, Hangdong; Fang, Minghu] Zhejiang Univ, Dept Phys, Hangzhou 310027, Zhejiang, Peoples R China; [Wang, Lin] Carnegie Inst Sci, Geophys Lab, HPSynC, Argonne, IL 60439 USA; [Yang, Ke; Li, Aiguo] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai Synchrotron Radiat Facil, Shanghai 201204, Peoples R China	Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Carnegie Institution for Science; South China University of Technology; National Institute of Standards & Technology (NIST) - USA; Zhejiang University; Carnegie Institution for Science; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Zhao, ZX (corresponding author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.	hmao@gl.ciw.edu; zhxzhao@iphy.ac.cn	WANG, LIN/G-7884-2012; Wang, Lin/N-4161-2017; Dai, Xi/C-4236-2008; Sun, Liling/AAA-9515-2021; Dai, Xi/HCG-9886-2022; Huang, Cheng/AAA-9365-2021	Dai, Xi/0000-0002-2396-0966; Dong, Xiaoli/0000-0002-6268-2049	NSCF; 973 projects; Chinese Academy of Sciences; EFree, an Energy Frontier Research Center; US Department of Energy, Office of Science, Office of Basic Energy Sciences (DOE-BES); CIW; CDAC; UNLV; LLNL through DOE-NNSA; NSF	NSCF; 973 projects(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); EFree, an Energy Frontier Research Center; US Department of Energy, Office of Science, Office of Basic Energy Sciences (DOE-BES)(United States Department of Energy (DOE)); CIW; CDAC(United States Department of Energy (DOE)); UNLV; LLNL through DOE-NNSA(National Nuclear Security Administration); NSF(National Science Foundation (NSF))	We thank I. I. Mazin, W. Bao, and T. Xiang for discussions and J. S. Schilling for the help with the alternating-current susceptibility technique. This work in China was supported by the NSCF, 973 projects, and Chinese Academy of Sciences. This work in the USA was supported as part of the EFree, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences (DOE-BES). The High Pressure Collaborative Access Team (HPCAT) is supported by CIW, CDAC, UNLV and LLNL through funding from the DOE-NNSA, the DOE-BES and the NSF. The Advanced Photon Source (APS) is supported by the DOE-BES.	Bao W, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/8/086104; Chen XH, 2008, NATURE, V453, P761, DOI 10.1038/nature07045; Debessai M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.197002; Fang MH, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/27009; Guo JG, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.180520; Jin K, 2011, NATURE, V476, P73, DOI 10.1038/nature10308; Krzton-Maziopa A, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/5/052203; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; Mazin Igor, 2011, Physics, V4, DOI 10.1103/Physics.4.26; Medvedev S, 2009, NAT MATER, V8, P630, DOI [10.1038/NMAT2491, 10.1038/nmat2491]; Okuhata T, 2007, J PHYS SOC JPN, V76, P188, DOI 10.1143/JPSJS.76SA.188; Ren ZA, 2008, CHINESE PHYS LETT, V25, P2215, DOI 10.1088/0256-307X/25/6/080; Si QM, 2010, SCIENCE, V329, P1161, DOI 10.1126/science.1191195; Torikachvili MS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057006; Uji S, 2001, NATURE, V410, P908, DOI 10.1038/35073531; Wang AF, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.060512; Wang DM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.132502; Wang HD, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/47004; Yuan HQ, 2003, SCIENCE, V302, P2104, DOI 10.1126/science.1091648	21	264	276	8	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					67	69		10.1038/nature10813	http://dx.doi.org/10.1038/nature10813			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22367543	Green Submitted			2022-12-28	WOS:000300877900045
J	Shalchi, Z; Lightman, SL; Pusey, CD; Taylor, SRJ				Shalchi, Zaid; Lightman, Susan L.; Pusey, Charles D.; Taylor, Simon R. J.			A sore red eye with systemic involvement	BRITISH MEDICAL JOURNAL			English	Editorial Material							WEGENERS-GRANULOMATOSIS; RANDOMIZED-TRIAL; VASCULITIS; CYCLOPHOSPHAMIDE; METHOTREXATE; RITUXIMAB; THERAPY		[Taylor, Simon R. J.] Royal Surrey Cty Hosp NHS Fdn Trust, Natl Inst Hlth Res, Guildford, Surrey, England; [Taylor, Simon R. J.] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Multidisciplinary Vasculitis Clin, Natl Inst Hlth Res, London, England; [Taylor, Simon R. J.] UCL Inst Ophthalmol, Natl Inst Hlth Res, London, England; [Pusey, Charles D.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, London SW7 2AZ, England	Royal Surrey County Hospital; Imperial College London; University of London; University College London; Imperial College London	Taylor, SRJ (corresponding author), Royal Surrey Cty Hosp NHS Fdn Trust, Natl Inst Hlth Res, Guildford, Surrey, England.	s.r.taylor@ucl.ac.uk	Taylor, Simon/C-1496-2008	Taylor, Simon/0000-0002-1228-881X				Akpek EK, 2004, OPHTHALMOLOGY, V111, P501, DOI 10.1016/j.ophtha.2003.06.006; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; Gomez-Puerta JA, 2009, AM J PATHOL, V175, P1790, DOI 10.2353/ajpath.2009.090533; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hu N, 2009, AUTOIMMUN REV, V8, P510, DOI 10.1016/j.autrev.2008.01.003; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Jayne DRW, 2007, J AM SOC NEPHROL, V18, P2180, DOI 10.1681/ASN.2007010090; Kallenberg CGM, 2008, AUTOIMMUN REV, V8, P29, DOI 10.1016/j.autrev.2008.07.020; Langford CA, 1999, THORAX, V54, P629, DOI 10.1136/thx.54.7.629; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Mohammad AJ, 2007, RHEUMATOLOGY, V46, P1329, DOI 10.1093/rheumatology/kem107; Raiji VR, 2009, AM J OPHTHALMOL, V148, P946, DOI 10.1016/j.ajo.2009.07.021; Reinhold-Keller E, 2000, ARTHRITIS RHEUM, V43, P1021, DOI 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J; Schilder AM, 2010, AUTOIMMUN REV, V9, P483, DOI 10.1016/j.autrev.2010.02.006; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Taylor SRJ, 2009, ARTHRITIS RHEUM-US, V60, P1540, DOI 10.1002/art.24454; Taylor SRJ, 2007, EXPERT REV OPHTHALMO, V2, P91, DOI 10.1586/17469899.2.1.91; Villa-Forte A, 2007, MEDICINE, V86, P269, DOI 10.1097/MD.0b013e3181568ec0	18	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2012	344								e1121	10.1136/bmj.e1121	http://dx.doi.org/10.1136/bmj.e1121			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900KB	22368284	Green Submitted			2022-12-28	WOS:000300884700001
J	Velders, GJM; Ravishankara, AR; Miller, MK; Molina, MJ; Alcamo, J; Daniel, JS; Fahey, DW; Montzka, SA; Reimann, S				Velders, Guus J. M.; Ravishankara, A. R.; Miller, Melanie K.; Molina, Mario J.; Alcamo, Joseph; Daniel, John S.; Fahey, David W.; Montzka, Stephen A.; Reimann, Stefan			Preserving Montreal Protocol Climate Benefits by Limiting HFCs	SCIENCE			English	Editorial Material									[Velders, Guus J. M.] Natl Inst Publ Hlth & Environm RIVM, NL-3720 BA Bilthoven, Netherlands; [Ravishankara, A. R.; Daniel, John S.; Fahey, David W.; Montzka, Stephen A.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Miller, Melanie K.] Touchdown Consulting, B-1310 La Hulpe, Belgium; [Molina, Mario J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Alcamo, Joseph] UNEP, Nairobi, Kenya; [Reimann, Stefan] Swiss Fed Labs Mat Sci & Technol Empa, CH-8600 Dubendorf, Switzerland	Netherlands National Institute for Public Health & the Environment; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Velders, GJM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, NL-3720 BA Bilthoven, Netherlands.	guus.velders@rivm.nl	Ravishankara, Akkihebbal R/A-2914-2011; montzka, stephen/V-6162-2019; Fahey, David W/G-4499-2013; Daniel, John S/D-9324-2011; Reimann, Stefan/A-2327-2009; Velders, Guus/H-1204-2013	montzka, stephen/0000-0002-9396-0400; Fahey, David W/0000-0003-1720-0634; Reimann, Stefan/0000-0002-9885-7138; Velders, Guus/0000-0002-6597-7088				Houghton J. T., 2001, CLIMATE CHANGE 2001; Metz B., 2005, SPECIAL REPORT SAFEG; Montzka SA, 2011, NATURE, V476, P43, DOI 10.1038/nature10322; RAMANATHAN V, 1975, SCIENCE, V190, P50, DOI 10.1126/science.190.4209.50; TEAP, 2010, PROGR REP TECHN EC A, V1; TEAP, 2011, 2010 ASS REP TECHN E; UNEP, 2010, 22 M PART MONTR PROT; UNEP, 2011, HFCS CRIT LINK PROT; Velders GJM, 2007, P NATL ACAD SCI USA, V104, P4814, DOI 10.1073/pnas.0610328104; Velders GJM, 2009, P NATL ACAD SCI USA, V106, P10949, DOI 10.1073/pnas.0902817106; WMO: Scientific Assessment of Ozone Depletion, 2010, 52 WMO	11	107	112	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					922	923		10.1126/science.1216414	http://dx.doi.org/10.1126/science.1216414			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900ZQ	22362993				2022-12-28	WOS:000300931800029
J	Duprat, C; Protiere, S; Beebe, AY; Stone, HA				Duprat, C.; Protiere, S.; Beebe, A. Y.; Stone, H. A.			Wetting of flexible fibre arrays	NATURE			English	Article								Fibrous media are functional and versatile materials, as demonstrated by their ubiquity both in natural systems such as feathers(1-4) and adhesive pads(5) and in engineered systems from nanotextured surfaces(6) to textile products(7), where they offer benefits in filtration, insulation, wetting and colouring. The elasticity and high aspect ratios of the fibres allow deformation under capillary forces, which cause mechanical damage(8), matting(5,9) self-assembly(10,11) or colour changes(12), with many industrial and ecological consequences. Attempts to understand these systems have mostly focused on the wetting of rigid fibres(13-17) or on elastocapillary effects in planar geometries(18) and on a fibre brush withdrawn from an infinite bath(19). Here we consider the frequently encountered case of a liquid drop deposited on a flexible fibre array and show that flexibility, fibre geometry and drop volume are the crucial parameters that are necessary to understand the various observations referred to above. We identify the conditions required for a drop to remain compact with minimal spreading or to cause a pair of elastic fibres to coalesce. We find that there is a critical volume of liquid, and, hence, a critical drop size, above which this coalescence does not occur. We also identify a drop size that maximizes liquid capture. For both wetting and deformation of the substrates, we present rules that are deduced from the geometric and material properties of the fibres and the volume of the drop. These ideas are applicable to a wide range of fibrous materials, as we illustrate with examples for feathers, beetle tarsi, sprays and microfabricated systems.	[Duprat, C.; Beebe, A. Y.; Stone, H. A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Protiere, S.] CNRS, UMR 7190, Inst Jean le Rond dAlembert, F-75005 Paris, France; [Protiere, S.] Univ Paris 06, UMR 7190, Inst Jean le Rond dAlembert, F-75005 Paris, France	Princeton University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite	Stone, HA (corresponding author), Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.	hastone@princeton.edu			Unilever; NFS; Emergence(s) Program of the City of Paris; CNRS; Div Of Chem, Bioeng, Env, & Transp Sys [1132835] Funding Source: National Science Foundation	Unilever(Unilever); NFS; Emergence(s) Program of the City of Paris; CNRS(Centre National de la Recherche Scientifique (CNRS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	C.D. and H.A.S. acknowledge Unilever and the NFS for financial support. S. P. acknowledges financial support from the Emergence(s) Program of the City of Paris and CNRS and thanks Princeton University for its hospitality. We thank A. Lips and P. Warren for comments.	Bedarkar A, 2010, APPL SURF SCI, V256, P7260, DOI 10.1016/j.apsusc.2010.05.061; Chandra D, 2010, ACCOUNTS CHEM RES, V43, P1080, DOI 10.1021/ar100001a; Chandra D, 2009, ACS APPL MATER INTER, V1, P1698, DOI 10.1021/am900253z; Dawson C, 1999, J THEOR BIOL, V199, P291, DOI 10.1006/jtbi.1999.0959; Eadie L, 2011, J R SOC INTERFACE, V8, P761, DOI 10.1098/rsif.2010.0487; Eisner T, 2000, P NATL ACAD SCI USA, V97, P6568, DOI 10.1073/pnas.97.12.6568; HARTUNG R, 1967, J WILDLIFE MANAGE, V31, P798, DOI 10.2307/3797987; Hubbe MA, 2006, BIORESOURCES, V1, P281; KAMO J, 1992, J MEMBRANE SCI, V70, P217, DOI 10.1016/0376-7388(92)80107-U; Keis K, 2004, NATO SCI SER II MATH, V169, P175; Kwon HM, 2008, J APPL PHYS, V103, DOI 10.1063/1.2913512; Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002; Minor FW, 1959, TEXT RES J, V29, P940; O'Hara PD, 2010, MAR POLLUT BULL, V60, P672, DOI 10.1016/j.marpolbul.2009.12.008; Pokroy B, 2009, SCIENCE, V323, P237, DOI 10.1126/science.1165607; Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023; PRINCEN HM, 1970, J COLLOID INTERF SCI, V34, P171, DOI 10.1016/0021-9797(70)90167-0; Py C, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/44005; RIJKE AM, 1968, J EXP BIOL, V48, P185; Rijke AM, 2010, WILSON J ORNITHOL, V122, P563, DOI 10.1676/09-172.1; Roman B, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/49/493101; Wu XF, 2010, J COLLOID INTERF SCI, V341, P326, DOI 10.1016/j.jcis.2009.09.019; Zi J, 2003, P NATL ACAD SCI USA, V100, P12576, DOI 10.1073/pnas.2133313100	23	199	200	12	347	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					510	513		10.1038/nature10779	http://dx.doi.org/10.1038/nature10779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358841				2022-12-28	WOS:000300770500047
J	Ly, KN; Xing, J; Klevens, RM; Jiles, RB; Ward, JW; Holmberg, SD				Ly, Kathleen N.; Xing, Jian; Klevens, R. Monina; Jiles, Ruth B.; Ward, John W.; Holmberg, Scott D.			The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-INFECTION; LIVER-DISEASE; PREVALENCE; IDENTIFICATION; MANAGEMENT; MORBIDITY; DEATH; ERA	Background: The increasing health burden and mortality from hepatitis B virus (HBV) and hepatitis C virus (HCV) in the United States are underappreciated. Objective: To examine mortality from HBV; HCV; and, for comparison, HIV. Design: Analysis of U.S. multiple-cause mortality data from 1999 to 2007 from the National Center for Health Statistics. Setting: All U.S. states and the District of Columbia. Participants: Approximately 22 million decedents. Measurements: Age-adjusted mortality rates from HBV, HCV, and HIV. Logistic regression analyses of 2007 data generated 4 independent models per outcome (HCV- or HBV-related deaths) that each included 1 of 4 comorbid conditions and all sociodemographic characteristics. Results: Between 1999 and 2007, recorded deaths from HCV increased significantly to 15 106, whereas deaths from HIV declined to 12 734 by 2007. Factors associated with HCV-related deaths included chronic liver disease, HBV co-infection, alcohol-related conditions, minority status, and HIV co-infection. Factors that increased odds of HBV-related death included chronic liver disease, HCV co-infection, Asian or Pacific Islander descent, HIV co-infection, and alcohol-related conditions. Most deaths from HBV and HCV occurred in middle-aged persons. Limitation: A person other than the primary physician of the decedent frequently completed the death certificate, and HCV and HBV often were not detected and thus not reported as causes of death. Conclusion: By 2007, HCV had superseded HIV as a cause of death in the United States, and deaths from HCV and HBV disproportionately occurred in middle-aged persons. To achieve decreases in mortality similar to those seen with HIV requires new policy initiatives to detect patients with chronic hepatitis and link them to care and treatment.	[Ly, Kathleen N.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Ly, KN (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, 1600 Clifton Rd NE,Mailstop G-37, Atlanta, GA 30333 USA.	kathleenly@cdc.gov	Cheng, Yushao/E-6256-2011		Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	By the Centers for Disease Control and Prevention.	Adih William K, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P5, DOI 10.1177/1545109710384505; American Cancer Society, 2010, CANC FACTS FIG 2010; [Anonymous], 2021, VIR HEP SURV REP US; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Cohen C, 2011, J VIRAL HEPATITIS, V18, P377, DOI 10.1111/j.1365-2893.2010.01401.x; Colvin HM, 2010, HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, P1; Denniston MM, 2012, HEPATOL IN PRESS; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Everhart J, 2008, BURDEN DIGESTIVE DIS; Hahn RA, 2002, PUBLIC HEALTH REP, V117, P37, DOI 10.1016/S0033-3549(04)50106-1; Institute for Social Research University of Michigan, 2011, COD CAUS DEATH; Kallman JB, 2009, ALIMENT PHARM THER, V29, P1019, DOI 10.1111/j.1365-2036.2009.03961.x; Klein RJ., 2001, HLTH PEOPLE 2010 STA, DOI DOI 10.1037/E583772012-001; Koh HK, 2010, AM ASS STUD LIV DIS; Manos MM, 2008, HEPATOLOGY, V47, P1150, DOI 10.1002/hep.22181; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; National Center for Health Statistics, 2003, US STAND DEATH CERT; National Center for Health Statistics, 2010, INSTR CLASS UND CAUS, VICD-10; National Center for Health Statistics, 1999, PUBL US DAT SET DOC; National Center for Health Statistics, 2003, DHHS PUBL; O'Brien SF, 2010, TRANSFUSION MED, V20, P15, DOI 10.1111/j.1365-3148.2009.00969.x; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Seeff L B, 1997, Clin Liver Dis, V1, P587, DOI 10.1016/S1089-3261(05)70323-8; Selik RM, 2003, JAIDS-J ACQ IMM DEF, V32, P62, DOI 10.1097/00126334-200301010-00009; Shehab TM, 2003, AM J GASTROENTEROL, V98, P639, DOI 10.1111/j.1572-0241.2003.07331.x; Spradling P, 2011, 49 ANN M INF DIS SOC; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Thomas DL, 2005, CLIN LIVER DIS, V9, pvi; US Department of Health Human Services, 2011, COMB SIL EP VIR HEP; VOGT T, 2007, 45 ANN M INF DIS SOC, P172; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; World Health Organization, 1998, INT CLASS DIS; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1	40	575	584	0	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					271	U33		10.7326/0003-4819-156-4-201202210-00004	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896YO	22351712				2022-12-28	WOS:000300607600003
J	Kadowaki, T; Kubota, N; Ueki, K; Yamauchi, T				Kadowaki, Takashi; Kubota, Naoto; Ueki, Kohjiro; Yamauchi, Toshimasa			SnapShot: Physiology of Insulin Signaling	CELL			English	Editorial Material							NUTRIENT HOMEOSTASIS; RECEPTOR; RESISTANCE; TISSUE; MICE		[Kadowaki, Takashi; Kubota, Naoto; Ueki, Kohjiro; Yamauchi, Toshimasa] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan.		Kubota, Naoto/N-7892-2015					Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; KADOWAKI T, 1988, SCIENCE, V240, P787, DOI 10.1126/science.2834824; Kadowaki T, 2012, CELL, V148, P624, DOI 10.1016/j.cell.2012.01.034; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179	10	7	9	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					834	U226	834.e1	10.1016/j.cell.2012.02.004	http://dx.doi.org/10.1016/j.cell.2012.02.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341452	Bronze			2022-12-28	WOS:000300622400024
J	Stone, RL; Nick, AM; McNeish, IA; Balkwill, F; Han, HD; Bottsford-Miller, J; Rupaimoole, R; Armaiz-Pena, GN; Pecot, CV; Coward, J; Deavers, MT; Vasquez, HG; Urbauer, D; Landen, CN; Hu, W; Gershenson, H; Matsuo, K; Shahzad, MMK; King, ER; Tekedereli, I; Ozpolat, B; Ahn, EH; Bond, VK; Wang, R; Drew, AF; Gushiken, F; Lamkin, D; Collins, K; DeGeest, K; Lutgendorf, SK; Chiu, W; Lopez-Berestein, G; Afshar-Kharghan, V; Sood, AK				Stone, Rebecca L.; Nick, Alpa M.; McNeish, Iain A.; Balkwill, Frances; Han, Hee Dong; Bottsford-Miller, Justin; Rupaimoole, Rajesha; Armaiz-Pena, Guillermo N.; Pecot, Chad V.; Coward, Jermaine; Deavers, Michael T.; Vasquez, Hernan G.; Urbauer, Diana; Landen, Charles N.; Hu, Wei; Gershenson, Hannah; Matsuo, Koji; Shahzad, Mian M. K.; King, Erin R.; Tekedereli, Ibrahim; Ozpolat, Bulent; Ahn, Edward H.; Bond, Virginia K.; Wang, Rui; Drew, Angela F.; Gushiken, Francisca; Lamkin, Donald; Collins, Katherine; DeGeest, Koen; Lutgendorf, Susan K.; Chiu, Wah; Lopez-Berestein, Gabriel; Afshar-Kharghan, Vahid; Sood, Anil K.			Paraneoplastic Thrombocytosis in Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERLEUKIN-6; THROMBOPOIETIN; ANGIOGENESIS; ASPIRIN; GROWTH; MODEL; MICE	BACKGROUND The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear. METHODS We analyzed clinical data on 619 patients with epithelial ovarian cancer to test associations between platelet counts and disease outcome. Human samples and mouse models of epithelial ovarian cancer were used to explore the underlying mechanisms of paraneoplastic thrombocytosis. The effects of platelets on tumor growth and angiogenesis were ascertained. RESULTS Thrombocytosis was significantly associated with advanced disease and shortened survival. Plasma levels of thrombopoietin and interleukin-6 were significantly elevated in patients who had thrombocytosis as compared with those who did not. In mouse models, increased hepatic thrombopoietin synthesis in response to tumor-derived interleukin-6 was an underlying mechanism of paraneoplastic thrombocytosis. Tumorderived interleukin-6 and hepatic thrombopoietin were also linked to thrombocytosis in patients. Silencing thrombopoietin and interleukin-6 abrogated thrombocytosis in tumor-bearing mice. Anti-interleukin-6 antibody treatment significantly reduced platelet counts in tumor-bearing mice and in patients with epithelial ovarian cancer. In addition, neutralizing interleukin-6 significantly enhanced the therapeutic efficacy of paclitaxel in mouse models of epithelial ovarian cancer. The use of an antiplatelet antibody to halve platelet counts in tumor-bearing mice significantly reduced tumor growth and angiogenesis. CONCLUSIONS These findings support the existence of a paracrine circuit wherein increased production of thrombopoietic cytokines in tumor and host tissue leads to paraneoplastic thrombocytosis, which fuels tumor growth. We speculate that countering paraneoplastic thrombocytosis either directly or indirectly by targeting these cytokines may have therapeutic potential. (Funded by the National Cancer Institute and others.)	[Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Unit 1362, Houston, TX 77230 USA; [Rupaimoole, Rajesha; Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77230 USA; [Armaiz-Pena, Guillermo N.; Tekedereli, Ibrahim; Ozpolat, Bulent; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77230 USA; [Pecot, Chad V.] Univ Texas MD Anderson Canc Ctr, Dept Hematol & Oncol, Houston, TX 77230 USA; [Deavers, Michael T.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77230 USA; [Vasquez, Hernan G.; Afshar-Kharghan, Vahid] Univ Texas MD Anderson Canc Ctr, Dept Benign Hematol, Houston, TX 77230 USA; [Urbauer, Diana] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77230 USA; [Gushiken, Francisca] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA; [Han, Hee Dong; Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77230 USA; [Wang, Rui; Chiu, Wah] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel] UT Hlth, Dept Nanomed & Bioengn, Houston, TX USA; [McNeish, Iain A.; Balkwill, Frances; Coward, Jermaine] Univ London, Barts Canc Inst, London WC1E 7HU, England; [Landen, Charles N.] Univ Alabama Birmingham, Div Gynecol Oncol, Dept Obstet & Gynecol, Birmingham, AL USA; [Ahn, Edward H.; Bond, Virginia K.] Univ Maryland, Dept Obstet & Gynecol, Baltimore, MD 21201 USA; [Drew, Angela F.] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH USA; [Lamkin, Donald; Collins, Katherine; Lutgendorf, Susan K.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Lamkin, Donald; Lutgendorf, Susan K.] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA; [Lamkin, Donald; DeGeest, Koen; Lutgendorf, Susan K.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [DeGeest, Koen; Lutgendorf, Susan K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of London; Queen Mary University London; University of Alabama System; University of Alabama Birmingham; University System of Maryland; University of Maryland Baltimore; University System of Ohio; University of Cincinnati; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Unit 1362, POB 301439, Houston, TX 77230 USA.	asood@mdanderson.org	Lamkin, Donald M/GQA-5975-2022; rupaimoole, rajesha/K-3272-2016; Coward, Jermaine/F-2903-2016; Coward, Jermaine/C-1779-2012	rupaimoole, rajesha/0000-0002-4795-7921; Coward, Jermaine/0000-0002-2309-9379; Matsuo, Koji/0000-0002-6232-8701; Balkwill, Frances/0000-0002-5587-9759; Armaiz-Pena, Guillermo N/0000-0002-9081-5339; McNeish, Iain/0000-0002-9387-7586	Gynecologic Cancer Foundation; National Institutes of Health [CA109298, P50 CA083639, P50 CA098258, CA128797, RC2GM092599, CA140933, CA016672, U54 CA151668, R01CA104825]; Ovarian Cancer Research Fund; Department of Defense [OC073399, W81XWH-10-1-0158, BC085265]; Baylor College of Medicine; M. D. Anderson Cancer Center; Zarrow Foundation; Marcus Foundation; Estate of C. G. Johnson, Jr.; United Kingdom Medical Research Council; Blanton-Davis Ovarian Cancer Research Program; Laura and John Arnold Foundation; RGK Foundation; Bettyann Asche Murray Distinguished Professorship; National Cancer Institute [T32 CA101642, T32 CA009666]; Queen Mary, University of London; Medical Research Council [G0501974, G0601891] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA104825, R01CA109298, P50CA083639, R01CA140933, T32CA009666, U54CA151668, P50CA098258, T32CA101642, R01CA128797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092599] Funding Source: NIH RePORTER; MRC [G0501974, G0601891] Funding Source: UKRI	Gynecologic Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Department of Defense(United States Department of Defense); Baylor College of Medicine; M. D. Anderson Cancer Center; Zarrow Foundation; Marcus Foundation; Estate of C. G. Johnson, Jr.; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Blanton-Davis Ovarian Cancer Research Program; Laura and John Arnold Foundation; RGK Foundation; Bettyann Asche Murray Distinguished Professorship; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Queen Mary, University of London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported in part by a Gail MacNeil KOH Research Award from the Gynecologic Cancer Foundation; grants (CA109298, P50 CA083639, P50 CA098258, CA128797, RC2GM092599, CA140933, CA016672, U54 CA151668, and R01CA104825) from the National Institutes of Health; a Program Project Development Grant from the Ovarian Cancer Research Fund; grants (OC073399, W81XWH-10-1-0158, and BC085265) from the Department of Defense; the Baylor College of Medicine and M. D. Anderson Cancer Center Multidisciplinary Research Program; the Zarrow Foundation; the Marcus Foundation; the Estate of C. G. Johnson, Jr.; the United Kingdom Medical Research Council; the Blanton-Davis Ovarian Cancer Research Program; the Laura and John Arnold Foundation; the RGK Foundation; the Bettyann Asche Murray Distinguished Professorship; and training grants (T32 CA101642 supported Drs. Stone, Nick, Bottsford- Miller, and King and T32 CA009666 supported Dr. Pecot) from the National Cancer Institute. The siltuximab trial was funded by the United Kingdom Medical Research Council and sponsored and monitored by Queen Mary, University of London.	Akl EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006652; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Borsig L, 2008, EXPERT REV ANTICANC, V8, P1247, DOI 10.1586/14737140.8.8.1247; BRANEHOG I, 1975, SCAND J HAEMATOL, V15, P321; Burmester H, 2005, J INTERF CYTOK RES, V25, P407, DOI 10.1089/jir.2005.25.407; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Deng L, 2005, CLIN CANCER RES, V11, P8258, DOI 10.1158/1078-0432.CCR-05-1189; Ho-Tin-Noe B, 2009, CANCER RES, V69, P5623, DOI 10.1158/0008-5472.CAN-09-1370; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kaushansky K, 2006, NEW ENGL J MED, V354, P2034, DOI 10.1056/NEJMra052706; Kaushansky K, 1998, NEW ENGL J MED, V339, P746, DOI 10.1056/NEJM199809103391107; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Leslie M, 2010, SCIENCE, V328, P562, DOI 10.1126/science.328.5978.562; LEVIN J, 1964, ARCH INTERN MED, V114, P497, DOI 10.1001/archinte.1964.03860100079008; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lu C, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.028; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Merritt WM, 2010, NEW ENGL J MED, V363, P1877; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Riess L, 1872, ARCH ANAT PHYSL WISS, V39, P237; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Shahzad MMK, 2009, CANCER BIOL THER, V8, P1027, DOI 10.4161/cbt.8.11.8523; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Trousseau A, 1867, LECT CLIN MED DELIVE	28	522	548	6	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					610	618		10.1056/NEJMoa1110352	http://dx.doi.org/10.1056/NEJMoa1110352			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IL	22335738	Green Accepted			2022-12-28	WOS:000300279800006
J	Mustafic, H; Jabre, P; Caussin, C; Murad, MH; Escolano, S; Tafflet, M; Perier, MC; Marijon, E; Vernerey, D; Empana, JP; Jouven, X				Mustafic, Hazrije; Jabre, Patricia; Caussin, Christophe; Murad, Mohammad H.; Escolano, Sylvie; Tafflet, Muriel; Perier, Marie-Cecile; Marijon, Eloi; Vernerey, Dewi; Empana, Jean-Philippe; Jouven, Xavier			Main Air Pollutants and Myocardial Infarction A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FINE-PARTICULATE MATTER; ISCHEMIC-HEART-DISEASE; SHORT-TERM EXPOSURE; HOSPITAL ADMISSIONS; CASE-CROSSOVER; TIME-SERIES; DAILY MORTALITY; RESPIRATORY-DISEASES; EMERGENCY ADMISSIONS; RATE-VARIABILITY	Context Short-term exposure to high levels of air pollution may trigger myocardial infarction (MI), but this association remains unclear. Objective To assess and quantify the association between short-term exposure to major air pollutants (ozone, carbon monoxide, nitrogen dioxide, sulfur dioxide, and particulate matter <= 10 mu m [PM10] and <= 2.5 mu m [PM2.5] in diameter) on MI risk. Data Sources EMBASE, Ovid MEDLINE in-process and other nonindexed citations, and Ovid MEDLINE (between 1948 and November 28, 2011), and EBM Reviews-Cochrane Central Register of Controlled Trials and EBM Reviews-Cochrane Database of Systematic Reviews (between 2005 and November 28, 2011) were searched for a combination of keywords related to the type of exposure (air pollution, ozone, carbon monoxide, nitrogen dioxide, sulfur dioxide, PM10, and PM2.5) and to the type of outcome (MI, heart attack, acute coronary syndrome). Study Selection Two independent reviewers selected studies of any study design and in any language, using original data and investigating the association between short-term exposure (for up to 7 days) to 1 or more air pollutants and subsequent MI risk. Selection was performed from abstracts and titles and pursued by reviewing the full text of potentially eligible studies. Data Extraction Descriptive and quantitative information was extracted from each selected study. Using a random effects model, relative risks (RRs) and 95% CIs were calculated for each increment of 10 mu g/m(3) in pollutant concentration, with the exception of carbon monoxide, for which an increase of 1 mg/m(3) was considered. Data Synthesis After a detailed screening of 117 studies, 34 studies were identified. All the main air pollutants, with the exception of ozone, were significantly associated with an increase in MI risk (carbon monoxide: 1.048; 95% CI, 1.026-1.070; nitrogen dioxide: 1.011; 95% CI, 1.006-1.016; sulfur dioxide: 1.010; 95% CI, 1.003-1.017; PM10: 1.006; 95% CI, 1.002-1.009; and PM2.5: 1.025; 95% CI, 1.015-1.036). For ozone, the RR was 1.003 (95% CI, 0.997-1.010; P=.36). Subgroup analyses provided results comparable with those of the overall analyses. Population attributable fractions ranged between 0.6% and 4.5%, depending on the air pollutant. Conclusion All the main air pollutants, with the exception of ozone, were significantly associated with a near-term increase in MI risk. JAMA. 2012;307(7):713-721	[Mustafic, Hazrije; Jabre, Patricia; Escolano, Sylvie; Tafflet, Muriel; Perier, Marie-Cecile; Marijon, Eloi; Vernerey, Dewi; Empana, Jean-Philippe; Jouven, Xavier] Univ Paris 05, Paris Cardiovasc Res Ctr, INSERM, U970, Paris, France; [Jabre, Patricia] Univ Paris 05, SAMU Paris, Necker Enfants Malades Hosp, Assistance Publ Hop Paris, Paris, France; [Caussin, Christophe] Marie Lannelongue Hosp, Dept Cardiol, Le Plessis Robinson, France; [Murad, Mohammad H.] Mayo Clin, Div Prevent Med & Hlth Care Policy & Res, Rochester, MN USA; [Mustafic, Hazrije] Ctr Prevent Med, Ramazan Mustafic Ctr, Bar, Montenegro	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Hopital Marie Lannelongue; Mayo Clinic	Mustafic, H (corresponding author), INSERM, Paris Cardiovasc Res Ctr PARCC, U970, Team 4, 56 rue Leblanc, F-75015 Paris, France.	hazrije.mustafic@inserm.fr	Empana, Jean-Philippe/AAF-6923-2021; Murad, M. Hassan/AAW-4367-2020	Empana, Jean-Philippe/0000-0002-1469-7772; MUSTAFIC, Hazrije/0000-0002-5011-2110; escolano, sylvie/0000-0003-0864-4321; Murad, Mohammad Hassan/0000-0001-5502-5975	Boston Scientific; INSERM (National Research Institute)	Boston Scientific(Boston Scientific); INSERM (National Research Institute)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Caussin reported receiving consultancy fees from Boston Scientific; payment for lectures including service on speakers bureaus from Daichii Sankyo and Novartis; and travel/meeting expenses from Medtronic, Edwards LifeScience, and Abbott. Dr Jouven reported receiving a grant from INSERM (National Research Institute). No other authors reported any financial disclosures.	AYRES JG, CARDIOVASCULAR DIS A; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013; Belleudi V, 2010, EPIDEMIOLOGY, V21, P414, DOI 10.1097/EDE.0b013e3181d5c021; Berglind N, 2010, INT J ENV RES PUB HE, V7, P1486, DOI 10.3390/ijerph7041486; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5531; Bouthillier L, 1998, AM J PATHOL, V153, P1873, DOI 10.1016/S0002-9440(10)65701-X; Braga ALF, 2001, J OCCUP ENVIRON MED, V43, P927; Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13; Cendon S, 2006, REV SAUDE PUBL, V40, P414, DOI 10.1590/S0034-89102006000300008; Chardon B, 2008, REV EPIDEMIOL SANTE, V56, P31, DOI 10.1016/j.respe.2007.11.002; Chardon B, 2007, ENVIRON RISQUE SANTE, V6, P345; Cheng MF, 2009, J TOXICOL ENV HEAL A, V72, P1135, DOI 10.1080/15287390903091756; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; Dilaveris P, 2006, HEART, V92, P1747, DOI 10.1136/hrt.2006.091884; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Eilstein D, 2001, REV EPIDEMIOL SANTE, V49, P13; Filleul L, 2001, REV MAL RESPIR, V18, P387; Henrotin JB, 2010, HEART, V96, P1990, DOI 10.1136/hrt.2010.200337; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoek G, 2000, J AIR WASTE MANAGE, V50, P1380, DOI 10.1080/10473289.2000.10464182; Hsieh YL, 2010, J TOXICOL ENV HEAL A, V73, P757, DOI 10.1080/15287391003684789; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Kunzli N, 2005, J EPIDEMIOL COMMUN H, V59, P527, DOI 10.1136/jech.2004.027391; Lanki T, 2006, OCCUP ENVIRON MED, V63, P844, DOI 10.1136/oem.2005.023911; Liao DP, 2009, J TOXICOL ENV HEAL A, V72, P30, DOI 10.1080/15287390802445483; Linn WS, 2000, ENVIRON HEALTH PERSP, V108, P427, DOI 10.2307/3454383; Lu Y, 2007, BIOSTATISTICS, V8, P337, DOI 10.1093/biostatistics/kxl013; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Mann JK, 2002, ENVIRON HEALTH PERSP, V110, P1247, DOI 10.1289/ehp.021101247; Mate T, 2010, SCI TOTAL ENVIRON, V408, P5750, DOI 10.1016/j.scitotenv.2010.07.083; Medina S, 1997, ENVIRON RES, V75, P73, DOI 10.1006/enrs.1997.3773; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Nuvolone D, 2011, AM J EPIDEMIOL, V174, P63, DOI 10.1093/aje/kwr046; Peng RD, 2008, JAMA-J AM MED ASSOC, V299, P2172, DOI 10.1001/jama.299.18.2172; Peters A, 2001, CIRCULATION, V103, P2810; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Peters Annette, 2005, Res Rep Health Eff Inst, P1; Poloniecki JD, 1997, OCCUP ENVIRON MED, V54, P535, DOI 10.1136/oem.54.8.535; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 1999, AM HEART J, V138, P890, DOI 10.1016/S0002-8703(99)70014-1; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Rich DQ, 2010, ENVIRON HEALTH PERSP, V118, P1229, DOI 10.1289/ehp.0901624; Ruidavets JB, 2005, CIRCULATION, V111, P563, DOI 10.1161/01.CIR.0000154546.32135.6E; Sedgwick P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5372; Sharovsky R, 2004, BRAZ J MED BIOL RES, V37, P1651, DOI 10.1590/S0100-879X2004001100009; Stieb DM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-25; Sullivan J, 2005, EPIDEMIOLOGY, V16, P41, DOI 10.1097/01.ede.0000147116.34813.56; Ueda K, 2009, CIRC J, V73, P1248, DOI 10.1253/circj.CJ-08-1149; Wells G., NEWCASTLE OTTAWA SCA; Ye F, 2001, ENVIRON HEALTH PERSP, V109, P355, DOI 10.2307/3454894; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zanobetti A, 2006, J EPIDEMIOL COMMUN H, V60, P890, DOI 10.1136/jech.2005.039834; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58; Zhang ZM, 2009, ENVIRON HEALTH PERSP, V117, P751, DOI 10.1289/ehp.0800046	59	511	538	15	151	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					713	721		10.1001/jama.2012.126	http://dx.doi.org/10.1001/jama.2012.126			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22337682				2022-12-28	WOS:000300278500028
J	Pinto, RZ; Maher, CG; Ferreira, ML; Ferreira, PH; Hancock, M; Oliveira, VC; McLachlan, AJ; Koes, B				Pinto, Rafael Zambelli; Maher, Chris G.; Ferreira, Manuela L.; Ferreira, Paulo H.; Hancock, Mark; Oliveira, Vinicius C.; McLachlan, Andrew J.; Koes, Bart			Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; PLACEBO-CONTROLLED TRIAL; LUMBAR DISC HERNIATION; DOUBLE-BLIND; CONSERVATIVE TREATMENT; CLINICAL-TRIAL; TIAPROFENIC ACID; NEUROPATHIC PAIN; RATING QUALITY; ORAL MELOXICAM	Objective To investigate the efficacy and tolerability of analgesic and adjuvant pain drugs typically administered in primary care for the management of patients with sciatica. Design Systematic review. Data source International Pharmaceutical Abstracts, PsycINFO, Medline, Embase, Cochrane Central Register of Clinical Trials (CENTRAL), CINAHL, and LILACS. Study selection Randomised controlled trials assessing the efficacy and tolerability of drugs versus placebo or other treatment for sciatica. Data extraction Two independent reviewers extracted data and assessed methodological quality using the PEDro scale. Pain and disability outcomes were converted to a common 0 to 100 scale. Data were pooled with a random effects model, and the GRADE approach was used in summary conclusions. Results Twenty three published reports met the inclusion criteria. The evidence to judge the efficacy of non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, antidepressants, anticonvulsants, muscle relaxants, and opioid analgesics ranged from moderate to low quality. Most of the pooled estimates did not favour the active treatment over placebo. The pooled results of two trials of corticosteroids (mean difference in overall and leg pain -12.2, 95% confidence interval -20.9 to -3.4) and a single trial of the anticonvulsant gabapentin for chronic sciatica (mean difference in overall pain relief -26.6, -38.3 to -14.9) showed some benefits but only in the short term. The median rate of adverse events was 17% (interquartile range 10-30%) for the active drugs and 11% (3-23%) for placebo. Trial limitations included failure to use validated outcome measures, lack of long term follow-up, and small sample size. Conclusions As the existing evidence from clinical trials is of low quality, the efficacy and tolerability of drugs commonly prescribed for the management of sciatica in primary care is unclear.	[Pinto, Rafael Zambelli; Maher, Chris G.; Ferreira, Manuela L.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2050, Australia; [Ferreira, Paulo H.; Hancock, Mark] Univ Sydney, Fac Hlth Sci, Discipline Physiotherapy, Sydney, NSW 2050, Australia; [Hancock, Mark] Macquarie Univ, Fac Human Sci, Sydney, NSW, Australia; [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Ctr Educ & Res Ageing, Concord Hosp, Sydney, NSW 2050, Australia; [Koes, Bart] Erasmus MC, Univ Med Ctr, Dept Gen Practice, Rotterdam, Netherlands	George Institute for Global Health; University of Sydney; University of Sydney; Macquarie University; Concord Repatriation General Hospital; University of Sydney; Erasmus University Rotterdam; Erasmus MC	Pinto, RZ (corresponding author), Univ Sydney, George Inst Global Hlth, POB M201, Sydney, NSW 2050, Australia.	rafaelzambelli@gmail.com	Koes, Bart w/K-4614-2016; Pinto, Rafael Zambelli/I-2892-2012; Pinto, Rafael/GWC-5559-2022; Ferreira, Manuela L/B-9880-2014; Ferreira, Paulo H/N-3061-2017; Maher, Christopher/AAC-6267-2019; Ferreira, Manuela/AAQ-5446-2020; OLIVEIRA, VINICIUS CUNHA/E-1366-2014	Koes, Bart w/0000-0002-0450-9969; Pinto, Rafael Zambelli/0000-0002-2775-860X; Ferreira, Paulo H/0000-0002-5861-7770; Maher, Christopher/0000-0002-1628-7857; Ferreira, Manuela/0000-0002-3479-0683; OLIVEIRA, VINICIUS CUNHA/0000-0002-8658-3774; Hancock, Mark/0000-0002-9277-5377; McLachlan, Andrew/0000-0003-4674-0242	Capes Foundation, Ministry of Education of Brazil; Australian Research Council	Capes Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Australian Research Council(Australian Research Council)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. RZP is supported by Capes Foundation, Ministry of Education of Brazil. CGM is supported by a research fellowship funded by the Australian Research Council.	[Anonymous], COCHRANE HDB SYSTEMA; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Atkinson JH, 1998, PAIN, V76, P287, DOI 10.1016/S0304-3959(98)00064-5; Auvinet B, 1995, CLIN THER, V17, P1078, DOI 10.1016/0149-2918(95)80086-7; Balague F, 1999, SPINE, V24, P2516, DOI 10.1097/00007632-199912010-00014; Baron R, 2010, PAIN, V150, P420, DOI 10.1016/j.pain.2010.04.013; BERRY H, 1988, J INT MED RES, V16, P75, DOI 10.1177/030006058801600201; BORMS T, 1988, DRUGS, V35, P85, DOI 10.2165/00003495-198800351-00019; BRAUN H, 1982, MED WELT, V33, P490; Cherkin DC, 1998, SPINE, V23, P607, DOI 10.1097/00007632-199803010-00015; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1; Deyo RA, 2010, COCHRANE DB SYST REV, V1; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; Dincer U, 2007, JOINT BONE SPINE, V74, P467, DOI 10.1016/j.jbspin.2006.09.016; Dreiser RL, 2001, INFLAMM RES, V50, pS17; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Finckh A, 2006, SPINE, V31, P377, DOI 10.1097/01.brs.0000199917.04145.80; Friedman BW, 2008, SPINE, V33, pE624, DOI 10.1097/BRS.0b013e3181822711; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; GOLDIE I, 1968, ACTA ORTHOP SCAND, V39, P117, DOI 10.3109/17453676808989446; GREVSTEN S, 1975, Z RHEUMATOL, V34, P444; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; HAIMOVIC IC, 1986, NEUROLOGY, V36, P1593, DOI 10.1212/WNL.36.12.1593; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Herrmann WA, 2009, INT J CLIN PRACT, V63, P1613, DOI 10.1111/j.1742-1241.2009.02187.x; HOFFERBERTH B, 1982, ARCH PSYCHIAT NERVEN, V231, P359, DOI 10.1007/BF00345591; Holve RL, 2008, J AM BOARD FAM MED, V21, P469, DOI 10.3122/jabfm.2008.05.070220; Kanayama M, 2005, J NEUROSURG-SPINE, V2, P441, DOI 10.3171/spi.2005.2.4.0441; Khoromi S, 2005, J PAIN, V6, P829, DOI 10.1016/j.jpain.2005.08.002; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; Koes BW, 2007, BMJ-BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223.428495.BE; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Konstantinou K, 2008, SPINE, V33, P2464, DOI 10.1097/BRS.0b013e318183a4a2; Luijsterburg PAJ, 2007, EUR SPINE J, V16, P881, DOI 10.1007/s00586-007-0367-1; Macedo LG, 2010, J CLIN EPIDEMIOL, V63, P920, DOI 10.1016/j.jclinepi.2009.10.005; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; National Institute for Health and Clinical Excellence, 2011, NEUR PAIN PHARM MAN, V96; Palmer KT, 2003, OCCUP ENVIRON MED, V60, P715, DOI 10.1136/oem.60.10.715; Peul WC, 2008, BRIT MED J, V336, P1355, DOI 10.1136/bmj.a143; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; RACHID A, 1992, REV BRAS MED, V49, P37; RADIN EL, 1968, LANCET, V2, P736; SCHUERMANS Y, 1988, DRUGS, V35, P83, DOI 10.2165/00003495-198800351-00018; Selim AJ, 1998, SPINE, V23, P470, DOI 10.1097/00007632-199802150-00013; Tan Toni, 2010, BMJ, V340, pc1079, DOI 10.1136/bmj.c1079; Tubach F, 2004, J CLIN EPIDEMIOL, V57, P174, DOI 10.1016/S0895-4356(03)00257-9; Vogt MT, 2005, SPINE, V30, P1075, DOI 10.1097/01.brs.0000160843.77091.07; Vroomen PCAJ, 2000, J SPINAL DISORD, V13, P463, DOI 10.1097/00002517-200012000-00001; Wang B. X., 2004, CHINESE J CLIN REHAB, V8, P3413; WEBER H, 1993, SPINE, V18, P1433, DOI 10.1097/00007632-199309010-00006; Weber H, 1980, J Oslo City Hosp, V30, P69; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; World Health Organisation Collaborating Centre for Drugs Statistics Methodology, 2011, INT LANG DRUG UT RES; Yildirim K, 2003, PAIN CLINIC, V15, P213, DOI 10.1163/156856903767650718; Younes M, 2006, JOINT BONE SPINE, V73, P538, DOI 10.1016/j.jbspin.2005.10.022	59	120	123	0	51	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2012	344								e497	10.1136/bmj.e497	http://dx.doi.org/10.1136/bmj.e497			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896HW	22331277	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000300557300002
J	Wachter, RM; Bell, D				Wachter, Robert M.; Bell, Derek			Renaissance of hospital generalists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MEDICAL UNITS; OLDER PATIENTS; CARE; ENGLAND; WORKING		[Wachter, Robert M.] Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA; [Bell, Derek] Univ London Imperial Coll Sci Technol & Med, London, England	University of California System; University of California San Francisco; Imperial College London	Wachter, RM (corresponding author), Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA.	bobw@medicine.ucsf.edu		Bell, Derek/0000-0002-9944-1097				*AC MED TASKF, 2007, AC MED CAR RIGHT PER; Auerbach AD, 2010, ARCH INTERN MED, V170, P2004, DOI 10.1001/archinternmed.2010.432; Bell D, 2008, BRIT J HOSP MED, V69, pM107, DOI 10.12968/hmed.2008.69.Sup7.30432; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Byrne D, 2011, EUR J INTERN MED, V22, P344, DOI 10.1016/j.ejim.2011.05.016; Goddard AF, 2010, CLIN MED, V10, P330; Goulding L, 2011, BMJ QUAL SAF    1118; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; Joint Royal Colleges of Physicians Training Board, AC INT MED AIM SUBSP; Jones MC, 2009, BRIT J HOSP MED, V70, pS8; Kuo YF, 2011, ANN INTERN MED, V155, P152, DOI 10.7326/0003-4819-155-3-201108020-00005; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; McKean SCW, 2006, J HOSP MED, V1, P57, DOI 10.1002/jhm.7; Peterson MC, 2009, MAYO CLIN PROC, V84, P248, DOI 10.1016/S0025-6196(11)61142-7; *ROYAL COLL PHYS, 2004, AC MED MAK WORK PAT; Scott I, 2009, INT J QUAL HEALTH C, V21, P397, DOI 10.1093/intqhc/mzp045; Seiler A, 2011, J HOSP MED      1031; Subbe CP, 2011, EUR J INTERN MED, V22, P339, DOI 10.1016/j.ejim.2011.05.015; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Wachter RM, 2011, J HOSP MED, V6, pE1, DOI 10.1002/jhm.913; Ward D, 2009, CLIN MED, V9, P553, DOI 10.7861/clinmedicine.9-6-553; Weber EJ, 2011, ANN EMERG MED, V57, P79, DOI 10.1016/j.annemergmed.2010.08.013; Weingarten SR, 2002, ARCH INTERN MED, V162, P527, DOI 10.1001/archinte.162.5.527	25	28	28	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2012	344								e652	10.1136/bmj.e652	http://dx.doi.org/10.1136/bmj.e652			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896HW	22331278				2022-12-28	WOS:000300557300003
J	Karunadasa, HI; Montalvo, E; Sun, YJ; Majda, M; Long, JR; Chang, CJ				Karunadasa, Hemamala I.; Montalvo, Elizabeth; Sun, Yujie; Majda, Marcin; Long, Jeffrey R.; Chang, Christopher J.			A Molecular MoS2 Edge Site Mimic for Catalytic Hydrogen Generation	SCIENCE			English	Article							H-2 EVOLUTION; MOLYBDENUM; COBALT; ELECTROCATALYSTS; COMPLEXES; WATER; NANOCATALYSTS; REDUCTION; CHEMISTRY; LIGANDS	Inorganic solids are an important class of catalysts that often derive their activity from sparse active sites that are structurally distinct from the inactive bulk. Rationally optimizing activity is therefore beholden to the challenges in studying these active sites in molecular detail. Here, we report a molecule that mimics the structure of the proposed triangular active edge site fragments of molybdenum disulfide (MoS2), a widely used industrial catalyst that has shown promise as a low-cost alternative to platinum for electrocatalytic hydrogen production. By leveraging the robust coordination environment of a pentapyridyl ligand, we synthesized and structurally characterized a well-defined Mo-IV-disulfide complex that, upon electrochemical reduction, can catalytically generate hydrogen from acidic organic media as well as from acidic water.	[Karunadasa, Hemamala I.; Montalvo, Elizabeth; Sun, Yujie; Majda, Marcin; Long, Jeffrey R.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Karunadasa, Hemamala I.; Sun, Yujie; Chang, Christopher J.] Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Long, Jeffrey R.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Long, JR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jrlong@berkeley.edu; chrischang@berkeley.edu	Sun, Yujie/A-9428-2012; Karunadasa, Hemamala I./ABE-6223-2020		Department of Energy (DOE) Lawrence Berkeley National Laboratory Helios Solar Energy Research Center [51HE112B]; Office of Science of the U.S. Department of Energy [DE-SC0004993]; University of California [CCDC-798834]	Department of Energy (DOE) Lawrence Berkeley National Laboratory Helios Solar Energy Research Center; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); University of California(University of California System)	Initial synthetic and electrochemical studies were supported by the Department of Energy (DOE) Lawrence Berkeley National Laboratory Helios Solar Energy Research Center (51HE112B to C.J.C.). Further electrochemical studies are based on work performed by the Joint Center for Artificial Photosynthesis, a DOE Energy Innovation Hub, supported through the Office of Science of the U.S. Department of Energy under award DE-SC0004993 (J.R.L.). C.J.C. is an investigator with the Howard Hughes Medical Institute. We thank B. Lassalle, J. Yano, and V. Yachandra for obtaining the x-ray absorption spectroscopy spectra; J. Breen for fabrication of electrochemical cells; Y. Hwang for assistance with gas chromatography; A. T. Iavarone for obtaining the mass spectra; and the University of California President's Postdoctoral Fellowship program for support of E. M. Structural parameters for 1 are available free of charge from the Cambridge Crystallographic Data Centre under identification number CCDC-798834. A patent has been filed by Lawrence Berkeley National Laboratory based on the results presented herein.	Appel AM, 2005, J AM CHEM SOC, V127, P12717, DOI 10.1021/ja054034o; Bard A. J., 1980, ELECTROCHEMICAL METH; Berben LA, 2010, CHEM COMMUN, V46, P398, DOI 10.1039/b921559j; Bernhardt PV, 1999, INORG CHEM, V38, P5086, DOI 10.1021/ic981425d; CEYER ST, 1988, ANNU REV PHYS CHEM, V39, P479, DOI 10.1146/annurev.pc.39.100188.002403; Cotton FA, 1997, INORG CHEM, V36, P2267, DOI 10.1021/ic961071v; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Dance I, 2005, J AM CHEM SOC, V127, P10925, DOI 10.1021/ja0504946; DUCHET JC, 1983, J CATAL, V80, P386, DOI 10.1016/0021-9517(83)90263-4; ERTL G, 1990, ANGEW CHEM INT EDIT, V29, P1219, DOI 10.1002/anie.199012191; FISHER B, 1980, J AM CHEM SOC, V102, P7361, DOI 10.1021/ja00544a035; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Gloaguen F, 2009, CHEM SOC REV, V38, P100, DOI 10.1039/b801796b; Hansen LP, 2011, ANGEW CHEM INT EDIT, V50, P10153, DOI 10.1002/anie.201103745; Hinnemann B, 2005, J AM CHEM SOC, V127, P5308, DOI 10.1021/ja0504690; Jaramillo TF, 2008, J PHYS CHEM C, V112, P17492, DOI 10.1021/jp802695e; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Karunadasa HI, 2010, NATURE, V464, P1329, DOI 10.1038/nature08969; KELLETT RM, 1985, INORG CHEM, V24, P2378, DOI 10.1021/ic00209a012; KOPF H, 1978, Z NATURFORSCH B, V33, P1398; Lauritsen JV, 2007, NAT NANOTECHNOL, V2, P53, DOI 10.1038/nnano.2006.171; Lauritsen JV, 2004, J CATAL, V221, P510, DOI 10.1016/j.jcat.2003.09.015; Li YG, 2011, J AM CHEM SOC, V133, P7296, DOI 10.1021/ja201269b; Merki D, 2011, CHEM SCI, V2, P1262, DOI 10.1039/c1sc00117e; MURPHY VJ, 1995, J AM CHEM SOC, V117, P3522, DOI 10.1021/ja00117a021; PRINS R, 1989, CATAL REV, V31, P1, DOI 10.1080/01614948909351347; Shin JH, 2001, J CHEM SOC DALTON, P1732, DOI 10.1039/b100372k; Shin JH, 2006, INORG CHIM ACTA, V359, P2942, DOI 10.1016/j.ica.2005.12.037; Smith PD, 2000, J AM CHEM SOC, V122, P2946, DOI 10.1021/ja9938332; Smith SJ, 2006, INORG CHEM, V45, P679, DOI 10.1021/ic051443c; SOMORJAI GA, 1989, PROG SURF SCI, V30, P201, DOI 10.1016/0079-6816(89)90009-9; Stubbert BD, 2011, J AM CHEM SOC, V133, P18070, DOI 10.1021/ja2078015; Sun YJ, 2011, J AM CHEM SOC, V133, P9212, DOI 10.1021/ja202743r; TOPSOE NY, 1993, J CATAL, V139, P641, DOI 10.1006/jcat.1993.1056; Wells A.F., 1975, STRUCTURAL INORGANIC, V4th; Zong X, 2008, J AM CHEM SOC, V130, P7176, DOI 10.1021/ja8007825	36	975	990	26	1034	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					698	702		10.1126/science.1215868	http://dx.doi.org/10.1126/science.1215868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323816				2022-12-28	WOS:000300047100047
J	Koralek, AC; Jin, X; Ii, JDL; Costa, RM; Carmena, JM				Koralek, Aaron C.; Jin, Xin; Ii, John D. Long; Costa, Rui M.; Carmena, Jose M.			Corticostriatal plasticity is necessary for learning intentional neuroprosthetic skills	NATURE			English	Article							PREFRONTAL CORTEX; STRIATAL NEURONS; ACQUISITION; CONSOLIDATION; PERFORMANCE; CONTINGENCY; ACTIVATION; NETWORKS; CIRCUITS	The ability to learn new skills and perfect them with practice applies not only to physical skills but also to abstract skills(1), like motor planning or neuroprosthetic actions. Although plasticity in corticostriatal circuits has been implicated in learning physical skills(2-4), it remains unclear if similar circuits or processes are required for abstract skill learning. Here we use a novel behavioural task in rodents to investigate the role of corticostriatal plasticity in abstract skill learning. Rodents learned to control the pitch of an auditory cursor to reach one of two targets by modulating activity in primary motor cortex irrespective of physical movement. Degradation of the relation between action and outcome, as well as sensory-specific devaluation and omission tests, demonstrate that these learned neuroprosthetic actions are intentional and goal-directed, rather than habitual. Striatal neurons change their activity with learning, with more neurons modulating their activity in relation to target-reaching as learning progresses. Concomitantly, strong relations between the activity of neurons in motor cortex and the striatum emerge. Specific deletion of striatal NMDA receptors impairs the development of this corticostriatal plasticity, and disrupts the ability to learn neuroprosthetic skills. These results suggest that corticostriatal plasticity is necessary for abstract skill learning, and that neuroprosthetic movements capitalize on the neural circuitry involved in natural motor learning.	[Jin, Xin; Costa, Rui M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Koralek, Aaron C.; Ii, John D. Long; Carmena, Jose M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, Program Cognit Sci, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, UC Berkeley & UC San Francisco Joint Grad Grp Bio, Berkeley, CA 94720 USA; [Costa, Rui M.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Fundacao Champalimaud	Costa, RM (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.	ruicosta@fchampalimaud.org; carmena@eecs.berkeley.edu		Costa, Rui M./0000-0003-0495-8374; Koralek, Aaron/0000-0001-5205-0171	National Science Foundation [0954243]; Multiscale Systems Research Center; Defense Advanced Research Projects Agency [N66001-10-C-2008]; Division of Intramural Clinical and Basic Research of the National Institute on Alcohol Abuse and Alcoholism [239527]; European Research Council [STG 243393]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Multiscale Systems Research Center; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Division of Intramural Clinical and Basic Research of the National Institute on Alcohol Abuse and Alcoholism; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Venkatraman for the three-axis accelerometer, Y. Li for the RGS9L-Cre mice, K. Nakazawa for the NMDAR1-loxP mice, G. Luo for genotyping, M. Davis for advice on staining and G. Martins for performing immunohistochemistry. This work was supported by National Science Foundation CAREER Award 0954243, the Multiscale Systems Research Center and the Defense Advanced Research Projects Agency contract N66001-10-C-2008 to J. M. C., and the Division of Intramural Clinical and Basic Research of the National Institute on Alcohol Abuse and Alcoholism, Marie Curie International Reintegration Grant 239527 and European Research Council STG 243393 to R.M.C.	Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Beauchamp MH, 2003, NEUROIMAGE, V20, P1649, DOI 10.1016/j.neuroimage.2003.07.003; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; Fincham JM, 2006, P NATL ACAD SCI USA, V103, P12941, DOI 10.1073/pnas.0605493103; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; VanLehn K, 1996, ANNU REV PSYCHOL, V47, P513, DOI 10.1146/annurev.psych.47.1.513; Venkatraman S, 2010, J NEUROPHYSIOL, V104, P569, DOI 10.1152/jn.00121.2010; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012	30	240	244	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					331	335		10.1038/nature10845	http://dx.doi.org/10.1038/nature10845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22388818	Green Accepted			2022-12-28	WOS:000301481800049
J	Ananthakrishnan, AN; Higuchi, LM; Huang, ES; Khalili, H; Richter, JM; Fuchs, CS; Chan, AT				Ananthakrishnan, Ashwin N.; Higuchi, Leslie M.; Huang, Edward S.; Khalili, Hamed; Richter, James M.; Fuchs, Charles S.; Chan, Andrew T.			Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LONG-TERM USE; OLMSTED COUNTY; PREVALENCE; FREQUENCY; REPRODUCIBILITY; SUPPRESSION; MECHANISMS; MINNESOTA; VALIDITY	Background: Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are anti-inflammatory but have been linked in some studies to Crohn disease (CD) and ulcerative colitis (UC). Objective: To assess the association between aspirin and NSAID use and incident CD and UC. Design: Prospective cohort study. Setting: Nurses' Health Study I. Patients: 76 795 U. S. women who provided biennially updated data about aspirin and NSAID use. Measurements: Incident CD and UC between 1990 and 2008 (outcome) and NSAID and aspirin use (exposure). Results: 123 incident cases of CD and 117 cases of UC occurred over 18 years and 1 295 317 person-years of follow-up. Compared with nonusers, women who used NSAIDs at least 15 days per month seemed to have increased risk for both CD (absolute difference in age-adjusted incidence, 6 cases per 100 000 person-years [95% CI, 0 to 13]; multivariate hazard ratio, 1.59 [CI, 0.99 to 2.56]) and UC (absolute difference, 7 cases per 100 000 person-years [CI, 1 to 12]; multivariate hazard ratio, 1.87 [CI, 1.16 to 2.99]). Less frequent NSAID use was not clearly associated with risk for CD or UC, and there was no clear association between aspirin use and disease. Limitations: Cohort participants were exclusively women, most of whom were white. Aspirin and NSAID use were self-reported. Conclusion: Frequent use of NSAIDs but not aspirin seemed to be associated with increased absolute incidence of CD and UC. The findings have more mechanistic than clinical implications, because the absolute incidence of CD or UC associated with NSAIDs was low and the increase in risk for CD or UC associated with NSAIDs is unlikely to alter the balance of more common and clinically significant risks and benefits associated with these agents.	[Chan, Andrew T.] Harvard Univ, Massachusetts Gen Hosp, Gastrointestinal Unit,Childrens Hosp Boston, Brigham & Womens Hosp,Sch Med, Boston, MA 02114 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Chan, AT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Gastrointestinal Unit,Childrens Hosp Boston, Brigham & Womens Hosp,Sch Med, 55 Fruit St,GRJ 722, Boston, MA 02114 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767	American Gastroenterological Association; IBD Working Group; Broad Medical Research Program; National Institutes of Health [R01 CA137178, P01 CA87969, P30 DK043351, K08 DK064256]; Broad Medical Research Foundation; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA137178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, K08DK064256] Funding Source: NIH RePORTER	American Gastroenterological Association; IBD Working Group; Broad Medical Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	American Gastroenterological Association, IBD Working Group, Broad Medical Research Program, and National Institutes of Health.; By the American Gastroenterological Association (Dr. Ananthakrishnan), the Broad Medical Research Foundation ( Dr. Chan), the IBD Working Group ( Dr. Khalili), and the National Institutes of Health (R01 CA137178, P01 CA87969, P30 DK043351, and K08 DK064256).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Bernstein CN, 2010, AM J GASTROENTEROL, V105, P1994, DOI 10.1038/ajg.2010.140; Bonner GF, 2000, AM J GASTROENTEROL, V95, P1946; Capone ML, 2004, CIRCULATION, V109, P1468, DOI 10.1161/01.CIR.0000124715.27937.78; Chan AT, 2007, ARCH INTERN MED, V167, P562, DOI 10.1001/archinte.167.6.562; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chan AT, 2006, CIRCULATION, V113, P1578, DOI 10.1161/CIRCULATIONAHA.105.595793; Chumanevich AA, 2010, CARCINOGENESIS, V31, P1787, DOI 10.1093/carcin/bgq158; Cornish JA, 2008, AM J GASTROENTEROL, V103, P2394, DOI 10.1111/j.1572-0241.2008.02064.x; Cosnes J, 2008, INFLAMM BOWEL DIS, V14, pS14, DOI 10.1002/ibd.20555; Danese S, 2006, WORLD J GASTROENTERO, V12, P4807; DUGGAN DE, 1975, BIOCHEM PHARMACOL, V24, P1749, DOI 10.1016/0006-2952(75)90450-5; Evans JMM, 1997, GUT, V40, P619, DOI 10.1136/gut.40.5.619; Felder JB, 2000, AM J GASTROENTEROL, V95, P1949; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Gleeson MH, 2003, ALIMENT PHARM THER, V17, P817, DOI 10.1046/j.1365-2036.2003.01519.x; Hedin CR, 2011, GUT, V60, DOI 10.1136/gut.2011.239301.314; Huang ES, 2011, AM J MED, V124, P426, DOI 10.1016/j.amjmed.2010.12.022; JENKINS AP, 1991, GUT, V32, P66, DOI 10.1136/gut.32.1.66; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Korzenik JR, 2006, CLIN GASTROENTEROL H, V4, P157, DOI 10.1016/j.cgh.2005.11.007; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Loftus EV, 2000, GUT, V46, P336, DOI 10.1136/gut.46.3.336; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; MOUM B, 1995, DIGESTION, V56, P377, DOI 10.1159/000201262; Musumba C, 2009, ALIMENT PHARM THER, V30, P517, DOI 10.1111/j.1365-2036.2009.04086.x; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rodriguez LAG, 2005, ALIMENT PHARM THER, V22, P309, DOI 10.1111/j.1365-2036.2005.02564.x; Singh S, 2009, AM J GASTROENTEROL, V104, P1298, DOI 10.1038/ajg.2009.15; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; STOWE SP, 1990, GASTROENTEROLOGY, V98, P104, DOI 10.1016/0016-5085(90)91297-J; Takeuchi K, 2006, CLIN GASTROENTEROL H, V4, P196, DOI 10.1016/S1542-3565(05)00980-8; TANNER AR, 1988, DIGESTION, V41, P116, DOI 10.1159/000199740; Thiebaut ACM, 2007, ANN INTERN MED, V146, P65, DOI 10.7326/0003-4819-146-1-200701020-00012; Ulrych T, 2011, J THROMB HAEMOST, V9, P790, DOI 10.1111/j.1538-7836.2011.04194.x; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	41	140	141	2	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2012	156	5					350	U170		10.7326/0003-4819-156-5-201203060-00007	http://dx.doi.org/10.7326/0003-4819-156-5-201203060-00007			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902OC	22393130	Green Accepted			2022-12-28	WOS:000301046800003
J	Chalancon, G; Kruse, K; Babu, MM				Chalancon, Guilhem; Kruse, Kai; Babu, M. Madan			Reconfiguring Regulation	SCIENCE			English	Editorial Material							GENOME-REDUCED BACTERIUM; GENE-EXPRESSION; SYSTEMS		[Chalancon, Guilhem; Kruse, Kai; Babu, M. Madan] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Chalancon, G (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	madanm@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019	Kruse, Kai/0000-0002-7951-7357	Medical Research Council [MC_U105185859] Funding Source: Medline; MRC [MC_U105185859] Funding Source: UKRI; Medical Research Council [1359160] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bork P, 2005, CELL, V121, P507, DOI 10.1016/j.cell.2005.05.001; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Otto A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1137; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	14	2	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1050	1051		10.1126/science.1219303	http://dx.doi.org/10.1126/science.1219303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383834				2022-12-28	WOS:000300931100029
J	Ginsberg, GM; Lauer, JA; Zelle, S; Baeten, S; Baltussen, R				Ginsberg, Gary M.; Lauer, Jeremy A.; Zelle, Sten; Baeten, Steef; Baltussen, Rob			Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MILLENNIUM DEVELOPMENT GOALS; HUMAN-PAPILLOMAVIRUS TYPES; IMPROVING HEALTH; UTILITY ANALYSIS; CONSUMPTION; VACCINATION; PREVALENCE; WORLDWIDE; DISEASE; BURDEN	Objective To determine the costs and health effects of interventions to combat breast, cervical, and colorectal cancers in order to guide resource allocation decisions in developing countries. Setting Two World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE); and countries in South East Asia with high adult and high child mortality (SearD). Design Cost effectiveness analysis of prevention and treatment strategies for breast, cervical, and colorectal cancer, using mathematical modelling based on a lifetime population model. Data sources Demographic and epidemiological data were taken from the WHO mortality and global burden of disease databases. Estimates of intervention coverage, effectiveness, and resource needs were based on clinical trials, treatment guidelines, and expert opinion. Unit costs were taken from the WHO-CHOICE price database. Main outcome measures Cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results In both regions certain interventions in cervical cancer control (screening through cervical smear tests or visual inspection with acetic acid in combination with treatment) and colorectal cancer control (increasing the coverage of treatment interventions) cost <$Int2000 per DALY averted and can be considered highly cost effective. In the sub-Saharan African region screening for colorectal cancer (by colonoscopy at age 50 in combination with treatment) costs $Int2000-6000 per DALY averted and can be considered cost effective. In both regions certain interventions in breast cancer control (treatment of all cancer stages in combination with mammography screening) cost $Int2000-6000 per DALY averted and can also be considered cost effective. Other interventions, such as campaigns to eat more fruit and vegetable or subsidies in colorectal cancer control, are not cost effective according to the criteria defined. Conclusion Highly cost effective interventions to combat cervical and colorectal cancer are available in the African and Asian sub-regions. In cervical cancer control, these include screening through smear tests or visual inspection in combination with treatment. In colorectal cancer, increasing treatment coverage is highly cost effective (screening through colonoscopy is cost effective in the African sub-region). In breast cancer control, mammography screening in combination with treatment of all stages is cost effective.	[Ginsberg, Gary M.] Minist Hlth, Dept Med Technol Assessment, Jerusalem, Israel; [Lauer, Jeremy A.] World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland; [Baeten, Steef] Erasmus MC, Inst Hlth Policy & Management, Rotterdam, Netherlands; [Zelle, Sten; Baltussen, Rob] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, Nijmegen, Netherlands	World Health Organization; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Ginsberg, GM (corresponding author), Minist Hlth, Dept Med Technol Assessment, Ben Tbai 2, Jerusalem, Israel.	gary.ginsberg@moh.health.gov.il	Baltussen, R.M.P.M./L-4181-2015	Ginsberg, Gary/0000-0003-1315-890X; Lauer, Jeremy A/0000-0003-0652-0691				Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Alam M, 2001, ARCH DERMATOL, V137, P337; Alliance for Cervical Cancer Prevention (ACCP), 2004, ISS DEPTH; [Anonymous], 2011, SOFTW PROGR UNC AN; Armstrong LR, 2000, CLIN INFECT DIS, V31, P107, DOI 10.1086/313914; Bland KI, 1998, CANCER-AM CANCER SOC, V83, P1262, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1262::AID-CNCR28>3.0.CO;2-2; Boer R, 2001, QUANTITATIVE METHODS, P13; Bornstein J, 2007, ISR MED ASSOC J, V9, P156; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BROWN ML, 1993, BREAST CANCER RES TR, V25, P113, DOI 10.1007/BF00662136; Brown RE, 2006, CURR MED RES OPIN, V22, P663, DOI 10.1185/030079906X99972; [Cervix Cancer Screening IARC Working Group on the Evaluation of Cancer Prevention Strategies], 2004, IARC HDB CANC PREV; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Coleman MA, 2011, VACCINE; de Velde NV, 2007, AM J EPIDEMIOL, V165, P762, DOI 10.1093/aje/kwk059; DEKONING HJ, 1991, INT J CANCER, V49, P531, DOI 10.1002/ijc.2910490410; Dixon H, 1998, PREV MED, V27, P572, DOI 10.1006/pmed.1998.0328; Edejer T, 2003, MAKING CHOICES HLTH; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Franceschi S, 2003, INT J CANCER, V107, P127, DOI 10.1002/ijc.11350; Ginsberg Gary M, 2010, Cost Eff Resour Alloc, V8, P2, DOI 10.1186/1478-7547-8-2; Ginsberg GM, 2007, VACCINE, V25, P6677, DOI 10.1016/j.vaccine.2007.07.018; Ginsberg GM, 2009, VACCINE, V27, P6060, DOI 10.1016/j.vaccine.2009.07.026; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Harford JB, 2011, BREAST, V20, pS20, DOI 10.1016/j.breast.2011.02.007; HERRINTON LJ, 1995, AM J EPIDEMIOL, V142, P961, DOI 10.1093/oxfordjournals.aje.a117744; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kim JJ, 2009, ANN INTERN MED, V151, P538, DOI 10.7326/0003-4819-151-8-200910200-00007; Kim JJ, 2005, JNCI-J NATL CANCER I, V97, P888, DOI 10.1093/jnci/dji162; Launois R, 1996, PHARMACOECONOMICS, V10, P504, DOI 10.2165/00019053-199610050-00008; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Management Sciences for Health, 2006, INT DRUG PRIC IND GU; MD Anderson Cancer Center, 2004, CLIN PRACT GUID MD A; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1; *NAT COMPR CANC NE, 2004, CLIN PRACT GUID ONC; Newall AT, 2007, LANCET INFECT DIS, V7, P289, DOI 10.1016/S1473-3099(07)70083-X; Norum J, 1997, BREAST CANCER RES TR, V45, P7, DOI 10.1023/A:1005804101106; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Sankaranarayanan R, 1998, CANC SURVIVAL DEV CO, P173; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Shireman TI, 2001, INT J TECHNOL ASSESS, V17, P146, DOI 10.1017/S0266462301104137; US National Institute of Health, 2011, NAT CANC I REC; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Wagner JL, 1995, OTABPH146; *WHO COMM MACROECO, 2001, MACR HLTH INV HLTH E; WHO Department of Essential Health Technologies, 2005, ESS HLTH CAR TECHN P; World Health Organization, 2008, GLOB BURD DIS 2004 U	54	45	47	1	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e614	10.1136/bmj.e614	http://dx.doi.org/10.1136/bmj.e614			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389347	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000301232600007
J	Lai, CSW; Franke, TF; Gan, WB				Lai, Cora Sau Wan; Franke, Thomas F.; Gan, Wen-Biao			Opposite effects of fear conditioning and extinction on dendritic spine remodelling	NATURE			English	Article							PREFRONTAL CORTEX; MEMORY; AMYGDALA; NEURONS; RAT; CONSOLIDATION; MECHANISMS; CIRCUITS; CONTEXT	It is generally believed that fear extinction is a form of new learning that inhibits rather than erases previously acquired fear memories(1-3). Although this view has gained much support from behavioural and electrophysiological studies(1-10), the hypothesis that extinction causes the partial erasure of fear memories remains viable. Using transcranial two-photon microscopy(11,12), we investigated how neural circuits are modified by fear learning and extinction by examining the formation and elimination of postsynaptic dendritic spines of layer-V pyramidal neurons in the mouse frontal association cortex. Here we show that fear conditioning by pairing an auditory cue with a footshock increases the rate of spine elimination. By contrast, fear extinction by repeated presentation of the same auditory cue without a footshock increases the rate of spine formation. The degrees of spine remodelling induced by fear conditioning and extinction strongly correlate with the expression and extinction of conditioned fear responses, respectively. Notably, spine elimination and formation induced by fear conditioning and extinction occur on the same dendritic branches in a cue-and location-specific manner: cue-specific extinction causes formation of dendritic spines within a distance of two micrometres from spines that were eliminated after fear conditioning. Furthermore, reconditioning preferentially induces elimination of dendritic spines that were formed after extinction. Thus, within vastly complex neuronal networks, fear conditioning, extinction and reconditioning lead to opposing changes at the level of individual synapses. These findings also suggest that fear memory traces are partially erased after extinction.	[Lai, Cora Sau Wan; Gan, Wen-Biao] NYU, Sch Med, Skirball Inst, Mol Neurobiol Program,Dept Physiol & Neurosci, New York, NY 10016 USA; [Franke, Thomas F.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Franke, Thomas F.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University	Gan, WB (corresponding author), NYU, Sch Med, Skirball Inst, Mol Neurobiol Program,Dept Physiol & Neurosci, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	, 0000-0002-5721-4259/K-3037-2019	, 0000-0002-5721-4259/0000-0002-5721-4259	National Institutes of Health [NS047325]; Alzheimer's Association; National Science Foundation [IOS-0757780]; NARSAD; G. Harold & Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); National Science Foundation(National Science Foundation (NSF)); NARSAD(NARSAD); G. Harold & Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. LeDoux as well as all the members in the Gan laboratory for comments on the manuscript. This work was supported by National Institutes of Health grant NS047325 and the Investigator-Initiated Research Grant from the Alzheimer's Association (W.-B.G.), and by the National Science Foundation (#IOS-0757780), a 2008 NARSAD Independent Investigator Award and the G. Harold & Leila Y. Mathers Foundation (T.F.F.).	Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; CONDE F, 1995, J COMP NEUROL, V352, P567, DOI 10.1002/cne.903520407; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hong I, 2009, EUR J NEUROSCI, V30, P2089, DOI 10.1111/j.1460-9568.2009.07004.x; Kim JH, 2008, J NEUROSCI, V28, P1282, DOI 10.1523/JNEUROSCI.4736-07.2008; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lin CH, 2003, J NEUROSCI, V23, P8310; MCDONALD AJ, 1987, J COMP NEUROL, V262, P46, DOI 10.1002/cne.902620105; Merlo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003687; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rescorla RA, 1975, J EXPT PSYCHOL ANIMA, V1, P88, DOI DOI 10.1037/0097-7403.1.1.88; Sacchetti B, 2003, EXP BRAIN RES, V152, P323, DOI 10.1007/s00221-003-1534-1; THOMAS DR, 1986, J EXP ANAL BEHAV, V46, P305, DOI 10.1901/jeab.1986.46-305; Tronson NC, 2009, J NEUROSCI, V29, P3387, DOI 10.1523/JNEUROSCI.5619-08.2009; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	24	269	271	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					87	U130		10.1038/nature10792	http://dx.doi.org/10.1038/nature10792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22343895				2022-12-28	WOS:000300877900050
J	Spence, D				Spence, Des			FROM THE FRONTLINE Off the record	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 29	2012	344								e1475	10.1136/bmj.e1475	http://dx.doi.org/10.1136/bmj.e1475			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XE	22378930				2022-12-28	WOS:000301231400013
J	Medzhitov, R; Schneider, DS; Soares, MP				Medzhitov, Ruslan; Schneider, David S.; Soares, Miguel P.			Disease Tolerance as a Defense Strategy	SCIENCE			English	Review							UNFOLDED PROTEIN RESPONSE; HEME OXYGENASE-1; RESISTANCE; PROTECTION; AVOIDANCE; INFECTION; STRESS; PATHOGENESIS; EVOLUTION; VIRULENCE	The immune system protects from infections primarily by detecting and eliminating the invading pathogens; however, the host organism can also protect itself from infectious diseases by reducing the negative impact of infections on host fitness. This ability to tolerate a pathogen's presence is a distinct host defense strategy, which has been largely overlooked in animal and human studies. Introduction of the notion of "disease tolerance" into the conceptual tool kit of immunology will expand our understanding of infectious diseases and host pathogen interactions. Analysis of disease tolerance mechanisms should provide new approaches for the treatment of infections and other diseases.	[Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA; [Schneider, David S.] Stanford Univ, Dept Microbiol & Immunol, Palo Alto, CA 94305 USA; [Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal	Howard Hughes Medical Institute; Yale University; Stanford University; Instituto Gulbenkian de Ciencia	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu; dschneider@stanford.edu; mpsoares@igc.gulbenkian.pt	Soares, Miguel P/G-4188-2011	Soares, Miguel/0000-0002-9314-4833	Howard Hughes Medical Institute; NIH [RO1AI055502, RO1DK071754, R37AI046688, RO1AI060164, 1DP1OD008167-01]; New England Regional Center of Excellence; Ellison Medical Foundation; Fundacao para a Ciencia e Tecnologia [PTDC/SAU-TOX/116627/2010, PTDC/BIA-BCM/101311/2008, PTDC/SAU-FCF/100762/2008]; European Community [LSH-2005-1.2.5-1]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008167] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation(Lawrence Ellison Foundation); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work in the authors' laboratories was supported by the Howard Hughes Medical Institute (R.M.); NIH grants RO1AI055502, RO1DK071754, and R37AI046688 (R.M.); NIH grants RO1AI060164 and 1DP1OD008167-01 (D.S.S.); New England Regional Center of Excellence (R.M.); Ellison Medical Foundation (D.S.S.); Fundacao para a Ciencia e Tecnologia grants PTDC/SAU-TOX/116627/2010, PTDC/BIA-BCM/101311/2008, and PTDC/SAU-FCF/100762/2008 (M.S.); European Community, 6th Framework Grant, XENOME, LSH-2005-1.2.5-1. (M.S.); and the Bill & Melinda Gates Foundation (M.S.).	Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; CALDWELL RM, 1958, SCIENCE, V128, P714, DOI 10.1126/science.128.3326.714; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; GROMKOWSKI SH, 1989, EUR J IMMUNOL, V19, P1709, DOI 10.1002/eji.1830190927; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Kavaliers M, 2004, HORM BEHAV, V46, P272, DOI 10.1016/j.yhbeh.2004.03.005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; Kurtz CC, 2006, AM J PHYSIOL-GASTR L, V291, pG895, DOI 10.1152/ajpgi.00155.2006; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Little TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001006; Majno G., 2004, CELLS TISSUES DIS PR; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Miller MR, 2006, EVOLUTION, V60, P945, DOI 10.1111/j.0014-3820.2006.tb01173.x; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Nash A, 2001, MIMS PATHOGENESIS IN; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; PLAYFAIR JHL, 1990, IMMUNOL TODAY, V11, P25; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHAFER JF, 1971, ANNU REV PHYTOPATHOL, V9, P235, DOI 10.1146/annurev.py.09.090171.001315; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Shinzawa N, 2009, CELL HOST MICROBE, V6, P244, DOI 10.1016/j.chom.2009.07.010; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	55	984	1014	4	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					936	941		10.1126/science.1214935	http://dx.doi.org/10.1126/science.1214935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363001	Green Accepted			2022-12-28	WOS:000300931800037
J	Treacy, MMJ; Borisenko, KB				Treacy, M. M. J.; Borisenko, K. B.			The Local Structure of Amorphous Silicon	SCIENCE			English	Article							MEDIUM-RANGE ORDER; FLUCTUATION MICROSCOPY; GLASSES; DIFFRACTION; SIMULATION; MODELS	It is widely believed that the continuous random network (CRN) model represents the structural topology of amorphous silicon. The key evidence is that the model can reproduce well experimental reduced density functions (RDFs) obtained by diffraction. By using a combination of electron diffraction and fluctuation electron microscopy (FEM) variance data as experimental constraints in a structural relaxation procedure, we show that the CRN is not unique in matching the experimental RDF. We find that inhomogeneous paracrystalline structures containing local cubic ordering at the 10 to 20 angstrom length scale are also fully consistent with the RDF data. Crucially, they also matched the FEM variance data, unlike the CRN model. The paracrystalline model has implications for understanding phase transformation processes in various materials that extend beyond amorphous silicon.	[Treacy, M. M. J.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Borisenko, K. B.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Borisenko, K. B.] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England	Arizona State University; Arizona State University-Tempe; University of Oxford; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Treacy, MMJ (corresponding author), Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA.	treacy@asu.edu	Borisenko, Konstantin/N-9762-2019	Borisenko, Konstantin/0000-0002-2368-4500	Leverhulme Trust; U.S. Department of Energy [DE-PS02-09ER09-01]; UK Engineering and Physical Sciences Research Council [EP/F048009/1]	Leverhulme Trust(Leverhulme Trust); U.S. Department of Energy(United States Department of Energy (DOE)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.M.J.T acknowledges support from the Leverhulme Trust and from the U.S. Department of Energy, Contract no. DE-PS02-09ER09-01. K.B.B. thanks the UK Engineering and Physical Sciences Research Council (grant EP/F048009/1) for support. We thank B. Haberl, J. S. Williams, J. E. Bradby, and A. C. Y. Liu for providing the data used in this report. The data used in this work have been presented previously in (31) and (26).	Barkema GT, 2000, PHYS REV B, V62, P4985, DOI 10.1103/PhysRevB.62.4985; Biswas P, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.054204; Biswas P, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.195207; Bogle SN, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/45/455204; Borisenko KB, 2012, ACTA MATER, V60, P359, DOI 10.1016/j.actamat.2011.09.039; Cheng YQ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014207; Cockayne DJH, 2007, ANNU REV MATER RES, V37, P159, DOI 10.1146/annurev.matsci.35.082803.103337; Gibson JM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.125504; Gibson JM, 1999, MATER RES SOC SYMP P, V540, P27; Haberl B, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155209; Hosemann R., 1962, DIRECT ANAL DIFFRACT; Hwang J, 2009, J MATER RES, V24, P3121, DOI 10.1557/JMR.2009.0386; Jakse N, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976428; KAMITAKAHARA WA, 1987, PHYS REV B, V36, P6539, DOI 10.1103/PhysRevB.36.6539; KEEN DA, 1990, NATURE, V344, P423, DOI 10.1038/344423a0; Laaziri K, 1999, PHYS REV B, V60, P13520, DOI 10.1103/PhysRevB.60.13520; Lee BS, 2009, SCIENCE, V326, P980, DOI 10.1126/science.1177483; Lee TH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145702; MARIANS CS, 1990, J NON-CRYST SOLIDS, V124, P242, DOI 10.1016/0022-3093(90)90269-R; MOSS SC, 1969, PHYS REV LETT, V23, P1167, DOI 10.1103/PhysRevLett.23.1167; Pauly S, 2010, NAT MATER, V9, P473, DOI [10.1038/NMAT2767, 10.1038/nmat2767]; Pedersen UR, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.105701; PRESS WH, 1992, NUMERICAL RECIPES; Tanaka H, 2010, NAT MATER, V9, P324, DOI [10.1038/NMAT2634, 10.1038/nmat2634]; TERSOFF J, 1988, PHYS REV B, V38, P9902, DOI 10.1103/PhysRevB.38.9902; Treacy MMJ, 1998, J NON-CRYST SOLIDS, V231, P99, DOI 10.1016/S0022-3093(98)00371-8; Treacy MMJ, 2000, J NON-CRYST SOLIDS, V266, P150, DOI 10.1016/S0022-3093(99)00794-2; Turnbull D., 1972, J NONCRYST SOLIDS, V8-10, P19; Vink RLC, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.245214; Vink RLC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115210; Vink RLC, 2001, J NON-CRYST SOLIDS, V282, P248, DOI 10.1016/S0022-3093(01)00342-8; Voyles PM, 2002, ULTRAMICROSCOPY, V93, P147, DOI 10.1016/S0304-3991(02)00155-9; Voyles PM, 2001, PHYS REV LETT, V86, P5514, DOI 10.1103/PhysRevLett.86.5514; WOOTEN F, 1985, PHYS REV LETT, V54, P1392, DOI 10.1103/PhysRevLett.54.1392; Wright AC, 2008, PHYS CHEM GLASSES-B, V49, P103; Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006; Zhao G, 2009, ULTRAMICROSCOPY, V109, P177, DOI 10.1016/j.ultramic.2008.10.006	37	156	161	2	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					950	953		10.1126/science.1214780	http://dx.doi.org/10.1126/science.1214780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363003				2022-12-28	WOS:000300931800041
J	Reinitz, J				Reinitz, John			Pattern formation	NATURE			English	Editorial Material							DROSOPHILA		[Reinitz, John] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Reinitz, J (corresponding author), Univ Chicago, Dept Stat, Chicago, IL 60637 USA.	reinitz@galton.uchicago.edu						Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	4	15	15	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					464	464		10.1038/482464a	http://dx.doi.org/10.1038/482464a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358813				2022-12-28	WOS:000300770500018
J	Bach, RG				Bach, Richard G.			Colchicine reduced further recurrence after a first recurrence of pericarditis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Bach, RG (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.		Bach, Richard/AAI-2515-2021; Bach, Richard G/G-9764-2011; brucato, antonio/C-5983-2019	brucato, antonio/0000-0002-7566-5600				FOWLER N O, 1990, Cardiology Clinics, V8, P621; Imazio M, 2005, CIRCULATION, V112, P2012, DOI 10.1161/CIRCULATIONAHA.105.542738; Imazio M, 2005, AM J CARDIOL, V96, P736, DOI 10.1016/j.amjcard.2005.04.055; Imazio M, 2010, EUR HEART J, V31, P2749, DOI 10.1093/eurheartj/ehq319	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-4	10.7326/0003-4819-156-4-201202210-02004	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351730				2022-12-28	WOS:000208885400003
J	Zhang, BC; Kracker, S; Yasuda, T; Casola, S; Vanneman, M; Homig-Holzel, C; Wang, Z; Derudder, E; Li, S; Chakraborty, T; Cotter, SE; Koyama, S; Currie, T; Freeman, GJ; Kutok, JL; Rodig, SJ; Dranoff, G; Rajewsky, K				Zhang, Baochun; Kracker, Sven; Yasuda, Tomoharu; Casola, Stefano; Vanneman, Matthew; Homig-Holzel, Cornelia; Wang, Zhe; Derudder, Emmanuel; Li, Shuang; Chakraborty, Tirtha; Cotter, Shane E.; Koyama, Shohei; Currie, Treeve; Freeman, Gordon J.; Kutok, Jeffery L.; Rodig, Scott J.; Dranoff, Glenn; Rajewsky, Klaus			Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model	CELL			English	Article							NF-KAPPA-B; CYTOTOXIC T-LYMPHOCYTES; CELL-DEVELOPMENT; IFN-GAMMA; RESPONSES; EXPRESSION; ANTIBODIES; PEPTIDES; SURVIVAL; SIGNALS	B cells infected by Epstein-Barr virus (EBV), a transforming virus endemic in humans, are rapidly cleared by the immune system, but some cells harboring the virus persist for life. Under conditions of immunosuppression, EBV can spread from these cells and cause life-threatening pathologies. We have generated mice expressing the transforming EBV latent membrane protein 1 (LMP1), mimicking a constitutively active CD40 coreceptor, specifically in B cells. Like human EBV-infected cells, LMP1(+) B cells were efficiently eliminated by T cells, and breaking immune surveillance resulted in rapid, fatal lymphoproliferation and lymphomagenesis. The lymphoma cells expressed ligands for a natural killer (NK) cell receptor, NKG2D, andcould betargetedby anNKG2D-Fc fusion protein. These experiments indicate a central role for LMP1 in the surveillance and transformation of EBV-infected B cells in vivo, establish a preclinical model for B cell lymphomagenesis in immunosuppressed patients, and validate a new therapeutic approach.	[Zhang, Baochun; Kracker, Sven; Yasuda, Tomoharu; Casola, Stefano; Wang, Zhe; Derudder, Emmanuel; Li, Shuang; Chakraborty, Tirtha; Rajewsky, Klaus] Harvard Univ, Program Cellular & Mol Med, Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Zhang, Baochun; Kracker, Sven; Yasuda, Tomoharu; Casola, Stefano; Wang, Zhe; Derudder, Emmanuel; Li, Shuang; Chakraborty, Tirtha; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Casola, Stefano; Homig-Holzel, Cornelia; Rajewsky, Klaus] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Vanneman, Matthew; Koyama, Shohei; Freeman, Gordon J.; Dranoff, Glenn] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Vanneman, Matthew; Koyama, Shohei; Freeman, Gordon J.; Dranoff, Glenn] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02215 USA; [Vanneman, Matthew; Koyama, Shohei; Freeman, Gordon J.; Dranoff, Glenn] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Cotter, Shane E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Cotter, Shane E.] Harvard Univ, Brigham & Womens Hosp, Dept Radiat Oncol, Sch Med, Boston, MA 02115 USA; [Currie, Treeve; Kutok, Jeffery L.; Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Cologne; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Rajewsky, K (corresponding author), Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.	klaus.rajewsky@mdc-berlin.de	Casola, Stefano/AAN-8319-2021; Casola, Stefano/O-3922-2014; Yasuda, Tomoharu/J-5102-2019; Freeman, Gordon/AAC-5380-2019; Kracker, Sven/H-3681-2017; Vanneman, Matthew/AAM-6732-2021; Rodig, Scott/Y-3889-2019; Koyama, Shohei/AAU-4113-2021	Casola, Stefano/0000-0001-5580-0986; Freeman, Gordon/0000-0002-7210-5616; Kracker, Sven/0000-0003-4543-8236; Vanneman, Matthew/0000-0003-3877-782X; Koyama, Shohei/0000-0002-6897-9417; Zhang, Baochun/0000-0003-1759-1161; Derudder, Emmanuel/0000-0003-1421-4045; Yasuda, Tomoharu/0000-0001-9997-6852; Rajewsky, Klaus/0000-0002-6633-6370	NIH [CA098285, CA078378, AI56299]; Leukemia and Lymphoma SCOR; Leukemia and Lymphoma Society; JSPS; Astellas Foundation for Research on Metabolic Disorders; NATIONAL CANCER INSTITUTE [P50CA100707, R01CA143083, R01CA050947, R01CA098285, P01CA078378, P01CA155258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma SCOR; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. S. Cobbold for the anti-CD4, -CD8, and -Thy1 hybridomas; Dr. L. Lanier for the CX5 hybridoma; Dr. R. Schreiber for anti-TNF alpha (TN3-19.12) and anti-IFN gamma (H22) antibodies; Drs. E. Cahir-McFarland and E. Kieff for MSCV-IRES-GFP- and MSCV-LMP1-IRES-GFP-expressing vectors; Dr. D. Raulet for NKG2D<SUP>-/-</SUP> mice; Mr. P. Sage and Dr. A. Sharpe for CIITA<SUP>-/-</SUP> mice; Drs. U. Basu, F. Meng, and F. Alt for the anti-AID antibody; and Dr. M. Schmidt-Supprian for the J<INF>H</INF> probe. We thank the NIH Tetramer Facility at Emory University for the PE-conjugated mCD1d-PBS57 tetramer. We are grateful to M. Bamberg, J. Xia, D. Ghitza, C. Grosse, X. Chen, A. Pellerin, J. Grundy, and J. Wang for technical assistance; M. Ottaviano for administrative assistance; S. Koralov for help with sequence analysis and intracellular cytokine staining; S. Peng for HPRT primers; K. Kochert for advice on statistics; and D. Calado, M. Janz, K. Wucherpfennig, and all Rajewsky lab members for critical comments and suggestions. This work was supported by NIH grants CA098285, CA078378, and AI56299 and a Leukemia and Lymphoma SCOR. B.Z. is supported by a postdoctoral fellowship of the Leukemia and Lymphoma Society. T.Y is supported by a JSPS Postdoctoral Fellowship for Research Abroad and by the Astellas Foundation for Research on Metabolic Disorders.	Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Blankenstein T, 2003, CURR OPIN IMMUNOL, V15, P148, DOI 10.1016/S0952-7915(03)00007-4; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Capello D, 2003, BLOOD, V102, P3775, DOI 10.1182/blood-2003-05-1683; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Craig FE, 2007, DIAGN MOL PATHOL, V16, P158, DOI 10.1097/PDM.0b013e31804f54a9; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; Harris N.L., 2001, TUMOURS HAEMATOPOIET, P267; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jinushi M, 2008, P NATL ACAD SCI USA, V105, P1285, DOI 10.1073/pnas.0711293105; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Khanna R, 2000, ANNU REV MICROBIOL, V54, P19, DOI 10.1146/annurev.micro.54.1.19; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Le Clorennec C, 2006, BLOOD, V107, P2070, DOI 10.1182/blood-2005-05-2053; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Rastelli J, 2008, BLOOD, V111, P1448, DOI 10.1182/blood-2007-10-117655; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Savoldo B, 2006, BLOOD, V108, P2942, DOI 10.1182/blood-2006-05-021782; SCHULTZE JL, 1995, P NATL ACAD SCI USA, V92, P8200, DOI 10.1073/pnas.92.18.8200; Schultze JL, 1997, BLOOD, V89, P3806, DOI 10.1182/blood.V89.10.3806.3806_3806_3816; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Souza TA, 2005, P NATL ACAD SCI USA, V102, P18093, DOI 10.1073/pnas.0509311102; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Vakiani E, 2008, HEMATOL ONCOL, V26, P199, DOI 10.1002/hon.859; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhang L, 2005, J GENE MED, V7, P354, DOI 10.1002/jgm.677; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	50	104	112	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					739	751		10.1016/j.cell.2011.12.031	http://dx.doi.org/10.1016/j.cell.2011.12.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341446	Bronze, Green Accepted			2022-12-28	WOS:000300622400015
J	Herman, DS; Lam, L; Taylor, MRG; Wang, LB; Teekakirikul, P; Christodoulou, D; Conner, L; DePalma, SR; McDonough, B; Sparks, E; Teodorescu, DL; Cirino, AL; Banner, NR; Pennell, DJ; Graw, S; Merlo, M; Di Lenarda, A; Sinagra, G; Bos, JM; Ackerman, MJ; Mitchell, RN; Murry, CE; Lakdawala, NK; Ho, CY; Barton, PJR; Cook, SA; Mestroni, L; Seidman, JG; Seidman, CE				Herman, Daniel S.; Lam, Lien; Taylor, Matthew R. G.; Wang, Libin; Teekakirikul, Polakit; Christodoulou, Danos; Conner, Lauren; DePalma, Steven R.; McDonough, Barbara; Sparks, Elizabeth; Teodorescu, Debbie Lin; Cirino, Allison L.; Banner, Nicholas R.; Pennell, Dudley J.; Graw, Sharon; Merlo, Marco; Di Lenarda, Andrea; Sinagra, Gianfranco; Bos, J. Martijn; Ackerman, Michael J.; Mitchell, Richard N.; Murry, Charles E.; Lakdawala, Neal K.; Ho, Carolyn Y.; Barton, Paul J. R.; Cook, Stuart A.; Mestroni, Luisa; Seidman, J. G.; Seidman, Christine E.			Truncations of Titin Causing Dilated Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TIBIAL MUSCULAR-DYSTROPHY; MUSCLE FILAMENT TITIN; C-TERMINAL TITIN; CARDIAC-HYPERTROPHY; GENE; MUTATIONS; EXPRESSION; TENSION; DOMAIN; TTN	BACKGROUND Dilated cardiomyopathy and hypertrophic cardiomyopathy arise from mutations in many genes. TTN, the gene encoding the sarcomere protein titin, has been insufficiently analyzed for cardiomyopathy mutations because of its enormous size. METHODS We analyzed TTN in 312 subjects with dilated cardiomyopathy, 231 subjects with hypertrophic cardiomyopathy, and 249 controls by using next-generation or dideoxy sequencing. We evaluated deleterious variants for cosegregation in families and assessed clinical characteristics. RESULTS We identified 72 unique mutations (25 nonsense, 23 frameshift, 23 splicing, and 1 large tandem insertion) that altered full-length titin. Among subjects studied by means of next-generation sequencing, the frequency of TTN mutations was significantly higher among subjects with dilated cardiomyopathy (54 of 203 [27%]) than among subjects with hypertrophic cardiomyopathy (3 of 231 [1%], P = 3x10(-16)) or controls (7 of 249 [3%], P = 9x10(-14)). TTN mutations cosegregated with dilated cardiomyopathy in families (combined lod score, 11.1) with high (>95%) observed penetrance after the age of 40 years. Mutations associated with dilated cardiomyopathy were overrepresented in the titin A-band but were absent from the Z-disk and M-band regions of titin (P <= 0.01 for all comparisons). Overall, the rates of cardiac outcomes were similar in subjects with and those without TTN mutations, but adverse events occurred earlier in male mutation carriers than in female carriers (P = 4x10(-5)). CONCLUSIONS TTN truncating mutations are a common cause of dilated cardiomyopathy, occurring in approximately 25% of familial cases of idiopathic dilated cardiomyopathy and in 18% of sporadic cases. Incorporation of sequencing approaches that detect TTN truncations into genetic testing for dilated cardiomyopathy should substantially increase test sensitivity, thereby allowing earlier diagnosis and therapeutic intervention for many patients with dilated cardiomyopathy. Defining the functional effects of TTN truncating mutations should improve our understanding of the pathophysiology of dilated cardiomyopathy. (Funded by the Howard Hughes Medical Institute and others.)	[Herman, Daniel S.; Lam, Lien; Wang, Libin; Teekakirikul, Polakit; Christodoulou, Danos; Conner, Lauren; DePalma, Steven R.; McDonough, Barbara; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lam, Lien; Wang, Libin; DePalma, Steven R.; McDonough, Barbara; Sparks, Elizabeth; Seidman, Christine E.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Teekakirikul, Polakit; Teodorescu, Debbie Lin; Cirino, Allison L.; Lakdawala, Neal K.; Ho, Carolyn Y.; Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Mitchell, Richard N.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Taylor, Matthew R. G.; Mestroni, Luisa] Univ Colorado, Cardiovasc Inst, Denver, CO 80202 USA; [Graw, Sharon] Univ Colorado, Dept Psychiat, Denver, CO 80202 USA; [Banner, Nicholas R.; Pennell, Dudley J.; Barton, Paul J. R.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton & Harefield Natl Hlth Serv Fdn Tru, London SW7 2AZ, England; [Barton, Paul J. R.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London SW7 2AZ, England; [Barton, Paul J. R.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Merlo, Marco; Sinagra, Gianfranco] Osped Riuniti, Cardiovasc Dept, Trieste, Italy; [Merlo, Marco; Sinagra, Gianfranco] Univ Trieste, Trieste, Italy; [Di Lenarda, Andrea] Azienda Serv Sanit 1, Ctr Cardiovasc, Trieste, Italy; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Med, Rochester, MN USA; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Pediat, Rochester, MN USA; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Imperial College London; University of Trieste; University of Trieste; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, NRB 256,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Teodorescu, Debbie/A-2689-2019; Cook, Stuart/G-9567-2011; sinagra, gianfranco gs/P-7643-2014; Di Lenarda, Andrea/AAC-2377-2022; Sinagra, Gianfranco/AAE-3943-2020	Teodorescu, Debbie/0000-0002-8981-227X; Di Lenarda, Andrea/0000-0001-8482-4872; Mestroni, Luisa/0000-0003-1116-2286; DePalma, Steven/0000-0002-0381-5016; Pennell, Dudley/0000-0001-5523-1314; Barton, Paul/0000-0002-1165-7767; Ho, Carolyn/0000-0002-7334-7924; Cook, Stuart/0000-0001-6628-194X; Teekakirikul, Polakit/0000-0003-2407-7355; SINAGRA, GIANFRANCO/0000-0003-2700-8478	Howard Hughes Medical Institute; National Institutes of Health; Leducq Foundation; American Heart Association; Muscular Dystrophy Association; U.K. National Institute for Health Research Cardiovascular Biomedical Research Unit (Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College; British Heart Foundation; Medical Research Council U.K.; J. Ira and Nicki Harris Family Research Award; National Heart, Lung, and Blood Institute [N01-HV-48194]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059139, R01HL080494, U01HL098166, R01HL084553, U01HL066582, P50HL052320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; MRC [MC_U120085815] Funding Source: UKRI; British Heart Foundation [SP/10/10/28431] Funding Source: researchfish; Medical Research Council [MC_U120085815] Funding Source: researchfish	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); U.K. National Institute for Health Research Cardiovascular Biomedical Research Unit (Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College; British Heart Foundation(British Heart Foundation); Medical Research Council U.K.(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); J. Ira and Nicki Harris Family Research Award; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Howard Hughes Medical Institute (to Dr. C.E. Seidman); the National Institutes of Health (to Drs. Herman, Taylor, Graw, Ackerman, Mitchell, Murry, Ho, Mestroni, and J.G. Seidman); the Leducq Foundation (to Drs. Cook, J.G. Seidman, and C. E. Seidman); the American Heart Association and the Muscular Dystrophy Association (to Drs. Taylor and Mestroni); the U.K. National Institute for Health Research Cardiovascular Biomedical Research Unit (Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College), the British Heart Foundation, and the Medical Research Council U.K. (to Drs. Banner, Pennell, Cook, and Barton); and the J. Ira and Nicki Harris Family Research Award (to Dr. Ho). Sequencing in subjects with dilated cardiomyopathy in group C was funded by a contract from the National Heart, Lung, and Blood Institute (N01-HV-48194).	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; [Anonymous], 2010, R LANG ENV STAT COMP; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Cazorla O, 2001, CIRC RES, V88, P1028, DOI 10.1161/hh1001.090876; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Gerull B, 2006, J MOL MED-JMM, V84, P478, DOI 10.1007/s00109-006-0060-6; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gramlich M, 2009, J MOL CELL CARDIOL, V47, P352, DOI 10.1016/j.yjmcc.2009.04.014; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423; Guo W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/753675; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hackman P, 2008, NEUROMUSCULAR DISORD, V18, P922, DOI 10.1016/j.nmd.2008.07.010; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; HOROWITS R, 1986, NATURE, V323, P160, DOI 10.1038/323160a0; Jones RC, 2004, J AM COLL CARDIOL, V44, P1025, DOI 10.1016/j.jacc.2004.05.077; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Liversage AD, 2001, J MOL BIOL, V305, P401, DOI 10.1006/jmbi.2000.4279; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; Musa H, 2006, J CELL SCI, V119, P4322, DOI 10.1242/jcs.03198; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Peng J, 2007, CIRCULATION, V115, P743, DOI 10.1161/CIRCULATIONAHA.106.645499; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; TRINICK J, 1984, J MOL BIOL, V180, P331, DOI 10.1016/S0022-2836(84)80007-8; van der Ven PFM, 2000, J CELL SCI, V113, P1405; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Zimmerman RS, 2010, GENET MED, V12, P268, DOI 10.1097/GIM.0b013e3181d6f7c0	41	804	826	6	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					619	628		10.1056/NEJMoa1110186	http://dx.doi.org/10.1056/NEJMoa1110186			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IL	22335739	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000300279800007
J	Vonlanthen, P; Bittner, D; Hudson, AG; Young, KA; Muller, R; Lundsgaard-Hansen, B; Roy, D; Di Piazza, S; Largiader, CR; Seehausen, O				Vonlanthen, P.; Bittner, D.; Hudson, A. G.; Young, K. A.; Mueller, R.; Lundsgaard-Hansen, B.; Roy, D.; Di Piazza, S.; Largiader, C. R.; Seehausen, O.			Eutrophication causes speciation reversal in whitefish adaptive radiations	NATURE			English	Article							ECOLOGICAL SPECIATION; LAKE; HYBRIDIZATION; FISH; REQUIREMENTS; CONSERVATION; BIODIVERSITY; GASTEROSTEUS; EVOLUTION; PATTERNS	Species diversity can be lost through two different but potentially interacting extinction processes: demographic decline and speciation reversal through introgressive hybridization. To investigate the relative contribution of these processes, we analysed historical and contemporary data of replicate whitefish radiations from 17 pre-alpine European lakes and reconstructed changes in genetic species differentiation through time using historical samples. Here we provide evidence that species diversity evolved in response to ecological opportunity, and that eutrophication, by diminishing this opportunity, has driven extinctions through speciation reversal and demographic decline. Across the radiations, the magnitude of eutrophication explains the pattern of species loss and levels of genetic and functional distinctiveness among remaining species. We argue that extinction by speciation reversal may be more widespread than currently appreciated. Preventing such extinctions will require that conservation efforts not only target existing species but identify and protect the ecological and evolutionary processes that generate and maintain species.	[Vonlanthen, P.; Hudson, A. G.; Lundsgaard-Hansen, B.; Di Piazza, S.; Seehausen, O.] Univ Bern, Inst Ecol & Evolut, Div Aquat Ecol & Evolut, CH-3012 Bern, Switzerland; [Vonlanthen, P.; Bittner, D.; Hudson, A. G.; Young, K. A.; Mueller, R.; Lundsgaard-Hansen, B.; Roy, D.; Di Piazza, S.; Seehausen, O.] EAWAG Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, CH-6047 Kastanienbaum, Switzerland; [Bittner, D.] Univ Bern, Inst Ecol & Evolut, Computat & Mol Populat Genet CMPG Lab, CH-3012 Bern, Switzerland; [Young, K. A.] Environm Agcy, Cardiff CF24 0TP, S Glam, Wales; [Roy, D.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Largiader, C. R.] Univ Hosp Bern, Inselspital, Inst Clin Chem, CH-3010 Bern, Switzerland; [Largiader, C. R.] Univ Bern, Inselspital, CH-3010 Bern, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern; Dalhousie University; University of Bern; University Hospital of Bern; University of Bern	Seehausen, O (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Aquat Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland.	ole.seehausen@eawag.ch	Largiader, Carlo R/B-8798-2008; Hudson, Alan/J-9380-2014; Seehausen, Ole/C-8272-2011; Vonlanthen, Pascal/G-9224-2011	Largiader, Carlo R/0000-0002-0889-8922; Hudson, Alan/0000-0001-6436-2025; Seehausen, Ole/0000-0001-6598-1434; 	Eawag Action Field Grant 'AquaDiverse-understanding and predicting changes in aquatic biodiversity'	Eawag Action Field Grant 'AquaDiverse-understanding and predicting changes in aquatic biodiversity'	We thank all professional fishermen who provided fish specimens. We thank M. Kugler from the Amt fur Natur, Jagd und Fischerei, St. Gallen and the institute of Seenforschung and Fischereiwesen Langenargen for providing historical whitefish scales from Lake Constance. We acknowledge the Swiss Federal Institute for Aquatic Science and Technology (EAWAG), the Internationale Gewasserschutzkomission fur den Bodensee (IGKB) and the Federal Office for Environment (FOEN) for providing environmental data. We also thank G. Periat, S. Mwaiko, M. Barluenga, H. Araki, M. Maan, J. Brodersen, P. Nosil, K. Wagner and all members of the Fish Ecology and Evolution laboratory for assistance in the laboratory, and for comments and suggestions on the manuscript, B. Muller for help with the analysis of the oxygen profiles, and C. Melian for help with data analyses. We acknowledge financial support by the Eawag Action Field Grant 'AquaDiverse-understanding and predicting changes in aquatic biodiversity' (to O.S.).	Bernatchez L, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P175; Bittner D, 2010, MOL ECOL, V19, P2152, DOI 10.1111/j.1365-294X.2010.04623.x; Blumenshine SC, 1997, J N AM BENTHOL SOC, V16, P466, DOI 10.2307/1468138; Brede N, 2009, P NATL ACAD SCI USA, V106, P4758, DOI 10.1073/pnas.0807187106; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Coyne J.A., 2004, SPECIATION; Czerkies P, 2002, AQUACULTURE, V211, P375, DOI 10.1016/S0044-8486(02)00049-2; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; De Leon LF, 2011, EVOLUTION, V65, P2258, DOI 10.1111/j.1558-5646.2011.01297.x; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Gilman RT, 2011, EVOLUTION, V65, P2592, DOI 10.1111/j.1558-5646.2011.01320.x; GOLDSCHMIDT T, 1993, CONSERV BIOL, V7, P686, DOI 10.1046/j.1523-1739.1993.07030686.x; Grant BR, 2008, PHILOS T R SOC B, V363, P2821, DOI 10.1098/rstb.2008.0051; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Harrod C, 2010, J ANIM ECOL, V79, P1057, DOI 10.1111/j.1365-2656.2010.01702.x; Heath D, 2010, EVOL APPL, V3, P77, DOI 10.1111/j.1752-4571.2009.00100.x; Hendry AP, 2006, P R SOC B, V273, P1887, DOI 10.1098/rspb.2006.3534; Hudson AG, 2011, P ROY SOC B-BIOL SCI, V278, P58, DOI 10.1098/rspb.2010.0925; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; LIECHTI P, 1994, SCHRIFTENREIHE UMWEL, V237; MCPHAIL JD, 1993, CAN J ZOOL, V71, P515, DOI 10.1139/z93-072; Muller R, 2004, FISHERIES MANAG ECOL, V11, P251, DOI 10.1111/j.1365-2400.2004.00393.x; MULLER R, 1992, HYDROBIOLOGIA, V243, P261, DOI 10.1007/BF00007041; Powers SP, 2005, MAR ECOL PROG SER, V302, P233, DOI 10.3354/meps302233; Pritchard JK, 2000, GENETICS, V155, P945; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rosenzweig ML, 2001, P NATL ACAD SCI USA, V98, P5404, DOI 10.1073/pnas.101092798; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Seehausen O, 2009, NATURE, V458, P1122, DOI 10.1038/4581122a; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Steinmann P., 1950, SCHWEIZ Z HYDROL, V12, P340, DOI DOI 10.1007/BF02489885; Straile D, 1998, ICES J MAR SCI, V55, P775, DOI 10.1006/jmsc.1998.0397; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Verschuren D, 2002, P ROY SOC B-BIOL SCI, V269, P289, DOI 10.1098/rspb.2001.1850; Vonlanthen P, 2009, J EVOLUTION BIOL, V22, P498, DOI 10.1111/j.1420-9101.2008.01670.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Wasko AP, 2003, HEREDITAS, V138, P161, DOI 10.1034/j.1601-5223.2003.01503.x; Woods PJ, 2009, J EVOLUTION BIOL, V22, P2305, DOI 10.1111/j.1420-9101.2009.01846.x	47	302	311	13	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					357	U1500		10.1038/nature10824	http://dx.doi.org/10.1038/nature10824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337055				2022-12-28	WOS:000300287100037
J	Ekelund, U; Luan, JA; Sherar, LB; Esliger, DW; Griew, P; Cooper, A				Ekelund, Ulf; Luan, Jian'an; Sherar, Lauren B.; Esliger, Dale W.; Griew, Pippa; Cooper, Ashley		ICAD Collaborators	Moderate to Vigorous Physical Activity and Sedentary Time and Cardiometabolic Risk Factors in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; POPULATION-BASED SAMPLE; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; METABOLIC RISK; CARDIORESPIRATORY FITNESS; AEROBIC EXERCISE; BODY-FAT; DESIGN; OVERWEIGHT	Context Sparse data exist on the combined associations between physical activity and sedentary time with cardiometabolic risk factors in healthy children. Objective To examine the independent and combined associations between objectively measured time in moderate- to vigorous-intensity physical activity (MVPA) and sedentary time with cardiometabolic risk factors. Design, Setting, and Participants Pooled data from 14 studies between 1998 and 2009 comprising 20 871 children (aged 4-18 years) from the International Children's Accelerometry Database. Time spent in MVPA and sedentary time were measured using accelerometry after reanalyzing raw data. The independent associations between time in MVPA and sedentary time, with outcomes, were examined using meta-analysis. Participants were stratified by tertiles of MVPA and sedentary time. Main Outcome Measures Waist circumference, systolic blood pressure, fasting triglycerides, high-density lipoprotein cholesterol, and insulin. Results Times (mean [SD] min/d) accumulated by children in MVPA and being sedentary were 30 (21) and 354 (96), respectively. Time in MVPA was significantly associated with all cardiometabolic outcomes independent of sex, age, monitor wear time, time spent sedentary, and waist circumference (when not the outcome). Sedentary time was not associated with any outcome independent of time in MVPA. In the combined analyses, higher levels of MVPA were associated with better cardiometabolic risk factors across tertiles of sedentary time. The differences in outcomes between higher and lower MVPA were greater with lower sedentary time. Mean differences in waist circumference between the bottom and top tertiles of MVPA were 5.6 cm (95% CI, 4.8-6.4 cm) for high sedentary time and 3.6 cm (95% CI, 2.8-4.3 cm) for low sedentary time. Mean differences in systolic blood pressure for high and low sedentary time were 0.7 mm Hg (95% CI, -0.07 to 1.6) and 2.5 mmHg (95% CI, 1.7-3.3), and for high-density lipoprotein cholesterol, differences were -2.6 mg/dL(95% CI, -1.4 to -3.9) and -4.5 mg/dL(95% CI, -3.3 to -5.6), respectively. Geometric mean differences for insulin and triglycerides showed similar variation. Those in the top tertile of MVPA accumulated more than 35 minutes per day in this intensity level compared with fewer than 18 minutes per day for those in the bottom tertile. In prospective analyses (N=6413 at 2.1 years' follow-up), MVPA and sedentary time were not associated with waist circumference at follow-up, but a higher waist circumference at baseline was associated with higher amounts of sedentary time at follow-up. Conclusion Higher MVPA time by children and adolescents was associated with better cardiometabolic risk factors regardless of the amount of sedentary time. JAMA. 2012;307(7):704-712	[Ekelund, Ulf; Luan, Jian'an] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Ekelund, Ulf] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Sherar, Lauren B.; Esliger, Dale W.] Univ Saskatchewan, Coll Kinesiol, Saskatoon, SK, Canada; [Sherar, Lauren B.; Esliger, Dale W.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Griew, Pippa] Univ Exeter, Sch Sport & Hlth Sci, Exeter, Devon, England; [Cooper, Ashley] Univ Bristol, Sch Policy Studies, Bristol, Avon, England	University of Cambridge; Orebro University; Norwegian School of Sport Sciences; University of Saskatchewan; Loughborough University; University of Exeter; University of Bristol	Ekelund, U (corresponding author), Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, POB 285, Cambridge CB2 0QQ, England.	ulf.ekelund@mrc-epid.cam.ac.uk	Hrafnkelsson, Hannes/C-8490-2011; Esliger, Dale W/E-1796-2016; Ekelund, Ulf/AAE-8471-2019; Sardinha, Luís Bettencourt/F-2641-2013; Sardinha, Luís B./ABG-5389-2020; Griffin, Simon J/K-3106-2013; Cooper, Ashley/D-9956-2014	Esliger, Dale W/0000-0002-1236-6419; Ekelund, Ulf/0000-0003-2115-9267; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Sardinha, Luís B./0000-0002-6230-6027; Griffin, Simon J/0000-0002-2157-4797; Cooper, Ashley/0000-0001-8644-3870; Sherar, Lauren/0000-0002-9942-5433; Puder, Jardena/0000-0002-0460-7614; DAVEY, RACHEL/0000-0002-6117-2872	NPRI-UK; British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Executive Health Department; Stroke Association; Welsh Assembly Government; World Cancer Research Fund; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0501311, MC_U106179474, G0701877, MC_U106179473, G0501294] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G9815508, G0501294, G0701877, MC_U106179474, G0501311, MC_U106179473] Funding Source: researchfish	NPRI-UK; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Executive Health Department; Stroke Association; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for the project was provided by the NPRI-UK. Funding partners: British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Executive Health Department; The Stroke Association; Welsh Assembly Government; and World Cancer Research Fund.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Andersen LB, 2010, METABOLISM, V59, P561, DOI 10.1016/j.metabol.2009.08.019; [Anonymous], 2005, ANTHR PHYS ACT MON P; Australian Government Department of Health and Ageing, PHYS ACT REC 12 18 Y; Australian Government Department of Health and Ageing, PHYS ACT REC 5 12 YE; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Buchan DS, 2011, SCAND J MED SCI SPOR, V21, pE341, DOI 10.1111/j.1600-0838.2011.01303.x; Canadian Society for Exercise Physiology, CAN PHYS ACT GUID IN, VAccessed June 30, 2011; Carrel AL, 2005, ARCH PEDIAT ADOL MED, V159, P963, DOI 10.1001/archpedi.159.10.963; Centers for Disease Control and Prevention, 2005, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, PHYS ACT EV; Centers for Disease Control and Prevention, 2010, NAT HLTH NUTR EX SUR; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Department of Health, UK PHYS ACT GUID; Eiberg S, 2005, BRIT J SPORT MED, V39, P725, DOI 10.1136/bjsm.2004.015230; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Ekelund U, 2005, DIABETES CARE, V28, P1195, DOI 10.2337/diacare.28.5.1195; Ekelund U, 2008, AM J CLIN NUTR, V88, P612, DOI 10.1093/ajcn/88.3.612; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Fisher A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018576; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gore Stacy A, 2003, Eat Behav, V4, P399, DOI 10.1016/S1471-0153(03)00053-9; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Kelley GA, 2007, ATHEROSCLEROSIS, V191, P447, DOI 10.1016/j.atherosclerosis.2006.04.019; Kwon S, 2011, MED SCI SPORT EXER, V43, P443, DOI 10.1249/MSS.0b013e3181ef3b0a; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; Nassis GP, 2005, METABOLISM, V54, P1472, DOI 10.1016/j.metabol.2005.05.013; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Niederer I, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-94; Page AS, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-2; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1041, DOI 10.1136/bmj.38979.623773.55; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Rizzo NS, 2007, J PEDIATR-US, V150, P388, DOI 10.1016/j.jpeds.2006.12.039; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Sherar LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-485; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Steele RM, 2009, AM J CLIN NUTR, V90, P1185, DOI 10.3945/ajcn.2009.28153; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tolfrey K, 2008, MED SCI SPORT EXER, V40, P1049, DOI 10.1249/MSS.0b013e31816770fe; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Vereecken CA, 2006, PUBLIC HEALTH NUTR, V9, P244, DOI 10.1079/PHN2005847; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wiecha JL, 2006, ARCH PEDIAT ADOL MED, V160, P436, DOI 10.1001/archpedi.160.4.436; Wong MY, 1999, STAT MED, V18, P2831, DOI 10.1002/(SICI)1097-0258(19991115)18:21<2831::AID-SIM282>3.3.CO;2-V; Zahner L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-147	55	775	786	3	141	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					704	712		10.1001/jama.2012.156	http://dx.doi.org/10.1001/jama.2012.156			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22337681	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000300278500027
J	Tweedy, DS				Tweedy, Damon S.			A Perfect Match	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA	Duke University	Tweedy, DS (corresponding author), Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA.	damon.tweedy@dm.duke.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					673	673		10.1001/jama.2012.139	http://dx.doi.org/10.1001/jama.2012.139			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22337678				2022-12-28	WOS:000300278500023
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Atos and changes to disabled people's benefits	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 14	2012	344								e1114	10.1136/bmj.e1114	http://dx.doi.org/10.1136/bmj.e1114			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896HZ	22334571				2022-12-28	WOS:000300557600031
J	Baird, SJ; Garfein, RS; McIntosh, CT; Ozler, B				Baird, Sarah J.; Garfein, Richard S.; McIntosh, Craig T.; Oezler, Berk			Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial	LANCET			English	Article							RURAL SOUTH-AFRICA; TRANSACTIONAL SEX; YOUNG-WOMEN; PREVENTION; BEHAVIOR; POVERTY; IMPACT; RISK	Background Lack of education and an economic dependence on men are often suggested as important risk factors for HIV infection in women. We assessed the efficacy of a cash transfer programme to reduce the risk of sexually transmitted infections in young women. Methods In this cluster randomised trial, never-married women aged 13-22 years were recruited from 176 enumeration areas in the Zomba district of Malawi and randomly assigned with computer-generated random numbers by enumeration area (1:1) to receive cash payments (intervention group) or nothing (control group). Intervention enumeration areas were further randomly assigned with computer-generated random numbers to conditional (school attendance required to receive payment) and unconditional (no requirements to receive payment) groups. Participants in both intervention groups were randomly assigned by a lottery to receive monthly payments ranging from US$1 to $5, while their parents were independently assigned with computer-generated random numbers to receive $4-10. Behavioural risk assessments were done at baseline and 12 months; serology was tested at 18 months. Participants were not masked to treatment status but counsellors doing the serologic testing were. The primary outcomes were prevalence of HIV and herpes simplex virus 2 (HSV-2) at 18 months and were assessed by intention-to-treat analyses. The trial is registered, number NCT01333826. Findings 88 enumeration areas were assigned to receive the intervention and 88 as controls. For the 1289 individuals enrolled in school at baseline with complete interview and biomarker data, weighted HIV prevalence at 18 month follow-up was 1.2% (seven of 490 participants) in the combined intervention group versus 3.0% (17 of 799 participants) in the control group (adjusted odds ratio [OR] 0.36, 95% CI 0.14-0.91); weighted HSV-2 prevalence was 0.7% (five of 488 participants) versus 3.0% (27 of 796 participants; adjusted OR 0.24, 0.09-0.65). In the intervention group, we noted no difference between conditional versus unconditional intervention groups for weighted HIV prevalence (3/235 [1%] vs 4/255 [2%]) or weighted HSV-2 prevalence (4/233 [1%] vs 1/255 [<1%]). For individuals who had already dropped out of school at baseline, we detected no significant difference between intervention and control groups for weighted HIV prevalence (23/210 [10%] vs 17/207 [8%]) or weighted HSV-2 prevalence (17/211 [8%] vs 17/208 [8%]). Interpretation Cash transfer programmes can reduce HIV and HSV-2 infections in adolescent schoolgirls in low-income settings. Structural interventions that do not directly target sexual behaviour change can be important components of HIV prevention strategies.	[Oezler, Berk] World Bank, Dev Res Grp, Washington, DC 20433 USA; [Garfein, Richard S.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [McIntosh, Craig T.] Univ Calif San Diego, Sch Int Relat & Pacific Studies, San Diego, CA 92103 USA; [Baird, Sarah J.] George Washington Univ, Dept Global Hlth, Washington, DC USA	The World Bank; University of California System; University of California San Diego; University of California System; University of California San Diego; George Washington University	Ozler, B (corresponding author), World Bank, Dev Res Grp, 1818 H St NW, Washington, DC 20433 USA.	bozler@worldbank.org			Global Development Network; Bill & Melinda Gates Foundation; National Bureau of Economic Research Africa; World Bank's Research Support Budget; World Bank	Global Development Network; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Bureau of Economic Research Africa; World Bank's Research Support Budget; World Bank(The World Bank India)	Global Development Network, Bill & Melinda Gates Foundation, National Bureau of Economic Research Africa Project, World Bank's Research Support Budget, and several World Bank trust funds (Gender Action Plan, Knowledge for Change Program, and Spanish Impact Evaluation fund).	Baird S, 2011, Q J ECON, V126, P1709, DOI 10.1093/qje/qjr032; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; De Janvry A, 2004, ARE UPDATE, V7; Duflo E, 2006, 4024 WORLD BANK, P4024; Gong E, 2011, HIV TESTING RISKY SE; Government Of Malawi, MAL POV VULN ASS INV; Hallman Kelly, 2005, Afr J AIDS Res, V4, P37, DOI 10.2989/16085900509490340; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; *JOINT UN PROGR HI, 2009, AIDS EP UPD; *JOINT UN PROGR HI, 2008, REP GLOB AIDS EP; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; McCoy SI, 2010, AIDS BEHAV, V14, P469, DOI 10.1007/s10461-009-9644-9; National Statistical Office of Malawi, MAL DEM HLTH SURV 20; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Roberts C, 1999, BRIT MED J, V319, P185, DOI 10.1136/bmj.319.7203.185; Robinson J, 2011, AM ECON J-APPL ECON, V3, P35, DOI 10.1257/app.3.1.35; Schultz TP, 2004, J DEV ECON, V74, P199, DOI 10.1016/j.jdeveco.2003.12.009; Shelton JD, 2005, LANCET, V366, P1057, DOI 10.1016/S0140-6736(05)67401-6; Swidler A, 2007, STUD FAMILY PLANN, V38, P147, DOI 10.1111/j.1728-4465.2007.00127.x; Temin M., 2010, START GIRL NEW AGEND; Thornton RL, 2008, AM ECON REV, V98, P1829, DOI 10.1257/aer.98.5.1829; World Bank, 2009, COND CASH TRANSF RED	25	401	401	1	59	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 7	2012	379	9823					1320	1329		10.1016/S0140-6736(11)61709-1	http://dx.doi.org/10.1016/S0140-6736(11)61709-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922FB	22341825				2022-12-28	WOS:000302531100029
J	Dudakov, JA; Hanash, AM; Jenq, RR; Young, LF; Ghosh, A; Singer, NV; West, ML; Smith, OM; Holland, AM; Tsai, JJ; Boyd, RL; van den Brink, MRM				Dudakov, Jarrod A.; Hanash, Alan M.; Jenq, Robert R.; Young, Lauren F.; Ghosh, Arnab; Singer, Natalie V.; West, Mallory L.; Smith, Odette M.; Holland, Amanda M.; Tsai, Jennifer J.; Boyd, Richard L.; van den Brink, Marcel R. M.			Interleukin-22 Drives Endogenous Thymic Regeneration in Mice	SCIENCE			English	Article							INNATE LYMPHOID-CELLS; ROR-GAMMA-T; EPITHELIAL-CELLS; INDUCER CELLS; IL-22; SIGNALS; DIFFERENTIATION; RECONSTITUTION; INFLAMMATION; HOMEOSTASIS	Endogenous thymic regeneration is a crucial function that allows for renewal of immune competence after stress, infection, or immunodepletion. However, the mechanisms governing this regeneration remain poorly understood. We detail such a mechanism, centered on interleukin-22 (IL-22) and triggered by the depletion of CD4(+)CD8(+) double-positive thymocytes. Intrathymic levels of IL-22 were increased after thymic insult, and thymic recovery was impaired in IL-22-deficient mice. IL-22, which signaled through thymic epithelial cells and promoted their proliferation and survival, was up-regulated by radio-resistant ROR gamma(t)(+)CCR6(+)NKp46(-) lymphoid tissue inducer cells after thymic injury in an IL-23-dependent manner. Administration of IL-22 enhanced thymic recovery after total body irradiation. These studies reveal mechanisms of endogenous thymic repair and offer innovative regenerative strategies for improving immune competence.	[Dudakov, Jarrod A.; Young, Lauren F.; Ghosh, Arnab; Singer, Natalie V.; West, Mallory L.; Smith, Odette M.; Holland, Amanda M.; Tsai, Jennifer J.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Dudakov, Jarrod A.; Boyd, Richard L.] Monash Univ, Monash Immunol & Stem Cell Labs, Melbourne, Vic 3800, Australia; [Hanash, Alan M.; Jenq, Robert R.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Jenq, Robert R.; van den Brink, Marcel R. M.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Holland, Amanda M.; Tsai, Jennifer J.; van den Brink, Marcel R. M.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Monash University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Dudakov, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	dudakovj@mskcc.org; vandenbm@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022	Dudakov, Jarrod/0000-0001-6220-5632; Ghosh, Arnab/0000-0003-3355-5427	NIH [HL069929, CA107096, AI080455, HL095075]; U.S. Department of Defense USAMRAA [W81XWH-09-1-0294]; Radiation Effects Research Foundation of the National Institute of Allergy and Infectious Diseases; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Peter Solomon Fund; Australian National Health and Medical Research Council [1012401]; Leukemia and Lymphoma Society [5534-11]; American Society of Hematology; American Society for Blood and Marrow Transplant; American Association of Cancer Research; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA009207, R01CA107096] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929, R01HL095075, K08HL115355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense USAMRAA(United States Department of Defense); Radiation Effects Research Foundation of the National Institute of Allergy and Infectious Diseases; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Peter Solomon Fund; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Society of Hematology; American Society for Blood and Marrow Transplant; American Association of Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Farr for the gift of the TE-71 TEC cell line; D. Littman, W. Ouyang, A. Beaulieu, J. Sun, and S. Prockop for the gift of mice; R. Essner and D. Schwartz for technical assistance; E. Velardi and Y. Shono for helpful discussion; and L. Reilly, B. Morcerf, and B. Rojas for administrative assistance. M.R.M.v.d.B. also thanks his former mentor J. J. van Rood. Supported by NIH R01 awards HL069929, CA107096, AI080455, and HL095075, U.S. Department of Defense USAMRAA award W81XWH-09-1-0294, the Radiation Effects Research Foundation of the National Institute of Allergy and Infectious Diseases, the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center (funded by W. H. Goodwin and A. Goodwin), the Lymphoma Foundation, Alex's Lemonade Stand, and the Peter Solomon Fund. J. A. D. was supported by fellowships from the Australian National Health and Medical Research Council (CJ Martin Biomedical Research Fellowship, 1012401) and the Leukemia and Lymphoma Society (5534-11). A. M. Ha. was supported by a Research Training Award for Fellows from the American Society of Hematology and a New Investigator Award from the American Society for Blood and Marrow Transplant. A. G. was supported by supported by a Judah Folkman Fellowship from the American Association of Cancer Research. A provisional patent application has been filed on the use of IL-22 as a thymopoietic growth factor (U.S. 61/487,517) with J. A. D, A. M. Ha., and M.R.M.v.d.B. listed as inventors.	Alpdogan O, 2006, BLOOD, V107, P2453, DOI 10.1182/blood-2005-07-2831; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Kanai M, 2003, ONCOGENE, V22, P548, DOI 10.1038/sj.onc.1206109; Kim MY, 2005, J IMMUNOL, V174, P6686, DOI 10.4049/jimmunol.174.11.6686; Mak TW, 2001, NAT REV IMMUNOL, V1, P11, DOI 10.1038/35095551; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Purton JF, 2004, J IMMUNOL, V173, P3816, DOI 10.4049/jimmunol.173.6.3816; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; STOREK J, 1995, BONE MARROW TRANSPL, V16, P413; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; van den Brink MRM, 2004, NAT REV IMMUNOL, V4, P856, DOI 10.1038/nri1484; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	29	254	271	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					91	95		10.1126/science.1218004	http://dx.doi.org/10.1126/science.1218004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22383805	Green Accepted			2022-12-28	WOS:000302405400058
J	Donovan, B; Guy, R				Donovan, Basil; Guy, Rebecca			Developments in research for STI prevention in Peru	LANCET			English	Editorial Material							SEXUALLY-TRANSMITTED INFECTIONS; FEMALE SEX WORKERS; STDS; MANAGEMENT; TRIAL; HIV		[Donovan, Basil; Guy, Rebecca] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia; [Donovan, Basil] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Donovan, B (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia.	bdonovan@kirby.unsw.edu.au	Donovan, Basil J/K-1246-2012	Donovan, Basil J/0000-0001-8851-4126; Guy, Rebecca/0000-0002-2929-4634				Donovan B, 2004, LANCET, V363, P545, DOI 10.1016/S0140-6736(04)15543-8; Garcia P, 2003, B WORLD HEALTH ORGAN, V81, P806; Garcia PJ, 2012, LANCET, V379, P1120, DOI 10.1016/S0140-6736(11)61846-1; Garcia PJ, 1998, SEX TRANSM INFECT, V74, pS153; Ginige Samitha, 2006, Sex Health, V3, P221, DOI 10.1071/SH06013; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Sanchez J, 1996, AM J PUBLIC HEALTH, V86, P1098, DOI 10.2105/AJPH.86.8_Pt_1.1098; Sanchez J, 2003, SEX TRANSM DIS, V30, P273, DOI 10.1097/00007435-200304000-00001; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Wilson DP, 2010, SEX TRANSM INFECT, V86, P117, DOI 10.1136/sti.2009.036673	10	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 24	2012	379	9821					1081	1082		10.1016/S0140-6736(12)60152-4	http://dx.doi.org/10.1016/S0140-6736(12)60152-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916VR	22341823				2022-12-28	WOS:000302131800010
J	Kaouane, N; Porte, Y; Vallee, M; Brayda-Bruno, L; Mons, N; Calandreau, L; Marighetto, A; Piazza, PV; Desmedt, A				Kaouane, Nadia; Porte, Yves; Vallee, Monique; Brayda-Bruno, Laurent; Mons, Nicole; Calandreau, Ludovic; Marighetto, Aline; Piazza, Pier Vincenzo; Desmedt, Aline			Glucocorticoids Can Induce PTSD-Like Memory Impairments in Mice	SCIENCE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SCRIPT-DRIVEN IMAGERY; AMYGDALA; FEAR; HIPPOCAMPUS; BRAIN; ACTIVATION; PATHWAY; TRAUMA	Posttraumatic stress disorder (PTSD) is characterized by a hypermnesia of the trauma and by a memory impairment that decreases the ability to restrict fear to the appropriate context. Infusion of glucocorticoids in the hippocampus after fear conditioning induces PTSD-like memory impairments and an altered pattern of neural activation in the hippocampal-amygdalar circuit. Mice become unable to identify the context as the correct predictor of the threat and show fear responses to a discrete cue not predicting the threat in normal conditions. These data demonstrate PTSD-like memory impairments in rodents and identify a potential pathophysiological mechanism of this condition.	[Kaouane, Nadia; Porte, Yves; Vallee, Monique; Brayda-Bruno, Laurent; Mons, Nicole; Marighetto, Aline; Piazza, Pier Vincenzo; Desmedt, Aline] Univ Bordeaux, Dept Life Sci, F-33077 Bordeaux, France; [Kaouane, Nadia; Porte, Yves; Brayda-Bruno, Laurent; Mons, Nicole; Marighetto, Aline; Desmedt, Aline] Ctr Neurosci Integrat & Cognit, CNRS, UMR 5228, F-33405 Talence, France; [Kaouane, Nadia; Vallee, Monique; Brayda-Bruno, Laurent; Marighetto, Aline; Piazza, Pier Vincenzo; Desmedt, Aline] INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France; [Calandreau, Ludovic] Univ Tours Haras Nationaux, INRA, Ctr Tours Nouzilly Physiol Reprod & Comportements, CNRS,UMR 6175,UMR 85, F-37380 Nouzilly, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Piazza, PV (corresponding author), Univ Bordeaux, Dept Life Sci, F-33077 Bordeaux, France.	pier-vincenzo.piazza@inserm.fr; aline.desmedt@inserm.fr	Mons, Nicole/AAD-5541-2019	VALLEE, Monique/0000-0002-3642-4257; Desmedt, aline/0000-0002-1179-7161; Marighetto, Aline/0000-0002-8893-278X; Kaouane, Nadia/0000-0001-7359-0898	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Fondation pour la Recherche sur le Cerveau; Conseil Regional d'Aquitaine; Ministere de l'Enseignement superieur et de la Recherche; University of Bordeaux	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche sur le Cerveau; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Ministere de l'Enseignement superieur et de la Recherche; University of Bordeaux	We thank F. Naneix for helpful discussions and C. Dupuy, A. Faugere, A. Grel, and F. Rouge-Pont for technical help. N.K., A. D., and P. V. P. conceived and designed the experiments. N.K., M. V., N.M., Y.P., L. B. B., L. C., and A. D. performed the experiments. N.K., M. V., and A. D. analyzed the data. N.K., A. M., A. D., and P. V. P. wrote the manuscript. This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Fondation pour la Recherche sur le Cerveau, Conseil Regional d'Aquitaine, Ministere de l'Enseignement superieur et de la Recherche, and University of Bordeaux.	APA, 2000, DIAGN STAT MAN MENT; BREMNER JD, 1995, J TRAUMA STRESS, V8, P527, DOI 10.1002/jts.2490080403; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Calandreau L, 2006, J NEUROSCI, V26, P13556, DOI 10.1523/JNEUROSCI.3713-06.2006; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Desmedt A, 1998, J NEUROSCI, V18, P480; Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Layton B, 2002, J NEUROPSYCH CLIN N, V14, P254, DOI 10.1176/appi.neuropsych.14.3.254; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Piazza PV, 1997, BRAIN RES REV, V25, P359, DOI 10.1016/S0165-0173(97)00025-8; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Scicli AP, 2004, BEHAV NEUROSCI, V118, P5, DOI 10.1037/0735-7044.118.1.5; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Smith SD, 2008, J ABNORM PSYCHOL, V117, P479, DOI 10.1037/0021-843X.117.2.479; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Trifilieff P, 2007, NEUROBIOL LEARN MEM, V88, P424, DOI 10.1016/j.nlm.2007.05.004; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009; van Zuiden M, 2012, BIOL PSYCHIAT, V71, P309, DOI 10.1016/j.biopsych.2011.10.026; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41	28	159	167	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2012	335	6075					1510	1513		10.1126/science.1207615	http://dx.doi.org/10.1126/science.1207615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22362879				2022-12-28	WOS:000301837000053
J	Miyanari, Y; Torres-Padilla, ME				Miyanari, Yusuke; Torres-Padilla, Maria-Elena			Control of ground-state pluripotency by allelic regulation of Nanog	NATURE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; REPLICATION; MAINTENANCE; EXPRESSION	Pluripotency is established through genome-wide reprogramming during mammalian pre-implantation development, resulting in the formation of the naive epiblast. Reprogramming involves both the resetting of epigenetic marks and the activation of pluripotent-cell-specific genes such as Nanog and Oct4 (also known as Pou5f1)(1-4). The tight regulation of these genes is crucial for reprogramming, but the mechanisms that regulate their expression in vivo have not been uncovered. Here we show that Nanog-but not Oct4-is monoallelically expressed in early pre-implantation embryos. Nanog then undergoes a progressive switch to biallelic expression during the transition towards ground-state pluripotency in the naive epiblast of the late blastocyst. Embryonic stem (ES) cells grown in leukaemia inhibitory factor (LIF) and serum express Nanog mainly monoallelically and show asynchronous replication of the Nanog locus, a feature of monoallelically expressed genes(5), but ES cells activate both alleles when cultured under 2i conditions, which mimic the pluripotent ground state in vitro. Live-cell imaging with reporter ES cells confirmed the allelic expression of Nanog and revealed allelic switching. The allelic expression of Nanog is regulated through the fibroblast growth factor-extracellular signal-regulated kinase signalling pathway, and it is accompanied by chromatin changes at the proximal promoter but occurs independently of DNA methylation. Nanog-heterozygous blastocysts have fewer inner-cell-mass derivatives and delayed primitive endoderm formation, indicating a role for the biallelic expression of Nanog in the timely maturation of the inner cell mass into a fully reprogrammed pluripotent epiblast. We suggest that the tight regulation of Nanog dose at the chromosome level is necessary for the acquisition of ground-state pluripotency during development. Our data highlight an unexpected role for allelic expression in controlling the dose of pluripotency factors in vivo, adding an extra level to the regulation of reprogramming.	[Miyanari, Yusuke; Torres-Padilla, Maria-Elena] Univ Strasbourg, Cite Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire,INSERM,U964, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Torres-Padilla, ME (corresponding author), Univ Strasbourg, Cite Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire,INSERM,U964, F-67404 Illkirch Graffenstaden, France.	metp@igbmc.fr			AVENIR/INSERM; Epigenesys NoE; FRM Alsace; EMBO [ALTF864-2008]; JSPS;  [ANR-09-Blanc-0114]	AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Epigenesys NoE; FRM Alsace; EMBO(European Molecular Biology Organization (EMBO)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	We thank M. Okano for providing the triple DNA methyltransferase knockout cells, P. Avner and P. Clerc for hybrid ES cells, H. Scholer for the Oct4 probe (GOF6.1), J. Jaubert for M. musculus castaneus mice, R. Kemler and S. Rudloff for the Nanog<SUP>Gt1</SUP> mice, G. Charvin for advice on time-lapse analysis. We also thank M. Koch, A. Dierich, M.-C. Birling, E. Heard and I. Okamoto for advice, and A. Burton, E. Heard and O. Pourquie for critical reading of the manuscript. M.-E.T.-P. acknowledges funding from AVENIR/INSERM, ANR-09-Blanc-0114, Epigenesys NoE and FRM Alsace. Y.M. is a recipient of an EMBO long-term fellowship (ALTF864-2008, 2009) and a JSPS postdoctoral fellowship (2010-2011).	Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Jorgensen HF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r169; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sage D, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-17; Shufaro Y, 2010, STEM CELLS, V28, P443, DOI 10.1002/stem.303; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weaver JR, 2009, MAMM GENOME, V20, P532, DOI 10.1007/s00335-009-9225-2; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	27	177	179	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2012	483	7390					470	U123		10.1038/nature10807	http://dx.doi.org/10.1038/nature10807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22327294				2022-12-28	WOS:000301771200044
J	Nasca, TJ; Philibert, I; Brigham, T; Flynn, TC				Nasca, Thomas J.; Philibert, Ingrid; Brigham, Timothy; Flynn, Timothy C.			The Next GME Accreditation System - Rationale and Benefits	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EDUCATION; MEDICINE; COMPETENCE; OUTCOMES; CARE		[Nasca, Thomas J.; Philibert, Ingrid; Brigham, Timothy; Flynn, Timothy C.] Accreditat Council Grad Med Educ, Chicago, IL USA; [Nasca, Thomas J.; Brigham, Timothy] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Flynn, Timothy C.] Univ Florida, Coll Med, Gainesville, FL USA	Jefferson University; State University System of Florida; University of Florida	Nasca, TJ (corresponding author), Accreditat Council Grad Med Educ, Chicago, IL USA.		Philibert, Ingrid/V-2656-2019					Allan J, 1996, STUD HIGH EDUC, V21, P93, DOI 10.1080/03075079612331381487; [Anonymous], 2008, IMP STAT REV PROGR R; [Anonymous], 2011, GRAD MED ED FIN FOC; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Association of American Medical Colleges, 2000, DISC INN PAT CAR RES; Bell Richard H, 2011, Surgeon, V9 Suppl 1, pS10, DOI 10.1016/j.surge.2010.11.007; BENSON JA, 1987, ANN INTERN MED, V107, P775, DOI 10.7326/0003-4819-107-5-775; Betancourt JR, 2006, ACAD MED, V81, P788, DOI 10.1097/00001888-200609000-00004; Council on Graduate Medical Education, 2007, 18 REP NEW PAR PHYS; De Oliveira GS, 2011, J CLIN ANESTH, V23, P176, DOI 10.1016/j.jclinane.2011.02.001; Green Michael L, 2009, J Grad Med Educ, V1, P5, DOI 10.4300/01.01.0003; Hicks Patricia J, 2010, J Grad Med Educ, V2, P410, DOI 10.4300/JGME-D-10-00126.1; Josiah Macy Jr. Foundation, 2011, TEAM BAS COMP BUILD; Josiah Macy Jr. Foundation, 2011, ENS EFF PHYS WORKF U; Kahn MW, 2008, NEW ENGL J MED, V358, P1988, DOI 10.1056/NEJMp0801863; Kumagai AK, 2009, ACAD MED, V84, P782, DOI 10.1097/ACM.0b013e3181a42398; Lypson ML, 2004, ACAD MED, V79, P564, DOI 10.1097/00001888-200406000-00013; McCullough LB, 2011, AM J MED QUAL 1123; Moskowitz EJ, 2007, AM J MED QUAL, V22, P351, DOI 10.1177/1062860607305381; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Norcini J, 2011, MED TEACH, V33, P206, DOI 10.3109/0142159X.2011.551559; Ogrinc G, 2004, J GEN INTERN MED, V19, P496, DOI 10.1111/j.1525-1497.2004.30102.x; Plochg T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-64; Swing Susan R, 2009, J Grad Med Educ, V1, P278, DOI 10.4300/JGME-D-09-00010.1; Varkey Prathibha, 2009, J Grad Med Educ, V1, P93, DOI 10.4300/01.01.0015; Weinstein DF, 2002, NEW ENGL J MED, V347, P1275, DOI 10.1056/NEJMsb022065; Whitcomb ME, 2003, ACAD MED, V78, P112; Zinner DE, 2009, JAMA-J AM MED ASSOC, V302, P969, DOI 10.1001/jama.2009.1265	28	994	1008	6	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2012	366	11					1051	1056		10.1056/NEJMsr1200117	http://dx.doi.org/10.1056/NEJMsr1200117			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908HZ	22356262	Bronze			2022-12-28	WOS:000301482800012
J	Buescher, JM; Liebermeister, W; Jules, M; Uhr, M; Muntel, J; Botella, E; Hessling, B; Kleijn, RJ; Le Chat, L; Lecointe, F; Mader, U; Nicolas, P; Piersma, S; Rugheimer, F; Becher, D; Bessieres, P; Bidnenko, E; Denham, EL; Dervyn, E; Devine, KM; Doherty, G; Drulhe, S; Felicori, L; Fogg, MJ; Goelzer, A; Hansen, A; Harwood, CR; Hecker, M; Hubner, S; Hultschig, C; Jarmer, H; Klipp, E; Leduc, A; Lewis, P; Molina, F; Noirot, P; Peres, S; Pigeonneau, N; Pohl, S; Rasmussen, S; Rinn, B; Schaffer, M; Schnidder, J; Schwikowski, B; Van Dijl, JM; Veiga, P; Walsh, S; Wilkinson, AJ; Stelling, J; Aymerich, S; Sauer, U				Buescher, Joerg Martin; Liebermeister, Wolfram; Jules, Matthieu; Uhr, Markus; Muntel, Jan; Botella, Eric; Hessling, Bernd; Kleijn, Roelco Jacobus; Le Chat, Ludovic; Lecointe, Francois; Maeder, Ulrike; Nicolas, Pierre; Piersma, Sjouke; Ruegheimer, Frank; Becher, Doerte; Bessieres, Philippe; Bidnenko, Elena; Denham, Emma L.; Dervyn, Etienne; Devine, Kevin M.; Doherty, Geoff; Drulhe, Samuel; Felicori, Liza; Fogg, Mark J.; Goelzer, Anne; Hansen, Annette; Harwood, Colin R.; Hecker, Michael; Hubner, Sebastian; Hultschig, Claus; Jarmer, Hanne; Klipp, Edda; Leduc, Aurelie; Lewis, Peter; Molina, Frank; Noirot, Philippe; Peres, Sabine; Pigeonneau, Nathalie; Pohl, Susanne; Rasmussen, Simon; Rinn, Bernd; Schaffer, Marc; Schnidder, Julian; Schwikowski, Benno; Van Dijl, Jan Maarten; Veiga, Patrick; Walsh, Sean; Wilkinson, Anthony J.; Stelling, Joerg; Aymerich, Stephane; Sauer, Uwe			Global Network Reorganization During Dynamic Adaptations of Bacillus subtilis Metabolism	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; YEAST; RECONSTRUCTION; STARVATION; COMPLEXITY; SYSTEMS	Adaptation of cells to environmental changes requires dynamic interactions between metabolic and regulatory networks, but studies typically address only one or a few layers of regulation. For nutritional shifts between two preferred carbon sources of Bacillus subtilis, we combined statistical and model-based data analyses of dynamic transcript, protein, and metabolite abundances and promoter activities. Adaptation to malate was rapid and primarily controlled posttranscriptionally compared with the slow, mainly transcriptionally controlled adaptation to glucose that entailed nearly half of the known transcription regulation network. Interactions across multiple levels of regulation were involved in adaptive changes that could also be achieved by controlling single genes. Our analysis suggests that global trade-offs and evolutionary constraints provide incentives to favor complex control programs.	[Uhr, Markus; Stelling, Joerg] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Buescher, Joerg Martin; Kleijn, Roelco Jacobus; Schnidder, Julian; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Basel, Switzerland; [Liebermeister, Wolfram; Klipp, Edda] Humboldt Univ, D-10115 Berlin, Germany; [Jules, Matthieu; Le Chat, Ludovic; Lecointe, Francois; Noirot, Philippe; Pigeonneau, Nathalie; Aymerich, Stephane] INRA, UMR1319 Micalis, F-78350 Jouy En Josas, France; [Muntel, Jan; Hessling, Bernd; Maeder, Ulrike; Becher, Doerte] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany; [Nicolas, Pierre; Bessieres, Philippe; Goelzer, Anne; Leduc, Aurelie] INRA, UR1077, F-78350 Jouy En Josas, France; [Devine, Kevin M.; Hansen, Annette; Hubner, Sebastian] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Piersma, Sjouke; Denham, Emma L.; Van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands; [Denham, Emma L.; Van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Doherty, Geoff; Lewis, Peter] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Felicori, Liza] Sysdiag CNRS Bio Rad, UMR 3145, F-34184 Montpellier 4, France; [Fogg, Mark J.; Wilkinson, Anthony J.] Univ York, York Struct Biol Lab, Dept Chem, York YO10 5YW, N Yorkshire, England; [Harwood, Colin R.; Pohl, Susanne] Univ Newcastle Tyne, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Hultschig, Claus; Rinn, Bernd; Walsh, Sean] ETH, Ctr Informat Sci & Databases, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Jarmer, Hanne; Rasmussen, Simon] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Ruegheimer, Frank; Drulhe, Samuel; Schwikowski, Benno] Inst Pasteur, Syst Biol Lab, Dept Genomes & Genet, F-75015 Paris, France; [Ruegheimer, Frank; Drulhe, Samuel; Schwikowski, Benno] CNRS, URA 2171, F-75015 Paris, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Humboldt University of Berlin; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ernst Moritz Arndt Universitat Greifswald; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Trinity College Dublin; University of Groningen; University of Groningen; University of Newcastle; Centre National de la Recherche Scientifique (CNRS); University of York - UK; Newcastle University - UK; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Denmark; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Stelling, J (corresponding author), ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.	joerg.stelling@bsse.ethz.ch; stephane.aymerich@grignon.inra.fr; sauer@ethz.ch	van Dijl, Jan Maarten/G-1205-2013; Rasmussen, Simon/AAA-2308-2020; Rasmussen, Simon/G-6258-2016; Veiga, Patrick/A-9862-2011; Stelling, Joerg/F-7499-2010; Felicori, Liza F/I-6683-2013; Jules, Matthieu/GVU-5315-2022; Sauer, Uwe/Y-3556-2019; Becher, Doerte/B-4454-2015; Liebermeister, Wolfram/AAC-7326-2020; Harwood, Colin/AGF-0120-2022; Denham, Emma/P-3979-2014	Rasmussen, Simon/0000-0001-6323-9041; Rasmussen, Simon/0000-0001-6323-9041; Veiga, Patrick/0000-0001-6318-8547; Stelling, Joerg/0000-0002-1145-891X; Jules, Matthieu/0000-0003-0817-8949; Becher, Doerte/0000-0002-9630-5735; Liebermeister, Wolfram/0000-0002-2568-2381; Peres, Sabine/0000-0002-4467-9989; Harwood, Colin/0000-0002-3624-0001; Denham, Emma/0000-0002-5123-4099; Lecointe, Francois/0000-0002-9596-2514; Goelzer, Anne/0000-0003-2222-6142; Schwikowski, Benno/0000-0001-5127-5619; Fogg, Mark/0000-0002-6692-122X; Wilkinson, Anthony/0000-0003-4577-9479; Buescher, Joerg/0000-0002-6547-0076	European Commission [LSHG-CT-2006-037469]; Department of Education, Science and Training [CG110055]; National Health and Medical Research Council [455646]	European Commission(European CommissionEuropean Commission Joint Research Centre); Department of Education, Science and Training; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded through the European Commission 7th Framework project BaSysBio (LSHG-CT-2006-037469), coordinated by P. Noirot, the Department of Education, Science and Training (CG110055), and the National Health and Medical Research Council (455646). Data, algorithms, and mathematical models have been deposited in a publicly accessible relational database (www.basysbio.eu/nutrientshift/ and table S1).	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Botella E, 2010, MICROBIOL-SGM, V156, P1600, DOI 10.1099/mic.0.035758-0; Bradley PH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000270; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Doan T, 2003, MOL MICROBIOL, V47, P1709, DOI 10.1046/j.1365-2958.2003.03404.x; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Haykin S., 2001, REDES NEURAIS PRINC; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kleijn RJ, 2010, J BIOL CHEM, V285, P1587, DOI 10.1074/jbc.M109.061747; Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Moxley JF, 2009, P NATL ACAD SCI USA, V106, P6477, DOI 10.1073/pnas.0811091106; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604; Rossell S, 2006, P NATL ACAD SCI USA, V103, P2166, DOI 10.1073/pnas.0509831103; Sauer U, 2007, SCIENCE, V316, P550, DOI 10.1126/science.1142502; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	23	193	196	4	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1099	1103		10.1126/science.1206871	http://dx.doi.org/10.1126/science.1206871			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383848				2022-12-28	WOS:000300931100047
J	Moughamian, AJ; Holzbaur, ELF				Moughamian, Armen J.; Holzbaur, Erika L. F.			Synaptic Vesicle Distribution by Conveyor Belt	CELL			English	Editorial Material							CYTOPLASMIC DYNEIN; TRANSPORT; DYNACTIN; NEURONS; MOTOR; AXON	The equal distribution of synaptic vesicles among synapses along the axon is critical for robust neurotransmission. Wong et al. show that the continuous circulation of synaptic vesicles throughout the axon driven by molecular motors ultimately yields this even distribution.	[Moughamian, Armen J.; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Holzbaur, ELF (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, D400 Richards Bldg,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu						Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; GAREN SH, 1983, DEV BIOL, V96, P445, DOI 10.1016/0012-1606(83)90182-3; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; WONG, 2012, CELL	13	10	10	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					849	851		10.1016/j.cell.2012.02.007	http://dx.doi.org/10.1016/j.cell.2012.02.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385955	Bronze			2022-12-28	WOS:000300985000007
J	Zhang, Y; McCord, RP; Ho, YJ; Lajoie, BR; Hildebrand, DG; Simon, AC; Becker, MS; Alt, FW; Dekker, J				Zhang, Yu; McCord, Rachel Patton; Ho, Yu-Jui; Lajoie, Bryan R.; Hildebrand, Dominic G.; Simon, Aline C.; Becker, Michael S.; Alt, Frederick W.; Dekker, Job			Spatial Organization of the Mouse Genome and Its Role in Recurrent Chromosomal Translocations	CELL			English	Article							DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; SEQUENCING REVEALS; B-CELLS; C-MYC; MECHANISMS; CANCER; REARRANGEMENTS; LYMPHOCYTES; STABILITY	The extent to which the three-dimensional organization of the genome contributes to chromosomal translocations is an important question in cancer genomics. We generated a high-resolution Hi-C spatial organization map of the G1-arrested mouse pro-B cell genome and used high-throughput genome-wide translocation sequencing to map translocations from target DNA double-strand breaks (DSBs) within it. RAG endonuclease-cleaved antigen-receptor loci are dominant translocation partners for target DSBs regardless of genomic position, reflecting high-frequency DSBs at these loci and their colocalization in a fraction of cells. To directly assess spatial proximity contributions, we normalized genomic DSBs via ionizing radiation. Under these conditions, translocations were highly enriched in cis along single chromosomes containing target DSBs and within other chromosomes and subchromosomal domains in a manner directly related to pre-existing spatial proximity. By combining two high-throughput genomic methods in a genetically tractable system, we provide a new lens for viewing cancer genomes.	[Zhang, Yu; Ho, Yu-Jui; Hildebrand, Dominic G.; Simon, Aline C.; Becker, Michael S.; Alt, Frederick W.] Childrens Hosp, Program Cellular & Mol Med, Immune Dis Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; [Zhang, Yu; Ho, Yu-Jui; Hildebrand, Dominic G.; Simon, Aline C.; Becker, Michael S.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yu; Ho, Yu-Jui; Hildebrand, Dominic G.; Simon, Aline C.; Becker, Michael S.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [McCord, Rachel Patton; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Programs Syst Biol, Worcester, MA 01605 USA; [McCord, Rachel Patton; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Programs Gene Funct & Express, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Alt, FW (corresponding author), Childrens Hosp, Program Cellular & Mol Med, Immune Dis Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu; job.dekker@umassmed.edu		Ho, Yu-jui/0000-0002-7540-024X; Becker, Michael/0000-0001-5502-7444; McCord, Rachel/0000-0003-0010-5323	NIH [3P01CA092625-09S1, R01 HG003143]; Leukemia and Lymphoma Society of America (LLS) SCOR; W.M. Keck Foundation; German National Merit Foundation; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100617] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America (LLS) SCOR; W.M. Keck Foundation(W.M. Keck Foundation); German National Merit Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant ARRA Supplement 3P01CA092625-09S1 and a Leukemia and Lymphoma Society of America (LLS) SCOR grant to F. W. A. and by NIH grant R01 HG003143 and a W.M. Keck Foundation Distinguished Young Scholar Award to J.D. Y.Z. was supported by CRI postdoctoral fellowship. D. G. H., A. C. S., and M. G. B. were supported by the German National Merit Foundation. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Barreca A, 2011, J MOL ENDOCRINOL, V47, pR11, DOI 10.1530/JME-11-0004; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Mahowald GK, 2009, P NATL ACAD SCI USA, V106, P18339, DOI 10.1073/pnas.0902545106; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Ohno H, 2006, J CLIN EXP HEMATOP, V46, P43, DOI 10.3960/jslrt.46.43; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Sengupta K, 2008, CHROMOSOMA, V117, P499, DOI 10.1007/s00412-008-0171-7; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	49	381	398	0	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					908	921		10.1016/j.cell.2012.02.002	http://dx.doi.org/10.1016/j.cell.2012.02.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22341456	Green Accepted, Bronze			2022-12-28	WOS:000300985000012
J	Achterbergh, R; Vermeer, HJ; Curtis, BR; Porcelijn, L; Aster, RH; Deenik, W; Daemen-Gubbels, C				Achterbergh, Roos; Vermeer, Henricus J.; Curtis, Brian R.; Porcelijn, Leendert; Aster, Richard H.; Deenik, Wendy; Daemen-Gubbels, Catharine			Thrombocytopenia in a nutshell	LANCET			English	Editorial Material									[Achterbergh, Roos; Vermeer, Henricus J.; Deenik, Wendy; Daemen-Gubbels, Catharine] Tergooiziekenhuizen, Dept Internal Med, NL-1201 DA Hilversum, Netherlands; [Vermeer, Henricus J.] Albert Schweitzer Hosp, Dordrecht, Netherlands; [Porcelijn, Leendert] Sanquin Blood Supply, Amsterdam, Netherlands; [Curtis, Brian R.; Aster, Richard H.] Blood Ctr Wisconsin, Platelet & Neutrophil Immunol Lab, Milwaukee, WI USA	Albert Schweitzer Ziekenhuis; Versiti Blood Center of Wisconsin	Achterbergh, R (corresponding author), Tergooiziekenhuizen, Dept Internal Med, van Riebeeckweg 212, NL-1201 DA Hilversum, Netherlands.	r.achterbergh@hotmail.com	Curtis, Brian R/AAT-7861-2020	Porcelijn, Leendert/0000-0001-9441-0446	NHLBI NIH HHS [R01 HL013629] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013629] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arnold J, 1998, LANCET, V352, P618, DOI 10.1016/S0140-6736(98)05194-0; CURTIS BR, 1994, BLOOD, V84, P176, DOI 10.1182/blood.V84.1.176.bloodjournal841176; Davies JK, 2001, LANCET, V358, P2126, DOI 10.1016/S0140-6736(01)07220-8; LAVY R, 1964, J ALLERGY, V35, P386, DOI 10.1016/0021-8707(64)90065-6; Royer DJ, 2010, EUR J HAEMATOL, V84, P421, DOI 10.1111/j.1600-0609.2010.01415.x	5	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2012	379	9817					776	776		10.1016/S0140-6736(11)61643-7	http://dx.doi.org/10.1016/S0140-6736(11)61643-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899CU	22364760	Green Accepted			2022-12-28	WOS:000300792600034
J	Canto, JG; Rogers, WJ; Goldberg, RJ; Peterson, ED; Wenger, NK; Vaccarino, V; Kiefe, CI; Frederick, PD; Sopko, G; Zheng, ZJ				Canto, John G.; Rogers, William J.; Goldberg, Robert J.; Peterson, Eric D.; Wenger, Nanette K.; Vaccarino, Viola; Kiefe, Catarina I.; Frederick, Paul D.; Sopko, George; Zheng, Zhi-Jie		NRMI Investigators	Association of Age and Sex With Myocardial Infarction Symptom Presentation and In-Hospital Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; NATIONAL REGISTRY; RISK-FACTORS; WOMEN; SURVIVAL; GENDER	Context Women are generally older than men at hospitalization for myocardial infarction (MI) and also present less frequently with chest pain/discomfort. However, few studies have taken age into account when examining sex differences in clinical presentation and mortality. Objective To examine the relationship between sex and symptom presentation and between sex, symptom presentation, and hospital mortality, before and after accounting for age in patients hospitalized with MI. Design, Setting, and Patients Observational study from the National Registry of Myocardial Infarction, 1994-2006, of 1 143 513 registry patients (481 581 women and 661 932 men). Main Outcome Measures We examined predictors of MI presentation without chest pain and the relationship between age, sex, and hospital mortality. Results The proportion of MI patients who presented without chest pain was significantly higher for women than men (42.0% [95% CI, 41.8%-42.1%] vs 30.7% [95% CI, 30.6%-30.8%]; P<.001). There was a significant interaction between age and sex with chest pain at presentation, with a larger sex difference in younger than older patients, which became attenuated with advancing age. Multivariable adjusted age-specific odds ratios (ORs) for lack of chest pain for women (referent, men) were younger than 45 years, 1.30 (95% CI, 1.23-1.36); 45 to 54 years, 1.26 (95% CI, 1.22-1.30); 55 to 64 years, 1.24 (95% CI, 1.21-1.27); 65 to 74 years, 1.13 (95% CI, 1.11-1.15); and 75 years or older, 1.03 (95% CI, 1.02-1.04). Two-way interaction (sex and age) on MI presentation without chest pain was significant (P<.001). The in-hospital mortality rate was 14.6% for women and 10.3% for men. Younger women presenting without chest pain had greater hospital mortality than younger men without chest pain, and these sex differences decreased or even reversed with advancing age, with adjusted OR for age younger than 45 years, 1.18 (95% CI, 1.00-1.39); 45 to 54 years, 1.13 (95% CI, 1.02-1.26); 55 to 64 years, 1.02 (95% CI, 0.96-1.09); 65 to 74 years, 0.91 (95% CI, 0.88-0.95); and 75 years or older, 0.81 (95% CI, 0.79-0.83). The 3-way interaction (sex, age, and chest pain) on mortality was significant (P<.001). Conclusion In this registry of patients hospitalized with MI, women were more likely than men to present without chest pain and had higher mortality than men within the same age group, but sex differences in clinical presentation without chest pain and in mortality were attenuated with increasing age. JAMA. 2012;307(8):813-822 www.jama.com	[Canto, John G.] Watson Clin, Lakeland, FL 33805 USA; [Canto, John G.] Lakeland Reg Med Ctr, Lakeland, FL USA; [Rogers, William J.] Univ Alabama Birmingham, Med Ctr, Birmingham, AL USA; [Goldberg, Robert J.; Kiefe, Catarina I.] Univ Massachusetts, Med Ctr, Dept Quantitat Hlth Sci, Worcester, MA USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Wenger, Nanette K.; Vaccarino, Viola] Emory Univ, Dept Med, Div Cardiol, Emory Sch Med, Atlanta, GA 30322 USA; [Vaccarino, Viola] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Frederick, Paul D.] ICON Late Phase & Outcomes Res, San Francisco, CA USA; [Sopko, George] NHLBI, NIH, Bethesda, MD 20892 USA; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China	University of Alabama System; University of Alabama Birmingham; University of Massachusetts System; University of Massachusetts Worcester; Duke University; Emory University; Emory University; Rollins School Public Health; ICON plc; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Shanghai Jiao Tong University	Canto, JG (corresponding author), Watson Clin, 1600 Lakeland Hill Blvd, Lakeland, FL 33805 USA.	jcanto@watsonclinic.com	, Viola/AAW-5600-2020; Peterson, Eric David/ABF-5033-2021	Frederick, Paul/0000-0002-7936-5488	National Institutes of Health [U01HL 105268, U54 RR 026088]; Genentech; Bristol-Myers Squibb; sanofi-aventis; Eli Lilly; Schering Plough/Merck; Johnson Johnson; St Jude Inc; Bayer; Pfizer; Merck; NHLBT; Gilead Sciences; Abbott; AstraZeneca; Abbott Women's Advisory Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech(Roche HoldingGenentech); Bristol-Myers Squibb(Bristol-Myers Squibb); sanofi-aventis(Sanofi-Aventis); Eli Lilly(Eli Lilly); Schering Plough/Merck(Merck & CompanySchering Plough Corporation); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); St Jude Inc; Bayer(Bayer AG); Pfizer(Pfizer); Merck(Merck & Company); NHLBT; Gilead Sciences(Gilead Sciences); Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); Abbott Women's Advisory Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kiefe reports receiving partial funding from the National Institutes of Health (grants U01HL 105268 and U54 RR 026088). Mr Frederick reports being an employee of ICON Clinical Research, which received support from Genentech, to provide biostatistical and analytic services. Dr Peterson reported receiving research grants from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly, Schering Plough/Merck, Johnson & Johnson, and St Jude Inc and consultant fees from Bayer and Pfizer. Dr Wenger reported receiving research grants and/or trial committee or data and safety monitoring board compensation from Pfizer, Merck, NHLBT, Gilead Sciences, Abbott, and Eli Lilly; she also reported receiving consultant fees from Gilead Sciences, AstraZeneca, Abbott Women's Advisory Board, Merck, and Pfizer.	Albert CM, 1996, CIRCULATION, V93, P1170, DOI 10.1161/01.CIR.93.6.1170; Benderly M, 1997, AM J EPIDEMIOL, V146, P153; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; Canto JG, 2002, ARCH INTERN MED, V162, P587, DOI 10.1001/archinte.162.5.587; Canto JG, 2007, ARCH INTERN MED, V167, P2405, DOI 10.1001/archinte.167.22.2405; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Hsia J, 2004, AM J CARDIOL, V93, P673, DOI 10.1016/j.amjcard.2003.12.002; JOHANSSON S, 1984, AM J EPIDEMIOL, V119, P610, DOI 10.1093/oxfordjournals.aje.a113778; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Maynard C, 1997, ARCH INTERN MED, V157, P1379, DOI 10.1001/archinte.157.12.1379; ROBINSON K, 1988, J AM COLL CARDIOL, V11, P932, DOI 10.1016/S0735-1097(98)90048-1; Shin JY, 2010, HEART LUNG, V39, P283, DOI 10.1016/j.hrtlng.2009.10.010; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Vaccarino V, 2009, ARCH INTERN MED, V169, P1767, DOI 10.1001/archinternmed.2009.332; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	22	425	440	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					813	822		10.1001/jama.2012.199	http://dx.doi.org/10.1001/jama.2012.199			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FQ	22357832	Green Accepted, Bronze			2022-12-28	WOS:000300551300024
J	Ito, K				Ito, Kouta			Antidepressants were associated with increased risk for adverse outcomes in depressed elders	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Ito, K (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.			Morriss, Richard/0000-0003-2910-4121				Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Nakajima GA, 2007, J AM GERIATR SOC, V55, pS302, DOI 10.1111/j.1532-5415.2007.01336.x	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-13	10.7326/0003-4819-156-4-201202210-02013	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351739				2022-12-28	WOS:000208885400012
J	Qureshi, N; Armstrong, S; Dhiman, P; Saukko, P; Middlemass, J; Evans, PH; Kai, J				Qureshi, Nadeem; Armstrong, Sarah; Dhiman, Paula; Saukko, Paula; Middlemass, Joan; Evans, Philip H.; Kai, Joe		ADDFAM Added Value Family Hist CVD	Effect of Adding Systematic Family History Enquiry to Cardiovascular Disease Risk Assessment in Primary Care	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; COST-EFFECTIVENESS; PRIMARY PREVENTION; IMPACT; FRAMINGHAM; DESIGN; TRIAL; IMPLEMENTATION; INTERVENTION; ATORVASTATIN	Background: Evidence of the value of systematically collecting family history in primary care is limited. Objective: To evaluate the feasibility of systematically collecting family history of coronary heart disease in primary care and the effect of incorporating these data into cardiovascular risk assessment. Design: Pragmatic, matched-pair, cluster randomized, controlled trial. (International Standardized Randomized Controlled Trial Number Register: ISRCTN 17943542). Setting: 24 family practices in the United Kingdom. Participants: 748 persons aged 30 to 65 years with no previously diagnosed cardiovascular risk, seen between July 2007 and March 2009. Intervention: Participants in control practices had the usual Framingham-based cardiovascular risk assessment with and without use of existing family history information in their medical records. Participants in intervention practices also completed a questionnaire to systematically collect their family history. All participants were informed of their risk status. Participants with high cardiovascular risk were invited for a consultation. Measurements: The primary outcome was the proportion of participants with high cardiovascular risk (10-year risk >= 20%). Other measures included questionnaire completion rate and anxiety score. Results: 98% of participants completed the family history questionnaire. The mean increase in proportion of participants classified as having high cardiovascular risk was 4.8 percentage points in the intervention practices, compared with 0.3 percentage point in control practices when family history from patient records was incorporated. The 4.5-percentage point difference between groups (95% CI, 1.7 to 7.2 percentage points) remained significant after adjustment for participant and practice characteristics (P = 0.007). Anxiety scores were similar between groups. Limitations: Relatively few participants were from ethnic minority or less-educated groups. The potential to explore behavioral change and clinical outcomes was limited. Many data were missing for anxiety scores. Conclusion: Systematically collecting family history increases the proportion of persons identified as having high cardiovascular risk for further targeted prevention and seems to have little or no effect on anxiety.	[Qureshi, Nadeem] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; Univ Loughborough, Loughborough, Leics, England; Lincoln Univ, Lincoln, NE USA; Peninsula Med Sch, Exeter, Devon, England	University of Nottingham; Loughborough University; University of Exeter	Qureshi, N (corresponding author), Univ Nottingham, Div Primary Care, Tower Bldg,13th Floor,University Pk, Nottingham NG7 2RD, England.	nadeem.qureshi@nottingham.ac.uk	Saukko, Paula M/G-3341-2019	Evans, Philip/0000-0002-5277-3545; Sach, Tracey/0000-0002-8098-9220; Williams, Laura/0000-0001-6296-6677; Kai, Joe/0000-0001-9040-9384; Humphries, Stephen E/0000-0002-8221-6547; Qureshi, Nadeem/0000-0003-4909-0644	United Kingdom Department of Health [HSR 36A]	United Kingdom Department of Health	By grant HSR 36A from the Genetics Health Services Research program of the United Kingdom Department of Health.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]; Bhopal R, 2005, J PUBLIC HEALTH-UK, V27, P93, DOI 10.1093/pubmed/fdh202; CALNAN M, 1994, BRIT J GEN PRACT, V44, P224; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chamnan P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1693; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cooper A, 2008, CLIN GUIDELINES EVID; De Sutter J, 2003, EUR HEART J, V24, P249, DOI 10.1016/S0195-668X(02)00386-X; Doherty S C, 1998, J Cardiovasc Risk, V5, P147, DOI 10.1097/00043798-199806000-00002; Donner A, 2000, DESIGN ANAL CLUSTER, P100; Feero WG, 2008, J AM MED INFORM ASSN, V15, P723, DOI 10.1197/jamia.M2793; FORD AS, 1983, SOC SCI MED, V17, P1505, DOI 10.1016/0277-9536(83)90095-3; Frezzo TM, 2003, GENET MED, V5, P84, DOI 10.1097/01.GIM.0000055197.23822.5E; GAIL MH, 1992, CONTROL CLIN TRIALS, V13, P6, DOI 10.1016/0197-2456(92)90026-V; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; Hall R, 2007, FAM PRACT, V24, P435, DOI 10.1093/fampra/cmm037; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Jones AF, 2001, HEART, V85, P37, DOI 10.1136/heart.85.1.37; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Lawson KD, 2010, HEART, V96, P208, DOI 10.1136/hrt.2009.177204; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; National Health Service, 2008, PUTT PREV 1 VASC CHE; O'Neill SM, 2009, AM J PREV MED, V36, P506, DOI 10.1016/j.amepre.2009.03.002; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Pijl M, 2009, DIABETES CARE, V32, P597, DOI 10.2337/dc08-1049; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Qureshi N, 2005, FAM PRACT, V22, P663, DOI 10.1093/fampra/cmi073; Qureshi N, 2001, FAM PRACT, V18, P78, DOI 10.1093/fampra/18.1.78; Qureshi N, 2006, THESIS U NOTTINGHAM; Qureshi Nadeem, 2009, Evid Rep Technol Assess (Full Rep), P1; Qureshi N, 2009, BRIT J GEN PRACT, V59, P773, DOI 10.3399/bjgp09X472674; Qureshi N, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-184; Qureshi Nadeem, 2007, Evid Rep Technol Assess (Full Rep), P1; ROE L, 1994, FAM PRACT, V11, P375, DOI 10.1093/fampra/11.4.375; Ruffin MT, 2011, ANN FAM MED, V9, P3, DOI 10.1370/afm.1197; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Sheridan S, 2003, J GEN INTERN MED, V18, P1039, DOI 10.1111/j.1525-1497.2003.30107.x; Stiell IG, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-4; Stiell IG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4146; Valdez R, 2010, ANNU REV PUBL HEALTH, V31, P69, DOI 10.1146/annurev.publhealth.012809.103621; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	48	83	83	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					253	U15		10.7326/0003-4819-156-4-201202210-00002	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00002			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896YO	22351711				2022-12-28	WOS:000300607600001
J	MacArthur, DG; Balasubramanian, S; Frankish, A; Huang, N; Morris, J; Walter, K; Jostins, L; Habegger, L; Pickrell, JK; Montgomery, SB; Albers, CA; Zhang, ZDD; Conrad, DF; Lunter, G; Zheng, HC; Ayub, Q; DePristo, MA; Banks, E; Hu, M; Handsaker, RE; Rosenfeld, JA; Fromer, M; Jin, M; Mu, XJ; Khurana, E; Ye, K; Kay, M; Saunders, GI; Suner, MM; Hunt, T; Barnes, IHA; Amid, C; Carvalho-Silva, DR; Bignell, AH; Snow, C; Yngvadottir, B; Bumpstead, S; Cooper, DN; Xue, YL; Romero, IG; Wang, J; Li, YR; Gibbs, RA; McCarroll, SA; Dermitzakis, ET; Pritchard, JK; Barrett, JC; Harrow, J; Hurles, ME; Gerstein, MB; Tyler-Smith, C				MacArthur, Daniel G.; Balasubramanian, Suganthi; Frankish, Adam; Huang, Ni; Morris, James; Walter, Klaudia; Jostins, Luke; Habegger, Lukas; Pickrell, Joseph K.; Montgomery, Stephen B.; Albers, Cornelis A.; Zhang, Zhengdong D.; Conrad, Donald F.; Lunter, Gerton; Zheng, Hancheng; Ayub, Qasim; DePristo, Mark A.; Banks, Eric; Hu, Min; Handsaker, Robert E.; Rosenfeld, Jeffrey A.; Fromer, Menachem; Jin, Mike; Mu, Xinmeng Jasmine; Khurana, Ekta; Ye, Kai; Kay, Mike; Saunders, Gary Ian; Suner, Marie-Marthe; Hunt, Toby; Barnes, If H. A.; Amid, Clara; Carvalho-Silva, Denise R.; Bignell, Alexandra H.; Snow, Catherine; Yngvadottir, Bryndis; Bumpstead, Suzannah; Cooper, David N.; Xue, Yali; Romero, Irene Gallego; Wang, Jun; Li, Yingrui; Gibbs, Richard A.; McCarroll, Steven A.; Dermitzakis, Emmanouil T.; Pritchard, Jonathan K.; Barrett, Jeffrey C.; Harrow, Jennifer; Hurles, Matthew E.; Gerstein, Mark B.; Tyler-Smith, Chris		1000 Genomes Project Consortium	A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes	SCIENCE			English	Article							POSITIVE SELECTION; ANNOTATION; MECHANISMS; NUMBER; FORM	Genome-sequencing studies indicate that all humans carry many genetic variants predicted to cause loss of function (LoF) of protein-coding genes, suggesting unexpected redundancy in the human genome. Here we apply stringent filters to 2951 putative LoF variants obtained from 185 human genomes to determine their true prevalence and properties. We estimate that human genomes typically contain similar to 100 genuine LoF variants with similar to 20 genes completely inactivated. We identify rare and likely deleterious LoF alleles, including 26 known and 21 predicted severe disease-causing variants, as well as common LoF variants in nonessential genes. We describe functional and evolutionary differences between LoF-tolerant and recessive disease genes and a method for using these differences to prioritize candidate genes found in clinical sequencing studies.	[MacArthur, Daniel G.; Frankish, Adam; Huang, Ni; Morris, James; Walter, Klaudia; Jostins, Luke; Albers, Cornelis A.; Ayub, Qasim; Hu, Min; Kay, Mike; Saunders, Gary Ian; Suner, Marie-Marthe; Hunt, Toby; Barnes, If H. A.; Amid, Clara; Carvalho-Silva, Denise R.; Bignell, Alexandra H.; Snow, Catherine; Yngvadottir, Bryndis; Bumpstead, Suzannah; Xue, Yali; Romero, Irene Gallego; Barrett, Jeffrey C.; Harrow, Jennifer; Hurles, Matthew E.; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [MacArthur, Daniel G.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Balasubramanian, Suganthi; Habegger, Lukas; Jin, Mike; Mu, Xinmeng Jasmine; Khurana, Ekta; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Balasubramanian, Suganthi; Habegger, Lukas; Mu, Xinmeng Jasmine; Khurana, Ekta; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pickrell, Joseph K.; Romero, Irene Gallego; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Montgomery, Stephen B.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Montgomery, Stephen B.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Albers, Cornelis A.] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Albers, Cornelis A.] NHS Blood & Transplant, Cambridge CB2 0PT, England; [Zhang, Zhengdong D.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Conrad, Donald F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Lunter, Gerton] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Zheng, Hancheng; Wang, Jun; Li, Yingrui] BGI Shenzhen, Shenzhen 518083, Peoples R China; [DePristo, Mark A.; Banks, Eric; Handsaker, Robert E.; Fromer, Menachem; McCarroll, Steven A.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Handsaker, Robert E.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Rosenfeld, Jeffrey A.] Univ Med & Dent New Jersey, IST High Performance & Res Comp, Newark, NJ 07103 USA; [Ye, Kai] Leiden Univ, Med Ctr, Mol Epidemiol Sect, NL-2300 RC Leiden, Netherlands; [Amid, Clara] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SD, England; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	Wellcome Trust Sanger Institute; University of Sydney; Yale University; Yale University; University of Chicago; Stanford University; Stanford University; University of Geneva; University of Cambridge; Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); University of Oxford; Wellcome Centre for Human Genetics; Beijing Genomics Institute (BGI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; European Molecular Biology Laboratory (EMBL); Cardiff University; Baylor College of Medicine; Howard Hughes Medical Institute; University of Chicago; Yale University	MacArthur, DG (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	macarthur@atgu.mgh.harvard.edu	Ye, Kai/B-3640-2012; Fromer, Menachem/G-2116-2012; Albers, Kees/A-4170-2015; Lunter, Gerton/H-4939-2016; Khurana, Ekta/C-4933-2013; Cooper, David N/H-4384-2011; Li, Yingrui/K-1064-2015; Wang, Jun/A-7261-2013; Dermitzakis, Emmanouil/B-7687-2013; Ye, Kai/GSD-9856-2022; Mills, Ryan/F-4225-2010; Mu, Xinmeng/P-2562-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Fromer, Menachem/0000-0003-3749-4342; Albers, Kees/0000-0003-4115-3727; Cooper, David N/0000-0002-8943-8484; Ye, Kai/0000-0002-2851-6741; Mills, Ryan/0000-0003-3425-6998; Mu, Xinmeng/0000-0002-8079-0828; Kay, Mike/0000-0002-3282-0834; Balasubramanian, Suganthi/0000-0003-2243-5948; Walter, Klaudia/0000-0003-4448-0301; Amid, Clara/0000-0001-6534-7425; Frankish, Adam/0000-0002-4333-628X; Lunter, Gerton/0000-0002-3798-2058; Leinonen, Rasko/0000-0002-2639-7187; Bignell, alexandra/0000-0002-5926-7020; Snow, Catherine/0000-0002-1672-3532; Wang, Jun/0000-0002-8540-8931; Barrett, Jeffrey/0000-0002-1152-370X; MacArthur, Daniel/0000-0002-5771-2290; Wang, Jun/0000-0002-2113-5874; Montgomery, Stephen/0000-0002-5200-3903; Ayub, Qasim/0000-0003-3291-0917; Gallego Romero, Irene/0000-0003-1613-8998; Carvalho-Silva, Dr D/0000-0001-5662-1840; Keinan, Alon/0000-0002-9760-1122; Clarke, Laura/0000-0002-5989-6898; Saunders, Gary/0000-0002-7468-0008; Hunt, Toby/0000-0001-8377-0841; Harrow, Jennifer/0000-0003-0338-3070	Wellcome Trust [098051, 090532/Z/09/Z]; Australian National Health and Medical Research Council; Swiss National Science Foundation; Louis Jeantet Foundation; NIH-National Institute of Mental Health; Netherlands Organisation for Scientific Research (NWO) [639.021.125]; National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531]; Chinese 863 program [2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240080A]; Danish Natural Science Research Council; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; BBSRC [BB/I02593X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I02593X/1] Funding Source: researchfish; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022707] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis Jeantet Foundation; NIH-National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	T. Shah provided the Pyvoker software used for manual assignment of genotypes based on intensity clusters; S. Edkins was involved in the Sequenom validation; and the genotyping groups at Illumina, the Wellcome Trust Sanger Institute, and The Broad Institute of Harvard and MIT provided raw intensity data for the three Illumina arrays used for genotyping validation. The work performed at the Wellcome Trust Sanger Institute was supported by Wellcome Trust grant 098051; D. G. M. was supported by a fellowship from the Australian National Health and Medical Research Council; G. L. by the Wellcome Trust (090532/Z/09/Z); E. T. D. and S. B. M. by the Swiss National Science Foundation, the Louis Jeantet Foundation, and the NIH-National Institute of Mental Health GTEx fund; K.Y. by the Netherlands Organisation for Scientific Research (NWO) VENI grant 639.021.125; and H.Z., Y.L., and J.W. by a National Basic Research Program of China (973 program no. 2011CB809200), the National Natural Science Foundation of China (30725008, 30890032, 30811130531), the Chinese 863 program (2006AA02A302, 2009AA022707), the Shenzhen Municipal Government of China (grants JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, and ZYC200903240080A), and the Ole Romer grant from the Danish Natural Science Research Council, as well as funding from the Shenzhen Municipal Government and the Local Government of Yantian District of Shenzhen. M. B. G. and C.T.-S. contributed equally to this work as senior authors. J.K.P. is on the scientific advisory board of 23andMe, and R. A. G. has a shared investment in Life Technologies. Raw sequence data for the 1000 Genomes pilot projects are available from www.1000genomes.org, and a curated list of the loss-of-function variants described in this manuscript is provided in the supporting online material.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Balasubramanian S, 2011, GENE DEV, V25, P1, DOI 10.1101/gad.1968411; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casola C, 2012, GENOME RES, V22, P429, DOI 10.1101/gr.127738.111; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fry AE, 2009, HUM MOL GENET, V18, P2683, DOI 10.1093/hmg/ddp192; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; McCune AR, 2002, SCIENCE, V296, P2398, DOI 10.1126/science.1071757; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Uzumcu A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.032904; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26	28	805	822	9	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					823	828		10.1126/science.1215040	http://dx.doi.org/10.1126/science.1215040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344438	Green Published, Green Accepted			2022-12-28	WOS:000300356400036
J	Pagel, M				Pagel, Mark			Adapted to culture	NATURE			English	Editorial Material									Univ Reading, Sch Biol Sci, Reading RG6 2AH, Berks, England	University of Reading	Pagel, M (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 2AH, Berks, England.	m.pagel@reading.ac.uk						Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Heyes CM, 1998, BEHAV BRAIN SCI, V21, P101, DOI 10.1017/S0140525X98000703; Laland KN, 2008, CURR BIOL, V18, pR366, DOI 10.1016/j.cub.2008.02.049; Pagel Mark., 2012, WIRED CULTURE; Pinker S, 2003, BLANK SLATE MODERN D; Ridley M., 2010, RATIONAL OPTIMIST PR; Stringer C, 2011, ORIGIN OUR SPECIES; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	10	18	18	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					297	299		10.1038/482297a	http://dx.doi.org/10.1038/482297a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	892LG	22337031	Bronze			2022-12-28	WOS:000300287100014
J	Plevka, P; Perera, R; Cardosa, J; Kuhn, RJ; Rossmann, MG				Plevka, Pavel; Perera, Rushika; Cardosa, Jane; Kuhn, Richard J.; Rossmann, Michael G.			Crystal Structure of Human Enterovirus 71	SCIENCE			English	Article							PICORNAVIRUS; RECEPTOR; DISEASE		[Plevka, Pavel; Perera, Rushika; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Cardosa, Jane] Sentinext Therapeut, George Town 10050, Malaysia	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	mr@purdue.edu	Plevka, Pavel/H-8661-2014; Perera, Rushika/E-7183-2017; Kuhn, Richard/AAR-2722-2021	Plevka, Pavel/0000-0003-4215-3315; Perera, Rushika/0000-0001-6798-2537; Kuhn, Richard/0000-0003-4148-1026	Department of Energy [DE-AC02-06CH11357]; NIH [AI11219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI011219, R01AI011219] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Advanced Photon Source (supported by the Department of Energy contract DE-AC02-06CH11357) staff, V. Srajer and R. Henning of the BioCARS beamline 14 (NIH National Center for Research Resources RR007707), R. Fischetti of GM/CA beamline 23, and S. Kelly and P. Chipman for their help. Supported by NIH grant AI11219 to M.G.R. Coordinates were deposited with the Protein Data Bank as entry 4AED.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Miyamura K, 2011, J GEN VIROL, V92, P287, DOI 10.1099/vir.0.022418-0; ROSSMANN MG, 1994, PROTEIN SCI, V3, P1712, DOI 10.1002/pro.5560031010; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Rossmann MG, 2002, TRENDS MICROBIOL, V10, P324, DOI 10.1016/S0966-842X(02)02383-1; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	8	152	169	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1274	1274		10.1126/science.1218713	http://dx.doi.org/10.1126/science.1218713			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22383808	Green Accepted			2022-12-28	WOS:000304905300037
J	Johnston, DT; Macdonald, FA; Gill, BC; Hoffman, PF; Schrag, DP				Johnston, D. T.; Macdonald, F. A.; Gill, B. C.; Hoffman, P. F.; Schrag, D. P.			Uncovering the Neoproterozoic carbon cycle	NATURE			English	Article							SNOWBALL-EARTH; GRAND-CANYON; CHUAR GROUP; OCEAN; GLACIATION; HISTORY; CONSTRAINTS; INITIATION; OXIDATION; MONGOLIA	Interpretations of major climatic and biological events in Earth history are, in large part, derived from the stable carbon isotope records of carbonate rocks and sedimentary organic matter(1,2). Neoproterozoic carbonate records contain unusual and large negative isotopic anomalies within long periods (10-100 million years) characterized by delta C-13 in carbonate (delta C-13(carb)) enriched to more than 15 per mil. Classically, delta C-13(carb) is interpreted as a metric of the relative fraction of carbon buried as organic matter in marine sediments(2-4), which can be linked to oxygen accumulation through the stoichiometry of primary production(3,5). If a change in the isotopic composition of marine dissolved inorganic carbon is responsible for these excursions, it is expected that records of delta C-13(carb) and delta C-13 in organic carbon (delta C-13(org)) will covary, offset by the fractionation imparted by primary production(5). The documentation of several Neoproterozoic delta C-13(carb) excursions that are decoupled from delta C-13(org), however, indicates that other mechanisms(6-8) may account for these excursions. Here we present delta C-13 data from Mongolia, northwest Canada and Namibia that capture multiple large-amplitude (over 10 per mil) negative carbon isotope anomalies, and use these data in a new quantitative mixing model to examine the behaviour of the Neoproterozoic carbon cycle. We find that carbonate and organic carbon isotope data from Mongolia and Canada are tightly coupled through multiple delta C-13(carb) excursions, quantitatively ruling out previously suggested alternative explanations, such as diagenesis(7,8) or the presence and terminal oxidation of a large marine dissolved organic carbon reservoir(6). Our data from Namibia, which do not record isotopic covariance, can be explained by simple mixing with a detrital flux of organic matter. We thus interpret delta C-13(carb) anomalies as recording a primary perturbation to the surface carbon cycle. This interpretation requires the revisiting of models linking drastic isotope excursions to deep ocean oxygenation and the opening of environments capable of supporting animals(9-11).	[Johnston, D. T.; Macdonald, F. A.; Gill, B. C.; Hoffman, P. F.; Schrag, D. P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Hoffman, P. F.] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 2Y2, Canada	Harvard University; University of Victoria	Johnston, DT (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	johnston@eps.harvard.edu	Gill, Benjamin C/B-8047-2012	Gill, Benjamin C/0000-0001-7402-0811; Johnston, David/0000-0002-2487-1084	Yukon Geological Survey; NSF [EAR-IF 0949227]; KINSC; ESEP; Harvard University; NASA NAI	Yukon Geological Survey; NSF(National Science Foundation (NSF)); KINSC; ESEP; Harvard University; NASA NAI(National Aeronautics & Space Administration (NASA))	Laboratory assistance was provided by G. Eischeid, E. Northrop, E. Kennedy, T. O'Brien, A. Breus and A. Masterson. We thank G. Halverson, A. Bradley, E. Tziperman and P. Huybers for discussions and comments. We thank the Yukon Geological Survey, the NSF (grant number EAR-IF 0949227 to D. T. J.), KINSC (Haverford College), Henry and Wendy Breck (to D. P. S.), ESEP (Canadian Institute for Advanced Research, to P. F. H.), Harvard University and NASA NAI (D. T. J. and F. A. M.) for	Bjerrum CJ, 2011, P NATL ACAD SCI USA, V108, P5542, DOI 10.1073/pnas.1101755108; Bristow TF, 2008, GEOLOGY, V36, P863, DOI 10.1130/G24968A.1; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Dehler CM, 2005, GEOL SOC AM BULL, V117, P32, DOI 10.1130/B25471.1; Derry LA, 2010, EARTH PLANET SC LETT, V294, P152, DOI 10.1016/j.epsl.2010.03.022; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Halverson GP, 2010, PRECAMBRIAN RES, V182, P337, DOI 10.1016/j.precamres.2010.04.007; Halverson GP, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000244; Halverson GP, 2005, GEOL SOC AM BULL, V117, P1181, DOI 10.1130/B25630.1; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hoffmann KH, 2004, GEOLOGY, V32, P817, DOI 10.1130/G20519.1; Johnston DT, 2010, EARTH PLANET SC LETT, V290, P64, DOI 10.1016/j.epsl.2009.11.059; Kaufman AJ, 1997, P NATL ACAD SCI USA, V94, P6600, DOI 10.1073/pnas.94.13.6600; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; Levashova NM, 2010, TECTONOPHYSICS, V485, P306, DOI 10.1016/j.tecto.2010.01.012; Macdonald FA, 2010, SCIENCE, V327, P1241, DOI 10.1126/science.1183325; Macdonald FA, 2009, GEOLOGY, V37, P123, DOI 10.1130/G24797A.1; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; McCay GA, 2006, GEOLOGY, V34, P909, DOI 10.1130/G22694A.1; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; McKirdy DM, 2001, PRECAMBRIAN RES, V106, P149, DOI 10.1016/S0301-9268(00)00130-3; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Schrag DP, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000219; Swanson-Hysell NL, 2010, SCIENCE, V328, P608, DOI 10.1126/science.1184508; Tziperman E, 2011, P NATL ACAD SCI USA, V108, P15091, DOI 10.1073/pnas.1016361108	30	131	134	5	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					320	U110		10.1038/nature10854	http://dx.doi.org/10.1038/nature10854			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22388817	Green Submitted			2022-12-28	WOS:000301481800046
J	Charchar, FJ; Bloomer, LDS; Barnes, TA; Cowley, MJ; Nelson, CP; Wang, YZ; Denniff, M; Debiec, R; Christofidou, P; Nankervis, S; Dominiczak, AF; Bani-Mustafa, A; Balmforth, AJ; Hall, AS; Erdmann, J; Cambien, F; Deloukas, P; Hengstenberg, C; Packard, C; Schunkert, H; Ouwehand, WH; Ford, I; Goodall, AH; Jobling, MA; Samani, NJ; Tomaszewski, M				Charchar, Fadi J.; Bloomer, Lisa D. S.; Barnes, Timothy A.; Cowley, Mark J.; Nelson, Christopher P.; Wang, Yanzhong; Denniff, Matthew; Debiec, Radoslaw; Christofidou, Paraskevi; Nankervis, Scott; Dominiczak, Anna F.; Bani-Mustafa, Ahmed; Balmforth, Anthony J.; Hall, Alistair S.; Erdmann, Jeanette; Cambien, Francois; Deloukas, Panos; Hengstenberg, Christian; Packard, Chris; Schunkert, Heribert; Ouwehand, Willem H.; Ford, Ian; Goodall, Alison H.; Jobling, Mark A.; Samani, Nilesh J.; Tomaszewski, Maciej			Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome	LANCET			English	Article							BLOOD-PRESSURE; LEUKOCYTE RECRUITMENT; ASSOCIATION ANALYSIS; HAPLOGROUP-I; ATHEROSCLEROSIS; MORTALITY; RISK	Background A sexual dimorphism exists in the incidence and prevalence of coronary artery disease-men are more commonly affected than are age-matched women. We explored the role of the Y chromosome in coronary artery disease in the context of this sexual inequity. Methods We genotyped 11 markers of the male-specific region of the Y chromosome in 3233 biologically unrelated British men from three cohorts: the British Heart Foundation Family Heart Study (BHF-FHS), West of Scotland Coronary Prevention Study (WOSCOPS), and Cardiogenics Study. On the basis of this information, each Y chromosome was tracked back into one of 13 ancient lineages defined as haplogroups. We then examined associations between common Y chromosome haplogroups and the risk of coronary artery disease in cross-sectional BHF-FHS and prospective WOSCOPS. Finally, we undertook functional analysis of Y chromo some effects on monocyte and macrophage transcriptome in British men from the Cardiogenics Study. Findings Of nine haplogroups identified, two (R1b1b2 and I) accounted for roughly 90% of the Y chromosome variants among British men. Carriers of haplogroup I had about a 50% higher age-adjusted risk of coronary artery disease than did men with other Y chromosome lineages in BHF-FHS (odds ratio 1.75, 95% CI 1.20-2.54, p=0.004), WOSCOPS (1.45, 1.08-1.95, p=0.012), and joint analysis of both populations (1.56, 1.24-1.97, p=0.0002). The association between haplogroup I and increased risk of coronary artery disease was independent of traditional cardiovascular and socioeconomic risk factors. Analysis of macrophage transcriptome in the Cardiogenics Study revealed that 19 molecular pathways showing strong differential expression between men with haplogroup I and other lineages of the Y chromosome were interconnected by common genes related to inflammation and immunity, and that some of them have a strong relevance to atherosclerosis. Interpretation The human Y chromosome is associated with risk of coronary artery disease in men of European ancestry, possibly through interactions of immunity and inflammation.	[Bloomer, Lisa D. S.; Barnes, Timothy A.; Nelson, Christopher P.; Denniff, Matthew; Debiec, Radoslaw; Christofidou, Paraskevi; Goodall, Alison H.; Samani, Nilesh J.; Tomaszewski, Maciej] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Charchar, Fadi J.; Nankervis, Scott; Bani-Mustafa, Ahmed] Univ Ballarat, Sch Hlth Sci, Ballarat, Vic 3353, Australia; [Jobling, Mark A.] Univ Leicester, Dept Genet, Leicester LE3 9QP, Leics, England; [Cowley, Mark J.] Garvan Inst Med Res, Wills Bioinformat Ctr, Sydney, NSW, Australia; [Wang, Yanzhong] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Dominiczak, Anna F.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Packard, Chris] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Packard, Chris] Univ Glasgow, Dept Vasc Biochem, Glasgow, Lanark, Scotland; [Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, Div Epidemiol, LIGHT, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Erdmann, Jeanette] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, Paris, France; [Cambien, Francois] Sch Med, Paris, France; [Deloukas, Panos; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Hengstenberg, Christian] Univ Regensburg, Poliklin Innere Med 2, Regensburg, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Nelson, Christopher P.; Goodall, Alison H.; Samani, Nilesh J.; Tomaszewski, Maciej] Glenfield Gen Hosp, Natl Inst Hlth Res, Biomed Res Unit, Leicester LE3 9QP, Leics, England	University of Leicester; Federation University Australia; University of Leicester; Garvan Institute of Medical Research; University of London; King's College London; University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow; University of Leeds; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Wellcome Trust Sanger Institute; University of Regensburg; University of Cambridge; NHS Blood & Transplant (NHSBT); University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Tomaszewski, M (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Leicester LE3 9QP, Leics, England.	mt142@le.ac.uk	Cowley, Mark/D-4504-2012; Erdmann, Jeanette/P-7513-2014; Simon, Simon/D-5128-2012; Ford, Ian/ABE-6145-2020; Cambien, Francois/AAP-9751-2020; Cowley, Mark/K-8731-2019; Hengstenberg, Christian/U-5485-2019; Hall, Alistair/K-1953-2019; Deloukas, Panos/B-2922-2013; Erdmann, Jeanette/A-4417-2009; Wang, Yanzhong/GRY-3114-2022; Bani-Mustafa, Ahmed/K-8552-2019; Charchar, Fadi/I-6656-2017; Dominiczak, Anna F/P-9390-2017; Bani-Mustafa, Ahmed/V-9297-2018	Erdmann, Jeanette/0000-0002-4486-6231; Cowley, Mark/0000-0002-9519-5714; Deloukas, Panos/0000-0001-9251-070X; Charchar, Fadi/0000-0002-6164-9941; Dominiczak, Anna F/0000-0003-4913-3608; Ouwehand, Willem/0000-0002-7744-1790; Nelson, Christopher/0000-0001-8025-2897; Tomaszewski, Maciej/0000-0001-8215-6567; Bani-Mustafa, Ahmed/0000-0003-4083-1952; Wang, Yanzhong/0000-0002-0768-1676; Nankervis, Scott/0000-0003-3455-7424; Goodall, Alison/0000-0002-7883-9645; Jobling, Mark/0000-0002-8061-1308; Debiec, Radoslaw/0000-0003-2292-467X; Hall, Alistair/0000-0003-0306-7887	British Heart Foundation [PG/06/097/21331]; UK National Institute for Health Research; LEW Carty Charitable Fund; National Health and Medical Research Council of Australia; European Union [LSHM-CT-2006-037593]; Wellcome Trust [WT-0841383/2/07/2]; Cambridge NIHR Biomedical Research Centre; NIHR [RP-PG-0310-1002]; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation [PG/12/9/29376] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK National Institute for Health Research(National Institute for Health Research (NIHR)); LEW Carty Charitable Fund; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	British Heart Foundation; UK National Institute for Health Research; LEW Carty Charitable Fund; National Health and Medical Research Council of Australia; European Union 6th Framework Programme; Wellcome Trust.; This study was funded by the British Heart Foundation project grant (PG/06/097/21331) to MT. NJS holds a personal chair supported by the British Heart Foundation and is a UK National Institute for Health Research (NIHR) senior investigator. FJC is supported by research grants from the LEW Carty Charitable Fund and National Health and Medical Research Council of Australia. The Cardiogenics project was supported by the European Union 6th Framework Programme (LSHM-CT-2006-037593). Contributors to Cardiogenics Transcriptome Study are listed in the webappendix p 16. AFD held a personal chair supported by the British Heart Foundation between 2006 and 2010. MAJ is a Wellcome Trust senior fellow in biomedical science (087576). Collection of healthy participants for this study was supported by the Cambridge NIHR Biomedical Research Centre and by an NIHR programme grant to WHO (RP-PG-0310-1002) and a project grant from the Wellcome Trust to WHO (WT-0841383/2/07/2). Work described in this paper is part of the research portfolio supported by the Leicester NIHR Biomedical Research Unit in Cardiovascular Disease.	Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P839, DOI 10.1136/jech.2009.088427; Braunersreuther V, 2006, CELL MOL LIFE SCI, V63, P2079, DOI 10.1007/s00018-006-6127-2; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Charchar FJ, 2004, ARTERIOSCL THROM VAS, V24, P308, DOI 10.1161/01.ATV.0000113291.39267.0a; Charchar FJ, 2003, TRENDS ENDOCRIN MET, V14, P163, DOI 10.1016/S1043-2760(03)00032-8; Charchar FJ, 2002, HYPERTENSION, V39, P353, DOI 10.1161/hy0202.103413; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Curtiss LK, 2009, NEW ENGL J MED, V360, P1144, DOI 10.1056/NEJMcibr0810383; Ellis JA, 2000, HYPERTENSION, V36, P731, DOI 10.1161/01.HYP.36.5.731; Ellis N, 2002, GENOME RES, V12, P339; Ely D, 2010, STEROIDS, V75, P747, DOI 10.1016/j.steroids.2009.10.015; Eriksson EE, 2004, CURR OPIN LIPIDOL, V15, P553, DOI 10.1097/00041433-200410000-00009; Graves JAM, 2006, CURR OPIN GENET DEV, V16, P219, DOI 10.1016/j.gde.2006.04.007; Hagg S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000754; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Higgins CD, 2007, HUM GENET, V121, P691, DOI 10.1007/s00439-007-0365-8; Holmes MV, 2011, NAT REV CARDIOL, V8, P207, DOI 10.1038/nrcardio.2011.6; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; King TE, 2009, MOL BIOL EVOL, V26, P1093, DOI 10.1093/molbev/msp022; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Liu H, 2011, NUCLEIC ACIDS RES, V39, pD991, DOI 10.1093/nar/gkq1106; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; McCarthy M, 2000, LANCET, V356, P1088, DOI 10.1016/S0140-6736(05)74535-9; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Peisajovich A, 2008, EXPERT REV CLIN IMMU, V4, P379, DOI 10.1586/1744666X.4.3.379; Preuss M, 2010, CIRC-CARDIOVASC GENE, V3, P475, DOI 10.1161/CIRCGENETICS.109.899443; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sezgin E, 2009, HUM GENET, V125, P281, DOI 10.1007/s00439-008-0620-7; Shankar RR, 2007, AM J HYPERTENS, V20, P27, DOI 10.1016/j.amjhyper.2006.06.013; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ulrich S, 1999, LANCET, V353, P925, DOI 10.1016/S0140-6736(05)75030-3; van Gils JM, 2009, J LEUKOCYTE BIOL, V85, P195, DOI 10.1189/jlb.0708400; Vollset SE, 2010, SCAND J PUBLIC HEALT, V38, P127, DOI 10.1177/1403494810379893; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562	47	150	152	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2012	379	9819					915	922		10.1016/S0140-6736(11)61453-0	http://dx.doi.org/10.1016/S0140-6736(11)61453-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906NY	22325189	Green Submitted, Green Published			2022-12-28	WOS:000301353700031
J	Hogarth, A; Graham, L; Baig, W; Tayebjee, M				Hogarth, Andrew; Graham, Lee; Baig, Wazir; Tayebjee, Muzahir			Syncope: a rare manifestation of a common condition	LANCET			English	Editorial Material							VENTRICULAR-FIBRILLATION; ISCHEMIA		[Hogarth, Andrew; Graham, Lee; Baig, Wazir; Tayebjee, Muzahir] Leeds Gen Infirm, Yorkshire Heart Ctr, Dept Cardiol, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Hogarth, A (corresponding author), Leeds Gen Infirm, Yorkshire Heart Ctr, Dept Cardiol, Leeds LS1 3EX, W Yorkshire, England.	andy_hogarth2003@yahoo.co.uk						INTERIAN A, 1987, AM J CARDIOL, V59, P1200, DOI 10.1016/0002-9149(87)90877-0; Makikallio TH, 2002, ANN MED, V34, P130, DOI 10.1080/07853890252953527; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Mustafa MUA, 1998, HEART, V80, P86, DOI 10.1136/hrt.80.1.86; Vlay SC, 2000, PACE, V23, P1576, DOI 10.1046/j.1460-9592.2000.01576.x	5	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2012	379	9818					866	866		10.1016/S0140-6736(11)61787-X	http://dx.doi.org/10.1016/S0140-6736(11)61787-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901RB	22386039				2022-12-28	WOS:000300983400037
J	Zhang, LX; Wang, F; Wang, L; Wang, WK; Liu, BC; Liu, J; Chen, MH; He, Q; Liao, YH; Yu, XQ; Chen, N; Zhang, JE; Hu, Z; Liu, FY; Hong, DQ; Ma, LJ; Liu, H; Zhou, XL; Chen, JH; Pan, L; Chen, W; Wang, WM; Li, XM; Wang, HY				Zhang, Luxia; Wang, Fang; Wang, Li; Wang, Wenke; Liu, Bicheng; Liu, Jian; Chen, Menghua; He, Qiang; Liao, Yunhua; Yu, Xueqing; Chen, Nan; Zhang, Jian-e; Hu, Zhao; Liu, Fuyou; Hong, Daqing; Ma, Lijie; Liu, Hong; Zhou, Xiaoling; Chen, Jianghua; Pan, Ling; Chen, Wei; Wang, Weiming; Li, Xiaomei; Wang, Haiyan			Prevalence of chronic kidney disease in China: a cross-sectional survey	LANCET			English	Article							GLOMERULAR-FILTRATION-RATE; RISK-FACTORS; POPULATION; EPIDEMIOLOGY; HYPERTENSION; ALBUMINURIA; ASSOCIATION; BURDEN; WOMEN; CKD	Background The prevalence of chronic kidney disease is high in developing countries. However, no national survey of chronic kidney disease has been done incorporating both estimated glomerular filtration rate (eGFR) and albuminuria in a developing country with the economic diversity of China. We aimed to measure the prevalence of chronic kidney disease in China with such a survey. Methods We did a cross-sectional survey of a nationally representative sample of Chinese adults. Chronic kidney disease was defined as eGFR less than 60 mL/min per 1.73 m(2) or the presence of albuminuria. Participants completed a lifestyle and medical history questionnaire and had their blood pressure measured, and blood and urine samples taken. Serum creatinine was measured and used to estimate glomerular filtration rate. Urinary albumin and creatinine were tested to assess albuminuria. The crude and adjusted prevalence of indicators of kidney damage were calculated and factors associated with the presence of chronic kidney disease analysed by logistic regression. Findings 50 550 people were invited to participate, of whom 47 204 agreed. The adjusted prevalence of eGFR less than 60 mL/min per 1.73 m(2) was 1.7% (95% CI 1.5-1.9) and of albuminuria was 9.4% (8.9-10.0). The overall prevalence of chronic kidney disease was 10.8% (10.2-11.3); therefore the number of patients with chronic kidney disease in China is estimated to be about 119.5 million (112.9-125.0 million). In rural areas, economic development was independently associated with the presence of albuminuria. The prevalence of chronic kidney disease was high in north (16.9% [15.1-18.7]) and southwest (18.3% [16.4-20.4]) regions compared with other regions. Other factors independently associated with kidney damage were age, sex, hypertension, diabetes, history of cardiovascular disease, hyperuricaemia, area of residence, and economic status. Interpretation Chronic kidney disease has become an important public health problem in China. Special attention should be paid to residents in economically improving rural areas and specific geographical regions in China.	[Zhang, Luxia; Wang, Fang; Li, Xiaomei; Wang, Haiyan] Peking Univ, Hosp 1, Div Nephrol, Inst Nephrol, Beijing 100871, Peoples R China; [Wang, Li; Hong, Daqing] Sichuan Acad Med Sci, Div Nephrol, Chengdu, Peoples R China; [Wang, Li; Hong, Daqing] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Wang, Wenke; Ma, Lijie] Chifeng Second Hosp, Div Nephrol, Chifeng, Peoples R China; [Liu, Bicheng; Liu, Hong] Southwest Univ, Zhongda Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Liu, Bicheng; Liu, Hong] Southwest Univ, Zhongda Hosp, Div Nephrol, Nanjing, Jiangsu, Peoples R China; [Liu, Jian] Xinjiang Med Univ, Hosp 1, Div Nephrol, Uramuqi, Peoples R China; [Chen, Menghua; Zhou, Xiaoling] Ningxia Univ Med, Affiliated Hosp, Div Nephrol, Yinchuan, Peoples R China; [He, Qiang; Chen, Jianghua] Zhejiang Univ, Affiliated Hosp 1, Div Nephrol, Hangzhou 310003, Zhejiang, Peoples R China; [Liao, Yunhua; Pan, Ling] Guangxi Univ Med, Affiliated Hosp 1, Div Nephrol, Nanning, Peoples R China; [Yu, Xueqing; Chen, Wei] Sun Yat Sen Univ, Affiliated Hosp 1, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Nan; Wang, Weiming] Shanghai Jiao Tong Univ, Ruijin Hosp, Div Nephrol, Shanghai 200030, Peoples R China; [Zhang, Jian-e] Hubei Univ Med, Taihe Hosp, Div Nephrol, Shiyan, Peoples R China; [Hu, Zhao] Shandong Univ, Qilu Hosp, Div Nephrol, Jinan 250100, Peoples R China; [Liu, Fuyou] Cent S Univ, Xiangya Hosp 2, Div Nephrol, Changsha, Peoples R China	Peking University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Southeast University - China; Southwest University - China; Southeast University - China; Southwest University - China; Xinjiang Medical University; Ningxia Medical University; Zhejiang University; Guangxi Medical University; Sun Yat Sen University; Shanghai Jiao Tong University; Hubei University of Medicine; Shandong University; Central South University	Wang, HY (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China.	why@bjmu.edu.cn	zhou, xuan/GZA-8157-2022	Luxia, Zhang/0000-0003-2349-2936	Ministry of Science and Technology (China) [2007BAI04B10]; Science and Technology Commission of Shanghai [08dz1900502, 07JC14037]; Natural Science Funds of Ning Xia [NZ08102]; Science and Technology Department [30660069]; National Natural Science Foundation of China; Department of Health, Jiangsu Province [H200936]; Sichuan Science and Technology Department [05SG1635]; Ministry of Education (China) [BMU2009131]; International Society of Nephrology Research Committee; China Health and Medical Development Foundation	Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Funds of Ning Xia; Science and Technology Department(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health, Jiangsu Province; Sichuan Science and Technology Department; Ministry of Education (China)(Ministry of Education, China); International Society of Nephrology Research Committee; China Health and Medical Development Foundation	This study was supported by the National Key Technology R&D Program from the Ministry of Science and Technology (China; 2007BAI04B10); the Science and Technology Commission of Shanghai (08dz1900502 and 07JC14037); the Natural Science Funds of Ning Xia (NZ08102); the Science and Technology Department, the National Natural Science Funds (30660069); the National Natural Science Foundation of China; the Department of Health, Jiangsu Province (H200936); the Key Scientific and Technology Project from the Sichuan Science and Technology Department (05SG1635); the Program for New Century Excellent Talents in University from the Ministry of Education (China; BMU2009131); the International Society of Nephrology Research Committee; and the China Health and Medical Development Foundation. We thank Yong Jiang of the Chinese Center for Disease Control and Prevention for his contribution to the design of the study and statistical support, and William G Couser for constructive comments for the report.	Agarwal SK, 2005, NEPHROL DIAL TRANSPL, V20, P1638, DOI 10.1093/ndt/gfh855; [Anonymous], 1994, Vital Health Stat 1, P1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bello AK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09802.x; Chen N, 2009, NEPHROL DIAL TRANSPL, V24, P2117, DOI 10.1093/ndt/gfn767; Chen W, 2011, NEPHROL DIAL TRANSPL, V26, P1592, DOI 10.1093/ndt/gfq608; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P201; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Ito J, 2008, NEPHRON CLIN PRACT, V109, pC25, DOI 10.1159/000134379; Jin S, 2008, 10 REPORT CHINESE NA; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Lin L, 2002, ZHONGHUA YU FANG YI, V36, P5; LIU LS, 1990, CLIN EXP HYPERTENS A, V12, P831; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; O'Donnell JK, 2011, NEPHROL DIAL TRANSPL, V26, P2798, DOI 10.1093/ndt/gfq385; Shi L, 2006, TISSUE ANTIGENS, V67, P38, DOI 10.1111/j.1399-0039.2005.00526.x; Varma PP, 2010, NEPHROL DIAL TRANSPL, V25, P3011, DOI 10.1093/ndt/gfq131; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang LX, 2009, SEMIN NEPHROL, V29, P483, DOI 10.1016/j.semnephrol.2009.06.012	31	1300	1872	46	639	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2012	379	9818					815	822		10.1016/S0140-6736(12)60033-6	http://dx.doi.org/10.1016/S0140-6736(12)60033-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901RB	22386035				2022-12-28	WOS:000300983400031
J	Bennett, VC				Bennett, Vickie C.			Probing the Mantle Past	SCIENCE			English	Editorial Material							EARTHS MANTLE		Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	Australian National University	Bennett, VC (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia.	bennett@anu.au.edu		Bennett, Vickie/0000-0003-0937-3471				Bennett VC, 2002, GEOCHIM COSMOCHIM AC, V66, P2615, DOI 10.1016/S0016-7037(02)00862-1; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; FROUDE DO, 1983, NATURE, V304, P616, DOI 10.1038/304616a0; Jackson MG, 2010, NATURE, V466, P853, DOI 10.1038/nature09287; Maier WD, 2009, NATURE, V460, P620, DOI 10.1038/nature08205; Solomatov VS, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005319; Touboul M, 2012, SCIENCE, V335, P1065, DOI 10.1126/science.1216351; Willbold M, 2011, NATURE, V477, P195, DOI 10.1038/nature10399	8	0	0	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1051	1052		10.1126/science.1219126	http://dx.doi.org/10.1126/science.1219126			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383835				2022-12-28	WOS:000300931100030
J	Chipuk, JE; McStay, GP; Bharti, A; Kuwana, T; Clarke, CJ; Siskind, LJ; Obeid, LM; Green, DR				Chipuk, Jerry E.; McStay, Gavin P.; Bharti, Archana; Kuwana, Tomomi; Clarke, Christopher J.; Siskind, Leah J.; Obeid, Lina M.; Green, Douglas R.			Sphingolipid Metabolism Cooperates with BAK and BAX to Promote the Mitochondrial Pathway of Apoptosis	CELL			English	Article							RADIATION-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; OUTER-MEMBRANE; CELL-DEATH; BH3 DOMAINS; CERAMIDE; SPHINGOMYELINASE; IDENTIFICATION; INHIBITION; SPHINGOSINE-1-PHOSPHATE	Mitochondria are functionally and physically associated with heterotypic membranes, yet little is known about how these interactions impact mitochondrial outer-membrane permeabilization (MOMP) and apoptosis. We observed that dissociation of heterotypic membranes from mitochondria inhibited BAK/BAX-dependent cytochrome c (cyto c) release. Biochemical purification of neutral sphingomyelinases that correlated with MOMP sensitization suggested that sphingolipid metabolism coordinates BAK/BAX activation. Using purified lipids and enzymes, sensitivity to MOMP was achieved by in vitro reconstitution of the sphingolipid metabolic pathway. Sphingolipid metabolism inhibitors blocked MOMP from heavy membrane preparations but failed to influence MOMP in the presence of sphingolipid-reconstituted, purified mitochondria. Furthermore, the sphingolipid products, sphingosine-1-PO4 and hexadecenal, cooperated specifically with BAK and BAX, respectively. Sphingolipid metabolism was also required for cellular responses to apoptosis. Our studies suggest that BAK/BAX activation and apoptosis are coordinated through BH3-only proteins and a specific lipid milieu that is maintained by heterotypic membrane-mitochondrial interactions.	[Chipuk, Jerry E.; Bharti, Archana] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [McStay, Gavin P.; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Kuwana, Tomomi] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52252 USA; [Clarke, Christopher J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Siskind, Leah J.; Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Siskind, Leah J.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Div Gen Med & Geriatr, Charleston, SC 29425 USA	Icahn School of Medicine at Mount Sinai; St Jude Children's Research Hospital; University of Iowa; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Chipuk, JE (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA.	jerry.chipuk@mssm.edu; douglas.green@stjude.org	Green, Douglas R/N-8083-2018; McStay, Gavin/K-9574-2013	Green, Douglas R/0000-0002-7332-1417; McStay, Gavin/0000-0003-1363-8719; obeid, lina/0000-0002-0734-0847; Chipuk, Jerry Edward/0000-0002-1337-842X; Siskind, Leah/0000-0001-5026-5187	NIH [CA157740, P20AA017067, AI52735, CA69381, AG024478]; NCI Cancer Center Core [P30CA21765]; VA Merit; VA [CDA-2]; VA REAP; ACS [IRG-97-219-11]; Cancer Center [P30 CA138313]; COBRE in Lipidomics and Pathobiology [NIH/NCRRP20 RR17677]; American Lebanese Syrian Associated Charities; March of Dimes Foundation [5-FY11-74]; NATIONAL CANCER INSTITUTE [P01CA069381, R01CA157740, P30CA138313, P30CA021765] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); VA Merit(US Department of Veterans Affairs); VA(US Department of Veterans Affairs); VA REAP; ACS(American Cancer Society); Cancer Center; COBRE in Lipidomics and Pathobiology; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); March of Dimes Foundation(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We would like to thank Dr. Ronald Gordon (MSSM) for TEM analysis; Dr. Richard Kolesnick (Memorial Sloan-Kettering) for the asm<SUP>-/-</SUP> liver; Dr. Joseph Opferman (SJCRH) for the MxCre bak<SUP>-/-</SUP> bax<SUP>-/f</SUP> animals; all members of the Obeid and Hannun laboratories (MUSC) for excellent discussion and training in sphingolipid biology, especially Drs. K. Alexa Orr Gandy, Stefka Spassieva, and Xingjun Wu; The Hartwell Center for Bioinformatics and Biotechnology; and members of the Kuwana Laboratory for technical assistance. This work was supported by: NIH CA157740 (to J.E.C.), pilot project from NIH P20AA017067 (to J.E.C.), NIH AI52735 (to D. R. G.), CA69381 (to D. R. G.), NIH AG024478 (to T. K.), an NCI Cancer Center Core Grant P30CA21765 (SJCRH), VA Merit (to L.M.O.), VA CDA-2 Award (to L.J.S), pilot project from the VA REAP (to L.J.S., and L.M.O.), the ACS IRG # IRG-97-219-11 (subaward to L.J.S.), Lipidomics Shared Resource of the Hollings Cancer Center supported by a Cancer Center Support Grant (P30 CA138313), pilot project (to L.J.S) from the NIH/NCRRP20 RR17677 COBRE in Lipidomics and Pathobiology, and the American Lebanese Syrian Associated Charities. This work was also supported in part by a Research Grant 5-FY11-74 from the March of Dimes Foundation (to J.E.C.).	Alphonse G, 2004, ONCOGENE, V23, P2703, DOI 10.1038/sj.onc.1207357; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Clarke CJ, 2011, BIOCHEM J, V435, P381, DOI 10.1042/BJ20101752; Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Demircan B, 2009, GENE CHROMOSOME CANC, V48, P83, DOI 10.1002/gcc.20620; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Kumar A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.3; Kumar A, 2011, CELL SIGNAL, V23, P1144, DOI 10.1016/j.cellsig.2011.02.009; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pyne NJ, 2009, ADV ENZYME REGUL, V49, P214, DOI 10.1016/j.advenzreg.2009.01.011; Rodriguez-Lafrasse C, 2002, INT J CANCER, V101, P589, DOI 10.1002/ijc.10652; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; WAGNER T, 1977, EXP CELL RES, V107, P1, DOI 10.1016/0014-4827(77)90379-2; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yabu T, 2009, J BIOL CHEM, V284, P20349, DOI 10.1074/jbc.M109.004580; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yang Z, 2006, FEMS YEAST RES, V6, P751, DOI 10.1111/j.1567-1364.2006.00052.x; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	62	298	311	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					988	1000		10.1016/j.cell.2012.01.038	http://dx.doi.org/10.1016/j.cell.2012.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385963	Green Accepted, Bronze			2022-12-28	WOS:000300985000018
J	Henry, GT; Fortner, CK; Bastian, KC				Henry, Gary T.; Fortner, C. Kevin; Bastian, Kevin C.			The Effects of Experience and Attrition for Novice High-School Science and Mathematics Teachers	SCIENCE			English	Article							STUDENT-ACHIEVEMENT; CREDENTIALS; QUALITY	Because of the current high proportion of novice high-school teachers, many students' mastery of science and mathematics depends on the effectiveness of early-career teachers. In this study, which used value-added models to analyze high-school teachers' effectiveness in raising test scores on 1.05 million end-of-course exams, we found that the effectiveness of high-school science and mathematics teachers increased substantially with experience but exhibited diminishing rates of return by their fourth year; that teachers of algebra 1, algebra 2, biology, and physical science who continued to teach for at least 5 years were more effective as novice teachers than those who left the profession earlier; and that novice teachers of physics, chemistry, physical science, geometry, and biology exhibited steeper growth in effectiveness than did novice non-science, technology, engineering, and mathematics teachers.	[Henry, Gary T.; Bastian, Kevin C.] Univ N Carolina, Dept Publ Policy & Educ Policy Initiat Carolina, Chapel Hill, NC 27599 USA; [Fortner, C. Kevin] Georgia State Univ, Dept Educ Policy Studies, Coll Educ, Atlanta, GA 30303 USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia State University	Henry, GT (corresponding author), Univ N Carolina, Dept Publ Policy & Educ Policy Initiat Carolina, Abernethy Hall,Campus Box 3435, Chapel Hill, NC 27599 USA.	gthenry@unc.edu		Fortner, Charles Kevin/0000-0002-1910-4972	Teacher Quality Research Initiative by the University of North Carolina General Administration	Teacher Quality Research Initiative by the University of North Carolina General Administration	We recognize ongoing financial support for this research from the Teacher Quality Research Initiative provided by the University of North Carolina General Administration.	Bacolod MP, 2007, REV ECON STAT, V89, P737, DOI 10.1162/rest.89.4.737; Boyd D, 2006, EDUC FINANC POLICY, V1, P176, DOI 10.1162/edfp.2006.1.2.176; Chingos MM, 2011, ECON EDUC REV, V30, P449, DOI 10.1016/j.econedurev.2010.12.010; Clotfelter CT, 2007, ECON EDUC REV, V26, P673, DOI 10.1016/j.econedurev.2007.10.002; Clotfelter CT, 2010, J HUM RESOUR, V45, P655, DOI 10.1353/jhr.2010.0023; Clotfelter CT, 2005, ECON EDUC REV, V24, P377, DOI 10.1016/j.econedurev.2004.06.008; Coleman J., 1966, EQUALITY ED OPPORTUN; Goldhaber D, 2007, J HUM RESOUR, V42, P765, DOI 10.3368/jhr.XLII.4.765; Goldhaber D, 2011, J POLICY ANAL MANAG, V30, P57, DOI 10.1002/pam.20549; Henry GT, 2011, EDUC RESEARCHER, V40, P271, DOI 10.3102/0013189X11419042; Ingersoll R, 2010, EDUC LEADERSHIP, V67, P14; Ingersoll RM, 2003, EDUC LEADERSHIP, V60, P30; Krieg JM, 2006, ECON EDUC REV, V25, P13, DOI 10.1016/j.econedurev.2004.09.004; Lankford H, 2002, EDUC EVAL POLICY AN, V24, P37, DOI 10.3102/01623737024001037; North Carolina Department of Public Instruction, 2008, N CAR MATH TESTS; North Carolina Department of Public Instruction, 2009, N CAR SCI TESTS TECH; Reynolds D., 2011, ANN M INT C SCH EFF; Reynolds D., 2000, INT HDB SCH EFFECTIV; Rivkin SG, 2005, ECONOMETRICA, V73, P417, DOI 10.1111/j.1468-0262.2005.00584.x; Rockoff JE, 2004, AM ECON REV, V94, P247, DOI 10.1257/0002828041302244; Scafidi B., 2006, ADV EC ANAL POLICY, V6, P1, DOI DOI 10.2202/1538-0637.1604; Staiger DO, 2010, J ECON PERSPECT, V24, P97, DOI 10.1257/jep.24.3.97	22	51	52	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1118	1121		10.1126/science.1215343	http://dx.doi.org/10.1126/science.1215343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900ZL	22383852				2022-12-28	WOS:000300931100052
J	Kuchen, EE; Fox, S; de Reuille, PB; Kennaway, R; Bensmihen, S; Avondo, J; Calder, GM; Southam, P; Robinson, S; Bangham, A; Coen, E				Kuchen, Erika E.; Fox, Samantha; de Reuille, Pierre Barbier; Kennaway, Richard; Bensmihen, Sandra; Avondo, Jerome; Calder, Grant M.; Southam, Paul; Robinson, Sarah; Bangham, Andrew; Coen, Enrico			Generation of Leaf Shape Through Early Patterns of Growth and Tissue Polarity	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SHOOT-MERISTEMLESS; LEAVES; MECHANISMS; COTYLEDON; GENES; CELL	A major challenge in biology is to understand how buds comprising a few cells can give rise to complex plant and animal appendages like leaves or limbs. We address this problem through a combination of time-lapse imaging, clonal analysis, and computational modeling. We arrive at a model that shows how leaf shape can arise through feedback between early patterns of oriented growth and tissue deformation. Experimental tests through partial leaf ablation support this model and allow reevaluation of previous experimental studies. Our model allows a range of observed leaf shapes to be generated and predicts observed clone patterns in different species. Thus, our experimentally validated model may underlie the development and evolution of diverse organ shapes.	[de Reuille, Pierre Barbier; Kennaway, Richard; Southam, Paul; Bangham, Andrew] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Kuchen, Erika E.; Fox, Samantha; Bensmihen, Sandra; Avondo, Jerome; Calder, Grant M.; Robinson, Sarah; Coen, Enrico] John Innes Ctr, Norwich NR4 7UH, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bangham, A (corresponding author), Univ E Anglia, Sch Comp Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.bangham@uea.ac.uk; enrico.coen@jic.ac.uk	Barbier de Reuille, Pierre/J-5017-2012; Kennaway, Richard/F-8190-2013; Robinson, Sarah/AAX-6505-2020	Barbier de Reuille, Pierre/0000-0002-9970-765X; Kennaway, Richard/0000-0001-9702-644X; Fox, Samantha/0000-0003-1271-6412; bensmihen, sandra/0000-0003-1351-7220; Robinson, Sarah/0000-0001-7643-1059	U.K. Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F005997/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000152, BB/F005997/1] Funding Source: researchfish	U.K. Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the U.K. Biotechnology and Biological Sciences Research Council (BBSRC). We thank S. Sauret-Gueto, C. Hindle, and J. Chan for help in developing the tracking chamber; K. Lee for imaging cut leaves with OPT; and S. Grandison for mathematical support. The authors declare no competing financial interests. Further information and software can be downloaded at www.uea.ac.uk/cmp/research/cmpbio/Gftbox.	Aida M, 1999, DEVELOPMENT, V126, P1563; [Anonymous], 2011, PRINCIPLES DEV; Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Boutte Y, 2007, CURR OPIN PLANT BIOL, V10, P616, DOI 10.1016/j.pbi.2007.07.008; Fleming AJ, 2003, PLANT BIOLOGY, V5, P341, DOI 10.1055/s-2003-42718; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Hasson A, 2011, PLANT CELL, V23, P54, DOI 10.1105/tpc.110.081448; HEJNOWICZ Z, 1984, J THEOR BIOL, V110, P93, DOI 10.1016/S0022-5193(84)80017-X; Held LI., 2002, IMAGINAL DISCS GENET; Kennaway R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002071; Kim GT, 2006, PHYSIOL PLANTARUM, V126, P494, DOI 10.1111/j.1399-3054.2005.00634.x; Rolland-Lagan AG, 2003, NATURE, V422, P161, DOI 10.1038/nature01443; Sarojam R, 2010, PLANT CELL, V22, P2113, DOI 10.1105/tpc.110.075853; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Schmundt D, 1998, PLANT J, V16, P505, DOI 10.1046/j.1365-313x.1998.00314.x; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; Stopper GF, 2005, DEV BIOL, V288, P21, DOI 10.1016/j.ydbio.2005.09.010; Swink F., 1994, PLANTS CHICAGO REGIO; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; WOLF SD, 1986, AM J BOT, V73, P832, DOI 10.2307/2444294	21	158	160	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1092	1096		10.1126/science.1214678	http://dx.doi.org/10.1126/science.1214678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383846				2022-12-28	WOS:000300931100045
J	Xu, X; Hou, Y; Yin, XY; Bao, L; Tang, AF; Song, LT; Li, FQ; Tsang, S; Wu, K; Wu, HJ; He, WM; Zeng, L; Xing, MJ; Wu, RH; Jiang, H; Liu, X; Cao, DD; Guo, GW; Hu, XD; Gui, YT; Li, ZS; Xie, WY; Sun, XJ; Shi, M; Cai, ZM; Wang, B; Zhong, MM; Li, JX; Lu, ZH; Gu, N; Zhang, XQ; Goodman, L; Bolund, L; Wang, J; Yang, HM; Kristiansen, K; Dean, M; Li, YR; Wang, J				Xu, Xun; Hou, Yong; Yin, Xuyang; Bao, Li; Tang, Aifa; Song, Luting; Li, Fuqiang; Tsang, Shirley; Wu, Kui; Wu, Hanjie; He, Weiming; Zeng, Liang; Xing, Manjie; Wu, Renhua; Jiang, Hui; Liu, Xiao; Cao, Dandan; Guo, Guangwu; Hu, Xueda; Gui, Yaoting; Li, Zesong; Xie, Wenyue; Sun, Xiaojuan; Shi, Min; Cai, Zhiming; Wang, Bin; Zhong, Meiming; Li, Jingxiang; Lu, Zuhong; Gu, Ning; Zhang, Xiuqing; Goodman, Laurie; Bolund, Lars; Wang, Jian; Yang, Huanming; Kristiansen, Karsten; Dean, Michael; Li, Yingrui; Wang, Jun			Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor	CELL			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; LUNG-CANCER; SULT1A1 POLYMORPHISM; LYSINE ACETYLATION; RENAL-CARCINOMA; HIF PATHWAY; GENOME; GENE; EXPRESSION; PROTEIN	Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer and has very few mutations that are shared between different patients. To better understand the intratumoral genetics underlying mutations of ccRCC, we carried out single-cell exome sequencing on a ccRCC tumor and its adjacent kidney tissue. Our data indicate that this tumor was unlikely to have resulted from mutations in VHL and PBRM1. Quantitative population genetic analysis indicates that the tumor did not contain any significant clonal subpopulations and also showed that mutations that had different allele frequencies within the population also had different mutation spectrums. Analyses of these data allowed us to delineate a detailed intratumoral genetic landscape at a single-cell level. Our pilot study demonstrates that ccRCC may be more genetically complex than previously thought and provides information that can lead to new ways to investigate individual tumors, with the aim of developing more effective cellular targeted therapies.	[Xu, Xun; Hou, Yong; Yin, Xuyang; Bao, Li; Song, Luting; Li, Fuqiang; Wu, Kui; Wu, Hanjie; He, Weiming; Zeng, Liang; Xing, Manjie; Wu, Renhua; Jiang, Hui; Liu, Xiao; Cao, Dandan; Guo, Guangwu; Hu, Xueda; Wang, Bin; Zhong, Meiming; Li, Jingxiang; Zhang, Xiuqing; Goodman, Laurie; Bolund, Lars; Wang, Jian; Yang, Huanming; Kristiansen, Karsten; Dean, Michael; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Xu, Xun] BGI Amer, Cambridge, MA 02142 USA; [Hou, Yong; Lu, Zuhong; Gu, Ning] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Hou, Yong; Lu, Zuhong; Gu, Ning] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Tang, Aifa; Li, Zesong; Sun, Xiaojuan; Cai, Zhiming] Shenzhen Second Peoples Hosp, Dept Urol, Shenzhen 518035, Peoples R China; [Tang, Aifa; Li, Zesong; Sun, Xiaojuan; Cai, Zhiming] Shenzhen Univ, Inst Urogenital Dis, Shenzhen 518060, Peoples R China; [Tsang, Shirley] BioMatrix LLC, Rockville, MD 20849 USA; [Wu, Hanjie] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou 510641, Guangdong, Peoples R China; [Xie, Wenyue; Shi, Min; Cai, Zhiming] Peking Univ, Shenzhen PKU HKUST Med Ctr, Inst Urol,Shenzhen Hosp, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen 518036, Peoples R China; [Bolund, Lars] Univ Aarhus, Inst Human Genet, DK-8100 Aarhus, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1165 Copenhagen, Denmark; [Dean, Michael] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA	Beijing Genomics Institute (BGI); Southeast University - China; Southeast University - China; Second People's Hospital of Shenzhen; Shenzhen University; South China University of Technology; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Aarhus University; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn; deanm@mail.nih.gov; liyr@genomics.org.cn; wangj@genomics.org.cn	Wu, Hanjie/AAY-2936-2020; Dean, Michael/R-7501-2019; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Xu, Xun/AAI-6763-2020; Lu, Zuhong/A-5448-2013; Kristiansen, Karsten/J-5148-2014; Dean, Michael C/G-8172-2012; Liu, Xiao/P-2732-2015; gui, yaoting/GLT-3684-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Wu, Hanjie/0000-0002-5451-4969; Xu, Xun/0000-0002-5338-5173; Kristiansen, Karsten/0000-0002-6024-0917; Dean, Michael C/0000-0003-2234-0631; Liu, Xiao/0000-0002-8073-0534; CAO, Dandan/0000-0003-2899-8813; Lu, Zuhong/0000-0003-3332-2615; Wang, Jun/0000-0002-8540-8931; Goodman, Laurie/0000-0001-9724-5976; Wang, Jun/0000-0002-2113-5874; hou, yong/0000-0002-0420-0726	National Basic Research Program of China (973 program) [2011CB809202, 2011CB809203]; Chinese 863 program [2009AA022707, 2012AA02A201]; Shenzhen Municipal Government of China [ZYC201005250020A]; Key Laboratory Project, Shenzhen City [CX B200903 110066A, CXB201108250096A]; Shenzhen Key Laboratory of Gene Bank for National Life Science; Innovative Research Team of Guangdong; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A, CXB201005250016A]; Danish Natural Science Research Council; Danish National Research Foundation; National Natural Science Foundation of China; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; National Cancer Institute, National Institutes of Health, USA; NATIONAL CANCER INSTITUTE [ZIABC011300] Funding Source: NIH RePORTER	National Basic Research Program of China (973 program)(National Basic Research Program of China); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Key Laboratory Project, Shenzhen City; Shenzhen Key Laboratory of Gene Bank for National Life Science; Innovative Research Team of Guangdong; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Shenzhen Key Laboratory, Shenzhen, China; Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; National Cancer Institute, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Basic Research Program of China (973 program numbers 2011CB809202 and 2011CB809203), the Chinese 863 program (numbers 2009AA022707 and 2012AA02A201), the Shenzhen Municipal Government of China (grant ZYC201005250020A), the Key Laboratory Project Supported by Shenzhen City (grants CX B200903 110066A and CXB201108250096A), and Shenzhen Key Laboratory of Gene Bank for National Life Science. This project was also supported by grants from the Innovative Research Team Project of Guangdong, the Guangdong Enterprise Key Laboratory of Human Disease Genomics, and the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A and CXB201005250016A). We also acknowledge the Ole Romer grant from the Danish Natural Science Research Council, the Danish National Research Foundation, the National Natural Science Foundation of China, and funds from the Shenzhen Municipal Government and the Local Government of Yantian District of Shenzhen. We also acknowledge support from the Intramural Research Program of the National Cancer Institute, National Institutes of Health, USA.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audenet F., 2012, BJU INT, V109, P1864, DOI [DOI 10.1111/j.1464-410X.2011.10661.x, 10.1111/j.1464-410X.2011.10661.x]; Baudot A, 2009, EMBO REP, V10, P359, DOI 10.1038/embor.2009.46; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bourachot B, 2003, EMBO J, V22, P6505, DOI 10.1093/emboj/cdg621; Caplin M, 2000, BRIT J SURG, V87, P1035, DOI 10.1046/j.1365-2168.2000.01488.x; Chen M, 2009, INT J CANCER, V125, P2342, DOI 10.1002/ijc.24642; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Geng H, 2011, J BIOL CHEM, V286, P38095, DOI 10.1074/jbc.M111.257055; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; HALL JL, 1983, MOL CELL BIOL, V3, P854, DOI 10.1128/MCB.3.5.854; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Liang G, 2004, CARCINOGENESIS, V25, P773, DOI 10.1093/carcin/bgh053; Ling JW, 2009, MOL HUM REPROD, V15, P739, DOI 10.1093/molehr/gap066; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ng CS, 2008, AM J ROENTGENOL, V191, P1220, DOI 10.2214/AJR.07.3568; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pei JM, 2010, GENE CHROMOSOME CANC, V49, P610, DOI 10.1002/gcc.20771; PISEGNA JR, 1992, BIOCHEM BIOPH RES CO, V189, P296, DOI 10.1016/0006-291X(92)91557-7; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Pugh TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn378; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salas S, 2009, INT J CANCER, V125, P851, DOI 10.1002/ijc.24457; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Takashima N, 2006, ONCOL REP, V15, P667; Tang DL, 2003, BREAST CANCER RES TR, V78, P217, DOI 10.1023/A:1022968303118; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Ye Y, 2010, ONCOGENE, V29, P3619, DOI 10.1038/onc.2010.116; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yu HG, 2006, INT J CANCER, V119, P2724, DOI 10.1002/ijc.22207; Zhang GQ, 2009, J BIOL CHEM, V284, P29050, DOI 10.1074/jbc.M109.010249; Zheng LZ, 2003, CANCER LETT, V202, P61, DOI 10.1016/j.canlet.2003.08.007	55	460	500	4	217	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					886	895		10.1016/j.cell.2012.02.025	http://dx.doi.org/10.1016/j.cell.2012.02.025			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385958	Bronze, Green Accepted			2022-12-28	WOS:000300985000010
J	Braden, B				Braden, Barbara			RATIONAL TESTING Diagnosis of Helicobacter pylori infection	BRITISH MEDICAL JOURNAL			English	Editorial Material							BLEEDING PEPTIC-ULCER; STOOL ANTIGEN TEST; METAANALYSIS; ACCURACY; ERADICATION; TRIAL; CLARITHROMYCIN; MANAGEMENT; DYSPEPSIA; GASTRITIS		Oxford Univ Hosp Trust, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford	Braden, B (corresponding author), Oxford Univ Hosp Trust, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England.	Barbara.braden@ouh.nhs.uk	Braden, Barbara/AAH-8693-2021; Braden, Barbara/AAI-7869-2020	Braden, Barbara/0000-0002-8534-6873				Annibale B, 1999, ANN INTERN MED, V131, P668, DOI 10.7326/0003-4819-131-9-199911020-00006; Barkun AN, ANN INTERN MED, V152, P101; Chan FKL, 2002, LANCET, V359, P9, DOI 10.1016/S0140-6736(02)07272-0; CUTLER AF, 1995, GASTROENTEROLOGY, V109, P136, DOI 10.1016/0016-5085(95)90278-3; Ford AC, 2008, ALIMENT PHARM THER, V28, P534, DOI 10.1111/j.1365-2036.2008.03784.x; Ford AC, 2008, DIGEST DIS, V26, P225, DOI 10.1159/000121351; Gisbert JR, 2006, AM J GASTROENTEROL, V101, P1921, DOI 10.1111/j.1572-0241.2006.00668.x; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P848, DOI 10.1111/j.1572-0241.2006.00528.x; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P35, DOI 10.1111/j.1365-2036.2006.02737.x; Gisbert JP, 2004, HELICOBACTER, V9, P347, DOI 10.1111/j.1083-4389.2004.00235.x; Grove DI, 1998, PATHOLOGY, V30, P183, DOI 10.1080/00313029800169206; Guell M, 2006, ALIMENT PHARM THER, V23, P53, DOI 10.1111/j.1365-2036.2006.02726.x; Hunt RH, 2011, J GASTROINTEST LIVER, V20, P299, DOI 10.1097/MCG.0b013e31820fb8f6; Kabir S, 2004, HELICOBACTER, V9, P115, DOI 10.1111/j.1083-4389.2004.00207.x; Kiesslich R, 2005, GASTROENTEROLOGY, V128, P2119, DOI 10.1053/j.gastro.2004.12.035; Laine L, 1998, ANN INTERN MED, V129, P547, DOI 10.7326/0003-4819-129-7-199810010-00007; Leodolter A, 1999, AM J GASTROENTEROL, V94, P2100, DOI 10.1111/j.1572-0241.1999.01284.x; Liou JM, 2010, GUT, V59, P572, DOI 10.1136/gut.2009.198309; Loy CT, 1996, AM J GASTROENTEROL, V91, P1138; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Prell C, 2009, J CLIN MICROBIOL, V47, P3980, DOI 10.1128/JCM.01204-09; Rostami N, 2008, AM J HEMATOL, V83, P376, DOI 10.1002/ajh.21125; Shimoyama T, 2011, J GASTROENTEROL, V46, P487, DOI 10.1007/s00535-011-0371-4; Vaira D, 2010, ALIMENT PHARM THER, V31, P331, DOI 10.1111/j.1365-2036.2009.04196.x; Vaira D, 2001, GUT, V48, P287, DOI 10.1136/gut.48.3.287; Zullo A, 2010, CLIN GASTROENTEROL H, V8, P105, DOI 10.1016/j.cgh.2009.07.017	26	20	21	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2012	344								e828	10.1136/bmj.e828	http://dx.doi.org/10.1136/bmj.e828			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900KB	22368293				2022-12-28	WOS:000300884700006
J	Frierson, DMW				Frierson, Dargan M. W.			Frictional Dissipation-Blame It on the Rain	SCIENCE			English	Editorial Material							PART I; ATMOSPHERE; BUDGET; CYCLE; WORK; DEEP		Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Frierson, DMW (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	dargan@atmos.washington.edu	Frierson, Dargan/F-1763-2010	Frierson, Dargan/0000-0001-8952-5644	Div Atmospheric & Geospace Sciences [0846641] Funding Source: National Science Foundation	Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Caldeira K, 2007, CLIMATIC CHANGE, V85, P267, DOI 10.1007/s10584-007-9335-3; Frierson DMW, 2006, J ATMOS SCI, V63, P2548, DOI 10.1175/JAS3753.1; Goody R, 2003, J ATMOS SCI, V60, P2827, DOI 10.1175/1520-0469(2003)060<2827:OTMEOD>2.0.CO;2; Goody R, 2007, J ATMOS SCI, V64, P2735, DOI 10.1175/JAS3967.1; Hartmann D. L., 1994, GLOBAL PHYS CLIMATOL; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; KNUTSON TR, 1995, J CLIMATE, V8, P2181, DOI 10.1175/1520-0442(1995)008<2181:TMROTT>2.0.CO;2; Pauluis O, 2002, J ATMOS SCI, V59, P125, DOI 10.1175/1520-0469(2002)059<0125:EBOAAI>2.0.CO;2; Pauluis O, 2000, J ATMOS SCI, V57, P989, DOI 10.1175/1520-0469(2000)057<0989:FDIAPA>2.0.CO;2; Pauluis O, 2012, SCIENCE, V335, P953, DOI 10.1126/science.1215869; Pauluis O, 2011, J ATMOS SCI, V68, P91, DOI 10.1175/2010JAS3530.1; Pierrehumbert RT, 2002, NATURE, V419, P191, DOI 10.1038/nature01088; Trenberth KE, 2009, B AM METEOROL SOC, V90, P311, DOI 10.1175/2008BAMS2634.1; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1	14	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					925	926		10.1126/science.1219015	http://dx.doi.org/10.1126/science.1219015			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22362995				2022-12-28	WOS:000300931800031
J	Jansen, VAA; Mashanova, A; Petrovskii, S				Jansen, Vincent A. A.; Mashanova, Alla; Petrovskii, Sergei			Comment on "Levy Walks Evolve Through Interaction Between Movement and Environmental Complexity"	SCIENCE			English	Editorial Material									[Jansen, Vincent A. A.; Mashanova, Alla] Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Petrovskii, Sergei] Univ Leicester, Dept Math, Leicester LE1 7RH, Leics, England	University of London; Royal Holloway University London; University of Leicester	Jansen, VAA (corresponding author), Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	vincent.jansen@rhul.ac.uk		Petrovskii, Sergei/0000-0001-6259-2695; Mashanova, Alla/0000-0003-3273-8184; Jansen, Vincent A.A./0000-0002-6518-2090	BBSRC [BB/G007934/1, BB/G00787X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G00787X/1, BB/G007934/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; de Jager M, 2011, SCIENCE, V334, P1639; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Grunbaum D, 2011, SCIENCE, V332, P1514, DOI 10.1126/science.1208445; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952	9	78	78	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071								10.1126/science.1215747	http://dx.doi.org/10.1126/science.1215747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22362991				2022-12-28	WOS:000300931800025
J	Mulla, O; Prowse, S; Sanders, T; Nix, P				Mulla, Omar; Prowse, Simon; Sanders, Tim; Nix, Paul			10-MINUTE CONSULTATION Epistaxis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mulla, Omar; Prowse, Simon; Nix, Paul] Leeds Gen Infirm, Dept Ear Nose & Throat, Leeds LS1 3EX, W Yorkshire, England; [Sanders, Tim] Shap Med Practice, Penrith CA10 3LW, England	Leeds General Infirmary; University of Leeds	Mulla, O (corresponding author), Leeds Gen Infirm, Dept Ear Nose & Throat, Leeds LS1 3EX, W Yorkshire, England.	omarmulla@doctors.org.uk		Nix, Paul/0000-0002-7284-710X					0	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2012	344								e1097	10.1136/bmj.e1097	http://dx.doi.org/10.1136/bmj.e1097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JY	22362457				2022-12-28	WOS:000300884400001
J	Wu, X; Northcott, PA; Dubuc, A; Dupuy, AJ; Shih, DJH; Witt, H; Croul, S; Bouffet, E; Fults, DW; Eberhart, CG; Garzia, L; Van Meter, T; Zagzag, D; Jabado, N; Schwartzentruber, J; Majewski, J; Scheetz, TE; Pfister, SM; Korshunov, A; Li, XN; Scherer, SW; Cho, YJ; Akagi, K; MacDonald, TJ; Koster, J; McCabe, MG; Sarver, AL; Collins, VP; Weiss, WA; Largaespada, DA; Collier, LS; Taylor, MD				Wu, Xiaochong; Northcott, Paul A.; Dubuc, Adrian; Dupuy, Adam J.; Shih, David J. H.; Witt, Hendrik; Croul, Sidney; Bouffet, Eric; Fults, Daniel W.; Eberhart, Charles G.; Garzia, Livia; Van Meter, Timothy; Zagzag, David; Jabado, Nada; Schwartzentruber, Jeremy; Majewski, Jacek; Scheetz, Todd E.; Pfister, Stefan M.; Korshunov, Andrey; Li, Xiao-Nan; Scherer, Stephen W.; Cho, Yoon-Jae; Akagi, Keiko; MacDonald, Tobey J.; Koster, Jan; McCabe, Martin G.; Sarver, Aaron L.; Collins, V. Peter; Weiss, William A.; Largaespada, David A.; Collier, Lara S.; Taylor, Michael D.			Clonal selection drives genetic divergence of metastatic medulloblastoma	NATURE			English	Article							CANCER; ABERRATIONS; MUTAGENESIS; EXPRESSION; CELLS; MYCN	Medulloblastoma, the most common malignant paediatric brain tumour, arises in the cerebellum and disseminates through the cerebrospinal fluid in the leptomeningeal space to coat the brain and spinal cord(1). Dissemination, a marker of poor prognosis, is found in up to 40% of children at diagnosis and inmost children at the time of recurrence. Affected children therefore are treated with radiation to the entire developing brain and spinal cord, followed by high-dose chemotherapy, with the ensuing deleterious effects on the developing nervous system(2). The mechanisms of dissemination through the cerebrospinal fluid are poorly studied, and medulloblastoma metastases have been assumed to be biologically similar to the primary tumour(3,4). Here we show that in both mouse and human medulloblastoma, the metastases from an individual are extremely similar to each other but are divergent from the matched primary tumour. Clonal genetic events in the metastases can be demonstrated in a restricted subclone of the primary tumour, suggesting that only rare cells within the primary tumour have the ability to metastasize. Failure to account for the bicompartmental nature of metastatic medulloblastoma could be a major barrier to the development of effective targeted therapies.	[Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Wu, Xiaochong; Northcott, Paul A.; Dubuc, Adrian; Shih, David J. H.; Garzia, Livia] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Wu, Xiaochong; Northcott, Paul A.; Dubuc, Adrian; Shih, David J. H.; Garzia, Livia] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Dupuy, Adam J.; Scheetz, Todd E.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Witt, Hendrik; Pfister, Stefan M.] Univ Heidelberg Hosp, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany; [Witt, Hendrik; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Croul, Sidney] Univ Toronto, Dept Lab Med & Pathobiol, Arthur & Sonia Labatt Brain Tumour Res Ctr, Univ Hlth Network Pathol, Toronto, ON M5S 1A1, Canada; [Bouffet, Eric] Hosp Sick Children, Brain Tumour Program, Toronto, ON M5G 1X8, Canada; [Fults, Daniel W.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84132 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Baltimore, MD 21210 USA; [Van Meter, Timothy] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Zagzag, David] NYU, Sch Med, Div Neuropathol, Dept Pathol & Neurosurg, New York, NY 10016 USA; [Jabado, Nada; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Jabado, Nada; Majewski, Jacek] McGill Univ, Dept Expt Med, Montreal, PQ H3Z 2Z3, Canada; [Schwartzentruber, Jeremy] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Korshunov, Andrey] Heidelberg Univ, German Canc Res Inst DKFZ, D-69120 Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Li, Xiao-Nan] Texas Childrens Canc Ctr, Brain Tumor Program, Houston, TX 77030 USA; [Li, Xiao-Nan] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5S 1A1, Canada; [Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5S 1A1, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5S 1A1, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Akagi, Keiko] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [MacDonald, Tobey J.] Emory Univ, Sch Med, Pediat Neurooncol Program, Atlanta, GA 30307 USA; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1100 DE Amsterdam, Netherlands; [McCabe, Martin G.] Univ Manchester, Sch Canc & Enabling Sci, Manchester M20 4BX, Lancs, England; [Sarver, Aaron L.; Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Collins, V. Peter] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Pediat & Neurol Surg, San Francisco, CA 94143 USA; [Collier, Lara S.] Univ Wisconsin, Sch Pharmacol, Madison, WI 53715 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Iowa; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Utah System of Higher Education; University of Utah; Johns Hopkins University; Virginia Commonwealth University; New York University; McGill University; McGill University; McGill University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Texas Children's Cancer Center; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Stanford University; Stanford University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Emory University; University of Amsterdam; Academic Medical Center Amsterdam; University of Manchester; University of Minnesota System; University of Minnesota Twin Cities; University of Cambridge; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison	Taylor, MD (corresponding author), Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada.	mdtaylor@sickkids.ca	Gotoh, Osamu/B-4704-2012; Pfister, Stefan M/F-6860-2013; Bouffet, Eric/AAB-8999-2020; Shih, David J. H./AAE-8726-2019; McCabe, Martin/P-5896-2015; Northcott, Paul A/N-4022-2018; Shih, David J H/H-3186-2011; Jabado, Nada/AAN-4026-2020; Largaespada, David/C-9832-2014; Koster, Jan/C-5934-2008; MacDonald, Tobey/D-4554-2013; Witt, Hendrik/L-7810-2015; Scherer, Stephen W./B-3785-2013	Pfister, Stefan M/0000-0002-5447-5322; Shih, David J. H./0000-0002-9802-4937; McCabe, Martin/0000-0002-5138-0707; Northcott, Paul A/0000-0002-1220-5252; Shih, David J H/0000-0002-9802-4937; Koster, Jan/0000-0002-0890-7585; Scherer, Stephen W./0000-0002-8326-1999; Scheetz, Todd/0000-0002-1965-5811; Taylor, Michael/0000-0001-7009-3466; Croul, Sidney/0000-0002-2224-5485; Dupuy, Adam/0000-0002-8561-4911; Schwartzentruber, Jeremy/0000-0002-6183-2092; Weiss, William/0000-0003-2230-9132; Korshunov, Andrey/0000-0002-5257-3623	National Institutes of Health [R01CA148699, NS055089]; Pediatric Brain Tumor Foundation; Canadian Cancer Society; Brainchild; American Brain Tumor Association; Canadian Institutes of Health Research; Kimmel Foundation;  [K01CA122183]; The Brain Tumour Charity [10/106] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA113636, K01CA122183, R01CA108622, R01CA148699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS)); Brainchild; American Brain Tumor Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kimmel Foundation; ; The Brain Tumour Charity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.D.T. holds a Canadian Institutes of Health Research Clinician-Scientist Phase II Award, was a Sontag Foundation Distinguished Scholar, and is supported by grants from the National Institutes of Health (R01CA148699), the Pediatric Brain Tumor Foundation, the Canadian Cancer Society, and Brainchild. X. W. was supported by a fellowship from the American Brain Tumor Association in tribute to Tracy Greenwood. L. G. was supported by a fellowship from the Davis M. Ferguson Fund from the American Brain Tumor Association. A. D. was supported by a Vanier Doctoral Fellowship from the Canadian Institutes of Health Research. L. S. C. was supported by a grant (K01CA122183) and a Kimmel Scholar award from the Kimmel Foundation. C. E. was supported by a grant from the National Institutes of Health (NS055089). We thank S. Archer for technical writing assistance.	Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; GNEKOW AK, 1995, MED PEDIATR ONCOL, V24, P104, DOI 10.1002/mpo.2950240209; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Helms AW, 2000, DEVELOPMENT, V127, P1185; Korshunov A, 2008, ACTA NEUROPATHOL, V116, P383, DOI 10.1007/s00401-008-0422-y; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rao G, 2003, NEOPLASIA, V5, P198, DOI 10.1016/S1476-5586(03)80052-0; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Talmadge JE, 2007, CANCER RES, V67, P11471, DOI 10.1158/0008-5472.CAN-07-2496; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Wetmore C, 2001, CANCER RES, V61, P513	28	304	315	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					529	U254		10.1038/nature10825	http://dx.doi.org/10.1038/nature10825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22343890	Green Submitted, Green Accepted			2022-12-28	WOS:000300770500051
J	Lang, ES				Lang, Eddy S.			The optimal HbA(1c) cutpoint to screen for diabetes in the emergency department was 6.0%	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calgary, Calgary, AB, Canada	University of Calgary	Lang, ES (corresponding author), Univ Calgary, Calgary, AB, Canada.		Lang, Eddy/AAS-2080-2020					Hopper I, 2011, EUR J CARDIOV PREV R, V18, P813, DOI 10.1177/1741826711421687; Kelen GD, 2008, ACAD EMERG MED, V15, P194, DOI 10.1111/j.1553-2712.2008.00068.x; Koziol-McLain J, 2010, ANN EMERG MED, V56, P413, DOI 10.1016/j.annemergmed.2010.05.001	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-11	10.7326/0003-4819-156-4-201202210-02011	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351737				2022-12-28	WOS:000208885400010
J	Holmgren, T; Hallgren, HB; Oberg, B; Adolfsson, L; Johansson, K				Holmgren, Theresa; Hallgren, Hanna Bjornsson; Oberg, Birgitta; Adolfsson, Lars; Johansson, Kajsa			Effect of specific exercise strategy on need for surgery in patients with subacromial impingement syndrome: randomised controlled study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHOULDER IMPINGEMENT; ROTATOR CUFF; ACHILLES TENDINOPATHY; NONOPERATIVE TREATMENT; SUPERVISED EXERCISES; ARTHROSCOPIC SURGERY; CLINICAL-OUTCOMES; REHABILITATION; PAIN; PHYSIOTHERAPY	Objective To evaluate if a specific exercise strategy, targeting the rotator cuff and scapula stabilisers, improves shoulder function and pain more than unspecific exercises in patients with subacromial impingement syndrome, thereby decreasing the need for arthroscopic subacromial decompression. Design Randomised, participant and single assessor blinded, controlled study. Setting Department of orthopaedics in a Swedish university hospital. Participants 102 patients with long standing (over six months) persistent subacromial impingement syndrome in whom earlier conservative treatment had failed, recruited through orthopaedic specialists. Interventions The specific exercise strategy consisted of strengthening eccentric exercises for the rotator cuff and concentric/eccentric exercises for the scapula stabilisers in combination with manual mobilisation. The control exercise programme consisted of unspecific movement exercises for the neck and shoulder. Patients in both groups received five to six individual guided treatment sessions during 12 weeks. In between these supervised sessions the participants performed home exercises once or twice a day for 12 weeks. Main outcome measures The primary outcome was the Constant-Murley shoulder assessment score evaluating shoulder function and pain. Secondary outcomes were patients' global impression of change because of treatment and decision regarding surgery. Results Most (97, 95%) participants completed the 12 week study. There was a significantly greater improvement in the Constant-Murley score in the specific exercise group than in the control exercise group (24 points (95% confidence interval 19 to 28.0) v 9 points (5 to 13); mean difference between group: 15 points (8.5 to 20.6)). Significantly more patients in the specific exercise group reported successful outcome (defined as large improvement or recovered) in the patients' global assessment of change because of treatment: 69% (35/51) v 24% (11/46); odds ratio 7.6, 3.1 to 18.9; P<0.001. A significantly lower proportion of patients in the specific exercise group subsequently chose to undergo surgery: 20% (10/51) v 63% (29/46); odds ratio 7.7, 3.1 to 19.4; P<0.001). Conclusion A specific exercise strategy, focusing on strengthening eccentric exercises for the rotator cuff and concentric/eccentric exercises for the scapula stabilisers, is effective in reducing pain and improving shoulder function in patients with persistent subacromial impingement syndrome. By extension, this exercise strategy reduces the need for arthroscopic subacromial decompression within the three month timeframe used in the study.	[Holmgren, Theresa; Oberg, Birgitta; Johansson, Kajsa] Linkoping Univ, Dept Med & Hlth Sci, Div Physiotherapy, SE-58183 Linkoping, Sweden; [Hallgren, Hanna Bjornsson; Adolfsson, Lars] Linkoping Univ Hosp, Dept Orthopaed, SE-58185 Linkoping, Sweden	Linkoping University; Linkoping University	Holmgren, T (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Physiotherapy, SE-58183 Linkoping, Sweden.	theresa.holmgren@liu.se	Johansson, Kajsa/AET-7150-2022; adolfsson, lars/D-4837-2017	adolfsson, lars/0000-0001-7873-3093	physiotherapy orthopaedic department of the University Hospital in Linkoping, Sweden; research council in the south east of Sweden (FORSS)	physiotherapy orthopaedic department of the University Hospital in Linkoping, Sweden; research council in the south east of Sweden (FORSS)	We acknowledge the support and contribution of the physiotherapy orthopaedic department of the University Hospital in Linkoping, Sweden. We also thank Henrik Magnusson for all statistical assistance.; This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. TH is funded in part by the research council in the south east of Sweden (FORSS).	Andersen NH, 1999, J SHOULDER ELB SURG, V8, P99, DOI 10.1016/S1058-2746(99)90000-9; Arroll B, 2005, BRIT J GEN PRACT, V55, P224; Bennell K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2756; Bernhardsson S, 2011, CLIN REHABIL, V25, P69, DOI 10.1177/0269215510376005; Bohmer Audhild S., 1998, Physiotherapy Theory and Practice, V14, P93, DOI 10.3109/09593989809057152; Brox JI, 1999, J SHOULDER ELB SURG, V8, P102, DOI 10.1016/S1058-2746(99)90001-0; BROX JI, 1993, BMJ-BRIT MED J, V307, P899, DOI 10.1136/bmj.307.6909.899; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Bullock MP, 2005, MANUAL THER, V10, P28, DOI 10.1016/j.math.2004.07.002; Camargo Paula R., 2009, Physiotherapy Theory and Practice, V25, P463, DOI [10.1080/09593980802662145, 10.3109/09593980802662145]; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Coghlan JA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005619.pub2; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Cools AM, 2005, J ATHL TRAINING, V40, P104; Cools AM, 2003, AM J SPORT MED, V31, P542, DOI 10.1177/03635465030310041101; Cools AM, 2007, AM J SPORT MED, V35, P1744, DOI 10.1177/0363546507303560; Crow R., 1999, HEALTH TECHNOL ASSES, V3, P1, DOI [DOI 10.3310/HTA3030, DOI 10.3310/hta3030]; Deutscher D, 2009, ARCH PHYS MED REHAB, V90, P1349, DOI 10.1016/j.apmr.2009.02.005; Dickens VA, 2005, PHYSIOTHERAPY, V91, P159, DOI 10.1016/j.physio.2004.10.008; Dorrestijn O, 2009, J SHOULDER ELB SURG, V18, P652, DOI 10.1016/j.jse.2009.01.010; Ellenbecker TS, 2010, BRIT J SPORT MED, V44, P319, DOI 10.1136/bjsm.2009.058875; Ellman H, 1987, Arthroscopy, V3, P173, DOI 10.1016/S0749-8063(87)80061-0; Frost P, 2002, AM J IND MED, V41, P11, DOI 10.1002/ajim.10019; Green S, 2003, Cochrane Database Syst Rev, pCD004258; Haahr JP, 2005, ANN RHEUM DIS, V64, P760, DOI 10.1136/ard.2004.021188; HAWKINS RJ, 1980, AM J SPORT MED, V8, P151, DOI 10.1177/036354658000800302; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; JOBE FW, 1983, CLIN ORTHOP RELAT R, P117; Johansson K, 2002, BRIT J GEN PRACT, V52, P145; Jonsson P, 2006, KNEE SURG SPORT TR A, V14, P76, DOI 10.1007/s00167-004-0611-8; Jonsson P, 2005, BRIT J SPORT MED, V39, P847, DOI 10.1136/bjsm.2005.018630; Kelly SM, 2010, CLIN REHABIL, V24, P99, DOI 10.1177/0269215509342336; Ketola S, 2009, J BONE JOINT SURG BR, V91B, P1326, DOI 10.1302/0301-620X.91B10.22094; Kibler W Ben, 2006, Instr Course Lect, V55, P35; Kingma JJ, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.030916; Krogsboll LT, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-1; Kromer TO, 2009, J REHABIL MED, V41, P870, DOI 10.2340/16501977-0453; Kuhn JE, 2009, J SHOULDER ELB SURG, V18, P138, DOI 10.1016/j.jse.2008.06.004; LEROUX JL, 1995, REV RHUM, V62, P423; Lewis JS, 2005, J SHOULDER ELB SURG, V14, P385, DOI 10.1016/J.JSE.2004.08.007; Lombardi I, 2008, ARTHRIT RHEUM-ARTHR, V59, P615, DOI 10.1002/art.23576; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Magnussen RA, 2009, CLIN J SPORT MED, V19, P54, DOI 10.1097/JSM.0b013e31818ef090; McClure PW, 2006, PHYS THER, V86, P1075, DOI 10.1093/ptj/86.8.1075; Michener Lori A, 2004, J Hand Ther, V17, P152, DOI 10.1197/j.jht.2004.02.004; Miranda H, 2001, OCCUP ENVIRON MED, V58, P528, DOI 10.1136/oem.58.8.528; Morrison DS, 1997, J BONE JOINT SURG AM, V79A, P732, DOI 10.2106/00004623-199705000-00013; NEER CS, 1977, ORTHOP CLIN N AM, V8, P583; Patel VR, 1999, J SHOULDER ELB SURG, V8, P231, DOI 10.1016/S1058-2746(99)90134-9; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rees JD, 2009, BRIT J SPORT MED, V43, P242, DOI 10.1136/bjsm.2008.052910; Seitz AL, 2011, CLIN BIOMECH, V26, P1, DOI 10.1016/j.clinbiomech.2010.08.001; Silbernagel KG, 2007, AM J SPORT MED, V35, P897, DOI 10.1177/0363546506298279; Soyer J, 2003, ARTHROSCOPY, V19, P34, DOI 10.1053/jars.2003.50005; Thomas E, 2005, ANN RHEUM DIS, V64, P1056, DOI 10.1136/ard.2004.029959; Thomee R, 1997, PHYS THER, V77, P1690, DOI 10.1093/ptj/77.12.1690; Thorstensson CA, 2006, DISABIL REHABIL, V28, P51, DOI 10.1080/09638280500163927; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Tyler TF, 2000, AM J SPORT MED, V28, P668; Virta L, 2009, EUR J PHYSIOTHER, V11, P166, DOI 10.1080/14038190802460481; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	147	149	1	54	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2012	344								e787	10.1136/bmj.e787	http://dx.doi.org/10.1136/bmj.e787			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900IY	22349588	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000300881600009
J	Aida, T; Meijer, EW; Stupp, SI				Aida, T.; Meijer, E. W.; Stupp, S. I.			Functional Supramolecular Polymers	SCIENCE			English	Review							PEPTIDE-AMPHIPHILE NANOFIBERS; HEXA-PERI-HEXABENZOCORONENES; SELF-ASSEMBLING NANOFIBERS; DENDRON RODCOIL MOLECULES; GRAPHITIC NANOTUBES; COAXIAL NANOTUBES; NANOSTRUCTURES; MINERALIZATION; HETEROJUNCTION; REGENERATION	Supramolecular polymers can be random and entangled coils with the mechanical properties of plastics and elastomers, but with great capacity for processability, recycling, and self-healing due to their reversible monomer-to-polymer transitions. At the other extreme, supramolecular polymers can be formed by self-assembly among designed subunits to yield shape-persistent and highly ordered filaments. The use of strong and directional interactions among molecular subunits can achieve not only rich dynamic behavior but also high degrees of internal order that are not known in ordinary polymers. They can resemble, for example, the ordered and dynamic one-dimensional supramolecular assemblies of the cell cytoskeleton and possess useful biological and electronic functions.	[Stupp, S. I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Aida, T.] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Aida, T.] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Meijer, E. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands; [Stupp, S. I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Stupp, S. I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Stupp, S. I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA	Northwestern University; University of Tokyo; RIKEN; Eindhoven University of Technology; Northwestern University; Northwestern University; Northwestern University	Stupp, SI (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.	s-stupp@northwestern.edu	Stupp, Samuel/AGV-1942-2022; Meijer, E.W./K-7632-2013	Meijer, E.W./0000-0003-4126-7492	Japan Science and Technology Agency; RIKEN; Dutch National Science Foundation NWO; ERC; U.S. Department of Energy Basic Energy Sciences [DE-FG02-00ER45810]; EFRC Non-Equilibrium Research Center [DE-SC0000989]; NIH [NIDCR: 2R01DE015920-06, NIBIB: 2R01EB003806-06A2]; NSF [DMR-1006713]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015920] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1006713] Funding Source: National Science Foundation	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); RIKEN; Dutch National Science Foundation NWO(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission); U.S. Department of Energy Basic Energy Sciences(United States Department of Energy (DOE)); EFRC Non-Equilibrium Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Experimental work featured in this Review was supported by the Japan Science and Technology Agency and RIKEN (T.A.'s laboratory); the Dutch National Science Foundation NWO and ERC (E.W.M.'s laboratory); and the U.S. Department of Energy Basic Energy Sciences Program (grants DE-FG02-00ER45810 and EFRC Non-Equilibrium Research Center DE-SC0000989), the NIH (grants NIDCR: 2R01DE015920-06 and NIBIB: 2R01EB003806-06A2), and the NSF (grant DMR-1006713) (S.I.S.'s laboratory). We thank M. Seniw (Northwestern Univ.) for the preparation of figures and A. Tayi (Northwestern Univ.) and K. Pieterse (Eindhoven Univ. of Technology) for assistance with the preparation of the manuscript.	Abbel R, 2009, J AM CHEM SOC, V131, P833, DOI 10.1021/ja807996y; Ajayaghosh A, 2001, J AM CHEM SOC, V123, P5148, DOI 10.1021/ja005933+; Beckers EHA, 2006, J AM CHEM SOC, V128, P649, DOI 10.1021/ja0568042; Burnworth M, 2011, NATURE, V472, P334, DOI 10.1038/nature09963; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Cui HG, 2010, SCIENCE, V327, P555, DOI 10.1126/science.1182340; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; Didraga C, 2004, J PHYS CHEM B, V108, P14976, DOI 10.1021/jp048288s; Eisele DM, 2009, NAT NANOTECHNOL, V4, P658, DOI 10.1038/nnano.2009.227; El Hamaoui B, 2007, CHEM COMMUN, P2384, DOI 10.1039/b618821d; El-ghayoury A, 2000, CHEM COMMUN, P1969, DOI 10.1039/b005903j; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fouquey C., 1990, ADV MATER, V2, P254; GARDNER GB, 1995, NATURE, V374, P792, DOI 10.1038/374792a0; Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; Henry L., 1878, ANN SOC SCI BRUX, V3, P267; Hill JP, 2004, SCIENCE, V304, P1481, DOI 10.1126/science.1097789; Jin W, 2005, P NATL ACAD SCI USA, V102, P10801, DOI 10.1073/pnas.0500852102; Jin W, 2008, J AM CHEM SOC, V130, P9434, DOI 10.1021/ja801179e; Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855; KATO T, 1989, J AM CHEM SOC, V111, P8533, DOI 10.1021/ja00204a044; Kautz H, 2006, MACROMOLECULES, V39, P4265, DOI 10.1021/ma060706z; LEHN JM, 1990, ANGEW CHEM INT EDIT, V29, P1304, DOI 10.1002/anie.199013041; Lohmeijer BGG, 2002, ANGEW CHEM INT EDIT, V41, P3825, DOI 10.1002/1521-3773(20021018)41:20<3825::AID-ANIE3825>3.0.CO;2-6; Mata A, 2010, BIOMATERIALS, V31, P6004, DOI 10.1016/j.biomaterials.2010.04.013; Messmore BW, 2004, J AM CHEM SOC, V126, P14452, DOI 10.1021/ja049325w; O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]; Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926; Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555; Rozkiewicz DI, 2011, ANGEW CHEM INT EDIT, V50, P6324, DOI 10.1002/anie.201100821; Sakai N, 2010, J AM CHEM SOC, V132, P6923, DOI 10.1021/ja101944r; Schenning APHJ, 2005, CHEM COMMUN, P3245, DOI 10.1039/b501804h; Schenning APHJ, 2002, J AM CHEM SOC, V124, P10252, DOI 10.1021/ja020378s; Schmid SA, 2009, J AM CHEM SOC, V131, P17696, DOI 10.1021/ja9080452; Schoonbeek FS, 1999, ANGEW CHEM INT EDIT, V38, P1393, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1393::AID-ANIE1393>3.0.CO;2-H; Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Sisson AL, 2008, ANGEW CHEM INT EDIT, V47, P3727, DOI 10.1002/anie.200800203; Sofos M, 2009, NAT MATER, V8, P68, DOI [10.1038/nmat2336, 10.1038/NMAT2336]; Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; STUPP SI, 1993, SCIENCE, V259, P59, DOI 10.1126/science.259.5091.59; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Wu JS, 2007, CHEM REV, V107, P718, DOI 10.1021/cr068010r; Xiao SX, 2006, J AM CHEM SOC, V128, P10700, DOI 10.1021/ja0642360; Yamamoto Y, 2006, SCIENCE, V314, P1761, DOI 10.1126/science.1134441; Yamamoto Y, 2006, ADV MATER, V18, P1297, DOI 10.1002/adma.200502116; Yamamoto Y, 2009, P NATL ACAD SCI USA, V106, P21051, DOI 10.1073/pnas.0905655106; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/NMAT2778, 10.1038/nmat2778]; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369; Zubarev ER, 2001, J AM CHEM SOC, V123, P4105, DOI 10.1021/ja015653+	59	2525	2551	132	3794	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					813	817		10.1126/science.1205962	http://dx.doi.org/10.1126/science.1205962			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344437	Green Accepted			2022-12-28	WOS:000300356400034
J	Friedman, LJ; Gelles, J				Friedman, Larry J.; Gelles, Jeff			Mechanism of Transcription Initiation at an Activator-Dependent Promoter Defined by Single-Molecule Observation	CELL			English	Article							COLI RNA-POLYMERASE; OPEN COMPLEX-FORMATION; PROKARYOTIC ENHANCER; FACTOR SIGMA(54); DNA; PROTEIN; BINDING; ELONGATION; PATHWAY; ORGANIZATION	Understanding the pathway and kinetic mechanisms of transcription initiation is essential for quantitative understanding of gene regulation, but initiation is a multistep process, the features of which can be obscured in bulk analysis. We used a multiwavelength single-molecule fluorescence colocalization approach, CoSMoS, to define the initiation pathway at an activator-dependent bacterial sigma(54) promoter that recapitulates characteristic features of eukaryotic promoters activated by enhancer binding proteins. The experiments kinetically characterize all major steps of the initiation process, revealing heretofore unknown features, including reversible formation of two closed complexes with greatly differing stabilities, multiple attempts for each successful formation of an open complex, and efficient release of s 54 from the polymerase core at the start of transcript synthesis. Open complexes are committed to transcription, suggesting that regulation likely targets earlier steps in the mechanism. CoSMoS is a powerful, generally applicable method to elucidate the mechanisms of transcription and other multistep biochemical processes.	[Friedman, Larry J.; Gelles, Jeff] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University	Friedman, LJ (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	larryfj@brandeis.edu; gelles@brandeis.edu		Friedman, Larry/0000-0003-4946-8731; Gelles, Jeff/0000-0001-7910-3421	NIGMS [K25 GM00714, R01 GM43369, R01 GM81648]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081648, R37GM043369, R01GM043369, K25GM000714] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rippe for plasmids and A. Hochschild, A. Hoskins, R. Landick, M. Marr, J. Mumm, and M. Osborne for helpful discussions. This work was supported by grants K25 GM00714 (to L.J.F.), R01 GM43369, and R01 GM81648 (to J.G.) from the NIGMS.	Amit R, 2011, CELL, V146, P105, DOI 10.1016/j.cell.2011.06.024; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Bondarenko V, 2002, NUCLEIC ACIDS RES, V30, P636, DOI 10.1093/nar/30.3.636; Bose D, 2008, MOL CELL, V32, P337, DOI 10.1016/j.molcel.2008.09.015; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Burrows PC, 2008, J MOL BIOL, V375, P43, DOI 10.1016/j.jmb.2007.10.045; Burrows PC, 2009, J MOL BIOL, V387, P306, DOI 10.1016/j.jmb.2009.01.052; CANNON W, 1993, MOL MICROBIOL, V8, P287, DOI 10.1111/j.1365-2958.1993.tb01573.x; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Chen BY, 2007, STRUCTURE, V15, P429, DOI 10.1016/j.str.2007.02.007; Colquhoun David, 1995, P589; Crawford DJ, 2008, RNA, V14, P170, DOI 10.1261/rna.794808; Darst SA, 2004, TRENDS BIOCHEM SCI, V29, P159, DOI 10.1016/j.tibs.2004.02.005; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; Deighan P, 2011, GENE DEV, V25, P77, DOI 10.1101/gad.1991811; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Friedman LJ, 2006, BIOPHYS J, V91, P1023, DOI 10.1529/biophysj.106.084004; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Ho MX, 2009, CURR OPIN STRUC BIOL, V19, P715, DOI 10.1016/j.sbi.2009.10.010; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; Huo YX, 2006, MOL MICROBIOL, V59, P168, DOI 10.1111/j.1365-2958.2005.04943.x; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Joly N, 2012, BBA-MOL CELL RES, V1823, P108, DOI 10.1016/j.bbamcr.2011.08.012; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; Kontur WS, 2008, J MOL BIOL, V376, P1034, DOI 10.1016/j.jmb.2007.11.064; Lee CR, 2010, MOL MICROBIOL, V78, P1468, DOI 10.1111/j.1365-2958.2010.07419.x; Lin YC, 2005, NAT STRUCT MOL BIOL, V12, P603, DOI 10.1038/nsmb949; Magasanik B., 1996, ESCHERICHIA COLI SAL, P1344; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; MORRIS L, 1994, J BIOL CHEM, V269, P11563; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; NINFA AJ, 1987, CELL, V50, P1039, DOI 10.1016/0092-8674(87)90170-X; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; REITZER LJ, 1987, J BACTERIOL, V169, P4279, DOI 10.1128/jb.169.9.4279-4284.1987; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Rippe K, 1997, J MOL BIOL, V270, P125, DOI 10.1006/jmbi.1997.1079; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; SASSEDWIGHT S, 1990, CELL, V62, P945, DOI 10.1016/0092-8674(90)90269-K; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Susa M, 2006, MOL MICROBIOL, V59, P1807, DOI 10.1111/j.1365-2958.2006.05058.x; Szalewska-Palasz A, 2007, J BIOL CHEM, V282, P18046, DOI 10.1074/jbc.M610181200; TINTUT Y, 1995, GENE DEV, V9, P2305, DOI 10.1101/gad.9.18.2305; Villain-Guillot P, 2007, DRUG DISCOV TODAY, V12, P200, DOI 10.1016/j.drudis.2007.01.005; WEDEL A, 1995, GENE DEV, V9, P2042, DOI 10.1101/gad.9.16.2042; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x	56	92	93	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					679	689		10.1016/j.cell.2012.01.018	http://dx.doi.org/10.1016/j.cell.2012.01.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341441	Green Accepted, Bronze			2022-12-28	WOS:000300622400010
J	Gourse, RL; Landick, R				Gourse, Richard L.; Landick, Robert			CoSMoS Unravels Mysteries of Transcription Initiation	CELL			English	Editorial Material							BACTERIAL RNA-POLYMERASE; RECOGNITION; DNA		[Gourse, Richard L.; Landick, Robert] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gourse, RL (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	rgourse@bact.wisc.edu; landick@biochem.wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038660, R37GM037048] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM037048, R01 GM038660] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; MCCLURE WR, 1980, P NATL ACAD SCI-BIOL, V77, P5634, DOI 10.1073/pnas.77.10.5634; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x	10	9	9	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					635	637		10.1016/j.cell.2012.01.042	http://dx.doi.org/10.1016/j.cell.2012.01.042			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341438	Bronze, Green Accepted			2022-12-28	WOS:000300622400006
J	Smith, JA; Mays, N				Smith, Judith A.; Mays, Nicholas			GP led commissioning: time for a cool appraisal	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; UK		[Smith, Judith A.] Nuffield Trust, London W1G 7LP, England; [Mays, Nicholas] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Smith, JA (corresponding author), Nuffield Trust, London W1G 7LP, England.	judith.smith@nuffieldtrust.org.uk	Smith, Judith/AAW-3070-2021	Smith, Judith/0000-0003-4036-4063				[Anonymous], 2011, DEV CLIN COMM GROUPS; Audit Commission, 2009, MOR LESS AR PROD EFF; Audit Commission, 2008, IS TREATM WORK PROGR; Baker GR, 2008, HIGH PERFORMING HEAL; Blunt I, 2010, TRENDS EMERGENCY ADM; Casalino LP, 2011, GP COMMISSIONING NHS; CURRY N, 2008, PRACTICE BASED COMMI; Department of Health, 2010, EQ EXC LIB NHS; DOWLING B, 2003, NEW PRIMARY CARE MOD; Figueras J., 2005, PURCHASING IMPROVE H; Goodwin N, 2012, REPORT DEP HLTH NHS; Ham C, 1996, MILBANK Q, V74, P191, DOI 10.2307/3350246; LIGHT DW, 1998, EFFECTIVE COMMISSION; Locock L, 2004, Health Serv Manage Res, V17, P24, DOI 10.1258/095148404322772705; Mays N, 2001, PURCHASING HLTH CARE; Smith J, 2005, BRIT MED J, V331, P1397, DOI 10.1136/bmj.331.7529.1397; Smith J, 2004, PUBLIC MONEY MANAGE, V24, P87, DOI 10.1111/j.1467-9302.2004.00400.x; Smith J, 2010, NEXT COMMISSIONING E; Smith J, 2009, PRACTICE BASED COMMI; Smith J, 2004, REV EFFECTIVENESS PR	20	11	11	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2012	344								e980	10.1136/bmj.e980	http://dx.doi.org/10.1136/bmj.e980			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IP	22344307	Green Submitted			2022-12-28	WOS:000300559200005
J	Sridhar, D				Sridhar, Devi			Regulate alcohol for global health	NATURE			English	Editorial Material									[Sridhar, Devi] Univ Oxford Wolfson Coll, Dept Publ Hlth, Oxford OX2 6UD, England; [Sridhar, Devi] Univ Oxford Wolfson Coll, George Ctr Healthcare Innovat, Oxford OX2 6UD, England	University of Oxford; University of Oxford	Sridhar, D (corresponding author), Univ Oxford Wolfson Coll, Dept Publ Hlth, Oxford OX2 6UD, England.	devi.sridhar@dph.ox.ac.uk						Gostin LO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001031; L'hirondel A, 1998, World Health Stat Q, V51, P79; World Health Organization, 2011, GLOB STAT REP ALC HL	3	22	22	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					302	302		10.1038/482302a	http://dx.doi.org/10.1038/482302a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	892LG	22337033	Bronze			2022-12-28	WOS:000300287100016
J	Garbutt, JM; Banister, C; Spitznagel, E; Piccirillo, JF				Garbutt, Jane M.; Banister, Christina; Spitznagel, Edward; Piccirillo, Jay F.			Amoxicillin for Acute Rhinosinusitis A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; RESPIRATORY-TRACT INFECTIONS; ACUTE MAXILLARY SINUSITIS; DOUBLE-BLIND; ANTIBIOTIC-TREATMENT; PRIMARY-CARE; COMPLAINTS; CHILDREN; ADULTS	Context Evidence to support antibiotic treatment for acute rhinosinusitis is limited, yet antibiotics are commonly used. Objective To determine the incremental effect of amoxicillin treatment over symptomatic treatments for adults with clinically diagnosed acute rhinosinusitis. Design, Setting, and Participants A randomized, placebo-controlled trial of adults with uncomplicated, acute rhinosinusitis were recruited from 10 community practices in Missouri between November 1, 2006, and May 1, 2009. Interventions Ten-day course of either amoxicillin (1500 mg/d) or placebo administered in 3 doses per day. All patients received a 5- to 7-day supply of symptomatic treatments for pain, fever, cough, and nasal congestion to use as needed. Main Outcome Measures The primary outcome was improvement in disease-specific quality of life after 3 to 4 days of treatment assessed with the Sinonasal Outcome Test-16 (minimally important difference of 0.5 units on a 0-3 scale). Secondary outcomes included the patient's retrospective assessment of change in sinus symptoms and functional status, recurrence or relapse, and satisfaction with and adverse effects of treatment. Outcomes were assessed by telephone interview at days 3, 7, 10, and 28. Results A total of 166 adults (36% male; 78% with white race) were randomized to amoxicillin (n=85) or placebo (n=81); 92% concurrently used 1 or more symptomatic treatments (94% for amoxicillin group vs 90% for control group; P=.34). The mean change in Sinonasal Outcome Test-16 scores was not significantly different between groups on day 3 (decrease of 0.59 in the amoxicillin group and 0.54 in the control group; mean difference between groups of 0.03 [95% CI, -0.12 to 0.19]) and on day 10 (mean difference between groups of 0.01 [95% CI, -0.13 to 0.15]), but differed at day 7 favoring amoxicillin (mean difference between groups of 0.19 [95% CI, 0.024 to 0.35]). There was no statistically significant difference in reported symptom improvement at day 3 (37% for amoxicillin group vs 34% for control group; P=.67) or at day 10 (78% vs 80%, respectively; P=.71), whereas at day 7 more participants treated with amoxicillin reported symptom improvement (74% vs 56%, respectively; P=.02). No between-group differences were found for any other secondary outcomes. No serious adverse events occurred. Conclusion Among patients with acute rhinosinusitis, a 10-day course of amoxicillin compared with placebo did not reduce symptoms at day 3 of treatment.	[Garbutt, Jane M.] Washington Univ, Sch Med, Div Gen Med Sci, St Louis, MO 63110 USA; [Garbutt, Jane M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Garbutt, Jane M.; Banister, Christina] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Spitznagel, Edward] Washington Univ, Sch Med, Dept Math, St Louis, MO 63110 USA; [Piccirillo, Jay F.] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Garbutt, JM (corresponding author), Washington Univ, Sch Med, Div Gen Med Sci, Campus Box 8005,660 S Euclid Ave, St Louis, MO 63110 USA.	jgarbutt@dom.wustl.edu	li, li/E-9763-2012		Carey Perkins LLP; National Institutes of Health; Department of Defense; Federal Emergency Management Agency; National Institute of Allergy and Infectious Diseases [U01-AI064655-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI064655] Funding Source: NIH RePORTER	Carey Perkins LLP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Federal Emergency Management Agency; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Piccirillo reported that he has received financial compensation for expert testimony and review of medical records related to litigation surrounding delay in diagnosis for cancer from Carey Perkins LLP and surrounding complications of sleep apnea from Attorney Duncan E. Ragsdale; has grants pending with the National Institutes of Health, the Department of Defense, and the Federal Emergency Management Agency; has received honoraria from Emory University and New York University for invited speaker positions for grand rounds; has received royalties for the Sinonasal Outcome Test; and is chair of data and safety monitoring boards for Apnex Medical and the National Institutes of Health, National Institute on Deafness and Other Communication Disorders. No other author reported disclosures.; This study was funded by grant U01-AI064655-01A1 from the National Institute of Allergy and Infectious Diseases.	Agency for Healthcare Research and Quality, DIAGN TREATM COMM AC; Ahovuo-Saloranta A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000243.pub2; Anderson ER, 1999, OTOLARYNG HEAD NECK, V121, P702, DOI 10.1053/hn.1999.v121.a100114; ASELTINE RH, 1995, MED CARE, V33, pAS67; AXELSSON A, 1970, ACTA OTO-LARYNGOL, V70, P71, DOI 10.3109/00016487009181861; Cals JWL, 2010, ANN FAM MED, V8, P124, DOI 10.1370/afm.1090; de Ferranti SD, 1998, BMJ-BRIT MED J, V317, P632, DOI 10.1136/bmj.317.7159.632; Dolor RJ, 2001, JAMA-J AM MED ASSOC, V286, P3097, DOI 10.1001/jama.286.24.3097; Falagas ME, 2008, LANCET INFECT DIS, V8, P543, DOI 10.1016/S1473-3099(08)70202-0; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Garbutt J, 2006, PEDIATRICS, V117, pE1087, DOI 10.1542/peds.2005-2651; Garbutt J, 2011, ARCH OTOLARYNGOL, V137, P792, DOI 10.1001/archoto.2011.120; Garbutt JM, 2001, PEDIATRICS, V107, P619, DOI 10.1542/peds.107.4.619; Gill JM, 2006, FAM MED, V38, P349; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Hickner JM, 2001, ANN INTERN MED, V134, P498, DOI 10.7326/0003-4819-134-6-200103200-00017; Hughes JM, 2011, JAMA-J AM MED ASSOC, V305, P1027, DOI 10.1001/jama.2011.279; Juniper EF, 1998, J ALLERGY CLIN IMMUN, V102, P16, DOI 10.1016/S0091-6749(98)70048-X; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Kassel JC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006821.pub2; Lindbaek M, 1996, BMJ-BRIT MED J, V313, P325, DOI 10.1136/bmj.313.7053.325; Martin CL, 2004, J CLIN EPIDEMIOL, V57, P429, DOI 10.1016/j.jclinepi.2003.09.008; Merenstein D, 2005, J FAM PRACTICE, V54, P144; Piccirillo JF, 2002, OTOLARYNG HEAD NECK, V126, P41, DOI 10.1067/mhn.2002.121022; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Stalman W, 1997, BRIT J GEN PRACT, V47, P794; Tan T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a437; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; WALD ER, 1986, PEDIATRICS, V77, P795; Williamson IG, 2007, JAMA-J AM MED ASSOC, V298, P2487, DOI 10.1001/jama.298.21.2487; Zalmanovici A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005149.pub2	31	53	57	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					685	692		10.1001/jama.2012.138	http://dx.doi.org/10.1001/jama.2012.138			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22337680	Green Accepted			2022-12-28	WOS:000300278500025
J	Inaba, M; Yamanaka, H; Kondo, S				Inaba, Masafumi; Yamanaka, Hiroaki; Kondo, Shigeru			Pigment Pattern Formation by Contact-Dependent Depolarization	SCIENCE			English	Article							ZEBRAFISH		[Inaba, Masafumi; Yamanaka, Hiroaki; Kondo, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Kondo, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	skondo@fbs.osaka-u.ac.jp		Kondo, Shigeru/0000-0003-0192-5526; Inaba, Masafumi/0000-0001-6896-5819	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Uehara Memorial Foundation; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [22370079] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Kawakami for providing the Tol2 vector and Y. Kurachi, K. Furutani, M. Okada, A. Ogura, and K. Ida for helpful discussions. This study was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Research on (B)] and grants from the Uehara Memorial Foundation and Mitsubishi Foundation.	Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; Meinhardt H., 1982, MODELS BIOL PATTERN; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Takahashi G, 2008, PIGM CELL MELANOMA R, V21, P677, DOI 10.1111/j.1755-148X.2008.00504.x; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757	9	127	133	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					677	677		10.1126/science.1212821	http://dx.doi.org/10.1126/science.1212821			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323812				2022-12-28	WOS:000300047100042
J	Lim, SS; Mokdad, AH				Lim, Stephen S.; Mokdad, Ali H.			Socioeconomic inequalities and infectious disease burden	LANCET			English	Editorial Material							MORTALITY		[Lim, Stephen S.; Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Lim, SS (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	stevelim@uw.edu	Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339				Baker MG, 2012, LANCET, V379, P1112, DOI 10.1016/S0140-6736(11)61780-7; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260	6	7	7	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2012	379	9821					1080	1081		10.1016/S0140-6736(12)60151-2	http://dx.doi.org/10.1016/S0140-6736(12)60151-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916VR	22353261				2022-12-28	WOS:000302131800009
J	Hurwitz, B; Dupree, M				Hurwitz, Brian; Dupree, Marguerite			Why celebrate Joseph Lister?	LANCET			English	Editorial Material									[Hurwitz, Brian] Kings Coll London, Dept English Language & Literature, Ctr Humanities & Hlth, London WC2R 2LS, England; [Hurwitz, Brian] Kings Coll London, Div Hlth & Social Care, London WC2R 2LS, England; [Dupree, Marguerite] Univ Glasgow, Ctr Hist Med, Glasgow, Lanark, Scotland	University of London; King's College London; University of London; King's College London; University of Glasgow	Hurwitz, B (corresponding author), Kings Coll London, Dept English Language & Literature, Ctr Humanities & Hlth, London WC2R 2LS, England.	brian.hurwitz@kcl.ac.uk			Wellcome Trust [086071] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Granshaw Lindsay, 1992, MED INNOVATIONS HIST, P17; Growther A, 2007, MED LIVES AGE SURG R; Lister J., 1867, LANCET, V90, P668, DOI [10.1016/S0140-6736(02)58116-2, DOI 10.1016/S0140-6736(02)58116-2]; LISTER J, 1858, PHILOS T ROY SOC LON, V148, P645, DOI DOI 10.1098/RST1.1858.0031; Lister Lawrence C., 1827, OXFORD DICT NATL BIO	5	5	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2012	379	9820					E39	E40		10.1016/S0140-6736(12)60245-1	http://dx.doi.org/10.1016/S0140-6736(12)60245-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	911JE	22385682				2022-12-28	WOS:000301712300002
J	Ichimura, A; Hirasawa, A; Poulain-Godefroy, O; Bonnefond, A; Hara, T; Yengo, L; Kimura, I; Leloire, A; Liu, N; Iida, K; Choquet, H; Besnard, P; Lecoeur, C; Vivequin, S; Ayukawa, K; Takeuchi, M; Ozawa, K; Tauber, M; Maffeis, C; Morandi, A; Buzzetti, R; Elliott, P; Pouta, A; Jarvelin, MR; Korner, A; Kiess, W; Pigeyre, M; Caiazzo, R; Van Hul, W; Van Gaal, L; Horber, F; Balkau, B; Levy-Marchal, C; Rouskas, K; Kouvatsi, A; Hebebrand, J; Hinney, A; Scherag, A; Pattou, F; Meyre, D; Koshimizu, T; Wolowczuk, I; Tsujimoto, G; Froguel, P				Ichimura, Atsuhiko; Hirasawa, Akira; Poulain-Godefroy, Odile; Bonnefond, Amelie; Hara, Takafumi; Yengo, Loic; Kimura, Ikuo; Leloire, Audrey; Liu, Ning; Iida, Keiko; Choquet, Helene; Besnard, Philippe; Lecoeur, Cecile; Vivequin, Sidonie; Ayukawa, Kumiko; Takeuchi, Masato; Ozawa, Kentaro; Tauber, Maithe; Maffeis, Claudio; Morandi, Anita; Buzzetti, Raffaella; Elliott, Paul; Pouta, Anneli; Jarvelin, Marjo-Riitta; Koerner, Antje; Kiess, Wieland; Pigeyre, Marie; Caiazzo, Roberto; Van Hul, Wim; Van Gaal, Luc; Horber, Fritz; Balkau, Beverley; Levy-Marchal, Claire; Rouskas, Konstantinos; Kouvatsi, Anastasia; Hebebrand, Johannes; Hinney, Anke; Scherag, Andre; Pattou, Francois; Meyre, David; Koshimizu, Taka-aki; Wolowczuk, Isabelle; Tsujimoto, Gozoh; Froguel, Philippe			Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human	NATURE			English	Article							PANCREATIC BETA-CELLS; CHAIN FATTY-ACIDS; INSULIN-RESISTANCE; BODY-MASS; CHILDHOOD OBESITY; PROTEIN FUNCTION; EARLY-ONSET; RECEPTOR; POPULATION; MUTATIONS	Free fatty acids provide an important energy source as nutrients, and act as signalling molecules in various cellular processes(1-4). Several G-protein-coupled receptors have been identified as free-fatty-acid receptors important in physiology as well as in several diseases(3,5-13). GPR120 (also known as O3FAR1) functions as a receptor for unsaturated long-chain free fatty acids and has a critical role in various physiological homeostasis mechanisms such as adipogenesis, regulation of appetite and food preference(5,6,14-16). Here we show that GPR120-deficient mice fed a high-fat diet develop obesity, glucose intolerance and fatty liver with decreased adipocyte differentiation and lipogenesis and enhanced hepatic lipogenesis. Insulin resistance in such mice is associated with reduced insulin signalling and enhanced inflammation in adipose tissue. In human, we show that GPR120 expression in adipose tissue is significantly higher in obese individuals than in lean controls. GPR120 exon sequencing in obese subjects reveals a deleterious non-synonymous mutation (p.R270H) that inhibits GPR120 signalling activity. Furthermore, the p.R270H variant increases the risk of obesity in European populations. Overall, this study demonstrates that the lipid sensor GPR120 has a key role in sensing dietary fat and, therefore, in the control of energy balance in both humans and rodents.	[Poulain-Godefroy, Odile; Bonnefond, Amelie; Yengo, Loic; Leloire, Audrey; Choquet, Helene; Lecoeur, Cecile; Vivequin, Sidonie; Morandi, Anita; Rouskas, Konstantinos; Meyre, David; Wolowczuk, Isabelle; Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR 8199, F-59000 Lille, France; [Ichimura, Atsuhiko; Hirasawa, Akira; Hara, Takafumi; Kimura, Ikuo; Liu, Ning; Iida, Keiko; Ayukawa, Kumiko; Takeuchi, Masato; Ozawa, Kentaro; Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Sakyo Ku, Kyoto 6068501, Japan; [Pigeyre, Marie; Caiazzo, Roberto; Pattou, Francois] Lille Nord France Univ, INSERM, U859, F-59000 Lille, France; [Besnard, Philippe] Univ Bourgogne, INSERM, UMR U866, AgroSup Dijon, F-21078 Dijon, France; [Tauber, Maithe] Ctr Hosp Univ, Childrens Hosp, INSERM, U563, F-31000 Toulouse, France; [Maffeis, Claudio; Morandi, Anita] Reg Ctr Juvenile Diabet Obes & Clin Nutr, I-37134 Verona, Italy; [Maffeis, Claudio] Univ Verona, Dept Mother & Child, Paediat Sect, I-37134 Verona, Italy; [Buzzetti, Raffaella] Univ Roma La Sapienza, Dept Clin Sci, I-00161 Rome, Italy; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, HPA Ctr Environm & Hlth,MRC, London W2 1PG, England; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Univ Oulu, Natl Publ Hlth Inst, Bioctr Oulu, SF-90220 Oulu, Finland; [Pouta, Anneli] Univ Oulu, Inst Clin Med Obstet & Gynecol, SF-90220 Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, SF-90220 Oulu, Finland; [Koerner, Antje; Kiess, Wieland] Univ Leipzig, Ctr Pediat Res, Dept Womens & Child Hlth, D-04317 Leipzig, Germany; [Pigeyre, Marie; Caiazzo, Roberto; Pattou, Francois] Lille Univ Hosp, F-59000 Lille, France; [Van Hul, Wim] Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; [Van Gaal, Luc] Univ Antwerp Hosp, Dept Endocrinol, B-2650 Antwerp, Belgium; [Horber, Fritz] Clin Lindberg, Dept Med, Dept Surg & Internal Med, CH-8400 Winterthur, Switzerland; [Horber, Fritz] Univ Bern, CH-3011 Bern, Switzerland; [Balkau, Beverley] Ctr Res Epidemiol & Populat Hlth CRESP, INSERM, U780, F-94800 Villejuif, France; [Balkau, Beverley] Univ Paris 11, F-91405 Orsay, France; [Levy-Marchal, Claire] Hop Robert Debre, INSERM, U690, F-75935 Paris, France; [Rouskas, Konstantinos; Kouvatsi, Anastasia] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki 54124, Greece; [Hebebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, D-45147 Essen, Germany; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, D-45122 Essen, Germany; [Meyre, David] McMaster Univ, Hamilton, ON L8S 4L8, Canada; [Koshimizu, Taka-aki] Jichi Med Univ, Div Mol Pharmacol, Dept Pharmacol, Shimotsuke, Tochigi 3290498, Japan; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London W12 0NN, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Verona; Sapienza University Rome; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; Leipzig University; Universite de Lille - ISITE; CHU Lille; University of Antwerp; University of Antwerp; University of Bern; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Aristotle University of Thessaloniki; University of Duisburg Essen; University of Duisburg Essen; McMaster University; Jichi Medical University; Imperial College London	Froguel, P (corresponding author), Lille Pasteur Inst, CNRS, UMR 8199, F-59000 Lille, France.	gtsuji@pharm.kyoto-u.ac.jp; p.froguel@imperial.ac.uk	Hinney, Anke/D-6953-2011; Körner, Antje/B-3988-2015; Meyre, David/D-7315-2011; TAUBER, Maithe/K-7386-2014; Koshimizu, Taka-aki/G-2740-2015; Kimura, Ikuo/B-4193-2015; Scherag, Andre/B-3805-2014; Bonnefond, Amélie/O-2784-2017; Pattou, Francois/O-6151-2017; Buzzetti, Raffaella/K-3090-2016; Yengo, Loic/D-2692-2017; caiazzo, robert/Y-9692-2019; horber, Fritz/AAL-5419-2020; Poulain-Godefroy, Odile/AAF-5474-2021; Morandi, Anita/AAC-4067-2022; Maffeis, Claudio/AAG-5347-2020; Caiazzo, Robert/D-1958-2013; FROGUEL, Philippe/O-6799-2017	Hinney, Anke/0000-0001-5659-0706; Körner, Antje/0000-0001-6001-0356; Meyre, David/0000-0003-4850-7444; Bonnefond, Amélie/0000-0001-9976-3005; Pattou, Francois/0000-0001-8388-3766; Buzzetti, Raffaella/0000-0003-1490-6041; Yengo, Loic/0000-0002-4272-9305; caiazzo, robert/0000-0001-5383-0540; FROGUEL, Philippe/0000-0003-2972-0784; Van Hul, Wim/0000-0002-5065-7858; Pigeyre, Marie/0000-0003-2984-8366; POULAIN-GODEFROY, Odile/0000-0001-8805-9450; Ichimura, Atsuhiko/0000-0003-0366-5211; Choquet, Helene/0000-0001-9839-8667; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Elliott, Paul/0000-0002-7511-5684; MORANDI, Anita/0000-0002-2631-9330; Scherag, Andre/0000-0002-9406-4704; Koshimizu, Taka-aki/0000-0001-5292-7535; wolowczuk, isabelle/0000-0001-6692-6904	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Conseil Regional Nord Pas de Calais/FEDER; Agence Nationale de la Recherche; Academy of Finland; University Hospital of Oulu (Finland); University of Oulu (Finland); European Commission (EURO-BLCS) [QLG1-CT-2000-01643]; Medical Research Council [G0500539, G0600705]; MRC [G0600705, G1002084] Funding Source: UKRI; Grants-in-Aid for Scientific Research [23890019] Funding Source: KAKEN; Medical Research Council [G1002084, G0801056B] Funding Source: researchfish	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Conseil Regional Nord Pas de Calais/FEDER(Region Hauts-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Academy of Finland(Academy of Finland); University Hospital of Oulu (Finland); University of Oulu (Finland); European Commission (EURO-BLCS)(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are indebted to all subjects who participated in these studies. In Japan, the study was supported in part by research grants from the Japan Society for the Promotion of Science; the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Japan Science and Technology Agency; and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy. A.I. is a fellow of the Japan Society for the Promotion of Science. A.B. is a fellow of the EU-funded EUROCHIP consortium. In France, the study was supported by le Conseil Regional Nord Pas de Calais/FEDER and the Agence Nationale de la Recherche (Programme de Recherche en Nutrition et Alimentation, SensoFAT). The Northern Finland Birth Cohort Studies 1986 received financial support from the Academy of Finland, the University Hospital of Oulu (Finland), the University of Oulu (Finland), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), and the Medical Research Council (G0500539, G0600705, PrevMetSyn/SALVE). We thank the ABOS consortium and the CIC-CCPPRB (Lille CHRU) team for their help in sample handling and clinical data collection. We are grateful to M. Deweirder and F. Allegaert for human DNA bank management.	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Brown JM, 2010, ARTERIOSCL THROM VAS, V30, P24, DOI 10.1161/ATVBAHA.109.198036; Buzzetti R, 2005, PEDIATR RES, V57, P138, DOI 10.1203/01.PDR.0000147728.62185.21; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Ichimura A, 2010, MOL PHARMACOL, V77, P1016, DOI 10.1124/mol.109.063321; Ichimura A, 2009, PROSTAG OTH LIPID M, V89, P82, DOI 10.1016/j.prostaglandins.2009.05.003; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jaquet D, 2004, HORM RES, V62, P92, DOI 10.1159/000079709; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jeyakumar SM, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-27; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Miyauchi S, 2009, N-S ARCH PHARMACOL, V379, P427, DOI 10.1007/s00210-008-0390-8; Morandi A, 2009, OBESITY, V17, P202, DOI 10.1038/oby.2008.470; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Nunez EA, 1997, PROSTAG LEUKOTR ESS, V57, P107, DOI 10.1016/S0952-3278(97)90500-7; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; POSKITT EME, 1995, ACTA PAEDIATR, V84, P961, DOI 10.1111/j.1651-2227.1995.tb13806.x; Poulain-Godefroy O, 2008, AM J PHYSIOL-REG I, V295, pR1, DOI 10.1152/ajpregu.00926.2007; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Rouskas K, 2008, INT J OBESITY, V32, P1618, DOI 10.1038/ijo.2008.167; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Steffen R, 2009, OBES SURG, V19, P3, DOI 10.1007/s11695-008-9675-8; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Sun Q, 2010, MOL PHARMACOL, V78, P804, DOI 10.1124/mol.110.066324; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200	48	473	494	4	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					350	U149		10.1038/nature10798	http://dx.doi.org/10.1038/nature10798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22343897	Green Published			2022-12-28	WOS:000301481800053
J	Bayon, G; Dennielou, B; Etoubleau, J; Ponzevera, E; Toucanne, S; Bermell, S				Bayon, Germain; Dennielou, Bernard; Etoubleau, Joel; Ponzevera, Emmanuel; Toucanne, Samuel; Bermell, Sylvain			Intensifying Weathering and Land Use in Iron Age Central Africa	SCIENCE			English	Article							BANTU EXPANSION; RIVER SYSTEMS; RAIN-FOREST; BP; ATLANTIC; MARINE; CONSTRAINTS; SEDIMENTS; HOLOCENE; CAMEROON	About 3000 years ago, a major vegetation change occurred in Central Africa, when rainforest trees were abruptly replaced by savannas. Up to this point, the consensus of the scientific community has been that the forest disturbance was caused by climate change. We show here that chemical weathering in Central Africa, reconstructed from geochemical analyses of a marine sediment core, intensified abruptly at the same period, departing substantially from the long-term weathering fluctuations related to the Late Quaternary climate. Evidence that this weathering event was also contemporaneous with the migration of Bantu-speaking farmers across Central Africa suggests that human land-use intensification at that time had already made a major impact on the rainforest.	[Bayon, Germain; Dennielou, Bernard; Etoubleau, Joel; Ponzevera, Emmanuel; Toucanne, Samuel; Bermell, Sylvain] IFREMER, Unite Rech Geosci Marines, F-29280 Plouzane, France	Ifremer	Bayon, G (corresponding author), IFREMER, Unite Rech Geosci Marines, F-29280 Plouzane, France.	gbayon@ifremer.fr	Bayon, Germain/F-9754-2010; Toucanne, Samuel/H-3437-2011	Bayon, Germain/0000-0002-6791-4953; Toucanne, Samuel/0000-0002-4858-8953; Dennielou, Bernard/0000-0002-9528-2746	French National Research Agency (ANR) [2010 JCJC 609 01]	French National Research Agency (ANR)(French National Research Agency (ANR))	This work was sponsored by the French National Research Agency (ANR), via the ECO-MIST project (2010 JCJC 609 01). Core KZAI-01 was collected during the Zaiango project funded by IFREMER and TOTAL (chief scientist: B. Savoye). We thank F. Jansen for providing five radiocarbon dates and giving access to the x-ray fluorescence core-scanner data set for core GeoB6518; J. Maley for stimulating discussion, sharing bibliographic resources, and providing Lake Barombi Mbo pollen data; Y. Germain for help in the laboratory; and W. F. Ruddiman, N. C. Chu, and five anonymous referees for their constructive comments on the manuscript. The data reported in this paper are listed in the SOM.	Allegre CJ, 1996, CHEM GEOL, V131, P93, DOI 10.1016/0009-2541(96)00028-9; Bayon G, 2009, EARTH PLANET SC LETT, V277, P318, DOI 10.1016/j.epsl.2008.10.028; Bayon G, 2006, GEOLOGY, V34, P433, DOI 10.1130/G22130.1; Clist B., 1989, AFR ARCHAEOL REV, V7, P59, DOI DOI 10.1007/BF01116838; Denbow J, 1990, AFR ARCHAEOL REV, V8, P139, DOI DOI 10.1007/BF01116874; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Eggert M. K. H., 1993, ARCHAEOLOGY AFRICA F, P289; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; GOLDSTEIN SL, 1984, EARTH PLANET SC LETT, V70, P221, DOI 10.1016/0012-821X(84)90007-4; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; HUFFMAN TN, 1982, ANNU REV ANTHROPOL, V11, P133, DOI 10.1146/annurev.an.11.100182.001025; Maley J, 2002, IDS BULL-I DEV STUD, V33, P13, DOI 10.1111/j.1759-5436.2002.tb00003.x; Maley J, 1998, REV PALAEOBOT PALYNO, V99, P157, DOI 10.1016/S0034-6667(97)00047-X; Mbida VM, 2000, J ARCHAEOL SCI, V27, P151, DOI 10.1006/jasc.1999.0447; Ndong AA, 2002, ANTHROPOLOGIE, V106, P135; Neumann K, 2012, QUATERN INT, V249, P53, DOI 10.1016/j.quaint.2011.03.024; Ngomanda A, 2009, QUATERNARY RES, V71, P307, DOI 10.1016/j.yqres.2008.12.002; Oslisly R., 1994, GROWTH FARMING COMMU, V29-30, P324; Phillipson DW, 1993, AFRICAN ARCHAEOLOGY; Raymond PA, 2003, SCIENCE, V301, P88, DOI 10.1126/science.1083788; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; Schneider RR, 1997, PALEOCEANOGRAPHY, V12, P463, DOI 10.1029/96PA03640; SCHWARTZ D, 1990, CR ACAD SCI II, V310, P1293; SCHWARTZ D, 1992, B SOC GEOL FR, V163, P353; Sowunmi MA, 1999, VEG HIST ARCHAEOBOT, V8, P199, DOI 10.1007/BF02342720; VANSINA J, 1984, J AFR HIST, V25, P129, DOI 10.1017/S0021853700022829; Vincens A, 1999, J BIOGEOGR, V26, P879, DOI 10.1046/j.1365-2699.1999.00333.x; Weijers JWH, 2007, SCIENCE, V315, P1701, DOI 10.1126/science.1138131; Weijers JWH, 2009, GEOCHIM COSMOCHIM AC, V73, P119, DOI 10.1016/j.gca.2008.10.016; WHITE AF, 1995, GEOCHIM COSMOCHIM AC, V59, P1729, DOI 10.1016/0016-7037(95)00078-E; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991; Zangato E, 2010, J AFR ARCHAEOL, V8, P7, DOI 10.3213/1612-1651-10153	33	136	138	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2012	335	6073					1219	1222		10.1126/science.1215400	http://dx.doi.org/10.1126/science.1215400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22323737	Green Published			2022-12-28	WOS:000301225100043
J	Lederle, FA; Pocha, C				Lederle, Frank A.; Pocha, Christine			Screening for Liver Cancer: The Rush to Judgment	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEPATOCELLULAR-CARCINOMA; UNITED-STATES; SURVEILLANCE; CIRRHOSIS	In 2005, a professional society issued a level I recommendation to use ultrasonography to screen the 3 million Americans with cirrhosis for hepatocellular carcinoma (HCC) every 6 months. This designation was based on a large randomized trial from China that reported a reduction in HCC deaths from screening in carriers of hepatitis B surface antigen. However, besides the difference in population, this trial did not report all deaths, excluded patients after randomization, and would almost certainly have found no significant difference if the cluster randomization had been accounted for in the analysis. Misplaced confidence in the Chinese trial has led many writers to accept the effectiveness of HCC screening as proven, making it more difficult to conduct the high-quality randomized trials that are needed to ensure optimal patient care.	[Lederle, Frank A.; Pocha, Christine] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Lederle, FA (corresponding author), Vet Affairs Med Ctr, Dept Med 111 O, 1 Vet Dr, Minneapolis, MN 55417 USA.	frank.lederle@va.gov						Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen JG, 2003, J MED SCREEN, V10, P204, DOI 10.1258/096914103771773320; Davila JA, 2011, ANN INTERN MED, V155, P275, DOI 10.7326/0003-4819-155-4-201108160-00019; Davila JA, 2011, ANN INTERN MED, V154, P85, DOI 10.7326/0003-4819-154-2-201101180-00006; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; Isaakidis P, 2003, AM J EPIDEMIOL, V158, P921, DOI 10.1093/aje/kwg232; Kerry SM, 1998, BMJ-BRIT MED J, V316, P54, DOI 10.1136/bmj.316.7124.54; Lauer MS, 2011, ARCH INTERN MED, V171, P1268, DOI 10.1001/archinternmed.2011.205; Lee TH, 2002, NEW ENGL J MED, V346, P529, DOI 10.1056/NEJM200202143460715; National Cancer Institute, 2011, LIV HEP CANC SCREEN; Poustchi H, 2011, HEPATOLOGY, V54, P1998, DOI 10.1002/hep.24581; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Senn S, 2004, STAT MED, V23, P3729, DOI 10.1002/sim.2074; Sharma P, 2011, DIGEST DIS SCI, V56, P569, DOI 10.1007/s10620-010-1453-5; Stravitz RT, 2008, AM J MED, V121, P119, DOI 10.1016/j.amjmed.2007.09.020; Stroffolini T, 2004, DIGEST LIVER DIS, V36, P56, DOI 10.1016/j.dld.2003.07.007; Teefey SA, 2003, RADIOLOGY, V226, P533, DOI 10.1148/radiol.2262011980; Trevisani F, 2002, AM J GASTROENTEROL, V97, P734; Ward BW, 2010, VITAL HLTH STAT, P1; Wong CR, 2009, DIGEST DIS SCI, V54, P2712, DOI 10.1007/s10620-009-1015-x; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	22	68	69	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2012	156	5					387	U214		10.7326/0003-4819-156-5-201203060-00012	http://dx.doi.org/10.7326/0003-4819-156-5-201203060-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902OC	22393134				2022-12-28	WOS:000301046800007
J	Dean, LG; Kendal, RL; Schapiro, SJ; Thierry, B; Laland, KN				Dean, L. G.; Kendal, R. L.; Schapiro, S. J.; Thierry, B.; Laland, K. N.			Identification of the Social and Cognitive Processes Underlying Human Cumulative Culture	SCIENCE			English	Article							CHIMPANZEES PAN-TROGLODYTES; WILD CHIMPANZEES; CAPUCHIN MONKEYS; EVOLUTION; TRANSMISSION; STRATEGIES; INNOVATION; TRADITIONS; PRIMATE	The remarkable ecological and demographic success of humanity is largely attributed to our capacity for cumulative culture, with knowledge and technology accumulating over time, yet the social and cognitive capabilities that have enabled cumulative culture remain unclear. In a comparative study of sequential problem solving, we provided groups of capuchin monkeys, chimpanzees, and children with an experimental puzzlebox that could be solved in three stages to retrieve rewards of increasing desirability. The success of the children, but not of the chimpanzees or capuchins, in reaching higher-level solutions was strongly associated with a package of sociocognitive processes-including teaching through verbal instruction, imitation, and prosociality-that were observed only in the children and covaried with performance.	[Kendal, R. L.] Univ Durham, Dept Anthropol, Ctr Coevolut Biol & Culture, Durham DH1 3LE, England; [Dean, L. G.; Laland, K. N.] Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9TS, Fife, Scotland; [Schapiro, S. J.] Univ Texas MD Anderson Canc Ctr, Michale E Keeling Ctr Comparat Med & Res, Bastrop, TX 78602 USA; [Thierry, B.] Univ Strasbourg, Ctr Natl Rech Sci, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, F-67087 Strasbourg, France	Durham University; University of St Andrews; University of Texas System; UTMD Anderson Cancer Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kendal, RL (corresponding author), Univ Durham, Dept Anthropol, Ctr Coevolut Biol & Culture, Durham DH1 3LE, England.	rachel.kendal@durham.ac.uk; knl1@st-andrews.ac.uk	Dean, Lewis/J-4508-2013	Dean, Lewis/0000-0002-8392-5273; Laland, Kevin/0000-0002-2457-0900; Schapiro, Steven J./0000-0001-5406-1739	European Commission [FP6-2004-NESTPATH-043434]; European Research Council [EVOCULTURE, 232823]; Royal Society; NIH [RR-15090]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR015090] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by the CULTAPTATION project (European Commission contract FP6-2004-NESTPATH-043434), a European Research Council Advanced Grant (EVOCULTURE, 232823) (K.N.L.), and a Royal Society Dorothy Hodgkin Fellowship (R. L. K.). Chimpanzees at M. D. Anderson Cancer Center were supported by NIH Cooperative Agreement RR-15090. We thank S. Pavonetti, A. Whiten, C. Caldwell, C. Tennie, M. Tomasello, C. van Schaik, the CCBC/EARG journal club (Durham), and members of the Laland lab for advice and/or useful comments on earlier drafts of our manuscript, and J. Zampol for drawing Fig. 1. All research was approved by the ethics committee at the University of St. Andrews and the relevant committees at the research facilities and follows the relevant legislation in the UK, USA, and France. Data are available from the authors upon request.	Basalla G., 1988, EVOLUTION TECHNOLOGY; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Boesch C, 2003, EVOL ANTHROPOL, V12, P82, DOI 10.1002/evan.10106; Boesch C, 1998, CURR ANTHROPOL, V39, P591, DOI 10.1086/204785; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Caldwell CA, 2008, EVOL HUM BEHAV, V29, P165, DOI 10.1016/j.evolhumbehav.2007.12.001; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Csibra G, 2006, ATTENTION PERFORM, P249; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Enquist M, 2007, J THEOR BIOL, V246, P129, DOI 10.1016/j.jtbi.2006.12.022; Galef B G, 1992, Hum Nat, V3, P157, DOI 10.1007/BF02692251; GIRALDEAU LA, 1987, ANIM BEHAV, V35, P387, DOI 10.1016/S0003-3472(87)80262-2; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; HEYES CM, 1993, ANIM BEHAV, V46, P999, DOI 10.1006/anbe.1993.1281; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Hrubesch C, 2009, ANIM COGN, V12, P209, DOI 10.1007/s10071-008-0183-y; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Laland KN, 2004, LEARN BEHAV, V32, P4; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Reader SM, 2001, INT J PRIMATOL, V22, P787, DOI 10.1023/A:1012069500899; Sanz CM, 2009, INT J PRIMATOL, V30, P411, DOI 10.1007/s10764-009-9350-5; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello Michael, 1994, P301; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031; WOOD D, 1976, J CHILD PSYCHOL PSYC, V17, P89, DOI 10.1111/j.1469-7610.1976.tb00381.x	32	284	292	2	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1114	1118		10.1126/science.1213969	http://dx.doi.org/10.1126/science.1213969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900ZL	22383851	Green Accepted			2022-12-28	WOS:000300931100051
J	Kurzban, R; Barrett, HC				Kurzban, Robert; Barrett, H. Clark			Origins of Cumulative Culture	SCIENCE			English	Editorial Material									[Kurzban, Robert] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Barrett, H. Clark] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA	University of Pennsylvania; University of California System; University of California Los Angeles	Kurzban, R (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	kurzban@psych.upenn.edu	Barrett, H Clark/AAE-2086-2019	Barrett, H Clark/0000-0002-4157-6511				BALDA RP, 1992, ANIM BEHAV, V44, P761, DOI 10.1016/S0003-3472(05)80302-1; Boyer P, 1998, AM ANTHROPOL, V100, P876, DOI 10.1525/aa.1998.100.4.876; Chudek M, 2012, EVOL HUM BEHAV, V33, P46, DOI 10.1016/j.evolhumbehav.2011.05.005; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; Garcia J, 1966, PSYCHON SCI, V4, P123, DOI [10.3758/BF03342209, DOI 10.3758/BF03342209]; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Richerson P. J., 2005, NOT GENES ALONE CULT; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001	10	11	11	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1056	1057		10.1126/science.1219232	http://dx.doi.org/10.1126/science.1219232			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900ZL	22383839				2022-12-28	WOS:000300931100034
J	Collins, J				Collins, James			SYNTHETIC BIOLOGY Bits and pieces come to life	NATURE			English	Editorial Material									Boston Univ, Boston, MA 02215 USA	Boston University	Collins, J (corresponding author), Boston Univ, Boston, MA 02215 USA.	jcollins@bu.edu						Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson D, 2010, SCIENCE, V329, P5987; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640	5	34	35	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					S8	S10		10.1038/483S8a	http://dx.doi.org/10.1038/483S8a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900HP	22378128				2022-12-28	WOS:000300877900003
J	Huang, J; Gurung, B; Wan, BB; Matkar, S; Veniaminova, NA; Wan, K; Merchant, JL; Hua, XX; Lei, M				Huang, Jing; Gurung, Buddha; Wan, Bingbing; Matkar, Smita; Veniaminova, Natalia A.; Wan, Ke; Merchant, Juanita L.; Hua, Xianxin; Lei, Ming			The same pocket in menin binds both MLL and JUND but has opposite effects on transcription	NATURE			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; ENDOCRINE NEOPLASIA TYPE-1; PROTEIN; GENE; INTERACTS; FAMILY	Menin is a tumour suppressor protein whose loss or inactivation causes multiple endocrine neoplasia 1 (MEN1), a hereditary autosomal dominant tumour syndrome that is characterized by tumorigenesis in multiple endocrine organs(1). Menin interacts with many proteins and is involved in a variety of cellular processes(2-8). Menin binds the JUN family transcription factor JUND and inhibits its transcriptional activity(2,9). Several MEN1 missense mutations disrupt the menin-JUND interaction, suggesting a correlation between the tumour-suppressor function of menin and its suppression of JUND-activated transcription(2,10). Menin also interacts with mixed lineage leukaemia protein 1 (MLL1), a histone H3 lysine 4 methyltransferase, and functions as an oncogenic cofactor to upregulate gene transcription and promote MLL1-fusion-protein-induced leukaemogenesis(5,7,11,12). A recent report on the tethering of MLL1 to chromatin binding factor lens epithelium-derived growth factor (LEDGF) by menin indicates that menin is a molecular adaptor coordinating the functions of multiple proteins(13). Despite its importance, how menin interacts with many distinct partners and regulates their functions remains poorly understood. Here we present the crystal structures of human menin in its free form and in complexes with MLL1 or with JUND, or with an MLL1-LEDGF heterodimer. These structures show that menin contains a deep pocket that binds short peptides of MLL1 or JUND in the same manner, but that it can have opposite effects on transcription. The menin-JUND interaction blocks JUN N-terminal kinase (JNK)-mediated JUND phosphorylation and suppresses JUND-induced transcription. In contrast, menin promotes gene transcription by binding the transcription activator MLL1 through the peptide pocket while still interacting with the chromatin-anchoring protein LEDGF at a distinct surface formed by both menin and MLL1.	[Huang, Jing; Wan, Bingbing; Wan, Ke; Lei, Ming] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Huang, Jing; Wan, Bingbing; Wan, Ke; Lei, Ming] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Gurung, Buddha; Matkar, Smita; Hua, Xianxin] Univ Penn, Perelman Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Veniaminova, Natalia A.; Merchant, Juanita L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Merchant, Juanita L.] Univ Michigan, Div Gastroenterol, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lei, M (corresponding author), Univ Michigan, Sch Med, Howard Hughes Med Inst, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	huax@mail.med.upenn.edu; leim@umich.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184; Wan, Bingbing/0000-0001-8629-0616	National Institutes of Health [GM 083015-01, R01-DK085121, R37-DK45729]; American Cancer Society; American Association for Cancer Research Caring for Carcinoid Foundation; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097555, R01DK085121, R37DK045729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Association for Cancer Research Caring for Carcinoid Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Wilding for the human JUND complementary DNA and P. Cherepanov for the human LEDGF cDNA. We thank Y. Chen and W. Deng for help at various stages of the project. M. L. is a Howard Hughes Medical Institute Early Career Scientist. Work was supported by National Institutes of Health grants (GM 083015-01 to M. L., R01-DK085121 to X. H. and R37-DK45729 to J.L.M.), an American Cancer Society Research Scholar grant (to M. L.) and an American Association for Cancer Research Caring for Carcinoid Foundation Grant (to X. H.). The General Medicine and Cancer Institutes Collaborative Access Team has been funded in whole or in part with federal funds from the National Cancer Institute (grant Y1-CO-1020) and the National Institute of General Medical Science (grant Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Busygina V, 2006, CANCER RES, V66, P8397, DOI 10.1158/0008-5472.CAN-06-0061; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen G, 2008, MOL CANCER RES, V6, P1894, DOI 10.1158/1541-7786.MCR-07-2206; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Gallo A, 2002, ONCOGENE, V21, P6434, DOI 10.1038/sj.onc.1205822; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Groussin L, 1999, EUR J ENDOCRINOL, V141, P15, DOI 10.1530/eje.0.1410015; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jin SH, 2003, CANCER RES, V63, P4204; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knapp JI, 2000, ONCOGENE, V19, P4706, DOI 10.1038/sj.onc.1203832; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Llano M, 2009, CURR TOP MICROBIOL, V339, P125, DOI 10.1007/978-3-642-02175-6_7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mensah-Osman EJ, 2011, AM J PHYSIOL-GASTR L, V301, pG783, DOI 10.1152/ajpgi.00160.2011; Murai MJ, 2011, J BIOL CHEM, V286, P31742, DOI 10.1074/jbc.M111.258186; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang YQ, 2007, MOL CELL ENDOCRINOL, V265, P34, DOI 10.1016/j.mce.2006.12.032; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	27	187	193	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					542	U141		10.1038/nature10806	http://dx.doi.org/10.1038/nature10806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22327296	Green Accepted			2022-12-28	WOS:000300770500054
J	Kiire, CA; Chong, NV				Kiire, Christine A.; Chong, N. Victor			Managing retinal vein occlusion	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MACULAR EDEMA SECONDARY; BEVACIZUMAB		[Kiire, Christine A.; Chong, N. Victor] Oxford Univ Hosp, Oxford Eye Hosp, Oxford OX3 9DU, England		Chong, NV (corresponding author), Oxford Univ Hosp, Oxford Eye Hosp, Oxford OX3 9DU, England.	victor.chong@eye.ox.ac.uk	Chong, Victor/Q-6565-2018	Chong, Victor/0000-0002-7693-522X				[Anonymous], 1984, AM J OPHTHALMOL, V98, P271; Beutel Julia, 2010, International Ophthalmology, V30, P15, DOI 10.1007/s10792-008-9282-7; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Chalam KV, 2008, EUR J OPHTHALMOL, V18, P255, DOI 10.1177/112067210801800214; Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1425; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1434; Davidorf FH, 2006, RETINA-J RET VIT DIS, V26, P354, DOI 10.1097/00006982-200603000-00017; Di Capua M, 2012, NUTR METAB CARDIOVAS, V22, P23, DOI 10.1016/j.numecd.2010.03.008; Figueroa MS, 2010, BRIT J OPHTHALMOL, V94, P1052, DOI 10.1136/bjo.2009.173732; GEWAILY D, 2009, COCHRANE DB SYST REV, V1; Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032; Hoeh AE, 2009, GRAEF ARCH CLIN EXP, V247, P1635, DOI 10.1007/s00417-009-1151-1; Hu CC, 2009, BRIT J OPHTHALMOL, V93, P717, DOI 10.1136/bjo.2008.151605; Ip MS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1101, DOI 10.1001/archophthalmol.2009.234; Prager F, 2009, BRIT J OPHTHALMOL, V93, P452, DOI 10.1136/bjo.2008.141085; Regeneron Pharmaceuticals, 2011, REG BAYER REP POS RE; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Rogers SL, 2010, OPHTHALMOLOGY, V117, P1094, DOI 10.1016/j.ophtha.2010.01.058; SHILLING JS, 1984, BRIT J OPHTHALMOL, V68, P196, DOI 10.1136/bjo.68.3.196; The Royal College of Ophthalmologists, 2010, INT GUID MAN RET VEI; Wong TY, 2010, NEW ENGL J MED, V363, P2135, DOI 10.1056/NEJMcp1003934; Wroblewski JJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P374, DOI 10.1001/archophthalmol.2009.14	24	20	22	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2012	344								e499	10.1136/bmj.e499	http://dx.doi.org/10.1136/bmj.e499			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900JQ	22362114	Green Submitted			2022-12-28	WOS:000300883600004
J	Kusin, S				Kusin, Shana			Putting the "Art" in "Crash Cart"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kusin, Shana] Oregon Hlth & Sci Univ, Oregon Poison Ctr, Portland, OR 97201 USA; [Kusin, Shana] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Kusin, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Poison Ctr, Portland, OR 97201 USA.	shanakusin@gmail.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					793	794		10.1001/jama.2012.181	http://dx.doi.org/10.1001/jama.2012.181			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FQ	22357830				2022-12-28	WOS:000300551300021
J	Salkovskis, P; Wolpert, L				Salkovskis, Paul; Wolpert, Lewis			Does psychoanalysis have a valuable place in modern mental health services? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							COGNITIVE-BEHAVIORAL THERAPY; PSYCHODYNAMIC PSYCHOTHERAPY		[Salkovskis, Paul] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Wolpert, Lewis] UCL, Dept Cell & Dev Biol, London, England	University of Bath; University of London; University College London	Salkovskis, P (corresponding author), Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England.	P.M.Salkovskis@bath.ac.uk		Salkovskis, Paul/0000-0002-2951-2283				LEADER D, 2008, GUARDIAN        0909; Pribram K.H., 1976, FREUDS PROJECT REASS; Salkovskis PM, 2002, BEHAV COGN PSYCHOTH, V30, P3, DOI 10.1017/S1352465802001029; Salkovskis Paul M., 1996, P533; Sorensen P, 2011, PSYCHOL MED, V41, P431, DOI 10.1017/S0033291710000292; YATES AJ, 1983, BRIT J CLIN PSYCHOL, V22, P107, DOI 10.1111/j.2044-8260.1983.tb00584.x	6	9	9	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 20	2012	344								e1188	10.1136/bmj.e1188	http://dx.doi.org/10.1136/bmj.e1188			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900IY	22349581				2022-12-28	WOS:000300881600010
J	Holmes, D				Holmes, David			Emeli Sande: a more cerebral chanteuse	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 18	2012	379	9816					607	607		10.1016/S0140-6736(12)60257-8	http://dx.doi.org/10.1016/S0140-6736(12)60257-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	897ES	22340292	Bronze			2022-12-28	WOS:000300629000017
J	Ghosh, A; Holt, WE				Ghosh, Attreyee; Holt, William E.			Plate Motions and Stresses from Global Dynamic Models	SCIENCE			English	Article							MANTLE FLOW; TOPOGRAPHY; SLAB	Delineating the driving forces behind plate motions is important for understanding the processes that have shaped Earth throughout its history. However, the accurate prediction of plate motions, boundary-zone deformation, rigidity, and stresses remains a difficult frontier in numerical modeling. We present a global dynamic model that produces a good fit to such parameters by accounting for lateral viscosity variations in the top 200 kilometers of Earth, together with forces associated with topography and lithosphere structure, as well as coupling with mantle flow. The relative importance of shallow structure versus deeper mantle flow varies over Earth's surface. Our model reveals where mantle flow contributes toward driving or resisting plate motions. Furthermore, subducted slabs need not act as strong stress guides to satisfy global observations of plate motions and stress.	[Ghosh, Attreyee; Holt, William E.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ghosh, A (corresponding author), SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA.	atreig@gmail.com	Ghosh, Attreyee/G-6858-2011	Ghosh, Attreyee/0000-0003-4443-1235; Holt, William/0000-0002-0267-5306	NSF [EAR-0911300]; Division Of Earth Sciences [0911300, 1052989] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by NSF grant EAR-0911300. Maps were prepared using Generic Mapping Tools version 4.5.7. We thank D. Argus and C. Kreemer for sharing their kinematic models and GPS data for comparison with the dynamic models, L. Wen for help with using his code, and three anonymous reviewers for their comments that substantially improved the manuscript. We are grateful to UNAVCO, Incorporated Research Institutions for Seismology, NSF-EarthScope, International GNSS Service, NASA, and countless researchers for facilitation and availability of geodetic and seismic data. The codes are available as a zip file as part of the supporting online material.	Argus DF, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003751; BAI WM, 1992, J GEOPHYS RES-SOL EA, V97, P11729, DOI 10.1029/91JB00292; Becker TW, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2001GC000171; Bilek SL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022922; Billen MI, 2008, ANNU REV EARTH PL SC, V36, P325, DOI 10.1146/annurev.earth.36.031207.124129; Bird P, 1998, J GEOPHYS RES-SOL EA, V103, P10115, DOI 10.1029/98JB00198; Bird P, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005460; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Faccenna C, 2010, NATURE, V465, P602, DOI 10.1038/nature09064; Forte AM, 2010, TECTONOPHYSICS, V481, P3, DOI 10.1016/j.tecto.2009.06.010; Ghosh A, 2006, GEOLOGY, V34, P321, DOI 10.1130/G22071.1; Ghosh A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034365; Ghosh A, 2009, GEOPHYS J INT, V179, P787, DOI 10.1111/j.1365-246X.2009.04326.x; Heidbach O., 2008, 2008 DATABASE RELEAS; Jadamec MA, 2010, NATURE, V465, P338, DOI 10.1038/nature09053; Kreemer C, 2003, GEOPHYS J INT, V154, P8, DOI 10.1046/j.1365-246X.2003.01917.x; Kreemer C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027058; Lithgow-Bertelloni C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002467; LITHGOWBERTELLONI C, 1995, GEOPHYS RES LETT, V22, P1317, DOI 10.1029/95GL01325; Moresi L, 1996, EARTH PLANET SC LETT, V138, P15, DOI 10.1016/0012-821X(95)00221-W; Ozeren MS, 2010, GEOPHYS J INT, V183, P1165, DOI 10.1111/j.1365-246X.2010.04819.x; RICARD Y, 1989, J GEOPHYS RES-SOLID, V94, P17543, DOI 10.1029/JB094iB12p17543; RICHARDSON RM, 1979, REV GEOPHYS, V17, P981, DOI 10.1029/RG017i005p00981; Stadler G, 2010, SCIENCE, V329, P1033, DOI 10.1126/science.1191223; Steinberger B, 2001, EARTH PLANET SC LETT, V186, P75, DOI 10.1016/S0012-821X(01)00229-1; TAO WC, 1993, NATURE, V361, P626, DOI 10.1038/361626a0	26	88	90	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					838	843		10.1126/science.1214209	http://dx.doi.org/10.1126/science.1214209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344441				2022-12-28	WOS:000300356400040
J	Halfmann, R; Jarosz, DF; Jones, SK; Chang, A; Lancaster, AK; Lindquist, S				Halfmann, Randal; Jarosz, Daniel F.; Jones, Sandra K.; Chang, Amelia; Lancaster, Alex K.; Lindquist, Susan			Prions are a common mechanism for phenotypic inheritance in wild yeasts	NATURE			English	Article							GENETIC-VARIATION; EVOLVABILITY PROPERTIES; EVOLUTION; STRESS; CHAPERONE; PSI+; RESISTANCE; HSP104; HSP70	The self-templating conformations of yeast prion proteins act as epigenetic elements of inheritance. Yeast prions might provide a mechanism for generating heritable phenotypic diversity that promotes survival in fluctuating environments and the evolution of new traits. However, this hypothesis is highly controversial. Prions that create new traits have not been found in wild strains, leading to the perception that they are rare 'diseases' of laboratory cultivation. Here we biochemically test approximately 700 wild strains of Saccharomyces for [PSI+] or [MOT3(+)], and find these prions in many. They conferred diverse phenotypes that were frequently beneficial under selective conditions. Simple meiotic re-assortment of the variation harboured within a strain readily fixed one such trait, making it robust and prion-independent. Finally, we genetically screened for unknown prion elements. Fully one-third of wild strains harboured them. These, too, created diverse, often beneficial phenotypes. Thus, prions broadly govern heritable traits in nature, in a manner that could profoundly expand adaptive opportunities.	[Halfmann, Randal; Jarosz, Daniel F.; Jones, Sandra K.; Chang, Amelia; Lancaster, Alex K.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Halfmann, Randal; Chang, Amelia; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Lindquist_admin@wi.mit.edu	Lancaster, Alexander K/K-2855-2013	Lancaster, Alexander K/0000-0002-0002-9263; Halfmann, Randal/0000-0002-6592-1471; Jarosz, Daniel/0000-0003-3497-5888	G. Harold and Leila Y. Mathers Foundation; HHMI; NIH [K99 GM098600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM098600] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to L. Bisson and L. Joseph, who provided the Department of Viticulture and Enology yeast collection from the University of California, Davis, USA. We also received strains from G. Fink, E. Louis, F. Dietrich and S. Dietzmann, and L. Kruglyak. We thank M. Taipale, K. Allendoerfer, K. Matlack, L. Pepper, V. Khurana, G. Fink, L. Joseph, A. Hochwagen and G. Walker for materials, discussions, and/or critical reading of the manuscript. N. Azubuine and T. Nanchung provided a constant supply of plates and media. S. L. is a Howard Hughes Medical Institute (HHMI) investigator. This work was supported by grants from the G. Harold and Leila Y. Mathers Foundation and HHMI. D.F.J. was supported as an HHMI fellow of the Damon Runyon Cancer Research Foundation (DRG-1964-08) and by an NIH Pathway to independence award (K99 GM098600). S.K.J. was supported as a summer research student by the Howard Hughes Medical Institute (HHMI) Exceptional Research Opportunities Program (EXROP).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Crow ET, 2011, SEMIN CELL DEV BIOL, V22, P452, DOI 10.1016/j.semcdb.2011.03.003; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Diezmann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005317; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIUDICI P, 1994, AM J ENOL VITICULT, V45, P107; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Griswold CK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000517; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Lancaster AK, 2009, EVOLUTION, V63, P2350, DOI 10.1111/j.1558-5646.2009.00729.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Masel J, 2003, EVOLUTION, V57, P1498; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wickner RB, 2011, SEMIN CELL DEV BIOL, V22, P469, DOI 10.1016/j.semcdb.2011.02.021	46	299	302	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					363	U1507		10.1038/nature10875	http://dx.doi.org/10.1038/nature10875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337056	Green Submitted, Green Accepted			2022-12-28	WOS:000300287100038
J	Homme, J; Wiswell, J				Homme, James; Wiswell, Jeff			Vernal Keratoconjunctivitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Homme, James; Wiswell, Jeff] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Homme, J (corresponding author), Mayo Clin, Rochester, MN 55905 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					647	647		10.1056/NEJMicm1014624	http://dx.doi.org/10.1056/NEJMicm1014624			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IL	22335742				2022-12-28	WOS:000300279800010
J	Moser, AL; Bellan, PM				Moser, Auna L.; Bellan, Paul M.			Magnetic reconnection from a multiscale instability cascade	NATURE			English	Article							KINK	Magnetic reconnection, the process whereby magnetic field lines break and then reconnect to form a different topology, underlies critical dynamics of magnetically confined plasmas in both nature(1-4) and the laboratory(5-9). Magnetic reconnection involves localized diffusion of the magnetic field across plasma, yet observed reconnection rates are typically much higher than can be accounted for using classical electrical resistivity(10). It is generally proposed(10) that the field diffusion underlying fast reconnection results instead from some combination of non-magnetohydrodynamic processes that become important on the 'microscopic' scale of the ion Larmor radius or the ion skin depth. A recent laboratory experiment(11) demonstrated a transition from slow to fast magnetic reconnection when a current channel narrowed to a microscopic scale, but did not address how a macroscopic magnetohydrodynamic system accesses the microscale. Recent theoretical models(12) and numerical simulations(13,14) suggest that a macroscopic, two-dimensional magnetohydrodynamic current sheet might do this through a sequence of repetitive tearing and thinning into two-dimensional magnetized plasma structures having successively finer scales. Here we report observations demonstrating a cascade of instabilities from a distinct, macroscopic-scale magnetohydrodynamic instability to a distinct, microscopic-scale (ion skin depth) instability associated with fast magnetic reconnection. These observations resolve the full three-dimensional dynamics and give insight into the frequently impulsive nature of reconnection in space and laboratory plasmas.	[Moser, Auna L.; Bellan, Paul M.] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Moser, AL (corresponding author), CALTECH, Pasadena, CA 91125 USA.	auna@caltech.edu			US DOE; NSF; AFOSR	US DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work supported by the US DOE, NSF and AFOSR.	Bellan P. M., 2000, SPHEROMAKS, P60; Berger T, 2011, NATURE, V472, P197, DOI 10.1038/nature09925; Brown MR, 1999, PHYS PLASMAS, V6, P1717, DOI 10.1063/1.873430; CHANDRASEKHAR S, 1961, HYDRODYNAMIC HYDROMA, P464; Che H, 2011, NATURE, V474, P184, DOI 10.1038/nature10091; Colgate SA, 2001, PHYS PLASMAS, V8, P2425, DOI 10.1063/1.1351827; Drake JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025957; Egedal J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.015003; GEKELMAN W, 1984, J GEOPHYS RES-SPACE, V89, P2715, DOI 10.1029/JA089iA05p02715; Hsu SC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.215002; Hsu SC, 2002, MON NOT R ASTRON SOC, V334, P257, DOI 10.1046/j.1365-8711.2002.05422.x; Kumar D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.105003; Liu C, 2007, ASTROPHYS J, V669, P1372, DOI 10.1086/521644; MIKIC Z, 1988, ASTROPHYS J, V328, P830, DOI 10.1086/166341; PASCHMANN G, 1979, NATURE, V282, P243, DOI 10.1038/282243a0; Shibata K, 2001, EARTH PLANETS SPACE, V53, P473, DOI 10.1186/BF03353258; Srivastava AK, 2010, ASTROPHYS J, V715, P292, DOI 10.1088/0004-637X/715/1/292; TAYLOR JB, 1986, REV MOD PHYS, V58, P741, DOI 10.1103/RevModPhys.58.741; Uzdensky DA, 2006, ASTROPHYS J, V647, P1192, DOI 10.1086/505621; WESSON JA, 1990, NUCL FUSION, V30, P2545, DOI 10.1088/0029-5515/30/12/008; YAMADA M, 1994, PHYS PLASMAS, V1, P3269, DOI 10.1063/1.870479; Yamada M, 2010, REV MOD PHYS, V82, P603, DOI 10.1103/RevModPhys.82.603; Yun GS, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3437075; Zhou GP, 2006, ASTROPHYS J, V651, P1238, DOI 10.1086/507977	24	59	59	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					379	381		10.1038/nature10827	http://dx.doi.org/10.1038/nature10827			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337058				2022-12-28	WOS:000300287100041
J	Truog, RD				Truog, Robert D.			200TH ANNIVERSARY ARTICLE Patients and Doctors - The Evolution of a Relationship	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THERAPEUTIC MISCONCEPTION; CLINICAL-TRIALS; EQUIPOISE; ETHICS		[Truog, Robert D.] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Truog, Robert D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Truog, Robert D.] Childrens Hosp, Div Crit Care Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA.							APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; LEVINSKY NG, 1984, NEW ENGL J MED, V311, P1573, DOI 10.1056/NEJM198412133112412; Miller FG, 2003, HASTINGS CENT REP, V33, P19, DOI 10.2307/3528434; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301	5	87	90	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					581	585		10.1056/NEJMp1110848	http://dx.doi.org/10.1056/NEJMp1110848			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	892IL	22335734	Bronze			2022-12-28	WOS:000300279800001
J	Sukkar, E				Sukkar, Elizabeth			EUROPEAN MEDICINES AGENCY Sunshine at the European regulator	BRITISH MEDICAL JOURNAL			English	Editorial Material							RULES					lizsukkar@hotmail.com						Benkimoun P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d8309; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5902; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Kmietowicz Z, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7283; Turone F, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3747	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2012	344								e976	10.1136/bmj.e976	http://dx.doi.org/10.1136/bmj.e976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IB	22337754				2022-12-28	WOS:000300557800006
J	Bafeta, A; Dechartres, A; Trinquart, L; Yavchitz, A; Boutron, I; Ravaud, P				Bafeta, Aida; Dechartres, Agnes; Trinquart, Ludovic; Yavchitz, Amelie; Boutron, Isabelle; Ravaud, Philippe			Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; PUBLICATION BIAS; METHODOLOGICAL QUALITY; ALLOCATION CONCEALMENT; OSTEOARTHRITIS TRIALS; EMPIRICAL-EVIDENCE; CONSORT STATEMENT; CLINICAL-TRIALS; METAANALYSES	Objective To compare estimates of intervention effects between single centre and multicentre randomised controlled trials with continuous outcomes. Design Meta-epidemiological study. Data sources 26 meta-analyses totalling 292 randomised controlled trials (177 single centre, 115 multicentre) with continuous outcomes published between January 2007 and January 2010 in the Cochrane database of systematic reviews. Data extraction Data were extracted on characteristics of trials, single or multicentre status, risk of bias using the risk of bias tool of the Cochrane Collaboration, and results. Data synthesis The intervention effects were estimated with standardised mean differences. For each meta-analysis, random effects meta-regression was used to estimate the difference in standardised mean differences between single centre and multicentre trials. Differences in standardised mean differences were then pooled across meta-analyses by a random-effects meta-analysis model. A combined difference in standardised mean differences of less than 0 indicated that single centre trials showed larger treatment effects, on average, than did multicentre trials. Because single centre trials may be more prone to publication bias and may have lower methodological quality than multicentre trials, sensitivity analyses were done with adjustment for sample size and domains of the risk of bias tool. Results Single centre trials showed larger intervention effects than did multicentre trials (combined difference in standardised mean differences -0.09, 95% confidence interval -0.17 to -0.01, P=0.04), with low heterogeneity across individual meta-analyses (I-2=0%, between meta-analyses variance tau(2)=0.00). Adjustment for sample size slightly attenuated the difference (-0.08, -0.17 to 0.01). Adjustment for risk of bias yielded similar estimates with wider confidence intervals, some of them crossing 0 (-0.09, -0.17 to 0.00 for overall risk of bias). Conclusions On average, single centre clinical trials with continuous outcomes showed slightly larger intervention effects than did multicentre trials. Further research is needed to investigate potential causes of these differences.	[Dechartres, Agnes; Boutron, Isabelle; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75004 Paris, France; [Bafeta, Aida; Dechartres, Agnes; Yavchitz, Amelie; Boutron, Isabelle; Ravaud, Philippe] INSERM, U738, Paris, France; [Dechartres, Agnes; Boutron, Isabelle; Ravaud, Philippe] Univ Paris Descartes Sorbonne Paris Cite, Paris, France; [Trinquart, Ludovic; Ravaud, Philippe] French Cochrane Ctr, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dechartres, A (corresponding author), Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, 1 Pl Parvis Notre Dame, F-75004 Paris, France.	agnes.dechartres@htd.aphp.fr	ravaud, philippe/C-1694-2009; aida, bafeta/T-5582-2019; Trinquart, Ludovic/H-4961-2019	aida, bafeta/0000-0001-8947-7881; Trinquart, Ludovic/0000-0002-3028-4900; Yavchitz, Amelie/0000-0002-9911-8556; Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206				Akechi T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005537.pub2; Bellomo R, 2009, CRIT CARE MED, V37, P3114, DOI 10.1097/CCM.0b013e3181bc7bd5; Bellu R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004212.pub3; BERLIN JA, 1989, J AM STAT ASSOC, V84, P381; Boutron I, 2003, JAMA-J AM MED ASSOC, V290, P1062, DOI 10.1001/jama.290.8.1062; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Bowen A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub2; Calderon Moises A, 2007, COCHRANE DATABASE SY; Chalk C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004572.pub2; Cramp F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006145.pub2; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; Eccleston C, 2009, COCHRANE DATABASE SY; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Foster G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005108.pub2; Fransen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub2; French B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006073.pub2; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Gava I, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005333.pub2; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Guaiana G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004186.pub2; Hesse M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006265.pub2; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kirwan JR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006356; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Mason AR, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005028.pub2; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Nicolai SPA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006888.pub2; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Nuesch E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1633, DOI 10.1002/art.24894; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Sirtori V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004433.pub2; Smith I, 2009, COCHRANE DATABASE SY; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Spittle AJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub2; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Tacklind J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001423.pub2; Tanaka Y, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004081.pub2; Tendal B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3128; Thomson AB, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006520.pub2; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Urquhart DM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001703.pub3; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yu LM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-59; Zijdenbos Ingeborg L, 2009, COCHRANE DATABASE SY	54	80	80	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2012	344								e813	10.1136/bmj.e813	http://dx.doi.org/10.1136/bmj.e813			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896HZ	22334559	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000300557600006
J	Corbacioglu, S; Cesaro, S; Faraci, M; Valteau-Couanet, D; Gruhn, B; Rovelli, A; Boelens, JJ; Hewitt, A; Schrum, J; Schulz, AS; Muller, I; Stein, J; Wynn, R; Greil, J; Sykora, KW; Matthes-Martin, S; Fuhrer, M; O'Meara, A; Toporski, J; Sedlacek, P; Schlegel, PG; Ehlert, K; Fasth, A; Winiarski, J; Arvidson, J; Mauz-Korholz, C; Ozsahin, H; Schrauder, A; Bader, P; Massaro, J; D'Agostino, R; Hoyle, M; Iacobelli, M; Debatin, KM; Peters, C; Dini, G				Corbacioglu, Selim; Cesaro, Simone; Faraci, Maura; Valteau-Couanet, Dominique; Gruhn, Bernd; Rovelli, Attilio; Boelens, Jaap J.; Hewitt, Annette; Schrum, Johanna; Schulz, Ansgar S.; Mueller, Ingo; Stein, Jerry; Wynn, Robert; Greil, Johann; Sykora, Karl-Walter; Matthes-Martin, Susanne; Fuehrer, Monika; O'Meara, Anne; Toporski, Jacek; Sedlacek, Petr; Schlegel, Paul G.; Ehlert, Karoline; Fasth, Anders; Winiarski, Jacek; Arvidson, Johan; Mauz-Koerholz, Christine; Ozsahin, Hulya; Schrauder, Andre; Bader, Peter; Massaro, Joseph; D'Agostino, Ralph; Hoyle, Margaret; Iacobelli, Massimo; Debatin, Klaus-Michael; Peters, Christina; Dini, Giorgio			Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial	LANCET			English	Article							BONE-MARROW-TRANSPLANTATION; COMPETING RISKS; CHILDREN; LIVER; DIAGNOSIS; COHORT; BLOOD; PREVENTION; RECIPIENTS; BUSULFAN	Background Hepatic veno-occlusive disease is a leading cause of morbidity and mortality after haemopoietic stem-cell transplantation (HSCT). We aimed to assess whether defibrotide can reduce the incidence of veno-occlusive disease in this setting. Methods In our phase 3 open-label, randomised controlled trial, we enrolled patients at 28 European university hospitals or academic medical centres. Eligible patients were younger than 18 years, had undergone myeloablative conditioning before allogeneic or autologous HSCT, and had one or more risk factor for veno-occlusive disease based on modified Seattle criteria. We centrally assigned eligible participants on the basis of a computer-generated randomisation sequence (1: 1), stratified by centre and presence of osteopetrosis, to receive intravenous defibrotide prophylaxis (treatment group) or not (control group). The primary endpoint was incidence of veno-occlusive disease by 30 days after HSCT, adjudicated by a masked, independent review committee, in eligible patients who consented to randomisation (intention-to-treat population), and was assessed with a competing risk approach. Patients in either group who developed veno-occlusive disease received defibrotide for treatment. We assessed adverse events to 180 days after HSCT in all patients who received allocated prophylaxis. This trial is registered with ClinicalTrials.gov, number NCT00272948. Findings Between Jan 25, 2006, and Jan 29, 2009, we enrolled 356 eligible patients to the intention-to-treat population. 22 (12%) of 180 patients randomly allocated to the defibrotide group had veno-occlusive disease by 30 days after HSCT compared with 35 (20%) of 176 controls (risk difference -7.7%, 95% CI -15.3 to -0.1; Z test for competing risk analysis p=0.0488; log-rank test p=0.0507). 154 (87%) of 177 patients in the defibrotide group had adverse events by day 180 compared with 155 (88%) of 176 controls. Interpretation Defibrotide prophylaxis seems to reduce incidence of veno-occlusive disease and is well tolerated. Thus, such prophylaxis could present a useful clinical option for this serious complication of HSCT.	[Corbacioglu, Selim] Univ Regensburg, D-93053 Regensburg, Germany; [Cesaro, Simone] Univ Padua, Padua, Italy; [Faraci, Maura; Dini, Giorgio] G Gaslini Inst Children, Genoa, Italy; [Valteau-Couanet, Dominique] Inst Gustave Roussy, Villejuif, France; [Gruhn, Bernd] Univ Hosp Jena, Jena, Germany; [Rovelli, Attilio] Univ Milano Bicocca, Monza, Italy; [Boelens, Jaap J.] Univ Med Ctr, Utrecht, Netherlands; [Hewitt, Annette] Great Ormond St Hosp Sick Children, London, England; [Schrum, Johanna] Univ Hamburg Eppendorf, Hamburg, Germany; [Schulz, Ansgar S.; Debatin, Klaus-Michael] Univ Childrens Hosp, Ulm, Germany; [Mueller, Ingo] Univ Childrens Hosp, Tubingen, Germany; [Stein, Jerry] Schneider Childrens Med Ctr, Petah Tiqwa, Israel; [Wynn, Robert] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England; [Greil, Johann] Univ Childrens Hosp, Heidelberg, Germany; [Sykora, Karl-Walter] Hannover Med Sch, Hannover, Germany; [Matthes-Martin, Susanne; Peters, Christina] St Anna Childrens Hosp, A-1090 Vienna, Austria; [Fuehrer, Monika] Univ Childrens Hosp, Munich, Germany; [O'Meara, Anne] Our Ladys Childrens Hosp, Dublin, Ireland; [Toporski, Jacek] Skane Univ Hosp, Lund, Sweden; [Sedlacek, Petr] Univ Hosp Motol, Prague, Czech Republic; [Schlegel, Paul G.] Univ Childrens Hosp, Wurzburg, Germany; [Ehlert, Karoline] Univ Childrens Hosp, Munster, Germany; [Fasth, Anders] Univ Gothenburg, Dept Pediat, Gothenburg, Sweden; [Winiarski, Jacek] Karolinska Inst, Stockholm, Sweden; [Arvidson, Johan] Uppsala Univ, Childrens Hosp, Uppsala, Sweden; [Mauz-Koerholz, Christine] Univ Halle Wittenberg, Halle, Germany; [Ozsahin, Hulya] Univ Childrens Hosp, Geneva, Switzerland; [Schrauder, Andre] Univ Hosp Schleswig Holstein, Kiel, Germany; [Bader, Peter] Univ Childrens Hosp, Frankfurt, Germany; [Massaro, Joseph; D'Agostino, Ralph] Boston Univ, Boston, MA 02215 USA; [Hoyle, Margaret; Iacobelli, Massimo] Gentium SpA, Villa Guardia, Como, Italy	University of Regensburg; University of Padua; University of Genoa; IRCCS Istituto Giannina Gaslini; UNICANCER; Gustave Roussy; Friedrich Schiller University of Jena; University of Milano-Bicocca; Utrecht University; Utrecht University Medical Center; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Royal Manchester Children's Hospital; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Saint Anna Children's Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Lund University; Skane University Hospital; Motol University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Gothenburg; Karolinska Institutet; Uppsala University; Martin Luther University Halle Wittenberg; University of Geneva; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Boston University	Corbacioglu, S (corresponding author), Univ Regensburg, Childrens Hosp Regensburg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	selim.corbacioglu@klinik.uni-regensburg.de	Cesaro, Simone/F-8118-2019; Debatin, Klaus-Michael/J-9704-2014; Toporski, Jacek/H-3047-2018; Faraci, Maura/AAB-3687-2019; Schrappe, Martin/ABA-6144-2020; Ozsahin, Hulya/FSE-2148-2022; Fasth, Anders/I-1109-2019; Führer, Monika/HHZ-6375-2022; Corbacioglu, Selim/N-6152-2019; Cesaro, Simone/I-3272-2019; Mauz-Koerholz, Christine/AAX-4349-2020; Müller, Ingo/AAW-9025-2021	Cesaro, Simone/0000-0002-8698-9547; Debatin, Klaus-Michael/0000-0002-8397-1886; Toporski, Jacek/0000-0001-6012-0651; Faraci, Maura/0000-0001-5715-501X; Cesaro, Simone/0000-0002-8698-9547; Müller, Ingo/0000-0002-7477-6632; Massaro, Joseph/0000-0002-2682-4812; Peters, Christina/0000-0003-0369-8515; Fasth, Anders/0000-0002-0033-740X; Wynn, robert/0000-0002-6046-8428; Boelens, Jaap Jan/0000-0003-2232-6952	Gentium; Medac; Gentium SpA; European Blood and Marrow Transplantation (EBMT) Group; European Group for Blood and Marrow Transplantation	Gentium; Medac; Gentium SpA; European Blood and Marrow Transplantation (EBMT) Group; European Group for Blood and Marrow Transplantation	SCo, JM, and RD'A received fees from Gentium for review activities on this report. JM received payment from Gentium for writing and reviewing the report. JM received payment from Gentium for writing assistance. SCo and CP's institution received grants to their institutions from Gentium and KW-S's institution received a grant from Medac. CP has given lectures and is on the speakers bureau for the Center for International Blood and Marrow Transplant Research, Amgen, and Fresenius. SCo, JM, and SM-M have received support for travel relating to the report from Gentium. SCo and JM have received consultancy fees or honorarium from Gentium and CP has received such fees from Medac. MH and MI are employees and have stock in Gentium. CP has received support for travel, accommodation, and meetings from Amomed and Gentium. All other authors declare that they have no conflicts of interest.; This trial was supported by Gentium SpA and the European Blood and Marrow Transplantation (EBMT) Group (clinical trial insurance and study management/monitoring costs). We thank the nurses, staff, clinical research coordinators, and especially the patients and families involved in the trial for their participation; the following contributors for their support in this clinical trial: Stefan Suciu (Organization for Research and Treatment of Cancer in Brussels, Belgium), Lawrence Faulkner (Cure2Children Foundation in Florence, Italy), Mutlu Arat (Sisli Florence Nightingale Hospital in Istanbul, Turkey), and Paul Richardson (Dana-Farber Cancer Institute in Boston, MA, USA) from the Data and Safety Monitoring Board; Jacek Wachowiak (Poznan University of Medical Sceinces, Poznan, Poland), Guido Finazzi (Ospedali Riuniti in Bergamo, Italy), and Tiziano Barbui (Research Foundation of Ospedale Maggiore in Bergamo, Italy) from the Independent Review Committee; and Michael Pfitzenmaier, Rainer Muche, Friederike Rohlmann, and Susanne Stohr for their contributions to data management; Marco Sardella and Giorgia Finetto of Gentium SpA for safety and study management; and Cornelio Uderzo for his thorough review of the manuscript. Medical writing support was provided by Katherine Duxbury and Kate Silverthorne at FireKite (Berkshire, UK) and sponsored by Gentium SpA.; Gentium SpA, European Group for Blood and Marrow Transplantation.	AALEN OO, 1978, SCAND J STAT, V5, P141; Barker CC, 2003, BONE MARROW TRANSPL, V32, P79, DOI 10.1038/sj.bmt.1704069; CARRERAS E, 1993, ANN HEMATOL, V66, P77, DOI 10.1007/BF01695888; Carreras E, 1998, BLOOD, V92, P3599; Cesaro S, 2005, HAEMATOLOGICA, V90, P1396; Chalandon Y, 2004, BIOL BLOOD MARROW TR, V10, P347, DOI 10.1016/j.bbmt.2004.01.002; Chopra R, 2000, BRIT J HAEMATOL, V111, P1122, DOI 10.1046/j.1365-2141.2000.02475.x; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Coppell JA, 2010, BIOL BLOOD MARROW TR, V16, P157, DOI 10.1016/j.bbmt.2009.08.024; Corbacioglu S, 2006, BONE MARROW TRANSPL, V38, P547, DOI 10.1038/sj.bmt.1705485; Corbacioglu S, 2004, BONE MARROW TRANSPL, V33, P189, DOI 10.1038/sj.bmt.1704329; Dignan F, 2007, BONE MARROW TRANSPL, V40, P79, DOI 10.1038/sj.bmt.1705696; Echart CL, 2009, BLOOD COAGUL FIBRIN, V20, P627, DOI 10.1097/MBC.0b013e32832da1e3; Eissner G, 2002, BLOOD, V100, P334, DOI 10.1182/blood.V100.1.334; Ertault-Daneshpouy M, 2004, BLOOD, V103, P4681, DOI 10.1182/blood-2003-05-1548; Falanga A, 2003, LEUKEMIA, V17, P1636, DOI 10.1038/sj.leu.2403004; Horn B, 2002, BONE MARROW TRANSPL, V29, P409, DOI 10.1038/sj.bmt.1703393; JONES RJ, 1987, TRANSPLANTATION, V44, P778, DOI 10.1097/00007890-198712000-00011; Lucarelli G, 1996, BLOOD, V87, P2082, DOI 10.1182/blood.V87.5.2082.bloodjournal8752082; LUCARELLI G, 1990, NEW ENGL J MED, V322, P417, DOI 10.1056/NEJM199002153220701; MCDONALD GB, 1993, ANN INTERN MED, V118, P255, DOI 10.7326/0003-4819-118-4-199302150-00003; MCDONALD GB, 1984, HEPATOLOGY, V4, P116, DOI 10.1002/hep.1840040121; Mckoy JM, 2007, LEUKEMIA RES, V31, P599, DOI 10.1016/j.leukres.2006.07.005; Mitsiades CS, 2009, CLIN CANCER RES, V15, P1210, DOI 10.1158/1078-0432.CCR-08-1270; Ostrovsky O, 2010, BLOOD, V115, P2319, DOI 10.1182/blood-2009-08-236455; Ouachee-Chardin M, 2006, PEDIATRICS, V117, pE743, DOI 10.1542/peds.2005-1789; Qureshi A, 2008, PEDIATR BLOOD CANCER, V50, P831, DOI 10.1002/pbc.21425; Reiss U, 2002, J PEDIAT HEMATOL ONC, V24, P746, DOI 10.1097/00043426-200212000-00013; Richardson P, 1999, BRIT J HAEMATOL, V107, P485, DOI 10.1046/j.1365-2141.1999.01680.x; Richardson P., 2009, BLOOD, V114, P654; Richardson PG, 2010, BIOL BLOOD MARROW TR, V16, P1005, DOI 10.1016/j.bbmt.2010.02.009; Richardson PG, 2002, BLOOD, V100, P4337, DOI 10.1182/blood-2002-04-1216; RINGDEN O, 1994, TRANSPLANT P, V26, P1831; Rowlings PA, 1997, BRIT J HAEMATOL, V97, P855, DOI 10.1046/j.1365-2141.1997.1112925.x; Ruutu T, 2007, HAEMATOL-HEMATOL J, V92, P95, DOI 10.3324/haematol.10699; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Schulz AS, 2002, BLOOD, V99, P3458, DOI 10.1182/blood.V99.9.3458; Tai BC, 2001, STAT MED, V20, P661, DOI 10.1002/sim.711; Vassal G, 1996, CANCER CHEMOTH PHARM, V37, P247	39	212	226	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2012	379	9823					1301	1309		10.1016/S0140-6736(11)61938-7	http://dx.doi.org/10.1016/S0140-6736(11)61938-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922FB	22364685				2022-12-28	WOS:000302531100027
J	Molyneux, EM; Rochford, R; Griffin, B; Newton, R; Jackson, G; Menon, G; Harrison, CJ; Israels, T; Bailey, S				Molyneux, Elizabeth M.; Rochford, Rosemary; Griffin, Beverly; Newton, Robert; Jackson, Graham; Menon, Geetha; Harrison, Christine J.; Israels, Trijn; Bailey, Simon			Burkitt's lymphoma	LANCET			English	Article							EPSTEIN-BARR-VIRUS; NON-HODGKINS-LYMPHOMA; ACTIVE ANTIRETROVIRAL THERAPY; B-CELL LYMPHOMAS; C-MYC; MULTIAGENT CHEMOTHERAPY; GENE REARRANGEMENTS; GENOMIC INSTABILITY; AFRICAN CHILDREN; ADULT BURKITT	Burkitt's lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma and is the fastest growing human tumour. The disease is associated with Epstein-Barr virus and was one of the first tumours shown to have a chromosomal translocation that activates an oncogene (c-MYC). Burkitt's lymphoma is the most common childhood cancer in areas where malaria is holoendemic. The incidence is very high in immunosuppressed patients in non-endemic areas, especially when associated with HIV infection. Outcome with intensive chemotherapy has improved and is now excellent in children, but the prognosis is poor in elderly adults. The success of intensive treatment relies on good supportive care. The therapy offered in oncology units in low-income countries is not as aggressive as in centres in high-income countries and outcomes are less successful. Adjuvant monoclonal antibody therapy with rituximab shows promise for improved outcomes and reduced toxic effects in the future.	[Molyneux, Elizabeth M.] Coll Med, Blantyre, Malawi; [Rochford, Rosemary] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY USA; [Griffin, Beverly] Univ London Imperial Coll Sci Technol & Med, Sch Med, London, England; [Newton, Robert] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Newton, Robert] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Jackson, Graham] Newcastle Hosp NHS Trust, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England; [Menon, Geetha] Newcastle Hosp NHS Trust, Dept Histopathol, Newcastle Upon Tyne, Tyne & Wear, England; [Harrison, Christine J.] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England; [Israels, Trijn] Emmas Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands; [Bailey, Simon] Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of Malawi; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Imperial College London; University of York - UK; University of Hull; University of York - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Newcastle University - UK	Molyneux, EM (corresponding author), Coll Med, Box 360, Blantyre, Malawi.	emolyneux@malawi.net	Jackson, Graham/GMW-7638-2022	Jackson, Graham/0000-0003-0756-969X; Harrison, Christine/0000-0002-0526-6794	NATIONAL CANCER INSTITUTE [R01CA102667] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102667] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adde M, 1998, SEMIN ONCOL, V25, P33; Agsalda Melissa, 2009, Adv Hematol, V2009, P412163, DOI 10.1155/2009/412163; Arora RS, 2007, PEDIATR BLOOD CANCER, V49, P941, DOI 10.1002/pbc.21127; AYA T, 1991, LANCET, V337, P1190, DOI 10.1016/0140-6736(91)92861-U; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Bellan C, 2005, BLOOD, V106, P1031, DOI 10.1182/blood-2005-01-0168; BERNHEIM A, 1981, CANCER GENET CYTOGEN, V3, P307, DOI 10.1016/0165-4608(81)90039-X; BERTRAND S, 1981, EUR J CANCER, V17, P577, DOI 10.1016/0014-2964(81)90060-8; Breen EC, 2006, TUMOR BIOL, V27, P187, DOI 10.1159/000093022; BURKITT D, 1966, BMJ-BRIT MED J, V1, P569, DOI 10.1136/bmj.1.5487.569; BURKITT D, 1962, Br Med J, V2, P1019; BURKITT D, 1958, BRIT J SURG, V46, P218, DOI 10.1002/bjs.18004619704; BURKITT D, 1962, BRIT J CANCER, V16, P379, DOI 10.1038/bjc.1962.43; Burkitt D, 1964, LYMPHOMA SYNDROME DE; Burkitt D, 1964, 17 ANN S FUND CANC R, P615; BURKITT DP, 1971, P ROY SOC MED, V64, P909, DOI 10.1177/003591577106400914; BURKITT DP, 1969, JNCI-J NATL CANCER I, V42, P19; Cairo MS, 2002, LEUKEMIA, V16, P594, DOI 10.1038/sj.leu.2402402; Capolunghi F, 2008, J IMMUNOL, V180, P800, DOI 10.4049/jimmunol.180.2.800; Cardy AH, 2001, KUWAIT MED J, V33, P293; Carpenter LM, 2008, INT J CANCER, V122, P1319, DOI 10.1002/ijc.23254; Chene A, 2009, SEMIN CANCER BIOL, V19, P411, DOI 10.1016/j.semcancer.2009.10.002; CHINTU C, 1995, ARCH DIS CHILD, V73, P100, DOI 10.1136/adc.73.2.100; COHEN JI, 1991, J VIROL, V65, P5880, DOI 10.1128/JVI.65.11.5880-5885.1991; Cook-Mozaffari P, 1998, BRIT J CANCER, V78, P1521, DOI 10.1038/bjc.1998.717; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; DAVIES J N P, 1948, East Afr Med J, V25, P454; DETHE G, 1977, LANCET, V1, P335; DETHE G, 1985, BIOMED PHARMACOTHER, V39, P49; DOLL DC, 1982, LANCET, V1, P1026; Donati D, 2006, J INFECT DIS, V193, P971, DOI 10.1086/500839; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; El Kababri MMF, 2009, HEMATOL M REP, V3, P88; ELMES BGT, 1947, ANN TROP MED PARASIT, V41, P321, DOI 10.1080/00034983.1947.11685336; Engels EA, 2010, JAIDS-J ACQ IMM DEF, V54, P78, DOI 10.1097/01.qai.0000371677.48743.8d; Epeldegui M, 2007, AIDS, V21, P2265, DOI 10.1097/QAD.0b013e3282ef9f59; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Felice MS, 2009, HEMATOL M REP, V3, P26; Ferry JA, 2006, ONCOLOGIST, V11, P375, DOI 10.1634/theoncologist.11-4-375; Fujita S, 2004, ARCH PATHOL LAB MED, V128, P549; Galicier L, 2007, BLOOD, V110, P2846, DOI 10.1182/blood-2006-10-051771; Gerrard M, 2008, BRIT J HAEMATOL, V141, P840, DOI 10.1111/j.1365-2141.2008.07144.x; GESER A, 1982, INT J CANCER, V29, P397, DOI 10.1002/ijc.2910290406; Griffin TC, 2009, PEDIATR BLOOD CANCER, V52, P177, DOI 10.1002/pbc.21753; Grulich AE, 2000, AIDS, V14, P133, DOI 10.1097/00002030-200001280-00008; Guikema JEJ, 2006, GENE CHROMOSOME CANC, V45, P808, DOI 10.1002/gcc.20345; Harif M, 2008, PEDIATR BLOOD CANCER, V50, P1138, DOI 10.1002/pbc.21452; Hesseling P, 2009, ANN TROP PAEDIATR, V29, P29, DOI 10.1179/146532809X402006; Hesseling P, 2005, PEDIATR BLOOD CANCER, V44, P245, DOI 10.1002/pbc.20254; Hesseling PB, 2008, T ROY SOC TROP MED H, V102, P602, DOI 10.1016/j.trstmh.2008.02.009; Hochberg D, 2004, P NATL ACAD SCI USA, V101, P239, DOI 10.1073/pnas.2237267100; Hoelzer D, 1996, BLOOD, V87, P495, DOI 10.1182/blood.V87.2.495.bloodjournal872495; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Israels T, 2008, PEDIATR BLOOD CANCER, V51, P639, DOI 10.1002/pbc.21703; Israels T, 2009, PEDIATR BLOOD CANCER, V53, P47, DOI 10.1002/pbc.22032; Jaffe Elaine S, 2009, Hematology Am Soc Hematol Educ Program, P523, DOI 10.1182/asheducation-2009.1.523; Jaffe ES, 2001, WHO CLASSIFICATION T; KAFUKO GW, 1970, INT J CANCER, V6, P1, DOI 10.1002/ijc.2910060102; KAISERMCCAW B, 1977, INT J CANCER, V19, P482, DOI 10.1002/ijc.2910190408; KALTER SP, 1985, BLOOD, V66, P655; Kamranvar SA, 2007, ONCOGENE, V26, P5115, DOI 10.1038/sj.onc.1210324; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758; Kelly GL, 2005, J VIROL, V79, P10709, DOI 10.1128/JVI.79.16.10709-10717.2005; Klapper W, 2008, BLOOD, V112, P1374, DOI 10.1182/blood-2008-01-136465; Klumb CE, 2009, HEMATOLOGY M REPORTS, V3, P15; Knowles DM, 2003, HEMATOL ONCOL CLIN N, V17, P785, DOI 10.1016/S0889-8588(03)00050-9; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Labrecque LG, 1999, INT J CANCER, V81, P6, DOI 10.1002/(SICI)1097-0215(19990331)81:1&lt;6::AID-IJC2&gt;3.0.CO;2-2; Lacasce A, 2004, LEUKEMIA LYMPHOMA, V45, P761, DOI 10.1080/1042819031000141301; LAM KMC, 1991, LANCET, V337, P876, DOI 10.1016/0140-6736(91)90203-2; Lindstrom MS, 2002, SEMIN CANCER BIOL, V12, P381, DOI 10.1016/S1044-579X(02)00058-5; Lovisa F, 2009, LAB INVEST, V89, P1182, DOI 10.1038/labinvest.2009.81; LUCAS SB, 1994, INT J CANCER, V59, P20, DOI 10.1002/ijc.2910590106; MacNeil A, 2003, BRIT J CANCER, V88, P1566, DOI 10.1038/sj.bjc.6600929; Magrath I, 1996, J CLIN ONCOL, V14, P925, DOI 10.1200/JCO.1996.14.3.925; MAGRATH IT, 1991, AM J PEDIAT HEMATOL, V13, P222; MANOLOV G, 1972, NATURE, V237, P33, DOI 10.1038/237033a0; Martinez-Maza O, 2002, CURR OPIN ONCOL, V14, P528, DOI 10.1097/00001622-200209000-00009; Mbulaiteye SM, 2009, PEDIATR BLOOD CANCER, V53, P366, DOI 10.1002/pbc.22047; Mead GM, 2002, ANN ONCOL, V13, P1264, DOI 10.1093/annonc/mdf253; Meremikwu MM, 2005, TROP MED INT HEALTH, V10, P92, DOI 10.1111/j.1365-3156.2004.01348.x; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Morrow RH, 1982, CANCER EPIDEMIOL, V779-94; MURPHY SB, 1980, SEMIN ONCOL, V7, P332; Mutalima Nora, 2010, Infect Agent Cancer, V5, P5, DOI 10.1186/1750-9378-5-5; Mutalima N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002505; Mwanda O W, 2004, East Afr Med J, pS68; Nelson M, 2010, BRIT J HAEMATOL, V148, P600, DOI 10.1111/j.1365-2141.2009.07967.x; NERI A, 1991, BLOOD, V77, P1092; Newton R, 2001, INT J CANCER, V92, P622, DOI 10.1002/1097-0215(20010601)92:5&lt;622::AID-IJC1256&gt;3.0.CO;2-K; NIEDOBITEK G, 1995, BLOOD, V86, P659, DOI 10.1182/blood.V86.2.659.bloodjournal862659; Njie R, 2009, J INFECT DIS, V199, P31, DOI 10.1086/594373; NKRUMAH FK, 1976, CANCER, V37, P671, DOI 10.1002/1097-0142(197602)37:2<671::AID-CNCR2820370210>3.0.CO;2-D; OCONOR GT, 1960, J PEDIATR-US, V56, P526, DOI 10.1016/S0022-3476(60)80369-1; Ong SK, 2001, T ROY SOC TROP MED H, V95, P93, DOI 10.1016/S0035-9203(01)90348-7; Orem Jackson, 2007, Afr Health Sci, V7, P166; Orem J, 2009, PEDIATR BLOOD CANCER, V52, P455, DOI 10.1002/pbc.21769; Parkin DM, 2003, IARC SCI PUBL, V153, P324; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Paschos K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000492; PATTE C, 1991, J CLIN ONCOL, V9, P123, DOI 10.1200/JCO.1991.9.1.123; Patte C, 2001, BLOOD, V97, P3370, DOI 10.1182/blood.V97.11.3370; PELICCI PG, 1986, P NATL ACAD SCI USA, V83, P2984, DOI 10.1073/pnas.83.9.2984; Perkins Archibald S, 2008, Hematology Am Soc Hematol Educ Program, P341, DOI 10.1182/asheducation-2008.1.341; Phillips JA, 2007, T ROY SOC TROP MED H, V101, P1265, DOI 10.1016/j.trstmh.2007.06.020; Potup P, 2009, SE ASIAN J TROP MED, V40, P651; Rainey JJ, 2007, TROP MED INT HEALTH, V12, P936, DOI 10.1111/j.1365-3156.2007.01875.x; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Rasti N, 2005, SCAND J IMMUNOL, V61, P461, DOI 10.1111/j.1365-3083.2005.01589.x; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Rochford R, 2005, NAT REV MICROBIOL, V3, P182, DOI 10.1038/nrmicro1089; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; Schulz TF, 1996, LANCET, V348, P587, DOI 10.1016/S0140-6736(95)11033-X; SHIRAMIZU B, 1991, BLOOD, V77, P1516; Sinfield RL, 2007, PEDIATR BLOOD CANCER, V48, P515, DOI 10.1002/pbc.20917; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; Swerdlow SH, 2008, WHO CLASSIFICATION T; Szczepanski T, 2001, LEUKEMIA, V15, P1415, DOI 10.1038/sj.leu.2402206; THIJS A, 1957, Ann Soc Belg Med Trop (1920), V37, P483; Thomas DA, 2006, CANCER-AM CANCER SOC, V106, P1569, DOI 10.1002/cncr.21776; Thomas DA, 1999, J CLIN ONCOL, V17, P2461, DOI 10.1200/JCO.1999.17.8.2461; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; TOMKINSON B, 1993, J VIROL, V67, P2014, DOI 10.1128/JVI.67.4.2014-2025.1993; van den Bosch CA, 2004, LANCET ONCOL, V5, P738, DOI 10.1016/S1470-2045(04)01638-9; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Imhoff GW, 2005, LEUKEMIA, V19, P945, DOI 10.1038/sj.leu.2403733; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; Windebank K, 2009, PAEDIAT HAEMATOLOGY, P443; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Xue SA, 2002, INT J CANCER, V99, P635, DOI 10.1002/ijc.10372; YAWETZ S, 1995, BLOOD, V85, P1843, DOI 10.1182/blood.V85.7.1843.bloodjournal8571843; Yone CLRP, 2006, T ROY SOC TROP MED H, V100, P669, DOI 10.1016/j.trstmh.2005.08.009; ZECH L, 1976, INT J CANCER, V17, P47, DOI 10.1002/ijc.2910170108; Zeng WZ, 2009, CLIN NUCL MED, V34, P355, DOI 10.1097/RLU.0b013e3181a34552; Zoufaly A, 2009, J INFECT DIS, V200, P79, DOI 10.1086/599313	138	333	350	3	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2012	379	9822					1234	1244		10.1016/S0140-6736(11)61177-X	http://dx.doi.org/10.1016/S0140-6736(11)61177-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918DV	22333947	Green Accepted			2022-12-28	WOS:000302230400036
J	Jiang, XD; Clark, RA; Liu, LZ; Wagers, AJ; Fuhlbrigge, RC; Kupper, TS				Jiang, Xiaodong; Clark, Rachael A.; Liu, Luzheng; Wagers, Amy J.; Fuhlbrigge, Robert C.; Kupper, Thomas S.			Skin infection generates non-migratory memory CD8(+) T-RM cells providing global skin immunity	NATURE			English	Article							MIGRATION; TRAFFICKING; EFFECTOR; RESIDENT; HETEROGENEITY; ACTIVATION; SELECTIN; TISSUE	Protective T-cell memory has long been thought to reside in blood and lymph nodes, but recently the concept of immune memory in peripheral tissues mediated by resident memory T (T-RM) cells has been proposed(1-5). Here we show in mice that localized vaccinia virus (VACV) skin infection generates long-lived non-recirculating CD8(+) skin T-RM cells that reside within the entire skin. These skin T-RM cells are potent effector cells, and are superior to circulating central memory T (T-CM) cells at providing rapid long-term protection against cutaneous re-infection. We find that CD8(+) T cells are rapidly recruited to skin after acute VACV infection. CD8(+) T-cell recruitment to skin is independent of CD4(+) T cells and interferon-c, but requires the expression of E-and P-selectin ligands by CD8(+) T cells. Using parabiotic mice, we further show that circulating CD8(+) T-CM and CD8(+) skin T-RM cells are both generated after skin infection; however, CD8(+) T-CM cells recirculate between blood and lymph nodes whereas T-RM cells remain in the skin. Cutaneous CD8(+) T-RM cells produce effector cytokines and persist for at least 6 months after infection. Mice with CD8(+) skin T-RM cells rapidly cleared a subsequent re-infection with VACV whereas mice with circulating T-CM but no skin T-RM cells showed greatly impaired viral clearance, indicating that T-RM cells provide superior protection. Finally, we show that T-RM cells generated as a result of localized VACV skin infection reside not only in the site of infection, but also populate the entire skin surface and remain present for many months. Repeated re-infections lead to progressive accumulation of highly protective T-RM cells in non-involved skin. These findings have important implications for our understanding of protective immune memory at epithelial interfaces with the environment, and suggest novel strategies for vaccines that protect against tissue tropic organisms.	[Jiang, Xiaodong; Clark, Rachael A.; Liu, Luzheng; Fuhlbrigge, Robert C.; Kupper, Thomas S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Jiang, Xiaodong; Clark, Rachael A.; Liu, Luzheng; Fuhlbrigge, Robert C.; Kupper, Thomas S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst,Joslin Diabet Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	Kupper, TS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA.	tkupper@partners.org	Kupper, Thomas/O-4962-2019		National Institutes of Health (NIH) [R01AI041707, R37AI025082, TR01AI097128]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041707, R01AI025082, R37AI025082, R01AI097128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056720, R01AR065807] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank T. Tian, R. Purwar and Q. Zhan for technical assistance. We thank J. J. Campbell for discussion of the project. This work was supported by National Institutes of Health (NIH) grants R01AI041707, R37AI025082 and TR01AI097128 to T.S.K.	Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Chong BF, 2004, J IMMUNOL, V172, P1575, DOI 10.4049/jimmunol.172.3.1575; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; Freyschmidt EJ, 2010, J IMMUNOL, V185, P1295, DOI 10.4049/jimmunol.0903144; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Jiang XD, 2010, P NATL ACAD SCI USA, V107, P7443, DOI 10.1073/pnas.0912943107; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Sanz P, 1999, P NATL ACAD SCI USA, V96, P2692, DOI 10.1073/pnas.96.6.2692; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4	30	603	616	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					227	U129		10.1038/nature10851	http://dx.doi.org/10.1038/nature10851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22388819	Green Accepted			2022-12-28	WOS:000301174900042
J	Yip, WCM; Hsiao, WC; Chen, W; Hu, SL; Ma, J; Maynard, A				Yip, Winnie Chi-Man; Hsiao, William C.; Chen, Wen; Hu, Shanlian; Ma, Jin; Maynard, Alan			Early appraisal of China's huge and complex health-care reforms	LANCET			English	Review							COOPERATIVE MEDICAL SCHEME; SYSTEM REFORM; RURAL CHINA; FINANCIAL PROTECTION; CHRONIC DISEASES; MIGRANT WORKERS; INSURANCE; ADJUSTMENT; CHALLENGES; EMERGENCE	China's 3 year, CN(sic)850 billion (US$125 billion) reform plan, launched in 2009, marked the first phase towards achieving comprehensive universal health coverage by 2020. The government's undertaking of systemic reform and its affirmation of its role in financing health care together with priorities for prevention, primary care, and redistribution of finance and human resources to poor regions are positive developments. Accomplishing nearly universal insurance coverage in such a short time is commendable. However, transformation of money and insurance coverage into cost-effective services is difficult when delivery of health care is hindered by waste, inefficiencies, poor quality of services, and scarcity and maldistribution of the qualified workforce. China must reform its incentive structures for providers, improve governance of public hospitals, and institute a stronger regulatory system, but these changes have been slowed by opposition from stakeholders and lack of implementation capacity. The pace of reform should be moderated to allow service providers to develop absorptive capacity. Independent, outcome-based monitoring and evaluation by a third-party are essential for mid-course correction of the plans and to make officials and providers accountable.	[Yip, Winnie Chi-Man] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Hsiao, William C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Cambridge, MA 02138 USA; [Chen, Wen; Hu, Shanlian] Fudan Univ, Sch Publ Hlth, Dept Hlth Econ, Shanghai 200433, Peoples R China; [Ma, Jin] Shanghai Jiao Tong Univ, Coll Publ Hlth, Shanghai 200030, Peoples R China; [Maynard, Alan] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Fudan University; Shanghai Jiao Tong University; University of York - UK	Yip, WCM (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	winnie.yip@dph.ox.ac.uk						[Anonymous], 2011, LANCET, V378, P457, DOI 10.1016/S0140-6736(11)61232-4; [Anonymous], 2011, COMMUNICATION   1116; [Anonymous], COMP BIDD ESS MED HI; Babiarz KS, 2010, BMJ-BRIT MED J, V341, P5617; Bai CE, HLTH INSURANCE CONSU; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Brixi H, 2011, EQUITY PUBLIC GOVERN; Central Committee of the Communist Party and State Council, STAND C STAT COUNC C; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; China National Health Development Research Centre, 2011, SUMM CHIN TOT HLTH E; Diderichsen F, 2004, RESOURCE ALLOCATION; Dollar D, INTERGOVERNMENTAL FI; Feng C, 2006, CHINA DAILY     1024; Feng XL, 2010, BJOG-INT J OBSTET GY, V117, P1527, DOI 10.1111/j.1471-0528.2010.02707.x; Feng XL, 2011, LANCET, V378, P1493, DOI 10.1016/S0140-6736(11)61096-9; Feng XL, 2011, B WORLD HEALTH ORGAN, V89, P432, DOI 10.2471/BLT.10.085274; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Guo Y, 2011, EC ANAL CHINAS GOVT; He J, 2009, LANCET, V374, P1765, DOI 10.1016/S0140-6736(09)61199-5; Hu S, 2010, STUDY EQUALITY PUBLI, P92; Hu S, 2011, HLTH NEWS       0304; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Huang Y, 2011, FOREIGN AFF, V90, P119; Lei XY, 2009, HEALTH ECON, V18, pS25, DOI 10.1002/hec.1501; Liu D., 2011, ZEF DISCUSSION PAPER, V155; Liu GG, 2011, MED COSTS CHANGED RO; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Long QA, 2010, TROP MED INT HEALTH, V15, P1210, DOI 10.1111/j.1365-3156.2010.02602.x; Ministry of Finance of the People's Republic of China, ALL GOV FUND HLTH; Ministry of Health of the People's Republic of China, NAT ESS MED LIST PRI; Ministry of Health of the People's Republic of China, CHIN HLTH UND STAT B; Ministry of Health of the People's Republic of China, 2011, REP IMPL NAT ESS MED; Ministry of Health of the People's Republic of China, 2010, CHIN HLTH STAT YB 20; Ministry of Health People's Republic of China, 2011, REP WOM CHILDR HLTH; Ministry of Human Resources and Social Security of the People's Republic of China, LAB SOC SEC UND STAT; Mou J, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-214; National Bureau of Statistics and Ministry of Human Resources and Social Security, 2010, CHIN LAB STAT YB 200; National Development and Reform Commission Ministry of Health The State Commission Offi ce for Public Sector Reform Ministry of Education Ministry of Finance Ministry of Human Resources and Social Security, PLAN EST GEN PRACT L; Peng YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-69; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; Rice N, 2001, MILBANK Q, V79, P81, DOI 10.1111/1468-0009.00197; Shi F, 2011, J MED FORUM, V32, P107; Shi LW, 2011, VALUE HEALTH, V14, pA14, DOI 10.1016/j.jval.2011.02.085; Smith SC, 2010, CIRC-CARDIOVASC QUAL, V3, P226, DOI 10.1161/CIRCOUTCOMES.110.957183; State Council People's Republic of China, 2009, CURR MAJ PROJ HLTH C; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; Sun XY, 2009, HEALTH ECON, V18, P103, DOI 10.1002/hec.1346; Sun ZG, 2011, EC SOCIAL DEV 12 5 Y; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Wagstaff A, 2008, J HEALTH ECON, V27, P990, DOI 10.1016/j.jhealeco.2008.02.002; Wagstaff A, 2009, HEALTH ECON, V18, pS7, DOI 10.1002/hec.1518; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang LD, 2005, COMPREHENSIVE REPORT; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang SY, 2011, HLTH HARMONIOUS LIFE; Wang Y, 2008, TROP MED INT HEALTH, V13, P927, DOI 10.1111/j.1365-3156.2008.02093.x; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; You XD, 2009, HEALTH POLICY, V91, P1, DOI 10.1016/j.healthpol.2008.11.012; Zarocostas J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4801; Zhang JP, 2008, ARCH PSYCHIAT NURS, V22, P39, DOI 10.1016/j.apnu.2007.04.007; ZhiGan S, COMMUNICATION; Zhu MM, 2008, HEALTH POLICY, V88, P371, DOI 10.1016/j.healthpol.2008.04.008	69	807	831	34	488	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2012	379	9818					833	842		10.1016/S0140-6736(11)61880-1	http://dx.doi.org/10.1016/S0140-6736(11)61880-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386036				2022-12-28	WOS:000300983400033
J	Zhang, LL; Liu, X; Li, YP; Liu, Y; Liu, ZP; Lin, JC; Shen, J; Tang, XF; Zhang, Y; Liang, WN				Zhang, Lulu; Liu, Xu; Li, Youping; Liu, Yuan; Liu, Zhipeng; Lin, Juncong; Shen, Ji; Tang, Xuefeng; Zhang, Yi; Liang, Wannian			Emergency medical rescue efforts after a major earthquake: lessons from the 2008 Wenchuan earthquake	LANCET			English	Review							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; HURRICANE KATRINA; PART I; DISASTERS; TRIAGE; IMPACT; CASUALTIES; EVACUATION; MANAGEMENT	Major earthquakes often result in incalculable environmental damage, loss of life, and threats to health. Tremendous progress has been made in response to many medical challenges resulting from earthquakes. However, emergency medical rescue is complicated, and great emphasis should be placed on its organisation to achieve the best results. The 2008 Wenchuan earthquake was one of the most devastating disasters in the past 10 years and caused more than 370 000 casualties. The lessons learnt from the medical disaster relief effort and the subsequent knowledge gained about the regulation and capabilities of medical and military back-up teams should be widely disseminated. In this Review we summarise and analyse the emergency medical rescue efforts after the Wenchuan earthquake. Establishment of a national disaster medical response system, an active and effective commanding system, successful coordination between rescue forces and government agencies, effective treatment, a moderate, timely and correct public health response, and long-term psychological support are all crucial to reduce mortality and morbidity and promote overall effectiveness of rescue efforts after a major earthquake.	[Zhang, Lulu; Liu, Xu; Liu, Yuan; Liu, Zhipeng; Lin, Juncong; Zhang, Yi] Second Mil Med Univ, Inst Mil Hlth Management, Shanghai 200433, Peoples R China; [Li, Youping] Sichuan Univ, W China Hosp, Chengdu 610064, Peoples R China; [Shen, Ji] Hlth Dept Sichuan Prov, Chengdu, Peoples R China; [Tang, Xuefeng] Ctr Dis Control & Prevent Sichuan Prov, Chengdu, Peoples R China; [Liang, Wannian] Minist Hlth, Dept Emergency, Beijing 100044, Peoples R China	Naval Medical University; Sichuan University	Zhang, LL (corresponding author), Second Mil Med Univ, Inst Mil Hlth Management, Shanghai 200433, Peoples R China.	zllrmit@yahoo.com.cn; liangwn@moh.cn.gov	LIU, ZHIPENG/GWQ-5972-2022; liu, zhipeng/HCI-3638-2022		National Natural Science Foundation of China [70333002, 71103194]; National Key Technologies RD Programme [2009BAI87B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Programme(National Key Technology R&D Program)	Our work is supported by the National Natural Science Foundation of China (70333002 and 71103194), and National Key Technologies R&D Programme (2009BAI87B05).	Akbari ME, 2004, PUBLIC HEALTH, V118, P403, DOI 10.1016/j.puhe.2004.05.010; [Anonymous], XINHUA NEWS; [Anonymous], XINHUA NEWS; [Anonymous], XINHUA POLITICS; [Anonymous], PEOPLE NEWS; Auerbach PS, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1001555; Bar-On E, 2011, INJURY, V42, P1053, DOI 10.1016/j.injury.2011.03.054; Bostick NA, 2008, DISASTER MED PUBLIC, V2, pS35, DOI 10.1097/DMP.0b013e3181825a2b; Bozkurt M, 2007, INJURY, V38, P290, DOI 10.1016/j.injury.2006.10.013; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P93; Chan CC, 2003, ANN EPIDEMIOL, V13, P502, DOI 10.1016/S1047-2797(03)00040-1; Chan EYY, 2008, LANCET, V372, P359, DOI 10.1016/S0140-6736(08)61141-1; Chan EYY, 2011, EUR J EMERG MED, V18, P111, DOI 10.1097/MEJ.0b013e32833dba19; [陈锦 CHEN Jin], 2009, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V9, P1267; Chinese Center for Disease Control and Prevention, TECH GUID COMM DIS P; Chinese Center for Disease Control and Prevention, 2008, PREL RISK ASS MAJ IN; Chinese Ministry of Health, 2008, WENCH EARTHQ SIT TRI; Chinese National Institute for Communicable Disease Control and Prevention, HLTH STAT DAT; Cranmer HH, 2005, NEW ENGL J MED, V353, P1541, DOI 10.1056/NEJMp058234; Cui XH, 2008, NEW EC, V11, P50; Dan D, 2010, J TRAUMA, V68, P1417, DOI 10.1097/TA.0b013e3181c9b301; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Deng Shaolin, 2010, J Evid Based Med, V3, P62, DOI 10.1111/j.1756-5391.2010.01084.x; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; Evans GW, 2002, J ENVIRON PSYCHOL, V22, P221, DOI 10.1006/jevp.2002.0256; Fernando D., 2006, REPORT RAPID ASSESSM; Ginzburg E, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1002026; Government of Sichuan Province, REB PLAN FAM LOST ME; Gu YQ, 2008, CHINA J EMERG RESUSC, V3, P334; Guo Y, 2010, PRACT PREV MED, V17, P2193; Hamilton DR, 2009, ANN EMERG MED, V53, P505, DOI 10.1016/j.annemergmed.2008.10.014; He Q, 2011, J TRAUMA, V70, P1213, DOI 10.1097/TA.0b013e3182117b57; [何忠杰 HE Zhongjie], 2008, [中国急救医学, Chinese Journal of Critical Care Medicine], V28, P796; Hu SQ, 2008, J NANCHANG COLL, V5, P163; IFRC RCS, PAK EARTHQ REV EM RE; International Atomic Energy Agency, HAIT EARTHQ UPD 3 MO; Iserson KV, 2007, ANN EMERG MED, V49, P275, DOI 10.1016/j.annemergmed.2006.05.019; Jhung MA, 2007, AM J PREV MED, V33, P207, DOI 10.1016/j.amepre.2007.04.030; [姜洁 Jiang Jie], 2010, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V10, P550; Jin Q., 2008, CHIN EVID BASED MED, V8, P685; Khadivi R, TENT CLASSROOMS SCH; Kun P, 2010, PUBLIC HEALTH, V124, P573, DOI 10.1016/j.puhe.2010.06.001; Li JH, 2008, HOSP ADM J CHIN PEOP, V15, P10007; Li JY, 2011, J YIBIN U, V11, P81; [李婷 LI Ting], 2011, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V11, P605; Li X. R., 2008, J CHINESE LANDSCAPE, V24, P1; Liu SJ, 2010, INT J GYNECOL OBSTET, V108, P161, DOI 10.1016/j.ijgo.2009.08.030; [刘娅 Liu Ya], 2011, [中国公共卫生, China Public Health], V27, P303; Lukens M, MORE LESSONS EMERGIN; Ma OJ, 2007, CRIT CARE MED, V35, pS275, DOI 10.1097/01.CCM.0000260677.29207.B4; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Matsuoka T, 2000, PUBLIC HEALTH, V114, P249, DOI 10.1016/S0033-3506(00)00339-5; [苗崇刚 Miao Chonggang], 2004, [自然灾害学报, Journal of Natural Disasters], V13, P48; Miller AC, 2008, PREHOSPITAL DISASTER, V23, P185, DOI 10.1017/S1049023X00005835; Ministry of Land and Resources of the People's Republic of China, CHIN MAJ EARTHQ ZON; Nie H, 2011, INJURY, V42, P515, DOI 10.1016/j.injury.2010.01.113; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Peleg K, 2002, ISRAEL MED ASSOC J, V4, P361; Peng ZC, 2008, J CHINA EXEC LEADERS, V4, P53; Qu WP, 2008, AERONAUT INT COOPERA, V4, P24; Ruggiero KJ, 2006, BEHAV THER, V37, P190, DOI 10.1016/j.beth.2005.12.001; Sariego Jack, 2006, Disaster Manag Response, V4, P114, DOI 10.1016/j.dmr.2006.09.001; Schultz CH, 2007, ANN EMERG MED, V50, P320, DOI 10.1016/j.annemergmed.2007.03.025; Shah S, 2010, AM J EMERG MED, V28, P970, DOI 10.1016/j.ajem.2010.06.017; Shuai XH, 2004, EARTHQUAKE, V3, P101; Tahir H, 2006, BRIT MED J, V332, P244, DOI 10.1136/bmj.332.7535.244; Takano T, 2001, J EPIDEMIOL COMMUN H, V55, P263, DOI 10.1136/jech.55.4.263; Tanaka H, 1998, J Emerg Med, V16, P439, DOI 10.1016/S0736-4679(98)00014-6; The Central People's Government of the People's Republic of China, INF BORN WENCH EARTH; The National Center for PTSD, 2001, MASS VIOL EARL INT E; United Nations Educational Scientific and Cultural Organization, UNESCO HELPS DEV SPE; Urbina E, 2003, TRANSPORT RES A-POL, V37, P257, DOI 10.1016/S0965-8564(02)00015-0; van der Tol A, 2009, NEPHROL DIAL TRANSPL, V24, P907, DOI 10.1093/ndt/gfn557; Waisman Y, 2006, CLIN PEDIATR EMERG M, V7, P52, DOI 10.1016/j.cpem.2006.01.006; Wang B, 2011, PSYCHIAT RES, V187, P392, DOI 10.1016/j.psychres.2009.07.001; Wen J, 2010, INT J GERONTOL, V4, P115, DOI 10.1016/S1873-9598(10)70034-X; WHO Collaborating Centre for Research on the Epidemiology of Disasters, EM DAT INT DIS DAT E; WHO Ministry of Health of NWFP, 2006, ASS PUBL HLTH FAC EA; World Health Organization, PUBL HLTH RISK ASS I; [吴先萍 WU Xianping], 2008, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V8, P803; Xiang B, 2009, J PEDIATR SURG, V44, P2273, DOI 10.1016/j.jpedsurg.2009.07.068; Xie Juan, 2008, J Evid Based Med, V1, P20, DOI 10.1111/j.1756-5391.2008.00010.x; Xu FZ, 2011, ZHEJIANG J PREV MED, V23, P32; Xu JG, 2011, WORLD NEUROSURG, V75, P390, DOI 10.1016/j.wneu.2011.02.006; Xu JP, 2011, COMPR PSYCHIAT, V52, P431, DOI 10.1016/j.comppsych.2010.08.002; [张本 ZHANG Ben], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P469; Zhang L, 2012, INJURY, V43, P1470, DOI 10.1016/j.injury.2010.11.036; Zhang LL, 2009, HOSP ADM J CHIN PEOP, V16, P249; Zhang LL, 2011, EMERG MED J, V28, P618, DOI 10.1136/emj.2009.087296; [张雁灵 ZHANG Yan-ling], 2009, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V34, P1; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Zhu LP, 2010, J MED COL PLA, V25, P98; 邹强, 2008, [中国危重病急救医学, Chinese Critical Care Medicine], V20, P625; 卢世璧, 2008, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V33, P919	94	97	111	4	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2012	379	9818					853	861		10.1016/S0140-6736(11)61876-X	http://dx.doi.org/10.1016/S0140-6736(11)61876-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386038				2022-12-28	WOS:000300983400035
J	Alexander, WA; Wiens, JP; Minton, TK; Nathanson, GM				Alexander, William A.; Wiens, Justin P.; Minton, Timothy K.; Nathanson, Gilbert M.			Reactions of Solvated Electrons Initiated by Sodium Atom Ionization at the Vacuum-Liquid Interface	SCIENCE			English	Article							AQUEOUS-SOLUTION; HYDRATED ELECTRONS; WATER CLUSTERS; RATE CONSTANTS; HYDROGEN; DYNAMICS; TEMPERATURE; COLLISIONS; DIFFUSION; GLYCEROL	Solvated electrons are powerful reagents in the liquid phase that break chemical bonds and thereby create additional reactive species, including hydrogen atoms. We explored the distinct chemistry that ensues when electrons are liberated near the liquid surface rather than within the bulk. Specifically, we detected the products resulting from exposure of liquid glycerol to a beam of sodium atoms. The Na atoms ionized in the surface region, generating electrons that reacted with deuterated glycerol, C3D5(OD)(3), to produce D atoms, D-2, D2O, and glycerol fragments. Surprisingly, 43 +/- 4% of the D atoms traversed the interfacial region and desorbed into vacuum before attacking C-D bonds to produce D-2.	[Alexander, William A.; Minton, Timothy K.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Wiens, Justin P.; Nathanson, Gilbert M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	Montana State University System; Montana State University Bozeman; University of Wisconsin System; University of Wisconsin Madison	Minton, TK (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	tminton@montana.edu; gmnathan@wisc.edu		Alexander, William/0000-0001-9492-1385; Minton, Timothy/0000-0003-4577-7879	NSF of the Center for Energetic Non-Equilibrium Chemistry at Interfaces [CHE-0943639]	NSF of the Center for Energetic Non-Equilibrium Chemistry at Interfaces	This work was supported by NSF grant CHE-0943639 as part of the Center for Energetic Non-Equilibrium Chemistry at Interfaces. We thank L. Sankaran, G. Schatz, I. Benjamin, and a reviewer for invaluable advice. The data described in this work can be obtained from the corresponding authors upon request.	Abel B, 2012, PHYS CHEM CHEM PHYS, V14, P22, DOI 10.1039/c1cp21803d; Barnett RN, 2011, J PHYS CHEM A, V115, P7378, DOI 10.1021/jp201560n; Benderskii VA, 1996, RUSS J ELECTROCHEM+, V32, P663; Bockris J.OM., 1998, MODERN ELECTROCHEMIS, V1; Bonin J, 2008, J PHYS CHEM A, V112, P1880, DOI 10.1021/jp710203v; BURCHILL CE, 1971, CAN J CHEMISTRY, V49, P2382, DOI 10.1139/v71-389; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Cwiklik L, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2902970; Ferro Y, 2004, J CHEM PHYS, V120, P8683, DOI 10.1063/1.1690238; Forck RM, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3439393; Garrett BC, 2005, CHEM REV, V105, P355, DOI 10.1021/cr030453x; Hammer NI, 2004, SCIENCE, V306, P675, DOI 10.1126/science.1102792; Lossack AM, 1998, J PHYS CHEM A, V102, P7462, DOI 10.1021/jp981936l; Madarasz A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2741514; Muenter AH, 2006, J PHYS CHEM B, V110, P4881, DOI 10.1021/jp0563235; MYRON JJJ, 1965, CAN J CHEMISTRY, V43, P381, DOI 10.1139/v65-050; Orlando TM, 1997, SURF SCI, V390, P79, DOI 10.1016/S0039-6028(97)00511-6; Paik DH, 2004, SCIENCE, V306, P672, DOI 10.1126/science.1102827; Park J, 2003, J CHEM PHYS, V118, P9990, DOI 10.1063/1.1573182; Roduner E, 2005, RADIAT PHYS CHEM, V72, P201, DOI 10.1016/j.radphyschem.2004.09.014; SAECKER ME, 1993, J CHEM PHYS, V99, P7056, DOI 10.1063/1.465425; Sagar DM, 2010, J AM CHEM SOC, V132, P6917, DOI 10.1021/ja101176r; SHIRAISHI H, 1994, J PHYS CHEM-US, V98, P5164, DOI 10.1021/j100070a037; Siefermann KR, 2010, NAT CHEM, V2, P274, DOI [10.1038/NCHEM.580, 10.1038/nchem.580]; Verlet JRR, 2005, SCIENCE, V307, P93, DOI 10.1126/science.1106719; Zhang JM, 2002, J CHEM PHYS, V117, P6239, DOI 10.1063/1.1460858	26	22	22	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1072	1075		10.1126/science.1215956	http://dx.doi.org/10.1126/science.1215956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383842				2022-12-28	WOS:000300931100039
J	Ding, ZH; Wu, CJ; Jaskelioff, M; Ivanova, E; Kost-Alimova, M; Protopopov, A; Chu, GC; Wang, GC; Lu, X; Labrot, ES; Hu, J; Wang, W; Xiao, YH; Zhang, HL; Zhang, JH; Zhang, JF; Gan, BY; Perry, SR; Jiang, S; Li, LR; Horner, JW; Wang, YA; Chin, LD; DePinho, RA				Ding, Zhihu; Wu, Chang-Jiun; Jaskelioff, Mariela; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Chu, Gerald C.; Wang, Guocan; Lu, Xin; Labrot, Emma S.; Hu, Jian; Wang, Wei; Xiao, Yonghong; Zhang, Hailei; Zhang, Jianhua; Zhang, Jingfang; Gan, Boyi; Perry, Samuel R.; Jiang, Shan; Li, Liren; Horner, James W.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.			Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases	CELL			English	Article							GENE-EXPRESSION ANALYSIS; INTRAEPITHELIAL NEOPLASIA; GENOME INSTABILITY; CANCER; CARCINOMA; PROTEIN; BREAST; DAMAGE; PTEN; MICE	To determine the role of telomere dysfunction and telomerase reactivation in generating pro-oncogenic genomic events and in carcinoma progression, an inducible telomerase reverse transcriptase (mTert) allele was crossed onto a prostate cancer-prone mouse model null for Pten and p53 tumor suppressors. Constitutive telomerase deficiency and associated telomere dysfunction constrained cancer progression. In contrast, telomerase reactivation in the setting of telomere dysfunction alleviated intratumoral DNA-damage signaling and generated aggressive cancers with rearranged genomes and new tumor biological properties (bone metastases). Comparative oncogenomic analysis revealed numerous recurrent amplifications and deletions of relevance to human prostate cancer. Murine tumors show enrichment of the TGF-beta/SMAD4 network, and genetic validation studies confirmed the cooperative roles of Pten, p53, and Smad4 deficiencies in prostate cancer progression, including skeletal metastases. Thus, telomerase reactivation in tumor cells experiencing telomere dysfunction enables full malignant progression and provides a mechanism for acquisition of cancer-relevant genomic events endowing new tumor biological capabilities.	[Wu, Chang-Jiun; Kost-Alimova, Maria; Protopopov, Alexei; Zhang, Jianhua; Horner, James W.; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Ding, Zhihu; Wang, Guocan; Lu, Xin; Hu, Jian; Wang, Wei; Jiang, Shan; Wang, Y. Alan; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kost-Alimova, Maria; Protopopov, Alexei; Zhang, Jianhua; Horner, James W.; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Ding, Zhihu; Wu, Chang-Jiun; Jaskelioff, Mariela; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Chu, Gerald C.; Wang, Guocan; Lu, Xin; Labrot, Emma S.; Hu, Jian; Wang, Wei; Xiao, Yonghong; Zhang, Hailei; Zhang, Jianhua; Zhang, Jingfang; Gan, Boyi; Perry, Samuel R.; Jiang, Shan; Li, Liren; Horner, James W.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Ding, Zhihu; Jaskelioff, Mariela; Wang, Guocan; Lu, Xin; Hu, Jian; Wang, Wei; Gan, Boyi; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ding, Zhihu; Jaskelioff, Mariela; Wang, Guocan; Lu, Xin; Hu, Jian; Wang, Wei; Gan, Boyi; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Chu, Gerald C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chin, LD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	lchin@mdanderson.org; rdepinho@mdanderson.org	Gan, Boyi/HDM-4206-2022	Ivanova, Elena/0000-0002-5069-4974; DePinho, Ronald/0000-0002-5625-577X	Damon Runyon Cancer Research Foundation; Multiple Myeloma Research Foundation; Prostate Cancer Foundation; DOD [W81XWH-07-PCRP-IDA]; Robert A. and Renee E. Belfer Foundation;  [NCI R01CA084628];  [U01CA141508]; NATIONAL CANCER INSTITUTE [R01CA084628, U01CA141508, K99CA194289] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Multiple Myeloma Research Foundation; Prostate Cancer Foundation; DOD(United States Department of Defense); Robert A. and Renee E. Belfer Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Zhou and J.P. Morin for excellent mouse husbandry and care, J. Paik, M. Kim, and H. Ying for helpful discussion. We thank W. Hahn for shRNA constructs. Z.D. was supported by the Damon Runyon Cancer Research Foundation. Y.A.W. was supported by the Multiple Myeloma Research Foundation. This work is supported by NCI R01CA084628 (R.A.D.), U01CA141508 (L.C. and R.A.D.), the Prostate Cancer Foundation (R.A.D. and Z.D.), and DOD W81XWH-07-PCRP-IDA (R.A.D. and Z.D.). R.A.D. was an American Cancer Society Research Professor and supported by the Robert A. and Renee E. Belfer Foundation. The gene signature and technology developed in this paper have been licensed by Metamark GENETICS (http://www.metamarkgenetics.com/). L.C. and R.A.D. are the founders of Metamark GENETICS. Z.D. and C.J.W. are consultants for Metamark GENETICS.	Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Acevedo VD, 2009, CELL CYCLE, V8, P580, DOI 10.4161/cc.8.4.7657; Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Guo YP, 1997, CLIN CANCER RES, V3, P2269; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jenkins RB, 1997, CANCER RES, V57, P524; Johnson TR, 2008, MOL CANCER RES, V6, P1639, DOI 10.1158/1541-7786.MCR-08-0052; Kallakury BVS, 1997, DIAGN MOL PATHOL, V6, P192, DOI 10.1097/00019606-199708000-00003; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Koeneman KS, 1998, J UROLOGY, V160, P1533, DOI 10.1016/S0022-5347(01)62608-9; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin Y, 1997, J UROLOGY, V157, P1161, DOI 10.1016/S0022-5347(01)65160-7; Marino S, 2000, GENE DEV, V14, P994; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Meeker AK, 2002, CANCER RES, V62, P6405; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Rubin MA, 2008, MODERN PATHOL, V21, pS44, DOI 10.1038/modpathol.2008.11; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Sommerfeld HJ, 1996, CANCER RES, V56, P218; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Vukovic B, 2003, ONCOGENE, V22, P1978, DOI 10.1038/sj.onc.1206227; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang WB, 1998, CANCER RES, V58, P619; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	57	161	167	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					896	907		10.1016/j.cell.2012.01.039	http://dx.doi.org/10.1016/j.cell.2012.01.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22341455	Bronze, Green Accepted			2022-12-28	WOS:000300985000011
J	Reichmann, D; Xu, Y; Cremers, CM; Ilbert, M; Mittelman, R; Fitzgerald, MC; Jakob, U				Reichmann, Dana; Xu, Ying; Cremers, Claudia M.; Ilbert, Marianne; Mittelman, Roni; Fitzgerald, Michael C.; Jakob, Ursula			Order out of Disorder: Working Cycle of an Intrinsically Unfolded Chaperone	CELL			English	Article							REDOX-REGULATED CHAPERONE; THERMODYNAMIC ANALYSIS; SUBSTRATE-BINDING; HSP33; ACTIVATION; DNAK; PROTEINS; DOMAIN; SWITCH; SITE	The redox-regulated chaperone Hsp33 protects organisms against oxidative stress that leads to protein unfolding. Activation of Hsp33 is triggered by the oxidative unfolding of its own redox-sensor domain, making Hsp33 a member of a recently discovered class of chaperones that require partial unfolding for full chaperone activity. Here we address the long-standing question of how chaperones recognize client proteins. We show that Hsp33 uses its own intrinsically disordered regions to discriminate between unfolded and partially structured folding intermediates. Binding to secondary structure elements in client proteins stabilizes Hsp33's intrinsically disordered regions, and this stabilization appears to mediate Hsp33's high affinity for structured folding intermediates. Return to nonstress conditions reduces Hsp33's disulfide bonds, which then significantly destabilizes the bound client proteins and in doing so converts them into less-structured, folding-competent client proteins of ATP-dependent foldases. We propose a model in which energy-independent chaperones use internal order-to-disorder transitions to control substrate binding and release.	[Reichmann, Dana; Cremers, Claudia M.; Ilbert, Marianne; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Mittelman, Roni] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Xu, Ying; Fitzgerald, Michael C.] Duke Univ, Dept Chem, Durham, NC 27708 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	ujakob@umich.edu	Reichmann, Dana/J-4999-2019; Ilbert, marianne/ABG-5015-2021	Reichmann, Dana/0000-0003-0315-5334; ilbert, marianne/0000-0002-9070-2334	National Institutes of Health [GM065318, GM084174]; European Molecular Biology Organization; Human Frontiers postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084174, R01GM065318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontiers postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Rudiger for providing us with the raw data of the DnaK peptide array, Drs. Yosseff and Schreiber for the use of ProteOn and the analysis software, and Dr. Kay for purified Arc repressor protein. We thank Dr. Mayer for running the DnaK binding predictor on the CS sequence. We are grateful to Drs. Bardwell, Xu, and Walter for critically commenting on the manuscript. This project was supported by National Institutes of Health grants GM065318 to U.J. and GM084174 to M. C. F. and by the European Molecular Biology Organization and Human Frontiers postdoctoral fellowship to D. R.	BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; Chen ZJ, 2006, BIOCHEMISTRY-US, V45, P12325, DOI 10.1021/bi0612263; Cremers CM, 2010, J BIOL CHEM, V285, P11243, DOI 10.1074/jbc.M109.084350; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Gaspar AM, 2008, EUR BIOPHYS J BIOPHY, V37, P573, DOI 10.1007/s00249-008-0266-3; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Tang L, 2007, ANAL CHEM, V79, P5869, DOI 10.1021/ac0700777; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Voelz VA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000281; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1346, DOI 10.1021/bi902010t	25	100	103	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					947	957		10.1016/j.cell.2012.01.045	http://dx.doi.org/10.1016/j.cell.2012.01.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385960	Green Accepted, Bronze			2022-12-28	WOS:000300985000015
J	Rehman, HU				Rehman, H. U.			CASE REPORT A woman with ketoacidosis but not diabetes	BRITISH MEDICAL JOURNAL			English	Editorial Material							ALCOHOLIC KETOACIDOSIS; METABOLIC-ACIDOSIS; MANAGEMENT; DIAGNOSIS		Regina Gen Hosp, Dept Med, Regina, SK S4P 0W5, Canada	University of Saskatchewan	Rehman, HU (corresponding author), Regina Gen Hosp, Dept Med, Regina, SK S4P 0W5, Canada.	habib31@sasktel.net						BRADEN GL, 1993, ARCH INTERN MED, V153, P2377, DOI 10.1001/archinte.153.20.2377; COOPERMAN MT, 1974, DIABETES, V23, P433, DOI 10.2337/diab.23.5.433; FULOP M, 1986, ALCOHOL CLIN EXP RES, V10, P610, DOI 10.1111/j.1530-0277.1986.tb05154.x; HALPERIN ML, 1983, METABOLISM, V32, P308, DOI 10.1016/0026-0495(83)90197-X; Hojer J, 1996, HUM EXP TOXICOL, V15, P482; Krautt JA, 2008, CLIN J AM SOC NEPHRO, V3, P208, DOI 10.2215/CJN.03220807; MCGARRY JD, 1981, DIABETES MELLITUS, V5, P185; Thomsen JL, 1997, FORENSIC SCI INT, V90, P233; Umpierrez GE, 2000, J CRIT CARE, V15, P52, DOI 10.1053/jcrc.2000.7900; WRENN KD, 1991, AM J MED, V91, P119, DOI 10.1016/0002-9343(91)90003-G	10	3	3	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2012	344								e1535	10.1136/bmj.e1535	http://dx.doi.org/10.1136/bmj.e1535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XJ	22381524				2022-12-28	WOS:000301231900009
J	Robinson, A				Robinson, Andrew			A clash of symbols	NATURE			English	Editorial Material												andrew.robinson33@virgin.net						Parkinson Richard, 2005, ROSETTA STONE; Robinson Andrew, 2012, CRACKING EGYPTIAN CO; Young Thomas, 1855, MISCELLANEOUS WORKS, VIII	3	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					27	28		10.1038/483027a	http://dx.doi.org/10.1038/483027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900HP	22382961				2022-12-28	WOS:000300877900024
J	Sheron, N; Gilmore, I; Parsons, C; Hawkey, C; Rhodes, J				Sheron, Nick; Gilmore, Ian; Parsons, Camille; Hawkey, Chris; Rhodes, Jon			Projections of alcohol-related deaths in England and Wales-tragic toll or potential prize?	LANCET			English	Editorial Material									[Sheron, Nick; Parsons, Camille] Southampton Univ Hosp, NHS Fdn Trust, NIHR Biomed Res Unit Nutr Diet & Lifestyle, Southampton SO16 6YD, Hants, England; [Gilmore, Ian; Rhodes, Jon] Royal Liverpool Hosp, Liverpool L7 8XP, Merseyside, England; [Gilmore, Ian; Rhodes, Jon] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Hawkey, Chris] Univ Nottingham Hosp, Fac Med & Hlth Sci, Queens Med Ctr, Nottingham NG7 2UH, England	University of Southampton; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Nottingham	Sheron, N (corresponding author), Southampton Univ Hosp, NHS Fdn Trust, NIHR Biomed Res Unit Nutr Diet & Lifestyle, Southampton SO16 6YD, Hants, England.	nick.sheron@soton.ac.uk		Sheron, Nick/0000-0001-5232-8292; Sheron, Nick/0000-0002-6156-8367				Chisholm D, 2006, DRUG ALCOHOL REV, V25, P553, DOI 10.1080/09595230600944487; Department of Health, 2011, PUBL HLTH RESP DEAL; Jones L., 2008, ALCOHOL ATTRIBUTABLE; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; Northern Ireland Executive, 2012, NO IR HLTH MIN E POO; Office for National Statistics, 2006, DEF ALC REL DEATHS; Office for National Statistics, 2010, MORT STAT DEATHS DR; Office for National Statistics, 2012, ALC REL DEATHS UK 20; Sheron N, 2011, LANCET, V377, P1297, DOI 10.1016/S0140-6736(11)60022-6; The Scottish Government, 2009, CHANG SCOTL REL ALC; Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x; *WHO REG OFF EUR, 2008, EUR HLTH DAT HFA DB; Winnett R, 2011, DAILY TELEGRAPH 1227	13	21	21	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 25	2012	379	9817					687	688		10.1016/S0140-6736(12)60244-X	http://dx.doi.org/10.1016/S0140-6736(12)60244-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	899CU	22353260				2022-12-28	WOS:000300792600004
J	Brenner, S				Brenner, Sydney			Life's code script	NATURE			English	Editorial Material									Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Brenner, S (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.							Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230	6	45	45	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					461	461		10.1038/482461a	http://dx.doi.org/10.1038/482461a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	898VM	22358811				2022-12-28	WOS:000300770500016
J	Moore, W				Moore, Wendy			PAST CARING Doctors in Dickens	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2012	344								e1193	10.1136/bmj.e1193	http://dx.doi.org/10.1136/bmj.e1193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	900JQ	22362247				2022-12-28	WOS:000300883600007
J	Ferrante di Ruffano, L; Hyde, CJ; McCaffery, KJ; Bossuyt, PMM; Deeks, JJ				Ferrante di Ruffano, Lavinia; Hyde, Christopher J.; McCaffery, Kirsten J.; Bossuyt, Patrick M. M.; Deeks, Jonathan J.			Assessing the value of diagnostic tests: a framework for designing and evaluating trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RANDOMIZED CONTROLLED-TRIAL; BREAST-CANCER; CHEST-PAIN; MANAGEMENT; IMPACT; RISK		[Ferrante di Ruffano, Lavinia; Deeks, Jonathan J.] Univ Birmingham, Sch Hlth & Populat Sci, Dept Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England; [Hyde, Christopher J.] Univ Exeter, Peninsula Coll Med & Dent, Inst Hlth Serv Res, PenTAG, Exeter, Devon, England; [McCaffery, Kirsten J.] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Bossuyt, Patrick M. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	University of Birmingham; University of Exeter; University of Plymouth; University of Sydney; University of Amsterdam; Academic Medical Center Amsterdam	Deeks, JJ (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Dept Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England.	j.deeks@bham.ac.uk	Bossuyt, Patrick M/AAR-1183-2021; Deeks, Jon/AAV-5745-2020; Bossuyt, Patrick M./B-4557-2016; McCaffery, Kirsten/K-7945-2019; di Ruffano, Lavinia Ferrante/J-4986-2012	Bossuyt, Patrick M/0000-0003-4427-0128; Deeks, Jon/0000-0002-8850-1971; Bossuyt, Patrick M./0000-0003-4427-0128; McCaffery, Kirsten/0000-0003-2696-5006; Christopher, Hyde/0000-0002-7349-0616; Ferrante di Ruffano, Lavinia/0000-0002-2004-0638	UK Medical Research Council [G0600545]; Medical Research Council Midland Hub for Trials Methodology Research, University of Birmingham [G0800808]; Medical Research Council [G0800808, G0600545] Funding Source: researchfish; MRC [G0800808, G0600545] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Midland Hub for Trials Methodology Research, University of Birmingham(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The development of the framework was funded partly by the UK Medical Research Council Methodology Programme (grant G0600545, awarded to JJD), as part of a wider investigation into the use of randomised trials for evaluating the clinical effectiveness of diagnostic tests. The funders had no involvement in the research project. JJD is partly supported by the Medical Research Council Midland Hub for Trials Methodology Research, University of Birmingham (grant G0800808).	Babjuk M, 2005, BJU INT, V96, P798, DOI 10.1111/j.1464-410X.2004.05715.x; Barton MB, 2004, J NATL CANCER I, V96, P529, DOI 10.1093/jnci/djh083; Bossuyt P M, 1999, Acad Radiol, V6 Suppl 1, pS77, DOI 10.1016/S1076-6332(99)80092-0; Bossuyt Patrick M M, 2009, Med Decis Making, V29, pE30, DOI 10.1177/0272989X09347013; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Bouza E, 2007, CLIN INFECT DIS, V44, P382, DOI 10.1086/510587; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Craig P., 2008, DEV EVALUATING COMPL; Deeks JJ., 2007, EVIDENCE BASED LAB M, P95; Djais N, 2005, APLAR J RHEUM, V8, P45, DOI DOI 10.1111/j.1479-8077.2005.00122.x; Ferrante di Ruffano L, 2012, J CLIN EPIDEMIOL, V65, P282, DOI 10.1016/j.jclinepi.2011.07.003; FINEBERG HV, 1978, AM J ROENTGENOL, V131, P1; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Goodacre S, 2004, BRIT MED J, V328, P254, DOI 10.1136/bmj.37956.664236.EE; Hauser MJ, 1991, DECISION MAKING PSYC; Haynes RB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub2; Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904; Hunink MGM, 2002, RADIOLOGY, V222, P604, DOI 10.1148/radiol.2223010335; Jeetley P, 2006, EUR J ECHOCARDIOGR, V7, P155, DOI 10.1016/j.euje.2005.05.002; Kock MCJM, 2005, RADIOLOGY, V237, P727, DOI 10.1148/radiol.2372040616; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lijmer JG, 2009, J CLIN EPIDEMIOL, V62, P364, DOI 10.1016/j.jclinepi.2008.06.017; McCaffery KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4491; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Ogden J, 2009, BJOG-INT J OBSTET GY, V116, P286, DOI 10.1111/j.1471-0528.2008.02035.x; Oosterheert JJ, 2005, CLIN INFECT DIS, V41, P1438, DOI 10.1086/497134; Pennant M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14500; Pletcher MJ, 2011, CIRCULATION, V123, P1116, DOI 10.1161/CIRCULATIONAHA.110.943860; Purushotham AD, 2005, J CLIN ONCOL, V23, P4312, DOI 10.1200/JCO.2005.03.228; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; SUMMERTON N, 1995, BRIT MED J, V310, P27, DOI 10.1136/bmj.310.6971.27; Sutton AJ, 2008, MED DECIS MAKING, V28, P650, DOI 10.1177/0272989X08324036; Viney RC, 2004, J CLIN ONCOL, V22, P2357, DOI 10.1200/JCO.2004.04.126	34	201	203	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2012	344								e686	10.1136/bmj.e686	http://dx.doi.org/10.1136/bmj.e686			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900JG	22354600	Bronze, Green Submitted			2022-12-28	WOS:000300882500026
J	Fusar-Poli, P; Yung, AR				Fusar-Poli, Paolo; Yung, Alison R.			Should attenuated psychosis syndrome be included in DSM-5?	LANCET			English	Editorial Material							CRITERIA; RISK		[Fusar-Poli, Paolo] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London SE5 8AF, England; [Yung, Alison R.] Univ Melbourne, Orygen Youth Hlth Res Ctr, Ctr Youth Mental Hlth, Melbourne, Vic, Australia	University of London; King's College London; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne	Fusar-Poli, P (corresponding author), Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London SE5 8AF, England.	p.fusar@libero.it	Fusar-Poli, Paolo/D-8605-2011; Yung, Alison/N-6729-2019	Fusar-Poli, Paolo/0000-0003-3582-6788; Yung, Alison/0000-0002-0401-9791				Addington J, 2005, BRIT J PSYCHIAT, V187, pS120, DOI 10.1192/bjp.187.48.s120; Drake RJ, 2010, SCHIZOPHR RES, V120, P38, DOI 10.1016/j.schres.2010.03.013; Fusar-Poli P, 2010, J PSYCHIATR RES, V44, P294, DOI 10.1016/j.jpsychires.2009.08.016; Fusar-Poli P, ARCH GEN PS IN PRESS; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Jacobs E, 2011, SCHIZOPHR RES, V131, P24, DOI 10.1016/j.schres.2011.06.022; McGorry PD, 2009, J CLIN PSYCHIAT, V70, P1206, DOI 10.4088/JCP.08r04472; Schimmelmann BG, 2011, SCHIZOPHR RES, V125, P99, DOI 10.1016/j.schres.2010.09.018; Thompson A, 2011, SCHIZOPHR RES, V126, P51, DOI 10.1016/j.schres.2010.09.024; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Yung AR, 2008, SCHIZOPHR RES, V105, P10, DOI 10.1016/j.schres.2008.07.012	11	48	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2012	379	9816					591	592		10.1016/S0140-6736(11)61507-9	http://dx.doi.org/10.1016/S0140-6736(11)61507-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	897ES	22340290				2022-12-28	WOS:000300629000005
J	Yoon, BC; Jung, H; Dwivedy, A; O'Hare, CM; Zivraj, KH; Holt, CE				Yoon, Byung C.; Jung, Hosung; Dwivedy, Asha; O'Hare, Catherine M.; Zivraj, Krishna H.; Holt, Christine E.			Local Translation of Extranuclear Lamin B Promotes Axon Maintenance	CELL			English	Article							MESSENGER-RNA; PROTEIN-SYNTHESIS; NUCLEAR LAMIN; GROWTH CONES; MITOCHONDRIAL DYSFUNCTION; RETINAL AXONS; COMPLEX; CELLS; CNS; LOCALIZATION	Local protein synthesis plays a key role in regulating stimulus-induced responses in dendrites and axons. Recent genome-wide studies have revealed that thousands of different transcripts reside in these distal neuronal compartments, but identifying those with functionally significant roles presents a challenge. We performed an unbiased screen to look for stimulus-induced, protein synthesis-dependent changes in the proteome of Xenopus retinal ganglion cell (RGC) axons. The intermediate filament protein lamin B2 (LB2), normally associated with the nuclear membrane, was identified as an unexpected major target. Axonal ribosome immunoprecipitation confirmed translation of lb2 mRNA in vivo. Inhibition of lb2 mRNA translation in axons in vivo does not affect guidance but causes axonal degeneration. Axonal LB2 associates with mitochondria, and LB2-deficient axons exhibit mitochondrial dysfunction and defects in axonal transport. Our results thus suggest that axonally synthesized lamin B plays a crucial role in axon maintenance by promoting mitochondrial function.	[Yoon, Byung C.; Jung, Hosung; Dwivedy, Asha; O'Hare, Catherine M.; Zivraj, Krishna H.; Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	ceh@mole.bio.cam.ac.uk	Jung, Hosung/A-4401-2012	Jung, Hosung/0000-0002-5059-8050; Yoon, Byung/0000-0003-2929-5677; Holt, Christine Elizabeth/0000-0003-2829-121X	Gates Cambridge Scholarship; Overseas Research Scholars Award; Wellcome Trust [085314/Z/08/Z]	Gates Cambridge Scholarship; Overseas Research Scholars Award; Wellcome Trust(Wellcome Trust)	We thank L. Strochlic and G.M.W. Cook for their groundwork in developing the proteomics technique; A. Kalous for assistance with retinal cultures; K. Lilley and members of her lab (R. Feret, M. Deery, and S. Hester) for technical assistance with DIGE experiments and MS analysis; A. Prochiantz for En-1; G. Krohne for LB2-GFP construct; N. Heintz for GFP-L10a construct; M. Coleman for Mito-GFP and RFP; and A. Sossick for OMX imaging. We are grateful to W. Harris and M. Agathocleous for many valuable discussions and M.-L. Baudet, J. Bixby, S. Bray, L. Leung, and A. Lin for critical reading of the manuscript. This work was supported by a Gates Cambridge Scholarship (B.C.Y.), Overseas Research Scholars Award (B.C.Y.), and Wellcome Trust Programme Grant (C.E.H..; grant 085314/Z/08/Z). B.C.Y. did experiments in Figures 1, 2, 3A, 3H, 3I, 4A-4C, 5, 6A-6H, 7D, 7E, S1, S2G, S2H, S3I, and S3J. H. J. did experiments in Figures 3D-3G, 4D-4F, 6I-6L, S3B-S3D, S3K, S4D, S4E, and S6B-S6H. A. D. did experiments in Figures 3J, 6L, 7A-7C, 7F-7I, S3L, S3M, S4A-S4C, S7A, an S7B. C.M.O. did experiments in Figure S7D and contributed to the writing. K.H.Z. did experiments in Figures 3B-3D and S3A. C.E.H. conceived and supervised the project. B.C.Y. designed proteomics experiments and identified LB2 and its LOF phenotypes. H.J. designed molecular biology, axon-TRAP, and LB2 Delta NLS experiments. H.J., B.C.Y., and C.E.H. wrote the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alvarez-Fischer D, 2011, NAT NEUROSCI, V14, P1260, DOI 10.1038/nn.2916; Andreassi C, 2010, NAT NEUROSCI, V13, P291, DOI 10.1038/nn.2486; Aschrafi A, 2010, MOL CELL NEUROSCI, V43, P422, DOI 10.1016/j.mcn.2010.01.009; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Busch A, 2009, EXP CELL RES, V315, P2373, DOI 10.1016/j.yexcr.2009.05.003; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; Fountoulakis M, 2002, ELECTROPHORESIS, V23, P311, DOI 10.1002/1522-2683(200202)23:2<311::AID-ELPS311>3.0.CO;2-0; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gioio AE, 2001, J NEUROSCI RES, V64, P447, DOI 10.1002/jnr.1096; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; HARRIS WA, 1987, DEVELOPMENT, V101, P123; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; HOLT CE, 1984, J NEUROSCI, V4, P1130; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Ikegami K, 2003, NEUROSCIENCE, V122, P617, DOI 10.1016/j.neuroscience.2003.08.057; Jing XT, 2009, DEVELOPMENT, V136, P2955, DOI 10.1242/dev.037739; Kaasik A, 2007, J BIOL CHEM, V282, P32821, DOI 10.1074/jbc.M702295200; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Lilley KS, 2002, CURR OPIN CHEM BIOL, V6, P46, DOI 10.1016/S1367-5931(01)00275-7; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; Simon DK, 1999, ANNU REV MED, V50, P111; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Su KG, 2009, CURR NEUROL NEUROSCI, V9, P411, DOI 10.1007/s11910-009-0060-3; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Taylor SW, 2002, J PROTEOME RES, V1, P451, DOI 10.1021/pr025533g; TOESCA A, 1992, CELL BIOL INT REP, V16, P165, DOI 10.1016/S0309-1651(06)80110-4; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Zhang QG, 2009, TRAFFIC, V10, P1337, DOI 10.1111/j.1600-0854.2009.00945.x; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	66	190	192	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					752	764		10.1016/j.cell.2011.11.064	http://dx.doi.org/10.1016/j.cell.2011.11.064			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341447	Green Published, hybrid			2022-12-28	WOS:000300622400016
J	Wiedenheft, B; Sternberg, SH; Doudna, JA				Wiedenheft, Blake; Sternberg, Samuel H.; Doudna, Jennifer A.			RNA-guided genetic silencing systems in bacteria and archaea	NATURE			English	Review							PROVIDES ACQUIRED-RESISTANCE; CRISPR RNA; IMMUNE-SYSTEM; TARGET RECOGNITION; ANTIVIRAL DEFENSE; ESCHERICHIA-COLI; STRUCTURAL BASIS; REPEATS CRISPRS; DNA; IDENTIFICATION	Clustered regularly interspaced short palindromic repeat (CRISPR) are essential components of nucleic-acid-based adaptive immune systems that are widespread in bacteria and archaea. Similar to RNA interference (RNAi) pathways in eukaryotes, CRISPR-mediated immune systems rely on small RNAs for sequence-specific detection and silencing of foreign nucleic acids, including viruses and plasmids. However, the mechanism of RNA-based bacterial immunity is distinct from RNAi. Understanding how small RNAs are used to find and destroy foreign nucleic acids will provide new insights into the diverse mechanisms of RNA-controlled genetic silencing systems.	[Wiedenheft, Blake; Doudna, Jennifer A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wiedenheft, Blake; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Sternberg, Samuel H.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Doudna, JA (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	doudna@berkeley.edu	Stern, David B/H-7852-2012	Sternberg, Samuel/0000-0001-8240-9114	National Science Foundation; National Defense Science & Engineering Graduate Research Fellowship programs	National Science Foundation(National Science Foundation (NSF)); National Defense Science & Engineering Graduate Research Fellowship programs	B.W. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. S. H. S. acknowledges support from the National Science Foundation and National Defense Science & Engineering Graduate Research Fellowship programs. J.A.D. is an Investigator of the Howard Hughes Medical Institute.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han D, 2009, FEBS LETT, V583, P1928, DOI 10.1016/j.febslet.2009.04.047; Han D, 2009, FEBS LETT, V583, P771, DOI 10.1016/j.febslet.2009.01.024; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hoskisson PA, 2007, CURR OPIN MICROBIOL, V10, P396, DOI 10.1016/j.mib.2007.04.003; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Manica A, 2011, MOL MICROBIOL, V80, P481, DOI 10.1111/j.1365-2958.2011.07586.x; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mokrousov Igor, 2007, Biotechnology Journal, V2, P901, DOI 10.1002/biot.200700035; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Snyder JC, 2010, APPL ENVIRON MICROB, V76, P7251, DOI 10.1128/AEM.01109-10; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	80	1203	1515	87	944	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					331	338		10.1038/nature10886	http://dx.doi.org/10.1038/nature10886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337052				2022-12-28	WOS:000300287100034
J	Burant, CF; Viswanathan, P; Marcinak, J; Cao, C; Vakilynejad, M; Xie, BH; Leifke, E				Burant, Charles F.; Viswanathan, Prabhakar; Marcinak, John; Cao, Charlie; Vakilynejad, Majid; Xie, Benhuai; Leifke, Eckhard			TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							PANCREATIC BETA-CELLS; INSULIN-SECRETION; GLUCOSE-TOLERANCE; FATTY-ACIDS; FASTING HYPERGLYCEMIA; GPR40; RECEPTOR; PROTEIN; IMPROVES; TARGETS	Background Activation of free fatty acid receptor 1 (FFAR1; also known as G-protein-coupled receptor 40) by fatty acids stimulated glucose-dependent beta-cell insulin secretion in preclinical models. We aimed to assess whether selective pharmacological activation of this receptor by TAK-875 in patients with type 2 diabetes mellitus improved glycaemic control without hypo glycaemia risk. Methods We undertook a phase 2, randomised, double-blind, and placebo-controlled and active-comparator-controlled trial in outpatients with type 2 diabetes who had not responded to diet or metformin treatment. Patients were randomly assigned equally to receive placebo, TAK-875 (6.25, 25, 50, 100, or 200 mg), or glimepiride (4 mg) once daily for 12 weeks. Patients and investigators were masked to treatment assignment. The primary outcome was change in haemoglobin A(1c) (HbA(1c)) from baseline. Analysis included all patients randomly assigned to treatment groups who received at least one dose of double-blind study drug. The trial is registered at ClinicalTrials.gov, NCT01007097. Findings 426 patients were randomly assigned to TAK-875 (n=303), placebo (n=61), and glimepiride (n=62). At week 12, significant least-squares mean reductions in HbA(1c) from baseline occurred in all TAK-875 (ranging from -1.12% [SE 0.113] with 50 mg to -0.65% [0.114] with 6.25 mg) and glimepiride (-1.05% [SE 0.111]) groups versus placebo (-0.13% [SE 0.115]; p value range 0.001 to < 0.0001). Treatment-emergent hypoglycaemic events were similar in the TAK-875 and placebo groups (2% [n=7, all TAK-875 groups] vs 3% [n=2]); significantly higher rates were reported in the glimepiride group (19% [n=12]; p value range 0.010-0.002 vs all TAK-875 groups). Incidence of treatment-emergent adverse events was similar in the TAK-875 overall (49%; n=147, all TAK-875 groups) and placebo groups (48%, n=29) and was lower than in the glimepiride group (61%, n=38). Interpretation TAK-875 significantly improved glycaemic control in patients with type 2 diabetes with minimum risk of hypoglycaemia. The results show that activation of FFAR1 is a viable therapeutic target for treatment of type 2 diabetes.	[Burant, Charles F.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48105 USA; [Viswanathan, Prabhakar; Marcinak, John; Cao, Charlie; Vakilynejad, Majid; Xie, Benhuai; Leifke, Eckhard] Takeda Global Res & Dev Ctr, Deerfield, IL USA	University of Michigan System; University of Michigan	Burant, CF (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48105 USA.	burantc@umich.edu	Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003	Takeda Global Research and Development; Takeda Global Research and Development (Deerfield, IL, USA)	Takeda Global Research and Development; Takeda Global Research and Development (Deerfield, IL, USA)	This study was sponsored by Takeda Global Research and Development (Deerfield, IL, USA). Editorial assistance and writing support was provided by Jane Phillips and Daniel McCallus of Complete Healthcare Communications (Chadds Ford, PA, USA) and by Brian G Shearer of Takeda Pharmaceuticals North America (Deerfield, IL, USA). Funding for this support was provided by Takeda Global Research and Development.	Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE401, DOI 10.1152/ajpendo.00674.2007; Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Alquier T, 2009, DIABETES, V58, P1035, DOI 10.2337/db09-0215; Barnett AH, 2010, INT J CLIN PRACT, V64, P1121, DOI 10.1111/j.1742-1241.2009.02332.x; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; DeFronzo RA, 2010, AM J MED, V123, pS38, DOI 10.1016/j.amjmed.2009.12.008; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Hidalgo MA, 2011, BIOCHEM BIOPH RES CO, V409, P280, DOI 10.1016/j.bbrc.2011.04.144; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Itoh Y, 2005, HEPATOL RES, V33, P171, DOI 10.1016/j.hepres.2005.09.028; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Leifke E, 2011, DIABETES, V60, pA114; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matsuno K, 2010, AM DIAB ASS 70 SCI S; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Naik H, 2012, J CLIN PHARMACOL, V52, P1007, DOI 10.1177/0091270011409230; Schmidt J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C110.200477; Shukla UA, 2004, ANN PHARMACOTHER, V38, P30, DOI 10.1345/aph.1C397; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Takeuchi K, 2010, DIABETOLOGIA S, V53, pS353; Tsujihata Y, 2010, DIABETES, V59, pA165; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Food & Drug Administration, 2009, GUID IND DRUG IND LI; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	27	202	207	0	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1403	1411		10.1016/S0140-6736(11)61879-5	http://dx.doi.org/10.1016/S0140-6736(11)61879-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926BR	22374408				2022-12-28	WOS:000302806800028
J	Guram, JS; Moffit, RE				Guram, Jeet S.; Moffit, Robert E.			The Medicare Advantage Success Story - Looking beyond the Cost Difference	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Guram, Jeet S.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Moffit, Robert E.] Heritage Fdn, Ctr Policy Innovat, Washington, DC 20002 USA	Harvard University; Harvard Medical School	Guram, JS (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.							Bayer E., 2010, INNOVATIONS REDUCING; Brennan N, 2010, AM J MANAG CARE, V16, P841; Feldman R, 2012, COMPETITIVE BIDDING; Medicare Payment Advisory Commission, 2011, REP C MED PAYM POL W; Pear R, 2011, NY TIMES        1214	5	9	9	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2012	366	13					1177	1179		10.1056/NEJMp1114019	http://dx.doi.org/10.1056/NEJMp1114019			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	915DW	22356263				2022-12-28	WOS:000302005100004
J	Gilman, RT; Nuismer, SL; Jhwueng, DC				Gilman, R. Tucker; Nuismer, Scott L.; Jhwueng, Dwueng-Chwuan			Coevolution in multidimensional trait space favours escape from parasites and pathogens	NATURE			English	Article							G-MATRIX; EVOLUTION; DIVERSITY; STABILITY; SELECTION; CONSTRAINTS; PARSNIP; HOSTS	Almost all species are subject to continuous attack by parasites and pathogens. Because parasites and pathogens tend to have shorter generation times(1,2) and often experience stronger selection due to interaction than their victims do(3,4), it is frequently argued that they should evolve more rapidly and thus maintain an advantage in the evolutionary race between defence and counter-defence(1,5). This prediction generates an apparent paradox: how do victim species survive and even thrive in the face of a continuous onslaught of more rapidly evolving enemies(5)? One potential explanation is that defence is physiologically, mechanically or behaviourally easier than attack, so that evolution is less constrained for victims than for parasites or pathogens(6). Another possible explanation is that parasites and pathogens have enemies themselves and that victim species persist because parasites and pathogens are regulated from the top down and thus generally have only modest demographic impacts on victimpopulations(7,8). Here we explore a third possibility: that victim species are not as evolutionarily impotent as conventional wisdom holds, but instead have unique evolutionary advantages that help to level the playing field. We use quantitative genetic analysis and individual-based simulations to show that victims can achieve such an advantage when coevolution involves multiple traits in both the host and the parasite.	[Gilman, R. Tucker; Jhwueng, Dwueng-Chwuan] Natl Inst Math & Biol Synth, Knoxville, TN 37916 USA; [Nuismer, Scott L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Nuismer, Scott L.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA	University of Tennessee System; University of Tennessee Knoxville; Idaho; University of Idaho; Idaho; University of Idaho	Gilman, RT (corresponding author), Natl Inst Math & Biol Synth, Knoxville, TN 37916 USA.	rtgilman@nimbios.org	Jhwueng, Dwueng-Chwuan/G-8238-2014; Gilman, R. Tucker/AAX-8512-2020	Jhwueng, Dwueng-Chwuan/0000-0001-5893-3645; 	National Science Foundation (NSF) [DMS 0540392, DEB 1118947]; US Department of Homeland Security; US Department of Agriculture through NSF [EF-0832858]; The University of Tennessee, Knoxville	National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Homeland Security(United States Department of Homeland Security (DHS)); US Department of Agriculture through NSF(National Science Foundation (NSF)); The University of Tennessee, Knoxville	We thank A. R. Ives and F. Debarre for comments. R. T. G. and D.C.J. are postdoctoral fellows at the National Institute for Mathematical and Biological Synthesis (NIMBioS). NIMBioS is sponsored by the National Science Foundation (NSF), the US Department of Homeland Security and the US Department of Agriculture through NSF award no. EF-0832858, with support from The University of Tennessee, Knoxville. Additional support for this research was provided by NSF grants DMS 0540392 and DEB 1118947 to S.L.N.	Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Agrawal AF, 2003, P ROY SOC B-BIOL SCI, V270, P323, DOI 10.1098/rspb.2002.2193; Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; BERENBAUM MR, 1986, EVOLUTION, V40, P1215, DOI 10.1111/j.1558-5646.1986.tb05746.x; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; FRANK SA, 1993, EVOLUTION, V47, P1721, DOI 10.2307/2410216; GOMEZ JM, 1994, ECOLOGY, V75, P1023, DOI 10.2307/1939426; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hochberg ME, 1997, OIKOS, V80, P342, DOI 10.2307/3546602; Jones AG, 2004, EVOLUTION, V58, P1639; Jones AG, 2003, EVOLUTION, V57, P1747; Jones SRM, 2001, DEV COMP IMMUNOL, V25, P841, DOI 10.1016/S0145-305X(01)00039-8; King KC, 2011, BIOL LETTERS, V7, P265, DOI 10.1098/rsbl.2010.0857; Kirkpatrick M, 2009, GENETICA, V136, P271, DOI 10.1007/s10709-008-9302-6; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Nuismer SL, 2008, J EVOLUTION BIOL, V21, P958, DOI 10.1111/j.1420-9101.2008.01551.x; Nuismer SL, 2005, EVOLUTION, V59, P2073; Page RDM, 1998, MOL PHYLOGENET EVOL, V9, P276, DOI 10.1006/mpev.1997.0458; Rasmann S, 2011, J ECOL, V99, P16, DOI 10.1111/j.1365-2745.2010.01713.x; THOMPSON JN, 1986, TRENDS ECOL EVOL, V1, P105, DOI 10.1016/0169-5347(86)90036-4; Toju H, 2011, AM NAT, V177, P562, DOI 10.1086/659624; VERMEIJ GJ, 1982, AM NAT, V120, P701, DOI 10.1086/284025; Zalucki MP, 2001, ECOL ENTOMOL, V26, P212, DOI 10.1046/j.1365-2311.2001.00313.x; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	29	58	58	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					328	330		10.1038/nature10853	http://dx.doi.org/10.1038/nature10853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22388815				2022-12-28	WOS:000301481800048
J	Chisholm, D; Baltussen, R; Evans, DB; Ginsberg, G; Lauer, JA; Lim, S; Ortegon, M; Salomon, J; Stanciole, A; Edejer, TTT				Chisholm, D.; Baltussen, R.; Evans, D. B.; Ginsberg, G.; Lauer, J. A.; Lim, S.; Ortegon, M.; Salomon, J.; Stanciole, A.; Edejer, T. Tan-Torres			What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS ANALYSIS; STRATEGIES; HEALTH		[Chisholm, D.; Evans, D. B.; Lauer, J. A.; Edejer, T. Tan-Torres] World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland; [Baltussen, R.] Radboud Univ Nijmegen, Dept Primary & Community Care, Nijmegen, Netherlands; [Ginsberg, G.] Minist Hlth, Dept Med Technol Assessment, Jerusalem, Israel; [Lim, S.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Ortegon, M.] Univ Rosario, Sch Med, Bogota, Colombia; [Salomon, J.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Stanciole, A.] World Bank, Washington, DC 20433 USA	World Health Organization; Radboud University Nijmegen; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Universidad del Rosario; Harvard University; Harvard T.H. Chan School of Public Health; The World Bank	Chisholm, D (corresponding author), World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland.	chisholmd@who.int	Baltussen, R.M.P.M./L-4181-2015; Salomon, Joshua/S-1929-2019	Salomon, Joshua/0000-0003-3929-5515; Ginsberg, Gary/0000-0003-1315-890X; Edejer, Tessa/0000-0003-1068-332X				Baltussen R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e615; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e612; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Gureje O, 2007, WORLD PSYCHIATRY, V6, P42; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Lai T, 2007, HEALTH POLICY, V84, P75, DOI 10.1016/j.healthpol.2007.02.012; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Stanciole AE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e608; *UN, 2001, DECL COMM HIV AIDS; United Nations, 2011, POL DECL HIGH LEV M; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2008, GLOB BURD DIS 2004 U	21	23	23	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e586	10.1136/bmj.e586	http://dx.doi.org/10.1136/bmj.e586			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389336	Green Accepted			2022-12-28	WOS:000301232600012
J	Hughes, JF; Skaletsky, H; Brown, LG; Pyntikova, T; Graves, T; Fulton, RS; Dugan, S; Ding, Y; Buhay, CJ; Kremitzki, C; Wang, QY; Shen, H; Holder, M; Villasana, D; Nazareth, LV; Cree, A; Courtney, L; Veizer, J; Kotkiewicz, H; Cho, TJ; Koutseva, N; Rozen, S; Muzny, DM; Warren, WC; Gibbs, RA; Wilson, RK; Page, DC				Hughes, Jennifer F.; Skaletsky, Helen; Brown, Laura G.; Pyntikova, Tatyana; Graves, Tina; Fulton, Robert S.; Dugan, Shannon; Ding, Yan; Buhay, Christian J.; Kremitzki, Colin; Wang, Qiaoyan; Shen, Hua; Holder, Michael; Villasana, Donna; Nazareth, Lynne V.; Cree, Andrew; Courtney, Laura; Veizer, Joelle; Kotkiewicz, Holland; Cho, Ting-Jan; Koutseva, Natalia; Rozen, Steve; Muzny, Donna M.; Warren, Wesley C.; Gibbs, Richard A.; Wilson, Richard K.; Page, David C.			Strict evolutionary conservation followed rapid gene loss on human and rhesus Y chromosomes	NATURE			English	Article							HUMAN X-CHROMOSOME; SEX-CHROMOSOMES; DEGENERATION; SEQUENCE; GENOME; PROTEINS; PRIMATES; WEIGHT	The human X and Y chromosomes evolved from an ordinary pair of autosomes during the past 200-300 million years(1-3). The human MSY (male-specific region of Y chromosome) retains only three percent of the ancestral autosomes' genes owing to genetic decay(4,5). This evolutionary decay was driven by a series of five 'stratification' events. Each event suppressed X-Y crossing over within a chromosome segment or 'stratum', incorporated that segment into the MSY and subjected its genes to the erosive forces that attend the absence of crossing over(2,6). The last of these events occurred 30 million years ago, 5 million years before the human and Old World monkey lineages diverged. Although speculation abounds regarding ongoing decay and looming extinction of the human Y chromosome(7-10), remarkably little is known about how many MSY genes were lost in the human lineage in the 25 million years that have followed its separation from the Old World monkey lineage. To investigate this question, we sequenced the MSY of the rhesus macaque, an Old World monkey, and compared it to the human MSY. We discovered that during the last 25 million years MSY gene loss in the human lineage was limited to the youngest stratum (stratum 5), which comprises three percent of the human MSY. In the older strata, which collectively comprise the bulk of the human MSY, gene loss evidently ceased more than 25 million years ago. Likewise, the rhesus MSY has not lost any older genes (from strata 1-4) during the past 25 million years, despite its major structural differences to the human MSY. The rhesus MSY is simpler, with few amplified gene families or palindromes that might enable intrachromosomal recombination and repair. We present an empirical reconstruction of human MSY evolution in which each stratum transitioned from rapid, exponential loss of ancestral genes to strict conservation through purifying selection.	[Hughes, Jennifer F.; Skaletsky, Helen; Brown, Laura G.; Pyntikova, Tatyana; Cho, Ting-Jan; Koutseva, Natalia; Rozen, Steve; Page, David C.] MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; [Hughes, Jennifer F.; Skaletsky, Helen; Brown, Laura G.; Pyntikova, Tatyana; Cho, Ting-Jan; Koutseva, Natalia; Rozen, Steve; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Graves, Tina; Fulton, Robert S.; Kremitzki, Colin; Courtney, Laura; Veizer, Joelle; Kotkiewicz, Holland; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Dugan, Shannon; Ding, Yan; Buhay, Christian J.; Wang, Qiaoyan; Shen, Hua; Holder, Michael; Villasana, Donna; Nazareth, Lynne V.; Cree, Andrew; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Baylor College of Medicine	Hughes, JF (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jhughes@wi.mit.edu	Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; Rozen, Steven G./0000-0002-4288-0056; Kremitzki, Colin/0000-0001-9175-3136	National Institutes of Health; Howard Hughes Medical Institute; Charles A. King Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257, U54HG003273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Charles A. King Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank V. Frazzoni, G. Rogers and S. Zaghlul for technical assistance; L. Lyons, W. Murphy and J. Womack for radiation hybrid panels; W. Johnson, E. Curran, S. O'Neil and A. Kaur for tissue samples; R. Harris for analyses of rhesus-human genome alignments; T. DiCesare for assistance with figures; and D. Bellott, M. Carmell, R. Desgraz, Y. Hu, B. Lesch, J. Mueller, K. Romer and S. Soh for comments on the manuscript. This work was supported by the National Institutes of Health, the Howard Hughes Medical Institute and the Charles A. King Trust.	Aitken RJ, 2002, NATURE, V415, P963, DOI 10.1038/415963a; Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Craves JAM, 2008, ANNU REV GENET, V42, P565, DOI 10.1146/annurev.genet.42.110807.091714; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 2006, CURR OPIN GENET DEV, V16, P219, DOI 10.1016/j.gde.2006.04.007; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Karere GM, 2008, GENOMICS, V92, P210, DOI 10.1016/j.ygeno.2008.05.013; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lahn BT, 2000, HUM MOL GENET, V9, P311, DOI 10.1093/hmg/9.2.311; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; RICE WR, 1987, GENETICS, V116, P161; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Schultz AH, 1938, ANAT REC, V72, P387, DOI 10.1002/ar.1090720310; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Slonim D, 1997, J COMPUT BIOL, V4, P487, DOI 10.1089/cmb.1997.4.487; Sykes B, 2004, ADAMS CURSE	30	176	179	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					82	U124		10.1038/nature10843	http://dx.doi.org/10.1038/nature10843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22367542	Green Submitted, Green Accepted			2022-12-28	WOS:000300877900049
J	Jeyaraj, D; Haldar, SM; Wan, XP; McCauley, MD; Ripperger, JA; Hu, K; Lu, Y; Eapen, BL; Sharma, N; Ficker, E; Cutler, MJ; Gulick, J; Sanbe, A; Robbins, J; Demolombe, S; Kondratov, RV; Shea, SA; Albrecht, U; Wehrens, XHT; Rosenbaum, DS; Jain, MK				Jeyaraj, Darwin; Haldar, Saptarsi M.; Wan, Xiaoping; McCauley, Mark D.; Ripperger, Juergen A.; Hu, Kun; Lu, Yuan; Eapen, Betty L.; Sharma, Nikunj; Ficker, Eckhard; Cutler, Michael J.; Gulick, James; Sanbe, Atsushi; Robbins, Jeffrey; Demolombe, Sophie; Kondratov, Roman V.; Shea, Steven A.; Albrecht, Urs; Wehrens, Xander H. T.; Rosenbaum, David S.; Jain, Mukesh K.			Circadian rhythms govern cardiac repolarization and arrhythmogenesis	NATURE			English	Article							QT SYNDROME; I-TO; HYPERTROPHY; EXPRESSION; INTERVAL; MAMMALS; DISEASE; DEATH	Sudden cardiac death exhibits diurnal variation in both acquired and hereditary forms of heart disease(1,2), but the molecular basis of this variation is unknown. A common mechanism that underlies susceptibility to ventricular arrhythmias is abnormalities in the duration (for example, short or long QT syndromes and heart failure)(3-5) or pattern (for example, Brugada's syndrome)(6) of myocardial repolarization. Here we provide molecular evidence that links circadian rhythms to vulnerability in ventricular arrhythmias in mice. Specifically, we show that cardiac ion-channel expression and QT-interval duration (an index of myocardial repolarization) exhibit endogenous circadian rhythmicity under the control of a clock-dependent oscillator, kruppel-like factor 15 (Klf15). Klf15 transcriptionally controls rhythmic expression of Kv channel-interacting protein 2 (KChIP2), a critical subunit required for generating the transient outward potassium current(7). Deficiency or excess of Klf15 causes loss of rhythmic QT variation, abnormal repolarization and enhanced susceptibility to ventricular arrhythmias. These findings identify circadian transcription of ion channels as a mechanism for cardiac arrhythmogenesis.	[Jeyaraj, Darwin; Haldar, Saptarsi M.; Lu, Yuan; Eapen, Betty L.; Sharma, Nikunj; Jain, Mukesh K.] Case Western Reserve Univ, Case Cardiovasc Res Inst, Harrington Heart & Vasc Inst, Dept Med,Sch Med, Cleveland, OH 44106 USA; [Jeyaraj, Darwin; Wan, Xiaoping; Ficker, Eckhard; Cutler, Michael J.; Rosenbaum, David S.] Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44109 USA; [McCauley, Mark D.; Wehrens, Xander H. T.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [McCauley, Mark D.; Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Ripperger, Juergen A.; Albrecht, Urs] Univ Fribourg, Div Biochem, Dept Med, CH-1700 Fribourg, Switzerland; [Hu, Kun; Shea, Steven A.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Hu, Kun; Shea, Steven A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gulick, James; Sanbe, Atsushi; Robbins, Jeffrey] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; [Demolombe, Sophie] Univ Nice Sophia Antipolis, UMR CNRS 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Kondratov, Roman V.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Kondratov, Roman V.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	Case Western Reserve University; Case Western Reserve University; Baylor College of Medicine; Baylor College of Medicine; University of Fribourg; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Cincinnati Children's Hospital Medical Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Jeyaraj, D (corresponding author), Case Western Reserve Univ, Case Cardiovasc Res Inst, Harrington Heart & Vasc Inst, Dept Med,Sch Med, Cleveland, OH 44106 USA.	darwinjeyaraj@gmail.com; mukesh.jain2@case.edu	Wehrens, Xander/AAQ-9574-2020; Albrecht, Urs/A-9831-2011; McCauley, Mark/AFQ-7490-2022; Hu, Kun/AAJ-1897-2020; Hu, Kun/GVS-8580-2022	Wehrens, Xander/0000-0001-5044-672X; Albrecht, Urs/0000-0002-0663-8676; McCauley, Mark/0000-0003-2743-2113; Hu, Kun/0000-0003-0350-3132; Kondratov, Roman/0000-0003-3449-745X; Shea, Steven/0000-0003-1949-0954	Heart RhythmSociety Fellowship; National Institutes of Health [HL094660, HL066991, HL086614]; American Heart Association [HL089598, HL091947, HL76446, HL102241, HL054807, HL075427, HL076754, HL084154, HL086548, HL097595]; Swiss National Science Foundation [31003A/131086, M01-RR02635]; Leducq Foundation of the ENAFRA Network [07CVD03]; Centre National de la Recherche Scientifique; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089598, K24HL076446, T32HL066991, R01HL091947, R01HL054807, R01HL084154, R00HL102241, R01HL097593, R29HL054807, R01HL110630, K99HL102241, R01HL076754, R01HL075427, R01HL086548, K08HL094660, K08HL086614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039547] Funding Source: NIH RePORTER	Heart RhythmSociety Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leducq Foundation of the ENAFRA Network(Leducq Foundation); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. F. Connors Jr for support, M. Mustar for illustrations, Y. Cui for experimental assistance, and members of the Jain laboratory for discussions. Funding sources: Heart RhythmSociety Fellowship (D.J.); National Institutes of Health grants HL094660 (D.J.), HL066991 (M.D.M.), HL086614 (S.M.H.), American Heart Association postdoctoral grant (N.S.), HL089598, HL091947 (X.H.W.), HL76446 (S.A.S.), HL102241 (K.H.), HL054807 (D.S.R.), HL075427, HL076754, HL084154, HL086548 and HL097595 (M.K.J.); Swiss National Science Foundation grants 31003A/131086 (U.A.) and M01-RR02635 (B.W.H.); Leducq Foundation grants of the ENAFRA Network 07CVD03 (S.D.); and the Centre National de la Recherche Scientifique (S.D.).	Antzelevitch C, 2007, AM J PHYSIOL-HEART C, V293, pH2024, DOI 10.1152/ajpheart.00355.2007; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; BEXTON RS, 1986, BRIT HEART J, V55, P253; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Fisch S, 2007, P NATL ACAD SCI USA, V104, P13851, DOI 10.1073/pnas.0706717104; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Hu K, 2011, CIRCULATION, V123, P961, DOI 10.1161/CIRCULATIONAHA.110.943019; KONG TQ, 1995, CIRCULATION, V92, P1507, DOI 10.1161/01.CIR.92.6.1507; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Libbus I, 2004, AM J PHYSIOL-HEART C, V286, pH1901, DOI 10.1152/ajpheart.00581.2003; Martino TA, 2009, CIRC RES, V105, P1047, DOI 10.1161/CIRCRESAHA.109.206201; Matsuo K, 1999, EUR HEART J, V20, P465, DOI 10.1053/euhj.1998.1332; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; MULLER JE, 1987, CIRCULATION, V75, P131, DOI 10.1161/01.CIR.75.1.131; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Paschos GK, 2010, CIRC RES, V106, P833, DOI 10.1161/CIRCRESAHA.109.211706; Patel U, 2009, CARDIOL REV, V17, P300, DOI 10.1097/CRD.0b013e3181c07592; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Tuteja G, 2008, NUCLEIC ACIDS RES, V36, P4149, DOI 10.1093/nar/gkn366; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Wagner S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P285, DOI 10.1161/CIRCEP.108.842799; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Yamashita T, 2003, CIRCULATION, V107, P1917, DOI 10.1161/01.CIR.0000058752.79734.F0	29	241	252	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					96	U141		10.1038/nature10852	http://dx.doi.org/10.1038/nature10852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22367544	Green Submitted, Green Accepted			2022-12-28	WOS:000300877900052
J	Sterzik, MF; Bagnulo, S; Palle, E				Sterzik, Michael F.; Bagnulo, Stefano; Palle, Enric			Biosignatures as revealed by spectropolarimetry of Earthshine	NATURE			English	Article							EXTRASOLAR PLANETS; VEGETATION SIGNATURE; POLARIZATION; SPECTRUM; SEARCH; ATMOSPHERES; SKYLIGHT; CLOUDS; LIFE	Low-resolution intensity spectra of Earth's atmosphere obtained from space reveal strong signatures of life ('biosignatures'), such as molecular oxygen and methane with abundances far from chemical equilibrium, as well as the presence of a 'red edge' (a sharp increase of albedo for wavelengths longer than 700 nm) caused by surface vegetation(1). Light passing through the atmosphere is strongly linearly polarized by scattering (from air molecules, aerosols and cloud particles) and by reflection (from oceans and land(2)). Spectropolarimetric observations of local patches of Earth's sky light from the ground contain signatures of oxygen, ozone and water, and are used to characterize the properties of clouds and aerosols(3,4). When applied to exoplanets, ground-based spectropolarimetry can better constrain properties of atmospheres and surfaces than can standard intensity spectroscopy(5-9). Here we report disk-integrated linear polarization spectra of Earthshine, which is sunlight that has been first reflected by Earth and then reflected back to Earth by the Moon(10-13). The observations allow us to determine the fractional contribution of clouds and ocean surface, and are sensitive to visible areas of vegetation as small as 10 per cent. They represent a benchmark for the diagnostics of the atmospheric composition, mean cloud height and surfaces of exoplanets.	[Sterzik, Michael F.] European So Observ, Santiago, Chile; [Bagnulo, Stefano] Armagh Observ, Armagh BT61 9DG, North Ireland; [Palle, Enric] Inst Astrofis Canarias, E-38205 Tenerife, Spain	European Southern Observatory; Instituto de Astrofisica de Canarias	Sterzik, MF (corresponding author), European So Observ, Alonso de Cordova 3107, Santiago, Chile.	msterzik@eso.org	Palle, Enric/AAE-4492-2019	Sterzik, Michael F./0000-0002-5784-4437; Palle, Enric/0000-0003-0987-1593	Spanish MICIIN [CGL2009-10641]	Spanish MICIIN(Spanish Government)	This Letter is based on data collected with the Very Large Telescope under ESO programme 87.C-0040(A) and (B). E.P. acknowledges support from the Spanish MICIIN, grant CGL2009-10641.	Aben I, 1999, GEOPHYS RES LETT, V26, P591, DOI 10.1029/1999GL900025; Appenzeller I., 1998, ESO MESSENGER, V94, P1; Arnold L, 2002, ASTRON ASTROPHYS, V392, P231, DOI 10.1051/0004-6361:20020933; Bailey J, 2007, ASTROBIOLOGY, V7, P320, DOI 10.1089/ast.2006.0039; Boesche E, 2008, APPL OPTICS, V47, P3467, DOI 10.1364/AO.47.003467; Buenzli E, 2009, ASTRON ASTROPHYS, V504, P259, DOI 10.1051/0004-6361/200911760; COFFEEN DL, 1979, J OPT SOC AM, V69, P1051, DOI 10.1364/JOSA.69.001051; Dollfus A., 1957, ANN ASTROPHYSIQUE S, V4, P3; Fox GK, 1998, MON NOT R ASTRON SOC, V298, P303, DOI 10.1046/j.1365-8711.1998.01633.x; GOLOUB P, 1994, IEEE T GEOSCI REMOTE, V32, P78, DOI 10.1109/36.285191; Karalidi T, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116449; Keller C. U, 2010, P SOC PHOTO-OPT INS, V7735; Kokhanovsky AA, 2011, PHYS EARTH SPACE ENV, P231, DOI 10.1007/978-3-642-14791-3_5; Montanes-Rodriguez P, 2006, ASTROPHYS J, V651, P544, DOI 10.1086/507694; Palle E, 2009, NATURE, V459, P814, DOI 10.1038/nature08050; SAGAN C, 1993, NATURE, V365, P715, DOI 10.1038/365715a0; Seager S, 2005, ASTROBIOLOGY, V5, P372, DOI 10.1089/ast.2005.5.372; Shkuratov Y, 2011, PLANET SPACE SCI, V59, P1326, DOI 10.1016/j.pss.2011.06.011; Stam DM, 2008, ASTRON ASTROPHYS, V482, P989, DOI 10.1051/0004-6361:20078358; Tinetti G, 2006, ASTROBIOLOGY, V6, P881, DOI 10.1089/ast.2006.6.881; Williams DM, 2008, ICARUS, V195, P927, DOI 10.1016/j.icarus.2008.01.002; Wolstencroft RD, 2005, ASTR SOC P, V343, P211; Woolf NJ, 2002, ASTROPHYS J, V574, P430, DOI 10.1086/340929	23	75	75	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					64	66		10.1038/nature10778	http://dx.doi.org/10.1038/nature10778			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22382980				2022-12-28	WOS:000300877900044
J	Verstovsek, S; Mesa, RA; Gotlib, J; Levy, RS; Gupta, V; DiPersio, JF; Catalano, JV; Deininger, M; Miller, C; Silver, RT; Talpaz, M; Winton, EF; Harvey, JH; Arcasoy, MO; Hexner, E; Lyons, RM; Paquette, R; Raza, A; Vaddi, K; Erickson-Viitanen, S; Koumenis, IL; Sun, W; Sandor, V; Kantarjian, HM				Verstovsek, Srdan; Mesa, Ruben A.; Gotlib, Jason; Levy, Richard S.; Gupta, Vikas; DiPersio, John F.; Catalano, John V.; Deininger, Michael; Miller, Carole; Silver, Richard T.; Talpaz, Moshe; Winton, Elliott F.; Harvey, Jimmie H., Jr.; Arcasoy, Murat O.; Hexner, Elizabeth; Lyons, Roger M.; Paquette, Ronald; Raza, Azra; Vaddi, Kris; Erickson-Viitanen, Susan; Koumenis, Iphigenia L.; Sun, William; Sandor, Victor; Kantarjian, Hagop M.			A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL-WORKING-GROUP; JAK2 INHIBITOR; INCB018424; CRITERIA; VOLUME	BACKGROUND Ruxolitinib, a selective inhibitor of Janus kinase (JAK) 1 and 2, has clinically significant activity in myelofibrosis. METHODS In this double-blind trial, we randomly assigned patients with intermediate-2 or high-risk myelofibrosis to twice-daily oral ruxolitinib (155 patients) or placebo (154 patients). The primary end point was the proportion of patients with a reduction in spleen volume of 35% or more at 24 weeks, assessed by means of magnetic resonance imaging. Secondary end points included the durability of response, changes in symptom burden (assessed by the total symptom score), and overall survival. RESULTS The primary end point was reached in 41.9% of patients in the ruxolitinib group as compared with 0.7% in the placebo group (P<0.001). A reduction in spleen volume was maintained in patients who received ruxolitinib; 67.0% of the patients with a response had the response for 48 weeks or more. There was an improvement of 50% or more in the total symptom score at 24 weeks in 45.9% of patients who received ruxolitinib as compared with 5.3% of patients who received placebo (P<0.001). Thirteen deaths occurred in the ruxolitinib group as compared with 24 deaths in the placebo group (hazard ratio, 0.50; 95% confidence interval, 0.25 to 0.98; P=0.04). The rate of discontinuation of the study drug because of adverse events was 11.0% in the ruxolitinib group and 10.6% in the placebo group. Among patients who received ruxolitinib, anemia and thrombocytopenia were the most common adverse events, but they rarely led to discontinuation of the drug (in one patient for each event). Two patients had transformation to acute myeloid leukemia; both were in the ruxolitinib group. CONCLUSIONS Ruxolitinib, as compared with placebo, provided significant clinical benefits in patients with myelofibrosis by reducing spleen size, ameliorating debilitating myelofibrosis-related symptoms, and improving overall survival. These benefits came at the cost of more frequent anemia and thrombocytopenia in the early part of the treatment period. (Funded by Incyte; COMFORT-I ClinicalTrials.gov number, NCT00952289.)	[Verstovsek, Srdan] Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Unit 428, Houston, TX 77030 USA; [Mesa, Ruben A.] Mayo Clin, Scottsdale, AZ USA; [Gotlib, Jason] Stanford Canc Inst, Stanford, CA USA; [Levy, Richard S.; Vaddi, Kris; Erickson-Viitanen, Susan; Koumenis, Iphigenia L.; Sun, William; Sandor, Victor] Incyte, Wilmington, DE USA; [Gupta, Vikas] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; [DiPersio, John F.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Catalano, John V.] Monash Univ, Frankston, Vic, Australia; [Catalano, John V.] Frankston Hosp, Frankston, Vic, Australia; [Deininger, Michael] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Deininger, Michael] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Miller, Carole] St Agnes Canc Inst, Baltimore, MD USA; [Silver, Richard T.] Weill Cornell Med Ctr, New York, NY USA; [Raza, Azra] Columbia Presbyterian Med Ctr, New York, NY 10032 USA; [Talpaz, Moshe] Univ Michigan, Ann Arbor, MI 48109 USA; [Winton, Elliott F.] Emory Univ, Sch Med, Atlanta, GA USA; [Harvey, Jimmie H., Jr.] Birmingham Hematol & Oncol, Birmingham, AL USA; [Arcasoy, Murat O.] Duke Univ Hlth Syst, Durham, NC USA; [Hexner, Elizabeth] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Lyons, Roger M.] Canc Care Ctr S Texas & US Oncol, San Antonio, TX USA; [Paquette, Ronald] Univ Calif Los Angeles, Div Hematol & Oncol, Los Angeles, CA USA	University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Mayo Clinic Phoenix; Stanford Cancer Institute; Incyte; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Washington University (WUSTL); Monash University; Frankston Hospital; Oregon Health & Science University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Cornell University; Columbia University; NewYork-Presbyterian Hospital; University of Michigan System; University of Michigan; Emory University; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles	Verstovsek, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Unit 428, 1515 Holcombe Blvd, Houston, TX 77030 USA.	sverstov@mdanderson.org	Hug, Balthasar L./G-1568-2010; Silver MD, Richard T/GRE-5925-2022; Hexner, Elizabeth/AAC-1442-2020	Hexner, Elizabeth/0000-0002-1125-4060; Gupta, Vikas/0000-0002-1419-8607; Verstovsek, MD, PhD, Professor of Medicine, Srdan/0000-0002-6912-8569; Talpaz, Moshe/0000-0003-3361-3981	Incyte; Exelixis; Celgene; NS Pharma; Infinity Pharmaceuticals; SBIO; Lilly Oncology; AstraZeneca; Geron; Bristol-Myers Squibb; YM BioSciences; Gilead; Roche; Novartis; Ariad; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Incyte; Exelixis; Celgene(Bristol-Myers SquibbCelgene Corporation); NS Pharma; Infinity Pharmaceuticals; SBIO; Lilly Oncology; AstraZeneca(AstraZeneca); Geron; Bristol-Myers Squibb(Bristol-Myers Squibb); YM BioSciences; Gilead(Gilead Sciences); Roche(Roche Holding); Novartis(Novartis); Ariad; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Verstovsek reports receiving grant support through his institution from Incyte, Exelixis, Celgene, NS Pharma, Infinity Pharmaceuticals, SBIO, Lilly Oncology, AstraZeneca, Geron, Bristol-Myers Squibb, YM BioSciences, Gilead, and Roche; Dr. Levy, being an employee of Incyte and receiving stock options as part of his compensation; Dr. Gupta, receiving grant support through his institution from Incyte and Novartis, consulting fees from Incyte and Novartis, and lecture fees from Novartis; Dr. Catalano, receiving consulting fees from Incyte; Dr. Deininger, receiving consulting fees from Bristol-Myers Squibb, Novartis, and Ariad, and grant support through his institution from Bristol-Myers Squibb; Dr. Miller, receiving grant support through her institution, consulting fees, and lecture fees from Novartis, and payments for development of educational presentations from Incyte and Novartis; Dr. Silver, receiving grant support through his institution from Incyte and lecture fees from Incyte, and holding stock in Incyte both individually and through his institution; Dr. Lyons, receiving grant support through his institution from Incyte; Dr. Paquette, receiving consulting fees paid through his institution from Incyte; Dr. Vaddi, being an employee of Incyte and receiving stock or stock options as a part of his compensation; Dr. Erickson-Viitanen, being an employee of Incyte and receiving stock or stock options as part of her compensation; Dr. Sun, being an employee of Incyte and receiving stock options as part of his compensation; Dr. Sandor, being an employee of Incyte and receiving stock or stock options as part of his compensation; and Dr. Kantarjian, receiving grant support through his institution from Incyte. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM. org.	Abdel-Wahab OI, 2009, ANNU REV MED, V60, P233, DOI 10.1146/annurev.med.60.041707.160528; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; Delhhommeau F, 2010, INT J HEMATOL, V91, P165, DOI 10.1007/s12185-010-0530-z; Harris A, 2010, EUR J RADIOL, V75, pE97, DOI 10.1016/j.ejrad.2009.08.013; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Mazonakis M, 2000, EUR RADIOL, V10, P1899, DOI 10.1007/s003300000551; Mesa RA, 2009, BLOOD, V114, P3917; Mesa RA, 2011, CANCER-AM CANCER SOC, V117, P4869, DOI 10.1002/cncr.26129; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Prassopoulos P, 1997, EUR RADIOL, V7, P246, DOI 10.1007/s003300050145; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2006, BLOOD, V108, P1497, DOI 10.1182/blood-2006-03-009746; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Vainchenker W, 2008, SEMIN CELL DEV BIOL, V19, P385, DOI 10.1016/j.semcdb.2008.07.002; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028	16	1327	1381	5	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					799	807		10.1056/NEJMoa1110557	http://dx.doi.org/10.1056/NEJMoa1110557			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900GI	22375971	Green Accepted			2022-12-28	WOS:000300874300006
J	Adler, M				Adler, Michael			How a Neurotoxin Survives	SCIENCE			English	Editorial Material							BOTULINUM NEUROTOXIN		USA, Med Res Inst Chem Def, Neurobehav Toxicol Branch, Analyt Toxicol Div, Aberdeen Proving Ground, MD 21010 USA	Research Institute of Chemical Defense - China	Adler, M (corresponding author), USA, Med Res Inst Chem Def, Neurobehav Toxicol Branch, Analyt Toxicol Div, 3100 Ricketts Point Rd, Aberdeen Proving Ground, MD 21010 USA.	michael.adler2@us.army.mil			NIAID NIH HHS [R01 AI091823] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091823] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen F, 1997, INFECT IMMUN, V65, P1626, DOI 10.1128/IAI.65.5.1626-1630.1997; Cheng LW, 2008, TOXICOLOGY, V249, P123, DOI 10.1016/j.tox.2008.04.018; Eisele KH, 2011, TOXICON, V57, P555, DOI 10.1016/j.toxicon.2010.12.019; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Maksymowych AB, 1999, INFECT IMMUN, V67, P4708, DOI 10.1128/IAI.67.9.4708-4712.1999; Sharma SK, 1998, J NAT TOXINS, V7, P239; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507	8	5	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					928	929		10.1126/science.1219602	http://dx.doi.org/10.1126/science.1219602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22362997	Green Accepted			2022-12-28	WOS:000300931800033
J	Loehlin, DW; Werren, JH				Loehlin, David W.; Werren, John H.			Evolution of Shape by Multiple Regulatory Changes to a Growth Gene	SCIENCE			English	Article							WING SIZE; DROSOPHILA; NASONIA; INSIGHTS; PATHWAY; MANNER	The genetic changes responsible for morphological differences between species are largely unidentified. Such changes can involve modifications of growth that are relevant to understanding evolution, development, and disease. We identified a gene that induces male-specific wing size and shape differences between Nasonia wasp species. Fine-scale mapping and in situ hybridization reveal that changes in at least three regions (two strictly in noncoding sequence) around the gene unpaired-like (upd-like) cause changes in spatial and temporal expression of upd-like in the developing wing and corresponding changes in wing width. Upd-like shows homology to the Drosophila unpaired gene, a well-studied signaling protein that regulates cell proliferation and differentiation. Our results indicate how multiple changes in the regulation of upd-like are involved in microevolution of morphological and sex-specific differences between species.	[Loehlin, David W.; Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Loehlin, DW (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	loehlin@wisc.edu; werr@mail.rochester.edu		Werren, John/0000-0001-9353-2070	NSF [DEB-0910017]; NIH [5R01 GM070026-04, 5R24 GM084917-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070026, R24GM084917] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Gu and J. Sysol for volunteer assistance with mapping; M. Rosenberg for sharing the Nasonia wingless plasmid; and H. Jasper, J. D. Lambert, M. Welte, D. Stern, D. Presgraves, D. Wheeler, R. Edwards, A. Avery, and M. Clark for advice and technical assistance. This work was supported by NSF Doctoral Dissertation Improvement Grant DEB-0910017 to D.W.L. and NIH grants 5R01 GM070026-04 and 5R24 GM084917-04 to J.H.W. Sequences are deposited at GenBank with accessions JQ082366 to JQ082369.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; [Anonymous], 1861, ORIGIN SPECIES MEANS; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Galilei G., 1914, DIALOGUES 2 NEW SCI; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; Loehlin DW, 2010, HEREDITY, V104, P260, DOI 10.1038/hdy.2009.146; Loehlin DW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000821; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; McKechnie SW, 2010, MOL ECOL, V19, P775, DOI 10.1111/j.1365-294X.2009.04509.x; Mukherjee T, 2005, ONCOGENE, V24, P2503, DOI 10.1038/sj.onc.1208487; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Raychoudhury R, 2010, HEREDITY, V104, P278, DOI 10.1038/hdy.2009.147; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Wasik BR, 2010, EVOL DEV, V12, P353, DOI 10.1111/j.1525-142X.2010.00422.x; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896; Werren J. H., 2009, EMERGING MODEL ORGAN, V2, P267; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Weston RF, 1999, J EVOLUTION BIOL, V12, P586, DOI 10.1046/j.1420-9101.1999.00048.x	27	52	52	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					943	947		10.1126/science.1215193	http://dx.doi.org/10.1126/science.1215193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363002	Green Accepted			2022-12-28	WOS:000300931800039
J	Yoon, SI; Kurnasov, O; Natarajan, V; Hong, MS; Gudkov, AV; Osterman, AL; Wilson, IA				Yoon, Sung-il; Kurnasov, Oleg; Natarajan, Venkatesh; Hong, Minsun; Gudkov, Andrei V.; Osterman, Andrei L.; Wilson, Ian A.			Structural Basis of TLR5-Flagellin Recognition and Signaling	SCIENCE			English	Article							INNATE IMMUNE-RESPONSE; BACTERIAL FLAGELLIN; CRYSTAL-STRUCTURE; TOLL-LIKE-RECEPTOR-5; PROTOFILAMENT; SURFACE; MOUSE	Toll-like receptor 5 (TLR5) binding to bacterial flagellin activates signaling through the transcription factor NF-kappa B and triggers an innate immune response to the invading pathogen. To elucidate the structural basis and mechanistic implications of TLR5-flagellin recognition, we determined the crystal structure of zebrafish TLR5 (as a variable lymphocyte receptor hybrid protein) in complex with the D1/D2/D3 fragment of Salmonella flagellin, FliC, at 2.47 angstrom resolution. TLR5 interacts primarily with the three helices of the FliC D1 domain using its lateral side. Two TLR5-FliC 1: 1 heterodimers assemble into a 2: 2 tail-to-tail signaling complex that is stabilized by quaternary contacts of the FliC D1 domain with the convex surface of the opposing TLR5. The proposed signaling mechanism is supported by structure-guided mutagenesis and deletion analyses on CBLB502, a therapeutic protein derived from FliC.	[Kurnasov, Oleg; Osterman, Andrei L.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Yoon, Sung-il; Hong, Minsun; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Natarajan, Venkatesh; Gudkov, Andrei V.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Gudkov, Andrei V.] Cleveland BioLabs Inc, Buffalo, NY 14203 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; Roswell Park Cancer Institute; Scripps Research Institute	Osterman, AL (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	osterman@sanfordburnham.org; wilson@scripps.edu		Gudkov, Andrei/0000-0003-2548-0154	NIH [AI042266, R01 AI080446, RC2 AI087616]; Skaggs Institute for Chemical Biology; Cleveland BioLabs Inc. (CBLI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, R01AI080446, R01AI042266, RC2AI087616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Cleveland BioLabs Inc. (CBLI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. S. Choo for critical comments on the manuscript, H. Tien and D. Marciano for automated crystal screening, X. Dai and M.-A. Elsliger for expert technical assistance, and K. Namba and K. Yonekura for generously sharing coordinates of flagellar filament. X-ray diffraction data sets were collected at SSRL beamline 11-1 and APS beamlines 23ID-B and 23ID-D. Supported by NIH grants AI042266 (I. A. W.), R01 AI080446 (A. V. G.), and RC2 AI087616 (A. V. G.); the Skaggs Institute for Chemical Biology (I. A. W.); and research grants from Cleveland BioLabs Inc. (CBLI) to Roswell Park Cancer Institute (A. V. G.) and Sanford-Burnham Medical Research Institute (A.L.O.). A.L.O. is a paid consultant for and holds stock options in CBLI which has developed the flagellin derivative CBLB502 into a radiation countermeasure. U. S. patent 8,007,812 for pharmacologically optimized FliC derivative CBLB502 is licensed to CBLI by Cleveland Clinic. Reagents are available under a materials transfer agreement. This is Scripps Research Institute manuscript 21369. The data presented in this paper are tabulated in the main paper and the supplementary material. Structure factors and coordinates for TLR5-N12<INF>VLR</INF> and TLR5-N14<INF>VLR</INF>/FliC-Delta D0 are deposited in the Protein Data Bank under accession codes 3V44 and 3V47, respectively.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Gavutis M, 2006, BIOPHYS J, V90, P3345, DOI 10.1529/biophysj.105.072546; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iqbal M, 2005, INFECT IMMUN, V73, P2344, DOI 10.1128/IAI.73.4.2344-2350.2005; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Ohto U, 2011, J MOL BIOL, V413, P815, DOI 10.1016/j.jmb.2011.09.020; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Yoon SI, 2011, NAT STRUCT MOL BIOL, V18, P1028, DOI 10.1038/nsmb.2106	24	357	399	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					859	864		10.1126/science.1215584	http://dx.doi.org/10.1126/science.1215584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344444	Green Accepted			2022-12-28	WOS:000300356400045
J	Lacks, DJ; Van Orman, JA; Lesher, CE				Lacks, Daniel J.; Van Orman, James A.; Lesher, Charles E.			Isotope fractionation in silicate melts	NATURE			English	Letter							THERMAL-DIFFUSION; LIQUIDS; TEMPERATURE; SEPARATION		[Lacks, Daniel J.] Case Western Reserve Univ, Dept Chem Engn, Cleveland, OH 44106 USA; [Van Orman, James A.] Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA; [Lesher, Charles E.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	Case Western Reserve University; Case Western Reserve University; University of California System; University of California Davis	Lacks, DJ (corresponding author), Case Western Reserve Univ, Dept Chem Engn, Cleveland, OH 44106 USA.	daniel.lacks@case.edu	Lesher, Charles E/A-2468-2015	Lesher, Charles E/0000-0003-4033-4809; Van Orman, James/0000-0001-8741-0288				Dominguez G, 2011, NATURE, V473, P70, DOI 10.1038/nature09911; Furry WH, 1939, PHYS REV, V55, P1083, DOI 10.1103/PhysRev.55.1083; Grachev AM, 2003, GEOCHIM COSMOCHIM AC, V67, P345, DOI 10.1016/S0016-7037(02)01115-8; Huang F, 2010, NATURE, V464, P396, DOI 10.1038/nature08840; Karplus M., 1970, ATOMS MOL INTRO STUD, V369; Kyser TK, 1998, CONTRIB MINERAL PETR, V133, P373, DOI 10.1007/s004100050459; MCMILLAN PF, 1992, CHEM GEOL, V96, P351, DOI 10.1016/0009-2541(92)90064-C; Nier AO, 1940, PHYS REV, V57, P30, DOI 10.1103/PhysRev.57.30; Reith D, 2000, J CHEM PHYS, V112, P2436, DOI 10.1063/1.480809; Richter FM, 2008, GEOCHIM COSMOCHIM AC, V72, P206, DOI 10.1016/j.gca.2007.10.016; Richter FM, 2009, GEOCHIM COSMOCHIM AC, V73, P4250, DOI 10.1016/j.gca.2009.04.011; Stier LG, 1942, PHYS REV, V62, P548, DOI 10.1103/PhysRev.62.548; Watson WW, 1940, PHYS REV, V57, P899, DOI 10.1103/PhysRev.57.899	13	4	5	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					E1	E1		10.1038/nature10764	http://dx.doi.org/10.1038/nature10764			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337062	Bronze			2022-12-28	WOS:000300287100001
J	Moro-Martin, A				Moro-Martin, Amaya			Spanish changes are scientific suicide	NATURE			English	Editorial Material									Spanish Natl Res Council, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Moro-Martin, A (corresponding author), Spanish Natl Res Council, Madrid, Spain.	amaya@cab.inta-csic.es		Moro Martin, Amaya/0000-0001-9504-8426					0	11	11	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					277	277		10.1038/482277a	http://dx.doi.org/10.1038/482277a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	892LG	22337013	Bronze			2022-12-28	WOS:000300287100006
J	Rest, A; Prieto, JL; Walborn, NR; Smith, N; Bianco, FB; Chornock, R; Welch, DL; Howell, DA; Huber, ME; Foley, RJ; Fong, W; Sinnott, B; Bond, HE; Smith, RC; Toledo, I; Minniti, D; Mandel, K				Rest, A.; Prieto, J. L.; Walborn, N. R.; Smith, N.; Bianco, F. B.; Chornock, R.; Welch, D. L.; Howell, D. A.; Huber, M. E.; Foley, R. J.; Fong, W.; Sinnott, B.; Bond, H. E.; Smith, R. C.; Toledo, I.; Minniti, D.; Mandel, K.			Light echoes reveal an unexpectedly cool eta Carinae during its nineteenth-century Great Eruption	NATURE			English	Article							LUMINOUS BLUE VARIABLES; HOMUNCULUS; SPECTRA; PROGENITORS; TRANSIENTS; SUPERNOVAE; DIVERSITY; NEBULA; ANALOG; MASS	eta Carinae is one of the most massive binary stars in the Milky Way(1,2). It became the second-brightest star in our sky during its mid-nineteenth-century 'Great Eruption', but then faded from view (with only naked-eye estimates of brightness(3,4)). Its eruption is unique in that it exceeded the Eddington luminosity limit for ten years. Because it is only 2.3 kiloparsecs away, spatially resolved studies of the nebula have constrained the ejected mass and velocity, indicating that during its nineteenth-century eruption, eta Car ejected more than ten solar masses in an event that released ten per cent of the energy of a typical core-collapse supernova(5,6), without destroying the star. Here we report observations of light echoes of eta Carinae from the 1838-1858 Great Eruption. Spectra of these light echoes show only absorption lines, which are blueshifted by -210 km s(-1), in good agreement with predicted expansion speeds(6). The light-echo spectra correlate best with those of G2-to-G5 supergiants, which have effective temperatures of around 5,000 kelvin. In contrast to the class of extragalactic outbursts assumed to be analogues of the Great Eruption of eta Carinae(7-12), the effective temperature of its outburst is significantly lower than that allowed by standard opaque wind models(13). This indicates that other physical mechanisms such as an energetic blast wave may have triggered and influenced the eruption.	[Rest, A.; Walborn, N. R.; Bond, H. E.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Prieto, J. L.] Carnegie Observ, Pasadena, CA 91101 USA; [Prieto, J. L.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Smith, N.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Bianco, F. B.; Howell, D. A.] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Bianco, F. B.; Howell, D. A.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Chornock, R.; Foley, R. J.; Fong, W.; Mandel, K.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Welch, D. L.; Sinnott, B.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Huber, M. E.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Smith, R. C.] Cerro Tololo Interamer Observ, Natl Opt Astron Observ, La Serena, Chile; [Toledo, I.] ALMA, San Pedro De Atacama, Ii Region, Chile; [Minniti, D.] Pontificia Univ Catolica Chile, Dept Astron & Astrophys, Santiago 22, Chile; [Mandel, K.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England	Space Telescope Science Institute; Carnegie Institution for Science; Princeton University; University of Arizona; University of California System; University of California Santa Barbara; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; McMaster University; Johns Hopkins University; National Optical Astronomy Observatory; Pontificia Universidad Catolica de Chile; Imperial College London	Rest, A (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	arest@stsci.edu	Rest, Armin/ABE-6469-2020; Howell, Andy/ABE-6446-2020; Minniti, Dante/AAD-7251-2021; bianco, federica/AAI-5454-2020	bianco, federica/0000-0003-1953-8727; Fong, Wen-fai/0000-0002-7374-935X; Welch, Doug/0000-0002-2350-0898; Minniti, Dante/0000-0002-7064-099X; Foley, Ryan/0000-0002-2445-5275	National Science Foundation; LCOGT	National Science Foundation(National Science Foundation (NSF)); LCOGT	We thank R. Humphreys, K. Davidson and J. Vink for comments and discussions. We thank S. Blondin for help with the continuum subtraction. The Blanco 4-m telescope is a facility of the Cerro Tololo Inter-American Observatory, National Optical Astronomy Observatory, which is operated by the Association of Universities for Research in Astronomy, under contract with the National Science Foundation. We use data from the UVES Paranal Observatory Project. The computations in this paper were run on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University. Observations were obtained at LCOGT, and F. B. B. and D. A. H. acknowledge support from LCOGT. J. L. P. is a Hubble Carnegie-Princeton Fellow. R. J. F. is a Clay Fellow.	Bagnulo S., 2003, MESSENGER, V114, P10; Cenarro AJ, 2001, MON NOT R ASTRON SOC, V326, P959, DOI 10.1046/j.1365-8711.2001.04688.x; Damineli A, 1996, ASTROPHYS J, V460, pL49, DOI 10.1086/309961; DAVIDSON K, 1987, ASTROPHYS J, V317, P760, DOI 10.1086/165324; Davidson K, 1997, ANNU REV ASTRON ASTR, V35, P1, DOI 10.1146/annurev.astro.35.1.1; Foley RJ, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/32; Frew D.J., 2004, JAD, V10, P6; GOODRICH RW, 1989, ASTROPHYS J, V342, P908, DOI 10.1086/167646; Humphreys RM, 1999, PUBL ASTRON SOC PAC, V111, P1124, DOI 10.1086/316420; HUMPHREYS RM, 1994, PUBL ASTRON SOC PAC, V106, P1025, DOI 10.1086/133478; Humphreys RM, 2008, ASTRON J, V135, P1249, DOI 10.1088/0004-6256/135/4/1249; Kashi A, 2010, ASTROPHYS J LETT, V709, pL11, DOI 10.1088/2041-8205/709/1/L11; Le Sueur A., 1869, P R SOC LONDON, V18, P245; Le Sueur A., 1870, P R SOC LONDON, V19, P18; Rest A, 2008, ASTROPHYS J LETT, V681, pL81, DOI 10.1086/590427; Rest A, 2005, NATURE, V438, P1132, DOI 10.1038/nature04365; Rest A, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/2; Smith N, 2005, MON NOT R ASTRON SOC, V357, P1330, DOI 10.1111/j.1365-2966.2005.08750.x; Smith N, 2004, ASTROPHYS J, V615, P475, DOI 10.1086/424030; Smith N, 2003, ASTRON J, V125, P1458, DOI 10.1086/346278; Smith N, 2008, NATURE, V455, P201, DOI 10.1038/nature07269; Smith N, 2006, ASTROPHYS J, V644, P1151, DOI 10.1086/503766; Smith N, 2011, MON NOT R ASTRON SOC, V415, P2009, DOI 10.1111/j.1365-2966.2011.18993.x; Smith N, 2011, MON NOT R ASTRON SOC, V415, P773, DOI 10.1111/j.1365-2966.2011.18763.x; Smith N, 2010, ASTRON J, V139, P1451, DOI 10.1088/0004-6256/139/4/1451; Van Dyk SD, 2000, PUBL ASTRON SOC PAC, V112, P1532, DOI 10.1086/317727; Vink J. S., 2009, ETA CARINAE LUMINOUS; WALBORN NR, 1977, ASTROPHYS J, V211, P181, DOI 10.1086/154917	28	59	59	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					375	378		10.1038/nature10775	http://dx.doi.org/10.1038/nature10775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337057	Green Submitted			2022-12-28	WOS:000300287100040
J	Marusic, A; Marusic, M				Marusic, Ana; Marusic, Matko			Can small journals provide leadership?	LANCET			English	Editorial Material							MEDICAL JOURNALS; STUDENTS; CROATIA; SCIENCE; TRIAL; WAR		[Marusic, Ana; Marusic, Matko] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split 21000, Croatia	University of Split	Marusic, A (corresponding author), Univ Split, Sch Med, Dept Res Biomed & Hlth, Split 21000, Croatia.	ana.marusic@mefst.hr	Marusic, Ana/E-7683-2013; Marusic, Matko/E-1834-2017	Marusic, Ana/0000-0001-6272-0917; Marusic, Matko/0000-0001-5562-1777				Bloom JD, 2007, J PUBLIC HEALTH POL, V28, P341, DOI 10.1057/palgrave.jphp.3200145; Bosch X, 2008, NATURE, V454, P574, DOI 10.1038/454574a; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Horton R, 1999, LANCET, V353, P2223, DOI 10.1016/S0140-6736(99)06043-2; Hren D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017406; Ivanis A, 2008, J GEN INTERN MED, V23, P1303, DOI 10.1007/s11606-008-0599-8; Jones R, 2008, LANCET, V371, P1410, DOI 10.1016/S0140-6736(08)60615-7; Laine C, 2007, LANCET, V369, P1909, DOI 10.1016/S0140-6736(07)60894-0; Marusic A, 2003, ACAD MED, V78, P1235, DOI 10.1097/00001888-200312000-00007; Marusic A, 2002, LANCET, V360, pS59, DOI 10.1016/S0140-6736(02)11825-3; Marusic A, 2004, EUROPEAN SCI EDITING, V30, P10; Marusic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023477; Marusic M, 2006, CROAT MED J, V47, P372; Marusic M, 2006, TEACH LEARN MED, V18, P126, DOI 10.1207/s15328015tlm1802_6; Marusic M, 2010, CROATIAN MED J; Marusic M, 2010, LANCET, V376, P1627, DOI 10.1016/S0140-6736(10)61999-X; Petrovecki M, 2001, CROAT MED J, V42, P7; Rudan I, 2011, J GLOB HLTH, V1, P1; Sambunjak D, 2006, J PUBLIC HEALTH POL, V27, P124, DOI 10.1057/palgrave.jphp.3200070; Sambunjak D, 2009, JAMA-J AM MED ASSOC, V302, P2591, DOI 10.1001/jama.2009.1858; Smith R, 2005, MED J AUSTRALIA, V183, P665, DOI 10.5694/j.1326-5377.2005.tb00072.x; Tatalovic M, CROATIAN MED J; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Vujaklija A, 2010, J INVEST MED, V58, P282, DOI 10.2310/JIM.0b013e3181cb42d9; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	25	9	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2012	379	9823					1361	1363		10.1016/S0140-6736(11)61508-0	http://dx.doi.org/10.1016/S0140-6736(11)61508-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922FB	22381455				2022-12-28	WOS:000302531100034
J	Simini, F; Gonzalez, MC; Maritan, A; Barabasi, AL				Simini, Filippo; Gonzalez, Marta C.; Maritan, Amos; Barabasi, Albert-Laszlo			A universal model for mobility and migration patterns	NATURE			English	Article							INTERVENING OPPORTUNITIES; NETWORK; GROWTH; TRADE	Introduced in its contemporary form in 1946 (ref. 1), but with roots that go back to the eighteenth century(2), the gravity law(1,3,4) is the prevailing framework with which to predict population movement(3,5,6), cargo shipping volume(7) and inter-city phone calls(8,9), as well as bilateral trade flows between nations(10). Despite its widespread use, it relies on adjustable parameters that vary from region to region and suffers from known analytic inconsistencies. Here we introduce a stochastic process capturing local mobility decisions that helps us analytically derive commuting and mobility fluxes that require as input only information on the population distribution. The resulting radiation model predicts mobility patterns in good agreement with mobility and transport patterns observed in a wide range of phenomena, from long-term migration patterns to communication volume between different regions. Given its parameter-free nature, the model can be applied in areas where we lack previous mobility measurements, significantly improving the predictive accuracy of most of the phenomena affected by mobility and transport processes(11-23).	[Simini, Filippo; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Simini, Filippo; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys Biol & Comp Sci, Boston, MA 02115 USA; [Simini, Filippo; Maritan, Amos] Univ Padua, Dipartimento Fis G Galilei, CNISM, I-35131 Padua, Italy; [Simini, Filippo; Maritan, Amos] Ist Nazl Fis Nucl, I-35131 Padua, Italy; [Simini, Filippo] Budapest Univ Technol & Econ, Inst Phys, H-1111 Budapest, Hungary; [Gonzalez, Marta C.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Northeastern University; Northeastern University; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); Budapest University of Technology & Economics; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	amos.maritan@pd.infn.it; alb@neu.edu	Barabasi, Albert-Laszlo/S-6474-2017; Gonzalez, Marta C./E-9456-2011	Gonzalez, Marta C./0000-0002-8482-0318; Barabasi, Albert/0000-0002-4028-3522; Maritan, Amos/0000-0002-3535-7873	Cariparo foundation; Network Science Collaborative Technology Alliance; US Army Research Laboratory [W911NF-09-2-0053]; Office of Naval Research [N000141010968]; Defense Threat Reduction Agency [WMD BRBAA07-J-2-0035, BRBAA08-Per4-C-2-0033]; James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems	Cariparo foundation(Fondazione Cariparo); Network Science Collaborative Technology Alliance; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Office of Naval Research(Office of Naval Research); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems	We thank J. P. Bagrow, A. Fava, F. Giannotti, Y.-R. Lin, J. Menche, Z. Neda, D. Pedreschi, D. Wang, G. Wilkerson and D. Bauer for many discussions, and N. Ferguson for prompting us to look into the gravity law. A.M. and F.S. acknowledge the Cariparo foundation for financial support. This work was supported by the Network Science Collaborative Technology Alliance sponsored by the US Army Research Laboratory under Agreement Number W911NF-09-2-0053; the Office of Naval Research under Agreement Number N000141010968; the Defense Threat Reduction Agency awards WMD BRBAA07-J-2-0035 and BRBAA08-Per4-C-2-0033; and the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems.	Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Block H., 1960, EC INFORM DECISION P, P172; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Garlaschelli D, 2007, EUR PHYS J B, V57, P159, DOI 10.1140/epjb/e2007-00131-6; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Jung WS, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48005; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; Lind PG, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036117; MAKSE HA, 1995, NATURE, V377, P608, DOI 10.1038/377608a0; Monge G., 1781, HIST ACAD ROYALE SCI; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; POYHONEN P, 1963, WELTWIRTSCH ARCH, V90, P93; ROGERSON PA, 1986, GEOGR ANAL, V18, P357; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Silvers AL, 1974, URBAN PLANNING ANAL; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; WILSON AG, 1969, J TRANSP ECON POLICY, V3, P108; Xu XJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056109	30	767	815	35	475	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					96	100		10.1038/nature10856	http://dx.doi.org/10.1038/nature10856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	919QN	22367540	Green Submitted			2022-12-28	WOS:000302343400041
J	Wiener, R; Zhang, XB; Wang, T; Wolberger, C				Wiener, Reuven; Zhang, Xiangbin; Wang, Tao; Wolberger, Cynthia			The mechanism of OTUB1-mediated inhibition of ubiquitination	NATURE			English	Article							CONJUGATING ENZYME COMPLEX; STRUCTURAL BASIS; POLYUBIQUITIN CHAINS; CRYSTAL-STRUCTURE; RECOGNITION; SPECIFICITY; SYSTEM; MODEL	Histones are ubiquitinated in response toDNAdouble-strand breaks (DSB), promoting recruitment of repair proteins to chromatin(1). UBC13 (also known as UBE2N) is a ubiquitin-conjugating enzyme (E2) that heterodimerizes withUEV1A(2) (also knownasUBE2V1) and synthesizes K63-linked polyubiquitin (K63Ub) chains at DSB sites in concert with the ubiquitin ligase (E3), RNF168 (ref. 3). K63Ub synthesis is regulated in a non-canonicalmanner by the deubiquitinating enzyme, OTUB1 (OTU domain-containing ubiquitin aldehydebinding protein 1), which binds preferentially to the UBC13 similar to Ub thiolester(4). Residues amino-terminal to the OTU domain, which had been implicated in ubiquitin binding(4), are required for binding to UBC13 similar to Ub and inhibition of K63Ub synthesis(5). Here we describe structural and biochemical studies elucidating how OTUB1 inhibits UBC13 and other E2 enzymes. We unexpectedly find that OTUB1 binding to UBC13 Ub is allosterically regulated by free ubiquitin, which binds to a second site in OTUB1 and increases its affinity for UBC13 similar to Ub, while at the same time disrupting interactions with UEV1A in a manner that depends on the OTUB1 N terminus. Crystal structures of an OTUB1-UBC13 complex and of OTUB1 bound to ubiquitin aldehyde and a chemical UBC13 similar to Ub conjugate show that binding of free ubiquitin to OTUB1 triggers conformational changes in the OTU domain and formation of a ubiquitinbinding helix in the N terminus, thus promoting binding of the conjugated donor ubiquitin in UBC13 similar to Ub to OTUB1. The donor ubiquitin thus cannot interact with the E2 enzyme, which has been shown to be important for ubiquitin transfer(6,7). The N-terminal helix of OTUB1 is positioned to interfere with UEV1A binding to UBC13, as well as with attack on the thiolester by an acceptor ubiquitin, thereby inhibiting K63Ub synthesis. OTUB1 binding also occludes the RING E3 binding site on UBC13, thus providing a further component of inhibition. The general features of the inhibition mechanism explain how OTUB1 inhibits other E2 enzymes4 in a non-catalytic manner.	[Wiener, Reuven; Zhang, Xiangbin; Wang, Tao; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Wiener, Reuven; Zhang, Xiangbin; Wang, Tao; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		Wolberger, Cynthia/0000-0001-8578-2969	US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]	US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Henderson for generating the human/worm OTUB1 clone and C. Berndsen, A. DiBello, A. Datta and M. Bianchet for discussions. GM/CA-CAT has been funded in whole or in part with funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berndsen CE, 2011, ANAL BIOCHEM, V418, P102, DOI 10.1016/j.ab.2011.06.034; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capodagli GC, 2011, J VIROL, V85, P3621, DOI 10.1128/JVI.02496-10; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	30	159	166	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					618	U143		10.1038/nature10911	http://dx.doi.org/10.1038/nature10911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22367539	Green Accepted			2022-12-28	WOS:000302006100043
J	Cramer, PE; Cirrito, JR; Wesson, DW; Lee, CYD; Karlo, JC; Zinn, AE; Casali, BT; Restivo, JL; Goebel, WD; James, MJ; Brunden, KR; Wilson, DA; Landreth, GE				Cramer, Paige E.; Cirrito, John R.; Wesson, Daniel W.; Lee, C. Y. Daniel; Karlo, J. Colleen; Zinn, Adriana E.; Casali, Brad T.; Restivo, Jessica L.; Goebel, Whitney D.; James, Michael J.; Brunden, Kurt R.; Wilson, Donald A.; Landreth, Gary E.			ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models	SCIENCE			English	Article							ALZHEIMERS-DISEASE; COMMON VARIANTS; DYSFUNCTION; BURDEN; MICE; METABOLISM; RECEPTORS; PATHOLOGY; MEMORY; CD2AP	Alzheimer's disease (AD) is associated with impaired clearance of beta-amyloid (A beta) from the brain, a process normally facilitated by apolipoprotein E (apoE). ApoE expression is transcriptionally induced through the action of the nuclear receptors peroxisome proliferator-activated receptor gamma and liver X receptors in coordination with retinoid X receptors (RXRs). Oral administration of the RXR agonist bexarotene to a mouse model of AD resulted in enhanced clearance of soluble A beta within hours in an apoE-dependent manner. A beta plaque area was reduced more than 50% within just 72 hours. Furthermore, bexarotene stimulated the rapid reversal of cognitive, social, and olfactory deficits and improved neural circuit function. Thus, RXR activation stimulates physiological A beta clearance mechanisms, resulting in the rapid reversal of a broad range of A beta-induced deficits.	[Cramer, Paige E.; Wesson, Daniel W.; Lee, C. Y. Daniel; Karlo, J. Colleen; Zinn, Adriana E.; Casali, Brad T.; Landreth, Gary E.] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA; [Cirrito, John R.; Restivo, Jessica L.; Goebel, Whitney D.] Washington Univ, Knight Alzheimers Dis Res Ctr, Hope Ctr Neurol Disorders, Dept Neurol,Sch Med, St Louis, MO 63110 USA; [Wesson, Daniel W.; Wilson, Donald A.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA; [Wesson, Daniel W.; Wilson, Donald A.] NYU, Sch Med, Orangeburg, NY 10962 USA; [James, Michael J.; Brunden, Kurt R.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	Case Western Reserve University; Washington University (WUSTL); Nathan Kline Institute for Psychiatric Research; New York University; University of Pennsylvania; Pennsylvania Medicine	Landreth, GE (corresponding author), Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA.	gel2@case.edu	Wesson, Daniel/AAJ-6719-2020	Wesson, Daniel/0000-0002-3192-3866; Wilson, Donald/0000-0001-8918-2151	Blanchette Hooker Rockefeller Foundation; Thome Foundation; Roby and Taft Funds for Alzheimer's Research; Painstone Foundation; American Health Assistance Foundation; Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; National Institute on Aging (NIA) [AG030482-03S1]; National Institute on Deafness and Other Communication Disorders [DC003906, RO1-AG037693]; NIA [K01 AG029524, P50-AG005681]; Shmerler family; Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University; Marian S. Ware Alzheimer Program; NATIONAL INSTITUTE ON AGING [R01AG030482, R01AG037693, K01AG029524, P50AG005681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906] Funding Source: NIH RePORTER	Blanchette Hooker Rockefeller Foundation; Thome Foundation; Roby and Taft Funds for Alzheimer's Research; Painstone Foundation; American Health Assistance Foundation(BrightFocus Foundation); Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Shmerler family; Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University; Marian S. Ware Alzheimer Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Dr. Mangelsdorf for discussions and M. Pendergast, G. Casadesus, and I. Nagle for technical assistance. This work was supported by the Blanchette Hooker Rockefeller Foundation, Thome Foundation, Roby and Taft Funds for Alzheimer's Research, Painstone Foundation, American Health Assistance Foundation, Cure Alzheimer's Fund, Coins for Alzheimer's Research Trust, and the National Institute on Aging (NIA) (grant AG030482-03S1 to G. E. L.); National Institute on Deafness and Other Communication Disorders (grant DC003906, RO1-AG037693 to D. A. W); NIA (grants K01 AG029524 and P50-AG005681), Shmerler family, and the Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University (to J.R.C.); and Marian S. Ware Alzheimer Program (to K. R. B.). All raw data are archived on \\gel-server1 for authorized users. P. E. C. and G. E. L. hold U.S. Provisional Patent Application no. 61/224,709 regarding bexarotene as a potential therapeutic for Alzheimer's disease and are founding scientists of ReXceptor, Inc., which has licensing options from Case Western Reserve University on the use of bexarotene in the treatment of Alzheimer's disease.	Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Farol Len T, 2004, Expert Rev Anticancer Ther, V4, P180, DOI 10.1586/14737140.4.2.180; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Mandrekar-Colucci S, 2011, EXPERT OPIN THER TAR, V15, P1085, DOI 10.1517/14728222.2011.594043; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Roses Allen D., 1994, Current Opinion in Biotechnology, V5, P663, DOI 10.1016/0958-1669(94)90091-4; Wesson DW, 2011, J NEUROSCI, V31, P15962, DOI 10.1523/JNEUROSCI.2085-11.2011; Wesson DW, 2011, BEHAV BRAIN RES, V216, P408, DOI 10.1016/j.bbr.2010.08.033; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010	24	793	854	9	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1503	1506		10.1126/science.1217697	http://dx.doi.org/10.1126/science.1217697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22323736	Green Accepted			2022-12-28	WOS:000301837000051
J	Hollville, E; Martin, SJ				Hollville, Emilie; Martin, Seamus J.			Greasing the Path to BAX/BAK Activation	CELL			English	Editorial Material							BCL-2 PROTEIN FAMILY; CELL-DEATH; MITOCHONDRIA; SPHINGOSINE; APOPTOSIS; SPHINGOSINE-1-PHOSPHATE; RELEASE	BAX/BAK activation leading to mitochondrial outer-membrane permeabilization is a key commitment point in apoptosis. Chipuk et al. now identify two sphingolipids as specific cofactors for BAX/BAK activation that lower the threshold for apoptosis-associated cytochrome c release. Association of mitochondria with other cellular membrane compartments is required for BAK/BAX exposure to these sphingolipids.	[Hollville, Emilie; Martin, Seamus J.] Smurfit Inst, Dept Genet, SFI Mol Cell Biol Lab, Dublin 2, Ireland; [Hollville, Emilie; Martin, Seamus J.] Trinity Coll Dublin, Immunol Res Ctr, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Martin, SJ (corresponding author), Smurfit Inst, Dept Genet, SFI Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie	Hollville, Emilie/AAA-3597-2022; Hollville, Emilie/GQZ-8301-2022; Hollville, Emilie/ABD-4798-2021	Hollville, Emilie/0000-0001-5711-8542; Martin, Seamus/0000-0002-8539-3143				Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Gude DR, 2008, FASEB J, V22, P2629, DOI 10.1096/fj.08-107169; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Weigert A, 2010, BLOOD, V115, P3531, DOI 10.1182/blood-2009-10-243444; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	10	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					845	846		10.1016/j.cell.2012.02.006	http://dx.doi.org/10.1016/j.cell.2012.02.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385953	Bronze, Green Submitted			2022-12-28	WOS:000300985000005
J	Clark, MK				Clark, Marin Kristen			Continental collision slowing due to viscous mantle lithosphere rather than topography	NATURE			English	Article							NORTHEASTERN TIBETAN PLATEAU; ALTYN-TAGH FAULT; TECTONIC EVOLUTION; INDIA; DEFORMATION; HISTORY; SYSTEM; GROWTH; REGION; MARGIN	Because the inertia of tectonic plates is negligible, plate velocities result from the balance of forces acting at plate margins and along their base(1). Observations of past plate motion derived from marine magnetic anomalies provide evidence of how continental deformation may contribute to plate driving forces(2-8). A decrease in convergence rate at the inception of continental collision is expected because of the greater buoyancy of continental than oceanic lithosphere(2,3), but post-collisional rates are less well understood. Slowing of convergence has generally been attributed to the development of high topography that further resists convergent motion(7-10); however, the role of deforming continental mantle lithosphere on plate motions has not previously been considered. Here I show that the rate of India's penetration into Eurasia has decreased exponentially since their collision. The exponential decrease in convergence rate suggests that contractional strain across Tibet has been constant throughout the collision at a rate of 7.03 x 10(-16) s(-1), which matches the current rate. A constant bulk strain rate of the orogen suggests that convergent motion is resisted by constant average stress (constant force) applied to a relatively uniform layer or interface at depth. This finding follows new evidence that the mantle lithosphere beneath Tibet is intact(11), which supports the interpretation that the long-term strain history of Tibet reflects deformation of the mantle lithosphere. Under conditions of constant stress and strength, the deforming continental lithosphere creates a type of viscous resistance that affects plate motion irrespective of how topography evolved.	Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Clark, MK (corresponding author), Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA.	marinkc@umich.edu			National Science Foundation [EAR-0549748, EAR-0908711]; Directorate For Geosciences [0908711, 1211434] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	I thank E. Hetland, N. Lewandowski and P. Molnar for discussions and comments, and P. Molnar and J. Stock for sharing their plate reconstruction data in advance of their publication. I also thank Peizhen Zhang and colleagues for leading our collaborative US-Chinese field efforts and cooperative study. L. Flesch and J. Freymueller provided critical feedback that greatly improved the quality of this manuscript. Support for this research was provided by the National Science Foundation, Continental Dynamics Program (EAR-0549748 and EAR-0908711).	ARTYUSHKOV EV, 1973, J GEOPHYS RES, V78, P7675, DOI 10.1029/JB078i032p07675; Bally A.W., 1986, 86327 USGS; BURCHFIEL BC, 1991, TECTONICS, V10, P1091, DOI 10.1029/90TC02685; Chen QZ, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2002JB002151; Clark MK, 2010, EARTH PLANET SC LETT, V296, P78, DOI 10.1016/j.epsl.2010.04.051; Copley A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006634; DEWEY JF, 1989, ECLOGAE GEOL HELV, V82, P717; Dupont-Nivet G, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002620; Duvall AR, 2011, EARTH PLANET SC LETT, V304, P520, DOI 10.1016/j.epsl.2011.02.028; ENGLAND P, 1985, J GEOPHYS RES-SOLID, V90, P3551, DOI 10.1029/JB090iB05p03551; ENGLAND P, 1989, J GEOPHYS RES-SOLID, V94, P17561, DOI 10.1029/JB094iB12p17561; Fang XM, 2003, EARTH PLANET SC LETT, V210, P545, DOI [10.1016/S0012-821X(03)00142-0, 10.1016/S0012-821X(03)-00142-0]; Flesch LM, 2005, EARTH PLANET SC LETT, V238, P248, DOI 10.1016/j.epsl.2005.06.023; Flesch LM, 2001, J GEOPHYS RES-SOL EA, V106, P16435, DOI 10.1029/2001JB000208; FORSYTH D, 1975, GEOPHYS J ROY ASTR S, V43, P163, DOI 10.1111/j.1365-246X.1975.tb00631.x; Garzione CN, 2006, EARTH PLANET SC LETT, V241, P543, DOI 10.1016/j.epsl.2005.11.026; Jolivet M, 2001, TECTONOPHYSICS, V343, P111, DOI 10.1016/S0040-1951(01)00196-2; Kapp P, 2007, GEOL SOC AM BULL, V119, P917, DOI 10.1130/B26033.1; Kirby E, 2002, TECTONICS, V21, DOI 10.1029/2000TC001246; McKenzie D, 2008, LITHOS, V102, P1, DOI 10.1016/j.lithos.2007.05.005; McQuarrie N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017992; Meade BJ, 2008, EARTH PLANET SC LETT, V275, P93, DOI 10.1016/j.epsl.2008.08.007; Merkouriev S, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001079; Merkouriev S, 2008, GEOPHYS J INT, V173, P1064, DOI 10.1111/j.1365-246X.2008.03761.x; Meyer B, 1998, GEOPHYS J INT, V135, P1, DOI 10.1046/j.1365-246X.1998.00567.x; Molnar P., 1988, PROCESSES CONTINENTA, V218, P179, DOI [10.1130/SPE218-p179, DOI 10.1130/SPE218-P179]; Molnar P, 2009, TECTONICS, V28, DOI 10.1029/2008TC002271; PATRIAT P, 1984, NATURE, V311, P615, DOI 10.1038/311615a0; Ritts BD, 2004, J GEOL, V112, P207, DOI 10.1086/381658; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; Spurlin MS, 2005, GEOL SOC AM BULL, V117, P1293, DOI 10.1130/B25572.1; Studnicki-Gizbert C, 2008, GEOSPHERE, V4, P713, DOI 10.1130/GES00136.1; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang Q, 2001, SCIENCE, V294, P574, DOI 10.1126/science.1063647; Yin A, 2002, GEOL SOC AM BULL, V114, P1257, DOI 10.1130/0016-7606(2002)114<1257:THOTAT>2.0.CO;2; Yin A, 2008, GEOL SOC AM BULL, V120, P847, DOI 10.1130/B26232.1; Zhang PZ, 2004, GEOLOGY, V32, P809, DOI 10.1130/G20554.1; Zheng DW, 2006, EARTH PLANET SC LETT, V248, P198, DOI 10.1016/j.epsl.2006.05.023	39	95	102	4	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					74	U1502		10.1038/nature10848	http://dx.doi.org/10.1038/nature10848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22382982				2022-12-28	WOS:000300877900047
J	Fu, M; Yu, XZ; Lu, J; Zuo, Y				Fu, Min; Yu, Xinzhu; Lu, Ju; Zuo, Yi			Repetitive motor learning induces coordinated formation of clustered dendritic spines in vivo	NATURE			English	Article							STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; CORTEX; MEMORY; CIRCUITS; STABILITY; MICE; LTP	Many lines of evidence suggest that memory in the mammalian brain is stored with distinct spatiotemporal patterns(1,2). Despite recent progresses in identifying neuronal populations involved in memory coding(3-5), the synapse-level mechanism is still poorly understood. Computational models and electrophysiological data have shown that functional clustering of synapses along dendritic branches leads to nonlinear summation of synaptic inputs and greatly expands the computing power of a neural network(6-10). However, whether neighbouring synapses are involved in encoding similar memory and how task-specific cortical networks develop during learning remain elusive. Using transcranial two-photon microscopy(11), we followed apical dendrites of layer 5 pyramidal neurons in the motor cortex while mice practised novel forelimb skills. Here we show that a third of new dendritic spines (postsynaptic structures of most excitatory synapses) formed during the acquisition phase of learning emerge in clusters, and that most such clusters are neighbouring spine pairs. These clustered new spines are more likely to persist throughout prolonged learning sessions, and even long after training stops, than non-clustered counterparts. Moreover, formation of new spine clusters requires repetition of the same motor task, and the emergence of succedent new spine(s) accompanies the strengthening of the first new spine in the cluster. We also show that under control conditions new spines appear to avoid existing stable spines, rather than being uniformly added along dendrites. However, succedent new spines in clusters overcome such a spatial constraint and form in close vicinity to neighbouring stable spines. Our findings suggest that clustering of new synapses along dendrites is induced by repetitive activation of the cortical circuitry during learning, providing a structural basis for spatial coding of motor memory in the mammalian brain.	[Fu, Min; Yu, Xinzhu; Zuo, Yi] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Lu, Ju] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Lu, Ju] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Stanford University; Stanford University	Zuo, Y (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	yizuo@ucsc.edu		Zuo, Yi/0000-0001-9020-0003	DANA Foundation; National Institutes of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094449, R56MH094449] Funding Source: NIH RePORTER	DANA Foundation; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. States, D. Garcia, L. Hinck, T. Jones, S. Song, W. Thompson and G. Wang for comments on this manuscript. We thank A. Perlik and T. Xu for technical support. This work was supported by grants from the DANA Foundation and the National Institutes of Mental Health to Y.Z.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Chen JL, 2010, CURR OPIN NEUROBIOL, V20, P557, DOI 10.1016/j.conb.2010.06.002; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Harms KJ, 2007, BRAIN RES, V1184, P65, DOI 10.1016/j.brainres.2006.02.094; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	32	284	289	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					92	U135		10.1038/nature10844	http://dx.doi.org/10.1038/nature10844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22343892	Green Accepted, Green Submitted			2022-12-28	WOS:000300877900051
J	Garg, AX; Meirambayeva, A; Huang, AJ; Kim, J; Prasad, GVR; Knoll, G; Boudville, N; Lok, C; McFarlane, P; Karpinski, M; Storsley, L; Klarenbach, S; Lam, N; Thomas, SM; Dipchand, C; Reese, P; Doshi, M; Gibney, E; Taub, K; Young, A				Garg, Amit X.; Meirambayeva, Aizhan; Huang, Anjie; Kim, Joseph; Prasad, G. V. Ramesh; Knoll, Greg; Boudville, Neil; Lok, Charmaine; McFarlane, Philip; Karpinski, Martin; Storsley, Leroy; Klarenbach, Scott; Lam, Ngan; Thomas, Sonia M.; Dipchand, Christine; Reese, Peter; Doshi, Mona; Gibney, Eric; Taub, Ken; Young, Ann		Donor Nephrectomy Outcomes Res DON	Cardiovascular disease in kidney donors: matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOMERULAR-FILTRATION; ELDERLY-PATIENTS; MORTALITY; OUTCOMES; METAANALYSIS; HYPERTENSION; PUBLICATION; NEPHRECTOMY; PREVALENCE; ONTARIO	Objective To determine whether people who donate a kidney have an increased risk of cardiovascular disease. Design Retrospective population based matched cohort study. Participants All people who were carefully selected to become a living kidney donor in the province of Ontario, Canada, between 1992 and 2009. The information in donor charts was manually reviewed and linked to provincial healthcare databases. Matched non-donors were selected from the healthiest segment of the general population. A total of 2028 donors and 20 280 matched non-donors were followed for a median of 6.5 years (maximum 17.7 years). Median age was 43 at the time of donation (interquartile range 34-50) and 50 at the time of follow-up (42-58). Main outcome measures The primary outcome was a composite of time to death or first major cardiovascular event. The secondary outcome was time to first major cardiovascular event censored for death. Results The risk of the primary outcome of death and major cardiovascular events was lower in donors than in non-donors (2.8 v 4.1 events per 1000 person years; hazard ratio 0.66, 95% confidence interval 0.48 to 0.90). The risk of major cardiovascular events censored for death was no different in donors than in non-donors (1.7 v 2.0 events per 1000 person years; 0.85, 0.57 to 1.27). Results were similar in all sensitivity analyses. Older age and lower income were associated with a higher risk of death and major cardiovascular events in both donors and non-donors when each group was analysed separately. Conclusions The risk of major cardiovascular events in donors is no higher in the first decade after kidney donation compared with a similarly healthy segment of the general population. While we will continue to follow people in this study, these interim results add to the evidence base supporting the safety of the practice among carefully selected donors.	[Garg, Amit X.; Meirambayeva, Aizhan; Lam, Ngan; Thomas, Sonia M.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [Garg, Amit X.; Meirambayeva, Aizhan; Lam, Ngan] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Garg, Amit X.; Huang, Anjie; Kim, Joseph] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kim, Joseph; Prasad, G. V. Ramesh; Lok, Charmaine; McFarlane, Philip] Univ Toronto, Div Nephrol, Toronto, ON, Canada; [Knoll, Greg] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Boudville, Neil] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Karpinski, Martin; Storsley, Leroy] Univ Manitoba, Nephrol Sect, Winnipeg, MB, Canada; [Klarenbach, Scott] Univ Alberta, Div Nephrol, Edmonton, AB, Canada; [Dipchand, Christine] Dalhousie Univ, Div Nephrol, Halifax, NS, Canada; [Reese, Peter] Univ Penn, Div Renal, Philadelphia, PA 19104 USA; [Doshi, Mona] Wayne State Univ, Div Nephrol, Detroit, MI USA; [Gibney, Eric] Piedmont Transplant Inst, Atlanta, GA USA; [Taub, Ken] Univ Calgary, Div Nephrol, Calgary, AB, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Ottawa; University of Western Australia; University of Manitoba; University of Alberta; Dalhousie University; University of Pennsylvania; Wayne State University; University of Calgary	Garg, AX (corresponding author), London Hlth Sci Ctr, London Kidney Clin Res Unit, Room ELL-101,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Muirhead, Norman/G-3337-2011; Lam, Ngan/AAX-3472-2020; Klarenbach, Scott/E-7731-2013; Boudville, Neil/H-8864-2014; Garg, Amit X/G-3295-2011	Lam, Ngan/0000-0002-0129-7091; Klarenbach, Scott/0000-0002-8611-1056; Lok, Charmaine/0000-0001-5365-0064; Thomas, Sonia M./0000-0002-4930-2275; Knoll, Greg/0000-0001-5442-9310; Boudville, Neil/0000-0002-5884-640X	Ontario Ministry of Health and Long-Term Care (MOHLTC); Canadian Institutes of Health Research; University of Ottawa Chair in Clinical Transplantation Research; Alberta Heritage Foundation for Medical Research/Alberta Innovates Health Solutions; Alberta Health and Wellness; University of Alberta	Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Ottawa Chair in Clinical Transplantation Research; Alberta Heritage Foundation for Medical Research/Alberta Innovates Health Solutions(Alberta Heritage Foundation for Medical Research); Alberta Health and Wellness; University of Alberta(University of Alberta)	This project was conducted at the Institute for Clinical Evaluative Sciences (ICES). ICES is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). AXG was supported by a Canadian Institutes of Health Research Clinician-Scientist Award. GK was supported by a University of Ottawa Chair in Clinical Transplantation Research. SK was supported by the Alberta Heritage Foundation for Medical Research/Alberta Innovates Health Solutions, a joint initiative between Alberta Health and Wellness and the University of Alberta. The opinions, results and conclusions reported in this paper are those of the authors and are independent of the funding sources. The funding sources did not influence any aspect of this study.	Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Austin PC, 2003, JAMA-J AM MED ASSOC, V289, P3241, DOI 10.1001/jama.289.24.3241; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Garg AX, 2008, TRANSPLANTATION, V86, P399, DOI 10.1097/TP.0b013e31817ba9e3; Haynes R, 2009, NAT CLIN PRACT NEPHR, V5, P126, DOI 10.1038/ncpneph1035; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Ibrahim HN, 2006, AM J TRANSPLANT, V6, P1479, DOI 10.1111/j.1600-6143.2006.01335.x; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Lin J, 2010, NEW ENGL J MED, V363, P797, DOI 10.1056/NEJMc1002100; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mjoen G, 2012, NEPHROL DIAL TRANSPL, V27, P443, DOI 10.1093/ndt/gfr303; Okamoto M, 2009, TRANSPLANTATION, V87, P419, DOI 10.1097/TP.0b013e318192dc95; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Statistics Canada, 2011, POP GROUPS 28 SEX 3; Statistics Canada, 2010, POP SEX AG GROUP PRO; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Tan L, 2011, J UROLOGY, V185, P1820, DOI 10.1016/j.juro.2010.12.036; Tomic A, 2010, INT SURG, V95, P343; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Young A, 2008, AM J TRANSPLANT, V8, P1878, DOI 10.1111/j.1600-6143.2008.02339.x; Young A, 2007, NEPHRON CLIN PRACT, V107, pC82, DOI 10.1159/000108648	30	135	136	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2012	344								e1203	10.1136/bmj.e1203	http://dx.doi.org/10.1136/bmj.e1203			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XJ	22381674	Green Published, hybrid			2022-12-28	WOS:000301231900002
J	Lane, R				Lane, Richard			Profile Azad Khan: prime mover behind NCD programmes in Bangladesh	LANCET			English	Biographical-Item																		KHAN AA, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 25	2012	379	9817					703	703		10.1016/S0140-6736(12)60297-9	http://dx.doi.org/10.1016/S0140-6736(12)60297-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899CU	22364752	Bronze			2022-12-28	WOS:000300792600013
J	Blum, ES; Abraham, MC; Yoshimura, S; Lu, Y; Shaham, S				Blum, Elyse S.; Abraham, Mary C.; Yoshimura, Satoshi; Lu, Yun; Shaham, Shai			Control of Nonapoptotic Developmental Cell Death in Caenorhabditis elegans by a Polyglutamine-Repeat Protein	SCIENCE			English	Article							C-ELEGANS; GENE; CASPASES; SURVIVAL; NEURONS	Death is a vital developmental cell fate. In Caenorhabditis elegans, programmed death of the linker cell, which leads gonadal elongation, proceeds independently of caspases and apoptotic effectors. To identify genes promoting linker-cell death, we performed a genome-wide RNA interference screen. We show that linker-cell death requires the gene pqn-41, encoding an endogenous polyglutamine-repeat protein. pqn-41 functions cell-autonomously and is expressed at the onset of linker-cell death. pqn-41 expression is controlled by the mitogen-activated protein kinase kinase SEK-1, which functions in parallel to the zinc-finger protein LIN-29 to promote cellular demise. Linker-cell death is morphologically similar to cell death associated with normal vertebrate development and polyglutamine-induced neurodegeneration. Our results may therefore provide molecular inroads to understanding nonapoptotic cell death in metazoan development and disease.	[Blum, Elyse S.; Abraham, Mary C.; Yoshimura, Satoshi; Lu, Yun; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10065 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10065 USA.	shaham@rockefeller.edu			National Center for Research Resources; Rockefeller Women & Science Fellowship Program; NIH [CA09673, R01HD042680]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042680] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081490] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Rockefeller Women & Science Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Darnell and Shaham lab members for discussions; N. Tishbi for technical assistance; and D. Kim, C. Bargmann, M. Kinet, M. Kato, P. Sternberg, K. Nishiwaki, and K. Matsumoto for reagents. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, funded by the National Center for Research Resources. E.S.B. is supported in part by the Rockefeller Women & Science Fellowship Program and NIH training grant CA09673. S.S. is supported by NIH grant R01HD042680.	Abraham MC, 2007, DEV CELL, V12, P73, DOI 10.1016/j.devcel.2006.11.012; Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Borsello T, 2002, J COMP NEUROL, V453, P361, DOI 10.1002/cne.10411; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, DEVELOPMENT, V112, P591; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Johnson AD, 2001, DEVELOPMENT, V128, P2857; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; PILAR G, 1976, J CELL BIOL, V68, P339, DOI 10.1083/jcb.68.2.339; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tamai KK, 2007, DEV BIOL, V308, P562, DOI 10.1016/j.ydbio.2007.05.024	24	58	64	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					970	973		10.1126/science.1215156	http://dx.doi.org/10.1126/science.1215156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363008	Green Accepted			2022-12-28	WOS:000300931800047
J	Bernal, O; Forero, JC; Forde, I				Bernal, Oscar; Camilo Forero, Juan; Forde, Ian			Colombia's response to healthcare crisis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bernal, Oscar; Camilo Forero, Juan] Univ Los Andes, Sch Govt, Bogota, Colombia; [Forde, Ian] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	Universidad de los Andes (Colombia); University of London; University College London	Bernal, O (corresponding author), Univ Los Andes, Sch Govt, Carrera 1 19-27,Bloque AU, Bogota, Colombia.	obernal@uniandes.edu.co		Bernal, oscar/0000-0003-2514-3318				AGENCIA PRESIDENCIAL PARA LA ACCION SOCIAL Y LA COOPERACION INTERNACIONAL, 2010, CAM REC 10 AN FAM AC; [Anonymous], 2011, ESPECTADOR      0509; [Anonymous], 2011, REV SEMANA       MAY, P1515; [Anonymous], 2011, HLTH STAT; Asi Vamos en Salud, 2010, PORC COB AF REG SUBS; Baris E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7456; Comision de Regulacion en Salud, 2011, AC 028 2011 CUAL SE; Comision de Regulacion en Salud, 2010, AC 019 2010 VAL UPC; Defensoria del Pueblo, 2011, TUT DER SAL 2010; Evasion del impuesto al valor agregado en Colombia: 2000-2008, 2009, EV IMP VAL AGR COL 2; Ministerio de la Proteccion Social, 2002, MES TEM PROC REF SIS; Ministerio de la Proteccion Social, 2011, ACT ACL POS S POS C; Presidencia de la Republica de Colombia, 2011, PRES SANT INF MILL D; Restrepo JH, 2007, REV EC I, V9, P279; Santa Maria M, 2011, COL CONST COURT BOG; Superintendencia Nacional de Salud, 2011, INF GEST 2010; The World Bank, 2011, GINI IND; United Nations Development Programme, 2011, INT HUM DEV IND; World Bank, 2011, IND; World Health Organization, 2011, WORLD HLTH STAT 2011; Yepes F, 2009, REFORMAS SALUD COLOM	21	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2012	344								e802	10.1136/bmj.e802	http://dx.doi.org/10.1136/bmj.e802			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JY	22362461				2022-12-28	WOS:000300884400002
J	Jin, LY; Pahuja, KB; Wickliffe, KE; Gorur, A; Baumgartel, C; Schekman, R; Rape, M				Jin, Lingyan; Pahuja, Kanika Bajaj; Wickliffe, Katherine E.; Gorur, Amita; Baumgaertel, Christine; Schekman, Randy; Rape, Michael			Ubiquitin-dependent regulation of COPII coat size and function	NATURE			English	Article							RETICULUM EXIT SITES; COLLAGEN SECRETION; MAMMALIAN-CELLS; LIGASE; CARGO; IDENTIFICATION; PROTEINS; ADAPTERS; ORGANIZATION; DEGRADATION	Packaging of proteins from the endoplasmic reticulum into COPII vesicles is essential for secretion. In cells, most COPII vesicles are approximately 60-80 nm in diameter, yet some must increase their size to accommodate 300-400 nm procollagen fibres or chylomicrons. Impaired COPII function results in collagen deposition defects, craniolenticulo-sutural dysplasia, or chylomicron retention disease, but mechanisms to enlarge COPII coats have remained elusive. Here, we identified the ubiquitin ligase CUL3-KLHL12 as a regulator of COPII coat formation. CUL3-KLHL12 catalyses the monoubiquitylation of the COPII-component SEC31 and drives the assembly of large COPII coats. As a result, ubiquitylation by CUL3-KLHL12 is essential for collagen export, yet less important for the transport of small cargo. We conclude that monoubiquitylation controls the size and function of a vesicle coat.	[Jin, Lingyan; Pahuja, Kanika Bajaj; Wickliffe, Katherine E.; Gorur, Amita; Baumgaertel, Christine; Schekman, Randy; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pahuja, Kanika Bajaj; Gorur, Amita; Schekman, Randy] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Rape, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mrape@berkeley.edu		Bajaj Pahuja, Kanika/0000-0001-8977-9812; Rape, Michael/0000-0003-4849-6343	Pew Foundation; NIH (NIGMS); Howard Hughes Medical Institute; CIRM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003088] Funding Source: NIH RePORTER	Pew Foundation; NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); CIRM(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Schulman for advice and gifts of cDNAs and proteins. We are grateful to J. Schaletzky for critically reading the manuscript and many discussions. We thank the members of the Rape and Schekman labs for advice and suggestions, L. Lim for providing Cul3-shRNAs, C. Glazier for contributions on BTB protein cloning, and A. Fischer and M. Richner for tissue culture support. This work was funded by grants from the Pew Foundation (M. R.), the NIH (NIGMS-RO1, M. R.; NIH Director's New Innovator Award, M. R.), and the Howard Hughes Medical Institute (R. S.). L. J. was funded by a CIRM predoctoral fellowship; she is a Tang fellow. K. B. P. is an HFSP long term post-doctoral fellow.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Myocardial Infarction Genetics Consortium, 2009, NAT GENET, V41, P762; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Saito K, 2011, MOL BIOL CELL, V22, P2301, DOI 10.1091/mbc.E11-02-0143; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stephens DJ, 2002, J CELL SCI, V115, P1149; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Uchida K, 2005, IMMUNOLOGY, V116, P53, DOI 10.1111/j.1365-2567.2005.02197.x; Wickstrom SA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005116; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	41	224	236	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					495	U213		10.1038/nature10822	http://dx.doi.org/10.1038/nature10822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358839	Green Submitted, Green Accepted			2022-12-28	WOS:000300770500044
J	Yao, XC; Wang, TX; Chen, HZ; Gao, WB; Fowler, AG; Raussendorf, R; Chen, ZB; Liu, NL; Lu, CY; Deng, YJ; Chen, YA; Pan, JW				Yao, Xing-Can; Wang, Tian-Xiong; Chen, Hao-Ze; Gao, Wei-Bo; Fowler, Austin G.; Raussendorf, Robert; Chen, Zeng-Bing; Liu, Nai-Le; Lu, Chao-Yang; Deng, You-Jin; Chen, Yu-Ao; Pan, Jian-Wei			Experimental demonstration of topological error correction	NATURE			English	Article							QUANTUM; CODES	Scalable quantum computing can be achieved only if quantum bits are manipulated in a fault-tolerant fashion. Topological error correction-a method that combines topological quantum computation with quantum error correction-has the highest known tolerable error rate for a local architecture. The technique makes use of cluster states with topological properties and requires only nearest-neighbour interactions. Here we report the experimental demonstration of topological error correction with an eight-photon cluster state. We show that a correlation can be protected against a single error on any quantum bit. Also, when all quantum bits are simultaneously subjected to errors with equal probability, the effective error rate can be significantly reduced. Our work demonstrates the viability of topological error correction for fault-tolerant quantum information processing.	[Yao, Xing-Can; Wang, Tian-Xiong; Chen, Hao-Ze; Gao, Wei-Bo; Chen, Zeng-Bing; Liu, Nai-Le; Lu, Chao-Yang; Deng, You-Jin; Chen, Yu-Ao; Pan, Jian-Wei] Univ Sci & Technol China, Natl Lab Phys Sci Microscale, Shanghai Branch, Shanghai 201315, Peoples R China; [Yao, Xing-Can; Wang, Tian-Xiong; Chen, Hao-Ze; Gao, Wei-Bo; Chen, Zeng-Bing; Liu, Nai-Le; Lu, Chao-Yang; Deng, You-Jin; Chen, Yu-Ao; Pan, Jian-Wei] Univ Sci & Technol China, Dept Modern Phys, Shanghai 201315, Peoples R China; [Fowler, Austin G.] Univ Melbourne, Sch Phys, CQC2T, Melbourne, Vic 3010, Australia; [Raussendorf, Robert] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Melbourne; University of British Columbia	Chen, YA (corresponding author), Univ Sci & Technol China, Natl Lab Phys Sci Microscale, Shanghai Branch, Shanghai 201315, Peoples R China.	yuaochen@ustc.edu.cn; pan@ustc.edu.cn	Fowler, Austin/J-4961-2012; Lu, Chao-Yang/D-8481-2011; Chen, Yu-Ao/B-2057-2013; gao, WEIBO/F-9408-2017; Pan, Jian-Wei/A-2332-2010; Yao, Xingcan/A-2457-2013; Deng, Youjin/G-5640-2011	Lu, Chao-Yang/0000-0002-8227-9177; Chen, Yu-Ao/0000-0002-2309-2281; gao, WEIBO/0000-0003-3971-621X; Pan, Jian-Wei/0000-0002-6100-5142; Yao, Xingcan/0000-0003-2331-7687; Deng, Youjin/0000-0001-9743-4013; Raussendorf, Robert/0000-0003-4983-9213	NNSF of China; CAS; National Fundamental Research Program [2011CB921300]; NSERC	NNSF of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); National Fundamental Research Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We acknowledge discussions with M. A. Martin-Delgado and O. Guhne. We are grateful to X.-H. Bao for his original idea of the ultrabright entanglement and to C.-Z. Peng for his idea of reducing high-order emission. We would also like to thank C. Liu and S. Folling for their help in designing the figures. This work has been supported by the NNSF of China, the CAS, the National Fundamental Research Program (under grant no. 2011CB921300) and NSERC.	Aoki T, 2009, NAT PHYS, V5, P541, DOI 10.1038/NPHYS1309; Barrett SD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.200502; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Bombin H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.180501; Calderbank AR, 1996, PHYS REV A, V54, P1098, DOI 10.1103/PhysRevA.54.1098; Chen SA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.173004; Chiaverini J, 2004, NATURE, V432, P602, DOI 10.1038/nature03074; Cory DG, 1998, PHYS REV LETT, V81, P2152, DOI 10.1103/PhysRevLett.81.2152; Dennis E, 2002, J MATH PHYS, V43, P4452, DOI 10.1063/1.1499754; Devitt SJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083032; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Fowler AG, 2009, QUANTUM INF COMPUT, V9, P721; Gottesman D, 1998, PHYS REV A, V57, P127, DOI 10.1103/PhysRevA.57.127; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Hatcher A, 2002, ALGEBRAIC TOPOLOGY; Hensinger WK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164910; Hime T, 2006, SCIENCE, V314, P1427, DOI 10.1126/science.1134388; Hofmann HF, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.024308; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Kardynal BE, 2008, NAT PHOTONICS, V2, P425, DOI 10.1038/nphoton.2008.101; Kiesel N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210502; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Knill E, 2001, PHYS REV LETT, V86, P5811, DOI 10.1103/PhysRevLett.86.5811; Lu CY, 2008, P NATL ACAD SCI USA, V105, P11050, DOI 10.1073/pnas.0800740105; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; O'Brien JL, 2007, SCIENCE, V318, P1567, DOI 10.1126/science.1142892; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Raussendorf R, 2006, ANN PHYS-NEW YORK, V321, P2242, DOI 10.1016/j.aop.2006.01.012; Raussendorf R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190504; Schindler P, 2011, SCIENCE, V332, P1059, DOI 10.1126/science.1203329; Schlingemann D, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.012308; SHOR PW, 1994, AN S FDN CO, P124; Spedalieri FM, 2009, QUANTUM INF COMPUT, V9, P666; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Stock R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.170501; Wilczek F., 1990, FRACTIONAL STAT ANYO, DOI [10.1142/0961, DOI 10.1142/0961]; Yao X.-C., 2011, NATURE PHOT IN PRESS	43	141	146	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					489	494		10.1038/nature10770	http://dx.doi.org/10.1038/nature10770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358838	Green Submitted			2022-12-28	WOS:000300770500043
J	Topaloglu, AK; Tello, JA; Kotan, LD; Ozbek, MN; Yilmaz, MB; Erdogan, S; Gurbuz, F; Temiz, F; Millar, RP; Yuksel, B				Topaloglu, A. Kemal; Tello, Javier A.; Kotan, L. Damla; Ozbek, Mehmet N.; Yilmaz, M. Bertan; Erdogan, Seref; Gurbuz, Fatih; Temiz, Fatih; Millar, Robert P.; Yuksel, Bilgin			Inactivating KISS1 Mutation and Hypogonadotropic Hypogonadism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PROTEIN-COUPLED RECEPTOR; IN-VIVO; GENE; MICE	Gonadotropin-releasing hormone (GnRH) is the central regulator of gonadotropins, which stimulate gonadal function. Hypothalamic neurons that produce kisspeptin and neurokinin B stimulate GnRH release. Inactivating mutations in the genes encoding the human kisspeptin receptor (KISS1R, formerly called GPR54), neurokinin B (TAC3), and the neurokinin B receptor (TACR3) result in pubertal failure. However, human kisspeptin loss-of-function mutations have not been described, and contradictory findings have been reported in Kiss1-knockout mice. We describe an inactivating mutation in KISS1 in a large consanguineous family that results in failure of pubertal progression, indicating that functional kisspeptin is important for puberty and reproduction in humans. (Funded by the Scientific and Technological Research Council of Turkey [TUBITAK] and others.)	[Topaloglu, A. Kemal; Gurbuz, Fatih; Temiz, Fatih; Yuksel, Bilgin] Cukurova Univ, Fac Med, Dept Pediat Endocrinol, TR-01330 Adana, Turkey; [Yilmaz, M. Bertan] Cukurova Univ, Fac Med, Dept Med Biol, TR-01330 Adana, Turkey; [Erdogan, Seref] Cukurova Univ, Fac Med, Dept Physiol, TR-01330 Adana, Turkey; [Topaloglu, A. Kemal; Kotan, L. Damla] Cukurova Univ, Inst Sci, Dept Biotechnol, TR-01330 Adana, Turkey; [Ozbek, Mehmet N.] Diyarbakir Childrens Hosp, Dept Pediat Endocrinol, Diyarbakir, Turkey; [Tello, Javier A.; Millar, Robert P.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Millar, Robert P.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Millar, Robert P.] Univ Cape Town, Receptor Biol Grp, ZA-7925 Cape Town, South Africa	Cukurova University; Cukurova University; Cukurova University; Cukurova University; Diyarbakir Obstetrics & Pediatrics Hospital; University of Edinburgh; University of Pretoria; University of Cape Town	Topaloglu, AK (corresponding author), Cukurova Univ, Fac Med, Dept Pediat Endocrinol, TR-01330 Adana, Turkey.	ktopaloglu@cu.edu.tr	Gürbüz, Fatih/J-2700-2013; Kotan, Leman Damla/A-2474-2015; ERDOGAN, SEREF/A-1067-2018; Tello, Javier Ananda A/B-3203-2012; yilmaz, bertan/G-8633-2018; TOPALOGLU, ALI/O-1408-2015	Gürbüz, Fatih/0000-0003-2160-9838; Kotan, Leman Damla/0000-0001-6176-8986; ERDOGAN, SEREF/0000-0002-4405-3054; Tello, Javier Ananda A/0000-0001-6637-2155; yilmaz, bertan/0000-0001-5558-3299; Millar, Robert P/0000-0003-3606-2708; yuksel, bilgin/0000-0003-4378-3255	Scientific and Technological Research Council of Turkey (TUBITAK) [109S455]; International Centre for Genetic Engineering and Biotechnology [CRP/TUR10-01]; Cukurova University Scientific Research Projects Unit [BAP-26]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); International Centre for Genetic Engineering and Biotechnology; Cukurova University Scientific Research Projects Unit(Cukurova University)	Supported by the Scientific and Technological Research Council of Turkey (TUBITAK) (project number 109S455), the International Centre for Genetic Engineering and Biotechnology (project number CRP/TUR10-01), and the Cukurova University Scientific Research Projects Unit (project number BAP-26).	Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Chan YM, 2009, J NEUROENDOCRINOL, V21, P1015, DOI 10.1111/j.1365-2826.2009.01926.x; Curtis AE, 2010, AM J PHYSIOL-ENDOC M, V298, pE296, DOI 10.1152/ajpendo.00426.2009; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Gutierrez-Pascual E, 2009, MOL PHARMACOL, V76, P58, DOI 10.1124/mol.108.053751; Hayes FJ, 1999, J CLIN ENDOCR METAB, V84, P1028, DOI 10.1210/jc.84.3.1028; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Mayer C, 2011, NAT NEUROSCI, V14, P704, DOI 10.1038/nn.2818; Millar RP, 2010, BRAIN RES, V1364, P81, DOI 10.1016/j.brainres.2010.09.044; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Niida A, 2006, BIOORG MED CHEM LETT, V16, P134, DOI 10.1016/j.bmcl.2005.09.054; Orsini MJ, 2007, J MED CHEM, V50, P462, DOI 10.1021/jm0609824; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Plant TM, 2008, J NEUROENDOCRINOL, V20, P719, DOI 10.1111/j.1365-2826.2008.01708.x; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; SILVERMAN AJ, 1985, NEUROSCIENCE, V16, P69, DOI 10.1016/0306-4522(85)90048-X; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Wahab F, 2011, MOL CELL ENDOCRINOL, V346, P29, DOI 10.1016/j.mce.2011.05.043	24	314	331	3	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					629	635		10.1056/NEJMoa1111184	http://dx.doi.org/10.1056/NEJMoa1111184			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IL	22335740	Green Published			2022-12-28	WOS:000300279800008
J	Morice, P; Uzan, C; Uzan, S				Morice, Philippe; Uzan, Catherine; Uzan, Serge			Cancer in pregnancy: a challenging conflict of interest	LANCET			English	Editorial Material							GUIDELINES; FERTILITY; MANAGEMENT		[Morice, Philippe; Uzan, Catherine] Inst Gustave Roussy, Dept Gynaecol Surg, F-94805 Villejuif, France; [Morice, Philippe; Uzan, Catherine] Inst Gustave Roussy, Unit INSERM U 10 30, F-94805 Villejuif, France; [Morice, Philippe] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Uzan, Serge] Hop Tenon, Assistance Publ Hop Paris, Paris, France; [Uzan, Serge] Univ Paris 06, Paris, France; [Uzan, Serge] Int Acad Perinatal Med, Barcelona, Spain	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Morice, P (corresponding author), Inst Gustave Roussy, Dept Gynaecol Surg, Rue Camille Desmoulins, F-94805 Villejuif, France.	philippe.morice@igr.fr	Morice, Philippe/ABC-3179-2021	Morice, Philippe/0000-0003-0579-9993				Amant F, 2012, LANCET, V379, P570, DOI 10.1016/S0140-6736(11)61092-1; Amant F, 2010, EUR J CANCER, V46, P3158, DOI 10.1016/j.ejca.2010.09.010; Amant F, 2009, INT J GYNECOL CANCER, V19, pS1, DOI 10.1111/IGC.0b013e3181a1d0ec; Brenner B, 2012, LANCET, V379, P580, DOI 10.1016/S0140-6736(11)61348-2; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Letourneau JM, 2011, NAT REV CLIN ONCOL, V8, P56, DOI 10.1038/nrclinonc.2010.133; Marret H, 2010, EUR J OBSTET GYN R B, V149, P18, DOI 10.1016/j.ejogrb.2009.12.001; Morice P, 2012, LANCET, V379, P558, DOI 10.1016/S0140-6736(11)60829-5; Morice P, 2009, INT J GYNECOL CANCER, V19, P1638, DOI 10.1111/IGC.0b013e3181a83017; Pentheroudakis G, 2006, EUR J CANCER, V42, P126, DOI 10.1016/j.ejca.2005.10.014; Pentheroudakis G, 2010, ANN ONCOL, V21, pv266, DOI 10.1093/annonc/mdq198; Stensheim H, 2009, J CLIN ONCOL, V27, P45, DOI 10.1200/JCO.2008.17.4110; Van Calsteren K, 2010, J CLIN ONCOL, V28, P683, DOI 10.1200/JCO.2009.23.2801; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81	14	31	34	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					495	496		10.1016/S0140-6736(11)61814-X	http://dx.doi.org/10.1016/S0140-6736(11)61814-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891AO	22325648				2022-12-28	WOS:000300188800004
J	Lu, C; Ward, PS; Kapoor, GS; Rohle, D; Turcan, S; Abdel-Wahab, O; Edwards, CR; Khanin, R; Figueroa, ME; Melnick, A; Wellen, KE; O'Rourke, DM; Berger, SL; Chan, TA; Levine, RL; Mellinghoff, IK; Thompson, CB				Lu, Chao; Ward, Patrick S.; Kapoor, Gurpreet S.; Rohle, Dan; Turcan, Sevin; Abdel-Wahab, Omar; Edwards, Christopher R.; Khanin, Raya; Figueroa, Maria E.; Melnick, Ari; Wellen, Kathryn E.; O'Rourke, Donald M.; Berger, Shelley L.; Chan, Timothy A.; Levine, Ross L.; Mellinghoff, Ingo K.; Thompson, Craig B.			IDH mutation impairs histone demethylation and results in a block to cell differentiation	NATURE			English	Article							INTEGRATED GENOMIC ANALYSIS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; LEUKEMIA; GENE; DNA; TRANSCRIPTION; SETDB1; TUMORS; BRAIN	Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in gliomas, acute myeloid leukaemias (AML) and chondrosarcomas, and share a novel enzymatic property of producing 2-hydroxyglutarate (2HG) from alpha-ketoglutarate(1-6). Here we report that 2HG-producing IDH mutants can prevent the histone demethylation that is required for lineage-specific progenitor cells to differentiate into terminally differentiated cells. In tumour samples from glioma patients, IDH mutations were associated with a distinct gene expression profile enriched for genes expressed in neural progenitor cells, and this was associated with increased histone methylation. To test whether the ability of IDH mutants to promote histone methylation contributes to a block in cell differentiation in non-transformed cells, we tested the effect of neomorphic IDH mutants on adipocyte differentiation in vitro. Introduction of either mutant IDH or cell-permeable 2HG was associated with repression of the inducible expression of lineage-specific differentiation genes and a block to differentiation. This correlated with a significant increase in repressive histone methylation marks without observable changes in promoter DNA methylation. Gliomas were found to have elevated levels of similar histone repressive marks. Stable transfection of a 2HG-producing mutant IDH into immortalized astrocytes resulted in progressive accumulation of histone methylation. Of the marks examined, increased H3K9 methylation reproducibly preceded a rise in DNA methylation as cells were passaged in culture. Furthermore, we found that the 2HG-inhibitable H3K9 demethylase KDM4C was induced during adipocyte differentiation, and that RNA-interference suppression of KDM4C was sufficient to block differentiation. Together these data demonstrate that 2HG can inhibit histone demethylation and that inhibition of histone demethylation can be sufficient to block the differentiation of non-transformed cells.	[Lu, Chao; Ward, Patrick S.; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Lu, Chao; Ward, Patrick S.; Wellen, Kathryn E.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Kapoor, Gurpreet S.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Rohle, Dan; Turcan, Sevin; Abdel-Wahab, Omar; Chan, Timothy A.; Levine, Ross L.; Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rohle, Dan; Mellinghoff, Ingo K.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10065 USA; [Edwards, Christopher R.; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Figueroa, Maria E.; Melnick, Ari] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY 10065 USA; [O'Rourke, Donald M.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Cornell University; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center	Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	thompsonc@mskcc.org	Turcan, Sevin/AAF-1095-2019; levine, ross/AAE-7658-2019; Lu, Chao/E-8047-2012; Figueroa, Maria/AAE-8662-2019; Chan, Timothy A/ABD-5850-2021; Melnick, Ari/AAA-5763-2020; O'Rourke, Donald/AAC-3376-2021; Grieshaber-Bouyer, Ricardo/R-7512-2016; Ward, Patrick/H-2361-2014	Turcan, Sevin/0000-0002-0885-5607; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Lu, Chao/0000-0003-0982-8122; Mellinghoff, Ingo/0000-0002-4347-8149; Berger, Shelley/0000-0001-5398-4400; O'Rourke, Donald/0000-0002-8479-7314; Figueroa, Maria Eugenia/0000-0003-4887-4981; Ward, Patrick/0000-0001-6437-8174; Abdel-Wahab, Omar/0000-0002-3907-6171	National Cancer Institute; National Institutes of Health; Howard Hughes Medical Institute; MSKCC; Abramson Cancer Center at University of Pennsylvania; Doris Duke Charitable Foundation; American Society of Clinical Oncology;  [NCI-U54CA143798]; NATIONAL CANCER INSTITUTE [R01CA105463, U54CA143798, R01CA078831] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); MSKCC; Abramson Cancer Center at University of Pennsylvania; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Society of Clinical Oncology; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Thompson laboratory for technical help and critical reading of the manuscript. We thank T. A. Gocke and the genomic core of University of Pennsylvania for their assistance with the microarray study; the molecular cytology core facility of Memorial Sloan-Kettering Cancer Center (MSKCC) for technical help with the immunohistochemistry study; and O. Ouerfelli and M. K. Spassova at the organic synthesis core of MSKCC for the synthesis of octyl-2HG. This work was supported by grants from the National Cancer Institute and National Institutes of Health. R. L. L. is an Early Career Award recipient of the Howard Hughes Medical Institute and the Geoffrey Beene Junior Chair at MSKCC. D.M.O'R. is supported by the Betsy Cohen Fund of the Abramson Cancer Center at University of Pennsylvania. I. K. M. is supported by NCI-U54CA143798, the Doris Duke Charitable Foundation, and an Advanced Clinical Research Award in Glioma from the American Society of Clinical Oncology.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Habib M, 1999, EXP CELL RES, V249, P46, DOI 10.1006/excr.1999.4434; Hu ZB, 2001, ONCOGENE, V20, P6946, DOI 10.1038/sj.onc.1204850; Ingvarsdottir K, 2007, MOL CELL BIOL, V27, P7856, DOI 10.1128/MCB.00801-07; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sonoda Y, 2001, CANCER RES, V61, P4956; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	30	1325	1373	7	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2012	483	7390					474	U130		10.1038/nature10860	http://dx.doi.org/10.1038/nature10860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22343901	Green Accepted			2022-12-28	WOS:000301771200045
J	Cook, DJ; Teves, L; Tymianski, M				Cook, Douglas J.; Teves, Lucy; Tymianski, Michael			Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain	NATURE			English	Article							ACUTE ISCHEMIC-STROKE; PROTEIN INTERACTIONS; NEUROPROTECTION; TRANSLATION; EVOLUTION; DIFFUSION; TRIALS; MODEL; RECOMMENDATIONS; PREDICTION	All attempts at treating strokes by pharmacologically reducing the human brain's vulnerability to ischaemia have failed, leaving stroke as a leading cause of death, disability and massive socioeconomic loss worldwide(1). Over decades, research has failed to translate over 1,000 experimental treatments from discovery in cells and rodents to use in humans(2-4), a scientific crisis that gave rise to the prevailing belief that pharmacological neuroprotection is not feasible or practicable in higher-order brains. To provide a strategy for advancing stroke therapy, we used higher-order gyrencephalic non-human primates, which bear genetic, anatomical and behavioural similarities to humans(5,6) and tested neuroprotection by PSD-95 inhibitors-promising compounds that uncouple postsynaptic density protein PSD-95 from neurotoxic signalling pathways(7-10). Here we show that stroke damage can be prevented in non-human primates in which a PSD-95 inhibitor is administered after stroke onset in clinically relevant situations. This treatment reduced infarct volumes as gauged by magnetic resonance imaging and histology, preserved the capacity of ischaemic cells to maintain gene transcription in genome-wide screens of ischaemic brain tissue, and significantly preserved neurological function in neuro-behavioural assays. The degree of tissue neuroprotection by magnetic resonance imaging corresponded strongly to the preservation of neurological function, supporting the intuitive but unproven dictum that integrity of brain tissue can reflect functional outcome. Our findings establish that tissue neuroprotection and improved functional outcome after stroke is unequivocally achievable in gyrencephalic non-human primates treated with PSD-95 inhibitors. Efforts must ensue to translate these findings to humans.	[Cook, Douglas J.; Teves, Lucy; Tymianski, Michael] Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; [Tymianski, Michael] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Tymianski, Michael] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Tymianski, Michael] Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Tymianski, M (corresponding author), Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada.	mike.tymianski@uhn.ca		Tymianski, Mike/0000-0002-6311-9565	Canadian Stroke Network; Heart and Stroke Foundation of Ontario [NA 6988]; Canada Research Chair	Canadian Stroke Network; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants to M.T. from the Canadian Stroke Network and the Heart and Stroke Foundation of Ontario, grant NA 6988. D.J.C. is a recipient of a Canadian Stroke Network postdoctoral research fellowship. M.T. is a Canada Research Chair (Tier 1) in Translational Stroke Research. We thank M. Madden, B. Maloo, A. Goldstein, B. Madeira, W. Foltz and Z. Lu for assistance. We thank M. Salter and M. Hill for a review of the manuscript.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; [Anonymous], 2006, NATURE, V444, P532; Bardutzky J, 2007, STROKE, V38, P1336, DOI 10.1161/01.STR.0000259636.26950.3b; Bratane BT, 2011, STROKE, V42, P3265, DOI 10.1161/STROKEAHA.111.618801; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Enard D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000840; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; FINDLAY JM, 1991, J NEUROSURG, V75, P425, DOI 10.3171/jns.1991.75.3.0425; Fisher M, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000074790; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hand PJ, 2006, NEUROLOGY, V66, P1159, DOI 10.1212/01.wnl.0000202524.43850.81; Johnston KC, 2007, STROKE, V38, P1820, DOI 10.1161/STROKEAHA.106.479154; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kosior JC, 2007, J MAGN RESON IMAGING, V25, P653, DOI 10.1002/jmri.20843; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marshall JWB, 2003, ILAR J, V44, P153, DOI 10.1093/ilar.44.2.153; Marshall JWB, 1996, NEURODEGENERATION, V5, P275, DOI 10.1006/neur.1996.0036; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roitberg B, 2003, NEUROL RES, V25, P68, DOI 10.1179/016164103101200950; Sacchetti ML, 2008, STROKE, V39, P1659, DOI 10.1161/STROKEAHA.107.505024; Sanossian N, 2009, CEREBROVASC DIS, V28, P539, DOI 10.1159/000247596; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Savitz SI, 2007, EXP NEUROL, V205, P20, DOI 10.1016/j.expneurol.2007.03.003; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; YANAGIHARA T, 1978, BRAIN RES, V158, P435, DOI 10.1016/0006-8993(78)90686-8	37	290	312	5	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2012	483	7388					213	U112		10.1038/nature10841	http://dx.doi.org/10.1038/nature10841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22388811				2022-12-28	WOS:000301174900039
J	Kim, JY; Liu, CY; Zhang, FY; Duan, X; Wen, ZX; Song, J; Feighery, E; Lu, B; Rujescu, D; St Clair, D; Christian, K; Callicott, JH; Weinberger, DR; Song, HJ; Ming, GL				Kim, Ju Young; Liu, Cindy Y.; Zhang, Fengyu; Duan, Xin; Wen, Zhexing; Song, Juan; Feighery, Emer; Lu, Bai; Rujescu, Dan; St Clair, David; Christian, Kimberly; Callicott, Joseph H.; Weinberger, Daniel R.; Song, Hongjun; Ming, Guo-Li			Interplay between DISC1 and GABA Signaling Regulates Neurogenesis in Mice and Risk for Schizophrenia	CELL			English	Article							NEWLY GENERATED NEURONS; ADULT BRAIN; GENE-EXPRESSION; MOUSE HIPPOCAMPUS; DOWN-REGULATION; STRESS; INTEGRATION; MATURATION; KCC2; CELL	How extrinsic stimuli and intrinsic factors interact to regulate continuous neurogenesis in the postnatal mammalian brain is unknown. Here we show that regulation of dendritic development of newborn neurons by Disrupted-in-Schizophrenia 1 (DISC1) during adult hippocampal neurogenesis requires neurotransmitter GABA-induced, NKCC1-dependent depolarization through a convergence onto the AKT-mTOR pathway. In contrast, DISC1 fails to modulate early-postnatal hippocampal neurogenesis when conversion of GABA-induced depolarization to hyperpolarization is accelerated. Extending the period of GABA-induced depolarization or maternal deprivation stress restores DISC1-dependent dendritic regulation through mTOR pathway during early-postnatal hippocampal neurogenesis. Furthermore, DISC1 and NKCC1 interact epistatically to affect risk for schizophrenia in two independent case control studies. Our study uncovers an interplay between intrinsic DISC1 and extrinsic GABA signaling, two schizophrenia susceptibility pathways, in controlling neurogenesis and suggests critical roles of developmental tempo and experience in manifesting the impact of susceptibility genes on neuronal development and risk for mental disorders.	[Kim, Ju Young; Liu, Cindy Y.; Duan, Xin; Wen, Zhexing; Song, Juan; Christian, Kimberly; Song, Hongjun; Ming, Guo-Li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Kim, Ju Young; Liu, Cindy Y.; Wen, Zhexing; Song, Juan; Christian, Kimberly; Song, Hongjun; Ming, Guo-Li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Zhang, Fengyu; Duan, Xin; Song, Hongjun; Ming, Guo-Li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Feighery, Emer; Lu, Bai; Callicott, Joseph H.; Weinberger, Daniel R.] NIMH, Gene Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Rujescu, Dan] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [St Clair, David] Univ Aberdeen, Royal Cornhill Hosp, Aberdeen AB25 2ZD, Scotland; [Weinberger, Daniel R.; Song, Hongjun] Lieber Inst Brain Dev, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Munich; University of Aberdeen	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu	Callicott, Joseph H/C-9102-2009; Callicott, Joseph H/AAE-7243-2022; Wen, Zhexing/B-9313-2014; St Clair, David/AAN-2412-2021; Wen, Zhexing/L-1228-2018; Rujescu, Dan/GRS-3875-2022; Zhang, Fengyu/M-1396-2019; Ming, Guo-li/J-7880-2013	Callicott, Joseph H/0000-0003-1298-3334; Wen, Zhexing/0000-0002-1518-3845; Zhang, Fengyu/0000-0001-8504-0770; Lu, Bai/0000-0001-5418-9759	NIH [NS048271, HD069184, NS047344, MH087874]; MSCRF; NARSAD; IMHRO; NIMH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087874, ZIAMH002734, R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R56NS047344, R01NS048271, R37NS047344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSCRF; NARSAD(NARSAD); IMHRO; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of Ming and Song Laboratories for help and critical comments, L. Liu, Y. Cai, N. Powanpangkul, and Q. Hussaini for technical support, and A. Chiang and J. Wang for help with tissue processing. This work was supported by the NIH (NS048271 and HD069184), MSCRF, and NARSAD to G-l.M., by the NIH (NS047344 and MH087874) and IMHRO to H. S., by the NIMH intramural program to D. W., and by postdoctoral fellowships from MSCRF to J. Y. K., Z.W., J. S., and K.	Almasy L, 2008, AM J PSYCHIAT, V165, P1185, DOI 10.1176/appi.ajp.2008.07121869; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Balu DT, 2011, NEUROSCI BIOBEHAV R, V35, P848, DOI 10.1016/j.neubiorev.2010.10.005; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Charych EI, 2009, NEUROPHARMACOLOGY, V57, P481, DOI 10.1016/j.neuropharm.2009.07.027; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Dean B, 2007, AUST NZ J PSYCHIAT, V41, P308, DOI 10.1080/00048670701213245; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kang EC, 2011, NEURON, V72, P559, DOI 10.1016/j.neuron.2011.09.032; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ming GL, 2009, CELL, V136, P990, DOI 10.1016/j.cell.2009.03.005; Nakata K, 2009, P NATL ACAD SCI USA, V106, P15873, DOI 10.1073/pnas.0903413106; Nicodemus KK, 2008, MOL PSYCHIATR, V13, P873, DOI 10.1038/sj.mp.4002153; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PERRY TL, 1979, LANCET, V1, P237; Platel JC, 2010, BRAIN RES REV, V63, P60, DOI 10.1016/j.brainresrev.2010.02.004; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shim S, 2009, NEURON, V64, P471, DOI 10.1016/j.neuron.2009.09.025; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Tamura M, 2011, J NEUROSCI, V31, P11505, DOI 10.1523/JNEUROSCI.3447-10.2011; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsuang Ming T, 2004, World Psychiatry, V3, P73; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wu YM, 2003, J NEUROPHYSIOL, V89, P2021, DOI 10.1152/jn.00856.2002; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	51	154	163	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					1051	1064		10.1016/j.cell.2011.12.037	http://dx.doi.org/10.1016/j.cell.2011.12.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385968	Bronze, Green Accepted			2022-12-28	WOS:000300985000023
J	Link, CD; Saldi, TK				Link, Christopher D.; Saldi, Tassa K.			Cell Death by Glutamine Repeats?	SCIENCE			English	Editorial Material									[Link, Christopher D.; Saldi, Tassa K.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Link, CD (corresponding author), Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA.	linkc@colorado.edu		SALDI, TASSA/0000-0002-5648-1355				Abraham MC, 2007, DEV CELL, V12, P73, DOI 10.1016/j.devcel.2006.11.012; Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	8	1	2	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					926	927		10.1126/science.1219834	http://dx.doi.org/10.1126/science.1219834			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22362996				2022-12-28	WOS:000300931800032
J	Palmer, LM; Schulz, JM; Murphy, SC; Ledergerber, D; Murayama, M; Larkum, ME				Palmer, Lucy M.; Schulz, Jan M.; Murphy, Sean C.; Ledergerber, Debora; Murayama, Masanori; Larkum, Matthew E.			The Cellular Basis of GABA(B)-Mediated Interhemispheric Inhibition	SCIENCE			English	Article							INTERNEURONS; NEURONS; ATTENTION; CORTEX; INPUT	Interhemispheric inhibition is thought to mediate cortical rivalry between the two hemispheres through callosal input. The long-lasting form of this inhibition is believed to operate via gamma-aminobutyric acid type B (GABA(B)) receptors, but the process is poorly understood at the cellular level. We found that the firing of layer 5 pyramidal neurons in rat somatosensory cortex due to contralateral sensory stimulation was inhibited for hundreds of milliseconds when paired with ipsilateral stimulation. The inhibition acted directly on apical dendrites via layer 1 interneurons but was silent in the absence of pyramidal cell firing, relying on metabotropic inhibition of active dendritic currents recruited during neuronal activity. The results not only reveal the microcircuitry underlying interhemispheric inhibition but also demonstrate the importance of active dendritic properties for cortical output.	[Palmer, Lucy M.; Schulz, Jan M.; Murphy, Sean C.; Ledergerber, Debora; Larkum, Matthew E.] Univ Bern, Inst Physiol, CH-3012 Bern, Switzerland; [Murayama, Masanori] RIKEN, Brain Sci Inst, Behav Neurophysiol Lab, Wako, Saitama 3510198, Japan; [Larkum, Matthew E.] Humboldt Univ, Dept Biol, D-10117 Berlin, Germany	University of Bern; RIKEN; Humboldt University of Berlin	Larkum, ME (corresponding author), Univ Bern, Inst Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	matthew.larkum@gmail.com	Murayama, Masanori/G-5457-2015; Murayama, Masanori/AHA-9840-2022	Murayama, Masanori/0000-0001-7623-010X; Schulz, Jan Michael/0000-0003-1557-5352; Palmer, Lucy/0000-0003-3676-657X; Larkum, Matthew/0000-0001-9799-2656	SystemsX.ch (NeuroChoice); Swiss National Science Foundation [PP00A-102721, 31003A_130694]	SystemsX.ch (NeuroChoice); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank B. Bettler, J. Seibt, E. Perez-Garci, T. Nyffeler, R. Muri and H. -R. Luscher for their helpful comments on the manuscript. We also thank B. Bettler and M. Gassman for kindly providing the knockout mice (GABA<INF>B1a</INF><SUP>-/-</SUP> and GABA<INF>B1b</INF><SUP>-/-</SUP>) and N. Nevian for technical assistance. This work was supported by SystemsX.ch (NeuroChoice) and the Swiss National Science Foundation (PP00A-102721 and 31003A_130694).	ASANUMA H, 1962, J NEUROPHYSIOL, V25, P198, DOI 10.1152/jn.1962.25.2.198; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Brecht M, 2002, J PHYSIOL-LONDON, V538, P495, DOI 10.1113/jphysiol.2001.012334; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cazzoli D, 2009, EUR J NEUROSCI, V29, P1271, DOI 10.1111/j.1460-9568.2009.06665.x; Chu ZG, 2003, J NEUROSCI, V23, P96; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Forss N, 1999, BRAIN, V122, P1889, DOI 10.1093/brain/122.10.1889; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; Gerloff C, 2002, ACTA PSYCHOL, V110, P161, DOI 10.1016/S0001-6918(02)00032-X; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Innocenti GM., 1986, CEREBRAL CORTEX VOL, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; Kobayashi M, 2004, NEUROLOGY, V62, P91, DOI 10.1212/WNL.62.1.91; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lopez-Bendito G, 2002, EUR J NEUROSCI, V15, P1766, DOI 10.1046/j.1460-9568.2002.02032.x; Murayama M, 2007, J NEUROPHYSIOL, V98, P1791, DOI 10.1152/jn.00082.2007; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Schnitzler A, 1996, EXP BRAIN RES, V112, P381; SEYAL M, 1995, ANN NEUROL, V38, P264, DOI 10.1002/ana.410380221; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Williams S., 1999, J PHYSL, V521, P161; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257	34	201	205	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					989	993		10.1126/science.1217276	http://dx.doi.org/10.1126/science.1217276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363012				2022-12-28	WOS:000300931800052
J	Smith, FA				Smith, Felisa A.			Some Like It Hot	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; BODY-SIZE; EVOLUTION; DYNAMICS		Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Smith, FA (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	fasmith@unm.edu	Smith, Felisa/ABE-6160-2021	Smith, Felisa/0000-0001-6262-436X				Figueirido B, 2012, P NATL ACAD SCI USA, V109, P722, DOI 10.1073/pnas.1110246108; Gingerich P.D., 1989, U MICHIGAN PAPERS PA, V28, P1; Haldane J. B. S., 1926, POSSIBLE WORLDS OTHE; Jackson ST, 2007, FRONT ECOL ENVIRON, V5, P455, DOI 10.1890/1540-9295(2007)5[455:LFFTPH]2.0.CO;2; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Pagani M, 2006, SCIENCE, V314, P1556, DOI 10.1126/science.1136110; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Secord R, 2012, SCIENCE, V335, P959, DOI 10.1126/science.1213859; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Woodburne MO, 2009, P NATL ACAD SCI USA, V106, P13399, DOI 10.1073/pnas.0906802106; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	16	6	6	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					924	925		10.1126/science.1219233	http://dx.doi.org/10.1126/science.1219233			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22362994				2022-12-28	WOS:000300931800030
J	Cooper, B				Cooper, Barry			The incomputable reality	NATURE			English	Editorial Material									Univ Leeds, Sch Math, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Cooper, B (corresponding author), Univ Leeds, Sch Math, Leeds LS2 9JT, W Yorkshire, England.	pmt6sbc@leeds.ac.uk			EPSRC [EP/G000212/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G000212/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Turing AM, 1939, P LOND MATH SOC, V45, P161; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230	2	7	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					465	465		10.1038/482465a	http://dx.doi.org/10.1038/482465a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358814	Bronze			2022-12-28	WOS:000300770500019
J	Kruse, AC; Hu, JX; Pan, AC; Arlow, DH; Rosenbaum, DM; Rosemond, E; Green, HF; Liu, T; Chae, PS; Dror, RO; Shaw, DE; Weis, WI; Wess, J; Kobilka, BK				Kruse, Andrew C.; Hu, Jianxin; Pan, Albert C.; Arlow, Daniel H.; Rosenbaum, Daniel M.; Rosemond, Erica; Green, Hillary F.; Liu, Tong; Chae, Pil Seok; Dror, Ron O.; Shaw, David E.; Weis, William I.; Wess, Juergen; Kobilka, Brian K.			Structure and dynamics of the M3 muscarinic acetylcholine receptor	NATURE			English	Article							CONFORMATIONAL-CHANGES; MOLECULAR-DYNAMICS; FORCE-FIELD; AMINO-ACID; BINDING; IDENTIFICATION; ACTIVATION; SITE; SELECTIVITY; VALIDATION	Acetylcholine, the first neurotransmitter to be identified(1), exerts many of its physiological actions via activation of a family of G-protein-coupled receptors (GPCRs) known as muscarinic acetylcholine receptors (mAChRs). Although the five mAChR subtypes (M1-M5) share a high degree of sequence homology, they show pronounced differences in G-protein coupling preference and the physiological responses they mediate(2-4). Unfortunately, despite decades of effort, no therapeutic agents endowed with clear mAChR subtype selectivity have been developed to exploit these differences(5,6). We describe here the structure of the G(q/11)-coupled M3 mAChR ('M3 receptor', from rat) bound to the bronchodilator drug tiotropium and identify the binding mode for this clinically important drug. This structure, together with that of the G(i/o)-coupled M2 receptor(7), offers possibilities for the design of mAChR subtype-selective ligands. Importantly, the M3 receptor structure allows a structural comparison between two members of a mammalian GPCR subfamily displaying different G-protein coupling selectivities. Furthermore, molecular dynamics simulations suggest that tiotropium binds transiently to an allosteric site en route to the binding pocket of both receptors. These simulations offer a structural view of an allosteric binding mode for an orthosteric GPCR ligand and provide additional opportunities for the design of ligands with different affinities or binding kinetics for different mAChR subtypes. Our findings not only offer insights into the structure and function of one of the most important GPCR families, but may also facilitate the design of improved therapeutics targeting these critical receptors.	[Kruse, Andrew C.; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Hu, Jianxin; Rosemond, Erica; Liu, Tong; Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, Bethesda, MD 20892 USA; [Pan, Albert C.; Arlow, Daniel H.; Green, Hillary F.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Rosenbaum, Daniel M.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chae, Pil Seok] Hanyang Univ, Dept Bionano Engn, Ansan 426791, South Korea; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); D. E. Shaw Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hanyang University; Stanford University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	jwess@helix.nih.gov; kobilka@stanford.edu	Pan, Albert/G-1475-2013; Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Dror, Ron/0000-0002-6418-2793; Rosemond, Erica/0000-0002-9188-7713; Pan, Albert/0000-0001-5050-5603; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [NS028471, GM56169]; Mathers Foundation; National Science Foundation; NIDDK, NIH, US Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118, R01GM056169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; National Science Foundation(National Science Foundation (NSF)); NIDDK, NIH, US Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health grants NS028471 (B. K. K.) and GM56169 (W. I. W.), from the Mathers Foundation (B. K. K. and W. I. W.), and from the National Science Foundation (A. C. K.). This work was supported in part by the Intramural Research Program, NIDDK, NIH, US Department of Health and Human Services. We thank R. Grisshammer and S. Costanzi for advice and discussions during various stages of the project, Y. Zhou for carrying out radioligand binding assays with several M3 receptor-T4 fusion constructs, D. Scarpazza for developing software that enabled forced dissociation simulations, and A. Taube, K. Palmo and D. Borhani for advice related to simulations.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barnes PJ, 2000, CHEST, V117, P63; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; BLIN N, 1995, J BIOL CHEM, V270, P17741, DOI 10.1074/jbc.270.30.17741; BLUML K, 1994, J BIOL CHEM, V269, P11537; BOLDEN C, 1992, J PHARMACOL EXP THER, V260, P576; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Casarosa P, 2010, J PHARMACOL EXP THER, V333, P201, DOI 10.1124/jpet.109.163188; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Dowling MR, 2006, BRIT J PHARMACOL, V148, P927, DOI 10.1038/sj.bjp.0706819; Dror RO, 2009, P C HIGH PERF COMP N; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; DRUBBISCH V, 1992, PHARMACEUT RES, V9, P1644, DOI 10.1023/A:1015885029612; ELLIS J, 1991, BIOCHEM PHARMACOL, V42, P1927, DOI 10.1016/0006-2952(91)90591-R; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Gautam D, 2009, P NATL ACAD SCI USA, V106, P6398, DOI 10.1073/pnas.0900977106; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Han SJ, 2005, J BIOL CHEM, V280, P24870, DOI 10.1074/jbc.M500379200; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kukkonen JP, 1996, J PHARMACOL EXP THER, V279, P593; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; Loewi O, 1921, PFLUG ARCH GES PHYS, V189, P239, DOI 10.1007/BF01738910; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Poulin B, 2010, P NATL ACAD SCI USA, V107, P9440, DOI 10.1073/pnas.0914801107; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Redka DS, 2008, MOL PHARMACOL, V74, P834, DOI 10.1124/mol.108.048074; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; TU T, 2008, P 2008 ACM IEEE C SU; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Werner H.J., 2010, MOLPRO VERSION 2010; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604	58	596	608	8	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					552	556		10.1038/nature10867	http://dx.doi.org/10.1038/nature10867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358844	Green Accepted			2022-12-28	WOS:000300770500056
J	Mefford, HC; Batshaw, ML; Hoffman, EP				Mefford, Heather C.; Batshaw, Mark L.; Hoffman, Eric P.			Genomics, Intellectual Disability, and Autism	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							15Q24 MICRODELETION SYNDROME; RARE CHROMOSOMAL DELETIONS; COPY NUMBER VARIANTS; DE-NOVO MUTATIONS; PERVASIVE DEVELOPMENTAL DISORDERS; IDIOPATHIC GENERALIZED EPILEPSY; MENTAL-RETARDATION; ARRAY CGH; SPECTRUM DISORDERS; BEHAVIORAL ABNORMALITIES		[Mefford, Heather C.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Batshaw, Mark L.; Hoffman, Eric P.] Childrens Natl Med Ctr, Dept Integrat Syst, Washington, DC 20010 USA; [Batshaw, Mark L.; Hoffman, Eric P.] Childrens Natl Med Ctr, Dept Biol, Washington, DC 20010 USA; [Batshaw, Mark L.; Hoffman, Eric P.] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA; [Batshaw, Mark L.; Hoffman, Eric P.] George Washington Univ, Sch Med, Washington, DC USA	University of Washington; University of Washington Seattle; Children's National Health System; Children's National Health System; Children's National Health System; George Washington University	Mefford, HC (corresponding author), Univ Washington, Dept Pediat, Div Med Genet, 1959 NE Pacific St,Box 356320, Seattle, WA 98195 USA.	hmefford@u.washington.edu		Hoffman, Eric/0000-0001-6470-5139	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029525] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029525] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR; Andrieux J, 2009, AM J MED GENET A, V149A, P2813, DOI 10.1002/ajmg.a.33097; Bachmann-Gagescu R, 2010, GENET MED, V12, P641, DOI 10.1097/GIM.0b013e3181ef4286; Balciuniene J, 2007, AM J HUM GENET, V80, P938, DOI 10.1086/513607; Ballif BC, 2007, AM J MED GENET A, V143A, P1850, DOI 10.1002/ajmg.a.31842; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Barak T, 2011, NAT GENET, V43, P590, DOI 10.1038/ng.836; Battaglia A, 2009, AM J MED GENET A, V149A, P1200, DOI 10.1002/ajmg.a.32847; Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Claes L, 2003, HUM MUTAT, V21, P615, DOI 10.1002/humu.10217; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Dibbens LM, 2009, HUM MOL GENET, V18, P3626, DOI 10.1093/hmg/ddp311; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; El-Hattab AW, 2010, GENET MED, V12, P573, DOI 10.1097/GIM.0b013e3181eb9b4a; El-Hattab AW, 2009, HUM GENET, V126, P589, DOI 10.1007/s00439-009-0706-x; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Grozeva D, 2011, SCHIZOPHR RES   1128; Haldeman-Englert C.R., 1993, GENEREVIEWS; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hempel M, 2009, AM J MED GENET A, V149A, P2106, DOI 10.1002/ajmg.a.33042; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jurado LAP, 1996, AM J HUM GENET, V59, P781; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Klopocki E, 2008, EUR J PEDIATR, V167, P903, DOI 10.1007/s00431-007-0616-7; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Koolen DA, 2009, J MED GENET, V46, P576, DOI 10.1136/jmg.2008.058701corr1; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Lisi EC, 2008, AM J MED GENET A, V146A, P601, DOI 10.1002/ajmg.a.32190; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Loirat C, 2010, NEPHROL DIAL TRANSPL, V25, P3430, DOI 10.1093/ndt/gfq380; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mefford HC, 2012, J MED GENET, V49, P110, DOI 10.1136/jmedgenet-2011-100499; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Moreno-De-Luca D, 2011, AM J HUM GENET, V88, P121, DOI 10.1016/j.ajhg.2010.12.005; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Murthy SK, 2007, CYTOGENET GENOME RES, V116, P135, DOI 10.1159/000097433; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ramalingam A, 2011, J HUM GENET, V56, P541, DOI 10.1038/jhg.2011.42; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Rosenfeld JA, 2010, J NEURODEV DISORD, V2, P26, DOI 10.1007/s11689-009-9037-4; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaffer LG, 2006, J PEDIAT, V149, P585; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; van Bon BWM, 2011, EUR J HUM GENET, V19, P400, DOI 10.1038/ejhg.2010.211; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; von der Lippe C, 2011, EUR J MED GENET, V54, P357, DOI 10.1016/j.ejmg.2010.12.008; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9	113	203	213	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					733	743		10.1056/NEJMra1114194	http://dx.doi.org/10.1056/NEJMra1114194			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356326	Green Accepted, Bronze			2022-12-28	WOS:000300551500011
J	Sosman, JA; Kim, KB; Schuchter, L; Gonzalez, R; Pavlick, AC; Weber, JS; McArthur, GA; Hutson, TE; Moschos, SJ; Flaherty, KT; Hersey, P; Kefford, R; Lawrence, D; Puzanov, I; Lewis, KD; Amaravadi, RK; Chmielowski, B; Lawrence, HJ; Shyr, Y; Ye, F; Li, J; Nolop, KB; Lee, RJ; Joe, AK; Ribas, A				Sosman, Jeffrey A.; Kim, Kevin B.; Schuchter, Lynn; Gonzalez, Rene; Pavlick, Anna C.; Weber, Jeffrey S.; McArthur, Grant A.; Hutson, Thomas E.; Moschos, Stergios J.; Flaherty, Keith T.; Hersey, Peter; Kefford, Richard; Lawrence, Donald; Puzanov, Igor; Lewis, Karl D.; Amaravadi, Ravi K.; Chmielowski, Bartosz; Lawrence, H. Jeffrey; Shyr, Yu; Ye, Fei; Li, Jiang; Nolop, Keith B.; Lee, Richard J.; Joe, Andrew K.; Ribas, Antoni			Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC MALIGNANT-MELANOMA; COOPERATIVE-ONCOLOGY-GROUP; RAF INHIBITOR PLX4032; PHASE-III TRIAL; DACARBAZINE; RESISTANCE; KINASE; BRAF(V600E); MUTATION; INTERFERON-ALPHA-2B	BACKGROUND Approximately 50% of melanomas harbor activating (V600) mutations in the serinethreonine protein kinase B-RAF (BRAF). The oral BRAF inhibitor vemurafenib (PLX4032) frequently produced tumor regressions in patients with BRAF V600-mutant metastatic melanoma in a phase 1 trial and improved overall survival in a phase 3 trial. METHODS We designed a multicenter phase 2 trial of vemurafenib in patients with previously treated BRAF V600-mutant metastatic melanoma to investigate the efficacy of vemurafenib with respect to overall response rate (percentage of treated patients with a tumor response), duration of response, and overall survival. The primary end point was the overall response rate as ascertained by the independent review committee; overall survival was a secondary end point. RESULTS A total of 132 patients had a median follow-up of 12.9 months (range, 0.6 to 20.1). The confirmed overall response rate was 53% (95% confidence interval [CI], 44 to 62; 6% with a complete response and 47% with a partial response), the median duration of response was 6.7 months (95% CI, 5.6 to 8.6), and the median progression-free survival was 6.8 months (95% CI, 5.6 to 8.1). Primary progression was observed in only 14% of patients. Some patients had a response after receiving vemurafenib for more than 6 months. The median overall survival was 15.9 months (95% CI, 11.6 to 18.3). The most common adverse events were grade 1 or 2 arthralgia, rash, photosensitivity, fatigue, and alopecia. Cutaneous squamous-cell carcinomas (the majority, keratoacanthoma type) were diagnosed in 26% of patients. CONCLUSIONS Vemurafenib induces clinical responses in more than half of patients with previously treated BRAF V600-mutant metastatic melanoma. In this study with a long follow-up, the median overall survival was approximately 16 months. (Funded by Hoffmann-La Roche; ClinicalTrials.gov number, NCT00949702.)	[Sosman, Jeffrey A.; Puzanov, Igor] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Shyr, Yu; Ye, Fei] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN USA; [Kim, Kevin B.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Schuchter, Lynn; Amaravadi, Ravi K.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Gonzalez, Rene; Lewis, Karl D.] Univ Colorado, Denver, CO 80202 USA; [Pavlick, Anna C.] NYU, Med Ctr, New York, NY 10016 USA; [Weber, Jeffrey S.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [McArthur, Grant A.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Hersey, Peter] Univ Newcastle, Newcastle, NSW 2300, Australia; [Kefford, Richard] Westmead Inst Canc Res, Westmead, NSW, Australia; [Kefford, Richard] Melanoma Inst Australia, Westmead, NSW, Australia; [Hutson, Thomas E.] Texas Oncol Baylor Sammons Canc Ctr, Dallas, TX USA; [Moschos, Stergios J.] Univ Pittsburgh, Pittsburgh, PA USA; [Flaherty, Keith T.; Lawrence, Donald] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Chmielowski, Bartosz; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Lawrence, H. Jeffrey] Roche Mol Syst, Pleasanton, CA USA; [Nolop, Keith B.] Plexxikon, Berkeley, CA USA; [Li, Jiang; Lee, Richard J.; Joe, Andrew K.] Hoffmann La Roche, Nutley, NJ USA	Vanderbilt University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Colorado System; University of Colorado Denver; New York University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Peter Maccallum Cancer Center; University of Newcastle; University of Sydney; Melanoma Institute Australia; Baylor University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Roche Holding; Plexxikon; Roche Holding	Sosman, JA (corresponding author), Vanderbilt Ingram Canc Ctr, 777 Preston Res Bldg, Nashville, TN 37232 USA.	jeff.sosman@vanderbilt.edu	PUZANOV, IGOR/AAP-2966-2020; Hutson, Thomas/AAS-9639-2020; gonzález, rene/W-2081-2019	PUZANOV, IGOR/0000-0002-9803-3497; Hutson, Thomas/0000-0002-4529-4212; McArthur, Grant/0000-0001-8908-6071; Chmielowski, Bartosz/0000-0002-2374-3320; Kefford, Richard/0000-0001-9251-9229; Weber, Jeffrey/0000-0002-4962-2957	Hoffmann-La Roche; NATIONAL CANCER INSTITUTE [K24CA097588, P30CA076292] Funding Source: NIH RePORTER	Hoffmann-La Roche(Hoffmann-La Roche); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Hoffmann-La Roche.	Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Atkins MB, 2008, J CLIN ONCOL, V26, P5748, DOI 10.1200/JCO.2008.17.5448; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Falkson CI, 1998, J CLIN ONCOL, V16, P1743, DOI 10.1200/JCO.1998.16.5.1743; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hodi FS, 2010, NEW ENGL J MED, V363, P1290; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Lacouture ME, 2010, J CLIN ONCOL S, V28, P15; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Middleton MR, 2000, J CLIN ONCOL, V18, P2351; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Robert C, 2011, CURR OPIN ONCOL, V23, P177, DOI 10.1097/CCO.0b013e3283436e8c; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Tsao H, 2004, NEW ENGL J MED, V351, P2461; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Yang H, 2010, CANCER RES, V70, P9527, DOI 10.1158/0008-5472.CAN-10-3605; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	39	1655	1705	1	136	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					707	714		10.1056/NEJMoa1112302	http://dx.doi.org/10.1056/NEJMoa1112302			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356324	Green Accepted, Green Published			2022-12-28	WOS:000300551500008
J	Campbell, PJ				Campbell, Peter J.			Telomeres and Cancer: From Crisis to Stability to Crisis to Stability	CELL			English	Editorial Material							TUMORS		Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England	Wellcome Trust Sanger Institute	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England.	pc8@sanger.ac.uk			Wellcome Trust [093867, 088340] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Hashimoto Y, 2008, J GASTROINTEST SURG, V12, P17, DOI 10.1007/s11605-007-0383-9; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6	10	21	23	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					633	635		10.1016/j.cell.2012.01.043	http://dx.doi.org/10.1016/j.cell.2012.01.043			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341437	Bronze, Green Accepted			2022-12-28	WOS:000300622400005
J	Tavares, L; Dimitrova, E; Oxley, D; Webster, J; Poot, R; Demmers, J; Bezstarosti, K; Taylor, S; Ura, H; Koide, H; Wutz, A; Vidal, M; Elderkin, S; Brockdorff, N				Tavares, Ligia; Dimitrova, Emilia; Oxley, David; Webster, Judith; Poot, Raymond; Demmers, Jeroen; Bezstarosti, Karel; Taylor, Stephen; Ura, Hiroki; Koide, Hiroshi; Wutz, Anton; Vidal, Miguel; Elderkin, Sarah; Brockdorff, Neil			RYBP-PRC1 Complexes Mediate H2A Ubiquitylation at Polycomb Target Sites Independently of PRC2 and H3K27me3	CELL			English	Article							EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; TRANSCRIPTION FACTOR YY1; GROUP PROTEINS RING1A/B; C-TERMINAL DOMAIN; HISTONE H2A; X-INACTIVATION; DEVELOPMENTAL REGULATORS; CHROMATIN-STRUCTURE; REPRESSIVE COMPLEX	Polycomb-repressive complex 1 (PRC1) has a central role in the regulation of heritable gene silencing during differentiation and development. PRC1 recruitment is generally attributed to interaction of the chromodomain of the core protein Polycomb with trimethyl histone H3K27 (H3K27me3), catalyzed by a second complex, PRC2. Unexpectedly we find that RING1B, the catalytic subunit of PRC1, and associated monoubiquitylation of histone H2A are targeted to closely overlapping sites in wild-type and PRC2-deficient mouse embryonic stem cells (mESCs), demonstrating an H3K27me3-independent pathway for recruitment of PRC1 activity. We show that this pathway is mediated by RYBP-PRC1, a complex comprising catalytic subunits of PRC1 and the protein RYBP. RYBP-PRC1 is recruited to target loci in mESCs and is also involved in Xist RNA-mediated silencing, the latter suggesting a wider role in Polycomb silencing. We discuss the implications of these findings for understanding recruitment and function of Polycomb repressors.	[Dimitrova, Emilia; Oxley, David; Webster, Judith; Elderkin, Sarah] Babraham Inst, Cambridge CB22 3AT, England; [Tavares, Ligia; Brockdorff, Neil] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Poot, Raymond] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen; Bezstarosti, Karel] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Taylor, Stephen] Univ Oxford, John Radcliffe Hosp, WIMM, Computat Biol Res Grp, Oxford OX3 9DS, England; [Ura, Hiroki; Koide, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan; [Wutz, Anton] Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Vidal, Miguel] CSIC, Ctr Invest Biol, Madrid 28040, Spain	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Oxford; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Kanazawa University; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Elderkin, S (corresponding author), Babraham Inst, Babraham Res Campus, Cambridge CB22 3AT, England.	sarah.elderkin@babraham.ac.uk; neil.brockdorff@bioch.ox.ac.uk	Ura, Hiroki/ABD-8427-2020; Demmers, Jeroen AA/F-4046-2016; Vidal, Miguel/M-8861-2016	Ura, Hiroki/0000-0002-7600-3481; Demmers, Jeroen AA/0000-0002-8757-9611; Koide, Hiroshi/0000-0001-5916-3179; Vidal, Miguel/0000-0003-4374-6761; Brockdorff, Neil/0000-0003-4838-2653; Tavares, Ligia/0000-0001-9487-7978	Wellcome Trust [090532/Z/09/Z]; MRC [G0900747 91070]; Wellcome Trust, UK [WT081385, WT085102MA]; BBSRC; FCT, Portugal; Spanish Ministry of Science and Innovation [BFU2010-18146]; Fundacion Ramon Areces; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H234, BBS/E/B/0000L748] Funding Source: researchfish; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; BBSRC [BBS/E/B/0000L748, BBS/E/B/0000H234] Funding Source: UKRI; MRC [G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank members of the lab and Rob Klose and Len R. Stephens for discussion and advice. We thank Haruhiko Koseki for providing RING1B and MPH1 antibodies and for helpful discussions. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z and MRC Hub grant G0900747 91070) for the generation of data. This work was funded by the Wellcome Trust, UK (N.B.; WT081385, S.E.; WT085102MA) and the BBSRC (E.D., D.O., and J.W.). L.T. received a PhD studentship from FCT, Portugal. M.V. is supported by grant BFU2010-18146 (Spanish Ministry of Science and Innovation) and Fundacion Ramon Areces.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Czypionka A, 2007, BIOCHEMISTRY-US, V46, P12764, DOI 10.1021/bi701343q; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Faust C, 1998, DEVELOPMENT, V125, P4495; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Herz HM, 2010, GENE DEV, V24, P857, DOI 10.1101/gad.1921610; Huen DS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-359; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kalenik JL, 1997, NUCLEIC ACIDS RES, V25, P843, DOI 10.1093/nar/25.4.843; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kyba M, 1998, MOL CELL BIOL, V18, P2712, DOI 10.1128/MCB.18.5.2712; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren XJ, 2011, MOL CELL BIOL, V31, P2100, DOI 10.1128/MCB.05088-11; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Ura H, 2008, J BIOL CHEM, V283, P9713, DOI 10.1074/jbc.M707275200; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang RJ, 2010, STRUCTURE, V18, P966, DOI 10.1016/j.str.2010.04.013; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200	76	415	431	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					664	678		10.1016/j.cell.2011.12.029	http://dx.doi.org/10.1016/j.cell.2011.12.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22325148	Green Published, hybrid			2022-12-28	WOS:000300622400009
J	Dhalla, F; Gulati, P; Sreerangaiah, D; Abraham, SM				Dhalla, Fatima; Gulati, Pooja; Sreerangaiah, Deepika; Abraham, Sonya M.			PICTURE QUIZ A man with thrombocytopenia	BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE FALCIPARUM-MALARIA; RANDOMIZED-TRIAL; ARTESUNATE; QUININE		[Gulati, Pooja; Abraham, Sonya M.] Chelsea & Westminster Hosp Fdn Trust, Charing Cross Hosp, London W6 8RF, England	Imperial College London	Abraham, SM (corresponding author), Chelsea & Westminster Hosp Fdn Trust, Charing Cross Hosp, London W6 8RF, England.	s.abraham@ic.ac.uk		Dhalla, Fatima/0000-0001-9244-2284				[Anonymous], 2010, HLTH PROTECTION REPO, V4; [Anonymous], 2010, DTB, V48, P129; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Faiz MA, 2005, LANCET, V366, P717; Fhogartaigh N, 2008, Q J MED, V101, P649; Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003; Seringe E, 2011, EMERG INFECT DIS, V17, P807, DOI 10.3201/eid1705.101527; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; WHO, 2010, SEV FALC MAL	9	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2012	344								e826	10.1136/bmj.e826	http://dx.doi.org/10.1136/bmj.e826			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896IP	22344305				2022-12-28	WOS:000300559200003
J	Moghal, N				Moghal, Nadeem			PERSONAL VIEW I don't need my own office	BRITISH MEDICAL JOURNAL			English	Editorial Material									Newcastle Hosp NHS Fdn Trust, Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Moghal, N (corresponding author), Newcastle Hosp NHS Fdn Trust, Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	nemoghal@googlemail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2012	344								e910	10.1136/bmj.e910	http://dx.doi.org/10.1136/bmj.e910			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IB	22337788				2022-12-28	WOS:000300557800004
J	Stumpf, MPH; Porter, MA				Stumpf, Michael P. H.; Porter, Mason A.			Critical Truths About Power Laws	SCIENCE			English	Editorial Material							DISTRIBUTIONS; MODELS		[Stumpf, Michael P. H.] Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England; [Porter, Mason A.] Univ Oxford, Math Inst, Oxford Ctr Ind & Appl Math, Oxford OX1 3LB, England; [Porter, Mason A.] Univ Oxford, CABDyN Complex Ctr, Oxford OX1 3LB, England	Imperial College London; University of Oxford; University of Oxford	Stumpf, MPH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England.	m.stumpf@imperial.ac.uk; porterm@maths.ox.ac.uk			Biotechnology and Biological Sciences Research Council [BB/F005210/1] Funding Source: Medline; BBSRC [BB/F005210/1] Funding Source: UKRI; EPSRC [EP/I017267/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I017267/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Avnir D, 1998, SCIENCE, V279, P39, DOI 10.1126/science.279.5347.39; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Clauset A., 2008, POWER LAWS MIST; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Gutenberg B., 1954, SEISMICITY EARTH ASS; Johnson N, 2011, SCIENCE, V333, P81, DOI 10.1126/science.1205068; Keller EF, 2005, BIOESSAYS, V27, P1060, DOI 10.1002/bies.20294; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Newman MEJ, 2011, AM J PHYS, V79, P800, DOI 10.1119/1.3590372; Sethna J. P., 2010, ENTROPY ORDER PARAME; Stumpf MPH, 2005, EUROPHYS LETT, V71, P152, DOI 10.1209/epl/i2004-10531-8; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Tanaka R, 2005, IEE P SYST BIOL, V152, P179, DOI 10.1049/ip-syb:20050042; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Willinger W, 2004, PROCEEDINGS OF THE 2004 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P130; Willinger W., 2009, NOT AM MATH SOC, V56, P586; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	20	366	369	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					665	666		10.1126/science.1216142	http://dx.doi.org/10.1126/science.1216142			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	889AY	22323807				2022-12-28	WOS:000300047100037
J	Ganz, PA; Barry, JM; Burke, W; Col, NF; Corso, PS; Dodson, E; Hammond, E; Kogan, BA; Lynch, CF; Newcomer, L; Seifter, EJ; Tooze, JA; Viswanath, K; Wessells, H				Ganz, Patricia A.; Barry, John M.; Burke, Wylie; Col, Nananda F.; Corso, Phaedra S.; Dodson, Everett; Hammond, Elizabeth; Kogan, Barry A.; Lynch, Charles F.; Newcomer, Lee; Seifter, Eric J.; Tooze, Janet A.; Viswanath, Kasisomayajula; Wessells, Hunter			National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ganz, Patricia A.] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Univ Washington, Sch Med, Seattle, WA USA; Univ New England, Biddeford, ME USA; Shared Decis Making Resources, Georgetown, ME USA; Univ Georgia, Athens, GA 30602 USA; Lombardi Comprehens Canc Ctr, Washington, DC USA; Georgetown Univ Hosp, Washington, DC 20007 USA; Univ Utah, Sch Med, Salt Lake City, UT USA; Amir Sys, Salt Lake City, UT USA; Albany Med Coll, Albany, NY 12208 USA; Urol Inst NE New York, Albany, NY USA; Univ Iowa, Iowa City, IA USA; United Healthcare, Minneapolis, MN USA; Johns Hopkins Univ, Sch Med, Lutherville Timonium, MD USA; Sidney Kimmel Comprehens Canc Ctr, Lutherville Timonium, MD USA; Wake Forest Sch Med, Winston Salem, NC USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of New England - Maine; University System of Georgia; University of Georgia; Georgetown University; Utah System of Higher Education; University of Utah; Albany Medical College; University of Iowa; UnitedHealth Group Incorporated; Johns Hopkins University; Wake Forest University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Ganz, PA (corresponding author), Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA.		Col, Nananda/AAE-3445-2019	Col, Nananda/0000-0001-7106-662X	NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA012197] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	144	146	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8					591	U118		10.7326/0003-4819-156-8-201204170-00010	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22351514				2022-12-28	WOS:000303151800018
J	Forner, A; Llovet, JM; Bruix, J				Forner, Alejandro; Llovet, Josep M.; Bruix, Jordi			Hepatocellular carcinoma	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEPATITIS-C; TRANSARTERIAL LIPIODOL CHEMOEMBOLIZATION; PERCUTANEOUS ETHANOL INJECTION; CHRONIC LIVER-DISEASE; ALPHA-FETOPROTEIN; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; INTERFERON THERAPY; CIRRHOTIC-PATIENTS	Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. Patients with cirrhosis are at highest risk of developing this malignant disease, and ultrasonography every 6 months is recommended. Surveillance with ultrasonography allows diagnosis at early stages when the tumour might be curable by resection, liver transplantation, or ablation, and 5-year survival higher than 50% can be achieved. Patients with small solitary tumours and very well preserved liver function are the best candidates for surgical resection. Liver transplantation is most beneficial for individuals who are not good candidates for resection, especially those within Milano criteria (solitary tumour <= 5 cm and up to three nodules <= 3 cm). Donor shortage greatly limits its applicability. Percutaneous ablation is the most frequently used treatment but its effectiveness is limited by tumour size and localisation. In asymptomatic patients with multifocal disease without vascular invasion or extrahepatic spread not amenable to curative treatments, chemoembolisation can provide survival benefit. Findings of randomised trials of sorafenib have shown survival benefits for individuals with advanced hepatocellular carcinoma, suggesting that molecular-targeted therapies could be effective in this chemoresistant cancer. Research is active in the area of pathogenesis and treatment of hepatocellular carcinoma.	[Forner, Alejandro; Llovet, Josep M.; Bruix, Jordi] Univ Barcelona, Hosp Clin Barcelona, August Pi & Sunyer Biomed Res Inst, Barcelona Clin,Liver Canc Grp,Liver Unit, Barcelona, Spain; [Forner, Alejandro; Llovet, Josep M.; Bruix, Jordi] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Llovet, Josep M.] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, Div Liver Dis, New York, NY USA; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Icahn School of Medicine at Mount Sinai; ICREA	Bruix, J (corresponding author), Hosp Clin Barcelona, IDIBAPS, Liver Unit, Barcelona Clin,Liver Canc Grp, Villarrel 170, Barcelona 08036, Spain.	jbruix@clinic.ub.es	Llovet, Josep M/D-4340-2014; Llovet, Josep M/ABB-6264-2021; Forner, Alejandro/C-8884-2016	Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; Forner, Alejandro/0000-0002-9014-4950; Bruix, Jordi/0000-0002-9826-0753	Bayer Schering Pharma; Bristol-Myers Squibb; Biocompatibles; Biosphere; Novartis; Imclone; Jennerex; Abbott; OSI; Terumo; Schering Plough; Eisai; Arqule; Angiodynamics; Kowa; GlaxoSmithKline; Sumitomo; Lilly; Spanish Biomedical Research Network (CIBER); Instituto de Salud Carlos III [PI 08/0146]; US National Institutes of Health-NIDDK [1R01DK076986-01]; National Institute of Health (Spain) [SAF-2007-61898]; Samuel Waxman Cancer Research Foundation; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076986] Funding Source: NIH RePORTER	Bayer Schering Pharma(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Biocompatibles; Biosphere; Novartis(Novartis); Imclone; Jennerex; Abbott(Abbott Laboratories); OSI(Astellas Pharmaceuticals); Terumo; Schering Plough(Merck & CompanySchering Plough Corporation); Eisai(Eisai Co Ltd); Arqule; Angiodynamics; Kowa; GlaxoSmithKline(GlaxoSmithKline); Sumitomo; Lilly(Eli Lilly); Spanish Biomedical Research Network (CIBER); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); US National Institutes of Health-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Health (Spain); Samuel Waxman Cancer Research Foundation; ICREA(ICREA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AF has received consultancy and lecture fees from Bayer Schering Pharma. JML has received grant support, consultancy fees, or both from Bayer Schering Pharma, Bristol-Myers Squibb, Biocompatibles, Biosphere, Novartis, Imclone, Jennerex, Abbott, and OSI. JB has received grant support, consultancy fees, or both from Bayer Schering Pharma, Bristol-Myers Squibb, Biocompatibles, Terumo, Novartis, Schering Plough, Eisai, Arqule, Angiodynamics, Kowa, GlaxoSmithKline, Sumitomo, Lilly, and OSI.; The Barcelona Clinic Liver Cancer (BCLC) is funded through the Spanish Biomedical Research Network (CIBER) for the area of Hepatic and Digestive disorders. This work was supported partly by grants from the Instituto de Salud Carlos III (PI 08/0146). JML has received grants from the US National Institutes of Health-NIDDK 1R01DK076986-01, National Institute of Health (Spain) grant I+D Program (SAF-2007-61898), and the Samuel Waxman Cancer Research Foundation.	Alazawi W, 2010, ALIMENT PHARM THER, V32, P344, DOI 10.1111/j.1365-2036.2010.04370.x; Arguedas MR, 2003, AM J GASTROENTEROL, V98, P679, DOI [10.1016/S0002-9270(02)06049-5, 10.1111/j.1572-0241.2003.07327.x]; Bargellini I, 2012, EUR J RADIOL, V81, P1173, DOI 10.1016/j.ejrad.2011.03.046; BEASLEY RP, 1981, LANCET, V2, P1129; Benson AB, 2009, J NATL COMPR CANC NE, V7, P350, DOI 10.6004/jnccn.2009.0027; BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005; Bosetti C, 2008, HEPATOLOGY, V48, P137, DOI 10.1002/hep.22312; Bravi F, 2009, HEPATOLOGY, V50, P1317, DOI 10.1002/hep.23272; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Breitenstein S, 2009, BRIT J SURG, V96, P975, DOI 10.1002/bjs.6731; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, GASTROENTEROLOGY, V140, P1990, DOI 10.1053/j.gastro.2011.03.010; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Cabibbo G, 2010, HEPATOLOGY, V51, P1274, DOI 10.1002/hep.23485; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042; Chen LD, 2010, EUR RADIOL, V20, P743, DOI 10.1007/s00330-009-1599-8; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Cheng A, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4000; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x; Croswell JM, 2010, SEMIN ONCOL, V37, P202, DOI 10.1053/j.seminoncol.2010.05.006; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Dawson LA, 2008, CANCER RADIOTHER, V12, P96, DOI 10.1016/j.canrad.2007.12.007; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Di Tommaso L, 2011, HEPATOLOGY, V53, P1549, DOI 10.1002/hep.24218; Doffoel M, 2008, EUR J CANCER, V44, P528, DOI 10.1016/j.ejca.2008.01.004; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Freeman RB, 2006, AM J TRANSPLANT, V6, P1416, DOI 10.1111/j.1600-6143.2006.01321.x; Germani G, 2010, J HEPATOL, V52, P380, DOI 10.1016/j.jhep.2009.12.004; Han KH, 2008, CANCER-AM CANCER SOC, V113, P995, DOI 10.1002/cncr.23684; Herrero JI, 2008, LIVER TRANSPLANT, V14, P272, DOI 10.1002/lt.21368; Hilgard P, 2010, HEPATOLOGY, V52, P1741, DOI 10.1002/hep.23944; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hsu CY, 2010, J HEPATOL, V53, P108, DOI 10.1016/j.jhep.2010.01.038; Huang GT, 2005, ANN SURG, V242, P36, DOI 10.1097/01.sla.0000167925.90380.fe; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Khalili K, 2011, J HEPATOL, V54, P723, DOI 10.1016/j.jhep.2010.07.025; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Lee SG, 2008, LIVER TRANSPLANT, V14, P935, DOI 10.1002/lt.21445; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; LIN DY, 1988, GASTROENTEROLOGY, V94, P453, DOI 10.1016/0016-5085(88)90436-2; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2002, GUT, V50, P123, DOI 10.1136/gut.50.1.123; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Macdonald DC, 2008, WORLD J GASTROENTERO, V14, P1657, DOI 10.3748/wjg.14.1657; Manghisi G, 1998, HEPATOLOGY, V28, P751; Marrero JA, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4001; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2008, ANN SURG ONCOL, V15, P1001, DOI 10.1245/s10434-007-9559-5; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Miyake Y, 2010, J VIRAL HEPATITIS, V17, P287, DOI 10.1111/j.1365-2893.2009.01181.x; Oliveri RS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004787.pub2; Orlando A, 2009, AM J GASTROENTEROL, V104, P514, DOI 10.1038/ajg.2008.80; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; PELLETIER G, 1990, J HEPATOL, V11, P181, DOI 10.1016/0168-8278(90)90110-D; Pomfret EA, 2010, LIVER TRANSPLANT, V16, P262, DOI 10.1002/lt.21999; Poustchi H, 2011, HEPATOLOGY, V54, P1998, DOI 10.1002/hep.24581; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qiu D, 2009, INT J CANCER, V124, P443, DOI 10.1002/ijc.23911; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941; Sala M, 2004, LIVER TRANSPLANT, V10, P1294, DOI 10.1002/lt.20202; Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006; Sangiovanni A, 2010, GUT, V59, P638, DOI 10.1136/gut.2009.187286; Sangro B, 2011, HEPATOLOGY, V54, P868, DOI 10.1002/hep.24451; Santi V, 2010, J HEPATOL, V53, P291, DOI 10.1016/j.jhep.2010.03.010; Sarasin FP, 1996, AM J MED, V101, P422, DOI 10.1016/S0002-9343(96)00197-0; Schnitzbauer AA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-190; Shen YC, 2010, J HEPATOL, V52, P889, DOI 10.1016/j.jhep.2009.12.041; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Singal AK, 2010, CLIN GASTROENTEROL H, V8, P192, DOI 10.1016/j.cgh.2009.10.026; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Tanaka Y, 2006, GASTROENTEROLOGY, V130, P703, DOI 10.1053/j.gastro.2006.01.032; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Tateishi R, 2005, GUT, V54, P419, DOI 10.1136/gut.2003.035055; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Trinchet JC, 2011, HEPATOLOGY, V54, P1987, DOI 10.1002/hep.24545; Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Vilana R, 2010, HEPATOLOGY, V51, P2020, DOI 10.1002/hep.23600; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Volk ML, 2008, AM J TRANSPLANT, V8, P839, DOI 10.1111/j.1600-6143.2007.02138.x; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhang BH, 1999, J MED SCREEN, V6, P108, DOI 10.1136/jms.6.2.108	127	4308	4650	58	756	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2012	379	9822					1245	1255		10.1016/S0140-6736(11)61347-0	http://dx.doi.org/10.1016/S0140-6736(11)61347-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918DV	22353262				2022-12-28	WOS:000302230400037
J	Gold, M				Gold, Marsha			Medicare Advantage - Lessons for Medicare's Future	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mathematica Policy Res, Washington, DC USA	Mathematica	Gold, M (corresponding author), Mathematica Policy Res, Washington, DC USA.							Aaron HJ, 2011, NEW ENGL J MED, V364, P1588, DOI 10.1056/NEJMp1103764; [Anonymous], 2011, REP C MED PAYM POL W, P293; Gold M, 2011, MEDICARE ADVANTAGE E; Gold M, 2003, HLTH AFF MILLWOOD, pW3; Gold M, 2010, HLTH AFF MILLWOOD, V29, P223; Gold M, 2009, HEALTH AFFAIR, V28, pW41, DOI 10.1377/hlthaff.28.1.w41	6	8	8	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2012	366	13					1174	1177		10.1056/NEJMp1200156	http://dx.doi.org/10.1056/NEJMp1200156			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	915DW	22356264				2022-12-28	WOS:000302005100003
J	Resnic, FS; Normand, SLT				Resnic, Frederic S.; Normand, Sharon-Lise T.			Postmarketing Surveillance of Medical Devices - Filling in the Gaps	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Resnic, Frederic S.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Resnic, FS (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.			Normand, Sharon-Lise/0000-0001-7027-4769				Gross T P, 1996, Stud Health Technol Inform, V28, P17; Miller MA, 2010, J AM COLL CARDIOL, V56, P738, DOI 10.1016/j.jacc.2010.05.021; Normand SL, 2010, MED CARE, V48, pS58, DOI 10.1097/MLR.0b013e3181de9cfa; Resnic FS, 2010, JAMA-J AM MED ASSOC, V304, P2019, DOI 10.1001/jama.2010.1633	4	70	70	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2012	366	10					875	877		10.1056/NEJMp1114865	http://dx.doi.org/10.1056/NEJMp1114865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904CY	22332950				2022-12-28	WOS:000301172500002
J	Zhang, XB; Hung, CL; Tung, SK; Chin, C				Zhang, Xibo; Hung, Chen-Lung; Tung, Shih-Kuang; Chin, Cheng			Observation of Quantum Criticality with Ultracold Atoms in Optical Lattices	SCIENCE			English	Article							PHASE-TRANSITION; CRITICAL-BEHAVIOR; SUPERFLUID; GAS; INSULATOR; LIQUID; BOSONS	Quantum criticality emerges when a many-body system is in the proximity of a continuous phase transition that is driven by quantum fluctuations. In the quantum critical regime, exotic, yet universal properties are anticipated; ultracold atoms provide a clean system to test these predictions. We report the observation of quantum criticality with two-dimensional Bose gases in optical lattices. On the basis of in situ density measurements, we observe scaling behavior of the equation of state at low temperatures, locate the quantum critical point, and constrain the critical exponents. We observe a finite critical entropy per particle that carries a weak dependence on the atomic interaction strength. Our experiment provides a prototypical method to study quantum criticality with ultracold atoms.	[Zhang, Xibo] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Zhang, XB (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	xibo@uchicago.edu; cchin@uchicago.edu			NSF [PHY-0747907]; NSF-MRSEC [DMR-0213745]; Packard foundation; Army Research Office; Defense Advanced Research Projects Agency	NSF(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Packard foundation(The David & Lucile Packard Foundation); Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We thank N. Prokof'ev and D.-W. Wang for discussions and numerical data; Q. Zhou, K. Hazzard, and N. Trivedi for discussions; and N. Gemelke and C. Parker for discussions and reading of the manuscript. The work was supported by NSF (grants PHY-0747907 and NSF-MRSEC DMR-0213745), the Packard foundation, and a grant from the Army Research Office with funding from the Defense Advanced Research Projects Agency Optical Lattice Emulator program. The data presented in this paper are available upon request sent to cchin@uchicago.edu.	Al Khawaja U, 2001, NATURE, V411, P918, DOI 10.1038/35082010; Baumann K, 2010, NATURE, V464, P1301, DOI 10.1038/nature09009; Capogrosso-Sansone B, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043010; Coldea R, 2010, SCIENCE, V327, P177, DOI 10.1126/science.1180085; Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; Donner T, 2007, SCIENCE, V315, P1556, DOI 10.1126/science.1138807; Fang SA, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.031605; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Gemelke N, 2009, NATURE, V460, P995, DOI 10.1038/nature08244; Haller E, 2010, NATURE, V466, P597, DOI 10.1038/nature09259; Hazzard KRA, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.013604; Hung CL, 2011, NATURE, V470, P236, DOI 10.1038/nature09722; Hung CL, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.160403; Jaramillo R, 2010, P NATL ACAD SCI USA, V107, P13631, DOI [10.1073/pnas.1005036107, 10.1073/pnas.100S036107]; Kato Y, 2008, NAT PHYS, V4, P617, DOI 10.1038/nphys983; Low R, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033422; Sachdev S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.085116; Sachdev S., 1999, QUANTUM PHASE TRANSI; Sachdev S, 2008, NAT PHYS, V4, P173, DOI 10.1038/nphys894; Sachdev S, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/16/164216; Sebastian SE, 2006, NATURE, V441, P617, DOI 10.1038/nature04732; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Trotzky S, 2010, NAT PHYS, V6, P998, DOI 10.1038/NPHYS1799; van der Marel D, 2003, NATURE, V425, P271, DOI 10.1038/nature01978; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Yefsah T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.130401; Zhang XB, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/045011; Zhou Q, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.245702	31	96	96	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1070	1072		10.1126/science.1217990	http://dx.doi.org/10.1126/science.1217990			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22345397	Green Submitted			2022-12-28	WOS:000300931100038
J	Armstrong, AA; Mohideen, F; Lima, CD				Armstrong, Anthony A.; Mohideen, Firaz; Lima, Christopher D.			Recognition of SUMO-modified PCNA requires tandem receptor motifs in Srs2	NATURE			English	Article							UBIQUITIN-BINDING DOMAINS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA; RECOMBINATION; CLAMP; PHOSPHORYLATION; POLYMERASES; RECRUITMENT	Ubiquitin (Ub) and ubiquitin-like (Ubl) modifiers such as SUMO (also known as Smt3 in Saccharomyces cerevisiae) mediate signal transduction through post-translational modification of substrate proteins in pathways that control differentiation, apoptosis and the cell cycle, and responses to stress such as the DNA damage response. In yeast, the proliferating cell nuclear antigen PCNA (also known as Pol30) is modified by ubiquitin in response to DNA damage and by SUMO during S phase. Whereas Ub-PCNA can signal for recruitment of translesion DNA polymerases, SUMO-PCNA signals for recruitment of the anti-recombinogenic DNA helicase Srs2. It remains unclear how receptors such as Srs2 specifically recognize substrates after conjugation to Ub and Ubls. Here we show, through structural, biochemical and functional studies, that the Srs2 carboxy-terminal domain harbours tandem receptor motifs that interact independently with PCNA and SUMO and that both motifs are required to recognize SUMO-PCNA specifically. The mechanism presented is pertinent to understanding how other receptors specifically recognize Ub- and Ubl-modified substrates to facilitate signal transduction.	[Armstrong, Anthony A.; Mohideen, Firaz; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA.	limac@mskcc.org		Lima, Christopher/0000-0002-9163-6092	NIH NCRR [RR-15301, P41RR012408]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH [R01 GM065872, F32 GM086066]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872, F32GM086066] Funding Source: NIH RePORTER	NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kuriyan and B. Kelch for coordinates of the T4 clamp before publication. NE-CAT beamlines (Advanced Photon Source) supported by RR-15301 (NIH NCRR). APS supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Beamline X29 (National Synchrotron Light Source) supported by the US Department of Energy, the Office of Basic Energy Sciences and P41RR012408 (NIH NCRR). A.A.A., F.M. and C.D.L. are supported by NIH R01 GM065872 to C.D.L. and F32 GM086066 to A.A.A.	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L, PYMOL MOL GRAPHICS S; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Freudenthal BD, 2011, J MOL BIOL, V406, P9, DOI 10.1016/j.jmb.2010.12.015; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Scott MT, 2000, J BIOL CHEM, V275, P11529, DOI 10.1074/jbc.275.15.11529; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Ulrich HD, 2007, BIOCHEM SOC T, V35, P1385, DOI 10.1042/BST0351385; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11	49	101	101	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					59	U99		10.1038/nature10883	http://dx.doi.org/10.1038/nature10883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22382979	Green Accepted			2022-12-28	WOS:000300877900043
J	Boyle, EM; Poulsen, G; Field, DJ; Kurinczuk, JJ; Wolke, D; Alfirevic, Z; Quigley, MA				Boyle, Elaine M.; Poulsen, Gry; Field, David J.; Kurinczuk, Jennifer J.; Wolke, Dieter; Alfirevic, Zarko; Quigley, Maria A.			Effects of gestational age at birth on health outcomes at 3 and 5 years of age: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LATE-PRETERM BIRTH; INTERNATIONAL SURVEY; INFANTS BORN; TERM INFANTS; MORBIDITY; MORTALITY; CHILDREN; ADOLESCENTS; VALIDITY; RISK	Objective To investigate the burden of later disease associated with moderate/late preterm (32-36 weeks) and early term (37-38 weeks) birth. Design Secondary analysis of data from the Millennium Cohort Study (MCS). Setting Longitudinal study of infants born in the United Kingdom between 2000 and 2002. Participants 18 818 infants participated in the MCS. Effects of gestational age at birth on health outcomes at 3 (n=14 273) and 5 years (n=14 056) of age were analysed. Main outcome measures Growth, hospital admissions, longstanding illness/disability, wheezing/asthma, use of prescribed drugs, and parental rating of their children's health. Results Measures of general health, hospital admissions, and longstanding illness showed a gradient of increasing risk of poorer outcome with decreasing gestation, suggesting a "dose-response" effect of prematurity. The greatest contribution to disease burden at 3 and 5 years was in children born late/moderate preterm or early term. Population attributable fractions for having at least three hospital admissions between 9 months and 5 years were 5.7% (95% confidence interval 2.0% to 10.0%) for birth at 32-36 weeks and 7.2% (1.4% to 13.6%) for birth at 37-38 weeks, compared with 3.8% (1.3% to 6.5%) for children born very preterm (<32 weeks). Similarly, 2.7% (1.1% to 4.3%), 5.4% (2.4% to 8.6%), and 5.4% (0.7% to 10.5%) of limiting longstanding illness at 5 years were attributed to very preterm birth, moderate/late preterm birth, and early term birth. Conclusions These results suggest that health outcomes of moderate/late preterm and early term babies are worse than those of full term babies. Additional research should quantify how much of the effect is due to maternal/fetal complications rather than prematurity itself.	[Boyle, Elaine M.; Field, David J.] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Poulsen, Gry; Kurinczuk, Jennifer J.; Quigley, Maria A.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Wolke, Dieter] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Wolke, Dieter] Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England; [Alfirevic, Zarko] Univ Liverpool, Dept Womens & Childrens Hlth, Inst Translat Med, Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England	University of Leicester; University of Oxford; University of Warwick; University of Warwick; University of Liverpool	Boyle, EM (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	eb124@le.ac.uk	Wolke, Dieter/C-5372-2008; Boyle, Elaine M/I-6298-2018	Wolke, Dieter/0000-0003-0304-268X; Boyle, Elaine M/0000-0002-5038-3148; Quigley, Maria/0000-0002-8058-6181	BUPA Foundation; National Institute for Health Research [RP-PG-0407-10029] Funding Source: researchfish	BUPA Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	The BUPA Foundation funded the study but had no role in the study design, data analysis and interpretation, or writing of the report.	Abe K, 2010, J PEDIATR-US, V157, P74, DOI 10.1016/j.jpeds.2010.01.008; Baron IS, 2011, EARLY HUM DEV, V87, P115, DOI 10.1016/j.earlhumdev.2010.11.010; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; Centre for Longitudinal Studies, 2010, MILL COH STUD 1 2 3; Chyi LJ, 2008, J PEDIATR-US, V153, P25, DOI 10.1016/j.jpeds.2008.01.027; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; D'Souza-Vazirani D, 2005, ARCH PEDIAT ADOL MED, V159, P167, DOI 10.1001/archpedi.159.2.167; Escobar GJ, 2006, SEMIN PERINATOL, V30, P28, DOI 10.1053/j.semperi.2006.01.005; Escobar GJ, 2005, ARCH DIS CHILD, V90, P125, DOI 10.1136/adc.2003.039974; Ketende S, 2008, MILLENNIUM COHORT ST; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Lindstrom K, 2009, PEDIATRICS, V123, pE47, DOI 10.1542/peds.2008-1654; Mac Bird T, 2010, PEDIATRICS, V126, pE311, DOI 10.1542/peds.2009-2869; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; McLaurin KK, 2009, PEDIATRICS, V123, P653, DOI 10.1542/peds.2008-1439; Moser K, 2007, HLTH STAT Q, V13, P27; Natarajan S, 2007, STAT MED, V26, P3229, DOI 10.1002/sim.2779; Oddie SJ, 2005, ARCH DIS CHILD, V90, P119, DOI 10.1136/adc.2003.040766; Petrini JR, 2009, J PEDIATR-US, V154, P169, DOI 10.1016/j.jpeds.2008.08.020; Plewis I., 2007, INT J SOC RES METHOD, V10, P325, DOI [DOI 10.1080/13645570701676955, 10.1080/13645570701676955]; Plewis I., 2007, MILLENNIUM COHORT ST; Poulsen G, 2011, J CLIN EPIDEMIOL, V64, P1444, DOI 10.1016/j.jclinepi.2011.03.007; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Tomashek KM, 2007, J PEDIATR-US, V151, P450, DOI 10.1016/j.jpeds.2007.05.002; van Baar AL, 2009, PEDIATRICS, V124, P251, DOI 10.1542/peds.2008-2315; Vernacchio L, 2007, J AM BOARD FAM MED, V20, P160, DOI 10.3122/jabfm.2007.02.060125; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	30	275	282	8	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2012	344								e896	10.1136/bmj.e896	http://dx.doi.org/10.1136/bmj.e896			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XJ	22381676	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000301231900003
J	Smith, R				Smith, Richard			PERSONAL VIEW Online marketing of medical procedures needs better regulation	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Smith, R (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England.	Richard.Smith@lshtm.ac.uk						Association of the British Pharmaceutical Industry, COD PRACT PHARM IND; British Association of Aesthetic Plastic Surgeons, 2012, SURG PUT FORW REG PR; Committee of Advertising Practice, 2008, COSM SURG ADS NEED E; European Commission, 2000, E COMM DIR; Lunt N, 2011, TOUR REV, V66, P57, DOI 10.1108/16605371111127224; Lunt Neil, 2010, Open Med Inform J, V4, P1, DOI 10.2174/1874431101004010001; Marmor T. R., 2009, BLUE GUID ADV PROM M; Muscat N., 2006, INT PASS SURV 2011; Smith R, 2011, HEALTH POLICY, V103, P276, DOI 10.1016/j.healthpol.2011.06.009; Smith RD, 2009, LANCET, V373, P768, DOI 10.1016/S0140-6736(08)61780-8; Thaler R., 2008, INT COMP LEGAL GUIDE	11	1	1	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 29	2012	344								e1399	10.1136/bmj.e1399	http://dx.doi.org/10.1136/bmj.e1399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XE	22378929				2022-12-28	WOS:000301231400011
J	Liu, S; Cipriano, LE; Holodniy, M; Owens, DK; Goldhaber-Fiebert, JD				Liu, Shan; Cipriano, Lauren E.; Holodniy, Mark; Owens, Douglas K.; Goldhaber-Fiebert, Jeremy D.			New Protease Inhibitors for the Treatment of Chronic Hepatitis C A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-STATE UTILITIES; QUALITY-OF-LIFE; VIRUS-INFECTION; PEGINTERFERON ALPHA-2B; VIROLOGICAL RESPONSE; GENETIC-VARIATION; ALL-CAUSE; RIBAVIRIN; IL28B; ASSOCIATION	Background: Chronic hepatitis C virus is difficult to treat and affects approximately 3 million Americans. Protease inhibitors increase the effectiveness of standard therapy, but they are costly. A genetic assay may identify patients most likely to benefit from this treatment advance. Objective: To assess the cost-effectiveness of new protease inhibitors and an interleukin (IL)-28B genotyping assay for treating chronic hepatitis C virus. Design: Decision-analytic Markov model. Data Sources: Published literature and expert opinion. Target Population: Treatment-naive patients with chronic, genotype 1 hepatitis C virus monoinfection. Time Horizon: Lifetime. Perspective: Societal. Intervention: Strategies are defined by the use of IL-28B genotyping and type of treatment (standard therapy [pegylated interferon with ribavirin]; triple therapy [standard therapy and a protease inhibitor]). Interleukin-28B-guided triple therapy stratifies patients with CC genotypes to standard therapy and those with non-CC types to triple therapy. Outcome Measures: Discounted costs (in 2010 U.S. dollars) and quality-adjusted life-years (QALYs); incremental cost-effectiveness ratios. Results of Base-Case Analysis: For patients with mild and advanced fibrosis, universal triple therapy reduced the lifetime risk for hepatocellular carcinoma by 38% and 28%, respectively, and increased quality-adjusted life expectancy by 3% and 8%, respectively, compared with standard therapy. Gains from IL-28B-guided triple therapy were smaller. If the protease inhibitor costs $1100 per week, universal triple therapy costs $102 600 per QALY (mild fibrosis) or $51 500 per QALY (advanced fibrosis) compared with IL-28B-guided triple therapy and $70 100 per QALY (mild fibrosis) and $36 300 per QALY (advanced fibrosis) compared with standard therapy. Results of Sensitivity Analysis: Results were sensitive to the cost of protease inhibitors and treatment adherence rates. Limitation: Data on the long-term comparative effectiveness of the new protease inhibitors are lacking. Conclusion: Both universal triple therapy and IL-28B-guided triple therapy are cost-effective when the least-expensive protease inhibitor are used for patients with advanced fibrosis.	[Goldhaber-Fiebert, Jeremy D.] Stanford Univ, CHP, PCOR, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Goldhaber-Fiebert, JD (corresponding author), Stanford Univ, CHP, PCOR, Ctr Primary Care & Outcomes Res, 117 Encina Commons, Stanford, CA 94305 USA.	shanliu@stanford.edu	Cipriano, Lauren E/C-3521-2017; Liu, Sheng/K-2815-2013	Cipriano, Lauren E/0000-0001-5568-4516; Holodniy, Mark/0000-0002-6655-7982; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	Stanford Graduate Fellowship; Social Sciences and Humanities Research Council of Canada; Institute for Operations Research and the Management Sciences; Department of Veterans Affairs; National Institutes of Health National Institute on Aging [K01 AG037593-01A1]; Stanford University;  [R01 DA15612-016]; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Institute for Operations Research and the Management Sciences; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Stanford University(Stanford University); ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Ms. Liu was supported by a Stanford Graduate Fellowship. Ms. Cipriano was supported by a doctoral scholarship from the Social Sciences and Humanities Research Council of Canada and by the Seth Bonder Scholarship for Applied Operations Research in Health Services from the Institute for Operations Research and the Management Sciences. Drs. Holodniy and Owens are supported by the Department of Veterans Affairs and supported in part by R01 DA15612-016. Dr. Goldhaber-Fiebert was supported in part by a National Institutes of Health National Institute on Aging Career Development Award (K01 AG037593-01A1; principal investigator, Dr. Goldhaber-Fiebert).; Stanford University.	Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Armstrong EP, 2004, CURR MED RES OPIN, V20, P671, DOI 10.1185/030079904125003485; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Bedossa P, 2009, J HEPATOL, V50, P1, DOI 10.1016/j.jhep.2008.10.014; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Birnkrant D, 2011, 201917 NDA US DEP HL; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Food and Drug Administration, 2011, BACKGR MAT BOC ADV C; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gold MR, 1996, COST EFFECTIVENESS H; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Gupta S, 2011, 18 C RETR OPP INF CR; Holtz-Eakin D, 2005, PRICES BRAND NAME DR; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen DM, 2009, ANN INTERN MED, V150, P528, DOI 10.7326/0003-4819-150-8-200904210-00007; Levin J., 2010, 61 ANN M AM ASS STUD; Liu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026783; McEvoy G., 2009, AHFS DRUG INFORM 200; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Merck & Co, 2011, FDA ANT DRUGS ADV CO; Mitra D, 2010, VALUE HEALTH, V13, P479, DOI 10.1111/j.1524-4733.2009.00691.x; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Pollack A., 2011, NY TIMES, pB2; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poret AW, 2002, DIS MANAG, V5, P95; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sherman KE, 2004, ARCH INTERN MED, V164, P2377, DOI 10.1001/archinte.164.21.2377; Siddiqui FA, 2008, HEPATOL INT, V2, P376, DOI 10.1007/s12072-008-9086-x; Stephens JM, 2010, 61 ANN M AM ASS STUD; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Surveillance Epidemiology and End Results, CANC STAT FACT SHEET; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thomson Corporation, 2009, RED BOOK 2009 PHARM; U.S. Department Of Labor Bureau of Labor Statistics, CONS PRIC IND; United States Department of Veterans Affairs, 2011, DRUG PHARM PRIC; van Heeswijk R, 2011, 18 C RETR OPP INF CR; Vertex Pharmaceuticals, 2011, 201917 NDA US FOOD D; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	57	155	157	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					279	U68		10.7326/0003-4819-156-4-201202210-00005	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00005			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896YO	22351713				2022-12-28	WOS:000300607600005
J	Stanbrook, MB				Stanbrook, Matthew B.			Prior use of inhaled corticosteroids was associated with less mortality in elders with COPD and pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.							Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-12	10.7326/0003-4819-156-4-201202210-02012	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351738				2022-12-28	WOS:000208885400011
J	Kaminski, D; Geisler, C				Kaminski, Deborah; Geisler, Cheryl			Survival Analysis of Faculty Retention in Science and Engineering by Gender	SCIENCE			English	Article							INTENTIONS; TURNOVER	Individual assistant professors (a total of 2966 faculty) hired in science and engineering since 1990 at 14 United States universities were tracked from time of hire to time of departure by using publicly available catalogs and bulletins. Results of survival analysis showed that the chance that any given faculty member will be retained over time is less than 50%; the median time to departure is 10.9 years. Of all those who enter as assistant professors, 64.2% were promoted to associate professor at the same institution. Overall, men and women are retained and promoted at the same rate. In mathematics, however, faculty leave significantly earlier than other disciplines, and women leave significantly sooner than men, 4.45 years compared with 7.33 years.	[Kaminski, Deborah] Rensselaer Polytech Inst, Dept Mech Aerosp & Nucl Engn, Troy, NY 12180 USA; [Geisler, Cheryl] Simon Fraser Univ, Harbour Ctr 7410, Fac Commun Art & Technol, Vancouver, BC V6B 5K3, Canada	Rensselaer Polytechnic Institute; Simon Fraser University	Kaminski, D (corresponding author), Rensselaer Polytech Inst, Dept Mech Aerosp & Nucl Engn, Troy, NY 12180 USA.	kamind@rpi.edu	Geisler, Cheryl/I-3770-2014	Geisler, Cheryl/0000-0001-7707-1622	NSF ADVANCE [0548354]	NSF ADVANCE(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank T. Willemain and K. Bennett for help with the analysis. This work was supported by NSF ADVANCE award 0548354. The data reported in this paper are archived in the supporting online material.	CALLISTER RR, 2006, J TECHNOLOGY TRANSFE, V31, P367; Cleary R., 2010, NOT AM MATH SOC, V57, P1306; Ding WW, 2006, SCIENCE, V313, P665, DOI 10.1126/science.1124832; Ehrenberg RG, 1991, ECON EDUC REV, V10, P99, DOI DOI 10.1016/0272-7757(91)90002-7; Gardner S., J PROFESSORIATE; Geisler C., 2007, NWSA J, V19, P145; Hosmer DWJ., 2008, APPL SURVIVAL ANAL; Ley TJ, 2008, SCIENCE, V322, P1472, DOI 10.1126/science.1165878; Marschke R, 2007, J HIGH EDUC-UK, V78, P1, DOI 10.1353/jhe.2007.0003; Nagowski M. P., 2006, AM EC SPRING, V50, P69; National Academy of Sciences National Academy of Engineering and Institute of Medicine, 2007, BIAS BARR FULF POT W; National Research Council Committee on Gender Differences in the Careers of Science Engineering and Mathematics Faculty; Committee on Women in Science Engineering and Medicine; and Committee on National Statistics, 2010, GEND DIFF CRIT TRANS; Nelson D., 2006, NATL ANAL DIVERSITY; Preston AE., 2004, LEAVING SCI; RAUSCH DK, 1989, CUPA J, V40, P1; Rosser VJ, 2004, RES HIGH EDUC, V45, P285, DOI 10.1023/B:RIHE.0000019591.74425.f1; University of Colorado at Boulder, 2001, FAC RECR RET TASK FO; Valian V, 1998, WHY SO SLOW ADVANCEM; Xu YJ, 2008, RES HIGH EDUC, V49, P607, DOI 10.1007/s11162-008-9097-4; Xu YHJ, 2008, RES HIGH EDUC, V49, P40, DOI 10.1007/s11162-007-9062-7; Zhou Y, 2004, RES HIGH EDUC, V45, P139, DOI 10.1023/B:RIHE.0000015693.38603.4c	21	89	89	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					864	866		10.1126/science.1214844	http://dx.doi.org/10.1126/science.1214844			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	893LC	22344445				2022-12-28	WOS:000300356400046
J	Xie, W; Barr, CL; Kim, A; Yue, F; Lee, AY; Eubanks, J; Dempster, EL; Ren, B				Xie, Wei; Barr, Cathy L.; Kim, Audrey; Yue, Feng; Lee, Ah Young; Eubanks, James; Dempster, Emma L.; Ren, Bing			Base-Resolution Analyses of Sequence and Parent-of-Origin Dependent DNA Methylation in the Mouse Genome	CELL			English	Article							DE-NOVO METHYLATION; NON-CPG METHYLATION; IMPRINTED GENES; STEM-CELLS; MAMMALIAN DEVELOPMENT; CHROMOSOME 2; IDENTIFICATION; DNMT3A; DOMAIN; BRAIN	Differential methylation of the two parental genomes in placental mammals is essential for genomic imprinting and embryogenesis. To systematically study this epigenetic process, we have generated a base-resolution, allele-specific DNA methylation (ASM) map in the mouse genome. We find parent-of-origin dependent (imprinted) ASM at 1,952 CG dinucleotides. These imprinted CGs form 55 discrete clusters including virtually all known germline differentially methylated regions (DMRs) and 23 previously unknown DMRs, with some occurring at microRNA genes. We also identify sequence-dependent ASM at 131,765 CGs. Interestingly, methylation at these sites exhibits a strong dependence on the immediate adjacent bases, allowing us to define a conserved sequence preference for the mammalian DNA methylation machinery. Finally, we report a surprising presence of non-CG methylation in the adult mouse brain, with some showing evidence of imprinting. Our results provide a resource for understanding the mechanisms of imprinting and allele-specific gene expression in mammalian cells.	[Barr, Cathy L.; Eubanks, James; Dempster, Emma L.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON M5G 2M9, Canada; [Xie, Wei; Kim, Audrey; Yue, Feng; Lee, Ah Young; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Barr, Cathy L.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dempster, Emma L.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Ren, Bing] Univ Calif San Diego, Sch Med, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Ludwig Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of London; King's College London; University of California System; University of California San Diego; University of California System; University of California San Diego	Barr, CL (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON M5G 2M9, Canada.	cbarr@uhnres.utoronto.ca; biren@ucsd.edu	Dempster, Emma L/C-8592-2014; Xie, Wei/J-1380-2017	Dempster, Emma L/0000-0003-1257-5314; Xie, Wei/0000-0003-2126-3849; Eubanks, James/0000-0001-8595-2024; Barr, Cathy/0000-0003-0361-0106	Krembil Seed Development Fund; Applied Biosystems (Life Technologies); Ludwig Institute for Cancer Research; NIH [U01ES017166]; National Human Genome Research Institute [R01 HG003991]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Krembil Seed Development Fund; Applied Biosystems (Life Technologies); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. Ryan Lister and Joseph Ecker for sharing the MethylC-Seq protocol and for valuable input on the experimental design. We are grateful to Dr. Paul Soloway for comments on the manuscript, Dr. Wei Wang for discussions, Ms. Lee Edsall and Samantha Kuan for technical support in deep sequencing, Richard Logan, Yu Feng, and Lissette Gomez for technical support in dissection of frontal cortex and extraction of DNA/RNA, Karen Wigg for initial RNA-Seq bioinformatics support, and members of the Ren laboratory for discussions. This study was funded in part by grants from the Krembil Seed Development Fund (C.L.B.), an Applied Biosystems (Life Technologies) 10K Genome Award (C.L.B.), and funding from the Ludwig Institute for Cancer Research (B.R.), the NIH Epigenomics Roadmap Project U01ES017166 (B.R.), and the National Human Genome Research Institute R01 HG003991 (B.R.).	Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen PY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r62; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cooper WN, 2010, BRIEF FUNCT GENOMICS, V9, P315, DOI 10.1093/bfgp/elq018; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Dyachenko OV, 2010, EPIGENETICS-US, V5, P569, DOI 10.4161/epi.5.7.12702; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; Hellman A, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-11; Hiura H, 2010, NUCLEIC ACIDS RES, V38, P4929, DOI 10.1093/nar/gkq200; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Singh P, 2011, MOL CELL BIOL, V31, P1757, DOI 10.1128/MCB.00961-10; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; SURANI MA, 1990, DEVELOPMENT, P89; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Tycko B, 2010, HUM MOL GENET, V19, pR210, DOI 10.1093/hmg/ddq376; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	60	362	379	1	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					816	831		10.1016/j.cell.2011.12.035	http://dx.doi.org/10.1016/j.cell.2011.12.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341451	Bronze, Green Accepted			2022-12-28	WOS:000300622400021
J	Neumann, PJ				Neumann, Peter J.			What We Talk about When We Talk about Health Care Costs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Neumann, Peter J.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Neumann, Peter J.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Neumann, PJ (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA.							[Anonymous], 2012, ANN INTERN MED, V156, P73; [Anonymous], 2011, COMMUNICATION   0606; Dentzer S, 2011, HEALTH AFFAIR, V30, P2252, DOI 10.1377/hlthaff.2011.1233; Stein R, 2012, SHOULD DOCTORS BE PA	4	22	22	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					585	586		10.1056/NEJMp1200390	http://dx.doi.org/10.1056/NEJMp1200390			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	892IL	22335735				2022-12-28	WOS:000300279800002
J	Morice, P; Uzan, C; Gouy, S; Verschraegen, C; Haie-Meder, C				Morice, Philippe; Uzan, Catherine; Gouy, Sebastien; Verschraegen, Claire; Haie-Meder, Christine			Gynaecological cancers in pregnancy	LANCET			English	Article							INVASIVE CERVICAL-CANCER; SQUAMOUS INTRAEPITHELIAL LESIONS; EPITHELIAL OVARIAN-CARCINOMA; CLINICAL-PRACTICE GUIDELINES; ENDODERMAL SINUS TUMOR; NON-HODGKINS LYMPHOMA; CELL LUNG-CANCER; NEOADJUVANT CHEMOTHERAPY; ADNEXAL MASSES; PLANNED DELAY	Cervical and ovarian cancers are the most common gynaecological cancers diagnosed during pregnancy. In early-stage cervical cancer during the first and at the beginning of the second trimester, the two main considerations for management of the patient are the tumour size (and stage) and nodal staging. MRI and laparoscopic lymphadenectomy are useful for clinicians planning a potentially conservative approach. The management of patients with locally advanced cervical disease is controversial and should be discussed on a case-by-case basis according to the tumour size, radiological findings, the term of pregnancy, and the patient's wishes. Different histological types of malignant ovarian diseases arise during pregnancy and their management depends on the diagnosis (histological subtypes, tumour differentiation, and nodal status), the tumour stage, and the trimester of the pregnancy. In patients with peritoneal spread or high-risk early-stage disease, neoadjuvant chemotherapy with pregnancy preservation could be appropriate.	[Morice, Philippe; Uzan, Catherine; Gouy, Sebastien] Inst Gustave Roussy, Dept Gynecol Surg, F-94805 Villejuif, France; [Morice, Philippe; Uzan, Catherine] Inst Gustave Roussy, Unit INSERM U 10 30, F-94805 Villejuif, France; [Haie-Meder, Christine] Inst Gustave Roussy, Dept Radiat Oncol, F-94805 Villejuif, France; [Morice, Philippe] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Verschraegen, Claire] Univ Vermont, Burlington, VT USA	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; University of Vermont	Morice, P (corresponding author), Inst Gustave Roussy, Dept Gynecol Surg, Rue Camille Desmoulins, F-94805 Villejuif, France.	morice@igr.fr	Verschraegen, Claire/AAE-7620-2020; Morice, Philippe/ABC-3179-2021	Verschraegen, Claire/0000-0001-6544-3089; Morice, Philippe/0000-0003-0579-9993				Abu-Rustum NR, 2010, GYNECOL ONCOL, V116, P151, DOI 10.1016/j.ygyno.2009.10.042; Ackermann S, 2006, ACTA OBSTET GYN SCAN, V85, P1134, DOI 10.1080/00016340600555926; ALLEN DG, 1995, AUST NZ J OBSTET GYN, V35, P408, DOI 10.1111/j.1479-828X.1995.tb02154.x; Alouini S, 2008, GYNECOL ONCOL, V108, P472, DOI 10.1016/j.ygyno.2007.12.006; Amant F, 2009, INT J GYNECOL CANCER, V19, pS1, DOI 10.1111/IGC.0b013e3181a1d0ec; [Anonymous], 2010, Prescrire Int, V19, P168; [Anonymous], 2004, OBSTET GYNECOL, V104, P647; AVILES A, 1991, AM J HEMATOL, V36, P243, DOI 10.1002/ajh.2830360404; Azim HA, 2010, EXPERT REV CLIN IMMU, V6, P821, DOI [10.1586/eci.10.77, 10.1586/ECI.10.77]; Bader AA, 2007, GYNECOL ONCOL, V105, P269, DOI 10.1016/j.ygyno.2007.01.009; Bartlett RM, 2010, J NUCL MED, V51, P288, DOI 10.2967/jnumed.109.068734; Bayhan G, 1999, EUR J GYNAECOL ONCOL, V20, P231; Behtash Nadereh, 2008, BMC Pregnancy Childbirth, V8, P3, DOI 10.1186/1471-2393-8-3; Benhaim Y, 2007, INT J GYNECOL CANCER, V17, P270, DOI 10.1111/j.1525-1438.2007.00783.x; Benhaim Y, 2008, EUR J OBSTET GYN R B, V136, P267, DOI 10.1016/j.ejogrb.2006.10.027; Boyd A, 2009, INT J GYNECOL CANCER, V19, P273, DOI 10.1111/IGC.0b013e31819bcff8; Caluwaerts S, 2006, INT J GYNECOL CANCER, V16, P905, DOI 10.1111/j.1525-1438.2006.00223.x; Camatte S, 2004, EUR J CANCER, V40, P1842, DOI 10.1016/j.ejca.2004.04.017; Cardonick E, 2004, LANCET ONCOL, V5, P283, DOI 10.1016/S1470-2045(04)01466-4; Cardonick E, 2010, AM J CLIN ONCOL-CANC, V33, P221, DOI 10.1097/COC.0b013e3181a44ca9; Chun KC, 2010, JPN J CLIN ONCOL, V40, P694, DOI 10.1093/jjco/hyq039; Colombo N, 2010, ANN ONCOL, V21, pv23, DOI 10.1093/annonc/mdq244; COVELL LM, 1977, AM J OBSTET GYNECOL, V127, P674, DOI 10.1016/0002-9378(77)90375-1; CREASMAN WT, 1995, INT J GYNECOL OBSTET, V50, P215, DOI 10.1016/0020-7292(95)90359-3; Dale DC, 2003, AM J HEMATOL, V72, P82, DOI 10.1002/ajh.10255; De Santis M, 2000, EUR J CANCER CARE, V9, P235, DOI 10.1046/j.1365-2354.2000.00231.x; Demeter A, 2002, EUR J GYNAECOL ONCOL, V23, P207; Doi D, 2009, ARCH GYNECOL OBSTET, V280, P633, DOI 10.1007/s00404-009-0950-2; Doyle S, 2009, CLIN RADIOL, V64, P857, DOI 10.1016/j.crad.2008.08.020; DUDAN R C, 1973, Gynecologic Oncology, V1, P283, DOI 10.1016/0090-8258(73)90020-6; DUGGAN B, 1993, OBSTET GYNECOL, V82, P598; ECONOMOS K, 1993, OBSTET GYNECOL, V81, P915; Elit L, 1999, GYNECOL ONCOL, V72, P123, DOI 10.1006/gyno.1998.5190; FALKSON HC, 1980, CANCER, V45, P1679, DOI 10.1002/1097-0142(19800401)45:7<1679::AID-CNCR2820450726>3.0.CO;2-Z; Favero G, 2010, GYNECOL ONCOL, V118, P123, DOI 10.1016/j.ygyno.2010.04.012; Ferrandina G, 2005, GYNECOL ONCOL, V97, P693, DOI 10.1016/j.ygyno.2005.02.011; Fukushima K, 2009, INT J GYNECOL CANCER, V19, P1439, DOI 10.1111/IGC.0b013e3181a83ebf; Germann N, 2005, ANN ONCOL, V16, P397, DOI 10.1093/annonc/mdi084; Germann N, 2004, ANN ONCOL, V15, P146, DOI 10.1093/annonc/mdh009; Giacalone PL, 1996, BRIT J OBSTET GYNAEC, V103, P932, DOI 10.1111/j.1471-0528.1996.tb09918.x; Gilani MM, 2007, INT J GYNECOL CANCER, V17, P1140, DOI 10.1111/j.1525-1438.2007.00917.x; GREER BE, 1989, GYNECOL ONCOL, V34, P61, DOI 10.1016/0090-8258(89)90108-X; Gurumurthy M, 2009, J PERINATOL, V29, P63, DOI 10.1038/jp.2008.128; HALILA H, 1986, CANCER, V57, P1327, DOI 10.1002/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO;2-Z; HENDERSON CE, 1993, GYNECOL ONCOL, V49, P92, DOI 10.1006/gyno.1993.1092; Herod JJO, 2010, BJOG-INT J OBSTET GY, V117, P1558, DOI 10.1111/j.1471-0528.2010.02723.x; HESS LW, 1988, AM J OBSTET GYNECOL, V158, P1029, DOI 10.1016/0002-9378(88)90212-8; Hoover K, 2011, AM J OBSTET GYNECOL, V205, P97, DOI 10.1016/j.ajog.2011.01.050; Huang HP, 2004, EUR J GYNAECOL ONCOL, V25, P635; Hunter MI, 2008, AM J OBSTET GYNECOL, V199, P3, DOI 10.1016/j.ajog.2008.04.010; Hunter MI, 2008, AM J OBSTET GYNECOL, V199, P10, DOI 10.1016/j.ajog.2007.12.011; Insinga RP, 2004, AM J OBSTET GYNECOL, V191, P105, DOI 10.1016/j.ajog.2004.01.043; International Federation of Gynecology and Obstetrics, 1987, AM J OBSTET GYNECOL, V156, P263; Ishioka S, 2009, INT J CLIN ONCOL, V14, P321, DOI 10.1007/s10147-008-0861-4; Jain AG, 1997, AM J OBSTET GYNECOL, V177, P298, DOI 10.1016/S0002-9378(97)70190-X; Kaplan KJ, 2004, CANCER CYTOPATHOL, V102, P228, DOI 10.1002/cncr.20428; Karam A, 2007, NAT CLIN PRACT ONCOL, V4, P375, DOI 10.1038/ncponc0821; Karateke A, 2010, EUR J OBSTET GYN R B, V152, P112, DOI 10.1016/j.ejogrb.2010.05.018; KARLEN JR, 1979, OBSTET GYNECOL, V53, P330; Kim JH, 2008, LUNG CANCER, V59, P270, DOI 10.1016/j.lungcan.2007.06.017; KING LA, 1991, GYNECOL ONCOL, V41, P78, DOI 10.1016/0090-8258(91)90259-8; KOC ON, 1994, EUR J CANCER, V30A, P716; Krafft A, 2009, FETAL DIAGN THER, V25, P239, DOI 10.1159/000223441; Lai CH, 1997, GYNECOL ONCOL, V64, P456, DOI 10.1006/gyno.1996.4603; Latimer J, 2007, CURR OPIN OBSTET GYN, V19, P140, DOI 10.1097/GCO.0b013e3280464f0c; Lee JM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.077; LEE RB, 1981, OBSTET GYNECOL, V58, P584; Leiserowitz GS, 2006, GYNECOL ONCOL, V101, P315, DOI 10.1016/j.ygyno.2005.10.022; Li RHW, 2007, J REPROD MED, V52, P575; LOWENTHAL RM, 1982, MED PEDIATR ONCOL, V10, P165, DOI 10.1002/mpo.2950100211; MALFETANO JH, 1990, OBSTET GYNECOL, V75, P545; Mandic A, 2009, AM J OBSTET GYNECOL, V201, pE6, DOI 10.1016/j.ajog.2009.05.002; Mantovani G, 2007, EUR J OBSTET GYN R B, V131, P238, DOI 10.1016/j.ejogrb.2006.04.006; Marana HRC, 2001, GYNECOL ONCOL, V80, P272, DOI 10.1006/gyno.2000.6055; Marnitz S, 2010, ONCOLOGY-BASEL, V79, P72, DOI 10.1159/000320156; Marret H, 2010, EUR J OBSTET GYN R B, V149, P18, DOI 10.1016/j.ejogrb.2009.12.001; Mendez LE, 2003, OBSTET GYNECOL, V102, P1200, DOI 10.1016/S0029-7844(03)00698-7; Mir O, 2010, ANN ONCOL, V21, P425, DOI 10.1093/annonc/mdp517; Mir O, 2008, CANCER, V113, P3069, DOI 10.1002/cncr.23935; MONK BJ, 1992, OBSTET GYNECOL, V80, P199; Mooney J, 1997, GYNECOL ONCOL, V65, P30, DOI 10.1006/gyno.1996.4592; Moore KN, 2007, GYNECOL ONCOL, V105, P299, DOI 10.1016/j.ygyno.2006.12.031; Morice P, 2009, INT J GYNECOL CANCER, V19, P1638, DOI 10.1111/IGC.0b013e3181a83017; Morimura Yutaka, 2002, Fukushima J Med Sci, V48, P27; Motegi M, 2007, OBSTET GYNECOL, V109, P537, DOI 10.1097/01.AOG.0000245450.62758.47; MURRAY NA, 1994, ARCH DIS CHILD-FETAL, V71, pF209, DOI 10.1136/fn.71.3.F209; NILOFF JM, 1984, OBSTET GYNECOL, V64, P703; NISKER JA, 1983, AM J OBSTET GYNECOL, V145, P203, DOI 10.1016/0002-9378(83)90492-1; Ohara N., 2000, Clinical and Experimental Obstetrics and Gynecology, V27, P123; ORTEGA J, 1977, CANCER, V40, P2829, DOI 10.1002/1097-0142(197712)40:6<2829::AID-CNCR2820400613>3.0.CO;2-I; Otton G, 2001, INT J GYNECOL CANCER, V11, P413, DOI 10.1046/j.1525-1438.2001.01047.x; Palaia I, 2007, AM J OBSTET GYNECOL, V197, pE5, DOI 10.1016/j.ajog.2007.07.034; Palmer J, 2009, BJOG-INT J OBSTET GY, V116, P480, DOI 10.1111/j.1471-0528.2008.02089.x; Patyna S, 2009, Birth Defects Res B Dev Reprod Toxicol, V86, P204, DOI 10.1002/bdrb.20194; Pavlidis NA, 2002, ONCOLOGIST, V7, P279; Pentheroudakis G, 2010, ANN ONCOL, V21, pv266, DOI 10.1093/annonc/mdq198; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Picone O, 2004, GYNECOL ONCOL, V94, P600, DOI 10.1016/j.ygyno.2004.05.030; PREM KA, 1966, AM J OBSTET GYNECOL, V95, P99, DOI 10.1016/0002-9378(66)90634-X; Rabaiotti E, 2010, TUMORI J, V96, P623, DOI 10.1177/030089161009600418; RAFFLES A, 1989, BRIT J OBSTET GYNAEC, V96, P1099, DOI 10.1111/j.1471-0528.1989.tb03389.x; Raghunath GR, 2006, J OBSTET GYN INDIA, V56, P446; Robinson AA, 2007, LANCET ONCOL, V8, P738, DOI 10.1016/S1470-2045(07)70242-5; Robinson WR, 1997, GYNECOL ONCOL, V64, P153, DOI 10.1006/gyno.1996.4546; Robova H, 2005, EUR J GYNAECOL ONCOL, V26, P611; Rouzi AA, 2009, ARCH GYNECOL OBSTET, V280, P823, DOI 10.1007/s00404-009-0992-5; Sayar H, 2005, OBSTET GYN CLIN N AM, V32, P569, DOI 10.1016/j.ogc.2005.08.003; Schmeler KM, 2005, OBSTET GYNECOL, V105, P1098, DOI 10.1097/01.AOG.0000157465.99639.e5; Seamon LG, 2009, GYNECOL ONCOL, V114, P540, DOI 10.1016/j.ygyno.2009.05.025; Seki N, 2010, EUR J GYNAECOL ONCOL, V31, P399; Selleret L, 2008, J Gynecol Obstet Biol Reprod (Paris), V37 Suppl 1, pS131, DOI 10.1016/j.jgyn.2007.11.018; Sheehan P, 2007, AUST FAM PHYSICIAN, V36, P698; Sherard GB, 2003, AM J OBSTET GYNECOL, V189, P358, DOI 10.1067/S0002-9378(03)00731-2; Silva LB, 2006, INT J GYNECOL CANCER, V16, P1454, DOI 10.1111/j.1525-1438.2006.00488.x; Sioutas A, 2011, GYNECOL ONCOL, V121, P420, DOI 10.1016/j.ygyno.2010.12.357; Siu SSN, 2006, CLIN PHARMACOKINET, V45, P419, DOI 10.2165/00003088-200645040-00006; Smyth EC, 2010, J CLIN ONCOL, V28, pE295, DOI 10.1200/JCO.2009.25.5604; Sood AK, 1996, GYNECOL ONCOL, V63, P294, DOI 10.1006/gyno.1996.0325; Sood AK, 2001, GYNECOL ONCOL, V83, P599, DOI 10.1006/gyno.2001.6439; SOROSKY JI, 1995, GYNECOL ONCOL, V59, P207; Spitzer M, 1998, J REPROD MED, V43, P387; Stan C, 2005, EUR J GYNAECOL ONCOL, V26, P649; Stensheim H, 2009, J CLIN ONCOL, V27, P45, DOI 10.1200/JCO.2008.17.4110; Tabata T, 2008, INT J GYNECOL CANCER, V18, P181, DOI 10.1111/j.1525-1438.2007.00974.X; Takushi M, 2002, GYNECOL ONCOL, V87, P185, DOI 10.1006/gyno.2002.6813; Tarantola RM, 2010, RETINA-J RET VIT DIS, V30, P1405, DOI 10.1097/IAE.0b013e3181f57d58; Taylor J, 2009, OBSTET GYNECOL, V114, P451, DOI 10.1097/AOG.0b013e3181a1d478; Telischak NA, 2008, AM J ROENTGENOL, V191, P364, DOI 10.2214/AJR.07.3509; Tewari K, 1998, CANCER, V82, P1529, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1529::AID-CNCR15>3.0.CO;2-6; Thomas GM, 2000, SEMIN RADIAT ONCOL, V10, P44, DOI 10.1016/S1053-4296(00)80020-X; TOMINAGA K, 1986, JPN J CANCER RES, V77, P1241; Traen K, 2006, EUR J GYNAECOL ONCOL, V27, P615; Ungar L, 2006, OBSTET GYNECOL, V108, P811, DOI 10.1097/01.AOG.0000216015.15415.5f; Van Calsteren K, 2010, INT J GYNECOL CANCER, V20, P1456, DOI 10.1111/IGC.0b013e3181fb18c8; Van Calsteren K, 2010, J CLIN ONCOL, V28, P683, DOI 10.1200/JCO.2009.23.2801; van de Nieuwenhof HP, 2008, INT J GYNECOL CANCER, V18, P1381, DOI 10.1111/j.1525-1438.2008.01193.x; van Vliet W, 1998, EUR J OBSTET GYN R B, V79, P153, DOI 10.1016/S0301-2115(98)00022-0; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Vlahos G, 2002, GYNECOL OBSTET INVES, V54, P78, DOI 10.1159/000067715; Whitecar P, 1999, AM J OBSTET GYNECOL, V181, P19, DOI 10.1016/S0002-9378(99)70429-1; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P340, DOI 10.1016/j.ajog.2007.07.050; YOUNG RH, 1984, GYNECOL ONCOL, V18, P181, DOI 10.1016/0090-8258(84)90026-X; Yumi H, 2008, SURG ENDOSC, V22, P849, DOI 10.1007/s00464-008-9758-6; Zanetta G, 1998, INT J GYNECOL CANCER, V8, P265; Zanotti KM, 2000, SEMIN ONCOL, V27, P686, DOI 10.1053/sonc.2000.18546; Zanotti-Fregonara P, 2008, J NUCL MED, V49, P679, DOI 10.2967/jnumed.107.048900; Zanotti-Fregonara P, 2010, J NUCL MED, V51, P803, DOI 10.2967/jnumed.109.071878; Zelmlickis D, 1992, ARCH INTERN MED, V152, P573	148	141	170	1	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					558	569		10.1016/S0140-6736(11)60829-5	http://dx.doi.org/10.1016/S0140-6736(11)60829-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22325661				2022-12-28	WOS:000300188800033
J	Zhang, P; Smith-Nguyen, EV; Keshwani, MM; Deal, MS; Kornev, AP; Taylor, SS				Zhang, Ping; Smith-Nguyen, Eric V.; Keshwani, Malik M.; Deal, Michael S.; Kornev, Alexandr P.; Taylor, Susan S.			Structure and Allostery of the PKA RII beta Tetrameric Holoenzyme	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; SITE MUTATIONS DEFINE; REGULATORY SUBUNIT; CATALYTIC SUBUNIT; II-BETA; CRYSTAL-STRUCTURE; TERMINAL TAIL; ALPHA; BINDING; MECHANISM	In its physiological state, cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) is a tetramer that contains a regulatory (R) subunit dimer and two catalytic (C) subunits. We describe here the 2.3 angstrom structure of full-length tetrameric RII beta(2):C-2 holoenzyme. This structure showing a dimer of dimers provides a mechanistic understanding of allosteric activation by cAMP. The heterodimers are anchored together by an interface created by the beta(4)-beta(5) loop in the RII beta subunit, which docks onto the carboxyl-terminal tail of the adjacent C subunit, thereby forcing the C subunit into a fully closed conformation in the absence of nucleotide. Diffusion of magnesium adenosine triphosphate (ATP) into these crystals trapped not ATP, but the reaction products, adenosine diphosphate and the phosphorylated RII beta subunit. This complex has implications for the dissociation-reassociation cycling of PKA. The quaternary structure of the RII beta tetramer differs appreciably from our model of the RI alpha tetramer, confirming the small-angle x-ray scattering prediction that the structures of each PKA tetramer are different.	[Zhang, Ping; Keshwani, Malik M.; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Smith-Nguyen, Eric V.; Deal, Michael S.; Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	staylor@ucsd.edu	zhang, ping/G-7165-2015; Kornev, Alexandr Petrovich/O-7826-2015	Kornev, Alexandr Petrovich/0000-0002-1543-3795; Zhang, Ping/0000-0002-0340-281X	NIH [GM34921]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Taylor laboratory for helpful discussions and the Advanced Light Source (beam line 8.2.2) staff of Lawrence Berkeley National Laboratory for beam access and help with data collection. This work was supported by NIH grant GM34921 (S.S.T.). Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession numbers 3TNP and 3TNQ.	Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Boettcher AJ, 2011, STRUCTURE, V19, P265, DOI 10.1016/j.str.2010.12.005; Brown SHJ, 2009, J MOL BIOL, V393, P1070, DOI 10.1016/j.jmb.2009.09.014; CADD GG, 1990, J BIOL CHEM, V265, P19502; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Czyzyk TA, 2008, P NATL ACAD SCI USA, V105, P276, DOI 10.1073/pnas.0710607105; Diller TC, 2000, PROTEIN EXPRES PURIF, V20, P357, DOI 10.1006/prep.2000.1312; Diskar M, 2007, CELL SIGNAL, V19, P2024, DOI 10.1016/j.cellsig.2007.05.012; Gangal M, 1999, P NATL ACAD SCI USA, V96, P12394, DOI 10.1073/pnas.96.22.12394; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Heller WT, 2004, J BIOL CHEM, V279, P19084, DOI 10.1074/jbc.M313405200; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; HERBERG FW, 1993, BIOCHEMISTRY-US, V32, P14015, DOI 10.1021/bi00213a035; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; RANGELALDAO R, 1976, J BIOL CHEM, V251, P3375; Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555; Vigil D, 2006, J MOL BIOL, V357, P880, DOI 10.1016/j.jmb.2006.01.006; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Zawadzki KM, 2004, J BIOL CHEM, V279, P7029, DOI 10.1074/jbc.M310804200; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	38	116	120	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					712	716		10.1126/science.1213979	http://dx.doi.org/10.1126/science.1213979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323819	Green Accepted			2022-12-28	WOS:000300047100051
J	Schnipper, JL; Rothschild, JM				Schnipper, Jeffrey L.; Rothschild, Jeffrey M.			Improving medication safety	LANCET			English	Editorial Material							INFORMATION-TECHNOLOGY; EVENTS; CARE; HOME		[Schnipper, Jeffrey L.; Rothschild, Jeffrey M.] Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital	Rothschild, JM (corresponding author), Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA.	jrothschild@partners.org						Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Bates DW, 2010, HEALTH AFFAIR, V29, P614, DOI 10.1377/hlthaff.2010.0007; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Berwick DM, 2011, NEW ENGL J MED, V365, P1753, DOI 10.1056/NEJMp1111671; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Holland R, 2005, BMJ-BRIT MED J, V330, P293, DOI 10.1136/bmj.38338.674583.AE; Institute of Medicine, 2011, HLTH IT PAT SAF BUIL; Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Schnipper JL, 2011, ARCH INTERN MED, V171, P1019, DOI 10.1001/archinternmed.2011.220; Schnipper JL, 2010, AM J MANAG CARE, V16, pSP72; Simon SR, 2009, J AM MED INFORM ASSN, V16, P465, DOI 10.1197/jamia.M3081; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658	13	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2012	379	9823					1278	1280		10.1016/S0140-6736(12)60078-6	http://dx.doi.org/10.1016/S0140-6736(12)60078-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922FB	22357107				2022-12-28	WOS:000302531100006
J	Molenaar, JJ; Koster, J; Zwijnenburg, DA; van Sluis, P; Valentijn, LJ; van der Ploeg, I; Hamdi, M; van Nes, J; Westerman, BA; van Arkel, J; Ebus, ME; Haneveld, F; Lakeman, A; Schild, L; Molenaar, P; Stroeken, P; van Noesel, MM; Ora, I; Santo, EE; Caron, HN; Westerhout, EM; Versteeg, R				Molenaar, Jan J.; Koster, Jan; Zwijnenburg, Danny A.; van Sluis, Peter; Valentijn, Linda J.; van der Ploeg, Ida; Hamdi, Mohamed; van Nes, Johan; Westerman, Bart A.; van Arkel, Jennemiek; Ebus, Marli E.; Haneveld, Franciska; Lakeman, Arjan; Schild, Linda; Molenaar, Piet; Stroeken, Peter; van Noesel, Max M.; Ora, Ingrid; Santo, Evan E.; Caron, Huib N.; Westerhout, Ellen M.; Versteeg, Rogier			Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes	NATURE			English	Article							ACTIVATING MUTATIONS; TUMOR-SUPPRESSOR; ALK KINASE; PATHWAY; ROLES; EXPRESSION; RECEPTOR; FAMILY; ACID	Neuroblastomais a childhood tumour of the peripheral sympathetic nervous system. The pathogenesis has for a long time been quite enigmatic, as only very few gene defects were identified in this often lethal tumour(1). Frequently detected gene alterations are limited to MYCN amplification (20%) and ALK activations (7%)(2-5). Here we present a whole-genome sequence analysis of 87 neuroblastoma of all stages. Few recurrent amino-acid-changing mutations were found. In contrast, analysis of structural defects identified a local shredding of chromosomes, known as chromothripsis, in 18% of high-stage neuroblastoma(6). These tumours are associated with a poor outcome. Structural alterations recurrently affected ODZ3, PTPRD and CSMD1, which are involved in neuronal growth cone stabilization(7-9). In addition, ATRX, TIAM1 and a series of regulators of the Rac/Rho pathway were mutated, further implicating defects in neuritogenesis in neuroblastoma. Most tumours with defects in these genes were aggressive high-stage neuroblastomas, but did not carry MYCN amplifications. The genomic landscape of neuroblastoma therefore reveals two novel molecular defects, chromothripsis and neuritogenesis gene alterations, which frequently occur in high-risk tumours.	[Molenaar, Jan J.; Koster, Jan; Zwijnenburg, Danny A.; van Sluis, Peter; Valentijn, Linda J.; van der Ploeg, Ida; Hamdi, Mohamed; van Nes, Johan; Westerman, Bart A.; van Arkel, Jennemiek; Ebus, Marli E.; Haneveld, Franciska; Lakeman, Arjan; Schild, Linda; Molenaar, Piet; Stroeken, Peter; Ora, Ingrid; Santo, Evan E.; Westerhout, Ellen M.; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogenom, NL-1105 AZ Amsterdam, Netherlands; [van Noesel, Max M.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol Hematol, NL-3015 GJ Rotterdam, Netherlands; [Ora, Ingrid] Lund Univ, Skane Univ Hosp, Dept Pediat Oncol & Hematol, S-22185 Lund, Sweden; [Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Lund University; Skane University Hospital; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Versteeg, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogenom, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.molenaar@amc.uva.nl; r.versteeg@amc.uva.nl	Øra, Ingrid/J-2596-2013; Westerman, Bart/ACM-8337-2022; Koster, Jan/C-5934-2008; Versteeg, Rogier/AAQ-1765-2020	Øra, Ingrid/0000-0002-3931-4125; Westerman, Bart/0000-0002-9898-9616; Koster, Jan/0000-0002-0890-7585; van Nes, Johan/0000-0001-7691-1431; Zwijnenburg, Danny/0000-0002-9353-8904; Versteeg, Rogier/0000-0001-7172-0388	Villa Joep Foundation; KIKA; Tom Voute Fund; Netherlands Cancer Foundation	Villa Joep Foundation; KIKA; Tom Voute Fund; Netherlands Cancer Foundation	The research in this paper was supported by grants from the Villa Joep Foundation, KIKA, Tom Voute Fund, and the Netherlands Cancer Foundation. We thank R. Tearle and G. Tyrelle (Complete Genomics) for expert support and R. Volckmann, N. Hasselt, T. van Groningen, E. Dolman, K. Drabek and I. Dokter for their help.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arregui CO, 2000, NEUROCHEM RES, V25, P95, DOI 10.1023/A:1007595617447; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Chen QR, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-70; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matsuo N, 2003, MOL CELL NEUROSCI, V24, P69, DOI 10.1016/S1044-7431(03)00122-2; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Molenaar JJ, 2003, GENE CHROMOSOME CANC, V36, P242, DOI 10.1002/gcc.10166; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Santo E.E., 2011, ONCOGENE        0822, DOI [10.1038/onc.2011.344, DOI 10.1038/ONC.2011.344]; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sun QL, 2000, MOL CELL NEUROSCI, V16, P686, DOI 10.1006/mcne.2000.0893; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; Vandesompele J, 2001, MED PEDIATR ONCOL, V36, P5, DOI 10.1002/1096-911X(20010101)36:1<5::AID-MPO1003>3.0.CO;2-E; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956	36	606	617	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					589	U107		10.1038/nature10910	http://dx.doi.org/10.1038/nature10910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22367537	hybrid, Green Published			2022-12-28	WOS:000302006100037
J	Cobey, S; Lipsitch, M				Cobey, Sarah; Lipsitch, Marc			Niche and Neutral Effects of Acquired Immunity Permit Coexistence of Pneumococcal Serotypes	SCIENCE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CONJUGATE VACCINATION; DISEASE; EVOLUTION; INFANTS; COLONIZATION; CHILDREN; VACCINES; MODELS	Over 90 capsular serotypes of Streptococcus pneumoniae, a common nasopharyngeal colonizer and major cause of pneumonia, bacteremia, and meningitis, are known. It is unclear why some serotypes can persist at all: They are more easily cleared from carriage and compete poorly in vivo. Serotype-specific immune responses, which could promote diversity in principle, are weak enough to allow repeated colonizations by the same type. We show that weak serotype-specific immunity and an acquired response not specific to the capsule can together reproduce observed diversity. Serotype-specific immunity stabilizes competition, and acquired immunity to noncapsular antigens reduces fitness differences. Our model can be used to explain the effects of pneumococcal vaccination and indicates general factors that regulate the diversity of pathogens.	[Cobey, Sarah; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Cobey, Sarah; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Cobey, S (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, 677 Huntington Ave, Boston, MA 02115 USA.	scobey@hsph.harvard.edu		Lipsitch, Marc/0000-0003-1504-9213	National Institute of Allergy and Infectious Diseases (NIAID) [5R01AI048935]; National Institute of General Medical Sciences (NIGMS) [1F32GM097997, U54GM088558]; Pfizer; Novartis; AIR Worldwide; Avian/Pandemic Flu Registry (Outcome Sciences); Roche; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097997, U54GM088558] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pfizer(Pfizer); Novartis(Novartis); AIR Worldwide; Avian/Pandemic Flu Registry (Outcome Sciences); Roche(Roche Holding); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Abdullahi and A. Scott for sharing their data on the duration of carriage; E. Lee for help reviewing carriage studies; C. Laine for sharing an unpublished earlier review of such studies; and C. Buckee, W. Hanage, B. Levin, R. Malley, V. Pitzer, D. Weinberger, and J. Zelner for helpful comments. Computations were run on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University. E-mail scobey@hsph.harvard.edu for the location of the code repository. The project was supported by awards 5R01AI048935 from the National Institute of Allergy and Infectious Diseases (NIAID) and 1F32GM097997 and U54GM088558 from the National Institute of General Medical Sciences (NIGMS). The content is solely the responsibility of the authors and does not necessarily represent the views of the NIGMS, NIAID, or the NIH. M. L. has received consulting fees or honoraria from Pfizer, Novartis, AIR Worldwide, and the Avian/Pandemic Flu Registry (Outcome Sciences), supported by Roche.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Buckee CO, 2010, P ROY SOC B-BIOL SCI, V277, P1635, DOI 10.1098/rspb.2009.2033; Buckee CO, 2009, P ROY SOC B-BIOL SCI, V276, P477, DOI 10.1098/rspb.2008.1122; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lipsitch M, 2012, EPIDEMIOLOGY, V23, P1, DOI [10.1097/EDE.0b013e31824f2f32, DOI 10.1097/EDE.0B013E31824F2F32]; Lipsitch M, 2009, EPIDEMICS-NETH, V1, P2, DOI 10.1016/j.epidem.2008.07.001; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; McLean AR, 1998, BRIT MED BULL, V54, P545; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Yu XH, 1999, J INFECT DIS, V180, P1569, DOI 10.1086/315096	32	114	115	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2012	335	6074					1376	1380		10.1126/science.1215947	http://dx.doi.org/10.1126/science.1215947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22383809	Green Accepted			2022-12-28	WOS:000301531600055
J	Grubb, MP; Warter, ML; Xiao, HY; Maeda, S; Morokuma, K; North, SW				Grubb, Michael P.; Warter, Michelle L.; Xiao, Hongyan; Maeda, Satoshi; Morokuma, Keiji; North, Simon W.			No Straight Path: Roaming in Both Ground- and Excited-State Photolytic Channels of NO3 -> NO+O-2	SCIENCE			English	Article							PHOTODISSOCIATION; MECHANISM; DYNAMICS; DECOMPOSITION; ACETALDEHYDE; FORMALDEHYDE; PRODUCTS; RADICALS	Roaming mechanisms have recently been observed in several chemical reactions alongside trajectories that pass through a traditional transition state. Here, we demonstrate that the visible light-induced reaction NO3 -> NO + O-2 proceeds exclusively by roaming. High-level ab initio calculations predict specific NO Lambda doublet propensities (orientations of the unpaired electron with respect to the molecular rotation plane) for this mechanism, which we discern experimentally by ion imaging. The data provide direct evidence for roaming pathways in two different electronic states, corresponding to both previously documented photolysis channels that produce NO + O-2. More broadly, the results raise intriguing questions about the overall prevalence of this unusual reaction mechanism.	[Grubb, Michael P.; Warter, Michelle L.; North, Simon W.] Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA; [Xiao, Hongyan; Maeda, Satoshi; Morokuma, Keiji] Kyoto Univ, Fukui Inst Fundamental Chem, Sakyo Ku, Kyoto 6068103, Japan; [Maeda, Satoshi] Kyoto Univ, Hakubi Ctr, Sakyo Ku, Kyoto 6068302, Japan; [Morokuma, Keiji] Emory Univ, Cherry L Emerson Ctr Sci Computat, Atlanta, GA 30322 USA; [Morokuma, Keiji] Emory Univ, Dept Chem, Atlanta, GA 30322 USA	Texas A&M University System; Texas A&M University College Station; Kyoto University; Kyoto University; Emory University; Emory University	North, SW (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA.	swnorth@tamu.edu	Maeda, Satoshi/H-3613-2014; North, Simon W/G-5054-2012	Maeda, Satoshi/0000-0001-8822-1147; North, Simon W/0000-0002-0795-796X	Robert A. Welch Foundation [A-1405]; Japan Science and Technology Agency; U.S. Air Force Office of Scientific Research at Emory University [FA9550-10-1-0304]; Core Research for Evolutional Science and Technology (CREST) in the Area of High Performance Computing for Multiscale and Multiphysics Phenomena at Kyoto University	Robert A. Welch Foundation(The Welch Foundation); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); U.S. Air Force Office of Scientific Research at Emory University; Core Research for Evolutional Science and Technology (CREST) in the Area of High Performance Computing for Multiscale and Multiphysics Phenomena at Kyoto University(Core Research for Evolutional Science and Technology (CREST))	We acknowledge G. Hall and P. Dagdigian for helpful discussions on L doublets and their dynamical implications. Support for this project was provided by the Robert A. Welch Foundation (A-1405), by a grant from the Japan Science and Technology Agency with Core Research for Evolutional Science and Technology (CREST) in the Area of High Performance Computing for Multiscale and Multiphysics Phenomena at Kyoto University, and by a grant from the U.S. Air Force Office of Scientific Research (grant FA9550-10-1-0304) at Emory University.	ANDRESEN P, 1983, PHYS REV LETT, V50, P486, DOI 10.1103/PhysRevLett.50.486; Bowman JM, 2011, ANNU REV PHYS CHEM, V62, P531, DOI 10.1146/annurev-physchem-032210-103518; BRONIKOWSKI MJ, 1990, CHEM PHYS LETT, V166, P5, DOI 10.1016/0009-2614(90)87041-O; Christoffel KM, 2009, J PHYS CHEM A, V113, P4138, DOI 10.1021/jp810517e; Grubb MP, 2011, J PHYS CHEM A, V115, P3218, DOI 10.1021/jp200110e; Grubb MP, 2010, J PHYS CHEM LETT, V1, P2455, DOI 10.1021/jz1008888; Harding LB, 2010, J PHYS CHEM LETT, V1, P3016, DOI 10.1021/jz101160u; Heazlewood BR, 2008, P NATL ACAD SCI USA, V105, P12719, DOI 10.1073/pnas.0802769105; Herath N, 2011, J PHYS CHEM LETT, V2, P642, DOI 10.1021/jz101731q; Houston PL, 2006, P NATL ACAD SCI USA, V103, P16079, DOI 10.1073/pnas.0604441103; LAHMANI F, 1986, CHEM PHYS LETT, V129, P24, DOI 10.1016/0009-2614(86)80162-2; Mikhaylichenko K, 1996, J CHEM PHYS, V105, P6807, DOI 10.1063/1.472527; Mikosch J, 2008, SCIENCE, V319, P183, DOI 10.1126/science.1150238; North SW, 2011, NAT CHEM, V3, P504, DOI 10.1038/nchem.1079; SMITH IWM, 1992, CHEM PHYS LETT, V200, P615, DOI 10.1016/0009-2614(92)80099-W; Suits AG, 2008, ACCOUNTS CHEM RES, V41, P873, DOI 10.1021/ar8000734; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; VANZEE RD, 1993, J CHEM PHYS, V99, P1664, DOI 10.1063/1.465335; Xiao HY, 2011, J PHYS CHEM LETT, V2, P934, DOI 10.1021/jz2003364	19	99	99	1	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1075	1078		10.1126/science.1216911	http://dx.doi.org/10.1126/science.1216911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383843				2022-12-28	WOS:000300931100040
J	Sprang, SR; Elk, JC				Sprang, Stephen R.; Elk, Jackson Chief			Structural Origins of Receptor Bias	SCIENCE			English	Editorial Material							BETA(2) ADRENERGIC-RECEPTOR; FUNCTIONAL SELECTIVITY; CRYSTAL-STRUCTURE; AGONISTS; BETA(2)-ADRENOCEPTOR; ACTIVATION; MECHANISM; BINDING		[Sprang, Stephen R.; Elk, Jackson Chief] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Montana System; University of Montana	Sprang, SR (corresponding author), Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA.	stephen.sprang@umontana.edu			NIDDK NIH HHS [R56 DK046371] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046371] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	15	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1055	1056		10.1126/science.1219302	http://dx.doi.org/10.1126/science.1219302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383838	Green Accepted			2022-12-28	WOS:000300931100033
J	Yun, MK; Wu, YN; Li, ZM; Zhao, Y; Waddell, MB; Ferreira, AM; Lee, RE; Bashford, D; White, SW				Yun, Mi-Kyung; Wu, Yinan; Li, Zhenmei; Zhao, Ying; Waddell, M. Brett; Ferreira, Antonio M.; Lee, Richard E.; Bashford, Donald; White, Stephen W.			Catalysis and Sulfa Drug Resistance in Dihydropteroate Synthase	SCIENCE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; CRYSTAL-STRUCTURE; FARNESYLPYROPHOSPHATE SYNTHETASE; STAPHYLOCOCCUS-AUREUS; MECHANISM; RECOGNITION; INHIBITORS	The sulfonamide antibiotics inhibit dihydropteroate synthase (DHPS), a key enzyme in the folate pathway of bacteria and primitive eukaryotes. However, resistance mutations have severely compromised the usefulness of these drugs. We report structural, computational, and mutagenesis studies on the catalytic and resistance mechanisms of DHPS. By performing the enzyme-catalyzed reaction in crystalline DHPS, we have structurally characterized key intermediates along the reaction pathway. Results support an S(N)1 reaction mechanism via formation of a novel cationic pterin intermediate. We also show that two conserved loops generate a substructure during catalysis that creates a specific binding pocket for p-aminobenzoic acid, one of the two DHPS substrates. This substructure, together with the pterin-binding pocket, explains the roles of the conserved active-site residues and reveals how sulfonamide resistance arises.	[Yun, Mi-Kyung; Wu, Yinan; Li, Zhenmei; Ferreira, Antonio M.; Bashford, Donald; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wu, Yinan; Bashford, Donald; White, Stephen W.] Univ Tennessee, Integrated Program Biomed Sci, Hlth Sci Ctr, Memphis, TN 38163 USA; [Zhao, Ying; Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Waddell, M. Brett] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Ferreira, Antonio M.] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	White, SW (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	stephen.white@stjude.org	White, Stephen W/N-8164-2018; Bashford, Donald/F-5905-2011; Lee, Richard/J-4997-2013; Lee, Richard/AAX-3996-2021; Ferreira, Antonio/I-4423-2013	Bashford, Donald/0000-0001-5776-3744; Lee, Richard/0000-0002-2397-0443; Lee, Richard/0000-0002-2397-0443; Ferreira, Antonio/0000-0002-6581-6233	NIH [AI070721]; NIH Cancer Center (CORE) [CA21765]; ALSAC (the American Lebanese Syrian Associated Charities); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Center (CORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC (the American Lebanese Syrian Associated Charities)(American Lebanese Syrian Associated Charities (ALSAC)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. DuBois, C. Pemble, S. Gajewski, and D. Miller for assistance with the YpDHPS structure determination; J. Bollinger and E. Enemark for technical assistance; D. Hammoudeh and C. Rock for helpful discussions; and staff at SERCAT for assistance with synchrotron data collection. Supported by NIH grant AI070721 (S.W.W. and R.E.L.), NIH Cancer Center (CORE) support grant CA21765, and ALSAC (the American Lebanese Syrian Associated Charities). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID and 22-BM beamlines at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found at www.ser-cat.org/members.html. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. Coordinates and structure factors for all the structures described have been deposited in the Protein Data Bank, and the PDB accession codes are listed in tables S1 and S2.	Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Anand N., 1996, BURGERS MED CHEM DRU, V2, P527; Babaoglu K, 2004, STRUCTURE, V12, P1705, DOI 10.1016/j.str.2004.07.011; Baca AM, 2000, J MOL BIOL, V302, P1193, DOI 10.1006/jmbi.2000.4094; BOCK L, 1974, J MED CHEM, V17, P23, DOI 10.1021/jm00247a006; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Hevener KE, 2010, J MED CHEM, V53, P166, DOI 10.1021/jm900861d; Huovinen P, 2001, CLIN INFECT DIS, V32, P1608, DOI 10.1086/320532; Hyun DY, 2009, PEDIATR INFECT DIS J, V28, P57, DOI 10.1097/INF.0b013e3181826e5e; Levy C, 2008, BIOCHEM J, V412, P379, DOI 10.1042/BJ20071598; MASH EA, 1981, J AM CHEM SOC, V103, P3927, DOI 10.1021/ja00403a055; Masters PA, 2003, ARCH INTERN MED, V163, P402, DOI 10.1001/archinte.163.4.402; MERALI S, 1990, ANTIMICROB AGENTS CH, V34, P1075, DOI 10.1128/AAC.34.6.1075; Pappas G, 2009, J CHEMOTHERAPY, V21, P115, DOI 10.1179/joc.2009.21.2.115; Pemble CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014165; POULTER CD, 1981, J AM CHEM SOC, V103, P3926, DOI 10.1021/ja00403a054; Rebeille F, 1997, EMBO J, V16, P947, DOI 10.1093/emboj/16.5.947; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; ROLAND S, 1979, J BIOL CHEM, V254, P337; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Skold O, 2000, DRUG RESIST UPDATE, V3, P155, DOI 10.1054/drup.2000.0146	22	127	128	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1110	1114		10.1126/science.1214641	http://dx.doi.org/10.1126/science.1214641			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383850	Green Accepted			2022-12-28	WOS:000300931100050
J	Bardes, CL				Bardes, Charles L.			Defining "Patient-Centered Medicine"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Weill Cornell Med Coll, New York, NY USA	Cornell University	Bardes, CL (corresponding author), Weill Cornell Med Coll, New York, NY USA.		Callahan, Charles D/L-1641-2013					Balint E, 1969, J R Coll Gen Pract, V17, P269; Berwick DM, 2009, HEALTH AFFAIR, V28, pW555, DOI 10.1377/hlthaff.28.4.w555; Cassell E.J., 1985, TALKING PATIENTS, VVol. 1; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Kleinman A., 1989, ILLNESS NARRATIVES S	5	166	172	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					782	783		10.1056/NEJMp1200070	http://dx.doi.org/10.1056/NEJMp1200070			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900GI	22375968				2022-12-28	WOS:000300874300003
J	Srivastava, R				Srivastava, Ranjana			What's the Alternative? The Worldwide Web of Integrative Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia.								0	4	5	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					783	785		10.1056/NEJMp1110812	http://dx.doi.org/10.1056/NEJMp1110812			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900GI	22375969				2022-12-28	WOS:000300874300004
J	Barnes, NLP; Ooi, JL; Yarnold, JR; Bundred, NJ				Barnes, Nicola L. P.; Ooi, Jane L.; Yarnold, John R.; Bundred, Nigel J.			Ductal carcinoma in situ of the breast	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SURGICAL ADJUVANT BREAST; RISK-FACTORS; CANCER; WOMEN; RADIOTHERAPY; MAMMOGRAPHY; RECURRENCE; TAMOXIFEN; OUTCOMES; THERAPY		[Barnes, Nicola L. P.; Ooi, Jane L.] Royal Bolton Hosp, Breast Unit, Bolton BL4 0JR, England; [Yarnold, John R.] Inst Canc Res, Radiotherapy Unit, London SW3 6JB, England; [Yarnold, John R.] Royal Marsden Hosp, London SW3 6JJ, England; [Bundred, Nigel J.] Univ S Manchester Hosp, Dept Surg Oncol, Manchester M20 8LR, Lancs, England	Royal Bolton Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Barnes, NLP (corresponding author), Royal Bolton Hosp, Breast Unit, Bolton BL4 0JR, England.	nicolabarnes@doctors.org.uk			NHS; NIHR; Cancer Research UK; Cancer Research UK [10588] Funding Source: researchfish	NHS; NIHR(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank the Sloane Project management team for up to date information on the Sloane Project numbers. JRY acknowledges NHS funding to the NIHR Biomedical Research Centre. NJB acknowledges funding from the NIHR Programme and Cancer Research UK.	Allred DC, 2002, BREAST CANCER RES TR, V76, pS36; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Barnes NLP, 2005, BRIT J SURG, V92, P429, DOI 10.1002/bjs.4878; Bijker N, 2001, J CLIN ONCOL, V19, P2263, DOI 10.1200/JCO.2001.19.8.2263; Bijker N, 2006, J CLIN ONCOL, V243, P381; Boland GP, 2003, BRIT J SURG, V90, P426, DOI 10.1002/bjs.4051; Brennan ME, 2011, RADIOLOGY, V260, P119, DOI 10.1148/radiol.11102368; Chen YY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-285; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Claus EB, 2005, JAMA-J AM MED ASSOC, V293, P964, DOI 10.1001/jama.293.8.964; Claus EB, 2001, J NATL CANCER I, V93, P1811, DOI 10.1093/jnci/93.23.1811; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; Emdin SO, 2006, ACTA ONCOL, V45, P536, DOI 10.1080/02841860600681569; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher ER, 1999, CANCER-AM CANCER SOC, V86, P429, DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; Goodwin A, 2009, COCHRANE DB SYST REV, V21; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Graff S, 2010, J NATL CANCER I, V102, P6, DOI 10.1093/jnci/djp497; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Hwang ES, 2004, CLIN CANCER RES, V10, P5160, DOI 10.1158/1078-0432.CCR-04-0165; Julien JP, 2000, LANCET, V355, P528, DOI 10.1016/S0140-6736(99)06341-2; Kennedy F, 2010, BREAST, V19, P382, DOI 10.1016/j.breast.2010.03.024; Lehman Constance D., 2010, Journal of the National Cancer Institute Monographs, P150, DOI 10.1093/jncimonographs/lgq030; Menes TS, 2009, CANCER EPIDEM BIOMAR, V18, P2822, DOI 10.1158/1055-9965.EPI-09-0745; National Institute for Health and Clinical Excellence CG80, 2009, EARL LOC ADV BREAST; NHS Breast Screening Programme, 2005, NAT PATH COORD GROUP; NHS Cancer Screening Programmes, 2009, ALL BREAST CANC REP; Ozanne EM, 2011, BREAST CANCER RES TR, V129, P165, DOI 10.1007/s10549-011-1430-5; Pappo Itzhak, 2005, Clin Breast Cancer, V6, P310, DOI 10.3816/CBC.2005.n.033; Partridge A, 2008, JNCI-J NATL CANCER I, V100, P243, DOI 10.1093/jnci/djn010; Silverstein Melvin J., 2010, Journal of the National Cancer Institute Monographs, P193, DOI 10.1093/jncimonographs/lgq040; Tang SSK, 2011, SURG ENDOSC, V25, P1712, DOI 10.1007/s00464-010-1465-4; Wapnir IL, 2011, J NATL CANCER I, V103, P478, DOI 10.1093/jnci/djr027	34	20	20	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 29	2012	344								e797	10.1136/bmj.e797	http://dx.doi.org/10.1136/bmj.e797			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XE	22378935				2022-12-28	WOS:000301231400008
J	Chakravarti, A; Kapoor, A				Chakravarti, Aravinda; Kapoor, Ashish			Mendelian Puzzles	SCIENCE			English	Editorial Material							HUMAN GENOME; DISEASE; COMMON; RARE		[Chakravarti, Aravinda; Kapoor, Ashish] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA	Johns Hopkins University	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA.	aravinda@jhmi.edu		Kapoor, Ashish/0000-0003-3977-6140				Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lee JH, 2012, SCIENCE, V335, P966, DOI 10.1126/science.1213506; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McKusick V.A., 1998, MENDELIAN INHERITANC; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Strachan T, 2011, HUMAN MOLECULAR GENETICS 4TH EDITION, P1; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	13	14	14	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					930	931		10.1126/science.1219301	http://dx.doi.org/10.1126/science.1219301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22362999				2022-12-28	WOS:000300931800035
J	MacKenzie, A				MacKenzie, Alex			Sense in Antisense Therapy for Spinal Muscular Atrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MOUSE MODEL; RESCUE; SMN		[MacKenzie, Alex] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [MacKenzie, Alex] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa	MacKenzie, A (corresponding author), Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada.							Atweh G, 2010, HEMATOL ONCOL CLIN N, V24, P1131, DOI 10.1016/j.hoc.2010.08.001; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Porensky PN, 2011, HUM MOL GENET   1230	5	10	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					761	763		10.1056/NEJMcibr1114629	http://dx.doi.org/10.1056/NEJMcibr1114629			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356331				2022-12-28	WOS:000300551500016
J	Udell, JA; Wang, CS; Tinmouth, J; FitzGerald, JM; Ayas, NT; Simel, DL; Schulzer, M; Mak, E; Yoshida, EM				Udell, Jacob A.; Wang, Charlie S.; Tinmouth, Jill; FitzGerald, J. Mark; Ayas, Najib T.; Simel, David L.; Schulzer, Michael; Mak, Edwin; Yoshida, Eric M.			Does This Patient With Liver Disease Have Cirrhosis?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC HEPATITIS-C; ALANINE AMINOTRANSFERASE RATIO; SIMPLE NONINVASIVE INDEXES; STANDARD LABORATORY TESTS; ASPARTATE-AMINOTRANSFERASE; PREDICTING CIRRHOSIS; AST/ALT RATIO; DIFFERENTIAL-DIAGNOSIS; TRANSIENT ELASTOGRAPHY; PHYSICAL-EXAMINATION	Context Among adult patients with liver disease, the ability to identify those most likely to have cirrhosis noninvasively is challenging. Objective To identify simple clinical indicators that can exclude or detect cirrhosis in adults with known or suspected liver disease. Data Sources We searched MEDLINE and EMBASE(1966 to December 2011) and reference lists from retrieved articles, previous reviews, and physical examination textbooks. Study Selection We retained 86 studies of adequate quality that evaluated the accuracy of clinical findings for identifying histologically proven cirrhosis. Data Extraction Two authors independently abstracted data (sensitivity, specificity, and likelihood ratios [LRs]) and assessed methodological quality. Random-effects meta-analyses were used to calculate summary LRs across studies. Results Among the 86 studies, 19 533 patients were included in this meta-analysis, among whom 4725 had biopsy-proven cirrhosis (prevalence rate, 24%; 95% CI, 20%-28%). Many physical examination and simple laboratory tests increase the likelihood of cirrhosis, though the presence of ascites (LR, 7.2; 95% CI, 2.9-12), a platelet count <160 x 10(3)/mu L (LR, 6.3; 95% CI, 4.3-8.3), spider nevi (LR, 4.3; 95% CI 2.4-6.2), or a combination of simple laboratory tests with the Bonacini cirrhosis discriminant score >7 (LR, 9.4; 95% CI, 2.6-37) are the most frequently studied, reliable, and informative results. For lowering the likelihood of cirrhosis, the most useful findings are a Lok index <0.2 (a score created from the platelet count, serum aspartate aminotransferase and alanine aminotransferase, and prothrombin international normalized ratio; LR, 0.09; 95% CI, 0.03-0.31); a platelet count >= 160 x 10(3)/mu L (LR, 0.29; 95% CI, 0.20-0.39); or the absence of hepatomegaly (LR, 0.37; 95% CI, 0.24-0.51). The overall impression of the clinician was not as informative as the individual findings or laboratory combinations. Conclusions For identifying cirrhosis, the presence of a variety of clinical findings or abnormalities in a combination of simple laboratory tests that reflect the underlying pathophysiology increase its likelihood. To exclude cirrhosis, combinations of normal laboratory findings are most useful. JAMA. 2012;307(8):832-842	[Udell, Jacob A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA; [Udell, Jacob A.] Harvard Univ, Sch Med, Boston, MA USA; [Wang, Charlie S.; Tinmouth, Jill] Sunnybrook Hlth Sci Ctr, Dept Med, Div Gastroenterol, Toronto, ON M4N 3M5, Canada; [Wang, Charlie S.; Tinmouth, Jill] Univ Toronto, Toronto, ON, Canada; [Wang, Charlie S.] Brantford Gen Hosp, Dept Med, Div Gastroenterol, Brantford, ON, Canada; [FitzGerald, J. Mark; Ayas, Najib T.] Vancouver Gen Hosp, Div Respirol, Dept Med, Vancouver, BC, Canada; [Mak, Edwin] Univ British Columbia, Pacific Parkinson Res Ctr, Vancouver, BC V5Z 1M9, Canada; [FitzGerald, J. Mark; Ayas, Najib T.; Schulzer, Michael] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Simel, David L.] Duke Univ, Dept Med, Durham Vet Affairs Med Ctr, Durham, NC USA; [Yoshida, Eric M.] Vancouver Gen Hosp, Dept Med, Div Gastroenterol, Vancouver, BC, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of British Columbia	Udell, JA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA.	judell@partners.org		Tinmouth, Jill/0000-0002-0264-2176; Udell, Jacob/0000-0001-7402-9584	Canadian Association of Gastroenterology-Axcan Pharma Inc; Canadian Institutes for Health Research (CIHR); Canadian Foundation for Women's Health; CHEST Foundation-Respiratory Association of Metropolitan Chicago; Canadian Institutes for Health Research Industry-Partnered (Astra-Zeneca); BC Lung Association; Michael Smith Foundation; VCHRI	Canadian Association of Gastroenterology-Axcan Pharma Inc(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Women's Health; CHEST Foundation-Respiratory Association of Metropolitan Chicago; Canadian Institutes for Health Research Industry-Partnered (Astra-Zeneca)(Canadian Institutes of Health Research (CIHR)); BC Lung Association; Michael Smith Foundation(Michael Smith Foundation for Health Research); VCHRI	This study was funded by a Canadian Association of Gastroenterology-Axcan Pharma Inc Resident Research Grant awarded to Dr Wang. Dr Udell is a recipient of a Postdoctoral Research Fellowship from the Canadian Institutes for Health Research (CIHR) and Canadian Foundation for Women's Health, and a CHEST Foundation-Respiratory Association of Metropolitan Chicago Clinical Research Award in Women's Health. Dr Tinmouth holds a Canadian Institutes for Health Research Industry-Partnered (Astra-Zeneca) New Investigator Award. Dr FitzGerald is a recipient of a Canadian Institute for Health Research and BC Lung Association Scientist award, and a Michael Smith Foundation Distinguished Scholar Award. Dr Ayas is supported by an Established Clinician Scientist Award from the VCHRI. Dr Yoshida has no competing funding or support interests associated with this work.	Adams LA, 2011, J GASTROEN HEPATOL, V26, P1536, DOI 10.1111/j.1440-1746.2011.06774.x; ADLER M, 1979, AM J MED, V67, P811, DOI 10.1016/0002-9343(79)90740-X; Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Al-Mohri H, 2005, HIV MED, V6, P375, DOI 10.1111/j.1468-1293.2005.00330.x; Anderson FH, 2000, HEPATOL RES, V18, P63, DOI 10.1016/S1386-6346(99)00085-6; Andriulli A, 2001, DIGEST DIS SCI, V46, P1409, DOI 10.1023/A:1010675401415; [Anonymous], 2006, SLEISENGER FORDTRANS; Arroyo V, 2000, J HEPATOL, V32, P157, DOI 10.1016/S0168-8278(00)80423-7; Aube C, 2004, EUR J GASTROEN HEPAT, V16, P743, DOI 10.1097/01.meg.0000108357.41221.e5; Bain VG, 2004, J VIRAL HEPATITIS, V11, P375, DOI 10.1111/j.1365-2893.2004.00520.x; Beaton M, 2002, HEPATOLOGY, V36, P673, DOI 10.1053/jhep.2002.35343; Bianchi L, 2001, J HEPATOL, V35, P290, DOI 10.1016/S0168-8278(01)00155-6; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302; Bonnard P, 2010, AM J TROP MED HYG, V82, P454, DOI 10.4269/ajtmh.2010.09-0088; Borenstein M., 2009, INTRO METAANALYSIS; Borroni G, 2006, ALIMENT PHARM THER, V24, P797, DOI 10.1111/j.1365-2036.2006.03034.x; Braden B, 2005, ALIMENT PHARM THER, V21, P179, DOI 10.1111/j.1365-2036.2005.02317.x; Braunstein GD, 2007, NEW ENGL J MED, V357, P1229, DOI 10.1056/NEJMcp070677; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Butterworth RE, 2000, J HEPATOL, V32, P171, DOI 10.1016/S0168-8278(00)80424-9; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; CARRELLA M, 1992, ANGIOLOGY, V43, P969, DOI 10.1177/000331979204301202; Carrion AF, 2011, CLIN GASTROENTEROL H, V9, P834, DOI 10.1016/j.cgh.2011.04.027; Carvalho RJ, 2008, LIVER INT, V28, P486, DOI 10.1111/j.1478-3231.2008.01675.x; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Centers for Disease Control and Prevention, CHRON LIV DIS CIRRH; Chang PE, 2008, ALIMENT PHARM THER, V28, P51, DOI 10.1111/j.1365-2036.2008.03711.x; Chrysanthos NV, 2006, EUR J GASTROEN HEPAT, V18, P389, DOI 10.1097/00042737-200604000-00012; Cioni G, 1993, Eur J Med, V2, P408; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; COZZOLINO G, 1983, AM J GASTROENTEROL, V78, P442; Croquet V, 2002, EUR J GASTROEN HEPAT, V14, P1133, DOI 10.1097/00042737-200210000-00015; Custro N, 2001, DIABETES METAB, V27, P476; CZAJA AJ, 1980, MAYO CLIN PROC, V55, P360; de Bruyn G, 2001, BMC Med Inform Decis Mak, V1, P6, DOI 10.1186/1472-6947-1-6; Dinesen L, 2008, DIGEST LIVER DIS, V40, P743, DOI 10.1016/j.dld.2008.01.013; El-Gindy Iman, 2003, Egypt J Immunol, V10, P27; ESPINOZA P, 1987, DIGEST DIS SCI, V32, P244, DOI 10.1007/BF01297048; Fontana RJ, 2002, HEPATOLOGY, V36, pS57, DOI 10.1053/jhep.2002.36800; Fujii H, 2009, J GASTROENTEROL, V44, P608, DOI 10.1007/s00535-009-0046-6; Garcia-Tsao G, 2007, AM J GASTROENTEROL, V102, P2086, DOI 10.1111/j.1572-0241.2007.01481.x; Gentilini P, 1997, AM J GASTROENTEROL, V92, P66; Giannini E, 2003, ARCH INTERN MED, V163, P218, DOI 10.1001/archinte.163.2.218; Giannini E, 1999, DIGEST DIS SCI, V44, P1249, DOI 10.1023/A:1026609231094; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Gokula R M, 2003, J Postgrad Med, V49, P272; GOLDBERG S, 1986, AM J GASTROENTEROL, V81, P1029; Goldman MP, 2004, AM J CLIN DERMATOL, V5, P423, DOI 10.2165/00128071-200405060-00007; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Gordon A, 2005, J GASTROEN HEPATOL, V20, P825, DOI 10.1111/j.1440-1746.2005.03828.x; GORDON GG, 1975, J CLIN ENDOCR METAB, V40, P1018, DOI 10.1210/jcem-40-6-1018; GROVER SA, 1993, JAMA-J AM MED ASSOC, V270, P2218, DOI 10.1001/jama.270.18.2218; Hamberg KJ, 1996, J CLIN EPIDEMIOL, V49, P1295, DOI 10.1016/0895-4356(95)00517-X; HAY CRM, 1987, BLOOD, V69, P1595; HAY JE, 1989, HEPATOLOGY, V9, P193, DOI 10.1002/hep.1840090205; HOLZBERG M, 1984, LANCET, V1, P896; Iacobellis A, 2005, ALIMENT PHARM THER, V22, P769, DOI 10.1111/j.1365-2036.2005.02633.x; Iacobellis A, 2005, AM J GASTROENTEROL, V100, P868, DOI 10.1111/j.1572-0241.2005.40881.x; Ichino N, 2010, WORLD J GASTROENTERO, V16, P4809, DOI 10.3748/wjg.v16.i38.4809; Ikeda K, 2000, HEPATOL RES, V18, P252, DOI 10.1016/S1386-6346(00)00074-7; Imperiale TF, 2000, AM J GASTROENTEROL, V95, P2328, DOI 10.1111/j.1572-0241.2000.02322.x; Islam S, 2005, SCAND J GASTROENTERO, V40, P867, DOI 10.1080/00365520510015674; Kaneda H, 2006, J GASTROEN HEPATOL, V21, P1459, DOI 10.1111/j.1440-1746.2006.04447.x; Kaul V, 2002, AM J GASTROENTEROL, V97, P2623, DOI 10.1111/j.1572-0241.2002.06040.x; Khasnis A, 2002, J Postgrad Med, V48, P307; Kichian K, 2003, CAN J GASTROENTEROL, V17, P38, DOI 10.1155/2003/268528; Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x; Lackner C, 2005, HEPATOLOGY, V41, P1376, DOI 10.1002/hep.20717; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; LASHNER BA, 1988, AM J MED, V85, P609; Lebrec D, 2005, EUR J GASTROEN HEPAT, V17, P403, DOI 10.1097/00042737-200504000-00003; Lefton HB, 2009, MED CLIN N AM, V93, P787, DOI 10.1016/j.mcna.2009.03.002; Lizardi-Cervera Javier, 2003, Ann Hepatol, V2, P122; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Loko MA, 2008, AM J GASTROENTEROL, V103, P1973, DOI 10.1111/j.1572-0241.2008.01954.x; Lu SN, 2006, CANCER-AM CANCER SOC, V107, P2212, DOI 10.1002/cncr.22242; Luo JC, 2002, HEPATO-GASTROENTEROL, V49, P478; Macias J, 2006, GUT, V55, P409, DOI 10.1136/gut.2005.065904; Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513; MARMO R, 1993, ITAL J GASTROENTEROL, V25, P1; McCormick PA, 2004, EUR J GASTROEN HEPAT, V16, P1331, DOI 10.1097/00042737-200412000-00016; Menke J, 2010, METHOD INFORM MED, V49, P54, DOI 10.3414/ME09-01-0001; Menke J, 2010, METHOD INFORM MED, V49, P62, DOI DOI 10.3414/ME09-01-0001; Mistry F P, 1991, Indian J Gastroenterol, V10, P82; Montazeri G, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-32; Murray KF, 2005, HEPATOLOGY, V41, P1407, DOI 10.1002/hep.20704; Myers KA, 2001, JAMA-J AM MED ASSOC, V286, P341, DOI 10.1001/jama.286.3.341; NAKAMURA T, 1967, TOHOKU J EXP MED, V93, P179, DOI 10.1620/tjem.93.179; NANJI AA, 1989, ENZYME, V41, P112, DOI 10.1159/000469062; NAYLOR CD, 1994, JAMA-J AM MED ASSOC, V271, P1859, DOI 10.1001/jama.271.23.1859; Nguyen D, 2011, HEPATOLOGY, V53, P2107, DOI 10.1002/hep.24401; Niederau C, 2008, LIVER INT, V28, P659, DOI 10.1111/j.1478-3231.2008.01694.x; NISHIKAWA Y, 1984, CLIN BIOCHEM, V17, P327, DOI 10.1016/S0009-9120(84)90661-1; Nunes D, 2005, JAIDS-J ACQ IMM DEF, V40, P538, DOI 10.1097/01.qai.0000184856.31695.bf; Nyblom H, 2006, LIVER INT, V26, P840, DOI 10.1111/j.1478-3231.2006.01304.x; Oberti F, 1997, GASTROENTEROLOGY, V113, P1609, DOI 10.1053/gast.1997.v113.pm9352863; OBRIEN DP, 1994, J ROY SOC MED, V87, P320; PAGLIARO L, 1982, ITAL J GASTROENTEROL, V14, P166; Park GJH, 2000, J GASTROEN HEPATOL, V15, P386, DOI 10.1046/j.1440-1746.2000.02172.x; Perera GA, 1942, J AMER MED ASSOC, V119, P1417, DOI 10.1001/jama.1942.72830340004008c; Perrillo RP, 1997, HEPATOLOGY, V26, pS57, DOI 10.1002/hep.510260710; Poynard T, 1997, J VIRAL HEPATITIS, V4, P199, DOI 10.1046/j.1365-2893.1997.00141.x; Pradat P, 2002, HEPATOLOGY, V36, P973, DOI 10.1053/jhep.2002.35530; PROPST A, 1995, DIGEST DIS SCI, V40, P1805, DOI 10.1007/BF02212706; Quereda C, 2004, HUM PATHOL, V35, P1083, DOI 10.1016/j.humpath.2004.05.015; Quinn P G, 1997, Gastroenterologist, V5, P58; RANKIN JGD, 1978, ALCOHOL CLIN EXP RES, V2, P327, DOI 10.1111/j.1530-0277.1978.tb04738.x; Reedy DW, 1998, DIGEST DIS SCI, V43, P2156, DOI 10.1023/A:1018888021118; Renou C, 2001, AM J GASTROENTEROL, V96, P1657, DOI 10.1111/j.1572-0241.2001.03830.x; Reuben A, 2002, HEPATOLOGY, V35, P735, DOI 10.1053/jhep.2002.0350735; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Rodriguez-Vilarrupla A, 2007, ANN HEPATOL, V6, P28, DOI 10.1016/S1665-2681(19)31950-7; Romagnuolo J, 2001, AM J GASTROENTEROL, V96, P3165, DOI 10.1111/j.1572-0241.2001.05275.x; Ruiz MA, 1997, MIL MED, V162, P560, DOI 10.1093/milmed/162.8.560; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; Saleh HA, 2007, J GASTROINTEST LIVER, V16, P425; SCHENKER S, 1962, AM J DIG DIS, V7, P449, DOI 10.1007/BF02232364; Schneider ARJ, 2006, CLIN EXP PHARMACOL P, V33, P300, DOI 10.1111/j.1440-1681.2006.04365.x; Schoniger-Hekele M, 2006, DIGEST DIS SCI, V51, P338, DOI 10.1007/s10620-006-3135-x; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P525, DOI 10.3748/wjg.v13.i4.525; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Shire NJ, 2009, CLIN GASTROENTEROL H, V7, P471, DOI 10.1016/j.cgh.2008.12.016; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; Simel DL, 2009, RATIONAL CLIN EXAMIN, P15; Sirli R, 2010, HEPAT MON, V10, P88; Skelly MM, 2001, J HEPATOL, V35, P195, DOI 10.1016/S0168-8278(01)00094-0; Snyder N, 2006, J CLIN GASTROENTEROL, V40, P535, DOI 10.1097/00004836-200607000-00013; Talley NJ, 2005, CLIN EXAMINATION SYS; TERRY R, 1954, LANCET, V1, P757; THEODOSSI A, 1981, Liver, V1, P21; TINE F, 1990, INT CONGR SER, V910, P187; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; VANDAMMIERAS MCE, 1983, HAEMOSTASIS, V13, P201; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang CS, 2005, JAMA-J AM MED ASSOC, V294, P1944, DOI 10.1001/jama.294.15.1944; Westin J, 2008, SCAND J GASTROENTERO, V43, P73, DOI 10.1080/00365520701514461; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2; WILLIAMS JW, 1992, JAMA-J AM MED ASSOC, V267, P2645, DOI 10.1001/jama.267.19.2645; Wong VWS, 2009, ALIMENT PHARM THER, V29, P387, DOI 10.1111/j.1365-2036.2008.03896.x; Zeremski M, 2005, J HEPATOL, V43, P2, DOI 10.1016/j.jhep.2005.05.007; Zhu X, 2011, DIGEST DIS SCI, V56, P2742, DOI 10.1007/s10620-011-1659-1; ZOLI M, 1995, AM J GASTROENTEROL, V90, P1428	147	117	120	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					832	842		10.1001/jama.2012.186	http://dx.doi.org/10.1001/jama.2012.186			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FQ	22357834				2022-12-28	WOS:000300551300026
J	Kleinman, A				Kleinman, Arthur			The art of medicine Culture, bereavement, and psychiatry	LANCET			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Kleinman, A (corresponding author), Harvard Univ, William James Hall Room 330, Cambridge, MA 02138 USA.	kleinman@wjh.harvard.edu						American Psychiatric Association. (n.d.), DSM 5 DEV; Aries Philippe., 1981, HOUR OUR DEATH TRANS; Carey B, 2012, NY TIMES        0125; Kleinman A., 1988, RETHINKING PSYCHIAT; Lock M, 2010, ANTHR BIOMEDICINE; Wakefield, 2007, LOSS SADNESS; Wakefield JC, 2012, WORLD PSYCHIATRY, V11, P3, DOI 10.1016/j.wpsyc.2012.01.002	7	55	56	2	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2012	379	9816					608	609		10.1016/S0140-6736(12)60258-X	http://dx.doi.org/10.1016/S0140-6736(12)60258-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	897ES	22355809				2022-12-28	WOS:000300629000018
J	Liu, LJ; Stegman, DR				Liu, Lijun; Stegman, Dave R.			Origin of Columbia River flood basalt controlled by propagating rupture of the Farallon slab	NATURE			English	Article							NORTH-AMERICA; PACIFIC-NORTHWEST; COAST RANGE; PLUME; SUBDUCTION; GENESIS; OREGON; EVOLUTION; HISTORY; MODELS	The origin of the Steens-Columbia River (SCR) flood basalts, which is presumed to be the onset of Yellowstone volcanism, has remained controversial, with the proposed conceptual models involving either a mantle plume(1-5) or back-arc processes(6-8). Recent tomographic inversions based on the US Array data reveal unprecedented detail of upper-mantle structures of the western USA(9) and tightly constrain geodynamic models simulating Farallon subduction, which has been proposed to influence the Yellowstone volcanism(5,6). Here we show that the best-fitting geodynamic model(10) depicts an episode of slab tearing about 17 million years ago under eastern Oregon, where an associated sub-slab asthenospheric upwelling thermally erodes the Farallon slab, leading to formation of a slab gap at shallow depth. Driven by a gradient of dynamic pressure, the tear ruptured quickly north and south and within about two million years covering a distance of around 900 kilometres along all of eastern Oregon and northern Nevada. This tear would be consistent with the occurrence of major volcanic dikes during the SCR-Northern Nevada Rift flood basalt event both in space and time. The model predicts a petrogenetic sequence for the flood basalt with sources of melt starting from the base of the slab, at first remelting oceanic lithosphere and then evolving upwards, ending with remelting of oceanic crust. Such a progression helps to reconcile the existing controversies on the interpretation of SCR geochemistry and the involvement of the putative Yellowstone plume. Our study suggests a new mechanism for the formation of large igneous provinces.	[Liu, Lijun; Stegman, Dave R.] Univ Calif San Diego, Scripps Inst Oceanog, IGPP, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Liu, LJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, IGPP, La Jolla, CA 92093 USA.	lil019@ucsd.edu	Liu, Lijun/C-2840-2012; Stegman, Dave/F-5794-2010	Stegman, Dave/0000-0001-8012-6145	XSEDE [EAR100021]; John Miles Fellowship; Cecil and Ida Green Foundation; G. Unger Vetlesen Foundation	XSEDE; John Miles Fellowship; Cecil and Ida Green Foundation; G. Unger Vetlesen Foundation	We thank R. Carlson and D. Blackman for discussions. Computational resources were provided by XSEDE project EAR100021. L. L. was funded by the John Miles Fellowship and the Cecil and Ida Green Foundation. D. R. S. was supported in part by the G. Unger Vetlesen Foundation.	Atwater T, 1998, INTEGRATED EARTH AND ENVIRONMENTAL EVOLUTION OF THE SOUTHWESTERN UNITED STATES, P393; BECK ME, 1984, GEOLOGY, V12, P737, DOI 10.1130/0091-7613(1984)12<737:HTWCRM>2.0.CO;2; BRANDON AD, 1988, EARTH PLANET SC LETT, V88, P273, DOI 10.1016/0012-821X(88)90084-2; Bunge HP, 2000, NATURE, V405, P337, DOI 10.1038/35012586; Camp VE, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002838; Camp VE, 2008, GEOSPHERE, V4, P480, DOI 10.1130/GES00175.1; CARLSON RW, 1984, GEOCHIM COSMOCHIM AC, V48, P2357, DOI 10.1016/0016-7037(84)90231-X; CARLSON RW, 1987, J GEOPHYS RES-SOLID, V92, P6191, DOI 10.1029/JB092iB07p06191; Christiansen RL, 2002, GEOL SOC AM BULL, V114, P1245, DOI 10.1130/0016-7606(2002)114<1245:UMOOTY>2.0.CO;2; Dodson A, 1997, EARTH PLANET SC LETT, V150, P443, DOI 10.1016/S0012-821X(97)00090-3; DUNCAN RA, 1982, J GEOPHYS RES, V87, P827, DOI 10.1029/JB087iB13p10827; GEIST D, 1993, GEOLOGY, V21, P789, DOI 10.1130/0091-7613(1993)021<0789:OOTCPA>2.3.CO;2; Glen JMG, 2002, GEOLOGY, V30, P647, DOI 10.1130/0091-7613(2002)030<0647:LSFRTI>2.0.CO;2; Hales TC, 2005, NATURE, V438, P842, DOI 10.1038/nature04313; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Hooper PR, 2007, GEOL SOC AM SPEC PAP, V430, P635, DOI 10.1130/2007.2430(30); Humphreys E. D., 2000, GSA TODAY, V10, P1; HUMPHREYS ED, 1995, GEOLOGY, V23, P987, DOI 10.1130/0091-7613(1995)023<0987:PLROTF>2.3.CO;2; Liu LJ, 2008, SCIENCE, V322, P934, DOI 10.1126/science.1162921; Liu LJ, 2011, EARTH PLANET SC LETT, V311, P1, DOI 10.1016/j.epsl.2011.09.027; McQuarrie N, 2005, GEOSPHERE, V1, P147, DOI 10.1130/GES00016.1; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Pierce K.L., 1992, TRACK YELLOWSTONE HO, V179, P1, DOI DOI 10.1130/MEM179-P1; PRIEST GR, 1990, J GEOPHYS RES-SOLID, V95, P19583, DOI 10.1029/JB095iB12p19583; Schellart WP, 2010, SCIENCE, V329, P316, DOI 10.1126/science.1190366; Schmandt B, 2010, EARTH PLANET SC LETT, V297, P435, DOI 10.1016/j.epsl.2010.06.047; Schmeling H, 2008, PHYS EARTH PLANET IN, V171, P198, DOI 10.1016/j.pepi.2008.06.028; Sigloch K, 2008, NAT GEOSCI, V1, P458, DOI 10.1038/ngeo231; Sigloch K, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003421; Smith RB, 2009, J VOLCANOL GEOTH RES, V188, P26, DOI 10.1016/j.jvolgeores.2009.08.020; Takahahshi E, 1998, EARTH PLANET SC LETT, V162, P63, DOI 10.1016/S0012-821X(98)00157-5; Wortel MJR, 2000, SCIENCE, V290, P1910, DOI 10.1126/science.290.5498.1910; Zhong SJ, 2000, J GEOPHYS RES-SOL EA, V105, P11063, DOI 10.1029/2000JB900003	33	111	117	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					386	U1508		10.1038/nature10749	http://dx.doi.org/10.1038/nature10749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337059				2022-12-28	WOS:000300287100043
J	Silbergleit, R; Durkalski, V; Lowenstein, D; Conwit, R; Pancioli, A; Palesch, Y; Barsan, W				Silbergleit, Robert; Durkalski, Valerie; Lowenstein, Daniel; Conwit, Robin; Pancioli, Arthur; Palesch, Yuko; Barsan, William		NETT Investigators	Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAZEPAM; MIDAZOLAM; SEIZURES	BACKGROUND Early termination of prolonged seizures with intravenous administration of benzodiazepines improves outcomes. For faster and more reliable administration, paramedics increasingly use an intramuscular route. METHODS This double-blind, randomized, noninferiority trial compared the efficacy of intramuscular midazolam with that of intravenous lorazepam for children and adults in status epilepticus treated by paramedics. Subjects whose convulsions had persisted for more than 5 minutes and who were still convulsing after paramedics arrived were given the study medication by either intramuscular autoinjector or intravenous infusion. The primary outcome was absence of seizures at the time of arrival in the emergency department without the need for rescue therapy. Secondary outcomes included endotracheal intubation, recurrent seizures, and timing of treatment relative to the cessation of convulsive seizures. This trial tested the hypothesis that intramuscular midazolam was noninferior to intravenous lorazepam by a margin of 10 percentage points. RESULTS At the time of arrival in the emergency department, seizures were absent without rescue therapy in 329 of 448 subjects (73.4%) in the intramuscular-midazolam group and in 282 of 445 (63.4%) in the intravenous-lorazepam group (absolute difference, 10 percentage points; 95% confidence interval, 4.0 to 16.1; P<0.001 for both noninferiority and superiority). The two treatment groups were similar with respect to need for endotracheal intubation (14.1% of subjects with intramuscular midazolam and 14.4% with intravenous lorazepam) and recurrence of seizures (11.4% and 10.6%, respectively). Among subjects whose seizures ceased before arrival in the emergency department, the median times to active treatment were 1.2 minutes in the intramuscularmidazolam group and 4.8 minutes in the intravenous-lorazepam group, with corresponding median times from active treatment to cessation of convulsions of 3.3 minutes and 1.6 minutes. Adverse-event rates were similar in the two groups. CONCLUSIONS For subjects in status epilepticus, intramuscular midazolam is at least as safe and effective as intravenous lorazepam for prehospital seizure cessation. (Funded by the National Institute of Neurological Disorders and Stroke and others; ClinicalTrials. gov number, NCT00809146.)	[Silbergleit, Robert; Barsan, William] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48105 USA; [Durkalski, Valerie; Palesch, Yuko] Med Univ S Carolina, Dept Med, Div Biostat & Epidemiol, Charleston, SC USA; [Lowenstein, Daniel] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Conwit, Robin] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD USA; [Pancioli, Arthur] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA	University of Michigan System; University of Michigan; Medical University of South Carolina; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University System of Ohio; University of Cincinnati	Silbergleit, R (corresponding author), Univ Michigan, Dept Emergency Med, Suite 3100,24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105 USA.	robert.silbergleit@umich.edu	Milling, Truman J/N-6601-2017; Beltran, Gerald W/O-2584-2013	Milling, Truman J/0000-0002-5588-0426; Beltran, Gerald W/0000-0001-8670-4786; Vibbert, Matthew/0000-0001-6699-6646; Ortega-Gutierrez, Santiago/0000-0002-3408-1297; Quinn, James/0000-0002-3694-2118; McMullan, Jason/0000-0002-7656-7447	National Institute of Neurological Disorders and Stroke (NINDS) [U01NS056975, U01NS059041]; National Institutes of Health Office; Biomedical Advanced Research and Development Authority of the Assistant Secretary for Preparedness and Response; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U10NS059012, U01NS059041, U10NS058940, U10NS058982, U10NS058931, U01NS056975, U10NS058927] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Office; Biomedical Advanced Research and Development Authority of the Assistant Secretary for Preparedness and Response; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by awards from the National Institute of Neurological Disorders and Stroke (NINDS) (U01NS056975 and U01NS059041); the National Institutes of Health Office of the Director CounterACT Program; and the Biomedical Advanced Research and Development Authority of the Assistant Secretary for Preparedness and Response.	Aldredge BK, 2001, NEW ENGL J MED, V345, P1860; Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; [Anonymous], 2010, GUID IND NO IN PRESS; Chamberlain JM, 1997, PEDIATR EMERG CARE, V13, P92, DOI 10.1097/00006565-199704000-00002; DUNNETT CW, 1977, BIOMETRICS, V33, P593, DOI 10.2307/2529457; Gottwald MD, 1999, AM J EMERG MED, V17, P333, DOI 10.1016/S0735-6757(99)90079-7; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; Lowenstein DH, 2001, CONTROL CLIN TRIALS, V22, P290, DOI 10.1016/S0197-2456(01)00120-9; McMullan J, 2010, ACAD EMERG MED, V17, P575, DOI 10.1111/j.1553-2712.2010.00751.x; Millikan D, 2009, EMERG MED CLIN N AM, V27, P101, DOI 10.1016/j.emc.2008.12.001; Warden CR, 2006, PREHOSP EMERG CARE, V10, P463, DOI 10.1080/10903120600885126	11	403	412	3	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					591	600		10.1056/NEJMoa1107494	http://dx.doi.org/10.1056/NEJMoa1107494			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IL	22335736	Green Accepted			2022-12-28	WOS:000300279800004
J	McMahon, LF; Chopra, V				McMahon, Laurence F., Jr.; Chopra, Vineet			Health Care Cost and Value The Way Forward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McMahon, Laurence F., Jr.; Chopra, Vineet] Univ Michigan Hlth Syst, Dept Internal Med, Div Gen Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan	McMahon, LF (corresponding author), 300 N Ingalls St,Room 7C27, Ann Arbor, MI 48109 USA.	lmcmahon@umich.edu		Chopra, Vineet/0000-0001-8670-9376				Farquhar DB, 2009, FDA LAW BLOG    0902; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; Klepper B, 2011, HEALTHAFFAIRS B 0809; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; Medicare Payment Advisory Commission, MOV FORW SUST GROWTH; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; Sisko AM, 2010, HEALTH AFFAIR, V29, P1933, DOI 10.1377/hlthaff.2010.0788; Staples MP, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3952; Weiszman RKL, 2010, BOSTON GLOBE    0429	10	29	29	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					671	672		10.1001/jama.2012.136	http://dx.doi.org/10.1001/jama.2012.136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22337677				2022-12-28	WOS:000300278500022
J	Rison, SCG; Locke, TP; Rosenthal, E; Gandhi, S				Rison, Stuart C. G.; Locke, Toby P.; Rosenthal, Eric; Gandhi, Sandeep			PICTURE QUIZ A man with hypertension and two murmurs	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONGENITAL HEART-DISEASE; AORTIC REGURGITATION; COARCTATION; ADULT; MANAGEMENT		[Rison, Stuart C. G.; Locke, Toby P.] Kings Coll London, London SE1 1UL, England; [Rosenthal, Eric] St Thomas Hosp, Evelina Childrens Hosp, London, England; [Gandhi, Sandeep] Medway Maritime Hosp, Gillingham, Kent, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Medway Maritime Hospital	Rison, SCG (corresponding author), Kings Coll London, London SE1 1UL, England.	stuart.rison@doctors.org.uk	Rison, Stuart/AAC-4733-2021; Rosenthal, Eric/I-7469-2012	Rison, Stuart/0000-0003-3289-6668; Rosenthal, Eric/0000-0003-3030-9749				Alegria JR, 2008, NAT CLIN PRACT CARD, V5, P484, DOI 10.1038/ncpcardio1258; Babu AN, 2003, ANN INTERN MED, V138, P736, DOI 10.7326/0003-4819-138-9-200305060-00010; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Beekman RH, 2008, MOSS ADAMS HEART DIS, V2, P987; Danzer CS, 1919, AM J MED SCI, V157, P513, DOI 10.1097/00000441-191904000-00007; Egan Matthew, 2009, Expert Rev Cardiovasc Ther, V7, P1401, DOI 10.1586/erc.09.111; Goh TH, 2008, HEART LUNG CIRC, V17, P80, DOI 10.1016/j.hlc.2006.12.005; Hussein A, 2009, EUR J ECHOCARDIOGR, V10, P625, DOI 10.1093/ejechocard/jep014; Hutchison SJ, 2009, AORTIC DIS CLIN DIAG, P271; Rosenthal E, 2005, HEART, V91, P1495, DOI 10.1136/hrt.2004.057182; Rosenthal E, 2001, J AM COLL CARDIOL, V38, P1524, DOI 10.1016/S0735-1097(01)01573-X; ROSLER H, 1928, WIEN ARCH INN MED, V15, P521; Tanous D, 2009, CURR OPIN CARDIOL, V24, P509, DOI 10.1097/HCO.0b013e328330cc22; Teixeira AM, 2005, CARDIOL YOUNG, V15, P525, DOI 10.1017/S1047951105001435; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Warnes CA, 2005, J AM COLL CARDIOL, V46, P1, DOI 10.1016/j.jacc.2005.02.083; WOODRING JH, 1985, AM J ROENTGENOL, V144, P23, DOI 10.2214/ajr.144.1.23	17	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2012	344								e956	10.1136/bmj.e956	http://dx.doi.org/10.1136/bmj.e956			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896IB	22337753				2022-12-28	WOS:000300557800005
J	Song, JK; Teplova, M; Ishibe-Murakami, S; Patel, DJ				Song, Jikui; Teplova, Marianna; Ishibe-Murakami, Satoko; Patel, Dinshaw J.			Structure-Based Mechanistic Insights into DNMT1-Mediated Maintenance DNA Methylation	SCIENCE			English	Article							METHYLTRANSFERASE; REPLICATION; COMPLEX; DOMAIN; DNMT1; CYTOSINE; TARGET	DNMT1, the major maintenance DNA methyltransferase in animals, helps to regulate gene expression, genome imprinting, and X-chromosome inactivation. We report on the crystal structure of a productive covalent mouse DNMT1(731-1602)-DNA complex containing a central hemimethylated CpG site. The methyl group of methylcytosine is positioned within a shallow hydrophobic concave surface, whereas the cytosine on the target strand is looped out and covalently anchored within the catalytic pocket. The DNA is distorted at the hemimethylated CpG step, with side chains from catalytic and recognition loops inserting through both grooves to fill an intercalation-type cavity associated with a dual base flip-out on partner strands. Structural and biochemical data establish how a combination of active and autoinhibitory mechanisms ensures the high fidelity of DNMT1-mediated maintenance DNA methylation.	[Song, Jikui; Teplova, Marianna; Ishibe-Murakami, Satoko; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org			Abby Rockefeller Mauze Trust; STARR Foundation; Maloris Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Trust; STARR Foundation; Maloris Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by funds from the Abby Rockefeller Mauze Trust and STARR and Maloris Foundations (D.J.P.). We thank T. Bestor and M. Goll for helpful discussions, and the staff of the NE-CAT beamlines at the Advanced Photon Source, Argonne National laboratory, for access and assistance with data collection. The structure of the complex has been deposited under accession no. 4DA4 in the Protein Data Bank.	Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; OSTERMAN DG, 1988, BIOCHEMISTRY-US, V27, P5204, DOI 10.1021/bi00414a039; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108	16	220	230	4	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					709	712		10.1126/science.1214453	http://dx.doi.org/10.1126/science.1214453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323818	Green Accepted			2022-12-28	WOS:000300047100050
J	Thompson, MA; Mugavero, MJ; Amico, KR; Cargill, VA; Chang, LRW; Gross, R; Orrell, C; Altice, FL; Bangsberg, DR; Bartlett, JG; Beckwith, CG; Dowshen, N; Gordon, CM; Horn, T; Kumar, P; Scott, JD; Stirratt, MJ; Remien, RH; Simoni, JM; Nachega, JB				Thompson, Melanie A.; Mugavero, Michael J.; Amico, K. Rivet; Cargill, Victoria A.; Chang, Larry W.; Gross, Robert; Orrell, Catherine; Altice, Frederick L.; Bangsberg, David R.; Bartlett, John G.; Beckwith, Curt G.; Dowshen, Nadia; Gordon, Christopher M.; Horn, Tim; Kumar, Princy; Scott, James D.; Stirratt, Michael J.; Remien, Robert H.; Simoni, Jane M.; Nachega, Jean B.			Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HUMAN-IMMUNODEFICIENCY-VIRUS; DIRECTLY OBSERVED THERAPY; BEHAVIORAL STRESS-MANAGEMENT; INFECTED PEDIATRIC-PATIENTS; EVIDENCE-BASED INTERVENTION; MARGINAL STRUCTURAL MODEL; SELF-ADMINISTERED THERAPY; SINGLE-TABLET REGIMEN; INJECTION-DRUG USERS	Description: After HIV diagnosis, timely entry into HIV medical care and retention in that care are essential to the provision of effective antiretroviral therapy (ART). Adherence to ART is among the key determinants of successful HIV treatment outcome and is essential to minimize the emergence of drug resistance. The International Association of Physicians in AIDS Care convened a panel to develop evidence-based recommendations to optimize entry into and retention in care and ART adherence for people with HIV. Methods: A systematic literature search was conducted to produce an evidence base restricted to randomized, controlled trials and observational studies with comparators that had at least 1 measured biological or behavioral end point. A total of 325 studies met the criteria. Two reviewers independently extracted and coded data from each study using a standardized data extraction form. Panel members drafted recommendations based on the body of evidence for each method or intervention and then graded the overall quality of the body of evidence and the strength for each recommendation. Recommendations: Recommendations are provided for monitoring entry into and retention in care, interventions to improve entry and retention, and monitoring of and interventions to improve ART adherence. Recommendations cover ART strategies, adherence tools, education and counseling, and health system and service delivery interventions. In addition, they cover specific issues pertaining to pregnant women, incarcerated individuals, homeless and marginally housed individuals, and children and adolescents, as well as substance use and mental health disorders. Recommendations for future research in all areas are also provided.	AIDS Res Consortium Atlanta, Atlanta, GA USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Connecticut, Storrs, CT USA; NIH, Off AIDS Res, Bethesda, MD 20892 USA; NIMH, Bethesda, MD 20892 USA; Univ Stellenbosch, Johns Hopkins Univ, Baltimore, MD USA; Univ Penn, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Cape Town, ZA-7925 Cape Town, South Africa; Yale Univ, New Haven, CT USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; Miriam Hosp, Providence, RI 02906 USA; AIDSmeds Com, New York, NY USA; Columbia Univ, New York, NY USA; Georgetown Univ, Washington, DC USA; Western Univ Hlth Sci, Pomona, CA USA; Univ Washington, Seattle, WA 98195 USA	University of Alabama System; University of Alabama Birmingham; University of Connecticut; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Cape Town; Yale University; Harvard University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Columbia University; Georgetown University; Western University of Health Sciences; University of Washington; University of Washington Seattle	Thompson, MA (corresponding author), Int Assoc Phys AIDS Care, 1640 Rhode Isl Ave NW,Suite 200, Washington, DC 20036 USA.	iapac@iapac.org	Orrell, Catherine/AAF-3405-2019; /AAE-4700-2020	Orrell, Catherine/0000-0003-1134-7475; Nachega, Jean/0000-0002-2862-4443; Amico, K Rivet/0000-0002-4458-6934; Simoni, Jane/0000-0002-8711-1576	IAPAC; U.S. National Institutes of Health's Office of AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH086338, P30MH043520, K24MH093243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA021095] Funding Source: NIH RePORTER	IAPAC; U.S. National Institutes of Health's Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Development of the guidelines was jointly sponsored by IAPAC and the U.S. National Institutes of Health's Office of AIDS Research.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Agwu AL, 2011, JAIDS-J ACQ IMM DEF, V58, P100, DOI 10.1097/QAI.0b013e31822327df; Altice F, 2011, 18 C RETR OPP INF BO; Altice FL, 2007, CLIN INFECT DIS, V45, P770, DOI 10.1086/521166; Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Amico KR, 2006, JAIDS-J ACQ IMM DEF, V41, P285; Andersen M, 2007, J ASSOC NURSE AIDS C, V18, P33, DOI 10.1016/j.jana.2007.03.007; [Anonymous], 2011, GUID US ANT AG HIV I; [Anonymous], 6 INT AIDS SOC C HIV; [Anonymous], 2011, HIV AIDS PREV RES SY; Antoni MH, 2006, PSYCHOSOM MED, V68, P143, DOI 10.1097/01.psy.0000195749.60049.63; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Babudieri S, 2000, JAMA-J AM MED ASSOC, V284, P179, DOI 10.1001/jama.284.2.179; Bae JW, 2011, AIDS, V25, P279, DOI 10.1097/QAD.0b013e328340feb0; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Barbaro G, 2002, CIRCULATION, V106, P1420, DOI 10.1161/01.CIR.0000031704.78200.59; Belzer ME, 1999, J ADOLESCENT HEALTH, V25, P316, DOI 10.1016/S1054-139X(99)00052-X; Berg KM, 2011, DRUG ALCOHOL DEPEN, V113, P192, DOI 10.1016/j.drugalcdep.2010.07.025; Berger S, 2008, AIDS, V22, P767, DOI 10.1097/QAD.0b013e3282f511dc; Berrien VM, 2004, AIDS PATIENT CARE ST, V18, P355, DOI 10.1089/1087291041444078; Bisson GP, 2008, JAIDS-J ACQ IMM DEF, V49, P107, DOI 10.1097/QAI.0b013e3181820141; Boyle BA, 2008, HIV CLIN TRIALS, V9, P164, DOI 10.1310/hct0903-164; Brackis-Cott Elizabeth, 2003, J Pediatr Health Care, V17, P252, DOI 10.1016/S0891-5245(02)88313-4; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; Broadhead RS, 2002, SOC SCI MED, V55, P235, DOI 10.1016/S0277-9536(01)00167-8; Brock TP, 2007, INT J MED INFORM, V76, P829, DOI 10.1016/j.ijmedinf.2006.09.024; Brouwers MC, 2010, PREV MED, V51, P421, DOI 10.1016/j.ypmed.2010.08.005; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Centers for Disease Control and Prevention, 2011, HIV SURV REP 2009, V21; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Chiou PY, 2006, J ADV NURS, V55, P169, DOI 10.1111/j.1365-2648.2006.03902.x; Chung M, 2009, 4 INT C HIV TREATM A; CLARKE S, 2002, AIDS READ, V12, P312; Clarke Susan, 2002, AIDS Read, V12, P305; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Collier AC, 2005, J INFECT DIS, V192, P1398, DOI 10.1086/466526; Conway B, 2004, CLIN INFECT DIS, V38, pS402, DOI 10.1086/421404; Copenhaver M, 2009, AIDS PATIENT CARE ST, V23, P277, DOI 10.1089/apc.2008.0157; Craw JA, 2008, JAIDS-J ACQ IMM DEF, V47, P597, DOI 10.1097/QAI.0b013e3181684c51; Cunningham CO, 2011, SUBST USE MISUSE, V46, P218, DOI 10.3109/10826084.2011.522840; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Davila J, 2010, 5 INT C HIV TREATM A; De Bruin M, 2005, AIDS PATIENT CARE ST, V19, P384; de Bruin M, 2010, HEALTH PSYCHOL, V29, P421, DOI 10.1037/a0020335; de Bruin M, 2010, ARCH INTERN MED, V170, P240, DOI 10.1001/archinternmed.2009.536; Deering KN, 2009, AIDS PATIENT CARE ST, V23, P603, DOI 10.1089/apc.2009.0022; DeJesus E, 2009, JAIDS-J ACQ IMM DEF, V51, P163, DOI 10.1097/QAI.0b013e3181a572cf; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Deschamps AE, 2008, AIDS PATIENT CARE ST, V22, P735, DOI 10.1089/apc.2007.0229; DiIorio C, 2008, AIDS CARE, V20, P273, DOI 10.1080/09540120701593489; DiIorio Colleen, 2003, J Assoc Nurses AIDS Care, V14, P52; Dowshen N, 2011, PEDIATRICS, V128, P762, DOI 10.1542/peds.2011-0068; Dube MP, 2010, J INFECT DIS, V201, P1783, DOI 10.1086/652751; Duong M, 2001, CLIN INFECT DIS, V33, P386, DOI 10.1086/321876; Duran S, 2003, AIDS, V17, P1096, DOI 10.1097/00002030-200305020-00025; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Ellis DA, 2006, AIDS PATIENT CARE ST, V20, P112, DOI 10.1089/apc.2006.20.112; Eron JJ, 2000, AIDS, V14, P671, DOI 10.1097/00002030-200004140-00006; European AIDS Clinical Society (EACS), 2011, GUID VERS 6 0; Fairley CK, 2003, INT J STD AIDS, V14, P805, DOI 10.1258/095646203322556129; Farley J, 2003, JAIDS-J ACQ IMM DEF, V33, P211, DOI 10.1097/00126334-200306010-00016; Feaster DJ, 2010, DRUG ALCOHOL DEPEN, V111, P227, DOI 10.1016/j.drugalcdep.2010.04.017; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fletcher CV, 2005, JAIDS-J ACQ IMM DEF, V40, P301, DOI 10.1097/01.qai.0000180078.53321.6a; Flexner C, 2010, CLIN INFECT DIS, V50, P1041, DOI 10.1086/651118; Frick P, 2006, AIDS PATIENT CARE ST, V20, P511, DOI 10.1089/apc.2006.20.511; Friedland G, 2010, JAIDS-J ACQ IMM DEF, V55, pS37, DOI 10.1097/QAI.0b013e3181f9c0b6; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Garcia Rosa, 2005, Braz J Infect Dis, V9, P494, DOI 10.1590/S1413-86702005000600007; Gardner EA, 2008, AIDS, V22, P75, DOI 10.1097/QAD.0b013e3282f366ff; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Garvie PA, 2007, PEDIATRICS, V119, pE893, DOI 10.1542/peds.2006-1488; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Giordano TP, 2003, JAIDS-J ACQ IMM DEF, V32, P399, DOI 10.1097/00126334-200304010-00009; Glikman D, 2007, PEDIATRICS, V119, pE1142, DOI 10.1542/peds.2006-2614; Golin CE, 2006, JAIDS-J ACQ IMM DEF, V42, P42, DOI 10.1097/01.qai.0000219771.97303.0a; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Gonzalez Maria J Cuevas, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P245, DOI 10.1177/1545109707305444; Goujard C, 2003, JAIDS-J ACQ IMM DEF, V34, P191, DOI 10.1097/00126334-200310010-00009; Graham J, 2007, AIDS BEHAV, V11, P385, DOI 10.1007/s10461-006-9164-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Green S., 2009, COCHRANE HDB SYSTEMA; Grodensky GC, 2011, 4 INT C HIV TREATM A; Gross R, 2001, AIDS, V15, P2109, DOI 10.1097/00002030-200111090-00006; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Gross R, 2009, ARCH INTERN MED, V169, P1224, DOI 10.1001/archinternmed.2009.172; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hammett T., 2007, 217736 NCJ US DEP JU; Hardy H, 2009, 4 INT C HIV TREATM A; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, pS31, DOI 10.1089/apc.2011.9878; Hirsch JD, 2009, J MANAGE CARE PHARM, V15, P32, DOI 10.18553/jmcp.2009.15.1.32; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Holzemer WL, 2006, NURS RES, V55, P189, DOI 10.1097/00006199-200605000-00005; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Hugen PWH, 2002, J ACQ IMMUN DEF SYND, V30, P324, DOI [10.1097/00126334-200207010-00009, 10.1097/01.QAI.0000014768.35851.DB]; Idoko JA, 2007, INT J STD AIDS, V18, P760, DOI 10.1258/095646207782212252; Ines SM, 2008, CURR HIV RES, V6, P164, DOI 10.2174/157016208783885047; Javanbakht Marjan, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P143, DOI 10.1177/1545109706291706; Johnson MO, 2007, JAIDS-J ACQ IMM DEF, V46, P574, DOI 10.1097/QAI.0b013e318158a474; Johnson MO, 2011, ANN BEHAV MED, V41, P83, DOI 10.1007/s12160-010-9230-4; Jurgens R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-26; Kalichman SC, 2005, J ASSOC NURSE AIDS C, V16, P3, DOI 10.1016/j.jana.2005.07.001; Kalichman SC, 2011, AM J PUBLIC HEALTH, V101, P531, DOI 10.2105/AJPH.2010.197608; Kalra S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-2; Kipp W, 2010, CURR HIV RES, V8, P179, DOI 10.2174/157016210790442722; Klein SJ, 2002, AIDS EDUC PREV, V14, P114, DOI 10.1521/aeap.14.7.114.23856; Knobel H, 1999, Enferm Infecc Microbiol Clin, V17, P78; Koenig LJ, 2008, HEALTH PSYCHOL, V27, P159, DOI 10.1037/0278-6133.27.2.159; Kushel MB, 2006, CLIN INFECT DIS, V43, P234, DOI 10.1086/505212; Laine C, 2000, OBSTET GYNECOL, V95, P167, DOI 10.1016/S0029-7844(99)00523-2; Laine C, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00011; Leisegang R, 2011, 18 C RETR OPP INF BO; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Levy RW, 2004, AIDS PATIENT CARE ST, V18, P728, DOI 10.1089/apc.2004.18.728; Llibre JM, 2011, AIDS, V25, P1683, DOI 10.1097/QAD.0b013e3283499cd9; Lucas GM, 2006, CLIN INFECT DIS, V42, P1628, DOI 10.1086/503905; Lucas GM, 2004, CLIN INFECT DIS, V38, pS409, DOI 10.1086/421405; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Lucas GM, 2010, ANN INTERN MED, V152, P704, DOI 10.7326/0003-4819-152-11-201006010-00003; Lyon ME, 2003, AIDS PATIENT CARE ST, V17, P299, DOI 10.1089/108729103322108175; Macalino GE, 2007, AIDS, V21, P1473, DOI 10.1097/QAD.0b013e32811ebf68; MacDonell KE, 2011, AIDS PATIENT CARE ST, V25, P47, DOI 10.1089/apc.2010.0172; Maitland D, 2008, HIV MED, V9, P667, DOI 10.1111/j.1468-1293.2008.00618.x; Mann T, 2001, ANN BEHAV MED, V23, P26, DOI 10.1207/S15324796ABM2301_5; Mannheimer SB, 2006, JAIDS-J ACQ IMM DEF, V43, pS41, DOI 10.1097/01.qai.0000245887.58886.ac; Margolin A, 2003, HEALTH PSYCHOL, V22, P223, DOI 10.1037/0278-6133.22.2.223; Marhefka SL, 2006, AIDS PATIENT CARE ST, V20, P429, DOI 10.1089/apc.2006.20.429; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Martin S, 2007, PEDIATR INFECT DIS J, V26, P61, DOI 10.1097/01.inf.0000250625.80340.48; Martinez J, 2003, J ADOLESCENT HEALTH, V33, P23, DOI 10.1016/S1054-139X(03)00159-9; Maru DSR, 2009, JAIDS-J ACQ IMM DEF, V50, P176, DOI 10.1097/QAI.0b013e3181938e7e; Matovu F, 2011, 18 C RETR OPP INF BO, P1016; McKeegan K, 2011, 6 INT C HIV TREATM A; McPherson-Baker S., 2000, AIDS Care, V12, P399, DOI 10.1080/09540120050123792; Megazzini KM, 2010, AIDS, V24, P447, DOI 10.1097/QAD.0b013e328334b285; Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208; Mellins CA, 2004, PEDIATR INFECT DIS J, V23, P1035, DOI 10.1097/01.inf.0000143646.15240.ac; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; Milam J, 2005, JAIDS-J ACQ IMM DEF, V40, P356, DOI 10.1097/01.qai.0000159710.98960.81; Miller L G, 2000, HIV Clin Trials, V1, P36; Milloy MJ, 2011, J INFECT DIS, V203, P1215, DOI 10.1093/infdis/jir032; Mitty JA, 2005, JAIDS-J ACQ IMM DEF, V39, P545; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Molina JM, 2007, AIDS RES HUM RETROV, V23, P1505, DOI 10.1089/aid.2007.0107; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Mostashari F, 1998, J ACQ IMMUN DEF SYND, V18, P341, DOI 10.1097/00042560-199808010-00005; Muller AD, 2008, PEDIATR INFECT DIS J, V27, P257, DOI 10.1097/INF.0b013e31815b1ad4; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Mugusi F, 2009, TROP MED INT HEALTH, V14, P1226, DOI 10.1111/j.1365-3156.2009.02359.x; Munoz M, 2010, AIDS BEHAV, V14, P721, DOI 10.1007/s10461-009-9559-5; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Murphy Debra A, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P113, DOI 10.1177/1545109707301243; Myung P, 2007, AM J PUBLIC HEALTH, V97, P974, DOI 10.2105/AJPH.2005.083253; Naar-King S, 2006, AIDS PATIENT CARE ST, V20, P44, DOI 10.1089/apc.2006.20.44; Naar-King S, 2007, AIDS PATIENT CARE ST, V21, pS40, DOI 10.1089/apc.2007.9988; Naar-King S, 2009, ARCH PEDIAT ADOL MED, V163, P1092, DOI 10.1001/archpediatrics.2009.212; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nachega JB, 2010, AIDS, V24, P1273, DOI 10.1097/QAD.0b013e328339e20e; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Palepua A, 2006, DRUG ALCOHOL DEPEN, V84, P188, DOI 10.1016/j.drugalcdep.2006.02.003; Parienti JJ, 2007, AIDS, V21, P2217, DOI 10.1097/QAD.0b013e3282eff388; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Parsons JT, 2005, AIDS PATIENT CARE ST, V19, P31, DOI 10.1089/apc.2005.19.31; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pearson CR, 2007, JAIDS-J ACQ IMM DEF, V46, P238, DOI 10.1097/QAI.0b013e318153f7ba; Petersen ML, 2007, CLIN INFECT DIS, V45, P908, DOI 10.1086/521250; Petry NM, 2010, J CONSULT CLIN PSYCH, V78, P89, DOI 10.1037/a0016778; Pontali E, 2005, HIV CLIN TRIALS, V6, P25; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Portsmouth SD, 2005, HIV MED, V6, P185, DOI 10.1111/j.1468-1293.2005.00287.x; Pradier C, 2003, HIV CLIN TRIALS, V4, P121; Purcell DW, 2007, JAIDS-J ACQ IMM DEF, V46, pS35, DOI 10.1097/QAI.0b013e31815767c4; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Rajabiun S, 2007, AIDS PATIENT CARE ST, V21, pS9, DOI 10.1089/apc.2007.9991; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Rawlings MK, 2003, JAIDS-J ACQ IMM DEF, V34, P174, DOI 10.1097/00126334-200310010-00007; Reddington C, 2000, PEDIATR INFECT DIS J, V19, P1148, DOI 10.1097/00006454-200012000-00005; Remien RH, 2005, AIDS, V19, P807, DOI 10.1097/01.aids.0000168975.44219.45; Reynolds NR, 2008, JAIDS-J ACQ IMM DEF, V47, P62, DOI 10.1097/QAI.0b013e3181582d54; Rich JD, 2001, J URBAN HEALTH, V78, P279, DOI 10.1093/jurban/78.2.279; Rigsby MO, 2000, J GEN INTERN MED, V15, P841, DOI 10.1046/j.1525-1497.2000.00127.x; Robertson MJ, 2004, AM J PUBLIC HEALTH, V94, P1207, DOI 10.2105/AJPH.94.7.1207; Rosen DL, 2004, J HEALTH CARE POOR U, V15, P413, DOI 10.1353/hpu.2004.0047; Rosen MI, 2007, AIDS PATIENT CARE ST, V21, P30, DOI 10.1089/apc.2006.0028; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; Roux P, 2008, ADDICTION, V103, P1828, DOI 10.1111/j.1360-0443.2008.02323.x; Ruiz I, 2010, ENFERM INFEC MICR CL, V28, P409, DOI 10.1016/j.eimc.2009.03.018; Ryscavage PA, 2011, JAIDS-J ACQ IMM DEF, V58, P193, DOI [10.1097/QAI.0B013E31822D7564, 10.1097/QAI.0b013e31822d7564]; Sabin LL, 2010, AIDS BEHAV, V14, P580, DOI 10.1007/s10461-009-9615-1; Safren SA, 2003, AIDS CARE, V15, P787, DOI 10.1080/09540120310001618630; Safren SA, 2001, BEHAV RES THER, V39, P1151, DOI 10.1016/S0005-7967(00)00091-7; Safren SA, 2009, HEALTH PSYCHOL, V28, P1, DOI 10.1037/a0012715; Samet JH, 2005, ANTIVIR THER, V10, P83; Sampaio-Sa M, 2008, AIDS BEHAV, V12, pS54, DOI 10.1007/s10461-008-9414-0; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Sarna A, 2008, JAIDS-J ACQ IMM DEF, V48, P611, DOI 10.1097/QAI.0b013e3181806bf1; Seal DW, 2005, CURR OPIN PSYCHIATR, V18, P530, DOI 10.1097/01.yco.0000179492.08064.de; Serrano C, 2010, ASIA PAC J CLIN NUTR, V19, P68; Simoni JM, 2007, HEALTH PSYCHOL, V26, P488, DOI 10.1037/0278-6133.26.4.488; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Simoni JM, 2011, AIDS BEHAV, V15, P919, DOI 10.1007/s10461-010-9828-3; Simoni JM, 2009, JAIDS-J ACQ IMM DEF, V52, P465, DOI 10.1097/QAI.0b013e3181b9300c; Small W, 2009, AIDS CARE, V21, P708, DOI 10.1080/09540120802511869; Smith SR, 2003, PATIENT EDUC COUNS, V50, P187; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Stringer JSA, 2003, JAIDS-J ACQ IMM DEF, V32, P506, DOI 10.1097/00126334-200304150-00007; Sullivan LE, 2006, CLIN INFECT DIS, V43, pS184, DOI 10.1086/508182; Taiwo BO, 2010, JAIDS-J ACQ IMM DEF, V54, P85, DOI 10.1097/01.qai.0000371678.25873.1c; Thigpen MC, 2011, 6 INT AIDS SOC C HIV; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tripathi A, 2011, AIDS RES HUM RETROV, V27, P751, DOI [10.1089/aid.2010.0268, 10.1089/AID.2010.0268]; Tsai AC, 2010, ARCH GEN PSYCHIAT, V67, P1282, DOI 10.1001/archgenpsychiatry.2010.160; Tuldra A, 2000, J ACQ IMMUN DEF SYND, V25, P221, DOI 10.1097/00126334-200011010-00003; Uhlmann S, 2010, ADDICTION, V105, P907, DOI 10.1111/j.1360-0443.2010.02905.x; UNAIDS, 2011, UNAIDS DAT TABL 2011; Uzma Q, 2009, 4 INT C HIV TREATM A; van Servellen G, 2005, AIDS PATIENT CARE ST, V19, P745; Wagner GJ, 2006, AIDS, V20, P1295, DOI 10.1097/01.aids.0000232238.28415.d2; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Webel AR, 2010, AIDS CARE, V22, P1029, DOI 10.1080/09540120903214389; Weber R, 2004, ANTIVIR THER, V9, P85; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; Weiss SM, 2011, INT J WOMENS HEALTH, V3, P63, DOI 10.2147/IJWH.S5947; Wells G., NEWCASTLE OTTAWA SCA; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WHO, 2010, ANT THER HIV INF AD; Williams AB, 2006, JAIDS-J ACQ IMM DEF, V42, P314, DOI 10.1097/01.qai.0000221681.60187.88; Wilson IB, 2010, JAIDS-J ACQ IMM DEF, V53, P338, DOI 10.1097/QAI.0b013e3181c7a245; Wohl AR, 2011, AIDS CARE, V23, P988, DOI 10.1080/09540121.2010.542125; Wohl AR, 2006, CLIN INFECT DIS, V42, P1619, DOI 10.1086/503906; Wohl DA, 2011, AIDS BEHAV, V15, P356, DOI 10.1007/s10461-010-9843-4; Wolitski RJ, 2010, AIDS BEHAV, V14, P493, DOI 10.1007/s10461-009-9643-x; World Health Organization, 2021, ANT DRUGS TREAT PREG; Yasuda JM, 2004, ANTIVIR THER, V9, P753; Yun LWH, 2005, JAIDS-J ACQ IMM DEF, V38, P432, DOI 10.1097/01.qai.0000147524.19122.fd; Zaller N, 2007, PUBLIC HEALTH REP, V122, P49, DOI 10.1177/003335490712200107; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17	260	445	455	1	88	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2012	156	11					817	+		10.7326/0003-4819-156-11-201206050-00419	http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00419			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	954ZK	22393036	Green Accepted			2022-12-28	WOS:000304986500007
J	Fuller-Thomson, E; Brennenstuhl, S				Fuller-Thomson, Esme; Brennenstuhl, Sarah			People with disabilities: the forgotten victims of violence	LANCET			English	Editorial Material							SEVERE MENTAL-ILLNESS; CRIME VICTIMIZATION; WOMEN; ABUSE; PREVALENCE; ADULTS		[Fuller-Thomson, Esme] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON M6S 3W6, Canada; [Fuller-Thomson, Esme] Univ Toronto, Dept Family & Community Med, Toronto, ON M6S 3W6, Canada; [Brennenstuhl, Sarah] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M6S 3W6, Canada	University of Toronto; University of Toronto; University of Toronto	Fuller-Thomson, E (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON M6S 3W6, Canada.	esme.fuller.thomson@utoronto.ca	Cleland, John G./AAZ-4185-2020	Cleland, John G./0000-0002-1471-7016				Barranti CCR, 2008, J SOC WORK DISABIL R, V7, P115, DOI 10.1080/15367100802081169; Curry MA, 2011, VIOLENCE VICTIMS, V26, P430, DOI 10.1891/0886-6708.26.4.430; Goodman LA, 2001, J TRAUMA STRESS, V14, P615, DOI 10.1023/A:1013026318450; Hanson RF, 2010, J TRAUMA STRESS, V23, P207, DOI 10.1002/jts.20503; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Lund EM, 2011, TRAUMA VIOLENCE ABUS, V12, P171, DOI 10.1177/1524838011416377; McFarlane J, 2001, J WOMEN HEALTH GEN-B, V10, P861, DOI 10.1089/152460901753285750; Nosek MA, 2001, SEX DISABIL, V19, P177, DOI 10.1023/A:1013152530758; Teplin LA, 2005, ARCH GEN PSYCHIAT, V62, P911, DOI 10.1001/archpsyc.62.8.911; United Nations, 2003, INT YEAR DIS PERS 19 INT YEAR DIS PERS 19; Walsh E, 2003, BRIT J PSYCHIAT, V183, P233, DOI 10.1192/bjp.183.3.233; WHO, 2009, RED VIOL VICT ID CAR	12	2	3	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 28	2012	379	9826					1573	1574		10.1016/S0140-6736(12)60077-4	http://dx.doi.org/10.1016/S0140-6736(12)60077-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22377289				2022-12-28	WOS:000303452600009
J	Allesina, S; Tang, S				Allesina, Stefano; Tang, Si			Stability criteria for complex ecosystems	NATURE			English	Article							FOOD WEBS; ECOLOGICAL COMMUNITIES; MUTUALISTIC NETWORKS; INTERACTION STRENGTH; BIODIVERSITY; ARCHITECTURE; DIVERSITY; MATRICES; MODELS	Forty years ago, May proved(1,2) that sufficiently large or complex ecological networks have a probability of persisting that is close to zero, contrary to previous expectations(3-5). May analysed large networks in which species interact at random(1,2,6). However, in natural systems pairs of species have well-defined interactions (for example predator-prey, mutualistic or competitive). Here we extend May's results to these relationships and find remarkable differences between predator-prey interactions, which are stabilizing, and mutualistic and competitive interactions, which are destabilizing. We provide analytic stability criteria for all cases. We use the criteria to prove that, counterintuitively, the probability of stability for predator-prey networks decreases when a realistic food web structure is imposed(7,8) or if there is a large preponderance of weak interactions(9,10). Similarly, stability is negatively affected by nestedness(11-14) in bipartite mutualistic networks. These results are found by separating the contribution of network structure and interaction strengths to stability. Stable predator-prey networks can be arbitrarily large and complex, provided that predator-prey pairs are tightly coupled. The stability criteria are widely applicable, because they hold for any system of differential equations.	[Allesina, Stefano; Tang, Si] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Allesina, Stefano] Univ Chicago, Computat Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Allesina, S (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	sallesina@uchicago.edu	Allesina, Stefano/A-2255-2009; Tang, Si/D-6633-2018	Allesina, Stefano/0000-0003-0313-8374; Tang, Si/0000-0002-1050-8604	National Science Foundation [EF0827493]; Direct For Biological Sciences [0827493] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Bergelson, L.-F. Bersier, A. M. de Roos, A. Eklof, C. A. Klausmeier, S. P. Lalley, R. M. May, K. S. McCann, M. Novak, P.P.A. Staniczenko and J. D. Yeakel for comments and discussion. This researchwas supported by National Science Foundation grant EF0827493.	Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Cohen J. E., 1990, COMMUNITY FOODWEBS D; DEANGELIS DL, 1987, ECOL MONOGR, V57, P1, DOI 10.2307/1942636; Elton, 2001, ANIMAL ECOLOGY; Emmerson M, 2004, P ROY SOC B-BIOL SCI, V271, P397, DOI 10.1098/rspb.2003.2592; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Kokkoris GD, 2002, J ANIM ECOL, V71, P362, DOI 10.1046/j.1365-2656.2002.00604.x; LEVINS RICHARD, 1968; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; May RM, 2001, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; SOMMERS HJ, 1988, PHYS REV LETT, V60, P1895, DOI 10.1103/PhysRevLett.60.1895; Tao T, 2010, ANN PROBAB, V38, P2023, DOI 10.1214/10-AOP534; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535	24	665	672	29	507	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2012	483	7388					205	208		10.1038/nature10832	http://dx.doi.org/10.1038/nature10832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22343894	Green Submitted			2022-12-28	WOS:000301174900037
J	de Mel, S; McKenzie, D; Woodruff, C				de Mel, Suresh; McKenzie, David; Woodruff, Christopher			One-Time Transfers of Cash or Capital Have Long-Lasting Effects on Microenterprises in Sri Lanka	SCIENCE			English	Article							RETURNS	Standard economic theory suggests that one-time business grants can have at most temporary effects, and accordingly, policies to increase incomes of the self-employed in developing countries typically rely on sustained engagement. In contrast, we found long-lasting impacts from one-time grants given in a randomized experiment to subsistence firms. Five years after we gave $100 or $200 to 115 of 197 male and 100 of 190 female Sri Lankan microenterprise owners, we found 10-percentage-point-higher enterprise survival rates, and $8-to-$12-per-month-higher profits for male-owned businesses that received the grants. Female-owned businesses showed no long-term (or short-term) impacts. Our follow-up investigation interviewed 94% of the original sample and collected survivorship data from the remaining 6%, demonstrating that tracking long-term outcomes is both feasible and worthwhile. The results suggest that one-off grants may have lasting impacts on some types of subsistence firms, challenging the view that sustained engagement is always required.	[McKenzie, David] World Bank, Dev Res Grp, Washington, DC 20433 USA; [de Mel, Suresh] Univ Peradeniya, Dept Econ, Peradeniya 20400, Sri Lanka; [Woodruff, Christopher] Univ Warwick, Dept Econ, Coventry CV4 7AL, W Midlands, England	The World Bank; University of Peradeniya; University of Warwick	McKenzie, D (corresponding author), World Bank, Dev Res Grp, 1818 H St NW, Washington, DC 20433 USA.	dmckenzie@worldbank.org			NSF [SES-0523167, SES-0617424]; World Bank	NSF(National Science Foundation (NSF)); World Bank(The World Bank India)	We thank M. Groh for excellent research assistance and two anonymous reviewers and the editors for helpful comments. Financial support from NSF grants SES-0523167 and SES-0617424, the World Bank's Gender Action Plan, and the World Bank's Research Support Budget is gratefully acknowledged. The data are available at http://www2.warwick.ac.uk/fac/soc/economics/staff/academic/woodruff/data, and replication files are provided in the SOM.	[Anonymous], 1999, BANKER POOR MICROLEN; ARMENDARIZ B, 2007, EC MICROFINANCE; Baird S, 2011, WORMS WORK LONG RUN; Banejee AV, 2007, J ECON PERSPECT, V21, P141, DOI 10.1257/jep.21.1.141; Banerjee A., 2007, CLIMBING OUT POVERTY; Banerjee A., 2010, 278 BREAD; BANERJEE AV, 1993, J POLIT ECON, V101, P274, DOI 10.1086/261876; de Mel S, 2008, Q J ECON, V123, P1329, DOI 10.1162/qjec.2008.123.4.1329; de Mel S, 2009, AM ECON J-APPL ECON, V1, P1, DOI 10.1257/app.1.3.1; Duflo E, 2011, AM ECON REV, V101, P2350, DOI 10.1257/aer.101.6.2350; Emran M. S., 2007, MICROFINANCE M UNPUB; Fafchamps Marcel, 2011, 5706 WORLD BANK; Fiszbein A, 2009, CONDITIONAL CASH TRA; Friedman W., 2011, NBER WORKING PAPERS; Hanlon J., 2011, JUST GIVE MONEY POOR; Jensen R, 2010, Q J ECON, V125, P515, DOI 10.1162/qjec.2010.125.2.515; Karlan D, 2011, SCIENCE, V332, P1278, DOI 10.1126/science.1200138; Lokshin M, 2004, STUD NONLINEAR DYN E, V8; McKenzie D, 2008, WORLD BANK ECON REV, V22, P457, DOI 10.1093/wber/lhn017; McKenzie DJ, 2006, ECON DEV CULT CHANGE, V55, P3, DOI 10.1086/505725; Ozier O., 2011, IMPACT SECONDARY SCH; Ravallion M., 2009, EC VOICE, V6, P15, DOI [10.2202/1553-3832.1368, DOI 10.2202/1553-3832.1368]; Socio-economic and Gender Analysis Programme, 2002, SOC GEND AN PROGR GU; Valdivia M., 2011, TRAINING TECHNICAL A; Woolcock M, 2009, J DEV EFFECT, V1, P1, DOI 10.1080/19439340902727719	25	71	71	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					962	966		10.1126/science.1212973	http://dx.doi.org/10.1126/science.1212973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900ZQ	22363007				2022-12-28	WOS:000300931800045
J	Aharonian, FA; Bogovalov, SV; Khangulyan, D				Aharonian, F. A.; Bogovalov, S. V.; Khangulyan, D.			Abrupt acceleration of a 'cold' ultrarelativistic wind from the Crab pulsar	NATURE			English	Article							MAGNETIC-FIELD; X-RAY; NEBULA; RADIATION; MODEL	Pulsars are thought to eject electron-positron winds that energize the surrounding environment, with the formation of a pulsar wind nebula(1). The pulsar wind originates close to the light cylinder, the surface at which the pulsar co-rotation velocity equals the speed of light, and carries away much of the rotational energy lost by the pulsar. Initially the wind is dominated by electromagnetic energy (Poynting flux) but later this is converted to the kinetic energy of bulk motion(2). It is unclear exactly where this takes place and to what speed the wind is accelerated. Although some preferred models imply a gradual acceleration over the entire distance from the magnetosphere to the point at which the wind terminates(3,4), a rapid acceleration close to the light cylinder cannot be excluded(5,6). Here we report that the recent observations of pulsed, very high-energy gamma-ray emission from the Crab pulsar(7-9) are explained by the presence of a cold (in the sense of the low energy of the electrons in the frame of the moving plasma) ultrarelativistic wind dominated by kinetic energy. The conversion of the Poynting flux to kinetic energy should take place abruptly in the narrow cylindrical zone of radius between 20 and 50 light-cylinder radii centred on the axis of rotation of the pulsar, and should accelerate the wind to a Lorentz factor of (0.5-1.0) x 10(6). Although the ultrarelativistic nature of the wind does support the general model of pulsars, the requirement of the very high acceleration of the wind in a narrow zone not far from the light cylinder challenges current models.	[Aharonian, F. A.] Dublin Inst Adv Studies, Sch Cosm Phys, Dublin 2, Ireland; [Aharonian, F. A.] Max Planck Inst Nucl Phys, D-69117 Heidelberg, Germany; [Bogovalov, S. V.] Natl Res Nucl Univ MEPhI, Moscow 115409, Russia; [Khangulyan, D.] Inst Space & Astronaut Sci JAXA, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan	Dublin Institute for Advanced Studies; Max Planck Society; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Aharonian, FA (corresponding author), Dublin Inst Adv Studies, Sch Cosm Phys, 31 Fitzwilliam Pl, Dublin 2, Ireland.	felix.aharonian@dias.ie	Khangulyan, Dmitry/AAH-1940-2019	Khangulyan, Dmitry/0000-0002-7576-7869				Abdo AA, 2010, ASTROPHYS J, V708, P1254, DOI 10.1088/0004-637X/708/2/1254; Aleksic J, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/43; Aleksic J., 2011, ASTRON ASTROPH UNPUB; Aliu E, 2011, SCIENCE, V334, P69, DOI 10.1126/science.1208192; Atoyan A. M., 1992, MON NOT R ASTRON SOC, V278, P161; Beskin VS, 2006, MON NOT R ASTRON SOC, V367, P375, DOI 10.1111/j.1365-2966.2006.09957.x; Bogovalov SV, 2000, MON NOT R ASTRON SOC, V313, P504, DOI 10.1046/j.1365-8711.2000.03250.x; Chkheidze N, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/62; CORONITI FV, 1990, ASTROPHYS J, V349, P538, DOI 10.1086/168340; de Jager O. C., 1992, ASTROPHYS J, V283, P710; GOULD RJ, 1965, PHYS REV LETT, V15, P577, DOI 10.1103/PhysRevLett.15.577; Hirotani K., 2010, ASTROPHYS J, V688, P1254; KENNEL CF, 1984, ASTROPHYS J, V283, P710, DOI 10.1086/162357; Kuiper L, 2001, ASTRON ASTROPHYS, V378, P918, DOI 10.1051/0004-6361:20011256; Lyubarsky Y, 2001, ASTROPHYS J, V547, P437, DOI 10.1086/318354; Lyutikov M., 2011, ASTROPHYS J UNPUB; Osmanov Z., 2008, ASTRON ASTROPHYS, V502, pL25; REES MF, 1974, MON NOT R ASTRON SOC, V167, P1; Rots AH, 2004, ASTROPHYS J, V605, pL129, DOI 10.1086/420842; STURROCK PA, 1971, ASTROPHYS J, V164, P529, DOI 10.1086/150865; Tang APS, 2008, ASTROPHYS J, V676, P562, DOI 10.1086/527029; Vlahakis N, 2004, ASTROPHYS J, V600, P324, DOI 10.1086/379701; WILSON DB, 1978, MON NOT R ASTRON SOC, V185, P297, DOI 10.1093/mnras/185.2.297	23	91	92	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					507	509		10.1038/nature10793	http://dx.doi.org/10.1038/nature10793			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22343893				2022-12-28	WOS:000300770500046
J	Huybrechts, KF; Gerhard, T; Crystal, S; Olfson, M; Avorn, J; Levin, R; Lucas, JA; Schneeweiss, S				Huybrechts, K. F.; Gerhard, T.; Crystal, S.; Olfson, M.; Avorn, J.; Levin, R.; Lucas, J. A.; Schneeweiss, S.			Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							ATYPICAL ANTIPSYCHOTICS; BEHAVIORAL SYMPTOMS; ALZHEIMERS-DISEASE; MEDICATION USE; ELDERLY USERS; DEMENTIA; MORTALITY; ADULTS; ADJUSTMENT; EFFICACY	Objective To assess risks of mortality associated with use of individual antipsychotic drugs in elderly residents in nursing homes. Design Population based cohort study with linked data from Medicaid, Medicare, the Minimum Data Set, the National Death Index, and a national assessment of nursing home quality. Setting Nursing homes in the United States. Participants 75 445 new users of antipsychotic drugs (haloperidol, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone). All participants were aged >= 65, were eligible for Medicaid, and lived in a nursing home in 2001-5. Main outcome measures Cox proportional hazards models were used to compare 180 day risks of all cause and cause specific mortality by individual drug, with propensity score adjustment to control for potential confounders. Results Compared with risperidone, users of haloperidol had an increased risk of mortality (hazard ratio 2.07, 95% confidence interval 1.89 to 2.26) and users of quetiapine a decreased risk (0.81, 0.75 to 0.88). The effects were strongest shortly after the start of treatment, remained after adjustment for dose, and were seen for all causes of death examined. No clinically meaningful differences were observed for the other drugs. There was no evidence that the effect measure modification in those with dementia or behavioural disturbances. There was a dose-response relation for all drugs except quetiapine. Conclusions Though these findings cannot prove causality, and we cannot rule out the possibility of residual confounding, they provide more evidence of the risk of using these drugs in older patients, reinforcing the concept that they should not be used in the absence of clear need. The data suggest that the risk of mortality with these drugs is generally increased with higher doses and seems to be highest for haloperidol and least for quetiapine.	[Huybrechts, K. F.; Avorn, J.; Levin, R.; Schneeweiss, S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Huybrechts, K. F.; Avorn, J.; Levin, R.; Schneeweiss, S.] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Gerhard, T.; Crystal, S.] Rutgers State Univ, Ernest Mario Sch Pharm, New Brunswick, NJ 08901 USA; [Olfson, M.] Columbia Univ, New York, NY 10032 USA; [Lucas, J. A.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08901 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Columbia University; Rutgers State University New Brunswick	Huybrechts, KF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA.	khuybrechts@partners.org	Schneeweiss, Sebastian/C-2125-2013; Olfson, Mark/AAA-8547-2021	Schneeweiss, Sebastian/0000-0003-2575-467X; Gerhard, Tobias/0000-0002-8598-5771	AHRQ/FDA [HS017918]; AHRQ [HS016097]; National Institute of Mental Health [R01-MH078708]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016097] Funding Source: NIH RePORTER	AHRQ/FDA; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by AHRQ/FDA Award HS017918 and AHRQ Award HS016097. KFH and SS were partially funded by National Institute of Mental Health R01-MH078708. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P5; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Atkins M., 1997, PSYCHIATR BULL, V21, P224, DOI DOI 10.1192/PB.21.4.224; Avorn J, 2005, CLIN GERIATRIC PSYCH, P23; Beck CK, 1998, AM J GERIAT PSYCHIAT, V6, pS41, DOI 10.1097/00019442-199821001-00006; BEERS M, 1988, JAMA-J AM MED ASSOC, V260, P3016, DOI 10.1001/jama.260.20.3016; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Briesacher BA, 2005, ARCH INTERN MED, V165, P1280, DOI 10.1001/archinte.165.11.1280; Bronskill SE, 2004, J AM GERIATR SOC, V52, P749, DOI 10.1111/j.1532-5415.2004.52212.x; Camp CJ, 2002, PSYCHIATR SERV, V53, P1397, DOI 10.1176/appi.ps.53.11.1397; Chan YC, 1999, PHARMACOTHERAPY, V19, P811, DOI 10.1592/phco.19.10.811.31560; Chen Y, 2010, ARCH INTERN MED, V170, P89, DOI 10.1001/archinternmed.2009.469; Cummings JL, 2005, CNS SPECTRUMS, V10, P22, DOI 10.1017/S1092852900014206; Department of Health and Human Services Office of the Inspector General, 2011, MED AT ANT DRUG CLAI; FDA, 2011, INF HEALTHC PROF ANT; *FDA PUBL HLTH ADV, 2010, DEATHS ANT ELD PAT B; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Huybrechts KF, 2011, AM J EPIDEMIOL, V174, P1089, DOI 10.1093/aje/kwr213; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; Jeste DV, 2008, NEUROPSYCHOPHARMACOL, V33, P957, DOI 10.1038/sj.npp.1301492; Lawlor BA, 2004, J CLIN PSYCHIAT, V65, P5; Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P1; Liperoti R, 2003, J CLIN PSYCHIAT, V64, P1106, DOI 10.4088/JCP.v64n0918; Liperoti R, 2009, J CLIN PSYCHIAT, V70, P1340, DOI 10.4088/JCP.08m04597yel; Maher AR, 2011, JAMA-J AM MED ASSOC, V306, P1359, DOI 10.1001/jama.2011.1360; Maixner SM, 1999, J CLIN PSYCHIAT, V60, P29; Patorno E, 2010, JAMA-J AM MED ASSOC, V303, P1401, DOI 10.1001/jama.2010.410; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; RAY WA, 1980, AM J PUBLIC HEALTH, V70, P485, DOI 10.2105/AJPH.70.5.485; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rochon PA, 2007, ARCH INTERN MED, V167, P676, DOI 10.1001/archinte.167.7.676; Rossom RC, 2010, J AM GERIATR SOC, V58, P1027, DOI 10.1111/j.1532-5415.2010.02873.x; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Sesso HD, 2006, CONTEMP CLIN TRIALS, V27, P333, DOI 10.1016/j.cct.2005.11.007; Setoguchi S, 2008, J AM GERIATR SOC, V56, P1644, DOI 10.1111/j.1532-5415.2008.01839.x; Snowden M, 2003, J AM GERIATR SOC, V51, P1305, DOI 10.1046/j.1532-5415.2003.51417.x; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Tariot PN, 1999, J CLIN PSYCHIAT, V60, P29; Wang PS, 2006, CURR NEUROL NEUROSCI, V6, P490, DOI 10.1007/s11910-006-0051-6; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607	45	169	174	0	28	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2012	344								e977	10.1136/bmj.e977	http://dx.doi.org/10.1136/bmj.e977			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JY	22362541	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000300884400010
J	Pereira, HM; Borda-de-Agua, L; Martins, IS				Pereira, Henrique Miguel; Borda-de-Agua, Luis; Martins, Ines Santos			Geometry and scale in species-area relationships	NATURE			English	Letter							EXTINCTION RATES; CLIMATE-CHANGE; BIODIVERSITY; DIVERSITY; FUTURE; SCENARIOS		[Pereira, Henrique Miguel; Borda-de-Agua, Luis; Martins, Ines Santos] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal	Universidade de Lisboa	Pereira, HM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal.	hpereira@fc.ul.pt	Martins, Inês Santos/L-8212-2014; Pereira, Henrique/B-3975-2009; Borda-de-Agua, Luis/D-6063-2011	Martins, Inês Santos/0000-0003-4328-7286; Pereira, Henrique/0000-0003-1043-1675; Borda-de-Agua, Luis/0000-0002-0802-6235				Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kinzig AP, 2000, ECOLOGY, V81, P3305, DOI 10.1890/0012-9658(2000)081[3305:IOEARF]2.0.CO;2; Mace G.M., 2005, ECOSYSTEMS HUMAN WEL, P77; MACE GM, 1994, PHILOS T ROY SOC B, V344, P91, DOI 10.1098/rstb.1994.0056; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; REID WV, 1992, TROPICAL DEFORESTATI, P53; Rosenzweig ML, 2001, P NATL ACAD SCI USA, V98, P5404, DOI 10.1073/pnas.101092798; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; SMITH FDM, 1993, NATURE, V364, P494, DOI 10.1038/364494b0; van Vuuren DP, 2006, ECOL SOC, V11	15	37	37	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					E3	E4		10.1038/nature10857	http://dx.doi.org/10.1038/nature10857			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358846				2022-12-28	WOS:000300770500001
J	Mousley, CJ; Yuan, PH; Gaur, NA; Trettin, KD; Nile, AH; Deminoff, SJ; Dewar, BJ; Wolpert, M; Macdonald, JM; Herman, PK; Hinnebusch, AG; Bankaitis, VA				Mousley, Carl J.; Yuan, Peihua; Gaur, Naseem A.; Trettin, Kyle D.; Nile, Aaron H.; Deminoff, Stephen J.; Dewar, Brian J.; Wolpert, Max; Macdonald, Jeffrey M.; Herman, Paul K.; Hinnebusch, Alan G.; Bankaitis, Vytas A.			A Sterol-Binding Protein Integrates Endosomal Lipid Metabolism with TOR Signaling and Nitrogen Sensing	CELL			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GOLGI-APPARATUS; COMPLEX; TRANSPORT; PATHWAY; GCN4; TRANSCRIPTION; TRAFFICKING; TRANSLATION; HOMEOSTASIS	Kes1, and other oxysterol-binding protein superfamily members, are involved in membrane and lipid trafficking through trans-Golgi network (TGN) and endosomal systems. We demonstrate that Kes1 represents a sterol-regulated antagonist of TGN/endosomal phosphatidylinositol-4-phosphate signaling. This regulation modulates TOR activation by amino acids and dampens gene expression driven by Gcn4, the primary transcriptional activator of the general amino acid control regulon. Kes1-mediated repression of Gcn4 transcription factor activity is characterized by nonproductive Gcn4 binding to its target sequences, involves TGN/endosome-derived sphingolipid signaling, and requires activity of the cyclin-dependent kinase 8 (CDK8) module of the enigmatic "large Mediator'' complex. These data describe a pathway by which Kes1 integrates lipid metabolism with TORC1 signaling and nitrogen sensing.	[Mousley, Carl J.; Yuan, Peihua; Trettin, Kyle D.; Nile, Aaron H.; Wolpert, Max; Bankaitis, Vytas A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Gaur, Naseem A.; Hinnebusch, Alan G.] Eugene Shriver Natl Inst Child Hlth & Human Dev, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Deminoff, Stephen J.; Herman, Paul K.] Ohio State Univ, Dept Mol Genet & Microbiol, Columbus, OH 43210 USA; [Dewar, Brian J.; Macdonald, Jeffrey M.] Univ N Carolina, Dept Biomed Engn, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mousley, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	mousley@email.unc.edu; vytas@med.unc.edu	Yuan, Peihua/G-9088-2013	Yuan, Peihua/0000-0002-4633-0692; Mousley, Carl/0000-0002-0192-7030; Nile, Aaron/0000-0002-7370-8769; Gaur, Naseem/0000-0002-1224-8789	NIH [GM44530, GM65227]; NIEHS [T32EX007126, GM075941]; UNC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044530, R01GM065227, R21GM075941] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UNC(Secretaria de Ciencia y Tecnologia (SECYT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This paper is dedicated to the memories of Christian Raetz and Eugene Kennedy. The work was supported by NIH grant GM44530 to V.A.B.; N.G. and A.G.H. were supported by the Intramural Research Program of the NIH; S.J.D. and P.K.H. by NIH grant GM65227 awarded to P.K.H.; and B.J.D. and J.M.M. by NIEHS T32EX007126 and GM075941. K.D.T. acknowledges support from the UNC William W. and Ida W. Taylor Honors Mentored Research Fellows Program. We thank Doug Cyr, Scott Moye Rowley, Chris Burd, and Dan Klionsky for strains and plasmids, Colin Stirling for CPY antibody, Chris Stefan, Scott Emr, and Maria Cardenas for discussions, and Lora Yanagisawa, Victoria Hewitt, and Robert Sons for comments on the manuscript. We acknowledge the UNC Lineberger Comprehensive Cancer Center Genome Analysis and Nucleic Acids Core facilities.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Chen H, 2009, PROTEIN PEPTIDE LETT, V16, P450, DOI 10.2174/092986609787848036; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Dewar BJ, 2010, METABOLOMICS, V6, P439, DOI 10.1007/s11306-010-0204-0; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Grundmann O, 2001, J BIOL CHEM, V276, P25661, DOI 10.1074/jbc.M101068200; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schulz T. A., 2009, BIOCHIM BIOPHYS ACTA, V1771, P769; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang F, 2008, MOL CELL BIOL, V28, P6796, DOI 10.1128/MCB.00800-08	38	70	73	1	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					702	715		10.1016/j.cell.2011.12.026	http://dx.doi.org/10.1016/j.cell.2011.12.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341443	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000300622400012
J	Amant, F; Loibl, S; Neven, P; Van Calsteren, K				Amant, Frederic; Loibl, Sibylle; Neven, Patrick; Van Calsteren, Kristel			Breast cancer in pregnancy	LANCET			English	Article							CHEMOTHERAPEUTIC-AGENTS; TRANSPLACENTAL TRANSFER; CHILDHOOD-CANCER; YOUNG-WOMEN; RADIATION; RISK; RADIOTHERAPY; MANAGEMENT; CARCINOMA; ANTHRACYCLINES	Breast cancer staging and treatment are possible during pregnancy, and should be defined in a multidisciplinary setting. Tumour biology, tumour stage, and gestational stage at diagnosis determine the appropriate approach. Surgery for breast cancer is possible during all trimesters of pregnancy. Radiotherapy is possible during pregnancy but, dependent on the fetal dose received, can result in poor fetal outcomes. The decision to give radiotherapy should be made on an individual basis. Evidence increasingly supports administration of chemotherapy from 14 weeks' gestation onwards. New breast cancer treatments might be applicable to pregnant patients, but tamoxifen and trastuzumab are contraindicated during pregnancy. Cancer treatment during pregnancy will decrease the need for early delivery and thus prematurity, which is a major concern in management of breast cancer in pregnancy.	[Amant, Frederic; Neven, Patrick] Katholieke Univ Leuven, Leuven Canc Inst, Multidisciplinary Breast Canc Ctr, Louvain, Belgium; [Loibl, Sibylle] Klinikum Offenbach, German Breast Grp, Dept Med, Offenbach, Germany; [Loibl, Sibylle] KlinikumOffenbach, Dept Res, Offenbach, Germany; [Van Calsteren, Kristel] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium	KU Leuven; German Breast Group; Sana Klinikum Offenbach; Sana Klinikum Offenbach; KU Leuven; University Hospital Leuven	Amant, F (corresponding author), UZ Gasthuisberg Leuven, Herestr 49, B-3000 Louvain, Belgium.	frederic.amant@uzleuven.be		Amant, Frederic/0000-0002-5452-4905				Amant F, 2012, LANCET ONCOL, V13, P256, DOI 10.1016/S1470-2045(11)70363-1; Amant F, 2010, EUR J CANCER, V46, P3158, DOI 10.1016/j.ejca.2010.09.010; Amant F, 2010, J CLIN ONCOL, V28, pE304, DOI 10.1200/JCO.2010.28.1741; Amant F, 2009, INT J GYNECOL CANCER, V19, pS1, DOI 10.1111/IGC.0b013e3181a1d0ec; [Anonymous], HLTH EFF ECTS DUE RA, V2; Antypas C, 1998, INT J RADIAT ONCOL, V40, P995, DOI 10.1016/S0360-3016(97)00909-7; ARCECI RJ, 1988, P NATL ACAD SCI USA, V85, P4350, DOI 10.1073/pnas.85.12.4350; Aronowitz R. A., 2007, UNNATURAL HIST BREAS; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Aviles A, 2006, ANN ONCOL, V17, P286, DOI 10.1093/annonc/mdj053; Aviles A, 2001, CLIN LYMPHOMA, V2, P173, DOI 10.3816/CLM.2001.n.023; Azim HA, 2010, EXPERT REV CLIN IMMU, V6, P821, DOI [10.1586/eci.10.77, 10.1586/ECI.10.77]; Berry DL, 1999, J CLIN ONCOL, V17, P855, DOI 10.1200/JCO.1999.17.3.855; Bonilla L, 2010, JNCI-J NATL CANCER I, V102, P1845, DOI 10.1093/jnci/djq409; Bonnier P, 1997, INT J CANCER, V72, P720, DOI 10.1002/(SICI)1097-0215(19970904)72:5<720::AID-IJC3>3.0.CO;2-U; Cardonick E, 2004, LANCET ONCOL, V5, P283, DOI 10.1016/S1470-2045(04)01466-4; Cardonick E, 2010, CANCER J, V16, P76, DOI 10.1097/PPO.0b013e3181ce46f9; Cohen-Kerem R, 2005, AM J SURG, V190, P467, DOI 10.1016/j.amjsurg.2005.03.033; Colleoni M, 2002, ANN ONCOL, V13, P273, DOI 10.1093/annonc/mdf039; COLLINS JC, 1995, J REPROD MED, V40, P785; Dale DC, 2003, AM J HEMATOL, V72, P82, DOI 10.1002/ajh.10255; de Wildt SN, 2009, NAT CLIN PRACT ONCOL, V6, P175, DOI 10.1038/ncponc1320; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; Dominici Laura S, 2010, Breast Dis, V31, P1, DOI 10.3233/BD-2009-0289; Ebert U, 1997, PHARMACOL THERAPEUT, V74, P207, DOI 10.1016/S0163-7258(97)82004-9; ELLEDGE RM, 1993, CANCER, V71, P2499, DOI 10.1002/1097-0142(19930415)71:8<2499::AID-CNCR2820710812>3.0.CO;2-S; Ellner SJ, 2003, NUCL MED BIOL, V30, P805, DOI 10.1016/j.nucmedbio.2003.10.001; Evseenko DA, 2006, AM J PHYSIOL-REG I, V290, pR1357, DOI 10.1152/ajpregu.00630.2005; Fenig E, 2001, CANCER TREAT REV, V27, P1, DOI 10.1053/ctrv.2000.0193; Garcia-Manero M, 2009, EJSO-EUR J SURG ONC, V35, P215, DOI 10.1016/j.ejso.2008.04.010; Gedeon C, 2006, PLACENTA, V27, P861, DOI 10.1016/j.placenta.2005.09.001; Gentilini O, 2004, ANN ONCOL, V15, P1348, DOI 10.1093/annonc/mdh355; Gentilini O, 2010, EUR J NUCL MED MOL I, V37, P78, DOI 10.1007/s00259-009-1217-7; Germann N, 2004, ANN ONCOL, V15, P146, DOI 10.1093/annonc/mdh009; Giacalone PL, 1999, CANCER-AM CANCER SOC, V86, P2266, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2266::AID-CNCR14>3.0.CO;2-7; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Gumus N, 2008, BREAST, V17, P429, DOI 10.1016/j.breast.2008.02.008; Hahn KME, 2006, CANCER, V107, P1219, DOI 10.1002/cncr.22081; Halaska MJ, 2009, BREAST J, V15, P461, DOI 10.1111/j.1524-4741.2009.00760.x; HALL EJ, 1991, RADIOGRAPHICS, V11, P509, DOI 10.1148/radiographics.11.3.1852943; Han B, 2009, HEALTH PHYS, V97, P581, DOI 10.1097/01.HP.0000363838.70546.4c; International Atomic Energy Agency, 2006, NUCL MED RES MAN; Isaacs RJ, 2001, GYNECOL ONCOL, V80, P405, DOI 10.1006/gyno.2000.6080; ISHIDA T, 1992, JPN J CANCER RES, V83, P1143, DOI 10.1111/j.1349-7006.1992.tb02737.x; Ives A, 2012, PSYCHO-ONCOLOGY, V21, P754, DOI 10.1002/pon.1970; Kal HB, 2005, LANCET ONCOL, V6, P328, DOI 10.1016/S1470-2045(05)70169-8; Kanal E, 2007, AM J ROENTGENOL, V188, P1447, DOI 10.2214/AJR.06.1616; Keleher Angela, 2004, Breast J, V10, P492, DOI 10.1111/j.1075-122X.2004.21503.x; Khera SY, 2008, BREAST J, V14, P250, DOI 10.1111/j.1524-4741.2008.00570.x; Klotz HAWE, 1869, THESIS HALLE WITTENB; Levy S, 2009, BONE, V44, P428, DOI 10.1016/j.bone.2008.11.001; Lohaugen GCC, 2010, DEV MED CHILD NEUROL, V52, P1133, DOI 10.1111/j.1469-8749.2010.03743.x; Loibl S, 2006, CANCER-AM CANCER SOC, V106, P237, DOI 10.1002/cncr.21610; Loibl S, 2010, SAN ANT BREAST CANC; Luis SA, 2009, J MED IMAG RADIAT ON, V53, P559, DOI 10.1111/j.1754-9485.2009.02124.x; Lycette JL, 2006, CLIN BREAST CANCER, V7, P342, DOI 10.3816/CBC.2006.n.049; Mazonakis M, 2003, INT J RADIAT ONCOL, V55, P386, DOI 10.1016/S0360-3016(02)04206-2; Middleton LP, 2003, CANCER, V98, P1055, DOI 10.1002/cncr.11614; Minino AM, 2009, NCHS DATA BRIEF, V2011, P1; Mir O, 2010, ANN ONCOL, V21, P425, DOI 10.1093/annonc/mdp517; Molckovsky A, 2008, BREAST CANCER RES TR, V108, P333, DOI 10.1007/s10549-007-9616-6; Moran BJ, 2007, LANCET ONCOL, V8, P536, DOI 10.1016/S1470-2045(07)70171-7; Munter MW, 2010, FERTIL STERIL, V94, DOI 10.1016/j.fertnstert.2010.04.005; National Research Council, 2002, BEIR 7 HLTH RISKS EX; Navrozoglou I, 2008, EJSO-EUR J SURG ONC, V34, P837, DOI 10.1016/j.ejso.2008.01.029; Ni Mhuireachtaigh R, 2006, J CLIN ANESTH, V18, P60, DOI 10.1016/j.jclinane.2004.11.009; NUGENT P, 1985, ARCH SURG-CHICAGO, V120, P1221; Office for National Statistics, 2010, CANC STAT REG REG CA; Oto A, 2007, AM J PERINAT, V24, P243, DOI 10.1055/s-2007-973444; Pavlidis N., 2008, V178, P183; Pavlidis N, 2005, CANCER TREAT REV, V31, P439, DOI 10.1016/j.ctrv.2005.04.010; Peccatori FA, 2009, BREAST CANCER RES TR, V115, P591, DOI 10.1007/s10549-008-0159-2; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; PETREK JA, 1991, CANCER-AM CANCER SOC, V67, P869, DOI 10.1002/1097-0142(19910215)67:4<869::AID-CNCR2820670402>3.0.CO;2-Q; PRESS MF, 1990, ONCOGENE, V5, P953; Rajaraman P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d472; Reed W, 2003, VIRCHOWS ARCH, V443, P44, DOI 10.1007/s00428-003-0817-z; Ring AE, 2005, J CLIN ONCOL, V23, P4192, DOI 10.1200/JCO.2005.03.038; Rodriguez-Pinilla E, 1998, TERATOLOGY, V58, P2, DOI 10.1002/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-4; Rouzier R, 2011, ANN ONCOL, V22, P1582, DOI 10.1093/annonc/mdq642; Shannon J, 2001, J CLIN PATHOL, V54, P762, DOI 10.1136/jcp.54.10.762; Shousha S, 2000, ARCH PATHOL LAB MED, V124, P1053; Smit JW, 1999, J CLIN INVEST, V104, P1441, DOI 10.1172/JCI7963; Sorosky JI, 1997, OBSTET GYN CLIN N AM, V24, P591, DOI 10.1016/S0889-8545(05)70324-7; Stensheim H, 2009, J CLIN ONCOL, V27, P45, DOI 10.1200/JCO.2008.17.4110; STOVALL M, 1995, MED PHYS, V22, P63, DOI 10.1118/1.597525; Syme MR, 2004, CLIN PHARMACOKINET, V43, P487, DOI 10.2165/00003088-200443080-00001; Tamaru S, 2011, EARLY HUM DEV, V87, P55, DOI 10.1016/j.earlhumdev.2010.10.004; Taylor D, 2011, J MED IMAG RADIAT ON, V55, P33, DOI 10.1111/j.1754-9485.2010.02227.x; Ulery M, 2009, J MIDWIFERY WOM HEAL, V54, P357, DOI 10.1016/j.jmwh.2008.12.007; Van Calsteren K, 2010, GYNECOL ONCOL, V119, P594, DOI 10.1016/j.ygyno.2010.08.019; Van Calsteren Kristel, 2006, J Clin Oncol, V24, pe16, DOI 10.1200/JCO.2006.06.1382; Van Calsteren K, 2011, REPROD SCI, V18, P57, DOI 10.1177/1933719110379650; Van Calsteren K, 2010, INT J GYNECOL CANCER, V20, P1456, DOI 10.1111/IGC.0b013e3181fb18c8; Van Calsteren K, 2010, ACTA OBSTET GYN SCAN, V89, P1338, DOI 10.3109/00016349.2010.512070; Van Calsteren K, 2010, J CLIN ONCOL, V28, P683, DOI 10.1200/JCO.2009.23.2801; VanderGiessen PH, 1997, RADIOTHER ONCOL, V42, P257, DOI 10.1016/S0167-8140(96)01884-1; Wapner RJ, 2007, NEW ENGL J MED, V357, P1190, DOI 10.1056/NEJMoa071453; WIEBE VJ, 1994, CRIT REV ONCOL HEMAT, V16, P75, DOI 10.1016/1040-8428(94)90043-4; Wohlfahrt J, 2002, CANCER CAUSE CONTROL, V13, P169, DOI 10.1023/A:1014345903347; ZEMLICKIS D, 1992, AM J OBSTET GYNECOL, V166, P781, DOI 10.1016/0002-9378(92)91334-7	101	146	158	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					570	579		10.1016/S0140-6736(11)61092-1	http://dx.doi.org/10.1016/S0140-6736(11)61092-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22325662				2022-12-28	WOS:000300188800034
J	Van Tuyl, R; Pereltsvaig, A				Van Tuyl, Rory; Pereltsvaig, Asya			Comment on "Phonemic Diversity Supports a Serial Founder Effect Model of Language Expansion from Africa"	SCIENCE			English	Editorial Material									[Pereltsvaig, Asya] Stanford Univ, Dept Linguist, Stanford, CA 94305 USA	Stanford University		roryvantuyl@gmail.com	Wang, Chuan-Chao/B-2975-2011; Li, Hui/A-2014-2010; Pereltsvaig, Asya/V-8982-2019	Wang, Chuan-Chao/0000-0001-9628-0307; Dediu, Dan/0000-0002-0704-6365; Cysouw, Michael/0000-0003-3168-4946				Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Maddieson I, 2011, WORLD ATLAS LANGUAGE	4	6	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069								10.1126/science.1209176	http://dx.doi.org/10.1126/science.1209176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	889AY	22323804				2022-12-28	WOS:000300047100030
J	Pettifor, A; Mccoy, SI; Padian, N				Pettifor, Audrey; McCoy, Sandra I.; Padian, Nancy			Paying to prevent HIV infection in young women?	LANCET			English	Editorial Material							INTERVENTION; EDUCATION; RISK		[McCoy, Sandra I.; Padian, Nancy] Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94704 USA; [Pettifor, Audrey] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill	Padian, N (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94704 USA.	nancy.padian@gmail.com	Pettifor, Audrey/H-6793-2019	Pettifor, Audrey/0000-0002-3387-0817	NICHD NIH HHS [R24 HD050924] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abdool-Karim Q, PROOF CONCEPT CLUSTE; [Anonymous], 2002, ED HIV AIDS WIND HOP; [Anonymous], 068 HPTN; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Dunbar MS, 2010, J PREV INTERV COMMUN, V38, P147, DOI 10.1080/10852351003640849; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; McCoy SI, 2010, AIDS BEHAV, V14, P469, DOI 10.1007/s10461-009-9644-9; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Pettifor AE, 2008, INT J EPIDEMIOL, V37, P1266, DOI 10.1093/ije/dyn131; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; SCHULTZ T, 2000, IMPACT PROGRESA SCH	14	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2012	379	9823					1280	1282		10.1016/S0140-6736(12)60036-1	http://dx.doi.org/10.1016/S0140-6736(12)60036-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922FB	22341826				2022-12-28	WOS:000302531100007
J	Werner, RM				Werner, Rachel M.			Will Using Medicare Data to Rate Doctors Benefit Patients?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PAY-FOR-PERFORMANCE; REPORT CARDS; QUALITY		[Werner, Rachel M.] Univ Penn, Philadelphia, PA 19104 USA; [Werner, Rachel M.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center	Werner, RM (corresponding author), Univ Penn, 1230 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	rwerner@upenn.edu		Werner, Rachel/0000-0003-3435-4221				Alonso-Zaldivar R, 2011, FEDS ALLOW USE MEDIC; Bundorf MK, 2009, J HEALTH ECON, V28, P718, DOI 10.1016/j.jhealeco.2009.01.001; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, FED REG, V76, P76542; Dafny L, 2008, RAND J ECON, V39, P790, DOI 10.1111/j.1756-2171.2008.00039.x; Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; Jung K, 2011, J HEALTH ECON, V30, P832, DOI 10.1016/j.jhealeco.2011.05.006; Pope DG, 2009, J HEALTH ECON, V28, P1154, DOI 10.1016/j.jhealeco.2009.08.006; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Tu JV, 2009, JAMA-J AM MED ASSOC, V302, P2330, DOI 10.1001/jama.2009.1731; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277; Werner RM, 2011, HEALTH SERV RES, V46, P555, DOI 10.1111/j.1475-6773.2010.01205.x; Werner RM, 2009, HEALTH SERV RES, V44, P1169, DOI 10.1111/j.1475-6773.2009.00967.x	16	5	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					532	U1500		10.7326/0003-4819-156-7-201204030-00396	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00396			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	921GP	22331620				2022-12-28	WOS:000302466400007
J	Black, N				Black, Nick			Declining health-care productivity in England: the making of a myth	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England.	nick.black@lshtm.ac.uk						[Anonymous], BBC NEWS; Berwick DM, 2005, BMJ-BRIT MED J, V330, P975, DOI 10.1136/bmj.330.7498.975; Black N, 1999, LANCET, V353, P1205, DOI 10.1016/S0140-6736(99)00108-7; Black N, 2010, BMJ-BRIT MED J, V340, P933; Black N, 2006, BRIT MED J, V333, P312, DOI 10.1136/bmj.333.7563.312; BUNKER JP, 2001, MED MATTERS ALL; Commons Public Accounts Committee, MPS PUBL REP NHS HOS; Connolly S, 2010, FUNDING PERFORMANCE; Dawson D, 2005, DEV NEW APPROACHES M; Department of Health, 2005, HEALTHC OUTP PROD AC; Department of Health, 2008, HIGH QUAL CAR ALL; Hardie M., 2011, PUBLIC SERVICE OUTPU; Mullin C, 2010, DECLINE FALL DIARIES; National Audit Office, HC491 NAT AUD OFF; NHS Digital, PAT REP OUTC MEAS PR; Penaloza M., 2010, PUBLIC SERVICE OUTPU; Shahian DM, 2010, NEW ENGL J MED, V363, P2530, DOI 10.1056/NEJMsa1006396; Social Market Foundation, A BURNH MP LAUNCH PR	18	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 24	2012	379	9821					1167	1169		10.1016/S0140-6736(11)61782-0	http://dx.doi.org/10.1016/S0140-6736(11)61782-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916VR	22333946				2022-12-28	WOS:000302131800038
J	Samuel, VT; Shulman, GI				Samuel, Varman T.; Shulman, Gerald I.			Mechanisms for Insulin Resistance: Common Threads and Missing Links	CELL			English	Review							PROTEIN-KINASE-C; FATTY LIVER-DISEASE; ADIPOSE TRIGLYCERIDE LIPASE; TUMOR-NECROSIS-FACTOR; ENDOPLASMIC-RETICULUM STRESS; DIET-INDUCED OBESITY; NF-KAPPA-B; DEPENDENT DIABETES-MELLITUS; INDUCED HEPATIC STEATOSIS; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY	Insulin resistance is a complex metabolic disorder that defies explanation by a single etiological pathway. Accumulation of ectopic lipid metabolites, activation of the unfolded protein response (UPR) pathway, and innate immune pathways have all been implicated in the pathogenesis of insulin resistance. However, these pathways are also closely linked to changes in fatty acid uptake, lipogenesis, and energy expenditure that can impact ectopic lipid deposition. Ultimately, these cellular changes may converge to promote the accumulation of specific lipid metabolites (diacylglycerols and/or ceramides) in liver and skeletal muscle, a common final pathway leading to impaired insulin signaling and insulin resistance.	[Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT 06516 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Samuel, VT (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	varman.samuel@yale.edu; gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	Howard Hughes Medical Institute; Veterans Affairs Merit Review Program; United States Department of Health and Human Services [DK-40936, DK-49230, DK-059635, DK-45735, DK-08638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, U24DK059635, R01DK049230, P01DK068229, R01DK040936, U2CDK059635, R24DK085638] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Veterans Affairs Merit Review Program(US Department of Veterans Affairs); United States Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We apologize to the many individuals whose valuable contributions to this field were unable to be cited due to space restrictions. The authors receive funding support from the Howard Hughes Medical Institute (GIS) and Veterans Affairs Merit Review Program (VTS) and grants from the United States Department of Health and Human Services (DK-40936, DK-49230, DK-059635, DK-45735, and DK-08638).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; ANDERSON CM, 1991, J BIOL CHEM, V266, P21760; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; Badin PM, 2011, DIABETES, V60, P1734, DOI 10.2337/db10-1364; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Bezaire V, 2009, FEBS LETT, V583, P3045, DOI 10.1016/j.febslet.2009.08.019; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; Birkenfeld AL, 2011, J BIOL CHEM, V286, P36163, DOI 10.1074/jbc.M111.228817; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Bruce CR, 2004, AM J PHYSIOL-ENDOC M, V287, pE616, DOI 10.1152/ajpendo.00150.2004; Bunout D, 1996, AM J CLIN NUTR, V63, P373, DOI 10.1093/ajcn/63.3.373; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Caimari A, 2007, OBESITY, V15, P591, DOI 10.1038/oby.2007.563; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Ciaraldi TP, 1995, J CLIN INVEST, V96, P2820, DOI 10.1172/JCI118352; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; CLOWES GHA, 1978, AM J SURG, V135, P577, DOI 10.1016/0002-9610(78)90040-5; COGHLAN MP, 1994, BIOCHEM J, V303, P893, DOI 10.1042/bj3030893; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2938, DOI 10.1172/JCI118001; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; da-Silva WS, 2011, FEBS LETT, V585, P539, DOI 10.1016/j.febslet.2010.12.044; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Dubuquoy C, 2011, J HEPATOL, V55, P145, DOI 10.1016/j.jhep.2010.10.024; Fabbrini E, 2010, GASTROENTEROLOGY, V139, P448, DOI 10.1053/j.gastro.2010.04.056; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Flach RJR, 2011, J BIOL CHEM, V286, P22195, DOI 10.1074/jbc.M110.210237; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Frangioudakis G, 2009, DIABETOLOGIA, V52, P2616, DOI 10.1007/s00125-009-1543-0; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; HARING H, 1986, J BIOL CHEM, V261, P3869; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; IOCHIDA LC, 1989, LIFE SCI, V45, P1567, DOI 10.1016/0024-3205(89)90423-2; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; JACOBS S, 1983, P NATL ACAD SCI-BIOL, V80, P6211, DOI 10.1073/pnas.80.20.6211; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Jucker BM, 1997, J BIOL CHEM, V272, P10464, DOI 10.1074/jbc.272.16.10464; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; KARASIK A, 1990, J BIOL CHEM, V265, P10226; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; KAWAKAMI M, 1987, J BIOCHEM-TOKYO, V101, P331, DOI 10.1093/oxfordjournals.jbchem.a121917; KELLERER M, 1995, J CLIN INVEST, V96, P6, DOI 10.1172/JCI118073; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Krssak M, 2000, J CLIN ENDOCR METAB, V85, P748, DOI 10.1210/jc.85.2.748; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lefterova MI, 2009, DIABETES, V58, P1879, DOI 10.2337/db08-1706; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; LEWIS RE, 1990, BIOCHEMISTRY-US, V29, P1807, DOI 10.1021/bi00459a020; Li L, 2009, CYTOKINE, V45, P12, DOI 10.1016/j.cyto.2008.10.006; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Li YL, 2003, ENDOCRINOLOGY, V144, P3505, DOI 10.1210/en.2003-0236; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Miyake Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1550, DOI 10.1271/bbb.90057; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Novak NL, 2011, CURR PHARM DESIGN, V17, P1218, DOI 10.2174/138161211795656783; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; PILLAY TS, 1990, BIOCHEM SOC T, V18, P494, DOI 10.1042/bst0180494; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Qiao AJ, 2011, HEPATOLOGY, V54, P509, DOI 10.1002/hep.24402; Raddatz K, 2011, DIABETOLOGIA, V54, P1447, DOI 10.1007/s00125-011-2073-0; RANDLE PJ, 1963, LANCET, V1, P785; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; RAYMOND RM, 1981, SURGERY, V90, P853; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, MOL CELL BIOL, V30, P106, DOI 10.1128/MCB.01162-09; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; SHANGRAW RE, 1989, METABOLISM, V38, P983, DOI 10.1016/0026-0495(89)90010-3; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; STONE DB, 1969, METABOLIS, V18, P620, DOI 10.1016/0026-0495(69)90097-3; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Szendroedi J, 2011, ROLE DIACYLGLYCEROL; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tantiwong P, 2010, AM J PHYSIOL-ENDOC M, V299, pE794, DOI 10.1152/ajpendo.00776.2009; Teruel T, 2001, DIABETES, V50, P2563, DOI 10.2337/diabetes.50.11.2563; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; van der Crabben SN, 2008, J CLIN ENDOCR METAB, V93, P638, DOI 10.1210/jc.2006-2491; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Watt MJ, 2005, DIABETOLOGIA, V48, P105, DOI 10.1007/s00125-004-1598-x; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamada PM, 2010, ENDOCRINOLOGY, V151, P5741, DOI 10.1210/en.2010-0672; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yang JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013858; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650	178	1383	1458	30	414	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					852	871		10.1016/j.cell.2012.02.017	http://dx.doi.org/10.1016/j.cell.2012.02.017			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385956	Green Accepted, Bronze			2022-12-28	WOS:000300985000008
J	Dove, W; Susman, M				Dove, William; Susman, Millard			RETROSPECTIVE James F. Crow (1916-2012)	SCIENCE			English	Biographical-Item									[Dove, William; Susman, Millard] Univ Wisconsin, McArdle Lab Canc Res, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dove, W (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Genet Lab, 1400 Univ Ave, Madison, WI 53706 USA.	dove@oncology.wisc.edu; msusman@wisc.edu							0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					812	812		10.1126/science.1219557	http://dx.doi.org/10.1126/science.1219557			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344436				2022-12-28	WOS:000300356400033
J	Galvis, HMT; Bitter, JH; Khare, CB; Ruitenbeek, M; Dugulan, AI; de Jong, KP				Galvis, Hirsa M. Torres; Bitter, Johannes H.; Khare, Chaitanya B.; Ruitenbeek, Matthijs; Dugulan, A. Iulian; de Jong, Krijn P.			Supported Iron Nanoparticles as Catalysts for Sustainable Production of Lower Olefins	SCIENCE			English	Article							FISCHER-TROPSCH SYNTHESIS; CARBON NANOTUBES; CO HYDROGENATION; CONVERSION; SELECTIVITY; FEEDSTOCKS; GAS	Lower olefins are key building blocks for the manufacture of plastics, cosmetics, and drugs. Traditionally, olefins with two to four carbons are produced by steam cracking of crude oil-derived naphtha, but there is a pressing need for alternative feedstocks and processes in view of supply limitations and of environmental issues. Although the Fischer-Tropsch synthesis has long offered a means to convert coal, biomass, and natural gas into hydrocarbon derivatives through the intermediacy of synthesis gas (a mixture of molecular hydrogen and carbon monoxide), selectivity toward lower olefins tends to be low. We report on the conversion of synthesis gas to C-2 through C-4 olefins with selectivity up to 60 weight percent, using catalysts that constitute iron nanoparticles (promoted by sulfur plus sodium) homogeneously dispersed on weakly interactive a-alumina or carbon nanofiber supports.	[Galvis, Hirsa M. Torres; Bitter, Johannes H.; de Jong, Krijn P.] Univ Utrecht, Debye Inst Nanomat Sci, NL-3508 TB Utrecht, Netherlands; [Khare, Chaitanya B.; Ruitenbeek, Matthijs] DOW Benelux BV, NL-4530 AA Terneuzen, Netherlands; [Dugulan, A. Iulian] Delft Univ Technol, Fundamental Aspects Mat & Energy Grp, NL-2629 JB Delft, Netherlands	Utrecht University; Dow Chemical Company; Dow Benelux BV; Delft University of Technology	de Jong, KP (corresponding author), Univ Utrecht, Debye Inst Nanomat Sci, POB 80083, NL-3508 TB Utrecht, Netherlands.	k.p.dejong@uu.nl	Ruitenbeek, Matthijs/F-1681-2010; Weng, Yujing/H-5081-2012; Galvis, Hirsa M. Torres/L-2275-2013; de Jong, Krijn P/C-5319-2009	Ruitenbeek, Matthijs/0000-0002-9910-8358; Weng, Yujing/0000-0001-7053-281X; Galvis, Hirsa M. Torres/0000-0002-4855-2619; Dugulan, Achim Iulian/0000-0001-5559-9573	ACTS-ASPECT (NWO); NWO-TOP; NWO-NRSCC	ACTS-ASPECT (NWO); NWO-TOP(Netherlands Organization for Scientific Research (NWO)); NWO-NRSCC	Supported by ACTS-ASPECT (NWO) and by NWO-TOP and NRSCC. We thank M. Van de Vijver for the catalytic tests at 20 bar performed at DOW Benelux, E. J. M. Hensen for his contribution in the discussion of the Mossbauer spectroscopy results, and C. van der Spek for the TEM images. ACTS-ASPECT (NWO) has filed a patent application based on the work reported here.	Baker B. G., 1986, U.S. Patent, Patent No. 4610975; BARRAULT J, 1980, REACT KINET CATAL L, V15, P153, DOI 10.1007/BF02062425; BUKUR DB, 1990, IND ENG CHEM RES, V29, P1588, DOI 10.1021/ie00104a003; Bussemeier B, 1986, US Patent, Patent No. 4564642; Chen W, 2008, J AM CHEM SOC, V130, P9414, DOI 10.1021/ja8008192; Corma A, 2005, CATAL TODAY, V107-08, P699, DOI 10.1016/j.cattod.2005.07.109; Cubeiro ML, 1998, APPL CATAL A-GEN, V167, P183, DOI 10.1016/S0926-860X(97)00300-1; Davis BH, 2003, CATAL TODAY, V84, P83, DOI 10.1016/S0920-5861(03)00304-3; de Jong KP, 2006, OIL GAS SCI TECHNOL, V61, P527, DOI 10.2516/ogst:2006029a; De Jong KP, 2000, CATAL REV, V42, P481, DOI 10.1081/CR-100101954; Diercks R, 2008, CHEM ENG TECHNOL, V31, P631, DOI 10.1002/ceat.200800061; Dupain X, 2006, APPL CATAL B-ENVIRON, V63, P277, DOI 10.1016/j.apcatb.2005.10.012; Jin YM, 2000, J CATAL, V196, P8, DOI 10.1006/jcat.2000.3024; JONES VK, 1986, J PHYS CHEM-US, V90, P4832, DOI 10.1021/j100411a023; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Olah GA, 2005, ANGEW CHEM INT EDIT, V44, P2636, DOI 10.1002/anie.200462121; SHROFF MD, 1995, J CATAL, V156, P185, DOI 10.1006/jcat.1995.1247; SOLED S, 1990, CATAL LETT, V7, P271, DOI 10.1007/BF00764508; SOMMEN APB, 1985, APPL CATAL, V14, P277, DOI 10.1016/S0166-9834(00)84360-2; Steynberg A., 2004, FISCHERTROPSCH TECHN; van Dillen AJ, 2003, J CATAL, V216, P257, DOI 10.1016/S0021-9517(02)00130-6; van Steen E, 2002, CATAL TODAY, V71, P327, DOI 10.1016/S0920-5861(01)00459-X; Vispute TP, 2010, SCIENCE, V330, P1222, DOI 10.1126/science.1194218; Wang Ch, 2003, J NAT GAS CHEM, V12, P10; Wang SB, 2004, ENERG FUEL, V18, P1126, DOI 10.1021/ef0340716; XU LY, 1995, CATAL LETT, V31, P253	26	854	888	47	1143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					835	838		10.1126/science.1215614	http://dx.doi.org/10.1126/science.1215614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344440	Green Submitted			2022-12-28	WOS:000300356400039
J	Spence, D				Spence, Des			FROM THE FRONTLINE The NHS bill puts profit before patients	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2012	344								e1082	10.1136/bmj.e1082	http://dx.doi.org/10.1136/bmj.e1082			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IB	22337787				2022-12-28	WOS:000300557800008
J	Cysouw, M; Dediu, D; Moran, S				Cysouw, Michael; Dediu, Dan; Moran, Steven			Comment on "Phonemic Diversity Supports a Serial Founder Effect Model of Language Expansion from Africa"	SCIENCE			English	Editorial Material							TONE		[Cysouw, Michael; Moran, Steven] Univ Munich, Res Unit Quantitat Language Comparison, D-80539 Munich, Germany; [Dediu, Dan] Max Planck Inst Psycholinguist, Language & Genet Dept, NL-6525 XD Nijmegen, Netherlands; [Dediu, Dan] Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands	University of Munich; Max Planck Society; Radboud University Nijmegen	Cysouw, M (corresponding author), Univ Munich, Res Unit Quantitat Language Comparison, Geschwister Scholl Pl 1, D-80539 Munich, Germany.	cysouw@lmu.de	Dediu, Dan/E-3279-2012	Dediu, Dan/0000-0002-0704-6365; Cysouw, Michael/0000-0003-3168-4946				Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Betti L, 2009, P ROY SOC B-BIOL SCI, V276, P809, DOI 10.1098/rspb.2008.1563; Bowern C, 2011, LINGUIST TYPOL, V15, P207, DOI DOI 10.1515/LITY.2011.015); Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Dediu D, 2011, P ROY SOC B-BIOL SCI, V278, P474, DOI 10.1098/rspb.2010.1595; Haspelmath Martin, 2005, WORLD ATLAS LANGUAGE; Jaeger T.F., 2011, LINGUIST TYPOL, V15, P281, DOI [10.1515/lity.2011.021, DOI 10.1515/LITY.2011.021, DOI 10.1075/LA.227.04SZM]; Maddieson I, 2011, LINGUIST TYPOL, V15, P267, DOI 10.1515/LITY.2011.020; Maddieson Ian, 1990, UCLA PHONOLOGICAL SE; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; MITHEN S, 2003, AFTER ICE; Nichols Johanna, 1992, LINGUISTIC DIVERSITY; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Thomason S. G., 1988, LANGUAGE CONTACT CRE	14	19	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069								10.1126/science.1208841	http://dx.doi.org/10.1126/science.1208841			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	889AY	22323802	Green Published			2022-12-28	WOS:000300047100028
J	Blake, DT				Blake, David T.			NEUROSCIENCE How brains learn to control machines	NATURE			English	Editorial Material							BASAL GANGLIA; PERCEPTION		[Blake, David T.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Blake, David T.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Blake, DT (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.	dblake@georgiahealth.edu						ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Humayun MS, 2003, VISION RES, V43, P2573, DOI 10.1016/S0042-6989(03)00457-7; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wilke R, 2011, INVEST OPHTH VIS SCI, V52, P5995, DOI 10.1167/iovs.10-6946	9	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					284	285		10.1038/nature10951	http://dx.doi.org/10.1038/nature10951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	908HP	22388810				2022-12-28	WOS:000301481800037
J	Makkar, RR; Smith, RR; Cheng, K; Malliaras, K; Thomson, LEJ; Berman, D; Czer, LSC; Marban, L; Mendizabal, A; Johnston, PV; Russell, SD; Schuleri, KH; Lardo, AC; Gerstenblith, G; Marban, E				Makkar, Raj R.; Smith, Rachel R.; Cheng, Ke; Malliaras, Konstantinos; Thomson, Louise E. J.; Berman, Daniel; Czer, Lawrence S. C.; Marban, Linda; Mendizabal, Adam; Johnston, Peter V.; Russell, Stuart D.; Schuleri, Karl H.; Lardo, Albert C.; Gerstenblith, Gary; Marban, Eduardo			Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial	LANCET			English	Article							CARDIAC STEM-CELLS; PERCUTANEOUS CORONARY INTERVENTION; BONE-MARROW; PROGENITOR CELLS; MONONUCLEAR-CELLS; SCAR SIZE; THERAPY; REPAIR; EXPANSION; EFFICACY	Background Cardiosphere-derived cells (CDCs) reduce scarring after myocardial infarction, increase viable myocardium, and boost cardiac function in preclinical models. We aimed to assess safety of such an approach in patients with left ventricular dysfunction after myocardial infarction. Methods In the prospective, randomised CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction (CADUCEUS) trial, we enrolled patients 2-4 weeks after myocardial infarction (with left ventricular ejection fraction of 25-45%) at two medical centres in the USA. An independent data coordinating centre randomly allocated patients in a 2: 1 ratio to receive CDCs or standard care. For patients assigned to receive CDCs, autologous cells grown from endomyocardial biopsy specimens were infused into the infarct-related artery 1.5-3 months after myocardial infarction. The primary endpoint was proportion of patients at 6 months who died due to ventricular tachycardia, ventricular fibrillation, or sudden unexpected death, or had myocardial infarction after cell infusion, new cardiac tumour formation on MRI, or a major adverse cardiac event (MACE; composite of death and hospital admission for heart failure or non-fatal recurrent myocardial infarction). We also assessed preliminary efficacy endpoints on MRI by 6 months. Data analysers were masked to group assignment. This study is registered with ClinicalTrials.gov, NCT00893360. Findings Between May 5, 2009, and Dec 16, 2010, we randomly allocated 31 eligible participants of whom 25 were included in a per-protocol analysis (17 to CDC group and eight to standard of care). Mean baseline left ventricular ejection fraction (LVEF) was 39% (SD 12) and scar occupied 24% (10) of left ventricular mass. Biopsy samples yielded prescribed cell doses within 36 days (SD 6). No complications were reported within 24 h of CDC infusion. By 6 months, no patients had died, developed cardiac tumours, or MACE in either group. Four patients (24%) in the CDC group had serious adverse events compared with one control (13%; p=1.00). Compared with controls at 6 months, MRI analysis of patients treated with CDCs showed reductions in scar mass (p=0.001), increases in viable heart mass (p=0.01) and regional contractility (p=0.02), and regional systolic wall thickening (p=0.015). However, changes in end-diastolic volume, end-systolic volume, and LVEF did not differ between groups by 6 months. Interpretation We show intracoronary infusion of autologous CDCs after myocardial infarction is safe, warranting the expansion of such therapy to phase 2 study. The unprecedented increases we noted in viable myocardium, which are consistent with therapeutic regeneration, merit further assessment of clinical outcomes.	[Makkar, Raj R.; Smith, Rachel R.; Cheng, Ke; Malliaras, Konstantinos; Thomson, Louise E. J.; Berman, Daniel; Czer, Lawrence S. C.; Marban, Linda; Marban, Eduardo] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Mendizabal, Adam] EMMES Corp, Rockville, MD USA; [Johnston, Peter V.; Russell, Stuart D.; Schuleri, Karl H.; Lardo, Albert C.; Gerstenblith, Gary] Johns Hopkins Univ, Baltimore, MD USA	Cedars Sinai Medical Center; Emmes Corporation; Johns Hopkins University	Marban, E (corresponding author), Cedars Sinai Heart Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	eduardo.marban@csmc.edu	Czer, Lawrence/R-7901-2019; Johnston, Peter V/AAX-5573-2021; Cheng, Ke/HCH-8846-2022; Marban, Eduardo/GWC-8514-2022	Czer, Lawrence/0000-0001-5744-2625; Johnston, Peter V/0000-0002-4258-6981; 	US National Heart, Lung and Blood Institute; Cedars-Sinai Board of Governors Heart Stem Cell Center; Capricor; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081028] Funding Source: NIH RePORTER	US National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cedars-Sinai Board of Governors Heart Stem Cell Center; Capricor; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	US National Heart, Lung and Blood Institute and Cedars-Sinai Board of Governors Heart Stem Cell Center.; EM and LM are founders and equity holders in Capricor. RRS and LM are employed by Capricor. KM receives consulting fees from Capricor. Capricor provided no funding for this study.	[Anonymous], 2000, AM HERITAGE DICT ENG; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; de Haan S, 2011, HEART, V97, P1951, DOI 10.1136/heartjnl-2011-300060; Dill T, 2009, AM HEART J, V157, P541, DOI 10.1016/j.ahj.2008.11.011; Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Li T-S, J AM COLL C IN PRESS; Li TS, 2011, CARDIOVASC RES, V89, P157, DOI 10.1093/cvr/cvq251; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Mahrholdt H, 2002, CIRCULATION, V106, P2322, DOI 10.1161/01.CIR.0000036368.63317.1C; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Ordovas KG, 2011, RADIOLOGY, V261, P358, DOI 10.1148/radiol.11091882; Orn S, 2007, AM J CARDIOL, V99, P1109, DOI 10.1016/j.amjcard.2006.11.059; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Pride YB, 2010, AM J CARDIOL, V106, P635, DOI 10.1016/j.amjcard.2010.04.012; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052; Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670; Wohrle J, 2010, AM J CARDIOL, V105, P804, DOI 10.1016/j.amjcard.2009.10.060; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhang SN, 2009, CLIN CARDIOL, V32, P458, DOI 10.1002/clc.20575	33	1022	1074	0	143	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 10	2012	379	9819					895	904		10.1016/S0140-6736(12)60195-0	http://dx.doi.org/10.1016/S0140-6736(12)60195-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906NY	22336189	Green Accepted			2022-12-28	WOS:000301353700029
J	Siu, CW; Tse, HF				Siu, Chung-Wah; Tse, Hung-Fat			Cardiac regeneration: messages from CADUCEUS	LANCET			English	Editorial Material							STEM-CELLS; TRIAL		[Tse, Hung-Fat] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Ageing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Tse, HF (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	hftse@hkucc.hku.hk	Siu, Chung Wah/C-6947-2011; Tse, Hung-Fat/C-4426-2009	Tse, Hung-Fat/0000-0002-9578-7808				Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Koitabashi N, 2012, NAT REV CARDIOL, V9, P147, DOI 10.1038/nrcardio.2011.172; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	11	22	22	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 10	2012	379	9819					870	871		10.1016/S0140-6736(12)60236-0	http://dx.doi.org/10.1016/S0140-6736(12)60236-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906NY	22336188				2022-12-28	WOS:000301353700007
J	Roberts, EK; Lu, A; Bergman, TJ; Beehner, JC				Roberts, Eila K.; Lu, Amy; Bergman, Thore J.; Beehner, Jacinta C.			A Bruce Effect in Wild Geladas	SCIENCE			English	Article							PREGNANCY BLOCK; REPRODUCTIVE CONDITION; MALE TAKEOVERS; SOCIAL-FACTORS; BABOONS; VOLE; MOUSE; INFANTICIDE; ADVANTAGES; MORTALITY	Female rodents are known to terminate pregnancies after exposure to unfamiliar males ("Bruce effect"). Although laboratory support abounds, direct evidence for a Bruce effect under natural conditions is lacking. Here, we report a strong Bruce effect in a wild primate, the gelada (Theropithecus gelada). Female geladas terminate 80% of pregnancies in the weeks after a dominant male is replaced. Further, data on interbirth intervals suggest that pregnancy termination offers fitness benefits for females whose offspring would otherwise be susceptible to infanticide. Taken together, data support the hypothesis that the Bruce effect can be an adaptive strategy for females.	[Roberts, Eila K.; Lu, Amy; Bergman, Thore J.; Beehner, Jacinta C.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Lu, Amy] New York Consortium Evolutionary Primatol, New York, NY 10016 USA; [Bergman, Thore J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Beehner, Jacinta C.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Beehner, JC (corresponding author), Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48109 USA.	jbeehner@umich.edu	Bergman, Thore J/B-8196-2008; Beehner, Jacinta/E-8467-2012	Bergman, Thore J/0000-0002-9615-5001; Beehner, Jacinta/0000-0001-6566-6872	Wildlife Conservation Society [67250]; National Geographic Society [8100-06]; Leakey Foundation; National Science Foundation [BCS-0715179, BCS-0824592]; University of Michigan; Ethiopian Wildlife Conservation Authority; Simien Mountains National Park	Wildlife Conservation Society; National Geographic Society(National Geographic Society); Leakey Foundation; National Science Foundation(National Science Foundation (NSF)); University of Michigan(University of Michigan System); Ethiopian Wildlife Conservation Authority; Simien Mountains National Park	Supported by the Wildlife Conservation Society (SSF grant 67250), the National Geographic Society (grant 8100-06), the Leakey Foundation, the National Science Foundation (grants BCS-0715179 and BCS-0824592), and the University of Michigan. Thanks to the Ethiopian Wildlife Conservation Authority, the wardens and staff of the Simien Mountains National Park, and the participants of the University of Michigan Gelada Research project, particularly A. Le Roux, N. Snyder-Mackler, D. Pappano, C. Wilton, J. Jarvey, S. Liberman, A. Spencer, V. Wilson, N. Sands, M. Zakalik, H. Gelaye, E. Jejaw, and A. Fanta for help in the field and T. Parr for help in the laboratory. All protocols were noninvasive and were approved in Ethiopia (Ethiopian Wildlife Conservation Authority) and the United States (University of Michigan University Committee on Use and Care of Animals, protocols 09554 and 0001011). The authors declare no competing financial interests. All authors contributed extensively to the work presented in this paper. Data available in the SOM.	Agoramoorthy G., 1988, HUM EVOL, V3, P279; Agoramoorthy G., 1988, HUM EVOL, V3, P297, DOI DOI 10.1007/BF02435859; Bartos L, 2011, BEHAV ECOL SOCIOBIOL, V65, P1567, DOI 10.1007/s00265-011-1166-6; Becker SD, 2008, CHEM SIGNAL, V11, P141, DOI 10.1007/978-0-387-73945-8_13; Becker SD, 2009, P ROY SOC B-BIOL SCI, V276, P1723, DOI 10.1098/rspb.2008.1780; Beehner JC, 2008, AM J PRIMATOL, V70, P1152, DOI 10.1002/ajp.20614; Beehner JC, 2006, BEHAV ECOL, V17, P741, DOI 10.1093/beheco/arl006; Beehner JC, 2006, HORM BEHAV, V49, P688, DOI 10.1016/j.yhbeh.2005.12.016; BERGER J, 1983, NATURE, V303, P59, DOI 10.1038/303059a0; Bergman TJ, 2011, AM J PHYS ANTHROPOL, V144, P88; BERTRAM BCR, 1975, J ZOOL, V177, P463; Bronson F. H., 1980, MODULATION REPROD PR, P243; BRUCE HM, 1960, J REPROD FERTIL, V1, P96, DOI 10.1530/jrf.0.0010096; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; COLMENARES F, 1988, FOLIA PRIMATOL, V50, P157, DOI 10.1159/000156343; Darwin C., 1871, DESCENT MAN SELECTIO; de la Maza HM, 1999, BEHAV ECOL SOCIOBIOL, V45, P107, DOI 10.1007/s002650050544; DOMINIC CJ, 1966, J REPROD FERTIL, V11, P415; Dunbar R., 1984, REPROD DECISIONS EC; HAMILTON WJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P357; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; LABOV JB, 1981, AM NAT, V118, P361, DOI 10.1086/283828; Mahady SJ, 2002, BEHAV ECOL SOCIOBIOL, V52, P31, DOI 10.1007/s00265-002-0484-0; MALLORY FF, 1977, CAN J ZOOL, V55, P1, DOI 10.1139/z77-001; MILLIGAN SR, 1976, J REPROD FERTIL, V46, P97, DOI 10.1530/jrf.0.0460097; MORI U, 1985, Z TIERPSYCHOL, V67, P215; PARKES AS, 1961, SCIENCE, V134, P1049, DOI 10.1126/science.134.3485.1049; PEREIRA ME, 1983, AM J PRIMATOL, V4, P93, DOI 10.1002/ajp.1350040109; Pillay N, 2009, BEHAVIOUR, V146, P139, DOI 10.1163/156853908X390968; SCHWAGMEYER PL, 1979, AM NAT, V114, P932, DOI 10.1086/283541; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; Wolff JO, 2003, BIOSCIENCE, V53, P421, DOI 10.1641/0006-3568(2003)053[0421:LSWRFO]2.0.CO;2	33	93	94	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1222	1225		10.1126/science.1213600	http://dx.doi.org/10.1126/science.1213600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22362878				2022-12-28	WOS:000301225100044
J	Hotz, M; Leisner, C; Chen, DC; Manatschal, C; Wegleiter, T; Ouellet, J; Lindstrom, D; Gottschling, DE; Vogel, J; Barral, Y				Hotz, Manuel; Leisner, Christian; Chen, Daici; Manatschal, Cristina; Wegleiter, Thomas; Ouellet, Jimmy; Lindstrom, Derek; Gottschling, Dan E.; Vogel, Jackie; Barral, Yves			Spindle Pole Bodies Exploit the Mitotic Exit Network in Metaphase to Drive Their Age-Dependent Segregation	CELL			English	Article							MICROTUBULE ORGANIZATION; BODY INHERITANCE; PROTEIN; ORIENTATION; CENTROSOME; ASYMMETRY; KINASE; YEAST; CHECKPOINT; HOMOLOG	Like many asymmetrically dividing cells, budding yeast segregates mitotic spindle poles nonrandomly between mother and daughter cells. During metaphase, the spindle positioning protein Kar9 accumulates asymmetrically, localizing specifically to astral microtubules emanating from the old spindle pole body (SPB) and driving its segregation to the bud. Here, we show that the SPB component Nud1/centriolin acts through the mitotic exit network (MEN) to specify asymmetric SPB inheritance. In the absence of MEN signaling, Kar9 asymmetry is unstable and its preference for the old SPB is disrupted. Consistent with this, phosphorylation of Kar9 by the MEN kinases Dbf2 and Dbf20 is not required to break Kar9 symmetry but is instead required to maintain stable association of Kar9 with the old SPB throughout metaphase. We propose that MEN signaling links Kar9 regulation to SPB identity through biasing and stabilizing the age-insensitive, cyclin-B-dependent mechanism of symmetry breaking.	[Hotz, Manuel; Leisner, Christian; Manatschal, Cristina; Wegleiter, Thomas; Ouellet, Jimmy; Barral, Yves] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland; [Chen, Daici; Vogel, Jackie] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Lindstrom, Derek; Gottschling, Dan E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; McGill University; Fred Hutchinson Cancer Center	Barral, Y (corresponding author), ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch	Chen, Daici/AAI-7285-2020	Chen, Daici/0000-0002-8872-0592; Barral, Yves/0000-0002-0989-3373; Ouellet, Jimmy/0000-0002-0215-7023	ERC; SNF; CIHR [MOP-64404]; NIH [AG023779]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023779, R37AG023779] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); SNF; CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Baldi, M. Bayer, A. Bolognesi, S. Buvelot-Frei, F. Caudron, L. Clay, A. Denoth, A. Farcas, M. Faty, P. Meraldi, M. Peter, J. Saarikangas, and C. Weirich for discussion and critical reading of the manuscript and N. Paget and R. Visintin for technical help. We also thank M. Charbonneau, S. Piatti, and F. Uhlmann for strains and reagents and the Light Microscopy Centre of the ETH Zurich for technical support. M. H. and Y.B. were supported by ETHZ and grants of ERC and SNF to Y.B. D. C. and J. V. were supported by CIHR grant MOP-64404 to J. V. D. L. and D. E. G. were supported by NIH grant AG023779 to D.E.G.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Barral Y, 2009, INT REV CEL MOL BIO, V278, P149, DOI 10.1016/S1937-6448(09)78004-9; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Bloom J, 2011, J BIOL CHEM, V286, P5434, DOI 10.1074/jbc.M110.205054; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Caydasi AK, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-28; Cepeda-Garcia C, 2010, MOL BIOL CELL, V21, P2685, DOI 10.1091/mbc.E10-03-0197; Conduit PT, 2010, CURR BIOL, V20, P2187, DOI 10.1016/j.cub.2010.11.055; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Gordon O, 2006, EMBO J, V25, P3856, DOI 10.1038/sj.emboj.7601254; Grava S, 2006, DEV CELL, V10, P425, DOI 10.1016/j.devcel.2006.02.018; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Gruneberg U, 2000, EMBO J, V19, P6475, DOI 10.1093/emboj/19.23.6475; Guthrie C, 1991, GUIDE YEAST GENETICS; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245; Kaltschmidt JA, 2002, J CELL SCI, V115, P2257; Kammerer D, 2010, CURR BIOL, V20, P1233, DOI 10.1016/j.cub.2010.05.064; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Konig C, 2010, J CELL BIOL, V188, P351, DOI 10.1083/jcb.200911128; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Leisner C, 2008, CURR BIOL, V18, P1249, DOI 10.1016/j.cub.2008.07.091; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Meednu N, 2008, GENETICS, V180, P2033, DOI 10.1534/genetics.108.095042; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Monje-Casas F, 2009, DEV CELL, V16, P132, DOI 10.1016/j.devcel.2008.11.002; Moore JK, 2007, MOL BIOL CELL, V18, P1187, DOI 10.1091/mbc.E06-04-0360; Moore JK, 2006, MOL BIOL CELL, V17, P178, DOI 10.1091/mbc.e05-06-0565; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Verzijlbergen KF, 2010, P NATL ACAD SCI USA, V107, P64, DOI 10.1073/pnas.0911164107; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024; Yoder TJ, 2003, MOL BIOL CELL, V14, P3494, DOI 10.1091/mbc.E02-10-0655; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	52	50	51	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					958	972		10.1016/j.cell.2012.01.041	http://dx.doi.org/10.1016/j.cell.2012.01.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385961	Green Accepted, Bronze			2022-12-28	WOS:000300985000016
J	Barbier, E				Barbier, Edward			Tax 'societal ills' to save the planet	NATURE			English	Editorial Material									Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA	University of Wyoming	Barbier, E (corresponding author), Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA.	ebarbier@uwyo.edu						[Anonymous], 2010, UN C TRAD DEV; Brzoska M, 2004, KYKLOS, V57, P149, DOI 10.1111/j.0023-5962.2004.00248.x; Ebeling J, 2008, PHILOS T R SOC B, V363, P1917, DOI 10.1098/rstb.2007.0029; Gates B., 2011, INNOVATION IMPACT FI; Spahn P. B, 2010, BROKER, V22, P10	5	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					30	30		10.1038/483030a	http://dx.doi.org/10.1038/483030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900HP	22382963	Bronze			2022-12-28	WOS:000300877900026
J	Kala, J; Mostow, EN				Kala, Jaya; Mostow, Eliot N.			Eruptive Xanthoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kala, Jaya] Akron Gen Med Ctr, Akron, OH 44307 USA; [Mostow, Eliot N.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Akron General Medical Center; Case Western Reserve University	Kala, J (corresponding author), Akron Gen Med Ctr, Akron, OH 44307 USA.	jayakala13@gmail.com							0	5	5	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					835	835		10.1056/NEJMicm1105301	http://dx.doi.org/10.1056/NEJMicm1105301			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900GI	22375975				2022-12-28	WOS:000300874300010
J	Olsen, SR; Bortone, DS; Adesnik, H; Scanziani, M				Olsen, Shawn R.; Bortone, Dante S.; Adesnik, Hillel; Scanziani, Massimo			Gain control by layer six in cortical circuits of vision	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; PRIMARY SOMATOSENSORY CORTEX; RESPONSE PROPERTIES; CORTICOTHALAMIC FEEDBACK; INTERLAMINAR CONNECTIONS; RECEPTIVE-FIELDS; END-INHIBITION; SYNAPTIC INPUT; NEURONS	After entering the cerebral cortex, sensory information spreads through six different horizontal neuronal layers that are interconnected by vertical axonal projections. It is believed that through these projections layers can influence each other's response to sensory stimuli, but the specific role that each layer has in cortical processing is still poorly understood. Here we show that layer six in the primary visual cortex of the mouse has a crucial role in controlling the gain of visually evoked activity in neurons of the upper layers without changing their tuning to orientation. This gain modulation results from the coordinated action of layer six intracortical projections to superficial layers and deep projections to the thalamus, with a substantial role of the intracortical circuit. This study establishes layer six as a major mediator of cortical gain modulation and suggests that it could be a node through which convergent inputs from several brain areas can regulate the earliest steps of cortical visual processing.	[Olsen, Shawn R.; Bortone, Dante S.; Adesnik, Hillel; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Olsen, Shawn R.; Bortone, Dante S.; Adesnik, Hillel; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.	srolsen@ucsd.edu; massimo@biomail.ucsd.edu		Olsen, Shawn/0000-0002-9568-7057	Helen Hay Whitney Foundation; NINDS [5T32NS007220-28]; National Institutes of Health [RO1 NS069010]; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007220, RC1NS069010] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to M. Carandini, J. Isaacson and the members of the Scanziani and Isaacson laboratories for helpful discussions of this project, to J. Isaacson, R. Malinow and T. Komiyama for providing feedback on the manuscript, to P. Abelkop for histological help and neonatal viral injections, to J. Evora for mouse colony support and genotyping, to B. Atallah for sharing the technique for silencing the cortex by photostimulation of parvalbumin neurons and for help with the in vivo recording setup and to W. Bruns for help coding analysis software. We thank the UCSD Neuroscience Microscopy Facility (P30 NS047101) for the use of their imaging equipment. S.R.O. and H.A. were supported by postdoctoral fellowships from the Helen Hay Whitney Foundation. D.S.B was supported by a UCSD Neurobiology Training Grant (NINDS: 5T32NS007220-28). M.S. is an investigator of the Howard Hughes Medical Institute. This work was also supported National Institutes of Health grant RO1 NS069010 and by the Gatsby Charitable Foundation.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Andolina IM, 2007, P NATL ACAD SCI USA, V104, P1685, DOI 10.1073/pnas.0609318104; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bagnall MW, 2011, NEURON, V71, P180, DOI 10.1016/j.neuron.2011.05.032; Binzegger T, 2007, J NEUROSCI, V27, P12242, DOI 10.1523/JNEUROSCI.3753-07.2007; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Briggs F, 2008, CURR OPIN NEUROBIOL, V18, P403, DOI 10.1016/j.conb.2008.09.002; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Casagrande V. A., 1994, AFFERENT IINTRINSIC; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cudeiro J, 2006, TRENDS NEUROSCI, V29, P298, DOI 10.1016/j.tins.2006.05.002; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GRIEVE KL, 1991, EXP BRAIN RES, V87, P521; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lorente de No R, 1943, PHYSL NERVOUS SYSTEM, P274; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCLURKIN JW, 1984, J PHYSIOL-LONDON, V348, P135, DOI 10.1113/jphysiol.1984.sp015103; Murphy BK, 2003, J NEUROSCI, V23, P10040; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Ringach DL, 2002, J NEUROSCI, V22, P5639; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Thomson AM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00013; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Wang W, 2006, NAT NEUROSCI, V9, P1330, DOI 10.1038/nn1768; Worgotter F, 1998, J PHYSIOL-LONDON, V509, P797, DOI 10.1111/j.1469-7793.1998.797bm.x; Zhang ZW, 1997, J NEUROSCI, V17, P6365	50	330	333	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					47	U83		10.1038/nature10835	http://dx.doi.org/10.1038/nature10835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22367547	Green Accepted			2022-12-28	WOS:000300877900041
J	Gu, SY; Rumpel, S; Zhou, J; Strotmeier, J; Bigalke, H; Perry, K; Shoemaker, CB; Rummel, A; Jin, RS				Gu, Shenyan; Rumpel, Sophie; Zhou, Jie; Strotmeier, Jasmin; Bigalke, Hans; Perry, Kay; Shoemaker, Charles B.; Rummel, Andreas; Jin, Rongsheng			Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex	SCIENCE			English	Article							CLOSTRIDIUM-BOTULINUM; RECEPTOR RECOGNITION; NONTOXIC COMPONENT; PROGENITOR TOXIN; SEROTYPE; BINDING; TRANSLOCATION; PURIFICATION; SEQUENCE; DOMAINS	Botulinum neurotoxins (BoNTs) are highly poisonous substances that are also effective medicines. Accidental BoNT poisoning often occurs through ingestion of Clostridium botulinum-contaminated food. Here, we present the crystal structure of a BoNT in complex with a clostridial nontoxic nonhemagglutinin (NTNHA) protein at 2.7 angstroms. Biochemical and functional studies show that NTNHA provides large and multivalent binding interfaces to protect BoNT from gastrointestinal degradation. Moreover, the structure highlights key residues in BoNT that regulate complex assembly in a pH-dependent manner. Collectively, our findings define the molecular mechanisms by which NTNHA shields BoNT in the hostile gastrointestinal environment and releases it upon entry into the circulation. These results will assist in the design of small molecules for inhibiting oral BoNT intoxication and of delivery vehicles for oral administration of biologics.	[Gu, Shenyan; Zhou, Jie; Jin, Rongsheng] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Rumpel, Sophie; Strotmeier, Jasmin; Bigalke, Hans; Rummel, Andreas] Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany; [Perry, Kay] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA; [Perry, Kay] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, Div Infect Dis, North Grafton, MA 01536 USA	Sanford Burnham Prebys Medical Discovery Institute; Hannover Medical School; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Jin, RS (corresponding author), Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rjin@sanfordburnham.org	Rummel, Andreas/I-7449-2013; Jin, Rongsheng/M-7797-2013; Gu, Shenyan/F-5501-2011	Jin, Rongsheng/0000-0003-0348-7363; Perry, Kay/0000-0002-4046-1704; Rummel, Andreas/0000-0002-0645-1641	Alfred P. Sloan Research Fellowship; Deutsche Forschungsgemeinschaft (DFG) [Exzellenzinitiative GSC 108]; Robert-Koch-Institut [1362/I-979]; National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health and Human Services (HHS) [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI091823] Funding Source: NIH RePORTER	Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Robert-Koch-Institut; National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health and Human Services (HHS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Brunger and T. Binz for critical reading of the manuscript; the staff of beamline 9-2 at the Stanford Synchrotron Radiation Lightsource (SSRL) and the NE-CAT staff of the Advanced Photon Source (APS), particularly K. Rajashankar, for assistance in data collection; G. Yao, N. Krez, A. M. Kruel, and J. Tremblay for excellent technical assistance; and R. Liddington and A. Bobkov for assistance with ITC and AUC. This work was partly supported by an Alfred P. Sloan Research Fellowship (R.J.), by the Deutsche Forschungsgemeinschaft (DFG Exzellenzinitiative GSC 108 to S.R.), by the Robert-Koch-Institut (1362/I-979 to A.R.), and by grants from the National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health and Human Services (HHS), under award number U54 AI057159 (C.B.S.). Atomic coordinates and structure factors for the VHH-bound M-PTC, M-PTC, and BoNT/Ai have been deposited with the Protein Data Bank under accession codes 3V0A, 3V0B, and 3V0C, respectively. Sanford-Burnham Medical Research Institute has a pending patent application, titled "Botulinum neurotoxin protective complex delivery compositions," that was filed in November of 2011. BoNT availability is subject to the restrictions that apply to HHS select agents and NIAID Category A pathogens.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2007, NAT STRUCT MOL BIOL, V14, P9, DOI 10.1038/nsmb0107-9; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Burkard F, 1997, J STRUCT BIOL, V120, P78, DOI 10.1006/jsbi.1997.3910; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen F, 1997, INFECT IMMUN, V65, P1626, DOI 10.1128/IAI.65.5.1626-1630.1997; Cheng LW, 2008, TOXICOLOGY, V249, P123, DOI 10.1016/j.tox.2008.04.018; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; DEPAIVA A, 1993, J BIOL CHEM, V268, P20838; EAST AK, 1994, CURR MICROBIOL, V29, P69, DOI 10.1007/BF01575751; Eisele KH, 2011, TOXICON, V57, P555, DOI 10.1016/j.toxicon.2010.12.019; Eswaramoorthy S, 2004, BIOCHEMISTRY-US, V43, P2209, DOI 10.1021/bi035844k; FUJII N, 1993, J GEN MICROBIOL, V139, P79, DOI 10.1099/00221287-139-1-79; Hasegawa K, 2007, J BIOL CHEM, V282, P24777, DOI 10.1074/jbc.M703446200; Ito H, 2011, FEMS IMMUNOL MED MIC, V61, P323, DOI 10.1111/j.1574-695X.2011.00779.x; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Kouguchi H, 2002, J BIOL CHEM, V277, P2650, DOI 10.1074/jbc.M106762200; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin GY, 2010, APPL ENVIRON MICROB, V76, P40, DOI 10.1128/AEM.01882-09; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; OHISHI I, 1977, INFECT IMMUN, V16, P107, DOI 10.1128/IAI.16.1.107-109.1977; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Sagane Y, 2002, BIOCHEM BIOPH RES CO, V292, P434, DOI 10.1006/bbrc.2002.6689; SHONE CC, 1985, EUR J BIOCHEM, V151, P75, DOI 10.1111/j.1432-1033.1985.tb09070.x; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wang JF, 2008, J BIOL CHEM, V283, P16993, DOI 10.1074/jbc.M710442200	32	149	161	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					977	981		10.1126/science.1214270	http://dx.doi.org/10.1126/science.1214270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363010	Green Accepted			2022-12-28	WOS:000300931800049
J	Pauluis, O; Dias, J				Pauluis, Olivier; Dias, Juliana			Satellite Estimates of Precipitation-Induced Dissipation in the Atmosphere	SCIENCE			English	Article							RADIATIVE-CONVECTIVE EQUILIBRIUM; RAIN-PROFILING ALGORITHM; ENTROPY BUDGET; WORK	A substantial amount of frictional dissipation in the atmosphere occurs in the microphysical shear zones surrounding falling precipitation. The dissipation rate is computed here from recently available satellite retrieval from the Tropical Rainfall Measurement Missions and is found to average 1.8 watts per square meter between 30 degrees S and 30 degrees N. The geographical distribution of the precipitation-induced dissipation is closely tied to that of precipitation but also reveals a stronger dissipation rate for continental convection than for maritime convection. Because the precipitation-induced dissipation is of the same magnitude as the turbulent dissipation of the kinetic energy in the atmosphere, changes in the hydrological cycle could potentially have a direct impact on the amount of kinetic energy generated and dissipated by the atmospheric circulation.	[Pauluis, Olivier] NYU, Courant Inst Math Sci, New York, NY 10012 USA; [Dias, Juliana] NOAA, Div Phys Sci, ESRL, Boulder, CO 80305 USA	New York University; National Oceanic Atmospheric Admin (NOAA) - USA	Pauluis, O (corresponding author), NYU, Courant Inst Math Sci, 251 Mercer St, New York, NY 10012 USA.	pauluis@cims.nyu.edu			NSF [ATM-0545047, AGS-0944058]; Div Atmospheric & Geospace Sciences [0944058] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The TRMM 3A25 data were obtained from the TRMM Science Data and Information System (TSDIS) at Goddard Space Flight Center, NASA. The authors are thankful to A. Ackerman, A. Del Genio, G. Tselioudis, and A. Fridlind for their comments on a previous version of this manuscript. This work has been supported by NSF grants ATM-0545047 and AGS-0944058.	Becker E, 2003, MON WEATHER REV, V131, P508, DOI 10.1175/1520-0493(2003)131<0508:FHIGCM>2.0.CO;2; Bellerby T, 2000, J APPL METEOROL, V39, P2115, DOI 10.1175/1520-0450(2001)040<2115:REFACO>2.0.CO;2; Bowman KP, 2005, J CLIMATE, V18, P178, DOI 10.1175/JCLI3259.1; Emanuel KA, 1996, J ATMOS SCI, V53, P3276, DOI 10.1175/1520-0469(1996)053<3276:MCVABS>2.0.CO;2; Goody R, 2003, J ATMOS SCI, V60, P2827, DOI 10.1175/1520-0469(2003)060<2827:OTMEOD>2.0.CO;2; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; Iguchi T, 2009, J METEOROL SOC JPN, V87A, P1, DOI 10.2151/jmsj.87A.1; Lorenz E. N., 1967, NATURE THEORY GEN CI; Mitrescu C, 2010, J APPL METEOROL CLIM, V49, P991, DOI 10.1175/2009JAMC2181.1; Pauluis O, 2002, J ATMOS SCI, V59, P125, DOI 10.1175/1520-0469(2002)059<0125:EBOAAI>2.0.CO;2; Pauluis O, 2000, J ATMOS SCI, V57, P989, DOI 10.1175/1520-0469(2000)057<0989:FDIAPA>2.0.CO;2; Pauluis O, 2002, J ATMOS SCI, V59, P140, DOI 10.1175/1520-0469(2002)059<0140:EBOAAI>2.0.CO;2; Pauluis O, 2011, J ATMOS SCI, V68, P91, DOI 10.1175/2010JAS3530.1; Pauluis OM, 2005, UND COM SYS, P107; Peixoto J.P., 1992, PHYS CLIMATE, P520; PEIXOTO JP, 1991, J GEOPHYS RES-ATMOS, V96, P10981, DOI 10.1029/91JD00721; Renno NO, 1996, J ATMOS SCI, V53, P572, DOI 10.1175/1520-0469(1996)053<0572:NCAAHE>2.0.CO;2; Stephens GL, 2002, B AM METEOROL SOC, V83, P1771, DOI 10.1175/BAMS-83-12-1771	18	36	36	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					953	956		10.1126/science.1215869	http://dx.doi.org/10.1126/science.1215869			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363004				2022-12-28	WOS:000300931800042
J	Lu, A; Aronowitz, P				Lu, Albert; Aronowitz, Paul			Sigmoid Perforation in Association with Colonoscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lu, Albert] Loma Linda Univ, Loma Linda, CA 92350 USA; [Aronowitz, Paul] Calif Pacific Med Ctr, San Francisco, CA USA	Loma Linda University; California Pacific Medical Center	Lu, A (corresponding author), Loma Linda Univ, Loma Linda, CA 92350 USA.	allu@llu.edu							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					744	744		10.1056/NEJMicm1106348	http://dx.doi.org/10.1056/NEJMicm1106348			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356327				2022-12-28	WOS:000300551500012
J	Hoffman, RM				Hoffman, Richard M.			Vitamin E supplementation increased risk for prostate cancer in healthy men at a median of 7 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									New Mexico VA Hlth Care Syst, Albuquerque, NM 87108 USA		Hoffman, RM (corresponding author), New Mexico VA Hlth Care Syst, Albuquerque, NM 87108 USA.							Coulter ID, 2006, J GEN INTERN MED, V21, P735, DOI 10.1111/j.1525-1497.2006.00483.x; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; *OFF DIET SUPPL, DIET SUPPL FACT SHEE	4	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-3	10.7326/0003-4819-156-4-201202210-02003	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351729				2022-12-28	WOS:000208885400002
J	Ricci, ML; Fontana, S; Pinci, F; Fiumana, E; Pedna, MF; Farolfi, P; Sabattini, MAB; Scaturro, M				Ricci, Maria Luisa; Fontana, Stefano; Pinci, Federica; Fiumana, Emanuela; Pedna, Maria Federica; Farolfi, Paolo; Sabattini, Maria Antonietta Bucci; Scaturro, Maria			Pneumonia associated with a dental unit waterline	LANCET			English	Editorial Material							LEGIONELLA		[Ricci, Maria Luisa; Fontana, Stefano; Pinci, Federica; Scaturro, Maria] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Fiumana, Emanuela] Azienda Unita Sanit Locale, Forli, Italy; [Pedna, Maria Federica] Azienda Unita Sanit Locale, Cesena, Italy; [Sabattini, Maria Antonietta Bucci] Agenzia Reg Prevenz & Ambiente, Bologna, Italy; [Farolfi, Paolo] GB Morgagni Pierantoni Hosp, Dept Emergency Anaesthesia, Forli, Italy; [Farolfi, Paolo] GB Morgagni Pierantoni Hosp, Intens Care Unit, Forli, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Ricci, ML (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	marialuisa.ricci@iss.it	Fontana, Stefano/J-9992-2016; RICCI, MARIA LUISA/C-8824-2016; Scaturro, Maria/B-5005-2013	Fontana, Stefano/0000-0003-0668-4514; Scaturro, Maria/0000-0001-5614-8678; Ricci, Maria Luisa/0000-0001-5294-5135				[Anonymous], SEQUENCE BASED TYPIN; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fry NK, 2002, EUR J CLIN MICROBIOL, V21, P722, DOI 10.1007/s10096-002-0790-5; Szymanska J, 2004, ANN AGR ENV MED, V11, P9; UK Department of Health-Commissioning and Systems Management, 2009, 0105 UK DEP HLTH COM	5	93	106	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 18	2012	379	9816					684	684		10.1016/S0140-6736(12)60074-9	http://dx.doi.org/10.1016/S0140-6736(12)60074-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897ES	22340301				2022-12-28	WOS:000300629000039
J	Douglas, SM; Bachelet, I; Church, GM				Douglas, Shawn M.; Bachelet, Ido; Church, George M.			A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads	SCIENCE			English	Article							DNA-ORIGAMI; NANOSCALE SHAPES; FOLDING DNA; CELLS; ENGAGEMENT; EXPRESSION; APTAMERS; LIGANDS	We describe an autonomous DNA nanorobot capable of transporting molecular payloads to cells, sensing cell surface inputs for conditional, triggered activation, and reconfiguring its structure for payload delivery. The device can be loaded with a variety of materials in a highly organized fashion and is controlled by an aptamer-encoded logic gate, enabling it to respond to a wide array of cues. We implemented several different logical AND gates and demonstrate their efficacy in selective regulation of nanorobot function. As a proof of principle, nanorobots loaded with combinations of antibody fragments were used in two different types of cell-signaling stimulation in tissue culture. Our prototype could inspire new designs with different selectivities and biologically active payloads for cell-targeting tasks.	[Church, George M.] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Church, GM (corresponding author), Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.		Douglas, Shawn/GVU-2004-2022	Douglas, Shawn/0000-0001-5398-9041; church, george/0000-0001-6232-9969	Burroughs Wellcome Fund; Wyss Technology Development Fellowship; Life Sciences Research Foundation; Grants-in-Aid for Scientific Research [23770216] Funding Source: KAKEN	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Wyss Technology Development Fellowship; Life Sciences Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Ritz for providing NKL cells; C. Reynolds for technical assistance with NKL cells; C. Strong and G. McGill for assistance with 3D visualization using Molecular Maya; A. Marblestone for helpful discussions; and J. Markson for comments on the manuscript. S. M. D. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and a Wyss Technology Development Fellowship, and I. B. is supported by a fellowship from the Life Sciences Research Foundation. S. M. D. and I. B. designed and performed the experiments and analyzed the data; S. M. D., I. B., and G. M. C. wrote the manuscript.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Ding B, 2006, SCIENCE, V314, P1583, DOI 10.1126/science.1131372; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Hamaguchi N, 2001, ANAL BIOCHEM, V294, P126, DOI 10.1006/abio.2001.5169; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kuzuya A, 2009, CHEMBIOCHEM, V10, P1811, DOI 10.1002/cbic.200900229; Nutiu R, 2003, J AM CHEM SOC, V125, P4771, DOI 10.1021/ja028962o; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Stephanopoulos N, 2010, NANO LETT, V10, P2714, DOI 10.1021/nl1018468; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Vitale C, 2001, P NATL ACAD SCI USA, V98, P5764, DOI 10.1073/pnas.091097198; Voigt NV, 2010, NAT NANOTECHNOL, V5, P200, DOI [10.1038/nnano.2010.5, 10.1038/NNANO.2010.5]; Ye ZY, 2008, INFECT IMMUN, V76, P2541, DOI 10.1128/IAI.01310-07; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	24	1426	1470	47	1419	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					831	834		10.1126/science.1214081	http://dx.doi.org/10.1126/science.1214081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344439				2022-12-28	WOS:000300356400038
J	Thadhani, R; Appelbaum, E; Pritchett, Y; Chang, YC; Wenger, J; Tamez, H; Bhan, I; Agarwal, R; Zoccali, C; Wanner, C; Lloyd-Jones, D; Cannata, J; Thompson, BT; Andress, D; Zhang, WY; Packham, D; Singh, B; Zehnder, D; Shah, A; Pachika, A; Manning, WJ; Solomon, SD				Thadhani, Ravi; Appelbaum, Evan; Pritchett, Yili; Chang, Yuchiao; Wenger, Julia; Tamez, Hector; Bhan, Ishir; Agarwal, Rajiv; Zoccali, Carmine; Wanner, Christoph; Lloyd-Jones, Donald; Cannata, Jorge; Thompson, B. Taylor; Andress, Dennis; Zhang, Wuyan; Packham, David; Singh, Bhupinder; Zehnder, Daniel; Shah, Amil; Pachika, Ajay; Manning, Warren J.; Solomon, Scott D.			Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease The PRIMO Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR MASS; GLOMERULAR-FILTRATION-RATE; D-RECEPTOR ACTIVATION; LEFT ATRIAL VOLUME; CARDIOVASCULAR MAGNETIC-RESONANCE; RENIN-ANGIOTENSIN SYSTEM; HEART-FAILURE; D DEFICIENCY; RENAL-FUNCTION; 1,25-DIHYDROXYVITAMIN D-3	Context Vitamin D is associated with decreased cardiovascular-related morbidity and mortality, possibly by modifying cardiac structure and function, yet firm evidence for either remains lacking. Objective To determine the effects of an active vitamin D compound, paricalcitol, on left ventricular mass over 48 weeks in patients with an estimated glomerular filtration rate of 15 to 60 mL/min/1.73 m(2). Design, Setting, and Participants Multinational, double-blind, randomized placebo-controlled trial among 227 patients with chronic kidney disease, mild to moderate left ventricular hypertrophy, and preserved left ventricular ejection fraction, conducted in 11 countries from July 2008 through September 2010. Intervention Participants were randomly assigned to receive oral paricalcitol, 2 mu g/d (n=115), or matching placebo (n=112). Main Outcome Measures Change in left ventricular mass index over 48 weeks by cardiovascular magnetic resonance imaging. Secondary end points included echo-cardiographic changes in left ventricular diastolic function. Results Treatment with paricalcitol reduced parathyroid hormone levels within 4 weeks and maintained levels within the normal range throughout the study duration. At 48 weeks, the change in left ventricular mass index did not differ between treatment groups (paricalcitol group, 0.34 g/m(2.7) [95% CI, -0.14 to 0.83 g/m(2.7)] vs placebo group, -0.07 g/m(2.7) [95% CI, -0.55 to 0.42 g/m(2.7)]). Doppler measures of diastolic function including peak early diastolic lateral mitral annular tissue velocity (paricalcitol group, -0.01 cm/s [95% CI, -0.63 to 0.60 cm/s] vs placebo group, -0.30 cm/s [95% CI, -0.93 to 0.34 cm/s]) also did not differ. Episodes of hypercalcemia were more frequent in the paricalcitol group compared with the placebo group. Conclusion Forty-eight week therapy with paricalcitol did not alter left ventricular mass index or improve certain measures of diastolic dysfunction in patients with chronic kidney disease.	[Thadhani, Ravi; Wenger, Julia; Tamez, Hector; Bhan, Ishir] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Chang, Yuchiao] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Thompson, B. Taylor] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Appelbaum, Evan; Manning, Warren J.] Beth Israel Deaconess Med Ctr, Dept Med, Perfuse Cardiovasc Magnet Resonance Core Lab, Boston, MA 02215 USA; [Appelbaum, Evan; Manning, Warren J.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA; [Manning, Warren J.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Shah, Amil; Pachika, Ajay; Solomon, Scott D.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Andress, Dennis; Zhang, Wuyan; Pachika, Ajay] Abbott Labs, Abbott Pk, IL 60064 USA; [Agarwal, Rajiv] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; [Zoccali, Carmine] Inst Biomed & Immunol Mol Alberto Monroy Clin Epi, Nephrol Dialysis & Transplantat Unit, Reggio Di Calabria, Italy; [Zoccali, Carmine] Inst Biomed & Immunol Mol Alberto Monroy Clin Epi, CNR, Reggio Di Calabria, Italy; [Wanner, Christoph] Univ Wurzburg, Univ Hosp, Dept Med, Div Nephrol, Wurzburg, Germany; [Lloyd-Jones, Donald] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Cannata, Jorge] Hosp Univ Cent Asturias, Inst Reina Sofia Invest, Serv Metab Oseo & Mineral, Inst Carlos III, Oviedo, Spain; [Packham, David] Royal Melbourne Hosp, Dept Nephrol, Reservoir Private Hosp, Melbourne Renal Res Grp, Melbourne, Vic 3050, Australia; [Packham, David] Austin Hosp, Dept Nephrol, Melbourne, Vic 3084, Australia; [Singh, Bhupinder] SW Kidney Inst, Tempe, AZ USA; [Zehnder, Daniel] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Abbott Laboratories; Indiana University System; Indiana University Bloomington; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Wurzburg; Northwestern University; Feinberg School of Medicine; Central University Hospital Asturias; Royal Melbourne Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Warwick	Thadhani, R (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Nephrol, 55 Fruit St,Bulfinch 127, Boston, MA 02114 USA.	thadhani.r@mgh.harvard.edu	Solomon, Scott/I-5789-2013; Lloyd-Jones, Donald M/C-5899-2009; Cannata-Andía, Jorge B L/L-2260-2013; Zoccali, Carmine/B-9445-2009; Zoccali, Carmine/AAR-4473-2020; Agarwal, Rajiv/H-3454-2019	Cannata-Andía, Jorge B L/0000-0001-6543-9960; Zoccali, Carmine/0000-0002-6616-1996; Agarwal, Rajiv/0000-0001-8355-7100; Lloyd-Jones, Donald/0000-0003-0847-6110	Abbott Laboratories; Pfizer; Roche; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); Pfizer(Pfizer); Roche(Roche Holding); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Thadhani reported receiving a coordinating grant from Abbott Laboratories to the Massachusetts General Hospital and speaker's fees and travel support from Abbott Laboratories. Drs Pritchett, Andress, and Zhang are employees of Abbott Laboratories and may own Abbott stock or options. Dr Agarwal reported receiving honoraria for serving on the speaker's bureau and steering committees of Abbott Laboratories. Dr Zoccali reported receiving consulting/honorarium fees and travel support from Abbott Laboratories, honoraria for lectures from Genzyme, Roche, Amgen, Abbott Laboratories, and Malesci and research grants from Pfizer, Roche, and Abbott Laboratories. Drs Wanner and Packham serve on an advisory board and have received travel support from Abbott Laboratories. Dr Wanner has received research support and speakers fees from Abbott Laboratories. Dr Zehnder reported receiving honoraria for serving on a steering committee and for lectures from Abbott Laboratories and receiving grants from Abbott Laboratories. Dr Manning received travel support for a CMR meeting from Abbott Laboratories. Dr Solomon is supported by a research grant from Abbott Laboratories to the Brigham and Women's Hospital. No other disclosures were reported.	Agarwal R, 2011, KIDNEY INT, V80, P1073, DOI 10.1038/ki.2011.207; Alborzi P, 2008, HYPERTENSION, V52, P249, DOI 10.1161/HYPERTENSIONAHA.108.113159; Alfakih K, 2003, J MAGN RESON IMAGING, V17, P323, DOI 10.1002/jmri.10262; APPLETON CP, 1993, J AM COLL CARDIOL, V22, P1972, DOI 10.1016/0735-1097(93)90787-2; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Bae S, 2011, CARDIOVASC RES, V91, P632, DOI 10.1093/cvr/cvr133; Bellenger NG, 2000, EUR HEART J, V21, P1387, DOI 10.1053/euhj.2000.2011; BERTOLI M, 1990, CLIN NEPHROL, V33, P98; Bodyak N, 2007, P NATL ACAD SCI USA, V104, P16810, DOI 10.1073/pnas.0611202104; BOTTINI PB, 1995, AM J HYPERTENS, V8, P221, DOI 10.1016/0895-7061(94)00178-E; Brown J, 2009, PEDIATR CARDIOL, V30, P818, DOI 10.1007/s00246-009-9444-z; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; Coyne D, 2006, AM J KIDNEY DIS, V47, P263, DOI 10.1053/j.ajkd.2005.10.007; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Dobrez DG, 2004, NEPHROL DIAL TRANSPL, V19, P1174, DOI 10.1093/ndt/gfh123; Drechsler C, 2010, EUR HEART J, V31, P2253, DOI 10.1093/eurheartj/ehq246; Dries Daniel L, 2010, Heart Fail Clin, V6, P55, DOI 10.1016/j.hfc.2009.08.007; Edner M, 2000, Eur J Echocardiogr, V1, P87, DOI 10.1053/euje.2000.0013; Fishbane S, 2009, AM J KIDNEY DIS, V54, P647, DOI 10.1053/j.ajkd.2009.04.036; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Ho CY, 2006, CIRCULATION, V113, pE396, DOI 10.1161/CIRCULATIONAHA.105.579268; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jenkins C, 2004, J AM COLL CARDIOL, V44, P878, DOI 10.1016/j.jacc.2004.05.050; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Krishnan AV, 2011, VITAMIN D AND CANCER, P53, DOI 10.1007/978-1-4419-7188-3_3; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Larsson A, 2004, SCAND J CLIN LAB INV, V64, P25, DOI 10.1080/00365510410003723; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Mark PB, 2006, NEPHROL DIAL TRANSPL, V21, P402, DOI 10.1093/ndt/gfi187; Meris A, 2009, EUR HEART J, V30, P56, DOI 10.1093/eurheartj/ehn499; Myerson SG, 2002, HYPERTENSION, V39, P750, DOI 10.1161/hy0302.104674; Palmieri V, 2001, AM J CARDIOL, V88, P1163, DOI 10.1016/S0002-9149(01)02054-9; Patel RK, 2010, AM J KIDNEY DIS, V55, P1088, DOI 10.1053/j.ajkd.2009.12.033; Perez A, 1996, BRIT J DERMATOL, V134, P1070, DOI 10.1111/j.1365-2133.1996.tb07945.x; Pritchett Y, 2011, CLIN TRIALS, V8, P165, DOI 10.1177/1740774511399128; Przybylski R, 2010, NUTR METAB CARDIOVAS, V20, P641, DOI 10.1016/j.numecd.2009.07.009; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Roger SD, 2004, J AM SOC NEPHROL, V15, P148, DOI 10.1097/01.ASN.0000102471.89084.8B; Shapses SA, 2011, JAMA-J AM MED ASSOC, V305, P2565, DOI 10.1001/jama.2011.881; Shoben AB, 2008, J AM SOC NEPHROL, V19, P1613, DOI 10.1681/ASN.2007111164; Simpson RU, 2007, J STEROID BIOCHEM, V103, P521, DOI 10.1016/j.jsbmb.2006.12.098; Solomon SD, 2009, CIRCULATION, V119, P530, DOI 10.1161/CIRCULATIONAHA.108.826214; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stewart GA, 2005, KIDNEY INT, V67, P217, DOI 10.1111/j.1523-1755.2005.00072.x; Stokes 3rd J, 1989, HYPERTENSION S1, V13, pI13; Takemoto Y, 2005, AM J CARDIOL, V96, P832, DOI 10.1016/j.amjcard.2005.05.031; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Thadhani R, 2008, LANCET, V371, P542, DOI 10.1016/S0140-6736(08)60251-2; Thadhani R, 2011, AM J NEPHROL, V33, P139, DOI 10.1159/000323551; Tishkoff DX, 2008, ENDOCRINOLOGY, V149, P558, DOI 10.1210/en.2007-0805; Tripepi G, 2006, J HYPERTENS, V24, P1173, DOI 10.1097/01.hjh.0000226208.11184.bb; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; Tsutamoto T, 2009, EUR J HEART FAIL, V11, P653, DOI 10.1093/eurjhf/hfp072; vanderGeest RJ, 1997, J COMPUT ASSIST TOMO, V21, P756, DOI 10.1097/00004728-199709000-00019; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wu JM, 1996, J CLIN INVEST, V97, P1577, DOI 10.1172/JCI118582; Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101; Zittermann A, 2009, CLIN CHEM, V55, P1163, DOI 10.1373/clinchem.2008.120006	62	402	423	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					674	684		10.1001/jama.2012.120	http://dx.doi.org/10.1001/jama.2012.120			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22337679				2022-12-28	WOS:000300278500024
J	Kirby, T				Kirby, Tony			Frederic Amant: leading the agenda on cancer in pregnancy	LANCET			English	Biographical-Item																			0	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 11	2012	379	9815					511	511		10.1016/S0140-6736(12)60220-7	http://dx.doi.org/10.1016/S0140-6736(12)60220-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22325650				2022-12-28	WOS:000300188800014
J	McCullough, M				McCullough, Melissa			The art of medicine Bringing drama into medical education	LANCET			English	Editorial Material									Queens Univ Belfast, Ctr Med Educ, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	McCullough, M (corresponding author), Queens Univ Belfast, Ctr Med Educ, Belfast BT9 7BL, Antrim, North Ireland.	m.mccullough@qub.ac.uk							0	20	20	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 11	2012	379	9815					512	513		10.1016/S0140-6736(12)60221-9	http://dx.doi.org/10.1016/S0140-6736(12)60221-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891AO	22334885	Bronze			2022-12-28	WOS:000300188800015
J	Chartrand, C; Leeflang, MMG; Minion, J; Brewer, T; Pai, M				Chartrand, Caroline; Leeflang, Mariska M. G.; Minion, Jessica; Brewer, Timothy; Pai, Madhukar			Accuracy of Rapid Influenza Diagnostic Tests A Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							DIRECTIGEN FLU-A+B; A H1N1 VIRUS; REVERSE TRANSCRIPTION-PCR; SHELL VIAL CULTURE; NEURAMINIDASE DETECTION ASSAY; RESPIRATORY SYNCYTIAL VIRUS; DIRECT FLUORESCENT ASSAY; BLOT ENZYME-IMMUNOASSAY; ANTIGEN TEST; B VIRUSES	Background: Timely diagnosis of influenza can help clinical management. Purpose: To examine the accuracy of rapid influenza diagnostic tests (RIDTs) in adults and children with influenza-like illness and evaluate factors associated with higher accuracy. Data Sources: PubMed and EMBASE through December 2011; BIOSIS and Web of Science through March 2010; and citations of articles, guidelines, reviews, and manufacturers. Study Selection: Studies that compared RIDTs with a reference standard of either reverse transcriptase polymerase chain reaction (first choice) or viral culture. Data Extraction: Reviewers abstracted study data by using a standardized form and assessed quality by using Quality Assessment of Diagnostic Accuracy Studies criteria. Data Synthesis: 159 studies evaluated 26 RIDTs, and 35% were conducted during the H1N1 pandemic. Failure to report whether results were assessed in a blinded manner and the basis for patient recruitment were important quality concerns. The pooled sensitivity and specificity were 62.3% (95% CI, 57.9% to 66.6%) and 98.2% (CI, 97.5% to 98.7%), respectively. The positive and negative likelihood ratios were 34.5 (CI, 23.8 to 45.2) and 0.38 (CI, 0.34 to 0.43), respectively. Sensitivity estimates were highly heterogeneous, which was partially explained by lower sensitivity in adults (53.9% [CI, 47.9% to 59.8%]) than in children (66.6% [CI, 61.6% to 71.7%]) and a higher sensitivity for influenza A (64.6% [CI, 59.0% to 70.1%) than for influenza B (52.2% [CI, 45.0% to 59.3%). Limitation: Incomplete reporting limited the ability to assess the effect of important factors, such as specimen type and duration of influenza symptoms, on diagnostic accuracy. Conclusion: Influenza can be ruled in but not ruled out through the use of RIDTs. Sensitivity varies across populations, but it is higher in children than in adults and for influenza A than for influenza B.	[Pai, Madhukar] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; Univ Montreal, CHU Sainte Justine, Montreal Chest Inst, Montreal, PQ, Canada; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Univ Alberta, Edmonton, AB, Canada	McGill University; McGill University; Universite de Montreal; University of Amsterdam; Academic Medical Center Amsterdam; University of Alberta	Pai, M (corresponding author), McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; Leeflang, Mariska/AAF-8199-2019; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; Leeflang, Mariska/0000-0001-5960-0471; PAL, MRINAL/0000-0002-1032-272X	Canadian Institutes of Health Research; Netherlands Organization for Scientific Research (NWO) [916.10.034]; Grand Challenges Canada and European and Developing Countries Clinical Trials Partnership	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Grand Challenges Canada and European and Developing Countries Clinical Trials Partnership	Canadian Institutes of Health Research.; The study was supported in part by the Canadian Institutes of Health Research. Dr. Pai is a recipient of a New Investigator Career Award from the Canadian Institutes of Health Research. He also receives research support from Grand Challenges Canada and European and Developing Countries Clinical Trials Partnership. Dr. Leeflang is supported by the Netherlands Organization for Scientific Research (NWO); project 916.10.034.	Abanses JC, 2006, PEDIATR EMERG CARE, V22, P145, DOI 10.1097/01.pec.0000202454.19237.b0; Agoritsas K, 2006, J CLIN MICROBIOL, V44, P2638, DOI 10.1128/JCM.02644-05; Al Johani S M, 2011, J Infect Public Health, V4, P7, DOI 10.1016/j.jiph.2010.10.004; Alexander R, 2005, COMMUN DIS INTELL, V29, P272; [Anonymous], 1999, MED LETT DRUGS THER, V41, P121; [Anonymous], 2005, WHO REC US RAP TEST; Arsene S, 2004, Roum Arch Microbiol Immunol, V63, P235; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Bellei N, 2003, J VIROL METHODS, V109, P85, DOI 10.1016/S0166-0934(03)00050-8; Bellmann-Weiler R, 2011, CLIN MICROBIOL INFEC, V17, P235, DOI 10.1111/j.1469-0691.2010.03235.x; Biggs C, 2010, EMERG MED J, V27, P5, DOI 10.1136/emj.2009.078683; Boivin G, 2004, J CLIN MICROBIOL, V42, P45, DOI 10.1128/JCM.42.1.45-51.2004; Boivin G, 2001, J CLIN MICROBIOL, V39, P730, DOI 10.1128/JCM.39.2.730-732.2001; Bonner AB, 2003, PEDIATRICS, V112, P363, DOI 10.1542/peds.112.2.363; Boon ACM, 2001, J MED VIROL, V65, P163, DOI 10.1002/jmv.2016; Booth S, 2006, J MED VIROL, V78, P619, DOI 10.1002/jmv.20584; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Cazacu AC, 2004, J CLIN MICROBIOL, V42, P3707, DOI 10.1128/jcm.42.8.3707-3710.2004; Cazacu AC, 2004, J CLIN MICROBIOL, V42, P3661, DOI [10.1128/JCM.42.8.3661-3664.2004, 10.1128/jcm.42.8.3661-3664.2004]; Cazacu AC, 2003, J CLIN MICROBIOL, V41, P2132, DOI 10.1128/JCM.41.5.2132-2134.2003; Centers for Disease Control and Prevention, GUID CLIN US RAP INF; Centers for Disease Control and Prevention, 2006, US INFL SENT PROV SU; Chan KH, 2002, J CLIN MICROBIOL, V40, P1675, DOI 10.1128/JCM.40.5.1675-1680.2002; Chen M, 2010, LABMEDICINE, V41, P731, DOI 10.1309/LM1SH48AEBLVMJUQ; Chen YX, 2010, J VIROL METHODS, V167, P100, DOI 10.1016/j.jviromet.2010.02.001; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Cheng XD, 2011, J CLIN VIROL, V50, P153, DOI 10.1016/j.jcv.2010.10.002; Choi WS, 2011, YONSEI MED J, V52, P683, DOI 10.3349/ymj.2011.52.4.683; Choi YJ, 2010, J MICROBIOL BIOTECHN, V20, P1450, DOI 10.4014/jmb.1004.04039; Choi YJ, 2010, J CLIN MICROBIOL, V48, P2260, DOI 10.1128/JCM.02392-09; Church DL, 2002, CLIN INFECT DIS, V34, P790, DOI 10.1086/338960; Cohen R, 2007, ARCH PEDIATRIE, V14, P926, DOI 10.1016/j.arcped.2007.02.087; Covalciuc KA, 1999, J CLIN MICROBIOL, V37, P3971, DOI 10.1128/JCM.37.12.3971-3974.1999; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; Cruz AT, 2008, J CLIN VIROL, V41, P143, DOI 10.1016/j.jcv.2007.11.006; Cruz AT, 2010, PEDIATRICS, V125, pE645, DOI 10.1542/peds.2009-3060; Cruz AT, 2006, ANN EMERG MED, V47, P250, DOI 10.1016/j.annemergmed.2005.10.019; Dale SE, 2008, J CLIN MICROBIOL, V46, P3804, DOI 10.1128/JCM.01779-08; De Witte E, 2011, EUR J CLIN MICROBIOL; Diederen BMW, 2010, EMERG INFECT DIS, V16, P897, DOI 10.3201/eid1605.091574; DOMINGUEZ EA, 1993, J CLIN MICROBIOL, V31, P2286, DOI 10.1128/JCM.31.9.2286-2290.1993; Drinka PJ, 2006, J AM MED DIR ASSOC, V7, P37, DOI 10.1016/j.jamda.2005.05.011; Dunn JJ, 2003, J CLIN MICROBIOL, V41, P2180, DOI 10.1128/JCM.41.5.2180-2183.2003; Effler PV, 2002, EMERG INFECT DIS, V8, P23, DOI 10.3201/eid0801.010067; Esposito S, 2003, ARCH DIS CHILD, V88, P525, DOI 10.1136/adc.88.6.525; Fader RC, 2005, J CLIN MICROBIOL, V43, P6133, DOI 10.1128/JCM.43.12.6133-6135.2005; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Fernandez C, 2010, POSTGRAD MED, V122, P28, DOI 10.3810/pgm.2010.01.2096; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Foo H, 2009, J CLIN VIROL, V46, P384, DOI 10.1016/j.jcv.2009.09.019; Fuenzalida L, 2010, CLIN MICROBIOL INFEC, V16, P1574, DOI [10.1111/j.1469-0691.2009.03160.x, 10.1111/j.1469-0691.2010.03160.x]; Ganzenmueller T, 2010, J MED MICROBIOL, V59, P713, DOI 10.1099/jmm.0.017244-0; Gao F, 2011, INFLUENZA OTHER RESP; Gavin P.J., 2004, CLIN APPL IMMUNOL RE, V4, P151, DOI DOI 10.1016/S1529-1049(03)00064-3; Ghebremedhin B, 2009, J MED MICROBIOL, V58, P365, DOI 10.1099/jmm.0.004358-0; Gimeno C, 2010, DIAGN MICR INFEC DIS, V68, P456, DOI 10.1016/j.diagmicrobio.2010.07.010; Gooskens J, 2008, J CLIN VIROL, V41, P7, DOI 10.1016/j.jcv.2007.10.023; Gordon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010364; Gordon A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007907; Grijalva CG, 2007, PEDIATRICS, V119, pE6, DOI 10.1542/peds.2006-1694; Grondahl B, 2005, CLIN MICROBIOL INFEC, V11, P848, DOI 10.1111/j.1469-0691.2005.01223.x; Hamilton MS, 2002, J CLIN MICROBIOL, V40, P2331, DOI 10.1128/JCM.40.7.2331-2334.2002; Hara M, 2008, LABMEDICINE, V39, P603, DOI 10.1309/LM6ONMGY7K9ETMGF; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Harnden A, 2003, BRIT MED J, V326, P480, DOI 10.1136/bmj.326.7387.480; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Hawkes M, 2010, PEDIATRICS, V125, pE639, DOI 10.1542/peds.2009-2669; Heikkinen T, 2002, J CLIN MICROBIOL, V40, P4337, DOI 10.1128/JCM.40.11.4337-4339.2002; Heinonen S, 2011, EUR J CLIN MICROBIOL, V30, P387, DOI 10.1007/s10096-010-1098-5; Herrmann B, 2001, J CLIN MICROBIOL, V39, P134, DOI 10.1128/JCM.39.1.134-138.2001; Hindiyeh M, 2000, J CLIN VIROL, V17, P119, DOI 10.1016/S1386-6532(00)00081-0; Hulson TD, 2001, J FAM PRACTICE, V50, P1051; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; JOHNSTON SLG, 1993, J CLIN MICROBIOL, V31, P142, DOI 10.1128/JCM.31.1.142-143.1993; Karre T, 2010, J CLIN MICROBIOL, V48, P343, DOI 10.1128/JCM.02063-09; Keitel K, 2011, EUR J PEDIATR, V170, P511, DOI 10.1007/s00431-010-1326-0; Kim YK, 2010, J CLIN VIROL, V49, P69, DOI 10.1016/j.jcv.2010.06.012; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Landry ML, 2008, J CLIN VIROL, V43, P148, DOI 10.1016/j.jcv.2008.06.006; Lee GC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-244; Lee HM, 2011, SCAND J INFECT DIS, V43, P43, DOI 10.3109/00365548.2010.508463; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Leonardi GP, 2010, J CLIN MICROBIOL, V48, P1189, DOI 10.1128/JCM.01657-09; LEONARDI GP, 1994, J CLIN MICROBIOL, V32, P70, DOI 10.1128/JCM.32.1.70-74.1994; Liao RS, 2009, J CLIN MICROBIOL, V47, P527, DOI 10.1128/JCM.01213-08; Likitnukul S, 2009, PEDIATR INFECT DIS J, V28, P1038, DOI 10.1097/INF.0b013e3181c176e3; Louie JK, 2010, EMERG INFECT DIS, V16, P824, DOI [10.3201/eid1605.091794, 10.3201/eid1605.091797]; Lucas PM, 2011, CLIN INFECT DIS, V52, pS116, DOI 10.1093/cid/ciq027; Marcante R, 1996, MICROBIOLOGICA, V19, P141; Nogueira JM, 2011, INFLUENZA OTHER RESP, V5, P146, DOI 10.1111/j.1750-2659.2010.00194.x; Mizuike R, 2011, CLIN VACCINE IMMUNOL, V18, P494, DOI 10.1128/CVI.00269-10; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Monto AS, 2004, CLIN INFECT DIS, V39, P459, DOI 10.1086/422646; Newton DW, 2002, J CLIN MICROBIOL, V40, P4353, DOI 10.1128/JCM.40.11.4353-4356.2002; Nilsson AC, 2008, INFECT CONT HOSP EP, V29, P177, DOI 10.1086/526446; Noel G, 2011, ARCH PEDIAT; Nougairede A, 2010, CLIN MICROBIOL INFEC, V16, P322, DOI 10.1111/j.1469-0691.2010.03168.x; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009215; Noyola DE, 2000, J CLIN MICROBIOL, V38, P1161, DOI 10.1128/JCM.38.3.1161-1165.2000; Noyola DE, 2000, PEDIATR DEVEL PATHOL, V3, P162, DOI 10.1007/s100240050020; de la Tabla VO, 2010, CLIN MICROBIOL INFEC, V16, P1358, DOI 10.1111/j.1469-0691.2010.03159.x; Pai MMM, 2004, EVID BASED MED, V141, pA11, DOI DOI 10.1136/EBM.9.4.101; Petrozzino JJ, 2010, J EMERG MED, V39, P476, DOI 10.1016/j.jemermed.2009.11.031; Pierron S, 2008, ARCH PEDIATRIE, V15, P1283, DOI 10.1016/j.arcped.2008.04.035; Poehling KA, 2006, ARCH PEDIAT ADOL MED, V160, P713, DOI 10.1001/archpedi.160.7.713; Poehling KA, 2002, PEDIATRICS, V110, P83, DOI 10.1542/peds.110.1.83; Poeppl W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028089; Pongthanapisith V, 2011, INFECTION, V39, P105, DOI 10.1007/s15010-011-0092-x; Pregliasco F, 2004, J MED VIROL, V73, P269, DOI 10.1002/jmv.20086; Quach C, 2002, CLIN DIAGN LAB IMMUN, V9, P925, DOI 10.1128/CDLI.9.4.925-926.2002; Rahman M, 2008, DIAGN MICR INFEC DIS, V62, P162, DOI 10.1016/j.diagmicrobio.2007.10.012; Rahman M, 2007, DIAGN MICR INFEC DIS, V58, P413, DOI 10.1016/j.diagmicrobio.2007.03.011; Rashid Harunor, 2007, Travel Med Infect Dis, V5, P310, DOI 10.1016/j.tmaid.2007.07.006; Rawlinson WD, 2004, J MED VIROL, V74, P127, DOI 10.1002/jmv.20155; Reina J, 2002, J CLIN MICROBIOL, V40, P3515, DOI 10.1128/JCM.40.9.3515-3517.2002; Reina J, 1996, DIAGN MICR INFEC DIS, V25, P143, DOI 10.1016/S0732-8893(96)00131-9; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rodriguez WJ, 2002, PEDIATR INFECT DIS J, V21, P193, DOI 10.1097/00006454-200203000-00006; Rouleau I, 2009, J CLIN MICROBIOL, V47, P2699, DOI 10.1128/JCM.00762-09; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sambol AR, 2010, J CLIN VIROL, V47, P229, DOI 10.1016/j.jcv.2009.12.015; Sandora TJ, 2010, PEDIATR INFECT DIS J, V29, P261, DOI 10.1097/INF.0b013e3181be9f9c; Scansen KA, 2010, J CLIN MICROBIOL, V48, P852, DOI 10.1128/JCM.01897-09; Schultze D, 2001, EUR J CLIN MICROBIOL, V20, P280, DOI 10.1007/s100960100475; Sharma V, 2002, ARCH PEDIAT ADOL MED, V156, P41, DOI 10.1001/archpedi.156.1.41; Simmerman JM, 2007, INT J INFECT DIS, V11, P166, DOI 10.1016/j.ijid.2006.01.005; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Smit M, 2007, DIAGN MICR INFEC DIS, V57, P67, DOI 10.1016/j.diagmicrobio.2006.11.003; Stebbins S, 2011, INFLUENZA OTHER RESP, V5, P104, DOI 10.1111/j.1750-2659.2010.00171.x; Steed L L, 1994, Clin Diagn Virol, V2, P261, DOI 10.1016/0928-0197(94)90050-7; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Stripeli F, 2010, EUR J CLIN MICROBIOL, V29, P683, DOI 10.1007/s10096-010-0914-2; Sung RYT, 2008, J CLIN MICROBIOL, V46, P3073, DOI 10.1128/JCM.01209-08; Suntarattiwong P, 2010, PEDIATR INFECT DIS J, V29, P366, DOI 10.1097/INF.0b013e3181c6f05c; Talbot HK, 2010, INFECT CONT HOSP EP, V31, P683, DOI 10.1086/653202; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; Velasco JMS, 2010, J CLIN VIROL, V48, P120, DOI 10.1016/j.jcv.2010.03.010; WANER JL, 1991, J CLIN MICROBIOL, V29, P479, DOI 10.1128/JCM.29.3.479-482.1991; Watcharananan S, 2010, J INFECTION, V60, P86, DOI 10.1016/j.jinf.2009.10.049; Weinberg A, 2005, J CLIN VIROL, V33, P172, DOI 10.1016/j.jcv.2004.12.013; Weitzel T, 2007, CLIN MICROBIOL INFEC, V13, P665, DOI 10.1111/j.1469-0691.2007.01739.x; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WHO, 2009, INFL SEAS; World Health Organization, 2010, PAND H1N1 2009 UPD 1; World Health Organization, 1999, WHO REC SURV STAND; Yoo Y, 2007, CLIN VACCINE IMMUNOL, V14, P1050, DOI 10.1128/CVI.00465-06; Zetti Z R, 2010, Med J Malaysia, V65, P27	154	312	330	4	58	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					500	U80		10.7326/0003-4819-156-7-201204030-00403	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00403			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921GP	22371850				2022-12-28	WOS:000302466400004
J	Baker, MG; Barnard, LT; Kvalsvig, A; Verrall, A; Zhang, J; Keall, M; Wilson, N; Wall, T; Howden-Chapman, P				Baker, Michael G.; Barnard, Lucy Telfar; Kvalsvig, Amanda; Verrall, Ayesha; Zhang, Jane; Keall, Michael; Wilson, Nick; Wall, Teresa; Howden-Chapman, Philippa			Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study	LANCET			English	Article							ACUTE RHEUMATIC-FEVER; UNITED-STATES; DEVELOPED COUNTRY; TRENDS; HOSPITALIZATIONS; CAMPYLOBACTERIOSIS; DEPRIVATION; POPULATION; MORTALITY; CHILDREN	Background Although the burden of infectious diseases seems to be decreasing in developed countries, few national studies have measured the total incidence of these diseases. We aimed to develop and apply a robust systematic method for monitoring the epidemiology of serious infectious diseases. Methods We did a national epidemiological study with all hospital admissions for infectious and non-infectious diseases in New Zealand from 1989 to 2008, to investigate trends in incidence and distribution by ethnic group and socioeconomic status. We extended a recoding system based on the ninth revision of international classification of diseases (ICD-9) to the tenth revision (ICD-10), and applied this to data for hospital admissions from the New Zealand Ministry of Health, National Minimum Dataset. We filtered results to account for changes in health-care practices over time. Acute overnight admissions were the events of interest. Findings Infectious diseases made the largest contribution to hospital admissions of any cause. Their contribution increased from 20.5% of acute admissions in 1989-93, to 26.6% in 2004-08. We noted clear ethnic and social inequalities in infectious disease risk. In 2004-08, the age-standardised rate ratio was 2.15 (95% CI 2.14-2.16) for Maori (indigenous New Zealanders) and 2.35 (2.34-2.37) for Pacific peoples compared with the European and other group. The ratio was 2.81 (2.80-2.83) for the most socioeconomically deprived quintile compared with the least deprived quintile. These inequalities have increased substantially in the past 20 years, particularly for Maori and Pacific peoples in the most deprived quintile. Interpretation These findings support the need for stronger prevention efforts for infectious diseases, and reinforce the need to reduce ethnic and social inequalities and to address disparities in broad social determinants such as income levels, housing conditions, and access to health services. Our method could be adapted for infectious disease surveillance in other countries.	[Baker, Michael G.; Barnard, Lucy Telfar; Kvalsvig, Amanda; Verrall, Ayesha; Zhang, Jane; Keall, Michael; Wilson, Nick; Howden-Chapman, Philippa] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Wall, Teresa] Minist Hlth, Maori Hlth Directorate, Wellington, New Zealand	University of Otago	Baker, MG (corresponding author), Univ Otago, Dept Publ Hlth, POB 7343, Wellington 6242, New Zealand.	michael.baker@otago.ac.nz	Barnard-Brak, Lucy/K-2009-2019; Verrall, Ayesha/U-7223-2019; Barnard-Brak, Lucy/T-6856-2018	Verrall, Ayesha/0000-0001-9672-1352; Barnard-Brak, Lucy/0000-0001-7239-0720	New Zealand Ministry of Health; New Zealand Health Research Council	New Zealand Ministry of Health; New Zealand Health Research Council(Health Research Council of New Zealand)	New Zealand Ministry of Health, New Zealand Health Research Council.	[Anonymous], 2004, ETHN DAT PROT HLTH D; Armstrong GL, 1999, ARCH INTERN MED, V159, P2531, DOI 10.1001/archinte.159.21.2531; Baker M, 2000, PEDIATR INFECT DIS J, V19, P983, DOI 10.1097/00006454-200010000-00009; Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610; Baker M, 2012, DISTRIBUTION HOUSEHO; Baker MG, 2007, EPIDEMIOL INFECT, V135, P163, DOI 10.1017/S0950268806006583; Baker MG, 2009, EUROSURVEILLANCE, V14, P6; Baker MG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-332; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Christensen KLY, 2009, CLIN INFECT DIS, V49, P1025, DOI 10.1086/605562; Ford AC, 2006, COCHRANE DB SYST REV, V19; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; Grant CC, 1999, NEW ZEAL MED J, V112, P345; Harris R, 2007, HAUORA MAORI STANDAR, P249; Holman RC, 2001, AM J PUBLIC HEALTH, V91, P425, DOI 10.2105/AJPH.91.3.425; Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x; Jaine R, 2011, PEDIATR INFECT DIS J, V30, P315, DOI 10.1097/INF.0b013e3181fbd85b; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Langley J, 2002, INJ PREV, V8, P332, DOI 10.1136/ip.8.4.332; Mills CF, 2002, NEW ZEAL MED J, V115, P254; *MIN HLTH, 2001, INT APPR INF DIS PRI; Ministry of Health, 2008, PRES ETHN COMP PRIOR; O'Hallahan J, 2009, NEW ZEAL MED J, V122, P48; O'Sullivan CE, 2010, EPIDEMIOL INFECT, V15, P1; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perry B., 2010, HOUSEHOLD INCOMES NZ; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Salmond C, 1998, AUST NZ J PUBL HEAL, V22, P835, DOI 10.1111/j.1467-842X.1998.tb01505.x; Sears A, 2011, EMERG INFECT DIS, V17, P1007, DOI [10.3201/eid/1706.101272, 10.3201/eid1706.101272]; Simonsen L, 1998, ARCH INTERN MED, V158, P1923, DOI 10.1001/archinte.158.17.1923; Statistics New Zealand, 2003, WHAT IS EXT CROWD NZ; Tobias M, 2008, AUST NZ J PUBL HEAL, V32, P431, DOI 10.1111/j.1753-6405.2008.00275.x	35	175	177	5	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 24	2012	379	9821					1112	1119		10.1016/S0140-6736(11)61780-7	http://dx.doi.org/10.1016/S0140-6736(11)61780-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916VR	22353263				2022-12-28	WOS:000302131800033
J	Thiele, H; Wohrle, J; Hambrecht, R; Rittger, H; Birkemeyer, R; Lauer, B; Neuhaus, P; Brosteanu, O; Sick, P; Wiemer, M; Kerber, S; Kleinertz, K; Eitel, I; Desch, S; Schuler, G				Thiele, Holger; Woehrle, Jochen; Hambrecht, Rainer; Rittger, Harald; Birkemeyer, Ralf; Lauer, Bernward; Neuhaus, Petra; Brosteanu, Oana; Sick, Peter; Wiemer, Marcus; Kerber, Sebastian; Kleinertz, Klaus; Eitel, Ingo; Desch, Steffen; Schuler, Gerhard			Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial	LANCET			English	Article							LEFT-VENTRICULAR FUNCTION; PRIMARY ANGIOPLASTY; DOUBLE-BLIND; RECOVERY; REVASCULARIZATION; MULTICENTER; CLOPIDOGREL; PROFILE; DESIGN	Background Intracoronary administration of an abciximab bolus during a primary percutaneous coronary intervention results in a high local drug concentration, improved perfusion, and reduction of infarct size compared with intravenous bolus application. However, the safety and efficacy of intracoronary versus standard intravenous bolus application in patients with ST-elevation myocardial infarction (STEMI) undergoing this intervention has not been tested in a large-scale clinical trial. Methods The AIDA STEMI trial was a randomised, open-label, multicentre trial. Patients presenting with STEMI in the previous 12 h with no contraindications for abciximab were randomly assigned in a 1: 1 ratio by a central web-based randomisation system to intracoronary versus intravenous abciximab bolus (0.25 mg/kg bodyweight) during percutaneous coronary intervention with a subsequent 12 h intravenous infusion 0.125 mu g/kg per min (maximum 10 mu g/min). The primary endpoint was a composite of all-cause mortality, recurrent infarction, or new congestive heart failure within 90 days of randomisation. Secondary endpoints were the time to occurrence of the primary endpoint, each individual component of that endpoint, early ST-segment resolution, thrombolysis in myocardial infarction (TIMI) flow grade, and enzymatic infarct size. A masked central committee adjudicated the primary outcome and its components. Treatment allo cation was not concealed from patients and investigators. This trial is registered with ClinicalTrials.gov, NCT00712101. Findings Between July, 2008, and April, 2011, 2065 patients were randomly assigned intracoronary abciximab (n=1032) or intravenous abciximab (n=1033). Intracoronary, as compared with intravenous abciximab, resulted in a similar rate of the primary composite clinical endpoint at 90 days in 1876 analysable patients (7.0% vs 7.6%; odds ratio [OR] 0.91; 95% CI 0.64-1.28; p=0.58). The incidence of death (4.5% vs 3.6%; 1.24; 0.78-1.97; p=0.36) and reinfarction (1.8% vs 1.8%; 1.0; 0.51-1.96; p=0.99) did not differ between the treatment groups, whereas less patients in the intracoronary group had new congestive heart failure (2.4% vs 4.1%; 0.57; 0.33-0.97; p=0.04). None of the secondary endpoints or safety measures differed significantly between groups. Interpretation In patients with STEMI undergoing primary percutaneous coronary intervention, intracoronary as compared to intravenous abciximab did not result in a difference in the combined endpoint of death, reinfarction, or congestive heart failure. Since intracoronary abciximab bolus administration is safe and might be related to reduced rates of congestive heart failure the intracoronary route might be preferred if abciximab is indicated.	[Thiele, Holger; Eitel, Ingo; Desch, Steffen; Schuler, Gerhard] Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany; [Woehrle, Jochen] Univ Ulm, Dept Internal Med Cardiol, Ulm, Germany; [Hambrecht, Rainer] Klinikum Links der Weser, Bremen, Germany; [Rittger, Harald] Klinikum Coburg, Coburg, Germany; [Birkemeyer, Ralf] Schwarzwald Baar Klinikum Villingen Schwenningen, Villingen Schwenningen, Germany; [Lauer, Bernward] Zentralklin Bad Berka, Bad Berka, Germany; [Neuhaus, Petra; Brosteanu, Oana] Univ Leipzig, Clin Trial Ctr, D-04289 Leipzig, Germany; [Sick, Peter] Krankenhaus Barmherzigen Bruder, Regensburg, Germany; [Wiemer, Marcus] Herz & Diabet Zentrum Nordrhein Westfalen, Bad Oeynhausen, Germany; [Kerber, Sebastian] Herz & Gefass Klin, Bad Neustadt an der Saale, Germany; [Kleinertz, Klaus] Ambulantes Herzzentrum Chemnitz, Chemnitz, Germany	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Klinikum Coburg; Zentralklinik Bad Berka; Leipzig University; Ruhr University Bochum	Thiele, H (corresponding author), Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany.	thielh@medizin.uni-leipzig.de	Thiele, Holger/ABE-6792-2020	Thiele, Holger/0000-0002-0169-998X	Lilly; Daiichi Sankyo; AstraZeneca; Boehringer Ingelheim; Medicines Company; Lilly, Germany; University of Leipzig-Heart Centre; University of Leipzig, Clinical Trial Centre Leipzig; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [FKZ 01KN1102]	Lilly(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Medicines Company; Lilly, Germany(Eli Lilly); University of Leipzig-Heart Centre; University of Leipzig, Clinical Trial Centre Leipzig; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF))	HT has received an unrestricted grant from Lilly; and speaker's fees from Lilly, Daiichi Sankyo, AstraZeneca, Boehringer Ingelheim, and the Medicines Company. JW and RB have received speaker's fees from Lilly. All other authors declare that they have no conflicts of interest.; This study was funded by Lilly, Germany, University of Leipzig-Heart Centre, and University of Leipzig, Clinical Trial Centre Leipzig, which is supported by the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) FKZ 01KN1102. We thank the patients who agreed to participate in this trial, the study contributors, and the investigators who recruited patients.	[Anonymous], 1989, NEW ENGL J MED, V320, P618; Bellandi F, 2004, CATHETER CARDIO INTE, V62, P186, DOI 10.1002/ccd.20041; Bertrand OF, 2010, AM J CARDIOL, V105, P1520, DOI 10.1016/j.amjcard.2010.01.006; De Luca G, 2009, EUR HEART J, V30, P2705, DOI 10.1093/eurheartj/ehp118; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Deibele AJ, 2010, CIRCULATION, V121, P784, DOI 10.1161/CIRCULATIONAHA.109.882746; Desch S, 2012, CLIN RES CARDIOL, V101, P117, DOI 10.1007/s00392-011-0372-6; Dominguez-Rodriguez A, 2009, ATHEROSCLEROSIS, V206, P523, DOI 10.1016/j.atherosclerosis.2009.03.011; Fox KAA, 2010, EUR HEART J, V31, P667, DOI 10.1093/eurheartj/ehp499; Gibson CM, 2011, AM HEART J, V161, P478, DOI 10.1016/j.ahj.2010.10.006; Gu YL, 2010, CIRCULATION, V122, P2709, DOI 10.1161/CIRCULATIONAHA.110.002741; Iversen A, 2011, J INTERV CARDIOL, V24, P105, DOI 10.1111/j.1540-8183.2010.00616.x; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Marciniak SJ, 2002, THROMB HAEMOSTASIS, V87, P1020; Mascelli MA, 1998, CIRCULATION, V97, P1680, DOI 10.1161/01.CIR.97.17.1680; Mehilli J, 2009, CIRCULATION, V119, P1933, DOI 10.1161/CIRCULATIONAHA.108.818617; Navarese EP, 2012, PLATELETS, V23, P274, DOI 10.3109/09537104.2011.619602; Neumann FJ, 1998, CIRCULATION, V98, P2695, DOI 10.1161/01.CIR.98.24.2695; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; POCOCK SJ, 1985, BMJ-BRIT MED J, V290, P39, DOI 10.1136/bmj.290.6461.39; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Sadandan S, RESULTS CRYSTAL AMI; Schroder R, 2004, CIRCULATION, V110, pE506, DOI 10.1161/01.CIR.0000147778.05979.E6; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Thiele H, 2008, CIRCULATION, V118, P49, DOI 10.1161/CIRCULATIONAHA.107.747642; Thiele H, 2010, AM HEART J, V159, P547, DOI 10.1016/j.ahj.2009.12.038; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	30	168	178	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	2012	379	9819					923	931		10.1016/S0140-6736(11)61872-2	http://dx.doi.org/10.1016/S0140-6736(11)61872-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	906NY	22357109				2022-12-28	WOS:000301353700032
J	Peiris, JSM; Poon, LLM; Guan, Y				Peiris, J. S. M.; Poon, L. L. M.; Guan, Y.			Surveillance of Animal Influenza for Pandemic Preparedness	SCIENCE			English	Editorial Material							A VIRUS; H1N1 INFLUENZA; UNITED-STATES; HONG-KONG; RECEPTOR SPECIFICITY; SWINE; TRANSMISSIBILITY; REASSORTMENT; EMERGENCE; EVOLUTION		[Peiris, J. S. M.; Poon, L. L. M.; Guan, Y.] Li Ka Shing Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Peiris, JSM (corresponding author), Li Ka Shing Fac Med, Sch Publ Hlth, Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	malik@hku.hk	Poon, Leo Lit Man/C-4382-2009; Poon, Leo/AAP-6887-2020	Poon, Leo Lit Man/0000-0002-9101-7953; Guan, Yi/0000-0001-6057-9243	PHS HHS [HHSN266200700005C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], PIP FRAMEWORK; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Capua I, 2010, EMERG INFECT DIS, V16, P719, DOI 10.3201/eid1604.091593; Chan RWY, 2011, J VIROL, V85, P11581, DOI 10.1128/JVI.05662-11; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI 10.3201/eid1709.110338; Enserink M, 2012, SCIENCE, V335, P20, DOI 10.1126/science.335.6064.20; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Lau EHY, 2007, EMERG INFECT DIS, V13, P1340, DOI 10.3201/eid1309.061549; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; National Center for Biotechnology Information (NIH), NAT CTR BIOT INF NIH; Nulluswami K., 2011, MMWR-MORBID MORTAL W, V60, P1; OECD, 2006, INN PHARM BIOT COMP; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; van Doremalen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025755; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; World Health Organization, 2011, ANT GEN CHAR INFL A; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108	28	34	34	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1173	1174		10.1126/science.1219936	http://dx.doi.org/10.1126/science.1219936			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22345402				2022-12-28	WOS:000301225100026
J	Huang, YWA; Ruiz, CR; Eyler, ECH; Lin, K; Meffert, MK				Huang, Yu-Wen A.; Ruiz, Claudia R.; Eyler, Elizabeth C. H.; Lin, Kathie; Meffert, Mollie K.			Dual Regulation of miRNA Biogenesis Generates Target Specificity in Neurotrophin-Induced Protein Synthesis	CELL			English	Article							MESSENGER-RNAS; TRANSLATION; EXPRESSION; MICRORNAS; INITIATION; LIN-28	Control of translation is a fundamental source of regulation in gene expression. The induction of protein synthesis by brain-derived neurotrophic factor (BDNF) critically contributes to enduring modifications of synaptic function, but how BDNF selectively affects only a minority of expressed mRNAs is poorly understood. We report that BDNF rapidly elevates Dicer, increasing mature miRNA levels and inducing RNA processing bodies in neurons. BDNF also rapidly induces Lin28, causing selective loss of Lin28-regulated miRNAs and a corresponding upregulation in translation of their target mRNAs. Binding sites for Lin28-regulated miRNAs are necessary and sufficient to confer BDNF responsiveness to a transcript. Lin28 deficiency, or expression of a Lin28-resistant Let-7 precursor miRNA, inhibits BDNF translation specificity and BDNF-dependent dendrite arborization. Our data establish that specificity in BDNF-regulated translation depends upon a two-part posttranscriptional control of miRNA biogenesis that generally enhances mRNA repression in association with GW182 while selectively derepressing and increasing translation of specific mRNAs.	[Huang, Yu-Wen A.; Ruiz, Claudia R.; Meffert, Mollie K.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Eyler, Elizabeth C. H.; Lin, Kathie; Meffert, Mollie K.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Meffert, MK (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	mkm@jhmi.edu			Braude Foundation, Johns Hopkins Brain Science Institute; Taiwan's National Science Council [TMS-094-2-A-030]; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080740] Funding Source: NIH RePORTER	Braude Foundation, Johns Hopkins Brain Science Institute; Taiwan's National Science Council; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Fritzler, J. Mendell, G. Hannon, and M. Caterina for generously sharing reagents and equipment. We thank J. Pomerantz and G. Seydoux for critical reading of the manuscript and scientific suggestions, and R. Green, D. Ginty, and A. Kolodkin for helpful discussions. This work was supported by the Braude Foundation, Johns Hopkins Brain Science Institute (to M. K. M.) and Research Grant TMS-094-2-A-030 from Taiwan's National Science Council (to Y.-W.A.H.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Takei N, 2009, J BIOL CHEM, V284, P26340, DOI 10.1074/jbc.M109.023010; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	40	92	95	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					933	946		10.1016/j.cell.2012.01.036	http://dx.doi.org/10.1016/j.cell.2012.01.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385959	Green Accepted, Bronze			2022-12-28	WOS:000300985000014
J	Pfingsten, JS; Goodrich, KJ; Taabazuing, C; Ouenzar, F; Chartrand, P; Cech, TR				Pfingsten, Jennifer S.; Goodrich, Karen J.; Taabazuing, Cornelius; Ouenzar, Faissal; Chartrand, Pascal; Cech, Thomas R.			Mutually Exclusive Binding of Telomerase RNA and DNA by Ku Alters Telomerase Recruitment Model	CELL			English	Article							DOUBLE-STRAND BREAKS; DOMAIN PROTEIN MPS3; SACCHAROMYCES-CEREVISIAE; YEAST TELOMERASE; CATALYTIC SUBUNIT; REPAIR PATHWAY; BUDDING YEAST; IN-VITRO; END; HETERODIMER	In Saccharomyces cerevisiae, the Ku heterodimer contributes to telomere maintenance as acomponent of telomeric chromatin and as an accessory subunit of telomerase. How Ku binding to double-stranded DNA (dsDNA) and to telomerase RNA (TLC1) promotes Ku's telomeric functions is incompletely understood. We demonstrate that deletions designed to constrict the DNA-binding ring of Ku80 disrupt nonhomologous end-joining (NHEJ), telomeric gene silencing, and telomere length maintenance, suggesting that these functions require Ku's DNA end-binding activity. Contrary to the current model, a mutant Ku with low affinity for dsDNA also loses affinity for TLC1 both in vitro and in vivo. Competition experiments reveal that wild-type Ku binds dsDNA and TLC1 mutually exclusively. Cells expressing the mutant Ku are deficient in nuclear accumulation of TLC1, as expected from the RNA-binding defect. These findings force reconsideration of the mechanisms by which Ku assists in recruiting telomerase to natural telomeres and broken chromosome ends.	[Pfingsten, Jennifer S.; Goodrich, Karen J.; Taabazuing, Cornelius; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, Biofrontiers Inst, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Ouenzar, Faissal; Chartrand, Pascal] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Universite de Montreal	Cech, TR (corresponding author), Univ Colorado, Dept Chem & Biochem, Biofrontiers Inst, Howard Hughes Med Inst, Campus Box 215, Boulder, CO 80309 USA.	thomas.cech@colorado.edu	Ouenzar, Faissal/AAF-4332-2020	Chartrand, Pascal/0000-0002-3006-7279; Taabazuing, Cornelius/0000-0003-2361-5457	Canadian Institutes of Health Research [MOP89768]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Alison Bertuch (Baylor College of Medicine) and Vicki Lundblad (Salk Institute) for generous gifts of yeast strains, Dan Gottschling (Fred Hutchinson Cancer Center) for providing plasmids and discussion, and Titia de Lange (Rockefeller University) for helpful ideas. We thank David B. McKay and Robert Batey (both University of Colorado-Boulder) for assisting in the computational analysis of the competition data and Jacob Schwartz for help with the analysis of real-time RT-PCR data. We also thank Robert Batey, Jeffrey Kieft, Jaya-krishnan Nandakumar, Jacob Schwartz, and Andrea Berman for comments on the manuscript. C. T. was an EXROP student of the Howard Hughes Medical Institute. This work was funded in part by Canadian Institutes of Health Research grant MOP89768 to P. C. J.S.P. and T. R. C. designed the experiments and wrote the paper with input from all authors. J.S.P. performed in vivo-based plating assays and northern blots, purified yeast Ku, and executed all in vitro-based assays. K.J.G. carried out Southern blots, northern Blots, westerns, plating assays, and quantitative RT-PCR. C. T. performed initial plating and Southern and northern experiments. F.O. and P. C. designed and performed cytolocalization of TLC1.	Antoniacci LM, 2007, CELL CYCLE, V6, P75, DOI 10.4161/cc.6.1.3647; Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003; Bianchi A, 1999, J BIOL CHEM, V274, P21223, DOI 10.1074/jbc.274.30.21223; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Bullock SL, 2010, NAT STRUCT MOL BIOL, V17, P703, DOI 10.1038/nsmb.1813; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Chan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000236; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gallardo F, 2008, EMBO J, V27, P748, DOI 10.1038/emboj.2008.21; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lopez CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002233; Ma YM, 2001, BIOCHEMISTRY-US, V40, P9638, DOI 10.1021/bi010932v; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Mozdy AD, 2008, MOL CELL BIOL, V28, P4152, DOI 10.1128/MCB.00512-08; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Pennaneach V, 2006, MOL MICROBIOL, V59, P1357, DOI 10.1111/j.1365-2958.2006.05026.x; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Qi HY, 2000, GENE DEV, V14, P1777; Reiter NJ, 2008, NUCLEIC ACIDS RES, V36, P1227, DOI 10.1093/nar/gkm1141; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Riha K, 2006, ANNU REV GENET, V40, P237, DOI 10.1146/annurev.genet.39.110304.095755; Roberts SA, 2007, J BIOL CHEM, V282, P10605, DOI 10.1074/jbc.M611125200; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Teixeira MT, 2002, EMBO REP, V3, P652, DOI 10.1093/embo-reports/kvf133; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Yoo S, 1998, BIOCHEMISTRY-US, V37, P1336, DOI 10.1021/bi972100w; Zappulla DC, 2011, RNA, V17, P298, DOI 10.1261/rna.2483611; Zappulla DC, 2005, NAT STRUCT MOL BIOL, V12, P1072, DOI 10.1038/nsmb1019; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261	59	72	72	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					922	932		10.1016/j.cell.2012.01.033	http://dx.doi.org/10.1016/j.cell.2012.01.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22365814	Green Accepted, Bronze			2022-12-28	WOS:000300985000013
J	Harrison, C; Kiladjian, JJ; Al-Ali, HK; Gisslinger, H; Waltzman, R; Stalbovskaya, V; McQuitty, M; Hunter, DS; Levy, R; Knoops, L; Cervantes, F; Vannucchi, AM; Barbui, T; Barosi, G				Harrison, Claire; Kiladjian, Jean-Jacques; Al-Ali, Haifa Kathrin; Gisslinger, Heinz; Waltzman, Roger; Stalbovskaya, Viktoriya; McQuitty, Mari; Hunter, Deborah S.; Levy, Richard; Knoops, Laurent; Cervantes, Francisco; Vannucchi, Alessandro M.; Barbui, Tiziano; Barosi, Giovanni			JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL-WORKING-GROUP; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; MYELOID METAPLASIA; ACTIVATING MUTATION; INCB018424; PATHOGENESIS; CRITERIA; SAFETY	BACKGROUND Treatment options for myelofibrosis are limited. We evaluated the efficacy and safety of ruxolitinib, a potent and selective Janus kinase (JAK) 1 and 2 inhibitor, as compared with the best available therapy, in patients with myelofibrosis. METHODS We assigned 219 patients with intermediate-2 or high-risk primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis to receive oral ruxolitinib or the best available therapy. The primary end point and key secondary end point of the study were the percentage of patients with at least a 35% reduction in spleen volume at week 48 and at week 24, respectively, as assessed with the use of magnetic resonance imaging or computed tomography. RESULTS A total of 28% of the patients in the ruxolitinib group had at least a 35% reduction in spleen volume at week 48, as compared with 0% in the group receiving the best available therapy (P<0.001); the corresponding percentages at week 24 were 32% and 0% (P<0.001). At 48 weeks, the mean palpable spleen length had decreased by 56% with ruxolitinib but had increased by 4% with the best available therapy. The median duration of response with ruxolitinib was not reached, with 80% of patients still having a response at a median follow-up of 12 months. Patients in the ruxolitinib group had an improvement in overall quality-of-life measures and a reduction in symptoms associated with myelofibrosis. The most common hematologic abnormalities of grade 3 or higher in either group were thrombocytopenia and anemia, which were managed with a dose reduction, interruption of treatment, or transfusion. One patient in each group discontinued treatment owing to thrombocytopenia, and none discontinued owing to anemia. Nonhematologic adverse events were rare and mostly grade 1 or 2. Two cases of acute myeloid leukemia were reported with the best available therapy. CONCLUSIONS Continuous ruxolitinib therapy, as compared with the best available therapy, was associated with marked and durable reductions in splenomegaly and disease-related symptoms, improvements in role functioning and quality of life, and modest toxic effects. An influence on overall survival has not yet been shown. (Funded by Novartis Pharmaceuticals; ClinicalTrials.gov number, NCT00934544.)	[Harrison, Claire] Guys Hosp, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, London SE1 9RT, England; [Kiladjian, Jean-Jacques] Hop St Louis, Paris, France; [Kiladjian, Jean-Jacques] Univ Paris Diderot, Paris, France; [Al-Ali, Haifa Kathrin] Univ Leipzig, Leipzig, Germany; [Gisslinger, Heinz] Med Univ Vienna, Vienna, Austria; [Waltzman, Roger] Novartis Pharmaceut, E Hanover, NJ USA; [Stalbovskaya, Viktoriya; McQuitty, Mari] Novartis Pharmaceut, Basel, Switzerland; [Hunter, Deborah S.; Levy, Richard] Incyte, Wilmington, DE USA; [Knoops, Laurent] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium; [Knoops, Laurent] Ludwig Inst Canc Res, Brussels, Belgium; [Cervantes, Francisco] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Vannucchi, Alessandro M.] Univ Florence, Florence, Italy; [Barbui, Tiziano] AO Osped Riuniti Bergamo, Bergamo, Italy; [Barosi, Giovanni] IRCCS Policlin San Matteo Fdn, Pavia, Italy	Guy's & St Thomas' NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Leipzig University; Medical University of Vienna; Novartis; Novartis; Incyte; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Ludwig Institute for Cancer Research; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Florence; Ospedali Riuniti di Bergamo; IRCCS Fondazione San Matteo	Harrison, C (corresponding author), Guys Hosp, Dept Haematol, Guys & St Thomas NHS Fdn Trust, London SE1 9RT, England.	claire.harrison@gstt.nhs.uk	Vannucchi, Alessandro M./K-7499-2016; al-ali, haifa kathrin k/B-3390-2014; Kiladjian, Jean-Jacques/K-5345-2019; Barosi, Giovanni/AAI-1714-2019	Vannucchi, Alessandro M./0000-0001-5755-0730; Kiladjian, Jean-Jacques/0000-0002-8121-438X; al-ali, haifa kathrin/0000-0001-5009-2239	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	Supported by Novartis Pharmaceuticals.	Abdel-Wahab OI, 2009, ANNU REV MED, V60, P233, DOI 10.1146/annurev.med.60.041707.160528; [Anonymous], 2011, JAK RUX; Apostolidou E, 2009, CLIN LYMPHOMA MYELOM, V9, pS340, DOI 10.3816/CLM.2009.s.033; Baxter EJ, 2005, LANCET, V366, P122; Carter GC, 2008, BLOOD, V112, P828; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shi JG, 2011, J CLIN PHARMACOL, V51, P1644, DOI 10.1177/0091270010389469; Tefferi A, 2008, AM J HEMATOL, V83, P491, DOI 10.1002/ajh.21183; Tefferi A, 2006, BLOOD, V108, P1497, DOI 10.1182/blood-2006-03-009746; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Verstovsek S, 2009, BLOOD, V114, P132; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79	23	1222	1272	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					787	798		10.1056/NEJMoa1110556	http://dx.doi.org/10.1056/NEJMoa1110556			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900GI	22375970				2022-12-28	WOS:000300874300005
J	Simmons, EM; Hartwig, JF				Simmons, Eric M.; Hartwig, John F.			Catalytic functionalization of unactivated primary C-H bonds directed by an alcohol	NATURE			English	Article							METHYL-GROUPS; HYDROXYLATION; COMPLEXES; OXIDATION; TERPENES	New synthetic methods for the catalytic functionalization of C-H bonds have the potential to revolutionize the synthesis of complex molecules(1-4). However, the realization of this synthetic potential requires the ability to functionalize selectively one C-H bond in a compound containing many such bonds and an array of functional groups. The site-selective functionalization of aliphatic C-H bonds is one of the greatest challenges that must be met for C-H bond functionalization to be used widely in complex-molecule synthesis(1,3,5,6), and processes catalysed by transition-metals provide the opportunity to control selectivity(7,8). Current methods for catalytic, aliphatic C-H bond functionalization typically rely on the presence of one inherently reactive C-H bond(9,10), or on installation and subsequent removal of directing groups that are not components of the desired molecule(8). To overcome these limitations, we sought catalysts and reagents that would facilitate aliphatic C-H bond functionalization at a single site, with chemoselectivity derived from the properties of the catalyst and site-selectivity directed by common functional groups(11) contained in both the reactant and the desired product. Here we show that the combination of an iridium-phenanthroline catalyst and a dihydridosilane reagent leads to the site-selective gamma-functionalization of primary C-H bonds controlled by a hydroxyl group, the most common functional group in natural products(12). The scope of the reaction encompasses alcohols and ketones bearing many substitution patterns and auxiliary functional groups; this broad scope suggests that this methodology will be suitable for the site-selective and diastereoselective functionalization of complex natural products.	[Simmons, Eric M.; Hartwig, John F.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hartwig, JF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 91820 USA.	jhartwig@berkeley.edu	Simmons, Eric/AAR-2677-2020	Simmons, Eric/0000-0002-3854-1561	US National Science Foundation [CHE-0910641]; US National Institutes of Health [GM087901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087901] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the US National Science Foundation (CHE-0910641 to J.F.H.) and the US National Institutes of Health (GM087901 to E.M.S.) for funding this work, and Johnson Matthey for a gift of [Ir(cod)OMe]<INF>2</INF>.	Boebel TA, 2008, J AM CHEM SOC, V130, P7534, DOI 10.1021/ja8015878; BOSWORTH N, 1972, J CHEM SOC PERK T 1, P943, DOI 10.1039/p19720000943; Chen K, 2008, J AM CHEM SOC, V130, P7247, DOI 10.1021/ja802491q; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; CORRIU RJP, 1973, J CHEM SOC CHEM COMM, P38, DOI 10.1039/c39730000038; Crotti C, 2007, DALTON T, P133, DOI 10.1039/b613837c; DENG JG, 1991, SYNTHESIS-STUTTGART, P963; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; Feng YQ, 2010, ANGEW CHEM INT EDIT, V49, P958, DOI 10.1002/anie.200905134; Garcia-Granados A, 2007, J ORG CHEM, V72, P3500, DOI 10.1021/jo070116e; Giannis A, 2009, ANGEW CHEM INT EDIT, V48, P7911, DOI 10.1002/anie.200902520; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P7420, DOI 10.1002/anie.200502767; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a; Henkel T, 1999, ANGEW CHEM INT EDIT, V38, P643, DOI 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G; Kasuya S, 2009, ORG LETT, V11, P3630, DOI 10.1021/ol901367m; KITAGAWA I, 1993, CHEM PHARM BULL, V41, P1337, DOI 10.1248/cpb.41.1337; Litvinas ND, 2009, ANGEW CHEM INT EDIT, V48, P4513, DOI 10.1002/anie.200901353; Lu Y, 2010, J AM CHEM SOC, V132, P5916, DOI 10.1021/ja101909t; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; MAJETICH G, 1995, TETRAHEDRON, V51, P7095, DOI 10.1016/0040-4020(95)00406-X; McMurray L, 2011, CHEM SOC REV, V40, P1885, DOI 10.1039/c1cs15013h; Miyazawa M, 2004, TETRAHEDRON, V60, P3091, DOI 10.1016/j.tet.2004.01.076; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; Ple K, 2004, EUR J ORG CHEM, V2004, P1588, DOI 10.1002/ejoc.200300723; Simmons EM, 2010, J AM CHEM SOC, V132, P17092, DOI 10.1021/ja1086547; Yu JQ, 2010, TOP CURR CHEM, V292, P1, DOI 10.1007/978-3-642-12356-6; Zalatan DN, 2010, TOP CURR CHEM, V292, P347, DOI 10.1007/128_2009_19	30	299	303	5	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					70	73		10.1038/nature10785	http://dx.doi.org/10.1038/nature10785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22382981				2022-12-28	WOS:000300877900046
J	Cheung, TH; Quach, NL; Charville, GW; Liu, L; Park, L; Edalati, A; Yoo, B; Hoang, P; Rando, TA				Cheung, Tom H.; Quach, Navaline L.; Charville, Gregory W.; Liu, Ling; Park, Lidia; Edalati, Abdolhossein; Yoo, Bryan; Hoang, Phuong; Rando, Thomas A.			Maintenance of muscle stem-cell quiescence by microRNA-489	NATURE			English	Article							SATELLITE CELLS; SKELETAL-MUSCLE; SELF-RENEWAL; IN-VIVO; PROGRESSION; MECHANISM; MAMMALS; DEK	Among the key properties that distinguish adult mammalian stem cells from their more differentiated progeny is the ability of stem cells to remain in a quiescent state for prolonged periods of time(1,2). However, the molecular pathways for the maintenance of stem-cell quiescence remain elusive. Here we use adult mouse muscle stem cells (satellite cells) as a model system and show that the microRNA (miRNA) pathway is essential for the maintenance of the quiescent state. Satellite cells that lack a functional miRNA pathway spontaneously exit quiescence and enter the cell cycle. We identified quiescence-specific miRNAs in the satellite-cell lineage by microarray analysis. Among these, miRNA-489 (miR-489) is highly expressed in quiescent satellite cells and is quickly downregulated during satellite-cell activation. Further analysis revealed that miR-489 functions as a regulator of satellite-cell quiescence, as it post-transcriptionally suppresses the oncogene Dek, the protein product of which localizes to the more differentiated daughter cell during asymmetric division of satellite cells and promotes the transient proliferative expansion of myogenic progenitors. Our results provide evidence of the miRNA pathway in general, and of a specific miRNA, miR-489, in actively maintaining the quiescent state of an adult stem-cell population.	[Cheung, Tom H.; Quach, Navaline L.; Charville, Gregory W.; Liu, Ling; Park, Lidia; Edalati, Abdolhossein; Yoo, Bryan; Hoang, Phuong; Rando, Thomas A.] Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Cheung, Tom H.; Quach, Navaline L.; Charville, Gregory W.; Liu, Ling; Park, Lidia; Edalati, Abdolhossein; Yoo, Bryan; Hoang, Phuong; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Charville, Gregory W.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr Excellence, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564; Hoang, Phuong/0000-0002-1689-5043	Glenn Foundation for Medical Research; National Institutes of Health (NIH) [P01 AG036695, R01 AG23806, R01 AR062185, DP1 OD000392]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062185, R01AR056849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, R37AG023806, F30AG035521, R01AG023806] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000392] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Rando laboratory for comments and discussions. We thank B. Olwin for providing the syndecan 4 antibody. This work was supported by the Glenn Foundation for Medical Research and by grants from the National Institutes of Health (NIH) (P01 AG036695, R01 AG23806 (R37 MERIT Award), R01 AR062185 and DP1 OD000392 (an NIH Director's Pioneer Award)) and the Department of Veterans Affairs (Merit Review) to T.A.R.	Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	25	317	328	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					524	U247		10.1038/nature10834	http://dx.doi.org/10.1038/nature10834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358842	Green Accepted			2022-12-28	WOS:000300770500050
J	Thomas, CD; Williamson, M				Thomas, Chris D.; Williamson, Mark			Extinction and climate change	NATURE			English	Letter							SPECIES-AREA RELATIONSHIPS; SHIFTS; RISK		[Thomas, Chris D.; Williamson, Mark] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of York - UK	Thomas, CD (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	chris.thomas@york.ac.uk	Thomas, Chris D/A-1894-2012; Thomas, Chris D/A-1460-2014	Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334				Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2004, NATURE, V430, DOI 10.1038/nature02719; Williamson M, 2003, J ECOL, V91, P904, DOI 10.1046/j.1365-2745.2003.00816.x; Williamson M. H., 1981, ISLAND POPULATIONS; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	15	26	27	0	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					E4	E5		10.1038/nature10858	http://dx.doi.org/10.1038/nature10858			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358847				2022-12-28	WOS:000300770500002
J	Cusick, RD; Kim, Y; Logan, BE				Cusick, Roland D.; Kim, Younggy; Logan, Bruce E.			Energy Capture from Thermolytic Solutions in Microbial Reverse-Electrodialysis Cells	SCIENCE			English	Article							AMMONIA-CARBON DIOXIDE; WASTE-WATER TREATMENT; FUEL-CELLS; POWER-GENERATION; OSMOSIS DESALINATION; HYDROGEN-PRODUCTION; ELECTROLYSIS CELLS; ELECTRICITY; MEMBRANE; DESIGN	Reverse electrodialysis allows for the capture of energy from salinity gradients between salt and fresh waters, but potential applications are currently limited to coastal areas and the need for a large number of membrane pairs. Using salt solutions that could be continuously regenerated with waste heat (>= 40 degrees C) and conventional technologies would allow much wider applications of salinity-gradient power production. We used reverse electrodialysis ion-exchange membrane stacks in microbial reverse-electrodialysis cells to efficiently capture salinity-gradient energy from ammonium bicarbonate salt solutions. The maximum power density using acetate reached 5.6 watts per square meter of cathode surface area, which was five times that produced without the dialysis stack, and 3.0 +/- 0.05 watts per square meter with domestic wastewater. Maximum energy recovery with acetate reached 30 +/- 0.5%.	[Cusick, Roland D.; Kim, Younggy; Logan, Bruce E.] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Logan, BE (corresponding author), Penn State Univ, Dept Civil & Environm Engn, 212 Sackett Bldg, University Pk, PA 16802 USA.	blogan@psu.edu	Kim, Younggy/E-7503-2011; Logan, Bruce E/E-7063-2012	Kim, Younggy/0000-0001-7766-9990; Logan, Bruce E/0000-0001-7478-8070	King Abdullah University of Science and Technology (KAUST) [KUS-I1-003-13]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This research was supported by award KUS-I1-003-13 from the King Abdullah University of Science and Technology (KAUST). The data are presented in the figures and supporting online material.	Ahn Y, 2010, BIORESOURCE TECHNOL, V101, P469, DOI 10.1016/j.biortech.2009.07.039; Cheng S, 2006, ENVIRON SCI TECHNOL, V40, P2426, DOI 10.1021/es051652w; Cusick RD, 2010, INT J HYDROGEN ENERG, V35, P8855, DOI 10.1016/j.ijhydene.2010.06.077; EIA, 2010, DOEEIA0384; Fan YZ, 2007, ENVIRON SCI TECHNOL, V41, P8154, DOI 10.1021/es071739c; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Kim JR, 2007, ENVIRON SCI TECHNOL, V41, P1004, DOI 10.1021/es062202m; Kim TW, 2012, DESALINATION, V284, P253, DOI 10.1016/j.desal.2011.09.008; Kim Y, 2011, P NATL ACAD SCI USA, V108, P16176, DOI 10.1073/pnas.1106335108; Kim Y, 2011, ENVIRON SCI TECHNOL, V45, P5834, DOI 10.1021/es200979b; Lalaurette E, 2009, INT J HYDROGEN ENERG, V34, P6201, DOI 10.1016/j.ijhydene.2009.05.112; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P2281, DOI 10.1021/es034923g; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344; Logan BE, 2004, ENVIRON SCI TECHNOL, V38, p160A, DOI 10.1021/es040468s; LOGAN BE, 1987, J WATER POLLUT CON F, V59, P1029; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; McCarty PL, 2011, ENVIRON SCI TECHNOL, V45, P7100, DOI 10.1021/es2014264; McCutcheon JR, 2005, DESALINATION, V174, P1, DOI 10.1016/j.desal.2004.11.002; McGinnis RL, 2007, J MEMBRANE SCI, V305, P13, DOI 10.1016/j.memsci.2007.08.027; Nam JY, 2010, J POWER SOURCES, V195, P6428, DOI 10.1016/j.jpowsour.2010.03.091; Parker DS, 2001, J ENVIRON ENG-ASCE, V127, P380, DOI 10.1061/(ASCE)0733-9372(2001)127:5(380); Ramon GZ, 2011, ENERG ENVIRON SCI, V4, P4423, DOI 10.1039/c1ee01913a; Rezaei F., 2009, APPL ENVIRON MICROB, V192, P304; Shizas I, 2004, J ENERG ENG, V130, P45, DOI 10.1061/(ASCE)0733-9402(2004)130:2(45); U.S. Department of Energy, 2005, DOEGO1020052135; Wang AJ, 2011, BIORESOURCE TECHNOL, V102, P4137, DOI 10.1016/j.biortech.2010.10.137; Wick G. L., 1978, Energy, V3, P96, DOI 10.1016/0360-5442(78)90059-2; Xie X, 2012, ENERG ENVIRON SCI, V5, P5265, DOI 10.1039/c1ee02122b	29	201	208	8	373	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2012	335	6075					1474	1477		10.1126/science.1219330	http://dx.doi.org/10.1126/science.1219330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22383807				2022-12-28	WOS:000301837000042
J	Fitoussi, C; Bourdon, B				Fitoussi, Caroline; Bourdon, Bernard			Silicon Isotope Evidence Against an Enstatite Chondrite Earth	SCIENCE			English	Article							FORMING GIANT IMPACT; INNER SOLAR-SYSTEM; OXYGEN-ISOTOPE; CORE FORMATION; CHEMICAL-COMPOSITION; ACCRETION; HETEROGENEITY; ELEMENTS; MODELS; METAL	The compositions of Earth materials are strikingly similar to those of enstatite chondrite meteorites in many isotope systems. Although this suggests that Earth largely accreted from enstatite chondrites, definitive proof of this model has been lacking. By comparing the silicon (Si) isotope signatures of several extraterrestrial materials with terrestrial samples, we show that they cannot be explained by core-formation scenarios involving a bulk Earth of enstatite chondrite composition. Si isotope similarities between the bulk silicate Earth and the Moon preclude the existence of a hidden reservoir in the lower mantle, a necessary condition of the enstatite chondrite model, and require an equilibrium process after the Moon-forming impact. A three-end-member chondritic mixing model for Earth reconciles the Si isotope similarities between enstatite chondrites and Earth.	[Fitoussi, Caroline; Bourdon, Bernard] Ecole Normale Super Lyon, Lab Geol Lyon, CNRS, F-69364 Lyon 07, France; [Fitoussi, Caroline; Bourdon, Bernard] Univ Lyon 1, F-69364 Lyon 07, France; [Fitoussi, Caroline; Bourdon, Bernard] ETH, Inst Geochem & Petrol, CH-8092 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fitoussi, C (corresponding author), Ecole Normale Super Lyon, Lab Geol Lyon, CNRS, 46 Allee Italie, F-69364 Lyon 07, France.	caroline.fitoussi@ens-lyon.fr						ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Armytage RMG, 2011, GEOCHIM COSMOCHIM AC, V75, P3662, DOI 10.1016/j.gca.2011.03.044; Badro J, 2007, EARTH PLANET SC LETT, V254, P233, DOI 10.1016/j.epsl.2006.11.025; Canup R. M., 2010, LUNAR PLANET SCI C, V41, P2488; Canup RM, 2008, PHILOS T R SOC A, V366, P4061, DOI 10.1098/rsta.2008.0101; Chakrabarti R, 2010, GEOCHIM COSMOCHIM AC, V74, P6921, DOI 10.1016/j.gca.2010.08.034; CLAYTON RN, 1984, J GEOPHYS RES, V89, pC245, DOI 10.1029/JB089iS01p0C245; CLAYTON RN, 1991, GEOCHIM COSMOCHIM AC, V55, P2317, DOI 10.1016/0016-7037(91)90107-G; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; Corgne A, 2008, GEOCHIM COSMOCHIM AC, V72, P574, DOI 10.1016/j.gca.2007.10.006; Fitoussi C, 2009, EARTH PLANET SC LETT, V287, P77, DOI 10.1016/j.epsl.2009.07.038; Georg RB, 2009, EARTH PLANET SC LETT, V283, P67, DOI 10.1016/j.epsl.2009.03.041; Jagoutz E., 1979, P LUNAR PLANET SCI, V2, P2031; JAVOY M, 1995, GEOPHYS RES LETT, V22, P2219, DOI 10.1029/95GL02015; Javoy M, 2010, EARTH PLANET SC LETT, V293, P259, DOI 10.1016/j.epsl.2010.02.033; Lodders K, 2000, SPACE SCI REV, V92, P341, DOI 10.1023/A:1005220003004; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; MASON B, 1966, GEOCHIM COSMOCHIM AC, V30, P23, DOI 10.1016/0016-7037(66)90089-5; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Regelous M, 2008, EARTH PLANET SC LETT, V272, P330, DOI 10.1016/j.epsl.2008.05.001; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; Rudge JF, 2010, NAT GEOSCI, V3, P439, DOI 10.1038/NGEO872; Savage PS, 2010, EARTH PLANET SC LETT, V295, P139, DOI 10.1016/j.epsl.2010.03.035; Shahar A, 2011, GEOCHIM COSMOCHIM AC, V75, P7688, DOI 10.1016/j.gca.2011.09.038; Shahar A, 2009, EARTH PLANET SC LETT, V288, P228, DOI 10.1016/j.epsl.2009.09.025; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Trinquier A, 2007, ASTROPHYS J, V655, P1179, DOI 10.1086/510360; Trinquier A, 2009, SCIENCE, V324, P374, DOI 10.1126/science.1168221; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Zambardi T, 2011, GEOSTAND GEOANAL RES, V35, P89, DOI 10.1111/j.1751-908X.2010.00067.x; Ziegler K, 2010, EARTH PLANET SC LETT, V295, P487, DOI 10.1016/j.epsl.2010.04.030	37	130	131	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1477	1480		10.1126/science.1219509	http://dx.doi.org/10.1126/science.1219509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22383806				2022-12-28	WOS:000301837000043
J	Park, H; Li, YL; Tsien, RW				Park, Hyokeun; Li, Yulong; Tsien, Richard W.			Influence of Synaptic Vesicle Position on Release Probability and Exocytotic Fusion Mode	SCIENCE			English	Article							KISS-AND-RUN; LIVING CELLS; SYNAPSES; RECEPTORS; ORGANIZATION; MICROSCOPY; BOUTONS; POOLS; BRAIN; REUSE	Neurotransmission depends on movements of transmitter-laden synaptic vesicles, but accurate, nanometer-scale monitoring of vesicle dynamics in presynaptic terminals has remained elusive. Here, we report three-dimensional, real-time tracking of quantum dot-loaded single synaptic vesicles with an accuracy of 20 to 30 nanometers, less than a vesicle diameter. Determination of the time, position, and mode of fusion, aided by trypan blue quenching of Qdot fluorescence, revealed that vesicles starting close to their ultimate fusion sites tended to fuse earlier than those positioned farther away. The mode of fusion depended on the prior motion of vesicles, with long-dwelling vesicles preferring kiss-and-run rather than full-collapse fusion. Kiss-and-run fusion events were concentrated near the center of the synapse, whereas full-collapse fusion events were broadly spread.	[Park, Hyokeun; Li, Yulong; Tsien, Richard W.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Tsien, Richard W.] NYU, Inst Neurosci, New York, NY 10016 USA; [Tsien, Richard W.] NYU, Dept Physiol & Neurosci, New York, NY 10016 USA	Stanford University; New York University; New York University	Tsien, RW (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	richard.tsien@nyumc.org	Park, Hyokeun/AAY-3073-2021	Park, Hyo Keun/0000-0002-2655-4795; Li, Yulong/0000-0002-9166-9919	National Institute of Mental Health (NIH); Burnett Family Foundation; Mathers Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064070] Funding Source: NIH RePORTER	National Institute of Mental Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Burnett Family Foundation; Mathers Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Q. Zhang for discussion and for first applying Qdots to the research on vesicle release; T. Watanabe for help with building the 3D microscope; S. Syed, S.-Y. Oh, and S. Ryu for analysis programs; I. Shim for help with data analysis; A. Mitra for the construct for PSD-95-GFP; H. Martens for biotinylated antibodies against VGAT; and members of the Tsien lab for discussion. Supported by grants from National Institute of Mental Health (NIH), the Burnett Family Foundation, and Mathers Foundation.	Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Diamond JS, 1997, J NEUROSCI, V17, P4672; Franks KM, 2003, J NEUROSCI, V23, P3186; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kharazia VN, 1997, NEUROSCI LETT, V238, P41, DOI 10.1016/S0304-3940(97)00846-X; Richards DA, 2009, J PHYSIOL-LONDON, V587, P5073, DOI 10.1113/jphysiol.2009.175315; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Uteshev VV, 1997, BIOPHYS J, V72, P1127, DOI 10.1016/S0006-3495(97)78761-7; Vanden Berghe P, 2006, J PHYSIOL-LONDON, V572, P707, DOI 10.1113/jphysiol.2005.100842; Watanabe TM, 2007, BIOCHEM BIOPH RES CO, V359, P1, DOI 10.1016/j.bbrc.2007.04.168; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	22	74	79	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2012	335	6074					1362	1366		10.1126/science.1216937	http://dx.doi.org/10.1126/science.1216937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22345401	Green Accepted			2022-12-28	WOS:000301531600051
J	Xiang, YT; Yu, X; Ungvari, GS; Lee, EHM; Chiu, HFK				Xiang, Yu-Tao; Yu, Xin; Ungvari, Gabor S.; Lee, Edwin H. M.; Chiu, Helen F. K.			China's National Mental Health Law: a 26-year work in progress	LANCET			English	Editorial Material									[Xiang, Yu-Tao; Lee, Edwin H. M.; Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Xiang, Yu-Tao] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Yu, Xin] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia	Chinese University of Hong Kong; Capital Medical University; Peking University; University of Notre Dame Australia	Xiang, YT (corresponding author), Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	xyutly@gmail.com	Lee, Ho Ming Edwin/A-4579-2012	Lee, Ho Ming Edwin/0000-0002-8909-0676				[Anonymous], 2010, LANCET; LaFraniere S., 2010, NY TIMES        1111; Legal Office of the State Council, 2011, VERS MENT H IN PRESS; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Standing Committee of the National People's Congress, 2011, VERS MENT H IN PRESS; Xiang YT, 2010, LANCET, V376, P1145, DOI 10.1016/S0140-6736(10)61539-5; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Zhang HL, 2011, OUTLOOK WEEKLY  0725	8	27	27	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2012	379	9818					780	782		10.1016/S0140-6736(11)61704-2	http://dx.doi.org/10.1016/S0140-6736(11)61704-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386014				2022-12-28	WOS:000300983400005
J	Nicolas, P; Mader, U; Dervyn, E; Rochat, T; Leduc, A; Pigeonneau, N; Bidnenko, E; Marchadier, E; Hoebeke, M; Aymerich, S; Becher, D; Bisicchia, P; Botella, E; Delumeau, O; Doherty, G; Denham, EL; Fogg, MJ; Fromion, V; Goelzer, A; Hansen, A; Haertig, E; Harwood, CR; Homuth, G; Jarmer, H; Jules, M; Klipp, E; Le Chat, L; Lecointe, F; Lewis, P; Liebermeister, W; March, A; Mars, RAT; Nannapaneni, P; Noone, D; Pohl, S; Rinn, B; Rugheimer, F; Sappa, PK; Samson, F; Schaffer, M; Schwikowski, B; Steil, L; Stulke, J; Wiegert, T; Devine, KM; Wilkinson, AJ; van Dijl, JM; Hecker, M; Volker, U; Bessieres, P; Noirot, P				Nicolas, Pierre; Maeder, Ulrike; Dervyn, Etienne; Rochat, Tatiana; Leduc, Aurelie; Pigeonneau, Nathalie; Bidnenko, Elena; Marchadier, Elodie; Hoebeke, Mark; Aymerich, Stephane; Becher, Doerte; Bisicchia, Paola; Botella, Eric; Delumeau, Olivier; Doherty, Geoff; Denham, Emma L.; Fogg, Mark J.; Fromion, Vincent; Goelzer, Anne; Hansen, Annette; Haertig, Elisabeth; Harwood, Colin R.; Homuth, Georg; Jarmer, Hanne; Jules, Matthieu; Klipp, Edda; Le Chat, Ludovic; Lecointe, Francois; Lewis, Peter; Liebermeister, Wolfram; March, Anika; Mars, Ruben A. T.; Nannapaneni, Priyanka; Noone, David; Pohl, Susanne; Rinn, Bernd; Ruegheimer, Frank; Sappa, Praveen K.; Samson, Franck; Schaffer, Marc; Schwikowski, Benno; Steil, Leif; Stuelke, Joerg; Wiegert, Thomas; Devine, Kevin M.; Wilkinson, Anthony J.; van Dijl, Jan Maarten; Hecker, Michael; Voelker, Uwe; Bessieres, Philippe; Noirot, Philippe			Condition-Dependent Transcriptome Reveals High-Level Regulatory Architecture in Bacillus subtilis	SCIENCE			English	Article							ESCHERICHIA-COLI; RNA-POLYMERASE; IDENTIFICATION; GENOME; GENE; SEQUENCES; LANDSCAPE; DNA; RHO	Bacteria adapt to environmental stimuli by adjusting their transcriptomes in a complex manner, the full potential of which has yet to be established for any individual bacterial species. Here, we report the transcriptomes of Bacillus subtilis exposed to a wide range of environmental and nutritional conditions that the organism might encounter in nature. We comprehensively mapped transcription units (TUs) and grouped 2935 promoters into regulons controlled by various RNA polymerase sigma factors, accounting for similar to 66% of the observed variance in transcriptional activity. This global classification of promoters and detailed description of TUs revealed that a large proportion of the detected antisense RNAs arose from potentially spurious transcription initiation by alternative sigma factors and from imperfect control of transcription termination.	[Dervyn, Etienne; Rochat, Tatiana; Pigeonneau, Nathalie; Bidnenko, Elena; Marchadier, Elodie; Aymerich, Stephane; Delumeau, Olivier; Jules, Matthieu; Le Chat, Ludovic; Lecointe, Francois; Noirot, Philippe] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Nicolas, Pierre; Leduc, Aurelie; Hoebeke, Mark; Fromion, Vincent; Goelzer, Anne; Samson, Franck; Bessieres, Philippe] INRA, Math Informat & Genome UR1077, F-78350 Jouy En Josas, France; [Maeder, Ulrike; Becher, Doerte; Schaffer, Marc; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17489 Greifswald, Germany; [Maeder, Ulrike; Homuth, Georg; Nannapaneni, Priyanka; Sappa, Praveen K.; Steil, Leif; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Bisicchia, Paola; Botella, Eric; Hansen, Annette; Noone, David] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Doherty, Geoff; Lewis, Peter] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Denham, Emma L.; van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands; [Denham, Emma L.; van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Fogg, Mark J.; Wilkinson, Anthony J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Haertig, Elisabeth] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Harwood, Colin R.; Pohl, Susanne] Newcastle Univ, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Jarmer, Hanne] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst, DK-2800 Lyngby, Denmark; [Klipp, Edda] Humboldt Univ, D-10115 Berlin, Germany; [Rinn, Bernd] ETH, Ctr Informat Sci & Databases, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Ruegheimer, Frank] Inst Pasteur, Syst Biol Lab, F-75724 Paris 15, France; [Ruegheimer, Frank] CNRS, URA 2171, F-75724 Paris 15, France; [Stuelke, Joerg] Univ Gottingen, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Wiegert, Thomas] Hsch Zittau Gorlitz, FN Biotechnol, D-02763 Zittau, Germany	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Trinity College Dublin; University of Newcastle; University of Groningen; University of Groningen; University of York - UK; Braunschweig University of Technology; Newcastle University - UK; Technical University of Denmark; Humboldt University of Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Gottingen; Technische Universitat Dresden	Noirot, P (corresponding author), INRA, Micalis UMR1319, F-78350 Jouy En Josas, France.	philippe.noirot@jouy.inra.fr	MARCHADIER, Elodie/AAC-8416-2019; Jules, Matthieu/GVU-5315-2022; Stülke, Jörg/AAD-1600-2021; MARCHADIER, Elodie/AAX-8887-2020; van Dijl, Jan Maarten/G-1205-2013; Steil, Leif/F-1246-2010; Becher, Doerte/B-4454-2015; Liebermeister, Wolfram/AAC-7326-2020; Harwood, Colin/AGF-0120-2022; Denham, Emma/P-3979-2014	MARCHADIER, Elodie/0000-0001-5618-6471; Jules, Matthieu/0000-0003-0817-8949; Steil, Leif/0000-0002-0733-8421; Becher, Doerte/0000-0002-9630-5735; Liebermeister, Wolfram/0000-0002-2568-2381; Lecointe, Francois/0000-0002-9596-2514; HOEBEKE, Mark/0000-0001-6311-9752; Mars, Ruben A T/0000-0002-3917-9517; Harwood, Colin/0000-0002-3624-0001; Schwikowski, Benno/0000-0001-5127-5619; Denham, Emma/0000-0002-5123-4099; Fogg, Mark/0000-0002-6692-122X; Stulke, Jorg/0000-0001-5881-5390; Wilkinson, Anthony/0000-0003-4577-9479; Volker, Uwe/0000-0002-5689-3448; Rochat, Tatiana/0000-0002-4533-1220	European Commission [LSHG-CT-2006-037469]; German Federal Ministry of Education and Research [0313978B]; Department of Education, Science and Training [CG110055]; National Health and Medical Research Council [455646]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Department of Education, Science and Training; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The data are deposited in the Gene Expression Omnibus (GEO) database (accession numbers GSE27219, GSE27303, GSE27419, and GSE27652), and are tabulated in the SOM and at www.basysbio.eu/bsubtranscriptome. This Web page provides links to the data archived in the GEO and Openbis databases. This study was supported by the European Commission-funded BaSysBio project (LSHG-CT-2006-037469), the SysMO network funded by the German Federal Ministry of Education and Research (0313978B), Department of Education, Science and Training (CG110055), and the National Health and Medical Research Council (455646). We are grateful to N. Pele, B. Giovani, C. Sautot, and B. Diep for management support. The authors declare no competing interests.	Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Fischer S.H., 2002, BACILLUS SUBTILIS IT, P181; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; Hoebeke M, 2003, BIOINFORMATICS, V19, P859, DOI 10.1093/bioinformatics/btg101; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lane WJ, 2006, PLOS BIOL, V4, P1491, DOI 10.1371/journal.pbio.0040269; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Nicolas P, 2009, BIOINFORMATICS, V25, P2341, DOI 10.1093/bioinformatics/btp395; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; QUIRK PG, 1993, J BACTERIOL, V175, P647, DOI 10.1128/JB.175.3.647-654.1993; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109	25	581	585	10	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1103	1106		10.1126/science.1206848	http://dx.doi.org/10.1126/science.1206848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383849				2022-12-28	WOS:000300931100048
J	Stanciole, AE; Ortegon, M; Chisholm, D; Lauer, JA				Stanciole, Anderson E.; Ortegon, Monica; Chisholm, Dan; Lauer, Jeremy A.			Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INHALED CORTICOSTEROIDS; DOUBLE-BLIND; MORTALITY; FLUTICASONE; SALMETEROL; INTERVENTION; DEVICE; BURDEN; HEALTH	Objectives To determine the population level costs, effects, and cost effectiveness of selected, individual based interventions to combat chronic obstructive pulmonary disease (COPD) and asthma in the context of low and middle income countries. Design Sectoral cost effectiveness analysis using a lifetime population model. Setting Two World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE); and countries in South East Asia with high adult and high child mortality (SearD). Data sources Disease rates and profiles were taken from the WHO Global Burden of Disease study; estimates of intervention effects and resource needs were drawn from clinical trials, observational studies, and treatment guidelines. Unit costs were taken from a WHO price database. Main outcome measures Cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results In both regions low dose inhaled corticosteroids for mild persistent asthma was considered the most cost effective intervention, with average cost per DALY averted about $Int2500. The next best value strategies were influenza vaccine for COPD in Sear-D (incremental cost $Int4950 per DALY averted) and low dose inhaled corticosteroids plus long acting beta agonists for moderate persistent asthma in Afr-E (incremental cost $Int9112 per DALY averted). Conclusions COPD is irreversible and progressive, and current treatment options produce relatively little gains relative to the cost. The treatment options available for asthma, however, generally decrease chronic respiratory disease burden at a relatively low cost.	[Stanciole, Anderson E.] World Bank, Washington, DC 20433 USA; [Ortegon, Monica] Univ Rosario, Med & Hlth Sci Sch, Bogota, Colombia; [Chisholm, Dan; Lauer, Jeremy A.] World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland	The World Bank; Universidad del Rosario; World Health Organization	Stanciole, AE (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.	astanciole@worldbank.org		Lauer, Jeremy A/0000-0003-0652-0691				Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; [Anonymous], GLOB STRAT DIAGN MAN; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; *AUSTR CTR ASTHM M, 2005, HLTH CAR EXP BURD DI; Barr RG, 2006, THORAX, V61, P854, DOI 10.1136/thx.2006.063271; Barr RG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002876.pub2; Bateman ED, 2002, EUR RESPIR J, V20, P588, DOI 10.1183/09031936.02.00294702; Bjermer L, 2003, BMJ-BRIT MED J, V327, P891, DOI 10.1136/bmj.327.7420.891; Borg S, 2004, VALUE HEALTH, V7, P153, DOI 10.1111/j.1524-4733.2004.72318.x; British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2008, BRIT GUID MAN ASTHM; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Chan-Yeung M, 2004, INT J TUBERC LUNG D, V8, P159; Chan-Yeung M, 2004, INT J TUBERC LUNG D, V8, P2; Coe R, 2002, RES CAPACITY BUILDIN, V4, P6; Croxton TL, 2006, AM J RESP CRIT CARE, V174, P373, DOI 10.1164/rccm.200507-1161WS; Ducharme FM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003137.pub3; Edejer T, 2003, MAKING CHOICES HLTH; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; *GINA, 2007, GLOB STRAT ASTHM MAN; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kavuru M, 2000, J ALLERGY CLIN IMMUN, V105, P1108, DOI 10.1067/mai.2000.105711; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Macie C, 2006, CHEST, V130, P640, DOI 10.1378/chest.130.3.640; Mannino D, 2005, EUR RESPIR J, V26, P189, DOI 10.1183/09031936.05.00063605; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Masoli M, 2004, GLOBAL BURDEN ASTHMA; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Mehta S., 2004, ENERGY SUSTAIN DEV, V8, P53, DOI DOI 10.1016/S0973-0826(08)60466-4; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Motala C, 2000, GUIDELINES MANAGEMEN; National Asthma Education and Prevention Program, 2007, HYPERLIPIDAEMIA; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Nonoyama ML, 2007, AM J RESP CRIT CARE, V176, P343, DOI 10.1164/rccm.200702-308OC; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Paramesh H., 2002, Indian Journal of Pediatrics, V69, P309, DOI 10.1007/BF02723216; Poole PJ, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002733.PUB2; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; RAM FS, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004403.PUB2; Rico-Mendez FG, 2005, ARCH BRONCONEUMOL, V41, P260, DOI 10.1016/S1579-2129(06)60220-6; Salomon JA, 2006, PRIORITY SETTING HLT; Sanderson K, 2004, QUAL LIFE RES, V13, P1255, DOI 10.1023/B:QURE.0000037482.92757.82; Shapiro G, 2000, AM J RESP CRIT CARE, V161, P527, DOI 10.1164/ajrccm.161.2.9905091; Shibuya K, 2001, CHRONIC OBSTRUCTIVE; Simonella L, 2006, INTERN MED J, V36, P244, DOI 10.1111/j.1445-5994.2006.01054.x; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Sin Don D, 2006, Proc Am Thorac Soc, V3, P624, DOI 10.1513/pats.200603-096SS; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; The International Union against Tuberculosis and Lung Disease, 2011, GLOB ASTHM REP 2011; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang IA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub2	53	24	25	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e608	10.1136/bmj.e608	http://dx.doi.org/10.1136/bmj.e608			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389338	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000301232600003
J	Wong, MY; Zhou, CM; Shakiryanova, D; Lloyd, TE; Deitcher, DL; Levitan, ES				Wong, Man Yan; Zhou, Chaoming; Shakiryanova, Dinara; Lloyd, Thomas E.; Deitcher, David L.; Levitan, Edwin S.			Neuropeptide Delivery to Synapses by Long-Range Vesicle Circulation and Sporadic Capture	CELL			English	Article							AXONAL-TRANSPORT; DROSOPHILA; EXPRESSION; IDENTIFICATION; RELEASE; MOTOR; DENDRITES; PROCTOLIN	Neurotransmission requires anterograde axonal transport of dense core vesicles (DCVs) containing neuropeptides and active zone components from the soma to nerve terminals. However, it is puzzling how one-way traffic could uniformly supply sequential release sites called en passant boutons. Here, Drosophila neuropeptide-containing DCVs are tracked in vivo for minutes with a new method called simultaneous photobleaching and imaging (SPAIM). Surprisingly, anterograde DCVs typically bypass proximal boutons to accumulate initially in the most distal bouton. Then, excess distal DCVs undergo dynactin-dependent retrograde transport back through proximal boutons into the axon. Just before re-entering the soma, DCVs again reverse for another round of anterograde axonal transport. While circulating over long distances, both anterograde and retrograde DCVs are captured sporadically in en passant boutons. Therefore, vesicle circulation, which includes long-range retrograde transport and inefficient bidirectional capture, overcomes the limitations of one-way anterograde transport to uniformly supply release sites with DCVs.	[Wong, Man Yan; Zhou, Chaoming; Shakiryanova, Dinara; Levitan, Edwin S.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Lloyd, Thomas E.] Johns Hopkins Sch Med, Dept Neurol & Neurosci, Baltimore, MD 21287 USA; [Deitcher, David L.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Medicine; Cornell University	Levitan, ES (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	elevitan@pitt.edu	Deitcher, David/K-6538-2019	Lloyd, Thomas/0000-0003-4756-3700; Bulgari, Dinara/0000-0001-5352-6207; Deitcher, David/0000-0002-8512-8868	National Institutes of Health [NIH R01 NS32385]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032385, K08NS062890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Daniel Altschuler (University of Pittsburgh) for comments; Haig Keshishian (Yale University) for the Geneswitch flies; Eric Rulifson (UCSF) for the preproDilp2 clone; Dick Nassel (Stockholm University) for anti-proctolin precursor serum; and Yuh-Nung Jan (UCSF) for the UAS-ManII-EGFP flies. This work was supported by a grant from the National Institutes of Health (NIH R01 NS32385 to E. S. L.).	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allen MJ, 1999, J NEUROSCI, V19, P9374; ALONSO G, 1983, CELL TISSUE RES, V233, P183; ANDERSON MS, 1988, J NEUROSCI, V8, P242; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Heifetz Y, 2004, P NATL ACAD SCI USA, V101, P6261, DOI 10.1073/pnas.0401337101; Husain QM, 2004, J NEUROBIOL, V59, P181, DOI 10.1002/neu.10309; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kula E, 2006, J BIOL RHYTHM, V21, P104, DOI 10.1177/0748730405285715; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Levitan ES, 2007, NAT PROTOC, V2, P1117, DOI 10.1038/nprot.2007.142; Loveall BJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-92; Nicholson L, 2008, GENETICS, V178, P215, DOI 10.1534/genetics.107.081968; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Rolls MM, 2011, DEV NEUROBIOL, V71, P419, DOI 10.1002/dneu.20836; Shakiryanova D, 2006, NAT NEUROSCI, V9, P896, DOI 10.1038/nn1719; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Sturman DA, 2006, BIOPHYS J, V90, pL45, DOI 10.1529/biophysj.106.080978; Taylor CAM, 2004, J NEUROBIOL, V58, P379, DOI 10.1002/neu.10301; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zupanc GKH, 1996, MICRON, V27, P35, DOI 10.1016/0968-4328(95)00028-3	27	109	109	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					1029	1038		10.1016/j.cell.2011.12.036	http://dx.doi.org/10.1016/j.cell.2011.12.036			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385966	Green Accepted, Bronze			2022-12-28	WOS:000300985000021
J	von Mutius, E; Drazen, JM				von Mutius, Erika; Drazen, Jeffrey M.			200th Anniversary Article: A Patient with Asthma Seeks Medical Advice in 1828, 1928, and 2012	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BECLOMETHASONE DIPROPIONATE; BRONCHIAL-ASTHMA; ALLERGIC-ASTHMA		[von Mutius, Erika] Univ Childrens Hosp, Div Pneumol & Allergol, Munich, Germany; [Drazen, Jeffrey M.] Harvard Univ, Sch Med, Boston, MA USA; [Drazen, Jeffrey M.] Brigham & Womens Hosp, Dept Med, Div Pulm, Boston, MA 02115 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	von Mutius, E (corresponding author), Univ Munich, Dr Von Haunerschen Kinderspital, Lindwurmstr 4, D-80337 Munich, Germany.		Drazen, Jeffrey M/E-5841-2012	von Mutius, Erika/0000-0002-8893-4515; Drazen, Jeffrey/0000-0003-2715-9890				[Anonymous], 1922, BOSTON MED SURG J, V187, P590; [Anonymous], 1847, BOSTON MED SURG J, V36, P436; [Anonymous], 1922, BOSTON MED SURG J, V186, P48; [Anonymous], 1833, BOSTON MED SURG J, V8, P341; Bell R, 1901, BOSTON MED SURG J, V144, P395, DOI 10.1056/NEJM190104251441702; BOUSQUET J, 1991, NEW ENGL J MED, V324, P1514; Bree, 1812, N ENGL J MED SURG, V1, P411; BROWN HM, 1972, BRIT MED J, V1, P585, DOI 10.1136/bmj.1.5800.585; Chiarenti F, 1827, N ENGL MED REV J, V1, P329; DAVIES G, 1977, ANN INTERN MED, V86, P549, DOI 10.7326/0003-4819-86-5-549; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; FLOYER JS, 1698, TREATISE ASTHMA DIVI; Goggio AF, 1944, NEW ENGL J MED, V231, P672, DOI 10.1056/NEJM194411162312002; Granville AB, 1820, N ENGL J MED SURG, V9, P193; MARKETOS SG, 1982, J ASTHMA, V19, P263, DOI 10.3109/02770908209104771; MCFADDEN ER, 1973, NEW ENGL J MED, V288, P221, DOI 10.1056/NEJM197302012880501; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Thomas WS, 1926, AM J MED SCI, V171, P719, DOI 10.1097/00000441-192605000-00012; THORN GW, 1950, NEW ENGL J MED, V242, P824, DOI 10.1056/NEJM195005252422105; Turnbull JA, 1920, BOSTON MED SURG J, V182, P493, DOI 10.1056/NEJM192005131822001	22	20	22	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					827	834		10.1056/NEJMra1102783	http://dx.doi.org/10.1056/NEJMra1102783			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900GI	22375974				2022-12-28	WOS:000300874300009
J	Gostin, LO				Gostin, Lawrence O.			Marketing Pharmaceuticals A Constitutional Right to Sell Prescriber-Identified Data?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Kohl H, 2007, J AM GERIATR SOC, V55, P1106, DOI 10.1111/j.1532-5415.2007.01286.x; Mello MM, 2011, NEW ENGL J MED, V365, P1248, DOI 10.1056/NEJMhle1107678; Orentlicher D, 2010, J LAW MED ETHICS, V38, P74, DOI 10.1111/j.1748-720X.2010.00468.x; Rein BW, 2011, BNA INSIGHTS, V80, P566	4	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					787	788		10.1001/jama.2012.182	http://dx.doi.org/10.1001/jama.2012.182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896FQ	22357827				2022-12-28	WOS:000300551300018
J	Huber, EM; Basler, M; Schwab, R; Heinemeyer, W; Kirk, CJ; Groettrup, M; Groll, M				Huber, Eva M.; Basler, Michael; Schwab, Ricarda; Heinemeyer, Wolfgang; Kirk, Christopher J.; Groettrup, Marcus; Groll, Michael			Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity	CELL			English	Article							IMMUNOPROTEASOME SUBUNIT LMP7; YEAST 20S PROTEASOME; T-CELL REPERTOIRE; CLASS-II REGION; IRREVERSIBLE INHIBITOR; ANTIGEN PRESENTATION; SELECTIVE INHIBITOR; ANGSTROM RESOLUTION; BRANCHED-CHAIN; S PROTEASOME	Constitutive proteasomes and immunoproteasomes shape the peptide repertoire presented by major histocompatibility complex class I (MHC-I) molecules by harboring different sets of catalytically active subunits. Here, we present the crystal structures of constitutive proteasomes and immunoproteasomes from mouse in the presence and absence of the epoxyketone inhibitor PR-957 (ONX 0914) at 2.9 angstrom resolution. Based on our X-ray data, we propose a unique catalytic feature for the immunoproteasome subunit beta 5i/LMP7. Comparison of ligand-free and ligand-bound proteasomes reveals conformational changes in the S1 pocket of beta 5c/X but not beta 5i, thereby explaining the selectivity of PR-957 for beta 5i. Time-resolved structures of yeast proteasome: PR-957 complexes indicate that ligand docking to the active site occurs only via the reactive head group and the P1 side chain. Together, our results support structure-guided design of inhibitory lead structures selective for immunoproteasomes that are linked to cytokine production and diseases like cancer and autoimmune disorders.	[Basler, Michael; Schwab, Ricarda; Groettrup, Marcus] Univ Constance, Dept Biol, Div Immunol, D-78457 Constance, Germany; [Huber, Eva M.; Heinemeyer, Wolfgang; Groll, Michael] Tech Univ Munich, Lehrstuhl Biochem, Dept Chem, Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Basler, Michael; Groettrup, Marcus] Univ Constance, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland; [Kirk, Christopher J.] Onyx Pharmaceut, San Francisco, CA 94080 USA	University of Konstanz; Technical University of Munich	Groettrup, M (corresponding author), Univ Constance, Dept Biol, Div Immunol, D-78457 Constance, Germany.	marcus.groettrup@uni-konstanz.de; michael.groll@ch.tum.de	Groll, Michael/F-5572-2015; Groettrup, Marcus/AAT-2623-2020; Huber, Eva/J-3130-2015	Basler, Michael/0000-0002-9428-2349	Deutsche Forschungsgemeinschaft [SFB595/TP A11, 1517/12-1]; BMBF-ProNET; Swiss National Fonds [31003A_138451]; Chemical Biology at Constance University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF-ProNET; Swiss National Fonds(Swiss National Science Foundation (SNSF)); Chemical Biology at Constance University	This work is dedicated to Professor Robert Huber on the occasion of his 75th birthday. We are grateful to B. Potts for fruitful discussions on the manuscript and to R. Huber for sharing his knowledge in the proteasome field with us. G. Werner, U. Beck, and the personnel of the animal research facility of Constance University are acknowledged for experimental support. We thank Richard Feicht for the purification of yCPs. The staff of the beamlines X06SA and X06DA at the Paul Scherrer Institute, SLS, Villigen, Switzerland, especially Takashi Tomizaki, is acknowledged for assistance during data collection. This work was supported by the Deutsche Forschungsgemeinschaft SFB595/TP A11 (M. Groll), BMBF-ProNET-T3 project To-03 (M. Groll), the Swiss National Fonds grant 31003A_138451 (M. Groettrup), and DFG grant 1517/12-1 (M. Groettrup, M.B.). R.S. is supported by the Graduate School of Chemical Biology at Constance University. M. Groll and M. Groettrup designed experiments. M.B. and R.S. purified cCPs and iCPs. E.M.H. performed activity tests and crystallographic experiments. W.H. and E.M.H. performed yeast genetics. C.J.K. provided PR-957 and edited the manuscript. E.M.H. and M. Groll collected and analyzed crystallographic data and wrote the manuscript. C.J.K. is an employee and stock holder of Onyx Pharmaceuticals.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Badros A, 2007, CANCER-AM CANCER SOC, V110, P1042, DOI 10.1002/cncr.22921; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; Cardozo C, 1998, J BIOL CHEM, V273, P16764, DOI 10.1074/jbc.273.27.16764; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Corey EJ, 1999, CHEM PHARM BULL, V47, P1; De M, 2003, J BIOL CHEM, V278, P6153, DOI 10.1074/jbc.M209292200; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GRANT EP, 1995, J IMMUNOL, V155, P3750; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1996, EUR J IMMUNOL, V26, P863, DOI 10.1002/eji.1830260421; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Groll M, 2006, J AM CHEM SOC, V128, P5136, DOI 10.1021/ja058320b; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Groll M, 2005, METHOD ENZYMOL, V398, P329, DOI 10.1016/S0076-6879(05)98027-0; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho YK, 2007, CHEM BIOL, V14, P419, DOI 10.1016/j.chembiol.2007.03.008; Ichikawa HT, 2012, ARTHRITIS RHEUM-US, V64, P493, DOI 10.1002/art.33333; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; Khan ML, 2011, FUTURE ONCOL, V7, P607, DOI [10.2217/fon.11.42, 10.2217/FON.11.42]; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Kingsbury DJ, 2000, J BIOL CHEM, V275, P24156, DOI 10.1074/jbc.M001742200; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nandi D, 1996, J IMMUNOL, V156, P2361; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; Nett M, 2009, J MED CHEM, V52, P6163, DOI 10.1021/jm901098m; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; Potts BC, 2011, CURR CANCER DRUG TAR, V11, P254; Puttaparthi K, 2005, EXP NEUROL, V196, P441, DOI 10.1016/j.expneurol.2005.08.027; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROMERO P, 1991, J EXP MED, V174, P603, DOI 10.1084/jem.174.3.603; Schmidtke G, 2000, J BIOL CHEM, V275, P22056, DOI 10.1074/jbc.M002513200; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Singh AV, 2011, BRIT J HAEMATOL, V152, P155, DOI 10.1111/j.1365-2141.2010.08491.x; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tomaru U, 2009, BLOOD, V113, P5186, DOI 10.1182/blood-2008-11-187633; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; Tu L, 2009, EUR J IMMUNOL, V39, P3385, DOI 10.1002/eji.200839117; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1467, DOI 10.1007/s00018-011-0654-1; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Visekruna A, 2009, INT J COLORECTAL DIS, V24, P1133, DOI 10.1007/s00384-009-0679-1; YEWDELL J, 1994, J IMMUNOL, V152, P1163	62	341	377	2	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					727	738		10.1016/j.cell.2011.12.030	http://dx.doi.org/10.1016/j.cell.2011.12.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341445	Green Submitted, Bronze			2022-12-28	WOS:000300622400014
J	Ohman, M				Ohman, Marie			A Cold Editor Makes the Adaptation	SCIENCE			English	Editorial Material							GENE-EXPRESSION; RNA; CHANNELS		Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden	Stockholm University	Ohman, M (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden.	marieohman@molbio.su.se	Ãhman, Marie/N-8561-2015	Ãhman, Marie/0000-0002-6636-5841				Garrett S, 2012, SCIENCE, V335, P848, DOI 10.1126/science.1212795; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Lu ZJ, 2006, NUCLEIC ACIDS RES, V34, P4912, DOI 10.1093/nar/gkl472; Palavicini JP, 2009, RNA, V15, P1208, DOI 10.1261/rna.1471209; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8	8	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					805	806		10.1126/science.1219300	http://dx.doi.org/10.1126/science.1219300			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344432				2022-12-28	WOS:000300356400028
J	Kuehn, BM				Kuehn, Bridget M.			Clinical Trial Network Removes Barriers Common to Studies of Neurological Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					655	655		10.1001/jama.2012.131	http://dx.doi.org/10.1001/jama.2012.131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22337666				2022-12-28	WOS:000300278500004
J	Ansari, AZ; Rosner, MR; Adler, J				Ansari, Aseem Z.; Rosner, Marsha Rich; Adler, Julius			Har Gobind Khorana 1922-2011 Obituary	CELL			English	Biographical-Item									[Ansari, Aseem Z.; Adler, Julius] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Adler, Julius] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Ansari, Aseem Z.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Rosner, Marsha Rich] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Chicago	Ansari, AZ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	ansari@biochem.wisc.edu	Ansari, Aseem/AAF-4945-2019		NATIONAL CANCER INSTITUTE [R01CA133508] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA133508] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1433	1435		10.1016/j.cell.2011.12.008	http://dx.doi.org/10.1016/j.cell.2011.12.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22355806	Bronze			2022-12-28	WOS:000298403400006
J	Hughes, K; Bellis, MA; Jones, L; Wood, S; Bates, G; Eckley, L; McCoy, E; Mikton, C; Shakespeare, T; Officer, A				Hughes, Karen; Bellis, Mark A.; Jones, Lisa; Wood, Sara; Bates, Geoff; Eckley, Lindsay; McCoy, Ellie; Mikton, Christopher; Shakespeare, Tom; Officer, Alana			Prevalence and risk of violence against adults with disabilities: a systematic review and meta-analysis of observational studies	LANCET			English	Article							SEVERE MENTAL-ILLNESS; CRIME VICTIMIZATION; SEXUAL ASSAULT; ABUSE; WOMEN; PEOPLE; PERPETRATOR; DEMENTIA; DISORDER; HEALTH	Background About 15% of adults worldwide have a disability. These individuals are frequently reported to be at increased risk of violence, yet quantitative syntheses of studies of this issue are scarce. We aimed to quantify violence against adults with disabilities. Methods In this systematic review and meta-analysis, we searched 12 electronic databases to identify primary research studies published between Jan 1, 1990, and Aug 17, 2010, reporting prevalence estimates of violence against adults (aged mainly >= 18 years) with disabilities, or their risk of violence compared with non-disabled adults. We included only studies reporting violence occurring within the 12 months before the study. We assessed studies with six core quality criteria, and pooled data for analysis. Findings Of 10 663 references initially identified, 26 were eligible for inclusion, with data for 21 557 individuals with disabilities. 21 studies provided data suitable for meta-analysis of prevalence of violence, and ten for meta-analysis of risks of violence. Pooled prevalence of any (physical, sexual, or intimate partner) recent violence was 24.3% (95% CI 18.3-31.0) in people with mental illnesses, 6.1% (2.5-11.1) in those with intellectual impairments, and 3.2% (2.5-4.1) in those with non-specific impairments. We identified substantial heterogeneity in most prevalence estimates (I-2 > 75%). We noted large uncertainty around pooled risk estimates. Pooled crude odds ratios for the risk of violence in disabled compared with non-disabled individuals were 1.50 (95% CI 1.09-2.05) for all studies combined, 1.31 (0.93-1.84) for people with non-specific impairments, 1.60 (1.05-2.45) for people with intellectual impairments, and 3.86 (0.91-16.43) for those with mental illnesses. Interpretation Adults with disabilities are at a higher risk of violence than are non-disabled adults, and those with mental illnesses could be particularly vulnerable. However, available studies have methodological weaknesses and gaps exist in the types of disability and violence they address. Robust studies are absent for most regions of the world, particularly low-income and middle-income countries.	[Hughes, Karen; Bellis, Mark A.; Jones, Lisa; Wood, Sara; Bates, Geoff; Eckley, Lindsay; McCoy, Ellie] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 2ET, Merseyside, England; [Mikton, Christopher; Shakespeare, Tom; Officer, Alana] WHO, Dept Violence & Injury Prevent & Disabil, CH-1211 Geneva, Switzerland	Liverpool John Moores University; World Health Organization	Bellis, MA (corresponding author), Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 2ET, Merseyside, England.	m.a.bellis@ljmu.ac.uk	Bellis, Mark A./HGA-2019-2022; Jones, Lisa/C-2678-2013	Jones, Lisa/0000-0001-5136-5614; Hughes, Karen/0000-0001-8097-3395; Bates, Geoff/0000-0001-6932-2372	WHO Department of Violence and Injury Prevention and Disability	WHO Department of Violence and Injury Prevention and Disability	WHO Department of Violence and Injury Prevention and Disability.	[Anonymous], 2011, BBC NEWS        0620; [Anonymous], 2009, BBC NEWS 0123 BBC NEWS 0123; Brownridge DA, 2009, CONTEMP SOCIOL PERSP, P232; CARLILE JB, 1991, CAN J PSYCHIAT, V36, P265, DOI 10.1177/070674379103600405; Cascardi M, 1996, PSYCHIATR SERV, V47, P531; Casteel C, 2008, INJURY PREV, V14, P87, DOI 10.1136/ip.2007.016451; Centre for Reviews and Dissemination, 2008, SYSTEMATIC REV CRDS; Chapple B, 2004, SOC PSYCH PSYCH EPID, V39, P836, DOI 10.1007/s00127-004-0819-4; Chartier MJ, 2007, AM J EPIDEMIOL, V165, P1031, DOI 10.1093/aje/kwk113; Compton SA, 1997, INT J GERIATR PSYCH, V12, P632, DOI 10.1002/(SICI)1099-1166(199706)12:6<632::AID-GPS570>3.3.CO;2-0; Cooper C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b155; Curtis P, 2011, PANORAMA CARE HOME A; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Goodman LA, 2001, J TRAUMA STRESS, V14, P615, DOI 10.1023/A:1013026318450; Hall P., 2010, CRIME ENGLAND WALES; Hiday VA, 1999, PSYCHIATR SERV, V50, P62, DOI 10.1176/ps.50.1.62; Hodgins S, 2007, BRIT J PSYCHIAT, V191, P343, DOI 10.1192/bjp.bp.106.06.029587; Hsu CC, 2009, AUST NZ J PSYCHIAT, V43, P460, DOI 10.1080/00048670902817737; Human RightsWatch, 2010, WE WER HUM DISCR VIO; Lin LP, 2009, RES DEV DISABIL, V30, P969, DOI 10.1016/j.ridd.2009.02.001; Marge Dorothy K., 2003, CALL ACTION ENDING C; Martin SL, 2006, VIOLENCE AGAINST WOM, V12, P823, DOI 10.1177/1077801206292672; Matthias RE, 2003, HEALTH SOC WORK, V28, P174, DOI 10.1093/hsw/28.3.174; McFarlane J, 2001, J WOMEN HEALTH GEN-B, V10, P861, DOI 10.1089/152460901753285750; McPherson MD, 2007, PSYCHIAT SERV, V58, P675, DOI 10.1176/appi.ps.58.5.675; Mericle AA, 2008, SOC PSYCH PSYCH EPID, V43, P392, DOI 10.1007/s00127-008-0322-4; Mohapatra S., 2005, ABUSE ACTIVITY LIMIT; Mullen P. E., 2006, ADV PSYCHIAT TREATME, V12, P239, DOI DOI 10.1192/APT.12.4.239; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nosek MA, 2001, SEX DISABIL, V19, P177, DOI 10.1023/A:1013152530758; Quarmby K, 2011, SCAPEGOAT WHY WE ARE; Rand MichaelL.R., 2009, CRIME PEOPLE DISABIL; Rurangirwa J, 2006, RES DEV DISABIL, V27, P381, DOI 10.1016/j.ridd.2005.01.003; Saxton M, 2001, VIOLENCE AGAINST WOM, V7, P393, DOI 10.1177/10778010122182523; Seo Y, 2008, J LEARN DISABIL-US, V41, P300, DOI 10.1177/0022219407311308; Silver E, 2005, AM J PUBLIC HEALTH, V95, P2015, DOI 10.2105/AJPH.2003.021436; Silver E, 2002, CRIMINOLOGY, V40, P191, DOI 10.1111/j.1745-9125.2002.tb00954.x; Slayter E., 2009, J AGGRESS MALTREAT T, V18, P182, DOI [10.1080/10926770802675668, DOI 10.1080/10926770802675668]; Stuart A, 1994, KENDALLS ADV THEORY; Teplin LA, 2005, ARCH GEN PSYCHIAT, V62, P911, DOI 10.1001/archpsyc.62.8.911; Walsh E, 2003, BRIT J PSYCHIAT, V183, P233, DOI 10.1192/bjp.183.3.233; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2011, GLOB BURD DIS DIS IN; World Health Organization, 2005, 58 WORLD HLTH ASS GE, P16; World Health Organization, 2002, WORLD REPORT VIOLENC	46	294	297	1	71	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 28	2012	379	9826					1621	1629		10.1016/S0140-6736(11)61851-5	http://dx.doi.org/10.1016/S0140-6736(11)61851-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22377290				2022-12-28	WOS:000303452600036
J	Dahabreh, IJ; Chung, M; Balk, EM; Yu, WW; Mathew, P; Lau, J; Ip, S				Dahabreh, Issa J.; Chung, Mei; Balk, Ethan M.; Yu, Winifred W.; Mathew, Paul; Lau, Joseph; Ip, Stanley			Active Surveillance in Men With Localized Prostate Cancer A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; COMPARING RADICAL PROSTATECTOMY; CONSERVATIVE MANAGEMENT; INITIAL TREATMENT; CAPSURE DATABASE; ANTIGEN ERA; ANDROGEN-DEPRIVATION; EXPECTANT MANAGEMENT; DISEASE PROGRESSION; PATIENT PREFERENCES	Background: Active surveillance (AS) and watchful waiting (WW) have been proposed as management strategies for low-risk, localized prostate cancer. Purpose: To systematically review strategies for observational management of prostate cancer (AS or WW), factors affecting their utilization, and comparative effectiveness of observational management versus immediate treatment with curative intent. Data Sources: MEDLINE and Cochrane databases (from inception to August 2011). Study Selection: Screened abstracts and reviewed full-text publications to identify eligible studies. Data Extraction: One reviewer extracted data, and another verified quantitative data. Two independent reviewers rated study quality and strength of evidence for comparative effectiveness. Data Synthesis: Sixteen independent cohorts defined AS, 42 studies evaluated factors that affect the use of observational strategies, and 2 evidence reports and 22 recent studies reported comparisons of WW versus treatment with curative intent. The most common eligibility criteria for AS were tumor stage (all cohorts), Gleason score (12 cohorts), prostate-specific antigen (PSA) concentration (10 cohorts), and number of biopsy cores positive for cancer (8 cohorts). For monitoring, studies used combinations of periodic PSA testing (all cohorts), digital rectal examination (14 cohorts), and rebiopsy (14 cohorts). Predictors of receiving no active treatment included older age, comorbid conditions, lower Gleason score, tumor stage, PSA concentration, and favorable risk group. No published studies compared AS with immediate treatment with curative intent. Watchful waiting was generally less effective than treatment with curative intent; however, applicability to contemporary patients may be limited. Limitations: Active surveillance and WW often could not be differentiated in the reviewed studies. Published randomized trials have assessed only WW and did not enroll patients diagnosed by PSA screening. Conclusion: Evidence is insufficient to assess whether AS is an appropriate option for men with localized prostate cancer. A standard definition of AS that clearly distinguishes it from WW is needed to clarify scientific discourse.	[Dahabreh, Issa J.; Chung, Mei; Balk, Ethan M.; Yu, Winifred W.; Mathew, Paul; Lau, Joseph; Ip, Stanley] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Tufts Evidence Based Practice Ctr, Boston, MA 02111 USA	Tufts Medical Center	Ip, S (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Tufts Evidence Based Practice Ctr, Box 63,800 Washington St, Boston, MA 02111 USA.	sip@tuftsmedicalcenter.org	Balk, Ethan/AAJ-2547-2020		Agency for Healthcare Research and Quality; Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA 290-2007-10055-I]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069772] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Agency for Healthcare Research and Quality.; This project was funded under contract HHSA 290-2007-10055-I from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.	Adamy A, 2011, J UROLOGY, V185, P477, DOI 10.1016/j.juro.2010.09.095; Adolfsson J, 2007, EUR UROL, V52, P1028, DOI 10.1016/j.eururo.2007.04.002; Agency for Healthcare Research and Quality, 2010, METH REF GUID EFF CO; Al Otaibi M, 2008, CANCER, V113, P286, DOI 10.1002/cncr.23575; Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; Anai S, 2008, J HEALTH CARE POOR U, V19, P164, DOI 10.1353/hpu.2008.0024; Anandadas CN, 2011, BJU INT, V107, P1762, DOI 10.1111/j.1464-410X.2010.09833.x; Andersson SO, 2011, SCAND J UROL NEPHROL, V45, P177, DOI 10.3109/00365599.2010.545075; [Anonymous], 2011, AM UR ASS ANN M WEBC; Bacon CG, 2001, J UROLOGY, V166, P1804, DOI 10.1016/S0022-5347(05)65679-0; BANGMA CH, 1995, J UROLOGY, V154, P1403, DOI 10.1016/S0022-5347(01)66877-0; Bannuru RR, 2011, ANN INTERN MED, V155, P171, DOI 10.7326/0003-4819-155-3-201108020-00347; Barocas DA, 2008, J UROLOGY, V180, P1330, DOI 10.1016/j.juro.2008.06.019; Berge V, 2007, EUR UROL, V52, P1036, DOI 10.1016/j.eururo.2006.12.012; Berry DL, 2003, UROL ONCOL-SEMIN O I, V21, P93, DOI 10.1016/S1078-1439(02)00209-0; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Carter CA, 2003, J CLIN ONCOL, V21, P4001, DOI 10.1200/JCO.2003.04.092; Chan JM, 2011, CANCER CAUSE CONTROL, V22, P141, DOI 10.1007/s10552-010-9684-5; Chapple A, 2002, BJU INT, V90, P257, DOI 10.1046/j.1464-410X.2002.02846.x; Chen Weng-Ming, 2003, J Chin Med Assoc, V66, P236; Choo R, 2001, INT J RADIAT ONCOL, V50, P615, DOI 10.1016/S0360-3016(01)01511-5; Cooperberg MR, 2011, J CLIN ONCOL, V29, P228, DOI 10.1200/JCO.2010.31.4252; Cooperberg MR, 2003, J UROLOGY, V170, pS21, DOI 10.1097/01.ju.0000095025.03331.c6; Corcoran AT, 2010, UROLOGY, V76, P703, DOI 10.1016/j.urology.2009.12.071; Crawford ED, 1997, UROLOGY, V50, P366; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P2664, DOI 10.1002/cncr.23502; Dall'Era MA, 2009, J UROLOGY, V181, P1622, DOI 10.1016/j.juro.2008.11.123; Davison BJ, 2009, ONCOL NURS FORUM, V36, P89, DOI 10.1188/09.ONF.89-96; Demark-Wahnefried W, 1998, CANCER, V83, P320, DOI 10.1002/(SICI)1097-0142(19980715)83:2<320::AID-CNCR16>3.0.CO;2-V; Diefenbach Michael A, 2002, Semin Urol Oncol, V20, P55, DOI 10.1053/suro.2002.30399; Durham John, 2003, N Z Med J, V116, pU476; Eggener SE, 2009, J UROLOGY, V181, P1635, DOI 10.1016/j.juro.2008.11.109; El-Geneidy M, 2004, BJU INT, V93, P510, DOI 10.1111/j.1464-410X.2003.04669.x; Eldefrawy A, 2011, UROL ONCOL; Elliott SP, 2007, J UROLOGY, V178, P529, DOI 10.1016/j.juro.2007.03.126; Ercole B, 2008, J UROLOGY, V180, P1336, DOI 10.1016/j.juro.2008.06.027; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; Francisco IFS, 2011, J UROLOGY, V185, P471, DOI 10.1016/j.juro.2010.09.115; Fransson P, 2009, SCAND J UROL NEPHROL, V43, P119, DOI 10.1080/00365590802519396; Giles SL, 2011, AM J ROENTGENOL, V196, P586, DOI 10.2214/AJR.10.5016; Gorin MA, 2011, UROLOGY, V77, P588, DOI 10.1016/j.urology.2010.10.039; Hadley J, 2010, JNCI-J NATL CANCER I, V102, P1780, DOI 10.1093/jnci/djq393; Hamilton AS, 2011, BJU INT, V107, P576, DOI 10.1111/j.1464-410X.2010.09514.x; HANDLEY R, 1988, BRIT J UROL, V62, P249, DOI 10.1111/j.1464-410X.1988.tb04328.x; Hardie C, 2005, BJU INT, V95, P956, DOI 10.1111/j.1464-410X.2005.05446.x; Harlan SR, 2003, J UROLOGY, V170, P1804, DOI 10.1097/01.ju.0000091641.34674.11; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Holmboe ES, 2000, J GEN INTERN MED, V15, P694, DOI 10.1046/j.1525-1497.2000.90842.x; Ip S, 2011, 204 AG HLTH RES QUAL; Ip S, 2010, AHRQ TECHNOLOGY ASSE; IVERSEN P, 1995, SCAND J UROL NEPHROL, P65; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Johansson E, 2009, EUR UROL, V55, P422, DOI 10.1016/j.eururo.2008.08.054; JOHANSSON JE, 1994, J UROLOGY, V152, P1753, DOI 10.1016/S0022-5347(17)32378-9; JONES GW, 1992, CANCER, V70, P307, DOI 10.1002/1097-0142(19920701)70:1+<307::AID-CNCR2820701319>3.0.CO;2-N; Kakehi Y, 2008, JPN J CLIN ONCOL, V38, P122, DOI 10.1093/jjco/hym161; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Konety BR, 2008, J UROLOGY, V179, P1797, DOI 10.1016/j.juro.2008.01.044; Koppie TM, 2000, J UROLOGY, V164, P81, DOI 10.1016/S0022-5347(05)67454-X; Krakowsky Y, 2010, J UROLOGY, V184, P131, DOI 10.1016/j.juro.2010.03.041; Lane JA, 2010, EUR J CANCER, V46, P3095, DOI 10.1016/j.ejca.2010.09.016; Latini DM, 2007, J UROLOGY, V178, P826, DOI 10.1016/j.juro.2007.05.039; Latini DM, 2006, CANCER, V106, P789, DOI 10.1002/cncr.21675; Lin GA, 2009, CA-CANCER J CLIN, V59, P379, DOI 10.3322/caac.20039; Litwin MS, 2002, CANCER, V95, P54, DOI 10.1002/cncr.10651; Loblaw A, 2010, J UROLOGY, V184, P1942, DOI 10.1016/j.juro.2010.06.101; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; Lubeck DP, 1999, UROLOGY, V53, P180, DOI 10.1016/S0090-4295(98)00408-7; Marr PL, 2006, J UROLOGY, V175, P1326, DOI 10.1016/S0022-5347(05)00647-6; McIntyre IG, 2001, UROLOGY, V58, P762, DOI 10.1016/S0090-4295(01)01358-9; Meng MV, 2005, J UROLOGY, V173, P1557, DOI 10.1097/01.ju.0000154610.81916.81; Meng MV, 2003, J UROLOGY, V170, P2279, DOI 10.1097/01.ju.0000094190.46523.b2; Metcalfe C, 2009, BRIT J CANCER, V101, P390, DOI 10.1038/sj.bjc.6605181; Mills N, 2006, CONTEMP CLIN TRIALS, V27, P413, DOI 10.1016/j.cct.2006.04.008; Miocinovic R, 2011, UROLOGY, V77, P980, DOI 10.1016/j.urology.2010.09.063; Moses KA, 2010, J CLIN ONCOL, V28, P1069, DOI 10.1200/JCO.2009.26.2469; Neulander EZ, 2000, BJU INT, V85, P699, DOI 10.1046/j.1464-410x.2000.00569.x; Newcomb LF, 2010, UROLOGY, V75, P407, DOI 10.1016/j.urology.2009.05.050; O'Rourke ME, 1999, CANCER INVEST, V17, P349, DOI 10.3109/07357909909032877; OLLENDORF D, 2009, MANAGEMENT OPTIONS L; Ollendorf DA., 2009, FINAL APPRAISAL DOCU; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Patel MI, 2004, J UROLOGY, V171, P1520, DOI 10.1097/01.ju.0000118224.54949.78; Penson DF, 2001, UROLOGY, V57, P499, DOI 10.1016/S0090-4295(00)01033-5; Porten SP, 2011, J CLIN ONCOL, V29, P2795, DOI 10.1200/JCO.2010.33.0134; Ramsey SD, 2011, WORLD J UROL, V29, P3, DOI 10.1007/s00345-010-0602-y; RANA A, 1993, BRIT J UROL, V71, P721, DOI 10.1111/j.1464-410X.1993.tb16073.x; Rice KR, 2011, UROL ONCOL; Ries LAG, 2007, NIH PUBLICATION, V07-6215; Roberts CB, 2011, AM J MED, V124, P235, DOI 10.1016/j.amjmed.2010.10.016; Ross AE, 2010, J CLIN ONCOL, V28, P2810, DOI 10.1200/JCO.2009.25.7311; Rothwell PM, 2005, LANCET, V365, P256; Sadetsky N, 2008, PROSTATE CANCER P D, V11, P280, DOI 10.1038/sj.pcan.4501015; Schapira MM, 2001, MED CARE, V39, P243, DOI 10.1097/00005650-200103000-00005; Schymura MJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-152; Shavers VL, 2004, MED CARE, V42, P239, DOI 10.1097/01.mlr.0000117361.61444.71; Shavers VL, 2004, J GEN INTERN MED, V19, P146, DOI 10.1111/j.1525-1497.2004.30209.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Snyder CF, 2010, CANCER-AM CANCER SOC, V116, P5391, DOI 10.1002/cncr.25517; Soloway MS, 2008, BJU INT, V101, P165, DOI 10.1111/j.1464-410X.2007.07190.x; Soloway MS, 2010, EUR UROL, V58, P831, DOI 10.1016/j.eururo.2010.08.027; Sommers BD, 2008, CANCER, V113, P2058, DOI 10.1002/cncr.23807; Stattin P, 2010, JNCI-J NATL CANCER I, V102, P950, DOI 10.1093/jnci/djq154; Steginga SK, 2002, BJU INT, V89, P255, DOI 10.1046/j.1464-4096.2001.01741.x; Stephenson RA, 2002, UROL CLIN N AM, V29, P173, DOI 10.1016/S0094-0143(02)00002-2; Stratton MS, 2003, ANTI-CANCER DRUG, V14, P595, DOI 10.1097/00001813-200309000-00004; Thong MSY, 2010, BJU INT, V105, P652, DOI 10.1111/j.1464-410X.2009.08815.x; van As NJ, 2008, EUR UROL, V54, P1297, DOI 10.1016/j.eururo.2008.02.039; van den Bergh RCN, 2010, BJU INT, V105, P956, DOI 10.1111/j.1464-410X.2009.08887.x; van den Bergh RCN, 2009, CANCER-AM CANCER SOC, V115, P3868, DOI 10.1002/cncr.24446; Venkitaraman R, 2008, INT J BIOL MARKER, V23, P192, DOI 10.1177/172460080802300310; Venkitaraman R, 2008, BJU INT, V101, P161, DOI 10.1111/j.1464-410X.2007.07175.x; Whitson JM, 2011, J UROLOGY, V185, P1656, DOI 10.1016/j.juro.2010.12.042; Widmark A, PROSPECTIVE RANDOMIZ; Wilson LS, 2007, CANCER-AM CANCER SOC, V109, P518, DOI 10.1002/cncr.22433; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Wilt TJ, 2009, CONTEMP CLIN TRIALS, V30, P81, DOI 10.1016/j.cct.2008.08.002; Wilt TJ, 2008, COMP EFFECTIVENESS R, V13; Wolters T, 2010, INT J CANCER, V126, P2387, DOI 10.1002/ijc.24870; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683; Wu HY, 2004, J UROLOGY, V171, P1111, DOI 10.1097/01.ju.0000113300.74132.8b; Xu JP, 2011, J NATL MED ASSOC, V103, P468, DOI 10.1016/S0027-9684(15)30359-X; Yan Y, 2000, CANCER, V88, P1122, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1122::AID-CNCR24>3.0.CO;2-Q; Zietman AL, 2001, J UROLOGY, V166, P1702, DOI 10.1016/S0022-5347(05)65657-1	124	61	63	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8					582	U110		10.7326/0003-4819-156-8-201204170-00009	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-00009			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22351515				2022-12-28	WOS:000303151800017
J	Rayman, MP				Rayman, Margaret P.			Selenium and human health	LANCET			English	Review							GLUTATHIONE-PEROXIDASE ACTIVITY; PROSTATE-CANCER RISK; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; ACUTE-PHASE RESPONSE; FOOD-CHAIN SELENIUM; LOW SERUM SELENIUM; PLASMA SELENIUM; SELENOPROTEIN-P; LUNG-CANCER	Selenium is incorporated into selenoproteins that have a wide range of pleiotropic effects, ranging from anti oxidant and anti-inflammatory effects to the production of active thyroid hormone. In the past 10 years, the discovery of disease-associated polymorphisms in seleno protein genes has drawn attention to the relevance of selenoproteins to health. Low selenium status has been associated with increased risk of mortality, poor immune function, and cognitive decline. Higher selenium status or selenium supplementation has antiviral effects, is essential for successful male and female reproduction, and reduces the risk of autoimmune thyroid disease. Prospective studies have generally shown some benefit of higher selenium status on the risk of prostate, lung, colorectal, and bladder cancers, but findings from trials have been mixed, which probably emphasises the fact that supplementation will confer benefit only if intake of a nutrient is inadequate. Supplementation of people who already have adequate intake with additional selenium might increase their risk of type-2 diabetes. The crucial factor that needs to be emphasised with regard to the health effects of selenium is the inextricable U-shaped link with status; whereas additional selenium intake may benefit people with low status, those with adequate-to-high status might be affected adversely and should not take selenium supplements.	Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England	University of Surrey	Rayman, MP (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England.	m.rayman@surrey.ac.uk			Wassen International; Pharma Nord	Wassen International; Pharma Nord	I have received a contribution towards funding of a PhD studentship from Wassen International and funding from Pharma Nord for the measurement of plasma selenium in a cohort of 1200 pregnant women.	Akbaraly NT, 2007, EPIDEMIOLOGY, V18, P52, DOI 10.1097/01.ede.0000248202.83695.4e; Akbaraly NT, 2005, CLIN CHEM, V51, P2117, DOI 10.1373/clinchem.2005.055301; Akbaraly TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-21; Allen NE, 2008, AM J CLIN NUTR, V88, P1567, DOI 10.3945/ajcn.2008.26205; Amaral AFS, 2010, CANCER EPIDEM BIOMAR, V19, P2407, DOI 10.1158/1055-9965.EPI-10-0544; Amiri M, 2010, BIOL TRACE ELEM RES, V135, P38, DOI 10.1007/s12011-009-8487-6; Ashrafi MR, 2007, PEDIATR NEUROL, V36, P25, DOI 10.1016/j.pediatrneurol.2006.09.001; Ashrafi MR, 2007, EPILEPSIA, V48, P1750, DOI 10.1111/j.1528-1167.2007.01143.x; Bates CJ, 2002, J TRACE ELEM MED BIO, V16, P1, DOI 10.1016/S0946-672X(02)80002-5; Beck MA, 2004, TRENDS MICROBIOL, V12, P417, DOI 10.1016/j.tim.2004.07.007; Beck MA, 2003, J NUTR, V133, p1463S, DOI 10.1093/jn/133.5.1463S; Bekaert B, 2009, AM J CLIN NUTR, V89, P1276, DOI 10.3945/ajcn.2009.27443; Berr C, 2000, J AM GERIATR SOC, V48, P1285, DOI 10.1111/j.1532-5415.2000.tb02603.x; Bjelakovic G, 2004, LANCET, V364, P1219, DOI 10.1016/S0140-6736(04)17138-9; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bleys J, 2008, ARCH INTERN MED, V168, P404, DOI 10.1001/archinternmed.2007.74; Bleys J, 2007, DIABETES CARE, V30, P829, DOI 10.2337/dc06-1726; Brinkman M, 2006, EUR J CANCER, V42, P2463, DOI 10.1016/j.ejca.2006.02.027; Broome CS, 2004, AM J CLIN NUTR, V80, P154; Burbano Ximena, 2002, HIV Clin Trials, V3, P483; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Carlson BA, 2010, P NUTR SOC, V69, P300, DOI 10.1017/S002966511000176X; Chen XH, 2003, J CLIN ENDOCR METAB, V88, P5963, DOI 10.1210/jc.2003-030544; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Cooper ML, 2008, CANCER RES, V68, P10171, DOI 10.1158/0008-5472.CAN-08-1827; Cotton PA, 2004, J AM DIET ASSOC, V104, P921, DOI 10.1016/j.jada.2004.03.019; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Czernichow S, 2006, AM J CLIN NUTR, V84, P395; Derumeaux H, 2003, EUR J ENDOCRINOL, V148, P309, DOI 10.1530/eje.0.1480309; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-85; Duffield AJ, 1999, AM J CLIN NUTR, V70, P896; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Duffield-Lillico AJ, 2003, JNCI-J NATL CANCER I, V95, P1477, DOI 10.1093/jnci/djg061; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Epplein M, 2009, CANCER EPIDEM BIOMAR, V18, P1962, DOI 10.1158/1055-9965.EPI-09-0003; Etminan M, 2005, CANCER CAUSE CONTROL, V16, P1125, DOI 10.1007/s10552-005-0334-2; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Fairweather-Tait SJ, 2010, AM J CLIN NUTR, V91, p1484S, DOI 10.3945/ajcn.2010.28674J; Flores-Mateo G, 2006, AM J CLIN NUTR, V84, P762, DOI 10.1093/ajcn/84.4.762; Florian S, 2010, FREE RADICAL BIO MED, V49, P1694, DOI 10.1016/j.freeradbiomed.2010.08.029; Food Standards Agency, 2009, SURV MEAS CONC MET O; Forceville X, 2007, J TRACE ELEM MED BIO, V21, P62, DOI 10.1016/j.jtemb.2007.09.021; Foresta C, 2002, BIOL REPROD, V67, P967, DOI 10.1095/biolreprod.102.003822; Gao SJ, 2007, AM J EPIDEMIOL, V165, P955, DOI 10.1093/aje/kwk073; Gao Y, 2003, DIABETES, V52, P929, DOI 10.2337/diabetes.52.4.929; Gill JK, 2009, CANCER CAUSE CONTROL, V20, P1161, DOI 10.1007/s10552-009-9304-4; GLATTRE E, 1989, INT J EPIDEMIOL, V18, P45, DOI 10.1093/ije/18.1.45; Hawkes WC, 2001, J ANDROL, V22, P764; Hawkes WC, 2001, BIOL TRACE ELEM RES, V81, P189, DOI 10.1385/BTER:81:3:189; Hesse-Baehr K., 2000, Biofactors, V11, P83; Hoffmann FW, 2010, J NUTR, V140, P1155, DOI 10.3945/jn.109.120725; Hoffmann PR, 2007, ARCH IMMUNOL THER EX, V55, P289, DOI 10.1007/s00005-007-0036-4; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hurst R, 2010, AM J CLIN NUTR, V91, P923, DOI 10.3945/ajcn.2009.28169; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Johnson CC, 2010, P NUTR SOC, V69, P119, DOI 10.1017/S0029665109991807; Kiremidjian-Schumacher L, 2000, BIOL TRACE ELEM RES, V73, P97, DOI 10.1385/BTER:73:2:97; Kljai K, 2001, BIOL TRACE ELEM RES, V83, P223, DOI 10.1385/BTER:83:3:223; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kupka R, 2008, AM J CLIN NUTR, V87, P1802, DOI 10.1093/ajcn/87.6.1802; Labunskyy VM, 2011, ANTIOXID REDOX SIGN, V14, P2327, DOI 10.1089/ars.2010.3526; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Lei C, 2009, CLIN CHIM ACTA, V399, P102, DOI 10.1016/j.cca.2008.09.025; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; LUOMA PV, 1984, RES COMMUN CHEM PATH, V46, P469; Mahabir S, 2007, INT J CANCER, V120, P1108, DOI 10.1002/ijc.22451; Mahabir S, 2010, CANCER EPIDEM BIOMAR, V19, P1976, DOI 10.1158/1055-9965.EPI-10-0067; Mahyar A, 2010, PEDIATR NEUROL, V43, P331, DOI 10.1016/j.pediatrneurol.2010.05.024; Marcocci C, 2011, NEW ENGL J MED, V364, P1920, DOI 10.1056/NEJMoa1012985; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Mistry HD, 2008, HYPERTENSION, V52, P881, DOI 10.1161/HYPERTENSIONAHA.108.116103; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Moses EK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.024; Nacamulli D, 2010, CLIN ENDOCRINOL, V73, P535, DOI 10.1111/j.1365-2265.2009.03758.x; *NAT CTR HLTH STAT, 2003, NAT HLTH NUTR EX SUR; Navarro-Alarcon M, 1999, SCI TOTAL ENVIRON, V228, P79, DOI 10.1016/S0048-9697(99)00034-0; Negro R, 2007, J CLIN ENDOCR METAB, V92, P1263, DOI 10.1210/jc.2006-1821; Nichol C, 1998, CLIN CHEM, V44, P1764; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Penney KL, 2010, CANCER PREV RES, V3, P604, DOI 10.1158/1940-6207.CAPR-09-0216; Peters U, 2008, MOL NUTR FOOD RES, V52, P1261, DOI 10.1002/mnfr.200800103; Peters U, 2008, CANCER CAUSE CONTROL, V19, P75, DOI 10.1007/s10552-007-9072-y; Peters U, 2007, AM J CLIN NUTR, V85, P209, DOI 10.1093/ajcn/85.1.209; Rajpathak S, 2005, J AM COLL NUTR, V24, P250, DOI 10.1080/07315724.2005.10719472; Ravaglia G, 2003, AM J CLIN NUTR, V77, P668, DOI 10.1093/ajcn/77.3.668; Ray AL, 2006, J NUTR, V136, P172, DOI 10.1093/jn/136.1.172; Rayman M, 2006, BIOL PSYCHIAT, V59, P147, DOI 10.1016/j.biopsych.2005.06.019; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Rayman MP, 2008, BRIT J NUTR, V100, P238, DOI 10.1017/S0007114508922522; Rayman MP, 2008, AM J CLIN NUTR, V87, P370, DOI 10.1093/ajcn/87.2.370; Rayman MP, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P531, DOI 10.1007/978-1-4614-1025-6_42; Rayman MP, 2011, ANN INTERN MED, V154, P656, DOI 10.7326/0003-4819-154-10-201105170-00005; Rayman MP, 2011, CAN MED ASSOC J, V183, P549, DOI 10.1503/cmaj.101095; Rayman MP, 2010, NUTR HEALTH SER, P411, DOI 10.1007/978-1-60761-627-6_19; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Rayman MP, 2009, JAMA-J AM MED ASSOC, V301, P1876, DOI 10.1001/jama.2009.625; Rayman MP, 2004, BRIT J NUTR, V92, P557, DOI 10.1079/BJN20041251; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Rayman MP, 2003, AM J OBSTET GYNECOL, V189, P1343, DOI 10.1067/S0002-9378(03)00723-3; Rayman MP, 2002, P NUTR SOC, V61, P203, DOI 10.1079/PNS2002153; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Reid ME, 2002, CANCER EPIDEM BIOMAR, V11, P1285; Renko K, 2009, FASEB J, V23, P1758, DOI 10.1096/fj.08-119370; ROY M, 1994, BIOL TRACE ELEM RES, V41, P103, DOI 10.1007/BF02917221; Ruston D., 2004, NATL DIET NUTR SURVE, V4; SCHIAVON R, 1994, EUR J CLIN CHEM CLIN, V32, P759; Schmutzler C, 2007, BIOL CHEM, V388, P1053, DOI 10.1515/BC.2007.122; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Schomburg L, 2008, MOL NUTR FOOD RES, V52, P1235, DOI 10.1002/mnfr.200700465; Schweizer U, 2004, BRAIN RES REV, V45, P164, DOI 10.1016/j.brainresrev.2004.03.004; Shahar A, 2010, MOVEMENT DISORD, V25, P1909, DOI 10.1002/mds.23218; Shaheen SO, 2007, THORAX, V62, P483, DOI 10.1136/thx.2006.071563; Shor-Posner G, 2002, J ACQ IMMUN DEF SYND, V29, P169, DOI 10.1097/00042560-200202010-00010; Steinbrecher A, 2010, CANCER EPIDEM BIOMAR, V19, P2958, DOI 10.1158/1055-9965.EPI-10-0364; Steinbrenner H, 2011, J CLIN BIOCHEM NUTR, V48, P40, DOI 10.3164/jcbn.11-002FR; Stranges S, 2006, AM J EPIDEMIOL, V163, P694, DOI 10.1093/aje/kwj097; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Takemoto AS, 2010, ETHNIC DIS, V20; Toulis KA, 2010, THYROID, V20, P1163, DOI 10.1089/thy.2009.0351; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Vanderlelie J, 2005, PLACENTA, V26, P53, DOI 10.1016/j.placenta.2004.04.002; Wei WQ, 2004, AM J CLIN NUTR, V79, P80; WHO, 1987, ENV HLTH CRIT; Wood, 2000, Integr Med, V2, P85, DOI 10.1016/S1096-2190(00)00009-3; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Xun PC, 2010, ATHEROSCLEROSIS, V210, P662, DOI 10.1016/j.atherosclerosis.2010.01.021; Yamashita Y, 2010, J BIOL CHEM, V285, P18134, DOI 10.1074/jbc.C110.106377; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620; Yu MW, 1999, AM J EPIDEMIOL, V150, P367, DOI 10.1093/oxfordjournals.aje.a010016; YU SY, 1990, BIOL TRACE ELEM RES, V24, P105, DOI 10.1007/BF02917199; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771	133	1905	2029	63	811	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2012	379	9822					1256	1268		10.1016/S0140-6736(11)61452-9	http://dx.doi.org/10.1016/S0140-6736(11)61452-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918DV	22381456				2022-12-28	WOS:000302230400038
J	Christie, JM; Arvai, AS; Baxter, KJ; Heilmann, M; Pratt, AJ; O'Hara, A; Kelly, SM; Hothorn, M; Smith, BO; Hitomi, K; Jenkins, GI; Getzoff, ED				Christie, John M.; Arvai, Andrew S.; Baxter, Katherine J.; Heilmann, Monika; Pratt, Ashley J.; O'Hara, Andrew; Kelly, Sharon M.; Hothorn, Michael; Smith, Brian O.; Hitomi, Kenichi; Jenkins, Gareth I.; Getzoff, Elizabeth D.			Plant UVR8 Photoreceptor Senses UV-B by Tryptophan-Mediated Disruption of Cross-Dimer Salt Bridges	SCIENCE			English	Article							SIGNALING COMPONENT UVR8; SCATTERING SAXS; ARABIDOPSIS; TRANSDUCTION; ASSEMBLIES; CHROMATIN; PROTEINS; TISSUE	The recently identified plant photoreceptor UVR8 (UV RESISTANCE LOCUS 8) triggers regulatory changes in gene expression in response to ultraviolet-B (UV-B) light through an unknown mechanism. Here, crystallographic and solution structures of the UVR8 homodimer, together with mutagenesis and far-UV circular dichroism spectroscopy, reveal its mechanisms for UV-B perception and signal transduction. beta-propeller subunits form a remarkable, tryptophan-dominated, dimer interface stitched together by a complex salt-bridge network. Salt-bridging arginines flank the excitonically coupled cross-dimer tryptophan "pyramid" responsible for UV-B sensing. Photoreception reversibly disrupts salt bridges, triggering dimer dissociation and signal initiation. Mutation of a single tryptophan to phenylalanine retunes the photoreceptor to detect UV-C wavelengths. Our analyses establish how UVR8 functions as a photoreceptor without a prosthetic chromophore to promote plant development and survival in sunlight.	[Christie, John M.; Baxter, Katherine J.; Heilmann, Monika; O'Hara, Andrew; Kelly, Sharon M.; Smith, Brian O.; Jenkins, Gareth I.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Christie, John M.; Arvai, Andrew S.; Pratt, Ashley J.; Hitomi, Kenichi; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Christie, John M.; Arvai, Andrew S.; Pratt, Ashley J.; Hitomi, Kenichi; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hothorn, Michael] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Hitomi, Kenichi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Hitomi, Kenichi] Natl Inst Biomed Innovat, Sect Lab Equipment, Osaka 5670085, Japan	University of Glasgow; Scripps Research Institute; Scripps Research Institute; Salk Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institute of Health Sciences - Japan	Jenkins, GI (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland.	jenkins@glasgow.ac.uk; edg@scripps.edu	Smith, Brian/AAJ-9393-2020; Kelly, Sharon/K-4611-2013; Hothorn, Michael/C-6807-2011; Pratt, Ashley/A-1754-2012; Smith, Brian O/J-1899-2015	Smith, Brian/0000-0003-3363-4168; Pratt, Ashley/0000-0002-9702-8805; Smith, Brian O/0000-0003-3363-4168; Baxter, Katherine/0000-0001-8237-9103; Hothorn, Michael/0000-0002-3597-5698; Kelly, Sharon/0000-0002-3516-1387; Christie, John/0000-0002-9976-0055	National Institutes of Health [GM37684]; Skaggs Institute for Chemical Biology; National Science Foundation; Royal Society; Leverhulme Trust [F/00179/AZ]; UK Biotechnology and Biological Sciences Research Council; Department of Energy, Office of Biological and Environmental Research; BBSRC [BB/F014961/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F014961/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Cloix, E. Kaiserli, N. Fraser, C. Hitomi, R. Rambo, J. Holton, J. A. Tainer, and the Structurally Integrated BiologY for Life Sciences (SIBYLS) beamline staff for discussions and assistance. This research was supported by National Institutes of Health grant GM37684 (E.D.G.); The Skaggs Institute for Chemical Biology (K.H., A.J.P.); National Science Foundation Predoctoral Fellowship (A.J.P.); Royal Society University Research Fellowship (J.M.C.); Leverhulme Trust grant F/00179/AZ (G.I.J., J.M.C., B.O.S.); and UK Biotechnology and Biological Sciences Research Council Ph.D. studentship (A.O.). J.M.C., E.D.G., K.H., and G.I.J. designed the research; A.S.A., K.B., J.M.C., K.H., M.H., S.M.K, A.O., and A.J.P. performed the research; M. Hothorn provided reagents; A.S.A., K.B., J.M.C., E.D.G., K.H., M.H., G.I.J., S.M.K., A.O., A.J.P. and B.O.S. analyzed data; and J.M.C., E.D.G., K.H., G.I.J., and A.J.P. prepared the manuscript. Crystallography and SAXS data were collected at SIBYLS through the Integrated Diffraction Analysis Technologies program supported by the Department of Energy, Office of Biological and Environmental Research. Crystallographic coordinates and structure factors are deposited in the Protein Data Bank with accession code 4D9S.	Andersson D, 2001, EUR J BIOCHEM, V268, P1118, DOI 10.1046/j.1432-1327.2001.01981.x; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Cloix C, 2008, MOL PLANT, V1, P118, DOI 10.1093/mp/ssm012; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; GRISHINA IB, 1994, FARADAY DISCUSS, V99, P245, DOI 10.1039/fd9949900245; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Ohmae E, 2001, J BIOCHEM-TOKYO, V130, P439, DOI 10.1093/oxfordjournals.jbchem.a003004; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1	18	320	351	8	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1492	1496		10.1126/science.1218091	http://dx.doi.org/10.1126/science.1218091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22323738	Green Accepted			2022-12-28	WOS:000301837000048
J	Dhruva, SS; Redberg, RF				Dhruva, Sanket S.; Redberg, Rita F.			Evaluating Sex Differences in Medical Device Clinical Trials Time for Action	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							APPROVAL; FOOD		[Redberg, Rita F.] Univ Calif San Francisco, Sch Med, Div Cardiol, Womens Cardiovasc Serv, San Francisco, CA 94143 USA; [Dhruva, Sanket S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Sch Med, Div Cardiol, Womens Cardiovasc Serv, 505 Parnassus Ave,M-1180, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu						[Anonymous], SUMM SAF EFF DAT THO; Asamoah AK, 2010, NEW ENGL J MED, V362, P2341, DOI 10.1056/NEJMp1005202; Dhruva SS, 2011, CIRC-CARDIOVASC QUAL, V4, P165, DOI 10.1161/CIRCOUTCOMES.110.958215; Dhruva SS, 2010, J AM COLL CARDIOL, V55, P261, DOI 10.1016/j.jacc.2009.08.053; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Ghanbari H, 2009, ARCH INTERN MED, V169, P1500, DOI 10.1001/archinternmed.2009.255; Thoratec Corporation, HEARTMATE 2 LEFT VEN; U.S. Food and Drug Administration, DRAFT GUID IND FOOD	8	22	23	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2012	307	11					1145	1146		10.1001/jama.2012.254	http://dx.doi.org/10.1001/jama.2012.254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911HN	22378695				2022-12-28	WOS:000301708000020
J	Gong, P; Liang, S; Carlton, EJ; Jiang, QW; Wu, JY; Wang, L; Remais, JV				Gong, Peng; Liang, Song; Carlton, Elizabeth J.; Jiang, Qingwu; Wu, Jianyong; Wang, Lei; Remais, Justin V.			Urbanisation and health in China	LANCET			English	Review							RAPID URBANIZATION; MIGRANT WORKERS; SYSTEM REFORM; URBAN; PREVALENCE; CANCER; TRENDS; HYPERTENSION; TRANSITION; OVERWEIGHT	China has seen the largest human migration in history, and the country's rapid urbanisation has important consequences for public health. A provincial analysis of its urbanisation trends shows shifting and accelerating rural-to-urban migration across the country and accompanying rapid increases in city size and population. The growing disease burden in urban areas attributable to nutrition and lifestyle choices is a major public health challenge, as are troubling disparities in health-care access, vaccination coverage, and accidents and injuries in China's rural-to-urban migrant population. Urban environmental quality, including air and water pollution, contributes to disease both in urban and in rural areas, and traffic-related accidents pose a major public health threat as the country becomes increasingly motorised. To address the health challenges and maximise the benefits that accompany this rapid urbanisation, innovative health policies focused on the needs of migrants and research that could close knowledge gaps on urban population exposures are needed.	[Gong, Peng] Tsinghua Univ, Minist Educ, Key Lab Earth Syst Modelling, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Liang, Song] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Gong, Peng] Univ Calif Berkeley, Sch Publ Hlth, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Carlton, Elizabeth J.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Jiang, Qingwu] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Sch Publ Hlth,Dept Epidemiol, Shanghai 200433, Peoples R China; [Wu, Jianyong; Remais, Justin V.] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Wang, Lei] Chinese Acad Sci, State Key Lab Remote Sensing Sci, Jointly Sponsored Inst Remote Sensing Applicat, Beijing, Peoples R China; [Wang, Lei] Beijing Normal Univ, Beijing 100875, Peoples R China	Tsinghua University; University System of Ohio; Ohio State University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Fudan University; Emory University; Rollins School Public Health; Chinese Academy of Sciences; Beijing Normal University	Remais, JV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	justin.remais@emory.edu	Remais, Justin/V-3207-2019; Wu, Jianyong/A-6854-2011; Gong, Peng/AAM-1516-2021; WANG, Lei/B-4845-2012	Remais, Justin/0000-0002-0223-4615; Wu, Jianyong/0000-0002-5864-3186; Gong, Peng/0000-0003-1513-3765; WANG, Lei/0000-0002-7163-3644; Jiang, Qingwu/0000-0001-8921-3317; Carlton, Elizabeth/0000-0002-8664-9606	National Institute for Allergy and Infectious Disease [K01AI091864, R01AI068854]; National Institutes of Health/National Science Foundation [0622743]; Emory Global Health Institute; National High Technology Programme of China [2009AA12200101]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01AI068854]; Public Health Preparedness for Infectious Diseases at the Ohio State University; American Recovery and Reinvestment Act [R01AI068854-04S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068854, K01AI091864] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/National Science Foundation(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Global Health Institute; National High Technology Programme of China; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Preparedness for Infectious Diseases at the Ohio State University; American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the China Medical Board for facilitating the manuscript. JVR is supported by the National Institute for Allergy and Infectious Disease (grant K01AI091864), by the National Institutes of Health/National Science Foundation Ecology of Infectious Disease Programme (grant 0622743), and by the Emory Global Health Institute Faculty Distinction Fund. PG is supported by the National High Technology Programme of China (grant 2009AA12200101). SL is supported partly by a National Institutes of Health/National Institute of Allergy and Infectious Diseases grant (R01AI068854) to the University of California, Berkeley, and by Public Health Preparedness for Infectious Diseases at the Ohio State University. EJC is supported by an American Recovery and Reinvestment Act supplement (grant R01AI068854-04S1) and by the National Institute for Allergy and Infectious Diseases (grant R01AI068854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper. No payment was received by any of the co-authors for the preparation of this report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Allender S, 2008, J URBAN HEALTH, V85, P938, DOI 10.1007/s11524-008-9325-4; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; [Anonymous], ASIA PACIFIC DEV J; Bauman A, 2008, OBES REV, V9, P119, DOI 10.1111/j.1467-789X.2007.00452.x; Browder GJ., 2007, STEPPING IMPROVING P; Chang D, 2009, CHINA OCCUP MED, V36, P326; Chen F, 2009, INT HDB POPULATION A, P152; Chen J, 2011, SOC SCI MED, V72, P1294, DOI 10.1016/j.socscimed.2011.02.016; Cui FQ, 2007, CHIN J VACCINES IMMU, V13, P1; Cui ZH, 2010, INT J PEDIATR OBES, V5, P365, DOI 10.3109/17477166.2010.490262; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; Du Y, 2006, TURNING POINT IN CHINAS ECONOMIC DEVELOPMENT, P172; Duan C., 2005, POPUL RES, V25, P29, DOI DOI 10.3969/J.ISSN.1000-6087.2005.01.004; Flaherty JH, 2007, J AM GERIATR SOC, V55, P1295, DOI 10.1111/j.1532-5415.2007.01273.x; Fu H, 2008, CHIN J HLTH POLICY, V1, P47; General Office of Ministry of Health of China, 2010, NOT CARR OUT HLTH CA; Giles J, CAN CHINAS RURAL ELD; Goldstein A, 1997, DEMOGRAPHY, V34, P481, DOI 10.2307/3038304; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Han YL, 2006, OCCUPATION HLTH, V22, P1277; HAYNES R, 1986, INT J EPIDEMIOL, V15, P268, DOI 10.1093/ije/15.2.268; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; Health Effects Institute (HEI), 2004, HLTH EFF OUTD AIR PO; Hu FB, 2011, OBES REV, V12, P552, DOI 10.1111/j.1467-789X.2011.00863.x; Hu G, 2008, INJURY PREV, V14, P149, DOI 10.1136/ip.2007.016469; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Huang YX, 2005, ACTA TROP, V96, P223, DOI 10.1016/j.actatropica.2005.07.015; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Jin F, 1999, INT J CANCER, V83, P435, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt;435::AID-IJC1&gt;3.0.CO;2-J; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Joseph A E, 1999, J Cross Cult Gerontol, V14, P153, DOI 10.1023/A:1006658706496; Krieger J, 2002, AM J PUBLIC HEALTH, V92, P758, DOI 10.2105/AJPH.92.5.758; LEE ES, 1966, DEMOGRAPHY, V3, P47, DOI 10.2307/2060063; Leon DA, 2008, INT J EPIDEMIOL, V37, P4, DOI 10.1093/ije/dym271; Li J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-364; Li MQ, 2006, DIS SURVEILL, V21, P57; Li Q., 2008, CHONGQIN MED, V31, P2398; Lin XD., 2011, CHINESE J CHILD HEAL, V19, P51; Lin YJ, 2007, CHIN J VACC IMMUN, V6, P87; Liu YT, 2010, HABITAT INT, V34, P135, DOI 10.1016/j.habitatint.2009.08.003; Liu ZK, 2009, AM J PUBLIC HEALTH, V99, P2049, DOI 10.2105/AJPH.2008.150474; Ma X, 2008, PSYCHOL MED, V38, P1723, DOI 10.1017/S0033291708003164; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Ministry of Health of China, 2010, MIN HLTH COMM SIT OC; Ministry of Health of China, 2008, HLTH STAT YB 2008; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Moore M, 2003, INT J HYG ENVIR HEAL, V206, P269, DOI 10.1078/1438-4639-00223; Mou J, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-214; National Bureau of Statistics of China, CHIN TOT POP STRUCT; NBSC, 2010, NAT STAT YB; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Pucher J, 2007, TRANSPORT REV, V27, P379, DOI 10.1080/01441640601089988; Qin XL, 2007, J APPL PREV MED, V13, P155; Ramesh M, 2009, SOC SCI MED, V68, P2256, DOI 10.1016/j.socscimed.2009.03.038; Remais JV, 2011, ENVIRON HEALTH PERSP, V119, P893, DOI 10.1289/ehp.1003024; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; SEPA, 2006, STAT ENV REP; Shen M, 2009, INJURY PREV, V15, P244, DOI 10.1136/ip.2008.019869; U. S. Census Bureau, 2011, INT DAT BAS; United Nations Department of Economic and Social Affairs, WORLD POP PROSP 2010; United Nations Human Settlement Program, 2003, GLOBAL REPORT HUMAN; United Nations Human Settlements Programme (UN Habitat), 2010, CIT ALL BRIDG URB DI; United Nations Population Division, 2011, WORLD POP PROSP 2010; Van de Poel E, 2012, HEALTH ECON, V21, P367, DOI 10.1002/hec.1717; Van de Poel E, 2009, ECON HUM BIOL, V7, P200, DOI 10.1016/j.ehb.2009.05.004; Wang B, 2010, SOC SCI MED, V71, P84, DOI 10.1016/j.socscimed.2010.03.021; Wang DW, 2006, CHINA WORLD ECON, V14, P102, DOI 10.1111/j.1749-124X.2006.00001.x; Wang L, 2012, CHINESE SCI BULL, V57, P2802, DOI 10.1007/s11434-012-5235-7; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wang W, 2010, INT J STD AIDS, V21, P410, DOI 10.1258/ijsa.2009.008518; Wang YP, 2010, HOUSING STUD, V25, P83, DOI 10.1080/02673030903362019; World Bank, 2007, COST POLL CHIN; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang Q.L., 2004, CHINA OCCUP MED, V31, P58; Yeh A. G. O., 2011, CHINAS POSTREFORM UR; Yusuf F, 2008, CHINA URBANIZES CONS; Zeng X, 1998, Zhonghua Liu Xing Bing Xue Za Zhi, V19, P277; ZENG Y, 1989, POPUL DEV REV, V15, P425; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; [张岚 ZHANG Lan], 2007, [环境与健康杂志, Journal of Environment and Health], V24, P595; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P21063, DOI 10.1073/pnas.0905756106; Zhou YX, 2003, CHINA QUART, P176, DOI 10.1017/S000944390300010X; Zhu YG, 2011, ENVIRON SCI TECHNOL, V45, P5099, DOI 10.1021/es2004254	85	754	796	83	867	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2012	379	9818					843	852		10.1016/S0140-6736(11)61878-3	http://dx.doi.org/10.1016/S0140-6736(11)61878-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386037	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-28	WOS:000300983400034
J	Coleman, T; Cooper, S; Thornton, JG; Grainge, MJ; Watts, K; Britton, J; Lewis, S				Coleman, Tim; Cooper, Sue; Thornton, James G.; Grainge, Matthew J.; Watts, Kim; Britton, John; Lewis, Sarah		Smoking Nicotine Pregnancy SNAP	A Randomized Trial of Nicotine-Replacement Therapy Patches in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMOKING-CESSATION; SMOKERS; PATTERNS; COTININE	BACKGROUND Nicotine-replacement therapy is effective for smoking cessation outside pregnancy and its use is widely recommended during pregnancy. We investigated the efficacy and safety of nicotine patches during pregnancy. METHODS We recruited participants from seven hospitals in England who were 16 to 50 years of age with pregnancies of 12 to 24 weeks' gestation and who smoked five or more cigarettes per day. Participants received behavioral cessation support and were randomly assigned to 8 weeks of treatment with active nicotine patches (15 mg per 16 hours) or matched placebo patches. The primary outcome was abstinence from the date of smoking cessation until delivery, as validated by measurement of exhaled carbon monoxide or salivary cotinine. Safety was assessed by monitoring for adverse pregnancy and birth outcomes. RESULTS Of 1050 participants, 521 were randomly assigned to nicotine-replacement therapy and 529 to placebo. There was no significant difference in the rate of abstinence from the quit date until delivery between the nicotine-replacement and placebo groups (9.4% and 7.6%, respectively; unadjusted odds ratio with nicotine-replacement therapy, 1.26; 95% confidence interval, 0.82 to 1.96), although the rate was higher at 1 month in the nicotine-replacement group than in the placebo group (21.3% vs. 11.7%). Compliance was low; only 7.2% of women assigned to nicotine-replacement therapy and 2.8% assigned to placebo used patches for more than 1 month. Rates of adverse pregnancy and birth outcomes were similar in the two groups. CONCLUSIONS Adding a nicotine patch (15 mg per 16 hours) to behavioral cessation support for women who smoked during pregnancy did not significantly increase the rate of abstinence from smoking until delivery or the risk of adverse pregnancy or birth outcomes. However, low compliance rates substantially limited the assessment of safety. (Funded by the National Institute for Health Research Health Technology Assessment Programme; Current Controlled Trials number, ISRCTN07249128.)	[Coleman, Tim; Cooper, Sue] Univ Nottingham, Div Primary Care, UK Ctr Tobacco Control Studies, Nottingham NG7 2RD, England; [Coleman, Tim; Cooper, Sue] Univ Nottingham, Sch Primary Care Res, Natl Inst Hlth Res, Nottingham NG7 2RD, England; [Thornton, James G.] Univ Nottingham, Div Obstet & Gynecol, Nottingham NG7 2RD, England; [Thornton, James G.] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham NG7 2RD, England; [Grainge, Matthew J.; Britton, John; Lewis, Sarah] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Watts, Kim] Univ Nottingham, Acad Div Midwifery, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Coleman, T (corresponding author), Univ Nottingham, Div Primary Care, UK Ctr Tobacco Control Studies, Nottingham NG7 2RD, England.		Britton, John R/G-9705-2011; Coughtrie, Michael/C-3855-2009; Marlow, Neil/D-2918-2009; Thornton, Jim/B-8336-2008; Cooper, Sue/A-7471-2011	Coughtrie, Michael/0000-0003-1989-1416; Marlow, Neil/0000-0001-5890-2953; Thornton, Jim/0000-0001-9764-6876; Grainge, Matthew/0000-0001-7181-4042; Coleman, Tim/0000-0002-7303-4805; Godfrey, Christine/0000-0001-6290-5532; Watts, Kim/0000-0002-6698-0692; Cooper, Sue/0000-0002-1994-6395	NIHR [06/07/01]; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; National Institute for Health Research [06/07/01] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by a grant from the NIHR Health Technology Assessment Programme (06/07/01).	Balmford J, 2011, NICOTINE TOB RES, V13, P94, DOI 10.1093/ntr/ntq215; Benowitz NL, 2000, TOB CONTROL, V9, P91, DOI 10.1136/tc.9.suppl_3.iii91; Bolling K., 2006, INFANT FEEDING SURVE; Cahill K., 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CDC006103.PUB2; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Coleman T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-2; Coleman T, 2011, ADDICTION, V106, P52, DOI 10.1111/j.1360-0443.2010.03179.x; Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594; Health Development Agency Expert Panel, 2003, STAND TRAIN SMOK CES; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; Hughes J, 2003, NICOTINE TOB RES, V5, P603, DOI 10.1080/1462220031000139330; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; Hughes JR, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000031.PUB3; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Munafo M, 2008, NICOTINE TOB RES, V10, P1609, DOI 10.1080/14622200802412895; Oncken C, 2008, OBSTET GYNECOL, V112, P859, DOI 10.1097/AOG.0b013e318187e1ec; Pickett KE, 2005, PAEDIATR PERINAT EP, V19, P368, DOI 10.1111/j.1365-3016.2005.00660.x; Pickett KE, 2003, OBSTET GYNECOL, V101, P140, DOI 10.1016/S0029-7844(02)02370-0; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Pollak KI, 2007, AM J PREV MED, V33, P297, DOI 10.1016/j.amepre.2007.05.006; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; *ROYAL COLL PHYS, 1992, SMOK YOUNG REP WORK; Society for the Study of Addiction treattobacco.net, TREATM GUID; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Stead L. F., 2008, COCHRANE DATABASE SY, V1; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; WHO, 2008, REP GLOB TOB EP 2008; Windsor RA, 2000, AM J OBSTET GYNECOL, V182, P68, DOI 10.1016/S0002-9378(00)70492-3; Wisborg K, 2000, OBSTET GYNECOL, V96, P967, DOI 10.1016/S0029-7844(00)01071-1	29	142	143	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					808	818		10.1056/NEJMoa1109582	http://dx.doi.org/10.1056/NEJMoa1109582			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900GI	22375972				2022-12-28	WOS:000300874300007
J	Heneghan, C; Langton, D; Thompson, M				Heneghan, Carl; Langton, David; Thompson, M.			MEDICAL DEVICES Ongoing problems with metal-on-metal hip implants	BRITISH MEDICAL JOURNAL			English	Editorial Material							FOLLOW-UP; RESURFACING ARTHROPLASTY; REPLACEMENT PATIENTS; CANCER INCIDENCE; NATIONWIDE; BEARINGS; COBALT; DEATH; IONS; ASR		[Heneghan, Carl] Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX1 2ET, England; [Langton, David] Univ Hosp N Tees, Joint Replacement Unit, Stockton On Tees, England	University of Oxford; University Hospital of North Tees	Heneghan, C (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX1 2ET, England.	carl.heneghan@phc.ox.ac.uk						Angerer J, 2012, COBALT BAT VALUE DOC; [Anonymous], 2000, BR J PERIOPER NURS, V10, P285; Bolt HM, 2012, ALKALI CHROMATES CR6; British Hip Society British Orthopaedic Association, 2011, UPD GUID LARG DIAM M; Case CP, 1996, CLIN ORTHOP RELAT R, pS269; Clarke MT, 2003, J BONE JOINT SURG BR, V85B, P913, DOI 10.1302/0301-620X.85B6.14166; Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; COLEMAN RF, 1973, BMJ-BRIT MED J, V1, P527, DOI 10.1136/bmj.1.5852.527; Cutts S, 2006, POSTGRAD MED J, V82, P802, DOI 10.1136/pgmj.2005.044594; European Commission, 2011, EUR DAT MED DEV EUDA; FDA, 2011, INF ORTH SURG MET ON; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; MacDonald SJ, 2004, J ARTHROPLASTY, V19, P71, DOI 10.1016/j.arth.2004.09.008; Medicines and Healthcare products Regulatory Agency (MHRA), 2010, MED DEV AL ALL MET O; Meier B, 2011, NY TIMES        1214; MHRA, 2007, GUID COMM DIR REC TO; Mulroy WF, 1996, J BONE JOINT SURG AM, V78A, P325, DOI 10.2106/00004623-199603000-00002; NICE, 2002, CLIN EFF COST EFF ME; Paavolainen P, 1999, J ARTHROPLASTY, V14, P272, DOI 10.1016/S0883-5403(99)90051-7; SCHIRRMA.UO, 1967, BRIT MED J, V1, P544, DOI 10.1136/bmj.1.5539.544; Siebel T, 2006, P I MECH ENG H, V220, P345, DOI 10.1243/095441105X69079; Tower SS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e430; van der Weegen W, 2011, J BONE JOINT SURG BR, V93B, P298, DOI 10.1302/0301-620X.93B3.25594; Visuri TI, 2006, P I MECH ENG H, V220, P399, DOI 10.1243/095441105X63282; Visuri T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-78; Visuri T, 2010, ACTA ORTHOP, V81, P77, DOI 10.3109/17453671003667150; Walsh J, 2011, METAL METAL TOTAL HI; Witzleb WC, 2006, ACTA ORTHOP, V77, P697, DOI 10.1080/17453670610012863	31	25	25	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 28	2012	344								e1349	10.1136/bmj.e1349	http://dx.doi.org/10.1136/bmj.e1349			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XA	22374740	Bronze, Green Submitted			2022-12-28	WOS:000301231000010
J	Rohrhoff, NJ				Rohrhoff, Nicholas J.			BECOMING A PHYSICIAN What Life Is Like	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Rohrhoff, NJ (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.							[Anonymous], 2011, C BUDG OFF 2011 LONG; Collins SR, 2011, HELP HORIZON FINDING; Department of Labor Bureau of Labor Statistics, CONSTR NAICS 23 WORK; Holahan J, 2009, RISING UNEMPLOYMENT; *WALM, RET PRESCR PROGR DRU	5	1	1	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					683	685		10.1056/NEJMp1112089	http://dx.doi.org/10.1056/NEJMp1112089			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896FS	22356321				2022-12-28	WOS:000300551500005
J	Fletcher, RH				Fletcher, Robert H.			Immunochemical FOBT was accurate for detecting colorectal cancer but less so for other GI lesions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Chapel Hill, NC USA	Harvard University	Fletcher, RH (corresponding author), Harvard Univ, Sch Med, Chapel Hill, NC USA.							Burch JA, 2007, J MED SCREEN, V14, P132, DOI 10.1258/096914107782066220; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-10	10.7326/0003-4819-156-4-201202210-02010	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351736				2022-12-28	WOS:000208885400009
J	Sacks, HS				Sacks, Henry S.			Adding procalcitonin-guided therapy to standard care did not reduce mortality in critically ill patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-6	10.7326/0003-4819-156-4-201202210-02006	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351732				2022-12-28	WOS:000208885400005
J	Joseph, KS; Liu, SL; Rouleau, J; Lisonkova, S; Hutcheon, JA; Sauve, R; Allen, AC; Kramer, MS				Joseph, K. S.; Liu, Shiliang; Rouleau, Jocelyn; Lisonkova, Sarka; Hutcheon, Jennifer A.; Sauve, Reg; Allen, Alexander C.; Kramer, Michael S.		Canadian Perinatal Surveillance Sy	Influence of definition based versus pragmatic birth registration on international comparisons of perinatal and infant mortality: population based retrospective study	BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; CLINICAL ESTIMATE; GESTATIONAL-AGE; HEALTH; INDICATORS; OUTCOMES; EUROPE; RATES	Objectives To examine variations in the registration of extremely low birthweight and early gestation births and to assess their effect on perinatal and infant mortality rankings of industrialised countries. Design Retrospective population based study. Setting Australia, Canada, European countries, and the United States for 2004; Australia, Canada, and New Zealand for 2007. Population National data on live births and on fetal, neonatal, and infant deaths. Main outcome measures Reported proportions of live births with birth weight/gestational age of less than 500 g, less than 1000 g, less than 24 weeks, and less than 28 weeks; crude rates of fetal, neonatal, and infant mortality; mortality rates calculated after exclusion of births under 500 g, under 1000 g, less than 24 weeks, and less than 28 weeks. Results The proportion of live births under 500 g varied widely from less than 1 per 10 000 live births in Belgium and Ireland to 10.8 per 10 000 live births in Canada and 16.9 in the United States. Neonatal deaths under 500 g, as a proportion of all neonatal deaths, also ranged from less than 1% in countries such as Luxembourg and Malta to 29.6% in Canada and 31.1% in the United States. Rankings of countries based on crude fetal, neonatal, and infant mortality rates differed substantially from rankings based on rates calculated after exclusion of births with a birth weight of less than 1000 g or a gestational age of less than 28 weeks. Conclusions International differences in reported rates of extremely low birthweight and very early gestation births probably reflect variations in registration of births and compromise the validity of international rankings of perinatal and infant mortality.	[Joseph, K. S.; Lisonkova, Sarka; Hutcheon, Jennifer A.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V6H 3N1, Canada; [Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6H 3N1, Canada; [Liu, Shiliang; Rouleau, Jocelyn] Publ Hlth Agcy Canada, Maternal & Infant Hlth Sect, Ottawa, ON K1A 0K9, Canada; [Sauve, Reg] Univ Calgary, Dept Pediat, Calgary, AB T2N 2T9, Canada; [Sauve, Reg] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada; [Allen, Alexander C.] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4N1, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3H 1P3, Canada	University of British Columbia; University of British Columbia; Public Health Agency of Canada; University of Calgary; University of Calgary; Dalhousie University; McGill University; McGill University	Joseph, KS (corresponding author), Childrens & Womens Hosp British Columbia, Room E419B,Shaughnessy Bldg,4500 Oak St, Vancouver, BC V6H 3N1, Canada.	kjoseph@cw.bc.ca	Shah, Prakesh S/I-8098-2013	Joseph, K.S./0000-0003-2317-5607; Hutcheon, Jennifer/0000-0002-6618-6018; Lisonkova, Sarka/0000-0002-1220-310X	Child and Family Research Institute; Canadian Institutes of Health Research [PLS56343]; Michael Smith Foundation for Health Research	Child and Family Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	The study received no funding. KSJ's work is supported by the Child and Family Research Institute and the Peter Lougheed Research Allowance of the Canadian Institutes of Health Research (PLS56343), SLisonkova is supported by a postdoctoral fellowship award from the Michael Smith Foundation for Health Research. JAH is supported by postdoctoral fellowship awards from the Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research.	Ananth CV, 2007, PAEDIATR PERINAT EP, V21, P22, DOI 10.1111/j.1365-3016.2007.00858.x; [Anonymous], MILL DEV GOALS REP 2; [Anonymous], INT STAT CLASS DIS R; Centers for Disease Control and Prevention, 2009, STILLB; Central Intelligence Agency, 2010, WORLD FACTB 2009; Confidential Enquiry into Maternal and Child Health, 2007, PER MORT 2005 ENGL W; Confidential Enquiry into Maternal and Child Health, 2006, PER MORT SURV 2004 E; DeNoon D, 2008, WEBMD HLTH NEWS; Ehrenthal DB, 2011, MATERN CHILD HLTH J, V15, P42, DOI 10.1007/s10995-010-0566-y; Engel M, 2008, LOS ANGELES TIM 1016; [Euro-Peristat Project SCPE Eurocat Euroneostat], 2008, EUR PER HLTH REP DAT; HOWELL EM, 1994, AM J PUBLIC HEALTH, V84, P850, DOI 10.2105/AJPH.84.5.850; Inter-agency Group for Child Mortality Estimation (UNICEF WHO World Bank UNPD universities and research institutions), 2010, WORLD DEV IND; Joseph KS, 2007, OBSTET GYNECOL, V109, P813, DOI 10.1097/01.AOG.0000255661.13792.c1; Kowaleski J, 1997, STATE DEFINITIONS RE; Kramer MS, 2002, PAEDIATR PERINAT EP, V16, P16, DOI 10.1046/j.1365-3016.2002.00390.x; Lack N, 2003, EUR J OBSTET GYN R B, V111, pS33, DOI 10.1016/j.ejogrb.2003.09.004; Laws P, 2009, PERINATAL STAT SERIE; Macfarlane A, 2003, EUR J OBSTET GYN R B, V111, pS15, DOI 10.1016/j.ejogrb.2003.09.003; Martin S, 2000, CAN MED ASSOC J, V162, P1032; Ministry of Health, 2009, 3 MIN HLTH; Mustafa G, 2001, PUBLIC HEALTH REP, V116, P15, DOI 10.1016/S0033-3549(04)50018-3; Organisation for Economic Co-operation and Development, 2010, OECD HLTH DAT 2010 S; Priest L, 2010, GLOBE MAIL      0522; Public Health Agency of Canada, 2008, CAN PER HLTH REP; SACHS BP, 1995, OBSTET GYNECOL, V85, P941, DOI 10.1016/0029-7844(95)00056-W; SEPKOWITZ S, 1995, INT J EPIDEMIOL, V24, P583, DOI 10.1093/ije/24.3.583; United Nations Children's Fund, 2009, STAT WORLDS CHILDR	28	85	86	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 17	2012	344								e746	10.1136/bmj.e746	http://dx.doi.org/10.1136/bmj.e746			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896IT	22344455	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000300559600002
J	Guttman, M; Rinn, JL				Guttman, Mitchell; Rinn, John L.			Modular regulatory principles of large non-coding RNAs	NATURE			English	Review							X-CHROMOSOME INACTIVATION; OPEN READING FRAMES; XIST RNA; TRANSCRIPTIONAL ACTIVITY; CHROMATIN STATE; GENE-EXPRESSION; HUMAN GENOME; STEM-CELLS; INTERGENIC TRANSCRIPTION; HISTONE MODIFICATION	It is clear that RNA has a diverse set of functions and is more than just a messenger between gene and protein. The mammalian genome is extensively transcribed, giving rise to thousands of non-coding transcripts. Whether all of these transcripts are functional is debated, but it is evident that there are many functional large non-coding RNAs (ncRNAs). Recent studies have begun to explore the functional diversity and mechanistic role of these large ncRNAs. Here we synthesize these studies to provide an emerging model whereby large ncRNAs might achieve regulatory specificity through modularity, assembling diverse combinations of proteins and possibly RNA and DNA interactions.	[Guttman, Mitchell; Rinn, John L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Guttman, Mitchell] MIT, Dept Biol, Cambridge, MA 02139 USA; [Rinn, John L.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University	Guttman, M (corresponding author), Broad Inst MIT & Harvard, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	mguttman@mit.edu; john_rinn@harvard.edu		Rinn, John/0000-0002-7231-7539	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES020260] Funding Source: Medline; NIGMS NIH HHS [P01 GM099117] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Korostelev A, 2007, TRENDS BIOCHEM SCI, V32, P434, DOI 10.1016/j.tibs.2007.08.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lin MF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000067; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; SALDITTGEORGIEFF M, 1981, MOL CELL BIOL, V1, P179, DOI 10.1128/MCB.1.2.179; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; WARNER JR, 1966, J MOL BIOL, V19, P349, DOI 10.1016/S0022-2836(66)80009-8; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Young TL, 2005, CURR BIOL, V15, P501, DOI 10.1016/j.cub.2005.02.027; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1	100	1624	1759	9	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					339	346		10.1038/nature10887	http://dx.doi.org/10.1038/nature10887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337053	Green Accepted			2022-12-28	WOS:000300287100035
J	Nakashiba, T; Cushman, JD; Pelkey, KA; Renaudineau, S; Buhl, DL; McHugh, TJ; Barrera, VR; Chittajallu, R; Iwamoto, KS; McBain, CJ; Fanselow, MS; Tonegawa, S				Nakashiba, Toshiaki; Cushman, Jesse D.; Pelkey, Kenneth A.; Renaudineau, Sophie; Buhl, Derek L.; McHugh, Thomas J.; Barrera, Vanessa Rodriguez; Chittajallu, Ramesh; Iwamoto, Keisuke S.; McBain, Chris J.; Fanselow, Michael S.; Tonegawa, Susumu			Young Dentate Granule Cells Mediate Pattern Separation, whereas Old Granule Cells Facilitate Pattern Completion	CELL			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ENHANCED SYNAPTIC PLASTICITY; DOUBLE DISSOCIATION; DORSAL HIPPOCAMPUS; CRITICAL PERIOD; NMDA RECEPTORS; SPATIAL MEMORY; GYRUS; CA3; NEURONS	Adult-born granule cells (GCs), a minor population of cells in the hippocampal dentate gyrus, are highly active during the first few weeks after functional integration into the neuronal network, distinguishing them from less active, older adult-born GCs and the major population of dentate GCs generated developmentally. To ascertain whether young and old GCs perform distinct memory functions, we created a transgenic mouse in which output of old GCs was specifically inhibited while leaving a substantial portion of young GCs intact. These mice exhibited enhanced or normal pattern separation between similar contexts, which was reduced following ablation of young GCs. Furthermore, these mutant mice exhibited deficits in rapid pattern completion. Therefore, pattern separation requires adult-born young GCs but not old GCs, and older GCs contribute to the rapid recall by pattern completion. Our data suggest that as adult-born GCs age, their function switches from pattern separation to rapid pattern completion.	[Nakashiba, Toshiaki; Renaudineau, Sophie; Buhl, Derek L.; McHugh, Thomas J.; Tonegawa, Susumu] MIT, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Dept Biol, Cambridge, MA 02139 USA; [Nakashiba, Toshiaki; Renaudineau, Sophie; Buhl, Derek L.; McHugh, Thomas J.; Tonegawa, Susumu] MIT, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Cushman, Jesse D.; Barrera, Vanessa Rodriguez; Fanselow, Michael S.] Univ Calif Los Angeles, Dept Psychol, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Pelkey, Kenneth A.; Chittajallu, Ramesh; McBain, Chris J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Cellular & Synapt Neurophysiol, Natl Inst Hlth, Bethesda, MD 20892 USA; [Iwamoto, Keisuke S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tonegawa, S (corresponding author), MIT, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Dept Biol, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Buhl, Derek/AAV-3911-2021; McHugh, Thomas/M-6159-2019; McHugh, Thomas J/A-6693-2010; Chittajallu, Ramesh/AAX-3749-2020	McHugh, Thomas/0000-0002-1243-5189; McHugh, Thomas J/0000-0002-1243-5189; Chittajallu, Ramesh/0000-0002-9794-0052; Buhl, Derek/0000-0003-4433-7150	Howard Hughes Medical Institute; Otsuka Maryland Research Institute; Picower Foundation; NIH [R01-MH078821, P50-MH58880, R01-MH62122]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, R01MH078821, R01MH062122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS058280] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Otsuka Maryland Research Institute; Picower Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank F. Bushard, A. Ogawa, J. Derwin, C. Lovett, D. Rooney, C. Twiss, M. Pfau, and M. Serock for excellent technical assistance, Tonegawa lab members including J. Biedenkapp, J. Young, and G. Dragoi for comments on earlier versions of the manuscript, N. Arzoumanian for help with manuscript preparation, C. Lois for plasmids, I. Wickersham and H.S. Seung for the rabies virus, and S. Lee for help with preliminary irradiation experiments. This work was supported by the Howard Hughes Medical Institute, the Otsuka Maryland Research Institute, the Picower Foundation, and NIH grants R01-MH078821 and P50-MH58880 to S.T.; NIH grant R01-MH62122 to M.S.F.; and NICHD intramural funding to C.J.M.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tabuchi K, 2000, J NEUROSCI RES, V59, P94, DOI 10.1002/(SICI)1097-4547(20000101)59:1<94::AID-JNR11>3.3.CO;2-H; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tronel S, 2012, HIPPOCAMPUS, V22, P292, DOI 10.1002/hipo.20895; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033	50	554	565	4	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					188	201		10.1016/j.cell.2012.01.046	http://dx.doi.org/10.1016/j.cell.2012.01.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22365813	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000302235400020
J	Coste, B; Xiao, BL; Santos, JS; Syeda, R; Grandl, J; Spencer, KS; Kim, SE; Schmidt, M; Mathur, J; Dubin, AE; Montal, M; Patapoutian, A				Coste, Bertrand; Xiao, Bailong; Santos, Jose S.; Syeda, Ruhma; Grandl, Joerg; Spencer, Kathryn S.; Kim, Sung Eun; Schmidt, Manuela; Mathur, Jayanti; Dubin, Adrienne E.; Montal, Mauricio; Patapoutian, Ardem			Piezo proteins are pore-forming subunits of mechanically activated channels	NATURE			English	Article							VOLTAGE SENSOR; MECHANOTRANSDUCTION; TRANSDUCTION; NEURONS; HEARING; TOXIN	Mechanotransduction has an important role in physiology. Biological processes including sensing touch and sound waves require as-yet-unidentified cation channels that detect pressure. Mouse Piezo1 (MmPiezo1) and MmPiezo2 (also called Fam38a and Fam38b, respectively) induce mechanically activated cationic currents in cells; however, it is unknown whether Piezo proteins are pore-forming ion channels or modulate ion channels. Here we show that Drosophila melanogaster Piezo (DmPiezo, also called CG8486) also induces mechanically activated currents in cells, but through channels with remarkably distinct pore properties including sensitivity to the pore blocker ruthenium red and single channel conductances. MmPiezo1 assembles as a similar to 1.2-million-dalton homo-oligomer, with no evidence of other proteins in this complex. Purified MmPiezo1 reconstituted into asymmetric lipid bilayers and liposomes forms ruthenium-red-sensitive ion channels. These data demonstrate that Piezo proteins are an evolutionarily conserved ion channel family involved in mechanotransduction.	[Coste, Bertrand; Xiao, Bailong; Grandl, Joerg; Spencer, Kathryn S.; Kim, Sung Eun; Schmidt, Manuela; Dubin, Adrienne E.; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Santos, Jose S.; Syeda, Ruhma; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Mathur, Jayanti; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; University of California System; University of California San Diego; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	mmontal@ucsd.edu; apatapou@gnf.org	KIM, SUNG EUN/E-4918-2011	Coste, Bertrand/0000-0002-0163-2494; Schmidt, Manuela/0000-0003-1972-3519; Grandl, Jorg/0000-0001-7179-7609	National Institutes of Dental and Craniofacial Research, Neurological Disorders, General Medical Sciences; Genomics Institute of the Novartis Research Foundation; American Heart Association; NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	National Institutes of Dental and Craniofacial Research, Neurological Disorders, General Medical Sciences; Genomics Institute of the Novartis Research Foundation; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. H. Ulbrich for providing Ca<SUP>2+</SUP> channel-, NMDA receptor- and CNG channel-GFP fusion constructs used as controls for photobleaching experiments. This research was supported by grants from the National Institutes of Dental and Craniofacial Research, Neurological Disorders, General Medical Sciences, and by The Genomics Institute of the Novartis Research Foundation. B.X. and J.G. are postdoctoral fellowship recipients from the American Heart Association and the NIH, respectively.	Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; DAVIS MJ, 1992, AM J PHYSIOL, V262, pC1083, DOI 10.1152/ajpcell.1992.262.4.C1083; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Ermakov YA, 2010, BIOPHYS J, V98, P1018, DOI 10.1016/j.bpj.2009.11.044; GAMBALE F, 1990, MOL BRAIN RES, V7, P123, DOI 10.1016/0169-328X(90)90089-V; GAMBALE F, 1988, BIOPHYS J, V53, P771, DOI 10.1016/S0006-3495(88)83157-6; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; MONTAL M, 1973, BIOCHIM BIOPHYS ACTA, V298, P750, DOI 10.1016/0005-2736(73)90092-8; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nilius B, 2010, EMBO REP, V11, P902, DOI 10.1038/embor.2010.181; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Reed-Geaghan EG, 2011, CURR OPIN GENET DEV, V21, P240, DOI 10.1016/j.gde.2010.12.009; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Tao X, 2008, J MOL BIOL, V382, P24, DOI 10.1016/j.jmb.2008.06.085; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	34	571	604	21	354	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					176	U72		10.1038/nature10812	http://dx.doi.org/10.1038/nature10812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22343900	Green Accepted			2022-12-28	WOS:000301174900030
J	Hauser, RG				Hauser, Robert G.			Here We Go Again - Another Failure of Postmarketing Device Surveillance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SAFETY		Minneapolis Heart Inst Fdn, Minneapolis, MN USA	Minneapolis Heart Institute Foundation	Hauser, RG (corresponding author), Minneapolis Heart Inst Fdn, Minneapolis, MN USA.		Hauser, Robert/AAP-1653-2020					[Anonymous], 2011, FDA CLASS VOL PHYS A; Chester K M, 2010, IMPORTANT INFORM RIA; Maisel WH, 2008, NEW ENGL J MED, V358, P985, DOI 10.1056/NEJMp0800495; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; Resnic FS, 2010, JAMA-J AM MED ASSOC, V304, P2019, DOI 10.1001/jama.2010.1633	5	58	58	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2012	366	10					873	875		10.1056/NEJMp1114695	http://dx.doi.org/10.1056/NEJMp1114695			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904CY	22332951				2022-12-28	WOS:000301172500001
J	Zhu, C; Young-soo, S; Beaglehole, R				Zhu, Chen; Young-soo, Shin; Beaglehole, Robert			Tobacco control in China: small steps towards a giant leap	LANCET			English	Editorial Material									[Zhu, Chen] Minist Hlth, Beijing 100044, Peoples R China; [Young-soo, Shin] WHO Western Pacific Off, Manila, Philippines; [Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Zhu, C (corresponding author), Minist Hlth, Beijing 100044, Peoples R China.	zchen@stn.sh.cn						Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], UN GEN ASS 66 SESS P; [Anonymous], 2011, XINHUA NEWS     0305; Bloomberg News, 2011, BLOOMBERG NEWS  0921; Chen Z, 2011, ANN REPORT HLTH STAT, VPublishing House of the Peking Union Medical College (Chin); Chinese Center for Disease Control and Prevention, 2011, GLOB AD TOB SURV GAT; Hu TW, 2010, TOB CONTROL, V19, P58, DOI 10.1136/tc.2009.031799; Koplan JP, 2010, LANCET, V375, P1330, DOI 10.1016/S0140-6736(10)60398-4; Liu YL, 2011, LANCET, V377, P1218, DOI 10.1016/S0140-6736(10)61391-8; The World Bank, 2011, HLTH HARM LIF CHIN S; WHO, 2011, SCAL ACT NONC DIS MU; World Bank, 1999, CURB EP GOV EC TOB C	12	20	20	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2012	379	9818					779	780		10.1016/S0140-6736(11)61933-8	http://dx.doi.org/10.1016/S0140-6736(11)61933-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386013				2022-12-28	WOS:000300983400004
J	Han, J; Kesner, P; Metna-Laurent, M; Duan, TT; Xu, L; Georges, F; Koehl, M; Abrous, DN; Mendizabal-Zubiaga, J; Grandes, P; Liu, QS; Bai, G; Wang, W; Xiong, LZ; Ren, W; Marsicano, G; Zhang, X				Han, Jing; Kesner, Philip; Metna-Laurent, Mathilde; Duan, Tingting; Xu, Lin; Georges, Francois; Koehl, Muriel; Abrous, Djoher Nora; Mendizabal-Zubiaga, Juan; Grandes, Pedro; Liu, Qingsong; Bai, Guang; Wang, Wei; Xiong, Lize; Ren, Wei; Marsicano, Giovanni; Zhang, Xia			Acute Cannabinoids Impair Working Memory through Astroglial CB1 Receptor Modulation of Hippocampal LTD	CELL			English	Article							LONG-TERM DEPRESSION; SYNAPTIC-TRANSMISSION; SPATIAL MEMORY; ENDOCANNABINOID SYSTEM; CA1 REGION; LOCALIZATION; POTENTIATION; PERFORMANCE; EXPRESSION; PLASTICITY	Impairment of working memory is one of the most important deleterious effects of marijuana intoxication in humans, but its underlying mechanisms are presently unknown. Here, we demonstrate that the impairment of spatial working memory (SWM) and in vivo long-term depression (LTD) of synaptic strength at hippocampal CA3-CA1 synapses, induced by an acute exposure of exogenous cannabinoids, is fully abolished in conditional mutant mice lacking type-1 cannabinoid receptors (CB1R) in brain astroglial cells but is conserved in mice lacking CB1R in glutamatergic or GABAergic neurons. Blockade of neuronal glutamate N-methyl-D-aspartate receptors (NMDAR) and of synaptic trafficking of glutamate alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid receptors (AMPAR) also abolishes cannabinoid effects on SWM and LTD induction and expression. We conclude that the impairment of working memory by marijuana and cannabinoids is due to the activation of astroglial CB1R and is associated with astroglia-dependent hippocampal LTD in vivo.	[Metna-Laurent, Mathilde; Koehl, Muriel; Abrous, Djoher Nora; Marsicano, Giovanni] INSERM, F-33000 Bordeaux, France; [Metna-Laurent, Mathilde; Georges, Francois; Koehl, Muriel; Abrous, Djoher Nora; Marsicano, Giovanni] Univ Bordeaux, U862, F-33000 Bordeaux, France; [Han, Jing; Ren, Wei] Shaanxi Normal Univ, Coll Life Sci, Xian 710062, Peoples R China; [Kesner, Philip; Zhang, Xia] Univ Ottawa, Inst Mental Hlth Res Royal, Dept Psychiat, Ottawa, ON K1Z 7K4, Canada; [Kesner, Philip; Zhang, Xia] Univ Ottawa, Inst Mental Hlth Res Royal, Dept Cellular & Mol Med, Ottawa, ON K1Z 7K4, Canada; [Duan, Tingting; Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China; [Duan, Tingting] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China; [Georges, Francois] CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Mendizabal-Zubiaga, Juan; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa 48940, Spain; [Liu, Qingsong] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Bai, Guang] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Program Neurosci, Baltimore, MD 21201 USA; [Wang, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430030, Hubai, Peoples R China; [Xiong, Lize] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Shaanxi Normal University; University of Ottawa; University of Ottawa; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; Medical College of Wisconsin; University System of Maryland; University of Maryland Baltimore; Huazhong University of Science & Technology; Air Force Military Medical University	Marsicano, G (corresponding author), INSERM, F-33000 Bordeaux, France.	giovanni.marsicano@inserm.fr; xia.zhang@rohcg.on.ca	Grandes, Pedro/H-7494-2015; Grandes, Pedro/AAA-1627-2019; Marsicano, Giovanni/I-9603-2016; Mendizabal, Juan Luis/H-6874-2015; Abrous, Nora-Djoher/N-6977-2017; Koehl, Muriel/C-3698-2011; Koehl, Muriel/ABI-2043-2020; , Ivan/D-6804-2012	Grandes, Pedro/0000-0003-3947-4230; Mendizabal, Juan Luis/0000-0002-4750-4797; Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; Zhang, Xia/0000-0002-4811-3229; Marsicano, Giovanni/0000-0003-3804-1951; , Ivan/0000-0002-3108-058X; abrous, nora/0000-0002-8589-305X; Xu, Lin/0000-0002-2710-3507; GEORGES, Francois/0000-0002-2628-2638	NIH [DA011322, DA024741, NS38077]; Basque Country Government [GIC07/70-IT-432-07]; Ministerio de Ciencia e Innovacion [SAF2009-07065]; Red de Trastornos Adictivos, RETICS; Instituto de Salud Carlos III; MICINN [RD07/0001/2001]; National Natural Science Foundation of China (NNSFC) [30725019, 81030021]; National High Technology Research and Development Program of China (863) [2007AA02Z310]; INSERM/Avenir; INSERM; European Research Council [ERC-2010-StG-260515]; EU [HEALTH-F22008-223713]; Fondation pour la Recherche Medicale; Region Aquitaine; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Cheung Kong Scholar (Chang Jiang Scholar) Award; Canadian Foundation for Innovation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024741] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basque Country Government(Basque Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Trastornos Adictivos, RETICS; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); INSERM/Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council(European Research Council (ERC)European Commission); EU(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Aquitaine(Region Nouvelle-Aquitaine); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cheung Kong Scholar (Chang Jiang Scholar) Award; Canadian Foundation for Innovation(Canada Foundation for Innovation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J.-C. Maillet and X. Li for technical assistance; D. Gonzales and the personnel of Animal Facility of the NeuroCentre Magendie for animal care and genotyping; Drs. D. Lagace (University of Ottawa), L. Renaud (University of Ottawa), Z. Jia (University of Toronto), P. Albert (University of Ottawa), B. Lutz (University of Mainz), and P. V. Piazza (INSERM) for discussion and comments. We also thank K. Mackie for providing the CB<INF>1</INF>R antibody, obtained with the NIH grant DA011322, as well as J. Rubenstein, M. Ekker, K. Nave, and F. Kirchhoff for providing the Cre-expressing mice used to generate conditional mutant mice. Support from China-Canada Joint Research grant (to L. Xu and X. Z.), The Basque Country Government grant (GIC07/70-IT-432-07, to P. G.), Ministerio de Ciencia e Innovacion (SAF2009-07065, to P. G.), Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, MICINN (RD07/0001/2001, to P. G.), NIH grants (DA024741, to Q. L.; NS38077, to G. B.), grants from National Natural Science Foundation of China (NNSFC, 30725019, 81030021, to W. W.), 973 Progress (2009CB941300, to L. Xu), NNSFC for distinguished young scholars (30725039, to L. X.), Major Program of NNSFC (30930091, to L. X.), National High Technology Research and Development Program of China (863, 2007AA02Z310, to W. R.), INSERM/Avenir (to G. M.), INSERM (to D.N.A.), European Research Council (ERC-2010-StG-260515, to G. M.), EU-FP7 (REPROBESITY, HEALTH-F22008-223713, to G. M.), Fondation pour la Recherche Medicale (to G. M.), Region Aquitaine (to M. M.-L., G. M., and D.N.A.), Canadian Institutes of Health Research (to X. Z.), Natural Sciences and Engineering Research Council of Canada (to X. Z.), Cheung Kong Scholar (Chang Jiang Scholar) Award (to X. Z.), and Canadian Foundation for Innovation (to X. Z.).	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bajo M, 2009, J NEUROSCI RES, V87, P766, DOI 10.1002/jnr.21889; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Brooks J.W., 2002, CURR ANAESTH CRIT CA, V13, P215; Carlini EA, 2004, TOXICON, V44, P461, DOI 10.1016/j.toxicon.2004.05.009; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Cui SS, 2001, J NEUROSCI, V21, P9867, DOI 10.1523/JNEUROSCI.21-24-09867.2001; Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006; Fadda P, 2004, NEUROPHARMACOLOGY, V47, P1170, DOI 10.1016/j.neuropharm.2004.08.009; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Hajos N, 2002, NEUROPHARMACOLOGY, V43, P503, DOI 10.1016/S0028-3908(02)00157-0; Hall W, 2005, LANCET ONCOL, V6, P35, DOI 10.1016/S1470-2045(05)70024-3; Hampson RE, 2000, J NEUROSCI, V20, P8932; Han J, 2011, NEUROREPORT, V22, P181, DOI 10.1097/WNR.0b013e328343f5cb; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Higgins GA, 2005, PSYCHOPHARMACOLOGY, V179, P85, DOI 10.1007/s00213-005-2203-9; Hill MN, 2004, EUR J NEUROSCI, V20, P859, DOI 10.1111/j.1460-9568.2004.03522.x; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Hoffman AF, 2010, J NEUROSCI, V30, P545, DOI 10.1523/JNEUROSCI.4920-09.2010; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; KELSEY JE, 1993, BEHAV NEUROSCI, V107, P565, DOI 10.1037/0735-7044.107.4.565; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; LEMBERGER L, 1980, ANNU REV PHARMACOL, V20, P151, DOI 10.1146/annurev.pa.20.040180.001055; Lichtman AH, 1996, PSYCHOPHARMACOLOGY, V126, P125, DOI 10.1007/BF02246347; Liu ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015634; Lovinger David M., 2008, V184, P435; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Maalouf M, 1998, BRAIN RES, V793, P149, DOI 10.1016/S0006-8993(98)00152-8; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Marsicano G, 2006, J Endocrinol Invest, V29, P27; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Moldrich G, 2000, PEPTIDES, V21, P1735, DOI 10.1016/S0196-9781(00)00324-7; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Nava F, 2001, NEUROPHARMACOLOGY, V41, P392, DOI 10.1016/S0028-3908(01)00075-2; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Ranganathan M, 2006, PSYCHOPHARMACOLOGY, V188, P425, DOI 10.1007/s00213-006-0508-y; Robinson L, 2007, BRIT J PHARMACOL, V151, P688, DOI 10.1038/sj.bjp.0707273; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Salio C, 2002, NEUROSCI LETT, V329, P13, DOI 10.1016/S0304-3940(02)00549-9; Sanderson DJ, 2008, PROG BRAIN RES, V169, P159, DOI 10.1016/S0079-6123(07)00009-X; Serpa A, 2009, EUR J PHARMACOL, V623, P41, DOI 10.1016/j.ejphar.2009.09.020; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Varvel SA, 2002, J PHARMACOL EXP THER, V301, P915, DOI 10.1124/jpet.301.3.915; Wise LE, 2009, NEUROPSYCHOPHARMACOL, V34, P2072, DOI 10.1038/npp.2009.31; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104	68	308	319	6	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					1039	1050		10.1016/j.cell.2012.01.037	http://dx.doi.org/10.1016/j.cell.2012.01.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385967	Bronze			2022-12-28	WOS:000300985000022
J	Prospero, JM; Bullard, JE; Hodgkins, R				Prospero, Joseph M.; Bullard, Joanna E.; Hodgkins, Richard			High-Latitude Dust Over the North Atlantic: Inputs from Icelandic Proglacial Dust Storms	SCIENCE			English	Article							DESERT DUST; DEPOSITION; PRECIPITATION; JOKULHLAUPS; TRANSPORT	Mineral aerosols play an important role in the atmosphere-ocean climate system. Research has focused almost exclusively on sources in low-latitude arid regions, but here we show that there are substantial sources in cold, higher latitudes. A 6-year record of measurements made on Heimaey, an island south of Iceland, reveals frequent dust events with concentrations exceeding 20 micrograms per cubic meter. Much of this potentially iron-rich dust is transported southward and deposited in the North Atlantic. Emissions are highest in spring and spatially and temporally associated with active glacial outwash plains; large dust events appear to be associated with glacial outburst floods. In response to global warming, ice retreat on Iceland and in other glacierized areas is likely to increase dust emissions from these regions.	[Bullard, Joanna E.; Hodgkins, Richard] Univ Loughborough, Polar & Alpine Res Ctr, Dept Geog, Loughborough LE11 3TU, Leics, England; [Prospero, Joseph M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine & Atmospher Chem, Miami, FL 33149 USA; [Prospero, Joseph M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33149 USA	Loughborough University; University of Miami; University of Miami	Bullard, JE (corresponding author), Univ Loughborough, Polar & Alpine Res Ctr, Dept Geog, Loughborough LE11 3TU, Leics, England.	j.e.bullard@lboro.ac.uk	Hodgkins, Richard/F-5430-2011; Prospero, Joseph/AAT-6996-2020	Prospero, Joseph/0000-0003-3608-6160	National Oceanic and Atmospheric Administration [NA90-RAH0075]; U.S. National Science Foundation [OCE-0623189, AGS-0962256]; Royal Society [RG062190]; Loughborough University; Div Atmospheric & Geospace Sciences [0962256] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); Loughborough University; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the Iceland Meteorological Service for their assistance in establishing our study and, specifically, E. Astradsson, who oversees operations on Heimaey. Sampling at Storhofoi has been carried out by the lighthouse keeper, O. J. Sigurosson, and more recently by his son, P. Freyr. In Miami, technical assistance was provided by T. Snowdon and chemical analyses by L. Custals. We thank O. Arnalds (Agricultural Research Institute, Iceland) for discussions on Iceland soils and geomorphic processes, H. Olafsson (University of Iceland, Geophysical Institute) for discussions on meteorology, and G. Gisladottir (Veourstofa Islands) for providing the meteorological data. The authors gratefully acknowledge the NOAA Air Resources Laboratory (ARL) for the provision of the HYSPLIT transport and dispersion model. This work was supported by the National Oceanic and Atmospheric Administration under cooperative agreement NA90-RAH0075 and by grants by the U.S. National Science Foundation OCE-0623189 and AGS-0962256. J.E.B. and R. H. were supported by Royal Society grant RG062190 and Loughborough University.	Agustsson H, 2009, METEOROL ATMOS PHYS, V103, P173, DOI 10.1007/s00703-008-0347-y; ARIMOTO R, 1995, J GEOPHYS RES-ATMOS, V100, P1199, DOI 10.1029/94JD02618; Arnalds O, 2004, CATENA, V56, P3, DOI 10.1016/j.catena.2003.10.002; Arnalds O, 2001, J ARID ENVIRON, V47, P359, DOI 10.1006/jare.2000.0680; Arnalds O, 2010, ICELAND AGR SCI, V23, P3; Bjornsson H, 2003, GLOBAL PLANET CHANGE, V35, P255, DOI 10.1016/S0921-8181(02)00130-3; Bjornsson H, 2008, JOKULL, V58, P365; Bullard JE, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002061; Bullard JE, 2011, AEOLIAN RES, V3, P43, DOI 10.1016/j.aeolia.2011.01.002; Crucius J., 2011, GEOPHYS RES LETT, V38, DOI DOI 10.1029/2010GL046573; Draxler R. R., 2011, HYSPLIT HYBRID SINGL; Einarsson M.A., 1980, WORLD SURVEY CLIMATO, V15, P673; Gasso S, 2010, ATMOS CHEM PHYS, V10, P8287, DOI 10.5194/acp-10-8287-2010; Gislason S. R., 1997, RH2597 SCI I; Hughes T, 1996, ARCTIC ALPINE RES, V28, P448, DOI 10.2307/1551856; Huneeus N, 2011, ATMOS CHEM PHYS, V11, P7781, DOI 10.5194/acp-11-7781-2011; Icelandic Meteorological Service, ER GRIMSV NOV 2004; Jansson P, 2005, GEOGR ANN A, V87A, P37, DOI 10.1111/j.0435-3676.2005.00243.x; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Johnson MS, 2011, ATMOS CHEM PHYS, V11, P2487, DOI 10.5194/acp-11-2487-2011; Kohfeld KE, 2003, QUATERNARY SCI REV, V22, P1859, DOI 10.1016/S0277-3791(03)00166-5; Krinner G, 2006, CLIM DYNAM, V27, P613, DOI 10.1007/s00382-006-0159-z; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; Magilligan FJ, 2002, GEOMORPHOLOGY, V44, P95, DOI 10.1016/S0169-555X(01)00147-7; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006653; Maria A, 2000, GEOL SOC AM BULL, V112, P1507, DOI 10.1130/0016-7606(2000)112<1507:SADOJK>2.0.CO;2; McKenna-Neuman C., 1986, AEOLIAN GEOMORPHOLOG, P213; Nielsdottir MC, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003410; Old GH, 2005, EARTH SURF PROC LAND, V30, P1441, DOI 10.1002/esp.1216; Orwin JF, 2010, GEOGR ANN A, V92A, P155, DOI 10.1111/j.1468-0459.2010.00387.x; Painter TH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030284; PROSPERO JM, 1995, SCI TOTAL ENVIRON, V160-61, P181, DOI 10.1016/0048-9697(95)04355-5; Prospero JM, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000095; Rosenfeld D, 2001, P NATL ACAD SCI USA, V98, P5975, DOI 10.1073/pnas.101122798; Russell AJ, 2010, QUATERNARY SCI REV, V29, P1363, DOI 10.1016/j.quascirev.2010.02.023; Schroth AW, 2009, NAT GEOSCI, V2, P337, DOI 10.1038/NGEO501; Snorrason A., 2002, Flood and megaflood processes and deposits: recent and ancient examples, P55; Taylor S.R., 1985, CONTINENTAL CRUST IT; Thorsteinsson T, 2011, ATMOS ENVIRON, V45, P5924, DOI 10.1016/j.atmosenv.2011.05.023; Trapp JM, 2010, MAR CHEM, V120, P71, DOI 10.1016/j.marchem.2008.10.004; Yoshioka M, 2007, J CLIMATE, V20, P1445, DOI 10.1175/JCLI4056.1; Zdanowicz CM, 2000, QUATERNARY RES, V53, P62, DOI 10.1006/qres.1999.2091	42	107	110	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1078	1082		10.1126/science.1217447	http://dx.doi.org/10.1126/science.1217447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383844				2022-12-28	WOS:000300931100041
J	Oullier, O				Oullier, Olivier			Clear up this fuzzy thinking on brain scans	NATURE			English	Editorial Material									[Oullier, Olivier] Aix Marseille Univ, Aix En Provence, France; [Oullier, Olivier] Ctr Strateg Anal, Aix En Provence, France	UDICE-French Research Universities; Aix-Marseille Universite	Oullier, O (corresponding author), Aix Marseille Univ, Aix En Provence, France.	olivier@oullier.fr							0	12	12	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					7	7		10.1038/483007a	http://dx.doi.org/10.1038/483007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900HP	22382941	Bronze			2022-12-28	WOS:000300877900014
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE It's good not to talk	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 29	2012	344								e1374	10.1136/bmj.e1374	http://dx.doi.org/10.1136/bmj.e1374			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XE	22378927				2022-12-28	WOS:000301231400009
J	Farmer, AJ; Perera, R; Ward, A; Heneghan, C; Oke, J; Barnett, AH; Davidson, MB; Guerci, B; Coates, V; Schwedes, U; O'Malley, S				Farmer, Andrew J.; Perera, Rafael; Ward, Alison; Heneghan, Carl; Oke, Jason; Barnett, Anthony H.; Davidson, Mayer B.; Guerci, Bruno; Coates, Vivien; Schwedes, Ulrich; O'Malley, Simon			Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYCEMIC CONTROL; PARALLEL-GROUP; MELLITUS; MANAGEMENT; EFFICACY; SYSTEM; IMPACT	Objective To assess the effectiveness of self monitoring blood glucose levels in people with non-insulin treated type 2 diabetes compared with clinical management without self monitoring, and to explore the effects in specific patient groups. Design Meta-analysis based on individual participant data. Data sources Medline, Embase, and a recent systematic review of trials on self monitoring of blood glucose. Chief investigators of trials published since 2000 were approached for additional information and individual patient data. Inclusion criteria Randomised controlled trials in patients with non-insulin treated type 2 diabetes comparing an intervention using self monitoring of blood glucose with clinical management not using self monitoring. Trials published from 2000 with at least 80 participants were included. Data collection Individual patient data were collected from electronic files and checked for integrity. Analysis All randomised participants were analysed using the intention to treat principle. A random effects model of complete cases was used to assess efficacy, a sensitivity analysis comprised imputed data, and prespecified subgroup analyses were carried out for age, sex, previous use of self monitoring, duration of diabetes, and levels of glycated haemoglobin (HbA(1c)) at baseline. Results 2552 patients were randomised in the six included trials. A mean reduction in HbA(1c) level of -2.7 mmol/mol (95% confidence interval -3.9 to -1.6; 0.25%) was observed for those using self monitoring of blood glucose levels compared with no self monitoring at six months. The mean reduction in HbA(1c) level between groups was 2.0 mmol/mol (3.2 to 0.8; 0.25%) at three months (five trials) and 2.5 mmol/mol (4.1 to 0.9; 0.35%) at 12 months (three trials). These estimates were unchanged after imputing missing data, and estimates of effect in trials with higher loss to follow-up or a possibility of co-intervention compared with those with lower loss to follow-up and no co-intervention did not differ significantly (P=0.21). The difference in HbA(1c) levels between groups was consistent across age, baseline HbA(1c) level, sex, and duration of diabetes, although the numbers of older and younger people and those with HbA(1c) levels >86 mmol/mol (10%) were insufficient for interpretation. No changes occurred in systolic blood pressure (-0.2 mm Hg, 95% confidence interval -1.4 to 1.0), diastolic blood pressure (-0.1 mm Hg, -0.9 to 0.6), or total cholesterol level (-0.1 mol/L, 95% confidence interval -0.2 to 0.1). Conclusions Evidence from this meta-analysis of individual patient data was not convincing for a clinically meaningful effect of clinical management of non-insulin treated type 2 diabetes by self monitoring of blood glucose levels compared with management without self monitoring, although the difference in HbA(1c) level between groups was statistically significant. The difference in levels was consistent across subgroups defined by personal and clinical characteristics.	[Farmer, Andrew J.; Perera, Rafael; Ward, Alison; Heneghan, Carl; Oke, Jason] Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2ET, England; [Farmer, Andrew J.; Perera, Rafael; Ward, Alison; Heneghan, Carl; Oke, Jason] NIHR Sch Primary Care Res, Oxford OX1 2ET, England; [Barnett, Anthony H.] Univ Birmingham, Div Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Davidson, Mayer B.] Charles Drew Univ, Dept Internal Med, Los Angeles, CA USA; [Guerci, Bruno] CHU Nancy, Hop Brabois, Vandoeuvre Les Nancy, France; [Guerci, Bruno] CIC Inserm, Vandoeuvre Les Nancy, France; [Coates, Vivien] Univ Ulster, Inst Nursing Res, Coleraine BT52 1SA, Londonderry, North Ireland; [Schwedes, Ulrich] Diabet Zentrum Hamburg City, Hamburg, Germany; [O'Malley, Simon] Royal Berkshire NHS Fdn Trust, Reading, Berks, England	University of Oxford; University of Birmingham; Charles R. Drew University of Medicine & Science; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Ulster University; Royal Berkshire Hospital	Farmer, AJ (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2ET, England.	andrew.farmer@phc.ox.ac.uk		Perera, Rafael/0000-0003-2418-2091	National Institute for Health Research (NIHR) School of Primary Care; NIHR Oxford Biomedical Research Centre; NIHR [018/0004]; LifeScan Scotland; Roche	National Institute for Health Research (NIHR) School of Primary Care(National Institute for Health Research (NIHR)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); LifeScan Scotland; Roche(Roche Holding)	AJF, RP, AW, JO, and CH are members of the National Institute for Health Research (NIHR) School of Primary Care. AJF receives support from the NIHR Oxford Biomedical Research Centre.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: this work is supported by the NIHR Health Technology Assessment Programme (grant No 018/0004); AHB has received lecture fees and advisory payments from LifeScan Scotland and Roche; no other relationships or activities are reported that could appear to have influenced the submitted work. The opinions expressed in this paper are not necessarily those of the Department of Health, UK.	Barnard Katharine D, 2010, BMC Res Notes, V3, P318, DOI 10.1186/1756-0500-3-318; Barnett AH, 2008, DIABETES OBES METAB, V10, P1239, DOI 10.1111/j.1463-1326.2008.00894.x; Belsey JD, 2009, INT J CLIN PRACT, V63, P439, DOI 10.1111/j.1742-1241.2008.01992.x; Bonomo K, 2010, DIABETES RES CLIN PR, V87, P246, DOI 10.1016/j.diabres.2009.10.021; Brown SA, 2002, DIABETES CARE, V25, P259, DOI 10.2337/diacare.25.2.259; Cho JH, 2006, DIABETES CARE, V29, P2625, DOI 10.2337/dc05-2371; Clar C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14120; Davidson MB, 2005, AM J MED, V118, P422, DOI 10.1016/j.amjmed.2004.12.006; Farmer AJ, 2009, PRIM CARE DIABETES, V3, P117, DOI 10.1016/j.pcd.2009.03.002; Farmer A, 2007, BMJ-BRIT MED J, V335, P132, DOI 10.1136/bmj.39247.447431.BE; Gelman A., 2007, DATA ANAL USING REGR; Guerci B, 2003, DIABETES METAB, V29, P587, DOI 10.1016/S1262-3636(07)70073-3; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hughes Mark D, 2009, J Diabetes Sci Technol, V3, P1219; *INT DIAB FED, 2009, SELF MON BLOOD GLUC; Jansen JP, 2006, CURR MED RES OPIN, V22, P671, DOI 10.1185/030079906X96308; Johnson JA, 2006, DIABETIC MED, V23, P1247, DOI 10.1111/j.1464-5491.2006.01973.x; Jones H, 2003, DIABETES CARE, V26, P732, DOI 10.2337/diacare.26.3.732; Joy S, 2003, DIABETES, V52, pA96; Kwon HS, 2004, DIABETES CARE, V27, P478, DOI 10.2337/diacare.27.2.478; McAndrew L, 2007, DIABETES EDUCATOR, V33, P991, DOI 10.1177/0145721707309807; McGeoch G, 2007, DIABETES-METAB RES, V23, P423, DOI 10.1002/dmrr.749; Moreland EC, 2006, ARCH INTERN MED, V166, P689, DOI 10.1001/archinte.166.6.689; Naik RG, 2008, DIABETES TECHNOL THE, V10, pS67, DOI 10.1089/dia.2008.0030; O'Kane MJ, 2008, BRIT MED J, V336, P1174, DOI 10.1136/bmj.39534.571644.BE; Parkin CG, 2009, DIABETES EDUCATOR, V35, P915, DOI 10.1177/0145721709347601; Piantadosi S, 2005, METAANALYSIS CLIN TR; Polonsky WH, 2011, DIABETES CARE, V34, P262, DOI 10.2337/dc10-1732; Poolsup N, 2009, DIABETES TECHNOL THE, V11, P775, DOI 10.1089/dia.2009.0091; Sarol JN, 2005, CURR MED RES OPIN, V21, P173, DOI 10.1185/030079904X20286; Scherbaum WA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003087; Schwedes U, 2002, DIABETES CARE, V25, P1928, DOI 10.2337/diacare.25.11.1928; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; SMBG International Working Group, 2008, Diabetes Res Clin Pract, V82, pe15, DOI 10.1016/j.diabres.2008.08.021; St John A, 2010, J DIABETES COMPLICAT, V24, P129, DOI 10.1016/j.jdiacomp.2009.01.002; Towfigh A, 2008, AM J MANAG CARE, V14, P468; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981	37	86	92	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2012	344								e486	10.1136/bmj.e486	http://dx.doi.org/10.1136/bmj.e486			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904WO	22371867	Green Submitted, hybrid			2022-12-28	WOS:000301229800001
J	Hrobjartsson, A; Thomsen, ASS; Emanuelsson, F; Tendal, B; Hilden, J; Boutron, I; Ravaud, P; Brorson, S				Hrobjartsson, Asbjorn; Thomsen, Ann Sofia Skou; Emanuelsson, Frida; Tendal, Britta; Hilden, Jorgen; Boutron, Isabelle; Ravaud, Philippe; Brorson, Stig			Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE MORPHOGENETIC PROTEIN-2; OPEN TIBIAL FRACTURES; TRANSMYOCARDIAL LASER REVASCULARIZATION; ALLOCATION CONCEALMENT; COLLAGEN; THERAPY; SAFETY; RELIABILITY; MULTICENTER; EFFICACY	Objective To evaluate the impact of non-blinded outcome assessment on estimated treatment effects in randomised clinical trials with binary outcomes. Design Systematic review of trials with both blinded and non-blinded assessment of the same binary outcome. For each trial we calculated the ratio of the odds ratios-the odds ratio from non-blinded assessments relative to the corresponding odds ratio from blinded assessments. A ratio of odds ratios <1 indicated that non-blinded assessors generated more optimistic effect estimates than blinded assessors. We pooled the individual ratios of odds ratios with inverse variance random effects meta-analysis and explored reasons for variation in ratios of odds ratios with meta-regression. We also analysed rates of agreement between blinded and non-blinded assessors and calculated the number of patients needed to be reclassified to neutralise any bias. Data Sources PubMed, Embase, PsycINFO, CINAHL, Cochrane Central Register of Controlled Trials, HighWire Press, and Google Scholar. Eligibility criteria for selecting studies Randomised clinical trials with blinded and non-blinded assessment of the same binary outcome. Results We included 21 trials in the main analysis (with 4391 patients); eight trials provided individual patient data. Outcomes in most trials were subjective-for example, qualitative assessment of the patient's function. The ratio of the odds ratios ranged from 0.02 to 14.4. The pooled ratio of odds ratios was 0.64 (95% confidence interval 0.43 to 0.96), indicating an average exaggeration of the non-blinded odds ratio by 36%. We found no significant association between low ratios of odds ratios and scores for outcome subjectivity (P=0.27); non-blinded assessor's overall involvement in the trial (P=0.60); or outcome vulnerability to non-blinded patients (P=0.52). Blinded and non-blinded assessors agreed in a median of 78% of assessments (interquartile range 64-90%) in the 12 trials with available data. The exaggeration of treatment effects associated with non-blinded assessors was induced by the misclassification of a median of 3% of the assessed patients per trial (1-7%). Conclusions On average, non-blinded assessors of subjective binary outcomes generated substantially biased effect estimates in randomised clinical trials, exaggerating odds ratios by 36%. This bias was compatible with a high rate of agreement between blinded and non-blinded outcome assessors and driven by the misclassification of few patients.	[Hrobjartsson, Asbjorn; Thomsen, Ann Sofia Skou; Emanuelsson, Frida; Tendal, Britta] Rigshosp, Nord Cochrane Ctr, Dept 3343, DK-2100 Copenhagen O, Denmark; [Hilden, Jorgen] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Boutron, Isabelle; Ravaud, Philippe] Univ Paris 05, INSERM, U738, Assistance Publ Hotel Dieu,French Cochrane Ctr, Paris, France; [Brorson, Stig] Herlev Univ Hosp, Dept Orthopaed Surg, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Herlev & Gentofte Hospital	Hrobjartsson, A (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 3343, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	ah@cochrane.dk	Thomsen, Ann Sofia Skou/AAT-7063-2020; Brorson, Stig/AAD-9703-2020; ravaud, philippe/C-1694-2009	Thomsen, Ann Sofia Skou/0000-0002-4249-581X; Brorson, Stig/0000-0001-5337-758X; Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206	Danish Council for Independent Research: Medical sciences	Danish Council for Independent Research: Medical sciences(Det Frie Forskningsrad (DFF))	The study was partially funded by the Danish Council for Independent Research: Medical sciences. The funder had no influence on study design and the collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication.	Aro HT, 2011, J BONE JOINT SURG AM, V93A, P801, DOI 10.2106/JBJS.I.01763; Baumann LS, 2007, DERMATOL SURG, V33, pS128, DOI 10.1111/j.1524-4725.2007.33352.x; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Burkhardt JE, 2010, TOXICOL PATHOL, V38, P666, DOI 10.1177/0192623310371221; Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1; Danner SA, 1996, AIDS, V10, pS7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; Dodd DC, 1988, COMMENTS TOXICOL, V2, P88; Dover JS, 2009, DERMATOL SURG, V35, P322, DOI 10.1111/j.1524-4725.2008.01060.x; Dror I, 2008, J FORENSIC SCI, V53, P900, DOI 10.1111/j.1556-4029.2008.00762.x; Dumville JC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b773; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Haahr MT, 2006, CLIN TRIALS, V3, P360, DOI 10.1177/1740774506069153; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Iglesia CB, 2010, OBSTET GYNECOL, V116, P293, DOI 10.1097/AOG.0b013e3181e7d7f8; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; Jull A, 2008, BRIT J SURG, V95, P175, DOI 10.1002/bjs.6059; Kadish A, 2011, AM HEART J, V161, P329, DOI 10.1016/j.ahj.2010.10.025; Karanicolas PJ, 2008, J BONE JOINT SURG AM, V90A, P1026, DOI 10.2106/JBJS.G.00963; Karanicolas PJ, 2009, J CLIN EPIDEMIOL, V62, P214, DOI 10.1016/j.jclinepi.2008.05.006; Landsman AS, 2010, J AM PODIAT MED ASSN, V100, P166, DOI 10.7547/1000166; LYONS JA, 1986, SEX ROLES, V14, P301; Marsh DM, 2007, ETHOLOGY, V113, P1089, DOI 10.1111/j.1439-0310.2007.01406.x; Martin DF, 2002, NEW ENGL J MED, V346, P1119, DOI 10.1056/NEJMoa011759; MASON P, 1992, J NEUROSCI, V12, P4023; McClure S, 2004, AAEP P, V50, P316; Medicis Aesthetics, 2011, FDA PMA P40024 S051; Meining A, 2002, GUT, V50, P599, DOI 10.1136/gut.50.5.599; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Miles WS, 2001, AM J SURG, V182, P143, DOI 10.1016/S0002-9610(01)00668-7; Miller RS, 2003, OTOLARYNG HEAD NECK, V128, P862, DOI 10.1016/S0194-5998(03)00460-1; Murtha AP, 2006, PLAST RECONSTR SURG, V117, P1769, DOI 10.1097/01.prs.0000209971.08264.b0; NOSEWORTHY JH, 1994, NEUROLOGY, V44, P16, DOI 10.1212/WNL.44.1.16; NOSEWORTHY JH, 1991, LANCET, V337, P1540, DOI 10.1016/0140-6736(91)93226-Y; Nuesch E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1633, DOI 10.1002/art.24894; Oesterle SN, 2000, LANCET, V356, P1705, DOI 10.1016/S0140-6736(00)03203-7; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Pogue J, 2009, CLIN TRIALS, V6, P239, DOI 10.1177/1740774509105223; Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P550, DOI 10.2106/JBJS.F.00683; Reynolds T, 2004, J Wound Care, V13, P71; Reynolds Tim, 2004, Br J Nurs, V13, pS21; ROSENTHAL R, 1978, AM PSYCHOL, V33, P1005; Rosenthal R, 1966, EXPT EFFECTS BEHAV R, P13; SALVIA JA, 1980, J SPEC EDUC, V14, P261, DOI 10.1177/002246698001400213; Smith S, 2007, DERMATOL SURG, V33, pS112, DOI 10.1111/j.1524-4725.2007.33350.x; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Still J, 2003, BURNS, V29, P837, DOI 10.1016/S0305-4179(03)00164-5; Swiontkowski MF, 2006, J BONE JOINT SURG AM, V88A, P1258, DOI 10.2106/JBJS.E.00499; Valldeoriola F, 2010, J NEUROL NEUROSUR PS, V81, P65, DOI 10.1136/jnnp.2009.174342; Waibel KH, 2006, CLIN INFECT DIS, V42, pE16, DOI 10.1086/499957; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	53	237	238	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2012	344								e1119	10.1136/bmj.e1119	http://dx.doi.org/10.1136/bmj.e1119			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904WO	22371859	hybrid, Green Submitted			2022-12-28	WOS:000301229800002
J	Bonilla, WV; Frohlich, A; Senn, K; Kallert, S; Fernandez, M; Johnson, S; Kreutzfeldt, M; Hegazy, AN; Schrick, C; Fallon, PG; Klemenz, R; Nakae, S; Adler, H; Merkler, D; Lohning, M; Pinschewer, DD				Bonilla, Weldy V.; Froehlich, Anja; Senn, Karin; Kallert, Sandra; Fernandez, Marylise; Johnson, Susan; Kreutzfeldt, Mario; Hegazy, Ahmed N.; Schrick, Christina; Fallon, Padraic G.; Klemenz, Roman; Nakae, Susumu; Adler, Heiko; Merkler, Doron; Loehning, Max; Pinschewer, Daniel D.			The Alarmin Interleukin-33 Drives Protective Antiviral CD8(+) T Cell Responses	SCIENCE			English	Article							IMMUNE-RESPONSE; IL-33; MICE; INFECTION; EXPRESSION; CYTOKINE; RECEPTOR; SIGNALS; ST2; INDUCTION	Pathogen-associated molecular patterns decisively influence antiviral immune responses, whereas the contribution of endogenous signals of tissue damage, also known as damage-associated molecular patterns or alarmins, remains ill defined. We show that interleukin-33 (IL-33), an alarmin released from necrotic cells, is necessary for potent CD8(+) T cell (CTL) responses to replicating, prototypic RNA and DNA viruses in mice. IL-33 signaled through its receptor on activated CTLs, enhanced clonal expansion in a CTL-intrinsic fashion, determined plurifunctional effector cell differentiation, and was necessary for virus control. Moreover, recombinant IL-33 augmented vaccine-induced CTL responses. Radio-resistant cells of the splenic T cell zone produced IL-33, and efficient CTL responses required IL-33 from radio-resistant cells but not from hematopoietic cells. Thus, alarmin release by radio-resistant cells orchestrates protective antiviral CTL responses.	[Froehlich, Anja; Hegazy, Ahmed N.; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Bonilla, Weldy V.; Kallert, Sandra; Fernandez, Marylise; Johnson, Susan; Kreutzfeldt, Mario; Schrick, Christina; Merkler, Doron; Pinschewer, Daniel D.] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Bonilla, Weldy V.; Kallert, Sandra; Fernandez, Marylise; Johnson, Susan; Pinschewer, Daniel D.] Univ Geneva, World Hlth Org Collaborating Ctr Vaccine Immunol, CH-1211 Geneva 4, Switzerland; [Froehlich, Anja; Hegazy, Ahmed N.; Loehning, Max] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Senn, Karin; Klemenz, Roman] Univ Zurich Hosp, Dept Pathol, Inst Canc Res, CH-8091 Zurich, Switzerland; [Kreutzfeldt, Mario; Schrick, Christina; Merkler, Doron] Univ Hosp Geneva, Div Clin Pathol, CH-1211 Geneva 4, Switzerland; [Hegazy, Ahmed N.] Charite, Dept Gastroenterol Hepatol & Endocrinol, D-13353 Berlin, Germany; [Fallon, Padraic G.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin 8, Ireland; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Adler, Heiko] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Adler, Heiko] CCG HCT, D-81377 Munich, Germany; [Merkler, Doron] Univ Gottingen, Dept Neuropathol, Univ Med Ctr, Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Geneva; University of Geneva; World Health Organization; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Zurich; University Zurich Hospital; University of Geneva; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Trinity College Dublin; University of Tokyo; Japan Science & Technology Agency (JST); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Gottingen	Lohning, M (corresponding author), Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany.	loehning@drfz.de; daniel.pinschewer@gmx.ch	Löhning, Max/AAL-2967-2021; Adler, Heiko/M-7355-2014; Fallon, Padraic/Y-2711-2019; Merkler, Doron/N-9157-2016	Löhning, Max/0000-0001-6382-7281; Adler, Heiko/0000-0002-6481-6709; Fallon, Padraic/0000-0002-8401-7293; Merkler, Doron/0000-0002-0247-2007; Hegazy, Ahmed N./0000-0002-2946-8251; Pinschewer, Daniel/0000-0002-1594-3189; Kreutzfeldt, Mario/0000-0003-0335-2733	Bundesministerium fur Bildung und Forschung (BMBF)-FORSYS; National Health and Medical Research Council; German Research Foundation [GRK1121, SFB618, SFB650]; Science Foundation Ireland; Program for Improvement of Research Environment for Young Researchers; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency, PRESTO; BMBF (NGFNplus) [FKZ PIM-01GS0802-3]; Wilhelm Sander-Stiftung; Volkswagen Foundation; Fondation Leenaards; European Community; Swiss National Science Foundation; Grants-in-Aid for Scientific Research [23390262] Funding Source: KAKEN	Bundesministerium fur Bildung und Forschung (BMBF)-FORSYS(Federal Ministry of Education & Research (BMBF)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); German Research Foundation(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Program for Improvement of Research Environment for Young Researchers; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, PRESTO(Japan Science & Technology Agency (JST)); BMBF (NGFNplus)(Federal Ministry of Education & Research (BMBF)); Wilhelm Sander-Stiftung; Volkswagen Foundation(Volkswagen); Fondation Leenaards; European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF)-FORSYS (A. F., M. L.), National Health and Medical Research Council (S.J.), German Research Foundation (GRK1121, A.N.H.), Science Foundation Ireland (P. G. F.), Program for Improvement of Research Environment for Young Researchers, the Special Coordination Funds for Promoting Science and Technology from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan Science and Technology Agency, PRESTO (S.N.), BMBF (NGFNplus, FKZ PIM-01GS0802-3; H. A.), Wilhelm Sander-Stiftung (H. A.), German Research Foundation (SFB618 and SFB650, M. L.), Volkswagen Foundation (Lichtenberg Program, M. L.), Fondation Leenaards (D. D. P.), European Community (D. D. P.), and Swiss National Science Foundation (D. M., D. D. P.). We thank A. Bergthaler, G. R. Burmester, C. Gabay, M. Geuking, A. Kamath, P. H. Lambert, J. Luban, B. Marsland, G. Palmer, A. Radbruch, C. A. Siegrist, and R. M. Zinkernagel for discussions and advice; H. Saito, National Research Institute for Child Health and Development, for Il33<SUP>-/-</SUP> mice obtained under a materials transfer agreement (MTA) through the RIKEN Center for Developmental Biology, Laboratory for Animal Resources and Genetic Engineering; A. McKenzie (for Il1rl1<SUP>-/-</SUP> mice obtained under MTA); the University of Zurich (for rLCMV technology obtained under MTA) and G. Jennings [Cytos Biotechnology AG, Schlieren, Switzerland, holding patent rights on VLPs provided] for reagents; and J. Weber and B. Steer for technical assistance. The data presented in this paper are tabulated in the main paper and the supporting online material. Microarray data are deposited with National Center for Biotechnology Information Gene Expression Omnibus (GEO, accession number GSE34392) and ArrayExpress (accession number E-MTAB-901). D. D. P. is or has been a shareholder, board member, and consultant to ArenaVax AG, Switzerland, and to Hookipa Biotech GmbH, Austria, commercializing rLCMV vectors (patent application EP 07 025 099.8, coauthored by D. D. P.). The authors declare that they do not have other competing financial interests.	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Becerra A, 2008, CYTOKINE, V41, P114, DOI 10.1016/j.cyto.2007.11.001; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dobrzanski MJ, 2004, J IMMUNOL, V172, P1380, DOI 10.4049/jimmunol.172.3.1380; EHTISHAM S, 1993, J VIROL, V67, P5247, DOI 10.1128/JVI.67.9.5247-5252.1993; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Le Goffic R, 2011, AM J RESP CELL MOL, V45, P1125, DOI 10.1165/rcmb.2010-0516OC; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Ljutic B, 2005, J IMMUNOL, V174, P4789, DOI 10.4049/jimmunol.174.8.4789; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Rahman AH, 2008, J IMMUNOL, V181, P3804, DOI 10.4049/jimmunol.181.6.3804; Rahman AH, 2011, BLOOD, V117, P3123, DOI 10.1182/blood-2010-11-318485; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Senn KA, 2000, EUR J IMMUNOL, V30, P1929, DOI 10.1002/1521-4141(200007)30:7&lt;1929::AID-IMMU1929&gt;3.0.CO;2-1; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yang QT, 2011, EUR J IMMUNOL, V41, P3351, DOI 10.1002/eji.201141629; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	37	301	319	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					984	989		10.1126/science.1215418	http://dx.doi.org/10.1126/science.1215418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22323740				2022-12-28	WOS:000300931800051
J	Hodges, A				Hodges, Andrew			The man behind the machine	NATURE			English	Editorial Material									Univ Oxford, Oxford OX1 2JD, England	University of Oxford	Hodges, A (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	andrew.hodges@wadh.ox.ac.uk							0	0	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					441	441		10.1038/482441a	http://dx.doi.org/10.1038/482441a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	898VM	22358790	Bronze			2022-12-28	WOS:000300770500007
J	Krimpenfort, P; Song, JY; Proost, N; Zevenhoven, J; Jonkers, J; Berns, A				Krimpenfort, Paul; Song, Ji-Ying; Proost, Natalie; Zevenhoven, John; Jonkers, Jos; Berns, Anton			Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours	NATURE			English	Article							DCC GENE; BREAST-CANCER; TRANSCRIPTIONAL TARGET; NETRIN RECEPTOR; NERVOUS-SYSTEM; CELL-DEATH; APOPTOSIS; P53; MICE; EXPRESSION	Since its discovery in the early 1990s the deleted in colorectal cancer (DCC) gene, located on chromosome 18q21, has been proposed as a tumour suppressor gene as its loss is implicated in the majority of advanced colorectal and many other cancers(1). DCC belongs to the family of netrin 1 receptors, which function as dependence receptors as they control survival or apoptosis depending on ligand binding. However, the role of DCC as a tumour suppressor remains controversial because of the rarity of DCC-specific mutations and the presence of other tumour suppressor genes in the same chromosomal region. Here we show that in a mouse model of mammary carcinoma based on somatic inactivation of p53, additional loss of DCC promotes metastasis formation without affecting the primary tumour phenotype. Furthermore, we demonstrate that in cell cultures derived from p53-deficient mouse mammary tumours DCC expression controls netrin-1-dependent cell survival, providing a mechanistic basis for the enhanced metastatic capacity of tumour cells lacking DCC. Consistent with this idea, in vivo tumour-cell survival is enhanced by DCC loss. Together, our data support the function of DCC as a context-dependent tumour suppressor that limits survival of disseminated tumour cells.	[Krimpenfort, Paul; Proost, Natalie; Zevenhoven, John; Berns, Anton] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Jonkers, Jos] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Jonkers, Jos] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, Dept Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands; [Berns, Anton] Netherlands Canc Inst, AMC, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.berns@nki.nl	Jonkers, Jos/AAG-3246-2019	Jonkers, Jos/0000-0002-9264-9792				Alberici P, 2006, ONCOGENE, V25, P1841, DOI 10.1038/sj.onc.1209226; CHO KR, 1994, GENOMICS, V19, P525, DOI 10.1006/geno.1994.1102; Delloye-Bourgeois C, 2009, JNCI-J NATL CANCER I, V101, P237, DOI 10.1093/jnci/djn491; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Hamamoto T, 2002, CANCER RES, V62, P5955; Hibi K, 2009, ANTICANCER RES, V29, P271; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2004, J CLIN ONCOL, V22, P3420, DOI 10.1200/JCO.2004.02.019; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Miyamoto Y, 2010, INT J ONCOL, V36, P1253, DOI 10.3892/ijo_00000609; PELTOMAKI P, 1991, CANCER RES, V51, P4135; Roush W, 1997, SCIENCE, V276, P534, DOI 10.1126/science.276.5312.534; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shin SK, 2007, GASTROENTEROLOGY, V133, P1849, DOI 10.1053/j.gastro.2007.08.074; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Uciechowski P, 2000, BRIT J CANCER, V83, P1664, DOI 10.1054/bjoc.2000.1501; Volenec A, 1997, NEUROREPORT, V8, P2913, DOI 10.1097/00001756-199709080-00022; Wang H, 2008, BIOCHEM BIOPH RES CO, V370, P594, DOI 10.1016/j.bbrc.2008.03.152	28	69	70	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					538	U134		10.1038/nature10790	http://dx.doi.org/10.1038/nature10790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358843				2022-12-28	WOS:000300770500053
J	Liu, N; Landreh, M; Cao, KJ; Abe, M; Hendriks, GJ; Kennerdell, JR; Zhu, YQ; Wang, LS; Bonini, NM				Liu, Nan; Landreh, Michael; Cao, Kajia; Abe, Masashi; Hendriks, Gert-Jan; Kennerdell, Jason R.; Zhu, Yongqing; Wang, Li-San; Bonini, Nancy M.			The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila	NATURE			English	Article							DOWN-REGULATION; LIFE-SPAN; DEGENERATION; BRAIN; TRANSCRIPTION; MELANOGASTER; EXPRESSION; DISEASE; TARGET; GENE	Human neurodegenerative diseases have the temporal hallmark of afflicting the elderly population. Ageing is one of the most prominent factors to influence disease onset and progression(1), yet little is known about the molecular pathways that connect these processes. To understand this connection it is necessary to identify the pathways that functionally integrate ageing, chronic maintenance of the brain and modulation of neurodegenerative disease. MicroRNAs (miRNA) are emerging as critical factors in gene regulation during development; however, their role in adult-onset, age-associated processes is only beginning to be revealed. Here we report that the conserved miRNA miR-34 regulates age-associated events and long-term brain integrity in Drosophila, providing a molecular link between ageing and neurodegeneration. Fly mir-34 expression exhibits adult-onset, brain-enriched and age-modulated characteristics. Whereas mir-34 loss triggers a gene profile of accelerated brain ageing, late-onset brain degeneration and a catastrophic decline in survival, mir-34 upregulation extends median lifespan and mitigates neurodegeneration induced by human pathogenic polyglutamine disease protein. Some of the age-associated effects of miR-34 require adult-onset translational repression of Eip74EF, an essential ETS domain transcription factor involved in steroid hormone pathways. Our studies indicate that miRNA-dependent pathways may have an impact on adult-onset, age-associated events by silencing developmental genes that later have a deleterious influence on adult life cycle and disease, and highlight fly miR-34 as a key miRNA with a role in this process.	[Liu, Nan; Landreh, Michael; Abe, Masashi; Hendriks, Gert-Jan; Kennerdell, Jason R.; Zhu, Yongqing; Bonini, Nancy M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Cao, Kajia; Wang, Li-San] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu	Liu, Nan/D-8913-2011	Hendriks, Gert-Jan/0000-0001-8798-1443; Landreh, Michael/0000-0002-7958-4074; Bonini, Nancy/0000-0003-0226-5291	NINDS [R01-NS043578]; Ellison Foundation; Penn Genome Frontiers Institute; NIA [U01-AG-032984-02, RC2-AG036528-01]; Penn Institute on Aging [AG010124]; NIH [T32 AG00255]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG032984, T32AG000255, RC2AG036528, P30AG010124] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ellison Foundation(Lawrence Ellison Foundation); Penn Genome Frontiers Institute; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Penn Institute on Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Thummel, T. Jongens and A. Bashirullah for reagents. We are grateful to A. Cashmore, A. Burguete, J. Kim, S. Cherry, B. Gregory, A. Gitler and the Bonini laboratory for discussion and critical reading of the manuscript. We thank X. Teng for assistance with fly paraffin section. This work was funded by the NINDS (R01-NS043578) and the Ellison Foundation (to N.M.B.). L.-S.W. and K. C. are supported by a pilot grant from Penn Genome Frontiers Institute. L.-S.W. is supported by NIA (U01-AG-032984-02 and RC2-AG036528-01) and a Penn Institute on Aging pilot grant (AG010124). N.M.B. is an Investigator of the Howard Hughes Medical Institute. J. R. K. received support from NIH T32 AG00255.	AMADUCCI L, 1994, CURR OPIN NEUROL, V7, P283, DOI 10.1097/00019052-199408000-00001; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Cao KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013098; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; FLETCHER JC, 1995, DEVELOPMENT, V121, P1411; Fletcher JC, 1997, P NATL ACAD SCI USA, V94, P4582, DOI 10.1073/pnas.94.9.4582; Gaughwin PM, 2011, HUM MOL GENET, V20, P2225, DOI 10.1093/hmg/ddr111; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Khanna A, 2011, AGING-US, V3, P223, DOI 10.18632/aging.100276; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Li XL, 2011, AGING-US, V3, P985, DOI 10.18632/aging.100371; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yang JR, 2013, AGE, V35, P11, DOI 10.1007/s11357-011-9324-3; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	33	284	303	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					519	U240		10.1038/nature10810	http://dx.doi.org/10.1038/nature10810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22343898	Green Accepted			2022-12-28	WOS:000300770500049
J	Di Sabatino, A; Corazza, GR				Di Sabatino, Antonio; Corazza, Gino Roberto			Nonceliac Gluten Sensitivity: Sense or Sensibility?	ANNALS OF INTERNAL MEDICINE			English	Article							IRRITABLE-BOWEL-SYNDROME; CELIAC-DISEASE; FOOD CHALLENGE; DOUBLE-BLIND; FREE DIET; EXPRESSION; SYMPTOMS; DIARRHEA	Recent studies support the existence of a new condition, nonceliac gluten sensitivity, which manifests as intestinal or extraintestinal symptoms that improve or disappear after gluten withdrawal in individuals with normal small-bowel mucosa and negative results on serum antitransglutaminase and antiendomysial antibody testing. Although the clinical value of this concept is under debate, the prevalence of nonceliac gluten sensitivity in the general population is supposed to be many times higher than that of celiac disease. The lack of an unambiguous definition of nonceliac gluten sensitivity, a major pitfall, is primarily related to the heterogeneous cause of this condition, whose symptoms are presumed to be caused by different mechanisms. If nonceliac gluten sensitivity is an etiologically heterogeneous syndrome, then management options should vary according to the predominant or concomitant underlying pathogenic pathways.	[Corazza, Gino Roberto] Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Ctr Studio & Curia Mallatia Celiaca, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia	Corazza, GR (corresponding author), Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Ctr Studio & Curia Mallatia Celiaca, Piazzale Golgi 5, I-27100 Pavia, Italy.	gr.corazza@smatteo.pv.it	Corazza, Gino Roberto/K-8500-2016; Di Sabatino, Antonio/K-8015-2016	Corazza, Gino Roberto/0000-0001-9532-0573; Di Sabatino, Antonio/0000-0002-0302-8645				ANDERSON IH, 1981, NEW ENGL J MED, V304, P891, DOI 10.1056/NEJM198104093041507; Asero R, 2009, CURR OPIN ALLERGY CL, V9, P379, DOI 10.1097/ACI.0b013e32832d9049; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; COOPER BT, 1981, GASTROENTEROLOGY, V81, P192; Corazza G. R., 1984, OPIOID PEPTIDES PERI, P243; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Inomata N, 2009, CURR OPIN ALLERGY CL, V9, P238, DOI 10.1097/ACI.0b013e32832aa5bc; Layton L., 2011, WASHINGTON POST 0429; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Painter K, 2008, US TODAY        0817; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Simpson S, 2011, GASTROENTEROLOGY, V140, pS443; Springen K, 2008, NEWSWEEK        1202; SUAREZ FL, 1995, NEW ENGL J MED, V333, P1, DOI 10.1056/NEJM199507063330101; Troncone R, 2011, J INTERN MED, V269, P582, DOI 10.1111/j.1365-2796.2011.02385.x; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; Wahnschaffe U, 2007, CLIN GASTROENTEROL H, V5, P844, DOI 10.1016/j.cgh.2007.03.021; Zuberbier T, 2004, ALLERGY, V59, P338, DOI 10.1046/j.1398-9995.2003.00403.x	20	87	88	0	45	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					309	U101		10.7326/0003-4819-156-4-201202210-00010	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896YO	22351716				2022-12-28	WOS:000300607600008
J	Dethoff, EA; Chugh, J; Mustoe, AM; Al-Hashimi, HM				Dethoff, Elizabeth A.; Chugh, Jeetender; Mustoe, Anthony M.; Al-Hashimi, Hashim M.			Functional complexity and regulation through RNA dynamics	NATURE			English	Review							AMINOACYL-TRANSFER-RNA; DELTA VIRUS RIBOZYME; THERMOSENSOR CONTROLS EXPRESSION; S RIBOSOMAL-RNA; HAMMERHEAD RIBOZYME; SECONDARY STRUCTURE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; GENE-EXPRESSION; IN-VITRO	Changes to the conformation of coding and non-coding RNAs form the basis of elements of genetic regulation and provide an important source of complexity, which drives many of the fundamental processes of life. Although the structure of RNA is highly flexible, the underlying dynamics of RNA are robust and are limited to transitions between the few conformations that preserve favourable base-pairing and stacking interactions. The mechanisms by which cellular processes harness the intrinsic dynamic behaviour of RNA and use it within functionally productive pathways are complex. The versatile functions and ease by which it is integrated into a wide variety of genetic circuits and biochemical pathways suggests there is a general and fundamental role for RNA dynamics in cellular processes.	[Dethoff, Elizabeth A.; Chugh, Jeetender; Mustoe, Anthony M.; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	hashimi@umich.edu	Chugh, Jeetender/S-4436-2019	Chugh, Jeetender/0000-0002-9996-5202	NSF; US National Institutes of Health [R01 AI066975, R01 GM089846]; US National Science Foundation (NSF) [CHE-0918817]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089846] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	E.A.D. and J.C. contributed equally to this Review. We thank C. Eichhorn and Q. Zhang for their input and assistance in the preparation of figures, and S. Butcher and S. Serganov for their comments on this Review. A. M. M. is supported by an NSF graduate research fellowship. The authors gratefully acknowledge the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for their support in the purchase of a 600 MHz spectrometer. This work was supported by the US National Institutes of Health (R01 AI066975 and R01 GM089846) and the US National Science Foundation (NSF Career Award CHE-0918817).	Abbink TEM, 2005, BIOCHEMISTRY-US, V44, P9058, DOI 10.1021/bi0502588; Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; Bailor MH, 2011, CURR OPIN STRUC BIOL, V21, P296, DOI 10.1016/j.sbi.2011.03.009; Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085; Bardaro MF, 2009, NUCLEIC ACIDS RES, V37, P1529, DOI 10.1093/nar/gkn1074; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bokinsky G, 2006, J MOL BIOL, V361, P771, DOI 10.1016/j.jmb.2006.06.048; Casey JL, 2012, CURR TOP MICROBIOL, V353, P123, DOI 10.1007/82_2011_146; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Chu VB, 2009, RNA, V15, P2195, DOI 10.1261/rna.1747509; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Diaz-Toledano R, 2009, NUCLEIC ACIDS RES, V37, P5498, DOI 10.1093/nar/gkp553; Duncan CDS, 2010, BIOCHEMISTRY-US, V49, P5418, DOI 10.1021/bi100267g; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Falb M, 2010, NUCLEIC ACIDS RES, V38, P6274, DOI 10.1093/nar/gkq380; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2010, ANNU REV BIOCHEM, V79, P381, DOI 10.1146/annurev-biochem-060408-173330; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Furtig B, 2010, ACS CHEM BIOL, V5, P753, DOI 10.1021/cb100025a; Giege R, 2008, NAT STRUCT MOL BIOL, V15, P1007, DOI 10.1038/nsmb.1498; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Greenfeld M, 2011, J BIOL CHEM, V286, P19872, DOI 10.1074/jbc.M111.235465; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Grundy FJ, 2002, P NATL ACAD SCI USA, V99, P11121, DOI 10.1073/pnas.162366799; Haller A, 2011, ACCOUNTS CHEM RES, V44, P1339, DOI 10.1021/ar200035g; Harris DA, 2002, BIOCHEMISTRY-US, V41, P12051, DOI 10.1021/bi026101m; HELD WA, 1974, J BIOL CHEM, V249, P3103; HERSCHLAG D, 1994, EMBO J, V13, P2913, DOI 10.1002/j.1460-2075.1994.tb06586.x; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kim HD, 2002, P NATL ACAD SCI USA, V99, P4284, DOI 10.1073/pnas.032077799; Kosowski TR, 2009, RNA, V15, P1345, DOI 10.1261/rna.1065209; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Le SY, 2002, NUCLEIC ACIDS RES, V30, P3574, DOI 10.1093/nar/gkf473; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lee TH, 2007, P NATL ACAD SCI USA, V104, P13661, DOI 10.1073/pnas.0705988104; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Menichelli E, 2007, J MOL BIOL, V367, P187, DOI 10.1016/j.jmb.2006.12.056; Miyazaki Y, 2010, J MOL BIOL, V396, P141, DOI 10.1016/j.jmb.2009.11.033; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; Mustoe AM, 2012, NUCLEIC ACIDS RES, V40, P892, DOI 10.1093/nar/gkr751; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Nocker A, 2001, NUCLEIC ACIDS RES, V29, P4800, DOI 10.1093/nar/29.23.4800; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Orr JW, 1998, J MOL BIOL, V275, P453, DOI 10.1006/jmbi.1997.1489; Pape T, 2000, NAT STRUCT BIOL, V7, P104; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; PYLE AM, 1995, CURR OPIN STRUC BIOL, V5, P303, DOI 10.1016/0959-440X(95)80091-3; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Schultes EA, 1999, J MOL EVOL, V49, P76, DOI 10.1007/PL00006536; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; Shajani Z, 2007, BIOCHEMISTRY-US, V46, P5875, DOI 10.1021/bi602658x; Shankar N, 2007, BIOCHEMISTRY-US, V46, P12665, DOI 10.1021/bi700802s; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Stelzer AC, 2010, ANGEW CHEM INT EDIT, V49, P5731, DOI 10.1002/anie.201000814; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Tama F, 2003, P NATL ACAD SCI USA, V100, P9319, DOI 10.1073/pnas.1632476100; Treiber DK, 2001, CURR OPIN STRUC BIOL, V11, P309, DOI 10.1016/S0959-440X(00)00206-2; Turner B, 2005, RNA, V11, P1192, DOI 10.1261/rna.2680605; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Venditti V, 2009, J MOL BIOL, V391, P894, DOI 10.1016/j.jmb.2009.07.003; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wang SL, 1999, BIOCHEMISTRY-US, V38, P14363, DOI 10.1021/bi9913202; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wilson TJ, 2005, BIOCHEM SOC T, V33, P461, DOI 10.1042/BST0330461; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Zacharias M, 1996, J MOL BIOL, V257, P276, DOI 10.1006/jmbi.1996.0162; Zhang Q, 2010, P NATL ACAD SCI USA, V107, P18761, DOI 10.1073/pnas.1013269107; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	100	220	224	1	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					322	330		10.1038/nature10885	http://dx.doi.org/10.1038/nature10885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337051	Green Accepted			2022-12-28	WOS:000300287100033
J	Wang, CC; Ding, QL; Tao, H; Li, H				Wang, Chuan-Chao; Ding, Qi-Liang; Tao, Huan; Li, Hui			Comment on "Phonemic Diversity Supports a Serial Founder Effect Model of Language Expansion from Africa"	SCIENCE			English	Editorial Material									[Li, Hui] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; Fudan Univ, Dept Chinese Language & Literature, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Li, H (corresponding author), Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	lihui.fudan@gmail.com	Wang, Chuan-Chao/AGY-2940-2022; Wang, Chuan-Chao/B-2975-2011	Wang, Chuan-Chao/0000-0003-4630-5232; Wang, Chuan-Chao/0000-0001-9628-0307				Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; *INT PHON ASS, 1999, HDB INT PHON ASS; Li Hui, 2008, COMMUN CONT ANTHR, V2, P42, DOI DOI 10.4236/COCA.2008.21007; Maddieson, 1996, SOUNDS WORLDS LANGUA; Maddieson I, 2011, WORLD ATLAS LANGUAGE; Venables WN., 2002, MODERN APPL STAT S	7	14	14	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069								10.1126/science.1207846	http://dx.doi.org/10.1126/science.1207846			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	889AY	22323803				2022-12-28	WOS:000300047100029
J	Miller, VM				Miller, Virginia M.			Family matters: sexual dimorphism in cardiovascular disease	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; HEART-DISEASE; Y-CHROMOSOME; ATHEROSCLEROSIS; ASSOCIATION; OUTCOMES; SURGERY; SOCIETY		[Miller, Virginia M.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Miller, Virginia M.] Mayo Clin, Dept Physiol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Miller, VM (corresponding author), Mayo Clin, Dept Surg, Rochester, MN 55905 USA.	miller.virginia@mayo.edu						Blauwet Lori A, 2007, Cardiol Rev, V15, P275, DOI 10.1097/CRD.0b013e318158b45b; Charchar FJ, 2012, LANCET, V379, P915, DOI 10.1016/S0140-6736(11)61453-0; Charchar FJ, 2004, ARTERIOSCL THROM VAS, V24, P308, DOI 10.1161/01.ATV.0000113291.39267.0a; Gottlieb S, 2000, CIRCULATION, V102, P2484, DOI 10.1161/01.CIR.102.20.2484; HENDEL RC, 1995, CIRCULATION, V91, P1044, DOI 10.1161/01.CIR.91.4.1044; Hogue CW, 2001, CIRCULATION, V103, P2133; Karp I, 2007, CAN MED ASSOC J, V176, P333, DOI 10.1503/cmaj.060627; King KM, 2004, JAMA-J AM MED ASSOC, V291, P1220, DOI 10.1001/jama.291.10.1220; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Turner ME, 2009, HYPERTENSION, V53, P430, DOI 10.1161/HYPERTENSIONAHA.108.124131; Vaccarino V, 2011, CARDIOVASC RES, V90, P9, DOI 10.1093/cvr/cvq394	13	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 10	2012	379	9819					873	875		10.1016/S0140-6736(12)60200-1	http://dx.doi.org/10.1016/S0140-6736(12)60200-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	906NY	22325188				2022-12-28	WOS:000301353700009
J	Wegwarth, O; Schwartz, LM; Woloshin, S; Gaissmaier, W; Gigerenzer, G				Wegwarth, Odette; Schwartz, Lisa M.; Woloshin, Steven; Gaissmaier, Wolfgang; Gigerenzer, Gerd			Do Physicians Understand Cancer Screening Statistics? A National Survey of Primary Care Physicians in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							SURVIVAL RATES; SENESCENCE; MORTALITY; TRIAL	Background: Unlike reduced mortality rates, improved survival rates and increased early detection do not prove that cancer screening tests save lives. Nevertheless, these 2 statistics are often used to promote screening. Objective: To learn whether primary care physicians understand which statistics provide evidence about whether screening saves lives. Design: Parallel-group, randomized trial (randomization controlled for order effect only), conducted by Internet survey. (ClinicalTrials.gov registration number: NCT00981019) Setting: National sample of U.S. primary care physicians from a research panel maintained by Harris Interactive (79% cooperation rate). Participants: 297 physicians who practiced both inpatient and outpatient medicine were surveyed in 2010, and 115 physicians who practiced exclusively outpatient medicine were surveyed in 2011. Intervention: Physicians received scenarios about the effect of 2 hypothetical screening tests: The effect was described as improved 5-year survival and increased early detection in one scenario and as decreased cancer mortality and increased incidence in the other. Measurements: Physicians' recommendation of screening and perception of its benefit in the scenarios and general knowledge of screening statistics. Results: Primary care physicians were more enthusiastic about the screening test supported by irrelevant evidence (5-year survival increased from 68% to 99%) than about the test supported by relevant evidence (cancer mortality reduced from 2 to 1.6 in 1000 persons). When presented with irrelevant evidence, 69% of physicians recommended the test, compared with 23% when presented with relevant evidence (P < 0.001). When asked general knowledge questions about screening statistics, many physicians did not distinguish between irrelevant and relevant screening evidence; 76% versus 81%, respectively, stated that each of these statistics proves that screening saves lives (P = 0.39). About one half (47%) of the physicians incorrectly said that finding more cases of cancer in screened as opposed to unscreened populations "proves that screening saves lives." Limitation: Physicians' recommendations for screening were based on hypothetical scenarios, not actual practice. Conclusion: Most primary care physicians mistakenly interpreted improved survival and increased detection with screening as evidence that screening saves lives. Few correctly recognized that only reduced mortality in a randomized trial constitutes evidence of the benefit of screening.	[Wegwarth, Odette] Max Planck Inst Human Dev & Educ, Harding Ctr Risk Literacy, D-14195 Berlin, Germany; Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Dartmouth, NS, Canada; Vet Affairs Outcomes Grp, White River Jct, VT USA	Max Planck Society	Wegwarth, O (corresponding author), Max Planck Inst Human Dev & Educ, Harding Ctr Risk Literacy, Lentzeallee 94, D-14195 Berlin, Germany.	wegwarth@mpib-berlin.mpg.de	Gigerenzer, Gerd/M-5595-2013; Gigerenzer, Gerd/A-6250-2012	Gigerenzer, Gerd/0000-0002-6163-5419; Gaissmaier, Wolfgang/0000-0001-6273-178X	Harding Center for Risk Literacy; Max Planck Institute for Human Development; National Cancer Institute [R01 CA104721]; NATIONAL CANCER INSTITUTE [R01CA104721] Funding Source: NIH RePORTER	Harding Center for Risk Literacy; Max Planck Institute for Human Development; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Harding Center for Risk Literacy, Max Planck Institute for Human Development.; The Harding Center for Risk Literacy, Max Planck Institute for Human Development, funded the study and provides support for Drs. Wegwarth, Gaissmaier, and Gigerenzer. Drs. Schwartz and Woloshin were supported by the National Cancer Institute (grant R01 CA104721).	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bramwell R, 2006, BMJ-BRIT MED J, V333, P284, DOI 10.1136/bmj.38884.663102.AE; CASSCELLS W, 1978, NEW ENGL J MED, V299, P999, DOI 10.1056/NEJM197811022991808; Centers for Disease Control and Prevention Office of Surveillance Epidemiology and Laboratory Services Behavioral Risk Factor Surveillance System, 2006, PREV TRENDS DAT NAT; Covey J, 2007, MED DECIS MAKING, V27, P638, DOI 10.1177/0272989x07306783; Eddy DM, 1982, JUDGMENT UNCERTAINTY, P249; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Hoffrage U, 1998, ACAD MED, V73, P538, DOI 10.1097/00001888-199805000-00024; Jain BP, 1998, ANN INTERN MED, V128, P72, DOI 10.7326/0003-4819-128-1-199801010-00019; McGettigan P, 1999, J GEN INTERN MED, V14, P633, DOI 10.1046/j.1525-1497.1999.09038.x; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; Rimer BK, 2004, CANCER-AM CANCER SOC, V101, P1214, DOI 10.1002/cncr.20512; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Serrano M, 2007, NEW ENGL J MED, V356, P1996, DOI 10.1056/NEJMcibr071461; SONDIK EJ, 1990, J NATL CANCER I, V82, P825; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Wegwarth O, 2011, PATIENT EDUC COUNS, V84, P251, DOI 10.1016/j.pec.2010.07.025; Wegwarth O, 2011, MED DECIS MAKING, V31, P386, DOI 10.1177/0272989X10391469; Welch HG, 2007, ARCH INTERN MED, V167, P2289, DOI 10.1001/archinte.167.21.2289; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975	23	182	185	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2012	156	5					340	U152		10.7326/0003-4819-156-5-201203060-00005	http://dx.doi.org/10.7326/0003-4819-156-5-201203060-00005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902OC	22393129	Green Published			2022-12-28	WOS:000301046800002
J	Meng, Q; Xu, L; Zhang, YG; Qian, JC; Cai, M; Xin, Y; Gao, J; Xu, K; Boerma, JT; Barber, SL				Meng, Qun; Xu, Ling; Zhang, Yaoguang; Qian, Juncheng; Cai, Min; Xin, Ying; Gao, Jun; Xu, Ke; Boerma, J. Ties; Barber, Sarah L.			Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study	LANCET			English	Article							RURAL CHINA; SYSTEM; DELIVERY; MARKET; REFORM	Background In the past decade, the Government of China initiated health-care reforms to achieve universal access to health care by 2020. We assessed trends in health-care access and financial protection between 2003, and 2011, nationwide. Methods We used data from the 2003, 2008, and 2011 National Health Services Survey (NHSS), which used multistage stratified cluster sampling to select 94 of 2859 counties from China's 31 provinces and municipalities. The 2011 survey was done with a subset of the NHSS sampling frame to monitor key indicators after the national health-care reforms were announced in 2009. Three sets of indicators were chosen to measure trends in access to coverage, health-care activities, and financial protection. Data were disaggregated by urban or rural residence and by three geographical regions: east, central, and west, and by household income. We examined change in equity across and within regions. Findings The number of households interviewed was 57 023 in 2003, 56 456 in 2008, and 18 822 in 2011. Response rates were 98.3%, 95.0%, and 95.5%, respectively. The number of individuals interviewed was 193 689 in 2003, 177 501 in 2008, and 59 835 in 2011. Between 2003 and 2011, insurance coverage increased from 29.7% (57 526 of 193 689) to 95.7% (57 262 of 59 835, p<0.0001). The average share of inpatient costs reimbursed from insurance increased from 14.4 (13.7-15.1) in 2003 to 46.9 (44.7-49.1) in 2011 (p<0.0001). Hospital delivery rates averaged 95.8% (1219 of 1272) in 2011. Hospital admissions increased 2.5 times to 8.8% (5288 of 59 835, p<0.0001) in 2011 from 3.6% (6981 of 193 689) in 2003. 12.9% of households (2425 of 18 800) had catastrophic health expenses in 2011. Caesarean section rates increased from 19.2% (736 of 3835) to 36.3% (443 of 1221, p<0.0001) between 2003 and 2011. Interpretation Remarkable increases in insurance coverage and inpatient reimbursement were accompanied by increased use and coverage of health care. Important advances have been made in achieving equal access to services and insurance coverage across and within regions. However, these increases have not been accompanied by reductions in catastrophic health expenses. With the achievement of basic health-services coverage, future challenges include stronger risk protection, and greater efficiency and quality of care.	[Barber, Sarah L.] WHO, Beijing 100600, Peoples R China; [Gao, Jun] WHO Western Pacific Reg Off, Div Hlth Sector Dev, Manila, Philippines; [Xu, Ke] WHO, Dept Hlth Financing, CH-1211 Geneva, Switzerland; [Boerma, J. Ties] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland	World Health Organization; WHO Western Pacific Regional Office; World Health Organization; World Health Organization	Barber, SL (corresponding author), WHO, Beijing 100600, Peoples R China.	barber.sarah.louise@gmail.com						Barber SL, 2010, 37 WHO; Bogg L, 2010, SOC SCI MED, V70, P1544, DOI 10.1016/j.socscimed.2010.01.026; Center for Health Statistics and Information, 2004, REP NAT HLTH SERV SU; Centre for Health Statistics and Information, 2011, CHIN HLTH STAT DIG; China National Bureau of Statistics, 2011, CHIN HLTH STAT YB 20; China National Health Economics Institute, 2009, CHIN NAT HLTH ACC RE, P77; Communist Party of China Central Committee, 2009, STAT COUNC IMPL PLAN; Communist Party of China Central Committee, 2009, OP COMM PART CHIN CE; Dong KY, 2009, CHINA ECON REV, V20, P591, DOI 10.1016/j.chieco.2009.05.011; Eggleston K, 2008, HEALTH ECON, V17, P149, DOI 10.1002/hec.1306; Lei XY, 2009, HEALTH ECON, V18, pS25, DOI 10.1002/hec.1501; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Ma J, 2008, HEALTH AFFAIR, V27, P937, DOI 10.1377/hlthaff.27.4.937; Nabar MS, 2011, IMF WORKING PAPERS; OECD, 2010, HLTH DAT 2010; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Wagstaff A, 2009, HEALTH ECON, V18, pS7, DOI 10.1002/hec.1518; Yan, 2011, XINHUA ENGLISH  0530; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460	19	427	440	14	195	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2012	379	9818					805	814		10.1016/S0140-6736(12)60278-5	http://dx.doi.org/10.1016/S0140-6736(12)60278-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386034				2022-12-28	WOS:000300983400030
J	Dunn, B				Dunn, Barbara			CANCER Solving an age-old problem	NATURE			English	Editorial Material									US Natl Canc Inst, Canc Prevent Div, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dunn, B (corresponding author), US Natl Canc Inst, Canc Prevent Div, Bethesda, MD 20892 USA.	dunnb@mail.nih.gov						American Cancer Society, 2011, LEARN CANC; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; David AR, 2010, NAT REV CANCER, V10, P728, DOI 10.1038/nrc2914; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; National Cancer Institute, 2011, HARMS SMOK HLTH BEN; World Health Organization, 2011, CANC CERV	6	19	20	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					S2	S6		10.1038/483S2a	http://dx.doi.org/10.1038/483S2a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900HP	22378123	Bronze			2022-12-28	WOS:000300877900001
J	Giacino, JT; Whyte, J; Bagiella, E; Kalmar, K; Childs, N; Khademi, A; Eifert, B; Long, D; Katz, DI; Cho, S; Yablon, SA; Luther, M; Hammond, FM; Nordenbo, A; Novak, P; Mercer, W; Maurer-Karattup, P; Sherer, M				Giacino, Joseph T.; Whyte, John; Bagiella, Emilia; Kalmar, Kathleen; Childs, Nancy; Khademi, Allen; Eifert, Bernd; Long, David; Katz, Douglas I.; Cho, Sooja; Yablon, Stuart A.; Luther, Marianne; Hammond, Flora M.; Nordenbo, Annette; Novak, Paul; Mercer, Walt; Maurer-Karattup, Petra; Sherer, Mark			Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMALLY CONSCIOUS STATE; RECOVERY; COMA; REHABILITATION; DISORDERS; SCALE	BACKGROUND Amantadine hydrochloride is one of the most commonly prescribed medications for patients with prolonged disorders of consciousness after traumatic brain injury. Preliminary studies have suggested that amantadine may promote functional recovery. METHODS We enrolled 184 patients who were in a vegetative or minimally conscious state 4 to 16 weeks after traumatic brain injury and who were receiving inpatient rehabilitation. Patients were randomly assigned to receive amantadine or placebo for 4 weeks and were followed for 2 weeks after the treatment was discontinued. The rate of functional recovery on the Disability Rating Scale (DRS; range, 0 to 29, with higher scores indicating greater disability) was compared over the 4 weeks of treatment (primary outcome) and during the 2-week washout period with the use of mixed-effects regression models. RESULTS During the 4-week treatment period, recovery was significantly faster in the amantadine group than in the placebo group, as measured by the DRS score (difference in slope, 0.24 points per week; P=0.007), indicating a benefit with respect to the primary outcome measure. In a prespecified subgroup analysis, the treatment effect was similar for patients in a vegetative state and those in a minimally conscious state. The rate of improvement in the amantadine group slowed during the 2 weeks after treatment (weeks 5 and 6) and was significantly slower than the rate in the placebo group (difference in slope, 0.30 points per week; P=0.02). The overall improvement in DRS scores between baseline and week 6 (2 weeks after treatment was discontinued) was similar in the two groups. There were no significant differences in the incidence of serious adverse events. CONCLUSIONS Amantadine accelerated the pace of functional recovery during active treatment in patients with post-traumatic disorders of consciousness. (Funded by the National Institute on Disability and Rehabilitation Research; ClinicalTrials.gov number, NCT00970944.)	[Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Giacino, Joseph T.; Kalmar, Kathleen; Khademi, Allen] JFK Johnson Rehabil Inst, Edison, NJ USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Whyte, John; Cho, Sooja] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Long, David] Bryn Mawr Rehab Hosp, Brain Injury Program, Malvern, PA USA; [Bagiella, Emilia] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Childs, Nancy; Mercer, Walt] Texas NeuroRehab Ctr, Austin, TX USA; [Eifert, Bernd; Maurer-Karattup, Petra] SRH Fachkrankenhaus, Neresheim, Germany; [Luther, Marianne] Schon Klin Bad Aibling, Bad Aibling, Germany; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Yablon, Stuart A.; Sherer, Mark] Methodist Rehabil Ctr, Jackson, MS USA; [Yablon, Stuart A.] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada; [Hammond, Flora M.] Carolinas Rehabil, Dept Phys Med & Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN USA; [Nordenbo, Annette] Copenhagen Univ Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, Glostrup, Denmark; [Nordenbo, Annette] Univ Copenhagen, Hvidovre Hosp, DK-2650 Hvidovre, Denmark; [Novak, Paul] Sunnyview Rehabil Hosp, Schenectady, NY USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA	Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Boston University; Yeshiva University; Columbia University; University of Alberta; Indiana University System; Indiana University Bloomington; University of Copenhagen; University of Copenhagen	Giacino, JT (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 125 Nashua St, Boston, MA 02114 USA.	jgiacino@partners.org	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Whyte, John/0000-0002-4381-1474; Katz, Douglas/0000-0002-7502-8505	National Institute on Disability and Rehabilitation Research [H133A031713]	National Institute on Disability and Rehabilitation Research	Supported by a grant from the National Institute on Disability and Rehabilitation Research (H133A031713).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 2005, REHABILITATION TRAUM, P305; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Peeters M, 2002, BRAIN RES, V949, P32, DOI 10.1016/S0006-8993(02)02961-X; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Schneider WN, 1999, BRAIN INJURY, V13, P863; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Zafonte RD, 1998, BRAIN INJURY, V12, P617	24	415	437	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					819	826		10.1056/NEJMoa1102609	http://dx.doi.org/10.1056/NEJMoa1102609			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900GI	22375973				2022-12-28	WOS:000300874300008
J	Shah, N				Shah, Nisha			A PATIENT'S JOURNEY Mood disorder in the perinatal period	BRITISH MEDICAL JOURNAL			English	Editorial Material									Camden & Islington NHS Fdn Trust, Highgate Mental Hlth Ctr, London N19 5NX, England		Shah, N (corresponding author), Camden & Islington NHS Fdn Trust, Highgate Mental Hlth Ctr, London N19 5NX, England.	Nisha.Shah@candi.nhs.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2012	344								e1209	10.1136/bmj.e1209	http://dx.doi.org/10.1136/bmj.e1209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XJ	22381523	Bronze			2022-12-28	WOS:000301231900008
J	Secord, R; Bloch, JI; Chester, SGB; Boyer, DM; Wood, AR; Wing, SL; Kraus, MJ; McInerney, FA; Krigbaum, J				Secord, Ross; Bloch, Jonathan I.; Chester, Stephen G. B.; Boyer, Doug M.; Wood, Aaron R.; Wing, Scott L.; Kraus, Mary J.; McInerney, Francesca A.; Krigbaum, John			Evolution of the Earliest Horses Driven by Climate Change in the Paleocene-Eocene Thermal Maximum	SCIENCE			English	Article							ISOTOPE FRACTIONATION; STABLE-ISOTOPES; BERGMANNS RULE; BIGHORN BASIN; BODY-SIZE; CARBON; MAMMALS; ENVIRONMENT; BOUNDARY; FUTURE	Body size plays a critical role in mammalian ecology and physiology. Previous research has shown that many mammals became smaller during the Paleocene-Eocene Thermal Maximum (PETM), but the timing and magnitude of that change relative to climate change have been unclear. A high-resolution record of continental climate and equid body size change shows a directional size decrease of similar to 30% over the first similar to 130,000 years of the PETM, followed by a similar to 76% increase in the recovery phase of the PETM. These size changes are negatively correlated with temperature inferred from oxygen isotopes in mammal teeth and were probably driven by shifts in temperature and possibly high atmospheric CO2 concentrations. These findings could be important for understanding mammalian evolutionary responses to future global warming.	[Secord, Ross] Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA; [Secord, Ross; Bloch, Jonathan I.; Wood, Aaron R.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Chester, Stephen G. B.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Boyer, Doug M.] CUNY Brooklyn Coll, Dept Anthropol & Archaeol, Brooklyn, NY 11210 USA; [Wood, Aaron R.] S Dakota Sch Mines & Technol, Dept Geol & Geol Engn, Rapid City, SD 57701 USA; [Wing, Scott L.] Smithsonian Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Kraus, Mary J.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [McInerney, Francesca A.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA; [Krigbaum, John] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA	University of Nebraska System; University of Nebraska Lincoln; State University System of Florida; University of Florida; Yale University; City University of New York (CUNY) System; Brooklyn College (CUNY); South Dakota School Mines & Technology; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Colorado System; University of Colorado Boulder; Northwestern University; State University System of Florida; University of Florida	Secord, R (corresponding author), Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA.	rsecord2@unl.edu	Kraus, Mary J/C-3323-2008; McInerney, Francesca/B-7894-2009; McInerney, Francesca A/ABE-3639-2020	Kraus, Mary J/0000-0002-1721-2566; McInerney, Francesca/0000-0002-2020-6650; McInerney, Francesca A/0000-0002-2020-6650; Boyer, Douglas/0000-0002-8697-2999; Bloch, Jonathan/0000-0003-1484-6931; Wing, Scott/0000-0002-2954-8905	NSF [EAR-0640076, EAR-0719941, EAR-0717892, EAR-0718740, EAR-0720268]	NSF(National Science Foundation (NSF))	We thank T. Bown, P. Gingerich, B. MacFadden, K. Rose, E. Sargis, and S. Strait for helpful discussions and advice; J. Curtis, B. Tucker, and A. Baczynski for help with isotope lab work; J. Bourque and A. Hastings for specimen preparation; and P. Koch and two anonymous reviewers for helpful comments. Supported by NSF grants EAR-0640076 (J.I.B., J.K., R.S.), EAR-0719941 (J.I.B.), EAR-0717892 (S.L.W.), EAR-0718740 (M.J.K.), and EAR-0720268 (F.A.M.). Data used in this paper are available in the SOM.	Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Chester SGB, 2010, J MAMM EVOL, V17, P227, DOI 10.1007/s10914-010-9141-y; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; Cui Y, 2011, NAT GEOSCI, V4, P481, DOI [10.1038/ngeo1179, 10.1038/NGEO1179]; DANSGAARD W, 1964, TELLUS, V16, P436; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gingerich P.D., 1989, U MICHIGAN PAPERS PA, V28, P1; Gingerich PD, 2001, GENETICA, V112, P127, DOI 10.1023/A:1013311015886; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Kraus MJ, 2007, PALAEOGEOGR PALAEOCL, V245, P444, DOI 10.1016/j.palaeo.2006.09.011; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Mayr E., 1963, ANIMAL SPECIES EVOLU; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Owensby Clenton E., 1996, P363, DOI 10.1016/B978-012420870-4/50056-6; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Rodriguez MA, 2008, GLOBAL ECOL BIOGEOGR, V17, P274, DOI 10.1111/j.1466-8238.2007.00363.x; Secord R, 2008, PALEOBIOLOGY, V34, P282, DOI 10.1666/0094-8373(2008)034[0282:SIIEEM]2.0.CO;2; Secord R, 2010, NATURE, V467, P955, DOI 10.1038/nature09441; Smith FA, 2009, GLOBAL PLANET CHANGE, V65, P122, DOI 10.1016/j.gloplacha.2008.10.015; Smith FA, 2007, EARTH PLANET SC LETT, V262, P50, DOI 10.1016/j.epsl.2007.07.021; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913	30	109	114	1	244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					959	962		10.1126/science.1213859	http://dx.doi.org/10.1126/science.1213859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363006	Green Published			2022-12-28	WOS:000300931800044
J	O'Carrigan, B; Cheong, JY				O'Carrigan, Brent; Cheong, Ju Yong			Patient With a Rash, Abdominal Pain, and Weight Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POLYARTERITIS-NODOSA		[O'Carrigan, Brent; Cheong, Ju Yong] Univ Sydney, Cent Clin Sch, Camperdown, NSW, Australia	University of Sydney	O'Carrigan, B (corresponding author), Univ Sydney, Royal Prince Alfred Hosp, Cent Clin Sch, Level 4,Bldg 63,Missenden Rd, Camperdown, NSW 2050, Australia.	b.ocarrigan@gmail.com	Hug, Balthasar L./G-1568-2010	O'Carrigan, Brent/0000-0001-8187-6298				Mahr A, 2004, ARTHRIT RHEUM-ARTHR, V51, P92, DOI 10.1002/art.20077; Pagnoux C, 2010, ARTHRITIS RHEUM-US, V62, P616, DOI 10.1002/art.27240	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					843	844		10.1001/jama.2012.198	http://dx.doi.org/10.1001/jama.2012.198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FQ	22357835				2022-12-28	WOS:000300551300027
J	Sievenpiper, JL; de Souza, RJ; Mirrahimi, A; Yu, ME; Carleton, AJ; Beyene, J; Chiavaroli, L; Di Buono, M; Jenkins, AL; Leiter, LA; Wolever, TMS; Kendall, CWC; Jenkins, DJA				Sievenpiper, John L.; de Souza, Russell J.; Mirrahimi, Arash; Yu, Matthew E.; Carleton, Amanda J.; Beyene, Joseph; Chiavaroli, Laura; Di Buono, Marco; Jenkins, Alexandra L.; Leiter, Lawrence A.; Wolever, Thomas M. S.; Kendall, Cyril W. C.; Jenkins, David J. A.			Effect of Fructose on Body Weight in Controlled Feeding Trials A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							SUGAR-SWEETENED BEVERAGES; SOFT DRINK CONSUMPTION; DIETARY FRUCTOSE; INSULIN SENSITIVITY; LIPID-METABOLISM; NATURAL SWEETENER; GLUCOSE; GAIN; ADOLESCENTS; SUCROSE	Background: The contribution of fructose consumption in Western diets to overweight and obesity in populations remains uncertain. Purpose: To review the effects of fructose on body weight in controlled feeding trials. Data Sources: MEDLINE, EMBASE, CINAHL, and the Cochrane Library (through 18 November 2011). Study Selection: At least 3 reviewers identified controlled feeding trials lasting 7 or more days that compared the effect on body weight of free fructose and nonfructose carbohydrate in diets providing similar calories (isocaloric trials) or of diets supplemented with free fructose to provide excess energy and usual or control diets (hypercaloric trials). Trials evaluating high-fructose corn syrup (42% to 55% free fructose) were excluded. Data Extraction: The reviewers independently reviewed and extracted relevant data; disagreements were reconciled by consensus. The Heyland Methodological Quality Score was used to assess study quality. Data Synthesis: Thirty-one isocaloric trials (637 participants) and 10 hypercaloric trials (119 participants) were included; studies tended to be small (<15 participants), short (<12 weeks), and of low quality. Fructose had no overall effect on body weight in isocaloric trials (mean difference, -0.14 kg [95% CI, -0.37 to 0.10 kg] for fructose compared with nonfructose carbohydrate). High doses of fructose in hypercaloric trials (+104 to 250 g/d, +18% to 97% of total daily energy intake) lead to significant increases in weight (mean difference, 0.53 kg [CI, 0.26 to 0.79 kg] with fructose). Limitations: Most trials had methodological limitations and were of poor quality. The weight-increasing effect of fructose in hypercaloric trials may have been attributable to excess energy rather than fructose itself. Conclusion: Fructose does not seem to cause weight gain when it is substituted for other carbohydrates in diets providing similar calories. Free fructose at high doses that provided excess calories modestly increased body weight, an effect that may be due to the extra calories rather than the fructose.	[Wolever, Thomas M. S.; Kendall, Cyril W. C.; Jenkins, David J. A.] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; [Sievenpiper, John L.] McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [de Souza, Russell J.] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Mirrahimi, Arash; Yu, Matthew E.; Chiavaroli, Laura; Jenkins, Alexandra L.] St Michaels Hosp, Risk Factor Modificat Ctr, Toronto, ON M5C 2T2, Canada; [Carleton, Amanda J.] Univ Toronto, Fac Med, Toronto, ON M5S 1A8, Canada; [Di Buono, Marco] Heart & Stroke Fdn, Toronto, ON M4P 1E4, Canada; [Leiter, Lawrence A.] St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON M5C 2T2, Canada	University of Toronto; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Jenkins, DJA (corresponding author), Univ Toronto, Fac Med, Dept Nutr Sci, FitzGerald Bldg,Room 340,150 Coll St, Toronto, ON M5S 3E2, Canada.	NutritionProject@smh.ca	de Souza, Russell J/ABB-7735-2021; Wolever, Thomas/AAC-8066-2022; Leiter, Lawrence/AAG-4059-2020	de Souza, Russell J/0000-0001-8945-513X; Di Buono, Marco/0000-0002-2221-7011	Canadian Institutes of Health Research; Canadian Institutes of Health Research Knowledge Synthesis; Calorie Control Council; Province of Ontario Postdoctoral Fellowship; Edie Steinberg Scholarship Fund; Edward Christie Stevens Fellowship in Medicine; Government of Canada through the Canada Research Chair Endowment	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Knowledge Synthesis(Canadian Institutes of Health Research (CIHR)); Calorie Control Council; Province of Ontario Postdoctoral Fellowship; Edie Steinberg Scholarship Fund; Edward Christie Stevens Fellowship in Medicine(University of Toronto); Government of Canada through the Canada Research Chair Endowment	Canadian Institutes of Health Research. (ClinicalTrials.gov registration number: NCT01363791); This work was funded by a Canadian Institutes of Health Research Knowledge Synthesis grant and a grant from the Calorie Control Council. Dr. Sievenpiper was supported in the initial stages of this work by a Province of Ontario Postdoctoral Fellowship and the Edie Steinberg Scholarship Fund and the Edward Christie Stevens Fellowship in Medicine. Dr. D.J.A. Jenkins was funded by the Government of Canada through the Canada Research Chair Endowment. None of the sponsors had a role in any aspect of the study, including its design and conduct; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Aeberli I, 2011, AM J CLIN NUTR, V94, P479, DOI 10.3945/ajcn.111.013540; ANDERSON JW, 1989, DIABETES CARE, V12, P337, DOI 10.2337/diacare.12.5.337; BANTLE JP, 1992, DIABETES CARE, V15, P1468, DOI 10.2337/diacare.15.11.1468; Bantle JP, 2000, AM J CLIN NUTR, V72, P1128; BECKNIELSEN H, 1980, AM J CLIN NUTR, V33, P273, DOI 10.1093/ajcn/33.2.273; Blayo A, 1990, MED NUTR, V26, P909; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2; Brymora A, 2011, NEPHROL DIAL TR 0525; Curtin F, 2002, STAT MED, V21, P2131, DOI 10.1002/sim.1205; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662; FORSTER H, 1973, DEUT MED WOCHENSCHR, V98, P1156, DOI 10.1055/s-0028-1106986; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; GRIGORESCO C, 1988, DIABETES CARE, V11, P546, DOI 10.2337/diacare.11.7.546; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Higgins HL, 1916, AM J PHYSIOL, V41, P258, DOI 10.1152/ajplegacy.1916.41.2.258; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; International Diabetes Federation, 2011, IDF DIAB ATL; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; KAUFMANN NA, 1966, ISRAEL J MED SCI, V2, P715; KOIVISTO VA, 1993, J INTERN MED, V233, P145, DOI 10.1111/j.1365-2796.1993.tb00667.x; Lathyris DN, 2007, INT J EPIDEMIOL, V36, P422, DOI 10.1093/ije/dym001; Le KA, 2006, AM J CLIN NUTR, V84, P1374, DOI 10.1093/ajcn/84.6.1374; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Livesey G, 2008, AM J CLIN NUTR, V88, P1419, DOI 10.3945/ajcn.2007.25700; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; Madero M, 2011, METABOLISM, V60, P1551, DOI 10.1016/j.metabol.2011.04.001; Malerbi DA, 1996, DIABETES CARE, V19, P1249, DOI 10.2337/diacare.19.11.1249; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Malik VS, 2009, AM J CLIN NUTR, V89, P438, DOI 10.3945/ajcn.2008.26980; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; Mattes RD, 2011, OBES REV, V12, P346, DOI 10.1111/j.1467-789X.2010.00755.x; MCATEER EJ, 1987, DIABETIC MED, V4, P62, DOI 10.1111/j.1464-5491.1987.tb00831.x; McDevitt RM, 2000, AM J CLIN NUTR, V72, P369; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; OSEI K, 1987, AM J MED, V83, P249, DOI 10.1016/0002-9343(87)90693-0; OSEI K, 1989, DIABETIC MED, V6, P506, DOI 10.1111/j.1464-5491.1989.tb01218.x; Panel on Macronutrients Panel on the Definition of Dietary Fiber Sub-committee on Upper Reference Levels of Nutrients Subcommittee on Interpretation and Uses of Dietary Reference Intakes and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine, 2002, DIET REF INT EN CARB; PELKONEN R, 1972, ACTA MED SCAND, P187; Rizkalla S W, 1986, Journ Annu Diabetol Hotel Dieu, P207; RIZKALLA SW, 1986, PHARMACOL BIOCHEM BE, V25, P681, DOI 10.1016/0091-3057(86)90159-0; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sieuenpiper JL, 2011, J AM DIET ASSOC, V111, P219, DOI 10.1016/j.jada.2010.12.001; Sievenpiper JL, 2011, P INT DIAB FED IDF 2; Sievenpiper JL, 2010, 28 INT S DIAB NUTR O; Sievenpiper JL, 2009, DIABETES CARE, V32, P1930, DOI 10.2337/dc09-0619; Silbernagel G, 2011, BRIT J NUTR, V106, P79, DOI 10.1017/S000711451000574X; Sobrecases H, 2010, DIABETES METAB, V36, P244, DOI 10.1016/j.diabet.2010.03.003; Sock ETN, 2010, BRIT J NUTR, V103, P939, DOI 10.1017/S0007114509992819; Stanhope KL, 2011, AM J CLIN NUTR, V94, P112, DOI 10.3945/ajcn.110.002246; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; SWANSON JE, 1992, AM J CLIN NUTR, V55, P851, DOI 10.1093/ajcn/55.4.851; Swarbrick MM, 2008, BRIT J NUTR, V100, P947, DOI 10.1017/S0007114508968252; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; THORBURN AW, 1989, AM J CLIN NUTR, V50, P1015, DOI 10.1093/ajcn/50.5.1015; THORBURN AW, 1990, METABOLISM, V39, P58, DOI 10.1016/0026-0495(90)90148-6; TURNER JL, 1979, AM J CLIN NUTR, V32, P1043, DOI 10.1093/ajcn/32.5.1043; US Department of Health and Human Services and US Department of Agriculture, 2010, REP DIET GUID ADV CO; Vaisman N, 2006, CLIN NUTR, V25, P617, DOI 10.1016/j.clnu.2005.11.013; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782	71	199	200	2	62	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					291	U91		10.7326/0003-4819-156-4-201202210-00007	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00007			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896YO	22351714				2022-12-28	WOS:000300607600006
J	Hu, J; Hwang, SS; Liesa, M; Gan, BY; Sahin, E; Jaskelioff, M; Ding, ZH; Ying, HQ; Boutin, AT; Zhang, HL; Johnson, S; Ivanova, E; Kost-Alimova, M; Protopopov, A; Wang, YA; Shirihai, OS; Chin, L; DePinho, RA				Hu, Jian; Hwang, Soyoon Sarah; Liesa, Marc; Gan, Boyi; Sahin, Ergun; Jaskelioff, Mariela; Ding, Zhihu; Ying, Haoqiang; Boutin, Adam T.; Zhang, Hailei; Johnson, Shawn; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Wang, Yaoqi Alan; Shirihai, Orian S.; Chin, Lynda; DePinho, Ronald A.			Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer	CELL			English	Article							TELOMERE DYSFUNCTION; DNA-DAMAGE; DEPENDENT APOPTOSIS; STEM-CELLS; DEFICIENCY; SUPPRESSION; GLUTAMINE; P53; MAINTENANCE; DISRUPTION	To assess telomerase as a cancer therapeutic target and determine adaptive mechanisms to telomerase inhibition, we modeled telomerase reactivation and subsequent extinction in T cell lymphomas arising in Atm(-/)-mice engineered with an inducible telomerase reverse transcriptase allele. Telomerase reactivation in the setting of telomere dysfunction enabled full malignant progression with alleviation of telomere dysfunction-induced checkpoints. These cancers possessed copy number alterations targeting key loci in human T cell lymphomagenesis. Upon telomerase extinction, tumor growth eventually slowed with reinstatement of telomere dysfunction-induced checkpoints, yet growth subsequently resumed as tumors acquired alternative lengthening of telomeres (ALT) and aberrant transcriptional networks centering on mitochondrial biology and oxidative defense. ALT+ tumors acquired amplification/overexpression of PGC-1 beta, a master regulator of mitochondrial biogenesis and function, and they showed marked sensitivity to PGC-1 beta or SOD2 knockdown. Genetic modeling of telomerase extinction reveals vulnerabilities that motivate coincidental inhibition of mitochondrial maintenance and oxidative defense mechanisms to enhance antitelomerase cancer therapy.	[Hu, Jian; Hwang, Soyoon Sarah; Ying, Haoqiang; Boutin, Adam T.; Kost-Alimova, Maria; Protopopov, Alexei; Wang, Yaoqi Alan; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Hu, Jian; Hwang, Soyoon Sarah; Gan, Boyi; Sahin, Ergun; Jaskelioff, Mariela; Ding, Zhihu; Ying, Haoqiang; Boutin, Adam T.; Zhang, Hailei; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Wang, Yaoqi Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Hu, Jian; Hwang, Soyoon Sarah; Gan, Boyi; Sahin, Ergun; Jaskelioff, Mariela; Ding, Zhihu; Ying, Haoqiang; Boutin, Adam T.; Zhang, Hailei; Johnson, Shawn; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Wang, Yaoqi Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hu, Jian; Gan, Boyi; Sahin, Ergun; Jaskelioff, Mariela; Ding, Zhihu; Ying, Haoqiang; Boutin, Adam T.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Liesa, Marc; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University	DePinho, RA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	rdepinho@mdanderson.org	Liesa, Marc/K-8590-2019; Gan, Boyi/HDM-4206-2022; Ying, Haoqiang/AAK-4325-2020	Liesa, Marc/0000-0002-5909-8570; Shirihai, Orian/0000-0002-9502-2661; Ivanova, Elena/0000-0002-5069-4974; DePinho, Ronald/0000-0002-5625-577X	leukemia and lymphoma society; Helen Hay Whitney fellowship; Fundacion Ramon Areces; NIH [R01-DK074778, R01-DK56690, R01CA84628, U01CA141508]; NATIONAL CANCER INSTITUTE [U01CA141508, R01CA084628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074778, R01DK035914, R01DK056690] Funding Source: NIH RePORTER	leukemia and lymphoma society(Leukemia and Lymphoma Society); Helen Hay Whitney fellowship; Fundacion Ramon Areces; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Jiang, R. Narurkar, and E. Fletcher-Sananikone for excellent mouse husbandry and care, and all members of DePinho and Chin labs for helpful discussion. We also thank Yingchui Liu for the Cox model analysis. J.H. and B.G. were supported by the leukemia and lymphoma society fellowship. A.T.B. is supported by the Helen Hay Whitney fellowship. M. L. is supported by the Fundacion Ramon Areces fellowship. O.S.S. is supported by R01 (R01-DK074778 and R01-DK56690) grants from NIH. L.C. and R.A.D. are supported by R01 (R01CA84628) and U01 (U01CA141508) grants from NIH. R.A.D. is an Ellison Foundation for Medical Research Senior Scholar and an American Cancer Society Research Professor.	Agrawal A, 2012, RECENT PAT ANTI-CANC, V7, P102, DOI 10.2174/157489212798357958; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Fan Q, 2009, NUCLEIC ACIDS RES, V37, P1740, DOI 10.1093/nar/gkn995; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Hall DB, 1996, NATURE, V382, P731, DOI 10.1038/382731a0; Harley CB, 1997, CANCER SURV, V29, P263; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lafferty-Whyte K, 2009, ONCOGENE, V28, P3765, DOI 10.1038/onc.2009.238; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Qi L, 2003, CANCER RES, V63, P8188; RETEL J, 1993, MUTAT RES, V299, P165, DOI 10.1016/0165-1218(93)90094-T; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Saharia A, 2009, ONCOGENE, V28, P1162, DOI 10.1038/onc.2008.458; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zeng SC, 2009, NAT CELL BIOL, V11, P616, DOI 10.1038/ncb1867; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	50	200	206	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					651	663		10.1016/j.cell.2011.12.028	http://dx.doi.org/10.1016/j.cell.2011.12.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341440	Green Accepted, Bronze			2022-12-28	WOS:000300622400008
J	Ramani, AK; Chuluunbaatar, T; Verster, AJ; Na, H; Vu, V; Pelte, N; Wannissorn, N; Jiao, A; Fraser, AG				Ramani, Arun K.; Chuluunbaatar, Tungalag; Verster, Adrian J.; Na, Hong; Vu, Victoria; Pelte, Nadege; Wannissorn, Nattha; Jiao, Alan; Fraser, Andrew G.			The Majority of Animal Genes Are Required for Wild-Type Fitness	CELL			English	Article							FUNCTIONAL GENOMIC ANALYSIS; RNA INTERFERENCE; ELEGANS GENOME; YEAST; PHENOTYPE; DISPENSABILITY; EVOLUTION; GENOTYPE; ORTHOLOG	Almost all eukaryotic genes are conserved, suggesting that they have essential functions. However, only a minority of genes have detectable loss-of-function phenotypes in experimental assays, and multiple theories have been proposed to explain this discrepancy. Here, we use RNA-mediated interference in C. elegans to examine how knockdown of any gene affects the overall fitness of worm populations. Whereas previous studies typically assess phenotypes that are detectable by eye after a single generation, we monitored growth quantitatively over several generations. In contrast to previous estimates, we find that, in these multigeneration population assays, the majority of genes affect fitness, and this suggests that genetic networks are not robust to mutation. Our results demonstrate that, in a single environmental condition, most animal genes play essential roles. This is a higher proportion than for yeast genes, and we suggest that the source of negative selection is different in animals and in unicellular eukaryotes.	[Ramani, Arun K.; Chuluunbaatar, Tungalag; Verster, Adrian J.; Na, Hong; Vu, Victoria; Pelte, Nadege; Wannissorn, Nattha; Jiao, Alan; Fraser, Andrew G.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Ramani, Arun K.; Chuluunbaatar, Tungalag; Verster, Adrian J.; Na, Hong; Vu, Victoria; Pelte, Nadege; Wannissorn, Nattha; Jiao, Alan; Fraser, Andrew G.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Fraser, AG (corresponding author), Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada.	andyfraser.utoronto@gmail.com		Fraser, Andrew/0000-0001-9939-6014	CIHR [488367]; NSERC [487143]; IOF [488530]; CFI [486071]; NSERC	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); IOF; CFI(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors would like to thank Corey Nislow, Charlie Boone, Michael Costanzo, John Calarco, Arneet Saltzman, and Don Moerman for helpful comments on the manuscript. The authors thank Brent Derry for the generous donation of a worm sorter, Union Biometrica for technical support, and CGC for providing us with worm strains. This research was supported, in part, by grants from CIHR (488367), NSERC (487143), IOF (488530), and CFI (486071) to A.G.F. and a NSERC grant (CGS-D) to A.J.V.	Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cutter AD, 2003, GENOME RES, V13, P2651, DOI 10.1101/gr.1659203; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Elvin M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-510; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hodgkin J, 1997, GENETICS, V146, P149; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; JOHNSEN RC, 1991, GENETICS, V129, P735; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kemphues Kenneth, 2005, WormBook, P1; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Krebs J.C., 2011, LEWINS GENES; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; Ramani AK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r101; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Stiernagle Theresa, 2006, WormBook, P1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tischler J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r69; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wang Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000329; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	56	33	33	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					792	802		10.1016/j.cell.2012.01.019	http://dx.doi.org/10.1016/j.cell.2012.01.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341449	Bronze			2022-12-28	WOS:000300622400019
J	Barratt, H; Raine, R				Barratt, Helen; Raine, Rosalind			Hospital service reconfiguration: the battle for hearts and minds	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE; MORTALITY; CHOICE; NHS		[Barratt, Helen; Raine, Rosalind] UCL, Ctr Appl Hlth Res, London WC1E 6BT, England	University of London; University College London	Barratt, H (corresponding author), UCL, Ctr Appl Hlth Res, Mortimer St, London WC1E 6BT, England.	h.barratt@ucl.ac.uk		Raine, Rosalind/0000-0003-0904-749X				[Anonymous], 2011, LEARN REV OV; Appleby J, 2004, BMJ-BRIT MED J, V329, P61, DOI 10.1136/bmj.329.7457.61; Barratt H, 2010, ENFIELD HARINGEY CLI; Black N, 1996, BRIT MED J, V312, P1215; College of Emergency Medicine, 2010, EM MED CONS WORKF RE; Crawford MJ, 2002, BRIT MED J, V325, P1263, DOI 10.1136/bmj.325.7375.1263; *DEP HLTH, 2000, NHS PLAN; Dreaper J, 2011, BBC NEWS        0824; Fotaki M, 2008, J HEALTH SERV RES PO, V13, P178, DOI 10.1258/jhsrp.2008.007163; Fuchs VR, 2011, NEW ENGL J MED, V364, P1985, DOI 10.1056/NEJMp1104675; Fulop N, 2012, HEALTH POLICY, V104, P128, DOI 10.1016/j.healthpol.2011.05.015; Gulland A, 2001, BRIT MED J, V322, P1443, DOI 10.1136/bmj.322.7300.1443; Ham C, 2011, OBSERVER        0619; Independent Reconfiguration Panel, 2011, IN ASS BARN ENF HAR; Jeffreys B, 2010, BBC NEWS        0413; Kmietowicz Z, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5848; Lansley A, 2010, DAILY TELEGRAPH 0521; Lister S, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5311; Mayer EK, 2009, BJU INT, V103, P341, DOI 10.1111/j.1464-410X.2008.08021.x; McKee M, 2005, LANCET, V365, P369; MORI, 2004, PUBL PERC PAT UNPUB; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; Nicholson D, 2010, NHS RECONFIGURATION; Palmer K, 2011, RECONFIGURING HLTH S; Partners UCL, 2011, OUR PROGR; Picker Institute, 2008, ACC PUBL VIEWS WHAT; Randhawa K, 2011, EVENING STANDAR 0127; Royal College of Obstetricians and Gynaecologists, 2009, IMP WORK TIM DIR O G; Royal College of Paediatrics and Child Health, 2008, MOD FUT; Royal College of Physicians, 2010, RCP POS STAT CAR MED; Spurgeon P, 2010, EVALUATING MODELS SE; Temple J., 2010, TIME TRAINING REV IM; Thorlby R., 2011, MANAGING HLTH REFORM; Timmins N, 2011, FINANCIAL TIMES 0302; van Gijn W, 2010, Eur J Surg Oncol, V36 Suppl 1, pS55, DOI 10.1016/j.ejso.2010.06.027; Young EL, 2007, J VASC SURG, V46, P1287, DOI 10.1016/j.jvs.2007.06.038	36	6	6	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2012	344								e953	10.1136/bmj.e953	http://dx.doi.org/10.1136/bmj.e953			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IP	22344306				2022-12-28	WOS:000300559200004
J	Hickey, M; Elliott, J; Davison, SL				Hickey, Martha; Elliott, Jane; Davison, Sonia Louise			THERAPEUTICS Hormone replacement therapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ESTROGEN PLUS PROGESTIN; HEALTHY POSTMENOPAUSAL WOMEN; VASOMOTOR SYMPTOMS; COST-EFFECTIVENESS; RECOMMENDATIONS; TIBOLONE; CANCER; BREAST; RISK; GABAPENTIN		[Hickey, Martha] Univ Melbourne, Royal Womens Hosp, Melbourne, Vic 3052, Australia; [Hickey, Martha] Univ Melbourne, Melbourne, Vic 3052, Australia; [Elliott, Jane] Univ Adelaide, Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA 5005, Australia; [Davison, Sonia Louise] Monash Univ, Womens Hlth Res Program, Dept Epidemiol & Prevent Med, Alfred Ctr,Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia	University of Melbourne; University of Melbourne; University of Adelaide; Monash University	Hickey, M (corresponding author), Univ Melbourne, Royal Womens Hosp, Melbourne, Vic 3052, Australia.	Martha.hickey@thewomens.org.au		Hickey, Martha/0000-0002-3941-082X				Aguirre W, 2010, GYNECOL ENDOCRINOL, V26, P333, DOI 10.3109/09513590903511539; Archer DF, 2007, J CLIN ENDOCR METAB, V92, P911, DOI 10.1210/jc.2006-2207; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Borrelli F, 2010, MATURITAS, V66, P333, DOI 10.1016/j.maturitas.2010.05.010; Bousser MG, 2000, CEPHALALGIA, V20, P155, DOI 10.1046/j.1468-2982.2000.00035.x; Canonico M, 2007, CIRCULATION, V115, P840, DOI 10.1161/CIRCULATIONAHA.106.642280; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743; Egarter C, 2002, ACTA OBSTET GYN SCAN, V81, P649, DOI 10.1034/j.1600-0412.2002.810711.x; Furness S., 2009, COCHRANE DB SYST REV, V2; Gebbie AE, 2011, MENOPAUSE INT, V16, P33; Gompel A, 2008, MATURITAS, V61, P227, DOI 10.1016/j.maturitas.2008.10.009; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Hammar ML, 2007, BJOG-INT J OBSTET GY, V114, P1522, DOI 10.1111/j.1471-0528.2007.01537.x; Harman SM, 2011, AM J MED, V124, P199, DOI 10.1016/j.amjmed.2010.09.021; Hunter MS, 2010, J PSYCHOSOM RES, V69, P491, DOI 10.1016/j.jpsychores.2010.04.005; Kelly CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c693; Kenemans P, 2009, LANCET ONCOL, V10, P135, DOI 10.1016/S1470-2045(08)70341-3; Lekander Ingrid, 2009, Menopause Int, V15, P19, DOI 10.1258/mi.2009.009004; Lekander I, 2009, J WOMENS HEALTH, V18, P1669, DOI 10.1089/jwh.2008.1246; Liu B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a386; Maclennan A H, 2004, Cochrane Database Syst Rev, pCD002978, DOI 10.1002/14651858.CD002978.pub2; Maki PM, 2010, MENOPAUSE, V17, P815, DOI 10.1097/gme.0b013e3181d763d2; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Politi MC, 2008, J GEN INTERN MED, V23, P1507, DOI 10.1007/s11606-008-0655-4; Rada G, 2011, COCHRANE DB SYST REV, V9; Reddy SY, 2006, OBSTET GYNECOL, V108, P41, DOI 10.1097/01.AOG.0000222383.43913.ed; Renoux C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2519; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Sare GM, 2008, EUR HEART J, V29, P2031, DOI 10.1093/eurheartj/ehn299; Sturdee DW, 2011, CLIMACTERIC, V14, P302, DOI 10.3109/13697137.2011.570590; Sturdee DW, 2010, CLIMACTERIC, V13, P509, DOI 10.3109/13697137.2010.522875; Suckling J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001500.pub2; Utian WH, 2010, MENOPAUSE, V17, P242, DOI 10.1097/gme.0b013e3181d0f6b9; Welton AJ, 2008, BMJ-BRIT MED J, V337, P1190; Wu O, 2006, HEALTH TECHNOL ASSES, V10, P1	38	32	32	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2012	344								e763	10.1136/bmj.e763	http://dx.doi.org/10.1136/bmj.e763			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896IP	22344303	Green Submitted			2022-12-28	WOS:000300559200001
J	Abramson, J; Paz, A; Philipson, KD				Abramson, Jeff; Paz, Aviv; Philipson, Kenneth D.			It's All in the Symmetry	SCIENCE			English	Editorial Material							SARCOLEMMAL NA+-CA2+ EXCHANGER		[Abramson, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Abramson, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	jabramson@mednet.ucla.edu	Paz, Aviv/AAN-3966-2021	Paz, Aviv/0000-0003-0792-492X	NIGMS NIH HHS [R01 GM078844] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385	9	7	7	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					669	670		10.1126/science.1218696	http://dx.doi.org/10.1126/science.1218696			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323810	Green Accepted			2022-12-28	WOS:000300047100040
J	Wang, TT; Parides, MK; Palese, P				Wang, Taia T.; Parides, Michael K.; Palese, Peter			Seroevidence for H5N1 Influenza Infections in Humans: Meta-Analysis	SCIENCE			English	Article							A H5N1; HONG-KONG; WORKERS; RISK		[Wang, Taia T.; Palese, Peter] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Parides, Michael K.] Mt Sinai Sch Med, Mt Sinai Ctr Biostat, New York, NY 10029 USA; [Parides, Michael K.] Mt Sinai Sch Med, Dept Hlth Evidence & Policy, New York, NY 10029 USA; [Palese, Peter] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Palese, P (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	peter.palese@mssm.edu	Parides, Michael/GON-8474-2022	Palese, Peter/0000-0002-0337-5823	NIH [U54 AI057158-04, HHSN2662000700010C, T32 AI007647]; Mount Sinai medical scientists training grant [T32 GM007280]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007647, U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007280] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Sinai medical scientists training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank N. Pica for generous assistance in the preparation of this manuscript and H. Jia for statistical analysis. This work was partially supported by NIH grants U54 AI057158-04 and HHSN2662000700010C. T.T.W. was supported by NIH training grant T32 AI007647 and Mount Sinai medical scientists training grant T32 GM007280.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Buchy P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010864; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; *WHO, 2006, WHO CAS DEF HUM INF; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	9	97	98	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1463	1463		10.1126/science.1218888	http://dx.doi.org/10.1126/science.1218888			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22362880	Green Accepted			2022-12-28	WOS:000301837000037
J	Bakker, MF; Jacobs, JWG; Welsing, PMJ; Verstappen, SMM; Tekstra, J; Ton, E; Geurts, MAW; van der Werf, JH; van Albada-Kuipers, GA; Veen, ZNJD; van der Veen, MJ; Verhoef, CM; Lafeber, FPJG; Bijlsma, JWJ				Bakker, Marije F.; Jacobs, Johannes W. G.; Welsing, Paco M. J.; Verstappen, Suzanne M. M.; Tekstra, Janneke; Ton, Evelien; Geurts, Monique A. W.; van der Werf, Jacobine H.; van Albada-Kuipers, Grietje A.; Jahangier-de Veen, Zalima N.; van der Veen, Maaike J.; Verhoef, Catharina M.; Lafeber, Floris P. J. G.; Bijlsma, Johannes W. J.		Utrecht Rheumatoid Arthrit Cohort	Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; EULAR RECOMMENDATIONS; COMBINATION THERAPY; DISEASE-ACTIVITY; JOINT DAMAGE; MANAGEMENT; GLUCOCORTICOIDS; SULFASALAZINE; METAANALYSIS; PROGRESSION	Background: Treatment strategies for tight control of early rheumatoid arthritis (RA) are highly effective but can be improved. Objective: To investigate whether adding prednisone, 10 mg/d, at the start of a methotrexate (MTX)-based treatment strategy for tight control in early RA increases its effectiveness. Design: A 2-year, prospective, randomized, placebo-controlled, double-blind, multicenter trial (CAMERA-II [Computer Assisted Management in Early Rheumatoid Arthritis trial-II]). (International Standard Randomised Controlled Trial Number: ISRCTN 70365169) Setting: 7 hospitals in the Netherlands. Patients: 236 patients with early RA (duration <1 year). Intervention: Patients were randomly assigned to an MTX-based, tight control strategy starting with either MTX and prednisone or MTX and placebo. Methotrexate treatment was tailored to the individual patient at monthly visits on the basis of predefined response criteria aiming for remission. Measurements: The primary outcome was radiographic erosive joint damage after 2 years. Secondary outcomes included response criteria, remission, and the need to add cyclosporine or a biologic agent to the treatment. Results: Erosive joint damage after 2 years was limited and less in the group receiving MTX and prednisone (n = 117) than in the group receiving MTX and placebo (n = 119). The MTX and prednisone strategy was also more effective in reducing disease activity and physical disability, achieving sustained remission, and avoiding the addition of cyclosporine or biologic treatment. Adverse events were similar in both groups, but some occurred less in the MTX and prednisone group. Limitation: A tight control strategy for RA implies monthly visits to an outpatient clinic, which is not always feasible. Conclusion: Inclusion of low-dose prednisone in an MTX-based treatment strategy for tight control in early RA improves patient outcomes.	[Jacobs, Johannes W. G.] Univ Med Ctr Utrecht, Dept Rheumatol & Immunol, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; St Antonius Hosp, Nieuwegein, Netherlands; Meander Med Ctr, Amersfoort, Netherlands; Tergooi Hosp, Hilversum, Netherlands; St Jansdal Hosp, Harderwijk, Netherlands; Flevohosp, Almere, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Meander Medisch Centrum	Jacobs, JWG (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Immunol, F02-127,POB 85500, NL-3508 GA Utrecht, Netherlands.	j.w.g.jacobs@umcutrecht.nl		Verstappen, Suzanne/0000-0001-6181-0646	Catharijne Foundation [20063]	Catharijne Foundation	Catharijne Foundation.; Grant Support: By the Catharijne Foundation (grant 20063).	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bakker MF, 2007, ANN RHEUM DIS, V66, P56, DOI 10.1136/ard.2007.078360; BIJLSMA JWJ, 1990, J REHABIL SCI, V3, P71; Boers M, 2003, ARTHRITIS RHEUM, V48, P1771, DOI 10.1002/art.11156; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Boers M, 2003, ANN RHEUM DIS, V62, P842, DOI 10.1136/ard.62.9.842; Braun J, 2009, CURR OPIN RHEUMATOL, V21, P216, DOI 10.1097/BOR.0b013e328329c79d; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Fuchs VR, 2010, NEW ENGL J MED, V362, P965, DOI 10.1056/NEJMp1000200; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Haugeberg G, 2005, ARCH INTERN MED, V165, P1293, DOI 10.1001/archinte.165.11.1293; Hoes JN, 2009, ANN RHEUM DIS, V68, P1833, DOI 10.1136/ard.2008.100008; Kirwan JR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006356; Knevel R, 2010, ANN RHEUM DIS, V69, P987, DOI 10.1136/ard.2009.126748; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Mease PJ, 2010, J RHEUMATOL, V37, P1570, DOI 10.3899/jrheum.091064; Michaud K, 2003, ARTHRITIS RHEUM-US, V48, P2750, DOI 10.1002/art.11439; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rantalaiho V, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3060; Salliot C, 2009, ANN RHEUM DIS, V68, P1100, DOI 10.1136/ard.2008.093690; Schett G, 2010, ANN RHEUM DIS, V69, P1415, DOI 10.1136/ard.2010.135061; Schipper LG, 2011, RHEUMATOLOGY, V50, P818, DOI 10.1093/rheumatology/keq235; Schipper LG, 2010, RHEUMATOLOGY, V49, P2154, DOI 10.1093/rheumatology/keq195; Schoels M, 2010, ANN RHEUM DIS, V69, P995, DOI 10.1136/ard.2009.126714; Scott DL, 2000, RHEUMATOLOGY, V39, P122, DOI 10.1093/rheumatology/39.2.122; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Van Everdingen AA, 2004, ARTHRIT RHEUM-ARTHR, V51, P233, DOI 10.1002/art.20251; van Everdingen AA, 2002, ANN INTERN MED, V136, P1, DOI 10.7326/0003-4819-136-1-200201010-00006; VANDERHEIJDE DM, 1989, LANCET, V1, P1036, DOI 10.1016/S0140-6736(89)92442-2; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; Visser K, 2009, ANN RHEUM DIS, V68, P1094, DOI 10.1136/ard.2008.092668	34	261	274	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2012	156	5					329	U138		10.7326/0003-4819-156-5-201203060-00004	http://dx.doi.org/10.7326/0003-4819-156-5-201203060-00004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902OC	22393128				2022-12-28	WOS:000301046800001
J	Ortegon, M; Lim, S; Chisholm, D; Mendis, S				Ortegon, Monica; Lim, Stephen; Chisholm, Dan; Mendis, Shanthi			Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MILLENNIUM DEVELOPMENT GOALS; MIDDLE-INCOME COUNTRIES; IMPROVING HEALTH; BLOOD-PRESSURE; INTERVENTIONS; CHOLESTEROL; GUIDELINES; MANAGEMENT; REDUCTION; SMOKING	Objective To determine the relative costs and health effects of interventions to combat cardiovascular disease, diabetes, and tobacco related disease in order to guide the allocation of resources in developing countries. Design Cost effectiveness analysis of 123 single or combined prevention and treatment strategies for cardiovascular disease, diabetes, and smoking by means of a lifetime population model. Setting Two World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE) and countries in South East Asia with high adult and high child mortality (SearD). Data sources Demographic and epidemiological data were taken from the WHO databases of mortality and global burden of disease. Estimates of intervention coverage, effectiveness, and resource needs were drawn from clinical trials, observational studies, and treatment guidelines. Unit costs were taken from the WHO-CHOICE (Choosing Interventions that are Cost-Effective) price database. Main outcome measures Cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results Most of the interventions studied were considered highly cost effective, meaning they generate one healthy year of life at a cost of <$Int2000 (which is the gross domestic product per capita of the two regions considered here). Interventions that offer particularly good monetary value, and which could be considered for prioritised implementation or scale up, include demand reduction strategies of the Framework Convention for Tobacco Control (<$Int950 and <$Int200 per DALY averted in AfrE and SearD respectively); combination drug therapy for people with a >25% chance of experiencing a cardiovascular event over the next decade, either alone or together with specific multidrug regimens for the secondary prevention of post-acute ischaemic heart disease and stroke (<$Int150 and <$Int230 per DALY averted in AfrE and SearD respectively); and retinopathy screening and glycaemic control for patients with diabetes (<$Int2100 and <$Int950 per DALY averted in AfrE and SearD respectively). Conclusion This comparative economic assessment has identified a set of population-wide and individual strategies for prevention and control of cardiovascular disease that are inexpensive and cost effective in low resource settings.	[Ortegon, Monica] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Lim, Stephen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Chisholm, Dan] World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland; [Mendis, Shanthi] World Hlth Org, Dept Chron Dis & Hlth Promot, Geneva, Switzerland	Universidad del Rosario; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; World Health Organization; World Health Organization	Ortegon, M (corresponding author), Carrera 24 63C-69, Bogota, Colombia.	monica.ortegon@urosario.edu.co	Mendis, Shanthi/GLT-0465-2022	mendis, shanthi/0000-0002-8959-5738				Abegunde D, 2006, ESSENTIAL MED NONCOM; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baltussen R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e615; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e612; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; Edejer T, 2003, MAKING CHOICES HLTH; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ezzati M, 2004, COMP QUANTIFICATION; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Grover SA, 2001, DIABETES CARE, V24, P45, DOI 10.2337/diacare.24.1.45; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P463, DOI 10.1053/j.ajkd.2009.11.017; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Jha P, 2006, DRUG ALCOHOL REV, V25, P597, DOI 10.1080/09595230600944511; Karthikeyan G, 2007, HEART, V93, P1334, DOI 10.1136/hrt.2007.131193; Lai T, 2007, HEALTH POLICY, V84, P75, DOI 10.1016/j.healthpol.2007.02.012; Lauer Jeremy A, 2003, Cost Eff Resour Alloc, V1, P6, DOI 10.1186/1478-7547-1-6; Manns B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5869; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Mihaylova B, 2005, LANCET, V365, P1779, DOI 10.1016/S0140-6736(05)63014-0; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Murray CJL, 2001, GLOBAL BURDEN DIS 20; Pezzella AT, 2011, GLOBAL EXPANSION CAR; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Rubinstein Adolfo, 2009, Cost Eff Resour Alloc, V7, P10, DOI 10.1186/1478-7547-7-10; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Stanciole AE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e608; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; United Nations General Assembly, 2011, A66L1 UN GEN ASS; Weatherly H, 2009, HEALTH POLICY, V93, P85, DOI 10.1016/j.healthpol.2009.07.012; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2011, INF US MONT CARL LEA; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, 2007, PACK ESS NONC PEN DI; World Health Organization, 2002, RED RISKS HLTH PROM	48	59	59	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e607	10.1136/bmj.e607	http://dx.doi.org/10.1136/bmj.e607			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XQ	22389337	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000301232600002
J	Kendall, T; Crawford, MJ; Taylor, C; Whittington, C; Rose, D				Kendall, Tim; Crawford, Mike J.; Taylor, Clare; Whittington, Craig; Rose, Diana		Guidance Dev Grp	GUIDELINES Improving the experience of care for adults using NHS mental health services: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kendall, Tim; Taylor, Clare] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [Crawford, Mike J.] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London SW7 2AZ, England; [Crawford, Mike J.] Cent & N W London NHS Fdn Trust, London NW1 2PL, England; [Whittington, Craig] UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England; [Rose, Diana] Kings Coll London, Inst Psychiat, SURE, London SE5 8AF, England	University of London; University College London; Imperial College London; University of London; University College London; University of London; King's College London	Kendall, T (corresponding author), UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England.	tim2.kendall@virgin.net	Rose, Diana/HGE-8574-2022; Whittington, Craig/B-1380-2008; Rose, Diana S/D-1387-2010	Whittington, Craig/0000-0002-1950-0334; Rose, Diana S/0000-0002-6393-6389; Crawford, Mike/0000-0003-3137-5772				Brugha T, 2009, ADULT PSYCHIAT MORBI; Care Quality Commission, 2009, INP SERV US SURV; Department of Constitutional Affairs, 2007, MENTAL CAPACITY ACT; Department of Health, 2008, 7432 CM DEP HLTH; Department of Health, 2010, NAT PAT CHOIC SURV E; Department of Health, 2010, NHS CONST ENGL; HM Government and Department of Health, 2011, NO HLTH MENT HLTH CR; National Centre for Social Research, 2010, COMM MENT HLTH SURV; National Institute for Health and Care Excellence (NICE), 2011, SERV US EXP AD MENT; Quirk A, 2001, SOC SCI MED, V53, P1565, DOI 10.1016/S0277-9536(00)00457-3; Repper J., 1997, EXPERIENCING PSYCHIA	11	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2012	344								e1089	10.1136/bmj.e1089	http://dx.doi.org/10.1136/bmj.e1089			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XJ	22381522				2022-12-28	WOS:000301231900007
J	Smol, JP				Smol, John P.			CLIMATE CHANGE A planet in flux	NATURE			English	Editorial Material									Queens Univ Kingston, Canada Res Chair Environm Change, Kingston, ON, Canada	Queens University - Canada	Smol, JP (corresponding author), Queens Univ Kingston, Canada Res Chair Environm Change, Kingston, ON, Canada.	smolj@queensu.ca		Smol, John/0000-0002-2499-6696				DOUGLAS MSV, 1994, SCIENCE, V266, P416, DOI 10.1126/science.266.5184.416; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104	4	78	79	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					S12	S15		10.1038/483S12a	http://dx.doi.org/10.1038/483S12a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22378120				2022-12-28	WOS:000300877900005
J	Spence, D				Spence, Des			FROM THE FRONTLINE Exploiting non-communicable disease	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2012	344								e1278	10.1136/bmj.e1278	http://dx.doi.org/10.1136/bmj.e1278			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JQ	22362249				2022-12-28	WOS:000300883600009
J	Faden, RR; Karron, RA				Faden, Ruth R.; Karron, Ruth A.			The Obligation to Prevent the Next Dual-Use Controversy	SCIENCE			English	Editorial Material							FLU		[Faden, Ruth R.] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Vaccine Initiat, Ctr Immunizat Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Faden, RR (corresponding author), Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA.	rfaden@jhu.edu						BERG P, 1974, SCIENCE, V185, P303, DOI 10.1126/science.185.4148.303; Butler D, 2012, NATURE, V481, P417, DOI 10.1038/481417a; Connor S., 2011, INDEPENDENT     1214; Editorial Board, 2012, NY TIMES        0108, pSR10; Enserink M, 2012, SCIENCE, V335, P20, DOI 10.1126/science.335.6064.20; Fouchier RAM, 2012, SCIENCE, V335, P662, DOI 10.1126/science.1218376; Fouchier RAM, 2012, SCIENCE, V335, P400, DOI [10.1126/science.1219412, 10.1126/science.335.6067.400]; Inglesby T., MILWAUKEE WISCONSIN; Jasanoff S., 2005, DESIGNS NATURE SCI D; Kraemer JD, 2012, SCIENCE, V335, P1047, DOI 10.1126/science.1219215; Ledford H, 2012, NATURE, V481, P9, DOI 10.1038/481009a; National Research Council, 2004, BIOT RES AG TERR; Schneider E., 2011, COMMUNICATION   1214; Vogel D., 2004, YB EUROPEAN ENV LAW, V3, P43; WHO, 2012, GLOB INFL PROGR; Wohlers Anton E, 2010, Politics Life Sci, V29, P17, DOI 10.2990/29_2_17; [No title captured]	17	10	10	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					802	804		10.1126/science.1219668	http://dx.doi.org/10.1126/science.1219668			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	893LC	22323739				2022-12-28	WOS:000300356400027
J	Quintana-Murci, L				Quintana-Murci, Lluis			Gene Losses in the Human Genome	SCIENCE			English	Editorial Material							EXPRESSION; POPULATION		Inst Pasteur, Unit Human Evolutionary Genet, CNRS, URA3012, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Quintana-Murci, L (corresponding author), Inst Pasteur, Unit Human Evolutionary Genet, CNRS, URA3012, Paris, France.	quintana@pasteur.fr	Quintana-Murci, Lluis/AAB-7468-2022	Quintana-Murci, Lluis/0000-0003-2429-6320				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maranville JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002162; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005	15	6	6	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					806	807		10.1126/science.1219299	http://dx.doi.org/10.1126/science.1219299			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	893LC	22344433				2022-12-28	WOS:000300356400029
J	Loewenstein, G; Sah, S; Cain, DM				Loewenstein, George; Sah, Sunita; Cain, Daylian M.			The Unintended Consequences of Conflict of Interest Disclosure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Sah, Sunita] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Sah, Sunita] Harvard Univ, Eth Ctr, Boston, MA 02115 USA; [Cain, Daylian M.] Yale Univ, Sch Management, New Haven, CT USA	Carnegie Mellon University; Duke University; Harvard University; Yale University	Loewenstein, G (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	gl20@andrew.cmu.edu	Loewenstein, George/G-7616-2014; Sah, Sunita/J-4613-2014	Loewenstein, George/0000-0003-2790-0474; Sah, Sunita/0000-0003-1671-4414				Bero L, 2009, CONFLICT INTEREST ME, P325; Cain DM, 2011, J CONSUM RES, V37, P836, DOI 10.1086/656252; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Fung A, 2007, FULL DISCLOSURE PERI; Gibbons RV, 1998, J GEN INTERN MED, V13, P151, DOI 10.1046/j.1525-1497.1998.00048.x; Hampson LA, 2006, NEW ENGL J MED, V355, P2330, DOI 10.1056/NEJMsa064160; Loewenstein G, 2011, AM ECON REV, V101, P423, DOI 10.1257/aer.101.3.423; Pearson SD, 2006, ARCH INTERN MED, V166, P623, DOI 10.1001/archinte.166.6.623; Sah S, DOCTORS DISCLOSURES; Sah S, BURDEN DISCLOSURE IN	10	174	178	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					669	670		10.1001/jama.2012.154	http://dx.doi.org/10.1001/jama.2012.154			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	892HY	22337676				2022-12-28	WOS:000300278500021
J	Winstock, AR; Mitcheson, L				Winstock, Adam R.; Mitcheson, Luke			New recreational drugs and the primary care approach to patients who use them	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GAMMA-HYDROXYBUTYRATE; NONMEDICAL USE; KETAMINE; MEPHEDRONE; HEALTH; CONSEQUENCES; DEPENDENCE; KID		[Winstock, Adam R.] Kings Coll London, S London & Maudsley NHS Trust, Inst Psychiat, Blackfriars Rd Community Drug & Alcohol Team, London SE1 8EL, England	South London & Maudsley NHS Trust; University of London; King's College London	Winstock, AR (corresponding author), Kings Coll London, S London & Maudsley NHS Trust, Inst Psychiat, Blackfriars Rd Community Drug & Alcohol Team, London SE1 8EL, England.	adam.winstock@slam.nhs.uk		Winstock, Adam/0000-0001-7854-8015				Aan het Rot M, 2010, BIOL PSYCHIAT, V67, P139, DOI DOI 10.1016/J.BIOPSYCH.2009.08.038; Advisory Council on the Misuse of Drugs, 2011, NOV PSYCH SUBST REP, P61; Baker A, 2005, ADDICTION, V100, P367, DOI 10.1111/j.1360-0443.2005.01002.x; Bell J, 2011, ADDICTION, V106, P442, DOI 10.1111/j.1360-0443.2010.03145.x; Copeland J, 2005, INT J DRUG POLICY, V16, P122, DOI 10.1016/j.drugpo.2004.12.003; Cottrell AM, 2008, J CLIN UROL, V1, P136, DOI 10.1016/j.bjmsu.2008.08.005; Curran HV, 2000, ADDICTION, V95, P575, DOI 10.1046/j.1360-0443.2000.9545759.x; Dillon P, 2003, DRUG ALCOHOL DEPEN, V69, P23, DOI 10.1016/S0376-8716(02)00243-0; European Monitoring Centre for Drugs and Drug Addiction, 2009, STAT DRUG PROBL EUR; James D, 2011, EMERG MED J, V28, P686, DOI 10.1136/emj.2010.096636; Jansen KLR, 2000, J PSYCHOACTIVE DRUGS, V32, P419, DOI 10.1080/02791072.2000.10400244; Jansen KLR, 2001, J PSYCHOACTIVE DRUGS, V33, P151, DOI 10.1080/02791072.2001.10400480; Lingford-Hughes A, J PSYCHOPHA IN PRESS; McCambridge J, 2006, ADDICTION, V101, P1014; McDonough M, 2004, DRUG ALCOHOL DEPEN, V75, P3, DOI 10.1016/j.drugalcdep.2004.01.012; Mitcheson L, 2008, INT J DRUG POLICY, V19, P304, DOI 10.1016/j.drugpo.2007.02.002; Moore NN, 1999, PSYCHOSOMATICS, V40, P356, DOI 10.1016/S0033-3182(99)71231-4; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Morgan CJA, 2010, ADDICTION, V105, P121, DOI 10.1111/j.1360-0443.2009.02761.x; Muetzelfeldt L, 2008, DRUG ALCOHOL DEPEN, V95, P219, DOI 10.1016/j.drugalcdep.2008.01.024; Munir VL, 2008, EMERG MED AUSTRALAS, V20, P521, DOI 10.1111/j.1742-6723.2008.01140.x; National Institute for Health and Clinical Excellence, 2007, NICE CLIN GUID 51 DR; National Institute for Health and Clinical Excellence, 2007, NICE PUBL HLTH INT G; Ng S. H., 2010, Hong Kong Medical Journal, V16, P6; Rodgers J, 2004, BRIT J PSYCHIAT, V184, P104, DOI 10.1192/bjp.184.2.104; Rollnick S., 2008, MOTIVATIONAL INTERVI; Rollnick S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1900; UK Home Office Statistical Bulletin, 2011, UK HOM OFF STAT B; Winstock A, 2011, ADDICTION, V106, P1991, DOI 10.1111/j.1360-0443.2011.03502.x; Winstock AR, 2011, ADDICTION, V106, P154, DOI 10.1111/j.1360-0443.2010.03130.x; Winstock AR, 2010, ADDICTION, V105, P1685, DOI [10.1111/j.1360-0443.2010.02934.x, 10.1111/j.1360-0443.2010.03163.x]; Winstock AR, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1605; Winstock AR, BR J UROL I IN PRESS; Wolff K, 2006, CNS DRUGS, V20, P199, DOI 10.2165/00023210-200620030-00003	34	16	17	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2012	344								e288	10.1136/bmj.e288	http://dx.doi.org/10.1136/bmj.e288			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IB	22337751				2022-12-28	WOS:000300557800001
J	Bailey, P				Bailey, Peter			PERSONAL VIEW Primary care duped: the government's bill will wreck the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material												peter.bailey@nhs.net							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 14	2012	344								e998	10.1136/bmj.e998	http://dx.doi.org/10.1136/bmj.e998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896HZ	22334562				2022-12-28	WOS:000300557600008
J	Oskin, ME; Arrowsmith, JR; Corona, AH; Elliott, AJ; Fletcher, JM; Fielding, EJ; Gold, PO; Garcia, JJG; Hudnut, KW; Liu-Zeng, J; Teran, OJ				Oskin, Michael E.; Arrowsmith, J. Ramon; Hinojosa Corona, Alejandro; Elliott, Austin J.; Fletcher, John M.; Fielding, Eric J.; Gold, Peter O.; Gonzalez Garcia, J. Javier; Hudnut, Ken W.; Liu-Zeng, Jing; Teran, Orlando J.			Near-Field Deformation from the El Mayor-Cucapah Earthquake Revealed by Differential LIDAR	SCIENCE			English	Article							1999 HECTOR MINE; SURFACE RUPTURE; SLIP DISTRIBUTION; BAJA-CALIFORNIA; LAGUNA-SALADA; FAULT; MEXICO; IRAN; CHINA; ZONE	Large [moment magnitude (M-w) >= 7] continental earthquakes often generate complex, multifault ruptures linked by enigmatic zones of distributed deformation. Here, we report the collection and results of a high-resolution (>= nine returns per square meter) airborne light detection and ranging (LIDAR) topographic survey of the 2010 M-w 7.2 El Mayor-Cucapah earthquake that produced a 120-kilometer-long multifault rupture through northernmost Baja California, Mexico. This differential LIDAR survey completely captures an earthquake surface rupture in a sparsely vegetated region with pre-earthquake lower-resolution (5-meter-pixel) LIDAR data. The postevent survey reveals numerous surface ruptures, including previously undocumented blind faults within thick sediments of the Colorado River delta. Differential elevation changes show distributed, kilometer-scale bending strains as large as similar to 10(3) microstrains in response to slip along discontinuous faults cutting crystalline bedrock of the Sierra Cucapah.	[Oskin, Michael E.; Elliott, Austin J.; Gold, Peter O.] Univ Calif Davis, Dept Geol, Davis, CA 95618 USA; [Arrowsmith, J. Ramon] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Hinojosa Corona, Alejandro; Fletcher, John M.; Gonzalez Garcia, J. Javier; Teran, Orlando J.] Ctr Invest Cient & Educ Super Ensenada, Ensenada 22860, Baja California, Mexico; [Fielding, Eric J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Hudnut, Ken W.] US Geol Survey, Pasadena, CA 91106 USA; [Liu-Zeng, Jing] China Earthquake Adm, Inst Geol, Natl Key Lab Earthquake Dy nam, Beijing 100029, Peoples R China	University of California System; University of California Davis; Arizona State University; Arizona State University-Tempe; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; China Earthquake Administration	Oskin, ME (corresponding author), Univ Calif Davis, Dept Geol, 1 Shields Ave, Davis, CA 95618 USA.	meoskin@ucdavis.edu	Hudnut, Kenneth W/AAB-4549-2020; Fielding, Eric Jameson/A-1288-2007; Liu-Zeng, Jing/F-8582-2011; Hinojosa, Alejandro/N-4017-2019; Fielding, Eric/L-8187-2019; Hudnut, Kenneth W/B-1945-2009; Liu-Zeng, jing/R-2522-2019; Hinojosa-Corona, Alejandro/L-5422-2015	Hudnut, Kenneth W/0000-0002-3168-4797; Fielding, Eric Jameson/0000-0002-6648-8067; Hinojosa, Alejandro/0000-0002-2282-337X; Fielding, Eric/0000-0002-6648-8067; Hudnut, Kenneth W/0000-0002-3168-4797; Liu-Zeng, jing/0000-0001-7108-6452; Hinojosa-Corona, Alejandro/0000-0002-2282-337X; Elliott, Austin/0000-0001-5924-7268; Fletcher, John M./0000-0003-2473-1740	NSF RAPID [EAR-1039168, 1039147]; NSF [EAR-0106924]; U.S. Geological Survey [02HQAG0008]; Consejo Nacional de Ciencia y Tecnologia [CB-2007-81463]; NASA's Earth Surface and Interior Focus Area; Directorate For Geosciences [1043051, 1039147] Funding Source: National Science Foundation	NSF RAPID(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); U.S. Geological Survey(United States Geological Survey); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NASA's Earth Surface and Interior Focus Area; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	LIDAR data acquisition supported by an NSF RAPID grant (EAR-1039168 and 1039147), with additional support from the Southern California Earthquake Center (supported by NSF-EAR-0106924 and U.S. Geological Survey grant 02HQAG0008) and Consejo Nacional de Ciencia y Tecnologia (grant CB-2007-81463). Part of this research was supported by NASA's Earth Surface and Interior Focus Area and performed at the Jet Propulsion Laboratory, California Institute of Technology. Y. Fialko, D. Sandwell, J. Galetzka, and A. Gonzalez assisted with Global Positioning System data acquisition and processing. C. Crosby, D. Haddad, O. Kreylos, A. Morelan, and T. Sato provided editorial and computational assistance. The National Center for Airborne Laser Mapping gathered and processed the postevent LIDAR data, distributed at OpenTopography (http://opentopography.org/id/OTLAS.122010.32611.1). We thank INEGI for granting access to the pre-event LIDAR data used for this study. Pre-event LIDAR digital elevation model and derived elevation difference data for the Sierra Cucapah rupture zone are available in the supporting online material.	Berberian M, 1999, GEOPHYS J INT, V136, P671, DOI 10.1046/j.1365-246x.1999.00762.x; Blisniuk K, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006346; Cochran ES, 2009, GEOLOGY, V37, P315, DOI 10.1130/G25306A.1; Elliott AJ, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005969; England P, 2011, NAT GEOSCI, V4, P348, DOI 10.1038/ngeo1168; Fialko Y, 2005, NATURE, V435, P295, DOI 10.1038/nature03425; Fielding EJ, 2009, NATURE, V458, P64, DOI 10.1038/nature07817; Fletcher JM, 2009, GEOSPHERE, V5, P385, DOI 10.1130/GES00206.1; Haeussler PJ, 2004, B SEISMOL SOC AM, V94, pS23, DOI 10.1785/0120040626; Harris RA, 1999, GEOPHYS RES LETT, V26, P2089, DOI 10.1029/1999GL900377; Hauksson E, 2011, PURE APPL GEOPHYS, V168, P1255, DOI 10.1007/s00024-010-0209-7; Huang WJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006361; Hudnut KW, 2002, B SEISMOL SOC AM, V92, P1570, DOI 10.1785/0120000934; Kaven JO, 2007, J STRUCT GEOL, V29, P1463, DOI 10.1016/j.jsg.2007.05.007; King GCP, 2007, B SEISMOL SOC AM, V97, P1833, DOI 10.1785/0120070048; Kirby E, 2007, TECTONICS, V26, DOI 10.1029/2006TC002033; Klinger Y, 2005, B SEISMOL SOC AM, V95, P1970, DOI 10.1785/0120040233; Liu-Zeng J, 2010, B SEISMOL SOC AM, V100, P2615, DOI 10.1785/0120090316; Lockner DA, 1998, J GEOPHYS RES-SOL EA, V103, P5107, DOI 10.1029/97JB03211; Manighetti I, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003174; MARONE C, 1988, GEOPHYS RES LETT, V15, P621, DOI 10.1029/GL015i006p00621; Michel R, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003776; MUELLER KJ, 1995, GEOL SOC AM BULL, V107, P8, DOI 10.1130/0016-7606(1995)107<0008:LQAOTL>2.3.CO;2; Shelef E, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006289; SIEH K, 1993, SCIENCE, V260, P171, DOI 10.1126/science.260.5105.171; Toda S., COULOMB 3 STRESS CHA; Treiman JA, 2002, B SEISMOL SOC AM, V92, P1171, DOI 10.1785/0120000923; Wei SJ, 2011, NAT GEOSCI, V4, P615, DOI 10.1038/ngeo1213; Wesnousky SG, 2006, NATURE, V444, P358, DOI 10.1038/nature05275	29	179	208	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					702	705		10.1126/science.1213778	http://dx.doi.org/10.1126/science.1213778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323817				2022-12-28	WOS:000300047100048
J	Zwier, TS				Zwier, Timothy S.			Probing Frozen Molecular Embraces	SCIENCE			English	Editorial Material							SPECTROSCOPY; IONS		Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zwier, TS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	zwier@purdue.edu						Garand E, 2012, SCIENCE, V335, P694, DOI 10.1126/science.1214948; Gulyuz K, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3585982; Gustafson JL, 2010, SCIENCE, V328, P1251, DOI 10.1126/science.1188403; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; Nguyen S, 2007, P NATL ACAD SCI USA, V104, P1111, DOI 10.1073/pnas.0609969104; Polfer NC, 2009, MASS SPECTROM REV, V28, P468, DOI 10.1002/mas.20215; Poully JC, 2010, INT J MASS SPECTROM, V297, P28, DOI 10.1016/j.ijms.2010.05.014; Rizzo TR, 2009, INT REV PHYS CHEM, V28, P481, DOI 10.1080/01442350903069931	8	4	4	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					668	669		10.1126/science.1218285	http://dx.doi.org/10.1126/science.1218285			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323809				2022-12-28	WOS:000300047100039
J	Bailey, CJ				Bailey, Clifford J.			Could FFAR1 assist insulin secretion in type 2 diabetes?	LANCET			English	Editorial Material							FATTY-ACID STIMULATION; IN-VIVO; GPR40; GLUCOSE		[Bailey, Clifford J.] Aston Univ, Birmingham B4 7ET, W Midlands, England; [Bailey, Clifford J.] Birmingham Childrens Hosp, Birmingham, W Midlands, England	Aston University; University of Birmingham	Bailey, CJ (corresponding author), Aston Univ, Birmingham B4 7ET, W Midlands, England.	c.j.bailey@aston.ac.uk		Bailey, Clifford J/0000-0002-6998-6811				Bailey C.C., 2009, DIABETES THERAPIES T; Ball AJ, 2000, EUR J PHARMACOL, V408, P327, DOI 10.1016/S0014-2999(00)00782-2; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Morgan NG, 2009, BIOCHEM PHARMACOL, V78, P1419, DOI 10.1016/j.bcp.2009.07.020; Rorsman P., 2005, BR J DIABETES VASC D, V5, P187; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130	13	7	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1370	1371		10.1016/S0140-6736(12)60165-2	http://dx.doi.org/10.1016/S0140-6736(12)60165-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926BR	22374407				2022-12-28	WOS:000302806800007
J	White, PD; Chalder, T				White, Peter D.; Chalder, Trudie			Chronic fatigue syndrome: treatment without a cause	LANCET			English	Editorial Material							COGNITIVE-BEHAVIOR THERAPY; TRIAL		[White, Peter D.] Queen Mary Univ London, Barts & London Sch Med & Dent, St Bartholomews Hosp, London EC1A 7BE, England; [Chalder, Trudie] Kings Coll London, Acad Dept Psychol Med, London WC2R 2LS, England	University of London; Queen Mary University London; University of London; King's College London	White, PD (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, St Bartholomews Hosp, London EC1A 7BE, England.	p.d.white@qmul.ac.uk	Chalder, Trudie/A-5717-2011	Chalder, Trudie/0000-0003-0775-1045; White, Peter/0000-0002-8193-5355				Castell BD, 2011, CLIN PSYCHOL-SCI PR, V18, P311, DOI 10.1111/j.1468-2850.2011.01262.x; Chalder T, 2010, PSYCHOL MED, V40, P1269, DOI 10.1017/S003329170999153X; Cohen J, 2011, SCIENCE, V333, P1694, DOI 10.1126/science.333.6050.1694; Crawley EM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000252; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; Internet World Stats, US POP STAT; Nijhof SL, 2012, LANCET, V379, P1412, DOI 10.1016/S0140-6736(12)60025-7; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; Stulemeijer M, 2005, BMJ-BRIT MED J, V330, P14, DOI 10.1136/bmj.38301.587106.63	10	5	5	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1372	1373		10.1016/S0140-6736(12)60197-4	http://dx.doi.org/10.1016/S0140-6736(12)60197-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	926BR	22385681				2022-12-28	WOS:000302806800008
J	Wende, H; Lechner, SG; Cheret, C; Bourane, S; Kolanczyk, ME; Pattyn, A; Reuter, K; Munier, FL; Carroll, P; Lewin, GR; Birchmeier, C				Wende, Hagen; Lechner, Stefan G.; Cheret, Cyril; Bourane, Steeve; Kolanczyk, Maria E.; Pattyn, Alexandre; Reuter, Katja; Munier, Francis L.; Carroll, Patrick; Lewin, Gary R.; Birchmeier, Carmen			The Transcription Factor c-Maf Controls Touch Receptor Development and Function	SCIENCE			English	Article							SENSORY NEURONS; MECHANORECEPTIVE AFFERENTS; CATARACT; RET; MUTATION; HAND; ORIENTATION; DEPENDENCE; SUBTYPES; DOMAIN	The sense of touch relies on detection of mechanical stimuli by specialized mechanosensory neurons. The scarcity of molecular data has made it difficult to analyze development of mechanoreceptors and to define the basis of their diversity and function. We show that the transcription factor c-Maf/c-MAF is crucial for mechanosensory function in mice and humans. The development and function of several rapidly adapting mechanoreceptor types are disrupted in c-Maf mutant mice. In particular, Pacinian corpuscles, a type of mechanoreceptor specialized to detect high-frequency vibrations, are severely atrophied. In line with this, sensitivity to high-frequency vibration is reduced in humans carrying a dominant mutation in the c-MAF gene. Thus, our work identifies a key transcription factor specifying development and function of mechanoreceptors and their end organs.	[Wende, Hagen; Lechner, Stefan G.; Cheret, Cyril; Kolanczyk, Maria E.; Reuter, Katja; Lewin, Gary R.; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bourane, Steeve] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Pattyn, Alexandre; Carroll, Patrick] INSERM, U1051, F-34091 Montpellier 05, France; [Munier, Francis L.] Jules Gonin Eye Hosp, CH-1004 Lausanne, Switzerland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Salk Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Birchmeier, C (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	cbirch@mdc-berlin.de	Alexandre, Pattyn/ABF-1346-2020; Carroll, Patrick/C-2933-2012; Lewin, Gary R/B-8028-2011; Carroll, Patrick/AAL-7773-2021; Bourane, Steeve/AAI-6143-2020; Reuter, Katja/AFM-3640-2022	Carroll, Patrick/0000-0003-3287-8195; Bourane, Steeve/0000-0002-9805-2196; Reuter, Katja/0000-0002-1559-9058; Lechner, Stefan/0000-0001-9402-9127; Sheean, Maria Elzbieta/0000-0003-3055-0495; Pattyn, Alexandre/0000-0003-1215-1482; Cheret, Cyril/0000-0001-7382-0403; Wende, Hagen/0000-0002-9168-8095; Lewin, Gary/0000-0002-2890-6352	 [SFB 665]		We are grateful to I. Schiffner, M. Terne, S. Buchert, C. Paseler, P. Stallerow, and the MDC transgenic and microarray units for technical support and animal husbandry and R. Schmidt-Ullrich, R. Hodge, A. Garratt, and W. Birchmeier (MDC, Berlin) for advice during analysis of hair types and critical reading of the manuscript. This work was funded by grants to C. B. and G. R. L. (SFB 665, NeuroCure). The authors declare no conflicts of interest.	Bensmaia SJ, 2008, J NEUROSCI, V28, P776, DOI 10.1523/JNEUROSCI.4162-07.2008; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Hansen L, 2009, INVEST OPHTH VIS SCI, V50, P3291, DOI 10.1167/iovs.08-3149; Heidenreich M, 2012, NAT NEUROSCI, V15, P138, DOI 10.1038/nn.2985; Honma Y, 2010, DEVELOPMENT, V137, P2319, DOI 10.1242/dev.046995; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; Johnson KO, 2000, J CLIN NEUROPHYSIOL, V17, P539, DOI 10.1097/00004691-200011000-00002; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Lecoin L, 2010, DEV NEUROBIOL, V70, P485, DOI 10.1002/dneu.20790; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Liu Y, 2011, CURR OPIN NEUROBIOL, V21, P52, DOI 10.1016/j.conb.2010.09.003; LOEWENSTEIN WR, 1965, J PHYSIOL-LONDON, V177, P377, DOI 10.1113/jphysiol.1965.sp007598; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Ma QF, 2009, NEURON, V64, P773, DOI 10.1016/j.neuron.2009.12.014; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Rajaram N, 2004, MOL CELL BIOL, V24, P5694, DOI 10.1128/MCB.24.13.5694-5709.2004; Ring BZ, 2000, DEVELOPMENT, V127, P307; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Vanita V, 2006, AM J MED GENET A, V140A, P558, DOI 10.1002/ajmg.a.31126; Zelena J, 1976, Prog Brain Res, V43, P59	30	98	102	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1373	1376		10.1126/science.1214314	http://dx.doi.org/10.1126/science.1214314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22345400				2022-12-28	WOS:000301531600054
J	Chisholm, D; Naci, H; Ali, A; Tran, NT; Peden, M				Chisholm, Dan; Naci, Huseyin; Ali, Adnan; Tran, Nhan T.; Peden, Margie			Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PUBLIC-HEALTH; HELMET; INTERVENTIONS	Objective To identify and estimate the population costs and effects of a selected set of enforcement strategies for reducing the burden of road traffic injuries in developing countries. Design Cost effectiveness analysis based on an epidemiological model. Setting Two epidemiologically defined World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE); and countries in South East Asia with high adult and high child mortality (SearD). Interventions Enforcement of speed limits via mobile speed cameras; drink-drive legislation and enforcement via breath testing campaigns; legislation and primary enforcement of seatbelt use in cars; legislation and enforcement of helmet use by motorcyclists; legislation and enforcement of helmet use by bicyclists. Main outcome measures Patterns of injury were fitted to a state transition model to determine the expected population level effects of intervention over a 10 year period, which were expressed in disability adjusted life years (DALYs) averted. Costs were expressed in international dollars ($Int) for the year 2005. Results The single most cost effective strategy varies by sub-region, but a combined intervention strategy that simultaneously enforces multiple road safety laws produces the most health gain for a given amount of investment. For example, the combined enforcement of speed limits, drink-driving laws, and motorcycle helmet use saves one DALY for a cost of $Int1000-3000 in the two sub-regions considered. Conclusions The potential impact of available road safety measures is inextricably bound by the underlying distribution of road traffic injuries across different road user groups and risk factors. Combined enforcement strategies are expected to represent the most efficient way to reduce the burden of road traffic injuries, because they benefit from considerable synergies on the cost side while generating greater overall health gains.	[Chisholm, Dan] World Hlth Org, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Naci, Huseyin] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England; [Ali, Adnan; Tran, Nhan T.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Baltimore, MD USA; [Peden, Margie] World Hlth Org, Dept Violence & Injury Prevent & Disabil, CH-1211 Geneva, Switzerland	World Health Organization; University of London; London School Economics & Political Science; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization	Chisholm, D (corresponding author), World Hlth Org, Dept Hlth Syst Financing, Ave Appia 20, CH-1211 Geneva, Switzerland.	chisholmd@who.int		Hyder, Adnan/0000-0002-7292-577X; Mary, Margaret/0000-0003-0872-9851				Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; [Anonymous], 2004, WORLD REP ROAD TRAFF; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Begg S., 2000, GLOBAL PROG EVID HLT, V2000, P1; Bishai David M, 2006, Cost Eff Resour Alloc, V4, P2, DOI 10.1186/1478-7547-4-2; Chisholm D, 2008, ROAD TRAFFIC INJURY, P4; Downing A., 2000, PRINT20000 TRL; Elvik R., 2004, HDB ROAD SAFETY MEAS; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Haileyesus T, 2007, INJURY PREV, V13, P202, DOI 10.1136/ip.2006.014019; Johns Benjamin, 2006, Cost Eff Resour Alloc, V4, P8, DOI 10.1186/1478-7547-4-8; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; KELLY P, 1991, ANN EMERG MED, V20, P852, DOI 10.1016/S0196-0644(05)81426-X; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Naci H, 2009, INJURY PREV, V15, P55, DOI 10.1136/ip.2008.018721; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Norton R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P737; ORSAY E, 1995, ANN EMERG MED, V26, P455, DOI 10.1016/S0196-0644(95)70114-1; Peek-Asa C, 1999, AM J PREV MED, V16, P57, DOI 10.1016/S0749-3797(98)00116-0; Rehm J, 2004, COMP QUANTIFICATION, P959; Ridolfo B, 2001, QUANTIFICATION DRUG; Robinson DL, 2006, BMJ-BRIT MED J, V332, P722, DOI 10.1136/bmj.332.7543.722-a; SHANKAR BS, 1992, ACCIDENT ANAL PREV, V24, P385, DOI 10.1016/0001-4575(92)90051-J; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Tan-Torres ET, 2003, MAKING CHOICES HLTH, V1; Thompson DC, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]	27	32	33	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e612	10.1136/bmj.e612	http://dx.doi.org/10.1136/bmj.e612			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389340	Green Published, hybrid			2022-12-28	WOS:000301232600005
J	Hakim, O; Misteli, T				Hakim, Ofir; Misteli, Tom			SnapShot: Chromosome Confirmation Capture	CELL			English	Editorial Material							CONFORMATION CAPTURE; YEAST GENOME; ORGANIZATION; LOCI		[Hakim, Ofir; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hakim, O (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.			Hakim, Ofir/0000-0003-0063-2721	Intramural NIH HHS [ZIA BC010309-14] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abou El Hassan M, 2009, Nucleic Acids Res, V37, pe35, DOI 10.1093/nar/gkp028; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tiwari V.K., 2009, COLD SPRING HARB PRO, DOI pdb.prot5168; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	20	37	37	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					1068	U245		10.1016/j.cell.2012.02.019	http://dx.doi.org/10.1016/j.cell.2012.02.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385969	Green Accepted, Bronze			2022-12-28	WOS:000300985000027
J	Mandal, PK; Rossi, DJ				Mandal, Pankaj K.; Rossi, Derrick J.			DNA-Damage-Induced Differentiation in Hematopoietic Stem Cells	CELL			English	Editorial Material								Aging of hematopoietic stem cells (HSCs) is accompanied by diminished functional potential. Wang et al. now provide evidence for an HSC-specific differentiation checkpoint mediated by the transcription factor BATF, which limits self-renewal of HSCs in response to the accumulation of DNA damage.	[Mandal, Pankaj K.; Rossi, Derrick J.] Harvard Univ, Program Cellular & Mol Med, Childrens Hosp Boston, Dept Stem Cell & Regenerat Biol,Immune Dis Inst, Boston, MA 02116 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Rossi, DJ (corresponding author), Harvard Univ, Program Cellular & Mol Med, Childrens Hosp Boston, Dept Stem Cell & Regenerat Biol,Immune Dis Inst, Boston, MA 02116 USA.	rossi@idi.harvard.edu	mandal, pankaj/B-4885-2016	Mandal, Pankaj/0000-0003-1993-9918				Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Liao JA, 2011, MOL CANCER RES, V9, P350, DOI 10.1158/1541-7786.MCR-10-0375; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040	10	19	19	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					847	848		10.1016/j.cell.2012.02.011	http://dx.doi.org/10.1016/j.cell.2012.02.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385954	Bronze			2022-12-28	WOS:000300985000006
J	Mayer, MP				Mayer, Matthias P.			The Unfolding Story of a Redox Chaperone	CELL			English	Editorial Material							REGULATED CHAPERONE; CRYSTAL-STRUCTURE; HSP33; SPECIFICITY; ACTIVATION; PROTEIN	Oxidative stress, especially in combination with heat stress, poses a life-threatening challenge to many organisms by causing protein misfolding and aggregation. In this issue, Reichmann et al. demonstrate how a destabilized linker region of the bacterial chaperone Hsp33 prevents aggregation of a denatured protein by stabilizing structural elements.	Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Mayer, MP (corresponding author), Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany.	m.mayer@zmbh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112				Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Janda I, 2004, STRUCTURE, V12, P1901, DOI 10.1016/j.str.2004.08.003; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Vijayalakshmi J, 2001, STRUCTURE, V9, P367, DOI 10.1016/S0969-2126(01)00597-4; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024	9	12	12	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					843	844		10.1016/j.cell.2012.02.029	http://dx.doi.org/10.1016/j.cell.2012.02.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385952	Bronze			2022-12-28	WOS:000300985000004
J	Falkowski, P				Falkowski, Paul			OCEAN SCIENCE The power of plankton	NATURE			English	Editorial Material									[Falkowski, Paul] Rutgers State Univ, Inst Marine & Coastal Sci, Piscataway, NJ 08855 USA; [Falkowski, Paul] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Falkowski, P (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Piscataway, NJ 08855 USA.	falko@marine.rutgers.edu						Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; REDFIELD AC, 1958, AM SCI, V46, P205; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	5	191	200	2	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					S17	S20		10.1038/483S17a	http://dx.doi.org/10.1038/483S17a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22378122	Bronze			2022-12-28	WOS:000300877900007
J	Crawford, MJ; Killaspy, H; Barnes, TRE; Barrett, B; Byford, S; Clayton, K; Dinsmore, J; Floyd, S; Hoadley, A; Johnson, T; Kalaitzaki, E; King, M; Leurent, B; Maratos, A; O'Neill, FA; Osborn, DP; Patterson, S; Soteriou, T; Tyrer, P; Waller, D				Crawford, Mike J.; Killaspy, Helen; Barnes, Thomas R. E.; Barrett, Barbara; Byford, Sarah; Clayton, Katie; Dinsmore, John; Floyd, Siobhan; Hoadley, Angela; Johnson, Tony; Kalaitzaki, Eleftheria; King, Michael; Leurent, Baptiste; Maratos, Anna; O'Neill, Francis A.; Osborn, David P.; Patterson, Sue; Soteriou, Tony; Tyrer, Peter; Waller, Diane		MATISSE Project Team	Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHOLOGICAL THERAPY; RELIABILITY; SYMPTOMS; RELAPSE; SCALE	Objectives To evaluate the clinical effectiveness of group art therapy for people with schizophrenia and to test whether any benefits exceed those of an active control treatment. Design Three arm, rater blinded, pragmatic, randomised controlled trial. Setting Secondary care services across 15 sites in the United Kingdom. Participants 417 people aged 18 or over, who had a diagnosis of schizophrenia and provided written informed consent to take part in the study. Interventions Participants, stratified by site, were randomised to 12 months of weekly group art therapy plus standard care, 12 months of weekly activity groups plus standard care, or standard care alone. Art therapy and activity groups had up to eight members and lasted for 90 minutes. In art therapy, members were given access to a range of art materials and encouraged to use these to express themselves freely. Members of activity groups were offered various activities that did not involve use of art or craft materials and were encouraged to collectively select those they wanted to pursue. Main outcome measures The primary outcomes were global functioning, measured using the global assessment of functioning scale, and mental health symptoms, measured using the positive and negative syndrome scale, 24 months after randomisation. Main secondary outcomes were levels of group attendance, social functioning, and satisfaction with care at 12 and 24 months. Results 417 participants were assigned to either art therapy (n=140), activity groups (n=140), or standard care alone (n=137). Primary outcomes between the three study arms did not differ. The adjusted mean difference between art therapy and standard care at 24 months on the global assessment of functioning scale was -0.9 (95% confidence interval -3.8 to 2.1), and on the positive and negative syndrome scale was 0.7 (-3.1 to 4.6). Secondary outcomes did not differ between those referred to art therapy or those referred to standard care at 12 or 24 months. Conclusions Referring people with established schizophrenia to group art therapy as delivered in this trial did not improve global functioning, mental health, or other health related outcomes.	[Crawford, Mike J.; Barnes, Thomas R. E.; Patterson, Sue; Tyrer, Peter; Waller, Diane] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Mental Hlth, Claybrook Ctr, London W6 8LN, England; [Killaspy, Helen; Hoadley, Angela; King, Michael; Osborn, David P.] UCL, Fac Brain Sci, Unit Mental Hlth Sci, London, England; [Barrett, Barbara; Byford, Sarah] Kings Coll London, Hlth Serv, Ctr Econ Mental Hlth, London WC2R 2LS, England; [Barrett, Barbara; Byford, Sarah] Kings Coll London, Populat Res Dept, London WC2R 2LS, England; [Clayton, Katie] Camden & Islington NHS Fdn Trust, London, England; [Dinsmore, John; O'Neill, Francis A.] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Floyd, Siobhan; Soteriou, Tony] Avon & Wiltshire Mental Hlth Partnership NHS Trus, Chippenham, Wilts, England; [Johnson, Tony] MRC Biostat Unit, Cambridge, England; [Johnson, Tony] MRC Clin Trials Unit London, London, England; [Kalaitzaki, Eleftheria; Leurent, Baptiste] MRC Gen Practice Res Framework, London, England; [Maratos, Anna] Cent & N W London NHS Fdn Trust, London, England	Imperial College London; University of London; University College London; University of London; King's College London; University of London; King's College London; Queens University Belfast; MRC Biostatistics Unit; Medical Research Council Clinical Trials Unit	Crawford, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Mental Hlth, Claybrook Ctr, London W6 8LN, England.	m.crawford@imperial.ac.uk	Barrett, Barbara M/F-7606-2010; King, Michael B/D-7477-2011; Byford, Sarah/D-1699-2010; O'Neill, Francis A/C-5582-2008; Osborn PhD FRCPsych, David/B-8165-2009	Barrett, Barbara M/0000-0002-0270-6256; King, Michael B/0000-0003-4715-7171; Byford, Sarah/0000-0001-7084-1495; O'Neill, Francis A/0000-0002-7531-7657; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Killaspy, Helen/0000-0003-2481-4802; Dinsmore, John/0000-0001-8387-3496; Crawford, Mike/0000-0003-3137-5772; Leurent, Baptiste/0000-0001-6420-6567	National Institute for Health Research [04/39/04]; Avon and Wiltshire Mental Health Partnership NHS Trust; Belfast Health and Social Care Trust; Camden and Islington NHS Foundation Trust; Central and North West London NHS Foundation Trust	National Institute for Health Research(National Institute for Health Research (NIHR)); Avon and Wiltshire Mental Health Partnership NHS Trust; Belfast Health and Social Care Trust; Camden and Islington NHS Foundation Trust; Central and North West London NHS Foundation Trust	The project was funded by the National Institute for Health Research Health Technology Assessment programme (project No 04/39/04) and received financial support from Avon and Wiltshire Mental Health Partnership NHS Trust, Belfast Health and Social Care Trust, Camden and Islington NHS Foundation Trust, and Central and North West London NHS Foundation Trust. The sponsors of the study played no part in the preparation of this paper. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Health Technology Assessment programme, the National Institute for Health Research, or the Department of Health.	ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; ANGRIST JD, 1995, J AM STAT ASSOC, V90, P431, DOI 10.2307/2291054; Atkinson C, 1994, PSYCHOL TESTING TREA, P404; British Association of Art Therapists, 2011, WHAT IS ART THER; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Crawford MJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-65; Crawford MJ, 2007, EVID-BASED MENT HEAL, V10, P69, DOI 10.1136/ebmh.10.3.69; George CF, 2000, BRIT J CLIN PHARMACO, V50, P166, DOI 10.1046/j.1365-2125.2000.00244.x; GREEN BL, 1987, HOSP COMMUNITY PSYCH, V38, P988; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Killaspy H, 2000, BRIT J PSYCHIAT, V176, P160, DOI 10.1192/bjp.176.2.160; Killick K, 1997, UNINTEGRATION CONTAI; Kuyken W, 2008, J CONSULT CLIN PSYCH, V76, P966, DOI 10.1037/a0013786; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; *NAT I HLTH CLIN E, 2009, NICE CLIN GUID, V82; Norman RMG, 2000, ACTA PSYCHIAT SCAND, V102, P303, DOI 10.1034/j.1600-0447.2000.102004303.x; Patterson S, 2011, J MENT HEALTH, V20, P328, DOI 10.3109/09638237.2011.556163; Pfammatter M, 2006, SCHIZOPHRENIA BULL, V32, pS64, DOI 10.1093/schbul/sbl030; Richardson P., 2007, J MENT HEALTH, V16, P483, DOI [DOI 10.1080/09638230701483111, https://doi.org/10.1080/09638230701483111]; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Rohricht F, 2006, PSYCHOL MED, V36, P669, DOI 10.1017/S0033291706007161; Ruddy R, 2005, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003728.PUB2; Spencer D, 2010, BRIT MED J, V341, pc6038; Talwar N, 2006, BRIT J PSYCHIAT, V189, P405, DOI 10.1192/bjp.bp.105.015073; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Tyrer P, 2005, INT J SOC PSYCHIATR, V51, P265, DOI 10.1177/0020764005057391; Waller D, 1996, GROUP INTERACTIVE AR; Walwyn R, 2010, STAT METHODS MED RES, V19, P291, DOI 10.1177/0962280209105017; [郑日昌 Zheng Richang], 2005, [心理学报, Acta Psychologica Sinica], V37, P403	30	59	59	5	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2012	344								e846	10.1136/bmj.e846	http://dx.doi.org/10.1136/bmj.e846			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XA	22374932	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000301231000001
J	Long, T; Wyse, S				Long, Tammy; Wyse, Sara			A Season for Inquiry: Investigating Phenology in Local Campus Trees	SCIENCE			English	Editorial Material									[Long, Tammy] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Wyse, Sara] Bethel Univ, St Paul, MN 55112 USA	Michigan State University	Long, T (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	longta@msu.edu			Division Of Undergraduate Education [0736928] Funding Source: National Science Foundation	Division Of Undergraduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		AAAS, 2011, VIS CHANG UND BIOL E; American Association for the Advancement of Science (AAAS), 1993, BENCHM SCI LIT; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286	4	5	5	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					932	933		10.1126/science.1213528	http://dx.doi.org/10.1126/science.1213528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363000	Bronze			2022-12-28	WOS:000300931800036
J	Smith, KJ; Wateska, AR; Nowalk, MP; Raymund, M; Nuorti, JP; Zimmerman, RK				Smith, Kenneth J.; Wateska, Angela R.; Nowalk, Mary Patricia; Raymund, Mahlon; Nuorti, J. Pekka; Zimmerman, Richard K.			Cost-effectiveness of Adult Vaccination Strategies Using Pneumococcal Conjugate Vaccine Compared With Pneumococcal Polysaccharide Vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; CHILDREN YOUNGER; HEART-FAILURE; UNITED-STATES; OLDER-ADULTS; DISEASE; PREVENTION; AGE	Context The cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) compared with 23-valent pneumococcal polysaccharide vaccine (PPSV23) among US adults is unclear. Objective To estimate the cost-effectiveness of PCV13 vaccination strategies in adults. Design, Setting, and Participants A Markov state-transition model, lifetime time horizon, societal perspective. Simulations were performed in hypothetical cohorts of US 50-year-olds. Vaccination strategies and effectiveness estimates were developed by a Delphi expert panel; indirect (herd immunity) effects resulting from childhood PCV13 vaccination were extrapolated based on observed PCV7 effects. Data sources for model parameters included Centers for Disease Control and Prevention Active Bacterial Core surveillance, National Hospital Discharge Survey and Nationwide Inpatient Sample data, and the National Health Interview Survey. Main Outcome Measures Pneumococcal disease cases prevented and incremental costs per quality-adjusted life-year (QALY) gained. Results In the base case scenario, administration of PCV13 as a substitute for PPSV23 in current recommendations (ie, vaccination at age 65 years and at younger ages if comorbidities are present) cost $28 900 per QALY gained compared with no vaccination and was more cost-effective than the currently recommended PPSV23 strategy. Routine PCV13 at ages 50 and 65 years cost $45 100 per QALY compared with PCV13 substituted in current recommendations. Adding PPSV23 at age 75 years to PCV13 at ages 50 and 65 years gained 0.00002 QALYs, costing $496 000 per QALY gained. Results were robust in sensitivity analyses and alternative scenarios, except when low PCV13 effectiveness against nonbacteremic pneumococcal pneumonia was assumed or when greater childhood vaccination indirect effects were modeled. In these cases, PPSV23 as currently recommended was favored. Conclusion Overall, PCV13 vaccination was favored compared with PPSV23, but the analysis was sensitive to assumptions about PCV13 effectiveness against nonbacteremic pneumococcal pneumonia and the magnitude of potential indirect effects from childhood PCV13 on pneumococcal serotype distribution. JAMA. 2012;307(8):804-812 www.jama.com	[Smith, Kenneth J.] Univ Pittsburgh, Sect Decis Sci & Clin Syst Management, Sch Med, Pittsburgh, PA 15213 USA; [Nuorti, J. Pekka] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	Smith, KJ (corresponding author), Univ Pittsburgh, Sect Decis Sci & Clin Syst Management, Sch Med, 200 Meyran Ave,Ste 200, Pittsburgh, PA 15213 USA.	smithkj2@upmc.edu		Zimmerman, Richard/0000-0001-5941-6092; Smith, Kenneth J/0000-0001-8088-566X	National Institute of Allergy and Infectious Diseases [R01 AI076256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076256] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases (R01 AI076256).	American Lung Association, TRENDS PNEUM INFL MO; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; [Anonymous], SEER AG SPEC CANC IN; [Anonymous], 2006, MED PHYS FEE SCHEDUL; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; CANTOR SB, 1994, MED DECIS MAKING, V14, P259, DOI 10.1177/0272989X9401400308; Carbonara S, 2009, CURR OPIN PULM MED, V15, P261, DOI 10.1097/MCP.0b013e3283287c3f; *CDCP, SELF REP PNEUM VACC; Centers for Disease Control and prevention, CDC VACC PRIC LIST; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fry AM, 2002, VACCINE, V21, P303, DOI 10.1016/S0264-410X(02)00451-6; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gold MR, 1996, COST EFFECTIVENESS H; Goldberg RJ, 1996, ARCH INTERN MED, V156, P505, DOI 10.1001/archinte.156.5.505; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hak E, 2008, NETH J MED, V66, P378; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Huang SS, 2011, VACCINE, V29, P3398, DOI 10.1016/j.vaccine.2011.02.088; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Jackson L, 1999, JAMA-J AM MED ASSOC, V281, P243, DOI 10.1001/jama.281.3.243; Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691; Kannel W B, 1992, Ann Epidemiol, V2, P5; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lu PJ, 2010, AM J PREV MED, V39, P287, DOI 10.1016/j.amepre.2010.06.004; Metersky ML, 2010, CHEST, V138, P486, DOI 10.1378/chest.10-0738; Millar EV, 2008, CLIN INFECT DIS, V47, P989, DOI 10.1086/591966; Moberley SA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub2; Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rubin JL, 2010, VACCINE, V28, P7634, DOI 10.1016/j.vaccine.2010.09.049; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Sisk JE, 2003, ANN INTERN MED, V138, P960, DOI 10.7326/0003-4819-138-12-200306170-00007; Smith KJ, 2008, VACCINE, V26, P1420, DOI 10.1016/j.vaccine.2008.01.007; US Census Bureau Population Division, NAT POP EST 2000S; US Food and Drug Administration, APPR PROD PREVN 13; Weycker D, 2010, VACCINE, V28, P4955, DOI 10.1016/j.vaccine.2010.05.030; Wyrwich KW, 2003, J GEN INTERN MED, V18, P196, DOI 10.1046/j.1525-1497.2003.20203.x; Zimmerman RK, 2010, VACCINE, V28, P6470, DOI 10.1016/j.vaccine.2010.07.037	49	106	108	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					804	812		10.1001/jama.2012.169	http://dx.doi.org/10.1001/jama.2012.169			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FQ	22357831	Green Accepted, Bronze			2022-12-28	WOS:000300551300023
J	Chou, R				Chou, Roger			Risk-stratified primary care management of low back pain reduced disability	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.			Chou, Roger/0000-0001-9889-8610				Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006	1	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-7	10.7326/0003-4819-156-4-201202210-02007	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351733				2022-12-28	WOS:000208885400006
J	Freeman, AL; Pendleton, RC				Freeman, Andrew L.; Pendleton, Robert C.			Review: VTE prophylaxis in nonsurgical inpatients reduces PE but not death, and increases major bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Freeman, Andrew L.; Pendleton, Robert C.] Univ Utah, Med Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Freeman, AL (corresponding author), Univ Utah, Med Ctr, Salt Lake City, UT 84112 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4							JC2-5	10.7326/0003-4819-156-4-201202210-02005	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LP	22351731				2022-12-28	WOS:000208885400004
J	Liu, CR; Chang, CR; Chern, Y; Wang, TH; Hsieh, WC; Shen, WC; Chang, CY; Chu, IC; Deng, N; Cohen, SN; Cheng, TH				Liu, Chia-Rung; Chang, Chuang-Rung; Chern, Yijuang; Wang, Tzu-Han; Hsieh, Wen-Chieh; Shen, Wen-Chuan; Chang, Chi-Yuan; Chu, I-Chieh; Deng, Ning; Cohen, Stanley N.; Cheng, Tzu-Hao			Spt4 Is Selectively Required for Transcription of Extended Trinucleotide Repeats	CELL			English	Article							RNA-POLYMERASE-II; NEURONAL INTRANUCLEAR INCLUSIONS; WILD-TYPE HUNTINGTIN; MUTANT HUNTINGTIN; IN-VITRO; NEUROLOGICAL PHENOTYPE; ELONGATION-FACTOR; TRIPLET REPEAT; CAG REPEATS; POLYGLUTAMINE	Lengthy trinucleotide repeats encoding polyglutamine (polyQ) stretches characterize the variant proteins of Huntington's disease and certain other inherited neurological disorders. Using a phenotypic screen to identify events that restore functionality to polyQ proteins in S. cerevisiae, we discovered that transcription elongation factor Spt4 is required to transcribe long trinucleotide repeats located either in ORFs or nonprotein-coding regions of DNA templates. Mutation of SPT4 selectively decreased synthesis of and restored enzymatic activity to expanded polyQ protein without affecting protein lacking long-polyQ stretches. RNA-seq analysis revealed limited effects of Spt4 on overall gene expression. Inhibition of Supt4h, the mammalian ortholog of Spt4, reduced mutant huntingtin protein in neuronal cells and decreased its aggregation and toxicity while not altering overall cellular mRNA synthesis. Our findings identify a cellular mechanism for transcription through repeated trinucleotides and a potential target for countermeasures against neurological disorders attributable to expanded trinucleotide regions.	[Liu, Chia-Rung; Wang, Tzu-Han; Hsieh, Wen-Chieh; Shen, Wen-Chuan; Chang, Chi-Yuan; Chu, I-Chieh; Cheng, Tzu-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chang, Chuang-Rung] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Deng, Ning; Cohen, Stanley N.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Cheng, Tzu-Hao] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Tsing Hua University; Academia Sinica - Taiwan; Stanford University; National Yang Ming Chiao Tung University	Cheng, TH (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155,Sect 2,Linong St, Taipei 112, Taiwan.	sncohen@stanford.edu; thcheng@ym.edu.tw	Chang, Chuang-Rung/C-1815-2012; Deng, Ning/H-6561-2014; chern, yijuang/S-7013-2018	Chang, Chuang-Rung/0000-0002-6124-5429; chern, yijuang/0000-0002-5842-5429; DENG, NING/0000-0002-1321-5508	CHDI Foundation; National Science Council [NSC-96-2311-B-010-001, NSC-98-2311-B-010-001-MY3]; Ministry of Education of the Republic of China; Friends of Stanford Foundation of Taiwan	CHDI Foundation; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education of the Republic of China(Ministry of Education, Taiwan); Friends of Stanford Foundation of Taiwan	We thank Chih-Yen King, Fang-Jen Lee, Jing-Jer Lin, Michael Sherman, Michael Snyder, Elena Cattaneo, Marcy MacDonald, and the HD Community BioRepository (http://ccr.coriell.org) sponsored by CHDI Foundation for providing experimental materials. We thank Cheng-Fu Kao for technical assistance in the ChIP assay and Yong Cheng, Zhihai Ma, Mark McCreary, and Richard Lin for assistance in compilation and analysis of RNA-seq data. T.-H.C. received grants from National Science Council (NSC-96-2311-B-010-001 and NSC-98-2311-B-010-001-MY3), and the "Aim for the Top University Plan'' grant from the Ministry of Education of the Republic of China. S.N. Cohen and N. Deng received support from Kwoh-Ting Li Professorship funds endowed by the Friends of Stanford Foundation of Taiwan.	Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Belotserkovskii BP, 2011, BIOPHYS J, V100, P675, DOI 10.1016/j.bpj.2010.12.3709; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Cheng TH, 2000, GENE DEV, V14, P452; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hands S, 2008, BBA-GENE REGUL MECH, V1779, P507, DOI 10.1016/j.bbagrm.2008.05.008; Hartzog GA, 1996, MOL CELL BIOL, V16, P2848; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kiyama R, 1996, NUCLEIC ACIDS RES, V24, P4577, DOI 10.1093/nar/24.22.4577; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lenzmeier BA, 2003, CYTOGENET GENOME RES, V100, P7, DOI 10.1159/000072836; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Lichota J, 2010, J NEUROCHEM, V113, P1, DOI [10.1111/j.1471-4159.2009.06544, 10.1111/j.1471-4159.2009.06544.x]; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MALONE EA, 1993, MOL GEN GENET, V237, P449, DOI 10.1007/BF00279450; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Parsons MA, 1998, J BIOL CHEM, V273, P26998, DOI 10.1074/jbc.273.41.26998; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Roy D, 2009, MOL CELL BIOL, V29, P3124, DOI 10.1128/MCB.00139-09; Salinas-Rios V, 2011, NUCLEIC ACIDS RES, V39, P7444, DOI 10.1093/nar/gkr429; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Varma H, 2007, NAT CHEM BIOL, V3, P99, DOI 10.1038/nchembio852; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wenzel S, 2010, BIOCHEM J, V425, P373, DOI 10.1042/BJ20091422; WINSTON F, 1984, GENETICS, V107, P179; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Xiao YY, 2005, STAT APPL GENET MOL, V4; Yu ZM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001340; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	61	73	78	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					690	701		10.1016/j.cell.2011.12.032	http://dx.doi.org/10.1016/j.cell.2011.12.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341442	Bronze			2022-12-28	WOS:000300622400011
J	Poirot, C; Abirached, F; Prades, M; Coussieu, C; Bernaudin, F; Piver, P				Poirot, Catherine; Abirached, Fadi; Prades, Marie; Coussieu, Christiane; Bernaudin, Francoise; Piver, Pascal			Induction of puberty by autograft of cryopreserved ovarian tissue	LANCET			English	Editorial Material							TRANSPLANTATION		[Poirot, Catherine; Prades, Marie] Grp Hosp Pitie Salpetriere, Reprod Biol Unit, Paris, France; [Coussieu, Christiane] Grp Hosp Pitie Salpetriere, Dept Med Biochem, Paris, France; [Abirached, Fadi] Intercommunal Creteil Hosp, Gynaecol Obstet Dept, Creteil, France; [Bernaudin, Francoise] Intercommunal Creteil Hosp, Reference Ctr Sickle Cell Dis, Dept Pediat, Creteil, France; [Piver, Pascal] Limoges Univ Hosp, Gynaecol Obstet Dept, Limoges, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; CHU Limoges	Poirot, C (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, Unite Fonctionnelle Biol Reprod, 83 Bd Hop, F-75013 Paris, France.	catherine.poirot@psl.aphp.fr	piver, pascal/B-1911-2017					Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665; Donnez J, 2011, ANN MED, V43, P437, DOI 10.3109/07853890.2010.546807; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; Roux C, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.12.022; Thibaud E, 1998, BONE MARROW TRANSPL, V21, P287, DOI 10.1038/sj.bmt.1701075	5	129	133	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					588	588		10.1016/S0140-6736(11)61781-9	http://dx.doi.org/10.1016/S0140-6736(11)61781-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22325664				2022-12-28	WOS:000300188800036
J	Chen, CC; Wu, JK; Lin, HW; Pai, TP; Fu, TF; Wu, CL; Tully, T; Chiang, AS				Chen, Chun-Chao; Wu, Jie-Kai; Lin, Hsuan-Wen; Pai, Tsung-Pin; Fu, Tsai-Feng; Wu, Chia-Lin; Tully, Tim; Chiang, Ann-Shyn			Visualizing Long-Term Memory Formation in Two Neurons of the Drosophila Brain	SCIENCE			English	Article							MUSHROOM BODY NEURONS; RICIN-A-CHAIN; OLFACTORY MEMORY; EUKARYOTIC RIBOSOMES; CONSOLIDATED MEMORY; FLUORESCENT PROTEIN; NMDA RECEPTORS; TRACE; GENE; RETRIEVAL	Long-term memory (LTM) depends on the synthesis of new proteins. Using a temperature-sensitive ribosome-inactivating toxin to acutely inhibit protein synthesis, we screened individual neurons making new proteins after olfactory associative conditioning in Drosophila. Surprisingly, LTM was impaired after inhibiting protein synthesis in two dorsal-anterior-lateral (DAL) neurons but not in the mushroom body (MB), which is considered the adult learning and memory center. Using a photoconvertible fluorescent protein KAEDE to report de novo protein synthesis, we have directly visualized cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB)-dependent transcriptional activation of calcium/calmodulin-dependent protein kinase II and period genes in the DAL neurons after spaced but not massed training. Memory retention was impaired by blocking neural output in DAL during retrieval but not during acquisition or consolidation. These findings suggest an extra-MB memory circuit in Drosophila: LTM consolidation (MB to DAL), storage (DAL), and retrieval (DAL to MB).	[Chen, Chun-Chao; Wu, Jie-Kai; Lin, Hsuan-Wen; Pai, Tsung-Pin; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; [Chen, Chun-Chao; Wu, Jie-Kai; Lin, Hsuan-Wen; Pai, Tsung-Pin; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Wu, Chia-Lin; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu 30013, Taiwan; [Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Nantou 54561, Taiwan; [Tully, Tim] Dart Neurosci LLC, San Diego, CA 92121 USA; [Chiang, Ann-Shyn] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Chiang, Ann-Shyn] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Chi Nan University; Academia Sinica - Taiwan; University of California System; University of California San Diego	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw		Chiang, Ann-Shyn/0000-0001-9668-7115; Wu, Jie-Kai/0000-0002-5142-1468; Fu, Tsai-Feng/0000-0002-0343-3018; Wu, Chia-Lin/0000-0002-7906-2364	Dart Neurosciences LLC; National Science Council; Ministry of Education	Dart Neurosciences LLC; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education	We thank S. Benzer, J. Blau, R. L. Davis, J. Hall, J. Hirsh, C. J. O'Kane, S. Kunes, L. Luo, T. Preat, M. Rosbash, S. Waddell, Y. Takamatsu, M. W. Young, and the Bloomington and Drosophila Genomics Resource Centers for fly stocks. We thank J. Hirsh, L. C. Griffith, and T. Preat for the antibodies. We also thank S. F. Teng for the preliminary test of UAS-kaede. This work was funded by grants from Dart Neurosciences LLC, National Science Council, and Ministry of Education to A.-S.C. C.-C. C., T. T., and A.-S.C. conceptualized the project and wrote the manuscript; C.-C. C. and A.-S.C. developed the methods and analyzed the data; C.-C. C., J.-K.W., T.-P. P., and C.-L. W carried out behavioral experiments; H.-W.L. and J.-K.W. performed imaging experiments; T.-F.F. generated the UAS-kaede transgenic flies; A.-S.C. supervised the project. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to A.-S.C.	Akalal DBG, 2011, J NEUROSCI, V31, P5643, DOI 10.1523/JNEUROSCI.3190-10.2011; Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Martinek S, 2000, GENETICS, V156, P1717; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pascual A, 2004, NATURE, V427, P605, DOI 10.1038/427605a; Pitman JL, 2011, CURR BIOL, V21, P855, DOI 10.1016/j.cub.2011.03.069; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005; Wu CL, 2011, CURR BIOL, V21, P848, DOI 10.1016/j.cub.2011.02.041; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030	42	115	119	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					678	685		10.1126/science.1212735	http://dx.doi.org/10.1126/science.1212735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323813				2022-12-28	WOS:000300047100043
J	Platzbecker, U; Bornhauser, M				Platzbecker, Uwe; Bornhaeuser, Martin			SOS for veno-occlusive disease: defibrotide prophylaxis	LANCET			English	Editorial Material							HEMATOPOIETIC-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; PREVENTION; COMPLICATIONS; TRIAL; LIVER		[Platzbecker, Uwe; Bornhaeuser, Martin] Univ Klinikum Carl Gustav Carus Dresden, Med Klin & Poliklin 1, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Platzbecker, U (corresponding author), Univ Klinikum Carl Gustav Carus Dresden, Med Klin & Poliklin 1, D-01307 Dresden, Germany.	uwe.platzbecker@uniklinikum-dresden.de						ATTAL M, 1992, BLOOD, V79, P2834; Chopra R, 2000, BRIT J HAEMATOL, V111, P1122, DOI 10.1046/j.1365-2141.2000.02475.x; CLIFT RA, 1993, BLOOD, V82, P2025; Corbacioglu S, 2012, LANCET, V379, P1301, DOI 10.1016/S0140-6736(11)61938-7; Eissner G, 2002, BLOOD, V100, P334, DOI 10.1182/blood.V100.1.334; GLUCKMAN E, 1990, BRIT J HAEMATOL, V74, P277, DOI 10.1111/j.1365-2141.1990.tb02583.x; Hogan WJ, 2004, BLOOD, V103, P78, DOI 10.1182/blood-2003-04-1311; McDonald GB, 2010, HEPATOLOGY, V51, P1450, DOI 10.1002/hep.23533; Richardson P, 2009, EXPERT REV HEMATOL, V2, P365, DOI 10.1586/ehm.09.30; Richardson P, 2009, BLOOD, V114, P272; Richardson PG, 2010, BIOL BLOOD MARROW TR, V16, P1005, DOI 10.1016/j.bbmt.2010.02.009; Ruutu T, 2002, BLOOD, V100, P1977, DOI 10.1182/blood-2001-12-0159; SHULMAN HM, 1994, HEPATOLOGY, V19, P1171, DOI 10.1002/hep.1840190515	13	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 7	2012	379	9823					1277	1278		10.1016/S0140-6736(12)60067-1	http://dx.doi.org/10.1016/S0140-6736(12)60067-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922FB	22364686				2022-12-28	WOS:000302531100005
J	Turcan, S; Rohle, D; Goenka, A; Walsh, LA; Fang, F; Yilmaz, E; Campos, C; Fabius, AWM; Lu, C; Ward, PS; Thompson, CB; Kaufman, A; Guryanova, O; Levine, R; Heguy, A; Viale, A; Morris, LGT; Huse, JT; Mellinghoff, IK; Chan, TA				Turcan, Sevin; Rohle, Daniel; Goenka, Anuj; Walsh, Logan A.; Fang, Fang; Yilmaz, Emrullah; Campos, Carl; Fabius, Armida W. M.; Lu, Chao; Ward, Patrick S.; Thompson, Craig B.; Kaufman, Andrew; Guryanova, Olga; Levine, Ross; Heguy, Adriana; Viale, Agnes; Morris, Luc G. T.; Huse, Jason T.; Mellinghoff, Ingo K.; Chan, Timothy A.			IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype	NATURE			English	Article							ISLAND METHYLATOR PHENOTYPE; INTEGRATED GENOMIC ANALYSIS; DNA METHYLATION; GLIOBLASTOMA-MULTIFORME; ANAPLASTIC ASTROCYTOMA; COLORECTAL-CANCER; GENE; PATHWAYS; IDENTIFICATION; ABNORMALITIES	Both genome-wide genetic and epigenetic alterations are fundamentally important for the development of cancers, but the interdependence of these aberrations is poorly understood. Glioblastomas and other cancers with the CpG island methylator phenotype (CIMP) constitute a subset of tumours with extensive epigenomic aberrations and a distinct biology(1-3). Glioma CIMP (G-CIMP) is a powerful determinant of tumour pathogenicity, but the molecular basis of G-CIMP remains unresolved. Here we show that mutation of a single gene, isocitrate dehydrogenase 1 (IDH1), establishes G-CIMP by remodelling the methylome. This remodelling results in reorganization of the methylome and transcriptome. Examination of the epigenome of a large set of intermediate-grade gliomas demonstrates a distinct G-CIMP phenotype that is highly dependent on the presence of IDH mutation. Introduction of mutant IDH1 into primary human astrocytes alters specific histone marks, induces extensive DNA hypermethylation, and reshapes the methylome in a fashion that mirrors the changes observed in G-CIMP-positive lower-grade gliomas. Furthermore, the epigenomic alterations resulting from mutant IDH1 activate key gene expression programs, characterize G-CIMP-positive proneural glioblastomas but not other glioblastomas, and are predictive of improved survival. Our findings demonstrate that IDH mutation is the molecular basis of CIMP in gliomas, provide a framework for understanding oncogenesis in these gliomas, and highlight the interplay between genomic and epigenomic changes in human cancers.	[Turcan, Sevin; Rohle, Daniel; Goenka, Anuj; Walsh, Logan A.; Fang, Fang; Yilmaz, Emrullah; Campos, Carl; Fabius, Armida W. M.; Kaufman, Andrew; Guryanova, Olga; Levine, Ross; Heguy, Adriana; Morris, Luc G. T.; Huse, Jason T.; Mellinghoff, Ingo K.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rohle, Daniel; Mellinghoff, Ingo K.; Chan, Timothy A.] Weill Cornell Coll Med, New York, NY 10065 USA; [Goenka, Anuj; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Lu, Chao; Ward, Patrick S.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Morris, Luc G. T.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Mellinghoff, Ingo K.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	mellingi@mskcc.org; chant@mskcc.org	Chan, Timothy A/ABD-5850-2021; Lu, Chao/E-8047-2012; Turcan, Sevin/AAF-1095-2019; levine, ross/AAE-7658-2019; Yilmaz, Emrullah/AAR-6228-2021; Heguy, Adriana/GPP-3907-2022; Yilmaz, Emrullah/ABA-5486-2021; Ward, Patrick/H-2361-2014	Turcan, Sevin/0000-0002-0885-5607; Yilmaz, Emrullah/0000-0003-2308-713X; Lu, Chao/0000-0003-0982-8122; Guryanova, Olga/0000-0002-6514-8466; Ward, Patrick/0000-0001-6437-8174; Campos, Carl/0000-0002-7616-8518; Mellinghoff, Ingo/0000-0002-4347-8149; Walsh, Logan/0000-0001-8771-2577	National Institutes of Health [R01CA154767-01]; National Cancer Institute [U54-CA143798]; American Society of Clinical Oncology; Doris Duke Charitable Fund; National Brain Tumor Society; MSKCC Brain Tumor Center; Louis Gerstner Foundation; STARR Cancer Consortium; Sontag Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA154767, U54CA143798, T32CA009685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Clinical Oncology; Doris Duke Charitable Fund(Doris Duke Charitable Foundation (DDCF)); National Brain Tumor Society; MSKCC Brain Tumor Center; Louis Gerstner Foundation; STARR Cancer Consortium; Sontag Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Kayserian, K. Huberman, I. Dolgalev and S. Thomas for technical expertise. We thank C. Sawyers and E. Holland for helpful discussions. This grant was supported in part by the National Institutes of Health (R01CA154767-01) (T. A. C.), the National Cancer Institute (U54-CA143798) (I. K. M.), an Advanced Clinical Research Award in Glioma from the American Society of Clinical Oncology (I. K. M.), the Doris Duke Charitable Fund (I. K. M., T. A. C.), a National Brain Tumor Society Systems Biology Research Grant (I. K. M.), the MSKCC Brain Tumor Center (T. A. C.), the Louis Gerstner Foundation (T. A. C.), the STARR Cancer Consortium (T. A. C.) and the Sontag Foundation (T.A.C., I.K.M.).	Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Cheng YW, 2008, CLIN CANCER RES, V14, P6005, DOI 10.1158/1078-0432.CCR-08-0216; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Docherty SJ, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-3; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pieper RO, 2003, FRONT BIOSCI-LANDMRK, V8, pS19, DOI 10.2741/983; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P2564, DOI 10.1158/0008-5472.CAN-07-6388; Sonoda Y, 2001, CANCER RES, V61, P4956; Sonoda Y, 2001, CANCER RES, V61, P6674; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	42	1309	1349	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2012	483	7390					479	U137		10.1038/nature10866	http://dx.doi.org/10.1038/nature10866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22343889	Green Accepted			2022-12-28	WOS:000301771200046
J	Zier, LS; Sottile, PD; Hong, SY; Weissfield, LA; White, DB				Zier, Lucas S.; Sottile, Peter D.; Hong, Seo Yeon; Weissfield, Lisa A.; White, Douglas B.			Surrogate Decision Makers' Interpretation of Prognostic Information A Mixed-Methods Study	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE-CARE UNITS; SERIOUSLY ILL; PHYSICIANS; PROBABILITY; OUTCOMES; PREFERENCES; SUPPORT; HEALTH; TRIAL; WORDS	Background: Little is known about why surrogate decision makers for patients with advanced illness often have overly optimistic expectations about prognosis. Objective: To determine how surrogates interpret prognostic statements and to explore factors influencing surrogates' interpretations of grim prognostic information. Design: Multicenter, mixed-methods study. Setting: Intensive care units of 3 hospitals in San Francisco, California. Participants: 80 surrogates of critically ill patients. Measurements: Participants recorded their interpretation of 16 prognostic statements using a standard probability scale. Generalized estimating equations were used to determine whether participants interpreted statements more optimistically as the expressed probability of survival decreased. Fifteen surrogates whose responses exhibited this trend participated in a semistructured interview. Results: Participants' interpretations of prognostic statements expressing a low risk for death were relatively accurate, but interpretations of statements conveying a high risk for death were more optimistic than the actual meaning (P < 0.001; generalized estimating equation model). Interpretations of the statement "90% chance of surviving" did not differ from the actual meaning, but interpretations of "5% chance of surviving" were more optimistic and showed substantial variability (median, 90% [interquartile range, 90% to 95%; P = 0.11] vs. 15% [interquartile range, 5% to 40%; P < 0.001], respectively). Two main themes from the interviews explained this trend: surrogates' need to register optimism in the face of a poor prognosis and surrogates' belief that patient attributes unknown to the physician would lead to better-than-predicted outcomes. Limitation: Surrogates' interpretations were elicited in an experimental setting rather than during actual clinician-surrogate conversations. Conclusion: Inaccurate interpretations of physicians' prognostications by surrogates arise partly from optimistic biases rather than simply from misunderstandings.	[White, Douglas B.] Univ Pittsburgh, Med Ctr, Program Eth & Decis Making Crit Illness, Dept Crit Care Med, Pittsburgh, PA 15261 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	White, DB (corresponding author), Univ Pittsburgh, Med Ctr, Program Eth & Decis Making Crit Illness, Dept Crit Care Med, 3550 Terrace St,Scaife Hall,Room 608,HPU010604, Pittsburgh, PA 15261 USA.	whitedb@upmc.edu			National Heart, Lung, and Blood Institute [R01HL094553]; Greenwall Foundation; University of California Berkeley-University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094553] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Greenwall Foundation; University of California Berkeley-University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.; Grant Support: By grants from the National Heart, Lung, and Blood Institute (R01HL094553), the Greenwall Foundation, and the University of California Berkeley-University of California San Francisco Joint Medical Program.	Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Boyd EA, 2010, CRIT CARE MED, V38, P1270, DOI 10.1097/CCM.0b013e3181d8a217; Burt R.S., 2005, BROKERAGE CLOSURE IN; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; DeMaio TJ., 1996, ANSWERING QUESTIONS, P177; Glaser B.G., 1965, AWARENESS DYING; Hoorens V., 1993, EUR REV SOC PSYCHOL, V4, P113, DOI DOI 10.1080/14792779343000040; Jansen Lynn A, 2011, IRB, V33, P1; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lloyd CB, 2004, CRIT CARE MED, V32, P649, DOI 10.1097/01.CCM.0000115636.29294.2F; MAZUR DJ, 1991, J GEN INTERN MED, V6, P237, DOI 10.1007/BF02598968; Meadow W, 2011, CRIT CARE MED, V39, P474, DOI 10.1097/CCM.0b013e318205df9b; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; NAKAO MA, 1983, AM J MED, V74, P1061, DOI 10.1016/0002-9343(83)90819-7; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Ohnishi M, 2002, FAM PRACT, V19, P7, DOI 10.1093/fampra/19.1.7; Paling J, 2003, BRIT MED J, V327, P745, DOI 10.1136/bmj.327.7417.745; Reyna VF, 2008, MED DECIS MAKING, V28, P850, DOI 10.1177/0272989X08327066; Reyna VF, 2008, MED DECIS MAKING, V28, P829, DOI 10.1177/0272989X08327069; ROBERTSON WO, 1983, JAMA-J AM MED ASSOC, V249, P2631, DOI 10.1001/jama.249.19.2631; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Strauss A., 1998, BASICS QUALITATIVE R; Sulmasy DP, 2010, CANCER-AM CANCER SOC, V116, P3702, DOI 10.1002/cncr.25201; Teno JM, 2000, J AM GERIATR SOC, V48, pS70, DOI 10.1111/j.1532-5415.2000.tb03144.x; White DB, 2007, CRIT CARE MED, V35, P442, DOI 10.1097/01.CCM.0000254723.28270.14; White DB, 2010, MED DECIS MAKING, V30, P76, DOI 10.1177/0272989X08317012; Zier LS, 2008, CRIT CARE MED, V36, P2341, DOI 10.1097/CCM.0b013e318180ddf9; Zier LS, 2009, CHEST, V136, P110, DOI 10.1378/chest.08-2753	30	107	109	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2012	156	5					360	U178		10.7326/0003-4819-156-5-201203060-00008	http://dx.doi.org/10.7326/0003-4819-156-5-201203060-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902OC	22393131	Green Accepted			2022-12-28	WOS:000301046800004
J	Xie, Y; Minna, JD				Xie, Yang; Minna, John D.			A lung cancer molecular prognostic test ready for prime time	LANCET			English	Editorial Material							ADJUVANT CHEMOTHERAPY; ADENOCARCINOMA; VALIDATION; SIGNATURE; SURVIVAL; TISSUE; CELLS		[Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Pharmacol, Dallas, TX 75390 USA; [Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Minna, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med & Pharmacol, Dallas, TX 75390 USA.	john.minna@utsouthwestern.edu			NCI NIH HHS [P50 CA070907] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Coombes KR, 2007, NAT MED, V13, P1276, DOI 10.1038/nm1107-1276b; Jeong Y, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000378; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Minna JD, 2007, J CLIN ONCOL, V25, P4329, DOI 10.1200/JCO.2007.12.3968; Ooi AT, 2010, CANCER RES, V70, P6639, DOI 10.1158/0008-5472.CAN-10-0455; Rekhtman N, 2011, MODERN PATHOL, V24, P1348, DOI 10.1038/modpathol.2011.92; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Travis WD, 2011, SEMIN RESP CRIT CARE, V32, P22, DOI 10.1055/s-0031-1272866; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Xie Y, 2008, NAT MED, V14, P812, DOI 10.1038/nm0808-812; Xie Y, 2010, J CLIN ONCOL, V28, P4404, DOI 10.1200/JCO.2010.31.0144; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	17	12	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2012	379	9818					785	787		10.1016/S0140-6736(12)60154-8	http://dx.doi.org/10.1016/S0140-6736(12)60154-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386017	Green Accepted			2022-12-28	WOS:000300983400008
J	Garcia, SM; Kolding, J; Rice, J; Rochet, MJ; Zhou, S; Arimoto, T; Beyer, JE; Borges, L; Bundy, A; Dunn, D; Fulton, EA; Hall, M; Heino, M; Law, R; Makino, M; Rijnsdorp, AD; Simard, F; Smith, ADM				Garcia, S. M.; Kolding, J.; Rice, J.; Rochet, M. -J.; Zhou, S.; Arimoto, T.; Beyer, J. E.; Borges, L.; Bundy, A.; Dunn, D.; Fulton, E. A.; Hall, M.; Heino, M.; Law, R.; Makino, M.; Rijnsdorp, A. D.; Simard, F.; Smith, A. D. M.			Reconsidering the Consequences of Selective Fisheries	SCIENCE			English	Editorial Material							BY-CATCH; MANAGING FISHERIES; MANAGEMENT; ECOSYSTEM; FISH; CONSERVATION; PHILOSOPHY; COMMUNITY; EVOLUTION; ATLANTIC		[Rochet, M. -J.] IFREMER, F-44300 Nantes, France; [Garcia, S. M.; Kolding, J.; Rice, J.; Makino, M.] Fisheries Expert Grp, Commiss Ecosyst Management, Int Union Conservat Nat IUCN CEM, B-1000 Brussels, Belgium; [Kolding, J.] Univ Bergen, Dept Biol, N-5020 Bergen, Norway; [Rice, J.] Fisheries & Oceans, Ottawa, ON K1A OE6, Canada; [Zhou, S.] CSIRO Marine & Atmospher Res, Brisbane, Qld 4001, Australia; [Arimoto, T.] Tokyo Univ Marine Sci & Technol, Tokyo 1088477, Japan; [Beyer, J. E.] Danish Natl Inst Aquat Resources DTU Aqua, DK-2920 Charlottenlund, Denmark; [Borges, L.] FishFix, Brussels, Belgium; [Bundy, A.] Bedford Inst Oceanog, Dartmouth, NS 83B 1A5, Canada; [Dunn, D.] Duke Univ, Marine Geospatial Ecol Lab, Beaufort, NC 28516 USA; [Fulton, E. A.; Smith, A. D. M.] CSIRO Marine & Atmospher Res, Hobart, Tas 7000, Australia; [Hall, M.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Heino, M.] Inst Marine Res, N-5005 Bergen, Norway; [Heino, M.] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Law, R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Makino, M.] Fisheries Res Agcy, Yokohama, Kanagawa 2206115, Japan; [Simard, F.] IUCN, Global Marine Programme, CH-1196 Gland, Switzerland; [Rijnsdorp, A. D.] Inst Marine Resources & Ecosyst Studies IMARES, NL-1976 Ijmuiden, Netherlands	Ifremer; University of Bergen; Fisheries & Oceans Canada; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Tokyo University of Marine Science & Technology; Technical University of Denmark; Bedford Institute of Oceanography; Duke University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Institute of Marine Research - Norway; International Institute for Applied Systems Analysis (IIASA); University of York - UK; Japan Fisheries Research & Education Agency (FRA); Wageningen University & Research	Rochet, MJ (corresponding author), IFREMER, F-44300 Nantes, France.	Marie.Joelle.Rochet@ifremer.fr	Fulton, Beth/AAJ-1398-2021; Zhou, Shijie/A-1886-2010; Bundy, Alida/H-2884-2015; Rijnsdorp, Adriaan/A-4217-2008; Heino, Mikko P/C-7241-2009; Smith, Tony D/A-4017-2012; Fulton, Beth/A-2871-2008; GARCIA, Serge Michel/D-6758-2012	Fulton, Beth/0000-0002-5904-7917; Zhou, Shijie/0000-0002-9358-1013; Bundy, Alida/0000-0002-4282-0715; Rijnsdorp, Adriaan/0000-0003-0785-9662; Heino, Mikko P/0000-0003-2928-3940; Fulton, Beth/0000-0002-5904-7917; Beyer, Jan/0000-0002-4310-4112; Dunn, Daniel/0000-0001-8932-0681				Andersen KH, 2010, P ROY SOC B-BIOL SCI, V277, P795, DOI 10.1098/rspb.2009.1512; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; [Anonymous], SAINSBURYS LAUNCHES; Beverton R.J.H., 1957, DYNAMICS EXPLOITED F, V1st; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bundy A, 2005, ICES J MAR SCI, V62, P503, DOI 10.1016/j.icesjms.2004.12.008; Clucas I., 1997, FAO FISH CIRC; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; Dunn DC, 2011, FISH FISH, V12, P110, DOI 10.1111/j.1467-2979.2010.00388.x; FAO, 2011, 957 FAO, P957; Garcia S. M., 2011, SCI WORKSH NAG JAP 1; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; GOBERT B, 1994, FISH RES, V19, P87, DOI 10.1016/0165-7836(94)90016-7; Hall SJ, 2005, FISH FISH, V6, P134, DOI 10.1111/j.1467-2979.2005.00183.x; Halliday RG, 2002, FISH RES, V57, P211, DOI 10.1016/S0165-7836(02)00079-6; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Jul-Larsen E., 2003, 42612 FAO; Kennelly SJ, 2002, FISH FISH, V3, P340, DOI 10.1046/j.1467-2979.2002.00090.x; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Link JS, 2011, FISH FISH, V12, P152, DOI 10.1111/j.1467-2979.2011.00411.x; Maunder MN, 2002, FISH FISH, V3, P251, DOI 10.1046/j.1467-2979.2002.00089.x; Misund O.A., 2002, HDB FISH BIOL FISHER, VVol. II, P13, DOI DOI 10.1002/9780470693919.CH2; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; POPE JG, 1991, ICES MAR SC, V193, P22; Rochet MJ, 2012, P ROY SOC B-BIOL SCI, V279, P284, DOI 10.1098/rspb.2011.0893; Rochet MJ, 2011, CAN J FISH AQUAT SCI, V68, P469, DOI 10.1139/F10-159; SISSENWINE MP, 1987, CAN J FISH AQUAT SCI, V44, P913, DOI 10.1139/f87-110; UN, 2002, ACONF19920 UN; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zhou SJ, 2010, P NATL ACAD SCI USA, V107, P9485, DOI 10.1073/pnas.0912771107	33	322	328	0	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1045	1047		10.1126/science.1214594	http://dx.doi.org/10.1126/science.1214594			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383833	Green Published			2022-12-28	WOS:000300931100027
J	Jordan, MJT; Kable, SH				Jordan, Meredith J. T.; Kable, Scott H.			Roaming Reaction Pathways Along Excited States	SCIENCE			English	Editorial Material							PHOTODISSOCIATION; DYNAMICS; NO3		[Jordan, Meredith J. T.; Kable, Scott H.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	University of Sydney	Jordan, MJT (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	m.jordan@chem.usyd.edu.au; scott.kable@sydney.edu.au	Jordan, Meredith/M-3901-2013	Jordan, Meredith/0000-0002-9871-8605; Kable, Scott/0000-0002-0331-6137				Bowman JM, 2011, ANNU REV PHYS CHEM, V62, P531, DOI 10.1146/annurev-physchem-032210-103518; DAVIS HF, 1993, J PHYS CHEM-US, V97, P2172, DOI 10.1021/j100112a018; Grubb MP, 2012, SCIENCE, V335, P1075, DOI 10.1126/science.1216911; Grubb MP, 2011, J PHYS CHEM A, V115, P3218, DOI 10.1021/jp200110e; Hause ML, 2011, NAT CHEM, V3, P932, DOI [10.1038/NCHEM.1194, 10.1038/nchem.1194]; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; Xiao HY, 2011, J PHYS CHEM LETT, V2, P934, DOI 10.1021/jz2003364	7	22	22	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1054	1055		10.1126/science.1218767	http://dx.doi.org/10.1126/science.1218767			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383837				2022-12-28	WOS:000300931100032
J	Wu, CY; Asokan, SB; Berginski, ME; Haynes, EM; Sharpless, NE; Griffith, JD; Gomez, SM; Bear, JE				Wu, Congying; Asokan, Sreeja B.; Berginski, Matthew E.; Haynes, Elizabeth M.; Sharpless, Norman E.; Griffith, Jack D.; Gomez, Shawn M.; Bear, James E.			Arp2/3 Is Critical for Lamellipodia and Response to Extracellular Matrix Cues but Is Dispensable for Chemotaxis	CELL			English	Article							EUKARYOTIC CHEMOTAXIS; ACTIN-FILAMENTS; CELL-MIGRATION; LEADING-EDGE; COMPLEX; MOTILITY; FIBROBLASTS; DICTYOSTELIUM; MECHANISMS; NETWORKS	Lamellipodia are sheet-like, leading edge protrusions in firmly adherent cells that contain Arp2/3-generated dendritic actin networks. Although lamellipodia are widely believed to be critical for directional cell motility, this notion has not been rigorously tested. Using fibroblasts derived from Ink4a/Arf-deficient mice, we generated a stable line depleted of Arp2/3 complex that lacks lamellipodia. This line shows defective random cell motility and relies on a filopodia-based protrusion system. Utilizing a microfluidic gradient generation system, we tested the role of Arp2/3 complex and lamellipodia in directional cell migration. Surprisingly, Arp2/3-depleted cells respond normally to shallow gradients of PDGF, indicating that lamellipodia are not required for fibroblast chemotaxis. Conversely, these cells cannot respond to a surface-bound gradient of extracellular matrix (haptotaxis). Consistent with this finding, cells depleted of Arp2/3 fail to globally align focal adhesions, suggesting that one principle function of lamellipodia is to organize cell-matrix adhesions in a spatially coherent manner.	[Wu, Congying; Asokan, Sreeja B.; Haynes, Elizabeth M.; Bear, James E.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Berginski, Matthew E.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Berginski, Matthew E.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Berginski, Matthew E.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Wu, Congying; Asokan, Sreeja B.; Haynes, Elizabeth M.; Sharpless, Norman E.; Griffith, Jack D.; Bear, James E.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Griffith, Jack D.] Univ N Carolina, Sch Med, Dept Biochem, Chapel Hill, NC 27599 USA; [Bear, James E.] Univ N Carolina, Sch Med, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bear, JE (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	jbear@email.unc.edu		Gomez, Shawn/0000-0002-8251-4552; Haynes, Elizabeth/0000-0002-5294-018X; Sharpless, Norman/0000-0001-7078-9455	HHMI, NIH [GM083035, UO1-CA141576, DK037871, GM31819, ES 13773]; LCCC Electron Microscopy Core [NIH CA16086]; UNC-Olympus Imaging Research Center, UNC Research Computing; Allbrittion lab; NATIONAL CANCER INSTITUTE [U01CA141576, P30CA016086, R01CA163896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083035, R01GM031819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379] Funding Source: NIH RePORTER	HHMI, NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LCCC Electron Microscopy Core; UNC-Olympus Imaging Research Center, UNC Research Computing; Allbrittion lab; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge support from HHMI, NIH grants to J.E.B. (GM083035), N.E.S. (UO1-CA141576), S. M. G. (DK037871), and J.D.G. (GM31819, ES 13773), the LCCC Electron Microscopy Core (supported by NIH CA16086) the UNC-Olympus Imaging Research Center, UNC Research Computing, the Allbrittion lab for use of facilities, members of the Bear lab for critical discussions, Zenon Rajfur for assistance with microinjection, and Klaus Hahn for the mCherry-FAK construct.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Di Nardo A, 2005, P NATL ACAD SCI USA, V102, P16263, DOI 10.1073/pnas.0508228102; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Melvin AT, 2011, BIOPHYS J, V100, P1893, DOI 10.1016/j.bpj.2011.02.047; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nicholson-Dykstra SM, 2008, CELL MOTIL CYTOSKEL, V65, P904, DOI 10.1002/cm.20312; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ozgur S, 2011, J STRUCT BIOL, V174, P37, DOI 10.1016/j.jsb.2010.10.015; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; SCHWOB E, 1992, NATURE, V355, P179, DOI 10.1038/355179a0; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; THIERY JP, 1984, CELL DIFFER DEV, V15, P1, DOI 10.1016/0045-6039(84)90024-1; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Vitriol EA, 2007, P NATL ACAD SCI USA, V104, P6702, DOI 10.1073/pnas.0701801104; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wickramarachchi DC, 2010, AUTOIMMUNITY, V43, P64, DOI 10.3109/08916930903374634; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yae K, 2006, MOL CELL BIOL, V26, P6185, DOI 10.1128/MCB.00018-06; Zaki M, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-28	38	321	326	3	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					973	987		10.1016/j.cell.2011.12.034	http://dx.doi.org/10.1016/j.cell.2011.12.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385962	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000300985000017
J	Humphreys, K; Piot, P				Humphreys, Keith; Piot, Peter			Scientific evidence alone is not sufficient basis for health policy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HARMFULNESS; RANKING; SCALES; DRUGS		[Humphreys, Keith] Vet Affairs Med Ctr, Menlo Pk, CA 94025 USA; [Humphreys, Keith] Stanford Univ Med Ctr, Menlo Pk, CA 94025 USA; [Piot, Peter] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of London; London School of Hygiene & Tropical Medicine	Humphreys, K (corresponding author), Vet Affairs Med Ctr, VAPAHCS 152-MPD,795 Willow Rd, Menlo Pk, CA 94025 USA.	Keith.Humphreys@stanford.edu						ALLEN GE, 1989, GENOME, V31, P885, DOI 10.1139/g89-156; Caulkins JP, 2011, ADDICTION, V106, P1886, DOI 10.1111/j.1360-0443.2011.03461.x; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Donohue JJ, 2005, STANFORD LAW REV, V58, P791; Fischer B, 2011, ADDICTION, V106, P1891, DOI 10.1111/j.1360-0443.2011.03487.x; Humphreys K, 2010, PSYCHOL SERV, V7, P275, DOI 10.1037/a0020390; Kendler HH, 1999, AM PSYCHOL, V54, P828, DOI 10.1037/0003-066X.54.10.828; Knight L., 2008, 1 10 YEARS 1996 2006; Nutt D, 2011, ADDICTION, V106, P1892, DOI 10.1111/j.1360-0443.2011.03527.x; Obot IS, 2011, ADDICTION, V106, P1894, DOI 10.1111/j.1360-0443.2011.03560.x; Piot P, 2007, AM J PUBLIC HEALTH, V97, P1934, DOI 10.2105/AJPH.2007.121418; Proctor R.N., 2012, GOLDEN HOLOCAUST, DOI [10.1525/9780520950436, DOI 10.1525/9780520950436]; Room R, 2011, ADDICTION, V106, P1895, DOI 10.1111/j.1360-0443.2011.03548.x; Rossow I, 2011, ADDICTION, V106, P1893, DOI 10.1111/j.1360-0443.2011.03535.x; Roth-Cline MD, 2006, CIRCULATION, V113, P2253, DOI 10.1161/CIRCULATIONAHA.105.604512; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; The White House Office of National AIDS Policy, 2010, NAT HIV AIDS STRAT U; White House Office of National Drug Control Policy, 2010, NAT DRUG CONTR STRAT	18	35	35	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2012	344								e1316	10.1136/bmj.e1316	http://dx.doi.org/10.1136/bmj.e1316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904WO	22371864	Green Accepted			2022-12-28	WOS:000301229800009
J	Becker, T; Franckenberg, S; Wickles, S; Shoemaker, CJ; Anger, AM; Armache, JP; Sieber, H; Ungewickell, C; Berninghausen, O; Daberkow, I; Karcher, A; Thomm, M; Hopfner, KP; Green, R; Beckmann, R				Becker, Thomas; Franckenberg, Sibylle; Wickles, Stephan; Shoemaker, Christopher J.; Anger, Andreas M.; Armache, Jean-Paul; Sieber, Heidemarie; Ungewickell, Charlotte; Berninghausen, Otto; Daberkow, Ingo; Karcher, Annette; Thomm, Michael; Hopfner, Karl-Peter; Green, Rachel; Beckmann, Roland			Structural basis of highly conserved ribosome recycling in eukaryotes and archaea	NATURE			English	Article							MESSENGER-RNA DECAY; NO-GO DECAY; FREE PROTEIN-SYNTHESIS; X-RAY-STRUCTURE; ATP-BINDING; TRANSLATION TERMINATION; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; 80S RIBOSOME; THERMOCOCCUS-KODAKARAENSIS	Ribosome-driven protein biosynthesis is comprised of four phases: initiation, elongation, termination and recycling. In bacteria, ribosome recycling requires ribosome recycling factor and elongation factor G, and several structures of bacterial recycling complexes have been determined. In the eukaryotic and archaeal kingdoms, however, recycling involves the ABC-type ATPase ABCE1 and little is known about its structural basis. Here we present cryo-electron microscopy reconstructions of eukaryotic and archaeal ribosome recycling complexes containing ABCE1 and the termination factor paralogue Pelota. These structures reveal the overall binding mode of ABCE1 to be similar to canonical translation factors. Moreover, the iron-sulphur cluster domain of ABCE1 interacts with and stabilizes Pelota in a conformation that reaches towards the peptidyl transferase centre, thus explaining how ABCE1 may stimulate peptide-release activity of canonical termination factors. Using the mechanochemical properties of ABCE1, a conserved mechanism in archaea and eukaryotes is suggested that couples translation termination to recycling, and eventually to re-initiation.	[Becker, Thomas; Franckenberg, Sibylle; Wickles, Stephan; Anger, Andreas M.; Armache, Jean-Paul; Sieber, Heidemarie; Ungewickell, Charlotte; Berninghausen, Otto; Karcher, Annette; Hopfner, Karl-Peter; Beckmann, Roland] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany; [Becker, Thomas; Franckenberg, Sibylle; Wickles, Stephan; Anger, Andreas M.; Armache, Jean-Paul; Sieber, Heidemarie; Ungewickell, Charlotte; Berninghausen, Otto; Karcher, Annette; Hopfner, Karl-Peter; Beckmann, Roland] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci Munich CiPSM, D-81377 Munich, Germany; [Shoemaker, Christopher J.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Karcher, Annette] Tietz Video & Image Proc Syst GmbH, D-82131 Gauting, Germany; [Thomm, Michael] Univ Icking, D-82057 Icking, Germany; [Thomm, Michael] Univ Regensburg, Dept Microbiol, NWF Biol & Preclin Med 3, D-93053 Regensburg, Germany	University of Munich; University of Munich; Howard Hughes Medical Institute; Johns Hopkins University; University of Regensburg	Beckmann, R (corresponding author), Univ Munich, Dept Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	becker@lmb.uni-muenchen.de; beckmann@lmb.uni-muenchen.de	Armache, Jean-Paul/U-3113-2019; Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357; Armache, Jean-Paul/0000-0001-9195-2282	Deutsche Forschungsgemeinschaft [SFB594, SFB646]; National Institutes of Health [U19 AI083025]; Fonds der chemischen Industrie; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Schele and A. Gilmozzi for technical assistance, and D. Wilson for critical discussions. This work was supported by grants from the Deutsche Forschungsgemeinschaft, SFB594 (to R. B.), SFB646 (to T. B., R. B. and K.-P. H.), National Institutes of Health U19 AI083025 (to K.-P. H.) and by the Fonds der chemischen Industrie (to S.F.).	Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; Barthelme D, 2011, P NATL ACAD SCI USA, V108, P3228, DOI 10.1073/pnas.1015953108; Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Chen LM, 2010, NAT STRUCT MOL BIOL, V17, P1233, DOI 10.1038/nsmb.1922; Coelho CMA, 2005, DEVELOPMENT, V132, P5411, DOI 10.1242/dev.02148; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endoh T, 2008, J BIOTECHNOL, V133, P177, DOI 10.1016/j.jbiotec.2007.08.036; Endoh T, 2007, APPL MICROBIOL BIOT, V74, P1153, DOI 10.1007/s00253-006-0753-3; Endoh T, 2006, J BIOTECHNOL, V126, P186, DOI 10.1016/j.jbiotec.2006.04.010; Estevez AM, 2004, MOL BIOCHEM PARASIT, V133, P137, DOI 10.1016/j.molbiopara.2003.09.009; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Karcher A, 2005, STRUCTURE, V13, P649, DOI 10.1016/j.str.2005.02.008; Karcher A, 2008, J BIOL CHEM, V283, P7962, DOI 10.1074/jbc.M707347200; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540	56	170	174	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					501	U221		10.1038/nature10829	http://dx.doi.org/10.1038/nature10829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358840	Green Accepted			2022-12-28	WOS:000300770500045
J	Ingleby, D; McKee, M; Mladovsky, P; Rechel, B				Ingleby, David; McKee, Martin; Mladovsky, Philipa; Rechel, Bernd			How the NHS measures up to other health systems	BRITISH MEDICAL JOURNAL			English	Editorial Material							INCOME		[McKee, Martin; Mladovsky, Philipa; Rechel, Bernd] European Observ Hlth Syst & Policies, London, England; [Ingleby, David] Univ Utrecht, Fac Social & Behav Sci, NL-3508 TC Utrecht, Netherlands; [McKee, Martin; Rechel, Bernd] London Sch Hyg & Trop Med, London WC1, England; [Mladovsky, Philipa] Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England	European Observatory on Health Systems & Policies; Utrecht University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science	McKee, M (corresponding author), European Observ Hlth Syst & Policies, London, England.	Martin.McKee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Mladovsky, Philipa/AAN-2264-2020	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Mladovsky, Philipa/0000-0001-7761-6928; Rechel, Bernd/0000-0001-8020-3956				Capocaccia R, 2003, ANN ONCOL, V14, pV14, DOI 10.1093/annonc/mdg751; *COMM FUND, 2010, 2010 COMM FUND INT H; Databriefing Appleby J., 2011, BMJ-BRIT MED J, V342, pd1836; Macmillan Cancer Support, 2011, LIV DIAGN MED CANC S; Mariotto A, 2002, CANCER CAUSE CONTROL, V13, P101, DOI 10.1023/A:1014380323037; Nolte E, 2011, HEALTH POLICY, V103, P47, DOI 10.1016/j.healthpol.2011.08.002; OECD, 2011, HLTH GLANC 2011 OECD; Schoen C, 2011, HEALTH AFFAIR, V30, P2437, DOI 10.1377/hlthaff.2011.0923; Schoen C, 2010, HEALTH AFFAIR, V29, P2323, DOI 10.1377/hlthaff.2010.0862; Thomson S, 2011, INT PROFILES HLTH CA; Woods LM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3399	12	10	10	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2012	344								e1079	10.1136/bmj.e1079	http://dx.doi.org/10.1136/bmj.e1079			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JQ	22362113	Green Accepted, Green Submitted			2022-12-28	WOS:000300883600012
J	Wirostko, BM; Tressler, C; Hwang, LJ; Burgess, G; Laties, AM				Wirostko, Barbara M.; Tressler, Charles; Hwang, Lie-Ju; Burgess, Gary; Laties, Alan M.			Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ISCHEMIC OPTIC NEUROPATHY; PHOSPHODIESTERASE TYPE-5; NITRIC-OXIDE; RETINAL VASODILATATION; INTRAOCULAR-PRESSURE; CONTRAST SENSITIVITY; UVEAL EFFUSION; 5 INHIBITORS; VIAGRA; EXPRESSION	Objective To assess the ocular effects and safety profile of chronic sildenafil oral dosing in patients with pulmonary arterial hypertension. Design 12 week, double masked, randomised, placebo controlled, phase III trial with open label extension. Setting 53 institutions worldwide. Participants 277 adults with idiopathic pulmonary arterial hypertension or pulmonary arterial hypertension associated with connective tissue disease or after congenital heart disease repair (mean pulmonary artery pressure >= 25 mm Hg; pulmonary capillary wedge pressure <= 15 mm Hg at rest). Interventions During the double masked study, oral sildenafil 20 mg, 40 mg, or 80 mg or placebo (1: 1: 1: 1) three times daily for 12 weeks was added to baseline drug treatment. In the extension study, the placebo, 20 mg and 40 mg groups received 40 mg three times daily titrated to 80 mg three times daily at week 6. After unmasking, the dose was titrated according to clinical need. Main outcome measure Ocular safety (ocular examinations, visual function tests, participants' reports of adverse events, and visual disturbance questionnaire completed by investigators) by treatment group at 12 weeks, 24 weeks, 18 months, and yearly. Results Findings of the objective assessments-that is, intraocular pressure and visual function tests (visual acuity, colour vision, and visual field)-were similar across groups (20 mg, n=69; 40 mg, n=67; 80 mg, n=71; placebo, n=70). No clinically significant changes occurred between baseline and 12 weeks, except for an efficacy signal in contrast sensitivity for the sildenafil 40 mg three times daily group. In right eyes, changes in intraocular pressure from baseline to week 12 ranged from a mean of -0.5 (95% confidence interval -1.3 to 0.2) mm Hg with placebo, -0.2 (-0.9 to 0.5) mm Hg with sildenafil 40 mg, and -0.1 (-0.7 to 0.5) mm Hg with 80 mg to 0.3 (-0.4 to 0.9) mm Hg with sildenafil 20 mg (the approved dose for pulmonary arterial hypertension). Mean changes from baseline to week 12 in contrast sensitivity in right eyes were -0.02 (SD 0.12) in the sildenafil 20 mg three times daily group compared with -0.05 (0.18) in the placebo group (P=0.044). Percentages of participants with deterioration in visual acuity (Snellen) from baseline to week 12 ranged from 10% (n=7) in the placebo group to 3% (n=2) in the sildenafil 20 mg three times daily group; the same percentages had visual field changes from normal to abnormal during the period in these two groups. The investigators did not deem any findings on colour vision assessment to be clinically significant. Findings of the objective assessments in the 40 mg and 80 mg three times daily sildenafil treatment groups and in left eyes were not substantially different, nor were any measures different throughout the open label extension compared with week 12. However, objective data were limited after month 18, as most participants had missing data or visual parameters were no longer collected by investigators. Incidence of ocular adverse events reported on the case report forms and assessed by the investigator was low with all doses, but a modest, dose related incidence of chromatopsia, cyanopsia, photophobia, and visual disturbance was reported with 80 mg three times daily consistent with the indicated dosing for erectile dysfunction. Retinal haemorrhages, captured on funduscopy, occurred in 2% (4/207) of sildenafil treated participants and none in the placebo group during the double masked study and in 4% (10/259) during the open label extension. Conclusions Sildenafil dosing up to 80 mg three times daily is safe and well tolerated from an ocular perspective in patients with pulmonary arterial hypertension. Daily chronic dosing in this patient population was not associated with visual change and had no detrimental effect on best corrected visual acuity, contrast sensitivity, colour vision, or visual field, or on slit lamp examinations, funduscopy, or intraocular pressure during the duration of this study.	[Wirostko, Barbara M.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Tressler, Charles] Pfizer Inc, SSRM Neurosci & Pain, New York, NY 10017 USA; [Hwang, Lie-Ju] Pfizer Inc, Ophthalmol, New York, NY 10017 USA; [Burgess, Gary] Pfizer UK, Asia R&D, Sandwich CT13 9AH, Kent, England; [Laties, Alan M.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Sch Med, Philadelphia, PA 19104 USA	Utah System of Higher Education; University of Utah; Pfizer; Pfizer; Pfizer; University of Pennsylvania; Pennsylvania Medicine	Wirostko, BM (corresponding author), Univ Utah, Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	barbara.wirostko@gmail.com			Pfizer UK, Sandwich, UK; Pfizer Inc, New York, NY, USA; Pfizer Inc	Pfizer UK, Sandwich, UK; Pfizer Inc, New York, NY, USA(Pfizer); Pfizer Inc(Pfizer)	This study was sponsored by Pfizer UK, Sandwich, UK. Editorial support, including contributing to the first draft of the manuscript, revising the paper on the basis of authors' feedback, and styling the paper for journal submission, was provided by Jane G Murphy of Zola Associates and was funded by Pfizer Inc, New York, NY, USA.; All authors have completed the ICMJE unified disclosure form at www.icmje.org/coi_disclosure.pdf and declare that BMW, previously an employee of Pfizer Inc, had support from Pfizer Inc for the submitted work; CT, L-JH, and GB, currently employees of Pfizer Inc, had support from Pfizer Inc for the submitted work; and AML, as a consultant for Pfizer Inc in the study conduct and in data analysis and interpretation, had support from Pfizer Inc for the submitted work. Ethical approval: Local institutional review boards or independent ethics committees approved the study protocol. All participants gave written informed consent.	Acaroglu G, 2006, NEURO-OPHTHALMOLOGY, V30, P117, DOI 10.1080/01658100600981063; Akduman L, 1996, AM J OPHTHALMOL, V121, P578, DOI 10.1016/S0002-9394(14)75439-X; Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473; Arevalo J Fernando, 2002, Curr Opin Ophthalmol, V13, P404, DOI 10.1097/00055735-200212000-00011; Becker RC, 2005, INVEST OPHTH VIS SCI, V46; Bertolucci A, 2003, ACTA OPHTHALMOL SCAN, V81, P198, DOI 10.1034/j.1600-0420.2003.00044.x; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; Cordell WH, 2009, ARCH OPHTHALMOL-CHIC, V127, P367, DOI 10.1001/archophthalmol.2009.36; Donahue SP, 1998, AM J OPHTHALMOL, V126, P476, DOI 10.1016/S0002-9394(98)00243-8; Dundar SO, 2001, EYE, V15, P507, DOI 10.1038/eye.2001.163; Foresta C, 2008, EYE, V22, P144, DOI 10.1038/sj.eye.6702908; Fraunfelder FW, 2008, RETINA-J RET VIT DIS, V28, P606, DOI 10.1097/IAE.0b013e31815ec2c8; Gabrieli CB, 2001, OPHTHALMOLOGY, V108, P877, DOI 10.1016/S0161-6420(00)00648-5; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2006, NEW ENGL J MED, V354, P2400, DOI [DOI 10.1056/NEJMOA050010, 10.1056/NEJMoa050010]; Gerometta R, 2010, INVEST OPHTH VIS SCI, V51, P3139, DOI 10.1167/iovs.09-4862; GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403; Gorkin L, 2006, INT J CLIN PRACT, V60, P500, DOI 10.1111/j.1368-5031.2006.00904.x; Grunwald JE, 2002, AM J OPHTHALMOL, V133, P809, DOI 10.1016/S0002-9394(02)01391-0; Grunwald JE, 2001, AM J OPHTHALMOL, V131, P751, DOI 10.1016/S0002-9394(00)00944-2; Hammond CJ, 1998, ARCH OPHTHALMOL-CHIC, V116, P1535; Harris A, 2008, BRIT J OPHTHALMOL, V92, P469, DOI 10.1136/bjo.2007.131789; Harris A, 1996, BRIT J OPHTHALMOL, V80, P209, DOI 10.1136/bjo.80.3.209; Hattenhauer MG, 1997, AM J OPHTHALMOL, V123, P103, DOI 10.1016/S0002-9394(14)70999-7; Hayreh SS, 2008, BRIT J OPHTHALMOL, V92, P1577, DOI 10.1136/bjo.2008.149013; Holland GN, 2010, AM J OPHTHALMOL, V149, P807, DOI 10.1016/j.ajo.2009.12.019; Jagle H, 2004, AM J OPHTHALMOL, V137, P842, DOI 10.1016/j.ajo.2003.11.081; JOHNSON LN, 1994, J NEURO-OPHTHALMOL, V14, P38; Kerr NM, 2009, CLIN EXP OPHTHALMOL, V37, P514, DOI 10.1111/j.1442-9071.2009.02070.x; Koksal M, 2005, ACTA OPHTHALMOL SCAN, V83, P355, DOI 10.1111/j.1600-0420.2005.00422.x; Krohn J, 2003, AM J OPHTHALMOL, V135, P705, DOI 10.1016/S0002-9394(02)02090-1; Laties A, 2006, J SEX MED, V3, P12, DOI 10.1111/j.1743-6109.2005.00194.x; Laties A EP, 1998, OPHTHALMIC RES, V30, P177; Laties AM, 2009, DRUG SAFETY, V32, P1, DOI 10.2165/00002018-200932010-00001; Laties AM, 2002, PROG RETIN EYE RES, V21, P485, DOI 10.1016/S1350-9462(02)00013-7; Laties AM, 1999, INVEST OPHTH VIS SCI, V40, pS693; Luu JK, 2001, AM J OPHTHALMOL, V132, P388, DOI 10.1016/S0002-9394(01)01052-2; McCulley TJ, 2002, OPHTHALMOLOGICA, V216, P455, DOI 10.1159/000067549; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Metelitsina TI, 2006, EXP EYE RES, V83, P128, DOI 10.1016/j.exer.2005.11.012; Metelitsina TI, 2005, EXP EYE RES, V81, P159, DOI 10.1016/j.exer.2005.01.017; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Murray F, 2002, BRIT J PHARMACOL, V137, P1187, DOI 10.1038/sj.bjp.0704984; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Pache M, 2002, BRIT J OPHTHALMOL, V86, P156, DOI 10.1136/bjo.86.2.156; Paris Gianmarco, 2001, International Ophthalmology, V23, P355, DOI 10.1023/A:1014410932321; Pfizer, 2011, VIAGR PRESCR INF; Polak K, 2003, INVEST OPHTH VIS SCI, V44, P4872, DOI 10.1167/iovs.03-0177; Pomeranz HD, 2002, OPHTHALMOLOGY, V109, P584, DOI 10.1016/S0161-6420(01)00976-9; Read RW, 2004, OCUL IMMUNOL INFLAMM, V12, P87, DOI 10.1080/09273940490895308; Saran BR, 2001, RETINA-J RET VIT DIS, V21, P34, DOI 10.1097/00006982-200102000-00006; Sawada N, 2009, MOL CELL BIOL, V29, P6018, DOI 10.1128/MCB.00225-09; SCHEIDER A, 1991, Fortschritte der Ophthalmologie, V88, P346; Sebkhi A, 2003, CIRCULATION, V107, P3230, DOI 10.1161/01.CIR.0000074226.20466.B1; Tripathi A, 2000, BRIT J OPHTHALMOL, V84, P934; VANCAMP G, 1990, CHEST, V98, P1543, DOI 10.1378/chest.98.6.1543b; Wallis R, 1998, OPHTHAL RES S1, V30, P68; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Xu L, 2007, EUR J OPHTHALMOL, V17, P459, DOI 10.1177/112067210701700335; Yajima T, 2000, AM J OPHTHALMOL, V129, P675, DOI 10.1016/S0002-9394(00)00375-5; Zoumalan CI, 2009, DOC OPHTHALMOL, V118, P225, DOI 10.1007/s10633-008-9148-3	62	35	35	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2012	344								e554	10.1136/bmj.e554	http://dx.doi.org/10.1136/bmj.e554			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	900JG	22354598	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000300882500027
J	Dove, CJ; Straker, LC				Dove, Carla J.; Straker, Lorian C.			Comment on "A Diverse Assemblage of Late Cretaceous Dinosaur and Bird Feathers from Canadian Amber"	SCIENCE			English	Editorial Material							THEROPOD DINOSAUR; SINOSAUROPTERYX; CHINA		[Dove, Carla J.; Straker, Lorian C.] Smithsonian Inst, Natl Museum Nat Hist, Div Birds, Washington, DC 20013 USA; [Straker, Lorian C.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21949900 Rio De Janeiro, Brazil	Smithsonian Institution; Smithsonian National Museum of Natural History; Universidade Federal do Rio de Janeiro	Dove, CJ (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Div Birds, MRC 116,POB 37102, Washington, DC 20013 USA.	dovec@si.edu	Straker, Lorian Cobra/J-5560-2016	Straker, Lorian Cobra/0000-0001-8431-7897				Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Lingham-Soliar T, 2007, P ROY SOC B-BIOL SCI, V274, P1823, DOI 10.1098/rspb.2007.0352; McKellar RC, 2011, SCIENCE, V333, P1619, DOI 10.1126/science.1203344; Prum RO, 1999, J EXP ZOOL, V285, P291	5	5	5	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070								10.1126/science.1216208	http://dx.doi.org/10.1126/science.1216208			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344430				2022-12-28	WOS:000300356400020
J	Lujambio, A; Lowe, SW				Lujambio, Amaia; Lowe, Scott W.			The microcosmos of cancer	NATURE			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; POSTTRANSCRIPTIONAL REGULATION; MICRORNA EXPRESSION; ACTIVATED MICRORNA; TUMOR SUPPRESSORS; RNA INTERFERENCE; P53 NETWORK; LUNG-CANCER; MYC	The discovery of microRNAs (miRNAs) almost two decades ago established a new paradigm of gene regulation. During the past ten years these tiny non-coding RNAs have been linked to virtually all known physiological and pathological processes, including cancer. In the same way as certain key protein-coding genes, miRNAs can be deregulated in cancer, in which they can function as a group to mark differentiation states or individually as bona fide oncogenes or tumour suppressors. Importantly, miRNA biology can be harnessed experimentally to investigate cancer phenotypes or used therapeutically as a target for drugs or as the drug itself.	[Lujambio, Amaia; Lowe, Scott W.] MSKCC, Canc Biol & Genet Program, New York, NY 10065 USA; [Lowe, Scott W.] MSKCC, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), MSKCC, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10065 USA.	lowes@mskcc.org		Lujambio, Amaia/0000-0002-2798-1481	EMBO; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016379] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We apologize to all colleagues whose work could not be cited owing to space restrictions. We thank L. Dow, A. Ventura, A. Saborowski and V. Aranda for their comments on the manuscript, and G. Hannon and L. He for the many discussions. A. L. is supported by an EMBO Long-Term Fellowship. S. W. L. is a Howard Hughes Medical Institute investigator.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bueno MJ, 2011, BLOOD, V117, P6255, DOI 10.1182/blood-2010-10-315432; Bui Thi V, 2010, Genes Cancer, V1, P568; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gumireddy K, 2008, ANGEW CHEM INT EDIT, V47, P7482, DOI 10.1002/anie.200801555; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Melo S, 2011, P NATL ACAD SCI USA, V108, P4394, DOI 10.1073/pnas.1014720108; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Veronese A, 2011, P NATL ACAD SCI USA, V108, P4840, DOI 10.1073/pnas.1101734108; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xiao JN, 2011, EMBO J, V30, P524, DOI 10.1038/emboj.2010.347; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	100	868	914	4	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					347	355		10.1038/nature10888	http://dx.doi.org/10.1038/nature10888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337054	Green Accepted			2022-12-28	WOS:000300287100036
J	Lee, JY; Jameson, SC				Lee, June-Yong; Jameson, Stephen C.			Remembering to Be Tolerant	SCIENCE			English	Editorial Material							IMMUNOTHERAPY; MIR-181A; ANTIGEN		[Lee, June-Yong; Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Sch Med, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities	Lee, JY (corresponding author), Univ Minnesota, Ctr Immunol, Sch Med, Minneapolis, MN 55414 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Lee, June-Yong/0000-0002-4476-725X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038903] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI038903] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Datta S, 2009, TRENDS IMMUNOL, V30, P430, DOI 10.1016/j.it.2009.06.002; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Klebanoff CA, 2005, TRENDS IMMUNOL, V26, P111, DOI 10.1016/j.it.2004.12.003; Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Ohlen C, 2002, J EXP MED, V195, P1407, DOI 10.1084/jem.20011063; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359	10	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					667	668		10.1126/science.1218927	http://dx.doi.org/10.1126/science.1218927			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323808				2022-12-28	WOS:000300047100038
J	Nogaro, MC; Pournaras, DJ; Prasannan, C; Chaudhuri, A				Nogaro, M-C; Pournaras, D. J.; Prasannan, C.; Chaudhuri, A.			10-MINUTE CONSULTATION Varicose veins	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nogaro, M-C; Pournaras, D. J.; Prasannan, C.; Chaudhuri, A.] Bedford Hosp NHS Trust, Bedford MK42 9DJ, England		Nogaro, MC (corresponding author), Bedford Hosp NHS Trust, Kempston Rd, Bedford MK42 9DJ, England.	marie.nogaro02@imperial.ac.uk	Chaudhuri, Arindam/X-1878-2019	Chaudhuri, Arindam/0000-0002-0452-0682				Bradbury A, 1999, BRIT MED J, V318, P353, DOI 10.1136/bmj.318.7180.353; Campbell B, 2006, BMJ-BRIT MED J, V333, P287, DOI 10.1136/bmj.333.7562.287; Gohel MS, 2007, BMJ-BRIT MED J, V335, P83, DOI 10.1136/bmj.39216.542442.BE; London NJM, 2000, BMJ-BRIT MED J, V320, P1391, DOI 10.1136/bmj.320.7246.1391; National Institute for Health and Clinical Excellence, 2001, REF ADV VAR VEINS	5	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2012	344								e667	10.1136/bmj.e667	http://dx.doi.org/10.1136/bmj.e667			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IH	22323510				2022-12-28	WOS:000300279400008
J	Hansen, MC; Potapov, PV; Moore, R; Hancher, M; Turubanova, SA; Tyukavina, A; Thau, D; Stehman, SV; Goetz, SJ; Loveland, TR; Kommareddy, A; Egorov, A; Chini, L; Justice, CO; Townshend, JRG				Hansen, M. C.; Potapov, P. V.; Moore, R.; Hancher, M.; Turubanova, S. A.; Tyukavina, A.; Thau, D.; Stehman, S. V.; Goetz, S. J.; Loveland, T. R.; Kommareddy, A.; Egorov, A.; Chini, L.; Justice, C. O.; Townshend, J. R. G.			High-Resolution Global Maps of 21st-Century Forest Cover Change	SCIENCE			English	Article							DEFORESTATION; TRANSITION; EMISSIONS	Quantification of global forest change has been lacking despite the recognized importance of forest ecosystem services. In this study, Earth observation satellite data were used to map global forest loss (2.3 million square kilometers) and gain (0.8 million square kilometers) from 2000 to 2012 at a spatial resolution of 30 meters. The tropics were the only climate domain to exhibit a trend, with forest loss increasing by 2101 square kilometers per year. Brazil's well-documented reduction in deforestation was offset by increasing forest loss in Indonesia, Malaysia, Paraguay, Bolivia, Zambia, Angola, and elsewhere. Intensive forestry practiced within subtropical forests resulted in the highest rates of forest change globally. Boreal forest loss due largely to fire and forestry was second to that in the tropics in absolute and proportional terms. These results depict a globally consistent and locally relevant record of forest change.	[Hansen, M. C.; Potapov, P. V.; Turubanova, S. A.; Tyukavina, A.; Chini, L.; Justice, C. O.; Townshend, J. R. G.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Moore, R.; Hancher, M.; Thau, D.] Google, Mountain View, CA USA; [Stehman, S. V.] SUNY Syracuse, Dept Forest & Nat Resources Management, Syracuse, NY USA; [Goetz, S. J.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Loveland, T. R.] US Geol Survey, Sioux Falls, SD 57198 USA; [Kommareddy, A.; Egorov, A.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA	University System of Maryland; University of Maryland College Park; Google Incorporated; State University of New York (SUNY) System; Woods Hole Research Center; United States Department of the Interior; United States Geological Survey; South Dakota State University	Hansen, MC (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	mhansen@umd.edu	Noojipady, Praveen/B-2511-2010; Tyukavina, Alexandra/AGW-0785-2022; potapov, peter/AAE-7388-2019; Goetz, Scott J/A-3393-2015; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLT-1531-2022; Loveland, Thomas/AAW-3332-2020; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022; Hansen, Matthew C/ABE-7226-2020	Goetz, Scott J/0000-0002-6326-4308; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Tyukavina, Alexandra/0000-0003-3872-9844; Jo, Euijung/0000-0003-1131-2723; Potapov, Peter/0000-0003-3977-0021	NASA [NNH05ZDA001N, NNH07ZDA001N, NNX12AB43G, NNX12AC78G, NNX08AP33A, NNG06GD95G]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074564, R01AI055509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for Landsat data analysis and characterization was provided by the Gordon and Betty Moore Foundation, the United States Geological Survey, and Google, Inc. GLAS data analysis was supported by the David and Lucile Packard Foundation. Development of all methods was supported by NASA through its Land Cover and Land Use Change, Terrestrial Ecology, Applied Sciences, and MEaSUREs programs (grants NNH05ZDA001N, NNH07ZDA001N, NNX12AB43G, NNX12AC78G, NNX08AP33A, and NNG06GD95G) and by the U.S. Agency for International Development through its CARPE program. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U. S. government. Results are depicted and viewable online at full resolution: http://earthenginepartners.appspot.com/science-2013-global-forest.	Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Edwards DP, 2011, NATURE, V477, P33, DOI 10.1038/477033a; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Food and Agricultural Organization of the United Nations, 2012, 169 FAO; Gardiner B., 2010, Destructive storms in European forests: past and forthcoming impacts; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hansen MC, 2004, ECOSYSTEMS, V7, P695, DOI 10.1007/s10021-004-0243-3; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Houghton R., 2001, CARBON MANAG, V1, P253; Instituto Nacional de Pesquisas Especias, 2013, MON BRAZ AM FOR SAT; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Potapov P, 2008, REMOTE SENS ENVIRON, V112, P3708, DOI 10.1016/j.rse.2008.05.006; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Prishchepov AV, 2013, LAND USE POLICY, V30, P873, DOI 10.1016/j.landusepol.2012.06.011; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rudel TK, 1998, RURAL SOCIOL, V63, P533, DOI 10.1111/j.1549-0831.1998.tb00691.x; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; United Nations Framework Convention on Climate Change, 2005, RED EM DEF DEV COUNT; Waterworth RM, 2007, FOREST ECOL MANAG, V238, P231, DOI 10.1016/j.foreco.2006.10.014	23	6084	6344	172	613	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					850	853		10.1126/science.1244693	http://dx.doi.org/10.1126/science.1244693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	22344443				2022-12-28	WOS:000326923000036
J	Butler, CC; Simpson, SA; Dunstan, F; Rollnick, S; Cohen, D; Gillespie, D; Evans, MR; Alam, MF; Bekkers, MJ; Evans, J; Moore, L; Howe, R; Hayes, J; Hare, M; Hood, K				Butler, Christopher C.; Simpson, Sharon A.; Dunstan, Frank; Rollnick, Stephen; Cohen, David; Gillespie, David; Evans, Meirion R.; Alam, M. Fasihul; Bekkers, Marie-Jet; Evans, John; Moore, Laurence; Howe, Robin; Hayes, Jamie; Hare, Monika; Hood, Kerenza			Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS; COMMUNICATION-SKILLS; SORE THROAT; RESISTANCE; INTERVENTIONS; STRATEGIES; COMMUNITY; OUTCOMES; QUALITY; CONSULTATIONS	Objective To evaluate the effectiveness and costs of a multifaceted flexible educational programme aimed at reducing antibiotic dispensing at the practice level in primary care. Design Randomised controlled trial with general practices as the unit of randomisation and analysis. Clinicians and researchers were blinded to group allocation until after randomisation. Setting 68 general practices with about 480 000 patients in Wales, United Kingdom. Participants 34 practices were randomised to receive the educational programme and 34 practices to be controls. 139 clinicians from the intervention practices and 124 from control practices had agreed to participate before randomisation. Practice level data covering all the clinicians in the 68 practices were analysed. Interventions Intervention practices followed the Stemming the Tide of Antibiotic Resistance (STAR) educational programme, which included a practice based seminar reflecting on the practices' own dispensing and resistance data, online educational elements, and practising consulting skills in routine care. Control practices provided usual care. Main outcome measures Total numbers of oral antibiotic items dispensed for all causes per 1000 practice patients in the year after the intervention, adjusted for the previous year's dispensing. Secondary outcomes included reconsultations, admissions to hospital for selected causes, and costs. Results The rate of oral antibiotic dispensing (items per 1000 registered patients) decreased by 14.1 in the intervention group but increased by 12.1 in the control group, a net difference of 26.1. After adjustment for baseline dispensing rate, this amounted to a 4.2% (95% confidence interval 0.6% to 7.7%) reduction in total oral antibiotic dispensing for the year in the intervention group relative to the control group (P=0.02). Reductions were found for all classes of antibiotics other than penicillinase-resistant penicillins but were largest and significant individually for phenoxymethylpenicillins (penicillin V) (7.3%, 0.4% to 13.7%) and macrolides (7.7%, 1.1% to 13.8%). There were no significant differences between intervention and control practices in the number of admissions to hospital or in reconsultations for a respiratory tract infection within seven days of an index consultation. The mean cost of the programme was 2923 pound ((sic)3491, $4572) per practice (SD 1187) pound. There was a 5.5% reduction in the cost of dispensed antibiotics in the intervention group compared with the control group (-0.4% to 11.4%), equivalent to a reduction of about 830 pound a year for an average intervention practice. Conclusion The STAR educational programme led to reductions in all cause oral antibiotic dispensing over the subsequent year with no significant change in admissions to hospital, reconsultations, or costs.	[Butler, Christopher C.; Simpson, Sharon A.; Dunstan, Frank; Rollnick, Stephen; Gillespie, David; Evans, Meirion R.; Bekkers, Marie-Jet; Evans, John; Hare, Monika; Hood, Kerenza] Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF14 4XN, S Glam, Wales; [Simpson, Sharon A.; Gillespie, David; Bekkers, Marie-Jet; Evans, John; Hare, Monika; Hood, Kerenza] Cardiff Univ, Sch Med, S E Wales Trials Unit, Cardiff CF14 4XN, S Glam, Wales; [Cohen, David; Alam, M. Fasihul] Univ Glamorgan, Hlth Econ & Policy Res Unit, Pontypridd CF37 1DL, M Glam, Wales; [Moore, Laurence] Cardiff Univ, Sch Social Sci, Cardiff Inst Soc & Hlth, Cardiff CF14 4XN, S Glam, Wales; [Howe, Robin] Univ Wales Hosp, Natl Publ Hlth Serv Microbiol Cardiff Velindre NH, Cardiff CF4 4XW, S Glam, Wales; [Hayes, Jamie] Univ Hosp Llandough, Acad Ctr, Welsh Med Resource Ctr WeMeReC, Penarth, S Glam, Wales	Cardiff University; Cardiff University; University of South Wales; Cardiff University; Cardiff University	Butler, CC (corresponding author), Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF14 4XN, S Glam, Wales.	butlercc@cf.ac.uk	Hood, Kerenza/C-2528-2008; Alam, M Fasihul/AAD-7268-2020; Evans, Meirion/C-2990-2008	Hood, Kerenza/0000-0002-5268-8631; Alam, M Fasihul/0000-0003-2590-851X; Gillespie, David/0000-0002-6934-2928; Simpson, Sharon Anne/0000-0002-6219-1768; Moore, Laurence/0000-0003-2182-823X; Evans, Meirion/0000-0003-3578-1866; Butler, Christopher/0000-0002-0102-3453	UK Medical Research Council [G0500956]; National Institute for Health and Social care Research; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0500956] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0500956] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health and Social care Research; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the UK Medical Research Council (G0500956). The South East Wales Trials Unit is funded by the National Institute for Health and Social care Research, which also provide service support costs.	Ahovuo-Saloranta A, 2008, COCHRANE DB SYST REV, V2; Alam MF, 2009, INT J ANTIMICROB AG, V33, P255, DOI 10.1016/j.ijantimicag.2008.08.027; Arnold SR, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003539.PUB2; Arroll B, 2006, BMJ-BRIT MED J, V333, P279, DOI 10.1136/bmj.38891.681215.AE; Ball P, 2002, J ANTIMICROB CHEMOTH, V49, P31, DOI 10.1093/jac/49.1.31; Bekkers MJ, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-34; [British Medical Association Royal Pharmaceutical Society of Great Britain], 2007, BRIT NAT FORM; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Butler CC, 1998, BRIT J GEN PRACT, V48, P1865; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Butler CC, 2001, J ANTIMICROB CHEMOTH, V48, P435, DOI 10.1093/jac/48.3.435; Butler CC, 2007, BRIT J GEN PRACT, V57, P785; Butler CC, 2006, BRIT J GEN PRACT, V56, P686; Cals JWL, 2007, PATIENT EDUC COUNS, V68, P270, DOI 10.1016/j.pec.2007.06.014; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Carter BR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-65; Coenen S, 2001, LANCET, V358, P1272, DOI 10.1016/S0140-6736(01)06364-4; Cosby JL, 2007, LANCET INFECT DIS, V7, P749, DOI 10.1016/S1473-3099(07)70263-3; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Curtis L., 2008, UNIT COSTS HLTH SOCI; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Del Mar CB, 2006, COCHRANE DB SYST REV, V4, DOI 10.1002/14651858.cd000023; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Eldridge S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4006; Finch RG, 2004, LANCET INFECT DIS, V4, P44, DOI 10.1016/S1473-3099(03)00860-0; Foy R, 2002, J CLIN EPIDEMIOL, V55, P717, DOI 10.1016/S0895-4356(02)00403-1; Francis NA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2885; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Grol R, 2002, QUAL SAF HEALTH CARE, V11, P110, DOI 10.1136/qhc.11.2.110; Guillemot D, 2005, CLIN INFECT DIS, V41, P930, DOI 10.1086/432721; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Lambert MF, 2007, J ANTIMICROB CHEMOTH, V59, P537, DOI 10.1093/jac/dkl511; Little P, 1997, BRIT MED J, V315, P350; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Martens JD, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-145; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McNulty CAM, 2010, J ANTIMICROB CHEMOTH, V65, P1526, DOI 10.1093/jac/dkq126; Meropol SB, 2009, BRIT J GEN PRACT, V59, P735, DOI 10.3399/bjgp09X472610; OBRIEN MAT, 2000, COCHRANE DB SYST REV, V2; Ostini R, 2009, ANN PHARMACOTHER, V43, P502, DOI 10.1345/aph.1L488; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Ranji SR, 2008, MED CARE, V46, P847, DOI 10.1097/MLR.0b013e318178eabd; Rollnick S, 2002, MED EDUC, V36, P678, DOI 10.1046/j.1365-2923.2002.01255.x; Rollnick S, 2002, MED EDUC, V36, P377, DOI 10.1046/j.1365-2923.2002.01174.x; Rollnick S., 2008, MOTIVATIONAL INTERVI; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; Schiff GD, 2009, JAMA-J AM MED ASSOC, V301, P865, DOI 10.1001/jama.2009.195; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Simpson SA, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-20; Smith SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000245.pub2, 10.1002/14651858.CD000245, DOI 10.1002/14651858.CD000245.PUB2]; Thompson PL, 2009, ARCH DIS CHILD, V94, P337, DOI 10.1136/adc.2008.147579; van Driel ML, 2007, QUAL SAF HEALTH CARE, V16, P197, DOI 10.1136/qshc.2006.018663; Venekamp RP, 2015, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000219.PUB4, 10.1002/14651858.CD000219.pub4]; Welschen I, 2004, BRIT MED J, V329, P431, DOI 10.1136/bmj.38182.591238.EB; Wood F, 2007, FAM PRACT, V24, P427, DOI 10.1093/fampra/cmm040; Xiao L, 2011, CLIN TRIALS, V8, P59, DOI 10.1177/1740774510391683	57	175	176	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2012	344								d8173	10.1136/bmj.d8173	http://dx.doi.org/10.1136/bmj.d8173			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889QO	22302780	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000300088500002
J	Quintero, E; Castells, A; Bujanda, L; Cubiella, J; Salas, D; Lanas, A; Andreu, M; Carballo, F; Morillas, JD; Hernandez, C; Jover, R; Montalvo, I; Arenas, J; Laredo, E; Hernandez, V; Iglesias, F; Cid, E; Zubizarreta, R; Sala, T; Ponce, M; Andres, M; Teruel, G; Peris, A; Roncales, MP; Polo-Tomas, M; Bessa, X; Ferrer-Armengou, O; Grau, J; Serradesanferm, A; Ono, A; Cruzado, J; Perez-Riquelme, F; Alonso-Abreu, I; de la Vega-Prieto, M; Reyes-Melian, JM; Cacho, G; Diaz-Tasende, J; Herreros-de-Tejada, A; Poves, C; Santander, C; Gonzalez-Navarro, A				Quintero, Enrique; Castells, Antoni; Bujanda, Luis; Cubiella, Joaquin; Salas, Dolores; Lanas, Angel; Andreu, Montserrat; Carballo, Fernando; Diego Morillas, Juan; Hernandez, Cristina; Jover, Rodrigo; Montalvo, Isabel; Arenas, Juan; Laredo, Eva; Hernandez, Vicent; Iglesias, Felipe; Cid, Estela; Zubizarreta, Raquel; Sala, Teresa; Ponce, Marta; Andres, Mercedes; Teruel, Gloria; Peris, Antonio; Roncales, Maria-Pilar; Polo-Tomas, Monica; Bessa, Xavier; Ferrer-Armengou, Olga; Grau, Jaume; Serradesanferm, Anna; Ono, Akiko; Cruzado, Jose; Perez-Riquelme, Francisco; Alonso-Abreu, Inmaculada; de la Vega-Prieto, Mariola; Maria Reyes-Melian, Juana; Cacho, Guillermo; Diaz-Tasende, Jose; Herreros-de-Tejada, Alberto; Poves, Carmen; Santander, Cecilio; Gonzalez-Navarro, Andres		COLONPREV Study Investigators	Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OCCULT BLOOD-TESTS; SURVEILLANCE; PREVENTION; QUALITY; RISK	BACKGROUND Colonoscopy and fecal immunochemical testing (FIT) are accepted strategies for colorectal-cancer screening in the average-risk population. METHODS In this randomized, controlled trial involving asymptomatic adults 50 to 69 years of age, we compared one-time colonoscopy in 26,703 subjects with FIT every 2 years in 26,599 subjects. The primary outcome was the rate of death from colorectal cancer at 10 years. This interim report describes rates of participation, diagnostic findings, and occurrence of major complications at completion of the baseline screening. Study outcomes were analyzed in both intention-to-screen and as-screened populations. RESULTS The rate of participation was higher in the FIT group than in the colonoscopy group (34.2% vs. 24.6%, P<0.001). Colorectal cancer was found in 30 subjects (0.1%) in the colonoscopy group and 33 subjects (0.1%) in the FIT group (odds ratio, 0.99; 95% confidence interval [CI], 0.61 to 1.64; P = 0.99). Advanced adenomas were detected in 514 subjects (1.9%) in the colonoscopy group and 231 subjects (0.9%) in the FIT group (odds ratio, 2.30; 95% CI, 1.97 to 2.69; P<0.001), and nonadvanced adenomas were detected in 1109 subjects (4.2%) in the colonoscopy group and 119 subjects (0.4%) in the FIT group (odds ratio, 9.80; 95% CI, 8.10 to 11.85; P<0.001). CONCLUSIONS Subjects in the FIT group were more likely to participate in screening than were those in the colonoscopy group. On the baseline screening examination, the numbers of subjects in whom colorectal cancer was detected were similar in the two study groups, but more adenomas were identified in the colonoscopy group. (Funded by Instituto de Salud Carlos III and others; ClinicalTrials.gov number, NCT00906997.)	[Castells, Antoni] Hosp Clin Barcelona, Dept Gastroenterol, CIBERehd, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; [Quintero, Enrique; Alonso-Abreu, Inmaculada] Hosp Univ Canarias, Dept Gastroenterol, Tenerife 38320, Spain; [Andreu, Montserrat; Bessa, Xavier; Ferrer-Armengou, Olga] Pompeu Fabra Univ, IMIM, Dept Gastroenterol, Barcelona, Spain; [Cubiella, Joaquin; Serradesanferm, Anna] Hosp Clin Barcelona, Unitat Avaluacio Suport & Prevent, E-08036 Barcelona, Spain; [Hernandez, Cristina] IMIM, Dept Epidemiol & Evaluat, Barcelona, Spain; [Bujanda, Luis] Univ Basque Country, CIBERehd, Donostia Hosp, Dept Gastroenterol, San Sebastian, Spain; [Montalvo, Isabel] Obra Social Kutxa, Inst Oncol, Dept Gastroenterol, San Sebastian, Spain; [Arenas, Juan] CIBERehd, Policlin Gipuzkoa, Dept Gastroenterol, San Sebastian, Spain; [Cubiella, Joaquin; Arenas, Juan] Complexo Hosp Univ Ourense, Dept Gastroenterol, Orense, Spain; [Salas, Dolores; Sala, Teresa; Andres, Mercedes; Teruel, Gloria] Conselleria Sanitat, Direcc Gen Salud Publ, Colorectal Canc Screening Program, Valencia, Spain; [Ponce, Marta] Hosp Univ La Fe, Dept Gastroenterol, Valencia, Spain; [Lanas, Angel; Roncales, Maria-Pilar; Polo-Tomas, Monica] Univ Zaragoza, Dept Gastroenterol, IIS Aragon, CIBERehd, Zaragoza, Spain; [Carballo, Fernando; Ono, Akiko] Hosp Univ Virgen de la Arrixaca, Unidad Gest Clin Digest, Murcia, Spain; [Cubiella, Joaquin] Serv Murciano Salud, Colorectal Canc Prevent Program Reg Murcia, Murcia, Spain; [Perez-Riquelme, Francisco] Consejeria Sanidad & Polit Social, Colorectal Canc Prevent Program Reg Murcia, Direcc Gen Salud Publ, Murcia, Spain; [Diego Morillas, Juan; Poves, Carmen] Hosp Clin San Carlos, Dept Gastroenterol, Madrid, Spain; [Cacho, Guillermo] Hosp Fdn Alcorcon, Dept Gastroenterol, Madrid, Spain; [Diaz-Tasende, Jose] Hosp 12 Octubre, Dept Gastroenterol, E-28041 Madrid, Spain; Hosp Princesa, Inst Invest Sanitaria Princesa, Dept Gastroenterol, Madrid, Spain; [Santander, Cecilio] CIBERehd, Madrid, Spain; [Gonzalez-Navarro, Andres] Consejeria Sanidad, Reg Off Oncol Coordinat, Madrid, Spain; [Jover, Rodrigo] Hosp Gen Univ Alicante, Gastroenterol Unit, Alicante, Spain; [Laredo, Eva] Osakidetza Basque Hlth Serv, Dept Gastroenterol, Lasarte Oria Hlth Ctr, Guipuzcoa, Spain; [Hernandez, Vicent; Iglesias, Felipe] Complexo Hosp Univ Vigo, Dept Gastroenterol, Vigo, Spain; [Zubizarreta, Raquel] Conselleria Sanidade, Direcc Xeral Innovac & Xest Saude Publ, Xunta De Galicia, Spain; [Peris, Antonio] Consorcio Hosp Castellon, Dept Gastroenterol, Castellon de La Plana, Spain; [Herreros-de-Tejada, Alberto] Hosp Puerta de Hierro, Dept Gastroenterol, Majadahonda, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad de la Laguna; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; University of Barcelona; Hospital Clinic de Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University Hospital Donostia; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Zaragoza; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico San Carlos; Alcorcon Foundation University Hospital; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; General University Hospital of Alicante; Complexo Hospitalario Universitario de Vigo; Hospital Puerta de Hierro-Majadahonda	Castells, A (corresponding author), Hosp Clin Barcelona, Dept Gastroenterol, CIBERehd, Inst Invest Biomed August Pi & Sunyer, Villarroel 170, E-08036 Barcelona, Spain.	equinter@gmail.com; castells@clinic.ub.es	BALAGUER, FRANCESC/G-2389-2016; Serra, Maria Sala/O-9420-2019; Moreira, Leticia/AAN-9863-2021; Bujanda, Luis/AAB-2485-2021; Jover, Rodrigo/ABC-3258-2021; SalasTrejo, Dolores/S-1139-2017; Macià, Francesc/N-2776-2017; Castells, Antoni/ABC-1002-2021; Enriquez-Navascues, Jose M/AAG-8632-2020; Gisbert, Javier P/ABB-7531-2021; HERNANDEZ, VICENT/K-2415-2019; Andreu, Montserrat/D-9911-2015; Quintero, Enrique/C-3841-2017; CUBIELLA, JOAQUIN/G-7692-2017; Grau, Jaume/K-9869-2019; Marin, Alicia C./H-3672-2014; Grau, Jaume/E-3570-2019; Carballo, Fernando/M-4668-2016	Serra, Maria Sala/0000-0002-9955-8746; Moreira, Leticia/0000-0002-4518-8591; Bujanda, Luis/0000-0002-4353-9968; Jover, Rodrigo/0000-0003-3742-3413; Macià, Francesc/0000-0002-6090-5894; Castells, Antoni/0000-0001-8431-2033; Enriquez-Navascues, Jose M/0000-0002-6486-1489; Gisbert, Javier P/0000-0003-2090-3445; HERNANDEZ, VICENT/0000-0003-1607-0831; Andreu, Montserrat/0000-0003-4286-1098; Quintero, Enrique/0000-0002-7244-8125; CUBIELLA, JOAQUIN/0000-0002-9994-4831; Marin, Alicia C./0000-0003-1008-1812; Grau, Jaume/0000-0002-6811-2215; Cacho Acosta, Guillermo/0000-0002-3065-5505; Diaz-Tasende, Jose/0000-0002-3274-7294; Santander Vaquero, Cecilio/0000-0001-5492-2535; Carballo, Fernando/0000-0003-1152-1517; Hernandez-Guerra, Manuel/0000-0002-3478-9981; Salces, Inmaculada/0000-0002-9318-6419; Portillo, Isabel/0000-0002-3871-3423; Gonzalez-Haba Ruiz, Mariano/0000-0001-8025-1704; ALTZIBAR, JONE MIREN/0000-0001-7037-7944; Bessa Caserras, Xavier/0000-0003-4680-1228; Vega, Pablo/0000-0001-7545-6297; Fernandez Rodriguez, Conrado M/0000-0002-1915-2157; Lopez-Ceron, Maria/0000-0002-7968-9204	Asociacion Espanola contra el Cancer (Fundacion Cientifica and Junta de Barcelona); Instituto de Salud Carlos III [PI08/90717]; FEDER; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009SGR849]; Obra Social de Kutxa, Diputacion Foral de Gipuzkoa [DFG 07/5]; Departamento de Sanidad del Gobierno Vasco, EITB-Maratoia [BIO 07/CA/19]; Accion Transversal contra el Cancer del CIBERehd [2008]; Direccion Xeral de Innovacion e Xestion da Saude Publica, Conselleria de Sanidade; Xunta de Galicia	Asociacion Espanola contra el Cancer (Fundacion Cientifica and Junta de Barcelona); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER(European Commission); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Obra Social de Kutxa, Diputacion Foral de Gipuzkoa; Departamento de Sanidad del Gobierno Vasco, EITB-Maratoia; Accion Transversal contra el Cancer del CIBERehd; Direccion Xeral de Innovacion e Xestion da Saude Publica, Conselleria de Sanidade; Xunta de Galicia(Xunta de GaliciaEuropean Commission)	Supported by grants from Asociacion Espanola contra el Cancer (Fundacion Cientifica and Junta de Barcelona), Instituto de Salud Carlos III (PI08/90717), FEDER funds, and Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009SGR849). Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by Instituto de Salud Carlos III. In the Basque Country, the study received additional grants from Obra Social de Kutxa, Diputacion Foral de Gipuzkoa (DFG 07/5), Departamento de Sanidad del Gobierno Vasco, EITB-Maratoia (BIO 07/CA/19), and Accion Transversal contra el Cancer del CIBERehd (2008). In Galicia, this work was supported by Direccion Xeral de Innovacion e Xestion da Saude Publica, Conselleria de Sanidade, and Xunta de Galicia. Eiken Chemical of Japan and its Spanish representatives, Palex Medical and Biogen Diagnostica, donated supplies and automated analyzers used for FIT.	Garcia MA, 2009, GASTROENT HEPAT-BARC, V32, P137, DOI 10.1016/j.gastrohep.2008.12.001; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Asociacion Espanola de Gastroenterologia y Sociedad Espanola de Endoscopia Digestiva, 2011, GUIA PRACT CLIN CAL; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, GASTROENTEROLOGY, V138, P870, DOI 10.1053/j.gastro.2009.10.054; Castells A, 2009, GASTROENTEROLOGY, V137, P404, DOI 10.1053/j.gastro.2009.06.015; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Dancourt V, 2008, EUR J CANCER, V44, P2254, DOI 10.1016/j.ejca.2008.06.041; European Commission, 2011, EUR GUID QUAL ASS CO; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Haug U, 2011, BRIT J CANCER, V104, P1779, DOI 10.1038/bjc.2011.160; Heitman SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000370; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Hol L, 2009, BRIT J CANCER, V100, P1103, DOI 10.1038/sj.bjc.6604961; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Imperiale TF, 2009, NEW ENGL J MED, V361, P2004; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Levi Z, 2011, INT J CANCER, V128, P2415, DOI 10.1002/ijc.25574; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman D, 2006, NEW ENGL J MED, V355, P2588, DOI 10.1056/NEJMe068254; Lieberman D, 2009, CURR OPIN GASTROEN, V25, P422, DOI 10.1097/MOG.0b013e32832d1e2a; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Parra-Blanco A, 2006, WORLD J GASTROENTERO, V12, P6161, DOI 10.3748/wjg.v12.i38.6161; Parra-Blanco A, 2010, J GASTROENTEROL, V45, P703, DOI 10.1007/s00535-010-0214-8; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Scholefield JH, 2002, J MED SCREEN, V9, P54, DOI 10.1136/jms.9.2.54; Segnan N, 2007, GASTROENTEROLOGY, V132, P2304, DOI 10.1053/j.gastro.2007.03.030; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Vilkin A, 2005, AM J GASTROENTEROL, V100, P2519, DOI 10.1111/j.1572-0241.2005.00231.x; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	38	583	602	4	105	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					697	706		10.1056/NEJMoa1108895	http://dx.doi.org/10.1056/NEJMoa1108895			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	27168447	Green Published			2022-12-28	WOS:000300551500007
J	Wu, D; Hu, Q; Yan, Z; Chen, W; Yan, CY; Huang, X; Zhang, J; Yang, PY; Deng, HT; Wang, JW; Deng, XW; Shi, YG				Wu, Di; Hu, Qi; Yan, Zhen; Chen, Wen; Yan, Chuangye; Huang, Xi; Zhang, Jing; Yang, Panyu; Deng, Haiteng; Wang, Jiawei; Deng, XingWang; Shi, Yigong			Structural basis of ultraviolet-B perception by UVR8	NATURE			English	Article							CATION-PI INTERACTIONS; PLANT PHOTORECEPTOR DOMAIN; BLUE; CRYPTOCHROMES; PHYTOCHROME; REGULATOR; SOFTWARE; REVEALS	The Arabidopsis thaliana protein UVR8 is a photoreceptor for ultraviolet-B. Upon ultraviolet-B irradiation, UVR8 undergoes an immediate switch from homodimer to monomer, which triggers a signalling pathway for ultraviolet protection. The mechanism by which UVR8 senses ultraviolet-B remains largely unknown. Here we report the crystal structure of UVR8 at 1.8 angstrom resolution, revealing a symmetric homodimer of seven-bladed beta-propeller that is devoid of any external cofactor as the chromophore. Arginine residues that stabilize the homodimeric interface, principally Arg 286 and Arg 338, make elaborate intramolecular cation-pi interactions with surrounding tryptophan amino acids. Two of these tryptophans, Trp 285 and Trp 233, collectively serve as the ultraviolet-B chromophore. Our structural and biochemical analyses identify the molecular mechanism for UVR8-mediated ultraviolet-B perception, in which ultraviolet-B radiation results in destabilization of the intramolecular cation-pi interactions, causing disruption of the critical intermolecular hydrogen bonds mediated by Arg 286 and Arg 338 and subsequent dissociation of the UVR8 homodimer.	[Wu, Di; Hu, Qi; Yan, Zhen; Zhang, Jing; Deng, Haiteng; Shi, Yigong] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Wu, Di; Hu, Qi; Yan, Zhen; Yan, Chuangye; Zhang, Jing; Deng, Haiteng; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Chen, Wen; Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Tsinghua University; Tsinghua University; Peking University; Tsinghua University; Peking University	Shi, YG (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Deng, Xing Wang/ABF-4107-2020; Yan, Chuangye/AAJ-5832-2021	Wang, Jiawei/0000-0001-9893-8539; Shi, Yigong/0000-0003-2030-168X; Yan, Zhen/0000-0002-1999-8451; Jan, Yuh Nung/0000-0003-1367-6299; Yan, Chuangye/0000-0001-9338-8048; Jan, Lily/0000-0003-3938-8498; Deng, Haiteng/0000-0001-9496-1280; Yan, Zhiqiang/0000-0003-4714-2076; He, Ye/0000-0002-3936-4958	Ministry of Science and Technology [2009CB918801, 2012CB910900]; National Natural Science Foundation; Beijing Municipal Commission of Education; Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. He and S. Huang at SSRF, and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU, for assistance. This work was supported by funds from the Ministry of Science and Technology (grant no. 2009CB918801 to Y.S., and 2012CB910900 to X.W.D.), the National Natural Science Foundation, and the Beijing Municipal Commissions of Education and Science and Technology.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; DeLano W.L, PYMOL MOL GRAPHICS S; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sinnokrot MO, 2002, J AM CHEM SOC, V124, P10887, DOI 10.1021/ja025896h; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van der Linden AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000503; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; YU HT, 1992, J AM CHEM SOC, V114, P8449, DOI 10.1021/ja00048a015	40	321	369	10	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					214	U96		10.1038/nature10931	http://dx.doi.org/10.1038/nature10931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22388820				2022-12-28	WOS:000303149900029
J	Hayden, EC				Hayden, Erika Check			Sequencing set to alter clinical landscape	NATURE			English	News Item																			0	18	20	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					288	288						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22329008	Bronze			2022-12-28	WOS:000300287100010
J	Hanson, MA; Roth, CB; Jo, EJ; Griffith, MT; Scott, FL; Reinhart, G; Desale, H; Clemons, B; Cahalan, SM; Schuerer, SC; Sanna, MG; Han, GW; Kuhn, P; Rosen, H; Stevens, RC				Hanson, Michael A.; Roth, Christopher B.; Jo, Euijung; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan; Cahalan, Stuart M.; Schuerer, Stephan C.; Sanna, M. Germana; Han, Gye Won; Kuhn, Peter; Rosen, Hugh; Stevens, Raymond C.			Crystal Structure of a Lipid G Protein-Coupled Receptor	SCIENCE			English	Article							LIGAND-BINDING POCKET; S1P(1); IDENTIFICATION; AGONIST; GPCR; RHODOPSIN; DISCOVERY; EDG1	The lyso-phospholipid sphingosine 1-phosphate modulates lymphocyte trafficking, endothelial development and integrity, heart rate, and vascular tone and maturation by activating G protein-coupled sphingosine 1-phosphate receptors. Here, we present the crystal structure of the sphingosine 1-phosphate receptor 1 fused to T4-lysozyme (S1P(1)-T4L) in complex with an antagonist sphingolipid mimic. Extracellular access to the binding pocket is occluded by the amino terminus and extracellular loops of the receptor. Access is gained by ligands entering laterally between helices I and VII within the transmembrane region of the receptor. This structure, along with mutagenesis, agonist structure-activity relationship data, and modeling, provides a detailed view of the molecular recognition and requirement for hydrophobic volume that activates S1P(1), resulting in the modulation of immune and stromal cell responses.	[Hanson, Michael A.; Roth, Christopher B.; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan] Receptos, San Diego, CA 92121 USA; [Jo, Euijung; Cahalan, Stuart M.; Sanna, M. Germana; Rosen, Hugh] Scripps Res Inst, Dept Biol Chem, La Jolla, CA 92037 USA; [Schuerer, Stephan C.; Han, Gye Won; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kuhn, Peter] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Rosen, Hugh] Scripps Res Inst, Mol Screening Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Hanson, MA (corresponding author), Receptos, 10835 Rd Cure,Suite 205, San Diego, CA 92121 USA.	mhanson@receptos.com; hrosen@scripps.edu; stevens@scripps.edu	Noojipady, Praveen/B-2511-2010; Tyukavina, Alexandra/AGW-0785-2022; potapov, peter/AAE-7388-2019; Goetz, Scott J/A-3393-2015; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLT-1531-2022; Loveland, Thomas/AAW-3332-2020; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022; Hansen, Matthew C/ABE-7226-2020	Goetz, Scott J/0000-0002-6326-4308; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Tyukavina, Alexandra/0000-0003-3872-9844; Jo, Euijung/0000-0003-1131-2723; Potapov, Peter/0000-0003-3977-0021	Protein Structure Initiative (PSI) [U54 GM094618]; NIH [P50 GM073197]; NIH Roadmap Molecular Libraries Probe Production Centers [U54 MH084512];  [AI074564];  [AI055509]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074564, R01AI055509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	Protein Structure Initiative (PSI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap Molecular Libraries Probe Production Centers; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the Protein Structure Initiative (PSI): Biology grant U54 GM094618 for structure production, NIH Roadmap grant P50 GM073197 for technology development, NIH Roadmap Molecular Libraries Probe Production Centers grant U54 MH084512 for antagonist and class II agonist identification, and AI074564 and AI055509 to H. R. and M. B. Oldstone for studying the role of S1P in infection and immunity. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences (NIGMS) or the NIH. We thank E. Chien for preliminary analysis; M. Mileni for critical evaluation of the structure; V. Cherezov, V. Katritch, and I. Wilson for careful review of the manuscript; J. Johnson, A. Leslie, W. Kabsch, and A. Perrakis for discussion and review of the experimental microdiffraction data assembly processing method; and A. Walker for assistance with manuscript preparation. We acknowledge J. Smith, R. Fischetti, and N. Sanishvili at the GM/CA-CAT beamline at the Advanced Photon Source, for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3V2W and 3V3Y. R. C. S. is a founder and on the Board of Directors, and H. R. is a founder and on the Scientific Advisory Board, of Receptos, a GPCR structure-based drug discovery company with an S1P<INF>1</INF> clinical compound. H. R. is an inventor on a patent application by The Scripps Research Institute (TSRI) on CYM-5442 and related S1P receptor modulators (US2010/0010001). Materials will be made available under a Material Transfer Agreement with TSRI.	[Anonymous], 2011, GLID VERS 5 7; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Fujiwara Y, 2007, J BIOL CHEM, V282, P2374, DOI 10.1074/jbc.M609648200; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schrodinger LLC, 2011, PRIM VERS 3 0; Schurer SC, 2008, ACS CHEM BIOL, V3, P486, DOI 10.1021/cb800051m; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Suite S., 2011, 2011 IND FIT DOCK PR; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	35	6084	6344	172	613	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					851	855		10.1126/science.1215904	http://dx.doi.org/10.1126/science.1215904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344443	Green Accepted			2022-12-28	WOS:000300356400043
